PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gale, EAM; Alberti, G; Zimmet, PZ				Gale, Edwin A. M.; Alberti, George; Zimmet, P. Z.			Should we dump the metabolic syndrome?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gale, Edwin A. M.] Univ Bristol, Southmead Hosp, Med Sch Unit, Bristol BS10 5NB, Avon, England; [Alberti, George] St Marys Hosp, Dept Endocrinol & Metab, London, England; [Alberti, George] Univ London Imperial Coll Sci Technol & Med, London, England; [Zimmet, P. Z.] Int Diabet Inst, Melbourne, Vic, Australia	Southmead Hospital; University of Bristol; Imperial College London; Imperial College London	Gale, EAM (corresponding author), Univ Bristol, Southmead Hosp, Med Sch Unit, Bristol BS10 5NB, Avon, England.	Edwin.Gale@bristol.ac.uk; george.alberti@ncl.ac.uk	Zimmet, Paul/O-8486-2019	Zimmet, Paul/0000-0003-0627-0776					0	55	59	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 22	2008	336	7645					640	641		10.1136/bmj.39477.500197.AD	http://dx.doi.org/10.1136/bmj.39477.500197.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RH	18356231	Green Published			2022-12-28	WOS:000254443400022
J	Sunshine, JM; Connolly, HC; Mccoy, TJ; Bus, SJ; La Croix, LM				Sunshine, J. M.; Connolly, H. C., Jr.; McCoy, T. J.; Bus, S. J.; La Croix, L. M.			Ancient asteroids enriched in refractory inclusions	SCIENCE			English	Article							SPECTROSCOPIC SURVEY; RICH INCLUSIONS; SOLAR-SYSTEM; PHASE-II; BELT; CHONDRITES; METEORITES; SAMPLES; AL-26	Calcium- and aluminum- rich inclusions ( CAIs) occur in all classes of chondritic meteorites and contain refractory minerals predicted to be the first condensates from the solar nebula. Near- infrared spectra of CAIs have strong 2- micrometer absorptions, attributed to iron oxide- bearing aluminous spinel. Similar absorptions are present in the telescopic spectra of several asteroids; modeling indicates that these contain similar to 30 +/- CAIs ( two to three times that of any meteorite). Survival of these undifferentiated, large ( 50- to 100- kilometer diameter) CAI- rich bodies suggests that they may have formed before the injection of radiogenic Al-26 into the solar system. They have also experienced only modest post- accretionary alteration. Thus, these asteroids have higher concentrations of CAI material, appear less altered, and are more ancient than any known sample in our meteorite collection, making them prime candidates for sample return.	[Sunshine, J. M.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Connolly, H. C., Jr.] CUNY, Dept Phys Sci, Kingsborough Community Coll, Brooklyn, NY 11235 USA; [Connolly, H. C., Jr.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Connolly, H. C., Jr.] Amer Museum Nat Hist, Dept Earth & Planetary Sci, New York, NY 11024 USA; [McCoy, T. J.; La Croix, L. M.] Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA; [Bus, S. J.] Univ Hawaii, Inst Astron, Hilo, HI 96720 USA; [La Croix, L. M.] Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA	University System of Maryland; University of Maryland College Park; City University of New York (CUNY) System; University of Arizona; American Museum of Natural History (AMNH); Smithsonian Institution; Smithsonian National Museum of Natural History; University of Hawaii System; University Hawaii Hilo; Nevada System of Higher Education (NSHE); University of Nevada Reno	Sunshine, JM (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	jess@astro.umd.edu	Lacroix, Lise-Marie/M-5219-2016	Lacroix, Lise-Marie/0000-0003-3351-7949; Sunshine, Jessica/0000-0002-9413-8785; McCoy, Timothy/0000-0002-4573-3553				Adams J.B., 1975, INFRARED RAMAN SPECT, P91; ALLEGRE CJ, 1995, GEOCHIM COSMOCHIM AC, V59, P1445, DOI 10.1016/0016-7037(95)00054-4; Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; BELTON MJS, 1994, SCIENCE, V265, P1543, DOI 10.1126/science.265.5178.1543; Brearley A.J., 1998, REV MINERALOGY, V36; BURBINE TH, 1992, METEORITICS, V27, P424, DOI 10.1111/j.1945-5100.1992.tb00224.x; Bus SJ, 2002, ICARUS, V158, P146, DOI 10.1006/icar.2002.6856; Bus SJ, 2002, ICARUS, V158, P106, DOI 10.1006/icar.2002.6857; BUS SJ, 1999, THESIS MIT; CLARK BE, 1995, J GEOPHYS RES-PLANET, V100, P14443, DOI 10.1029/95JE00720; Clark BE, 2002, ASTEROIDS, P585, DOI DOI 10.1016/0273-1177(91)90551-T; Cloutis EA, 2004, METEORIT PLANET SCI, V39, P545, DOI 10.1111/j.1945-5100.2004.tb00918.x; CLOUTIS EA, 1993, ICARUS, V105, P568, DOI 10.1006/icar.1993.1150; Connolly Jr H. C., 2006, MESS 2, P383; DAS A, 2007, LUNAR PLANET SCI, V38, P1338; GROSSMAN L, 1975, GEOCHIM COSMOCHIM AC, V39, P433, DOI 10.1016/0016-7037(75)90099-X; Hapke B, 2001, J GEOPHYS RES-PLANET, V106, P10039, DOI 10.1029/2000JE001338; Hapke B., 1993, THEORY REFLECTANCE E; JAROSEWICH E, 1990, METEORITICS, V25, P323, DOI 10.1111/j.1945-5100.1990.tb00717.x; JUREWICZ AJG, 1993, GEOCHIM COSMOCHIM AC, V57, P2123, DOI 10.1016/0016-7037(93)90098-H; MacPherson G.J., 1988, METEORITES EARLY SOL, P746; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; MUSTARD JF, 1987, J GEOPHYS RES-SOLID, V92, pE617, DOI 10.1029/JB092iB04p0E617; Pieters C. M., 2004, LPI, V1720; Rayner JT, 2004, P SOC PHOTO-OPT INS, V5492, P1498, DOI 10.1117/12.551107; Rivkin A. S., 1998, B AM ASTRON SOC, V30, P1023; Sahijpal S, 1998, ASTROPHYS J, V509, pL137, DOI 10.1086/311778; SUNSHINE JM, 1999, LUNAR PALNET SCI, V31, P1640; Veverka J, 2000, SCIENCE, V289, P2088, DOI 10.1126/science.289.5487.2088; XU S, 1995, ICARUS, V115, P1, DOI 10.1006/icar.1995.1075; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164; ZAPPALA V, 1995, ICARUS, V116, P291, DOI 10.1006/icar.1995.1127; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	34	56	56	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					514	517		10.1126/science.1154340	http://dx.doi.org/10.1126/science.1154340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18356491				2022-12-28	WOS:000255249300046
J	Moet, FJ; Pahan, D; Oskam, L; Richardus, JH				Moet, F. Johannes; Pahan, David; Oskam, Linda; Richardus, Jan H.		COLEP Study Grp	Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOUTHERN MARQUESAS; RISK-FACTORS; 25 MG; CHEMOPROPHYLAXIS; SEROLOGY	Objective To determine the effectiveness of chemoprophylaxis using a single dose of rifampicin to prevent leprosy in close contacts. Design Single centre, double blind, cluster randomised, placebo controlled trial. Setting Leprosy control programme in two districts of northwest Bangladesh with a population of more than four million. Participants 28 092 close contacts of 1037 patients with newly diagnosed leprosy. 21711 contacts fulfilled the study requirements. Interventions A single dose of rifampicin or placebo given to close contacts in the second month of starting the index patient's treatment, with follow-up for four years. Main outcome measure Development of clinical leprosy. Results 18 869 of the 21711 contacts (86.9%) were followed-up at four years. Ninety one of 9452 contacts in the placebo group and 59 of 9417 in the rifampicin group had developed leprosy. The overall reduction in incidence of leprosy using a single dose of rifampicin in the first two years was 57% (95% confidence interval 33% to 72%). The groups did not differ between two and four years. The overall number needed to treat (NNT) to prevent a single case of leprosy among contacts was 297 (95% confidence interval 176 to 537). Differences were found between subgroups at two years, both in reduction of incidence and in NNT. Conclusion A single dose of rifampicin given to contacts of patients with newly diagnosed leprosy is effective at preventing the development of clinical leprosy at two years. The effect was maintained, but no difference was seen between the placebo and rifampicin groups beyond two years. Trial registration Current Controlled Trials ISRCTN61223447.	[Moet, F. Johannes; Richardus, Jan H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Pahan, David] Leprosy Mission Bangladesh, Rural Hlth Program, Nilphamari, Bangladesh; [Oskam, Linda] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Richardus, JH (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.richardus@erasmusmc.nl	Richardus, Jan Hendrik/AAE-1278-2021	Richardus, Jan Hendrik/0000-0003-0564-6313; Klatser, Paul/0000-0003-2127-9138				Bakker MI, 2005, AM J TROP MED HYG, V72, P443, DOI 10.4269/ajtmh.2005.72.443; Buhrer-Sekula S, 2000, INT J LEPROSY, V68, P456; CARTEL JL, 1989, INT J LEPROSY, V57, P810; CARTEL JL, 1992, INT J LEPROSY, V60, P416; CHANTEAU S, 1993, INT J LEPROSY, V61, P533; DOUGLAS JT, 1987, INT J LEPROSY, V55, P718; DOULL JA, 1942, INT J LEPROSY, V10, P107; Fine PEM, 1997, AM J EPIDEMIOL, V146, P91, DOI 10.1093/oxfordjournals.aje.a009195; Moet FJ, 2006, J INFECT DIS, V193, P346, DOI 10.1086/499278; Moet FJ, 2004, LEPROSY REV, V75, P376; Noordeen S K, 1976, Lepr India, V48, P635; Noordeen S K, 1977, Lepr India, V49, P504; Noordeen SK, 1969, LEPR INDIA, V41, P247; Oskam L, 2003, LEPROSY REV, V74, P196; Ranade M G, 1995, Indian J Lepr, V67, P411; Smith CM, 2000, J INFECTION, V41, P137, DOI 10.1053/jinf.2000.0698; ULRICH M, 1991, INT J LEPROSY, V59, P405; WARDEKAR R. V., 1967, Leprosy in India, V39, P155	18	143	147	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2008	336	7647					761	764A		10.1136/bmj.39500.885752.BE	http://dx.doi.org/10.1136/bmj.39500.885752.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284JW	18332051	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000254703700033
J	Goldberg, AV; Molik, S; Tsaousis, AD; Neumann, K; Kuhnke, G; Delbac, F; Vivares, CP; Hirt, RP; Lill, R; Embley, TM				Goldberg, Alina V.; Molik, Sabine; Tsaousis, Anastasios D.; Neumann, Karina; Kuhnke, Grit; Delbac, Frederic; Vivares, Christian P.; Hirt, Robert P.; Lill, Roland; Embley, T. Martin			Localization and functionality of microsporidian iron-sulphur cluster assembly proteins	NATURE			English	Article							GENOME SEQUENCE; ENCEPHALITOZOON-CUNICULI; TRICHOMONAS-VAGINALIS; MITOCHONDRIAL REMNANT; ENTAMOEBA-HISTOLYTICA; SCAFFOLD PROTEINS; FE/S PROTEINS; BIOGENESIS; MATURATION; ISU1P	Microsporidia are highly specialized obligate intracellular parasites of other eukaryotes ( including humans(1)) that show extreme reduction at the molecular, cellular and biochemical level(2,3). Although microsporidia have long been considered as early branching eukaryotes that lack mitochondria(4), they have recently been shown to contain a tiny mitochondrial remnant called a mitosome(2,5). The function of the mitosome is unknown, because microsporidians lack the genes for canonical mitochondrial functions, such as aerobic respiration and haem biosynthesis. However, microsporidial genomes encode several components of the mitochondrial iron - sulphur ( Fe - S) cluster assembly machinery. Here we provide experimental insights into the metabolic function and localization of these proteins. We cloned, functionally characterized and localized homologues of several central mitochondrial Fe - S cluster assembly components for the microsporidians Encephalitozoon cuniculi and Trachipleistophora hominis. Several microsporidial proteins can functionally replace their yeast counterparts in Fe - S protein biogenesis. In E. cuniculi, the iron ( frataxin) and sulphur ( cysteine desulphurase, Nfs1) donors and the scaffold protein ( Isu1) co- localize with mitochondrial Hsp70 to the mitosome, consistent with it being the functional site for Fe - S cluster biosynthesis. In T. hominis, mitochondrial Hsp70 and the essential sulphur donor ( Nfs1) are still in the mitosome, but surprisingly the main pools of Isu1 and frataxin are cytosolic, creating a conundrum of how these key components of Fe - S cluster biosynthesis coordinate their function. Together, our studies identify the essential biosynthetic process of Fe - S protein assembly as a key function of microsporidian mitosomes.	[Goldberg, Alina V.; Hirt, Robert P.; Embley, T. Martin] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Molik, Sabine; Neumann, Karina; Kuhnke, Grit; Lill, Roland] Univ Marburg, Inst Zytobiol & Zytopathol, D-35033 Marburg, Germany; [Tsaousis, Anastasios D.] Univ Newcastle, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Delbac, Frederic; Vivares, Christian P.] Univ Clermont Ferrand, LBP, CNRS, UMR 6023, F-63177 Aubiere, France	Newcastle University - UK; Philipps University Marburg; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Embley, TM (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Catherine Cookson Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Lill@staff.uni-marburg.de; Martin.Embley@ncl.ac.uk	Hirt, Robert/R-5429-2017	Hirt, Robert/0000-0002-3760-9958; Lill, Roland/0000-0002-8345-6518; Embley, Thomas Martin/0000-0002-1484-340X; Tsaousis, Anastasios/0000-0002-5424-1905				Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Ali V, 2004, J BIOL CHEM, V279, P16863, DOI 10.1074/jbc.M313314200; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Burri L, 2006, P NATL ACAD SCI USA, V103, P15916, DOI 10.1073/pnas.0604109103; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Dutkiewicz R, 2006, J BIOL CHEM, V281, P7801, DOI 10.1074/jbc.M513301200; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Emelyanov VV, 2003, FEMS MICROBIOL LETT, V226, P257, DOI 10.1016/S0378-1097(03)00598-6; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Molik S, 2007, METHOD CELL BIOL, V80, P261, DOI 10.1016/S0091-679X(06)80013-0; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; Taupin V, 2006, PARASITOL RES, V99, P708, DOI 10.1007/s00436-006-0231-y; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Vavra J, 2005, FOLIA PARASIT, V52, P193, DOI 10.14411/fp.2005.024; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949	30	162	182	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2008	452	7187					624	U7		10.1038/nature06606	http://dx.doi.org/10.1038/nature06606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18311129				2022-12-28	WOS:000254567200044
J	Carr, JS; Najita, JR				Carr, John S.; Najita, Joan R.			Organic molecules and water in the planet formation region of young circumstellar disks	SCIENCE			English	Article							T-TAURI STARS; EMISSION; GAS; SPECTROGRAPH; SPECTRA; H2O; IRS	The chemical composition of protoplanetary disks is expected to hold clues to the physical and chemical processes that influence the formation of planetary systems. However, characterizing the gas composition in the planet formation region of disks has been a challenge to date. We report here that the protoplanetary disk within 3 astronomical units of AA Tauri possesses a rich molecular emission spectrum in the mid- infrared, indicating a high abundance of simple organic molecules ( HCN, C2H2, and CO2), water vapor, and OH. These results suggest that water is abundant throughout the inner disk and that the disk supports an active organic chemistry.	[Carr, John S.] USN, Res Lab, Remote Sensing Div, Washington, DC 20375 USA; [Najita, Joan R.] Natl Opt Astron Observ, Tucson, AZ 85719 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; National Optical Astronomy Observatory	Carr, JS (corresponding author), USN, Res Lab, Remote Sensing Div, Code 7210, Washington, DC 20375 USA.							BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; Bockelee-Morvan D, 2004, SPACE SCI S, P391; Boonman AMS, 2003, ASTRON ASTROPHYS, V399, P1063, DOI 10.1051/0004-6361:20021868; Boonman AMS, 2003, ASTRON ASTROPHYS, V403, P1003, DOI 10.1051/0004-6361:20030364; Carr JS, 2004, ASTROPHYS J, V603, P213, DOI 10.1086/381356; CECCARELLI C, 2007, PROTOSTARS PLANETS, V5, P47; Ciesla F.J., 2006, METEORITES EARLY SOL, VII, P209; DUTREY A, 2007, PROTOSTARS PLANETS, V5, P495; Furlan E, 2006, ASTROPHYS J SUPPL S, V165, P568, DOI 10.1086/505468; Glassgold AE, 2004, ASTROPHYS J, V615, P972, DOI 10.1086/424509; Houck JR, 2004, ASTROPHYS J SUPPL S, V154, P18, DOI 10.1086/423134; Kessler-Silacci J, 2006, ASTROPHYS J, V639, P275, DOI 10.1086/499330; Lahuis F, 2000, ASTRON ASTROPHYS, V355, P699; Lahuis F, 2006, ASTROPHYS J, V636, pL145, DOI 10.1086/500084; Markwick AJ, 2002, ASTRON ASTROPHYS, V385, P632, DOI 10.1051/0004-6361:20020050; McLean IS, 2000, P SOC PHOTO-OPT INS, V4008, P1048, DOI 10.1117/12.395422; Najita J, 1996, ASTROPHYS J, V462, P919, DOI 10.1086/177205; Najita J, 2003, ASTROPHYS J, V589, P931, DOI 10.1086/374809; Nomura H, 2007, ASTROPHYS J, V661, P334, DOI 10.1086/513419; Reipurth B., 2007, PROTOSTARS PLANETS, VV, P507; STEVENSON DJ, 1988, ICARUS, V75, P146, DOI 10.1016/0019-1035(88)90133-9; Turner NJ, 2006, ASTROPHYS J, V639, P1218, DOI 10.1086/499486; Willacy K, 1998, ASTRON ASTROPHYS, V338, P995	26	239	239	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1504	1506		10.1126/science.1153807	http://dx.doi.org/10.1126/science.1153807			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339932				2022-12-28	WOS:000253943800031
J	Ross, SR; Lukas, KE; Lonsdorf, EV; Stoinski, TS; Hare, B; Shumaker, R; Goodall, J				Ross, S. R.; Lukas, K. E.; Lonsdorf, E. V.; Stoinski, T. S.; Hare, B.; Shumaker, R.; Goodall, J.			Science priorities - Inappropriate use and portrayal of chimpanzees	SCIENCE			English	Editorial Material									[Ross, S. R.; Lonsdorf, E. V.] Lincoln Pk Zoo, Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL 60614 USA; [Ross, S. R.] AZA, Chimpanzee Species Survival Plan SSP, Silver Spring, MD 20910 USA; [Lukas, K. E.] Cleveland Metropk Zoo, Cleveland, OH USA; [Lukas, K. E.] Case Western Reserve Univ, Cleveland, OH 44109 USA; [Lonsdorf, E. V.] Univ Chicago, Comm Evolut Biol, Chicago, IL 60637 USA; [Stoinski, T. S.] Zoo Atlanta, Atlanta, GA 30315 USA; [Stoinski, T. S.] AZA, Ape Taxon Advisory Grp TAG, Silver Spring, MD 20910 USA; [Hare, B.] Duke Univ, Durham, NC 27708 USA; [Shumaker, R.] Great Ape Trust Iowa, Des Moines, IA 50320 USA; [Shumaker, R.] Krasnow Inst Adv Study, Fairfax, VA 22030 USA; [Goodall, J.] Jane Goodall Inst, Arlington, VA 22203 USA	Case Western Reserve University; University of Chicago; Duke University	Ross, SR (corresponding author), Lincoln Pk Zoo, Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL 60614 USA.	sross@lpzoo.org						Tutin C., 2005, REGIONAL ACTION PLAN	1	35	35	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1487	1487		10.1126/science.1154490	http://dx.doi.org/10.1126/science.1154490			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339923				2022-12-28	WOS:000253943800022
J	Chung, CH; Mirakhur, B; Chan, E; Le, Q; Berlin, J; Morse, M; Murphy, BA; Satinover, SM; Hosen, J; Mauro, D; Slebos, RJ; Zhou, QW; Gold, D; Hatley, T; Hicklin, DJ; Platts-Mills, TAE				Chung, Christine H.; Mirakhur, Beloo; Chan, Emily; Le, Quynh-Thu; Berlin, Jordan; Morse, Michael; Murphy, Barbara A.; Satinover, Shama M.; Hosen, Jacob; Mauro, David; Slebos, Robbert J.; Zhou, Qinwei; Gold, Diane; Hatley, Tina; Hicklin, Daniel J.; Platts-Mills, Thomas A. E.			Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; INFUSION REACTIONS; COLORECTAL-CANCER; MONOCLONAL-ANTIBODIES; PREVALENCE; ALLERGENS; SWEDEN; IMMUNOTHERAPY; DEFINITION; EXPERIENCE	Background: Cetuximab, a chimeric mouse-human IgG1 monoclonal antibody against the epidermal growth factor receptor, is approved for use in colorectal cancer and squamous-cell carcinoma of the head and neck. A high prevalence of hypersensitivity reactions to cetuximab has been reported in some areas of the United States. Methods: We analyzed serum samples from four groups of subjects for IgE antibodies against cetuximab: pretreatment samples from 76 case subjects who had been treated with cetuximab at multiple centers, predominantly in Tennessee, Arkansas, and North Carolina; samples from 72 control subjects in Tennessee; samples from 49 control subjects with cancer in northern California; and samples from 341 female control subjects in Boston. Results: Among 76 cetuximab-treated subjects, 25 had a hypersensitivity reaction to the drug. IgE antibodies against cetuximab were found in pretreatment samples from 17 of these subjects; only 1 of 51 subjects who did not have a hypersensitivity reaction had such antibodies (P<0.001). IgE antibodies against cetuximab were found in 15 of 72 samples (20.8%) from control subjects in Tennessee, in 3 of 49 samples (6.1%) from northern California, and in 2 of 341 samples (0.6%) from Boston. The IgE antibodies were shown to be specific for an oligosaccharide, galactose-alpha-1,3-galactose, which is present on the Fab portion of the cetuximab heavy chain. Conclusions: In most subjects who had a hypersensitivity reaction to cetuximab, IgE antibodies against cetuximab were present in serum before therapy. The antibodies were specific for galactose-alpha-1,3-galactose.	[Satinover, Shama M.; Hosen, Jacob; Platts-Mills, Thomas A. E.] Univ Virginia, Sch Med, Asthma & Allerg Dis Ctr, Charlottesville, VA 22908 USA; [Zhou, Qinwei; Hicklin, Daniel J.] ImClone Syst, Branchburg, NJ USA; [Gold, Diane] Harvard Univ, Channing Lab, Boston, MA 02115 USA; [Hatley, Tina] Allergy & Asthma Clin NW Arkansas, Bentonville, AK USA; [Chung, Christine H.; Chan, Emily; Berlin, Jordan; Murphy, Barbara A.] Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med, Nashville, TN 37212 USA; [Chung, Christine H.; Slebos, Robbert J.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Slebos, Robbert J.] Vanderbilt Univ, Sch Med, Dept Otolaryngol, Nashville, TN 37212 USA; [Mirakhur, Beloo; Mauro, David] Bristol Myers Squibb Co, Plainsboro, NJ USA; [Le, Quynh-Thu] Stanford Univ, Sch Med, Menlo Pk, CA USA; [Morse, Michael] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	University of Virginia; Eli Lilly; Harvard University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Bristol-Myers Squibb; Stanford University; Duke University	Platts-Mills, TAE (corresponding author), Univ Virginia, Sch Med, Asthma & Allerg Dis Ctr, Box 801355, Charlottesville, VA 22908 USA.	tap2z@virginia.edu	Hosen, Jacob/F-9224-2013	Hosen, Jacob/0000-0003-2559-0687; Le, Quynh Thu/0000-0002-3682-1439; Platts-Mills, Thomas/0000-0002-1263-329X	NATIONAL CANCER INSTITUTE [R01CA118582, P50CA095103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035796, R29AI035796, R37AI020565, R01AI020565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017982] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adedoyin J, 2007, J ALLERGY CLIN IMMUN, V119, P640, DOI 10.1016/j.jaci.2006.11.637; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cavalier E, 2006, ANN BIOL CLIN-PARIS, V64, P91; CHAPMAN MD, 1988, J IMMUNOL, V140, P812; Cheifetz A, 2005, MT SINAI J MED, V72, P250; Cheifetz A, 2003, AM J GASTROENTEROL, V98, P1315, DOI 10.1016/S0002-9270(03)00231-4; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cook-Bruns N, 2001, ONCOLOGY-BASEL, V61, P58, DOI 10.1159/000055403; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P1029, DOI 10.1016/j.jaci.2004.12.1131; Florvaag E, 2005, ACTA ANAESTH SCAND, V49, P437, DOI 10.1111/j.1399-6576.2004.00591.x; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Johansson SGO, 2005, ALLERGY, V60, P1312, DOI 10.1111/j.1398-9995.2005.00896.x; *JOINT TASK FORC P, 2005, J ALLERGY CLIN IM S2, V0115, pS 483; Koike C, 2007, P NATL ACAD SCI USA, V104, P559, DOI 10.1073/pnas.0610012104; Lewis SA, 2002, AM J RESP CRIT CARE, V165, P961, DOI 10.1164/ajrccm.165.7.2103044; Milland J, 2006, TISSUE ANTIGENS, V68, P459, DOI 10.1111/j.1399-0039.2006.00721.x; Needle MN, 2002, SEMIN ONCOL, V29, P55, DOI 10.1053/sonc.2002.35648; O'Neil BH, 2007, J CLIN ONCOL, V25, P3644, DOI 10.1200/JCO.2007.11.7812; Paschinger K, 2005, ACTA BIOCHIM POL, V52, P629; Platts-Mills TAE, 2007, J ALLERGY CLIN IMMUN, V120, P1058, DOI 10.1016/j.jaci.2007.06.032; Qian J, 2007, ANAL BIOCHEM, V364, P8, DOI 10.1016/j.ab.2007.01.023; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Sampson HA, 2005, J ALLERGY CLIN IMMUN, V115, P584, DOI 10.1016/j.jaci.2005.01.009; vanderVeen MJ, 1997, J ALLERGY CLIN IMMUN, V100, P327, DOI 10.1016/S0091-6749(97)70245-8; [No title captured]	28	1006	1076	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1109	1117		10.1056/NEJMoa074943	http://dx.doi.org/10.1056/NEJMoa074943			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337601	Green Accepted, Bronze			2022-12-28	WOS:000253877200004
J	He, Y; Ye, T; Su, M; Zhang, C; Ribbe, AE; Jiang, W; Mao, CD				He, Yu; Ye, Tao; Su, Min; Zhang, Chuan; Ribbe, Alexander E.; Jiang, Wen; Mao, Chengde			Hierarchical self-assembly of DNA into symmetric supramolecular polyhedra	NATURE			English	Article							DESIGN; OCTAHEDRON; ARRAYS	DNA is renowned for its double helix structure and the base pairing that enables the recognition and highly selective binding of complementary DNA strands. These features, and the ability to create DNA strands with any desired sequence of bases, have led to the use of DNA rationally to design various nanostructures and even execute molecular computations(1-4). Of the wide range of self- assembled DNA nanostructures reported, most are one- or two- dimensional(5-9). Examples of three- dimensional DNA structures include cubes(10), truncated octahedra(11), octohedra(12) and tetrahedra(13,14), which are all comprised of many different DNA strands with unique sequences. When aiming for large structures, the need to synthesize large numbers ( hundreds) of unique DNA strands poses a challenging design problem(9,15). Here, we demonstrate a simple solution to this problem: the design of basic DNA building units in such a way that many copies of identical units assemble into larger three- dimensional structures. We test this hierarchical self- assembly concept with DNA molecules that form three- point- star motifs, or tiles. By controlling the flexibility and concentration of the tiles, the one- pot assembly yields tetrahedra, dodecahedra or buckyballs that are tens of nanometres in size and comprised of four, twenty or sixty individual tiles, respectively. We expect that our assembly strategy can be adapted to allow the fabrication of a range of relatively complex three- dimensional structures.	[He, Yu; Ye, Tao; Zhang, Chuan; Ribbe, Alexander E.; Mao, Chengde] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Su, Min; Jiang, Wen] Purdue Univ, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA; [Su, Min; Jiang, Wen] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Mao, CD (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	mao@purdue.edu	Mao, Chengde/GPP-1546-2022; Ribbe, Alexander/D-4988-2009; jiang, wen/GYI-9662-2022; He, Yu/A-6189-2011; Zhang, Chuan/B-4349-2014	Ribbe, Alexander/0000-0002-9924-3429; Zhang, Chuan/0000-0003-2981-0923; Jiang, Wen/0000-0002-1292-2411				ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Feldkamp U, 2006, ANGEW CHEM INT EDIT, V45, P1856, DOI 10.1002/anie.200502358; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; Goodman RP, 2004, CHEM COMMUN, P1372, DOI 10.1039/b402293a; He Y, 2006, CHEM COMMUN, P968, DOI 10.1039/b513962g; He Y, 2005, J AM CHEM SOC, V127, P12202, DOI 10.1021/ja0541938; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Scheffler M, 1999, ANGEW CHEM INT EDIT, V38, P3312; Seeman NC, 2005, Q REV BIOPHYS, V38, P363, DOI 10.1017/S0033583505004087; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006	20	964	1003	21	628	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					198	U41		10.1038/nature06597	http://dx.doi.org/10.1038/nature06597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337818				2022-12-28	WOS:000253925600036
J	Kim, YM; Brinkmann, MM; Paquet, ME; Ploegh, HL				Kim, You-Me; Brinkmann, Melanie M.; Paquet, Marie-Eve; Ploegh, Hidde L.			UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes	NATURE			English	Article							PLASMA-MEMBRANE; CPG-DNA; SUBCELLULAR-LOCALIZATION; EXOGENOUS ANTIGEN; MESSENGER-RNA; PROTEIN; PATHWAY; ER; RECOGNITION; DISTINCT	Signalling by means of toll- like receptors ( TLRs) is essential for the development of innate and adaptive immune responses(1-3). UNC93B1, essential for signalling of TLR3, TLR7 and TLR9 in both humans and mice, physically interacts with these TLRs in the endoplasmic reticulum ( ER)(4-6). Here we show that the function of the polytopic membrane protein UNC93B1 is to deliver the nucleotide- sensing receptors TLR7 and TLR9 from the ER to endolysosomes. In dendritic cells of 3d mice, which express an UNC93B1 missense mutant ( H412R) incapable of TLR binding, neither TLR7 nor TLR9 exits the ER. Furthermore, the trafficking and signalling defects of the nucleotide- sensing TLRs in 3d dendritic cells are corrected by expression of wild- type UNC93B1. However, UNC93B1 is dispensable for ligand recognition and signal initiation by TLRs. To our knowledge, UNC93B1 is the first protein to be identified as a molecule specifically involved in trafficking of nucleotide- sensing TLRs. By inhibiting the interaction between UNC93B1 and TLRs it should be possible to achieve specific regulation of the nucleotide- sensing TLRs without compromising signalling via the cell- surface- disposed TLRs.	[Kim, You-Me; Brinkmann, Melanie M.; Paquet, Marie-Eve; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Kim, YM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ykim@wi.mit.edu; ploegh@wi.mit.edu	Kim, You-Me/I-5553-2013	Kim, You-Me/0000-0001-8780-704X				Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Conley ME, 2007, TRENDS IMMUNOL, V28, P99, DOI 10.1016/j.it.2007.01.001; Franz A, 2007, FEBS LETT, V581, P401, DOI 10.1016/j.febslet.2006.12.048; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Juschke C, 2004, CURR BIOL, V14, P406, DOI 10.1016/j.cub.2004.02.034; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	24	501	516	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					234	U80		10.1038/nature06726	http://dx.doi.org/10.1038/nature06726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18305481				2022-12-28	WOS:000253925600044
J	Reich, MR; Takemi, K; Roberts, MJ; Hsiao, WC				Reich, Michael R.; Takemi, Keizo; Roberts, Marc J.; Hsiao, William C.			Global action on health systems: a proposal for the Toyako G8 summit	LANCET			English	Editorial Material									[Reich, Michael R.] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; [Roberts, Marc J.; Hsiao, William C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Takemi, Keizo] Tokai Univ, Res Inst Sci & Technol, Tokyo 151, Japan	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Tokai University	Reich, MR (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	michael_reich@harvard.edu		Reich, Michael R./0000-0003-3338-0612				*ACT GLOB HLTH, GLOB FUND BOARD BACK; Atim C., 2002, SURVEY MUTUAL HLTH O; Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; *COMM HUM SEC, 2003, HUM SEC PROT EMP PEO; Koumura M, 2007, LANCET, V370, P1983, DOI 10.1016/S0140-6736(07)61726-7; Murray CJL, 2007, LANCET, V370, P1018, DOI 10.1016/S0140-6736(07)61458-5; Roberts M, 2002, LANCET, V359, P1055, DOI 10.1016/S0140-6736(02)08097-2; Roberts MJ., 2004, GETTING HLTH REFORM; Wang H, 2005, HEALTH POLICY PLANN, V20, P366, DOI 10.1093/heapol/czi045; *WHO REG OFF AFR, 2007, REP INT WORKSH PRIM; *WHO SECR, 2007, GLOB FUNDS STRAT APP; *WHO SECR, EXP GAVI ALL HLTH SY; *WHO UNICEF, 1978, PRIM HLTH CAR REP IN	14	78	78	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 8	2008	371	9615					865	869		10.1016/S0140-6736(08)60384-0	http://dx.doi.org/10.1016/S0140-6736(08)60384-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	272NQ	18328932				2022-12-28	WOS:000253866500033
J	Jiang, L; Althoff, EA; Clemente, FR; Doyle, L; Rothlisberger, D; Zanghellini, A; Gallaher, JL; Betker, JL; Tanaka, F; Barbas, CF; Hilvert, D; Houk, KN; Stoddard, BL; Baker, D				Jiang, Lin; Althoff, Eric A.; Clemente, Fernando R.; Doyle, Lindsey; Rothlisberger, Daniela; Zanghellini, Alexandre; Gallaher, Jasmine L.; Betker, Jamie L.; Tanaka, Fujie; Barbas, Carlos F., III; Hilvert, Donald; Houk, Kendall N.; Stoddard, Barry L.; Baker, David			De novo computational design of retro-aldol enzymes	SCIENCE			English	Article							EVOLUTION; PROTEINS; ANTIBODIES; MECHANISM; RESOLUTION; SELECTION	The creation of enzymes capable of catalyzing any desired chemical reaction is a grand challenge for computational protein design. Using new algorithms that rely on hashing techniques to construct active sites for multistep reactions, we designed retro- aldolases that use four different catalytic motifs to catalyze the breaking of a carbon- carbon bond in a nonnatural substrate. Of the 72 designs that were experimentally characterized, 32, spanning a range of protein folds, had detectable retro-aldolase activity. Designs that used an explicit water molecule to mediate proton shuffling were significantly more successful, with rate accelerations of up to four orders of magnitude and multiple turnovers, than those involving charged side- chain networks. The atomic accuracy of the design process was confirmed by the x- ray crystal structure of active designs embedded in two protein scaffolds, both of which were nearly superimposable on the design model.	[Jiang, Lin; Althoff, Eric A.; Rothlisberger, Daniela; Zanghellini, Alexandre; Gallaher, Jasmine L.; Betker, Jamie L.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Jiang, Lin; Zanghellini, Alexandre; Baker, David] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Clemente, Fernando R.; Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Doyle, Lindsey; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Tanaka, Fujie; Barbas, Carlos F., III] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Tanaka, Fujie; Barbas, Carlos F., III] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Tanaka, Fujie; Barbas, Carlos F., III] Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; [Hilvert, Donald] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; Fred Hutchinson Cancer Center; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Jiang, Lin/G-1575-2010; Tanaka, Fujie/K-2069-2014; Baker, David/K-8941-2012	Tanaka, Fujie/0000-0001-6388-9343; Baker, David/0000-0001-7896-6217; Doyle, Lindsey/0000-0002-0008-473X	NATIONAL CANCER INSTITUTE [R01CA097328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049857] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA097328] Funding Source: Medline; NIGMS NIH HHS [R01 GM049857] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Clemente FR, 2005, J AM CHEM SOC, V127, P11294, DOI 10.1021/ja0507620; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Fullerton SWB, 2006, BIOORGAN MED CHEM, V14, P3002, DOI 10.1016/j.bmc.2005.12.022; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Janssen DB, 2005, ENVIRON MICROBIOL, V7, P1868, DOI 10.1111/j.1462-2920.2005.00966.x; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Press W., 1992, NUMERICAL RECIPES FO; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Tanaka F, 2002, J AM CHEM SOC, V124, P3510, DOI 10.1021/ja0171815; Tanaka F, 2004, J MOL BIOL, V335, P1007, DOI 10.1016/j.jmb.2003.11.014; WAGNER J, 1995, SCIENCE, V270, P1797, DOI 10.1126/science.270.5243.1797; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhong GF, 1998, ANGEW CHEM INT EDIT, V37, P2481, DOI 10.1002/(SICI)1521-3773(19981002)37:18<2481::AID-ANIE2481>3.0.CO;2-T	22	828	887	6	367	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1387	1391		10.1126/science.1152692	http://dx.doi.org/10.1126/science.1152692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323453	Green Accepted			2022-12-28	WOS:000253712900043
J	Shinohara, M; Koga, T; Okamoto, K; Sakaguchi, S; Arai, K; Yasuda, H; Takai, T; Kodama, T; Morio, T; Geha, RS; Kitamura, D; Kurosaki, T; Ellmeier, W; Takayanagi, H				Shinohara, Masahiro; Koga, Takako; Okamoto, Kazuo; Sakaguchi, Shinya; Arai, Kimiko; Yasuda, Hisataka; Takai, Toshiyuki; Kodama, Tatsuhiko; Morio, Tomohiro; Geha, Raif S.; Kitamura, Daisuke; Kurosaki, Tomohiro; Ellmeier, Wilfried; Takayanagi, Hiroshi			Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals	CELL			English	Article							MICE LACKING; RAFTS PLAY; FAMILY; DEFICIENCY; ACTIVATION; PROTEIN; IMMUNE; OSTEOIMMUNOLOGY; PLC-GAMMA-2; SYSTEM	Certain autoimmune diseases result in abnormal bone homeostasis, but association of immunodeficiency with bone is poorly understood. Osteoclasts, which derive from bone marrow cells, are under the control of the immune system. Differentiation of osteoclasts is mainly regulated by signaling pathways activated by RANK and immune receptors linked to ITAM-harboring adaptors. However, it is unclear how the two signals merge to cooperate in osteoclast differentiation. Here we report that mice lacking the tyrosine kinases Btk and Tec show severe osteopetrosis caused by a defect in bone resorption. RANK and ITAM signaling results in formation of a Btk(Tec)/BLNK(SLP-76)-containing complex and PLC gamma-mediated activation of an essential calcium signal. Furthermore, Tec kinase inhibition reduces osteoclastic bone resorption in models of osteoporosis and inflammation-induced bone destruction. Thus, this study reveals the importance of the osteoclastogenic signaling complex composed of tyrosine kinases, which may provide the molecular basis for a new therapeutic strategy.	[Shinohara, Masahiro; Koga, Takako; Okamoto, Kazuo; Arai, Kimiko; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch, Dept Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; [Shinohara, Masahiro; Koga, Takako; Okamoto, Kazuo; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Ctr Excellence Program Frontier Res Mol Destruct, Bunkyo Ku, Tokyo 1138549, Japan; [Morio, Tomohiro] Tokyo Med & Dent Univ, Grad Sch, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo 1138549, Japan; [Sakaguchi, Shinya; Ellmeier, Wilfried] Med Univ Vienna, Inst Immunol, Ctr Physiol Pathophysiol & Immunol, A-1090 Vienna, Austria; [Arai, Kimiko] Tohoku Univ, Grad Sch Dent, Div Orthodont & Dentofacial Orthoped, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Takai, Toshiyuki] Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Yasuda, Hisataka] Oriental Yeast Co Ltd, Nagahama Inst Biochem Sci, Shiga 5260804, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Dept Mol Biol & Med, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; [Geha, Raif S.] Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Kitamura, Daisuke] Tokyo Univ Sci, Div Mol Biol, Res Inst Biol Sci, Nada Ku, Chiba 2780022, Japan; [Kurosaki, Tomohiro] RIKEN, Lab Lymphocyte Differentiat, Res Ctr Allergy & Immunol, RIKEN Yokohama Inst,Tsurumi Ku, Kanagawa 2300045, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Medical University of Vienna; Tohoku University; Tohoku University; Oriental Yeast Co., Ltd.; University of Tokyo; Harvard University; Boston Children's Hospital; Tokyo University of Science; RIKEN	Takayanagi, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Cell Signaling, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138549, Japan.	taka.csi@tmd.ac.jp	Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Morio, Tomohiro/0000-0002-9259-1025; Yasuda, Hisataka/0000-0003-3511-609X; Ellmeier, Wilfried/0000-0001-8192-8481; Sakaguchi, Shinya/0000-0002-0591-2469; Shinohara, Masahiro/0000-0002-5532-1042	Austrian Science Fund FWF [Y 163] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Aoki K, 2006, J CLIN INVEST, V116, P1525, DOI 10.1172/JCI22513; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; de Diego RP, 2006, J ALLERGY CLIN IMMUN, V117, P1462, DOI 10.1016/j.jaci.2006.01.037; Ellmeier W, 2000, J EXP MED, V192, P1611, DOI 10.1084/jem.192.11.1611; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Fernandes MJG, 2005, J LEUKOCYTE BIOL, V78, P524, DOI 10.1189/jlb.0804479; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Hashimoto S, 1999, BLOOD, V94, P2357, DOI 10.1182/blood.V94.7.2357.419k40_2357_2364; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hayashi K, 2003, IMMUNITY, V18, P825, DOI 10.1016/S1074-7613(03)00142-0; HORTON JE, 1972, SCIENCE, V177, P793, DOI 10.1126/science.177.4051.793; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jumaa H, 2003, NATURE, V423, P452, DOI 10.1038/nature01608; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KIRCHNER SG, 1985, RADIOLOGY, V156, P362, DOI 10.1148/radiology.156.2.4011897; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lopez-Granados E, 2007, P NATL ACAD SCI USA, V104, P5056, DOI 10.1073/pnas.0605715104; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; MANO H, 1995, BLOOD, V85, P343; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Pivniouk VI, 2000, CURR OPIN IMMUNOL, V12, P173, DOI 10.1016/S0952-7915(99)00068-0; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schmidt U, 2004, INT ARCH ALLERGY IMM, V134, P65, DOI 10.1159/000078339; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Wu YL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000586	44	234	260	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					794	806		10.1016/j.cell.2007.12.037	http://dx.doi.org/10.1016/j.cell.2007.12.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329366	Bronze			2022-12-28	WOS:000253818000017
J	Winkler, PM; Steiner, G; Vrtala, A; Vehkamaki, H; Noppel, M; Lehtinen, KEJ; Reischl, GP; Wagner, PE; Kulmala, M				Winkler, Paul M.; Steiner, Gerhard; Vrtala, Aron; Vehkamaki, Hanna; Noppel, Madis; Lehtinen, Kari E. J.; Reischl, Georg P.; Wagner, Paul E.; Kulmala, Markku			Heterogeneous nucleation experiments bridging the scale from molecular ion clusters to nanoparticles	SCIENCE			English	Article							ATMOSPHERIC PARTICLES; AEROSOL; GROWTH; RATES; PHASE	Generation, investigation, and manipulation of nanostructured materials are of fundamental and practical importance for several disciplines, including materials science and medicine. Recently, atmospheric new particle formation in the nanometer- size range has been found to be a global phenomenon. Still, its detailed mechanisms are mostly unknown, largely depending on the incapability to generate and measure nanoparticles in a controlled way. In our experiments, an organic vapor ( n- propanol) condenses on molecular ions, as well as on charged and uncharged inorganic nanoparticles, via initial activation by heterogeneous nucleation. We found a smooth transition in activation behavior as a function of size and activation to occur well before the onset of homogeneous nucleation. Furthermore, nucleation enhancement for charged particles and a substantial negative sign preference were quantitatively detected.	[Vehkamaki, Hanna; Kulmala, Markku] Univ Helsinki, Dept Phys Sci, FIN-00014 Helsinki, Finland; [Winkler, Paul M.; Steiner, Gerhard; Vrtala, Aron; Reischl, Georg P.; Wagner, Paul E.] Univ Vienna, Fak Phys, A-1090 Vienna, Austria; [Noppel, Madis] Univ Tartu, Inst Phys, EE-50090 Tartu, Estonia; [Lehtinen, Kari E. J.] Univ Kuopio, Dept Phys, FIN-70211 Kuopio, Finland; [Lehtinen, Kari E. J.] Finnish Meteorol Inst, FIN-70211 Kuopio, Finland	University of Helsinki; University of Vienna; University of Tartu; University of Tartu Institute of Physics; University of Eastern Finland; Finnish Meteorological Institute	Kulmala, M (corresponding author), Univ Helsinki, Dept Phys Sci, POB 64, FIN-00014 Helsinki, Finland.	markku.kulmala@helsinki.fi	Vehkamäki, Hanna/A-8262-2008; Steiner, Gerhard/AAD-4219-2020; Lehtinen, Kari/O-9559-2018; Kulmala, Markku T/I-7671-2016	Vehkamäki, Hanna/0000-0002-5018-1255; Steiner, Gerhard/0000-0003-3008-1414; Kulmala, Markku T/0000-0003-3464-7825; Noppel, Madis/0000-0003-3571-1841; Winkler, Paul/0000-0001-6861-6029	Austrian Science Fund (FWF) [P 19546] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Backman U, 2002, J NANOPART RES, V4, P325, DOI 10.1023/A:1021148001483; DASGUPTA NN, 1946, REV MOD PHYS, V18, P225; FLETCHER NH, 1958, J CHEM PHYS, V29, P572, DOI 10.1063/1.1744540; Gamero-Castano M, 2000, J AEROSOL SCI, V31, P757, DOI 10.1016/S0021-8502(99)00555-8; Kashchiev D., 2000, NUCL BASIC THEORY AP; Kim TO, 1998, AEROSOL SCI TECH, V29, P111, DOI 10.1080/02786829808965556; KODAS T, 1999, AEROSOL PROCESSING M; Kulmala M, 2006, ATMOS CHEM PHYS, V6, P787, DOI 10.5194/acp-6-787-2006; Kulmala M, 2004, ATMOS CHEM PHYS, V4, P2553, DOI 10.5194/acp-4-2553-2004; Kulmala M, 2005, BOREAL ENVIRON RES, V10, P79; Kulmala M, 2000, NATURE, V404, P66, DOI 10.1038/35003550; Kulmala M, 2003, SCIENCE, V302, P1000, DOI 10.1126/science.1090848; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Kulmala M, 2007, J AEROSOL SCI, V38, P289, DOI 10.1016/j.jaerosci.2006.11.008; Lushnikov AA, 2004, EUR PHYS J D, V29, P345, DOI 10.1140/epjd/e2004-00047-9; McMurry PH, 2000, ATMOS ENVIRON, V34, P1959, DOI 10.1016/S1352-2310(99)00455-0; Nadykto AB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.125701; Noppel M, 2003, J CHEM PHYS, V119, P10733, DOI 10.1063/1.1620499; Pruppacher HR, 1997, MICROPHYSICS CLOUDS; STREY R, 1994, J PHYS CHEM-US, V98, P7748, DOI 10.1021/j100083a003; Thomson W., 1872, P R SOC EDINB, V7, P63, DOI 10.1017/S0370164600041729; Vehkamaki H, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2723073; Wagner PE, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021605; WAGNER PE, 1985, J COLLOID INTERF SCI, V105, P456, DOI 10.1016/0021-9797(85)90319-4; WEDEKIND J, 2004, NUCL ATMOSPHERIC AER, P49; Wilck M, 1997, J AEROSOL SCI, V28, P959, DOI 10.1016/S0021-8502(96)00481-8; Wilson C, 1897, PHILOS T R SOC LON A, V189, P265, DOI [10.1098/rsta.1897.0011, DOI 10.1098/RSTA.1897.0011]; Yu FQ, 2000, GEOPHYS RES LETT, V27, P883, DOI 10.1029/1999GL011151	28	199	207	3	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1374	1377		10.1126/science.1149034	http://dx.doi.org/10.1126/science.1149034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323450				2022-12-28	WOS:000253712900039
J	Tapson, VF				Tapson, Victor F.			Medical progress: Acute pulmonary embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MOLECULAR-WEIGHT HEPARIN; DEEP VENOUS THROMBOSIS; VENA-CAVA FILTER; UNFRACTIONATED HEPARIN; D-DIMER; THROMBOLYTIC THERAPY; CLINICAL PROBABILITY; VEIN THROMBOSIS; HEART-FAILURE; HIGH-RISK		Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC 27710 USA	Duke University	Tapson, VF (corresponding author), Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Rm 351,Bell Bldg,Box 31175, Durham, NC 27710 USA.	tapso001@mc.duke.edu	Elizondo, Anthony/GMW-8877-2022					ALPERT JS, 1976, JAMA-J AM MED ASSOC, V236, P1477, DOI 10.1001/jama.236.13.1477; *AM PUBL HLTH ASS, 2008, PUBL HLTH LEAD C DEE; Bauer K. A., 2006, NEW ANTICOAGULANTS, P450; Beasley R, 2003, EUR RESPIR J, V21, P374, DOI 10.1183/09031936.03.00039403; BERGQVIST D, 1985, BRIT J SURG, V72, P105, DOI 10.1002/bjs.1800720211; BICK RL, 1992, SEMIN THROMB HEMOST, V18, P353, DOI 10.1055/s-2007-1002575; Bratzler DW, 1998, ARCH INTERN MED, V158, P1909, DOI 10.1001/archinte.158.17.1909; Brookenthal KR, 2001, J ARTHROPLASTY, V16, P293, DOI 10.1054/arth.2001.21499; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Buller HR, 2004, ANN INTERN MED, V140, P867, DOI 10.7326/0003-4819-140-11-200406010-00007; Buller HR, 2003, NEW ENGL J MED, V349, P1695; BULLER HR, 2005, CHEST, V27, P416; Campbell A, 2007, BMJ-BRIT MED J, V334, P674, DOI 10.1136/bmj.39098.583356.55; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; COLWELL, 1994, J BONE JOINT SURG AM, V76A, P474; COLWELL CW, 1994, J BONE JOINT SURG AM, V76A, P3, DOI 10.2106/00004623-199401000-00002; DALEN JE, 1967, AM J CARDIOL, V20, P3, DOI 10.1016/0002-9149(67)90104-X; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Elliott CG, 2005, CHEST, V128, P3372, DOI 10.1378/chest.128.5.3372; ELLIOTT CG, 1992, CHEST, V101, pS163, DOI 10.1378/chest.101.4.163S; Francis CW, 2007, NEW ENGL J MED, V357, P203; Francis CW, 2007, NEW ENGL J MED, V356, P1438, DOI 10.1056/NEJMcp067264; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; GINSBERG JS, 1995, BLOOD, V86, P3685, DOI 10.1182/blood.V86.10.3685.bloodjournal86103685; Goldhaber SZ, 2005, ARCH INTERN MED, V165, P2197, DOI 10.1001/archinte.165.19.2197; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; GOLDHABER SZ, 1993, LANCET, V341, P507, DOI 10.1016/0140-6736(93)90274-K; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; Gould MK, 1999, ANN INTERN MED, V130, P789, DOI 10.7326/0003-4819-130-10-199905180-00002; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; GREEN D, 1990, ANN INTERN MED, V113, P571, DOI 10.7326/0003-4819-113-8-571; Harenberg J, 2004, J THROMB HAEMOST, V2, P547, DOI 10.1111/j.1538-7933.2004.00647.x; Heit JA, 2005, BLOOD, V106, p267A; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Hirsh J, 2004, CHEST, V126, p188S, DOI 10.1378/chest.126.3_suppl.188S; Howell MD, 2001, J CLIN EPIDEMIOL, V54, P810, DOI 10.1016/S0895-4356(00)00373-5; Hull RD, 2000, ARCH INTERN MED, V160, P229, DOI 10.1001/archinte.160.2.229; Hull RD, 1997, ARCH INTERN MED, V157, P2562, DOI 10.1001/archinte.157.22.2562; HULL RD, 2007, 21 C INT SOC THROMB; Kaufman JA, 2006, J VASC INTERV RADIOL, V17, P449, DOI 10.1097/01.RVI.0000203418-39769.0D; Kearon C, 2006, ANN INTERN MED, V144, P812, DOI 10.7326/0003-4819-144-11-200606060-00007; Kleber FX, 2003, AM HEART J, V145, P614, DOI 10.1067/mhj.2003.189; Kluge A, 2006, AM J ROENTGENOL, V186, P1686, DOI 10.2214/AJR.05.0756; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Kruip MJHA, 2006, J INTERN MED, V260, P459, DOI 10.1111/j.1365-2796.2006.01709.x; Layish DT, 1997, CHEST, V111, P218, DOI 10.1378/chest.111.1.218; Le Gal G, 2006, J THROMB HAEMOST, V4, P724, DOI 10.1111/j.1538-7836.2006.01819.x; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Leacche M, 2005, J THORAC CARDIOV SUR, V129, P1018, DOI 10.1016/j.jtcvs.2004.10.023; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Leizorovicz A, 2005, J THROMB HAEMOST, V3, P28, DOI 10.1111/j.1538-7836.2004.01094.x; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; Loud PA, 2001, RADIOLOGY, V219, P498, DOI 10.1148/radiology.219.2.r01ma26498; Martel N, 2005, BLOOD, V106, P2710, DOI 10.1182/blood-2005-04-1546; Melanson SEF, 2006, ARCH PATHOL LAB MED, V130, P1326; Merli G, 2001, ANN INTERN MED, V134, P191, DOI 10.7326/0003-4819-134-3-200102060-00009; MEYER G, 1991, ANN THORAC SURG, V51, P232, DOI 10.1016/0003-4975(91)90792-O; Mismetti P, 2007, CHEST, V131, P223, DOI 10.1378/chest.06-0631; Moores LK, 2004, ANN INTERN MED, V141, P866, DOI 10.7326/0003-4819-141-11-200412070-00011; *NAT QUAL FOR, NQF PROJ BRIEF NAT V; Nicolaides AN, 2006, INT ANGIOL, V25, P101; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Palla A, 2004, NEW ENGL J MED, V350, P423; Partsch H, 2000, J VASC SURG, V32, P861, DOI 10.1067/mva.2000.110352; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Perrier A, 1996, ARCH INTERN MED, V156, P531, DOI 10.1001/archinte.156.5.531; Pruszczyk P, 2003, CHEST, V123, P1947, DOI 10.1378/chest.123.6.1947; Righini M, 2004, ARCH INTERN MED, V164, P2483, DOI 10.1001/archinte.164.22.2483; ROGERS FB, 1995, J AM COLL SURGEONS, V180, P641; Rosendaal FR, 2002, ARTERIOSCL THROM VAS, V22, P201, DOI 10.1161/hq0202.102318; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; ROSENDAAL FR, 2005, VENOUS THROMBOSIS RO, P1; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; SANDLER DA, 1989, J ROY SOC MED, V82, P203, DOI 10.1177/014107688908200407; Schoepf UJ, 2002, RADIOLOGY, V222, P483, DOI 10.1148/radiol.2222001802; Schulman S, 2006, J THROMB HAEMOST, V4, P734, DOI 10.1111/j.1538-7836.2006.01795.x; Segal JB, 2007, ANN INTERN MED, V146, P396, DOI 10.7326/0003-4819-146-3-200702060-00150; Segal JB, 2007, ANN INTERN MED, V146, P211, DOI 10.7326/0003-4819-146-3-200702060-00150; Sherman DG, 2007, LANCET, V369, P1347, DOI 10.1016/S0140-6736(07)60633-3; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Simonneau G, 1997, NEW ENGL J MED, V337, P663, DOI 10.1056/NEJM199709043371002; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; STEIN PD, 1991, CHEST, V100, P598, DOI 10.1378/chest.100.3.598; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; *SURG CAR IMPR PRO, SCIP PROC OUTC MEAS; Tapson VF, 1999, AM J RESP CRIT CARE, V160, P1043; TAPSON VF, 1994, CHEST, V105, P888, DOI 10.1378/chest.105.3.888; TAPSON VF, 1994, CHEST, V106, P1558, DOI 10.1378/chest.106.5.1558; Tapson VF, 2007, CHEST, V132, P936, DOI 10.1378/chest.06-2993; tenCate JW, 1997, NEW ENGL J MED, V337, P657; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; VIRCHOW R, 1856, PHLOGOSE THROMBOSE G; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; WITTY LA, 1994, ARCH INTERN MED, V154, P1601, DOI 10.1001/archinte.154.14.1601; Wood KE, 2002, CHEST, V121, P877, DOI 10.1378/chest.121.3.877	103	556	638	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					1037	1052		10.1056/NEJMra072753	http://dx.doi.org/10.1056/NEJMra072753			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18322285				2022-12-28	WOS:000253644700008
J	Heiss, G; Wallace, R; Anderson, GL; Aragaki, A; Beresford, SAA; Brzyski, R; Chlebowski, RT; Gass, M; LaCroix, A; Manson, JE; Prentice, RL; Rossouw, J; Stefanick, ML				Heiss, Gerardo; Wallace, Robert; Anderson, Garnet L.; Aragaki, Aaron; Beresford, Shirley A. A.; Brzyski, Robert; Chlebowski, Rowan T.; Gass, Margery; LaCroix, Andrea; Manson, Joann E.; Prentice, Ross L.; Rossouw, Jacques; Stefanick, Marcia L.		WHI Investigators	Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTMENOPAUSAL HORMONE-THERAPY; PLUS PROGESTIN; CANCER; WOMEN; SURVIVAL; BREAST; MAMMOGRAPHY; REPLACEMENT; DISEASE; TRIAL	Context The Women's Health Initiative ( WHI) trial of estrogen plus progestin vs placebo was stopped early, after a mean 5.6 years of follow- up, because the overall health risks of hormone therapy exceeded its benefits. Objective To report health outcomes at 3 years ( mean 2.4 years of follow- up) after the intervention was stopped. Design, Setting, and Participants The intervention phase was a double- blind, placebo- controlled, randomized trial of conjugated equine estrogens ( CEE) 0.625 mg daily plus medroxyprogesterone acetate ( MPA) 2.5 mg daily, in 16 608 women aged 50 through 79 years, recruited by 40 centers from 1993 to 1998. The postintervention phase commenced July 8, 2002, and included 15 730 women. Main Outcome Measures Semi- annual monitoring and outcomes ascertainment continued per trial protocol. The primary end points were coronary heart disease and invasive breast cancer. A global index summarizing the balance of risks and benefits included the 2 primary end points plus stroke, pulmonary embolism, endometrial cancer, colorectal cancer, hip fracture, and death due to other causes. Results The risk of cardiovascular events after the intervention was comparable by initial randomized assignments, 1.97% ( annualized rate) in the CEE plus MPA ( 343 events) and 1.91% in the placebo group ( 323 events). A greater risk of malignancies occurred in the CEE plus MPA than in the placebo group ( 1.56% [ n= 281] vs 1.26% [ n= 218]; hazard ratio [ HR], 1.24; 95% confidence interval [ CI], 1.04- 1.48). More breast cancers were diagnosed in women who had been randomly assigned to receive CEE plus MPA vs placebo ( 0.42% [ n= 79] vs 0.33% [ n= 60]; HR, 1.27; 95% CI, 0.91- 1.78) with a modest trend toward a lower HR during the follow- up after the intervention. All- cause mortality was somewhat higher in the CEE plus MPA than in the placebo group ( 1.20% [ n= 233] vs 1.06% [ n= 196]; HR, 1.15; 95% CI, 0.95- 1.39). The global index of risks and benefits was unchanged from randomization through March 31, 2005 ( HR, 1.12; 95% CI, 1.03- 1.21), indicating that the risks of CEE plus MPA exceed the benefits for chronic disease prevention. Conclusions The increased cardiovascular risks in the women assigned to CEE plus MPA during the intervention period were not observed after the intervention. A greater risk of fatal and nonfatal malignancies occurred after the intervention in the CEE plus MPA group and the global risk index was 12% higher in women randomly assigned to receive CEE plus MPA compared with placebo. Trial Registration clinicaltrials. gov Identifier: NCT00000611.	[Heiss, Gerardo] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Wallace, Robert] Univ Iowa, Iowa City, IA USA; [Anderson, Garnet L.; Aragaki, Aaron; Beresford, Shirley A. A.; LaCroix, Andrea; Prentice, Ross L.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Brzyski, Robert] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA; [Chlebowski, Rowan T.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Gass, Margery] Univ Cincinnati, Cincinnati, OH USA; [Manson, Joann E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Rossouw, Jacques] NHLBI, Bethesda, MD 20892 USA; [Stefanick, Marcia L.] Stanford Prevent Res Ctr, Stanford, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of Iowa; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Health San Antonio; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Stanford University	Heiss, G (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, 137 E Franklin St,Ste 306, Chapel Hill, NC 27514 USA.	gerardo_heiss@unc.edu		Anderson, Garnet/0000-0001-5087-7837				*AM COLL OBST GYN, 2004, OBSTET GYNECOL S, V104, pS1; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2006, MATURITAS, V55, P103, DOI 10.1016/j.maturitas.2006.05.004; Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; Breen N, 2007, CANCER-AM CANCER SOC, V109, P2405, DOI 10.1002/cncr.22723; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Cushman M, 2004, JAMA-J AM MED ASSOC, V292, P1573, DOI 10.1001/jama.292.13.1573; Ettinger B, 1996, OBSTET GYNECOL, V87, P6, DOI 10.1016/0029-7844(95)00358-4; Ganti AK, 2006, J CLIN ONCOL, V24, P59, DOI 10.1200/JCO.2005.02.9827; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Johnson MS, 2005, ANN INTERN MED, V142, P855, DOI 10.7326/0003-4819-142-10-200505170-00011; LaCroix Andrea Z, 2005, Am J Med, V118 Suppl 12B, P79, DOI 10.1016/j.amjmed.2005.09.039; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Marquez-Garban DC, 2007, STEROIDS, V72, P135, DOI 10.1016/j.steroids.2006.11.019; Ockene JK, 2005, JAMA-J AM MED ASSOC, V294, P183, DOI 10.1001/jama.294.2.183; Palomares MR, 1996, CANCER, V78, P2119, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2119::AID-CNCR12>3.0.CO;2-1; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; ROSS H, 2007, J CLIN ONCOL S, V24, P7039; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Wisnivesky JP, 2007, J CLIN ONCOL, V25, P1705, DOI 10.1200/JCO.2006.08.1455	26	271	283	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2008	299	9					1036	1045		10.1001/jama.299.9.1036	http://dx.doi.org/10.1001/jama.299.9.1036			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JH	18319414	Bronze, Green Published			2022-12-28	WOS:000253644800021
J	Thabut, G; Christie, JD; Ravaud, P; Castier, Y; Brugiere, O; Fournier, M; Mal, H; Leseche, G; Porcher, R				Thabut, Gabriel; Christie, Jason D.; Ravaud, Philippe; Castier, Yves; Brugiere, Olivier; Fournier, Michel; Mal, Herve; Leseche, Guy; Porcher, Raphael			Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data	LANCET			English	Article							PROPENSITY SCORE; NATIVE LUNG; EMPHYSEMA; BIAS	Background Both single and bilateral lung transplantation are recognised options for patients who have end-stage chronic obstructive pulmonary disease (COPD); however, which procedure leads to longer survival remains unclear. We aimed to compare survival after each procedure by analysing data from the registry of the International Society for Heart and Lung Transplantation. Methods We analysed data for 9883 patients with COPD, 3525 (35.7%) of whom underwent bilateral lung transplantation, and 6358 (64.3%) single lung transplantation, between 1987 and 2006. We accounted for possible selection bias with analysis of covariance, propensity-score risk adjustment, and propensity-based matching. Findings Median survival after either type of lung transplantation for patients with COPD was 5.0 years (95% Cl 4. 8-5. 2). Survival for patients who had lung transplantation before 1998 was 4.5 years (4.3-4.8), compared with 5.3 years (5.0-5.5) for those who had it after 1998 (p<0.0001). The proportion of patients who had bilateral lung transplantation increased from 101/467 (21.6%) in 1993 to 345/614 (56.2%) in 2006. Median survival time after bilateral lung transplantation was longer than that after single lung transplantation: 6.41 years (6.02-6.88) versus 4.59 years (4.41-4.76) (p<0.0001). Pretransplant characteristics of patients who had single and bilateral lung transplantation differed, but whichever method was used to adjust for baseline differences, bilateral lung transplantation was associated with longer survival than was single lung transplantation; the hazard ratio ranged from 0.83 (0.78-0.92) for analysis of covariance to 0.89 (0.80-0.97) for propensity-based matching. However, bilateral lung transplantation had little benefit compared with single lung transplantation for patients who were 60 years and older (HR 0 . 95; 0 . 81-1.13). Interpretation Bilateral lung transplantation leads to longer survival than single lung transplantation in patients with COPD, especially those who are younger than 60 years.	[Thabut, Gabriel; Brugiere, Olivier; Fournier, Michel; Mal, Herve] Hop Bichat Claude Bernard, Serv Pneumol B & Transplantat Pulm, APHP, F-75018 Paris, France; [Castier, Yves; Leseche, Guy] Hop Bichat Claude Bernard, Serv Chirurg Thorac & Vasc, APHP, F-75018 Paris, France; [Ravaud, Philippe] Hop Bichat Claude Bernard, Dept Epidemiol & Biostat, APHP, F-75018 Paris, France; [Ravaud, Philippe] Hop Bichat Claude Bernard, Rech Clin, APHP, F-75018 Paris, France; [Thabut, Gabriel; Ravaud, Philippe; Porcher, Raphael] Univ Paris 07, Paris, France; [Thabut, Gabriel; Ravaud, Philippe] French Inst Hlth & Med Res, INSERM, U738, Paris, France; [Porcher, Raphael] French Inst Hlth & Med Res, INSERM, U717, Paris, France; [Porcher, Raphael] Hop St Louis, Dept Biostat & Informat Med, APHP, Paris, France; [Christie, Jason D.] Univ Penn, Div Pulm & Crit Care Med, Dept Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; Pennsylvania Medicine	Thabut, G (corresponding author), Hop Bichat Claude Bernard, Serv Pneumol B & Transplantat Pulm, APHP, 46 Rue Henri Huchard, F-75018 Paris, France.	gabriel.thabut@bch.aphp.fr	ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206; Porcher, Raphael/0000-0002-5277-4679				Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Cassivi SD, 2002, ANN THORAC SURG, V74, P1663, DOI 10.1016/S0003-4975(02)04064-X; COOPER JD, 1989, AM REV RESPIR DIS, V139, P303, DOI 10.1164/ajrccm/139.2.303; CORRIS PA, 1999, THORAX S2, V54, P24; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; FROST AE, 1995, CHEST, V107, P981, DOI 10.1378/chest.107.4.981; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gunes A, 2006, INTERN MED J, V36, P5, DOI 10.1111/j.1445-5994.2006.01003.x; Hertz MI, 2006, J HEART LUNG TRANSPL, V25, P1179, DOI 10.1016/j.healun.2006.07.004; Hosmer D. W., 1999, APPL SURVIVAL ANAL; KALBFLEISH J, 2002, STAT ANAL FAILURE DA; LEVINE SM, 1994, AM J RESP CRIT CARE, V150, P398, DOI 10.1164/ajrccm.150.2.8049821; MAL H, 1989, AM REV RESPIR DIS, V140, P797, DOI 10.1164/ajrccm/140.3.797; Mal H, 2000, J HEART LUNG TRANSPL, V19, P220, DOI 10.1016/S1053-2498(99)00130-8; MAL H, 1994, AM J RESP CRIT CARE, V149, P1476, DOI 10.1164/ajrccm.149.6.8004301; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mant J, 2006, J CLIN EPIDEMIOL, V59, P862, DOI 10.1016/j.jclinepi.2005.11.021; Meyer DM, 2001, J HEART LUNG TRANSPL, V20, P935, DOI 10.1016/S1053-2498(01)00295-9; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; MIYOSHI S, 1990, CHEST, V97, P1130, DOI 10.1378/chest.97.5.1130; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Snell GI, 2006, INTERN MED J, V36, P3, DOI 10.1111/j.1445-5994.2006.00999.x; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Trulock EP, 2006, J HEART LUNG TRANSPL, V25, P880, DOI 10.1016/j.healun.2006.06.001; Trulock EP, 1998, CHEST, V113, p269S, DOI 10.1378/chest.113.4_Supplement.269S; Trulock EP, 1997, AM J RESP CRIT CARE, V155, P789, DOI 10.1164/ajrccm.155.3.9117010; TRULOCK EP, 1989, CHEST, V96, P738, DOI 10.1378/chest.96.4.738; Weill D, 2001, J HEART LUNG TRANSPL, V20, P739, DOI 10.1016/S1053-2498(00)00322-3; WILLIAMS TJ, 1992, AM REV RESPIR DIS, V145, P101, DOI 10.1164/ajrccm/145.1.101	32	129	136	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					744	751		10.1016/S0140-6736(08)60344-X	http://dx.doi.org/10.1016/S0140-6736(08)60344-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313503	Green Submitted			2022-12-28	WOS:000253596700028
J	[Anonymous]				[Anonymous]			Music in stroke rehabilitation	LANCET			English	Editorial Material																			0	4	4	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					698	698						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	268RI	18313483				2022-12-28	WOS:000253596700003
J	Mavalankar, D; Singh, A; Bhat, R; Desai, A; Patel, SR				Mavalankar, Dileep; Singh, Amarjit; Bhat, Ramesh; Desai, Ajesh; Patel, S. R.			Indian public-private partnership for skilled birth-attendance	LANCET			English	Editorial Material							MATERNAL MORTALITY		[Mavalankar, Dileep; Bhat, Ramesh; Patel, S. R.] Indian Inst Management, Ahmadabad 380015, Gujarat, India	Indian Institute of Management (IIM System); Indian Institute of Management Ahmedabad	Mavalankar, D (corresponding author), Indian Inst Management, Ahmadabad 380015, Gujarat, India.	dileep@iimahd.ernet.in	Mavalankar, Dileep/AAX-6931-2020; Bhat, Ramesh/F-5521-2017	Mavalankar, Dileep/0000-0003-0498-3799; Bhat, Ramesh/0000-0002-3222-2623				Bhat R, 2006, 20060803 IND I MAN; *GOV IND, 2004, HLTH INF IND 2004; *GOV IND, 1994, HLTH INF IND 1994; *GOV IND, 2006, MAT MORT IND 1997 20; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Maine D, 1991, SAFE MOTHERHOOD PROG; Mavalankar DV, 2005, AM J PUBLIC HEALTH, V95, P200, DOI 10.2105/AJPH.2003.036715; MAVALANKAR DV, 1999, IMPLEMENTING REPROD, P183; *MIN HLTH FAM WELF, 2007, NAT FAM HLTH SURV IN, P208; Peters D.H., 2002, BETTER HLTH SYSTEMS; Singh NB, 2006, PROG CRYST GROWTH CH, V52, P77, DOI 10.1016/j.pcrysgrow.2006.03.011; *WORLD BANK, 1997, 9489IN WORLD BANK AS	12	12	12	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2008	371	9613					631	632		10.1016/S0140-6736(08)60282-2	http://dx.doi.org/10.1016/S0140-6736(08)60282-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LL	18295010				2022-12-28	WOS:000253436700009
J	Pick, W				Pick, William			Lack of evidence hampers human-resources policy making	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; HEALTH		[Pick, William] Univ Cape Town, Sch Publ Hlth, ZA-7441 Cape Town, South Africa; [Pick, William] Univ Western Cape, Sch Publ Hlth, ZA-7441 Cape Town, South Africa	University of Cape Town; University of the Western Cape	Pick, W (corresponding author), Univ Cape Town, Sch Publ Hlth, ZA-7441 Cape Town, South Africa.	pickwm@mweb.co.za						Anderson JE, 1994, PUBLIC POLICYMAKING, V2nd; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chopra M, 2008, LANCET, V371, P668, DOI 10.1016/S0140-6736(08)60305-0; *GLOB FOR HLTH RES, 2000, 10 90 REP HLTH RES 1; GRINDLE MS, 1989, POLICY SCI, V22, P213, DOI 10.1007/BF00136320; REICH M, 1995, POLITICAL MAPPING CO; STONE D, 2001, BRIDG RES POL INT WO; United Nations Development Program, HUM DEV REP 2005 INT; WALT G, 1994, HEALTH POLICY PLANN, V9, P353, DOI 10.1093/heapol/9.4.353; Weimer DL, 1998, POLICY STUD J, V26, P114, DOI 10.1111/j.1541-0072.1998.tb01928.x; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	11	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2008	371	9613					629	630		10.1016/S0140-6736(08)60280-9	http://dx.doi.org/10.1016/S0140-6736(08)60280-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LL	18295008				2022-12-28	WOS:000253436700007
J	Morrison, SJ; Spradling, AC				Morrison, Sean J.; Spradling, Allan C.			Stem cells and niches: Mechanisms that promote stem cell maintenance throughout life	CELL			English	Review							HEMATOPOIETIC STEM; SELF-RENEWAL; SUBVENTRICULAR ZONE; SPINDLE ORIENTATION; PROGENITOR CELLS; TUMOR STROMA; GERMLINE; IDENTIFICATION; DIFFERENTIATION; PROLIFERATION	Niches are local tissue microenvironments that maintain and regulate stem cells. Long-predicted from mammalian studies, these structures have recently been characterized within several invertebrate tissues using methods that reliably identify individual stem cells and their functional requirements. Although similar single-cell resolution has usually not been achieved in mammalian tissues, principles likely to govern the behavior of niches in diverse organisms are emerging. Considerable progress has been made in elucidating how the microenvironment promotes stem cell maintenance. Mechanisms of stem cell maintenance are key to the regulation of homeostasis and likely contribute to aging and tumorigenesis when altered during adulthood.	[Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Ann Arbor, MI 48109 USA; [Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Spradling, Allan C.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Spradling, Allan C.] Carnegie Inst Sci, Howard Hughes Med Inst, Baltimore, MD 21218 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Carnegie Institution for Science; Carnegie Institution for Science; Howard Hughes Medical Institute	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Ann Arbor, MI 48109 USA.	seanjm@med.umich.edu; spradling@ciwemb.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gilboa L, 2006, NATURE, V443, P97, DOI 10.1038/nature05068; Gonczy P, 1997, DEVELOPMENT, V124, P4361; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; HARRISON DE, 1987, BLOOD, V69, P773; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Kirilly D, 2005, DEV CELL, V9, P651, DOI 10.1016/j.devcel.2005.09.013; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lopez-Onieva L, 2008, DEVELOPMENT, V135, P533, DOI 10.1242/dev.016121; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; NYSTUL T, 2007, SCIENCE, V315, P988; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; ROGERS MV, 1994, NEUROSCIENCE, V60, P479, DOI 10.1016/0306-4522(94)90259-3; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yang FC, 2003, J CLIN INVEST, V112, P1851, DOI 10.1172/JCI200319195; Yang FC, 2006, HUM MOL GENET, V15, P2421, DOI 10.1093/hmg/ddl165; Yoshida S, 2007, ANN NY ACAD SCI, V1120, P47, DOI 10.1196/annals.1411.003; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	116	1364	1419	7	254	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					598	611		10.1016/j.cell.2008.01.038	http://dx.doi.org/10.1016/j.cell.2008.01.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295578	Green Accepted, Bronze			2022-12-28	WOS:000253817900020
J	Murry, CE; Keller, G				Murry, Charles E.; Keller, Gordon			Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development	CELL			English	Review							VENTRAL MESENCEPHALIC TISSUE; IN-VITRO; PRIMITIVE STREAK; PROGENITOR CELLS; DIRECTED DIFFERENTIATION; YOLK-SAC; DOPAMINE NEURONS; SMOOTH-MUSCLE; GROWTH-FACTOR; HEMATOPOIETIC DIFFERENTIATION	The potential to generate virtually any differentiated cell type from embryonic stem cells (ESCs) offers the possibility to establish new models of mammalian development and to create new sources of cells for regenerative medicine. To realize this potential, it is essential to be able to control ESC differentiation and to direct the development of these cells along specific pathways. Embryology has offered important insights into key pathways regulating ESC differentiation, resulting in advances in modeling gastrulation in culture and in the efficient induction of endoderm, mesoderm, and ectoderm and many of their downstream derivatives. This has led to the identification of new multipotential progenitors for the hematopoietic, neural, and cardiovascular lineages and to the development of protocols for the efficient generation of a broad spectrum of cell types including hematopoietic cells, cardiomyocytes, oligodendrocytes, dopamine neurons, and immature pancreatic beta cells. The next challenge will be to demonstrate the functional utility of these cells, both in vitro and in preclinical models of human disease.	[Murry, Charles E.] Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Keller, G (corresponding author), McEwen Ctr Regenerat Med, Univ Hlth Network, MaRS Ctr, Toronto Med Discovery Tower,8th Floor,Room 8-706,, Toronto, ON M5G 1L7, Canada.	gkeller@uhnresearch.ca		Keller, Gordon/0000-0001-9309-9297				Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; Brolen GKC, 2005, DIABETES, V54, P2867, DOI 10.2337/diabetes.54.10.2867; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Burt RK, 2004, J EXP MED, V199, P895, DOI 10.1084/jem.20031916; Cabrera CM, 2006, CYTOTHERAPY, V8, P517, DOI 10.1080/14653240600944287; Cai J, 2007, CYTOTHERAPY, V9, P283, DOI 10.1080/14653240701247838; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; Choi K, 1998, DEVELOPMENT, V125, P725; Cicchetti F, 2002, EXP NEUROL, V177, P376, DOI 10.1006/exnr.2002.8007; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; CONLON FL, 1994, DEVELOPMENT, V120, P1919; CONTRERAS JL, 2002, KIDNEY INT S1, V61, P79; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dai W, 2007, J MOL CELL CARDIOL, V43, P504, DOI 10.1016/j.yjmcc.2007.07.001; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Davidson KC, 2007, MOL CELL NEUROSCI, V36, P408, DOI 10.1016/j.mcn.2007.07.013; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Drukker M, 2004, SPRINGER SEMIN IMMUN, V26, P201, DOI 10.1007/s00281-004-0163-5; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; DUSH MK, 1992, DEV BIOL, V151, P273, DOI 10.1016/0012-1606(92)90232-6; Dzierzak E, 2005, CURR OPIN HEMATOL, V12, P197, DOI 10.1097/01.moh.0000160736.44726.0e; Ebert SN, 2007, STEM CELLS, V25, P2936, DOI 10.1634/stemcells.2007-0216; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Emgard M, 2003, J NEUROCHEM, V86, P1223, DOI 10.1046/j.1471-4159.2003.01931.x; ERA T, 2007, IN PRESS STEM CELLS; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Forlani S, 2003, DEVELOPMENT, V130, P3807, DOI 10.1242/dev.00573; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Galic Z, 2006, P NATL ACAD SCI USA, V103, P11742, DOI 10.1073/pnas.0604244103; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Goy RL, 2007, EXPERT OPIN BIOL TH, V7, P1487, DOI 10.1517/14712598.7.10.1487; Graichen R, 2008, DIFFERENTIATION, V76, P357, DOI 10.1111/j.1432-0436.2007.00236.x; Guerette B, 1997, J IMMUNOL, V159, P2522; Hagell P, 2002, NAT NEUROSCI, V5, P627, DOI 10.1038/nn863; Hart AH, 2002, DEVELOPMENT, V129, P3597; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Joannides AJ, 2007, STEM CELLS, V25, P731, DOI 10.1634/stemcells.2006-0562; Kang SM, 2007, STEM CELLS, V25, P419, DOI 10.1634/stemcells.2005-0482; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kim DS, 2007, CELL TRANSPLANT, V16, P117; Kimura H, 2005, NEUROL RES, V27, P812, DOI 10.1179/016164105X63629; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; KISPERT A, 1994, DEV BIOL, V161, P179, DOI 10.1006/dbio.1994.1019; Klug MG, 1995, AM J PHYSIOL-HEART C, V269, pH1913, DOI 10.1152/ajpheart.1995.269.6.H1913; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Lindvall O, 2001, CLIN CHEM LAB MED, V39, P356, DOI 10.1515/CCLM.2001.056; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; Marchionini DM, 2004, CELL TRANSPLANT, V13, P273, DOI 10.3727/000000004783983972; Maye P, 2004, DEV BIOL, V265, P276, DOI 10.1016/j.ydbio.2003.09.027; McDevitt TC, 2005, J MOL CELL CARDIOL, V39, P865, DOI 10.1016/j.yjmcc.2005.09.007; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Menendez P, 2005, STEM CELL REV, V1, P151, DOI 10.1385/SCR:1:2:151; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Murtuza B, 2004, P NATL ACAD SCI USA, V101, P4216, DOI 10.1073/pnas.0306205101; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakano M, 2004, PANCREAS, V29, P104, DOI 10.1097/00006676-200408000-00004; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Narayan AD, 2006, BLOOD, V107, P2180, DOI 10.1182/blood-2005-05-1922; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Olsen AL, 2006, BLOOD, V107, P1265, DOI 10.1182/blood-2005-09-3621; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Priddle H, 2006, STEM CELLS, V24, P815, DOI 10.1634/stemcells.2005-0356; Qiu CH, 2008, BLOOD, V111, P2400, DOI 10.1182/blood-2007-07-102087; Rao BM, 2005, CURR OPIN BIOTECH, V16, P568, DOI 10.1016/j.copbio.2005.08.001; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rodriguez-Gomez JA, 2007, STEM CELLS, V25, P918, DOI 10.1634/stemcells.2006-0386; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; SASAKI H, 1993, DEVELOPMENT, V118, P47; Satin J, 2004, J PHYSIOL-LONDON, V559, P479, DOI 10.1113/jphysiol.2004.068213; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schierle GS, 1999, NAT MED, V5, P97, DOI 10.1038/4785; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Shim JH, 2007, DIABETOLOGIA, V50, P1228, DOI 10.1007/s00125-007-0634-z; Shin S, 2007, STEM CELLS, V25, P1298, DOI 10.1634/stemcells.2006-0660; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1308, DOI 10.1152/ajpheart.01277.2006; Skuk D, 2003, J NEUROPATH EXP NEUR, V62, P951, DOI 10.1093/jnen/62.9.951; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003; Spence JR, 2007, DEV DYNAM, V236, P3218, DOI 10.1002/dvdy.21366; Stevens KR, 2007, HUM GENE THER, V18, P401, DOI 10.1089/hum.2006.161; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tavian M, 2005, INT J DEV BIOL, V49, P243, DOI 10.1387/ijdb.041957mt; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian XH, 2006, STEM CELLS, V24, P1370, DOI 10.1634/stemcells.2005-0340; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Weinreich MA, 2006, BLOOD, V108, P3713, DOI 10.1182/blood-2006-01-012278; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; Woll PS, 2008, BLOOD, V111, P122, DOI 10.1182/blood-2007-04-084186; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yurek DM, 2004, CELL TRANSPLANT, V13, P295, DOI 10.3727/000000004783983954; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zandstra PW, 2003, TISSUE ENG, V9, P767, DOI 10.1089/107632703768247449; Zeineddine D, 2005, METH MOLEC MED, V112, P175; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	169	1239	1291	6	277	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					661	680		10.1016/j.cell.2008.02.008	http://dx.doi.org/10.1016/j.cell.2008.02.008			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295582	Bronze			2022-12-28	WOS:000253817900024
J	Vahisalu, T; Kollist, H; Wang, YF; Nishimura, N; Chan, WY; Valerio, G; Lamminmaki, A; Brosche, M; Moldau, H; Desikan, R; Schroeder, JI; Kangasjarvi, J				Vahisalu, Triin; Kollist, Hannes; Wang, Yong-Fei; Nishimura, Noriyuki; Chan, Wai-Yin; Valerio, Gabriel; Lamminmaki, Airi; Brosche, Mikael; Moldau, Heino; Desikan, Radhika; Schroeder, Julian I.; Kangasjarvi, Jaakko			SLAC1 is required for plant guard cell S-type anion channel function in stomatal signalling	NATURE			English	Article							ABSCISIC-ACID; PLASMA-MEMBRANE; ION CHANNELS; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; VICIA-FABA; CLOSURE; OZONE; MUTANT; TRANSDUCTION	Stomatal pores, formed by two surrounding guard cells in the epidermis of plant leaves, allow influx of atmospheric carbon dioxide in exchange for transpirational water loss. Stomata also restrict the entry of ozone - an important air pollutant that has an increasingly negative impact on crop yields, and thus global carbon fixation(1) and climate change(2). The aperture of stomatal pores is regulated by the transport of osmotically active ions and metabolites across guard cell membranes(3,4). Despite the vital role of guard cells in controlling plant water loss(3,4), ozone sensitivity(1,2) and CO2 supply(2,5-7), the genes encoding some of the main regulators of stomatal movements remain unknown. It has been proposed that guard cell anion channels function as important regulators of stomatal closure and are essential in mediating stomatal responses to physiological and stress stimuli(3,4,8). However, the genes encoding membrane proteins that mediate guard cell anion efflux have not yet been identified. Here we report the mapping and characterization of an ozone- sensitive Arabidopsis thaliana mutant, slac1. We show that SLAC1 ( SLOW ANION CHANNEL- ASSOCIATED 1) is preferentially expressed in guard cells and encodes a distant homologue of fungal and bacterial dicarboxylate/ malic acid transport proteins. The plasma membrane protein SLAC1 is essential for stomatal closure in response to CO2, abscisic acid, ozone, light/ dark transitions, humidity change, calcium ions, hydrogen peroxide and nitric oxide. Mutations in SLAC1 impair slow ( S- type) anion channel currents that are activated by cytosolic Ca2(+) and abscisic acid, but do not affect rapid ( R- type) anion channel currents or Ca2+ channel function. A low homology of SLAC1 to bacterial and fungal organic acid transport proteins, and the permeability of S- type anion channels to malate(9) suggest a vital role for SLAC1 in the function of S- type anion channels.	[Vahisalu, Triin; Kollist, Hannes; Lamminmaki, Airi; Brosche, Mikael; Kangasjarvi, Jaakko] Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland; [Vahisalu, Triin] Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, EE-51005 Tartu, Estonia; [Kollist, Hannes; Moldau, Heino] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia; [Wang, Yong-Fei; Nishimura, Noriyuki; Chan, Wai-Yin; Valerio, Gabriel; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Desikan, Radhika] Univ W England, Ctr Res Plant Sci, Bristol BS16 1QY, Avon, England	University of Helsinki; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Tartu; University of California System; University of California San Diego; University of West England	Kangasjarvi, J (corresponding author), Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland.	jaakko.kangasjarvi@helsinki.fi	Kangasjärvi, Jaakko/AAP-8639-2021; Kollist, Hannes/X-1446-2019; Kollist, Hannes/P-1548-2016; Brosché, Mikael/H-2260-2015; Kangasjärvi, Jaakko/A-3024-2015; Vahisalu, Triin/AAS-5223-2020; Nishimura, Noriyuki/E-3580-2010; Vahisalu, Triin/AAK-2337-2020	Kangasjärvi, Jaakko/0000-0002-8959-1809; Kollist, Hannes/0000-0002-6895-3583; Kollist, Hannes/0000-0002-6895-3583; Brosché, Mikael/0000-0002-1135-2496; Kangasjärvi, Jaakko/0000-0002-8959-1809; Vahisalu, Triin/0000-0001-6050-0320; Nishimura, Noriyuki/0000-0003-2946-3124; Schroeder, Julian/0000-0002-3283-5972; Lamminmaki, Airi/0000-0002-6133-8553	NIEHS NIH HHS [P42 ES010337-070008, P42 ES010337] Funding Source: Medline; NIGMS NIH HHS [R01 GM060396-07, R01 GM060396] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen GJ, 2002, PLANT CELL, V14, P1649, DOI 10.1105/tpc.010448; Allen GJ, 2001, NATURE, V411, P1053, DOI 10.1038/35082575; Camarasa C, 2001, APPL ENVIRON MICROB, V67, P4144, DOI 10.1128/AEM.67.9.4144-4151.2001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Desikan R, 2002, P NATL ACAD SCI USA, V99, P16314, DOI 10.1073/pnas.252461999; Frachisse JM, 1999, PLANT PHYSIOL, V121, P253, DOI 10.1104/pp.121.1.253; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hopkin M, 2007, NATURE, V448, P396, DOI 10.1038/448396b; Janausch IG, 2001, ARCH MICROBIOL, V176, P224, DOI 10.1007/s002030100317; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; KELLER BU, 1989, NATURE, V341, P450, DOI 10.1038/341450a0; Kollist T, 2007, PHYSIOL PLANTARUM, V129, P796, DOI 10.1111/j.1399-3054.2006.00851.x; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Li Y, 2004, PLANT SCI, V166, P415, DOI 10.1016/j.plantsci.2003.10.008; LINDER B, 1992, FEBS LETT, V313, P27, DOI 10.1016/0014-5793(92)81176-M; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; MACROBBIE EAC, 1981, J EXP BOT, V32, P545, DOI 10.1093/jxb/32.3.545; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; Pandey S, 2007, FEBS LETT, V581, P2325, DOI 10.1016/j.febslet.2007.04.008; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; SCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9535, DOI 10.1073/pnas.92.21.9535; SCHMIDT C, 1994, PLANT PHYSIOL, V106, P383, DOI 10.1104/pp.106.1.383; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Suh SJ, 2007, J BIOL CHEM, V282, P1916, DOI 10.1074/jbc.M607926200; Suntio T. M., 1994, Plant Molecular Biology Reporter, V12, P43, DOI 10.1007/BF02668663; TAYLOR DE, 1994, J BACTERIOL, V176, P2740, DOI 10.1128/JB.176.9.2740-2742.1994; Torsethaugen G, 1999, P NATL ACAD SCI USA, V96, P13577, DOI 10.1073/pnas.96.23.13577; VANKIRK CA, 1978, PLANT PHYSIOL, V61, P474, DOI 10.1104/pp.61.3.474; Webb AAR, 1997, PLANT PHYSIOL, V114, P1557, DOI 10.1104/pp.114.4.1557; Weigel D., 2002, ARABIDOPSIS LAB MANU; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; YANG Y, IN PRESS BMC PL METH; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	43	567	593	11	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2008	452	7186					487	U15		10.1038/nature06608	http://dx.doi.org/10.1038/nature06608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18305484	Green Accepted			2022-12-28	WOS:000254341300035
J	Tanaka, JI; Horiike, Y; Matsuzaki, M; Miyazaki, T; Ellis-Davies, GCR; Kasai, H				Tanaka, Jun-ichi; Horiike, Yoshihiro; Matsuzaki, Masanori; Miyazaki, Takashi; Ellis-Davies, Graham C. R.; Kasai, Haruo			Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines	SCIENCE			English	Article							LONG-TERM POTENTIATION; LTP; POLYRIBOSOMES; LOCALIZATION; HIPPOCAMPUS; GEOMETRY; BDNF; RAT	Long- term potentiation ( LTP) at glutamatergic synapses is considered to underlie learning and memory and is associated with the enlargement of dendritic spines. Because the consolidation of memory and LTP require protein synthesis, it is important to clarify how protein synthesis affects spine enlargement. In rat brain slices, the repetitive pairing of postsynaptic spikes and two- photon uncaging of glutamate at single spines ( a spike- timing protocol) produced both immediate and gradual phases of spine enlargement in CA1 pyramidal neurons. The gradual enlargement was strongly dependent on protein synthesis and brain- derived neurotrophic factor ( BDNF) action, often associated with spine twitching, and was induced specifically at the spines that were immediately enlarged by the synaptic stimulation. Thus, this spike- timing protocol is an efficient trigger for BDNF secretion and induces protein synthesis- dependent long- term enlargement at the level of single spines.	[Tanaka, Jun-ichi; Horiike, Yoshihiro; Matsuzaki, Masanori; Miyazaki, Takashi; Kasai, Haruo] Univ Tokyo, Lab Struct Physiol, Ctr Dis Biol & Integrat Med, Grad Sch Med, Tokyo 1130033, Japan; [Tanaka, Jun-ichi; Horiike, Yoshihiro; Matsuzaki, Masanori; Miyazaki, Takashi; Kasai, Haruo] Univ Tokyo, Ctr Nanobio Integrat, Tokyo 1130033, Japan; [Tanaka, Jun-ichi; Matsuzaki, Masanori; Miyazaki, Takashi; Kasai, Haruo] Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448787, Japan; [Tanaka, Jun-ichi; Matsuzaki, Masanori; Miyazaki, Takashi; Kasai, Haruo] Grad Univ Adv Studies SOKENDAI, Okazaki, Aichi 4448787, Japan; [Matsuzaki, Masanori] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Ellis-Davies, Graham C. R.] Drexel Univ, Coll Med, Dept Pharmacol & Physiol, Philadelphia, PA 19102 USA	University of Tokyo; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Drexel University	Kasai, H (corresponding author), Univ Tokyo, Lab Struct Physiol, Ctr Dis Biol & Integrat Med, Grad Sch Med, Tokyo 1130033, Japan.	hkasai@m.u-tokyo.ac.jp		Kasai, Haruo/0000-0003-2327-9027; Matsuzaki, Masanori/0000-0003-3872-4322	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395, R24GM065473] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053395-12, R01 GM053395, R24 GM065473] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aicardi G, 2004, P NATL ACAD SCI USA, V101, P15788, DOI 10.1073/pnas.0406960101; Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Santamaria F, 2006, NEURON, V52, P635, DOI 10.1016/j.neuron.2006.10.025; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Squire L. R., 1987, MEMORY BRAIN; STEWARD O, 1982, J NEUROSCI, V2, P284; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	23	449	468	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1683	1687		10.1126/science.1152864	http://dx.doi.org/10.1126/science.1152864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18309046	Green Accepted			2022-12-28	WOS:000254172300046
J	Caro, G; Bourdon, B; Halliday, AN; Quitte, G				Caro, Guillaume; Bourdon, Bernard; Halliday, Alex N.; Quitte, Ghylaine			Super-chondritic Sm/Nd ratios in Mars, the Earth and the Moon	NATURE			English	Article							EARLY DIFFERENTIATION; ISOTOPE SYSTEMATICS; MARTIAN METEORITES; CORE FORMATION; MAGMA OCEAN; NEODYMIUM; EVOLUTION; SAMARIUM; HETEROGENEITY; CHRONOLOGY	Small isotopic differences in the atomic abundance of neodymium-142 (Nd-142) in silicate rocks represent the time- averaged effect of decay of formerly live samarium- 146 (Sm-146) and provide constraints on the timescales and mechanisms by which planetary mantles first differentiated(1-4). This chronology, however, assumes that the composition of the total planet is identical to that of primitive undifferentiated meteorites called chondrites. The difference in the Nd-142/Nd-144 ratio between chondrites and terrestrial samples may therefore indicate very early isolation (<30Myr from the formation of the Solar System) of the upper mantle or a slightly non- chondritic bulk Earth composition(5,6). Here we present high-precision Nd-142 data for 16 martian meteorites and show that Mars also has a non- chondritic composition. Meteorites belonging to the shergottite subgroup define a planetary isochron yielding an age of differentiation of 40 +/- 18 Myr for the martian mantle. This isochron does not pass through the chondritic reference value ( 100 x epsilon Nd-142 = -21 +/- 3; Sm-147/Nd-144 = 0.1966)(6). The Earth, Moon and Mars all seem to have accreted in a portion of the inner Solar System with similar to 5 per cent higher Sm/Nd ratios than material accreted in the asteroid belt. Such chemical heterogeneities may have arisen from sorting of nebular solids or from impact erosion of crustal reservoirs in planetary precursors. The Nd-143 composition of the primitive mantle so defined by Nd-142 is strikingly similar to the putative endmember component 'FOZO' characterized by high He-3/He-4 ratios(7,8).	[Caro, Guillaume] Univ Paris 07, Lab Geochim & Cosmochimie, Inst Phys Globe, F-75252 Paris 05, France; [Bourdon, Bernard] ETH, Inst Isotope Geochem & Mineral Resources, CH-8092 Zurich, Switzerland; [Halliday, Alex N.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Quitte, Ghylaine] Ecole Normale Super Lyon, Lab Sci Terre, F-69364 Lyon 7, France	UDICE-French Research Universities; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford; Ecole Normale Superieure de Lyon (ENS de LYON)	Caro, G (corresponding author), Univ Paris 07, Lab Geochim & Cosmochimie, Inst Phys Globe, 4 Pl Jussieu, F-75252 Paris 05, France.	caro@crpg.cnrs-nancy.fr	Quitté, Ghylaine/N-8888-2013; Bourdon, Bernard/A-3303-2008		Science and Technology Facilities Council [PP/D001250/1] Funding Source: researchfish; STFC [PP/D001250/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Agnor C, 2004, ASTROPHYS J, V613, pL157, DOI 10.1086/425158; Andreasen R, 2008, EARTH PLANET SC LETT, V266, P14, DOI 10.1016/j.epsl.2007.10.009; Andreasen R, 2006, SCIENCE, V314, P806, DOI 10.1126/science.1131708; Borg LE, 2003, GEOCHIM COSMOCHIM AC, V67, P3519, DOI 10.1016/S0016-7037(03)00094-2; Bourdon B, 2007, CR GEOSCI, V339, P928, DOI 10.1016/j.crte.2007.09.002; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2007, EARTH PLANET SC LETT, V262, P505, DOI 10.1016/j.epsl.2007.08.009; Boyet M, 2006, EARTH PLANET SC LETT, V250, P254, DOI 10.1016/j.epsl.2006.07.046; Carlson RW, 2007, SCIENCE, V316, P1175, DOI 10.1126/science.1140189; Caro G, 2006, GEOCHIM COSMOCHIM AC, V70, P164, DOI 10.1016/j.gca.2005.08.015; Caro G, 2005, NATURE, V436, P246, DOI 10.1038/nature03827; Caro G, 2003, NATURE, V423, P428, DOI 10.1038/nature01668; Cuzzi JN, 2001, ASTROPHYS J, V546, P496, DOI 10.1086/318233; Debaille V, 2007, NATURE, V450, P525, DOI 10.1038/nature06317; Foley CN, 2005, GEOCHIM COSMOCHIM AC, V69, P4557, DOI 10.1016/j.gca.2005.05.009; HARPER CL, 1992, NATURE, V360, P728, DOI 10.1038/360728a0; HARPER CL, 1995, SCIENCE, V267, P213, DOI 10.1126/science.7809625; HART SR, 1992, SCIENCE, V256, P517, DOI 10.1126/science.256.5056.517; Hewins RH, 1996, EARTH PLANET SC LETT, V144, P1, DOI 10.1016/0012-821X(96)00159-8; JACOBSEN SB, 1984, EARTH PLANET SC LETT, V67, P137, DOI 10.1016/0012-821X(84)90109-2; Jagoutz E, 2000, METEORIT PLANET SCI, V35, pA83; JAGOUTZ E, 1991, SPACE SCI REV, V56, P13, DOI 10.1007/BF00178386; Kellogg JB, 2002, EARTH PLANET SC LETT, V204, P183, DOI 10.1016/S0012-821X(02)00981-0; Kleine T, 2004, GEOCHIM COSMOCHIM AC, V68, P2935, DOI 10.1016/j.gca.2004.01.009; Lee DC, 1997, NATURE, V388, P854, DOI 10.1038/42206; NYQUIST LE, 1995, GEOCHIM COSMOCHIM AC, V59, P2817, DOI 10.1016/0016-7037(95)00175-Y; PRINZHOFER A, 1992, GEOCHIM COSMOCHIM AC, V56, P797, DOI 10.1016/0016-7037(92)90099-5; Ranen MC, 2006, SCIENCE, V314, P809, DOI 10.1126/science.1132595; Rankenburg K, 2006, SCIENCE, V312, P1369, DOI 10.1126/science.1126114; Stracke A, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000824	30	125	130	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					336	339		10.1038/nature06760	http://dx.doi.org/10.1038/nature06760			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354479				2022-12-28	WOS:000254117400043
J	Binder, EB; Bradley, RG; Liu, W; Epstein, MP; Deveau, TC; Mercer, KB; Tang, Y; Gillespie, CF; Heim, CM; Nemeroff, CB; Schwartz, AC; Cubells, JF; Ressler, KJ				Binder, Elisabeth B.; Bradley, Rebekah G.; Liu, Wei; Epstein, Michael P.; Deveau, Todd C.; Mercer, Kristina B.; Tang, Yilang; Gillespie, Charles F.; Heim, Christine M.; Nemeroff, Charles B.; Schwartz, Ann C.; Cubells, Joseph F.; Ressler, Kerry J.			Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORTICOTROPIN-RELEASING-FACTOR; TRAUMA EXPOSURE; GLUCOCORTICOID-RECEPTOR; MENTAL-HEALTH; PSYCHOMETRIC PROPERTIES; ADVERSE EXPERIENCES; IMMUNOPHILIN FKBP51; ANXIETY DISORDERS; PHYSICAL ABUSE; PRIMARY-CARE	Context In addition to trauma exposure, other factors contribute to risk for development of posttraumatic stress disorder ( PTSD) in adulthood. Both genetic and environmental factors are contributory, with child abuse providing significant risk liability. Objective To increase understanding of genetic and environmental risk factors as well as their interaction in the development of PTSD by gene x environment interactions of child abuse, level of non - child abuse trauma exposure, and genetic polymorphisms at the stress- related gene FKBP5. Design, Setting, and Participants A cross- sectional study examining genetic and psychological risk factors in 900 nonpsychiatric clinic patients ( 762 included for all genotype studies) with significant levels of childhood abuse as well as non - child abuse trauma using a verbally presented survey combined with single- nucleotide polymorphism ( SNP) genotyping. Participants were primarily urban, low- income, black ( > 95%) men and women seeking care in the general medical care and obstetrics- gynecology clinics of an urban public hospital in Atlanta, Georgia, between 2005 and 2007. Main Outcome Measures Severity of adult PTSD symptomatology, measured with the modified PTSD Symptom Scale, non - child abuse (primarily adult) trauma exposure and child abuse measured using the traumatic events inventory and 8 SNPs spanning the FKBP5 locus. Results Level of child abuse and non - child abuse trauma each separately predicted level of adult PTSD symptomatology ( mean [ SD], PTSD Symptom Scale for no child abuse, 8.03 [ 10.48] vs >= 2 types of abuse, 20.93 [ 14.32]; and for no non - child abuse trauma, 3.58 [ 6.27] vs >= 4 types, 16.74 [ 12.90]; P <. 001). Although FKBP5 SNPs did not directly predict PTSD symptom outcome or interact with level of non - child abuse trauma to predict PTSD symptom severity, 4 SNPs in the FKBP5 locus significantly interacted ( rs9296158, rs3800373, rs1360780, and rs9470080; minimum P=. 0004) with the severity of child abuse to predict level of adult PTSD symptoms after correcting for multiple testing. This gene x environment interaction remained significant when controlling for depression severity scores, age, sex, levels of non - child abuse trauma exposure, and genetic ancestry. This genetic interaction was also paralleled by FKBP5 genotype- dependent and PTSD- dependent effects on glucocorticoid receptor sensitivity, measured by the dexamethasone suppression test. Conclusions Four SNPs of the FKBP5 gene interacted with severity of child abuse as a predictor of adult PTSD symptoms. There were no main effects of the SNPs on PTSD symptoms and no significant genetic interactions with level of non - child abuse trauma as predictor of adult PTSD symptoms, suggesting a potential gene- childhood environment interaction for adult PTSD.	[Ressler, Kerry J.] Emory Univ, Howard Hughes Med Inst, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Binder, Elisabeth B.; Bradley, Rebekah G.; Liu, Wei; Deveau, Todd C.; Gillespie, Charles F.; Heim, Christine M.; Nemeroff, Charles B.; Schwartz, Ann C.; Cubells, Joseph F.; Ressler, Kerry J.] Emory Univ, Dept Psychiat & Behav Sci, Sch Med, Atlanta, GA 30329 USA; [Binder, Elisabeth B.; Epstein, Michael P.; Mercer, Kristina B.; Tang, Yilang; Cubells, Joseph F.] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30329 USA; [Liu, Wei] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Bradley, Rebekah G.] Atlanta VA Med Ctr, Atlanta, GA USA; [Ressler, Kerry J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Emory University; Howard Hughes Medical Institute; Emory University; Emory University; Beijing Institute of Microbiology & Epidemiology; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Howard Hughes Medical Institute	Ressler, KJ (corresponding author), Emory Univ, Howard Hughes Med Inst, Yerkes Natl Primate Res Ctr, 954 Gatewood Dr, Atlanta, GA 30329 USA.	kressle@emory.edu	Heim, Christine/A-1183-2009; Ressler, Kerry J/N-8741-2018; Binder, Elisabeth B/K-8905-2014; Bradley, Bekh/H-8399-2012; Cubells, Joe F./V-2543-2018; Gillespie, Charles F/G-8481-2012; Heim, Christine/J-4693-2014; Tang, Yilang/AAH-7164-2020	Ressler, Kerry J/0000-0002-5158-1103; Gillespie, Charles F/0000-0001-5476-5920; Heim, Christine/0000-0002-6580-6326; Nemeroff, Charles/0000-0001-7867-1160; Tang, Yi-lang/0000-0003-0958-7904	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH071537, K01MH069884, R01MH042088, R01MH071537, P50MH058922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA015766] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alim TN, 2006, J NATL MED ASSOC, V98, P1630; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Bachmann AW, 2005, PSYCHONEUROENDOCRINO, V30, P297, DOI 10.1016/j.psyneuen.2004.08.006; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; BLALOCK H, 1972, SOCIAL STAT, P406; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; BREMNER JD, 1993, AM J PSYCHIAT, V150, P235; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3; Broekman BFP, 2007, NEUROSCI BIOBEHAV R, V31, P348, DOI 10.1016/j.neubiorev.2006.10.001; Carpenter LL, 2004, NEUROPSYCHOPHARMACOL, V29, P777, DOI 10.1038/sj.npp.1300375; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CHAKRABORTY R, 1986, AM J PHYS ANTHROPOL, V70, P489, DOI 10.1002/ajpa.1330700408; Coffey SF, 1998, J TRAUMA STRESS, V11, P393, DOI 10.1023/A:1024467507565; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; Davidson JRT, 2004, J NEUROPSYCH CLIN N, V16, P135, DOI 10.1176/appi.neuropsych.16.2.135; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Dong MX, 2004, CHILD ABUSE NEGLECT, V28, P771, DOI 10.1016/j.chiabu.2004.01.008; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; Falsetti SA., 1993, BEHAV THERAPIST, V16, P161, DOI DOI 10.1037/T05175-000; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Foley DL, 2004, ARCH GEN PSYCHIAT, V61, P738, DOI 10.1001/archpsyc.61.7.738; Frudakis T, 2003, J FORENSIC SCI, V48, P771; Gillespie CF, 2005, CNS SPECTRUMS, V10, P831, DOI 10.1017/S1092852900010439; Gillespie CF, 2005, CURR PSYCHIAT, V4, P15; Gillespie NA, 2005, PSYCHOL MED, V35, P101, DOI 10.1017/S0033291704002727; Grabe HJ, 2005, MOL PSYCHIATR, V10, P220, DOI 10.1038/sj.mp.4001555; Green BL, 2000, J TRAUMA STRESS, V13, P271, DOI 10.1023/A:1007758711939; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heim Christine, 2002, Semin Clin Neuropsychiatry, V7, P147, DOI 10.1053/scnp.2002.33127; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; Kaufman J, 2004, P NATL ACAD SCI USA, V101, P17316, DOI 10.1073/pnas.0404376101; Kaufman J, 2006, BIOL PSYCHIAT, V59, P673, DOI 10.1016/j.biopsych.2005.10.026; Keane TM, 2006, ANNU REV CLIN PSYCHO, V2, P161, DOI 10.1146/annurev.clinpsy.2.022305.095305; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kilpatrick DG, 2007, AM J PSYCHIAT, V164, P1693, DOI 10.1176/appi.ajp.2007.06122007; Koenen KC, 2007, J TRAUMA STRESS, V20, P737, DOI 10.1002/jts.20205; Koenen KC, 2005, MOL PSYCHIATR, V10, P1058, DOI 10.1038/sj.mp.4001727; Koenen KC, 2003, TWIN RES, V6, P218, DOI 10.1375/136905203765693870; Ladd CO, 2000, PROG BRAIN RES, V122, P81; Lang AJ, 2006, CHILD ABUSE NEGLECT, V30, P1281, DOI 10.1016/j.chiabu.2006.06.005; Liebschutz J, 2007, J GEN INTERN MED, V22, P719, DOI 10.1007/s11606-007-0161-0; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Newport DJ, 2004, BIOL PSYCHIAT, V55, P10, DOI 10.1016/S0006-3223(03)00692-9; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pitman RK, 2005, CNS SPECTRUMS, V10, P99, DOI 10.1017/S109285290001943X; Plotsky PM, 2005, NEUROPSYCHOPHARMACOL, V30, P2192, DOI 10.1038/sj.npp.1300769; Roemer L, 1998, J TRAUMA STRESS, V11, P597, DOI 10.1023/A:1024469116047; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Scammell JG, 2001, GEN COMP ENDOCR, V124, P152, DOI 10.1006/gcen.2001.7696; Schiene-Fischer C, 2001, FEBS LETT, V495, P1, DOI 10.1016/S0014-5793(01)02326-2; Schilling EA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-30; Schwartz AC, 2006, PSYCHOSOMATICS, V47, P136, DOI 10.1176/appi.psy.47.2.136; Schwartz AC, 2005, PSYCHIAT SERV, V56, P212, DOI 10.1176/appi.ps.56.2.212; Segman RH, 2005, MOL PSYCHIATR, V10, P500, DOI 10.1038/sj.mp.4001636; Segman RH, 2003, CNS SPECTRUMS, V8, P693, DOI 10.1017/S1092852900008889; Shriver Mark D., 2005, Human Genomics, V2, P81; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Stovall-McClough KC, 2006, J CONSULT CLIN PSYCH, V74, P219, DOI 10.1037/0022-006X.74.2.219; *US DEP HHS, 2007, CHILD MALTR 2005, V16; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Watts-English T, 2006, J SOC ISSUES, V62, P717, DOI 10.1111/j.1540-4560.2006.00484.x; Widom CS, 2006, BIOL PSYCHIAT, V60, P684, DOI 10.1016/j.biopsych.2006.03.039; Widom CS, 1999, AM J PSYCHIAT, V156, P1223; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Yehuda R, 2004, J CLIN PSYCHIAT, V65, P29; Yehuda R, 2004, BIOL PSYCHIAT, V55, P1110, DOI 10.1016/j.biopsych.2004.02.010; Yehuda R, 2004, AM J PSYCHIAT, V161, P1397, DOI 10.1176/appi.ajp.161.8.1397; YEHUDA R, 1991, BIOL PSYCHIAT, V30, P1031, DOI 10.1016/0006-3223(91)90123-4; YEHUDA R, 1995, AM J PSYCHIAT, V152, P1705; Yehuda R, 2001, DEV PSYCHOPATHOL, V13, P733, DOI 10.1017/S0954579401003170; Yehuda R, 2001, J PSYCHIAT RES, V35, P261, DOI 10.1016/S0022-3956(01)00032-2; Yehuda R, 2001, J CLIN PSYCHIAT, V62, P41; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901; [No title captured]	91	964	984	1	131	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1291	1305		10.1001/jama.299.11.1291	http://dx.doi.org/10.1001/jama.299.11.1291			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275NO	18349090	Green Accepted, Bronze			2022-12-28	WOS:000254079100020
J	Ellis, JM; Tan, HK; Gilbert, RE; Muller, DPR; Henley, W; Moy, R; Pumphrey, R; Ani, C; Davies, S; Edwards, V; Green, H; Salt, A; Logan, S				Ellis, Jill M.; Tan, Hooi Kuan; Gilbert, Ruth E.; Muller, David P. R.; Henley, William; Moy, Robert; Pumphrey, Rachel; Ani, Cornelius; Davies, Sarah; Edwards, Vanessa; Green, Heather; Salt, Alison; Logan, Stuart			Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VITAMIN-E; NUTRITIONAL SUPPLEMENTATION; OXIDATIVE STRESS; IN-VITRO; OXYGEN; METAANALYSIS; METABOLISM; MORTALITY; MINERALS	Objectives To assess whether supplementation with antioxidants, folinic acid, or both improves the psychomotor and language development of children with Down's syndrome. Design Randomised controlled trial with two by two factorial design. Setting Children living in the Midlands, Greater London, and the south west of England. Participants 156 infants aged under 7 months with trisomy 21. Intervention Daily oral supplementation with antioxidants (selenium 10 mu g, zinc 5 mg, vitamin A 0.9 mg, vitamin E 100 mg, and vitamin C 50 mg), folinic acid (0.1 mg), antioxidants and folinic acid combined, or placebo. Main outcome measures Griffiths developmental quotient and an adapted MacArthur communicative development inventory 18 months after starting supplementation; biochemical markers in blood and urine at age 12 months. Results Children randomised to antioxidant supplements attained similar developmental outcomes to those without antioxidants (mean Griffiths developmental quotient 57.3 v 56.1; adjusted mean difference 1.2 points, 95% confidence interval -2.2 to 4.6). Comparison of children randomised to folinic acid supplements or no folinic acid also showed no significant differences in Griffiths developmental quotient (mean 57.6 v 55.9; adjusted mean difference 1.7, -1.7 to 5.1). No between group differences were seen in the mean numbers of words said or signed: for antioxidants versus none the ratio of means was 0.85 (95% confidence interval 0.6 to 1.2), and for folinic acid versus none it was 1.24 (0.87 to 1.77). No significant differences were found between any of the groups in the biochemical outcomes measured. Adjustment for potential confounders did not appreciably change the results. Conclusions This study provides no evidence to support the use of antioxidant or folinic acid supplements in children with Down's syndrome. Trial registration Clinical trials NCT00378456.	[Edwards, Vanessa; Logan, Stuart] Peninsula Med Sch, Exeter EX1 2LU, Devon, England; [Ellis, Jill M.; Tan, Hooi Kuan; Gilbert, Ruth E.; Davies, Sarah; Salt, Alison] UCL, Inst Child Hlth, Ctr Evidence Based Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; [Muller, David P. R.; Green, Heather] UCL, Inst Child Hlth, Biochem Unit, London WC1N 1EH, England; [Henley, William] Univ Plymouth, Sch Math & Stat, Plymouth PL4 8AA, Devon, England; [Moy, Robert; Pumphrey, Rachel] Univ Birmingham, Inst Child Hlth, Birmingham B4 6NH, W Midlands, England; [Ani, Cornelius] Univ London Imperial Coll Sci Technol & Med, Acad Unit Child & Adolescent Psychiat, London W2 1PG, England	University of Exeter; University of London; University College London; University of London; University College London; University of Plymouth; University of Birmingham; Imperial College London	Logan, S (corresponding author), Peninsula Med Sch, St Lukes Campus, Exeter EX1 2LU, Devon, England.	stuart.logan@pms.ac.uk	Muller, David/C-1928-2008	Gilbert, Ruth/0000-0001-9347-2709	MRC [G0400546] Funding Source: UKRI; Medical Research Council [G0400546B] Funding Source: researchfish; Medical Research Council [G0400546] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; Ani C, 2000, DEV MED CHILD NEUROL, V42, P207, DOI 10.1017/S0012162200000359; BECKER L, 1991, PROG CLIN BIOL RES, V373, P133; BENNETT FC, 1983, PEDIATRICS, V72, P707; Bessard J, 2001, J CHROMATOGR B, V754, P333, DOI 10.1016/S0378-4347(00)00621-6; BIDDER RT, 1989, DEV MED CHILD NEUROL, V31, P532; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; BRAS A, 1989, OPHTHALMIC PAED GEN, V10, P271, DOI 10.3109/13816818909009882; BROOKSBANK BWL, 1984, DEV BRAIN RES, V16, P37, DOI 10.1016/0165-3806(84)90060-9; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; BUTTRISS JL, 1984, METHOD ENZYMOL, V105, P131, DOI 10.1016/S0076-6879(84)05018-7; *DEP HLTH, 1991, DIET REF VAL HLTH CH; *DOWNS SYNDR RES F, 2007, TARG NUTR INT DOWNS; Fenson L., 1993, MACARTHUR COMMUNICAT; GELB MJ, 2001, PADIATRICHE PRAXIS, V59, P703; Huang TH, 1998, J MED SCREEN, V5, P213, DOI 10.1136/jms.5.4.213; Jovanovic SV, 1998, FREE RADICAL BIO MED, V25, P1044, DOI 10.1016/S0891-5849(98)00137-3; KEDZIORA J, 1986, CLIN CHIM ACTA, V154, P191, DOI 10.1016/0009-8981(86)90030-6; KOLATA G, 1985, SCIENCE, V230, P1152, DOI 10.1126/science.2933807; Law J, 2004, FOLIA PHONIATR LOGO, V56, P199, DOI 10.1159/000078343; LEJEUNE J, 1990, AM J MED GENET, P20; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; METCALFE T, 1989, NEUROCHEM RES, V14, P1209, DOI 10.1007/BF00965511; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Montgomery Alan A, 2003, BMC Med Res Methodol, V3, P26, DOI 10.1186/1471-2288-3-26; Moore CS, 2007, MAMM GENOME, V18, P431, DOI 10.1007/s00335-007-9030-8; MURTHY DSK, 1989, ANN GENET-PARIS, V32, P47; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Podmore ID, 1998, NATURE, V392, P559, DOI 10.1038/33308; Pogribna M, 2001, AM J HUM GENET, V69, P88, DOI 10.1086/321262; Salman Michael, 2002, Eur J Paediatr Neurol, V6, P213, DOI 10.1053/ejpn.2002.0596; SINET PM, 1982, ANN NY ACAD SCI, V396, P83, DOI 10.1111/j.1749-6632.1982.tb26845.x; SMITH GF, 1984, J PEDIATR-US, V105, P228, DOI 10.1016/S0022-3476(84)80118-3; VASILIADES J, 1976, CLIN CHEM, V22, P1664; WEATHERS C, 1983, AM J MENT DEF, V88, P214	36	61	63	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2008	336	7644					594	597		10.1136/bmj.39465.544028.AE	http://dx.doi.org/10.1136/bmj.39465.544028.AE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18296460	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000254364500032
J	Young, J; De Sutter, A; Merenstein, D; van Essen, GA; Kaiser, L; Varonen, H; Williamson, I; Bucher, HC				Young, Jim; De Sutter, An; Merenstein, Dan; van Essen, Gerrit A.; Kaiser, Laurent; Varonen, Helena; Williamson, Ian; Bucher, Heiner C.			Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data	LANCET			English	Article							RESPIRATORY-TRACT INFECTIONS; ACUTE MAXILLARY SINUSITIS; GENERAL-PRACTICE; UNDERLYING RISK; PRIMARY-CARE; MARCH 20; AMOXICILLIN; RESISTANCE; PRINCIPLES; MANAGEMENT	Background Primary-care physicians continue to overprescribe antibiotics for acute rhinosinusitis because distinction between viral and bacterial sinus infection is difficult. We undertook a meta-analysis of randomised trials based on individual patients' data to assess whether common signs and symptoms can be used to identify a subgroup of patients who benefit from antibiotics. Methods We identified suitable trials-in which adult patients with rhinosinusitis-like complaints were randomly assigned to treatment with an antibiotic or a placebo-by searching the Cochrane Central Register of Controlled Trials, Medline, and Embase, and reference lists of reports describing such trials. Individual patients' data from 2547 adults in nine trials were checked and re-analysed. We assessed the overall effect of antibiotic treatment and the prognostic value of common signs and symptoms by the number needed to treat (NNT) with antibiotics to cure one additional patient. Findings 15 patients with rhinosinusitis-like complaints would have to be given antibiotics before an additional patient was cured (95% CI NNT[benefit] 7 to NNT[harm] 190). Patients with purulent discharge in the pharynx took longer to cure than those without this sign; the NNT was 8 patients with this sign before one additional patient was cured (95% CI NNT[benefit] 4 to NNT[harm] 47). Patients who were older, reported symptoms for longer, or reported more severe symptoms also took longer to cure but were no more likely to benefit from antibiotics than other patients. Interpretation Common clinical signs and symptoms cannot identify patients with rhinosinusitis for whom treatment is clearly justified. Antibiotics are not justified even if a patient reports symptoms for longer than 7-10 days.	[Young, Jim; Bucher, Heiner C.] Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland; [De Sutter, An] Univ Ghent, Dept Gen Practice & Primary Hlth Care, Ghent, Belgium; [Merenstein, Dan] Georgetown Univ, Med Ctr, Dept Family Med, Washington, DC 20007 USA; [van Essen, Gerrit A.] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Kaiser, Laurent] Univ Hosp Geneva, Dept Med, Div Infect Dis, Geneva, Switzerland; [Varonen, Helena] Univ Helsinki, Dept Gen Practice & Primary Care, Helsinki, Finland; [Williamson, Ian] Univ Southampton, Community Clin Sci Div, Fac Med, Southampton, Hants, England	University of Basel; Ghent University; Georgetown University; Utrecht University; University of Geneva; University of Helsinki; University of Southampton	Young, J (corresponding author), Univ Basel Hosp, Basel Inst Clin Epidemiol, Hebelstr 10, CH-4031 Basel, Switzerland.	jyoung@uhbs.ch		Young, Jim/0000-0002-4314-3007; Kaiser, Laurent/0000-0002-0857-2252				AHSEE K, 2005, CLIN EVID, V13, P646; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Andre M, 2002, SCAND J INFECT DIS, V34, P880, DOI 10.1080/0036554021000026952; Ashworth M, 2005, BRIT J GEN PRACT, V55, P603; BROSS IDJ, 1958, BIOMETRICS, V14, P18, DOI 10.2307/2527727; Bucher HC, 2003, ARCH INTERN MED, V163, P1793, DOI 10.1001/archinte.163.15.1793; Cherry DK, 2007, NATL AMBULATORY MED; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; de Ferranti SD, 1998, BMJ-BRIT MED J, V317, P632, DOI 10.1136/bmj.317.7159.632; De Sutter AI, 2002, J FAM PRACTICE, V51, P317; DESROSIERS M, 2002, J OTOLARYNGOL, V31, P2; DESUTTER AIM, 2006, COCHRANE DB SYST REV, V3; Fokkens W, 2007, RHINOLOGY, V45, P97; Gill JM, 2006, FAM MED, V38, P349; Gonzales R, 2001, ANN EMERG MED, V37, P690, DOI 10.1067/S0196-0644(01)70087-X; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hickner J, 2005, J FAM PRACTICE, V54, P152; Hickner JM, 2001, ANN EMERG MED, V37, P703; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; IP S, 2005, 124 AG HLTH CAR POL; Kaiser L, 2001, EUR J CLIN MICROBIOL, V20, P445, DOI 10.1007/s10096-001-8150-4; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klossek JM, 2005, INT J CLIN PRACT, V59, P230, DOI 10.1111/j.1742-1241.2005.00378.x; KUNIN CM, 1993, ANN INTERN MED, V118, P557, DOI 10.7326/0003-4819-118-7-199304010-00011; Kuyvenhoven M, 2006, FAM PRACT, V23, P175, DOI 10.1093/fampra/cmi122; LAU J, 1999, 9 AG HLTH CAR POL RE; Lindbaek M, 2004, DRUGS, V64, P805, DOI 10.2165/00003495-200464080-00002; Mallinckrodt CH, 2004, PHARM STAT, V3, P161, DOI 10.1002/pst.124; Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V116, P1289, DOI 10.1016/j.jaci.2005.08.044; Merenstein D, 2005, J FAM PRACTICE, V54, P144; MORRIS P, 2002, COCHRANE DB SYST REV, V4; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Norrelund N, 1978, Ugeskr Laeger, V140, P2792; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS1, DOI 10.1016/j.otohns.2007.06.726; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS32, DOI 10.1016/j.otohns.2007.06.724; Schering-Plough Research Institute, 2003, EFF SAF 200 MCG QD 2; Sharp SJ, 1996, BRIT MED J, V313, P735; Smith TC, 1995, STAT MED, V14, P2685, DOI 10.1002/sim.4780142408; Stalman W, 1997, BRIT J GEN PRACT, V47, P794; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Thompson SG, 2001, STAT METHODS MED RES, V10, P375, DOI 10.1191/096228001682157616; Turner RM, 2000, STAT MED, V19, P3417, DOI 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L; van Houwelingen H, 1999, STAT MED, V18, P110, DOI 10.1002/(SICI)1097-0258(19990115)18:1<110::AID-SIM14>3.3.CO;2-3; Varonen H, 2004, SCAND J PRIM HEALTH, V22, P122, DOI 10.1080/02813430410006323; Varonen H, 2003, SCAND J PRIM HEALTH, V21, P121, DOI 10.1080/02813430310001743; Walter SD, 2000, J CLIN EPIDEMIOL, V53, P931, DOI 10.1016/S0895-4356(00)00210-9; WILLIAMS JW, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000243; Williamson IG, 2007, JAMA-J AM MED ASSOC, V298, P2487, DOI 10.1001/jama.298.21.2487; Young J, 2003, J CLIN EPIDEMIOL, V56, P377, DOI 10.1016/S0895-4356(02)00590-5	51	135	142	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2008	371	9616					908	914		10.1016/S0140-6736(08)60416-X	http://dx.doi.org/10.1016/S0140-6736(08)60416-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342685				2022-12-28	WOS:000254056800027
J	Coward, F				Coward, Fiona			Archaeology - Standing on the shoulders of giants	SCIENCE			English	Editorial Material							EVOLUTION; CULTURE		[Coward, Fiona] Univ London Royal Holloway & Bedford New Coll, Dept Geog, Egham TW20 0EX, Surrey, England	University of London; Royal Holloway University London	Coward, F (corresponding author), Univ London Royal Holloway & Bedford New Coll, Dept Geog, Egham TW20 0EX, Surrey, England.	Fiona.Coward@rhul.ac.uk						Boyd R, 2005, ORIGIN EVOLUTION CUL; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; EVANS T, IN PRESS COMPLEXITY; GALLESE V, 2006, EMPATHY FAIRNESS, P3; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Matsuzawa T, 2007, DEVELOPMENTAL SCI, V10, P97, DOI 10.1111/j.1467-7687.2007.00570.x; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; SHENNAN S, 2002, MEMES HUMAN HIST DAR; Shennan SJ., 1999, MAMMALIAN SOCIAL LEA, P367; SMITH BH, 1995, ANNU REV ANTHROPOL, V24, P257, DOI 10.1146/annurev.an.24.100195.001353; Stout D, 2007, NEUROPSYCHOLOGIA, V45, P1091, DOI 10.1016/j.neuropsychologia.2006.09.014; Tomasello M, 1999, ANNU REV ANTHROPOL, V28, P509, DOI 10.1146/annurev.anthro.28.1.509; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004	14	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1493	1495		10.1126/science.1150898	http://dx.doi.org/10.1126/science.1150898			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339928				2022-12-28	WOS:000253943800027
J	Platt, MJ				Platt, Mary Jane			Long-term outcome for very preterm infants	LANCET			English	Editorial Material							BIRTH; CHILDREN; POPULATION; COHORT; MOTOR; AGE		Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Platt, MJ (corresponding author), Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England.	mjplatt@liverpool.ac.uk	Platt, MJ/K-4588-2012	Platt, MJ/0000-0002-9372-9575				Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Bowen JR, 2002, J PAEDIATR CHILD H, V38, P438, DOI 10.1046/j.1440-1754.2002.00039.x; Cooke RWI, 2003, ARCH DIS CHILD, V88, P482, DOI 10.1136/adc.88.6.482; Dodge JA, 1997, ARCH DIS CHILD, V77, P493, DOI 10.1136/adc.77.6.493; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Marlow N, 2007, PEDIATRICS, V120, P793, DOI 10.1542/peds.2007-0440; Moser Kath, 2007, Health Stat Q, P13; PHAROAH POD, 1994, ARCH DIS CHILD, V70, P264, DOI 10.1136/adc.70.4.264; Platt MJ, 2007, LANCET, V369, P43, DOI 10.1016/S0140-6736(07)60030-0; Sutton PD., 2004, NATL VITAL STAT REP, V55, P1; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201	12	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 8	2008	371	9615					787	788		10.1016/S0140-6736(08)60354-2	http://dx.doi.org/10.1016/S0140-6736(08)60354-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272NQ	18328908				2022-12-28	WOS:000253866500004
J	Bortnik, J; Thorne, RM; Meredith, NP				Bortnik, Jacob; Thorne, Richard M.; Meredith, Nigel P.			The unexpected origin of plasmaspheric hiss from discrete chorus emissions	NATURE			English	Article							MAGNETOSPHERICALLY REFLECTING WHISTLERS; RADIATION BELT ELECTRONS; FREQUENCY; SATELLITE	Plasmaspheric hiss(1) is a type of electromagnetic wave found ubiquitously in the dense plasma region that encircles the Earth, known as the plasmasphere(2). This important wave is known to remove(3-5) the high- energy electrons that are trapped along the Earth's magnetic field lines(6), and therefore helps to reduce the radiation hazards to satellites and humans in space. Numerous theories to explain the origin of hiss have been proposed over the past four decades, but none have been able to account fully for its observed properties. Here we show that a different wave type called chorus(7,8), previously thought to be unrelated to hiss, can propagate into the plasmasphere from tens of thousands of kilometres away, and evolve into hiss. Our new model naturally accounts for the observed frequency band of hiss, its incoherent nature, its day - night asymmetry in intensity, its association with solar activity and its spatial distribution. The connection between chorus and hiss is very interesting because chorus is instrumental in the formation of high- energy electrons outside the plasmasphere(9), whereas hiss depletes these electrons at lower equatorial altitudes(3,4).	[Bortnik, Jacob; Thorne, Richard M.] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Meredith, Nigel P.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	University of California System; University of California Los Angeles; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Bortnik, J (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, 405 Hilgard Ave, Los Angeles, CA 90095 USA.	jbortnik@gmail.com	Meredith, Nigel P/C-5806-2018	Meredith, Nigel/0000-0001-5032-3463; Horne, Richard/0000-0002-0412-6407	Natural Environment Research Council [bas010022] Funding Source: researchfish; NERC [bas010022] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Abel B, 1998, J GEOPHYS RES-SPACE, V103, P2385, DOI 10.1029/97JA02919; Bell TF, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014752; Bortnik J, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012237; Bortnik J, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009316; Bortnik J, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009387; BURTIS WJ, 1976, PLANET SPACE SCI, V24, P1007, DOI 10.1016/0032-0633(76)90119-7; CARPENTER DL, 1973, REV GEOPHYS, V11, P133, DOI 10.1029/RG011i001p00133; CARPENTER DL, 1992, J GEOPHYS RES-SPACE, V97, P1097, DOI 10.1029/91JA01548; CHURCH SR, 1983, J GEOPHYS RES-SPACE, V88, P7941, DOI 10.1029/JA088iA10p07941; DRAGANOV AB, 1992, GEOPHYS RES LETT, V19, P233, DOI 10.1029/91GL03167; DUNCKEL N, 1969, J GEOPHYS RES, V74, P6371, DOI 10.1029/JA074i026p06371; Green JL, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011622; Green JL, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010495; HAYAKAWA M, 1992, PLANET SPACE SCI, V40, P1325, DOI 10.1016/0032-0633(92)90089-7; Horne RB, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010811; LYONS LR, 1972, J GEOPHYS RES, V77, P3455, DOI 10.1029/JA077i019p03455; LYONS LR, 1973, J GEOPHYS RES, V78, P2142, DOI 10.1029/JA078i013p02142; Meredith NP, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011707; Meredith NP, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010387; Olson W.P., 1977, MAGNETOSPHERIC MAGNE; RUSSELL CT, 1969, J GEOPHYS RES, V74, P755, DOI 10.1029/JA074i003p00755; Santolik O, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011462; SMITH EJ, 1974, J GEOPHYS RES, V79, P2507, DOI 10.1029/JA079i016p02507; SONWALKAR VS, 1989, J GEOPHYS RES, V94, P6986, DOI 10.1029/JA094iA06p06986; TAYLOR WWL, 1968, J GEOPHYS RES, V73, P5615, DOI 10.1029/JA073i017p05615; Thorne RM, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011477; Thorne RM, 1974, GEOPHYS RES LETT, V1, DOI 10.1029/GL001i005p00193; THORNE RM, 1967, J GEOPHYS RES, V72, P857, DOI 10.1029/JZ072i003p00857; THORNE RM, 1973, J GEOPHYS RES, V78, P1581, DOI 10.1029/JA078i010p01581; VANALLEN JA, 1997, HIST GEOPHYSICS, V7, P235, DOI DOI 10.1029/HG007P0235	30	278	278	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					62	66		10.1038/nature06741	http://dx.doi.org/10.1038/nature06741			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322528				2022-12-28	WOS:000253671900046
J	Kong, MH; Corey, GR; Bashore, T; Harrison, JK				Kong, Melissa H.; Corey, G. Ralph; Bashore, Thomas; Harrison, J. Kevin			A key miscommunication	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PATENT DUCTUS-ARTERIOSUS		[Kong, Melissa H.; Corey, G. Ralph; Bashore, Thomas; Harrison, J. Kevin] Duke Univ, Med Ctr, Durham, NC 27705 USA	Duke University	Kong, MH (corresponding author), Duke Univ, Med Ctr, Durham, NC 27705 USA.	mh21@duke.edu						Ananthasubramaniam K, 2001, J AM SOC ECHOCARDIOG, V14, P321, DOI 10.1067/mje.2001.109684; CHEN MS, 2004, MANUAL CARDIOVASCULA, P432; FREEDOM RM, 1992, NEONATAL HEART DIS, P593; KAKU T, 1990, JPN HEART J, V31, P127; MULLINS CE, 1998, SCI PRACTICE PEDIAT, P1181; Perloff JK., 2003, CLIN RECOGNITION CON, P403; SHYU KG, 1995, CHEST, V108, P1201, DOI 10.1378/chest.108.5.1201; TOPOL EJ, 1998, TXB CARDIOVASCULAR M, P779; WOODRUFF WW, 1983, SOUTHERN MED J, V76, P1436, DOI 10.1097/00007611-198311000-00029	9	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					1054	1059		10.1056/NEJMcps071452	http://dx.doi.org/10.1056/NEJMcps071452			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18322287				2022-12-28	WOS:000253644700010
J	Maisel, WH				Maisel, William H.			Semper Fidelis - Consumer protection for patients with implanted medical devices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Dept Med, Med Device Safety Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Maisel, WH (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Med Device Safety Inst, Boston, MA 02215 USA.							[Anonymous], 2007, URG MED DEV INF SPRI; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P161, DOI 10.1001/jama.295.2.161-b; Maisel WH, 2005, JAMA-J AM MED ASSOC, V294, P955, DOI 10.1001/jama.294.8.955; 2008, WALL STREET J   0102, pA10	4	76	76	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					985	987		10.1056/NEJMp0800495	http://dx.doi.org/10.1056/NEJMp0800495			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269JG	18322280	Bronze			2022-12-28	WOS:000253644700001
J	Mohamed, Q; Evans, A				Mohamed, Quresh; Evans, Alison			Retinopathy, plasma glucose, and the diagnosis of diabetes	LANCET			English	Editorial Material									[Mohamed, Quresh; Evans, Alison] Cheltenham Gen Hosp, Cheltenham GL53 7AN, Glos, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Mohamed, Q (corresponding author), Cheltenham Gen Hosp, Cheltenham GL53 7AN, Glos, England.	quresh.mohamed@glos.nhs.uk						Engelgau MM, 1997, DIABETES CARE, V20, P785, DOI 10.2337/diacare.20.5.785; Gavin JR, 1997, DIABETES CARE, V20, P1183; LEVITAN EB, 2005, JAMA-J AM MED ASSOC, V293, P194; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Wong TY, 2008, LANCET, V371, P736, DOI 10.1016/S0140-6736(08)60343-8; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P301, DOI 10.1136/bjo.2005.084400; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yu T, 1998, ARCH OPHTHALMOL-CHIC, V116, P83, DOI 10.1001/archopht.116.1.83	10	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 1	2008	371	9614					700	702		10.1016/S0140-6736(08)60318-9	http://dx.doi.org/10.1016/S0140-6736(08)60318-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313485				2022-12-28	WOS:000253596700005
J	Aigner, S; Della Pietra, L; Japha, Y; Entin-Wohlman, O; David, T; Salem, R; Folman, R; Schmiedmayer, J				Aigner, S.; Della Pietra, L.; Japha, Y.; Entin-Wohlman, O.; David, T.; Salem, R.; Folman, R.; Schmiedmayer, J.			Long-range order in electronic transport through disordered metal films	SCIENCE			English	Article							ATOM CHIPS; FIELDS	Ultracold atom magnetic field microscopy enables the probing of current flow patterns in planar structures with unprecedented sensitivity. In polycrystalline metal ( gold) films, we observed long- range correlations forming organized patterns oriented at +/- 45 degrees relative to the mean current flow, even at room temperature and at length scales larger than the diffusion length or the grain size by several orders of magnitude. The preference to form patterns at these angles is a direct consequence of universal scattering properties at defects. The observed amplitude of the current direction fluctuations scales inversely to that expected from the relative thickness variations, the grain size, and the defect concentration, all determined independently by standard methods. Ultracold atom magnetometry thus enables new insight into the interplay between disorder and transport.	[Aigner, S.; Della Pietra, L.; Schmiedmayer, J.] Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; [Aigner, S.; Schmiedmayer, J.] Vienna Univ Technol, Osterreich Univ, Atominst, A-1020 Vienna, Austria; [Japha, Y.; Entin-Wohlman, O.; David, T.; Salem, R.; Folman, R.] Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel	Ruprecht Karls University Heidelberg; Technische Universitat Wien; Ben Gurion University	Schmiedmayer, J (corresponding author), Heidelberg Univ, Inst Phys, Philosophenweg 12, D-69120 Heidelberg, Germany.	schmiedmayer@atomchip.org	ENTIN, ORA/F-1114-2012; Schmiedmayer, Jörg/B-4717-2008; Schmiedmayer, Jörg/M-9669-2019	Schmiedmayer, Jörg/0000-0001-7799-5614; Schmiedmayer, Jörg/0000-0001-7799-5614; Della Pietra, Leonardo/0000-0001-9205-5372; Folman, Ron/0000-0002-3449-2563	Austrian Science Fund (FWF) [Z 118] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Bonn DA, 2006, NAT PHYS, V2, P159, DOI 10.1038/nphys248; CHAMBERS RG, 1950, PROC R SOC LON SER-A, V202, P378, DOI 10.1098/rspa.1950.0107; Feist J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.116804; Folman R, 2002, ADV ATOM MOL OPT PHY, V48, P263; Fortagh J, 2007, REV MOD PHYS, V79, P235, DOI 10.1103/RevModPhys.79.235; Groth S, 2004, APPL PHYS LETT, V85, P2980, DOI 10.1063/1.1804601; Ilani S, 2001, SCIENCE, V292, P1354, DOI 10.1126/science.1058645; Kruger P, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.063621; LANDAUER R, 1957, IBM J RES DEV, V1, P223, DOI 10.1147/rd.13.0223; MAYADAS AF, 1970, PHYS REV B, V1, P1382, DOI 10.1103/PhysRevB.1.1382; Reichel J, 2002, APPL PHYS B-LASERS O, V74, P469, DOI 10.1007/s003400200861; Schneider MA, 1996, APPL PHYS LETT, V69, P1327, DOI 10.1063/1.117583; Schumm T, 2005, EUR PHYS J D, V32, P171, DOI 10.1140/epjd/e2005-00016-x; SONDHEIMER EH, 1952, ADV PHYS, V1, P1, DOI 10.1080/00018735200101151; Steinhogl W, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075414; Wang DW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076802; Wildermuth S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2216932; Wildermuth S, 2005, NATURE, V435, P440, DOI 10.1038/435440a	18	57	57	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1226	1229		10.1126/science.1152458	http://dx.doi.org/10.1126/science.1152458			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309080	Green Submitted			2022-12-28	WOS:000253530600038
J	Trajkovic, K; Hsu, C; Chiantia, S; Rajendran, L; Wenzel, D; Wieland, F; Schwille, P; Brugger, B; Simons, M				Trajkovic, Katarina; Hsu, Chieh; Chiantia, Salvatore; Rajendran, Lawrence; Wenzel, Dirk; Wieland, Felix; Schwille, Petra; Bruegger, Britta; Simons, Mikael			Ceramide triggers budding of exosome vesicles into multivesicular Endosomes	SCIENCE			English	Article							BIOGENESIS; RAFT; MICRODOMAINS; ENDOCYTOSIS; PATHWAY; TSG101; HRS	Intraluminal vesicles of multivesicular endosomes are either sorted for cargo degradation into lysosomes or secreted as exosomes into the extracellular milieu. The mechanisms underlying the sorting of membrane into the different populations of intraluminal vesicles are unknown. Here, we find that cargo is segregated into distinct subdomains on the endosomal membrane and that the transfer of exosome- associated domains into the lumen of the endosome did not depend on the function of the ESCRT ( endosomal sorting complex required for transport) machinery, but required the sphingolipid ceramide. Purified exosomes were enriched in ceramide, and the release of exosomes was reduced after the inhibition of neutral sphingomyelinases. These results establish a pathway in intraendosomal membrane transport and exosome formation.	[Trajkovic, Katarina; Hsu, Chieh; Simons, Mikael] Univ Gottingen, Ctr Biochem & Mol Cell Biol, D-37073 Gottingen, Germany; [Trajkovic, Katarina; Hsu, Chieh; Simons, Mikael] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Wenzel, Dirk] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Wieland, Felix; Bruegger, Britta] Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany; [Chiantia, Salvatore; Schwille, Petra] Tech Univ Dresden, BioTec, D-01307 Dresden, Germany; [Rajendran, Lawrence] Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; [Simons, Mikael] Univ Gottingen, Dept Neurol, D-37073 Gottingen, Germany	University of Gottingen; Max Planck Society; Max Planck Society; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Max Planck Society; University of Gottingen	Simons, M (corresponding author), Univ Gottingen, Ctr Biochem & Mol Cell Biol, D-37073 Gottingen, Germany.	msimons@gwdg.de	Trajkovic, Katarina/AAJ-4219-2021; Schwille, Petra/A-4983-2010; Chiantia, Salvatore/A-4546-2010; Chiantia, Salvatore/U-6363-2019	Trajkovic, Katarina/0000-0002-2716-1491; Chiantia, Salvatore/0000-0003-0791-967X; Hsu, Chieh/0000-0002-4780-1222; Simons, Mikael/0000-0001-5329-192X; Rajendran, Lawrence/0000-0002-6390-1821				Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Li RX, 1999, J BIOL CHEM, V274, P21121, DOI 10.1074/jbc.274.30.21121; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	24	2166	2246	22	552	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1244	1247		10.1126/science.1153124	http://dx.doi.org/10.1126/science.1153124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309083				2022-12-28	WOS:000253530600044
J	Harper, GR; Pfennig, DW				Harper, George R., Jr.; Pfennig, David W.			Selection overrides gene flow to break down maladaptive mimicry	NATURE			English	Article							BIASED DISPERSAL; MODEL; SNAKE; POPULATIONS; PATTERNS; PREDATORS; TOOLS	Predators typically avoid dangerous species, and batesian mimicry evolves when a palatable species ( the 'mimic') co- opts a warning signal from a dangerous species ( the 'model') and thereby deceives its potential predators(1,2). Because predators would not be under selection to avoid the model and any of its look- alikes in areas where the model is absent ( that is, allopatry)(2-5), batesian mimics should occur only in sympatry with their model. However, contrary to this expectation, batesian mimics often occur in allopatry(6-8). Here we focus on one such example - a coral snake mimic(3,8). Using indirect DNA- based methods, we provide evidence suggesting that mimics migrate from sympatry, where mimicry is favoured(3,9), to allopatry, where it is disfavoured(10). Such gene flow is much stronger in nuclear genes than in maternally inherited mitochondrial genes, indicating that dispersal by males may explain the presence of mimetic phenotypes in allopatry. Despite this gene flow, however, individuals from allopatry resemble the model less than do individuals from sympatry. We show that this breakdown of mimicry probably reflects predator- mediated selection acting against individuals expressing the more conspicuous mimetic phenotype in allopatry. Thus, although gene flow may explain why batesian mimics occur in allopatry, natural selection may often override such gene flow and promote the evolution of non- mimetic phenotypes in such areas.	[Harper, George R., Jr.; Pfennig, David W.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Pfennig, DW (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	dpfennig@unc.edu		Harper, George/0000-0001-5649-1206				Armstrong MP, 2001, J HERPETOL, V35, P688, DOI 10.2307/1565915; Bates H.W., 1862, T LINN SOC LOND, V23, P495; Beerli P, 1999, GENETICS, V152, P763; Blouin-Demers G, 2002, CAN J ZOOL, V80, P1162, DOI 10.1139/Z02-096; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; BRODIE ED, 1993, EVOLUTION, V47, P227, DOI 10.1111/j.1558-5646.1993.tb01212.x; Brodie III ED, 2004, VENOMOUS REPTILES W, P617; BROWER LP, 1962, ECOLOGY, V43, P154; CLARKE C, 1975, PHILOS T ROY SOC B, V272, P229, DOI 10.1098/rstb.1975.0084; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; GREENE HW, 1981, SCIENCE, V213, P1207, DOI 10.1126/science.213.4513.1207; Harper GR, 2007, P R SOC B, V274, P1955, DOI 10.1098/rspb.2007.0558; HARPER GR, 2006, THESIS U N CAROLINA; Keogh JS, 2007, BIOL LETTERS, V3, P33, DOI 10.1098/rsbl.2006.0570; KING RB, 1995, EVOLUTION, V49, P885, DOI 10.1111/j.1558-5646.1995.tb02324.x; Nichols J., 2001, DISPERSAL; Palmer W. M., 1995, REPTILES N CAROLINA; Pfennig DW, 2007, BEHAV ECOL SOCIOBIOL, V61, P505, DOI 10.1007/s00265-006-0278-x; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SMITH SM, 1975, SCIENCE, V187, P759, DOI 10.1126/science.187.4178.759; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WALDBAUER GP, 1987, AM MIDL NAT, V118, P145, DOI 10.2307/2425637; Wallace Alfred Russel, 1870, CONTRIBUTIONS THEORY	29	47	48	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					1103	U6		10.1038/nature06532	http://dx.doi.org/10.1038/nature06532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305543				2022-12-28	WOS:000253453600041
J	Hsiao, FC; Hsieh, CH				Hsiao, Fone-Ching; Hsieh, Chang-Hsun			Severe soft-tissue infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hsiao, Fone-Ching; Hsieh, Chang-Hsun] Tri Serv Gen Hosp, Taipei 114, Taiwan	Tri-Service General Hospital	Hsiao, FC (corresponding author), Tri Serv Gen Hosp, Taipei 114, Taiwan.	m10959@ms94.url.com.tw							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					940	940		10.1056/NEJMicm066695	http://dx.doi.org/10.1056/NEJMicm066695			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18305269				2022-12-28	WOS:000253430200009
J	Mccoy, D; Bennett, S; Witter, S; Pond, B; Baker, B; Gow, J; Chand, S; Ensor, T; McPake, B				McCoy, David; Bennett, Sara; Witter, Sophie; Pond, Bob; Baker, Brook; Gow, Jeff; Chand, Sudeep; Ensor, Tim; McPake, Barbara			Salaries and incomes of health workers in sub-Saharan Africa	LANCET			English	Article								Public-sector health workers are vital to the functioning of health systems. We aimed to investigate pay structures for health workers in the public sector in sub-Saharan Africa; the adequacy of incomes for health workers; the management of public-sector pay; and the fiscal and macroeconomic factors that impinge on pay policy for the public sector. Because salary differentials affect staff migration and retention, we also discuss pay in the private sector. We surveyed historical trends in the pay of civil servants in Africa over the past 40 years. We used some empirical data, but found that accurate and complete data were scarce. The available data suggested that pay structures vary across countries, and are often structured in complex ways. Health workers also commonly use other sources of income to supplement their formal pay. The pay and income of health workers varies widely, whether between countries, by comparison with cost of living, or between the public and private sectors. To optimise the distribution and mix of health workers, policy interventions to address their pay and incomes are needed. Fiscal constraints to increased salaries might need to be overcome in many countries, and non-financial incentives improved.	[McCoy, David; Chand, Sudeep] UCL, Ctr Int Hlth & Dev, London WC1N 1EH, England; [Bennett, Sara; Pond, Bob] WHO, Alliance Hlth Syst & Policy Res, CH-1211 Geneva, Switzerland; [Witter, Sophie; Ensor, Tim] Univ Aberdeen, IMMPACT, Aberdeen AB9 1FX, Scotland; [Baker, Brook] Northeastern Univ, Sch Law, Hlth GAP, Boston, MA 02115 USA; [McPake, Barbara] Queen Margaret Univ, Edinburgh, Midlothian, Scotland; [Gow, Jeff] Univ Kwazulu Natal, Hlth Econ & HIV AIDS Res Div, Durban, South Africa	University of London; University College London; World Health Organization; University of Aberdeen; Northeastern University; Queen Margaret University; University of Kwazulu Natal	Mccoy, D (corresponding author), UCL, Ctr Int Hlth & Dev, 30 Guilford St, London WC1N 1EH, England.	d.mccoy@ucl.ac.uk	McPake, Barbara/AAE-8655-2021; Gow, Jeff/L-9647-2017; Ensor, Tim/ABD-5899-2020	McPake, Barbara/0000-0002-9904-1077; Gow, Jeff/0000-0002-5726-298X; Ensor, Tim/0000-0003-0279-9576; bennett, sara/0000-0001-8094-8798				[Anonymous], 2004, HUM RES HLTH OV CRIS; AZANGWEO G, 2001, ANNEX 2 INT EXPERIEN; *CGD, 2007, DOES IMF CONSTR HLTH; DASGUPTA M, 2004, DECENTRALIZED DELIVE; Davey G, 2006, LANCET, V367, P629, DOI 10.1016/S0140-6736(06)68239-1; Drager S, 2006, HLTH WORKERS WAGES O; DUBBLEDAM R, 2007, INDEPENDENT REV PROG; EGGER R, 2000, ACHIEVING RIGHT BALA; Ensor T, 2006, PAYING MOTIVATING CS; FEDELINO A, 2006, AID SCALING DO WAGE; Franco LM, 2002, SOC SCI MED, V54, P1255, DOI 10.1016/S0277-9536(01)00094-6; HAQUE N, 1998, QUALITY GOVERNANCE 2; Heller PS, 1984, GOVT EMPLOYMENT PAY; Hertzberg F., 1959, MOTIVATION WORK; *HLTH ALL INT, 2007, GLOB CONN HLTH ALL I; HUDDART J, 2004, ZAMBIA HIV AIDS WORK; *IM DEV, 2005, MAL NGO REM SURV 200; *IMF IND EV OFF, 2007, IMF AID SUBS AFR; International Bank of Reconstruction and Development, 1994, ADJ AFR REF RES ROAD; Lienert I, 1998, CIVIL SERVICE REFORM; Lienert Ian, 1997, DECADE CIVIL SERVICE; LINDQUIST DA, 1992, MED VET ENTOMOL, V6, P2, DOI 10.1111/j.1365-2915.1992.tb00027.x; Marphatia A. A., 2007, CONFRONTING CONTRADI; MCKINLEY T, 2006, MACROECONOMIC DEBATE; *MIN HLTH ZAMB, 2007, ZAMB PUBL EXP TRACK; OLUWU D, 1997, ROLE CIVIL SERVICE E; Organisation of African Unity, 2001, AFRICAN SUMMIT HIVAI; Roenen C, 1997, TROP MED INT HEALTH, V2, P127, DOI 10.1046/j.1365-3156.1997.d01-240.x; SAWE D, 2001, ANNEX 2 INT EXPERIEN; SCHIAVOCAMPO S, 1997, 1806 WORLD BANK; ULREICH R, 2001, ANNEX 2 INT EXPERIEN; Witter Sophie, 2007, Hum Resour Health, V5, P2, DOI 10.1186/1478-4491-5-2; World Health Organization, 2006, WORLD HLTH REP WORK	33	127	127	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2008	371	9613					675	681		10.1016/S0140-6736(08)60306-2	http://dx.doi.org/10.1016/S0140-6736(08)60306-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LL	18295025				2022-12-28	WOS:000253436700032
J	Tripp, HJ; Kitner, JB; Schwalbach, MS; Dacey, JWH; Wilhelm, LJ; Giovannoni, SJ				Tripp, H. James; Kitner, Joshua B.; Schwalbach, Michael S.; Dacey, John W. H.; Wilhelm, Larry J.; Giovannoni, Stephen J.			SAR11 marine bacteria require exogenous reduced sulphur for growth	NATURE			English	Article							DISSOLVED DIMETHYLSULFONIOPROPIONATE; BACTERIOPLANKTON COMMUNITIES; NORTH-ATLANTIC; SULFATE; REDUCTION; OCEAN; MICROORGANISMS; METABOLISM; GENOMICS; SEQUENCE	Sulphur is a universally required cell nutrient found in two amino acids and other small organic molecules. All aerobic marine bacteria are known to use assimilatory sulphate reduction to supply sulphur for biosynthesis, although many can assimilate sulphur from organic compounds that contain reduced sulphur atoms(1-3). An analysis of three complete 'Candidatus Pelagibacter ubique' genomes, and public ocean metagenomic data sets, suggested that members of the ubiquitous and abundant SAR11 alphaproteobacterial clade are deficient in assimilatory sulphate reduction genes. Here we show that SAR11 requires exogenous sources of reduced sulphur, such as methionine or 3-dimethylsulphoniopropionate (DMSP) for growth. Titrations of the algal osmolyte DMSP in seawater medium containing all other macronutrients in excess showed that 1.5 x 10(8) SAR11 cells are produced per nanomole of DMSP. Although it has been shown that other marine alphaproteobacteria use sulphur from DMSP in preference to sulphate(1,2), our results indicate that 'Cand. P. ubique' relies exclusively on reduced sulphur compounds that originate from other plankton.	[Tripp, H. James; Kitner, Joshua B.; Schwalbach, Michael S.; Wilhelm, Larry J.; Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Dacey, John W. H.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Oregon State University; Woods Hole Oceanographic Institution	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, 220 Nash Hall, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	van den Berg, Constant MG/A-7065-2012	van den Berg, Constant MG/0000-0003-2234-9345				Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; Bernal A, 2001, NUCLEIC ACIDS RES, V29, P126, DOI 10.1093/nar/29.1.126; Berndt C, 2004, J BIOL CHEM, V279, P7850, DOI 10.1074/jbc.M309332200; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; CUHEL RL, 1982, APPL ENVIRON MICROB, V43, P151, DOI 10.1128/AEM.43.1.151-159.1982; DANIELS L, 1986, APPL ENVIRON MICROB, V51, P703, DOI 10.1128/AEM.51.4.703-709.1986; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glaeser J, 1999, ARCH MICROBIOL, V171, P405, DOI 10.1007/s002030050727; HEINZINGER NK, 1995, J BACTERIOL, V177, P2813, DOI 10.1128/jb.177.10.2813-2820.1995; Hou SB, 2004, P NATL ACAD SCI USA, V101, P18036, DOI 10.1073/pnas.0407638102; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kiene RP, 2000, GEOCHIM COSMOCHIM AC, V64, P2797, DOI 10.1016/S0016-7037(00)00399-9; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; LIPPERT KD, 1969, ARCH MIKROBIOL, V65, P29, DOI 10.1007/BF00412063; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Neumann S, 2000, MOL BIOL REP, V27, P27, DOI 10.1023/A:1007058421714; Nicastro D., 2006, MICROSC MICROANAL, V12, P180, DOI [10.1017/S1431927606067456, DOI 10.1017/S1431927606067456]; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Ruckert C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-121; SCHUT F, 1993, APPL ENVIRON MICROB, V59, P2150, DOI 10.1128/AEM.59.7.2150-2160.1993; Simo R, 2002, LIMNOL OCEANOGR, V47, P53, DOI 10.4319/lo.2002.47.1.0053; Stingl U, 2007, ISME J, V1, P361, DOI 10.1038/ismej.2007.49; Street JH, 2005, MET IONS BIOL SYST, V43, P153; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; VENTURA S, 1988, ARCH MICROBIOL, V149, P273, DOI 10.1007/BF00411641; Zubkov MV, 2002, DEEP-SEA RES PT II, V49, P3017, DOI 10.1016/S0967-0645(02)00069-3	30	251	259	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					741	744		10.1038/nature06776	http://dx.doi.org/10.1038/nature06776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18337719				2022-12-28	WOS:000254792500043
J	Legros, M; Dehm, G; Arzt, E; Balk, TJ				Legros, Marc; Dehm, Gerhard; Arzt, Eduard; Balk, T. John			Observation of giant diffusivity along dislocation cores	SCIENCE			English	Article							PIPE DIFFUSION; EDGE DISLOCATION; SILICON; ALUMINUM; DEFECTS; AL	Diffusion of atoms in a crystalline lattice is a thermally activated process that can be strongly accelerated by defects such as grain boundaries or dislocations. When carried by dislocations, this elemental mechanism is known as "pipe diffusion." Pipe diffusion has been used to explain abnormal diffusion, Cottrell atmospheres, and dislocation- precipitate interactions during creep, although this rests more on conjecture than on direct demonstration. The motion of dislocations between silicon nanoprecipitates in an aluminum thin film was recently observed and controlled via in situ transmission electron microscopy. We observed the pipe diffusion phenomenon and measured the diffusivity along a single dislocation line. It is found that dislocations accelerate the diffusion of impurities by almost three orders of magnitude as compared with bulk diffusion.	[Legros, Marc] CEMES CNRS, F-31055 Toulouse, France; [Dehm, Gerhard] Univ Min & Met Leoben, Erich Schmid Inst Mat Sci, Austrian Acad Sci, Dept Mat Phys, A-8700 Leoben, Austria; [Arzt, Eduard] Max Planck Inst Met Res, D-70569 Stuttgart, Germany; [Balk, T. John] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA	Centre National de la Recherche Scientifique (CNRS); Austrian Academy of Sciences; University of Leoben; Max Planck Society; University of Kentucky	Legros, M (corresponding author), CEMES CNRS, F-31055 Toulouse, France.	legros@cemes.fr	Arzt, Eduard/AAL-1500-2020; Arzt, Eduard/B-5282-2008; Dehm, Gerhard/A-3066-2017; Dehm, Gerhard/C-8919-2014	Arzt, Eduard/0000-0002-0834-4540; Arzt, Eduard/0000-0002-0834-4540; Dehm, Gerhard/0000-0003-1601-8267				BALLUFFI RW, 1962, J APPL PHYS, V33, P817, DOI 10.1063/1.1777172; BALLUFFI RW, 1979, DISLOCATIONS SOLIDS, V13, P21; BERMOND JM, 1995, SURF SCI, V330, P48, DOI 10.1016/0039-6028(95)00230-8; Bernstein N, 1997, PHYS REV B, V56, P10488, DOI 10.1103/PhysRevB.56.10488; Blavette D, 1999, SCIENCE, V286, P2317, DOI 10.1126/science.286.5448.2317; BOLDING BC, 1990, PHYS REV B, V41, P10568, DOI 10.1103/PhysRevB.41.10568; BRECHET Y, 1995, ACTA METALL MATER, V43, P955, DOI 10.1016/0956-7151(94)00334-E; COULOMB P, 1958, CR HEBD ACAD SCI, V246, P1209; FUJIKAWA SI, 1978, METALL TRANS A, V9, P1811, DOI 10.1007/BF02663412; HUANG J, 1989, PHYS REV LETT, V63, P628, DOI 10.1103/PhysRevLett.63.628; Komninou P, 1999, J CRYST GROWTH, V203, P103, DOI 10.1016/S0022-0248(99)00082-2; LOVE GR, 1964, ACTA METALL MATER, V12, P731, DOI 10.1016/0001-6160(64)90220-2; Luo W, 2007, ACTA MATER, V55, P2579, DOI 10.1016/j.actamat.2006.12.023; MILLS MJ, 1989, PHILOS MAG A, V60, P355, DOI 10.1080/01418618908213867; Ogris E., 2002, J LIGHT MET, V2, P263, DOI [10.1016/S1471-5317(03)00010-5, 10.1016/0001-6160(88)90237-4, DOI 10.1016/0001-6160(88)90237-4]; Pandey AB, 1997, ACTA MATER, V45, P1297, DOI 10.1016/S1359-6454(96)00225-X; Picu RC, 2004, ACTA MATER, V52, P161, DOI 10.1016/j.actamat.2003.09.002; RABIER J, 1989, PHILOS MAG A, V59, P533, DOI 10.1080/01418618908229783; Schwink C, 1997, MAT SCI ENG A-STRUCT, V234, P1, DOI 10.1016/S0921-5093(97)00139-1; Srinivasan SG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.125502; SWIATNICKI WA, 1986, ACTA METALL MATER, V34, P599, DOI 10.1016/0001-6160(86)90175-6; Tang XH, 2003, J AM CERAM SOC, V86, P560, DOI 10.1111/j.1151-2916.2003.tb03341.x; Thompson K, 2007, SCIENCE, V317, P1370, DOI 10.1126/science.1145428; Vengrenovich RD, 2002, SCRIPTA MATER, V46, P363, DOI 10.1016/S1359-6462(01)01252-0; VOLIN TE, 1971, ACTA METALL MATER, V19, P263, DOI 10.1016/0001-6160(71)90092-7; VOORHEES PW, 1992, ANNU REV MATER SCI, V22, P197, DOI 10.1146/annurev.ms.22.080192.001213; Zhang LH, 2005, ACTA MATER, V53, P3635, DOI 10.1016/j.actamat.2005.04.018	27	297	300	8	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1646	1649		10.1126/science.1151771	http://dx.doi.org/10.1126/science.1151771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356520				2022-12-28	WOS:000254172300034
J	Kaunitz, AM				Kaunitz, Andrew M.			Hormonal contraception in women of older reproductive age	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONFATAL VENOUS THROMBOEMBOLISM; DOSE ORAL-CONTRACEPTIVES; INTRAUTERINE SYSTEM; BREAST-CANCER; MYOCARDIAL-INFARCTION; PERIMENOPAUSAL WOMEN; TRANSDERMAL PATCH; ETHINYL ESTRADIOL; POOLED ANALYSIS; RISK		Univ Florida, Coll Med, Dept Obstet & Gynecol, Jacksonville, FL USA	State University System of Florida; University of Florida	Kaunitz, AM (corresponding author), Univ Florida, Coll Med, Dept Obstet & Gynecol, Jacksonville, FL USA.		Kaunitz, Andrew/AAL-8448-2020					Abma J C, 1997, Vital Health Stat 23, P1; American College of Obstetrics and Gynecology, 2006, OBSTET GYNECOL, V73, P1453, DOI DOI 10.1097/00006250-200606000-00055.PUBMED:16738183; Barad D, 2005, FERTIL STERIL, V84, P374, DOI 10.1016/j.fertnstert.2005.01.132; Bastian LA, 2003, JAMA-J AM MED ASSOC, V289, P895, DOI 10.1001/jama.289.7.895; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Bragheto AM, 2007, CONTRACEPTION, V76, P195, DOI 10.1016/j.contraception.2007.05.091; Callaghan WM, 2003, OBSTET GYNECOL, V102, P1015, DOI 10.1016/S0029-7844(03)00740-3; Casper RF, 1997, MENOPAUSE, V4, P139; Creinin MD, 1996, FERTIL STERIL, V66, P101, DOI 10.1016/S0015-0282(16)58394-0; Davis A, 2000, OBSTET GYNECOL, V96, P913, DOI 10.1016/S0029-7844(00)01029-2; Fernandez E, 2001, BRIT J CANCER, V84, P722, DOI 10.1054/bjoc.2000.1622; Funk S, 2005, CONTRACEPTION, V71, P319, DOI 10.1016/j.contraception.2004.11.007; Gallo MF, 2005, CONTRACEPTION, V71, P162, DOI 10.1016/j.contraception.2004.09.005; Gambacciani M, 2006, MATURITAS, V54, P176, DOI 10.1016/j.maturitas.2005.10.007; GEBBIE AE, 1995, CONTRACEPTION, V52, P221, DOI 10.1016/0010-7824(95)00184-C; Gill JK, 2006, CANCER CAUSE CONTROL, V17, P1155, DOI 10.1007/s10552-006-0056-0; Haile RW, 2006, CANCER EPIDEM BIOMAR, V15, P1863, DOI 10.1158/1055-9965.EPI-06-0258; Hampton NRE, 2005, HUM REPROD, V20, P2653, DOI 10.1093/humrep/dei085; Hannaford PC, 2007, BRIT MED J, V335, P651, DOI 10.1136/bmj.39289.649410.55; Hurskainen R, 2004, JAMA-J AM MED ASSOC, V291, P1456, DOI 10.1001/jama.291.12.1456; Jick S, 2007, CONTRACEPTION, V76, P4, DOI 10.1016/j.contraception.2007.03.003; Jick SS, 2006, CONTRACEPTION, V73, P566, DOI 10.1016/j.contraception.2006.02.002; Kang BM, 1996, OBSTET GYNECOL, V88, P93, DOI 10.1016/0029-7844(96)00074-9; KAUNITZ AM, 2008, UPTODATE; Kaunitz AM, 2007, CONTRACEPTION, V75, pS130, DOI 10.1016/j.contraception.2007.01.012; Kaunitz Andrew M, 2002, Rev Endocr Metab Disord, V3, P277, DOI 10.1023/A:1020084728544; Keshavarz Homa, 2002, Morbidity and Mortality Weekly Report, V51, P1; MacClellan LR, 2007, STROKE, V38, P2438, DOI 10.1161/STROKEAHA.107.488395; Marchbanks PA, 2002, NEW ENGL J MED, V346, P2025, DOI 10.1056/NEJMoa013202; Margolis KL, 2007, FERTIL STERIL, V88, P310, DOI 10.1016/j.fertnstert.2006.11.206; Michaelsson K, 1999, LANCET, V353, P1481, DOI 10.1016/S0140-6736(98)09044-8; MOSHER WD, 2004, ADV DATA VITAL HLTH, V350; Narod SA, 2002, JNCI-J NATL CANCER I, V94, P1773, DOI 10.1093/jnci/94.23.1773; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; Nightingale A L, 2000, Eur J Contracept Reprod Health Care, V5, P265, DOI 10.1080/13625180008500402; Peterson HB, 2005, NEW ENGL J MED, V353, P2169, DOI 10.1056/NEJMcp044148; Petitti DB, 2004, NEW ENGL J MED, V350, P307; Rosenberga L, 2007, CONTRACEPTION, V76, P425, DOI 10.1016/j.contraception.2007.08.010; Schlesselman JJ, 1997, HUM REPROD, V12, P1851, DOI 10.1093/humrep/12.9.1851; Schwartz SM, 1998, STROKE, V29, P2277, DOI 10.1161/01.STR.29.11.2277; SHARGIL AA, 1985, INT J FERTIL, V30, P15; Sidney S, 1998, CIRCULATION, V98, P1058, DOI 10.1161/01.CIR.98.11.1058; Sidney S, 2004, CONTRACEPTION, V70, P3, DOI 10.1016/j.contraception.2004.02.010; Silvera SAN, 2005, CANCER CAUSE CONTROL, V16, P1059, DOI 10.1007/s10552-005-0343-1; Strauss Lilo T., 2004, Morbidity and Mortality Weekly Report, V53, P1; Strom BL, 2004, CONTRACEPTION, V69, P353, DOI 10.1016/j.contraception.2003.12.015; THOMAS DB, 1991, INT J CANCER, V49, P186; Trussell J, 2004, CONTRACEPTION, V70, P89, DOI 10.1016/j.contraception.2004.03.009; van den Heuvel MW, 2005, CONTRACEPTION, V72, P168, DOI 10.1016/j.contraception.2005.03.005; VIEGAS OAC, 1994, J BIOSOC SCI, V26, P261, DOI 10.1017/S0021932000021283; Whittemore AS, 2004, BRIT J CANCER, V91, P1911, DOI 10.1038/sj.bjc.6602239; WHO, 2004, MED EL CRIT CONTR US, V3; Wingo PA, 2007, OBSTET GYNECOL, V110, P793, DOI 10.1097/01.AOG.0000284446.22251.6e	53	48	51	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1262	1270		10.1056/NEJMcp0708481	http://dx.doi.org/10.1056/NEJMcp0708481			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275TL	18354104				2022-12-28	WOS:000254094400007
J	Lin, SW; Unno, Y; Hou, WS; Chang, P; Adachi, I; Aihara, H; Akai, K; Arinstein, K; Aulchenko, V; Aushev, T; Aziz, T; Bakich, AM; Balagura, V; Barberio, E; Bay, A; Bedny, I; Bitenc, U; Bondar, A; Bozek, A; Bracko, M; Browder, TE; Chang, MC; Chao, Y; Chen, A; Chen, KF; Chen, WT; Cheon, BG; Chiang, CC; Chistov, R; Cho, IS; Choi, SK; Choi, Y; Choi, YK; Cole, S; Dalseno, J; Danilov, M; Dash, M; Drutskoy, A; Eidelman, S; Epifanov, D; Fratina, S; Fujikawa, M; Furukawa, K; Gabyshev, N; Goldenzweig, P; Golob, B; Ha, H; Haba, J; Hara, T; Hayasaka, K; Hayashii, H; Hazumi, M; Heffernan, D; Hokuue, T; Hoshi, Y; Hsiung, YB; Hyun, HJ; Iijima, T; Ikado, K; Inami, K; Ishikawa, A; Ishino, H; Itoh, R; Iwabuchi, M; Iwasaki, M; Iwasaki, Y; Kah, DH; Kaji, H; Kataoka, SU; Kawai, H; Kawasaki, T; Kibayashi, A; Kichimi, H; Kikutani, E; Kim, HJ; Kim, SK; Kim, YJ; Kinoshita, K; Korpar, S; Kozakai, Y; Krizan, P; Krokovny, P; Kumar, R; Kuo, CC; Kuzmin, A; Kwon, YJ; Lee, MJ; Lee, SE; Lesiak, T; Li, J; Liu, Y; Liventsev, D; Mandl, F; Marlow, D; McOnie, S; Medvedeva, T; Mimashi, T; Mitaroff, W; Miyabayashi, K; Miyake, H; Miyazaki, Y; Mizuk, R; Mori, T; Nakamura, TT; Nakano, E; Nakao, M; Nakazawa, H; Nishida, S; Nitoh, O; Noguchi, S; Nozaki, T; Ogawa, S; Ogawa, Y; Ohshima, T; Okuno, S; Olsen, SL; Ozaki, H; Pakhlova, G; Park, CW; Park, H; Peak, LS; Pestotnik, R; Peters, M; Piilonen, LE; Poluektov, A; Sahoo, H; Sakai, Y; Schneider, O; Schumann, J; Schwartz, AJ; Seidl, R; Senyo, K; Sevior, ME; Shapkin, M; Shen, CP; Shibuya, H; Shidara, T; Shinomiya, S; Shiu, JG; Shwartz, B; Singh, JB; Sokolov, A; Somov, A; Stanic, S; Staric, M; Sumisawa, K; Sumiyoshi, T; Suzuki, S; Tajima, O; Takasaki, F; Tamura, N; Tanaka, M; Tawada, M; Taylor, GN; Teramoto, Y; Tikhomirov, I; Trabelsi, K; Uehara, S; Ueno, K; Uglov, T; Uno, S; Urquijo, P; Ushiroda, Y; Usov, Y; Varner, G; Varvell, KE; Vervink, K; Villa, S; Wang, CC; Wang, CH; Wang, MZ; Watanabe, Y; Wedd, R; Wicht, J; Won, E; Yabsley, BD; Yamaguchi, A; Yamashita, Y; Yamauchi, M; Yoshida, M; Yuan, CZ; Yusa, Y; Zhang, CC; Zhang, ZP; Zhilich, V; Zhulanov, V; Zupanc, A				Lin, S. -W.; Unno, Y.; Hou, W. -S.; Chang, P.; Adachi, I.; Aihara, H.; Akai, K.; Arinstein, K.; Aulchenko, V.; Aushev, T.; Aziz, T.; Bakich, A. M.; Balagura, V.; Barberio, E.; Bay, A.; Bedny, I.; Bitenc, U.; Bondar, A.; Bozek, A.; Bracko, M.; Browder, T. E.; Chang, M. -C.; Chao, Y.; Chen, A.; Chen, K. -F.; Chen, W. T.; Cheon, B. G.; Chiang, C. -C.; Chistov, R.; Cho, I. -S.; Choi, S. -K.; Choi, Y.; Choi, Y. K.; Cole, S.; Dalseno, J.; Danilov, M.; Dash, M.; Drutskoy, A.; Eidelman, S.; Epifanov, D.; Fratina, S.; Fujikawa, M.; Furukawa, K.; Gabyshev, N.; Goldenzweig, P.; Golob, B.; Ha, H.; Haba, J.; Hara, T.; Hayasaka, K.; Hayashii, H.; Hazumi, M.; Heffernan, D.; Hokuue, T.; Hoshi, Y.; Hsiung, Y. B.; Hyun, H. J.; Iijima, T.; Ikado, K.; Inami, K.; Ishikawa, A.; Ishino, H.; Itoh, R.; Iwabuchi, M.; Iwasaki, M.; Iwasaki, Y.; Kah, D. H.; Kaji, H.; Kataoka, S. U.; Kawai, H.; Kawasaki, T.; Kibayashi, A.; Kichimi, H.; Kikutani, E.; Kim, H. J.; Kim, S. K.; Kim, Y. J.; Kinoshita, K.; Korpar, S.; Kozakai, Y.; Krizan, P.; Krokovny, P.; Kumar, R.; Kuo, C. C.; Kuzmin, A.; Kwon, Y. -J.; Lee, M. J.; Lee, S. E.; Lesiak, T.; Li, J.; Liu, Y.; Liventsev, D.; Mandl, F.; Marlow, D.; McOnie, S.; Medvedeva, T.; Mimashi, T.; Mitaroff, W.; Miyabayashi, K.; Miyake, H.; Miyazaki, Y.; Mizuk, R.; Mori, T.; Nakamura, T. T.; Nakano, E.; Nakao, M.; Nakazawa, H.; Nishida, S.; Nitoh, O.; Noguchi, S.; Nozaki, T.; Ogawa, S.; Ogawa, Y.; Ohshima, T.; Okuno, S.; Olsen, S. L.; Ozaki, H.; Pakhlova, G.; Park, C. W.; Park, H.; Peak, L. S.; Pestotnik, R.; Peters, M.; Piilonen, L. E.; Poluektov, A.; Sahoo, H.; Sakai, Y.; Schneider, O.; Schuemann, J.; Schwartz, A. J.; Seidl, R.; Senyo, K.; Sevior, M. E.; Shapkin, M.; Shen, C. P.; Shibuya, H.; Shidara, T.; Shinomiya, S.; Shiu, J. -G.; Shwartz, B.; Singh, J. B.; Sokolov, A.; Somov, A.; Stanic, S.; Staric, M.; Sumisawa, K.; Sumiyoshi, T.; Suzuki, S.; Tajima, O.; Takasaki, F.; Tamura, N.; Tanaka, M.; Tawada, M.; Taylor, G. N.; Teramoto, Y.; Tikhomirov, I.; Trabelsi, K.; Uehara, S.; Ueno, K.; Uglov, T.; Uno, S.; Urquijo, P.; Ushiroda, Y.; Usov, Y.; Varner, G.; Varvell, K. E.; Vervink, K.; Villa, S.; Wang, C. C.; Wang, C. H.; Wang, M. -Z.; Watanabe, Y.; Wedd, R.; Wicht, J.; Won, E.; Yabsley, B. D.; Yamaguchi, A.; Yamashita, Y.; Yamauchi, M.; Yoshida, M.; Yuan, C. Z.; Yusa, Y.; Zhang, C. C.; Zhang, Z. P.; Zhilich, V.; Zhulanov, V.; Zupanc, A.		Belle Collaborat	Difference in direct charge-parity violation between charged and neutral B meson decays	NATURE			English	Article							DIRECT CP VIOLATION; ASYMMETRIES; BELLE	Equal amounts of matter and antimatter are predicted to have been produced in the Big Bang, but our observable Universe is clearly matter- dominated. One of the prerequisites(1) for understanding this elimination of antimatter is the nonconservation of charge- parity ( CP) symmetry. So far, two types of CP violation have been observed in the neutral K meson ( K-0) and B meson ( B-0) systems: CP violation involving the mixing(2) between K-0 and its antiparticle (K) over bar (0) ( and likewise(3,4) for B-0 and (B) over bar (0)), and direct CP violation in the decay of each meson(5-8). The observed effects for both types of CP violation are substantially larger for the B-0 meson system. However, they are still consistent with the standard model of particle physics, which has a unique source(9) of CP violation that is known to be too small(10) to account for the matter-dominated Universe. Here we report that the direct CP violation in charged B-+/- --> K-+/- pi(0) decay is different from that in the neutral B-0 counterpart. The direct CP- violating decay rate asymmetry, A(K)+/- (pi 0) ( that is, the difference between the number of observed B- --> K- pi(0) event versus B+ --> K+ pi(0) events, normalized to the sum of these events) is measured to be about +7%, with an uncertainty that is reduced by a factor of 1.7 from a previous measurement(7). However, the asymmetry A(K+/-) p(-/+) for B-0 --> K- pi(+) versus B-0 --> K+ pi(-) is at the -10% level(7,8). Although it is susceptible to strong interaction effects that need further clarification, this large deviation in direct CP violation between charged and neutral B meson decays could be an indication of new sources of CP violation - which would help to explain the dominance of matter in the Universe.	[Lin, S. -W.; Hou, W. -S.; Chang, P.; Chao, Y.; Chen, K. -F.; Chiang, C. -C.; Wang, C. C.] Natl Taiwan Univ, Dept Phys, Taipei 106, Taiwan; [Unno, Y.; Cheon, B. G.] Hanyang Univ, Seoul 133791, South Korea; [Adachi, I.; Akai, K.; Furukawa, K.; Haba, J.; Hazumi, M.; Itoh, R.; Iwasaki, Y.; Kibayashi, A.; Kichimi, H.; Kikutani, E.; Krokovny, P.; Mimashi, T.; Nakamura, T. T.; Nakao, M.; Nishida, S.; Nozaki, T.; Ogawa, Y.; Ozaki, H.; Sakai, Y.; Schuemann, J.; Shidara, T.; Sumisawa, K.; Tajima, O.; Takasaki, F.; Tanaka, M.; Tawada, M.; Trabelsi, K.; Uehara, S.; Uno, S.; Ushiroda, Y.; Yamauchi, M.; Yoshida, M.] High Energy Accelerator Res Org, KEK, Tsukuba, Ibaraki 3050801, Japan; [Aihara, H.] Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; [Arinstein, K.; Aulchenko, V.; Aushev, T.; Bedny, I.; Bondar, A.; Eidelman, S.; Epifanov, D.; Gabyshev, N.; Kuzmin, A.; Poluektov, A.; Shwartz, B.; Usov, Y.; Zhulanov, V.] Budker Inst Nucl Phys, Novosibirsk 630090, Russia; [Aushev, T.; Bay, A.; Vervink, K.; Villa, S.; Wicht, J.] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, CH-1015 Lausanne, Switzerland; [Aushev, T.; Balagura, V.; Chistov, R.; Danilov, M.; Liventsev, D.; Medvedeva, T.; Mizuk, R.; Pakhlova, G.; Tikhomirov, I.; Uglov, T.] State Atom Energy Commiss, Inst Theoret & Expt Phys, Moscow 117218, Russia; [Aziz, T.] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India; [Bakich, A. M.; Cole, S.; McOnie, S.; Peak, L. S.; Yabsley, B. D.] Univ Sydney, Sydney, NSW 2006, Australia; [Barberio, E.; Dalseno, J.; Taylor, G. N.; Urquijo, P.; Wedd, R.] Univ Melbourne, Sch Phys, Melbourne, Vic 3010, Australia; [Bracko, M.; Fratina, S.; Golob, B.; Korpar, S.; Pestotnik, R.; Staric, M.; Zupanc, A.] Jozef Stefan Inst, SI-1001 Ljubljana, Slovenia; [Bozek, A.] H Niewodniczanski Inst Nucl Phys, PL-31342 Krakow, Poland; [Bracko, M.] Univ Maribor, SI-2000 Maribor, Slovenia; [Browder, T. E.; Li, J.; Olsen, S. L.; Peters, M.; Sahoo, H.; Varner, G.] Univ Hawaii, Honolulu, HI 96822 USA; [Chang, M. -C.] Fu Jen Catholic Univ, Dept Phys, Taipei 242, Taiwan; [Chen, A.; Chen, W. T.; Kuo, C. C.] Natl Cent Univ, Chungli 32054, Taiwan; [Cho, I. -S.; Kwon, Y. -J.] Yonsei Univ, Seoul 120749, South Korea; [Choi, S. -K.] Gyeongsang Natl Univ, Jinju 660701, South Korea; [Choi, Y.; Choi, Y. K.; Park, C. W.] Sungkyunkwan Univ, Suwon 440746, South Korea; [Dash, M.; Piilonen, L. E.; Yusa, Y.] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; [Drutskoy, A.; Goldenzweig, P.; Kinoshita, K.; Schwartz, A. J.; Somov, A.] Univ Cincinnati, Cincinnati, OH 45221 USA; [Fujikawa, M.; Hayashii, H.; Kataoka, S. U.; Miyabayashi, K.; Noguchi, S.] Nara Womens Univ, Nara 6308506, Japan; [Golob, B.; Krizan, P.] Univ Ljubljana, Fac Math & Phys, SI-1001 Ljubljana, Slovenia; [Ha, H.; Won, E.] Korea Univ, Seoul 136701, South Korea; [Hara, T.; Heffernan, D.; Miyake, H.; Shinomiya, S.] Osaka Univ, Osaka 5600043, Japan; [Hayasaka, K.; Hokuue, T.; Iijima, T.; Ikado, K.; Inami, K.; Kaji, H.; Kozakai, Y.; Miyazaki, Y.; Mori, T.; Ohshima, T.; Senyo, K.] Nagoya Univ, Nagoya, Aichi 4648602, Japan; [Hoshi, Y.] Tohoku Gakuin Univ, Tagajo, Miyagi 9858537, Japan; [Hyun, H. J.; Kah, D. H.; Kim, H. J.; Park, H.] Kyungpook Natl Univ, Taegu 702701, South Korea; [Ishikawa, A.; Suzuki, S.] Saga Univ, Saga 8408502, Japan; [Ishino, H.] Tokyo Inst Technol, Tokyo 1528551, Japan; [Kim, Y. J.; Liu, Y.] Grad Univ Adv Studies, Hayama 2400193, Japan; [Kawai, H.] Chiba Univ, Chiba 2638522, Japan; [Kawasaki, T.; Tamura, N.] Niigata Univ, Niigata 9502181, Japan; [Kim, S. K.; Lee, M. J.] Seoul Natl Univ, Seoul 151742, South Korea; [Kumar, R.; Singh, J. B.] Panjab Univ, Chandigarh 160014, India; [Mandl, F.; Mitaroff, W.] Austrian Acad Sci, Inst Hochenergiephys, A-1050 Vienna, Austria; [Marlow, D.] Princeton Univ, Princeton, NJ 08544 USA; [Nakano, E.; Teramoto, Y.] Osaka City Univ, Osaka 5588585, Japan; [Nitoh, O.] Tokyo Univ Agr & Technol, Koganei, Tokyo 1848588, Japan; [Ogawa, S.; Shibuya, H.] Toho Univ, Chiba 2748510, Japan; [Okuno, S.; Watanabe, Y.] Kanagawa Univ, Yokohama, Kanagawa 2218686, Japan; [Olsen, S. L.; Shen, C. P.; Yuan, C. Z.; Zhang, C. C.] Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China; [Seidl, R.] Univ Illinois, Urbana, IL 61801 USA; [Seidl, R.] RIKEN BNL Res Ctr, Upton, NY 11973 USA; [Shapkin, M.; Sokolov, A.] Inst High Energy Phys, Protvino 142281, Russia; [Stanic, S.] Univ Nova Gorica, SL-5000 Nova Gorica, Slovenia; [Sumiyoshi, T.] Tokyo Metropolitan Univ, Tokyo 1920397, Japan; [Wang, C. H.] Natl United Univ, Miaoli 36003, Taiwan; [Yamaguchi, A.] Tohoku Univ, Sendai, Miyagi 9808578, Japan; [Yamashita, Y.] Nippon Dent Univ, Niigata 9518580, Japan; [Zhang, Z. P.] Univ Sci & Technol China, Anhua 230026, Peoples R China	National Taiwan University; Hanyang University; High Energy Accelerator Research Organization (KEK); University of Tokyo; Russian Academy of Sciences; Budker Institute of Nuclear Physics; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; Tata Institute of Fundamental Research (TIFR); University of Sydney; University of Melbourne; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; University of Maribor; University of Hawaii System; Fu Jen Catholic University; National Central University; Yonsei University; Gyeongsang National University; Sungkyunkwan University (SKKU); Virginia Polytechnic Institute & State University; University System of Ohio; University of Cincinnati; Nara Womens University; University of Ljubljana; Korea University; Osaka University; Nagoya University; Tohoku Gakuin University; Kyungpook National University; Saga University; Tokyo Institute of Technology; Graduate University for Advanced Studies - Japan; Chiba University; Niigata University; Seoul National University (SNU); Panjab University; Austrian Academy of Sciences; Princeton University; Osaka Metropolitan University; Tokyo University of Agriculture & Technology; Toho University; Kanagawa University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; University of Illinois System; University of Illinois Urbana-Champaign; RIKEN; National Research Centre - Kurchatov Institute; Institute of High Energy Physics - IHEP; University of Nova Gorica; Tokyo Metropolitan University; National United University; Tohoku University; Nippon Dental University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Chang, P (corresponding author), Natl Taiwan Univ, Dept Phys, Taipei 106, Taiwan.	pchang@phys.ntu.edu.tw	Dalseno, Jeremy/AAA-5567-2020; Aihara, Hiroaki/F-3854-2010; Schuemann, Jan/A-4346-2011; Kikutani, Eiji/AAC-6587-2019; Pakhlova, Galina V/C-5378-2014; Bedny, Igor/AAQ-9606-2021; Nitoh, Osamu/C-3522-2013; Kim, Sun/GSN-4867-2022; Lesiak, Tadeusz/P-2206-2017; Peters, Michael W/B-4973-2009; Hazumi, Masashi/A-4447-2011; hou, wei/GWM-4800-2022; Sahoo, Himansu S/GQZ-8361-2022; Schneider, Olivier P/R-9566-2018; Aushev, Tagir/AAN-9735-2020; Chistov, Ruslan/R-5574-2019; Chistov, Ruslan N/B-4893-2014; Shwartz, Boris/N-2673-2014; Kibayashi, Atsuko/K-7327-2015; Uglov, Timofey V/B-2406-2014; Singh, J B/ABF-5574-2021; Ishino, Hirokazu/C-1994-2015; Cheon, Byung Gu/B-3035-2008; Drutskoy, Alexey G/C-8833-2016; Won, Eunil/S-7182-2019; Pestotnik, Rok/A-3626-2008; Krokovny, Pavel/G-4421-2016; Kikutani, Eiji/E-8263-2012; Iwasaki, Masako/AAG-6574-2019; Kim, Sun Kee/G-2042-2015; Bondar, Alexander E./O-9312-2017; Marlow, Daniel R/C-9132-2014; Furukawa, Kazuro/C-2639-2011; Križan, Peter/L-7809-2016; Kuzmin, Alexander/AAR-8369-2021; Mizuk, Roman/B-3751-2014; Danilov, Mikhail/C-5380-2014; Sumiyoshi, Takayuki/Q-5536-2017	Dalseno, Jeremy/0000-0003-3288-4683; Aihara, Hiroaki/0000-0002-1907-5964; Schuemann, Jan/0000-0002-7554-8818; Kikutani, Eiji/0000-0003-1518-8045; Pakhlova, Galina V/0000-0001-7518-3022; Lesiak, Tadeusz/0000-0002-3966-2998; Hazumi, Masashi/0000-0001-6830-8309; Schneider, Olivier P/0000-0002-6014-7552; Aushev, Tagir/0000-0002-6347-7055; Chistov, Ruslan/0000-0003-1439-8390; Chistov, Ruslan N/0000-0003-1439-8390; Uglov, Timofey V/0000-0002-4944-1830; Singh, J B/0000-0001-9029-2462; Ishino, Hirokazu/0000-0002-8623-4080; Drutskoy, Alexey G/0000-0003-4524-0422; Won, Eunil/0000-0002-4245-7442; Krokovny, Pavel/0000-0002-1236-4667; Kikutani, Eiji/0000-0003-1518-8045; Iwasaki, Masako/0000-0002-9402-7559; Kim, Sun Kee/0000-0002-0013-0775; Furukawa, Kazuro/0000-0003-4187-2836; Križan, Peter/0000-0002-4967-7675; Kuzmin, Alexander/0000-0002-7011-5044; Danilov, Mikhail/0000-0001-9227-5164; Sumiyoshi, Takayuki/0000-0002-0486-3896; ji tian, zheng ren/0000-0002-6100-086X; Varvell, Kevin/0000-0003-1017-1295; HARA, Takanori/0000-0002-4321-0417; Mori, Takashi/0000-0003-0977-4021; HSIUNG, YEE/0000-0003-4801-1238; Stanic, Samo/0000-0003-3344-8381; Akai, Kazunori/0000-0001-7276-6986; USHIRODA, Yutaka/0000-0003-3174-403X; Sevior, Martin/0000-0002-4824-101X; TAYLOR, GEOFFREY/0000-0002-1831-4871; Tanaka, Manobu M/0000-0002-4697-894X; xiong er lang, xiao chuan/0000-0002-4203-444X; Barberio, Elisabetta/0000-0002-3111-0910; Zilic, Viktor/0000-0002-0907-5565; Haba, Junji/0000-0002-1018-219X; CHANG, PAO-TI/0000-0003-4064-388X; zhu ze, yi gao/0000-0001-7003-7210; Trabelsi, Karim/0000-0001-6567-3036; yan qi, yi ren/0000-0001-7261-2557; Browder, Thomas E/0000-0001-7357-9007; Poluektov, Anton/0000-0003-2222-9925; Piilonen, Leo/0000-0001-6836-0748; Nakamura, Tatsuro/0000-0002-7899-7133; Hayashii, Hisaki/0000-0002-5138-5903; Liventsev, Dmitri/0000-0003-3416-0056; Yabsley, Bruce/0000-0002-2680-0474; Ishikawa, Akimasa/0000-0002-3561-5633; URQUIJO, PHILLIP/0000-0002-0887-7953; Bozek, Andrzej/0000-0002-5915-1319; Shidara, Tetsuo/0000-0002-1639-5591; Yuan, Chang-Zheng/0000-0002-1652-6686; Bondar, Alexander/0000-0002-5089-5338; Nishida, Shohei/0000-0001-6373-2346; Tawada, Masafumi/0000-0002-6300-5891; Miyabayashi, Kenkichi/0000-0003-4352-734X; CHEN, KAI-FENG/0000-0003-1304-3782	Science and Technology Facilities Council [ST/F002289/1] Funding Source: researchfish; STFC [ST/F002289/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Abashian A, 2002, NUCL INSTRUM METH A, V479, P117, DOI 10.1016/S0168-9002(01)02013-7; Abulencia A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.211802; Alavi-Harati A, 1999, PHYS REV LETT, V83, P22, DOI 10.1103/PhysRevLett.83.22; Atwood D, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.036005; Aubert B, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.091102; Aubert B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.021603; Aubert B, 2004, PHYS REV LETT, V93, DOI [10.1103/PhysRevLett.93.131801, 10.1103/PhysRevLett.93.231801, 10.1103/PhysRevLett.93.041801, 10.1103/PhysRevLett.93.181801, 10.1103/PhysRevLett.93.081801]; Aubert B, 2001, PHYS REV LETT, V87, DOI [10.1103/PhysRevLett.87.151801, 10.1103/PhysRevLett.87.241801]; Baek S, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.057502; Baek S, 2007, PHYS LETT B, V653, P249, DOI 10.1016/j.physletb.2007.08.001; Barberio E, 2007, AVERAGES B HADRON PR; Beneke M, 2005, PHYS LETT B, V620, P143, DOI 10.1016/j.physletb.2005.06.045; Beneke M, 2003, NUCL PHYS B, V675, P333, DOI 10.1016/j.nuclphysb.2003.09.026; Charng YY, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.014036; Cheng HY, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.014006; Chiang CW, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.034020; CHRISTENSON JH, 1964, PHYS REV LETT, V13, P138, DOI 10.1103/PhysRevLett.13.138; COHEN AG, 1993, ANNU REV NUCL PART S, V43, P27; Fanti V, 1999, PHYS LETT B, V465, P335, DOI 10.1016/S0370-2693(99)01030-8; Gronau M, 2005, PHYS LETT B, V627, P82, DOI 10.1016/j.physletb.2005.09.014; Hou WS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.131801; Hou WS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.141601; Kakuno H, 2004, NUCL INSTRUM METH A, V533, P516, DOI 10.1016/j.nima.2004.06.159; Keum YY, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.054009; KOBAYASHI M, 1973, PROG THEOR PHYS, V49, P652, DOI 10.1143/PTP.49.652; Kurokawa S, 2003, NUCL INSTRUM METH A, V499, P1, DOI 10.1016/S0168-9002(02)01771-0; Li HN, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.114005; SAKHAROV AD, 1967, JETP LETT-USSR, V5, P24	30	103	103	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					332	U3		10.1038/nature06827	http://dx.doi.org/10.1038/nature06827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354478				2022-12-28	WOS:000254117400042
J	Abramson, JS; Kotton, CN; Elias, N; Sahani, DV; Hasserjian, RP; Den, RB; Elias, N; Rosenberg, ES; Attar, E				Abramson, Jeremy S.; Kotton, Camille N.; Elias, Nahel; Sahani, Dushyant V.; Hasserjian, Robert P.; Den, Robert B.; Elias, Nahel; Rosenberg, Eric S.; Attar, Eyal			A man with fever, abdominal pain, and pancytopenia after renal transplantation - Post-transplant lymphoproliferative disorder: Hepatosplenic T-cell lymphoma, gamma/delta type	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GAMMA-DELTA; CLINICOPATHOLOGICAL ENTITY; IMMUNOCOMPROMISED PATIENTS; DISEASE; CYCLOSPORINE; MALIGNANCY; RECIPIENTS; RECEPTOR; PATIENT; SERIES		[Abramson, Jeremy S.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Kotton, Camille N.] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA; [Abramson, Jeremy S.; Kotton, Camille N.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Elias, Nahel] Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; [Sahani, Dushyant V.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Hasserjian, Robert P.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Abramson, JS (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.		Elias, Nahel/AAO-8344-2020; Abramson, Jeremy/N-5178-2019	Elias, Nahel/0000-0001-6466-7347; Kotton, Camille/0000-0001-7320-2234				Aldinucci D, 2000, BRIT J HAEMATOL, V110, P188, DOI 10.1046/j.1365-2141.2000.02129.x; Belhadj K, 2003, BLOOD, V102, P4261, DOI 10.1182/blood-2003-05-1675; Bren A, 2005, TRANSPL P, V37, P1889, DOI 10.1016/j.transproceed.2005.02.112; Bustami RT, 2004, AM J TRANSPLANT, V4, P87, DOI 10.1046/j.1600-6135.2003.00274.x; Caillard S, 2006, AM J TRANSPLANT, V6, P2735, DOI 10.1111/j.1600-6143.2006.01540.x; Caillard S, 2005, TRANSPLANTATION, V80, P1233, DOI 10.1097/01.tp.0000179639.98338.39; CORAZZALLI G, 2005, HAEMATOLOGICA, V90, pECR14; de Wolf-Peeters C, 2000, HISTOPATHOLOGY, V36, P294; Dominguez E, 1995, J NEW YORK ENTOMOL S, V103, P15; Francois A, 1997, AM J SURG PATHOL, V21, P781, DOI 10.1097/00000478-199707000-00006; Funch DP, 2005, TRANSPLANTATION, V80, P1174, DOI 10.1097/01.tp.0000169035.10572.c6; Gentile TC, 1998, BRIT J HAEMATOL, V101, P507, DOI 10.1046/j.1365-2141.1998.00712.x; GRACE AA, 1987, KIDNEY INT, V32, P889, DOI 10.1038/ki.1987.291; Iannitto E, 2002, BRIT J HAEMATOL, V117, P995, DOI 10.1046/j.1365-2141.2002.03537_3.x; Jaffe Elaine S, 2006, Hematology Am Soc Hematol Educ Program, P317; Janka Gritta, 2005, Hematology Am Soc Hematol Educ Program, P82; Karras A, 2004, TRANSPLANTATION, V77, P238, DOI 10.1097/01.TP.0000107285.86939.37; Kasiske BL, 2004, AM J TRANSPLANT, V4, P905, DOI 10.1111/j.1600-6143.2004.00450.x; Kotton CN, 2005, J AM SOC NEPHROL, V16, P1758, DOI 10.1681/ASN.2004121113; Kraus MD, 1998, CANCER-AM CANCER SOC, V82, P983, DOI 10.1002/(SICI)1097-0142(19980301)82:5<983::AID-CNCR26>3.0.CO;2-W; Kwong YL, 2000, BRIT J HAEMATOL, V110, P197, DOI 10.1046/j.1365-2141.2000.02138.x; Libertiny G, 2001, BRIT J SURG, V88, P1330, DOI 10.1046/j.0007-1323.2001.01924.x; Mittal S, 2006, EUR J HAEMATOL, V76, P531, DOI 10.1111/j.1600-0609.2006.00646.x; MORRISON VA, 1994, AM J MED, V97, P14, DOI 10.1016/0002-9343(94)90043-4; Natkunam Y, 1999, AM J CLIN PATHOL, V111, P663; Navarro JT, 2003, LEUKEMIA LYMPHOMA, V44, P531, DOI 10.1080/1042819021000035662; Ooi J, 2001, Haematologica, V86, pE25; Opelz G, 2004, AM J TRANSPLANT, V4, P222, DOI 10.1046/j.1600-6143.2003.00325.x; Oyoshi MK, 2003, AM J PATHOL, V162, P1629, DOI 10.1016/S0002-9440(10)64297-6; Rajakariar R, 2004, AM J TRANSPLANT, V4, P1534, DOI 10.1111/j.1600-6143.2004.00521.x; ROSS CW, 1994, AM J CLIN PATHOL, V102, P310, DOI 10.1093/ajcp/102.3.310; SEKI S, 1990, J CLIN INVEST, V86, P409, DOI 10.1172/JCI114726; Trimarchi HM, 1999, TRANSPLANTATION, V67, P539, DOI 10.1097/00007890-199902270-00009; Vardiman J., 2001, WHO CLASSIFICATION T, V3; Weidmann E, 2000, HAEMATOLOGICA, V85, P1024; Weidmann E, 2000, LEUKEMIA, V14, P991, DOI 10.1038/sj.leu.2401784; WEISSMANN DJ, 1996, BLOOD, V88, P3626; Wlodarska I, 2002, GENE CHROMOSOME CANC, V33, P243, DOI 10.1002/gcc.10021; Wu H, 2000, AM J CLIN PATHOL, V113, P487, DOI 10.1309/YTTC-F55W-K9CP-EPX5; Yamazaki T, 2006, ACTA HAEMATOL-BASEL, V116, P90, DOI 10.1159/000093637	43	5	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1176	1187		10.1056/NEJMcpc0800380	http://dx.doi.org/10.1056/NEJMcpc0800380			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337607				2022-12-28	WOS:000253877200012
J	Jones, GH; Roussos, E; Krupp, N; Beckmann, U; Coates, AJ; Crary, F; Dandouras, I; Dikarev, V; Dougherty, MK; Garnier, P; Hansen, CJ; Hendrix, AR; Hospodarsky, GB; Johnson, RE; Kempf, S; Khurana, KK; Krimigis, SM; Kruger, H; Kurth, WS; Lagg, A; McAndrews, HJ; Mitchell, DG; Paranicas, C; Postberg, F; Russell, CT; Saur, J; Seiss, M; Spahn, F; Srama, R; Strobel, DF; Tokar, R; Wahlund, JE; Wilson, RJ; Woch, J; Young, D				Jones, G. H.; Roussos, E.; Krupp, N.; Beckmann, U.; Coates, A. J.; Crary, F.; Dandouras, I.; Dikarev, V.; Dougherty, M. K.; Garnier, P.; Hansen, C. J.; Hendrix, A. R.; Hospodarsky, G. B.; Johnson, R. E.; Kempf, S.; Khurana, K. K.; Krimigis, S. M.; Krueger, H.; Kurth, W. S.; Lagg, A.; McAndrews, H. J.; Mitchell, D. G.; Paranicas, C.; Postberg, F.; Russell, C. T.; Saur, J.; Seiss, M.; Spahn, F.; Srama, R.; Strobel, D. F.; Tokar, R.; Wahlund, J. -E.; Wilson, R. J.; Woch, J.; Young, D.			The dust halo of Saturn's largest icy moon, Rhea	SCIENCE			English	Article							PLANETARY SATELLITES; CASSINI; MAGNETOSPHERE; CLOUDS	Saturn's moon Rhea had been considered massive enough to retain a thin, externally generated atmosphere capable of locally affecting Saturn's magnetosphere. The Cassini spacecraft's in situ observations reveal that energetic electrons are depleted in the moon's vicinity. The absence of a substantial exosphere implies that Rhea's magnetospheric interaction region, rather than being exclusively induced by sputtered gas and its products, likely contains solid material that can absorb magnetospheric particles. Combined observations from several instruments suggest that this material is in the form of grains and boulders up to several decimetres in size and orbits Rhea as an equatorial debris disk. Within this disk may reside denser, discrete rings or arcs of material.	[Jones, G. H.; Roussos, E.; Krupp, N.; Dikarev, V.; Krueger, H.; Lagg, A.; Woch, J.] Max Planck Inst Sonnensystemforsch, D-37191 Katlenburg Lindau, Germany; [Jones, G. H.; Coates, A. J.; McAndrews, H. J.] UCL, Mullard Space Sci Lab, Dept Space & Climate Phys, Dorking RH5 6NT, Surrey, England; [Jones, G. H.; Coates, A. J.] UCL, Ctr Planetary Sci, London WC1E 6BT, England; [Beckmann, U.; Dikarev, V.; Kempf, S.; Postberg, F.; Srama, R.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Crary, F.; Young, D.] SW Res Inst, San Antonio, TX 78238 USA; [Dandouras, I.; Garnier, P.] Univ Toulouse 3, CNRS, Ctr Etud Spatiale Rayonnements, F-31400 Toulouse, France; [Dikarev, V.] St Petersburg State Univ, Inst Astron, St Petersburg 198504, Russia; [Dougherty, M. K.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2BW, England; [Garnier, P.; Wahlund, J. -E.] Swedish Inst Space Phys, S-75121 Uppsala, Sweden; [Hansen, C. J.; Hendrix, A. R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Hospodarsky, G. B.; Kurth, W. S.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Johnson, R. E.] Univ Virginia, Dept Mat Sci & Engn, Charlottesville, VA 22904 USA; [Khurana, K. K.; Russell, C. T.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Krimigis, S. M.; Mitchell, D. G.; Paranicas, C.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Krimigis, S. M.] Acad Athens, Athens 11527, Greece; [Saur, J.] Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany; [Seiss, M.; Spahn, F.] Univ Potsdam, AG Nichtlineare Dynam, D-14469 Potsdam, Germany; [Strobel, D. F.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [McAndrews, H. J.; Tokar, R.; Wilson, R. J.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Max Planck Society; University of London; University College London; University of London; University College London; Max Planck Society; Southwest Research Institute; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institute of Astronomy of the Russian Academy of Sciences; Saint Petersburg State University; Imperial College London; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Iowa; University of Virginia; University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Academy of Athens; University of Cologne; University of Potsdam; Johns Hopkins University; United States Department of Energy (DOE); Los Alamos National Laboratory	Jones, GH (corresponding author), Max Planck Inst Sonnensystemforsch, Max Planck Str 2, D-37191 Katlenburg Lindau, Germany.	ghj@mssl.ucl.ac.uk	Paranicas, Christopher/B-1470-2016; Dandouras, Iannis/V-2709-2017; Russell, Christopher T/E-7745-2012; Krimigis, Stamatios/G-4591-2019; Postberg, Frank/AAE-6295-2019; Saur, Joachim/V-6780-2019; Korpi-Lagg, Andreas/W-8166-2019; Strobel, Darrell5/AAO-6643-2021; Roussos, Elias/H-2249-2011; Kurth, William/AAA-7334-2019; Spahn, Frank/AAP-6234-2020; Mitchell, Donald G/H-4601-2016; Coates, Andrew/C-2396-2008; Hospodarsky, George B/A-7996-2015; Jones, Geraint H./C-1682-2008; Wahlund, Jan-Erik/AAL-6439-2021	Paranicas, Christopher/0000-0002-4391-8255; Dandouras, Iannis/0000-0002-7121-1118; Russell, Christopher T/0000-0003-1639-8298; Krimigis, Stamatios/0000-0003-2781-2386; Postberg, Frank/0000-0002-5862-4276; Saur, Joachim/0000-0003-1413-1231; Korpi-Lagg, Andreas/0000-0003-1459-7074; Strobel, Darrell5/0000-0002-0944-8675; Kurth, William/0000-0002-5471-6202; Mitchell, Donald G/0000-0003-1960-2119; Coates, Andrew/0000-0002-6185-3125; Hospodarsky, George B/0000-0001-9200-9878; Jones, Geraint H./0000-0002-5859-1136; Roussos, Elias/0000-0002-5699-0678; Khurana, Krishan/0000-0002-2856-1171; KEMPF, SASCHA/0000-0001-5236-3004	Science and Technology Facilities Council [PP/E001173/1, PP/D000912/1, PP/D005213/1, PP/E001076/1] Funding Source: researchfish; UK Space Agency [PP/D00084X/1] Funding Source: researchfish; STFC [PP/D000912/1, PP/E001173/1, PP/D005213/1, PP/E001076/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Birch PC, 2002, PHYS PLASMAS, V9, P1785, DOI 10.1063/1.1467655; CARBARY JF, 1983, J GEOPHYS RES-SPACE, V88, P8947, DOI 10.1029/JA088iA11p08947; CUZZI JN, 1988, ICARUS, V74, P284, DOI 10.1016/0019-1035(88)90043-7; Dougherty MK, 2004, SPACE SCI REV, V114, P331, DOI 10.1007/s11214-004-1432-2; Esposito LW, 2004, SPACE SCI REV, V115, P299, DOI 10.1007/s11214-004-1455-8; Everhart E., 1985, DYNAMICS COMETS THEI, P185; Gurnett DA, 2004, SPACE SCI REV, V114, P395, DOI 10.1007/s11214-004-1434-0; HAMILTON DP, 1991, ICARUS, V92, P118, DOI 10.1016/0019-1035(91)90039-V; Jones GH, 2006, SCIENCE, V311, P1412, DOI 10.1126/science.1121011; Kempf S, 2006, PLANET SPACE SCI, V54, P999, DOI 10.1016/j.pss.2006.05.012; Khurana KK, 2008, ICARUS, V193, P465, DOI 10.1016/j.icarus.2007.08.005; Krimigis SM, 2004, SPACE SCI REV, V114, P233, DOI 10.1007/s11214-004-1410-8; Krivov AV, 2003, PLANET SPACE SCI, V51, P251, DOI 10.1016/S0032-0633(02)00147-2; Kurth WS, 2006, PLANET SPACE SCI, V54, P988, DOI 10.1016/j.pss.2006.05.011; Roussos E, 2008, ICARUS, V193, P455, DOI 10.1016/j.icarus.2007.03.034; Saur J, 2005, ASTROPHYS J, V620, pL115, DOI 10.1086/428665; Srama R, 2004, SPACE SCI REV, V114, P465, DOI 10.1007/s11214-004-1435-z; Sremcevic M, 2003, PLANET SPACE SCI, V51, P455, DOI 10.1016/S0032-0633(03)00050-3; STUBBS TJ, 2005, LUN PLAN SCI C 36 LU; THOMSEN MF, 1980, J GEOPHYS RES-SPACE, V85, P5831, DOI 10.1029/JA085iA11p05831; WAGNER RJ, 2007, LUN PLAN SCI C 38 LU; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4	22	49	49	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1380	1384		10.1126/science.1151524	http://dx.doi.org/10.1126/science.1151524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323452				2022-12-28	WOS:000253712900041
J	McNamara, C; Zinkernagel, AS; Macheboeuf, P; Cunningham, MW; Nizet, V; Ghosh, P				McNamara, Case; Zinkernagel, Annelies S.; Macheboeuf, Pauline; Cunningham, Madeleine W.; Nizet, Victor; Ghosh, Partho			Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence	SCIENCE			English	Article							M-PROTEIN; CRYSTAL-STRUCTURES; TROPOMYOSIN; BINDING; FIBRINOGEN; STABILITY; PYOGENES; FRAGMENT; DESIGN; REGION	Antigenically variable M proteins are major virulence factors and immunogens of the human pathogen group A Streptococcus ( GAS). Here, we report the similar to 3 angstrom resolution structure of a GAS M1 fragment containing the regions responsible for eliciting type- specific, protective immunity and for binding fibrinogen, which promotes M1 proinflammatory and antiphagocytic functions. The structure revealed substantial irregularities and instabilities throughout the coiled coil of the M1 fragment. Similar structural irregularities occur in myosin and tropomyosin, explaining the patterns of cross- reactivity seen in autoimmune sequelae of GAS infection. Sequence idealization of a large segment of the M1 coiled coil enhanced stability but diminished fibrinogen binding, proinflammatory effects, and antibody cross- reactivity, whereas it left protective immunogenicity undiminished. Idealized M proteins appear to have promise as vaccine immunogens.	[McNamara, Case; Macheboeuf, Pauline; Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Zinkernagel, Annelies S.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Cunningham, Madeleine W.] Univ Oklahoma, Hlth Sci Ctr, Biomed Res Ctr, Oklahoma City, OK 73104 USA; [Nizet, Victor] Univ Calif San Diego, Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Ghosh, Partho] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Diego; University of California System; University of California San Diego	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pghosh@ucsd.edu	Nizet, Victor/AAF-3190-2019; Zinkernagel, Annelies S/F-1780-2017	Zinkernagel, Annelies S/0000-0003-4700-1118; Macheboeuf, Pauline/0000-0003-4523-9923; Nizet, Victor/0000-0003-3847-0422	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL056267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052453, R21AI071167, R01AI048694, R01AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326] Funding Source: NIH RePORTER; NHLBI NIH HHS [R56 HL056267] Funding Source: Medline; NIAID NIH HHS [R01 AI052453-08, R37 AI052453, R01 AI048694, R21 AI071167-01A1, R01 AI052453, R21 AI071167] Funding Source: Medline; NIGMS NIH HHS [T32 GM008326] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andre I, 2006, BIOCHEMISTRY-US, V45, P4559, DOI 10.1021/bi052455c; Blankenfeldt W, 2006, P NATL ACAD SCI USA, V103, P17713, DOI 10.1073/pnas.0606741103; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; CUNNINGHAM MW, 1992, P NATL ACAD SCI USA, V89, P1320, DOI 10.1073/pnas.89.4.1320; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hicks MR, 2002, J STRUCT BIOL, V137, P73, DOI 10.1006/jsbi.2002.4462; Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; MASSELL BF, 1969, J AMER MED ASSOC, V207, P1115, DOI 10.1001/jama.207.6.1115; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; Mertens NMJ, 2000, MOL IMMUNOL, V37, P901, DOI 10.1016/S0161-5890(01)00007-4; NILSON BHK, 1995, BIOCHEMISTRY-US, V34, P13688, DOI 10.1021/bi00041a051; PHILLIPS GN, 1981, P NATL ACAD SCI-BIOL, V78, P4689, DOI 10.1073/pnas.78.8.4689; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866	25	109	113	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1405	1408		10.1126/science.1154470	http://dx.doi.org/10.1126/science.1154470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323455	Green Accepted			2022-12-28	WOS:000253712900048
J	Polyak, V; Hill, C; Asmerom, Y				Polyak, Victor; Hill, Carol; Asmerom, Yemane			Age and evolution of the Grand Canyon revealed by U-Pb dating of water table-type speleothems	SCIENCE			English	Article								The age and evolution of the Grand Canyon have been subjects of great interest and debate since its discovery. We found that cave mammillaries ( water table indicator speleothems) from nine sites in the Grand Canyon showed uranium- lead dating evidence for an old western Grand Canyon on the assumption that groundwater table decline rates are equivalent to incision rates. Samples in the western Grand Canyon yielded apparent water table decline rates of 55 to 123 meters per million years over the past 17 million years, in contrast to eastern Grand Canyon samples that yielded much faster rates ( 166 to 411 meters per million years). Chronology and inferred incision data indicate that the Grand Canyon evolved via headward erosion from west to east, together with late- stage (similar to 3.7 million years ago) accelerated incision in the eastern block.	[Polyak, Victor; Hill, Carol; Asmerom, Yemane] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA	University of New Mexico	Polyak, V (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA.	polyak@unm.edu						ATKINSON TC, 1992, URANIUM SERIES DISEQ, P669; Beard L.S., 1996, RECONSTRUCTING HIST, P27, DOI DOI 10.1130/0-8137-2303-5.27; EDWARDS RL, 1987, EARTH PLANET SC LETT, V81, P175, DOI 10.1016/0012-821X(87)90154-3; Faulds J.E., 2001, COLORADO RIVER ORIGI, P81; Faulds J.E., 2001, COLORADO RIVER ORIGI, P93; Hill C., 1997, CAVE MINERALS WORLD; Hill CA, 2008, GEOMORPHOLOGY, V95, P316, DOI 10.1016/j.geomorph.2007.06.009; Hill C.A., 2001, COLORADO RIVER ORIGI, P141; Karlstrom KE, 2007, GEOL SOC AM BULL, V119, P1283, DOI 10.1130/0016-7606(2007)119[1283:AAFSOQ]2.0.CO;2; LANGE AL, 1955, PLATEAU, V27, P1; PEDERSON J, 2003, GEOLOGY, V31, pE17; Polyak V. J., 2004, GEOLOGICAL SOC AM AB, V36, P549; RANNEY WD, 2005, CARVING GRAND CANYON; Richards DA, 1998, GEOCHIM COSMOCHIM AC, V62, P3683, DOI 10.1016/S0016-7037(98)00256-7; Spencer J.E., 2001, COLORADO RIVER ORIGI, P89; SZABO BJ, 1994, QUATERNARY RES, V41, P56; WINOGRAD IJ, 1988, SCIENCE, V242, P1275, DOI 10.1126/science.242.4883.1275; Woodhead J, 2006, QUAT GEOCHRONOL, V1, P208, DOI 10.1016/j.quageo.2006.08.002; Young R. A., 2001, COLORADO RIVER ORIGI, V12, P199	19	90	93	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1377	1380		10.1126/science.1151248	http://dx.doi.org/10.1126/science.1151248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323451	Green Published			2022-12-28	WOS:000253712900040
J	Kangaspeska, S; Stride, B; Metivier, R; Polycarpou-Schwarz, M; Ibberson, D; Carmouche, RP; Benes, V; Gannon, F; Reid, G				Kangaspeska, Sara; Stride, Brenda; Metivier, Raphael; Polycarpou-Schwarz, Maria; Ibberson, David; Carmouche, Richard Paul; Benes, Vladimir; Gannon, Frank; Reid, George			Transient cyclical methylation of promoter DNA	NATURE			English	Article							ESTROGEN-RECEPTOR-ALPHA; CHROMATIN MODIFICATION; NUCLEAR RECEPTOR; GENE-REGULATION; TRANSCRIPTION; ORGANIZATION; MECHANISMS; DYNAMICS	Methylation of CpG dinucleotides is generally associated with epigenetic silencing of transcription and is maintained through cellular division(1-3). Multiple CpG sequences are rare in mammalian genomes, but frequently occur at the transcriptional start site of active genes, with most clusters of CpGs being hypomethylated(4). We reported previously that the proximal region of the trefoil factor 1 ( TFF1, also known as pS2) and oestrogen receptor alpha ( ER alpha) promoters could be partially methylated by treatment with deacetylase inhibitors(5), suggesting the possibility of dynamic changes in DNA methylation. Here we show that cyclical methylation and demethylation of CpG dinucleotides, with a periodicity of around 100 min, is characteristic for five selected promoters, including the oestrogen ( E2)- responsive pS2 gene, in human cells. When the pS2 gene is actively transcribed, DNA methylation occurs after the cyclical occupancy of ER alpha and RNA polymerase II ( polII). Moreover, we report conditions that provoke methylation cycling of the pS2 promoter in cell lines in which pS2 expression is quiescent and the proximal promoter is methylated. This coincides with a low- level re- expression of ER alpha and of pS2 transcripts.	[Kangaspeska, Sara; Stride, Brenda; Polycarpou-Schwarz, Maria; Ibberson, David; Carmouche, Richard Paul; Benes, Vladimir; Gannon, Frank; Reid, George] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Metivier, Raphael] Univ Rennes 1, SPARTE, CNRS, UMR 6026, F-35042 Rennes, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Reid, G (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	george.reid@embl.de	Hu, Ruogu/B-2203-2008; Gannon, Frank/G-1194-2015	Benes, Vladimir/0000-0002-0352-2547; Reid, George/0000-0002-0298-693X; Polycarpou-Schwarz, Maria/0000-0002-9125-6460				Costello JF, 2001, J MED GENET, V38, P285, DOI 10.1136/jmg.38.5.285; Dillon N, 2006, CHROMOSOME RES, V14, P117, DOI 10.1007/s10577-006-1027-8; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kress C, 2006, P NATL ACAD SCI USA, V103, P11112, DOI 10.1073/pnas.0601793103; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; METIVIER R, NATURE; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; NELSON JE, 1992, ANAL BIOCHEM, V207, P197, DOI 10.1016/0003-2697(92)90523-A; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Yokochi T, 2004, MOL PHARMACOL, V66, P1415, DOI 10.1124/mol.104.002634	23	512	536	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					112	U14		10.1038/nature06640	http://dx.doi.org/10.1038/nature06640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322535				2022-12-28	WOS:000253671900057
J	Martin, F; Aerts, A; Ahren, D; Brun, A; Danchin, EGJ; Duchaussoy, F; Gibon, J; Kohler, A; Lindquist, E; Pereda, V; Salamov, A; Shapiro, HJ; Wuyts, J; Blaudez, D; Buee, M; Brokstein, P; Canback, B; Cohen, D; Courty, PE; Coutinho, PM; Delaruelle, C; Detter, JC; Deveau, A; DiFazio, S; Duplessis, S; Fraissinet-Tachet, L; Lucic, E; Frey-Klett, P; Fourrey, C; Feussner, I; Gay, G; Grimwood, J; Hoegger, PJ; Jain, P; Kilaru, S; Labbe, J; Lin, YC; Legue, V; Le Tacon, F; Marmeisse, R; Melayah, D; Montanini, B; Muratet, M; Nehls, U; Niculita-Hirzel, H; Oudot-Le Secq, MP; Peter, M; Quesneville, H; Rajashekar, B; Reich, M; Rouhier, N; Schmutz, J; Yin, T; Chalot, M; Henrissat, B; Kues, U; Lucas, S; Van de Peer, Y; Podila, GK; Polle, A; Pukkila, PJ; Richardson, PM; Rouze, P; Sanders, IR; Stajich, JE; Tunlid, A; Tuskan, G; Grigoriev, IV				Martin, F.; Aerts, A.; Ahren, D.; Brun, A.; Danchin, E. G. J.; Duchaussoy, F.; Gibon, J.; Kohler, A.; Lindquist, E.; Pereda, V.; Salamov, A.; Shapiro, H. J.; Wuyts, J.; Blaudez, D.; Buee, M.; Brokstein, P.; Canback, B.; Cohen, D.; Courty, P. E.; Coutinho, P. M.; Delaruelle, C.; Detter, J. C.; Deveau, A.; DiFazio, S.; Duplessis, S.; Fraissinet-Tachet, L.; Lucic, E.; Frey-Klett, P.; Fourrey, C.; Feussner, I.; Gay, G.; Grimwood, J.; Hoegger, P. J.; Jain, P.; Kilaru, S.; Labbe, J.; Lin, Y. C.; Legue, V.; Le Tacon, F.; Marmeisse, R.; Melayah, D.; Montanini, B.; Muratet, M.; Nehls, U.; Niculita-Hirzel, H.; Oudot-Le Secq, M. P.; Peter, M.; Quesneville, H.; Rajashekar, B.; Reich, M.; Rouhier, N.; Schmutz, J.; Yin, T.; Chalot, M.; Henrissat, B.; Kuees, U.; Lucas, S.; Van de Peer, Y.; Podila, G. K.; Polle, A.; Pukkila, P. J.; Richardson, P. M.; Rouze, P.; Sanders, I. R.; Stajich, J. E.; Tunlid, A.; Tuskan, G.; Grigoriev, I. V.			The genome of Laccaria bicolor provides insights into mycorrhizal symbiosis	NATURE			English	Article							MEDICAGO-TRUNCATULA; PROTEINS; BIOLOGY	Mycorrhizal symbioses - the union of roots and soil fungi - are universal in terrestrial ecosystems and may have been fundamental to land colonization by plants(1,2). Boreal, temperate and montane forests all depend on ectomycorrhizae(1). Identification of the primary factors that regulate symbiotic development and metabolic activity will therefore open the door to understanding the role of ectomycorrhizae in plant development and physiology, allowing the full ecological significance of this symbiosis to be explored. Here we report the genome sequence of the ectomycorrhizal basidiomycete Laccaria bicolor ( Fig. 1) and highlight gene sets involved in rhizosphere colonization and symbiosis. This 65- megabase genome assembly contains 20,000 predicted protein- encoding genes and a very large number of transposons and repeated sequences. We detected unexpected genomic features, most notably a battery of effector- type small secreted proteins ( SSPs) with unknown function, several of which are only expressed in symbiotic tissues. The most highly expressed SSP accumulates in the proliferating hyphae colonizing the host root. The ectomycorrhizae- specific SSPs probably have a decisive role in the establishment of the symbiosis. The unexpected observation that the genome of L. bicolor lacks carbohydrate- active enzymes involved in degradation of plant cell walls, but maintains the ability to degrade non- plant cell wall polysaccharides, reveals the dual saprotrophic and biotrophic lifestyle of the mycorrhizal fungus that enables it to grow within both soil and living plant roots. The predicted gene inventory of the L. bicolor genome, therefore, points to previously unknown mechanisms of symbiosis operating in biotrophic mycorrhizal fungi. The availability of this genome provides an unparalleled opportunity to develop a deeper understanding of the processes by which symbionts interact with plants within their ecosystem to perform vital functions in the carbon and nitrogen cycles that are fundamental to sustainable plant productivity.	[Martin, F.; Brun, A.; Duchaussoy, F.; Gibon, J.; Kohler, A.; Pereda, V.; Wuyts, J.; Blaudez, D.; Buee, M.; Cohen, D.; Courty, P. E.; Delaruelle, C.; Deveau, A.; Duplessis, S.; Lucic, E.; Frey-Klett, P.; Fourrey, C.; Labbe, J.; Legue, V.; Le Tacon, F.; Montanini, B.; Oudot-Le Secq, M. P.; Peter, M.; Reich, M.; Rouhier, N.; Chalot, M.] Univ Nancy 1, INRA, UMR 1136, F-54280 Champenoux, France; [Aerts, A.; Lindquist, E.; Salamov, A.; Shapiro, H. J.; Brokstein, P.; Detter, J. C.; Lucas, S.; Richardson, P. M.; Grigoriev, I. V.] US DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Ahren, D.; Canback, B.; Rajashekar, B.; Tunlid, A.] Lund Univ, SE-22362 Lund, Sweden; [Danchin, E. G. J.; Coutinho, P. M.; Henrissat, B.] Univ Aix Marseille 1, CNRS, UMR 6098, F-13288 Marseille 9, France; [Danchin, E. G. J.; Coutinho, P. M.; Henrissat, B.] Univ Aix Marseille 2, CNRS, UMR 6098, F-13288 Marseille 9, France; [Wuyts, J.; Lin, Y. C.; Van de Peer, Y.; Rouze, P.] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [DiFazio, S.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; [Feussner, I.] Univ Gottingen, Dept Plant Biochem, D-37077 Gottingen, Germany; [Fraissinet-Tachet, L.; Gay, G.; Marmeisse, R.; Melayah, D.] Univ Lyon 1, CNRS, UMR USC INRA Ecol Microbienne, F-69622 Villeurbanne, France; [Grimwood, J.; Schmutz, J.] Stanford Univ, Sch Med, Stanford Human Genome Ctr, Dept Genet, Palo Alto, CA 94304 USA; [Hoegger, P. J.; Kilaru, S.; Reich, M.; Kuees, U.; Polle, A.] Univ Gottingen, Inst Forest Bot, D-37077 Gottingen, Germany; [Jain, P.; Muratet, M.; Podila, G. K.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; [Nehls, U.] Univ Tubingen, D-72076 Tubingen, Germany; [Niculita-Hirzel, H.; Sanders, I. R.] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Peter, M.] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Quesneville, H.] INRA, Unite Rech Genom Info, F-91034 Evry, France; [Yin, T.; Tuskan, G.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Pukkila, P. J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Rouze, P.] Univ Ghent, Lab Assoc INRA, B-9052 Ghent, Belgium; [Stajich, J. E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	INRAE; Universite de Lorraine; United States Department of Energy (DOE); Lund University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Flanders Institute for Biotechnology (VIB); Ghent University; West Virginia University; University of Gottingen; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Stanford University; University of Gottingen; University of Alabama System; University of Alabama Huntsville; Eberhard Karls University of Tubingen; University of Lausanne; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; INRAE; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of North Carolina; University of North Carolina Chapel Hill; Ghent University; University of California System; University of California Berkeley	Martin, F (corresponding author), Univ Nancy 1, INRA, UMR 1136, F-54280 Champenoux, France.	fmartin@nancy.inra.fr	Coutinho, Pedro M/C-4473-2008; Tuskan, Gerald/A-6225-2011; Van de Peer, Yves/D-4388-2009; Rajashekar, Balaji/W-8012-2018; , DUPLESSIS/G-4150-2011; Danchin, Etienne GJ/X-6969-2019; Kohler, Annegret/AAD-1876-2019; Grimwood, Jane/ABD-5737-2021; Quesneville, Hadi/AAG-1048-2020; Niculita-Hirzel, Helene/I-8741-2012; Kües, Ursula/B-8280-2008; LIN, Yao-Cheng/B-4394-2008; Schmutz, Jeremy/N-3173-2013; DEVEAU, Aurélie/AFH-1153-2022; Pereda-Loth, Veronica/A-1296-2011; Blaudez, Damien/AAF-6517-2020; Danchin, Etienne G.J./A-6648-2008; Henrissat, Bernard/J-2475-2012; CHALOT, Michel/A-1113-2012; Feussner, Ivo/H-9320-2013; Reich, Marlis/AAC-4604-2021; Peter, Martina/G-2284-2018; Stajich, Jason Eric/C-7297-2008; Labbe, Jessy/G-9532-2011; Niculita-Hirzel, Helene/AAS-5375-2021; , Deveau/AAD-4442-2020; Van de Peer, Yves/AAE-7666-2019; Sanders, Ian R/T-9988-2017	Tuskan, Gerald/0000-0003-0106-1289; Van de Peer, Yves/0000-0003-4327-3730; Rajashekar, Balaji/0000-0002-1665-5584; , DUPLESSIS/0000-0002-2072-2989; Danchin, Etienne GJ/0000-0003-4146-5608; Quesneville, Hadi/0000-0003-3001-4908; Kües, Ursula/0000-0001-9180-4079; LIN, Yao-Cheng/0000-0002-9390-795X; Schmutz, Jeremy/0000-0001-8062-9172; Danchin, Etienne G.J./0000-0003-4146-5608; Henrissat, Bernard/0000-0002-3434-8588; CHALOT, Michel/0000-0001-8614-0917; Feussner, Ivo/0000-0002-9888-7003; Reich, Marlis/0000-0001-7537-5809; Peter, Martina/0000-0002-6365-6889; Stajich, Jason Eric/0000-0002-7591-0020; Labbe, Jessy/0000-0003-0368-2054; Niculita-Hirzel, Helene/0000-0003-1467-8819; , Deveau/0000-0001-6266-5241; Van de Peer, Yves/0000-0003-4327-3730; Sanders, Ian R/0000-0002-9591-8214; Cohen, David/0000-0002-0320-8865; Nehls, Uwe/0000-0003-4421-6455; Marmeisse, Roland/0000-0003-1653-3517; Blaudez, Damien/0000-0003-3287-3482; Rouhier, Nicolas/0000-0002-2036-7884; COURTY, Pierre-Emmanuel/0000-0003-2789-7818; valerie, legue/0000-0001-6626-5149; DiFazio, Stephen/0000-0003-4077-1590; Grigoriev, Igor/0000-0002-3136-8903; Veneault-Fourrey, Claire/0000-0001-9778-2659; Montanini, Barbara/0000-0002-5419-7975; Kilaru, Sreedhar/0000-0002-8580-6358; Legue, Valerie/0000-0003-2090-9580; Buee, Marc/0000-0001-8614-3886; Polle, Andrea/0000-0001-8697-6394				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blancaflor EB, 2001, PROTOPLASMA, V217, P154, DOI 10.1007/BF01283396; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Chalot M, 2006, TRENDS PLANT SCI, V11, P263, DOI 10.1016/j.tplants.2006.04.005; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Klironomos JN, 2001, NATURE, V410, P651, DOI 10.1038/35070643; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Martin F, 2007, CURR OPIN PLANT BIOL, V10, P204, DOI 10.1016/j.pbi.2007.01.006; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Nehls U, 2007, PHYTOCHEMISTRY, V68, P82, DOI 10.1016/j.phytochem.2006.09.024; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SCHIEX T, LECT NOTES COMPUTER, V2066, P111; Tenney AE, 2004, GENOME RES, V14, P2330, DOI 10.1101/gr.2816704; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wirsel SGR, 2001, MOL PLANT MICROBE IN, V14, P1319, DOI 10.1094/MPMI.2001.14.11.1319; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	27	702	799	7	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					88	U7		10.1038/nature06556	http://dx.doi.org/10.1038/nature06556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322534	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000253671900052
J	Page, C				Page, Clive			In-vivo skills and UK competitiveness in biomedical sciences	LANCET			English	Editorial Material									Kings Coll London, Sackler Inst Pulm Pharmacol, Div Pharmaceut Sci, London SE1 1UL, England; Biosci Federat, Animal Sci Grp, Cambridge, England	University of London; King's College London	Page, C (corresponding author), Kings Coll London, Sackler Inst Pulm Pharmacol, Div Pharmaceut Sci, London SE1 1UL, England.	clive.page@kcl.ac.uk		Page, Clive Peter/0000-0002-9358-3799				Association of the British Pharmaceutical Industry and Biosciences Federation, 2007, IN VIV SCI UK SUST S; Bioscience Innovation Growth Team, 2003, BIOSC 2015 IMPR NAT; COOKSEY D, 2005, REV UK HLTH RES FUND; *FOOD DRUG ADM, 2006, INN STAGN CHALL OPP; *KINGS COLL LOND, 2007, INT MED MRES; PAGE CP, 1994, TRENDS PHARMACOL SCI, V15, P17, DOI 10.1016/0165-6147(94)90128-7; The Association of the British Pharmaceutical Industry, 2005, SUST SKILLS PIP PHAR	7	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 1	2008	371	9614					708	709		10.1016/S0140-6736(08)60323-2	http://dx.doi.org/10.1016/S0140-6736(08)60323-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313490				2022-12-28	WOS:000253596700010
J	Wong, TY; Liew, G; Tapp, RJ; Schmidt, MI; Wang, JJ; Mitchell, P; Klein, R; Klein, BEK; Zimmet, P; Shaw, J				Wong, Tien Y.; Liew, Gerald; Tapp, Robyn J.; Schmidt, Maria Ines; Wang, Jie Jin; Mitchell, Paul; Klein, Ronald; Klein, Barbara E. K.; Zimmet, Paul; Shaw, Jonathan			Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies	LANCET			English	Article							RISK-FACTORS; PREVALENCE; THRESHOLD; SIGNS	Background The WHO and American Diabetes Association criteria for diagnosing diabetes mellitus assume the presence of a glycaemic threshold with high sensitivity for identifying retinopathy. However, this assumption is based on data from three previous studies that had important limitations in detecting retinopathy. We aimed to provide updated data for the relation between fasting plasma glucose (FPG) and retinopathy, and to assess the diagnostic accuracy of current FPG thresholds in identifying both prevalent and incident retinopathy. Methods We examined the data from three cross-sectional adult populations: those in the Blue Mountains Eye Study (BMES, Australia, n=3162), the Australian Diabetes, Obesity and Lifestyle Study (AusDiab, Australia, n=2182), and the Multi-Ethnic Study of Atherosclerosis (MESA, USA, n=6079). Retinopathy was diagnosed from multiple retinal photographs of each eye, and graded according to the modified Airlie House Classification system. Plasma glucose concentrations were measured from fasting venous blood samples. Findings The overall prevalence of retinopathy was 11.5% in BMES (95% Cl 10.4-12.6%), 9.6% in AusDiab (8.4-10.9), and 15.8% in MESA (14.9-16.7). However, we found inconsistent evidence of a uniform glycaemic threshold for prevalent and incident retinopathy, with analyses suggesting a continuous relation. The widely used diabetes FPG cutoff of 7 . 0 mmol/L or higher had sensitivity less than 40% (range 14.8-39. 1) for detecting retinopathy, with specificity between 80.8% and 95.8%. The area under receiver operating characteristic curves for FPG and retinopathy was low and ranged from 0 . 56 to 0.61. Interpretation We saw no evidence of a clear and consistent glycaemic threshold for the presence or incidence of retinopathy across different populations. The current FPG cutoff of 7 . 0 mmol/L used to diagnose diabetes did not accurately identify people with and without retinopathy. These findings suggest that the criteria for diagnosing diabetes could need reassessment.	[Wong, Tien Y.; Wang, Jie Jin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; [Wong, Tien Y.; Tapp, Robyn J.; Zimmet, Paul; Shaw, Jonathan] Int Diabet Inst, Melbourne, Vic, Australia; [Wong, Tien Y.] Natl Univ Singapore, Singapore Eye Res Inst, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Liew, Gerald; Wang, Jie Jin; Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia; [Tapp, Robyn J.] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3168, Australia; [Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Sch Med, Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil; [Klein, Ronald; Klein, Barbara E. K.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA	Centre for Eye Research Australia; University of Melbourne; National University of Singapore; Singapore National Eye Center; University of Sydney; Monash University; Universidade Federal do Rio Grande do Sul; University of Wisconsin System; University of Wisconsin Madison	Wong, TY (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia.	twong@unimelb.edu.au	wang, jie/GRS-0942-2022; Liew, Gerald/AAB-6870-2022; Tapp, Robyn/F-4766-2013; Zimmet, Paul/O-8486-2019; Shaw, Jonathan/E-7388-2010; Mitchell, Paul/P-1498-2014; Wong, Tien Yin/AAC-9724-2020; Wang, Jie Jin/P-1499-2014; Schmidt, Maria/V-3196-2019; Schmidt, Maria Inês/AGT-5691-2022; Schmidt, Maria Inês/AGP-6441-2022	Zimmet, Paul/0000-0003-0627-0776; Shaw, Jonathan/0000-0002-6187-2203; Wong, Tien Yin/0000-0002-8448-1264; Wang, Jie Jin/0000-0001-9491-4898; Schmidt, Maria Inês/0000-0002-3837-0731; Tapp, Robyn/0000-0002-8553-2684; Klein, Ronald/0000-0002-4428-6237	NHLBI NIH HHS [N01HC95159, N01HC95165, R01 HL069979, N01-HC-95165, N01HC95169, N01-HC-95164, N01-HC-95159, N01-HC-95163, N01-HC-95161, HL69979-03, R01 HL069979-04, N01-HC-95160, N01-HC-95162] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095162, N01HC095164, N01HC095161, N01HC095160, N01HC095163, N01HC095159, N01HC095165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069979, R21HL095165, R43HL095169, R44HL095169] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; *AM AC OPHTH, DIAB RET DIS SEV SCA; American Diabetes Association, ALL DIAB; [Anonymous], 1996, DIABETES, V45, P1289; [Anonymous], 1991, Ophthalmology, V98, P786; Arky RA, 2005, NEW ENGL J MED, V353, P1511, DOI 10.1056/NEJM2e058204; Balkau B, 1999, DIABETES CARE, V22, P696, DOI 10.2337/diacare.22.5.696; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; Diabet Control Complications Trial Res Grp, 1995, OPHTHALMOLOGY, V102, P647; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Engelgau MM, 1997, DIABETES CARE, V20, P785, DOI 10.2337/diacare.20.5.785; *ETDRS COORD CTR, 1980, MAN OP; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gerstein HC, 1996, LANCET, V347, P949, DOI 10.1016/S0140-6736(96)91420-8; Ito C, 2000, DIABETES RES CLIN PR, V49, P181, DOI 10.1016/S0168-8227(00)00156-X; Kawasaki R, 2006, OPHTHALMOLOGY, V113, P1378, DOI 10.1016/j.ophtha.2006.02.052; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P92, DOI 10.1001/archopht.1994.01090130102026; KLEIN R, 1986, OPHTHALMOLOGY, V93, P1183; Klein Ronald, 2006, Trans Am Ophthalmol Soc, V104, P98; Lefebvre P, 2006, LANCET, V368, P1625, DOI 10.1016/S0140-6736(06)69671-2; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; Mitchell P, 1998, OPHTHALMOLOGY, V105, P406, DOI 10.1016/S0161-6420(98)93019-6; Nathan DM, 2007, DIABETIC MED, V24, P137; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; Shaw JE, 2000, DIABETES CARE, V23, P34, DOI 10.2337/diacare.23.1.34; Sicree R, 2006, DIABETES ATLAS, V3, P16; Tapp RJ, 2006, DIABETES RES CLIN PR, V73, P315, DOI 10.1016/j.diabres.2006.02.008; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; ULM K, 1991, STAT MED, V10, P341, DOI 10.1002/sim.4780100306; van Leiden HA, 2003, ARCH OPHTHALMOL-CHIC, V121, P245, DOI 10.1001/archopht.121.2.245; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P301, DOI 10.1136/bjo.2005.084400; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; World Health Organization, DEF DIAGN DIAB MELL; Yu T, 1998, ARCH OPHTHALMOL-CHIC, V116, P83, DOI 10.1001/archopht.116.1.83	36	162	171	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					736	743		10.1016/S0140-6736(08)60343-8	http://dx.doi.org/10.1016/S0140-6736(08)60343-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313502	Green Accepted			2022-12-28	WOS:000253596700027
J	Grabowsky, M				Grabowsky, Mark			The billion-dollar malaria moment	NATURE			English	Editorial Material							INSECTICIDE-TREATED BEDNETS; COVERAGE		Global Fund Fight AIDS TB & Malaria, CH-1214 Geneva, Switzerland		Grabowsky, M (corresponding author), Global Fund Fight AIDS TB & Malaria, 8 Chemin Blandonnet, CH-1214 Geneva, Switzerland.							Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Grabowsky M, 2005, B WORLD HEALTH ORGAN, V83, P195; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; *NAT AC BOARD GLOB, 2004, SAV LIV BUYING TIM E; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151	6	30	31	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					1051	1052		10.1038/4511051a	http://dx.doi.org/10.1038/4511051a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305524				2022-12-28	WOS:000253453600021
J	Higgs, DR				Higgs, Douglas R.			A new dawn for stem-cell therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DU, England	University of Oxford	Higgs, DR (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DU, England.			Higgs, Douglas/0000-0003-3579-8705	MRC [MC_U137961144] Funding Source: UKRI; Medical Research Council [MC_U137961144] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	5	11	12	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					964	966		10.1056/NEJMcibr0708823	http://dx.doi.org/10.1056/NEJMcibr0708823			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18305272				2022-12-28	WOS:000253430200015
J	Trounson, A; Klein, R; Murphy, R				Trounson, Alan; Klein, Robert; Murphy, Richard			Stem cell research in California: The game is on	CELL			English	Editorial Material								The California Initiative embodied in Proposition 71 was designed to boost embryonic stem cell research and its translation into cell therapies in the face of federal restrictions on such research. With funding starting to flow, the stem cell revolution is now underway.	[Trounson, Alan; Klein, Robert; Murphy, Richard] California Inst Regenerat Med, San Francisco, CA 94107 USA		Trounson, A (corresponding author), California Inst Regenerat Med, San Francisco, CA 94107 USA.	atrounson@cirm.ca.gov		Trounson, Alan/0000-0001-5469-0500				Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Seach N, 2007, CURR OPIN BIOTECH, V18, P441, DOI 10.1016/j.copbio.2007.07.001	2	6	6	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					522	524		10.1016/j.cell.2008.02.014	http://dx.doi.org/10.1016/j.cell.2008.02.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295567	Bronze			2022-12-28	WOS:000253817900009
J	Deppmann, CD; Mihalas, S; Sharma, N; Lonze, BE; Niebur, E; Ginty, DD				Deppmann, Christopher D.; Mihalas, Stefan; Sharma, Nikhil; Lonze, Bonnie E.; Niebur, Ernst; Ginty, David D.			A model for neuronal competition during development	SCIENCE			English	Article							NERVE GROWTH-FACTOR; RECEPTOR GENE-EXPRESSION; SYMPATHETIC NEURONS; IN-VIVO; SENSORY NEURONS; SURVIVAL; NGF; DEATH; MICE	We report that developmental competition between sympathetic neurons for survival is critically dependent on a sensitization process initiated by target innervation and mediated by a series of feedback loops. Target- derived nerve growth factor ( NGF) promoted expression of its own receptor TrkA in mouse and rat neurons and prolonged TrkA- mediated signals. NGF also controlled expression of brain- derived neurotrophic factor and neurotrophin- 4, which, through the receptor p75, can kill neighboring neurons with low retrograde NGF- TrkA signaling whereas neurons with high NGF- TrkA signaling are protected. Perturbation of any of these feedback loops disrupts the dynamics of competition. We suggest that three target- initiated events are essential for rapid and robust competition between neurons: sensitization, paracrine apoptotic signaling, and protection from such effects.	[Deppmann, Christopher D.; Mihalas, Stefan; Sharma, Nikhil; Lonze, Bonnie E.; Niebur, Ernst; Ginty, David D.] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Deppmann, Christopher D.; Sharma, Nikhil; Lonze, Bonnie E.; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Mihalas, Stefan; Niebur, Ernst] Johns Hopkins Univ, Sch Med, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu		Lonze, Bonnie/0000-0002-0973-1657	NATIONAL EYE INSTITUTE [R01EY016281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034814, R01NS034814, F32NS053187, R37NS034814] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY016281, EY016281] Funding Source: Medline; NINDS NIH HHS [R01 NS034814, NS34814, NS053187, F32 NS053187, R37 NS034814] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; Campenot R B, 1979, Methods Enzymol, V58, P302; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Lei L, 2001, DEVELOPMENT, V128, P1147; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; MILLER FD, 1991, J CELL BIOL, V112, P303, DOI 10.1083/jcb.112.2.303; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; WYATT S, 1995, J CELL BIOL, V130, P1435, DOI 10.1083/jcb.130.6.1435; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004	21	122	124	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2008	320	5874					369	373		10.1126/science.1152677	http://dx.doi.org/10.1126/science.1152677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18323418	Green Accepted			2022-12-28	WOS:000255026100042
J	Wintemute, GJ				Wintemute, Garen J.			Guns, fear, the constitution, and the public's health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Davis, Sch Med, Violence Prevent Res Program, Sacramento, CA 95817 USA	University of California System; University of California Davis	Wintemute, GJ (corresponding author), Univ Calif Davis, Sch Med, Violence Prevent Res Program, Sacramento, CA 95817 USA.							Cook PJ, 2000, GUN VIOLENCE REAL CO; Hemenway D, 1997, J CRIM LAW CRIM, V87, P1430, DOI 10.2307/1144020; LOFTIN C, 1991, NEW ENGL J MED, V325, P1615, DOI 10.1056/NEJM199112053252305; Wellford C. F., 2004, FIREARMS VIOLENCE CR	4	20	20	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 3	2008	358	14					1421	1424		10.1056/NEJMp0800859	http://dx.doi.org/10.1056/NEJMp0800859			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	282CY	18354096				2022-12-28	WOS:000254546400001
J	Emilsson, V; Thorleifsson, G; Zhang, B; Leonardson, AS; Zink, F; Zhu, J; Carlson, S; Helgason, A; Walters, GB; Gunnarsdottir, S; Mouy, M; Steinthorsdottir, V; Eiriksdottir, GH; Bjornsdottir, G; Reynisdottir, I; Gudbjartsson, D; Helgadottir, A; Jonasdottir, A; Jonasdottir, A; Styrkarsdottir, U; Gretarsdottir, S; Magnusson, KP; Stefansson, H; Fossdal, R; Kristjansson, K; Gislason, HG; Stefansson, T; Leifsson, BG; Thorsteinsdottir, U; Lamb, JR; Gulcher, JR; Reitman, ML; Kong, A; Schadt, EE; Stefansson, K				Emilsson, Valur; Thorleifsson, Gudmar; Zhang, Bin; Leonardson, Amy S.; Zink, Florian; Zhu, Jun; Carlson, Sonia; Helgason, Agnar; Walters, G. Bragi; Gunnarsdottir, Steinunn; Mouy, Magali; Steinthorsdottir, Valgerdur; Eiriksdottir, Gudrun H.; Bjornsdottir, Gyda; Reynisdottir, Inga; Gudbjartsson, Daniel; Helgadottir, Anna; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Styrkarsdottir, Unnur; Gretarsdottir, Solveig; Magnusson, Kristinn P.; Stefansson, Hreinn; Fossdal, Ragnheidur; Kristjansson, Kristleifur; Gislason, Hjortur G.; Stefansson, Tryggvi; Leifsson, Bjorn G.; Thorsteinsdottir, Unnur; Lamb, John R.; Gulcher, Jeffrey R.; Reitman, Marc L.; Kong, Augustine; Schadt, Eric E.; Stefansson, Kari			Genetics of gene expression and its effect on disease	NATURE			English	Article							INTEGRATIVE GENOMICS APPROACH; SEGREGATING MOUSE-POPULATION; LINKAGE ANALYSIS; ADIPOSE-TISSUE; OBESITY; NETWORKS; YEAST; ASSOCIATION; PEDIGREES; DISCOVERY	Common human diseases result from the interplay of many genes and environmental factors. Therefore, a more integrative biology approach is needed to unravel the complexity and causes of such diseases. To elucidate the complexity of common human diseases such as obesity, we have analysed the expression of 23,720 transcripts in large population- based blood and adipose tissue cohorts comprehensively assessed for various phenotypes, including traits related to clinical obesity. In contrast to the blood expression profiles, we observed a marked correlation between gene expression in adipose tissue and obesity- related traits. Genome- wide linkage and association mapping revealed a highly significant genetic component to gene expression traits, including a strong genetic effect of proximal ( cis) signals, with 50% of the cis signals overlapping between the two tissues profiled. Here we demonstrate an extensive transcriptional network constructed from the human adipose data that exhibits significant overlap with similar network modules constructed from mouse adipose data. A core network module in humans and mice was identified that is enriched for genes involved in the inflammatory and immune response and has been found to be causally associated to obesity- related traits.	[Emilsson, Valur; Thorleifsson, Gudmar; Zink, Florian; Helgason, Agnar; Walters, G. Bragi; Gunnarsdottir, Steinunn; Mouy, Magali; Steinthorsdottir, Valgerdur; Eiriksdottir, Gudrun H.; Bjornsdottir, Gyda; Reynisdottir, Inga; Gudbjartsson, Daniel; Helgadottir, Anna; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Styrkarsdottir, Unnur; Gretarsdottir, Solveig; Magnusson, Kristinn P.; Stefansson, Hreinn; Fossdal, Ragnheidur; Kristjansson, Kristleifur; Thorsteinsdottir, Unnur; Gulcher, Jeffrey R.; Kong, Augustine; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Emilsson, Valur; Zhang, Bin; Leonardson, Amy S.; Zhu, Jun; Carlson, Sonia; Lamb, John R.; Schadt, Eric E.] Rosetta Inpharmat LLC, Seattle, WA 98109 USA; [Gislason, Hjortur G.; Stefansson, Tryggvi; Leifsson, Bjorn G.] Natl Univ Hosp Reykjavik, Dept Surg, IS-101 Reykjavik, Iceland; [Reitman, Marc L.] Merck Res Labs, Rahway, NJ 07065 USA	Merck & Company; Landspitali National University Hospital; Merck & Company	Stefansson, K (corresponding author), deCODE Genet, IS-101 Reykjavik, Iceland.	eric_schadt@merck.com; kari.stefansson@decode.is	Helgason, Agnar/K-1522-2015; Magnusson, Kristinn/A-6479-2011; Magnusson, Kristinn P Pétur/X-4907-2019; Stefansson, Kari/AAE-7187-2019; Walters, G. Bragi/L-4215-2013; Reitman, Marc/B-4448-2013	Magnusson, Kristinn/0000-0003-4528-6826; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Walters, G. Bragi/0000-0002-5415-6487; Reitman, Marc/0000-0002-0426-9475; Reynisdottir, Inga/0000-0002-9730-7476; Helgason, Agnar/0000-0002-8545-3767; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Emilsson, Valur/0000-0001-9982-0524; Styrkarsdottir, Unnur/0000-0001-8146-8278; Stefansson, Hreinn/0000-0002-9331-6666; Carlson, Sonia/0000-0002-1413-4056				Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Badner JA, 1998, AM J HUM GENET, V63, P880, DOI 10.1086/302007; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; CHURCHILL GA, 1994, GENETICS, V138, P963; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; He YDD, 2003, BIOINFORMATICS, V19, P956, DOI 10.1093/bioinformatics/btg126; Hubbard T, 2005, NUCLEIC ACIDS RES, V33, pD447, DOI 10.1093/nar/gki138; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SCHADT EE, 2005, SCI STKE, pPE40; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Steemers FJ, 2005, PHARMACOGENOMICS, V6, P777, DOI 10.2217/14622416.6.7.777; Storey John D, 2003, Methods Mol Biol, V224, P149; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209	40	943	973	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2008	452	7186					423	U2		10.1038/nature06758	http://dx.doi.org/10.1038/nature06758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18344981				2022-12-28	WOS:000254341300022
J	Desnues, C; Rodriguez-Brito, B; Rayhawk, S; Kelley, S; Tran, T; Haynes, M; Liu, H; Furlan, M; Wegley, L; Chau, B; Ruan, YJ; Hall, D; Angly, FE; Edwards, RA; Li, LL; Thurber, RV; Reid, RP; Siefert, J; Souza, V; Valentine, DL; Swan, BK; Breitbart, M; Rohwer, F				Desnues, Christelle; Rodriguez-Brito, Beltran; Rayhawk, Steve; Kelley, Scott; Tran, Tuong; Haynes, Matthew; Liu, Hong; Furlan, Mike; Wegley, Linda; Chau, Betty; Ruan, Yijun; Hall, Dana; Angly, Florent E.; Edwards, Robert A.; Li, Linlin; Thurber, Rebecca Vega; Reid, R. Pamela; Siefert, Janet; Souza, Valeria; Valentine, David L.; Swan, Brandon K.; Breitbart, Mya; Rohwer, Forest			Biodiversity and biogeography of phages in modern stromatolites and thrombolites	NATURE			English	Article							ONLINE TOOL; VIRUSES; MARINE; DIVERSITY; ALIGNMENT	Viruses, and more particularly phages ( viruses that infect bacteria), represent one of the most abundant living entities in aquatic and terrestrial environments. The biogeography of phages has only recently been investigated and so far reveals a cosmopolitan distribution of phage genetic material ( or genotypes)(1-4). Here we address this cosmopolitan distribution through the analysis of phage communities in modern microbialites, the living representatives of one of the most ancient life forms on Earth. On the basis of a comparative metagenomic analysis of viral communities associated with marine ( Highborne Cay, Bahamas) and freshwater ( Pozas Azules II and Rio Mesquites, Mexico) microbialites, we show that some phage genotypes are geographically restricted. The high percentage of unknown sequences recovered from the three metagenomes (>97%), the low percentage similarities with sequences from other environmental viral ( n = 42) and microbial ( n = 36) metagenomes, and the absence of viral genotypes shared among microbialites indicate that viruses are genetically unique in these environments. Identifiable sequences in the Highborne Cay metagenome were dominated by single- stranded DNA microphages that were not detected in any other samples examined, including sea water, fresh water, sediment, terrestrial, extreme, metazoan- associated and marine microbial mats. Finally, a marine signature was present in the phage community of the Pozas Azules II microbialites, even though this environment has not been in contact with the ocean for tens of millions of years. Taken together, these results prove that viruses in modern microbialites display biogeographical variability and suggest that they may be derived from an ancient community.	[Desnues, Christelle; Rodriguez-Brito, Beltran; Rayhawk, Steve; Kelley, Scott; Tran, Tuong; Haynes, Matthew; Liu, Hong; Furlan, Mike; Wegley, Linda; Chau, Betty; Hall, Dana; Angly, Florent E.; Edwards, Robert A.; Li, Linlin; Thurber, Rebecca Vega; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Rodriguez-Brito, Beltran; Rayhawk, Steve; Edwards, Robert A.] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Kelley, Scott; Edwards, Robert A.; Rohwer, Forest] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Ruan, Yijun] Genome Inst Singapore, Singapore 138672, Singapore; [Edwards, Robert A.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Reid, R. Pamela] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Siefert, Janet] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Souza, Valeria] Univ Nacl Autonoma Mexico, Dept Ecol Evolut, Inst Ecol, Mexico City 04510, DF, Mexico; [Valentine, David L.; Swan, Brandon K.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Breitbart, Mya] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); United States Department of Energy (DOE); Argonne National Laboratory; University of Miami; Rice University; Universidad Nacional Autonoma de Mexico; University of California System; University of California Santa Barbara; State University System of Florida; University of South Florida	Desnues, C (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	cdesnues@yahoo.fr	Desnues, Christelle/B-1383-2010; Edwards, Robert/Q-1691-2019; Rohwer, Forest/AAC-5315-2019; Breitbart, Mya/B-1366-2009; Li, Linlin/E-3335-2010; Valentine, David/E-5594-2012; Swan, Brandon K/O-9824-2018; Angly, Florent E/A-7717-2011; Desnues, Christelle/ABG-2910-2021	Desnues, Christelle/0000-0002-2178-0355; Edwards, Robert/0000-0001-8383-8949; Breitbart, Mya/0000-0003-3210-2899; Swan, Brandon K/0000-0003-0465-1444; Angly, Florent E/0000-0002-8999-0738; Desnues, Christelle/0000-0002-2178-0355; Rohwer, Forest/0000-0003-1548-5429; souza, valeria/0000-0002-2992-4229; Valentine, David/0000-0001-5914-9107				Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Casas V, 2006, FEMS MICROBIOL LETT, V261, P141, DOI 10.1111/j.1574-6968.2006.00345.x; Chen F, 2001, APPL ENVIRON MICROB, V67, P539, DOI 10.1128/AEM.67.2.539-545.2001; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; FANE B, 2005, VIRUS TAXONOMY, P289; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; REID RP, 1999, ATOLL RES B, V466, P1; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; SAITO N, 1987, MOL BIOL EVOL, V79, P426; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sano E, 2004, APPL ENVIRON MICROB, V70, P5842, DOI 10.1128/AEM.70.10.5842-5846.2004; Schopf JW, 2006, PHILOS T R SOC B, V361, P869, DOI 10.1098/rstb.2006.1834; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; Souza V, 2006, P NATL ACAD SCI USA, V103, P6565, DOI 10.1073/pnas.0601434103; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walter M. R., 1976, STROMATOLITES; Whitaker RJ, 2006, PHILOS T R SOC B, V361, P1975, DOI 10.1098/rstb.2006.1927; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909	30	186	193	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					340	U5		10.1038/nature06735	http://dx.doi.org/10.1038/nature06735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18311127				2022-12-28	WOS:000254117400044
J	Babic, A; Lindner, AB; Vulic, M; Stewart, EJ; Radman, M				Babic, Ana; Lindner, Ariel B.; Vulic, Marin; Stewart, Eric J.; Radman, Miroslav			Direct visualization of horizontal gene transfer	SCIENCE			English	Article							ESCHERICHIA-COLI; DNA TRANSFER; CONJUGATIONAL RECOMBINATION; REPLICATION INITIATION; F-PILIN; SEQA; PROTEIN; MIGRATION; SEQUENCE; CONTACT	Conjugation allows bacteria to acquire genes for antibiotic resistance, novel virulence attributes, and alternative metabolic pathways. Using a fluorescent protein fusion, SeqA- YFP, we have visualized this process in real time and in single cells of Escherichia coli. We found that the F pilus mediates DNA transfer at considerable cell- to- cell distances. Integration of transferred DNA by recombination occurred in up to 96% of recipients; in the remaining cells, the transferred DNA was fully degraded by the RecBCD helicase/ nuclease. The acquired integrated DNA was tracked through successive replication rounds and was found to occasionally split and segregate with different chromosomes, leading to the inheritance of different gene clusters within the cell lineage. The incidence of DNA splitting corresponds to about one crossover per cell generation.	[Babic, Ana; Lindner, Ariel B.; Vulic, Marin; Stewart, Eric J.; Radman, Miroslav] INSERM, U571, F-75015 Paris, France; [Babic, Ana; Lindner, Ariel B.; Vulic, Marin; Stewart, Eric J.; Radman, Miroslav] Univ Paris Descartes Fac Med, F-75015 Paris, France; [Radman, Miroslav] Mediterranean Inst Life Sci, Split 21000, Croatia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Radman, M (corresponding author), INSERM, U571, F-75015 Paris, France.	radman@necker.fr	Lindner, Ariel B/I-8503-2016; Lindner, Ariel/K-9247-2019; Radman, Miroslav/HDM-5955-2022	Lindner, Ariel B/0000-0001-5015-6511; Lindner, Ariel/0000-0001-5015-6511; Radman, Miroslav/0000-0003-0216-3148; Radman, Miroslav/0000-0002-7034-4365				ACHTMAN M, 1978, J BACTERIOL, V135, P1053, DOI 10.1128/JB.135.3.1053-1061.1978; BARON LS, 1968, BACTERIOL REV, V32, P362, DOI 10.1128/MMBR.32.4_Pt_1.362-369.1968; BRENDLER T, 1995, EMBO J, V14, P4083, DOI 10.1002/j.1460-2075.1995.tb00080.x; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Delmas S, 2006, P NATL ACAD SCI USA, V103, P4564, DOI 10.1073/pnas.0509012103; Eggleston AK, 1997, CURR BIOL, V7, pR745, DOI 10.1016/S0960-9822(06)00394-0; FROST LS, 1984, J BACTERIOL, V160, P395, DOI 10.1128/JB.160.1.395-401.1984; HARRINGTON LC, 1990, J BACTERIOL, V172, P7263, DOI 10.1128/jb.172.12.7263-7264.1990; HAYES W, 1953, COLD SPRING HARB SYM, V18, P75, DOI 10.1101/SQB.1953.018.01.016; HELMSTETTER C, 1968, COLD SPRING HARB SYM, V33, P809, DOI 10.1101/SQB.1968.033.01.093; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; JACOB F, 1956, ANN I PASTEUR PARIS, V91, P486; Kohiyama M, 2003, SCIENCE, V301, P802, DOI 10.1126/science.1085154; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lawley TD, 2002, MOL MICROBIOL, V44, P947, DOI 10.1046/j.1365-2958.2002.02938.x; LEDERBERG J, 1946, COLD SPRING HARB SYM, V11, P113; LLOYD RG, 1995, GENETICS, V139, P1123; LOW B, 1968, P NATL ACAD SCI USA, V60, P160, DOI 10.1073/pnas.60.1.160; LOW KB, 1991, METHODS ENZYMOL, V204, P43; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Manchak J, 2002, MOL MICROBIOL, V43, P195, DOI 10.1046/j.1365-2958.2002.02731.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Onogi T, 1999, MOL MICROBIOL, V31, P1775, DOI 10.1046/j.1365-2958.1999.01313.x; PANICKER MM, 1985, J BACTERIOL, V162, P584, DOI 10.1128/JB.162.2.584-590.1985; RAYSSIGUIER C, 1991, BIOCHIMIE, V73, P371, DOI 10.1016/0300-9084(91)90103-8; SLATER S, 1995, CELL, V82, P927, DOI 10.1016/0092-8674(95)90272-4; SMITH GR, 1991, CELL, V64, P19, DOI 10.1016/0092-8674(91)90205-D; WILLETTS N, 1987, CELLULAR MOL BIOL, P1110	29	146	152	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1533	1536		10.1126/science.1153498	http://dx.doi.org/10.1126/science.1153498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339941				2022-12-28	WOS:000253943800041
J	Bonifacie, M; Jendrzejewski, N; Agrinier, P; Humler, E; Coleman, M; Javoy, M				Bonifacie, M.; Jendrzejewski, N.; Agrinier, P.; Humler, E.; Coleman, M.; Javoy, M.			The chlorine isotope composition of Earth's mantle	SCIENCE			English	Article							SEA-FLOOR SERPENTINITES; MIDOCEAN RIDGE BASALTS; OCEANIC-CRUST; BENEATH; BEHAVIOR; FLUIDS; FRACTIONATION; ASSIMILATION; EVAPORITES; ATLANTIC	Chlorine stable isotope compositions ( delta Cl-37) of 22 mid- ocean ridge basalts ( MORBs) correlate with Cl content. The high-delta Cl-37, Cl- rich basalts are highly contaminated by Cl- rich materials ( seawater, brines, or altered rocks). The low-delta(37) Cl, Cl- poor basalts approach the composition of uncontaminated, mantle- derived magmas. Thus, most or all oceanic lavas are contaminated to some extent during their emplacement. MORB- source mantle has delta(37) Cl <= -1.6 per mil (%), which is significantly lower than that of surface reservoirs (similar to 0 parts per thousand not equal). This isotopic difference between the surface and deep Earth results from net Cl isotopic fractionation ( associated with removal of Cl from the mantle and its return by subduction over Earth history) and/ or the addition ( to external reservoirs) of a late volatile supply that is Cl-37- enriched.	[Bonifacie, M.; Jendrzejewski, N.; Agrinier, P.; Humler, E.; Javoy, M.] Inst Phys Globe, CNRS INSU, UMR 7154, F-75251 Paris 05, France; [Bonifacie, M.; Jendrzejewski, N.; Agrinier, P.; Javoy, M.] UPD, CNRS INSU, UMR 7154, F-75251 Paris, France; [Bonifacie, M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Humler, E.] Univ Nantes, Lab Planetol & Geodynam, CNRS, UMR 6112, F-44322 Nantes 3, France; [Coleman, M.] Univ Reading, Sch Human & Environm Sci, Reading RG6 6AB, Berks, England; [Coleman, M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; California Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite; University of Reading; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Bonifacie, M (corresponding author), Inst Phys Globe, CNRS INSU, UMR 7154, 4 Pl Jussieu, F-75251 Paris 05, France.	bonifaci@gps.caltech.edu	Coleman, Max/GZK-5911-2022; Coleman, Max L/A-1303-2007; Agrinier, Pierre/F-6737-2017; Bonifacie, Magali/A-5656-2011; Bonifacie, Magali/P-7737-2019	Coleman, Max L/0000-0002-5514-1826; Bonifacie, Magali/0000-0002-4797-043X; Bonifacie, Magali/0000-0002-4797-043X				Barnes JD, 2006, CHEM GEOL, V228, P246, DOI 10.1016/j.chemgeo.2005.10.011; Bonifacie M, 2005, GEOCHIM COSMOCHIM AC, V69, pA787; Bonifacie M, 2005, CHEM GEOL, V221, P279, DOI 10.1016/j.chemgeo.2005.06.008; Bonifacie M, 2008, GEOCHIM COSMOCHIM AC, V72, P126, DOI 10.1016/j.gca.2007.10.010; Bonifacie M, 2007, CHEM GEOL, V242, P187, DOI 10.1016/j.chemgeo.2007.03.012; Bonifacie M, 2007, EARTH PLANET SC LETT, V260, P10, DOI 10.1016/j.epsl.2007.05.011; Eastoe CJ, 2007, APPL GEOCHEM, V22, P575, DOI 10.1016/j.apgeochem.2006.12.012; Ebongue VW, 2005, AAPG BULL, V89, P1005, DOI 10.1306/03100504040; Eggenkamp HGM, 1995, GEOCHIM COSMOCHIM AC, V59, P5169, DOI 10.1016/0016-7037(95)00353-3; Godon A, 2004, CHEM GEOL, V207, P1, DOI 10.1016/j.chemgeo.2003.11.019; Godon A, 2004, GEOCHIM COSMOCHIM AC, V68, P2153, DOI 10.1016/j.gca.2003.08.021; Jambon A, 1995, CHEM GEOL, V126, P101, DOI 10.1016/0009-2541(95)00112-4; Javoy M, 1998, CHEM GEOL, V147, P11, DOI 10.1016/S0009-2541(97)00169-1; KAUFMANN R, 1984, NATURE, V309, P338, DOI 10.1038/309338a0; LANGMUIR CH, 1992, GEOPH MONOG SERIES, V71, P183; MAGENHEIM AJ, 1995, EARTH PLANET SC LETT, V131, P427, DOI 10.1016/0012-821X(95)00017-7; Meyzen CM, 2003, NATURE, V421, P731, DOI 10.1038/nature01424; Michael PJ, 1998, J GEOPHYS RES-SOL EA, V103, P18325, DOI 10.1029/98JB00791; MICHAEL PJ, 1989, GEOCHIM COSMOCHIM AC, V53, P3131, DOI 10.1016/0016-7037(89)90094-X; RICHET P, 1977, ANNU REV EARTH PL SC, V5, P65, DOI 10.1146/annurev.ea.05.050177.000433; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Schauble EA, 2003, GEOCHIM COSMOCHIM AC, V67, P3267, DOI 10.1016/S0016-7037(02)01375-3; SCHILLING JG, 1980, PHILOS T R SOC A, V297, P147, DOI 10.1098/rsta.1980.0208; Sharp ZD, 2007, NATURE, V446, P1062, DOI 10.1038/nature05748; Sharp ZD, 2004, EARTH PLANET SC LETT, V226, P243, DOI 10.1016/j.epsl.2004.06.016; Webster JD, 1999, GEOCHIM COSMOCHIM AC, V63, P729, DOI 10.1016/S0016-7037(99)00043-5	26	84	87	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1518	1520		10.1126/science.1150988	http://dx.doi.org/10.1126/science.1150988			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339936				2022-12-28	WOS:000253943800036
J	Alimohammadi, M; Bjorklund, P; Hallgren, A; Pontynen, N; Szinnai, G; Shikama, N; Keller, MP; Ekwall, O; Kinkel, SA; Husebye, ES; Gustafsson, J; Rorsman, F; Peltonen, L; Betterle, C; Perheentupa, J; Akerstrom, G; Westin, G; Scott, HS; Hollander, GA; Kampe, O				Alimohammadi, Mohammad; Bjorklund, Peyman; Hallgren, Asa; Pontynen, Nora; Szinnai, Gabor; Shikama, Noriko; Keller, Marcel P.; Ekwall, Olov; Kinkel, Sarah A.; Husebye, Eystein S.; Gustafsson, Jan; Rorsman, Fredrik; Peltonen, Leena; Betterle, Corrado; Perheentupa, Jaakko; Akerstrom, Goran; Westin, Gunnar; Scott, Hamish S.; Hollaender, Georg A.; Kampe, Olle			Autoimmune polyendocrine syndrome type 1 and NALP5, parathyroid autoantigen	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CANDIDIASIS-ECTODERMAL DYSTROPHY; CALCIUM-SENSING RECEPTOR; REGULATORY T-CELLS; SYNDROME TYPE-I; ADRENAL INSUFFICIENCY; EMBRYONIC-DEVELOPMENT; ACID DECARBOXYLASE; DISEASE; MICE; AUTOANTIBODIES	Background: Autoimmune polyendocrine syndrome type 1 (APS-1) is a multiorgan autoimmune disorder caused by mutations in AIRE, the autoimmune regulator gene. Though recent studies concerning AIRE deficiency have begun to elucidate the molecular pathogenesis of organ-specific autoimmunity in patients with APS-1, the autoantigen responsible for hypoparathyroidism, a hallmark of APS-1 and its most common autoimmune endocrinopathy, has not yet been identified. Methods: We performed immunoscreening of a human parathyroid complementary DNA library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with reactivity to the NACHT leucine-rich-repeat protein 5 (NALP5). Subsequently, serum samples from 87 patients with APS-1 and 293 controls, including patients with other autoimmune disorders, were used to determine the frequency and specificity of autoantibodies against NALP5. In addition, the expression of NALP5 was investigated in various tissues. Results: NALP5-specific autoantibodies were detected in 49% of the patients with APS-1 and hypoparathyroidism but were absent in all patients with APS-1 but without hypoparathyroidism, in all patients with other autoimmune endocrine disorders, and in all healthy controls. NALP5 was predominantly expressed in the cytoplasm of parathyroid chief cells. Conclusions: NALP5 appears to be a tissue-specific autoantigen involved in hypoparathyroidism in patients with APS-1. Autoantibodies against NALP5 appear to be highly specific and may be diagnostic for this prominent component of APS-1.	[Alimohammadi, Mohammad; Bjorklund, Peyman; Hallgren, Asa; Ekwall, Olov; Gustafsson, Jan; Rorsman, Fredrik; Akerstrom, Goran; Westin, Gunnar; Kampe, Olle] Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden; [Pontynen, Nora; Peltonen, Leena] Univ Helsinki, Helsinki, Finland; [Pontynen, Nora; Peltonen, Leena] Natl Publ Hlth Inst, Biomed Helsinki, Helsinki, Finland; [Perheentupa, Jaakko] Univ Helsinki Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Szinnai, Gabor; Shikama, Noriko; Keller, Marcel P.; Hollaender, Georg A.] Univ Basel, Lab Pediat Immunol, Basel, Switzerland; [Szinnai, Gabor; Shikama, Noriko; Keller, Marcel P.; Hollaender, Georg A.] Univ Childrens Hosp, Basel, Switzerland; [Kinkel, Sarah A.; Scott, Hamish S.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Kinkel, Sarah A.; Scott, Hamish S.] Univ Melbourne, Parkville, Vic 3052, Australia; [Husebye, Eystein S.] Univ Bergen, Inst Med, Bergen, Norway; Haukeland Hosp, N-5021 Bergen, Norway; [Betterle, Corrado] Univ Padua, Padua, Italy	Uppsala University; Uppsala University Hospital; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Basel; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Bergen; University of Padua	Kampe, O (corresponding author), Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden.	olle.kampe@medsci.uu.se	Scott, Hamish/B-2122-2009; Björklund, Peyman/A-1509-2014	Scott, Hamish/0000-0002-5813-631X; Björklund, Peyman/0000-0002-9398-4496; Ekwall, Olov/0000-0002-4506-9955; Kampe, Olle/0000-0001-6091-9914; Hollander, Georg/0000-0002-8790-0874; Szinnai, Gabor/0000-0003-0559-2597				AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; AHONEN P, 1987, J CLIN ENDOCR METAB, V64, P494, DOI 10.1210/jcem-64-3-494; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Betterle C, 2002, ENDOCR REV, V23, P579; Betterle C, 2002, ENDOCR REV, V23, P327, DOI 10.1210/er.23.3.327; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Eisenbarth GS, 2004, NEW ENGL J MED, V350, P2068, DOI 10.1056/NEJMra030158; Ekwall O, 1998, LANCET, V352, P279, DOI 10.1016/S0140-6736(97)11050-9; Falorni A, 2004, J CLIN ENDOCR METAB, V89, P1598, DOI 10.1210/jc.2003-030954; Gavalas NG, 2007, J CLIN ENDOCR METAB, V92, P2107, DOI 10.1210/jc.2006-2466; GebreMedhin G, 1997, FEBS LETT, V412, P439, DOI 10.1016/S0014-5793(97)00797-7; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Gillard GO, 2007, J IMMUNOL, V178, P3007, DOI 10.4049/jimmunol.178.5.3007; Gylling M, 2003, J CLIN ENDOCR METAB, V88, P4602, DOI 10.1210/jc.2003-030700; Kekalainen E, 2007, J IMMUNOL, V178, P1208, DOI 10.4049/jimmunol.178.2.1208; KOJIMA A, 1981, IMMUNOGENETICS, V14, P15, DOI 10.1007/BF00344296; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Li YX, 1996, J CLIN INVEST, V97, P910, DOI 10.1172/JCI118513; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Pennetier S, 2004, BIOL REPROD, V71, P1359, DOI 10.1095/biolreprod.104.030288; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Skoldberg F, 2004, J CLIN ENDOCR METAB, V89, P1636, DOI 10.1210/jc.2003-031161; Soderbergh A, 2004, J CLIN ENDOCR METAB, V89, P557, DOI 10.1210/jc.2003-030279; TAGUCHI O, 1980, CLIN EXP IMMUNOL, V40, P540; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tung KSK, 2005, CURR TOP MICROBIOL, V293, P209; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; WINQVIST O, 1992, LANCET, V339, P1559, DOI 10.1016/0140-6736(92)91829-W	31	175	181	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					1018	1028		10.1056/NEJMoa0706487	http://dx.doi.org/10.1056/NEJMoa0706487			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18322283				2022-12-28	WOS:000253644700006
J	Metivier, R; Gallais, R; Tiffoche, C; Le Peron, C; Jurkowska, RZ; Carmouche, RP; Ibberson, D; Barath, P; Demay, F; Reid, G; Benes, V; Jeltsch, A; Gannon, F; Salbert, G				Metivier, Raphael; Gallais, Rozenn; Tiffoche, Christophe; Le Peron, Christine; Jurkowska, Renata Z.; Carmouche, Richard P.; Ibberson, David; Barath, Peter; Demay, Florence; Reid, George; Benes, Vladimir; Jeltsch, Albert; Gannon, Frank; Salbert, Gilles			Cyclical DNA methylation of a transcriptionally active promoter	NATURE			English	Article							ESTROGEN-RECEPTOR-ALPHA; REGULATED TRANSCRIPTION; NUCLEAR RECEPTOR; GENE ACTIVATION; GENOMIC DNA; DEMETHYLATION; GLYCOSYLASE; DNMT3A; ORGANIZATION; COMPLEX	Processes that regulate gene transcription are directly under the influence of the genome organization. The epigenome contains additional information that is not brought by DNA sequence, and generates spatial and functional constraints that complement genetic instructions. DNA methylation on CpGs constitutes an epigenetic mark generally correlated with transcriptionally silent condensed chromatin. Replication of methylation patterns by DNA methyltransferases maintains genome stability through cell division. Here we present evidence of an unanticipated dynamic role for DNA methylation in gene regulation in human cells. Periodic, strand- specific methylation/ demethylation occurs during transcriptional cycling of the pS2/TFF1 gene promoter on activation by oestrogens. DNA methyltransferases exhibit dual actions during these cycles, being involved in CpG methylation and active demethylation of (5m)CpGs through deamination. Inhibition of this process precludes demethylation of the pS2 gene promoter and its subsequent transcriptional activation. Cyclical changes in the methylation status of promoter CpGs may thus represent a critical event in transcriptional achievement.	[Metivier, Raphael; Gallais, Rozenn; Tiffoche, Christophe; Le Peron, Christine; Barath, Peter; Demay, Florence; Salbert, Gilles] Univ Rennes 1, CNRS, Equipe SPARTE,GFAS IFR 140, UMR 6026, F-35042 Rennes, France; [Jurkowska, Renata Z.; Jeltsch, Albert] Jacobs Univ Bremen, D-28759 Bremen, Germany; [Carmouche, Richard P.; Ibberson, David; Reid, George; Benes, Vladimir; Gannon, Frank] European Mol Biol Lab, D-69117 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Jacobs University; European Molecular Biology Laboratory (EMBL)	Metivier, R (corresponding author), Univ Rennes 1, CNRS, Equipe SPARTE,GFAS IFR 140, UMR 6026, Campus Beaulieu, F-35042 Rennes, France.	Raphael.Metivier@univ-rennes1.fr	Barath, Peter/T-7563-2019; Hu, Ruogu/B-2203-2008; li, ran/K-1896-2012; Gannon, Frank/G-1194-2015; Jeltsch, Albert/O-7404-2014; Salbert, Gilles/W-9196-2019; demay, florence/K-1881-2015; Jurkowska, Renata/AAE-2504-2020	Barath, Peter/0000-0001-7330-955X; Jeltsch, Albert/0000-0001-6113-9290; Salbert, Gilles/0000-0001-6115-4140; Jurkowska, Renata/0000-0002-4507-2222; florence, DEMAY/0000-0002-4855-7241; Benes, Vladimir/0000-0002-0352-2547; Reid, George/0000-0002-0298-693X				Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Dillon N, 2006, CHROMOSOME RES, V14, P117, DOI 10.1007/s10577-006-1027-8; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Fatemi M, 2002, EUR J BIOCHEM, V269, P4981, DOI 10.1046/j.1432-1033.2002.03198.x; Fritah A, 2006, J ENDOCRINOL, V191, P613, DOI 10.1677/joe.1.07009; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Gallais R, 2007, MOL ENDOCRINOL, V21, P2085, DOI 10.1210/me.2006-0490; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Jost JP, 2002, FEBS LETT, V527, P63, DOI 10.1016/S0014-5793(02)03166-6; Jost JP, 1999, NUCLEIC ACIDS RES, V27, P3245, DOI 10.1093/nar/27.16.3245; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kress C, 2006, P NATL ACAD SCI USA, V103, P11112, DOI 10.1073/pnas.0601793103; Lamm GM, 1996, NUCLEIC ACIDS RES, V24, P3739, DOI 10.1093/nar/24.19.3739; LETEURTRE F, 1994, J BIOL CHEM, V269, P7893; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Lucarelli M, 2001, J BIOL CHEM, V276, P7500, DOI 10.1074/jbc.M008234200; Matsuo K, 1998, EMBO J, V17, P1446, DOI 10.1093/emboj/17.5.1446; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; NELSON JE, 1992, ANAL BIOCHEM, V207, P197, DOI 10.1016/0003-2697(92)90523-A; Oka M, 2006, J BIOL CHEM, V281, P9901, DOI 10.1074/jbc.M511100200; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharath AN, 2000, BIOCHEMISTRY-US, V39, P14611, DOI 10.1021/bi001610e; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597; Zingg JM, 1996, NUCLEIC ACIDS RES, V24, P3267, DOI 10.1093/nar/24.16.3267	47	697	736	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					45	U2		10.1038/nature06544	http://dx.doi.org/10.1038/nature06544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322525				2022-12-28	WOS:000253671900043
J	King, MT; Fayers, PM				King, Madeleine T.; Fayers, Peter M.			Making quality-of-life results more meaningful for clinicians	LANCET			English	Editorial Material							TRIALS		[King, Madeleine T.] Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW 2043, Australia; [Fayers, Peter M.] Univ Aberdeen, Dept Publ Hlth, Aberdeen, Scotland; [Fayers, Peter M.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway	University of Technology Sydney; University of Aberdeen; Norwegian University of Science & Technology (NTNU)	King, MT (corresponding author), Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW 2043, Australia.	Madeleine.King@chere.uts.edu.au		Fayers, Peter/0000-0003-4778-1513				*CLIN TRIALS COOP, 1988, CANC THER EV PROGR G; Fayers P, 2002, EUR J CANCER, V38, pS125; Fayers P, 2001, EORTC QLQ C30 SCORIN; FAYERS PM, 2000, QUALITY LIFE ASSESSM, P325; Guyatt G, 2007, QUAL LIFE RES, V16, P1097, DOI 10.1007/s11136-007-9223-3; JOHNSON JR, 1985, CANCER TREAT REP, V69, P1155; Medical Research Council, 1998, GUID GOOD CLIN PRACT; *MRC, 1998, VIRT CYCL WORK TOG H; Osoba D, 2005, EUR J CANCER, V41, P280, DOI 10.1016/j.ejca.2004.10.017; Osoba D, 1992, Qual Life Res, V1, P211, DOI 10.1007/BF00635620; Schunemann HJ, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-62; Wisloff F, 1996, BRIT J HAEMATOL, V94, P324, DOI 10.1046/j.1365-2141.1996.d01-1802.x	12	21	21	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					709	710		10.1016/S0140-6736(08)60324-4	http://dx.doi.org/10.1016/S0140-6736(08)60324-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313491				2022-12-28	WOS:000253596700011
J	Stott, DJ; Langhorne, P; Knight, PV				Stott, David J.; Langhorne, Peter; Knight, Paul V.			Multidisciplinary care for elderly people in the community	LANCET			English	Editorial Material							CASE-MANAGEMENT; EVERCARE; COSTS		[Stott, David J.; Langhorne, Peter] Univ Glasgow, Glasgow Royal Infirm, Acad Sect Geriatr Med, Fac Med, Glasgow G31 2ER, Lanark, Scotland; [Knight, Paul V.] Glasgow Royal Infirm, Dept Med Elderly, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow; University of Glasgow	Stott, DJ (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Acad Sect Geriatr Med, Fac Med, Glasgow G31 2ER, Lanark, Scotland.	d.j.stott@clinmed.gla.ac.uk						Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Black DA, 2007, BMJ-BRIT MED J, V334, P3, DOI 10.1136/bmj.39027.550324.47; Chappell NL, 2004, GERONTOLOGIST, V44, P389, DOI 10.1093/geront/44.3.389; Gravelle H, 2007, BMJ-BRIT MED J, V334, P31, DOI 10.1136/bmj.39020.413310.55; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Macdonald A, 2007, AGE AGEING, V36, P16, DOI 10.1093/ageing/afl126; Phibbs CS, 2006, MED CARE, V44, P91, DOI 10.1097/01.mlr.0000188981.06522.e0; Sauvaget C, 2002, GERONTOLOGY, V48, P226, DOI 10.1159/000058355; Singh MAF, 2002, J AM GERIATR SOC, V50, P2089, DOI 10.1046/j.1532-5415.2002.50626.x; Young J, 2001, BRIT MED J, V322, P254, DOI 10.1136/bmj.322.7281.254	10	18	18	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					699	700		10.1016/S0140-6736(08)60317-7	http://dx.doi.org/10.1016/S0140-6736(08)60317-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	268RI	18313484				2022-12-28	WOS:000253596700004
J	Friedman, WE				Friedman, William E.			Hydatellaceae are water lilies with gymnospermous tendencies	NATURE			English	Article							FEMALE GAMETOPHYTE; ENDOSPERM; PHYLOGENY; EVOLUTION; NYMPHAEACEAE; ANGIOSPERMS; GENES; SEED	The flowering plant family Hydatellaceae was recently discovered to be allied to the ancient angiosperm lineage Nymphaeales ( water lilies)(1). Because of its critical phylogenetic position, members of the Hydatellaceae have the potential to provide insights into the origin and early diversification of angiosperms(2). Here I report that Hydatella expresses several rare embryological features that, in combination, are found only in members of the Nymphaeales. At maturity, the female gametophyte is four- celled, four- nucleate and will produce a diploid endosperm, as is characteristic of most early divergent angiosperm lineages(3,4). As with all members of the Nymphaeales, endosperm in Hydatella is minimally developed and perisperm is the major embryo- nourishing tissue within the seed(5,6). Remarkably, Hydatella exhibits a maternal seed-provisioning strategy that is unique among flowering plants, but common to all gymnosperms(7): pre- fertilization allocation of nutrients to the embryo- nourishing tissue. This exceptional case of pre- fertilization maternal provisioning of a seed in Hydatella may well be an apomorphic feature of Hydatellaceae alone but, given the newly discovered phylogenetic position of this family, potentially represents a plesiomorphic and transitional condition associated with the origin of flowering plants from gymnospermous ancestors.	Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Friedman, WE (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	ned@colorado.edu		Friedman, William Edward/0000-0003-0374-3427				COCUCCI A E, 1976, Kurtziana, V9, P19; DOYLE JA, 1994, PLANT SYST EVOL, P7; Floyd SK, 2001, PLANT SYST EVOL, V228, P153, DOI 10.1007/s006060170026; Floyd SK, 2000, INT J PLANT SCI, V161, pS57, DOI 10.1086/317579; Friedman WE, 2006, NATURE, V441, P337, DOI 10.1038/nature04690; Friedman WE, 1998, EVOLUTION, V52, P1016, DOI 10.1111/j.1558-5646.1998.tb01830.x; Friedman WE, 2003, INT J PLANT SCI, V164, pS293, DOI 10.1086/376877; Friedman WE, 2008, INT J PLANT SCI, V169, P79, DOI 10.1086/523354; Graham SW, 2000, AM J BOT, V87, P1712, DOI 10.2307/2656749; HAMANN U, 1976, New Zealand Journal of Botany, V14, P193; HAMANN U, 1975, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V96, P154; Hamann U., 1998, FAMILIES GENERA VASC, V4, P231, DOI [DOI 10.1007/978-3-662-03531-3_23, 10.1007/978-3-662-03531-3_23]; JOHNSON D. S., 1900, B TORREY BOT CLUB, V27, P365; JOHRI BM, 2002, COMP EMBRYOLOGY ANGI; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Parkinson CL, 1999, CURR BIOL, V9, P1485, DOI 10.1016/S0960-9822(00)80119-0; PRAKASH N., 1982, MALAYSIAN J SCI, V7, P11; Prakash N, 1998, PLANT FORM FUNCTION, P207; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Rudall PJ, 2007, AM J BOT, V94, P1073, DOI 10.3732/ajb.94.7.1073; Rudall PJ, 1997, INT J PLANT SCI, V158, P640, DOI 10.1086/297477; Rudall PJ, 1997, BOT REV, V63, P140, DOI 10.1007/BF02935930; Saarela JM, 2007, NATURE, V446, P312, DOI 10.1038/nature05612; SCHNEIDER EL, 1978, BOT GAZ, V139, P223, DOI 10.1086/336993; SHAMROV II, 2006, EMBRYOLOGY FLOWERING, P169; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Tiffney B. H., 1981, PALEOBOTANY PALEOECO, V2, P193; Tobe H, 2007, J PLANT RES, V120, P431, DOI 10.1007/s10265-007-0085-0; Williams JH, 2002, NATURE, V415, P522, DOI 10.1038/415522a	30	56	59	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					94	97		10.1038/nature06733	http://dx.doi.org/10.1038/nature06733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18354395				2022-12-28	WOS:000255398800045
J	Chao, BF; Wu, YH; Li, YS				Chao, B. F.; Wu, Y. H.; Li, Y. S.			Impact of artificial reservoir water impoundment on global sea level	SCIENCE			English	Article								By reconstructing the history of water impoundment in the world's artificial reservoirs, we show that a total of similar to 10,800 cubic kilometers of water has been impounded on land to date, reducing the magnitude of global sea level (GSL) rise by -30.0 millimeters, at an average rate of -0.55 millimeters per year during the past half century. This demands a considerably larger contribution to GSL rise from other (natural and anthropogenic) causes than otherwise required. The reconstructed GSL history, accounting for the impact of reservoirs by adding back the impounded water volume, shows an essentially constant rate of rise at +2.46 millimeters per year over at least the past 80 years. This value is contrary to the conventional view of apparently variable GSL rise, which is based on face values of observation.	[Chao, B. F.; Wu, Y. H.; Li, Y. S.] Natl Cent Univ, Coll Earth Sci, Chungli 32054, Taiwan	National Central University	Chao, BF (corresponding author), Natl Cent Univ, Coll Earth Sci, Chungli 32054, Taiwan.	bfchao@ncu.edu.tw	Chao, Benjamin Fong/N-6156-2013					Beckley BD, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030002; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Chao BF, 1995, GEOPHYS RES LETT, V22, P3529, DOI 10.1029/95GL02664; CHAO BF, 1991, EOS T AM GEOPHYS UN, V72, P492; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Gornitz V, 1997, GLOBAL PLANET CHANGE, V14, P147, DOI 10.1016/S0921-8181(96)00008-2; GORNITZ V, 2001, SEA LEVEL RISE; *INT COMM LARG DAM, 2007, WORLD REG DAMS; L'Vovich M.I., 1990, EARTH TRANSFORMED HU; MILLY PCD, 2006, WORLD CLIM RES PROGR; NEWMAN WS, 1986, NATURE, V320, P319, DOI 10.1038/320319a0; Sahagian D, 2000, GLOBAL PLANET CHANGE, V25, P39, DOI 10.1016/S0921-8181(00)00020-5; SAHAGIAN DL, 1994, NATURE, V367, P54, DOI 10.1038/367054a0; STORAGE WW, 2005, MAN MADE RESERVOIRS; TAYLOR RM, 1993, INT WATER POWER DAM; *UNESCO, 2003, WORLD WAT RES BEG 21; UNESCO, 1978, WORLD WAT BAL WAT RE; *US DEP INT, 1983, MAJ DAMS RES HYDR PL; Van der Leeden F., 1975, WATER RESOURCES WORL; World Commission on Dams, 2000, DAMS DEV	20	274	284	10	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2008	320	5873					212	214		10.1126/science.1154580	http://dx.doi.org/10.1126/science.1154580			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18339903				2022-12-28	WOS:000254836700038
J	McDermott, CJ; Shaw, PJ				McDermott, Christopher J.; Shaw, Pamela J.			Diagnosis and management of motor neurone disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; NUTRITIONAL-STATUS; ALS; SURVIVAL; EPIDEMIOLOGY; PROGRESSION; LIFE		[McDermott, Christopher J.; Shaw, Pamela J.] Univ Sheffield, Sheffield Care & Res Ctr Motor Neurone Disorders, Acad Neurol Unit, Sect Neurosci, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield	McDermott, CJ (corresponding author), Univ Sheffield, Sheffield Care & Res Ctr Motor Neurone Disorders, Acad Neurol Unit, Sect Neurosci, Sheffield S10 2RX, S Yorkshire, England.	Christopher.Mcdermott@sth.nhs.uk	Shaw, Pamela J/A-5215-2009; McDermott, Christopher J/B-4550-2009; McDermott, Chris/GQZ-3919-2022; McDermott, Christopher/AAU-4988-2020; Shaw, Pamela/E-6193-2010; Shaw, Pamela J/A-7620-2010	McDermott, Christopher/0000-0002-1269-9053; Shaw, Pamela/0000-0002-8925-2567				Andersen PM, 2005, EUR J NEUROL, V12, P921, DOI 10.1111/j.1468-1331.2005.01351.x; BARBER SC, 2007, MOTOR NEURON DISORDE, P57; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Borasio GD, 1998, J NEUROL SCI, V160, pS127, DOI 10.1016/S0022-510X(98)00211-1; Bourke SC, 2006, LANCET NEUROL, V5, P140, DOI 10.1016/S1474-4422(05)70326-4; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; HERN JEC, 1992, J NEUROL NEUROSUR PS, V55, P536; Jiang YM, 2005, ANN NEUROL, V57, P236, DOI 10.1002/ana.20379; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Mazzini L, 2008, J NEUROL SCI, V265, P78, DOI 10.1016/j.jns.2007.05.016; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Monk PN, 2006, NAT MED, V12, P885, DOI 10.1038/nm0806-885; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; O'Toole O, 2008, J NEUROL NEUROSUR PS, V79, P30, DOI 10.1136/jnnp.2007.117788; OBRIEN T, 1992, BRIT MED J, V304, P471, DOI 10.1136/bmj.304.6825.471; Orrell RW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002829.pub4; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Thornton FJ, 2002, RADIOLOGY, V224, P713, DOI 10.1148/radiol.2243010909; Traynor BJ, 2003, J NEUROL NEUROSUR PS, V74, P1258, DOI 10.1136/jnnp.74.9.1258; Worms PA, 2001, J NEUROL SCI, V191, P3, DOI 10.1016/S0022-510X(01)00630-X	25	101	103	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2008	336	7645					658	662		10.1136/bmj.39493.511759.BE	http://dx.doi.org/10.1136/bmj.39493.511759.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RH	18356234	Green Published			2022-12-28	WOS:000254443400027
J	Lenz, G; Davis, RE; Ngo, VN; Lam, L; George, TC; Wright, GW; Dave, SS; Zhao, H; Xu, WH; Rosenwald, A; Ott, G; Muller-Hermelink, HK; Gascoyne, RD; Connors, JM; Rimsza, LM; Campo, E; Jaffe, ES; Delabie, J; Smeland, EB; Fisher, RI; Chan, WC; Staudt, LM				Lenz, Georg; Davis, R. Eric; Ngo, Vu N.; Lam, Lloyd; George, Thaddeus C.; Wright, George W.; Dave, Sandeep S.; Zhao, Hong; Xu, Weihong; Rosenwald, Andreas; Ott, German; Muller-Hermelink, Hans Konrad; Gascoyne, Randy D.; Connors, Joseph M.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Delabie, Jan; Smeland, Erlend B.; Fisher, Richard I.; Chan, Wing C.; Staudt, Louis M.			Oncogenic CARD11 mutations in human diffuse large B cell lymphoma	SCIENCE			English	Article							HODGKIN LYMPHOMA; ACTIVATION; CARMA1; PHOSPHORYLATION; PROLIFERATION; CHEMOTHERAPY; REQUIREMENT; SURVIVAL	The ability to select a better option from multiple acceptable ones is important for animals to optimize their resources. The mechanisms that underlie such decision- making processes are not well understood. We found that selection of egg- laying site in Drosophila melanogaster is a suitable system to probe the neural circuit that governs simple decision- making processes. First, Drosophila females pursue active probing of the environment before depositing each egg, apparently to evaluate site quality for every egg. Second, Drosophila females can either accept or reject a sucrose- containing medium, depending on the context. Last, communication of the "acceptability" of the sucrose- containing medium as an egg- laying option to the reproductive system depends on the function of a group of insulin- like peptide 7 ( ILP7)- producing neurons. These findings suggest that selection of egg- laying site involves a simple decision- making process and provide an entry point toward a systematic dissection of this process.	[Lenz, Georg; Davis, R. Eric; Ngo, Vu N.; Lam, Lloyd; Dave, Sandeep S.; Zhao, Hong; Xu, Weihong; Staudt, Louis M.] NCI, Metab Branch, Div Canc Treatment & Diag, Canc Res Ctr, Bethesda, MD 20892 USA; [George, Thaddeus C.] Amnis Corp, Seattle, WA 98121 USA; [Wright, George W.] NCI, Biometr Res Branch, Div Canc Treatment & Diag, Canc Res Ctr, Bethesda, MD 20892 USA; [Rosenwald, Andreas; Ott, German; Muller-Hermelink, Hans Konrad] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany; [Gascoyne, Randy D.; Connors, Joseph M.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Campo, Elias] Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Jaffe, Elaine S.] NCI, Pathol Lab, Div Canc Treatment & Diag, Canc Res Ctr, Bethesda, MD 20892 USA; [Delabie, Jan] Rikshosp Radiumhosp Med Ctr, Dept Immunol, N-0310 Oslo, Norway; [Smeland, Erlend B.] Rikshosp Univ Hosp, Inst Canc Res, N-0310 Oslo, Norway; [Smeland, Erlend B.] Norwegian Radium Hosp, Ctr Canc Biomed, Fac Div, N-0310 Oslo, Norway; [Fisher, Richard I.] SW Oncol Grp, Ann Arbor, MI 48106 USA; [Fisher, Richard I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Chan, Wing C.] Univ Nebraska, Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Chan, Wing C.] Univ Nebraska, Med Ctr, Dept Microbiol, Omaha, NE 68198 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wurzburg; Bosch; Robert Bosch Krankenhaus; British Columbia Cancer Agency; University of Arizona; University of Barcelona; Hospital Clinic de Barcelona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; Southwest Oncology Group; University of Rochester; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Staudt, LM (corresponding author), NCI, Metab Branch, Div Canc Treatment & Diag, Canc Res Ctr, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Gascoyne, Randy D/A-6009-2013; Smeland, Erlend/AAO-3214-2020; Lenz, Georg/I-6844-2012; Wright, George W/M-1660-2017; Staudt, Louis/AAC-5324-2019; Jaffe, Elaine/G-8981-2014; Connors, Joseph/AAF-5284-2019; Campo, Elias/AAC-5593-2019	Gascoyne, Randy D/0000-0002-2610-5690; Connors, Joseph/0000-0002-1361-7531; Campo, Elias/0000-0001-9850-9793; Ngo, Vu/0000-0002-9501-6990; Delabie, Jan/0000-0001-5023-0689	NATIONAL CANCER INSTITUTE [ZIABC011008, Z01BC011070, U01CA084967, ZIASC000550] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [UO1-CA84967] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chan WC, 1997, BLOOD, V89, P3909; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Tanner MJ, 2007, J BIOL CHEM, V282, P17141, DOI 10.1074/jbc.M700169200; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824	23	622	663	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1676	1679		10.1126/science.1153629	http://dx.doi.org/10.1126/science.1153629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18323416				2022-12-28	WOS:000254172300044
J	Hwang, ST; Janik, JE; Jaffe, ES; Wilson, WH				Hwang, Sam T.; Janik, John E.; Jaffe, Elaine S.; Wilson, Wyndham H.			Mycosis fungoides and Sezary syndrome	LANCET			English	Review							CUTANEOUS-T-CELL; ELEVATED SERUM CTACK/CCL27; SKIN-ASSOCIATED CHEMOKINE; POLYMERASE-CHAIN-REACTION; TREATMENT-OF-CANCER; LONG-TERM SURVIVAL; PHASE-II TRIAL; DENDRITIC CELLS; IMMUNE-RESPONSES; HTLV-I	Mycosis fungoides and Sezary syndrome are the most common of the cutaneous T-cell lymphomas, which are a heterogeneous group of neoplasms that affect the skin as a primary site. Although the aetiologies of mycosis fungoides and Sezary syndrome are unknown, important insights have been gained in the immunological and genetic perturbations that are associated with these diseases. Unlike some B-cell lymphomas, cutaneous T-cell lymphomas as a group are rarely if ever curable and hence need chronic-disease management. New approaches to treatments are being investigated and include biological and cytotoxic drugs, phototherapy, and monoclonal antibodies that are directed towards novel molecular targets. New molecular technologies such as complementary-DNA microarray have the potential to increase the accuracy of diagnosis and provide important prognostic information. Treatments can be combined to greatly improve clinical outcome without substantially increasing toxic effects in advanced disease that is otherwise difficult to treat. Although present treatment strategies are generally not curative, there is hope that experimental treatments, particularly immunotherapy, might eventually reverse or suppress the abnormalities of mycosis fungoides and Sezary syndrome to the point at which they become non-life-threatening, chronic diseases.	[Hwang, Sam T.] NCI, Dermatol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Janik, John E.; Wilson, Wyndham H.] NCI, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Jaffe, Elaine S.] NCI, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hwang, ST (corresponding author), Bldg 10,Room 4N115,10 Ctr Dr, Bethesda, MD 20892 USA.	hwangs@mail.nih.gov	Jaffe, Elaine/G-8981-2014		NATIONAL CANCER INSTITUTE [Z01BC010924, ZIABC010924, Z01BC011070, Z01SC010277, ZIABC011070, ZIASC010277, ZIEBC011241] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abrams JT, 2001, ANN NY ACAD SCI, V941, P69; Adams AE, 2004, J AM ACAD DERMATOL, V51, P660, DOI 10.1016/j.jaad.2004.03.047; Asadullah K, 2000, EXP DERMATOL, V9, P248, DOI 10.1034/j.1600-0625.2000.009004248.x; Aubin F, 2003, EUR J DERMATOL, V13, P515; Bazarbachi A, 1997, BRIT J HAEMATOL, V98, P927, DOI 10.1046/j.1365-2141.1997.3213138.x; Berger CL, 2005, BLOOD, V105, P1640, DOI 10.1182/blood-2004-06-2181; Berger CL, 2001, INT J CANCER, V91, P438, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1073>3.0.CO;2-R; Berger CL, 2002, BLOOD, V99, P2929, DOI 10.1182/blood.V99.8.2929.h8002929_2929_2939; Biragyn A, 2004, BLOOD, V104, P1961, DOI 10.1182/blood-2004-02-0637; Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Blauvelt A, 1996, J INVEST DERMATOL, V106, P1047, DOI 10.1111/1523-1747.ep12338641; Bouzourene H, 1999, HISTOPATHOLOGY, V34, P118; BUNN PA, 1979, CANCER TREAT REP, V63, P725; Cavalli F, 2001, Hematology Am Soc Hematol Educ Program, P241; Chang YT, 1998, AM J DERMATOPATH, V20, P250, DOI 10.1097/00000372-199806000-00005; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Child FJ, 2002, J INVEST DERMATOL, V118, P941, DOI 10.1046/j.1523-1747.2002.01785.x; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Cornberg M, 2006, J CLIN INVEST, V116, P1443, DOI 10.1172/JCI27804; Criscione VD, 2007, ARCH DERMATOL, V143, P854, DOI 10.1001/archderm.143.7.854; Crowley JJ, 1998, J AM ACAD DERMATOL, V38, P696, DOI 10.1016/S0190-9622(98)70198-7; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Dereure O, 2002, J INVEST DERMATOL, V118, P949, DOI 10.1046/j.1523-1747.2002.01794.x; Dobbeling U, 1998, BLOOD, V92, P252, DOI 10.1182/blood.V92.1.252.413k08_252_258; Dooms H, 1998, J IMMUNOL, V161, P2141; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dummer R, 2004, BLOOD, V104, P1631, DOI 10.1182/blood-2004-01-0360; Dummer R, 2003, DERMATOLOGY, V207, P116, DOI 10.1159/000070962; Duvic M, 2001, ARCH DERMATOL, V137, P581; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Edelson R L, 1984, Photodermatol, V1, P209; Edelson RL, 2001, ANN NY ACAD SCI, V941, P1; Eichmuller S, 2001, P NATL ACAD SCI USA, V98, P629, DOI 10.1073/pnas.021386498; Ferenczi K, 2002, J INVEST DERMATOL, V119, P1405, DOI 10.1046/j.1523-1747.2002.19610.x; Fink-Puches R, 2002, BLOOD, V99, P800, DOI 10.1182/blood.V99.3.800; Florell SR, 2006, AM J CLIN PATHOL, V125, P727, DOI 10.1309/3JK2H6Y988NUAY37; Foss F, 2005, BLOOD, V106, P454, DOI 10.1182/blood-2004-11-4570; Foss F M, 2001, Clin Lymphoma, V1, P298, DOI 10.3816/CLM.2001.n.005; Foss FM, 2001, ANN NY ACAD SCI, V941, P166; Fujita Y, 2006, CLIN CANCER RES, V12, P2670, DOI 10.1158/1078-0432.CCR-05-1513; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; Geskin L, 2004, J INVEST DERMATOL, V122, pA51; Greinix HT, 1998, BLOOD, V92, P3098, DOI 10.1182/blood.V92.9.3098.421k32_3098_3104; HEALD PW, 1989, YALE J BIOL MED, V62, P629; Herne KL, 2003, BLOOD, V101, P2132, DOI 10.1182/blood-2002-07-2247; Hobbs Lisa, 2004, J Wound Ostomy Continence Nurs, V31, P95; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; HOPPE RT, 1995, J AM ACAD DERMATOL, V32, P448, DOI 10.1016/0190-9622(95)90067-5; Hwang S T, 2001, Adv Dermatol, V17, P211; IMBERTI L, 1991, SCIENCE, V254, P860, DOI 10.1126/science.1948066; Ishida T, 2004, CLIN CANCER RES, V10, P7529, DOI 10.1158/1078-0432.CCR-04-0983; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jackow CM, 1997, BLOOD, V89, P32, DOI 10.1182/blood.V89.1.32; Jackow CM, 1996, J INVEST DERMATOL, V107, P373, DOI 10.1111/1523-1747.ep12363352; Jaffe E.S., 2001, PATHOLOGY GENETICS T, VVolume 3; Jaffe ES, 1999, AM J CLIN PATHOL, V111, pS46; Jarmin DI, 2000, J IMMUNOL, V164, P3460, DOI 10.4049/jimmunol.164.7.3460; Kagami S, 2006, J INVEST DERMATOL, V126, P1189, DOI 10.1038/sj.jid.5700246; Kakinuma T, 2003, J AM ACAD DERMATOL, V48, P23, DOI 10.1067/mjd.2003.132; KAPLAN EH, 1990, J NATL CANCER I, V82, P208, DOI 10.1093/jnci/82.3.208; Karenko L, 2005, CANCER RES, V65, P8101, DOI 10.1158/0008-5472.CAN-04-0366; Kari L, 2003, J EXP MED, V197, P1477, DOI 10.1084/jem.20021726; Kennedy GA, 2003, EUR J HAEMATOL, V71, P250, DOI 10.1034/j.1600-0609.2003.00143.x; Kharbanda M, 2003, CLIN DIAGN LAB IMMUN, V10, P53, DOI 10.1128/CDLI.10.1.53-58.2003; Kim EJ, 2005, J CLIN INVEST, V115, P798, DOI 10.1172/JCI200524826; KIM Y, 2000, TLR9 AGONIST IMMUNOM; Kim YH, 2003, ARCH DERMATOL, V139, P857, DOI 10.1001/archderm.139.7.857; KIM YH, 1995, ARCH DERMATOL, V131, P1003, DOI 10.1001/archderm.131.9.1003; Kim YH, 1999, ARCH DERMATOL, V135, P26, DOI 10.1001/archderm.135.1.26; Knobler R, 2001, ANN NY ACAD SCI, V941, P123; Knox S, 1996, BLOOD, V87, P893, DOI 10.1182/blood.V87.3.893.bloodjournal873893; KOCH SE, 1987, J AM ACAD DERMATOL, V17, P563, DOI 10.1016/S0190-9622(87)70238-2; Kreitman RJ, 2000, J CLIN ONCOL, V18, P1622, DOI 10.1200/JCO.2000.18.8.1622; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; LAMBERG SI, 1979, ARCH DERMATOL, V115, P1103, DOI 10.1001/archderm.115.9.1103; Lamioni A, 2005, TRANSPLANTATION, V79, P846, DOI 10.1097/01.TP.0000157278.02848.C7; LEIB ML, 1991, ANN OPHTHALMOL, V23, P182; Leroy S, 2001, BRIT J DERMATOL, V144, P1016, DOI 10.1046/j.1365-2133.2001.04192.x; Lundin J, 2003, BLOOD, V101, P4267, DOI 10.1182/blood-2002-09-2802; LUTZNER M, 1975, ANN INTERN MED, V83, P534, DOI 10.7326/0003-4819-83-4-534; Maeda A, 2005, J IMMUNOL, V174, P5968, DOI 10.4049/jimmunol.174.10.5968; Maier T, 2003, BLOOD, V102, P2338, DOI 10.1182/blood-2002-08-2455; Mao X, 2003, BLOOD, V101, P1513, DOI 10.1182/blood-2002-08-2434; Marie I, 2005, ARCH DERMATOL, V141, P88, DOI 10.1001/archderm.141.1.88; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; MAROLLEAU JP, 1995, ARCH DERMATOL, V131, P574, DOI 10.1001/archderm.131.5.574; MCGREGOR JM, 1993, J AM ACAD DERMATOL, V29, P549, DOI 10.1016/0190-9622(93)70220-N; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Morice WG, 2006, AM J CLIN PATHOL, V125, P364, DOI 10.1309/25E9Y7RRAY84HTAT; Murakami T, 2003, J EXP MED, V198, P1337, DOI 10.1084/jem.20030593; Narducci MG, 2006, BLOOD, V107, P1108, DOI 10.1182/blood-2005-04-1492; Navas IC, 2000, AM J PATHOL, V156, P1565, DOI 10.1016/S0002-9440(10)65028-6; Nebozhyn M, 2006, BLOOD, V107, P3189, DOI 10.1182/blood-2005-07-2813; Ni X, 2001, CLIN CANCER RES, V7, P2682; Notohainiprodjo M, 2005, INT J CANCER, V115, P641, DOI 10.1002/ijc.20922; OLSEN EA, 1995, HEMATOL ONCOL CLIN N, V9, P1089, DOI 10.1016/S0889-8588(18)30060-1; Olsen Elise A, 2003, Dermatol Ther, V16, P311, DOI 10.1111/j.1396-0296.2003.01643.x; Pavlotsky F, 2006, J EUR ACAD DERMATOL, V20, P565, DOI 10.1111/j.1468-3083.2006.01557.x; Piekarz RL, 2006, CLIN CANCER RES, V12, P3762, DOI 10.1158/1078-0432.CCR-05-2095; Piekarz RL, 2004, BLOOD, V103, P4636, DOI 10.1182/blood-2003-09-3068; Piekarz RL, 2001, BLOOD, V98, P2865, DOI 10.1182/blood.V98.9.2865; Pimpinelli N, 2005, J AM ACAD DERMATOL, V53, P1053, DOI 10.1016/j.jaad.2005.08.057; Ponti R, 2005, BRIT J DERMATOL, V153, P565, DOI 10.1111/j.1365-2133.2005.06649.x; Poszepczynska-Guigne E, 2003, BRIT J DERMATOL, V148, P265, DOI 10.1046/j.1365-2133.2003.05030.x; Querfeld C, 2007, J AM ACAD DERMATOL, V56, P580, DOI 10.1016/j.jaad.2006.08.067; Reavely Margaret M, 2004, Dermatol Nurs, V16, P57; REAVELY MM, 2004, DERMATOL NURS, V16, P57; REAVELY MM, 2004, DERMATOL NURS, V16, P9; Richardson SK, 2006, CLIN LYMPHOMA MYELOM, V7, P226, DOI 10.3816/CLM.2006.n.063; Richardson Stephen K, 2003, J Cutan Med Surg, V7, P8; Rook AH, 1999, BLOOD, V94, P902, DOI 10.1182/blood.V94.3.902.415k23_902_908; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ruffini PA, 2002, HAEMATOLOGICA, V87, P989; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sandor V, 2002, CLIN CANCER RES, V8, P718; SAUSVILLE EA, 1988, ANN INTERN MED, V109, P372, DOI 10.7326/0003-4819-109-5-372; Scarisbrick JJ, 2000, BLOOD, V95, P2937, DOI 10.1182/blood.V95.9.2937.009k15_2937_2942; SHAPIRO PE, 1994, AM J SURG PATHOL, V18, P645, DOI 10.1097/00000478-199407000-00001; Sherman SI, 2003, CLIN LYMPHOMA, V3, P249, DOI 10.3816/CLM.2003.n.006; Siegel R S, 2000, Curr Treat Options Oncol, V1, P43, DOI 10.1007/s11864-000-0014-0; Singh F, 2004, J AM ACAD DERMATOL, V51, P570, DOI 10.1016/j.jaad.2003.05.010; Smoller BR, 1998, J CUTAN PATHOL, V25, P311, DOI 10.1111/j.1600-0560.1998.tb01751.x; Sokolowska-Wojdylo M, 2005, CLIN EXP DERMATOL, V30, P702, DOI 10.1111/j.1365-2230.2005.01904.x; Sokolowska-Wojdyo M, 2005, BRIT J DERMATOL, V152, P258, DOI 10.1111/J.1365-2133.2004.06325.X; Suchin KR, 2001, J AM ACAD DERMATOL, V44, P28, DOI 10.1067/mjd.2001.109853; Tanaka T, 2001, INT ARCH ALLERGY IMM, V125, P236, DOI 10.1159/000053821; Timmerman JM, 2002, BLOOD, V99, P1517, DOI 10.1182/blood.V99.5.1517; Tracey L, 2003, BLOOD, V102, P1042, DOI 10.1182/blood-2002-11-3574; Trautinger F, 2006, EUR J CANCER, V42, P1014, DOI 10.1016/j.ejca.2006.01.025; Tsai EY, 2006, ARCH DERMATOL, V142, P577, DOI 10.1001/archderm.142.5.577; Tumenjargal S, 2003, EUR J IMMUNOL, V33, P3175, DOI 10.1002/eji.200324244; van Doorn R, 2002, CANCER RES, V62, P5389; van Doorn R, 2002, ARCH DERMATOL, V138, P191, DOI 10.1001/archderm.138.2.191; Vermeer MH, 1999, AM J PATHOL, V154, P1203, DOI 10.1016/S0002-9440(10)65372-2; Vonderheid EC, 2002, J AM ACAD DERMATOL, V46, P95, DOI 10.1067/mjd.2002.118538; Vonderheid EC, 2006, LEUKEMIA LYMPHOMA, V47, P1841, DOI 10.1080/10428190600709655; VOWELS BR, 1992, J INVEST DERMATOL, V99, P90, DOI 10.1111/1523-1747.ep12611877; VOWELS BR, 1994, J INVEST DERMATOL, V103, P669, DOI 10.1111/1523-1747.ep12398454; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Weinstock MA, 1999, AM J PUBLIC HEALTH, V89, P1240, DOI 10.2105/AJPH.89.8.1240; Willemze R, 2006, J CUTAN PATHOL, V33, P18, DOI 10.1111/j.0303-6987.2006.00494.x; Willemze R, 1997, BLOOD, V90, P354; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Wilson LD, 2005, FRONT RADIAT THER ON, V39, P1, DOI 10.1159/000090798; WOOD GS, 1994, J CUTAN PATHOL, V21, P151, DOI 10.1111/j.1600-0560.1994.tb00250.x; Wood GS, 1996, J INVEST DERMATOL, V107, P301, DOI 10.1111/1523-1747.ep12363010; WOOD GS, 1994, J INVEST DERMATOL, V103, P34, DOI 10.1111/1523-1747.ep12389114; Wysocka M, 2004, BLOOD, V104, P4142, DOI 10.1182/blood-2004-03-1190; Yamanaka K, 2006, BLOOD, V107, P2440, DOI 10.1182/blood-2005-03-1139; Yamanaka K, 2006, CLIN CANCER RES, V12, P376, DOI 10.1158/1078-0432.CCR-05-1777; Yamanaka K, 2005, CLIN CANCER RES, V11, P5748, DOI 10.1158/1078-0432.CCR-04-2514; Yawalkar N, 2003, BLOOD, V102, P4059, DOI 10.1182/blood-2003-04-1044; Youn BS, 2002, APOPTOSIS, V7, P271, DOI 10.1023/A:1015320321511; Zackheim HS, 2002, J AM ACAD DERMATOL, V47, P155, DOI 10.1067/mjd.2002.120571; Zackheim HS, 1998, ARCH DERMATOL, V134, P949, DOI 10.1001/archderm.134.8.949; Zackheim HS, 1999, J AM ACAD DERMATOL, V40, P418, DOI 10.1016/S0190-9622(99)70491-3; Zaki MH, 2002, J INVEST DERMATOL, V118, P366, DOI 10.1046/j.1523-1747.2002.01646.x; ZUCKERFRANKLIN D, 1994, SEMIN DERMATOL, V13, P160	159	178	187	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2008	371	9616					945	957		10.1016/S0140-6736(08)60420-1	http://dx.doi.org/10.1016/S0140-6736(08)60420-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342689				2022-12-28	WOS:000254056800031
J	Ormiston, JA; Serruys, PW; Regar, E; Dudek, D; Thuesen, L; Webster, MWI; Onuma, Y; Garcia-Garcia, HM; McGreevy, R; Veldhof, S				Ormiston, John A.; Serruys, Patrick W.; Regar, Evelyn; Dudek, Dariusz; Thuesen, Leif; Webster, Mark W. I.; Onuma, Yoshinobu; Garcia-Garcia, Hector M.; McGreevy, Robert; Veldhof, Susan			A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial	LANCET			English	Article							1ST HUMAN-EXPERIENCE; INTRAVASCULAR ULTRASOUND; FOLLOW-UP/; II TRIAL; 6-MONTH; MULTICENTER; THROMBOSIS; COVERAGE; INSIGHTS; POLYMER	Background A fully bioabsorbable drug-eluting coronary stent that scaffolds the vessel wall when needed and then disappears once the acute recoil and constrictive remodelling processes have subsided has theoretical advantages. The bioasorbable everolimus-eluting stent (BVS) has a backbone of poly-L-lactic acid that provides the support and a coating of poly-D,L-lactic acid that contains and controls the release of the antiproliferative agent everolimus. We assessed the feasibility and safety of this BVS stent. Methods In this prospective, open-label study we enrolled 30 patients who had either stable, unstable, or silent ischaemia and a single de-novo lesion that was suitable for treatment with a single 3 . 0x12 mm or 3 . 0x18 mm stent. Patients were enrolled from four academic hospitals in Auckland, Rotterdam, Krakow, and Skejby. The composite endpoint was cardiac death, myocardial infarction, and ischaemia-driven target lesion revascularisation. Angiographic endpoints were available for 26 patients and intravascular-ultrasound endpoints for 24 patients. Clinical endpoints were assessed in all 30 patients at 6 and 12 months. In a subset of 13 patients, optical coherence tomography was undertaken at baseline and follow-up. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00300131. Findings Procedural success was 100% (30/30 patients), and device success 94% (29/31 attempts at implantation of the stent). At 1 year, the rate of major adverse cardiac events was 3 . 3%, with only one patient having a non-Q wave myocardial infarction and no target lesion revascularisations. No late stent thromboses were recorded. At 6-month follow-up, the angiographic in-stent late loss was 0 . 44 (0.35) mm and was mainly due to a mild reduction of the stent area (-11 . 8%) as measured by intravascular ultrasound. The neointimal area was small (0 . 30 [SD 0 . 44] mm(2)), with a minimal area obstruction of 5.5%. Interpretation This study shows the feasibility of implantation of the bioabsorbable everolimus-eluting stent, with an acceptable in-stent late loss, minimal intrastent neointimal hyperplasia, and a low stent area obstruction.	[Serruys, Patrick W.; Regar, Evelyn; Onuma, Yoshinobu] Erasmus Sch Ctr, Thoraxctr, NL-3015 GD Rotterdam, Netherlands; [Ormiston, John A.; Webster, Mark W. I.] Auckland City Hosp, Auckland, New Zealand; [Dudek, Dariusz] Jagiellonian Univ, Krakow, Poland; [Thuesen, Leif] Aarhus Univ Hosp, Skejby, Denmark; [Garcia-Garcia, Hector M.] Cardialysis BV, Rotterdam, Netherlands; [McGreevy, Robert] Abbott Vasc, Santa Clara, CA USA; [Veldhof, Susan] Abbott Vasc, Diegem, Belgium	Erasmus University Rotterdam; Auckland City Hospital; Jagiellonian University; Aarhus University; Cardialysis	Serruys, PW (corresponding author), Erasmus Sch Ctr, Thoraxctr, Ba-583,Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	p.w.j.c.serruys@erasmusmc.nl	Regar, Evelyn/AAD-8201-2019; Garcia-Garcia, Hector Manuel/AAG-7471-2020; Regar, E/ABA-3301-2020; Onuma, Yoshinobu/AHB-6273-2022	Garcia-Garcia, Hector Manuel/0000-0001-5100-0471; Onuma, Yoshinobu/0000-0001-7702-0649				Bruining N, 1998, CATHETER CARDIO DIAG, V43, P254, DOI 10.1002/(SICI)1097-0304(199803)43:3<254::AID-CCD3>3.0.CO;2-8; Costa RA, 2005, AM J CARDIOL, V95, P113, DOI 10.1016/j.amjcard.2004.08.074; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Fajadet J, 2006, CIRCULATION, V114, P798, DOI 10.1161/CIRCULATIONAHA.105.591206; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Fujimoto J.G.S.J., 2007, OPTICAL COHERENCE TO, V1st, DOI [10.3109/9780203931561, DOI 10.3109/9780203931561]; Grube E, 2004, CIRCULATION, V109, P2168, DOI 10.1161/01.CIR.0000128850.84227.FD; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; Meredith Ian T, 2005, EuroIntervention, V1, P157; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; Nair A, 2001, ULTRASOUND MED BIOL, V27, P1319, DOI 10.1016/S0301-5629(01)00436-7; Nair Anuja, 2007, EuroIntervention, V3, P113; Rensing BJ, 2001, EUR HEART J, V22, P2125, DOI 10.1053/euhj.2001.2892; Serruys Patrick W, 2006, EuroIntervention, V2, P286; Serruys Patrick W, 2005, EuroIntervention, V1, P58; Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; Sousa JE, 2001, CIRCULATION, V104, P2007, DOI 10.1161/hc4201.098056; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Tamai H, 2000, CIRCULATION, V102, P399; Tanabe K, 2005, CIRCULATION, V111, P900, DOI 10.1161/01.CIR.0000155607.54922.16; Tanigawa Jun, 2007, EuroIntervention, V3, P128; Tanimoto S, 2007, CATHETER CARDIO INTE, V70, P515, DOI 10.1002/ccd.21136; vonBirgelen C, 1997, CIRCULATION, V96, P2944, DOI 10.1161/01.CIR.96.9.2944	28	535	576	2	71	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2008	371	9616					899	907		10.1016/S0140-6736(08)60415-8	http://dx.doi.org/10.1016/S0140-6736(08)60415-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342684				2022-12-28	WOS:000254056800026
J	Parkes, G; Greenhalgh, T; Griffin, M; Dent, R				Parkes, Gary; Greenhalgh, Trisha; Griffin, Mark; Dent, Richard			Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MODEL	Objective To evaluate the impact of telling patients their estimated spirometric lung age as an incentive to quit smoking. Design Randomised controlled trial. Setting Five general practices in Hertfordshire, England. Participants 561 current smokers aged over 35. Intervention All participants were offered spirometric assessment of lung function. Participants in intervention group received their results in terms of "lung age" (the age of the average healthy individual who would perform similar to them on spirometry). Those in the control group received a raw figure for forced expiratory volume at one second (FEV1). Both groups were advised to quit and offered referral to local NHS smoking cessation services. Main outcome measures The primary outcome measure was verified cessation of smoking by salivary cotinine testing 12 months after recruitment. Secondary outcomes were reported changes in daily consumption of cigarettes and identification of new diagnoses of chronic obstructive lung disease. Results Follow-up was 89%. Independently verified quit rates at 12 months in the intervention and control groups, respectively, were 13.6% and 6.4% (difference 7.2%, P=0.005, 95% confidence interval 2.2% to 12.1%; number needed to treat 14). People with worse spirometric lung age were no more likely to have quit than those with normal lung age in either group. Cost per successful quitter was estimated at 280 pound ((euro) 365, $556). A new diagnosis of obstructive lung disease was made in 17% in the intervention group and 14% in the control group; a total of 16% (89/561) of participants. Conclusion Telling smokers their lung age significantly improves the likelihood of them quitting smoking, but the mechanism by which this intervention achieves its effect is unclear. Trial registration National Research Register N0096173751.	[Parkes, Gary] Limes Surg, Hoddesdon EN11 8EP, Herts, England; [Greenhalgh, Trisha; Griffin, Mark] UCL, Dept Primary Care & Populat Sci, London N19 5LW, England; [Dent, Richard] Queen Elizabeth II Hosp, Welwyn Garden City AL7 4HQ, Herts, England	University of London; University College London	Parkes, G (corresponding author), Limes Surg, Hoddesdon EN11 8EP, Herts, England.	Parkesko@hotmail.co.uk	Griffin, Mark/C-1827-2008; Greiver, Michelle/N-8764-2015; Greenhalgh, Trisha/B-1825-2015	Greiver, Michelle/0000-0001-8957-0285; Greenhalgh, Trisha/0000-0003-2369-8088				Bednarek M, 2006, THORAX, V61, P869, DOI 10.1136/thx.2006.059071; Bize R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004705.pub2; *BRIT THOR SOC, CLIN INF; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Hughes J., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000031.PUB2; Jones P W, 1994, Monaldi Arch Chest Dis, V49, P79; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Lancaster T., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000165.pub2, DOI 10.1002/14651858.CD000165.PUB2, 10.1002/14651858.CD000165.pub2.AMBIGUOUS]; McClure JB, 2001, BEHAV MED, V27, P37, DOI 10.1080/08964280109595770; Moody A, 2004, THORAX, V59, P1; MORRIS JF, 1985, PREV MED, V14, P655, DOI 10.1016/0091-7435(85)90085-4; *NAT I HLTH CLIN E, 2003, SMOK CESS DRAFT GUID; National Institute for Health and Clinical Excellence, 2006, BRIEF INT REF SMOK C; Price D, 2003, BMJ-BRIT MED J, V326, P1046, DOI 10.1136/bmj.326.7398.1046; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; Soriano JB, 2000, THORAX, V55, P789, DOI 10.1136/thorax.55.9.789; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Stead LF, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002850; van Schayck CP, 2002, BMJ-BRIT MED J, V324, P1370, DOI 10.1136/bmj.324.7350.1370; West R, 2005, ADDICTION, V100, P1036, DOI 10.1111/j.1360-0443.2005.01139.x; West R., 2006, THEORY ADDICTION	22	281	286	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2008	336	7644					598	600B		10.1136/bmj.39503.582396.25	http://dx.doi.org/10.1136/bmj.39503.582396.25			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18326503	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000254364500033
J	Christofk, HR; Vander Heiden, MG; Harris, MH; Ramanathan, A; Gerszten, RE; Wei, R; Fleming, MD; Schreiber, SL; Cantley, LC				Christofk, Heather R.; Vander Heiden, Matthew G.; Harris, Marian H.; Ramanathan, Arvind; Gerszten, Robert E.; Wei, Ru; Fleming, Mark D.; Schreiber, Stuart L.; Cantley, Lewis C.			The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth	NATURE			English	Article							ALLOSTERIC REGULATION; AEROBIC GLYCOLYSIS; INHIBITION; CELLS	Many tumour cells have elevated rates of glucose uptake but reduced rates of oxidative phosphorylation. This persistence of high lactate production by tumours in the presence of oxygen, known as aerobic glycolysis, was first noted by Otto Warburg more than 75 yr ago(1). How tumour cells establish this altered metabolic phenotype and whether it is essential for tumorigenesis is as yet unknown. Here we show that a single switch in a splice isoform of the glycolytic enzyme pyruvate kinase is necessary for the shift in cellular metabolism to aerobic glycolysis and that this promotes tumorigenesis. Tumour cells have been shown to express exclusively the embryonic M2 isoform of pyruvate kinase(2). Here we use short hairpin RNA to knockdown pyruvate kinase M2 expression in human cancer cell lines and replace it with pyruvate kinase M1. Switching pyruvate kinase expression to the M1 ( adult) isoform leads to reversal of the Warburg effect, as judged by reduced lactate production and increased oxygen consumption, and this correlates with a reduced ability to form tumours in nude mouse xenografts. These results demonstrate that M2 expression is necessary for aerobic glycolysis and that this metabolic phenotype provides a selective growth advantage for tumour cells in vivo.	[Christofk, Heather R.; Vander Heiden, Matthew G.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Harris, Marian H.; Fleming, Mark D.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ramanathan, Arvind; Gerszten, Robert E.; Wei, Ru; Schreiber, Stuart L.] Harvard Univ, Broad Inst, Chem Biol Program, Cambridge, MA 02142 USA; [Ramanathan, Arvind; Gerszten, Robert E.; Wei, Ru; Schreiber, Stuart L.] MIT, Cambridge, MA 02142 USA; [Gerszten, Robert E.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02129 USA; [Gerszten, Robert E.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA; [Gerszten, Robert E.] Harvard Univ, Sch Med, Donald W Reynolds Cardiovasc Clin Res Ctr Atheros, Boston, MA 02115 USA; [Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Beth Israel Deaconess Medical Center	Cantley, LC (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	lcantley@hms.harvard.edu	Cantley, Lewis C/D-1800-2014; Harris, Marian/R-7049-2019	Cantley, Lewis C/0000-0002-1298-7653; Fleming, Mark/0000-0003-0948-4024; Christofk, Heather/0000-0002-8662-4425	NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32 CA009172] Funding Source: Medline; NIGMS NIH HHS [R01 GM056203] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Budinger GRS, 1996, AM J PHYSIOL-LUNG C, V270, pL44, DOI 10.1152/ajplung.1996.270.1.L44; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Manes NP, 2005, ARCH BIOCHEM BIOPHYS, V438, P125, DOI 10.1016/j.abb.2005.04.011; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	19	1990	2108	8	341	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					230	U74		10.1038/nature06734	http://dx.doi.org/10.1038/nature06734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337823				2022-12-28	WOS:000253925600043
J	Stratta, P; Barbe, MC				Stratta, Piero; Barbe, Maria Cristina			Green urine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Stratta, Piero; Barbe, Maria Cristina] Amedeo Avogadro Univ, I-28100 Novara, Italy	University of Eastern Piedmont Amedeo Avogadro	Stratta, P (corresponding author), Amedeo Avogadro Univ, I-28100 Novara, Italy.	piero.stratta@med.unipmn.it							0	11	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					E12	E12		10.1056/NEJMicm065416	http://dx.doi.org/10.1056/NEJMicm065416			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337597				2022-12-28	WOS:000253877200011
J	Schuppan, D; Afdhal, NH				Schuppan, Detlef; Afdhal, Nezam H.			Liver cirrhosis	LANCET			English	Review							CHRONIC HEPATITIS-C; HEPATOCYTE TRANSPLANTATION; HEPATOCELLULAR-CARCINOMA; NONINVASIVE DIAGNOSIS; SAMPLING VARIABILITY; PORTAL-HYPERTENSION; STELLATE CELLS; DECOMPENSATED CIRRHOSIS; FIBROSIS PROGRESSION; ADEFOVIR DIPIVOXIL	Cirrhosis is defined as the histological development of regenerative nodules surrounded by fibrous bands in response to chronic liver injury, which leads to portal hypertension and end-stage liver disease. Recent advances in the understanding of the natural history and pathophysiology of cirrhosis, and in treatment of its complications, have resulted in improved management, quality of life, and life expectancy of patients. Liver transplantation remains the only curative option for a selected group of patients, but pharmacological treatments that can halt progression to decompensated cirrhosis or even reverse cirrhosis are currently being developed. This Seminar focuses on the diagnosis, complications, and management of cirrhosis, and new clinical and scientific developments.	[Schuppan, Detlef; Afdhal, Nezam H.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Schuppan, D (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02215 USA.	dschuppa@bidmc.harvard.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Afdhal, Nezam/0000-0002-7342-6593	NCCIH NIH HHS [U01 AT003571, U01 AT003571-01, U01 AT003571-02] Funding Source: Medline; NIAID NIH HHS [U19 AI066313-030003, U19 AI066313-039001, U19 AI066313-040003, U19 AI066313-019001, U19 AI066313-020003, U19 AI066313-029001, U19 AI066313-049001, U19 AI066313-010003] Funding Source: Medline; NIDDK NIH HHS [1 R21 DK076873-01A1, R21 DK076873-01A1] Funding Source: Medline; PHS HHS [U19 A1 066313] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U01AT003571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK076873] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABDI W, 1979, ARCH INTERN MED, V139, P667, DOI 10.1001/archinte.139.6.667; Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; Ahmad TA, 2002, CELL TRANSPLANT, V11, P399; Albrecht T, 1999, LANCET, V353, P1579, DOI 10.1016/S0140-6736(98)06373-9; Arguedas MR, 2003, HEPATOLOGY, V37, P192, DOI 10.1053/jhep.2003.50023; Asselah T, 2005, GASTROENTEROLOGY, V129, P2064, DOI 10.1053/j.gastro.2005.09.010; ATTALI P, 1987, ARCH INTERN MED, V147, P1065, DOI 10.1001/archinte.147.6.1065; Awaya H, 2002, RADIOLOGY, V224, P769, DOI 10.1148/radiol.2243011495; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2003, HEPATOLOGY, V37, P493, DOI 10.1053/jhep.2003.50127; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bellentani S, 1997, GUT, V41, P845, DOI 10.1136/gut.41.6.845; Bellentani S, 1999, GUT, V44, P874, DOI 10.1136/gut.44.6.874; Benten D, 2005, HEPATOLOGY, V42, P1072, DOI 10.1002/hep.20889; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; Berg T, 2004, HEPATOLOGY, V39, P1456, DOI 10.1002/hep.20226; Bircher J., 1999, OXFORD TXB CLIN HEPA; Bissell DM, 2001, HEPATOLOGY, V34, P859, DOI 10.1053/jhep.2001.28457; Blendis Laurie, 2003, Gastroenterology, V125, P622, DOI 10.1016/S0016-5085(03)00969-7; Blomley MJK, 2003, GUT, V52, P1188, DOI 10.1136/gut.52.8.1188; Bonkovsky HL, 1999, RADIOLOGY, V212, P227, DOI 10.1148/radiology.212.1.r99jl35227; Bosch J, 2003, LANCET, V361, P952, DOI 10.1016/S0140-6736(03)12778-X; Boyer TD, 2003, GASTROENTEROLOGY, V124, P1700, DOI 10.1016/S0016-5085(03)00377-9; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Burrel M, 2003, HEPATOLOGY, V38, P1034, DOI 10.1053/jhep.2003.50409; Butterworth RE, 2000, J HEPATOL, V32, P171, DOI 10.1016/S0168-8278(00)80424-9; Cai J, 2002, HEPATOLOGY, V36, P386, DOI 10.1053/jhep.2002.34614; Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; CATTAU EL, 1982, JAMA-J AM MED ASSOC, V247, P1164, DOI 10.1001/jama.247.8.1164; Chang TT, 2005, GASTROENTEROLOGY, V129, P1198, DOI 10.1053/j.gastro.2005.06.055; Choi D, 2001, J COMPUT ASSIST TOMO, V25, P777, DOI 10.1097/00004728-200109000-00018; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Colle IO, 2003, HEPATOLOGY, V37, P401, DOI 10.1053/jhep.2003.50060; Colletta C, 2005, HEPATOLOGY, V42, P838, DOI 10.1002/hep.20814; Conn H, 1993, DIS LIVER, P875; de Franchis R, 2004, DIGEST LIVER DIS, V36, P787, DOI 10.1016/j.dld.2004.08.001; DEFRANCHIS R, 1992, GASTROENTEROL CLIN N, V21, P85; Desmet VJ, 2004, J HEPATOL, V40, P860, DOI 10.1016/j.jhep.2004.03.007; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; DILELIO A, 1989, RADIOLOGY, V172, P389, DOI 10.1148/radiology.172.2.2526349; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Dufour JF, 1997, ANN INTERN MED, V127, P981, DOI 10.7326/0003-4819-127-11-199712010-00006; Edwards JT, 2000, CURR OPIN GASTROEN, V16, P275, DOI 10.1097/00001574-200005000-00011; El-Serag HB, 2002, HEPATOLOGY, V36, pS74, DOI 10.1053/jhep.2002.36807; EPSTEIN O, 1979, AM J MED, V67, P88, DOI 10.1016/0002-9343(79)90078-0; Erhardt A, 2003, J HEPATOL, V38, P335, DOI 10.1016/S0168-8278(02)00415-4; ERLINGER S, 1991, OXFORD TXB CLIN HEPA, P380; Everson GT, 2005, J HEPATOL, V42, pS65, DOI 10.1016/j.jhep.2005.01.009; Fallon MB, 2005, J CLIN GASTROENTEROL, V39, pS138, DOI 10.1097/01.mcg.0000155570.19340.61; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Fontana RJ, 2002, GASTROENTEROLOGY, V123, P719, DOI 10.1053/gast.2002.35352; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; FOUTCH PG, 1988, AM J GASTROENTEROL, V83, P723; FRACANZANI AL, 1995, HEPATOLOGY, V22, P1127, DOI 10.1002/hep.1840220417; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Fung J, 2005, LIVER TRANSPLANT, V11, P267, DOI 10.1002/lt.20373; Garcia-Tsao G, 2001, GASTROENTEROLOGY, V120, P726, DOI 10.1053/gast.2001.22580; Gaskari SA, 2006, NAT CLIN PRACT GASTR, V3, P329, DOI 10.1038/ncpgasthep0498; Giannini E, 2003, HEPATOLOGY, V38, P1312, DOI 10.1053/jhep.2003.50500; Gines P, 2003, LANCET, V362, P1819, DOI 10.1016/S0140-6736(03)14903-3; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Groszmann RJ, 2005, J CLIN GASTROENTEROL, V39, pS125, DOI 10.1097/01.mcg.0000155552.14396.3d; Gupta S, 2002, SEMIN CELL DEV BIOL, V13, P439, DOI 10.1016/S1084952102001325; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; Hellier S, 2003, HEPATOLOGY, V38, P1468, DOI [10.1016/j.hep.2003.09.027, 10.1053/jhep.2003.09027]; Huang HJ, 2006, GASTROENTEROLOGY, V130, P1679, DOI 10.1053/j.gastro.2006.02.032; Huo TI, 2005, J HEPATOL, V42, P826, DOI 10.1016/j.jhep.2005.01.019; INFANTERIVARD C, 1987, HEPATOLOGY, V7, P660, DOI 10.1002/hep.1840070408; Issa R, 2001, GUT, V48, P548, DOI 10.1136/gut.48.4.548; Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009; Ito K, 1999, AM J ROENTGENOL, V173, P591, DOI 10.2214/ajr.173.3.10470885; Kelleher TB, 2005, J HEPATOL, V43, P78, DOI 10.1016/j.jhep.2005.02.025; Kim CK, 2001, J ULTRAS MED, V20, P99; Knittel T, 1999, GASTROENTEROLOGY, V117, P1205, DOI 10.1016/S0016-5085(99)70407-5; Kobayashi N, 2000, HEPATOLOGY, V31, P851, DOI 10.1053/he.2000.5636; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI 10.1053/j.gastro.2005.05.053; Le Calvez S, 2004, HEPATOLOGY, V39, P862, DOI 10.1002/hep.20099; Lencioni R, 2002, EUR RADIOL, V12, P151, DOI 10.1007/s003300101022; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lok ASF, 2004, HEPATOLOGY, V39, P857, DOI 10.1002/hep.20110; Low TY, 2004, PROTEOMICS, V4, P3960, DOI 10.1002/pmic.200400852; Maddrey WC., 1999, SCHIFFS DIS LIVER, P205; Malhi H, 2002, P NATL ACAD SCI USA, V99, P13114, DOI 10.1073/pnas.192365499; Malhi H, 2002, J CELL SCI, V115, P2679; Martinez-Noguera A, 2002, SEMIN ULTRASOUND CT, V23, P19, DOI 10.1016/S0887-2171(02)90027-2; Matsuno Y, 2003, GENE THER, V10, P1559, DOI 10.1038/sj.gt.3302052; MUERCKE RC, 1956, BMJ-BRIT MED J, V4979, P1327; Muhlbauer M, 2003, GASTROENTEROLOGY, V125, P1085, DOI 10.1016/S0016-5085(03)01213-7; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Nagata H, 2003, GASTROENTEROLOGY, V124, P422, DOI 10.1053/gast.2003.50065; *NAT I DIAB DIG KI, 1994, PUBL NIH; Nowak G, 2005, GUT, V54, P972, DOI 10.1136/gut.2005.064477; Orrego H, 1987, GASTROENTEROLOGY, V92, P208, DOI 10.1016/0016-5085(87)90861-4; PAPADAKIS MA, 1990, Q J MED, V76, P675; Papatheodoridis GV, 1999, HEPATOLOGY, V29, P1085, DOI 10.1002/hep.510290437; Parkes J, 2006, J HEPATOL, V44, P462, DOI 10.1016/j.jhep.2005.10.019; Patel K, 2004, J HEPATOL, V41, P935, DOI 10.1016/j.jhep.2004.08.008; Peck-Radosavljevic M, 2000, BLOOD, V95, P795, DOI 10.1182/blood.V95.3.795.003k25_795_801; Perry I, 2005, CLIN EXP IMMUNOL, V139, P2, DOI 10.1111/j.1365-2249.2005.02662.x; Pinzani M, 2005, J HEPATOL, V42, pS22, DOI 10.1016/j.jhep.2004.12.008; Pinzani M, 2008, NAT CLIN PRACT GASTR, V5, P95, DOI 10.1038/ncpgasthep1025; PIROVINO M, 1988, KLIN WOCHENSCHR, V66, P298, DOI 10.1007/BF01727516; POWELL WJ, 1968, AM J MED, V44, P406, DOI 10.1016/0002-9343(68)90111-3; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2003, HEPATOLOGY, V38, P481, DOI 10.1053/jhep.2003.50319; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qayyum A, 2005, RADIOLOGY, V237, P507, DOI 10.1148/radiol.2372040539; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Riordan SM, 2006, J HEPATOL, V45, P744, DOI 10.1016/j.jhep.2006.08.001; Roberts MS, 2004, LIVER TRANSPLANT, V10, P886, DOI 10.1002/lt.20137; Roberts SK, 1996, GASTROENTEROLOGY, V110, P848, DOI 10.1053/gast.1996.v110.pm8608895; Rockey DC, 2005, CLIN GASTROENTEROL H, V3, P95, DOI 10.1016/S1542-3565(04)00445-8; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Rosenberg WMC, 2003, J HEPATOL, V38, P357, DOI 10.1016/S0168-8278(03)00010-2; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Runyon BA, 1997, SEMIN LIVER DIS, V17, P163, DOI 10.1055/s-2007-1007195; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Satsangi J, 2001, GASTROENTEROLOGY, V121, P124, DOI 10.1053/gast.2001.25527; SCHAFFNER F, 1963, GASTROENTEROLOGY, V44, P239; Schiff ER, 2003, HEPATOLOGY, V38, P1419, DOI 10.1016/j.hep.2003.09.040; Schiff ER, 2003, SCHIFFS DIS LIVER; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Schuppan D, 2001, SEMIN LIVER DIS, V21, P351, DOI 10.1055/s-2001-17556; Sherlock S, 2002, DIS LIVER BILIARY SY; Sherman M, 2004, HEPATOLOGY, V40, p664A; Silvestri L, 2003, INT J CANCER, V104, P310, DOI 10.1002/ijc.10937; Stickel F, 2005, ARCH INTERN MED, V165, P1835, DOI 10.1001/archinte.165.16.1835; Stickel F, 2002, GUT, V51, P132, DOI 10.1136/gut.51.1.132; Strom S, 2003, GASTROENTEROLOGY, V124, P568, DOI 10.1053/gast.2003.50072; TANGERMAN A, 1994, LANCET, V343, P483, DOI 10.1016/S0140-6736(94)92729-4; Tchelepi H, 2002, J ULTRAS MED, V21, P1023, DOI 10.7863/jum.2002.21.9.1023; Thorgeirsson SS, 2006, HEPATOLOGY, V43, P2, DOI 10.1002/hep.21015; TRIGER DR, 1973, LANCET, V1, P1494, DOI 10.1016/S0140-6736(73)91827-8; *US DEP HHS, 2005, NAT CTR HLTH STAT, V13; VANTHIEL DH, 1985, SEMIN LIVER DIS, V5, P35, DOI 10.1055/s-2008-1041756; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Villeneuve JP, 2000, HEPATOLOGY, V31, P207, DOI 10.1002/hep.510310130; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wanless IR, 2000, ARCH PATHOL LAB MED, V124, P1599; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wiesner RH, 2005, LIVER TRANSPLANT, V11, P261, DOI 10.1002/lt.20362; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; Wright M, 2003, GUT, V52, P1206, DOI 10.1136/gut.52.8.1206; Yoshizawa K, 2003, TISSUE ANTIGENS, V61, P159, DOI 10.1034/j.1399-0039.2003.00015.x; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	154	1378	1457	5	197	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2008	371	9615					838	851		10.1016/S0140-6736(08)60383-9	http://dx.doi.org/10.1016/S0140-6736(08)60383-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272NQ	18328931	Green Accepted			2022-12-28	WOS:000253866500031
J	Rogers, RG				Rogers, Rebecca G.			Urinary stress incontinence in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTICENTER RANDOMIZED-TRIAL; PELVIC ORGAN PROLAPSE; FREE VAGINAL TAPE; BURCH COLPOSUSPENSION; BREECH PRESENTATION; SEXUAL FUNCTION; OLDER WOMEN; DELIVERY; SURGERY; URGE		[Rogers, Rebecca G.] Univ New Mexico, Hlth Sci Ctr, Div Urogynecol & Female Pelv Med, Albuquerque, NM 87110 USA; Univ New Mexico, Hlth Sci Ctr, Reconstruct Surg Fellowship, Dept Obstet & Gynecol, Albuquerque, NM 87110 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Rogers, RG (corresponding author), Univ New Mexico, Hlth Sci Ctr, Div Urogynecol & Female Pelv Med, 2211 Lomas Blvd NE, Albuquerque, NM 87110 USA.	rrogers@salud.unm.edu						Albo ME, 2007, NEW ENGL J MED, V356, P2143, DOI 10.1056/NEJMoa070416; American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V105, P1533; Barber MD, 2005, CLEV CLIN J MED, V72, P225, DOI 10.3949/ccjm.72.3.225; Bo K, 2003, NEUROUROL URODYNAM, V22, P654, DOI 10.1002/nau.10153; Boyles SH, 2003, AM J OBSTET GYNECOL, V189, P70, DOI 10.1067/mob.2003.376; Brown JS, 2006, ANN INTERN MED, V144, P715, DOI 10.7326/0003-4819-144-10-200605160-00005; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; BUMP RC, 1993, OBSTET GYNECOL, V81, P421; Burgio KL, 2002, JAMA-J AM MED ASSOC, V288, P2293, DOI 10.1001/jama.288.18.2293; Burgio KL, 2003, OBSTET GYNECOL, V102, P1291, DOI 10.1016/j.obstetgynecol.2003.09.013; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; Clemons JL, 2004, AM J OBSTET GYNECOL, V191, P159, DOI 10.1016/j.ajog.2004.04.048; Fader M, 2007, COCHRANE DB SYST REV, V2; Farrell SA, 2001, OBSTET GYNECOL, V97, P350, DOI 10.1016/S0029-7844(00)01164-9; FitzGerald MP, 2002, AM J OBSTET GYNECOL, V187, P1384, DOI 10.1067/mob.2002.126865; Fritel X, 2005, BJOG-INT J OBSTET GY, V112, P1646, DOI 10.1111/j.1471-0528.2005.00763.x; Grady D, 2001, OBSTET GYNECOL, V97, P116, DOI 10.1016/S0029-7844(00)01115-7; Handa VL, 2004, AM J OBSTET GYNECOL, V191, P751, DOI 10.1016/j.ajog.2003.11.017; Hannah ME, 2004, AM J OBSTET GYNECOL, V191, P917, DOI 10.1016/j.ajog.2004.08.004; Hannah ME, 2002, JAMA-J AM MED ASSOC, V287, P1822, DOI 10.1001/jama.287.14.1822; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; Hay-Smith EJ, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD005654; HERZOG AR, 1990, J AM GERIATR SOC, V38, P273, DOI 10.1111/j.1532-5415.1990.tb03504.x; Kalish RB, 2004, OBSTET GYNECOL, V103, P1137, DOI 10.1097/01.AOG.0000128118.37737.df; Keilman LJ, 2005, PRIMARY CARE, V32, P699, DOI 10.1016/j.pop.2005.06.003; Leach GE, 1997, J UROLOGY, V158, P875, DOI 10.1016/S0022-5347(01)64346-5; Maito JM, 2006, J MIDWIFERY WOM HEAL, V51, P78, DOI 10.1016/j.jmwh.2005.09.003; Mariappan P, 2007, EUR UROL, V51, P67, DOI 10.1016/j.eururo.2006.08.041; Miller JM, 1998, J AM GERIATR SOC, V46, P870, DOI 10.1111/j.1532-5415.1998.tb02721.x; Minkoff H, 2003, NEW ENGL J MED, V348, P946, DOI 10.1056/NEJMsb022734; Norton P, 2006, LANCET, V367, P57, DOI 10.1016/S0140-6736(06)67925-7; Norton PA, 2002, AM J OBSTET GYNECOL, V187, P40, DOI 10.1067/mob.2002.124840; NYGAARD I, 1995, J REPROD MED, V40, P89; Nygaard IE, 2004, OBSTET GYNECOL, V104, P607, DOI 10.1097/01.AOG.0000137874.84862.94; Rogers RG, 2006, AM J OBSTET GYNECOL, V195, P1794, DOI 10.1016/j.ajog.2006.07.012; Rogers RG, 2004, AM J OBSTET GYNECOL, V191, P206, DOI 10.1016/j.ajog.2004.03.087; Rortveit G, 2003, NEW ENGL J MED, V348, P900, DOI 10.1056/NEJMoa021788; Sivaslioglu AA, 2007, INT UROGYNECOL J, V18, P1015, DOI 10.1007/s00192-006-0279-3; Subak LL, 2005, J UROLOGY, V174, P190, DOI 10.1097/01.ju.0000162056.30326.83; *SUBC INT CONT SOC, 2002, NEUROUROL URODYNAM, V21, P167; Sze EHM, 2002, OBSTET GYNECOL, V99, P572, DOI 10.1016/S0029-7844(01)01781-1; Thorp JM, 1999, AM J OBSTET GYNECOL, V181, P266, DOI 10.1016/S0002-9378(99)70546-6; VIKTRUP L, 1992, OBSTET GYNECOL, V79, P945; Viktrup L, 2001, AM J OBSTET GYNECOL, V185, P82, DOI 10.1067/mob.2001.114501; Waetjen LE, 2003, OBSTET GYNECOL, V101, P671, DOI 10.1016/S0029-7844(02)03124-1; Ward K, 2002, BMJ-BRIT MED J, V325, P67, DOI 10.1136/bmj.325.7355.67; Ward KL, 2004, AM J OBSTET GYNECOL, V190, P324, DOI 10.1016/j.ajog.2003.07.029	47	47	57	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					1029	1036		10.1056/NEJMcp0707023	http://dx.doi.org/10.1056/NEJMcp0707023			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18322284				2022-12-28	WOS:000253644700007
J	Steinbrook, R				Steinbrook, Robert			Financial support of Continuing Medical Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONFLICTS-OF-INTEREST; INDUSTRY		[Steinbrook, Robert] Dept Vet Affairs Med Ctr, Vet Affairs Outcomes Grp, White River Jct, VT 05009 USA; [Steinbrook, Robert] Dartmouth Med Sch, Hanover, NH USA	Dartmouth College	Steinbrook, R (corresponding author), Dept Vet Affairs Med Ctr, Vet Affairs Outcomes Grp, 215 N Main St 111B, White River Jct, VT 05009 USA.	robert.steinbrook@dartmouth.edu						*ACCR COUNC CONT M, 2007, ACCME POL UPD; *ACCR COUNC CONT M, ACCME STAND COMM SUP; Accreditation Council for Continuing Medical Education, ANN REP DAT 2006; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; *DEP HHS, 2003, FED REGISTER, V68, P23731; *DEP HHS, 1997, FED REGISTER, V62, P64093; FLETCHER SW, CHAIRM SUMM C CONT E; Iskowitz M, 2006, MED MARKETING ME AUG, P37; ISKOWITZ M, 2007, MED MARKETING ME AUG, P37; Katz Harvey P, 2002, J Contin Educ Health Prof, V22, P43, DOI 10.1002/chp.1340220106; KOPELOW M, 2007, ACCME RESPONDS SENAT; ROSS JS, MED ED SERVICES SUPP; Steinbrook R, 2005, NEW ENGL J MED, V352, P534, DOI 10.1056/NEJMp048322; Steinman MA, 2007, CAN FAM PHYSICIAN, V53, P1650; Studdert DM, 2004, NEW ENGL J MED, V351, P1891, DOI 10.1056/NEJMlim042229; *US SEN COMM FIN, 2007, COMM STAFF REP CHAIR; Van Harrison R, 2003, J Contin Educ Health Prof, V23, P198, DOI 10.1002/chp.1340230503	17	71	72	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2008	299	9					1060	1062		10.1001/jama.299.9.1060	http://dx.doi.org/10.1001/jama.299.9.1060			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JH	18319417				2022-12-28	WOS:000253644800025
J	Kittisupamongkol, W; Nilaratanakul, V; Kulwichit, W				Kittisupamongkol, Weekitt; Nilaratanakul, Voraphoj; Kulwichit, Wanta			Near-fatal bleeding, senna, and the opposite of lettuce	LANCET			English	Editorial Material							WARFARIN; DIARRHEA		[Kittisupamongkol, Weekitt; Nilaratanakul, Voraphoj; Kulwichit, Wanta] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand	Chulalongkorn University	Kulwichit, W (corresponding author), Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand.	wkulwich@gmail.com						BLACK JA, 1994, LANCET, V344, P1373, DOI 10.1016/S0140-6736(94)90737-4; *FAO UN, 2002, HUM VIT MIN REQ; Hylek EM, 1998, JAMA-J AM MED ASSOC, V279, P657, DOI 10.1001/jama.279.9.657; Smith JK, 1999, ANN PHARMACOTHER, V33, P301, DOI 10.1345/aph.18171; WILLIAMS JRB, 1976, Q J MED, V45, P63	5	3	4	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					784	784		10.1016/S0140-6736(08)60347-5	http://dx.doi.org/10.1016/S0140-6736(08)60347-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313506				2022-12-28	WOS:000253596700032
J	Dinneny, JR; Benfey, PN				Dinneny, Jose R.; Benfey, Philip N.			Plant stem cell niches: Standing the test of time	CELL			English	Article							ARABIDOPSIS ROOT-MERISTEM; SHOOT APEX; WUSCHEL; GROWTH; MODEL; FATE; PHYLLOTAXIS; REGULATORS; TRANSPORT; PROTEINS	Similar to animal stem cells, plant stem cells require special niche microenvironments to continuously generate the tissues that constitute the plant body. Recent work using computer modeling and live imaging is helping to elucidate some of the mechanisms responsible for the specification and maintenance of stem cells in the root and shoot.	[Dinneny, Jose R.; Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Dinneny, Jose/J-8312-2012	Dinneny, Jose/0000-0002-3998-724X				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Fiers M, 2005, PLANT CELL, V17, P2542, DOI 10.1105/tpc.105.034009; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Giulini A, 2004, NATURE, V430, P1031, DOI 10.1038/nature02778; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Likhoshvai V. A., 2007, Russian Journal of Developmental Biology, V38, P374, DOI 10.1134/S1062360407060057; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042	26	103	111	4	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					553	557		10.1016/j.cell.2008.02.001	http://dx.doi.org/10.1016/j.cell.2008.02.001			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295573	Bronze			2022-12-28	WOS:000253817900015
J	Orkin, SH; Zon, LI				Orkin, Stuart H.; Zon, Leonard I.			SnapShot: Hematopoiesis	CELL			English	Editorial Material							STEM-CELLS; LINEAGE COMMITMENT		[Orkin, Stuart H.; Zon, Leonard I.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Choi K, 1998, DEVELOPMENT, V125, P725; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005	9	46	47	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					712	U7		10.1016/j.cell.2008.02.013	http://dx.doi.org/10.1016/j.cell.2008.02.013			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295585	Bronze			2022-12-28	WOS:000253817900027
J	Harvey, THP; Butterfield, NJ				Harvey, Thomas H. P.; Butterfield, Nicholas J.			Sophisticated particle-feeding in a large Early Cambrian crustacean	NATURE			English	Article							FOSSIL RECORD; PHYLOGENY; EVOLUTION; ARTHROPODS; APPENDAGES; MORPHOLOGY; BEARING; CHINA; SETAE	Most Cambrian arthropods employed simple feeding mechanisms requiring only low degrees of appendage differentiation(1-3). In contrast, post- Cambrian crustaceans exhibit a wide diversity of feeding specializations and possess a vast ecological repertoire. Crustaceans are evident in the Cambrian fossil record, but have hitherto been known exclusively from small individuals with limited appendage differentiation(4). Here we describe a sophisticated feeding apparatus from an Early Cambrian arthropod that had a body length of several centimetres. Details of the mouthparts resolve this taxon as a probable crown- group ( pan) crustacean, while its feeding style, which allowed it to generate and handle fine food particles, significantly expands the known ecological capabilities of Cambrian arthropods. This Early Cambrian record predates the major expansions of large- bodied, particle- handling crustaceans by at least one hundred million years(5,6), emphasizing the importance of ecological context in driving adaptive radiations.	[Harvey, Thomas H. P.; Butterfield, Nicholas J.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Harvey, THP (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	thar04@esc.cam.ac.uk	Butterfield, Nicholas/AAV-8215-2021	Butterfield, Nicholas/0000-0002-3046-7520				Bambach R.K., 1985, P191; Bousfield E.L., 1995, Amphipacifica, V2, P3; Boxshall GA, 2004, BIOL REV, V79, P253, DOI 10.1017/S1464793103006274; Briggs D.E.G., 1983, Crustacean Issues, V1, P1; Briggs DEG, 2004, P ROY SOC B-BIOL SCI, V271, P131, DOI 10.1098/rspb.2003.2593; BRIGGS DEG, 1990, SYSTEMATICS ASS SPEC, V42, P165; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Budd GE, 2001, PERS PALEOB, P404; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P41, DOI 10.1111/j.1475-4983.2006.00613.x; BUTTERFIELD NJ, 1994, NATURE, V369, P477, DOI 10.1038/369477a0; Chen JY, 2001, P ROY SOC B-BIOL SCI, V268, P2181, DOI 10.1098/rspb.2001.1779; CISNE JL, 1974, EVOLUTION, V28, P337, DOI 10.1111/j.1558-5646.1974.tb00757.x; Coelho VR, 2000, ZOOL J LINN SOC-LOND, V130, P567, DOI 10.1111/j.1096-3642.2000.tb02202.x; Edgecombe Gregory D., 2003, African Invertebrates, V44, P115; Fryer G., 1960, Transactions of the Royal Society of Edinburgh, V64, P217; Garm A, 2000, MAR BIOL, V137, P123, DOI 10.1007/s002270000318; Garm A, 2004, J MORPHOL, V260, P85, DOI 10.1002/jmor.10213; Hou XG, 1996, PHILOS T ROY SOC B, V351, P1131; Hou XG, 2004, J PALEONTOL, V78, P700, DOI 10.1666/0022-3360(2004)078<0700:TLCCPF>2.0.CO;2; Hughes NC, 2003, INTEGR COMP BIOL, V43, P185, DOI 10.1093/icb/43.1.185; Maas Andreas, 2006, Palaeoworld, V15, P266, DOI 10.1016/j.palwor.2006.10.005; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Richter S, 2002, ORG DIVERS EVOL, V2, P217, DOI 10.1078/1439-6092-00048; Sepkoski J. John Jr, 1996, P211; Sepkoski JJ, 2000, CONTRIB ZOOL, V69, P213, DOI 10.1163/18759866-06904001; Walossek Dieter, 1993, Fossils and Strata, V32, P1; Waloszek D, 2007, PALAEOGEOGR PALAEOCL, V254, P273, DOI 10.1016/j.palaeo.2007.03.027; Zhang XG, 2007, NATURE, V449, P595, DOI 10.1038/nature06138	30	63	69	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2008	452	7189					868	871		10.1038/nature06724	http://dx.doi.org/10.1038/nature06724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18337723				2022-12-28	WOS:000255026000047
J	Winckler, G; Anderson, RF; Fleisher, MQ; Mcgee, D; Mahowald, N				Winckler, Gisela; Anderson, Robert F.; Fleisher, Martin Q.; McGee, David; Mahowald, Natalie			Covariant glacial-interglacial dust fluxes in the equatorial Pacific and Antarctica	SCIENCE			English	Article							OCEAN; CLIMATE; MAXIMUM; RECORD; DEPOSITION; SEDIMENTS; CYCLES; SEA; CO2	Dust plays a critical role in Earth's climate system and serves as a natural source of iron and other micronutrients to remote regions of the ocean. We have generated records of dust deposition over the past 500,000 years at three sites spanning the breadth of the equatorial Pacific Ocean. Equatorial Pacific dust fluxes are highly correlated with global ice volume and with dust fluxes to Antarctica, which suggests that dust generation in interhemispheric source regions exhibited a common response to climate change over late- Pleistocene glacial cycles. Our results provide quantitative constraints on the variability of aeolian iron supply to the equatorial Pacific Ocean and, more generally, on the potential contribution of dust to past climate change and to related changes in biogeochemical cycles.	[Winckler, Gisela; Anderson, Robert F.; Fleisher, Martin Q.; McGee, David] Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA; [Anderson, Robert F.; McGee, David] Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA; [Mahowald, Natalie] Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA	Columbia University; Columbia University; Cornell University	Winckler, G (corresponding author), Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA.	winckler@ldeo.columbia.edu	; Mahowald, Natalie/D-8388-2013	Anderson, Robert/0000-0002-8472-2494; Mahowald, Natalie/0000-0002-2873-997X				Anderson RF, 2006, EARTH PLANET SC LETT, V242, P406, DOI 10.1016/j.epsl.2005.11.061; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Basile I, 1997, EARTH PLANET SC LETT, V146, P573, DOI 10.1016/S0012-821X(96)00255-5; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Dymond J, 1997, PALEOCEANOGRAPHY, V12, P586, DOI 10.1029/97PA01135; Francois R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2005PA001235; Harrison SP, 2001, EARTH-SCI REV, V54, P43, DOI 10.1016/S0012-8252(01)00041-1; Higgins SM, 2002, EARTH PLANET SC LETT, V203, P383, DOI 10.1016/S0012-821X(02)00864-6; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Kawahata H, 2000, DEEP-SEA RES PT I, V47, P2061, DOI 10.1016/S0967-0637(00)00025-X; Kohfeld KE, 2001, EARTH-SCI REV, V54, P81, DOI 10.1016/S0012-8252(01)00042-3; KRISSEK LA, 1993, P OCEAN DRILLING PRO, V0130; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Luo C, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003483; Lyle M, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001019; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; Mahowald NM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026126; Mahowald NM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006653; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; McGee D, 2007, EARTH PLANET SC LETT, V257, P215, DOI 10.1016/j.epsl.2007.02.033; Miller RL, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004085; Mix A.C., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P371, DOI 10.2973/odp.proc.sr.138.120.1995; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; MURRAY RW, 1995, GLOBAL BIOGEOCHEM CY, V9, P667, DOI 10.1029/95GB02833; NAKAI S, 1993, EARTH PLANET SC LETT, V119, P143, DOI 10.1016/0012-821X(93)90012-X; PARRENIN F, 2007, CLIM PAST DISCUSS, V3, P19, DOI DOI 10.5194/CPD-3-19-2007; Patterson DB, 1999, GEOCHIM COSMOCHIM AC, V63, P615, DOI 10.1016/S0016-7037(99)00077-0; Prospero J. M., 1989, CHEM OCEANOGR, V10, P187; REA DK, 1994, REV GEOPHYS, V32, P159, DOI 10.1029/93RG03257; Ridgwell AJ, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000729; Ruddiman W.F., 2001, EARTHS CLIMATE PRESE; Schaefer JM, 2006, SCIENCE, V312, P1510, DOI 10.1126/science.1122872; Stancin AM, 2006, EARTH PLANET SC LETT, V248, P840, DOI 10.1016/j.epsl.2006.06.038; Taylor S.R., 1985, CONTINENTAL CRUST IT; Tegen I, 1996, NATURE, V380, P419, DOI 10.1038/380419a0; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Werner M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002365; Winckler G, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001177	38	169	180	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2008	320	5872					93	96		10.1126/science.1150595	http://dx.doi.org/10.1126/science.1150595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18309048				2022-12-28	WOS:000254633000038
J	Lim, KH; Ancrile, BB; Kashatus, DF; Counter, CM				Lim, Kian-Huat; Ancrile, Brooke B.; Kashatus, David F.; Counter, Christopher M.			Tumour maintenance is mediated by eNOS	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; KAPPA-B KINASE; PROTEIN S-NITROSYLATION; K-RAS; N-RAS; CELL-LINES; IN-VIVO; HA-RAS; ACTIVATION; CANCER	Tumour cells become addicted to the expression of initiating oncogenes like Ras, such that loss of oncogene expression in established tumours leads to tumour regression(1). HRas, NRas or KRas are mutated to remain in the active GTP- bound oncogenic state in many cancers(2). Although Ras activates several proteins to initiate human tumour growth, only PI3K, through activation of protein kinase B ( PKB; also known as AKT), must remain activated by oncogenic Ras to maintain this growth63. Here we show that blocking phosphorylation of the AKT substrate, endothelial nitric oxide synthase ( eNOS or NOS3), inhibits tumour initiation and maintenance. Moreover, eNOS enhances the nitrosylation and activation of endogenous wild- type Ras proteins, which are required throughout tumorigenesis. We suggest that activation of the PI3K - AKT - eNOS -( wild- type) Ras pathway by oncogenic Ras in cancer cells is required to initiate and maintain tumour growth.	[Lim, Kian-Huat; Ancrile, Brooke B.; Kashatus, David F.; Counter, Christopher M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Dept Radiat Oncol, Durham, NC 27710 USA.	count004@mc.duke.edu	Kashatus, David F/D-8299-2012	Kashatus, David F/0000-0001-8007-0612; Counter, Christopher M/0000-0003-0748-3079; Lim, Kian-Huat/0000-0002-2766-200X	NCI NIH HHS [R01 CA094184-04, R01 CA094184-03, R01 CA094184-02, R01 CA123031, R01 CA094184-01, R01 CA094184-05, R01 CA094184, R01 CA123031-01A2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA123031, R01CA094184] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Fotiadou PP, 2007, MOL CELL BIOL, V27, P6742, DOI 10.1128/MCB.00234-07; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Giuriato S, 2004, SEMIN CANCER BIOL, V14, P3, DOI 10.1016/j.semcancer.2003.11.002; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Hamilton M, 1998, ONCOGENE, V16, P1417, DOI 10.1038/sj.onc.1201653; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; HUANG DCS, 1993, MOL CELL BIOL, V13, P2420, DOI 10.1128/MCB.13.4.2420; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kita K, 1999, INT J CANCER, V80, P553, DOI 10.1002/(SICI)1097-0215(19990209)80:4<553::AID-IJC12>3.0.CO;2-6; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Li J, 2003, ONCOGENE, V22, P1243, DOI 10.1038/sj.onc.1206192; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Wan J, 2006, WORLD J GASTROENTERO, V12, P1033, DOI 10.3748/wjg.v12.i7.1037; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866	34	227	238	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2008	452	7187					646	U11		10.1038/nature06778	http://dx.doi.org/10.1038/nature06778			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18344980	Green Accepted, Bronze			2022-12-28	WOS:000254567200049
J	Hilf, RJC; Dutzler, R				Hilf, Ricarda J. C.; Dutzler, Raimund			X-ray structure of a prokaryotic pentameric ligand-gated ion channel	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SELECTIVITY FILTER; GATING MECHANISM; AMINO-ACIDS; K+ CHANNEL; BINDING; LOOP; MUTATIONS; REVEALS; PROGRAM	Pentameric ligand- gated ion channels ( pLGICs) are key players in the early events of electrical signal transduction at chemical synapses. The family codes for a structurally conserved scaffold of channel proteins that open in response to the binding of neurotransmitter molecules. All proteins share a pentameric organization of identical or related subunits that consist of an extracellular ligand- binding domain followed by a transmembrane channel domain. The nicotinic acetylcholine receptor ( nAChR) is the most thoroughly studied member of the pLGIC family ( for recent reviews see refs 1 - 3). Two sources of structural information provided an architectural framework for the family. The structure of the soluble acetylcholine- binding protein ( AChBP) defined the organization of the extracellular domain and revealed the chemical basis of ligand interaction(4-6). Electron microscopy studies of the nAChR from Torpedo electric ray have yielded a picture of the full- length protein and have recently led to the interpretation of an electron density map at 4.0 angstrom resolution(7-9). Despite the wealth of experimental information, high- resolution structures of any family member have so far not been available. Until recently, the pLGICs were believed to be only expressed in multicellular eukaryotic organisms. The abundance of prokaryotic genome sequences, however, allowed the identification of several homologous proteins in bacterial sources(10,11). Here we present the X- ray structure of a prokaryotic pLGIC from the bacterium Erwinia chrysanthemi ( ELIC) at 3.3 angstrom resolution. Our study reveals the first structure of a pLGIC at high resolution and provides an important model system for the investigation of the general mechanisms of ion permeation and gating within the family.	[Hilf, Ricarda J. C.; Dutzler, Raimund] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Dutzler, R (corresponding author), Univ Zurich, Dept Biochem, Winterthurer Str 190, CH-8057 Zurich, Switzerland.	dutzler@bioc.uzh.ch						ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; COHEN BN, 1992, J GEN PHYSIOL, V100, P373, DOI 10.1085/jgp.100.3.373; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; de La Fortelle E., 1997, METHOD ENZYMOL, P492; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; Le Novere N, 2001, NUCLEIC ACIDS RES, V29, P294, DOI 10.1093/nar/29.1.294; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nimigean CM, 2002, J GEN PHYSIOL, V120, P323, DOI 10.1085/jgp.20028614; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2003, FEBS LETT, V555, P91, DOI 10.1016/S0014-5793(03)01084-6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	43	568	577	3	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					375	U12		10.1038/nature06717	http://dx.doi.org/10.1038/nature06717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18322461				2022-12-28	WOS:000254117400052
J	[Anonymous]				[Anonymous]			Water: Water under pressure	NATURE			English	Editorial Material																			0	2	2	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					269	269		10.1038/452269a	http://dx.doi.org/10.1038/452269a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354450	Bronze			2022-12-28	WOS:000254117400012
J	Bezemer, ID; Bare, LA; Doggen, CJM; Arellano, AR; Tong, C; Rowland, CM; Catanese, J; Young, BA; Reitsma, PH; Devlin, JJ; Rosendaal, FR				Bezemer, Irene D.; Bare, Lance A.; Doggen, Carine J. M.; Arellano, Andre R.; Tong, Carmen; Rowland, Charles M.; Catanese, Joseph; Young, Bradford A.; Reitsma, Pieter H.; Devlin, James J.; Rosendaal, Frits R.			Gene variants associated with deep vein thrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VENOUS THROMBOSIS; PROTEIN-C; FACTOR-XI; MYOCARDIAL-INFARCTION; RISK-FACTOR; SUSCEPTIBILITY; ACTIVATION; MUTATIONS; INCREASE; REGION	Context The genetic causes of deep vein thrombosis ( DVT) are not fully understood. Objective To identify single- nucleotide polymorphisms ( SNPs) associated with DVT. Design, Setting, and Patients We used 3 case- control studies of first DVT. A total of 19 682 gene- centric SNPs were genotyped in 443 cases and 453 controls from the Leiden Thrombophilia Study ( LETS, 1988- 1992). Twelve hundred six SNPs associated with DVT were reinvestigated in the Multiple Environmental and Genetic Assessment of Risk Factors for Venous Thrombosis study ( MEGA- 1, 1999- 2004) in a subset of 1398 cases and 1757 controls. Nine SNPs associated with DVT in both LETS and MEGA- 1 were investigated a third time in 1314 cases and 2877 controls from MEGA- 2, a second subset of MEGA. Additional SNPs close to one SNP in CYP4V2 were genotyped in LETS and MEGA- 1. Main Outcome Measure Odds ratios ( ORs) for DVT were estimated by logistic regression. False discovery rates served to investigate the effect of multiple hypothesis testing. Results Of 9 SNPs genotyped in MEGA- 2, 3 were strongly associated with DVT ( P <. 05; false discovery rate <=. 10): rs13146272 in CYP4V2 ( risk allele frequency, 0.64), rs2227589 in SERPINC1 ( risk allele frequency, 0.10), and rs1613662 in GP6 ( risk allele frequency, 0.84). The OR for DVT per risk allele was 1.24 ( 95% confidence interval [ 95% CI], 1.11- 1.37) for rs13146272, 1.29 ( 95% CI, 1.10- 1.49) for rs2227589, and 1.15 ( 95% CI, 1.01- 1.30) for rs1613662. In the region of CYP4V2, we identified 4 additional SNPs ( in CYP4V2, KLKB1, and F11) that were also associated with both DVT ( highest OR per risk allele, 1.39; 95% CI, 1.11- 1.74) and coagulation factor XI level ( highest increase per risk allele, 8%; 95% CI, 5%- 11%). Conclusions We identified SNPs in several genes that were associated with DVT. We also found SNPs in the region around the SNP in CYP4V2 ( rs13146272) that were associated with both DVT and factor XI levels. These results show that common genetic variation plays an important role in determining thrombotic risk.	[Bezemer, Irene D.; Doggen, Carine J. M.; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; [Reitsma, Pieter H.; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands; [Reitsma, Pieter H.; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, NL-2300 RC Leiden, Netherlands; [Bare, Lance A.; Arellano, Andre R.; Tong, Carmen; Rowland, Charles M.; Catanese, Joseph; Young, Bradford A.; Devlin, James J.] Celera, Alameda, CA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rosendaal, FR (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, C9-P,POB 9600, NL-2300 RC Leiden, Netherlands.	f.r.rosendaal@lumc.nl	Rosendaal, Frits/Q-3842-2017	Rosendaal, Frits/0000-0003-2558-7496				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Chung T, 2007, J THROMB HAEMOST, V5, P918, DOI 10.1111/j.1538-7836.2007.02461.x; Gallimore MJ, 2004, THROMB RES, V114, P91, DOI 10.1016/j.thromres.2004.05.005; Gerdes VEA, 2004, J THROMB HAEMOST, V2, P1015, DOI 10.1111/j.1538-7836.2004.00726.x; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Hasstedt SJ, 1998, AM J HUM GENET, V63, P569, DOI 10.1086/301947; Heit JA, 2001, THROMB HAEMOSTASIS, V86, P452, DOI 10.1161/ATVBAHA.108.162545; Iakoubova OA, 2006, ARTERIOSCL THROM VAS, V26, P2763, DOI 10.1161/01.ATV.0000247248.76409.8b; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; Larsen TB, 2003, EPIDEMIOLOGY, V14, P328, DOI 10.1097/00001648-200305000-00013; Lee J, 2001, INVEST OPHTH VIS SCI, V42, P1707; Li AR, 2004, AM J HUM GENET, V74, P817, DOI 10.1086/383228; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; MCGRAW RA, 1985, P NATL ACAD SCI USA, V82, P2847, DOI 10.1073/pnas.82.9.2847; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; MILETICH J, 1987, NEW ENGL J MED, V317, P991, DOI 10.1056/NEJM198710153171604; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Shiffman D, 2006, ARTERIOSCL THROM VAS, V26, P1613, DOI 10.1161/01.ATV.0000226543.77214.e4; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Stein PD, 2002, CHEST, V122, P960, DOI 10.1378/chest.122.3.960; Tarumi T, 2003, J THROMB HAEMOST, V1, P1854, DOI 10.1046/j.1538-7836.2003.00302.x; van Stralen KJ, 2008, ARCH INTERN MED, V168, P21, DOI 10.1001/archinternmed.2007.5; Vlieg AV, 2000, BLOOD, V95, P3678; Weir B.S., 1996, GENETIC DATA ANAL	33	229	241	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1306	1314		10.1001/jama.299.11.1306	http://dx.doi.org/10.1001/jama.299.11.1306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349091	Bronze			2022-12-28	WOS:000254079100021
J	Fontanarosa, PB; Pasche, B; DeAngelis, CD				Fontanarosa, Phil B.; Pasche, Boris; DeAngelis, Catherine D.			Genetics and genomics for clinicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												phil.fontanarosa@jama-archives.org			NCI NIH HHS [R01 CA112520, R01 CA108741, P30 CA012197, R01 CA108741-01A2, R01 CA112520-01A1] Funding Source: Medline; NIAMS NIH HHS [P60 AR048098-070007, P60 AR048098] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108741, R01CA112520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR048098] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bovill EG, 2008, JAMA-J AM MED ASSOC, V299, P1362, DOI 10.1001/jama.299.11.1362; Feero WG, 2008, JAMA-J AM MED ASSOC, V299, P1351, DOI 10.1001/jama.299.11.1351; Feinberg AP, 2008, JAMA-J AM MED ASSOC, V299, P1345, DOI 10.1001/jama.299.11.1345; Ginsburg GS, 2008, JAMA-J AM MED ASSOC, V299, P1359, DOI 10.1001/jama.299.11.1359; Masciari S, 2008, JAMA-J AM MED ASSOC, V299, P1315, DOI 10.1001/jama.299.11.1315; Offit K, 2008, JAMA-J AM MED ASSOC, V299, P1353, DOI 10.1001/jama.299.11.1353; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Scheuner MT, 2008, JAMA-J AM MED ASSOC, V299, P1320, DOI 10.1001/jama.299.11.1320; Uhlmann WR, 2008, JAMA-J AM MED ASSOC, V299, P1356, DOI 10.1001/jama.299.11.1356; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277	14	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1364	1365		10.1001/jama.299.11.1364	http://dx.doi.org/10.1001/jama.299.11.1364			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349101	Green Accepted			2022-12-28	WOS:000254079100031
J	Hawkes, N				Hawkes, Nigel			There's no biological alternative, says Parliament	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes@thetimes.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 15	2008	336	7644					588	588		10.1136/bmj.39512.653727.59	http://dx.doi.org/10.1136/bmj.39512.653727.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18340072	Green Published			2022-12-28	WOS:000254364500029
J	Chaisson, RE; Martinson, NA				Chaisson, Richard E.; Martinson, Neil A.			Tuberculosis in Africa - Combating an HIV-driven crisis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMPACT		[Chaisson, Richard E.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21204 USA; [Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, ZA-2050 Johannesburg, South Africa	Johns Hopkins University; University of Witwatersrand	Chaisson, RE (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21204 USA.							Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; WHO, 2007, WHOHTMTB2007376	5	144	156	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1089	1092		10.1056/NEJMp0800809	http://dx.doi.org/10.1056/NEJMp0800809			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	272RK	18337598				2022-12-28	WOS:000253877200001
J	Eremina, V; Jefferson, JA; Kowalewska, J; Hochster, H; Haas, M; Weisstuch, J; Richardson, C; Kopp, JB; Kabir, MG; Backx, PH; Gerber, HP; Ferrara, N; Barisoni, L; Alpers, CE; Quaggin, SE				Eremina, Vera; Jefferson, J. Ashley; Kowalewska, Jolanta; Hochster, Howard; Haas, Mark; Weisstuch, Joseph; Richardson, Catherine; Kopp, Jeffrey B.; Kabir, M. Golam; Backx, Peter H.; Gerber, Hans-Peter; Ferrara, Napoleone; Barisoni, Laura; Alpers, Charles E.; Quaggin, Susan E.			VEGF inhibition and renal thrombotic microangiopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPERTENSION; PROTEINURIA; RISK	The glomerular microvasculature is particularly susceptible to injury in thrombotic microangiopathy, but the mechanisms by which this occurs are unclear. We report the cases of six patients who were treated with bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor (VEGF), in whom glomerular disease characteristic of thrombotic microangiopathy developed. To show that local reduction of VEGF within the kidney is sufficient to trigger the pathogenesis of thrombotic microangiopathy, we used conditional gene targeting to delete VEGF from renal podocytes in adult mice; this resulted in a profound thrombotic glomerular injury. These observations provide evidence that glomerular injury in patients who are treated with bevacizumab is probably due to direct targeting of VEGF by antiangiogenic therapy.	[Eremina, Vera; Quaggin, Susan E.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Eremina, Vera; Quaggin, Susan E.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Quaggin, Susan E.] Univ Toronto, St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada; [Jefferson, J. Ashley] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [Jefferson, J. Ashley; Alpers, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Hochster, Howard] NYU, Inst Canc, New York, NY USA; [Haas, Mark] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Weisstuch, Joseph; Barisoni, Laura] NYU, Sch Med, New York, NY USA; [Richardson, Catherine] Pacific Nephrol Assoc, Tacoma, WA USA; [Kopp, Jeffrey B.] NIDDKD, Kidney Dis Sect, Bethesda, MD 20892 USA; [Kabir, M. Golam; Backx, Peter H.] Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada; [Kabir, M. Golam; Backx, Peter H.] Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Gerber, Hans-Peter] Seattle Genet, Bothell, WA USA; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; New York University; Johns Hopkins University; Johns Hopkins Medicine; New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Seattle Genetics; Roche Holding; Genentech	Quaggin, SE (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	quaggin@mshri.on.ca	Jefferson, Jonathan/AAA-9679-2019; Kopp, Jeffrey B/O-2681-2015	Kopp, Jeffrey B/0000-0001-9052-186X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043308, Z01DK043308] Funding Source: NIH RePORTER; CIHR [62931, 105268, 44289, 36494] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CIHR(Canadian Institutes of Health Research (CIHR))		Advani A, 2007, P NATL ACAD SCI USA, V104, P14448, DOI 10.1073/pnas.0703577104; Ballermann BJ, 2007, NEPHRON PHYSIOL, V106, P19, DOI 10.1159/000101796; Ballermann BJ, 2005, KIDNEY INT, V67, P1668, DOI 10.1111/j.1523-1755.2005.00260.x; Foster RR, 2003, AM J PHYSIOL-RENAL, V284, pF1263, DOI 10.1152/ajprenal.00276.2002; George Betsy A, 2007, Am J Kidney Dis, V49, pe23, DOI 10.1053/j.ajkd.2006.11.024; Gerber HP, 2007, P NATL ACAD SCI USA, V104, P3478, DOI 10.1073/pnas.0611492104; Health Canada, DRUGS HLTH PROD SUMM; Izzedine H, 2007, NEPHROL DIAL TRANSPL, V22, P1481, DOI 10.1093/ndt/gfl565; Levine RJ, 2005, JAMA-J AM MED ASSOC, V293, P77, DOI 10.1001/jama.293.1.77; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li ZH, 2007, HYPERTENSION, V50, P686, DOI 10.1161/HYPERTENSIONAHA.107.092098; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Ohlson M, 2001, AM J PHYSIOL-RENAL, V281, pF103, DOI 10.1152/ajprenal.2001.281.1.F103; Ostendorf T, 1999, J CLIN INVEST, V104, P913, DOI 10.1172/JCI6740; Riely G, 2007, CLIN CANCER RES, V13, p4623S, DOI 10.1158/1078-0432.CCR-07-0544; Roncone D, 2007, NAT CLIN PRACT NEPHR, V3, P287, DOI 10.1038/ncpneph0476; Suga SI, 2001, KIDNEY INT, V60, P1297, DOI 10.1046/j.1523-1755.2001.00935.x; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039	19	1045	1095	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1129	1136		10.1056/NEJMoa0707330	http://dx.doi.org/10.1056/NEJMoa0707330			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337603	Green Accepted, Bronze			2022-12-28	WOS:000253877200006
J	Wakeley, J				Wakeley, John			Complex speciation of humans and chimpanzees	NATURE			English	Letter							HUMAN GENOME; SEQUENCE; TIME		[Wakeley, John] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Wakeley, J (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	wakeley@fas.harvard.edu						Barton NH, 2006, CURR BIOL, V16, pR647, DOI 10.1016/j.cub.2006.07.032; Goetting-Minesky MP, 2006, J MOL EVOL, V63, P537, DOI 10.1007/s00239-005-0308-8; Innan H, 2006, MOL BIOL EVOL, V23, P1040, DOI 10.1093/molbev/msj109; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149	6	37	37	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					E3	E4		10.1038/nature06805	http://dx.doi.org/10.1038/nature06805			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337768				2022-12-28	WOS:000253925600029
J	Harbarth, S; Fankhauser, C; Schrenzel, J; Christenson, J; Gervaz, P; Bandiera-Clerc, C; Renzi, G; Vernaz, N; Sax, H; Pittet, D				Harbarth, Stephan; Fankhauser, Carolina; Schrenzel, Jacques; Christenson, Jan; Gervaz, Pascal; Bandiera-Clerc, Catherine; Renzi, Gesuele; Vernaz, Nathalie; Sax, Hugo; Pittet, Didier			Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HAND HYGIENE; ACTIVE SURVEILLANCE; SITE INFECTION; CARE; MRSA; TRANSMISSION; VANCOMYCIN; CULTURES; PROGRAM; IMPACT	Context Experts and policy makers have repeatedly called for universal screening at hospital admission to reduce nosocomial methicillin- resistant Staphylococcus aureus ( MRSA) infection. Objective To determine the effect of an early MRSA detection strategy on nosocomial MRSA infection rates in surgical patients. Design, Setting, and Patients Prospective, interventional cohort study conducted between July 2004 and May 2006 among 21 754 surgical patients at a Swiss teaching hospital using a crossover design to compare 2 MRSA control strategies ( rapid screening on admission plus standard infection control measures vs standard infection control alone). Twelve surgical wards including different surgical specialties were enrolled according to a prespecified agenda, assigned to either the control or intervention group for a 9- month period, then switched over to the other group for a further 9 months. Interventions During the rapid screening intervention periods, patients admitted to the intervention wards for more than 24 hours were screened before or on admission by rapid, multiplex polymerase chain reaction. For both intervention ( n= 10 844) and control ( n= 10 910) periods, standard infection control measures were used for patients with MRSA in all wards and consisted of contact isolation of MRSA carriers, use of dedicated material ( eg, gown, gloves, mask if indicated), adjustment of perioperative antibiotic prophylaxis of MRSA carriers, computerized MRSA alert system, and topical decolonization ( nasal mupirocin ointment and chlorhexidine body washing) for 5 days. Main Outcome Measures Incidence of nosocomial MRSA infection, MRSA surgical site infection, and rates of nosocomial acquisition of MRSA. Results Overall, 10 193 of 10 844 patients ( 94%) were screened during the intervention periods. Screening identified 515 MRSA- positive patients ( 5.1%), including 337 previously unknown MRSA carriers. Median time from screening to notification of test results was 22.5 hours ( interquartile range, 12.2- 28.2 hours). In the intervention periods, 93 patients ( 1.11 per 1000 patient- days) developed nosocomial MRSA infection compared with 76 in the control periods ( 0.91 per 1000 patient- days; adjusted incidence rate ratio, 1.20; 95% confidence interval, 0.85- 1.69; P=. 29). The rate of MRSA surgical site infection and nosocomial MRSA acquisition did not change significantly. Fifty- three of 93 infected patients ( 57%) in the intervention wards were MRSA- free on admission and developed MRSA infection during hospitalization. Conclusion A universal, rapid MRSA admission screening strategy did not reduce nosocomial MRSA infection in a surgical department with endemic MRSA prevalence but relatively low rates of MRSA infection. Trial Registration isrctn. org Identifier: ISRCTN06603006.	[Harbarth, Stephan; Fankhauser, Carolina; Bandiera-Clerc, Catherine; Sax, Hugo; Pittet, Didier] Univ Geneva Hosp & Med Sch, Infect Control Program, CH-1211 Geneva, Switzerland; [Schrenzel, Jacques; Renzi, Gesuele] Univ Geneva Hosp & Med Sch, Microbiol Lab, CH-1211 Geneva, Switzerland; [Christenson, Jan; Gervaz, Pascal] Univ Geneva Hosp & Med Sch, Dept Surg, CH-1211 Geneva, Switzerland; [Vernaz, Nathalie] Univ Geneva Hosp & Med Sch, Hosp Pharm, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva	Harbarth, S (corresponding author), Univ Geneva Hosp & Med Sch, Infect Control Program, 24 Rue Micheli Crest, CH-1211 Geneva, Switzerland.	stephan.harbarth@hcuge.ch	Schrenzel, Jacques/AAC-5685-2021; Sax, Hugo S/A-9377-2016; Schrenzel, Jacques/P-8525-2017	Schrenzel, Jacques/0000-0001-5464-7764; Sax, Hugo S/0000-0002-1532-2198; Schrenzel, Jacques/0000-0001-5464-7764; Vernaz, Nathalie/0000-0002-1371-5510				Benneyan JC, 1998, INFECT CONT HOSP EP, V19, P265; Biant LC, 2004, BRIT MED J, V329, P149; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; Brandt C, 2004, INFECT CONT HOSP EP, V25, P313, DOI 10.1086/502398; Cepeda JA, 2005, LANCET, V365, P295, DOI 10.1016/S0140-6736(05)17783-6; Conterno LO, 2007, INFECT CONT HOSP EP, V28, P1134, DOI 10.1086/520099; Cunningham R, 2007, J HOSP INFECT, V65, P24, DOI 10.1016/j.jhin.2006.09.019; Curran ET, 2002, INFECT CONT HOSP EP, V23, P13, DOI 10.1086/501961; Diekema DJ, 2007, CLIN INFECT DIS, V44, P1101, DOI 10.1086/512820; Farr BM, 2007, INFECT CONT HOSP EP, V28, P589, DOI 10.1086/515710; Fierobe L, 1999, CLIN INFECT DIS, V29, P1231, DOI 10.1086/313454; Francois P, 2003, J CLIN MICROBIOL, V41, P254, DOI 10.1128/JCM.41.1.254-260.2003; Francois P, 2007, J CLIN MICROBIOL, V45, P2011, DOI 10.1128/JCM.00232-07; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Harbarth S, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.04.042; Harbarth S, 2006, CLIN MICROBIOL INFEC, V12, P1154, DOI 10.1111/j.1469-0691.2006.01572.x; Harbarth S, 1998, QJM-MON J ASSOC PHYS, V91, P519, DOI 10.1093/qjmed/91.8.519; Harbarth S, 2000, J HOSP INFECT, V46, P43, DOI 10.1053/jhin.2000.0798; Harbarth S, 2006, CRIT CARE, V10, DOI 10.1186/cc3982; *HLTH PROT AG, 2007, COMM Q 6 MONTHL ANN; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Jernigan JA, 2004, INFECT CONT HOSP EP, V25, P457, DOI 10.1086/502421; Loeffler JM, 2003, SCAND J INFECT DIS, V35, P843, DOI 10.1080/00365540310016646; MAIDE DJ, 2006, INT ANGIOL, V25, P204; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Manian FA, 2003, CLIN INFECT DIS, V36, P863, DOI 10.1086/368195; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Pittet D, 1996, INFECT CONT HOSP EP, V17, P496; Pittet D, 2004, INFECT CONT HOSP EP, V25, P264, DOI 10.1086/502389; Sankar B, 2005, INT ORTHOP, V29, P160, DOI 10.1007/s00264-005-0649-3; Sax H, 2007, J HOSP INFECT, V67, P9, DOI 10.1016/j.jhin.2007.06.004; Sax H, 2007, INFECT CONT HOSP EP, V28, P1267, DOI 10.1086/521663; Shitrit P, 2006, INFECT CONT HOSP EP, V27, P1004, DOI 10.1086/507914; Spiegelhalter DJ, 2005, BRIT MED J, V331, P1013, DOI 10.1136/bmj.331.7523.1013; Strausbaugh LJ, 2006, CLIN INFECT DIS, V42, P828, DOI 10.1086/500408; Weber SG, 2007, INFECT CONT HOSP EP, V28, P249, DOI 10.1086/512261; Wernitz MH, 2005, CLIN MICROBIOL INFEC, V11, P457, DOI 10.1111/j.1469-0691.2005.01152.x; Zanetti G, 2001, EMERG INFECT DIS, V7, P820; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	42	403	409	2	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2008	299	10					1149	1157		10.1001/jama.299.10.1149	http://dx.doi.org/10.1001/jama.299.10.1149			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272CE	18334690	Bronze			2022-12-28	WOS:000253835000018
J	Raya, RR				Raya, Rene R.			Philippine breastfeeding struggle continues	LANCET			English	Editorial Material									Act Econ Reforms, Quezon City 1101, Philippines		Raya, RR (corresponding author), Act Econ Reforms, Quezon City 1101, Philippines.	rrraya@gmail.com						CONDE CH, 2007, INT HEARLD TRIB 0717; DATINGUINOO VM, 2006, HLTH FILIPINO TEMPES; *DEM HLTH SURV, 2003, GEN TABL STATCOMPILE; *DEP HLTH, 1986, PHIL COD MARK BREAST; DONOHUE TJ, 2006, COMMUNICATION   0811; *FAO UN, 2004, ENT SAK OTH MICR POW; FEIST EM, 2006, COMMUNICATION   0130; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; MOUNTFORD M, 2006, COMMUNICATION   0620; *NAT ANT COMM, 2000, INF YOUNG CHILD FEED; RAMOS JG, 2007, CEASE DESIST ORDER I; *REP PHIL SUPR COU, 2007, PHARM HLTH CAR ASS P; WASSMER LP, 2006, COMMUNICATION   0112; World Health Organization, 1981, INT COD MARK BREAST	14	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 8	2008	371	9615					794	795		10.1016/S0140-6736(08)60358-X	http://dx.doi.org/10.1016/S0140-6736(08)60358-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272NQ	18328912				2022-12-28	WOS:000253866500008
J	Klein, DF				Klein, Donald F.			The loss of serendipity in psychopharmacology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MAJOR DEPRESSION; IMIPRAMINE; PREDICTORS; DISORDERS; RELAPSE		[Klein, Donald F.] NYU, Ctr Child Study, Phyllis Green & Randolph Cowen Inst Pediat Neuros, Med Ctr,Nathan S Kline Inst Psychiat Res, New York, NY 10016 USA; [Klein, Donald F.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA	Nathan Kline Institute for Psychiatric Research; New York University; Columbia University	Klein, DF (corresponding author), NYU, Ctr Child Study, Phyllis Green & Randolph Cowen Inst Pediat Neuros, Med Ctr,Nathan S Kline Inst Psychiat Res, Lexington Ave,14th Floor, New York, NY 10016 USA.	donaldk737@aol.com						Evins AE, 2003, J CLIN PSYCHIAT, V64, P9; KLEIN DF, 1967, ARCH GEN PSYCHIAT, V16, P118; McElroy SL, 2005, J CLIN PSYCHIAT, V66, P617, DOI 10.4088/JCP.v66n0512; McGrath PJ, 2006, AM J PSYCHIAT, V163, P1542, DOI 10.1176/appi.ajp.163.9.1542; McGrath PJ, 2000, J CLIN PSYCHIAT, V61, P518, DOI 10.4088/JCP.v61n0710; Ohlsen RI, 2005, J PSYCHOPHARMACOL, V19, P408, DOI 10.1177/0269881105053308; QUITKIN FM, 1989, ARCH GEN PSYCHIAT, V46, P787; UHLENHUTH EH, 1977, PSYCHOPHARMACOLOGY, V52, P79, DOI 10.1007/BF00426604; WIKLER A, 1953, J PHARMACOL EXP THER, V109, P8; ZITRIN CM, 1978, ARCH GEN PSYCHIAT, V35, P307	10	54	54	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2008	299	9					1063	1065		10.1001/jama.299.9.1063	http://dx.doi.org/10.1001/jama.299.9.1063			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JH	18319418				2022-12-28	WOS:000253644800026
J	Lazo, M; Selvin, E; Clark, JM				Lazo, Mariana; Selvin, Elizabeth; Clark, Jeanne M.			Brief communication: Clinical implications of short-term variability in liver function test results	ANNALS OF INTERNAL MEDICINE			English	Article							ALANINE AMINOTRANSFERASE LEVELS; BLOOD-PRESSURE; PRIMARY-CARE; YIELD	Background: Clinicians sometimes order liver tests as part of a screening examination or general work-up. Current guidelines do not recommend routine retesting of abnormal results in asymptomatic patients. Objective: To characterize the magnitude of intraindividual variability of liver test results and determine the proportion of adults with persistently elevated levels after 1 positive test. Design: Reliability study. Setting: The NHANES ( National Health and Nutrition Examination Survey) III First and Second Examinations ( 1988 to 1994). Participants: 1864 men and women age 18 years or older living in the United States. Measurements: Repeated measurements ( mean, 17.5 days apart) of aspartate aminotransferase ( AST), alanine aminotransferase ( ALT), alkaline phosphatase, gamma-glutamyltransferase, and bilirubin. Results: Using NHANES III cutoffs for normal levels, 38% of adults with initially elevated bilirubin levels had normal levels at the second examination. These proportions were 36%, 31%, 17%, and 12% for AST, ALT, alkaline phosphatase, and gamma-glutamyltranferase, respectively. More than 95% of initially normal results remained normal. The results did not differ by alcohol consumption; hepatitis A, B, or C serologic status; recent infection; body mass index; or sociodemographic characteristics. Intraindividual variability was significantly higher for bilirubin ( coefficient of variation, 23.4%) and ALT ( coefficient of variation, 20.4%) than for AST ( coefficient of variation, 13.9%), gamma-glutamyltransferase ( coefficient of variation, 13.8%), and alkaline phosphatase ( coefficient of variation, 6.7%). Limitations: Only 2 measurements were available. Complete liver disease history was lacking. Conclusion: If retested, more than 30% of adults with elevated AST, ALT, or bilirubin levels would be reclassified as normal. Clinicians should be aware of the high intraindividual variability in common liver tests, and practice guidelines should explicitly recommend retesting of asymptomatic individuals with abnormal liver test results.	[Lazo, Mariana; Selvin, Elizabeth; Clark, Jeanne M.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol Clin Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lazo, M (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol Clin Res, 2024 E Monument St,Suite 2-600, Baltimore, MD 21205 USA.	mlazo@jhsph.edu	Lazo, Mariana/A-9227-2018; Clark, Jeanne/AGG-8199-2022	Lazo, Mariana/0000-0002-3178-6734; Clark, Jeanne/0000-0003-1194-0092	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK076595] Funding Source: NIH RePORTER; NIDDK NIH HHS [K01 DK076595-01, K01 DK076595] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMBERG JM, 1982, J CHRON DIS, V35, P81, DOI 10.1016/0021-9681(82)90109-6; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; [Anonymous], 1994, VITAL HLTH STAT, P1; Bland JM, 1996, BRIT MED J, V312, P1654, DOI 10.1136/bmj.312.7047.1654; Dufour DR, 2000, CLIN CHEM, V46, P2050; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; GUNTER EW, 1996, LAB PROCEDURES 3 NAT; Kaplan MM, 2002, ANN INTERN MED, V137, P49, DOI 10.7326/0003-4819-137-1-200207020-00012; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; Lichtenstein GR, 2002, GASTROENTEROLOGY, V123, P1364, DOI 10.1053/gast.2002.36060; *NAT CTR HLTH STAT, 1999, 3 NAT HLTH NUTR EX S; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Rothschild JM, 2002, J EVAL CLIN PRACT, V8, P397, DOI 10.1046/j.1365-2753.2002.00366.x; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; Sherwood P, 2001, BRIT MED J, V322, P276, DOI 10.1136/bmj.322.7281.276; Stanforth PR, 2000, ANN EPIDEMIOL, V10, P271, DOI 10.1016/S1047-2797(00)00047-8; US Department of Health and Human Services, 1994, PLAN OP 3 NAT HLTH N	19	99	102	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2008	148	5					348	W76		10.7326/0003-4819-148-5-200803040-00005	http://dx.doi.org/10.7326/0003-4819-148-5-200803040-00005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268SX	18316753				2022-12-28	WOS:000253600800003
J	Jaenisch, R; Young, R				Jaenisch, Rudolf; Young, Richard			Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming	CELL			English	Review							PRIMORDIAL GERM-CELLS; DE-NOVO METHYLATION; OCT4 EXPRESSION; SOMATIC-CELLS; SELF-RENEWAL; C-MYC; DEVELOPMENTAL REGULATORS; TRANSCRIPTION FACTOR; MOUSE EPIBLAST; RECEPTOR GCNF	Reprogramming of somatic cells to a pluripotent embryonic stem cell-like state has been achieved by nuclear transplantation of a somatic nucleus into an enucleated egg and most recently by introducing defined transcription factors into somatic cells. Nuclear reprogramming is of great medical interest, as it has the potential to generate a source of patient-specific cells. Here, we review strategies to reprogram somatic cells to a pluripotent embryonic state and discuss our understanding of the molecular mechanisms of reprogramming based on recent insights into the regulatory circuitry of the pluripotent state.	[Jaenisch, Rudolf; Young, Richard] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jaenisch, Rudolf; Young, Richard] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu; young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, R01CA087869] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA084198, R01 CA087869] Funding Source: Medline; NICHD NIH HHS [R01 HD045022] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; ALVARADO AS, 2006, CELL, V124, P241, DOI DOI 10.1016/J.CELL.2006.01.012; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; BRAMBRINK T, 2008, CELL STEM CELL; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Croft AP, 2006, STEM CELLS, V24, P1841, DOI 10.1634/stemcells.2005-0609; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Greda P, 2006, REPRODUCTION, V132, P741, DOI 10.1530/rep.1.01204; Gu PL, 2006, MOL CELL BIOL, V26, P9471, DOI 10.1128/MCB.00898-06; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; HANNA J, 2007, IN PRESS SCIENCE; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Hochedlinger K, 2007, NAT GENET, V39, P136, DOI 10.1038/ng0207-136; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Inoue K, 2007, STEM CELLS, V25, P1279, DOI 10.1634/stemcells.2006-0747; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Li JS, 2007, P NATL ACAD SCI USA, V104, P2738, DOI 10.1073/pnas.0611358104; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Lovell-Badge R, 2007, NAT BIOTECHNOL, V25, P1114, DOI 10.1038/nbt1007-1114; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; NAGY A, 1990, DEVELOPMENT, V110, P815; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Narasimha M, 1997, CURR BIOL, V7, P881, DOI 10.1016/S0960-9822(06)00377-0; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Oback B, 2007, MOL REPROD DEV, V74, P646, DOI 10.1002/mrd.20654; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; PIKARSKY E, 1994, MOL CELL BIOL, V14, P1026, DOI 10.1128/MCB.14.2.1026; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Rizzino A, 2007, DEV DYNAM, V236, P3199, DOI 10.1002/dvdy.21285; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van de Ven C, 2007, EXP HEMATOL, V35, P1753, DOI 10.1016/j.exphem.2007.08.017; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wakayama S, 2007, STEM CELLS, V25, P986, DOI 10.1634/stemcells.2006-0615; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2006, STEM CELLS, V24, P168, DOI 10.1634/stemcells.2005-0292; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	144	1031	1185	4	234	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					567	582		10.1016/j.cell.2008.01.015	http://dx.doi.org/10.1016/j.cell.2008.01.015			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295576	Green Accepted, Bronze			2022-12-28	WOS:000253817900018
J	Rossi, DJ; Jamieson, CHM; Weissman, IL				Rossi, Derrick J.; Jamieson, Catriona H. M.; Weissman, Irving L.			Stems cells and the pathways to aging and cancer	CELL			English	Review							MURINE HEMATOPOIETIC STEM; AGE-RELATED-CHANGES; ACUTE MYELOID-LEUKEMIA; DNA-DAMAGE RESPONSE; LIFE-SPAN; SELF-RENEWAL; OXIDATIVE STRESS; DEPENDENCE DISTINGUISHES; TELOMERE DYSFUNCTION; BONE-MARROW	The aging of tissue-specific stem cell and progenitor cell compartments is believed to be central to the decline of tissue and organ integrity and function in the elderly. Here, we examine evidence linking stem cell dysfunction to the pathophysiological conditions accompanying aging, focusing on the mechanisms underlying stem cell decline and their contribution to disease pathogenesis.	[Rossi, Derrick J.] Harvard Univ, Stem Cell Inst, Immune Dis Inst, Boston, MA 02115 USA; [Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Jamieson, Catriona H. M.] Univ Calif San Diego, Moores Canc Ctr, Div Hematol Oncol, La Jolla, CA 92093 USA; [Jamieson, Catriona H. M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Weissman, Irving L.] Stanford Univ, Ctr Canc, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego; Stanford University; Stanford University	Rossi, DJ (corresponding author), Harvard Univ, Stem Cell Inst, Immune Dis Inst, Boston, MA 02115 USA.	rossi@idi.harvard.edu						Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Allsopp RC, 2003, NAT MED, V9, P369, DOI 10.1038/nm0403-369; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Bailey KJ, 2004, AGING CELL, V3, P391, DOI 10.1111/j.1474-9728.2004.00128.x; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beghe C, 2004, AM J MED, V116, P3, DOI 10.1016/j.amjmed.2003.12.009; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Bielas JH, 2000, P NATL ACAD SCI USA, V97, P11391, DOI 10.1073/pnas.190330997; Bielas JH, 2004, DNA REPAIR, V3, P711, DOI 10.1016/j.dnarep.2004.02.010; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Carreau M, 1999, EXP HEMATOL, V27, P1667, DOI 10.1016/S0301-472X(99)00102-2; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004; Chen JC, 2003, EXP HEMATOL, V31, P1097, DOI 10.1016/S0301-472X(03)00238-8; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ferron S, 2004, DEVELOPMENT, V131, P4059, DOI 10.1242/dev.01215; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Haneline LS, 1999, BLOOD, V94, P1; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harrington L, 2004, ONCOGENE, V23, P7283, DOI 10.1038/sj.onc.1207948; HARRISON DE, 1979, MECH AGEING DEV, V9, P427, DOI 10.1016/0047-6374(79)90083-6; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Lichtman MA, 2004, SEMIN ONCOL, V31, P185, DOI 10.1053/j.seminoncol.2003.12.029; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; Martin K, 1998, EXP CELL RES, V241, P316, DOI 10.1006/excr.1998.4001; Martin K, 1998, J CELL SCI, V111, P2297; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller JP, 2003, J IMMUNOL, V171, P2326, DOI 10.4049/jimmunol.171.5.2326; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; MOLOFSKY A, 2005, GENE DEV, V1432, pP16; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; MULLER S, 2006, CURR OPIN HEMATOL, V13, P243; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pearce DJ, 2007, STEM CELLS, V25, P828, DOI 10.1634/stemcells.2006-0405; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Rossi DJ, 2007, EXP GERONTOL, V42, P385, DOI 10.1016/j.exger.2006.11.019; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Samper E, 2002, BLOOD, V99, P2767, DOI 10.1182/blood.V99.8.2767; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; SIEGL C, 2007, GENE DEV, V21, P2234; Signer RAJ, 2007, BLOOD, V110, P1831, DOI 10.1182/blood-2007-01-069401; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Warren LA, 2007, AGING CELL, V6, P775, DOI 10.1111/j.1474-9726.2007.00337.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Yoshida K, 2006, EXP HEMATOL, V34, P274, DOI 10.1016/j.exphem.2005.11.016; Yuan YZ, 2001, P NATL ACAD SCI USA, V98, P10398, DOI 10.1073/pnas.171321298; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	157	651	671	0	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					681	696		10.1016/j.cell.2008.01.036	http://dx.doi.org/10.1016/j.cell.2008.01.036			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295583	Bronze			2022-12-28	WOS:000253817900025
J	Field, B; Osbourn, AE				Field, Ben; Osbourn, Anne E.			Metabolic diversification - Independent assembly of operon-like gene clusters in different plants	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; TRITERPENOIDS; BIOSYNTHESIS; SUPERFAMILY; DIVERSITY; EVOLUTION; PATTERNS; MUTANTS; STEROLS; RICE	Operons are clusters of unrelated genes with related functions that are a feature of prokaryotic genomes. Here, we report on an operon- like gene cluster in the plant Arabidopsis thaliana that is required for triterpene synthesis ( the thalianol pathway). The clustered genes are coexpressed, as in bacterial operons. However, despite the resemblance to a bacterial operon, this gene cluster has been assembled from plant genes by gene duplication, neofunctionalization, and genome reorganization, rather than by horizontal gene transfer from bacteria. Furthermore, recent assembly of operon- like gene clusters for triterpene synthesis has occurred independently in divergent plant lineages ( Arabidopsis and oat). Thus, selection pressure may act during the formation of certain plant metabolic pathways to drive gene clustering.	[Field, Ben; Osbourn, Anne E.] John Innes Ctr Plant Sci Res, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Osbourn, AE (corresponding author), John Innes Ctr Plant Sci Res, Dept Metab Biol, Colney Lane, Norwich NR4 7UH, Norfolk, England.	anne.osbourn@bbsrc.ac.uk	Martinez, Octavio/B-7375-2009; Field, Benjamin/AAR-8077-2020; Field, Ben/E-9762-2010	Field, Benjamin/0000-0003-2142-4606; Field, Ben/0000-0003-2142-4606	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abe I, 2007, NAT PROD REP, V24, P1311, DOI 10.1039/b616857b; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Clouse SD, 2002, PLANT CELL, V14, P1995, DOI 10.1105/tpc.140930; Ehlting J, 2006, BIOCHEM SOC T, V34, P1192, DOI 10.1042/BST0341192; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fazio GC, 2004, J AM CHEM SOC, V126, P5678, DOI 10.1021/ja0318784; Gierl A, 2001, PLANTA, V213, P493, DOI 10.1007/s004250100594; Hamberger B, 2006, BIOCHEM SOC T, V34, P1209, DOI 10.1042/BST0341209; Haralampidis K, 2001, P NATL ACAD SCI USA, V98, P13431, DOI 10.1073/pnas.231324698; Hostettmann K., 1995, SAPONINS, DOI 10.1017/CBO9780511565113; Jonczyk R, 2008, PLANT PHYSIOL, V146, P1053, DOI 10.1104/pp.107.111237; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Mylona P, 2008, PLANT CELL, V20, P201, DOI 10.1105/tpc.107.056531; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Papadopoulou K, 1999, P NATL ACAD SCI USA, V96, P12923, DOI 10.1073/pnas.96.22.12923; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; RETTIE AE, 1987, SCIENCE, V235, P890, DOI 10.1126/science.3101178; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; Yokota T, 1997, TRENDS PLANT SCI, V2, P137, DOI 10.1016/S1360-1385(97)01017-0; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	26	295	320	9	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					543	547		10.1126/science.1154990	http://dx.doi.org/10.1126/science.1154990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18356490				2022-12-28	WOS:000255249300054
J	Yanina, SV; Rosso, KM				Yanina, Svetlana V.; Rosso, Kevin M.			Linked reactivity at mineral-water interfaces through bulk crystal conduction	SCIENCE			English	Article							FLAT-BAND POTENTIALS; REDUCTIVE DISSOLUTION; ELECTRON-TRANSFER; SURFACE-CHARGE; HEMATITE; ALPHA-FE2O3; FACES; COMPLEXATION; SIMULATION; GOETHITE	The semiconducting properties of a wide range of minerals are often ignored in the study of their interfacial geochemical behavior. We show that surface-specific charge density accumulation reactions combined with bulk charge carrier diffusivity create conditions under which interfacial electron transfer reactions at one surface couple with those at another via current flow through the crystal bulk. Specifically, we observed that a chemically induced surface potential gradient across hematite (alpha-Fe2O3) crystals is sufficiently high and the bulk electrical resistivity sufficiently low that dissolution of edge surfaces is linked to simultaneous growth of the crystallographically distinct (001) basal plane. The apparent importance of bulk crystal conduction is likely to be generalizable to a host of naturally abundant semiconducting minerals playing varied key roles in soils, sediments, and the atmosphere.	[Yanina, Svetlana V.; Rosso, Kevin M.] Pacific NW Natl Lab, Div Chem & Mat Sci, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Rosso, KM (corresponding author), Pacific NW Natl Lab, Div Chem & Mat Sci, POB 999,MSIN K8-96, Richland, WA 99352 USA.	kevin.rosso@pnl.gov	Rosso, Kevin/AAQ-1561-2021					AVENA MJ, 1993, COLLOID SURFACE, V69, P217, DOI 10.1016/0166-6622(93)80003-X; Balko BA, 2001, J ELECTROCHEM SOC, V148, pE85, DOI 10.1149/1.1341239; BANWART S, 1989, COLLOID SURFACE, V39, P303, DOI 10.1016/0166-6622(89)80281-1; Barron V, 1996, J COLLOID INTERF SCI, V177, P407, DOI 10.1006/jcis.1996.0051; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; DAVIS JA, 1978, J COLLOID INTERF SCI, V63, P480, DOI 10.1016/S0021-9797(78)80009-5; DIMITRIJEVIC NM, 1984, J PHYS CHEM-US, V88, P4278, DOI 10.1021/j150663a018; Duckworth OW, 2001, GEOCHIM COSMOCHIM AC, V65, P4289, DOI 10.1016/S0016-7037(01)00696-2; Eggleston CM, 2003, GEOCHIM COSMOCHIM AC, V67, P985, DOI 10.1016/S0016-7037(02)01200-0; Gaboriaud F, 2003, GEOCHIM COSMOCHIM AC, V67, P967, DOI 10.1016/S0016-7037(02)00988-2; GARRETT CGB, 1955, PHYS REV, V99, P376, DOI 10.1103/PhysRev.99.376; GLEITZER C, 1991, APPL PHYS A-MATER, V53, P310, DOI 10.1007/BF00357193; Hiemstra T, 1999, LANGMUIR, V15, P8045, DOI 10.1021/la9903604; Iordanova N, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1869492; Kallay N, 2008, J COLLOID INTERF SCI, V318, P290, DOI 10.1016/j.jcis.2007.09.090; KENNEDY JH, 1978, J ELECTROCHEM SOC, V125, P723, DOI 10.1149/1.2131535; Kerisit S, 2006, GEOCHIM COSMOCHIM AC, V70, P1888, DOI 10.1016/j.gca.2005.12.021; Kerisit S, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768522; LAKIND JS, 1989, GEOCHIM COSMOCHIM AC, V53, P961, DOI 10.1016/0016-7037(89)90202-0; Larese-Casanova P, 2007, ENVIRON SCI TECHNOL, V41, P471, DOI 10.1021/es0617035; MULVANEY P, 1988, J PHYS CHEM-US, V92, P6732, DOI 10.1021/j100334a049; MULVANEY P, 1988, LANGMUIR, V4, P1206, DOI 10.1021/la00083a028; NAKAU T, 1960, J PHYS SOC JPN, V15, P727, DOI 10.1143/JPSJ.15.727; Rustad JR, 1999, SURF SCI, V424, P28, DOI 10.1016/S0039-6028(99)00009-6; Shuey RT, 1975, SEMICONDUCTING ORE M, V4; SUTER D, 1988, NATURWISSENSCHAFTEN, V75, P571, DOI 10.1007/BF00377723; Trainor TP, 2004, SURF SCI, V573, P204, DOI 10.1016/j.susc.2004.09.040; Venema P, 1998, J COLLOID INTERF SCI, V198, P282, DOI 10.1006/jcis.1997.5245; Williams AGB, 2004, ENVIRON SCI TECHNOL, V38, P4782, DOI 10.1021/es049373g; Yoon TH, 2004, GEOCHIM COSMOCHIM AC, V68, P4505, DOI 10.1016/j.gca.2004.04.025; Zarzycki P, 2007, APPL SURF SCI, V253, P7604, DOI 10.1016/j.apsusc.2007.03.064; ZINDER B, 1986, GEOCHIM COSMOCHIM AC, V50, P1861, DOI 10.1016/0016-7037(86)90244-9	32	289	294	17	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2008	320	5873					218	222		10.1126/science.1154833	http://dx.doi.org/10.1126/science.1154833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18323417	Green Published			2022-12-28	WOS:000254836700040
J	Skalsky, K; Yahav, D; Bishara, J; Pitlik, S; Leibovici, L; Paul, M				Skalsky, Keren; Yahav, Dafna; Bishara, Jihad; Pitlik, Silvio; Leibovici, Leonard; Paul, Mical			Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOXYCYCLINE PLUS STREPTOMYCIN; TETRACYCLINE-STREPTOMYCIN; ANTIMICROBIAL REGIMENS; ANTIBIOTIC-TREATMENT; RIFAMPIN; EFFICACY; CIPROFLOXACIN; THERAPY; COTRIMOXAZOLE; FAILURE	Objectives To determine and quantify differences in efficacy between treatment regimens for brucellosis. Design Systematic review and meta-analysis of randomised controlled trials assessing different antibiotic regimens and durations of treatment for human brucellosis. Data sources PubMed, CENTRAL, Lilacs, conference proceedings, and bibliographies with no restrictions on language, study year, or publication status. Review methods Search, application of inclusion and exclusion criteria, data extraction, and assessment of methodological quality independently performed in duplicate. Primary outcomes were relapse and overall failure resulting from primary failure or relapse. Relative risks with 95% confidence intervals were calculated and pooled with a fixed effect model. Results 30 trials and 77 treatment arms were included. Overall failure was significantly higher with doxycycline-rifampicin compared to doxycycline-streptomycin, mainly due to a higher rate of relapse (relative risk 2.80, 95% confidence interval 1.81 to 4.36; 13 trials, without heterogeneity). Results were consistent among patients with bacteraemia and complicated brucellosis. Doxycycline-streptomycin resulted in a significantly higher rate of failure than doxycycline-rifampicin-aminoglycoside (triple drug regimen) (2.50, 1.26 to 5.00; two trials). Gentamicin was not inferior to streptomycin (1.45, 0.52 to 4.00 for failure; two trials). Quinolones combined with rifampicin were significantly less effective than doxycycline combined with rifampicin or streptomycin (1.83, 1.11 to 3.02, for failure; five trials). Monotherapy was associated with a higher risk of failure than combined treatment when administered for a similar duration (2.56, 1.55 to 4.23; five trials). Treatment for six weeks or more offered an advantage over shorter treatment durations. Conclusions There are significant differences in effectiveness between currently recommended treatment regimens for brucellosis. The preferred treatment should be with dual or triple regimens including an aminoglycoside.	[Bishara, Jihad; Pitlik, Silvio; Paul, Mical] Beilinson Med Ctr, Rabin Med Ctr, Infect Dis Unit, IL-49100 Petah Tiqwa, Israel; [Bishara, Jihad; Pitlik, Silvio; Leibovici, Leonard; Paul, Mical] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Paul, M (corresponding author), Beilinson Med Ctr, Rabin Med Ctr, Infect Dis Unit, IL-49100 Petah Tiqwa, Israel.	pil1pel@zahav.net.il	Yahav, Dafna/AAX-9961-2020; Bishara, Jihad/AAV-1519-2021	Yahav, Dafna/0000-0003-3181-9791; 				Abramson O, 1997, ANTIMICROB AGENTS CH, V41, P1621, DOI 10.1128/AAC.41.7.1621; ACOCELLA G, 1989, J ANTIMICROB CHEMOTH, V23, P433, DOI 10.1093/jac/23.3.433; Agalar C, 1999, EUR J CLIN MICROBIOL, V18, P535, DOI 10.1007/s100960050344; AKALIN HE, 1990, EUR J CLIN MICROBIOL, P326; AKOVA M, 1993, ANTIMICROB AGENTS CH, V37, P1831, DOI 10.1128/AAC.37.9.1831; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; ALEISSA YA, 1990, PEDIATR INFECT DIS J, V9, P74, DOI 10.1097/00006454-199002000-00002; ALFARO ME, 2007, 17 EUR C CLIN MICR I; ALIDRISSI HY, 1989, J INT MED RES, V17, P363, DOI 10.1177/030006058901700409; Alp E, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-72; ALP E, 2006, 16 EUR C CLIN MICR I; ALSIBAI MB, 1992, ANTIMICROB AGENTS CH, V36, P150, DOI 10.1128/AAC.36.1.150; ARIZA J, 1985, J INFECT DIS, V152, P1358, DOI 10.1093/infdis/152.6.1358; ARIZA J, 1983, MED CLIN-BARCELONA, V81, P870; ARIZA J, 1992, ANN INTERN MED, V117, P25, DOI 10.7326/0003-4819-117-1-25; ARIZA J, 1985, ANTIMICROB AGENTS CH, V28, P548, DOI 10.1128/AAC.28.4.548; ARIZA J, 1978, P 1 MED C CHEM MADR, P769; ARIZA J, 1971, BMJ-BRIT MED J, V3, P159; Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; BAQUERO F, 1985, INT S BRUC MADR; Bayindir Y, 2003, J CHEMOTHERAPY, V15, P466, DOI 10.1179/joc.2003.15.5.466; BERTRAND A, 1979, NOUV PRESSE MED, V8, P3635; BERTRAND A, 1982, SEM HOP PARIS, V58, P281; BERTRAND A, 1985, INT M BRUC MADR; BUZON L, 1982, CHEMIOTERAPIA, V1, P221; BUZON LBF, 1985, INT S BRUC MADR; Cascio A, 2003, J CHEMOTHERAPY, V15, P248, DOI 10.1179/joc.2003.15.3.248; CASTILLO JDC, 1989, CHEMOTHERAPY, V35, P146; CISNEROS JM, 1990, ANTIMICROB AGENTS CH, V34, P881, DOI 10.1128/AAC.34.5.881; Colmenero JD, 1997, ANN RHEUM DIS, V56, P709, DOI 10.1136/ard.56.12.709; COLMENERO JD, 1994, ANTIMICROB AGENTS CH, V38, P2798, DOI 10.1128/AAC.38.12.2798; COLMENERO JD, 1986, MED CLIN-BARCELONA, V86, P43; CORBEL MJ, 2005, HARRISONS PRINCIPLES; DALESSANDRO L, 1974, MINERVA MED, V65, P2350; De Rosa F, 1970, Clin Ter, V53, P141; DOGANAY M, 1992, EUR J CLIN MICROBIOL, V11, P74; El Miedany YM, 2003, J RHEUMATOL, V30, P2666; Ersoy Y, 2005, TROP DOCT, V35, P210, DOI 10.1258/004947505774938765; ERSOY Y, 2001, 11 EUR C CLIN MICR I; ESPINOSA A, 1997, 37 INT C ANT AG CHEM; EVERETT ED, 2007, BRUCELLOSIS CHILDREN; EVERETT ED, 2007, CLIN MANIFESTATIONS; FARID Z, 1961, J TROP MED HYG, V64, P157; Feiz J M, 1973, Br J Clin Pract, V27, P410; FENG YM, 1994, ENDEMIC DIS COLLECTI, V15, P66; Fiaccadori F, 1972, G Clin Med, V53, P290; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; GEORGIADIS I, 1983, P 12 INT C CHEM VIEN; GODEAU P, 1984, SEM HOP PARIS, V60, P5; HADDADI A, 2003, IRANIAN J INFECT DIS, V20, P29; HALL WH, 1990, REV INFECT DIS, V12, P1060; HASHEMI SH, 1996, 5 IR C INF DIS TROP, P45; HERRELL WE, 1949, P STAFF M MAYO CLIN, V24, P138; HERRELL WE, 1950, JAMA-J AM MED ASSOC, V114, P519; Irmak H, 2003, TOHOKU J EXP MED, V201, P221, DOI 10.1620/tjem.201.221; Joint FAO/WHO Expert Committee on Brucellosis, 1986, WHO TECH REP SER, V740, P1; Kalo T, 1996, MED MALADIES INFECT, V26, P587, DOI 10.1016/S0399-077X(96)80077-1; Karabay O, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-18; KOSMIDIS J, 1985, P INT M BRUCELLOSIS, P127; Kosmidis J, 1982, CHEMOTHERAPIA S4, V1, P107; Kurmanova K B, 1995, Antibiot Khimioter, V40, P39; LANG R, 1992, CLIN INFECT DIS, V14, P506, DOI 10.1093/clinids/14.2.506; LANG R, 1990, J ANTIMICROB CHEMOTH, V26, P841, DOI 10.1093/jac/26.6.841; LANG R, 1992, J ANTIMICROB CHEMOTH, V29, P357, DOI 10.1093/jac/29.4.357; Liu J B, 1997, Zhongguo Zhong Xi Yi Jie He Za Zhi, V17, P470; LLORENSTEROL J, 1980, ARCH DIS CHILD, V55, P486, DOI 10.1136/adc.55.6.486; LUBANI MM, 1989, PEDIATR INFECT DIS J, V8, P75; LULU AR, 1988, Q J MED, V66, P39; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; MAGILL GB, 1953, ARCH INTERN MED, V91, P204, DOI 10.1001/archinte.1953.00240140064005; MARTINEZLUENGAS F, 1981, P 12 INT C CHEM FLOR, P935; MCDEVITT D G, 1970, British Journal of Industrial Medicine, V27, P67; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; MONTEJO JM, 1993, CLIN INFECT DIS, V16, P671, DOI 10.1093/clind/16.5.671; MUKOVOZOVA LA, 1986, TERAPEVT ARKH, V58, P43; NAJWA A, 1993, PEDIATR INFECT DIS J, V12, P377; NAVARRO A, 1984, ENF INFEC MICROBIOL, V2, P274; PANDOLFO GP, 1970, DIA MED, V42, P215; Pappas G, 2007, J INFECTION, V54, P459, DOI 10.1016/j.jinf.2006.09.015; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Pappas G, 2004, INT J ANTIMICROB AG, V24, P502, DOI 10.1016/j.ijantimicag.2004.05.003; PEREZ RP, 1997, REV MED URUG, V13, P110; Perez-Gorricho B, 2003, INT J ANTIMICROB AG, V21, P222, DOI 10.1016/S0924-8579(02)00360-6; POMBO MSD, 1988, C IB MED INT 18 C SE; Ranjbar M, 2007, INT J INFECT DIS, V11, P152, DOI 10.1016/j.ijid.2005.11.007; RIVEROPUENTE A, 1982, REV CLIN ESP, V166, P111; RIZZONAUDI J, 1967, POSTGRAD MED J, V43, P520, DOI 10.1136/pgmj.43.502.520; RODRIGUEZ M, 1986, SEMER, P32; Rodriguez Zapata M, 1987, Chemioterapia, V6, P360; RODRIGUEZCREIXE.M, 1980, CURRENT CHEMOTHERAPY, P1064; ROUSHAN MR, 2005, 15 EUR C CLIN MICR I; ROUSHAN MR, 2007, 17 EUR C CLIN MICR I; Roushan MRH, 2006, CLIN INFECT DIS, V42, P1075, DOI 10.1086/501359; Roushan MRH, 2004, SWISS MED WKLY, V134, P564; Salata RA, 2004, CECIL TXB MED; Saltoglu N, 2002, SAUDI MED J, V23, P921; SANCHEZ H, 1994, B SOC PERU MED INT, V7, P66; SANCHEZ H, 1991, B SOC PERU MED INT, V4, P6; SANCHEZ H, 1988, BRUCELOSIS HUMANA ES, P63; SHEHABI A, 1990, J INFECTION, V20, P5, DOI 10.1016/S0163-4453(90)92214-6; Solera J, 1997, DRUGS, V53, P245, DOI 10.2165/00003495-199753020-00005; Solera J, 1996, CLIN INFECT DIS, V22, P441, DOI 10.1093/clinids/22.3.441; SOLERA J, 1994, MED CLIN-BARCELONA, V102, P731; Solera J, 2001, CLIN INFECT DIS, V32, P506, DOI 10.1086/318503; SOLERA J, 1991, MED CLIN-BARCELONA, V96, P649; Solera J, 2004, CLIN INFECT DIS, V39, P1776, DOI 10.1086/426024; Solera J, 1997, ANTIMICROB AGENTS CH, V41, P80, DOI 10.1128/AAC.41.1.80; SOLERA J, 1995, ANTIMICROB AGENTS CH, V39, P2061, DOI 10.1128/AAC.39.9.2061; SOLERA J, 1993, REV ESPANOLA REUMATO, V20, P153; SOLERA J, 1992, REV ESPANOLA REUMATO, V19, P219; SPINK KW, 1960, JAMA-J AM MED ASSOC, V172, P697; VARGAS V, 1980, MED CLIN-BARCELONA, V75, P418; VIEIRA JD, 1984, CURR THER RES CLIN E, V35, P944; Young E J, 2005, PRINCIPLES PRACTICE	115	143	163	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2008	336	7646					701	704I		10.1136/bmj.39497.500903.25	http://dx.doi.org/10.1136/bmj.39497.500903.25			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZS	18321957	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000254675600028
J	Chen, YQ; Zhu, J; Lum, PY; Yang, X; Pinto, S; MacNeil, DJ; Zhang, CS; Lamb, J; Edwards, S; Sieberts, SK; Leonardson, A; Castellini, LW; Wang, S; Champy, MF; Zhang, B; Emilsson, V; Doss, S; Ghazalpour, A; Horvath, S; Drake, TA; Lusis, AJ; Schadt, EE				Chen, Yanqing; Zhu, Jun; Lum, Pek Yee; Yang, Xia; Pinto, Shirly; MacNeil, Douglas J.; Zhang, Chunsheng; Lamb, John; Edwards, Stephen; Sieberts, Solveig K.; Leonardson, Amy; Castellini, Lawrence W.; Wang, Susanna; Champy, Marie-France; Zhang, Bin; Emilsson, Valur; Doss, Sudheer; Ghazalpour, Anatole; Horvath, Steve; Drake, Thomas A.; Lusis, Aldons J.; Schadt, Eric E.			Variations in DNA elucidate molecular networks that cause disease	NATURE			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; UPSTREAM TRANSCRIPTION FACTOR-1; SEGREGATING MOUSE-POPULATION; TISSUE-SPECIFIC EXPRESSION; FACTOR-H POLYMORPHISM; GENE-EXPRESSION; LIPOPROTEIN-LIPASE; TRAIT ANALYSIS; ATHEROSCLEROSIS; IDENTIFY	Identifying variations in DNA that increase susceptibility to disease is one of the primary aims of genetic studies using a forward genetics approach. However, identification of disease- susceptibility genes by means of such studies provides limited functional information on how genes lead to disease. In fact, in most cases there is an absence of functional information altogether, preventing a definitive identification of the susceptibility gene or genes. Here we develop an alternative to the classic forward genetics approach for dissecting complex disease traits where, instead of identifying susceptibility genes directly affected by variations in DNA, we identify gene networks that are perturbed by susceptibility loci and that in turn lead to disease. Application of this method to liver and adipose gene expression data generated from a segregating mouse population results in the identification of a macrophage- enriched network supported as having a causal relationship with disease traits associated with metabolic syndrome. Three genes in this network, lipoprotein lipase ( Lpl), lactamase beta ( Lactb) and protein phosphatase 1- like ( Ppm1l), are validated as previously unknown obesity genes, strengthening the association between this network and metabolic disease traits. Our analysis provides direct experimental support that complex traits such as obesity are emergent properties of molecular networks that are modulated by complex genetic loci and environmental factors.	[Chen, Yanqing; Zhu, Jun; Lum, Pek Yee; Yang, Xia; Zhang, Chunsheng; Lamb, John; Edwards, Stephen; Sieberts, Solveig K.; Leonardson, Amy; Zhang, Bin; Emilsson, Valur; Schadt, Eric E.] Merck & Co Inc, Rosetta Inpharmat LLC, Seattle, WA 98109 USA; [Pinto, Shirly; MacNeil, Douglas J.] Merck & Co Inc, Dept Metab Disorders, Rahway, NJ 07065 USA; [Castellini, Lawrence W.; Wang, Susanna; Doss, Sudheer; Ghazalpour, Anatole; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Horvath, Steve; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Drake, Thomas A.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Champy, Marie-France] ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Merck & Company; Merck & Company; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schadt, EE (corresponding author), Merck & Co Inc, Rosetta Inpharmat LLC, 401 Terry Ave N, Seattle, WA 98109 USA.	eric_schadt@merck.com	Chen, Yanqing/B-5614-2009; Edwards, Stephen W/G-4482-2011	Edwards, Stephen/0000-0002-7985-111X; Chen, Yanqing/0000-0002-9534-6199; Emilsson, Valur/0000-0001-9982-0524; MacNeil, Doug/0000-0001-7089-0668	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, P01HL030568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071673] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL028481-240010, P01 HL028481-24, P01 HL030568-250011, P01 HL030568, P01 HL028481] Funding Source: Medline; NIDDK NIH HHS [R01 DK071673-03, R01 DK071673] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams LD, 2006, ARTERIOSCL THROM VAS, V26, P319, DOI 10.1161/01.ATV.0000196647.45718.d6; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Babinska A, 2002, THROMB HAEMOSTASIS, V88, P843, DOI 10.1055/s-0037-1613312; Bains RK, 2004, ENDOCRINOLOGY, V145, P2666, DOI 10.1210/en.2003-1608; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Castellani LW, 2001, DIABETES, V50, P643, DOI 10.2337/diabetes.50.3.643; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P16380; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ezzahiri R, 2006, APMIS, V114, P117, DOI 10.1111/j.1600-0463.2006.apm_205.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gaucher SP, 2004, J PROTEOME RES, V3, P495, DOI 10.1021/pr034102a; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hu YM, 2006, J LIPID RES, V47, P1908, DOI 10.1194/jlr.M600108-JLR200; Huertas-Vazquez A, 2005, ARTERIOSCL THROM VAS, V25, P1985, DOI 10.1161/01.ATV.0000175297.37214.a0; Jacobs C, 1997, SCIENCE, V278, P1731, DOI 10.1126/science.278.5344.1731b; JIANG CJ, 1995, GENETICS, V140, P1111; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Liobikas J, 2006, PROTEIN EXPRES PURIF, V45, P335, DOI 10.1016/j.pep.2005.08.006; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; PAIGEN B, 1987, BIOCHEM GENET, V25, P501, DOI 10.1007/BF00554352; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; Preiss-Landl K, 2002, CURR OPIN LIPIDOL, V13, P471, DOI 10.1097/00041433-200210000-00002; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SCHADT EE, 2005, SCI STKE, pPE40; Schadt EE, 2006, J LIPID RES, V47, P2601, DOI 10.1194/jlr.R600026-JLR200; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith TS, 2001, GENOMICS, V78, P12, DOI 10.1006/geno.2001.6643; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; WARDEN CH, 1993, SCIENCE, V261, P469, DOI 10.1126/science.8332912; Welch CL, 2004, PHYSIOL GENOMICS, V17, P48, DOI 10.1152/physiolgenomics.00124.2003; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yost T J, 1993, Obes Res, V1, P1	50	667	693	0	66	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 27	2008	452	7186					429	435		10.1038/nature06757	http://dx.doi.org/10.1038/nature06757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18344982	Green Accepted			2022-12-28	WOS:000254341300023
J	Leutgeb, S				Leutgeb, Stefan			Neuroscience - Detailed differences	SCIENCE			English	Editorial Material							DENTATE GYRUS; PATTERN SEPARATION; DISTINCT; MEMORY; CA3; HIPPOCAMPUS; SYSTEM		[Leutgeb, Stefan] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway; [Leutgeb, Stefan] Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Leutgeb, S (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway.	stefan.leutgeb@ntnu.no						Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Blumenfeld B, 2006, NEURON, V52, P383, DOI 10.1016/j.neuron.2006.08.016; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; McNaughton BL, 1996, J EXP BIOL, V199, P173; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004	12	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1623	1624		10.1126/science.1156724	http://dx.doi.org/10.1126/science.1156724			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356509				2022-12-28	WOS:000254172300023
J	Meijer, GI				Meijer, G. I.			Materials science - Who wins the nonvolatile memory race?	SCIENCE			English	Editorial Material							FILMS		[Meijer, G. I.] IBM Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland	International Business Machines (IBM)	Meijer, GI (corresponding author), IBM Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland.	inm@zurich.ibm.com						BAEK IG, 2004, IEEE IEDM 2004; Beck A, 2000, APPL PHYS LETT, V77, P139, DOI 10.1063/1.126902; CHEN YC, 2006, IEEE IEDM 2006; Feynman R.P., 1992, J MICROELECTROMECH S, V1, P60, DOI 10.1109/84.128057; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Janousch M, 2007, ADV MATER, V19, P2232, DOI 10.1002/adma.200602915; Kozicki MN, 2005, IEEE T NANOTECHNOL, V4, P331, DOI 10.1109/TNANO.2005.846936; LAI S, 2001, IEEE IEDM 2001; Liu SQ, 2000, APPL PHYS LETT, V76, P2749, DOI 10.1063/1.126464; OH JH, 2006, IEEE IEDM 2006; OVSHINSKY SR, 1968, PHYS REV LETT, V21, P1450, DOI 10.1103/PhysRevLett.21.1450; Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023	13	454	468	4	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2008	319	5870					1625	1626		10.1126/science.1153909	http://dx.doi.org/10.1126/science.1153909			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356511				2022-12-28	WOS:000254172300025
J	Koch, CG; Li, L; Sessler, DI; Figueroa, P; Hoeltge, GA; Mihaljevic, T; Blackstone, EH				Koch, Colleen Gorman; Li, Liang; Sessler, Daniel I.; Figueroa, Priscilla; Hoeltge, Gerald A.; Mihaljevic, Tomislav; Blackstone, Eugene H.			Duration of red-cell storage and complications after cardiac surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIONAL-DEATH-INDEX; PLATELET-ACTIVATING-FACTOR; NEUTROPHIL NADPH OXIDASE; STORED-BLOOD COMPONENTS; CRITICALLY-ILL PATIENTS; LONG-TERM SURVIVAL; RHEOLOGICAL PROPERTIES; CLINICAL CONSEQUENCES; TRANSFUSED BLOOD; MORTALITY	Background: Stored red cells undergo progressive structural and functional changes over time. We tested the hypothesis that serious complications and mortality after cardiac surgery are increased when transfused red cells are stored for more than 2 weeks. Methods: We examined data from patients given red-cell transfusions during coronary-artery bypass grafting, heart-valve surgery, or both between June 30, 1998, and January 30, 2006. A total of 2872 patients received 8802 units of blood that had been stored for 14 days or less ("newer blood''), and 3130 patients received 10,782 units of blood that had been stored for more than 14 days ("older blood''). Multivariable logistic regression with propensity-score methods was used to examine the effect of the duration of storage on outcomes. Survival was estimated by the Kaplan-Meier method and Blackstone's decomposition method. Results: The median duration of storage was 11 days for newer blood and 20 days for older blood. Patients who were given older units had higher rates of in-hospital mortality (2.8% vs. 1.7%, P=0.004), intubation beyond 72 hours (9.7% vs. 5.6%, P<0.001), renal failure (2.7% vs. 1.6%, P=0.003), and sepsis or septicemia (4.0% vs. 2.8%, P=0.01). A composite of complications was more common in patients given older blood (25.9% vs. 22.4%, P=0.001). Similarly, older blood was associated with an increase in the risk-adjusted rate of the composite outcome (P=0.03). At 1 year, mortality was significantly less in patients given newer blood (7.4% vs. 11.0%, P<0.001). Conclusions: In patients undergoing cardiac surgery, transfusion of red cells that had been stored for more than 2 weeks was associated with a significantly increased risk of postoperative complications as well as reduced short-term and long-term survival.	[Koch, Colleen Gorman] Cleveland Clin Fdn, Dept Cardiothorac Anesthesia, Cleveland, OH 44195 USA; [Li, Liang] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Koch, Colleen Gorman; Sessler, Daniel I.] Cleveland Clin Fdn, Dept Outcomes Res, Cleveland, OH 44195 USA; [Figueroa, Priscilla; Hoeltge, Gerald A.] Cleveland Clin Fdn, Dept Lab Med & Clin Pathol, Cleveland, OH 44195 USA; [Mihaljevic, Tomislav; Blackstone, Eugene H.] Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Koch, CG (corresponding author), Cleveland Clin, Dept Cardiothorac Anesthesia, 9500 Euclid Ave G3, Cleveland, OH 44195 USA.	kochc@ccf.org	Sessler, Daniel/D-3504-2011	Sessler, Daniel/0000-0001-9932-3077	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061655] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 061655] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basran S, 2006, ANESTH ANALG, V103, P15, DOI 10.1213/01.ane.0000221167.58135.3d; Berezina TL, 2002, J SURG RES, V102, P6, DOI 10.1006/jsre.2001.6306; BLACKSTONE EH, 1986, J AM STAT ASSOC, V81, P615, DOI 10.2307/2288989; CALLE EE, 1993, AM J EPIDEMIOL, V137, P235, DOI 10.1093/oxfordjournals.aje.a116664; Chapman JF, 2004, VOX SANG, V87, P143, DOI 10.1111/j.1741-6892.2004.00472.x; d'Almeida MS, 2000, TRANSFUSION MED, V10, P291, DOI 10.1046/j.1365-3148.2000.00267.x; de Watering LV, 2006, TRANSFUSION, V46, P1712, DOI 10.1111/j.1537-2995.00958.x; Engoren MC, 2002, ANN THORAC SURG, V74, P1180, DOI 10.1016/S0003-4975(02)03766-9; Glynn SA, 2003, JAMA-J AM MED ASSOC, V289, P2246, DOI 10.1001/jama.289.17.2246; Hamasaki N, 2000, VOX SANG, V79, P191, DOI 10.1159/000056729; Ho J, 2003, CRIT CARE MED, V31, pS687, DOI 10.1097/01.CCM.0000099349.17094.A3; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kirkpatrick UJ, 1998, BRIT J HAEMATOL, V101, P364; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037; Koch CG, 2006, ANN THORAC SURG, V82, P1747, DOI 10.1016/j.athoracsur.2006.05.045; KOZAN E, 2003, INT J HEALTHCARE TEC, V3, P203; Kuduvalli M, 2005, EUR J CARDIO-THORAC, V27, P592, DOI 10.1016/j.ejcts.2005.01.030; Leal-Noval SM, 2001, CHEST, V119, P1461, DOI 10.1378/chest.119.5.1461; Leal-Noval SR, 2003, ANESTHESIOLOGY, V98, P815, DOI 10.1097/00000542-200304000-00005; MACMAHON B, 1983, AM J PUBLIC HEALTH, V73, P1247, DOI 10.2105/AJPH.73.11.1247; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; MARIK PE, 1993, JAMA-J AM MED ASSOC, V269, P3024, DOI 10.1001/jama.269.23.3024; McLellan SA, 2002, BRIT J ANAESTH, V89, P537, DOI 10.1093/bja/aef218; Murphy GJ, 2004, ANN THORAC SURG, V77, P1553, DOI 10.1016/j.athoracsur.2003.10.045; Mynster T, 2001, DIS COLON RECTUM, V44, P955, DOI 10.1007/BF02235483; Offner PJ, 2002, ARCH SURG-CHICAGO, V137, P711, DOI 10.1001/archsurg.137.6.711; Purdy FR, 1997, CAN J ANAESTH, V44, P1256, DOI 10.1007/BF03012772; Raat NJ, 2005, CRIT CARE MED, V33, P39, DOI 10.1097/01.CCM.0000150655.75519.02; Ranucci Marco, 1994, Perfusion, V9, P319, DOI 10.1177/026765919400900503; Robinson WP, 2005, J TRAUMA, V58, P437, DOI 10.1097/01.TA.0000153935.18997.14; SILLIMAN CC, 1993, LIPIDS, V28, P415, DOI 10.1007/BF02535939; SILLIMAN CC, 1992, VOX SANG, V63, P133, DOI 10.1111/j.1423-0410.1992.tb02500.x; SILLIMAN CC, 1994, J LAB CLIN MED, V124, P684; Spahn DR, 2002, ANESTHESIOLOGY, V97, P1338, DOI 10.1097/00000542-200212000-00004; Taylor RW, 2002, CRIT CARE MED, V30, P2249, DOI 10.1097/00003246-200210000-00012; Tinmouth A, 2001, TRANSFUS MED REV, V15, P91, DOI 10.1053/tmrv.2001.22613; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; VALERI CR, 1971, VOX SANG, V20, P397, DOI 10.1111/j.1423-0410.1971.tb01807.x; Vamvakas EC, 2000, TRANSFUSION, V40, P101, DOI 10.1046/j.1537-2995.2000.40010101.x; Walsh TS, 2004, CRIT CARE MED, V32, P364, DOI 10.1097/01.CCM.0000108878.23703.E0; Weiskopf RB, 2006, ANESTHESIOLOGY, V104, P911, DOI 10.1097/00000542-200605000-00005; WENTWORTH DN, 1983, AM J PUBLIC HEALTH, V73, P1270, DOI 10.2105/AJPH.73.11.1270; WHITAKER BI, 2006, 2005 NATIONWIDE BLOO; WOLFE LC, 1989, SEMIN HEMATOL, V26, P307; Yoshida T, 2007, VOX SANG, V92, P22, DOI 10.1111/j.1423-0410.2006.00860.x; Zacharias A, 1996, CHEST, V110, P1173, DOI 10.1378/chest.110.5.1173; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1	48	1026	1091	0	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1229	1239		10.1056/NEJMoa070403	http://dx.doi.org/10.1056/NEJMoa070403			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275TL	18354101				2022-12-28	WOS:000254094400004
J	Bobrow, RS				Bobrow, Robert S.			My father	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rbobrow@notes.cc.sunysb.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1235	1236		10.1001/jama.299.11.1235	http://dx.doi.org/10.1001/jama.299.11.1235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349080				2022-12-28	WOS:000254079100001
J	Di Mario, C; Ferrante, G				Di Mario, Carlo; Ferrante, Giuseppe			Biodegradable drug-eluting stents: promises and pitfalls	LANCET			English	Editorial Material							TRANSLUMINAL CORONARY ANGIOPLASTY; INTRAVASCULAR ULTRASOUND; LATE THROMBOSIS; ATHERECTOMY		[Di Mario, Carlo] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London SW3 6NP, England; [Ferrante, Giuseppe] Univ Cattolica Sacro Cuore, Inst Cardiol, I-00168 Rome, Italy	Imperial College London; Royal Brompton Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Di Mario, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London SW3 6NP, England.	c.dimario@rbht.nhs.uk	Di Mario, Carlo/K-5185-2018; Ferrante, Giuseppe/AAN-7122-2020; Ferrante, Giuseppe/K-5384-2016	Di Mario, Carlo/0000-0002-4461-2055; Ferrante, Giuseppe/0000-0001-9175-1464; Ferrante, Giuseppe/0000-0001-9175-1464				Barlis P, 2007, EUR HEART J, V28, P2319, DOI 10.1093/eurheartj/ehm119; Bostman OM, 1998, J BONE JOINT SURG AM, V80A, P1791, DOI 10.2106/00004623-199812000-00010; DIMARIO C, 1995, AM J CARDIOL, V75, P772, DOI 10.1016/S0002-9149(99)80409-3; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Ferrari E, 2005, J AM COLL CARDIOL, V45, P456, DOI 10.1016/j.jacc.2004.11.041; Jaffe R, 2007, J AM COLL CARDIOL, V50, P119, DOI 10.1016/j.jacc.2007.04.031; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Mintz GS, 1999, AM J CARDIOL, V83, P1518, DOI 10.1016/S0002-9149(99)00140-X; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Tamai H, 2000, CIRCULATION, V102, P399; Tsuji T, 2004, CIRC J, V68, P135	12	10	10	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 15	2008	371	9616					873	874		10.1016/S0140-6736(08)60389-X	http://dx.doi.org/10.1016/S0140-6736(08)60389-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342665				2022-12-28	WOS:000254056800004
J	Chatenoud, L				Chatenoud, Lucienne			Chemical immunosuppression in islet transplantation - Friend or foe?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MICE; REGENERATION; RECOVERY; ANTIBODY		Univ Paris 05, Paris, France; INSERM, Unite 580, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chatenoud, L (corresponding author), Univ Paris 05, Paris, France.							CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Sherry NA, 2007, ENDOCRINOLOGY, V148, P5136, DOI 10.1210/en.2007-0358; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989	5	22	23	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1192	1193		10.1056/NEJMcibr0708067	http://dx.doi.org/10.1056/NEJMcibr0708067			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337609				2022-12-28	WOS:000253877200014
J	Gutnisky, DA; Dragoi, V				Gutnisky, Diego A.; Dragoi, Valentin			Adaptive coding of visual information in neural populations	NATURE			English	Article							ORIENTATION DISCRIMINATION; RAPID ADAPTATION; FIRING RATE; CORTEX; TRANSMISSION; VARIABILITY; STATISTICS; SYNCHRONY; DYNAMICS; MACAQUE	Our perception of the environment relies on the capacity of neural networks to adapt rapidly to changes in incoming stimuli(1-4). It is increasingly being realized that the neural code is adaptive(5), that is, sensory neurons change their responses and selectivity in a dynamic manner to match the changes in input stimuli(1,2,5). Understanding how rapid exposure, or adaptation, to a stimulus of fixed structure changes information processing by cortical networks is essential for understanding the relationship between sensory coding and behaviour(5-8). Physiological investigations of adaptation have contributed greatly to our understanding of how individual sensory neurons change their responses to influence stimulus coding(2,9-12), yet whether and how adaptation affects information coding in neural populations is unknown. Here we examine how brief adaptation ( on the timescale of visual fixation)(2,9,10) influences the structure of interneuronal correlations and the accuracy of population coding in the macaque ( Macaca mulatta) primary visual cortex ( V1). We find that brief adaptation to a stimulus of fixed structure reorganizes the distribution of correlations across the entire network by selectively reducing their mean and variability. The post- adaptation changes in neuronal correlations are associated with specific, stimulus- dependent changes in the efficiency of the population code, and are consistent with changes in perceptual performance after adaptation(2,13,14). Our results have implications beyond the predictions of current theories of sensory coding, suggesting that brief adaptation improves the accuracy of population coding to optimize neuronal performance during natural viewing.	[Gutnisky, Diego A.; Dragoi, Valentin] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Dragoi, V (corresponding author), Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA.	v.dragoi@uth.tmc.edu	Gutnisky, Diego/E-3846-2012	Gutnisky, Diego/0000-0002-8578-0039				Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Clifford CWG, 2001, VISION RES, V41, P151, DOI 10.1016/S0042-6989(00)00248-0; DAYAN P, 2001, THEORETICAL NEUROSCI, P108; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NEURON, V32, P1181, DOI 10.1016/S0896-6273(01)00540-2; Dragoi V, 2006, J COGNITIVE NEUROSCI, V18, P737, DOI 10.1162/jocn.2006.18.5.737; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; Kay S. M., 1993, FUNDAMENTALS STAT SI; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schneidman E, 2003, J NEUROSCI, V23, P11539; Schwabe L, 2002, BIOSYSTEMS, V67, P239, DOI 10.1016/S0303-2647(02)00082-5; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; TSO DY, 1986, J NEUROSCI, V6, P1160; van der Togt C, 2006, CEREB CORTEX, V16, P136, DOI 10.1093/cercor/bhi093; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wilke SD, 2002, NEUROCOMPUTING, V44, P1023, DOI 10.1016/S0925-2312(02)00506-4; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	32	213	213	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					220	U63		10.1038/nature06563	http://dx.doi.org/10.1038/nature06563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337822				2022-12-28	WOS:000253925600041
J	Mulholland, PJ; Helton, AM; Poole, GC; Hall, RO; Hamilton, SK; Peterson, BJ; Tank, JL; Ashkenas, LR; Cooper, LW; Dahm, CN; Dodds, WK; Findlay, SEG; Gregory, SV; Grimm, NB; Johnson, SL; McDowell, WH; Meyer, JL; Valett, HM; Webster, JR; Arango, CP; Beaulieu, JJ; Bernot, MJ; Burgin, AJ; Crenshaw, CL; Johnson, LT; Niederlehner, BR; O'Brien, JM; Potter, JD; Sheibley, RW; Sobota, DJ; Thomas, SM				Mulholland, Patrick J.; Helton, Ashley M.; Poole, Geoffrey C.; Hall, Robert O., Jr.; Hamilton, Stephen K.; Peterson, Bruce J.; Tank, Jennifer L.; Ashkenas, Linda R.; Cooper, Lee W.; Dahm, Clifford N.; Dodds, Walter K.; Findlay, Stuart E. G.; Gregory, Stanley V.; Grimm, Nancy B.; Johnson, Sherri L.; McDowell, William H.; Meyer, Judy L.; Valett, H. Maurice; Webster, Jackson R.; Arango, Clay P.; Beaulieu, Jake J.; Bernot, Melody J.; Burgin, Amy J.; Crenshaw, Chelsea L.; Johnson, Laura T.; Niederlehner, B. R.; O'Brien, Jonathan M.; Potter, Jody D.; Sheibley, Richard W.; Sobota, Daniel J.; Thomas, Suzanne M.			Stream denitrification across biomes and its response to anthropogenic nitrate loading	NATURE			English	Article							NITROGEN; WATERSHEDS; LAND; SIZE	Anthropogenic addition of bioavailable nitrogen to the biosphere is increasing(1,2) and terrestrial ecosystems are becoming increasingly nitrogen- saturated(3), causing more bioavailable nitrogen to enter groundwater and surface waters(4-6). Large- scale nitrogen budgets show that an average of about 20 - 25 per cent of the nitrogen added to the biosphere is exported from rivers to the ocean or inland basins(7,8), indicating that substantial sinks for nitrogen must exist in the landscape(9). Streams and rivers may themselves be important sinks for bioavailable nitrogen owing to their hydrological connections with terrestrial systems, high rates of biological activity, and streambed sediment environments that favour microbial denitrification(6,10,11). Here we present data from nitrogen stable isotope tracer experiments across 72 streams and 8 regions representing several biomes. We show that total biotic uptake and denitrification of nitrate increase with stream nitrate concentration, but that the efficiency of biotic uptake and denitrification declines as concentration increases, reducing the proportion of in- stream nitrate that is removed from transport. Our data suggest that the total uptake of nitrate is related to ecosystem photosynthesis and that denitrification is related to ecosystem respiration. In addition, we use a stream network model to demonstrate that excess nitrate in streams elicits a disproportionate increase in the fraction of nitrate that is exported to receiving waters and reduces the relative role of small versus large streams as nitrate sinks.	[Mulholland, Patrick J.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Mulholland, Patrick J.; Cooper, Lee W.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Helton, Ashley M.; Poole, Geoffrey C.; Meyer, Judy L.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Poole, Geoffrey C.] Ecometr Inc, Tucker, GA 30084 USA; [Hall, Robert O., Jr.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Hamilton, Stephen K.; Burgin, Amy J.; O'Brien, Jonathan M.] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Peterson, Bruce J.; Thomas, Suzanne M.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Tank, Jennifer L.; Arango, Clay P.; Beaulieu, Jake J.; Johnson, Laura T.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Ashkenas, Linda R.; Gregory, Stanley V.; Sobota, Daniel J.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Dahm, Clifford N.; Crenshaw, Chelsea L.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Dodds, Walter K.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Findlay, Stuart E. G.] Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Grimm, Nancy B.; Sheibley, Richard W.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Johnson, Sherri L.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [McDowell, William H.; Potter, Jody D.] Univ New Hampshire, Dept Nat Resources, Durham, NH 03824 USA; [Valett, H. Maurice; Webster, Jackson R.; Niederlehner, B. R.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Bernot, Melody J.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University System of Georgia; University of Georgia; University of Wyoming; Michigan State University; Marine Biological Laboratory - Woods Hole; University of Notre Dame; Oregon State University; University of New Mexico; Kansas State University; Cary Institute of Ecosystem Studies; Arizona State University; Arizona State University-Tempe; United States Department of Agriculture (USDA); United States Forest Service; University System Of New Hampshire; University of New Hampshire; Virginia Polytechnic Institute & State University; Ball State University	Mulholland, PJ (corresponding author), Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA.	mulhollandpj@ornl.gov	Burgin, Amy/ABI-2572-2020; Grimm, Nancy B/D-2840-2009; Hamilton, Stephen K/N-2979-2014; Mulholland, Patrick/C-3142-2012; Burgin, Amy J/C-1528-2010; McDowell, William H/E-9767-2010; Burgin, Amy/G-7444-2014; O'Brien, Jonathan/G-6786-2012; Cooper, Lee W./E-5251-2012	Burgin, Amy/0000-0001-8489-4002; Grimm, Nancy B/0000-0001-9374-660X; Hamilton, Stephen K/0000-0002-4702-9017; Burgin, Amy J/0000-0001-8489-4002; McDowell, William H/0000-0002-8739-9047; Burgin, Amy/0000-0001-8489-4002; Cooper, Lee W./0000-0001-7734-8388; Poole, Geoffrey/0000-0002-8458-0203; Sheibley, Richard/0000-0003-1627-8536; Potter, Jody/0000-0002-3757-138X; Dodds, Walter/0000-0002-6666-8930; Webster, Jackson/0000-0002-2649-0867; Niederlehner, Barbara/0000-0002-6933-336X				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; AUMEN NG, 1990, J N AM BENTHOL SOC, V9, P95; Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Bouwman AF, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002314; Boyer EW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002537; CHRISTENSEN PB, 1990, LIMNOL OCEANOGR, V35, P640, DOI 10.4319/lo.1990.35.3.0640; Dodds WK, 2002, J N AM BENTHOL SOC, V21, P206, DOI 10.2307/1468410; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hall RO, 2003, LIMNOL OCEANOGR, V48, P1120, DOI 10.4319/lo.2003.48.3.1120; Hamilton SK, 2007, LIMNOL OCEANOGR-METH, V5, P233, DOI 10.4319/lom.2007.5.233; Hedin LO, 1998, ECOLOGY, V79, P684, DOI 10.2307/176963; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Johnes PJ, 2002, BIOGEOCHEMISTRY, V57, P429, DOI 10.1023/A:1015721416839; McIsaac GF, 2001, NATURE, V414, P166, DOI 10.1038/35102672; Mulholland PJ, 2006, J N AM BENTHOL SOC, V25, P583, DOI 10.1899/0887-3593(2006)25[583:EOLONU]2.0.CO;2; Mulholland PJ, 2004, LIMNOL OCEANOGR, V49, P809, DOI 10.4319/lo.2004.49.3.0809; NEWBOLD JD, 1981, CAN J FISH AQUAT SCI, V38, P860, DOI 10.1139/f81-114; O'Brien JM, 2007, BIOGEOCHEMISTRY, V84, P31, DOI 10.1007/s10533-007-9073-7; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; Pina-Ochoa E, 2006, BIOGEOCHEMISTRY, V81, P111, DOI 10.1007/s10533-006-9033-7; Schlesinger WH, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004300; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Seitzinger SP, 2002, BIOGEOCHEMISTRY, V57, P199, DOI 10.1023/A:1015745629794; Sigman DM, 1997, MAR CHEM, V57, P227, DOI 10.1016/S0304-4203(97)00009-1; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Van Breemen N, 2002, BIOGEOCHEMISTRY, V57, P267, DOI 10.1023/A:1015775225913; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Webster Jackson R., 2007, P169, DOI 10.1016/B978-012332908-0.50010-3; Wollheim WM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025845	32	931	983	30	757	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2008	452	7184					202	U46		10.1038/nature06686	http://dx.doi.org/10.1038/nature06686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337819	Green Submitted			2022-12-28	WOS:000253925600037
J	Gintis, H				Gintis, Herbert			Behavior - Punishment and cooperation	SCIENCE			English	Editorial Material									[Gintis, Herbert] Santa Fe Inst, Santa Fe, NM 87501 USA	The Santa Fe Institute	Gintis, H (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	hgintis@comcast.net						[Anonymous], 1965, LOGIC COLLECTIVE ACT; Bochet O, 2006, J ECON BEHAV ORGAN, V60, P11, DOI 10.1016/j.jebo.2003.06.006; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Friedman M, 1962, CAPITALISM FREEDOM, DOI DOI 10.2307/825316; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; McWilliams W. C, 1973, IDEA FRATERNITY AM, P7; Young M, 1958, RISE MERITOCRACY	11	36	37	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1345	1346		10.1126/science.1155333	http://dx.doi.org/10.1126/science.1155333			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323439				2022-12-28	WOS:000253712900028
J	Smetacek, V; Cloern, JE				Smetacek, Victor; Cloern, James E.			Oceans - On phytoplankton trends	SCIENCE			English	Editorial Material							LONG-TERM; PLANKTON; FALL; RISE; BAY		[Smetacek, Victor] Helmholtz Fdn, Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Smetacek, Victor] Univ Bremen, D-28334 Bremen, Germany; [Cloern, James E.] US Geol Survey, Menlo Pk, CA 94025 USA	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen; United States Department of the Interior; United States Geological Survey	Smetacek, V (corresponding author), Helmholtz Fdn, Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany.	Victor.Smetacek@awi.de; jecloern@usgs.gov	Cloern, James E/C-1499-2011	Cloern, James/0000-0002-5880-6862				*AM GEOPH UN, 2007, AM GEOPH UN CHAPM C; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Beninca E, 2008, NATURE, V451, P822, DOI 10.1038/nature06512; Cheke RA, 2007, SCIENCE, V318, P577, DOI 10.1126/science.1150636; Cloern JE, 2007, P NATL ACAD SCI USA, V104, P18561, DOI 10.1073/pnas.0706151104; HENSEN V, 1887, KOMM WISS UNTERS UNT, V12, P1; Kideys AE, 2002, SCIENCE, V297, P1482, DOI 10.1126/science.1073002; MABERLY SC, 1994, FRESHWATER BIOL, V31, P19, DOI 10.1111/j.1365-2427.1994.tb00835.x; Mills Eric., 1989, BIOL OCEANOGRAPHY EA; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; PACE ML, 1998, TREE, V14, P483; RILEY GORDON A., 1955, DEEP SEA RES, V3, P224; Sarno D, 2005, J PHYCOL, V41, P151, DOI 10.1111/j.1529-8817.2005.04067.x; Smayda TJ, 1998, ICES J MAR SCI, V55, P562, DOI 10.1006/jmsc.1998.0385; SMETACEK V, 1985, ESTUARIES, V8, P145, DOI 10.2307/1351864; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; WILTSHIRE K, CHAPM C LONG TIM SER	17	79	80	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1346	1348		10.1126/science.1151330	http://dx.doi.org/10.1126/science.1151330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323440				2022-12-28	WOS:000253712900029
J	Miedinger, D; Daikeler, T				Miedinger, David; Daikeler, Thomas			Chronic venous insufficiency and dystrophic subcutaneous calcification	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Miedinger, David; Daikeler, Thomas] Univ Basel Hosp, CH-4031 Basel, Switzerland	University of Basel	Miedinger, D (corresponding author), Univ Basel Hosp, CH-4031 Basel, Switzerland.	miedingerd@uhbs.ch							0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					E10	E10		10.1056/NEJMicm067082	http://dx.doi.org/10.1056/NEJMicm067082			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18305262				2022-12-28	WOS:000253430200010
J	Crisp, N; Gawanas, B; Sharp, I				Crisp, Nigel; Gawanas, Bience; Sharp, Imogen		Task Force Scaling Up Educ	Training the health workforce: scaling up, saving lives	LANCET			English	Article							WORKERS; GOALS		[Sharp, Imogen] Dept Hlth, Global Hlth Workforce Alliance, Task Force Scaling Up Educ & Training Hlth Worker, London SW1A 2NS, England; [Crisp, Nigel] House Lords, London, England; [Gawanas, Bience] African Union Commiss, Addis Ababa, Ethiopia	African Union (AU)	Sharp, I (corresponding author), Dept Hlth, Global Hlth Workforce Alliance, Task Force Scaling Up Educ & Training Hlth Worker, Richmond House, London SW1A 2NS, England.	imogen.sharp@dh.gsi.gov.uk		Crisp, Nigel/0000-0002-9452-095X				*AFR UN, 2007, 3 SESS AFR UN C MIN; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; [Anonymous], 2001, MACR HLTH INV HLTH E; Bergstrom S, 2005, BJOG-INT J OBSTET GY, V112, P1168, DOI 10.1111/j.1471-0528.2005.00719.x; Dreesch N, 2005, HEALTH POLICY PLANN, V20, P267, DOI 10.1093/heapol/czi036; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Lugina H, 2006, HUMAN RESOURCES HLTH; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	9	70	70	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2008	371	9613					689	691		10.1016/S0140-6736(08)60309-8	http://dx.doi.org/10.1016/S0140-6736(08)60309-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LL	18295028				2022-12-28	WOS:000253436700035
J	Nsubuga, P; White, M; Fontaine, R; Simone, P				Nsubuga, Peter; White, Mark; Fontaine, Robert; Simone, Patricia			Training programmes for field epidemiology	LANCET			English	Editorial Material									[Nsubuga, Peter; White, Mark; Fontaine, Robert; Simone, Patricia] Ctr Dis Control & Prevent, Coordinating Off Global Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Nsubuga, P (corresponding author), Ctr Dis Control & Prevent, Coordinating Off Global Hlth, Atlanta, GA 30333 USA.	pcn0@cdc.gov						Chen L, 2007, LANCET, V370, P631, DOI 10.1016/S0140-6736(07)61314-2; NJENGA MK, IN PRESS J PUBLIC HL; Taylor CE, 1997, AM J PUBLIC HEALTH, V87, P922, DOI 10.2105/AJPH.87.6.922; Thacker SB, 2001, INT J EPIDEMIOL, V30, P320, DOI 10.1093/ije/30.2.320; White M, 2006, LANCET, V367, P1301, DOI 10.1016/S0140-6736(06)68556-5; White ME, 2001, AM J EPIDEMIOL, V154, P993, DOI 10.1093/aje/154.11.993; World Health Organization (WHO), 2016, INT HLTH REG 2005	7	22	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2008	371	9613					630	631		10.1016/S0140-6736(08)60281-0	http://dx.doi.org/10.1016/S0140-6736(08)60281-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LL	18295009	Green Submitted			2022-12-28	WOS:000253436700008
J	Pillay, Y; Mahlati, P				Pillay, Yogan; Mahlati, Percy			Health-worker salaries and incomes in sub-Saharan Africa	LANCET			English	Editorial Material									[Pillay, Yogan; Mahlati, Percy] Natl Dept Hlth, ZA-0001 Pretoria, South Africa		Pillay, Y (corresponding author), Natl Dept Hlth, ZA-0001 Pretoria, South Africa.	ypillay@intekom.co.za						African Union, 2007, AFR HLTH STRAT 2007; Clemens MA, 2007, NEW DATA AFRICAN HLT; Emeagwali P., 2010, THE BRAIN DRAIN; MCCOY D, EC HLTH SYSTEMS RES; Mccoy D, 2008, LANCET, V371, P675, DOI 10.1016/S0140-6736(08)60306-2; ORAEKI G, 2007, NIGERIA LG HLTH WORK; World Health Organization, 2006, GLOB SHORT HLTH WORK	7	9	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2008	371	9613					632	634		10.1016/S0140-6736(08)60283-4	http://dx.doi.org/10.1016/S0140-6736(08)60283-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LL	18295011				2022-12-28	WOS:000253436700010
J	Callery, MP; Freedman, SD				Callery, Mark P.; Freedman, Steven D.			A 21-year-old man with chronic pancreatitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CELIAC PLEXUS BLOCK; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; CYSTIC-FIBROSIS GENE; HEREDITARY PANCREATITIS; RECURRENT ACUTE; ABDOMINAL-PAIN; MUTATIONS; ULTRASOUND; EXOCRINE; SECRETIN		[Freedman, Steven D.] Beth Israel Deaconess Med Ctr, Pancreas Ctr, Boston, MA 02215 USA; [Callery, Mark P.] Beth Israel Deaconess Med Ctr, Div Gen Surg, Boston, MA 02215 USA; [Callery, Mark P.; Freedman, Steven D.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Freedman, SD (corresponding author), Beth Israel Deaconess Med Ctr, Pancreas Ctr, Dana 501,330 Brookline Ave, Boston, MA 02215 USA.	sfreedma@bidmc.harvard.edu						AMMANN RW, 1984, GASTROENTEROLOGY, V86, P820; Bishop MD, 2005, HUM GENET, V118, P372, DOI 10.1007/s00439-005-0059-z; Borowitz D, 2004, J PEDIATR-US, V145, P322, DOI 10.1016/j.jpeds.2004.04.049; BOZKURT T, 1994, GUT, V35, P1132, DOI 10.1136/gut.35.8.1132; Brown A, 1997, AM J GASTROENTEROL, V92, P2032; Catalano MF, 1998, GASTROINTEST ENDOSC, V48, P11, DOI 10.1016/S0016-5107(98)70122-1; Choudari CP, 2002, GASTROINTEST ENDOSC, V56, P66, DOI 10.1067/mge.2002.125103; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Freeman Martin L, 2005, Curr Treat Options Gastroenterol, V8, P127, DOI 10.1007/s11938-005-0005-0; Fregni F, 2005, ANN NEUROL, V58, P971, DOI 10.1002/ana.20651; GEENEN JE, 1991, GASTROINTEST ENDOSC, V37, P377, DOI 10.1016/S0016-5107(91)70739-6; Gelrud A, 2005, J GASTROINTEST SURG, V9, P2, DOI 10.1016/j.gassur.2004.08.009; Gelrud A, 2004, AM J GASTROENTEROL, V99, P1557, DOI 10.1111/j.1572-0241.2004.30834.x; Gorry MC, 1997, GASTROENTEROLOGY, V113, P1063, DOI 10.1053/gast.1997.v113.pm9322498; Gouyon B, 1997, GUT, V41, P821, DOI 10.1136/gut.41.6.821; Gress F, 1999, AM J GASTROENTEROL, V94, P900; Gress F, 2001, AM J GASTROENTEROL, V96, P409; HALGREEN H, 1986, SCAND J GASTROENTERO, V21, P104, DOI 10.3109/00365528609034631; Hammond B, 2004, AM SURGEON, V70, P546; Howes N, 2004, GASTROENTEROL CLIN N, V33, P767, DOI 10.1016/j.gtc.2004.07.003; ISAKSSON G, 1983, DIGEST DIS SCI, V28, P97, DOI 10.1007/BF01315137; Izbicki JR, 1998, ANN SURG, V228, P771, DOI 10.1097/00000658-199812000-00008; Kusano T, 1997, SURG LAPAROSC ENDOSC, V7, P213, DOI 10.1097/00019509-199706000-00007; LANKISCH PG, 1993, DIGESTION, V54, P148, DOI 10.1159/000201029; Lankisch PG, 1996, PANCREAS, V12, P149, DOI 10.1097/00006676-199603000-00007; LAYER P, 1994, GASTROENTEROLOGY, V107, P1481, DOI 10.1016/0016-5085(94)90553-3; LEE SP, 1992, NEW ENGL J MED, V326, P589, DOI 10.1056/NEJM199202273260902; LEUNG JWC, 1983, BRIT J SURG, V70, P730, DOI 10.1002/bjs.1800701212; Makowiec F, 2005, J GASTROINTEST SURG, V9, P1080, DOI 10.1016/j.gassur.2005.07.020; MOSSNER J, 1992, DIGESTION, V53, P54, DOI 10.1159/000200971; Nealon WH, 2003, ANN SURG, V237, P614, DOI 10.1097/00000658-200305000-00003; NEALON WH, 1993, ANN SURG, V217, P458, DOI 10.1097/00000658-199305010-00005; Okolo PI, 2000, GASTROINTEST ENDOSC, V52, P15, DOI 10.1067/mge.2000.106669; Rilo HLR, 2003, J GASTROINTEST SURG, V7, P978, DOI 10.1016/j.gassur.2003.09.008; Rosch T, 2002, ENDOSCOPY, V34, P765, DOI 10.1055/s-2002-34256; ROSSI RL, 1990, HEPATO-GASTROENTEROL, V37, P277; Sahai AV, 1998, GASTROINTEST ENDOSC, V48, P18, DOI 10.1016/S0016-5107(98)70123-3; Sakorafas GH, 2001, SURG CLIN N AM, V81, P457, DOI 10.1016/S0039-6109(05)70132-8; Saraswat VA, 2004, J GASTROEN HEPATOL, V19, P1206, DOI 10.1111/j.1440-1746.2004.03462.x; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Shea JC, 2003, PANCREATOLOGY, V3, P36, DOI 10.1159/000069144; Sherman S, 1996, GASTROINTEST ENDOSC, V44, P276, DOI 10.1016/S0016-5107(96)70164-5; SITGESSERRA A, 1988, BRIT J SURG, V75, P158, DOI 10.1002/bjs.1800750224; SLAFF J, 1984, GASTROENTEROLOGY, V87, P44; Smith MT, 1996, GASTROINTEST ENDOSC, V44, P268, DOI 10.1016/S0016-5107(96)70163-3; Somogyi L, 2003, PANCREAS, V27, P230, DOI 10.1097/00006676-200310000-00006; STEER ML, 1995, NEW ENGL J MED, V332, P1482, DOI 10.1056/NEJM199506013322206; Traverso LW, 1997, ANN SURG, V226, P429, DOI 10.1097/00000658-199710000-00004; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Whitcomb DC, 2004, AM J PHYSIOL-GASTR L, V287, pG315, DOI 10.1152/ajpgi.00115.2004; WIERSEMA MJ, 1993, ENDOSCOPY, V25, P555, DOI 10.1055/s-2007-1010405; Winston JH, 2005, PAIN, V117, P214, DOI 10.1016/j.pain.2005.06.013; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witzigmann H, 2003, SURGERY, V134, P53, DOI 10.1067/msy.2003.170; Yadav D, 2003, J CLIN GASTROENTEROL, V36, P54, DOI 10.1097/00004836-200301000-00016	55	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2008	299	13					1588	1594		10.1001/jama.299.9.jrr80001	http://dx.doi.org/10.1001/jama.299.9.jrr80001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	281RZ	18319401				2022-12-28	WOS:000254517900025
J	Delaney, BC; Qume, M; Moayyedi, P; Logan, RFA; Ford, AC; Elliott, C; McNulty, C; Wilson, S; Hobbs, FDR				Delaney, Brendan C.; Qume, Michelle; Moayyedi, Paul; Logan, Richard F. A.; Ford, Alexander C.; Elliott, Cathy; McNulty, Cliodna; Wilson, Sue; Hobbs, F. D. Richard			Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNINVESTIGATED DYSPEPSIA; MANAGING DYSPEPSIA; ERADICATION; ENDOSCOPY; PRACTITIONERS; INFECTION; ENGLAND	Objective To determine the cost effectiveness of Helicobacter pylori "test and treat" compared with empirical acid suppression in the initial management of patients with dyspepsia in primary care. Design Randomised controlled trial. Setting 80 general practices in the United Kingdom. Participants 699 patients aged 18-65 who presented to their general practitioner with epigastric pain, heartburn, or both without "alarm symptoms" for malignancy. Intervention Hpylori C-13 urea breath test plus one week of eradication treatment if positive or proton pump inhibitor alone; subsequent management at general practitioner's discretion. Main outcome measures Cost effectiveness in cost per quality adjusted life year (QALY) (EQ-5D) and effect on dyspeptic symptoms at one year measured with short form Leeds dyspepsia questionnaire. Results 343 patients were randomised to testing for H pylori, and 100 were positive. The successful eradication rate was 78%. 356 patients received proton pump inhibitor for 28 days. At 12 months no significant differences existed between the two groups in QALYs, costs, or dyspeptic symptoms. Minor reductions in costly resource use over the year in the test and treat group "paid back" the initial cost of the intervention. Conclusions Test and treat and acid suppression are equally cost effective in the initial management of dyspepsia. Empirical acid suppression is an appropriate initial strategy. As costs are similar overall, general practitioners should discuss with patients at which point to consider H pylori testing. Trial registration Current Controlled Trials ISRCTN87644265.	[Delaney, Brendan C.; Qume, Michelle; Wilson, Sue; Hobbs, F. D. Richard] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Moayyedi, Paul] McMaster Univ, Hamilton, ON, Canada; [Logan, Richard F. A.; Elliott, Cathy] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Ford, Alexander C.] Leeds Gen Infirm, Ctr Gastrointestinal Dis, Leeds, W Yorkshire, England; [McNulty, Cliodna] Hlth Protect Agcy Primary Care Unit, Gloucester, England	University of Birmingham; McMaster University; University of Nottingham; Leeds General Infirmary; University of Leeds	Delaney, BC (corresponding author), Univ Birmingham, Birmingham B15 2TT, W Midlands, England.	b.c.delaney@bham.ac.uk	Delaney, Brendan C/C-5578-2008; Ford, Alexander/K-5491-2012; Moayyedi, Paul/M-6178-2014	Ford, Alexander/0000-0001-6371-4359; Moayyedi, Paul/0000-0002-3616-9292; hobbs, richard/0000-0001-7976-7172	Medical Research Council [G0001078, MC_U122797164] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adang RP, 1996, DIGESTION, V57, P118, DOI 10.1159/000201325; Andrews CN, 2005, GASTROENTEROLOGY, V128, pA456, DOI 10.1053/j.gastro.2005.09.020; Baker R, 1996, BRIT J GEN PRACT, V46, P601; BATE CM, 1991, BR J MED EC, V1, P53; Briggs A.H., 1999, HEALTH TECHNOL ASSES, V3, P2; *BRIT MED ASS, 2005, 50 BMA RPS; Chiba N, 2004, ALIMENT PHARM THER, V19, P349, DOI 10.1111/j.1365-2036.2004.01865.x; Chiba N, 2002, BRIT MED J, V324, P1012, DOI 10.1136/bmj.324.7344.1012; CURTIS L, 2005, UNIT COSTS HLTH SOCI; Delaney B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001961.pub2; DELANEY B, 2000, HEALTH TECHNOL ASSES, V4, P1; Delaney BC, 2000, LANCET, V356, P1965, DOI 10.1016/S0140-6736(00)03308-0; DELANEY BC, 2006, HLTH CARE NEEDS ASSE; Delaney B, 2007, FAM PRACT, V24, P207, DOI 10.1093/fampra/cmm031; *DEP HLTH, 2006, NHS REF COSTS 2005; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Ford AC, 2005, GASTROENTEROLOGY, V128, P1838, DOI 10.1053/j.gastro.2005.03.004; Ford AC, 2004, AM J GASTROENTEROL, V99, P1833, DOI 10.1111/j.1572-0241.2004.40014.x; Fraser A, 2007, ALIMENT PHARM THER, V25, P477, DOI 10.1111/j.1365-2036.2006.03233.x; Jarbol DE, 2006, AM J GASTROENTEROL, V101, P1200, DOI 10.1038/ajg2006227; JONES RH, 1990, GUT, V31, P401, DOI 10.1136/gut.31.4.401; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Manes G, 2003, BRIT MED J, V326, P1118, DOI 10.1136/bmj.326.7399.1118; Mason JM, 2005, ALIMENT PHARM THER, V21, P1135, DOI 10.1111/j.1365-2036.2005.02445.x; MCCORMICK A, 1995, MORBIDITY STAT GEN P; *NAT I CLIN EXC, 2004, MAN DYSP AD PAT PRIM; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Stevens R, 2001, GASTROENTEROLOGY, V120, pA50; TALLEY NJ, 1993, GASTROENTEROLOGY, V105, P1378, DOI 10.1016/0016-5085(93)90142-Y; Talley NJ, 1999, GUT, V45, P37; *UK PRESCR PRIC AU, DRUG TAR 2005; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187	33	61	61	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2008	336	7645					651	654B		10.1136/bmj.39479.640486.AE	http://dx.doi.org/10.1136/bmj.39479.640486.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RH	18310262	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000254443400025
J	Guardavaccaro, D; Frescas, D; Dorrello, NV; Peschiaroli, A; Multani, AS; Cardozo, T; Lasorella, A; Iavarone, A; Chang, S; Hernando, E; Pagano, M				Guardavaccaro, Daniele; Frescas, David; Dorrello, N. Valerio; Peschiaroli, Angelo; Multani, Asha S.; Cardozo, Timothy; Lasorella, Anna; Iavarone, Antonio; Chang, Sandy; Hernando, Eva; Pagano, Michele			Control of chromosome stability by the beta-TrCP-REST-Mad2 axis	NATURE			English	Article							RESTRICTIVE SILENCER FACTOR; CELL LUNG-CANCER; TRCP-MEDIATED DEGRADATION; BOX PROTEIN BETA-TRCP1; BETA-TRCP; GLYCINE RECEPTOR; REST; TRANSCRIPTION; REPRESSOR; DIFFERENTIATION	REST/NRSF ( repressor-element-1-silencing transcription factor/ neuron- restrictive silencing factor) negatively regulates the transcription of genes containing RE1 sites(1,2). REST is expressed in non- neuronal cells and stem/ progenitor neuronal cells, in which it inhibits the expression of neuron- specific genes. Overexpression of REST is frequently found in human medulloblastomas and neuroblastomas(3-7), in which it is thought to maintain the stem character of tumour cells. Neural stem cells forced to express REST and c- Myc fail to differentiate and give rise to tumours in the mouse cerebellum(3). Expression of a splice variant of REST that lacks the carboxy terminus has been associated with neuronal tumours and small- cell lung carcinomas(8-10), and a frameshift mutant ( REST- FS), which is also truncated at the C terminus, has oncogenic properties(11). Here we show, by using an unbiased screen, that REST is an interactor of the F- box protein beta-TrCP. REST is degraded by means of the ubiquitin ligase SCF beta-TrCP during the G2 phase of the cell cycle to allow transcriptional derepression of Mad2, an essential component of the spindle assembly checkpoint. The expression in cultured cells of a stable REST mutant, which is unable to bind beta-TrCP, inhibited Mad2 expression and resulted in a phenotype analogous to that observed in Mad2(+/-) cells. In particular, we observed defects that were consistent with faulty activation of the spindle checkpoint, such as shortened mitosis, premature sister- chromatid separation, chromosome bridges and mis- segregation in anaphase, tetraploidy, and faster mitotic slippage in the presence of a spindle inhibitor. An indistinguishable phenotype was observed by expressing the oncogenic REST- FS mutant(11), which does not bind beta-TrCP. Thus, SCF beta-TrCP-dependent degradation of REST during G2 permits the optimal activation of the spindle checkpoint, and consequently it is required for the fidelity of mitosis. The high levels of REST or its truncated variants found in certain human tumours may contribute to cellular transformation by promoting genomic instability.	[Guardavaccaro, Daniele; Frescas, David; Dorrello, N. Valerio; Peschiaroli, Angelo; Hernando, Eva; Pagano, Michele] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Cardozo, Timothy] NYU, Sch Med, Dept Pharmacol, NYU Canc Inst, New York, NY 10016 USA; [Multani, Asha S.; Chang, Sandy] Univ Texas Houston, MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA; [Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA	New York University; New York University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Columbia University	Pagano, M (corresponding author), NYU, Sch Med, Dept Pathol, 550 1st Ave, MSB 599, New York, NY 10016 USA.	michele.pagano@nyumc.org		Guardavaccaro, Daniele/0000-0002-4517-1765; Hernando, Eva/0000-0003-1023-0312; PESCHIAROLI, ANGELO/0000-0001-6311-2382; pagano, michele/0000-0003-3210-2442; Iavarone, Antonio/0000-0002-0683-4634	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM057587, R01 GM057587-10] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Coulson JM, 2000, CANCER RES, V60, P1840; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fuller GN, 2005, MOL CANCER THER, V4, P343; Guardavaccaro D, 2006, MOL CELL, V22, P1, DOI 10.1016/j.molcel.2006.03.017; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Gurrola-Diaz C, 2003, ONCOGENE, V22, P5636, DOI 10.1038/sj.onc.1206790; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Higashino K, 2003, CANCER SCI, V94, P37, DOI 10.1111/j.1349-7006.2003.tb01349.x; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kudo Y, 2004, MOL CELL BIOL, V24, P8184, DOI 10.1128/MCB.24.18.8184-8194.2004; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Majumder S, 2006, CELL CYCLE, V5, P1929, DOI 10.4161/cc.5.17.2982; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Neumann SB, 2004, MOL BRAIN RES, V120, P173, DOI 10.1016/j.molbrainres.2003.10.021; Nishimura E, 1996, NEUROSCI LETT, V211, P101, DOI 10.1016/0304-3940(96)12722-1; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Su XH, 2006, MOL CELL BIOL, V26, P1666, DOI 10.1128/MCB.26.5.1666-1678.2006; Totrov M, 2001, BIOPOLYMERS, V60, P124, DOI 10.1002/1097-0282(2001)60:2<124::AID-BIP1008>3.0.CO;2-S; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X	32	157	162	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					365	U10		10.1038/nature06641	http://dx.doi.org/10.1038/nature06641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354482	Green Accepted			2022-12-28	WOS:000254117400050
J	Hightower, M; Pierce, SA				Hightower, Mike; Pierce, Suzanne A.			The energy challenge	NATURE			English	Editorial Material									[Hightower, Mike] Sandia Natl Labs, Energy Syst Anal Dept, Albuquerque, NM 87185 USA; [Pierce, Suzanne A.] Sandia Natl Labs, Geohydrol Dept, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Hightower, M (corresponding author), Sandia Natl Labs, Energy Syst Anal Dept, POB 5800, Albuquerque, NM 87185 USA.		Pierce, Suzanne A/M-4563-2013	Pierce, Suzanne A/0000-0002-3050-1987				FRONTINUS SJ, 1925, AQUIS URBIS ROMAE; Hightower M., 2007, WAT RESOUR IMPACT, V9, P8; Hutson S. S., 2004, 1268 USGS	3	167	168	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					285	286		10.1038/452285a	http://dx.doi.org/10.1038/452285a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354460				2022-12-28	WOS:000254117400024
J	Offit, K				Offit, Kenneth			Genomic profiles for disease risk - Predictive or premature?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER SUSCEPTIBILITY; BREAST-CANCER		[Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Offit, K (corresponding author), Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA.	offitk@mskcc.org						*AM COLL MED GEN, 2007, STAT DIR TO CONS GEN; Bolnick DA, 2007, SCIENCE, V318, P399, DOI 10.1126/science.1150098; *CDCP, FTC FACTS CONS AT HO; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; *CTR GAPP, 2007, DIR CONS GEN TEST EM; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; *GEN PUBL POL CTR, 2007, FDA REG GEN TESTS; Harmon A., 2007, NY TIMES, pA1; Hernandez, 2005, IMPLICATIONS GENOMIC; HSU A, WHITE PAPER 23 03 GU; KOLATA G, 2008, NY TIMES        0706, pA1; Libby EN, 2006, AM J HEMATOL, V81, P284, DOI 10.1002/ajh.20543; Myers MF, 2006, GENET MED, V8, P361, DOI 10.1097/01.gim.0000223544.68475.6c; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Offit K, 2007, SEMIN ONCOL, V34, P435, DOI 10.1053/j.seminoncol.2007.07.007; PEAR R, 2008, NY TIMES        0118, pA12; Robson M, 2007, NEW ENGL J MED, V357, P154, DOI 10.1056/NEJMcp071286; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; WILLIAMS S, DIRECT TO CONSUMER G; 2007, NAT GENET, V39, P1415	20	96	97	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1353	1355		10.1001/jama.299.11.1353	http://dx.doi.org/10.1001/jama.299.11.1353			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349097				2022-12-28	WOS:000254079100027
J	Wilson, JF				Wilson, Jennifer Fisher			Massachusetts health care reform is a pioneer effort, but complications remain	ANNALS OF INTERNAL MEDICINE			English	News Item							MEDICINE					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Gabel JR, 2008, HEALTH AFFAIR, V27, pW13, DOI 10.1377/hlthaff.27.1.w13; Schwartz MD, 2005, ANN INTERN MED, V142, P715, DOI 10.7326/0003-4819-142-8-200504190-00040; Sox HC, 2006, ANN INTERN MED, V145, P782, DOI 10.7326/0003-4819-145-10-200611210-00012; West CP, 2006, ANN INTERN MED, V145, P774, DOI 10.7326/0003-4819-145-10-200611210-00010; 2007, 2007 MMS PHYS WORKFA	5	21	21	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2008	148	6					489	492		10.7326/0003-4819-148-6-200803180-00029	http://dx.doi.org/10.7326/0003-4819-148-6-200803180-00029			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279KT	18347363				2022-12-28	WOS:000254354800024
J	Dentin, R; Hedrick, S; Xie, JX; Yates, J; Montminy, M				Dentin, Renaud; Hedrick, Susan; Xie, Jianxin; Yates, John, III; Montminy, Marc			Hepatic glucose sensing via the CREB coactivator CRTC2	SCIENCE			English	Article							O-GLYCOSYLATION; GENE-EXPRESSION; TORC2; PHOSPHORYLATION; PROTEINS; GLCNAC	Chronic hyperglycemia contributes to the development of diabetes- associated complications. Increases in the concentration of circulating glucose activate the hexosamine biosynthetic pathway ( HBP) and promote the O- glycosylation of proteins by O- glycosyl transferase ( OGT). We show that OGT triggered hepatic gluconeogenesis through the O- glycosylation of the transducer of regulated cyclic adenosine monophosphate response element - binding protein ( CREB) 2 ( TORC2 or CRTC2). CRTC2 was O- glycosylated at sites that normally sequester CRTC2 in the cytoplasm through a phosphorylation- dependent mechanism. Decreasing amounts of O- glycosylated CRTC2 by expression of the deglycosylating enzyme O- GlcNAcase blocked effects of glucose on gluconeogenesis, demonstrating the importance of the HBP in the development of glucose intolerance.	[Dentin, Renaud; Hedrick, Susan; Montminy, Marc] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Xie, Jianxin] Cell Signalling Technol, Danvers, MA 01923 USA; [Yates, John, III] Scripps Res Inst, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute	Montminy, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Dentin, Renaud/AAV-5818-2020	Dentin, Renaud/0000-0003-0988-4458	NIGMS NIH HHS [R01 GM037828, R37 GM037828] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037828] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Hakim AK, 2005, J CELL SCI, V118, P5661, DOI 10.1242/jcs.02670; Argaud D, 1997, J BIOL CHEM, V272, P12854, DOI 10.1074/jbc.272.19.12854; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kim JK, 2001, J CLIN INVEST, V108, P153, DOI 10.1172/JCI10294; Konrad RJ, 2000, BIOCHEM BIOPH RES CO, V267, P26, DOI 10.1006/bbrc.1999.1895; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Pedersen KB, 2007, AM J PHYSIOL-ENDOC M, V292, pE788, DOI 10.1152/ajpendo.00510.2006; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9	15	246	260	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1402	1405		10.1126/science.1151363	http://dx.doi.org/10.1126/science.1151363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323454				2022-12-28	WOS:000253712900047
J	Philbin, TG; Kuklewicz, C; Robertson, S; Hill, S; Konig, F; Leonhardt, U				Philbin, Thomas G.; Kuklewicz, Chris; Robertson, Scott; Hill, Stephen; Konig, Friedrich; Leonhardt, Ulf			Fiber-optical analog of the event horizon	SCIENCE			English	Article							PHOTONIC CRYSTAL FIBERS; BLACK-HOLE EVAPORATION; QUANTUM PHYSICS; LIGHT	The physics at the event horizon resembles the behavior of waves in moving media. Horizons are formed where the local speed of the medium exceeds the wave velocity. We used ultrashort pulses in microstructured optical fibers to demonstrate the formation of an artificial event horizon in optics. We observed a classical optical effect : the blue-shifting of light at a white-hole horizon. We also showed by theoretical calculations that such a system is capable of probing the quantum effects of horizons, in particular Hawking radiation.	[Philbin, Thomas G.; Kuklewicz, Chris; Robertson, Scott; Hill, Stephen; Konig, Friedrich; Leonhardt, Ulf] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Philbin, Thomas G.] Max Planck Res Grp Opt Informat & Photon, D-91058 Erlangen, Germany	University of St Andrews; Max Planck Society	Leonhardt, U (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.	ulf@st-andrews.ac.uk	Kuklewicz, Christopher/A-7286-2010		EPSRC [EP/D061830/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C523229/1, EP/D061830/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Agrawal G. P., 2001, NONLINEAR FIBER OPTI; Birrell N D, 1984, RECORDS, DOI DOI 10.1017/S1755267209001080; Brabec T, 2000, REV MOD PHYS, V72, P545, DOI 10.1103/RevModPhys.72.545; BROUT R, 1995, PHYS REP, V260, P329, DOI 10.1016/0370-1573(95)00008-5; Giovanazzi S, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.063602; Giovanazzi S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.061302; HAWKING SW, 1974, NATURE, V248, P30, DOI 10.1038/248030a0; Jacobson T, 1999, PROG THEOR PHYS SUPP, P1, DOI 10.1143/PTPS.136.1; Kartner F. X., 2004, FEW CYCLE LASER PULS; Leonhardt U, 2003, REP PROG PHYS, V66, P1207, DOI 10.1088/0034-4885/66/7/203; Leonhardt U, 2002, NATURE, V415, P406, DOI 10.1038/415406a; Milonni P.W., 2004, FAST LIGHT SLOW LIGH; Novello M., 2002, ARTIFICIAL BLACK HOL; Reeves WH, 2003, NATURE, V424, P511, DOI 10.1038/nature01798; Russell P, 2003, SCIENCE, V299, P358, DOI 10.1126/science.1079280; Schutzhold R, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.044019; Unruh W. G., 2007, QUANTUM ANALOGUES PH; UNRUH WG, 1981, PHYS REV LETT, V46, P1351, DOI 10.1103/PhysRevLett.46.1351; Volovik G.E., 2003, UNIVERSE HELIUM DROP; Volovik GE, 2002, JETP LETT+, V76, P240, DOI 10.1134/1.1520613	26	468	476	7	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1367	1370		10.1126/science.1153625	http://dx.doi.org/10.1126/science.1153625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323448	Green Submitted			2022-12-28	WOS:000253712900037
J	Beswick, AD; Rees, K; Dieppe, P; Ayis, S; Gooberman-Hill, R; Horwood, J; Ebrahim, S				Beswick, Andrew D.; Rees, Karen; Dieppe, Paul; Ayis, Salma; Gooberman-Hill, Rachael; Horwood, Jeremy; Ebrahim, Shah			Complex interventions to improve physical function and maintain independent living in elderly people: a systematic review and meta-analysis	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; PREVENTIVE HOME VISITS; COMPREHENSIVE GERIATRIC ASSESSMENT; HEALTH-PROMOTION PROGRAM; DWELLING OLDER-PEOPLE; CASE-MANAGEMENT; PRIMARY-CARE; FOLLOW-UP; GENERAL-PRACTICE; MULTIFACTORIAL INTERVENTION	Background In old age, reduction in physical function leads to loss of independence, the need for hospital and long-term nursing-home care, and premature death. We did a systematic review to assess the effectiveness of community-based complex interventions in preservation of physical function and independence in elderly people. Methods We searched systematically for randomised controlled trials assessing community-based multifactorial interventions in elderly people (mean age at least 65 years) living at home with at least 6 months of follow-up. Outcomes studied were living at home, death, nursing-home and hospital admissions, falls, and physical function. We did a meta-analysis of the extracted data. Findings We identified 89 trials including 97984 people. Interventions reduced the risk of not living at home (relative risk [RR] 0 . 95, 95% CI 0 . 93-0.97). Interventions reduced nursing-home admissions (0 . 87, 0.83-0.90), but not death (1.00, 0 . 97-1.02). Risk of hospital admissions (0 . 94, 0.91-0.97) and falls (0 . 90, 0 . 86-0.95) were reduced, and physical function (standardised mean difference -0 . 08, -0 . 11 to -0 . 06) was better in the intervention groups than in other groups. Benefit for any specific type or intensity of intervention was not noted. In populations with increased death rates, interventions were associated with reduced nursing-home admission. Benefit in trials was particularly evident in studies started before 1993. Interpretation Complex interventions can help elderly people to live safely and independently, and could be tailored to meet individuals' needs and preferences.	[Beswick, Andrew D.; Rees, Karen; Ayis, Salma; Gooberman-Hill, Rachael; Horwood, Jeremy] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Dieppe, Paul] Univ Oxford, Nuffield Dept Orthopaed, Oxford, England; [Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England	University of Bristol; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Beswick, AD (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall,Whiteladies Rd, Bristol BS8 2PR, Avon, England.	andy.beswick@bristol.ac.uk	Ayis, Salma/AAD-5336-2019; Horwood, Jeremy/AAH-2941-2019	Horwood, Jeremy/0000-0001-7092-4960; Ayis, Salma/0000-0002-0449-869X; Rees, Karen/0000-0003-1832-3679; Beswick, Andrew/0000-0002-7032-7514; Gooberman-Hill, Rachael/0000-0003-3353-2882				Age Concern, 2003, ADD QUAL QUANT OLD P; Ayis S, 2006, AGE AGEING, V35, P382, DOI 10.1093/ageing/afl004; BALABAN DJ, 1988, J FAM PRACTICE, V26, P307; Beck A, 1997, J AM GERIATR SOC, V45, P543, DOI 10.1111/j.1532-5415.1997.tb03085.x; Bernabei R, 1998, BMJ-BRIT MED J, V316, P1348, DOI 10.1136/bmj.316.7141.1348; Boult C, 2001, J AM GERIATR SOC, V49, P351, DOI 10.1046/j.1532-5415.2001.49076.x; Bowling A, 1999, J PUBLIC HEALTH MED, V21, P255, DOI 10.1093/pubmed/21.3.255; British Geriatrics Society Primary and Continuing Care Special Interest Group, 2005, SPEC HLTH NEEDS OLD; Burns R, 2000, J AM GERIATR SOC, V48, P8, DOI 10.1111/j.1532-5415.2000.tb03021.x; BURTON LC, 1995, PREV MED, V24, P492, DOI 10.1006/pmed.1995.1078; Byles JE, 2004, MED J AUSTRALIA, V181, P186, DOI 10.5694/j.1326-5377.2004.tb06233.x; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Caplan GA, 2004, J AM GERIATR SOC, V52, P1417, DOI 10.1111/j.1532-5415.2004.52401.x; CARPENTER GI, 1990, BMJ-BRIT MED J, V300, P1253, DOI 10.1136/bmj.300.6734.1253; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Clark F, 2001, J GERONTOL B-PSYCHOL, V56, pP60, DOI 10.1093/geronb/56.1.P60; Clark J, 2001, BRIT MED J, V323, P708, DOI 10.1136/bmj.323.7315.708; CLARKE M, 1992, AM J EPIDEMIOL, V136, P1517, DOI 10.1093/oxfordjournals.aje.a116473; Clemson L, 2004, J AM GERIATR SOC, V52, P1487, DOI 10.1111/j.1532-5415.2004.52411.x; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Coleman EA, 1999, J AM GERIATR SOC, V47, P775, DOI 10.1111/j.1532-5415.1999.tb03832.x; Crotty M, 2003, ARCH PHYS MED REHAB, V84, P1237, DOI 10.1016/S0003-9993(03)00141-2; Cunliffe AL, 2004, AGE AGEING, V33, P246, DOI 10.1093/ageing/afh076; Dalby DM, 2000, CAN MED ASSOC J, V162, P497; Davison J, 2005, AGE AGEING, V34, P162, DOI 10.1093/ageing/afi053; DEEKS JJ, 2005, COCHRANE HDB SYSTEMA; *DEP HLTH, 1989, TERMS SERV DOCT GEN; Department of Health, 2001, NAT SERV FRAM OLD PE; Department of Health, 2005, SUPP PEOPL LONG TERM; Department of Health, 2007, REC CAR NOT SINGL IN; Department of Health, 2002, HLTH SURV ENGL 2000; Douglass C, 2001, J Interprof Care, V15, P267, DOI 10.1080/13561820120063156; DUNN RB, 1994, ARCH GERONTOL GERIAT, V18, P15, DOI 10.1016/0167-4943(94)90044-2; Eekhof JAH, 2000, FAM PRACT, V17, P329, DOI 10.1093/fampra/17.4.329; Elkan R, 2001, BMJ-BRIT MED J, V323, P719, DOI 10.1136/bmj.323.7315.719; Engelhardt JB, 1996, J AM GERIATR SOC, V44, P847, DOI 10.1111/j.1532-5415.1996.tb03747.x; EPSTEIN AM, 1990, JAMA-J AM MED ASSOC, V263, P538, DOI 10.1001/jama.263.4.538; FABACHER D, 1994, J AM GERIATR SOC, V42, P630, DOI 10.1111/j.1532-5415.1994.tb06862.x; Fletcher AE, 2004, LANCET, V364, P1667, DOI 10.1016/S0140-6736(04)17353-4; FORD AB, 1971, J CHRON DIS, V24, P591, DOI 10.1016/0021-9681(71)90047-6; Fox PJ, 1997, AM J PREV MED, V13, P257, DOI 10.1016/S0749-3797(18)30172-7; Gagnon AJ, 1999, J AM GERIATR SOC, V47, P1118; Gallagher EM, 1996, CAN J AGING, V15, P84, DOI 10.1017/S0714980800013301; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Gravelle H, 2007, BMJ-BRIT MED J, V334, P31, DOI 10.1136/bmj.39020.413310.55; Gunner-Svensson F, 1984, Scand J Prim Health Care, V2, P49, DOI 10.3109/02813438409017704; HALL N, 1992, CAN J AGING, V11, P72, DOI 10.1017/S0714980800014537; HANSEN FR, 1992, AGE AGEING, V21, P445, DOI 10.1093/ageing/21.6.445; HANSEN FR, 1995, AGING-CLIN EXP RES, V7, P202, DOI 10.1007/BF03324316; Hebert R, 2001, AGE AGEING, V30, P265, DOI 10.1093/ageing/30.3.265; HENDRIKSEN C, 1984, BMJ-BRIT MED J, V289, P1522, DOI 10.1136/bmj.289.6457.1522; Hill-Westmoreland EE, 2002, NURS RES, V51, P1, DOI 10.1097/00006199-200201000-00002; Hogan DB, 2001, CAN MED ASSOC J, V165, P537; HORNBROOK MC, 1994, GERONTOLOGIST, V34, P16, DOI 10.1093/geront/34.1.16; Hughes SL, 2000, JAMA-J AM MED ASSOC, V284, P2877, DOI 10.1001/jama.284.22.2877; Hyde CJ, 2000, AGE AGEING, V29, P271, DOI 10.1093/ageing/29.3.271; Jitapunkul Sutthichai, 1998, Journal of the Medical Association of Thailand, V81, P352; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Kerse NM, 1999, BRIT MED J, V319, P683, DOI 10.1136/bmj.319.7211.683; Kiresuk T., 1994, GOAL ATTAINMENT SCAL; Kono A, 2004, AGING CLIN EXP RES, V16, P293; Leichsenring Kai, 2004, Int J Integr Care, V4, pe10; Leung ACT, 2004, J APPL GERONTOL, V23, P70, DOI 10.1177/0733464804263088; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; Lightbody E, 2002, AGE AGEING, V31, P203, DOI 10.1093/ageing/31.3.203; Lord SR, 2005, J AM GERIATR SOC, V53, P1296, DOI 10.1111/j.1532-5415.2005.53425.x; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; MARTIN F, 1994, AGE AGEING, V23, P228, DOI 10.1093/ageing/23.3.228; MCEWAN RT, 1990, BRIT J GEN PRACT, V40, P94; MELIN AL, 1992, MED CARE, V30, P1004, DOI 10.1097/00005650-199211000-00004; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MORRISSEY JP, 1995, MED CARE, V33, P315, DOI 10.1097/00005650-199504000-00001; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Newbury JW, 2001, MED J AUSTRALIA, V175, P104, DOI 10.5694/j.1326-5377.2001.tb143541.x; Newcomer R, 2004, EVAL HEALTH PROF, V27, P323, DOI 10.1177/0163278704270011; Nikolaus T, 1999, AGE AGEING, V28, P543, DOI 10.1093/ageing/28.6.543; Nikolaus T, 2003, J AM GERIATR SOC, V51, P300, DOI 10.1046/j.1532-5415.2003.51102.x; PATHY MSJ, 1992, LANCET, V340, P890, DOI 10.1016/0140-6736(92)93294-W; Phelan EA, 2004, J AM GERIATR SOC, V52, P211, DOI 10.1111/j.1532-5415.2004.52056.x; Reuben DB, 1999, J AM GERIATR SOC, V47, P269, DOI 10.1111/j.1532-5415.1999.tb02988.x; Rockwood K, 2000, J AM GERIATR SOC, V48, P1080, DOI 10.1111/j.1532-5415.2000.tb04783.x; RUBENSTEIN LV, 1989, ANN INTERN MED, V111, P836, DOI 10.7326/0003-4819-111-10-836; RUBIN CD, 1993, J AM GERIATR SOC, V41, P1023, DOI 10.1111/j.1532-5415.1993.tb06447.x; Sahlen KG, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-220; Schrijnemaekers V J, 1995, Home Health Care Serv Q, V15, P81, DOI 10.1300/J027v15n02_06; Scott JC, 2004, J AM GERIATR SOC, V52, P1463, DOI 10.1111/j.1532-5415.2004.52408.x; Shapiro A, 2002, GERONTOLOGIST, V42, P334, DOI 10.1093/geront/42.3.334; SILVERMAN M, 1995, J AM GERIATR SOC, V43, P733, DOI 10.1111/j.1532-5415.1995.tb07041.x; Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825; Sorensen K H, 1988, Compr Gerontol B, V2, P85; Steinberg M, 2000, J EPIDEMIOL COMMUN H, V54, P227, DOI 10.1136/jech.54.3.227; Stewart S, 2005, AGE AGEING, V34, P41, DOI 10.1093/ageing/afh230; Stewart S, 1998, J AM GERIATR SOC, V46, P174, DOI 10.1111/j.1532-5415.1998.tb02535.x; Stuck AE, 2000, ARCH INTERN MED, V160, P977, DOI 10.1001/archinte.160.7.977; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; STUCK AE, 1995, NEW ENGL J MED, V333, P1184, DOI 10.1056/NEJM199511023331805; Tinetti ME, 1999, ARCH PHYS MED REHAB, V80, P916, DOI 10.1016/S0003-9993(99)90083-7; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; TOWNSEND J, 1988, BMJ-BRIT MED J, V297, P544, DOI 10.1136/bmj.297.6647.544; Trentini M, 2001, AGING CLIN EXP RES, V13, P395, DOI 10.1007/BF03351509; Tulloch A J, 1979, J R Coll Gen Pract, V29, P733; van Haastregt JCM, 2000, BMJ-BRIT MED J, V321, P994, DOI 10.1136/bmj.321.7267.994; van Haastregt JCM, 2000, BMJ-BRIT MED J, V320, P754, DOI 10.1136/bmj.320.7237.754; VANROSSUM E, 1993, BMJ-BRIT MED J, V307, P27, DOI 10.1136/bmj.307.6895.27; Vass M, 2004, SCAND J PRIM HEALTH, V22, P106, DOI 10.1080/02813430410005829; VETTER NJ, 1984, BRIT MED J, V288, P369, DOI 10.1136/bmj.288.6414.369; VETTER NJ, 1992, BMJ-BRIT MED J, V304, P888, DOI 10.1136/bmj.304.6831.888; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800; Wallace JI, 1998, J GERONTOL A-BIOL, V53, pM301, DOI 10.1093/gerona/53A.4.M301; WILLIAMS EI, 1992, J PUBLIC HEALTH MED, V14, P138; WILLIAMS ME, 1987, J AM GERIATR SOC, V35, P1071, DOI 10.1111/j.1532-5415.1987.tb04923.x; WILLIAMSON J, 1964, LANCET, V1, P1117; World Health Organization, 2002, ACT AG POL FRAM; YEO G, 1987, J GERONTOL, V42, P252, DOI 10.1093/geronj/42.3.252; ZIMMER JG, 1985, AM J PUBLIC HEALTH, V75, P134, DOI 10.2105/AJPH.75.2.134	118	500	508	2	107	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					725	735		10.1016/S0140-6736(08)60342-6	http://dx.doi.org/10.1016/S0140-6736(08)60342-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313501	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000253596700026
J	Mizushima, N; Levine, B; Cuervo, AM; Klionsky, DJ				Mizushima, Noboru; Levine, Beth; Cuervo, Ana Maria; Klionsky, Danial J.			Autophagy fights disease through cellular self-digestion	NATURE			English	Review							CHAPERONE-MEDIATED AUTOPHAGY; INCLUSION-BODY FORMATION; REGULATES AUTOPHAGY; ALPHA-SYNUCLEIN; DEGRADATION; BECLIN-1; ROLES; DEATH; CELLS; NEURODEGENERATION	Autophagy, or cellular self-digestion, is a cellular pathway involved in protein and organelle degradation, with an astonishing number of connections to human disease and physiology. For example, autophagic dysfunction is associated with cancer, neurodegeneration, microbial infection and ageing. Paradoxically, although autophagy is primarily a protective process for the cell, it can also play a role in cell death. Understanding autophagy may ultimately allow scientists and clinicians to harness this process for the purpose of improving human health.	[Klionsky, Danial J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Klionsky, Danial J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Klionsky, Danial J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Cuervo, Ana Maria] Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Anat, Bronx, NY 10461 USA; [Cuervo, Ana Maria] Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Biol Struct, Bronx, NY 10461 USA; [Cuervo, Ana Maria] Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Dev & Mol Biol, Bronx, NY 10461 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Tokyo Medical & Dental University (TMDU); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Klionsky, DJ (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	klionsky@umich.edu	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Cuervo, Ana Maria/0000-0002-0771-700X	NIA NIH HHS [R01 AG021904-06, R01 AG021904, R21 AG025355, R21 AG025355-02, R03 AG019834-02] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R03AG019834, R01AG021904, R21AG025355] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bergamini E, 2005, EXPERT OPIN THER TAR, V9, P77, DOI 10.1517/14728222.9.1.77; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Botti J, 2006, AUTOPHAGY, V2, P67, DOI 10.4161/auto.2.2.2458; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hildebrandt W, 2004, J MOL MED, V82, P336, DOI 10.1007/s00109-004-0532-5; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Takacs-Vellai K, 2005, CURR BIOL, V15, P1513, DOI 10.1016/j.cub.2005.07.035; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	60	4919	5270	27	1432	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1069	1075		10.1038/nature06639	http://dx.doi.org/10.1038/nature06639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305538	Green Published, Green Accepted			2022-12-28	WOS:000253453600034
J	D'Haens, G; Baert, F; van Assche, G; Caenepeel, P; Vergauwe, P; Tuynman, H; De Vos, M; van Deventer, S; Stitt, L; Donner, A; Vermeire, S; Van De Mierop, FJ; Coche, JCR; van der Woude, J; Ochsenkuhn, T; van Bodegraven, AA; van Hootegem, PP; Lambrecht, GL; Mana, F; Rutgeerts, P; Feagan, BG; Hommes, D				D'Haens, Geert; Baert, Filip; van Assche, Gert; Caenepeel, Philip; Vergauwe, Philippe; Tuynman, Hans; De Vos, Martine; van Deventer, Sander; Stitt, Larry; Donner, Allan; Vermeire, Severine; Van De Mierop, Frank J.; Coche, Jean-Charles R.; van der Woude, Janneke; Ochsenkuehn, Thomas; van Bodegraven, Ad A.; van Hootegem, Philippe P.; Lambrecht, Guy L.; Mana, Fazia; Rutgeerts, Paul; Feagan, Brian G.; Hommes, Daniel		Belgian Inflammatory Bowel Dis Res; N Holland Gut Club	Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; EARLY RHEUMATOID-ARTHRITIS; DRUG-TREATMENT; INFLIXIMAB; METHOTREXATE; AZATHIOPRINE; MAINTENANCE; GUIDELINES; EFFICACY; THERAPY	Background Most patients who have active Crohn's disease are treated initially with corticosteroids. Although this approach usually controls symptoms, many patients become resistant to or dependent on corticosteroids, and long exposure is associated with an increased risk of mortality. We aimed to compare the effectiveness of early use of combined immunosuppression with conventional management in patients with active Crohn's disease who had not previously received glucocorticoids, antimetabolites, or infliximab. Methods We did a 2-year open-label randomised trial at 18 centres in Belgium, Holland, and Germany between May, 2001, and January, 2004. We randomly assigned 133 patients to either early combined immunosuppression or conventional treatment. The 67 patients assigned to combined immunosuppression received three infusions of infliximab (5 mg/kg of bodyweight) at weeks 0, 2, and 6, with azathioprine. We gave additional treatment with infliximab and, if necessary, corticosteroids, to control disease activity. 66 patients assigned to conventional management received corticosteroids, followed, in sequence, by azathioprine and infliximab. The primary outcome measures were remission without corticosteroids and without bowel resection at weeks 26 and 52. Analysis was by modified intention to treat. This trial was registered with ClinicalTrials.gov, number NCT00554710. Findings Four patients (two in each group) did not receive treatment as per protocol. At week 26, 39 (60.0%) of 65 patients in the combined immunosuppression group were in remission without corticosteroids and without surgical resection, compared with 23 (35.9%) of 64 controls, for an absolute difference of 24.1% (95% CI 7.3-40.8, p=0.0062). Corresponding rates at week 52 were 40/65 (61.5%) and 27/64 (42.2%) (absolute difference 19.3%, 95% CI 2.4-36.3, p=0.0278). 20 of the 65 patients (30.8%) in the early combined immunosuppression group had serious adverse events, compared with 19 of 64 (25.3%) controls (p=1.0). Interpretation Combined immunosuppression was more effective than conventional management for induction of remission and reduction of corticosteroid use in patients who had been recently diagnosed with Crohn's disease. Initiation of more intensive treatment early in the course of the disease could result in better outcomes.	[D'Haens, Geert] Imelda Gen Hosp, Imelda Gastrointestinal Clin Res Ctr, Dept Gastroenterol, B-2820 Bonheiden, Belgium; [Baert, Filip] H Hart Ziekenhuis, Roeselare, Belgium; [van Assche, Gert; Vermeire, Severine; Rutgeerts, Paul] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; [Caenepeel, Philip] Ziekenhuis Oost Limburg, Genk, Belgium; [Vergauwe, Philippe] Groeninge Ziekenhuis, Kortrijk, Belgium; [Tuynman, Hans] Med Ctr Alkmaar, Alkmaar, Netherlands; [De Vos, Martine] Ghent Univ Hosp, B-9000 Ghent, Belgium; [van Deventer, Sander] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Stitt, Larry; Donner, Allan; Feagan, Brian G.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON N6A 3K7, Canada; [Donner, Allan; Feagan, Brian G.] Robarts Res Inst, Robarts Clin Trials, London, ON N6A 5C1, Canada; [Van De Mierop, Frank J.] Algemeen Ziekenhuis St Augustinus, Antwerp, Belgium; [Coche, Jean-Charles R.] Clin St Pierre, Ottignies, Belgium; [van der Woude, Janneke] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Ochsenkuehn, Thomas] Univ Munich, Munich, Germany; [van Bodegraven, Ad A.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [van Hootegem, Philippe P.] Algemeen Ziekenhuis St Lucas, Brugge, Belgium; [Lambrecht, Guy L.] Algemeen Ziekenhuis Damiaan, Oostende, Belgium; [Mana, Fazia] VUB, Acad Ziekenhuis, Jette, Belgium; [Hommes, Daniel] Leiden Univ, Med Ctr, Leiden, Netherlands	Imeldaziekenhuis; KU Leuven; University Hospital Leuven; East Limburg Hospital; Medical Center Of Alkmaar; Ghent University; Ghent University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Western University (University of Western Ontario); Western University (University of Western Ontario); Erasmus University Rotterdam; Erasmus MC; University of Munich; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	D'Haens, G (corresponding author), Imelda Gen Hosp, Imelda Gastrointestinal Clin Res Ctr, Dept Gastroenterol, Imeldalaan 9, B-2820 Bonheiden, Belgium.	geert.dhaens@imelda.be	Feagan, Brian/G-3292-2011; Van Hootegem, Philippe/CAH-3580-2022; van Bodegraven, Ad A/L-3180-2013; Feagan, Brian G/M-4283-2015; van der Woude, Christien Janneke/H-6384-2011; van Bodegraven, Ad/ABG-4367-2020	Van Hootegem, Philippe/0000-0001-8258-6225; Vermeire, Severine/0000-0001-9942-3019				BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; CANDY S, 1995, GUT, V37, P674, DOI 10.1136/gut.37.5.674; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Feagan BG, 2000, NEW ENGL J MED, V342, P1627, DOI 10.1056/NEJM200006013422202; FEAGAN BG, 1995, NEW ENGL J MED, V332, P292, DOI 10.1056/NEJM199502023320503; FEAGAN BG, 1995, NEW ENGL J MED, V333, P601; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hommes DW, 2006, NETH J MED, V64, P219; IRVINE EJ, 1994, GASTROENTEROLOGY, V106, P287, DOI 10.1016/0016-5085(94)90585-1; Lemann M, 2006, GASTROENTEROLOGY, V130, P1054, DOI 10.1053/j.gastro.2006.02.014; Lichtenstein GR, 2006, CLIN GASTROENTEROL H, V4, P621, DOI 10.1016/j.cgh.2006.03.002; MALCHOW H, 1984, GASTROENTEROLOGY, V86, P249; Markowitz J, 2000, GASTROENTEROLOGY, V119, P895, DOI 10.1053/gast.2000.18144; MODIGLIANI R, 1990, GASTROENTEROLOGY, V98, P811, DOI 10.1016/0016-5085(90)90002-I; MUNKHOLM P, 1994, GUT, V35, P360, DOI 10.1136/gut.35.3.360; Panaccione R, 2004, CAN J GASTROENTEROL, V18, P503, DOI 10.1155/2004/670161; POCOCK SJ, 1983, CLIN TRIALS PRACTICA, P142; PRESENT DH, 1980, NEW ENGL J MED, V302, P981, DOI 10.1056/NEJM198005013021801; Rutgeerts P, 1999, GASTROENTEROLOGY, V117, P761, DOI 10.1016/S0016-5085(99)70332-X; Rutgeerts P, 2006, GASTROINTEST ENDOSC, V63, P433, DOI 10.1016/j.gie.2005.08.011; Sandborn WJ, 2002, AM J GASTROENTEROL, V97, P2962; Sandborn WJ, 1999, GASTROENTEROLOGY, V117, P527, DOI 10.1016/S0016-5085(99)70445-2; Sandborn WJ, 2002, GASTROENTEROLOGY, V122, P512, DOI 10.1053/gast.2002.31072; Schreiber S, 2001, INT J COLORECTAL DIS, V16, P1, DOI 10.1007/s003840100285; SINGLETON JW, 1979, GASTROENTEROLOGY, V77, P870; Smolen JS, 2006, ARTHRITIS RHEUM-US, V54, P702, DOI 10.1002/art.21678; SUMMERS RW, 1979, GASTROENTEROLOGY, V77, P847; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b	34	927	944	0	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2008	371	9613					660	667		10.1016/S0140-6736(08)60304-9	http://dx.doi.org/10.1016/S0140-6736(08)60304-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LL	18295023				2022-12-28	WOS:000253436700030
J	Priotto, G; Pinoges, L; Fursa, IB; Burke, B; Nicolay, N; Grillet, G; Hewison, C; Balasegaram, M				Priotto, Gerardo; Pinoges, Loretxu; Fursa, Isaac Badi; Burke, Barbara; Nicolay, Nathalie; Grillet, Guillaume; Hewison, Cathy; Balasegaram, Manica			Safety and effectiveness of first tine eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; PHASE-I TRIAL; ALPHA-DIFLUOROMETHYLORNITHINE; ORNITHINE-DECARBOXYLASE; MELARSOPROL TREATMENT; RISK-FACTORS; METABOLISM; INHIBITOR; DIAGNOSIS; ANGOLA		[Priotto, Gerardo; Pinoges, Loretxu; Nicolay, Nathalie] Epictr, F-75011 Paris, France; [Fursa, Isaac Badi; Burke, Barbara; Grillet, Guillaume; Hewison, Cathy; Balasegaram, Manica] Med Sans Frontieres, Paris, France	Doctors Without Borders	Priotto, G (corresponding author), Epictr, F-75011 Paris, France.	gpriotto@epicentre.msf.org	Priotto, Gerardo/AAS-9027-2021					ABELOFF MD, 1984, J CLIN ONCOL, V2, P124, DOI 10.1200/JCO.1984.2.2.124; [Anonymous], 1998, WHO TECHN REP SER, V881; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; BACCHI CJ, 1983, MOL BIOCHEM PARASIT, V7, P209, DOI 10.1016/0166-6851(83)90022-1; BAILEY JW, 1992, T ROY SOC TROP MED H, V86, P630, DOI 10.1016/0035-9203(92)90160-E; Burri C, 2001, TROP MED INT HEALTH, V6, P412, DOI 10.1046/j.1365-3156.2001.00725.x; Chappuis F, 2005, CLIN INFECT DIS, V41, P748, DOI 10.1086/432576; GRIFFIN CA, 1987, INVEST NEW DRUG, V5, P177; HAEGELE KD, 1981, CLIN PHARMACOL THER, V30, P210, DOI 10.1038/clpt.1981.150; Legros D, 1999, T ROY SOC TROP MED H, V93, P439, DOI 10.1016/S0035-9203(99)90151-7; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; MILORD F, 1993, T ROY SOC TROP MED H, V87, P473, DOI 10.1016/0035-9203(93)90044-Q; MILORD F, 1992, LANCET, V340, P652, DOI 10.1016/0140-6736(92)92180-N; *NCI CTEP NIH, 1999, COMM TOX CRIT VERS 2; PEPIN J, 1994, ADV PARASIT, V33, P1, DOI 10.1016/S0065-308X(08)60410-8; PEPIN J, 1995, T ROY SOC TROP MED H, V89, P92, DOI 10.1016/0035-9203(95)90673-8; Pepin J, 2000, B WORLD HEALTH ORGAN, V78, P1284; Schmid C, 2005, J INFECT DIS, V191, P1922, DOI 10.1086/429929; Stanghellini A, 2001, TROP MED INT HEALTH, V6, P330, DOI 10.1046/j.1365-3156.2001.00724.x; VANNIEUWENHOVE S, 1992, ANN SOC BELG MED TR, V72, P39; Woo P. T. K., 1970, Acta trop., V27, P384	22	53	55	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2008	336	7646					705	708A		10.1136/bmj.39485.592674.BE	http://dx.doi.org/10.1136/bmj.39485.592674.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZS	18321960	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000254675600029
J	Richardson, AR; Libby, SJ; Fang, FC				Richardson, Anthony R.; Libby, Stephen J.; Fang, Ferric C.			A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity	SCIENCE			English	Article							PYRUVATE FORMATE-LYASE; ENZYME; OXYGEN	Staphylococcus aureus is one of the most successful human pathogens, colonizing 2 billion individuals worldwide and causing invasive infections even in immunocompetent hosts. S. aureus can evade multiple components of host innate immunity, including the antimicrobial radical nitric oxide ( NO.) produced by activated phagocytes. We show that S. aureus is capable of metabolically adapting to nitrosative stress by expressing an NO.- inducible L- lactate dehydrogenase ( ldh1, SACOL0222) divergently transcribed from the NO.- detoxifying flavohemoglobin ( hmp). L- Lactate production allows S. aureus to maintain redox homeostasis during nitrosative stress and is essential for virulence. NO.- inducible lactate dehydrogenase activity and NO. resistance distinguish S. aureus from the closely related commensal species S. epidermidis and S. saprophyticus.	[Richardson, Anthony R.; Libby, Stephen J.; Fang, Ferric C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Fang, Ferric C.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fang, FC (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	fcfang@u.washington.edu		Fang, Ferric/0000-0002-3243-110X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039557, R01AI039557, T32AI055396] Funding Source: NIH RePORTER; NIAID NIH HHS [AI055396, AI039557] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersson JA, 2002, ACTA OTO-LARYNGOL, V122, P861, DOI 10.1080/003655402/000028053; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Broderick JB, 2000, BIOCHEM BIOPH RES CO, V269, P451, DOI 10.1006/bbrc.2000.2313; Brown GC, 1997, BIOCHEM SOC T, V25, P901, DOI 10.1042/bst0250901; Butler AR, 2002, CHEM REV, V102, P1155, DOI 10.1021/cr000076d; Choi KC, 1998, ADV PERIT D, V14, P173; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Perham R N, 1987, Biochem Soc Symp, V54, P67; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Shay AH, 2003, J INFECT DIS, V187, P700, DOI 10.1086/368370; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068	16	199	213	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1672	1676		10.1126/science.1155207	http://dx.doi.org/10.1126/science.1155207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356528				2022-12-28	WOS:000254172300043
J	Sreedharan, J; Blair, IP; Tripathi, VB; Hu, X; Vance, C; Rogelj, B; Ackerley, S; Durnall, JC; Williams, KL; Buratti, E; Baralle, F; de Belleroche, J; Mitchell, JD; Leigh, PN; Al-Chalabi, A; Miller, CC; Nicholson, G; Shaw, CE				Sreedharan, Jemeen; Blair, Ian P.; Tripathi, Vineeta B.; Hu, Xun; Vance, Caroline; Rogelj, Boris; Ackerley, Steven; Durnall, Jennifer C.; Williams, Kelly L.; Buratti, Emanuele; Baralle, Francisco; de Belleroche, Jacqueline; Mitchell, J. Douglas; Leigh, P. Nigel; Al-Chalabi, Ammar; Miller, Christopher C.; Nicholson, Garth; Shaw, Christopher E.			TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis	SCIENCE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; NEURON DISEASE-TYPE; INCLUSIONS; DEMENTIA; GENE; LOCUS; REGULATOR	Amyotrophic lateral sclerosis ( ALS) is a fatal motor neuron disorder characterized pathologically by ubiquitinated TAR DNA binding protein ( TDP- 43) inclusions. The function of TDP- 43 in the nervous system is uncertain, and a mechanistic role in neurodegeneration remains speculative. We identified neighboring mutations in a highly conserved region of TARDBP in sporadic and familial ALS cases. TARDBP(M337V) segregated with disease within one kindred and a genome- wide scan confirmed that linkage was restricted to chromosome 1p36, which contains the TARDBP locus. Mutant forms of TDP- 43 fragmented in vitro more readily than wild type and, in vivo, caused neural apoptosis and developmental delay in the chick embryo. Our evidence suggests a pathophysiological link between TDP- 43 and ALS.	[Sreedharan, Jemeen; Tripathi, Vineeta B.; Hu, Xun; Vance, Caroline; Rogelj, Boris; Ackerley, Steven; Leigh, P. Nigel; Al-Chalabi, Ammar; Miller, Christopher C.; Shaw, Christopher E.] Kings Coll London, MRC Ctr Neurodegenerat Res, Dept Clin Neurosci, London SE5 8AF, England; [Sreedharan, Jemeen; Tripathi, Vineeta B.; Hu, Xun; Vance, Caroline; Rogelj, Boris; Ackerley, Steven; Leigh, P. Nigel; Al-Chalabi, Ammar; Miller, Christopher C.; Shaw, Christopher E.] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London SE5 8AF, England; [Ackerley, Steven; Miller, Christopher C.] Kings Coll London, Dept Neurosci, MRC Ctr Neurodegenerat Res, London SE5 8AF, England; [Blair, Ian P.; Durnall, Jennifer C.; Williams, Kelly L.; Nicholson, Garth] ANZAC Res Inst, Northcott Neurosci Lab, Concord, NSW 2137, Australia; [Blair, Ian P.; Nicholson, Garth] Univ Sydney, Fac Med, Sydney, NSW 2139, Australia; [Buratti, Emanuele; Baralle, Francisco] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [de Belleroche, Jacqueline] Univ London Imperial Coll Sci Technol & Med, Div Neurosci & Mental Hlth, Fac Med, London W6 8RF, England; [de Belleroche, Jacqueline] Charing Cross Hosp, London W6 8RF, England; [Mitchell, J. Douglas] Royal Preston Hosp, Dept Neurol, Preston PR2 9HT, Lancs, England; [Nicholson, Garth] Concord Repatriat Gen Hosp, Mol Med Lab, Concord, NSW 2139, Australia	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Sydney; ANZAC Research Institute; University of Sydney; International Center for Genetic Engineering & Biotechnology (ICGEB); Imperial College London; Imperial College London; Royal Preston Hospital; Concord Repatriation General Hospital	Shaw, CE (corresponding author), Kings Coll London, MRC Ctr Neurodegenerat Res, Dept Clin Neurosci, London SE5 8AF, England.	chris.shaw@iop.kcl.ac.uk	Rogelj, Boris/G-9252-2011; Buratti, Emanuele/K-4691-2016; Williams, Kelly L/A-5545-2010; Vance, Caroline/Q-2633-2019; Vance, Caroline/C-3047-2012; Al-Chalabi, Ammar/E-5361-2010; Leigh, Peter/AAD-5638-2019; Miller, Christopher/H-5733-2012; Research Institute, ANZAC/CAE-9030-2022; sreedharan, jemeen/E-7327-2016	Rogelj, Boris/0000-0003-3898-1943; Buratti, Emanuele/0000-0002-1356-9074; Williams, Kelly L/0000-0001-6319-9473; Vance, Caroline/0000-0001-5780-6951; Vance, Caroline/0000-0001-5780-6951; Al-Chalabi, Ammar/0000-0002-4924-7712; Miller, Christopher/0000-0002-5130-1845; Blair, Ian/0000-0003-3083-0075; Nicholson, Garth/0000-0001-9694-066X; Shaw, Christopher/0000-0003-0251-0146; sreedharan, jemeen/0000-0002-8682-6844	Medical Research Council [G0500289B] Funding Source: researchfish; Medical Research Council [G0501573, G0000749, G0600974, G0500289] Funding Source: Medline; Wellcome Trust [076671] Funding Source: Medline; MRC [G0501573, G0600974, G0000749, G0500289] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P62, DOI 10.1097/nen.0b013e3181609361; GIJSELINCK I, 2007, IN PRESS NEUROBIOL A; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hasegawa M, 2007, BRAIN, V130, P1386, DOI 10.1093/brain/awm065; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; LEIGH PN, 1991, BRAIN, V114, P775, DOI 10.1093/brain/114.2.775; Lipton AM, 2004, ACTA NEUROPATHOL, V108, P379, DOI 10.1007/s00401-004-0900-9; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Rollinson S, 2007, NEUROSCI LETT, V419, P1, DOI 10.1016/j.neulet.2007.03.044; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Rothstein JD, 2007, ANN NEUROL, V61, P382, DOI 10.1002/ana.21155; Ruddy DM, 2003, AM J HUM GENET, V73, P390, DOI 10.1086/377157; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; SCHUMACHER A, IN PRESS NEUROBIOL A; Shaw C E, 2001, Curr Neurol Neurosci Rep, V1, P69, DOI 10.1007/s11910-001-0078-7; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030	26	1849	1917	8	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1668	1672		10.1126/science.1154584	http://dx.doi.org/10.1126/science.1154584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18309045	Green Accepted			2022-12-28	WOS:000254172300042
J	Fleming, JD; McSorley, A; Bates, KM				Fleming, John David; McSorley, Amanda; Bates, Kersten Morgan			Blood, semen, and an innocent man	LANCET			English	Editorial Material							HYPERTENSION		[Fleming, John David; McSorley, Amanda] Charing Cross Hosp, Dept Cardiol, London W6 8RF, England; [Bates, Kersten Morgan] Charing Cross Hosp, Dept Acute Med, London W6 8RF, England	Imperial College London; Imperial College London	Fleming, JD (corresponding author), Charing Cross Hosp, Dept Cardiol, Fulham Palace Rd, London W6 8RF, England.	jdfleming@gmail.com						Ahmad I, 2007, J UROLOGY, V177, P1613, DOI 10.1016/j.juro.2007.01.004; Jinza S, 1997, Hinyokika Kiyo, V43, P103; LIP GYH, 1994, J HYPERTENS, V12, P1297; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683	4	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 15	2008	371	9616					958	958		10.1016/S0140-6736(08)60421-3	http://dx.doi.org/10.1016/S0140-6736(08)60421-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342690				2022-12-28	WOS:000254056800032
J	Pryciak, PM				Pryciak, Peter M.			Systems biology - Customized signaling circuits	SCIENCE			English	Editorial Material							SCAFFOLDS; PROTEINS		[Pryciak, Peter M.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Pryciak, PM (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA.	peter.pryciak@umassmed.edu	Pryciak, Peter/P-7205-2019	Pryciak, Peter/0000-0001-9142-1369				Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Drubin DA, 2007, GENE DEV, V21, P242, DOI 10.1101/gad.1507207; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pawson T, 2005, FEBS LETT, V579, P1808, DOI 10.1016/j.febslet.2005.02.013; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335	11	6	6	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1489	1490		10.1126/science.1156414	http://dx.doi.org/10.1126/science.1156414			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339925				2022-12-28	WOS:000253943800024
J	Fernald, LCH; Gertler, PJ; Neufeld, LM				Fernald, Lia C. H.; Gertler, Paul J.; Neufeld, Lynnette M.			Role of cash in conditional cash transfer programmes for child health, growth, and development: an analysis of Mexico's Oportunidades	LANCET			English	Article							DEVELOPING-COUNTRIES; YOUNG-CHILDREN; POVERTY; IMPACT; INCOME; INTERVENTIONS; PROGRESA; ABILITY; STATES	Background Many governments have implemented conditional cash transfer (CCT) programmes with the goal of improving options for poor families through interventions in health, nutrition, and education. Families enrolled in CCT programmes receive cash in exchange for complying with certain conditions: preventive health requirements and nutrition supplementation, education, and monitoring designed to improve health outcomes and promote positive behaviour change. Our aim was to disaggregate the effects of cash transfer from those of other programme components. Methods In an intervention that began in 1998 in Mexico, low-income communities (n=506) were randomly assigned to be enrolled in a CCT programme (Oportuniadades, formerly Progresa) immediately or 18 months later. In 2003, children (n=2449) aged 24-68 months who had been enrolled in the programme their entire lives were assessed for a wide variety of outcomes. We used linear and logistic regression to determine the effect size for each outcome that is associated with a doubling of cash transfers while controlling for a wide range of covariates, including measures of household socioeconomic status. Findings A doubling of cash transfers was associated with higher height-for-age Z score (beta 0 . 20, 95% Cl 0 . 09-0 . 30; p<0. 0001), lower prevalence of stunting (-0. 10, -0 . 16 to -0.05; p<0. 0001), lower body-mass index for age percentile (-2.85, -5.54 to -0 . 15; p=0.04), and lower prevalence of being overweight (-0.08, -0.13 to -0.03; p=0. 001). A doubling of cash transfers was also associated with children doing better on a scale of motor development, three scales of cognitive development, and with receptive language. Interpretation Our results suggest that the cash transfer component of Oportunidades is associated with better outcomes in child health, growth, and development.	[Fernald, Lia C. H.; Gertler, Paul J.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Gertler, Paul J.] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Neufeld, Lynnette M.] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Instituto Nacional de Salud Publica	Fernald, LCH (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 50 Univ Hall,MC 7360, Berkeley, CA 94720 USA.	fernald@berkeley.edu		Fernald, Lia C.H./0000-0003-1555-4607	FIC NIH HHS [K01 TW006077, K01 TW006077-03, K01 TW006077-02, K01 TW006077-01, K01 TW006077-04] Funding Source: Medline; NICHD NIH HHS [R01 HD040864-03, R01 HD040864-01, R01 HD040864-04, R01 HD040864-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040864] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW006077] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		[Anonymous], 1965, PEABODY PICTURE VOCA; [Anonymous], 1997, WHAT MONEY CANT BUY; [Anonymous], 1999, DEV FREEDOM; BECKER GS, 1986, J LABOR ECON, V4, pS1, DOI 10.1086/298118; Behrman JR, 2005, OXFORD B ECON STAT, V67, P547, DOI 10.1111/j.1468-0084.2005.00131.x; BEHRMAN JR, RANDOMNESS EXPT SAMP; Blau DM, 1999, REV ECON STAT, V81, P261, DOI 10.1162/003465399558067; BOISSIERE M, 1985, AM ECON REV, V75, P1016; Bonvecchio A, 2007, J NUTR, V137, P440, DOI 10.1093/jn/137.2.440; Breslau N, 2001, J ABNORM CHILD PSYCH, V29, P273, DOI 10.1023/A:1010396027299; Cardwell Diane, 2007, NY TIMES        0330; Das J, 2005, WORLD BANK RES OBSER, V20, P57, DOI 10.1093/wbro/lki005; de Janvry A, 2006, WORLD BANK ECON REV, V20, P1, DOI 10.1093/wber/lhj002; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Falkingham J, 2002, MEASURING HLTH POVER; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; GARRETT P, 1994, CHILD DEV, V65, P331; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Guo G, 2000, DEMOGRAPHY, V37, P431, DOI 10.2307/2648070; HABICHT JP, 1974, B OFIC SANIT PANAM, V75, P375; HODDINOTT J, IMPACT PROGR CONSUMP; KORENMAN S, 1995, CHILD YOUTH SERV REV, V17, P127, DOI 10.1016/0190-7409(95)00006-X; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; MARTORELL R, 1995, J NUTR, V125, pS1127, DOI 10.1093/jn/125.suppl_4.1127S; MARTORELL R, 1995, J NUTR, V125, pS1060; Martorell R, 1989, ANTHROPOMETRIC STAND; MCGEE R, 2001, POVERTY ASSESSMENT P; MCKAY H, 1978, SCIENCE, V200, P270, DOI 10.1126/science.635585; Mistry RS, 2004, DEV PSYCHOL, V40, P727, DOI 10.1037/0012-1649.40.5.727; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Moser CON, 1998, WORLD DEV, V26, P1, DOI 10.1016/S0305-750X(97)10015-8; Munoz F, 1989, Rev Chil Pediatr, V60, P354; Nelson CA, 2000, HDB EARLY CHILDHOOD, V2nd; Neufeld L.M., 2006, EXTERNAL EVALUATION; NEUFELD LM, 2005, STUDY CONSUMPTION NU, V3, P119; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Rawlings LB, 2005, WORLD BANK RES OBSER, V20, P29, DOI 10.1093/wbro/lki001; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Rosselli M, 2001, DEV NEUROPSYCHOL, V20, P355, DOI 10.1207/S15326942DN2001_3; Schady N, 2006, ECONOMIA, V6, P185, DOI 10.1353/eco.2006.0021; SCHROEDER DG, 1995, J NUTR, V125, pS1051; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; SKOUFIAS E, EVALUATION SELECTION; SKOUFIAS E, 2000, IS PROGRESA WORKING; Stecklov G, 2007, POP STUD-J DEMOG, V61, P125, DOI 10.1080/00324720701300396; UMBEL VM, 1992, CHILD DEV, V63, P1012, DOI 10.2307/1131250; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Watanabe K, 2005, J NUTR, V135, P1918, DOI 10.1093/jn/135.8.1918; WHO, WHO CHILD GROWTH STA; WOODCOCK RW, 1996, BATERIA WOODCOCKMUNO; Yeung WJ, 2002, CHILD DEV, V73, P1861, DOI 10.1111/1467-8624.t01-1-00511; 1972, MCCARTHY SCALES CHIL	54	297	302	2	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2008	371	9615					828	837		10.1016/S0140-6736(08)60382-7	http://dx.doi.org/10.1016/S0140-6736(08)60382-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	272NQ	18328930	Green Accepted			2022-12-28	WOS:000253866500030
J	Ramaraj, R; Sorrell, VL				Ramaraj, Radhakrishnan; Sorrell, Vincent L.			Degenerative aortic stenosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RISK STRATIFICATION; VALVE-REPLACEMENT; TASK-FORCE; SURVIVAL; GUIDELINES; SOCIETY		[Ramaraj, Radhakrishnan; Sorrell, Vincent L.] Univ Arizona, Coll Med, Dept Internal Med, Cardiol Sect,Sarver Heart Ctr, Tucson, AZ 85724 USA	University of Arizona	Ramaraj, R (corresponding author), Univ Arizona, Coll Med, Dept Internal Med, Cardiol Sect,Sarver Heart Ctr, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	drkutty2@gmail.com						Bergler-Klein J, 2004, CIRCULATION, V109, P2302, DOI 10.1161/01.CIR.0000126825.50903.18; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Chambers J, 2005, BRIT MED J, V330, P801, DOI 10.1136/bmj.330.7495.801; Chan KL, 2003, J AM COLL CARDIOL, V42, P593, DOI 10.1016/S0735-1097(03)00786-1; Cosmi JE, 2002, ARCH INTERN MED, V162, P2345, DOI 10.1001/archinte.162.20.2345; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Cribier A, 2006, J AM COLL CARDIOL, V47, P1214, DOI 10.1016/j.jacc.2006.01.049; Glader CA, 2003, EUR HEART J, V24, P198, DOI 10.1016/S0195-668X(02)00385-8; Horstkotte D, 2004, EUR HEART J, V25, P267, DOI 10.1016/j.ehj.2003.11.008; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jimenez-Candil J, 2005, HEART, V91, P1311, DOI 10.1136/hrt.2004.047233; Khot UN, 2003, NEW ENGL J MED, V348, P1756, DOI 10.1056/NEJMoa022021; Kvidal P, 2000, J AM COLL CARDIOL, V35, P747, DOI 10.1016/S0735-1097(99)00584-7; Monin JL, 2003, CIRCULATION, V108, P319, DOI 10.1161/01.CIR.0000079171.43055.46; Moura LM, 2007, J AM COLL CARDIOL, V49, P554, DOI 10.1016/j.jacc.2006.07.072; Nashef SAM, 2002, EUR J CARDIO-THORAC, V22, P101, DOI 10.1016/S1010-7940(02)00208-7; Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903; Pereira JJ, 2002, J AM COLL CARDIOL, V39, P1356, DOI 10.1016/S0735-1097(02)01759-X; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Rosenhek R, 2004, EUR HEART J, V25, P199, DOI 10.1016/j.ehj.2003.12.002; SCHWARZ F, 1982, CIRCULATION, V66, P1105, DOI 10.1161/01.CIR.66.5.1105; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428	22	36	37	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2008	336	7643					550	555		10.1136/bmj.39478.498819.AD	http://dx.doi.org/10.1136/bmj.39478.498819.AD			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JV	18325966	Green Published			2022-12-28	WOS:000253998500032
J	Herrmann, B; Thoni, C; Gachter, S				Herrmann, Benedikt; Thoeni, Christian; Gachter, Simon			Antisocial punishment across societies	SCIENCE			English	Article							PAROCHIAL ALTRUISM; RECIPROCITY; EVOLUTION	We document the widespread existence of antisocial punishment, that is, the sanctioning of people who behave prosocially. Our evidence comes from public goods experiments that we conducted in 16 comparable participant pools around the world. However, there is a huge cross- societal variation. Some participant pools punished the high contributors as much as they punished the low contributors, whereas in others people only punished low contributors. In some participant pools, antisocial punishment was strong enough to remove the cooperation- enhancing effect of punishment. We also show that weak norms of civic cooperation and the weakness of the rule of law in a country are significant predictors of antisocial punishment. Our results show that punishment opportunities are socially beneficial only if complemented by strong social norms of cooperation.	[Herrmann, Benedikt; Gachter, Simon] Univ Nottingham, Ctr Decis Res & Expt Econ, Sch Econ, Nottingham NG7 2RD, England; [Thoeni, Christian] Univ St Gallen, FEW HSG, CH-9000 St Gallen, Switzerland	University of Nottingham; University of St Gallen	Gachter, S (corresponding author), Univ Nottingham, Ctr Decis Res & Expt Econ, Sch Econ, Sir Clive Granger Bldg,Univ Pk, Nottingham NG7 2RD, England.	simon.gaechter@nottingham.ac.uk	Thöni, Christian/AAA-6537-2020; Thöni, Christian/G-5032-2012; Gachter, Simon/C-9787-2009	Thöni, Christian/0000-0003-1190-8471; Thöni, Christian/0000-0003-1190-8471; Gachter, Simon/0000-0002-7182-8505				AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bahry DL, 2006, J ECON BEHAV ORGAN, V60, P37, DOI 10.1016/j.jebo.2004.07.005; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Boyd R., 1985, CULTURE EVOLUTIONARY; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Cinyabuguma M, 2006, EXP ECON, V9, P265, DOI 10.1007/s10683-006-9127-z; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Coleman JS., 1990, FDN SOCIAL THEORY; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Denant-Boemont L, 2007, ECON THEOR, V33, P145, DOI 10.1007/s00199-007-0212-0; Dixit Avansah K, 2004, LAWLESSNESS EC ALTER; Edgerton Robert, 1992, SICK SOC CHALLENGING; Ellickson R., 1991, ORDER WITHOUT LAW; ELSTER J, 1990, ETHICS, V100, P862, DOI 10.1086/293238; Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Hennig-Schmidt H, 2008, J ECON BEHAV ORGAN, V65, P373, DOI 10.1016/j.jebo.2005.10.003; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; HENRICH J, 2007, EVOLUTION COGNITION; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Hofstede G., 2001, CULTURES CONSEQUENCE, V2nd ed.; Inglehart R, 2000, AM SOCIOL REV, V65, P19, DOI 10.2307/2657288; KAUFMANN D, 4280 WORLD BANK; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; LIEBRAND WBG, 1986, J EXP SOC PSYCHOL, V22, P203, DOI 10.1016/0022-1031(86)90024-7; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; Monin B, 2007, REV INT PSYCHOL SOC, V20, P53; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E., 1990, GOVERNING COMMONS EV; Page T, 2005, ECON J, V115, P1032, DOI 10.1111/j.1468-0297.2005.01031.x; Posner Eric A., 2000, LAW SOCIAL NORMS; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Triandis H.C., 1995, INDIVIDUALISM COLLEC	41	1027	1041	5	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1362	1367		10.1126/science.1153808	http://dx.doi.org/10.1126/science.1153808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	270HW	18323447	Green Submitted, Green Accepted			2022-12-28	WOS:000253712900036
J	Gonzalez-Maeso, J; Ang, RL; Yuen, T; Chan, P; Weisstaub, NV; Lopez-Gimenez, JF; Zhou, MM; Okawa, Y; Callado, LF; Milligan, G; Gingrich, JA; Filizola, M; Meana, JJ; Sealfon, SC				Gonzalez-Maeso, Javier; Ang, Rosalind L.; Yuen, Tony; Chan, Pokman; Weisstaub, Noelia V.; Lopez-Gimenez, Juan F.; Zhou, Mingming; Okawa, Yuuya; Callado, Luis F.; Milligan, Graeme; Gingrich, Jay A.; Filizola, Marta; Meana, J. Javier; Sealfon, Stuart C.			Identification of a serotonin/glutamate receptor complex implicated in psychosis	NATURE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; SCHIZOPHRENIA; MODEL; RHODOPSIN; AGONIST; POSTMORTEM; PSILOCYBIN; PSYCHOPATHOLOGY	The psychosis associated with schizophrenia is characterized by alterations in sensory processing and perception(1,2). Some antipsychotic drugs were identified by their high affinity for serotonin 5-HT2A receptors (2AR)(3,4). Drugs that interact with metabotropic glutamate receptors (mGluR) also have potential for the treatment of schizophrenia(5-7). The effects of hallucinogenic drugs, such as psilocybin and lysergic acid diethylamide, require the 2AR(8-10) and resemble some of the core symptoms of schizophrenia(10-12). Here we show that the mGluR2 interacts through specific transmembrane helix domains with the 2AR, a member of an unrelated G- protein- coupled receptor family, to form functional complexes in brain cortex. The 2AR - mGluR2 complex triggers unique cellular responses when targeted by hallucinogenic drugs, and activation of mGluR2 abolishes hallucinogen- specific signalling and behavioural responses. In post- mortem human brain from untreated schizophrenic subjects, the 2AR is upregulated and the mGluR2 is downregulated, a pattern that could predispose to psychosis. These regulatory changes indicate that the 2AR mGluR2 complex may be involved in the altered cortical processes of schizophrenia, and this complex is therefore a promising new target for the treatment of psychosis.	[Gonzalez-Maeso, Javier; Ang, Rosalind L.; Yuen, Tony; Chan, Pokman; Okawa, Yuuya; Sealfon, Stuart C.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Filizola, Marta] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Sealfon, Stuart C.] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; [Weisstaub, Noelia V.; Zhou, Mingming; Gingrich, Jay A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Weisstaub, Noelia V.; Gingrich, Jay A.] Columbia Univ, Sackler Inst Labs, New York, NY 10032 USA; [Gingrich, Jay A.] Columbia Univ, Lieber Ctr Schizophrenia Res, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Lopez-Gimenez, Juan F.; Milligan, Graeme] Univ Glasgow, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Callado, Luis F.; Meana, J. Javier] Univ Basque Country, CIBER Mental Hlth, E-48940 Leioa, Spain; [Callado, Luis F.; Meana, J. Javier] Univ Basque Country, Dept Pharmacol, E-48940 Leioa, Spain	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; University of Glasgow; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Basque Country; University of Basque Country	Gonzalez-Maeso, J (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	javier.maeso@mssm.edu; stuart.sealfon@mssm.edu	Callado, Luis F./A-7024-2008; Lopez-Gimenez, Juan/K-5823-2014; Milligan, Graeme/F-9426-2011; Weisstaub, Noelia/ABA-1706-2021	Callado, Luis F./0000-0001-9941-012X; Lopez-Gimenez, Juan/0000-0003-3021-6200; Milligan, Graeme/0000-0002-6946-3519; CALLADO HERNANDO, LUIS FELIPE/0000-0002-5564-3447; SEALFON, Stuart/0000-0001-5791-1217; Filizola, Marta/0000-0002-4382-8276; MEANA, JOSE JAVIER/0000-0002-7913-6714	Medical Research Council [G9811527] Funding Source: Medline; NIDA NIH HHS [T32 DA007135, T32 DA007135-25S1, P01 DA012923-06A10004, P01 DA012923] Funding Source: Medline; NIGMS NIH HHS [T32 GM062754] Funding Source: Medline; NIMH NIH HHS [U01 MH083545] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012923, T32DA007135] Funding Source: NIH RePORTER; MRC [G9811527] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aghajanian GK, 2000, BRAIN RES REV, V31, P302, DOI 10.1016/S0165-0173(99)00046-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Benneyworth MA, 2007, MOL PHARMACOL, V72, P477, DOI 10.1124/mol.107.035170; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Blahos J, 1998, J BIOL CHEM, V273, P25765, DOI 10.1074/jbc.273.40.25765; Carlsson A, 2006, PHARMACOPSYCHIATRY, V39, pS10, DOI 10.1055/s-2006-931483; Chan PM, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni162; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Colpaert FC, 2003, NAT REV DRUG DISCOV, V2, P315, DOI 10.1038/nrd1062; DAVIDSON M, 1995, AM J PSYCHIAT, V152, P197; Dean B, 2003, J NEUROCHEM, V85, P1, DOI 10.1046/j.1471-4159.2003.01693.x; Ebersole BJ, 2003, MOL PHARMACOL, V63, P36, DOI 10.1124/mol.63.1.36; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2002, EUR J PHARMACOL, V452, P21, DOI 10.1016/S0014-2999(02)02242-2; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Gouzoulis-Mayfrank E, 2006, NEUROPSYCHOPHARMACOL, V31, P431, DOI 10.1038/sj.npp.1300882; Gouzoulis-Mayfrank E, 2005, PHARMACOPSYCHIATRY, V38, P301, DOI 10.1055/s-2005-916185; Gurevich EV, 1997, BIOL PSYCHIAT, V42, P529, DOI 10.1016/S0006-3223(97)00321-1; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lieberman JA, 1998, BIOL PSYCHIAT, V44, P1099, DOI 10.1016/S0006-3223(98)00187-5; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Marek GJ, 2000, J PHARMACOL EXP THER, V292, P76; Marek GJ, 2004, CURR OPIN PHARMACOL, V4, P18, DOI 10.1016/j.coph.2003.10.003; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Umbricht D, 2003, NEUROPSYCHOPHARMACOL, V28, P170, DOI 10.1038/sj.npp.1300005; Vollenweider FX, 2001, BRAIN RES BULL, V56, P495, DOI 10.1016/S0361-9230(01)00646-3; Vollenweider FX, 1997, NEUROPSYCHOPHARMACOL, V16, P357, DOI 10.1016/S0893-133X(96)00246-1; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Wright RA, 2001, J PHARMACOL EXP THER, V298, P453	44	619	652	1	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					93	U9		10.1038/nature06612	http://dx.doi.org/10.1038/nature06612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18297054	Green Accepted			2022-12-28	WOS:000253671900053
J	Dosanjh, DPS; Hinks, TSC; Innes, JA; Deeks, JJ; Pasvol, G; Hackforth, S; Varia, H; Millington, KA; Gunatheesan, R; Guyot-Revol, V; Lalvani, A				Dosanjh, Davinder P. S.; Hinks, Timothy S. C.; Innes, John A.; Deeks, Jonathan J.; Pasvol, Geoffrey; Hackforth, Sarah; Varia, Hansa; Millington, Kerry A.; Gunatheesan, Rubamalar; Guyot-Revol, Valerie; Lalvani, Ajit			Improved diagnostic evaluation of suspected tuberculosis	ANNALS OF INTERNAL MEDICINE			English	Article							INTERFERON-GAMMA ASSAYS; LINKED IMMUNOSPOT ASSAY; CELL-BASED ASSAY; MYCOBACTERIUM-TUBERCULOSIS; T-CELLS; LIKELIHOOD RATIOS; SKIN-TEST; IMMUNOCOMPROMISED PATIENTS; INFECTED INDIVIDUALS; LOGISTIC-REGRESSION	Background: The role of new T-cell-based blood tests for tuberculosis in the diagnosis of active tuberculosis is unclear. Objective: To compare the performance of 2 interferon-gamma assays and tuberculin skin testing in adults with suspected tuberculosis. Design: Prospective study conducted in routine practice. Setting: 2 urban hospitals in the United Kingdom. Patients: 389 adults, predominantly of South Asian and black ethnicity, with moderate to high clinical suspicion of active tuberculosis. Intervention: Tuberculin skin testing, the enzyme-linked immuno-spot assay ( ELISpot) incorporating early secretory antigenic target-6 and culture filtrate protein-10 ( standard ELISpot), and ELISpot incorporating a novel antigen, Rv3879c ( ELISpot(PLUS)) were performed during diagnostic assessment by independent persons who were blinded to results of the other test. Measurements: Sensitivity, specificity, predictive values, and likelihood ratios. Results: 194 patients had a final diagnosis of active tuberculosis, of which 79% were culture-confirmed. Sensitivity for culture-confirmed and highly probable tuberculosis was 89% ( 95% CI, 84% to 93%) with ELISpot(PLUS), 85% ( CI, 79% to 90%) with standard ELISpot, 79% ( CI, 72% to 85%) with 15-mm threshold tuberculin skin testing, and 83% ( CI, 77% to 89%) with stratified thresholds of 15 and 10 mm in vaccinated and unvaccinated patients, respectively. The ELISpotPLUS assay was more sensitive than tuberculin skin testing with 15-mm cutoff points ( P = 0.01) but not with stratified cutoff points ( P = 0.10). The ELISpotPLUS assay had 4% higher diagnostic sensitivity than standard ELISpot ( P = 0.02). Combined sensitivity of ELISpotPLUS and tuberculin skin testing was 99% ( CI, 95% to 100%), conferring a negative likelihood ratio of 0.02 ( CI, 0 to 0.06) when both test results were negative. Limitations: Local standards for tuberculin skin testing differed from others used internationally. The study sample included few immunosuppressed patients. Conclusion: The ELISpotPLUS assay is more sensitive than standard ELISpot and, when used in combination with tuberculin skin testing, enables rapid exclusion of active infection in patients with moderate to high pretest probability of tuberculosis.	[Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Resp Med, TB Immunol Grp, London W2 1PG, England; Univ Oxford, Oxford OX1 2JD, England; Univ Birmingham, Birmingham B15 2TT, W Midlands, England; Birmingham Heartlands Hosp, Birmingham, W Midlands, England; Northwick Pk Hosp & Clin Res Ctr, Harrow HA1 3UJ, Middx, England	Imperial College London; University of Oxford; University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham; Imperial College London	Lalvani, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Resp Med, TB Immunol Grp, St Marys Campus,Norfolk Pl, London W2 1PG, England.	a.lalvani@imperial.ac.uk	Pasvol, Geoffrey/B-7113-2009; Dosanjh, Davinder/ABD-8895-2021; Deeks, Jon/AAV-5745-2020	Dosanjh, Davinder/0000-0002-9169-5607; Deeks, Jon/0000-0002-8850-1971; Hinks, Timothy/0000-0003-0699-2373; Lalvani, Ajit/0000-0002-2396-246X	Wellcome Trust [064353] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBERT A, 1982, CLIN CHEM, V28, P1113; [Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Barnes PF, 2001, AM J RESP CRIT CARE, V163, P807, DOI 10.1164/ajrccm.163.4.ed0201c; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Chan SF, 2008, J CLIN EPIDEMIOL, V61, P52, DOI 10.1016/j.jclinepi.2007.02.012; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Dheda K, 2005, AIDS, V19, P2038, DOI 10.1097/01.aids.0000191923.08938.5b; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; HMSO, 1996, IMM INF DIS; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kang YA, 2007, CHEST, V132, P959, DOI 10.1378/chest.06-2805; KNOTTNERUS JA, 1992, MED DECIS MAKING, V12, P93, DOI 10.1177/0272989X9201200202; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lee E, 2002, CLIN INFECT DIS, V34, P365, DOI 10.1086/338149; Lee JY, 2006, EUR RESPIR J, V28, P24, DOI 10.1183/09031936.06.00016906; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Liu XQ, 2004, INFECT IMMUN, V72, P2574, DOI 10.1128/IAI.72.5.2574-2581.2004; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; *NAT COLL CTR CHRO, 2006, TUB CLIN DIAGN MAN T; Ormerod P, 2000, THORAX, V55, P887; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Piana F, 2006, EUR RESPIR J, V28, P31, DOI 10.1183/09031936.06.00110205; Piana F, 2006, AM J RESP CRIT CARE, V173, P130, DOI 10.1164/ajrccm.173.1.130; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Richeldi L, 2006, THORAX, V61, P180, DOI 10.1136/thx.2005.049759; Richeldi L, 2004, AM J RESP CRIT CARE, V170, P288, DOI 10.1164/rccm.200403-307OC; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Rose AMC, 2001, THORAX, V56, P173, DOI 10.1136/thorax.56.3.173; Schluger NW, 2002, CHEST, V122, P597, DOI 10.1378/chest.122.2.597; Small PM, 2000, LANCET, V356, P1048, DOI 10.1016/S0140-6736(00)02724-0; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3	48	120	130	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2008	148	5					325	W72		10.7326/0003-4819-148-5-200803040-00003	http://dx.doi.org/10.7326/0003-4819-148-5-200803040-00003			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268SX	18316751	Green Accepted			2022-12-28	WOS:000253600800001
J	Korenromp, EL; Kayondo, JK				Korenromp, Eline L.; Kayondo, Jane Kengeya			Reduced mortality with home-based HIV treatment in Uganda	LANCET			English	Editorial Material							MALARIA		[Korenromp, Eline L.] Global Fund Fight AIDS TB & Malaria, CH-1214 Geneva, Switzerland; [Korenromp, Eline L.] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Kayondo, Jane Kengeya] WHO, UNICEF UNDP World Bank, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland	Erasmus University Rotterdam; Erasmus MC; The World Bank; World Health Organization	Korenromp, EL (corresponding author), Global Fund Fight AIDS TB & Malaria, CH-1214 Geneva, Switzerland.	eline.korenromp@theglobalfund.org						Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Corbett EL, 2002, LANCET, V359, P2177, DOI 10.1016/S0140-6736(02)09095-5; Feachem RGA, 2004, TROP MED INT HEALTH, V9, P1139, DOI 10.1111/j.1365-3156.2004.01343.x; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; *INT AIDS SOC, 2007, SYDN DECL GOOD RES D; JOHANSSON EW, 2007, MALARIA CHILDREN PRO; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; UNAIDS, 2007, 2006 UNAIDS ANN REP; Vitoria M, 2006, ANTIRETROVIRAL THERA; World Health Organization HIV/AIDS Programme, 2007, TASK SHIFT TACKL HLT; World Health Organization HIV/AIDS Programme UNAIDS, 2007, GUID PROV IN HIV TES	12	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 1	2008	371	9614					703	705		10.1016/S0140-6736(08)60320-7	http://dx.doi.org/10.1016/S0140-6736(08)60320-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313487				2022-12-28	WOS:000253596700007
J	Zhao, CM; Deng, W; Gage, FH				Zhao, Chunmei; Deng, Wei; Gage, Fred H.			Mechanisms and functional implications of adult neurogenesis	CELL			English	Review							NEURAL STEM-CELLS; NEWLY GENERATED NEURONS; ENHANCED SYNAPTIC PLASTICITY; HIPPOCAMPAL NEUROGENESIS; OLFACTORY-BULB; DENTATE GYRUS; GRANULE CELLS; GROWTH-FACTOR; SUBVENTRICULAR ZONE; LEARNING INCREASES	The generation of new neurons is sustained throughout adulthood in the mammalian brain due to the proliferation and differentiation of adult neural stem cells. In this review, we discuss the factors that regulate proliferation and fate determination of adult neural stem cells and describe recent studies concerning the integration of newborn neurons into the existing neural circuitry. We further address the potential significance of adult neurogenesis in memory, depression, and neurodegenerative disorders such as Alzheimer's and Parkinson's disease.	[Zhao, Chunmei; Deng, Wei; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu						Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; BREUNIG JJ, 2007, ADULT NEUROGENESIS, P49; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Ghashghaei HT, 2007, GENE DEV, V21, P3258, DOI 10.1101/gad.1580407; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gong C, 2007, J NEUROSCI, V27, P1803, DOI 10.1523/JNEUROSCI.3111-06.2007; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; JANG MH, 2007, ADULT NEUROGENESIS, P397; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; JESSBERGER S, 2007, ADULT NEUROGENESIS, P535; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Klempin F, 2007, EUR ARCH PSY CLIN N, V257, P271, DOI 10.1007/s00406-007-0731-5; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; LINDVALL O, 2007, NEUROGENESIS FOLLOWI; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malberg JE, 2007, NEUROPSYCHOPHARMACOL, V32, P2360, DOI 10.1038/sj.npp.1301358; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Miller BH, 2008, NEUROPSYCHOPHARMACOL, V33, P1312, DOI 10.1038/sj.npp.1301497; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nacher J, 2006, HIPPOCAMPUS, V16, P267, DOI 10.1002/hipo.20160; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; Olariu A, 2005, J PHARMACOL SCI, V97, P1, DOI 10.1254/jphs.CPJ04004X; Oliver TG, 2004, NEURON, V42, P885, DOI 10.1016/j.neuron.2004.06.011; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Petreanu L, 2002, J NEUROSCI, V22, P6106; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Saghatelyan A, 2005, NEURON, V46, P103, DOI 10.1016/j.neuron.2005.02.016; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2004, TRENDS NEUROSCI, V27, P250, DOI 10.1016/j.tins.2004.03.007; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Shors TJ, 2007, BIOL PSYCHIAT, V62, P487, DOI 10.1016/j.biopsych.2006.10.033; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Walter C, 2007, J NEUROSCI, V27, P7541, DOI 10.1523/JNEUROSCI.0431-07.2007; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Winner B, 2008, NEUROBIOL AGING, V29, P913, DOI 10.1016/j.neurobiolaging.2006.12.016; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; ZHAO C, 2007, ADULT NEUROGENESIS, P101; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao MR, 2007, BIOL PSYCHIAT, V62, P381, DOI 10.1016/j.biopsych.2006.10.019	112	2275	2402	9	693	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					645	660		10.1016/j.cell.2008.01.033	http://dx.doi.org/10.1016/j.cell.2008.01.033			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295581	Bronze			2022-12-28	WOS:000253817900023
J	Cumming, RG; Sherrington, C; Lord, SR; Simpson, JM; Vogler, C; Cameron, ID; Naganathan, V				Cumming, Robert G.; Sherrington, Catherine; Lord, Stephen R.; Simpson, Judy M.; Vogler, Constance; Cameron, Ian D.; Naganathan, Vasi		Prevention Older Peoples Injury Fa	Cluster randomised trial of a targeted multifactorial intervention to prevent falls among older people in hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESOURCE UTILIZATION; INPATIENTS; REDUCTION; INJURIES; WARDS	Objective To determine the efficacy of a targeted multifactorial falls prevention programme in elderly care wards with relatively short lengths of stay. Design Cluster randomised trial. Setting 24 elderly care wards in 12 hospitals in Sydney, Australia. Participants 3999 patients, mean age 79 years, with a median hospital stay of seven days. Interventions A nurse and physiotherapist each worked for 25 hours a week for three months in all intervention wards. They provided a targeted multifactorial intervention that included a risk assessment of falls, staff and patient education, drug review, modification of bedside and ward environments, an exercise programme, and alarms for selected patients. Main outcome measure Falls during hospital stay. Results Intervention and control wards were similar at baseline for previous rates of fails and individual patient characteristics. Overall, 381 falls occurred during the study. No difference was found in fall rates during follow-up between intervention and control wards: respectively, 9.26 falls per 1000 bed days and 9.20 falls per 1000 bed days (P=0.96). The incidence rate ratio adjusted for individual lengths of stay and previous fall rates in the ward was 0.96 (95% confidence interval 0.72 to 1.28). Conclusion A targeted multifactorial falls prevention programme was not effective among older people in hospital wards with relatively short lengths of stay. Trial registration Australian New Zealand Clinical Trials Registry ACTRNO 12605000467639.	[Cumming, Robert G.; Naganathan, Vasi] Concord Hosp, Ctr Educ & Res Ageing, Concord, NSW 2139, Australia; [Cumming, Robert G.; Sherrington, Catherine; Simpson, Judy M.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Sherrington, Catherine] Univ Sydney, Fac Hlth Sci, Lidcombe, Australia; [Sherrington, Catherine; Lord, Stephen R.] Univ New S Wales, Prince Wales Med Res Inst, Kensington, NSW 2033, Australia; [Vogler, Constance] Royal N Shore Hosp, Dept Aged Care & Rehabil, St Leonards, NSW 2065, Australia; [Cameron, Ian D.] Univ Sydney, Rehabil Studies Unit, Ryde, Australia	Concord Repatriation General Hospital; University of Sydney; University of Sydney; Prince Wales Medical Research Institute; University of New South Wales Sydney; Royal North Shore Hospital; University of Sydney	Cumming, RG (corresponding author), Concord Hosp, Ctr Educ & Res Ageing, Concord, NSW 2139, Australia.	bobc@health.usyd.edu.au	Cumming, Robert G/R-1548-2016; Lord, Stephen R/C-9612-2011; Lindley, Richard/B-8148-2013; Sherrington, Catherine/S-9196-2019	Cumming, Robert G/0000-0002-0261-6103; Lindley, Richard/0000-0002-0104-5679; Sherrington, Catherine/0000-0001-8934-4368; Simpson, Judy M/0000-0001-5172-3004; Lord, Stephen R/0000-0002-7111-8802; Naganathan, Vasikaran/0000-0001-7243-0796				*AUSTR COUNC SAF Q, 2005, PREV FALLS HARM FALL; BATES DW, 1995, AM J MED, V99, P137, DOI 10.1016/S0002-9343(99)80133-8; Fonda D, 2006, MED J AUSTRALIA, V184, P379, DOI 10.5694/j.1326-5377.2006.tb00286.x; GILLESPIE LD, 2006, COCHRANE DB SYST REV; Haines TP, 2004, BMJ-BRIT MED J, V328, P676, DOI 10.1136/bmj.328.7441.676; Healey F, 2004, AGE AGEING, V33, P390, DOI 10.1093/ageing/afh130; Hill KD, 2007, AUST HEALTH REV, V31, P471, DOI 10.1071/AH070471; Hitcho EB, 2004, J GEN INTERN MED, V19, P732, DOI 10.1111/j.1525-1497.2004.30387.x; Lord S, 2001, FALLS OLDER PEOPLE R; MAYO NE, 1994, ARCH PHYS MED REHAB, V75, P1302; Nadkarni JB, 2005, GERONTOLOGY, V51, P329, DOI 10.1159/000086370; Oliver D, 2004, AGE AGEING, V33, P122, DOI 10.1093/ageing/afh017; Oliver D, 2007, BRIT MED J, V334, P82, DOI 10.1136/bmj.39049.706493.55; REUBEN DB, 1995, NEW ENGL J MED, V332, P1345, DOI 10.1056/NEJM199505183322007; SHANLEY C, 1998, PUTTING YOUR BEST FO; Thomas EJ, 2000, BRIT MED J, V320, P741, DOI 10.1136/bmj.320.7237.741; Vassallo M, 1998, INT J CLIN PRACT, V52, P233; Vassallo M, 2000, INT J CLIN PRACT, V54, P654; Vassallo M, 2004, J AM GERIATR SOC, V52, P335, DOI 10.1111/j.1532-5415.2004.52102.x; Vassallo M, 2003, AGE AGEING, V32, P338, DOI 10.1093/ageing/32.3.338	20	144	152	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2008	336	7647					758	760B		10.1136/bmj.39499.546030.BE	http://dx.doi.org/10.1136/bmj.39499.546030.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284JW	18332052	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000254703700032
J	Fries, M; Steele, A				Fries, Marc; Steele, Andrew			Graphite whiskers in CV3 meteorites	SCIENCE			English	Article							ACCELERATING UNIVERSE; BACKGROUND-RADIATION; POLYHEDRAL CRYSTALS; INTERSTELLAR-MEDIUM; METALLIC NEEDLES; DARK INCLUSIONS; DUST MODELS; EXTINCTION; SUPERNOVAE; CONES	Graphite whiskers ( GWs), an allotrope of carbon that has been proposed to occur in space, have been discovered in three CV- type carbonaceous chondrites via Raman imaging and electron microscopy. The GWs are associated with high- temperature calcium- aluminum inclusion ( CAI) rims and interiors, with the rim of a dark inclusion, and within an inclusion inside an unusual chondrule that bears mineralogy and texture indicative of high- temperature processing. Current understanding of CAI formation places their condensation, and that of associated GWs, relatively close to the Sun and early in the condensation sequence of protoplanetary disk materials. If this is the case, then it is a possibility that GWs are expelled from any young solar system early in its history, thus populating interstellar space with diffuse GWs. Graphite whiskers have been postulated to play a role in the near- infrared ( near- IR) dimming of type Ia supernovae, as well as in the thermalization of both the cosmic IR and microwave background and in galactic center dimming between 3 and 9 micrometers. Our observations, along with the further possibility that GWs could be manufactured during supernovae, suggest that GWs may have substantial effects in observational astronomy.	[Fries, Marc; Steele, Andrew] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA	Carnegie Institution for Science	Fries, M (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	Marc.D.Fries@jpl.nasa.gov	Steele, Andrew/A-3573-2013	Steele, Andrew/0000-0001-9643-2841				Aguirre A, 1999, ASTROPHYS J, V525, P583, DOI 10.1086/307945; Aguirre AN, 2000, ASTROPHYS J, V533, P1, DOI 10.1086/308660; Aguirre AN, 1999, ASTROPHYS J, V512, pL19, DOI 10.1086/311862; AMELINCKX S, 1992, J CRYST GROWTH, V121, P543, DOI 10.1016/0022-0248(92)90561-V; BACON R, 1960, J APPL PHYS, V31, P283, DOI 10.1063/1.1735559; Brenker FE, 2004, AM MINERAL, V89, P1280; DIMOVSKI S, 2006, NANOTUBES NANOFIBERS, P109; Dong J, 2002, APPL PHYS LETT, V80, P3733, DOI 10.1063/1.1481783; Dwek E, 2004, ASTROPHYS J, V611, pL109, DOI 10.1086/423893; Dwek E, 2004, ASTROPHYS J, V607, P848, DOI 10.1086/382653; Gogotsi Y, 2000, SCIENCE, V290, P317, DOI 10.1126/science.290.5490.317; Henning T, 1998, SCIENCE, V282, P2204, DOI 10.1126/science.282.5397.2204; HOYLE F, 1984, ASTROPHYS SPACE SCI, V103, P371, DOI 10.1007/BF00653751; Jaszczak JA, 2003, CARBON, V41, P2085, DOI 10.1016/S0008-6223(03)00214-8; Jaszczak JA, 2007, CAN MINERAL, V45, P379, DOI 10.2113/gscanmin.45.2.379; JOHNSON CA, 1990, GEOCHIM COSMOCHIM AC, V54, P819, DOI 10.1016/0016-7037(90)90376-V; KROT AN, 1995, METEORITICS, V30, P748, DOI 10.1111/j.1945-5100.1995.tb01173.x; Li A, 2001, ASTROPHYS J, V550, pL213, DOI 10.1086/319640; Li AG, 2003, ASTROPHYS J, V584, P593, DOI 10.1086/345753; Narlikar JV, 2002, PUBL ASTRON SOC PAC, V114, P1092, DOI 10.1086/342374; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Robaina AR, 2007, ASTRON ASTROPHYS, V464, P465, DOI 10.1051/0004-6361:20065292; Saito Y, 2007, CARBON, V45, P248, DOI 10.1016/j.carbon.2006.10.002; SEARS GW, 1959, J CHEM PHYS, V31, P358, DOI 10.1063/1.1730358; SHU F, 1994, ASTROPHYS J, V429, P781, DOI 10.1086/174363; Shu FH, 1997, SCIENCE, V277, P1475, DOI 10.1126/science.277.5331.1475; SIVARAM C, 1985, ASTROPHYS SPACE SCI, V117, P199, DOI 10.1007/BF00660923; Tan PH, 2004, PHILOS T R SOC A, V362, P2289, DOI 10.1098/rsta.2004.1442; Tan PH, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevLett.87.214301; WICKRAMASINGHE NC, 1994, ASTROPHYS SPACE SCI, V213, P143, DOI 10.1007/BF00627786; Wickramasinghe NC, 1996, ASTROPHYS SPACE SCI, V240, P157, DOI 10.1007/BF00640203; Zubko V, 2004, ASTROPHYS J SUPPL S, V152, P211, DOI 10.1086/382351	35	36	36	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2008	320	5872					91	93		10.1126/science.1153578	http://dx.doi.org/10.1126/science.1153578			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18309047				2022-12-28	WOS:000254633000037
J	Wen, JD; Lancaster, L; Hodges, C; Zeri, AC; Yoshimura, SH; Noller, HF; Bustamante, C; Tinoco, I				Wen, Jin-Der; Lancaster, Laura; Hodges, Courtney; Zeri, Ana-Carolina; Yoshimura, Shige H.; Noller, Harry F.; Bustamante, Carlos; Tinoco, Ignacio, Jr.			Following translation by single ribosomes one codon at a time	NATURE			English	Article							INITIATOR TRANSFER-RNA; ELONGATION-FACTOR TU; MESSENGER-RNA; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; OPTICAL TWEEZERS; FORCE; TRANSLOCATION; COMPLEXES	We have followed individual ribosomes as they translate single messenger RNA hairpins tethered by the ends to optical tweezers. Here we reveal that translation occurs through successive translocation- and- pause cycles. The distribution of pause lengths, with a median of 2.8 s, indicates that at least two rate- determining processes control each pause. Each translocation step measures three bases - one codon - and occurs in less than 0.1 s. Analysis of the times required for translocation reveals, surprisingly, that there are three substeps in each step. Pause lengths, and thus the overall rate of translation, depend on the secondary structure of the mRNA; the applied force destabilizes secondary structure and decreases pause durations, but does not affect translocation times. Translocation and RNA unwinding are strictly coupled ribosomal functions.	[Wen, Jin-Der; Bustamante, Carlos; Tinoco, Ignacio, Jr.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Lancaster, Laura; Noller, Harry F.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Lancaster, Laura; Noller, Harry F.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Hodges, Courtney; Bustamante, Carlos] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Zeri, Ana-Carolina] Brazilian Synchrotron Light Lab, BR-13083970 Campinas, SP, Brazil; [Yoshimura, Shige H.] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Phys & Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; Laboratorio Nacional de Luz Sincrotron (LNLS); Kyoto University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tinoco, I (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	intinoco@lbl.gov	Zeri, Ana/AAY-4799-2021; Yoshimura, Shige H./AAF-5463-2019; Wen, Jin-Der/A-3159-2014	Zeri, Ana/0000-0003-4169-4523; Yoshimura, Shige H./0000-0001-6033-1301; Hodges, H. Courtney/0000-0003-4441-497X; Bustamante, Carlos/0000-0002-2970-0073; Wen, Jin-Der/0000-0001-8317-4329	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM010840, R01 GM010840-49, R01 GM010840-50] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SL, 1999, P NATL ACAD SCI USA, V96, P14177, DOI 10.1073/pnas.96.25.14177; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; BOON K, 1992, EUR J BIOCHEM, V210, P177, DOI 10.1111/j.1432-1033.1992.tb17406.x; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; Culver GM, 2000, METHOD ENZYMOL, V318, P446; DOTY P., 1959, PROC NATL ACAD SCI, V45, P482, DOI 10.1073/pnas.45.4.482; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; FAVRE A, 1975, EUR J BIOCHEM, V57, P147, DOI 10.1111/j.1432-1033.1975.tb02285.x; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2003, BIOPOLYMERS, V68, P223, DOI 10.1002/bip.10210; Horan LH, 2007, P NATL ACAD SCI USA, V104, P4881, DOI 10.1073/pnas.0700762104; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Moore PB, 2003, ANNU REV BIOCHEM, V72, P813, DOI 10.1146/annurev.biochem.72.110601.135450; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Onoa B, 2003, SCIENCE, V299, P1892, DOI 10.1126/science.1081338; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tinoco I, 2004, ANNU REV BIOPH BIOM, V33, P363, DOI 10.1146/annurev.biophys.33.110502.140418; Tinoco I, 2006, Q REV BIOPHYS, V39, P325, DOI 10.1017/S0033583506004446; Traub P, 1981, RNA PROTEIN SYNTHESI, P521; Uemura S, 2007, NATURE, V446, P454, DOI 10.1038/nature05625; Vanzi F, 2005, BIOPHYS J, V89, P1909, DOI 10.1529/biophysj.104.056283; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Wen JD, 2007, BIOPHYS J, V92, P2996, DOI 10.1529/biophysj.106.094052; Wilson KS, 1998, CELL, V92, P131, DOI 10.1016/S0092-8674(00)80905-8; Wintermeyer W, 2004, BIOCHEM SOC T, V32, P733, DOI 10.1042/BST0320733; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	44	362	369	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2008	452	7187					598	603		10.1038/nature06716	http://dx.doi.org/10.1038/nature06716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18327250	Green Accepted			2022-12-28	WOS:000254567200038
J	Fisk, NM; Atun, R				Fisk, Nicholas M.; Atun, Rifat			Public-private partnership in cord blood banking	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSPLANTATION; ADULTS; UNITS		[Fisk, Nicholas M.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Tanaka Business Sch, London SW7 2AZ, England	Imperial College London; Imperial College London	Fisk, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England.	nfisk@uq.edu.au	Fisk, Nicholas M/B-2126-2009; Atun, Rifat/AAH-5537-2021	Fisk, Nicholas M/0000-0003-0031-7975; Atun, Rifat/0000-0002-1531-5983				Annas GJ, 1999, NEW ENGL J MED, V340, P1521, DOI 10.1056/NEJM199905133401923; [Anonymous], 2007, LANCET, V369, P437; [Anonymous], 2002, RCM Midwives, V5, P422; Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Cairo MS, 2007, PEDIATRICS, V119, P165, DOI 10.1542/peds.2006-2901; Council of Europa, 1997, CONV PROT HUM RIGHTS; Davey S, 2004, BRIT J HAEMATOL, V125, P358, DOI 10.1111/j.1365-2141.2004.04923.x; Edozien LC, 2006, BMJ-BRIT MED J, V333, P801, DOI 10.1136/bmj.38950.628519.68; *EUR GROUP ETH SCI, ETH ASP UMB CORD BLO; Fisk NM, 2005, PLOS MED, V2, P87, DOI 10.1371/journal.pmed.0020044; Hayani A, 2007, PEDIATRICS, V119, pE296, DOI 10.1542/peds.2006-1009; HIGHFIELD R, 2005, DAILY TELEGRAPH 0222; *HUM TISS AUTH, 2006, COD PRACT 6 DON ALL; Johnson FL, 1997, J PEDIAT HEMATOL ONC, V19, P183, DOI 10.1097/00043426-199705000-00001; Proctor SJ, 2001, BMJ-BRIT MED J, V323, P60, DOI 10.1136/bmj.323.7304.60; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; *ROYAL COLL OBST G, 2006, UMB CORD BLOOD BANK; Smythe J, 2007, STEM CELLS, V25, P2087, DOI 10.1634/stemcells.2007-0063; *VIRG HLTH BANK, 2007, STEM CELL STOR; WARWICK R, 2004, STEM CELLS OBSTET GY, V995, P1011	21	21	24	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2008	336	7645					642	644		10.1136/bmj.39489.454699.AD	http://dx.doi.org/10.1136/bmj.39489.454699.AD			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RH	18356233	Green Published			2022-12-28	WOS:000254443400023
J	Osterloo, MM; Hamilton, VE; Bandfield, JL; Glotch, TD; Baldridge, AM; Christensen, PR; Tornabene, LL; Anderson, FS				Osterloo, M. M.; Hamilton, V. E.; Bandfield, J. L.; Glotch, T. D.; Baldridge, A. M.; Christensen, P. R.; Tornabene, L. L.; Anderson, F. S.			Chloride-bearing materials in the southern highlands of Mars	SCIENCE			English	Article							THERMAL EMISSION SPECTROMETER; SURFACE; SPECTROSCOPY; MINERALS; BRINES	Chlorides commonly precipitate during the evaporation of surface water or groundwater and during volcanic outgassing. Spectrally distinct surface deposits consistent with chloride- bearing materials have been identified and mapped using data from the 2001 Mars Odyssey Thermal Emission Imaging System. These deposits are found throughout regions of low albedo in the southern highlands of Mars. Geomorphologic evidence from orbiting imagery reveals these deposits to be light- toned relative to their surroundings and to be polygonally fractured. The deposits are small (< similar to 25 km(2)) but globally widespread, occurring in middle to late Noachian terrains with a few occurrences in early Hesperian terrains. The identification of chlorides in the ancient southern highlands suggests that near- surface water was available and widespread in early Martian history.	[Osterloo, M. M.; Hamilton, V. E.; Anderson, F. S.] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Bandfield, J. L.; Baldridge, A. M.; Christensen, P. R.] Arizona State Univ, Sch Earth & Planetary Explorat, Tempe, AZ 85287 USA; [Glotch, T. D.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Tornabene, L. L.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Hawaii System; Arizona State University; Arizona State University-Tempe; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Arizona	Osterloo, MM (corresponding author), Univ Hawaii, Hawaii Inst Geophys & Planetol, 1680 East West Rd, Honolulu, HI 96822 USA.	osterloo@higp.hawaii.edu	Glotch, Timothy/B-6829-2008	Bandfield, Joshua/0000-0003-3571-3716; Tornabene, Livio Leonardo/0000-0002-1479-6711				Baldridge AM, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002315; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002289; Bandfield JL, 2003, ICARUS, V161, P47, DOI 10.1016/S0019-1035(02)00025-8; Bandfield JL, 2007, NATURE, V447, P64, DOI 10.1038/nature05781; BRASS GW, 1980, ICARUS, V42, P20, DOI 10.1016/0019-1035(80)90237-7; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9735, DOI 10.1029/1998JE000624; Christensen PR, 2004, SPACE SCI REV, V110, P85, DOI 10.1023/B:SPAC.0000021008.16305.94; CHRISTENSEN PR, 1999, CALIBRATION REPORT T; Eugster HP., 1978, LAKES, P237, DOI [10.1007/978-1-4757-1152-3_8, DOI 10.1007/978-1-4757-1152-3_8]; Farmer JD, 1999, J GEOPHYS RES-PLANET, V104, P26977, DOI 10.1029/1998JE000540; Farmer V.C., 1974, INFRARED SPECTRA MIN, P331; Goodall TM, 2000, SEDIMENTOLOGY, V47, P99, DOI 10.1046/j.1365-3091.2000.00279.x; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Knauth LP, 2002, ICARUS, V158, P267, DOI 10.1006/icar.2002.6866; Lane MD, 1998, ICARUS, V135, P528, DOI 10.1006/icar.1998.5998; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; MCEWEN AS, 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; PALLUCONI FD, 1981, ICARUS, V45, P415, DOI 10.1016/0019-1035(81)90044-0; Presley MA, 1997, J GEOPHYS RES-PLANET, V102, P6551, DOI 10.1029/96JE03303; Ruff SW, 1997, J GEOPHYS RES-SOL EA, V102, P14899, DOI 10.1029/97JB00593; Ruff SW, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001580; Tosca NJ, 2006, EARTH PLANET SC LETT, V241, P21, DOI 10.1016/j.epsl.2005.10.021; ZUBER MT, 1992, J GEOPHYS RES-PLANET, V97, P7781, DOI 10.1029/92JE00341	26	335	342	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2008	319	5870					1651	1654		10.1126/science.1150690	http://dx.doi.org/10.1126/science.1150690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356522				2022-12-28	WOS:000254172300036
J	Yang, CH; Belawat, P; Hafen, E; Jan, LY; Jan, YN				Yang, Chung-hui; Belawat, Priyanka; Hafen, Ernst; Jan, Lily Y.; Jan, Yuh-Nung			Drosophila egg-laying site selection as a system to study simple decision-making processes	SCIENCE			English	Article							MELANOGASTER; OCTOPAMINE; BEHAVIOR; PREFERENCE; RESPONSES; DOPAMINE; RECEPTOR; FLIES; ODOR	The ability to select a better option from multiple acceptable ones is important for animals to optimize their resources. The mechanisms that underlie such decision- making processes are not well understood. We found that selection of egg- laying site in Drosophila melanogaster is a suitable system to probe the neural circuit that governs simple decision- making processes. First, Drosophila females pursue active probing of the environment before depositing each egg, apparently to evaluate site quality for every egg. Second, Drosophila females can either accept or reject a sucrose- containing medium, depending on the context. Last, communication of the "acceptability" of the sucrose- containing medium as an egg- laying option to the reproductive system depends on the function of a group of insulin- like peptide 7 ( ILP7)- producing neurons. These findings suggest that selection of egg- laying site involves a simple decision- making process and provide an entry point toward a systematic dissection of this process.	[Yang, Chung-hui; Jan, Lily Y.; Jan, Yuh-Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol Biochem & Biophys, San Francisco, CA 94143 USA; [Belawat, Priyanka; Hafen, Ernst] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol Biochem & Biophys, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01 MH084234] Funding Source: Medline; NINDS NIH HHS [R01 NS040929-08, R01 NS40929, R37 NS040929, R01 NS047200-04, R01 NS040929] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS040929, R01NS047200, R01NS040929] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEMAND R, 1989, EXPERIENTIA, V45, P1147, DOI 10.1007/BF01950184; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Eisses KT, 1997, BEHAV GENET, V27, P171, DOI 10.1023/A:1025697627556; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hammer M, 1998, LEARN MEMORY, V5, P146; HUDSON P, 1981, NATURE, V291, P127, DOI 10.1038/291127a0; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Mery F, 2002, P NATL ACAD SCI USA, V99, P14274, DOI 10.1073/pnas.222371199; Monastirioti M, 1996, J NEUROSCI, V16, P3900; RICHMOND RC, 1979, BEHAV GENET, V9, P233, DOI 10.1007/BF01071304; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Spradling Allan C., 1993, P1; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; TAKAMURA T, 1980, BEHAV GENET, V10, P105, DOI 10.1007/BF01067322; THOMPSON KJ, 1986, J EXP BIOL, V122, P387; VANDELDEN W, 1990, BEHAV GENET, V20, P661, DOI 10.1007/BF01065877; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357	21	250	258	9	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1679	1683		10.1126/science.1151842	http://dx.doi.org/10.1126/science.1151842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356529	Green Accepted			2022-12-28	WOS:000254172300045
J	Ginsburg, GS; Burke, TW; Febbo, P				Ginsburg, Geoffrey S.; Burke, Thomas W.; Febbo, Phillip			Centralized biorepositories for genetic and genomic research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONFERS RISK		[Ginsburg, Geoffrey S.; Burke, Thomas W.; Febbo, Phillip] Duke Univ, Duke Inst Genome Sci & Policy, Ctr Genom Med, Durham, NC 27708 USA	Duke University	Ginsburg, GS (corresponding author), Duke Univ, Duke Inst Genome Sci & Policy, Ctr Genom Med, Box 3382,101 Sci Dr, Durham, NC 27708 USA.	geoffrey.ginsburg@duke.edu		Burke, Thomas/0000-0003-0592-5822				Charo RA, 2006, NEW ENGL J MED, V355, P1517, DOI 10.1056/NEJMp068192; EISEMAN E, 2003, CASE STUDIES EXISTIN; Eiseman E, 2000, HDB HUMAN TISSUE SOU; Evans BJ, 2006, J LEGAL MED, V27, P119, DOI 10.1080/01947640600716366; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; *ISBER, 2005, CELL PRESERV TECHNOL, V3, P5; *NAT CANC I, UN MED LANG SYST MET; *NAT CANC I, 2004, 132 NAT CANC ADV BOA; Patel AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-120; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Topol EJ, 2007, JAMA-J AM MED ASSOC, V298, P218, DOI 10.1001/jama.298.2.218	12	45	48	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1359	1361		10.1001/jama.299.11.1359	http://dx.doi.org/10.1001/jama.299.11.1359			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349099				2022-12-28	WOS:000254079100029
J	Gaziano, TA; Young, CR; Fitzmaurice, G; Atwood, S; Gaziano, JM				Gaziano, Thomas A.; Young, Cynthia R.; Fitzmaurice, Garrett; Atwood, Sidney; Gaziano, J. Michael			Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort	LANCET			English	Article							CORONARY-HEART-DISEASE; SERUM-CHOLESTEROL CONCENTRATION; MIDDLE-INCOME COUNTRIES; C-REACTIVE PROTEIN; GLOBAL BURDEN; PREDICTION; POPULATION; HYPERTENSION; PREVENTION; EVENTS	Background Around 80% of all cardiovascular deaths occur in developing countries. Assessment of those patients at high risk is an important strategy for prevention. Since developing countries have limited resources for prevention strategies that require laboratory testing, we assessed if a risk prediction method that did not require any laboratory tests could be as accurate as one requiring laboratory information. Methods The National Health and Nutrition Examination Survey (NHANES) was a prospective cohort study of 14407 US participants aged between 25-74 years at the time they were first examined (between 1971 and 1975). Our follow-up study population included participants with complete information on these surveys who did not report a history of cardiovascular disease (myocardial infarction, heart failure, stroke, angina) or cancer, yielding an analysis dataset N=6186. We compared how well either method could predict first-time fatal and non-fatal cardiovascular disease events in this cohort. For the laboratory-based model, which required blood testing, we used standard risk factors to assess risk of cardiovascular disease: age, systolic blood pressure, smoking status, total cholesterol, reported diabetes status, and current treatment for hypertension. For the non-laboratory-based model, we substituted body-mass index for cholesterol. Findings in the cohort of 6186, there were 1529 first-time cardiovascular events and 578 (38%) deaths due to cardiovascular disease over 21 years. In women, the laboratory-based model was 0.831. In men, the results were similar (0.784 for the laboratory-based model and 0.783 for the non-laboratory-based model). Results were similar between the laboratory-based and non-laboratory-based models in both men and women when restricted to fatal events only. Interpretation A method that uses non-laboratory-based risk factors predicted cardiovascular events as accurately as one that relied on laboratory-based values. This approach could simplify risk assessment in situations where laboratory testing is inconvenient or unavailable.	[Gaziano, Thomas A.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Atwood, Sidney] Brigham & Womens Hosp, Div Social Med & Hlth Inequal, Boston, MA 02115 USA; [Young, Cynthia R.] Harvard Univ, Sch Med, Boston, MA USA; [Fitzmaurice, Garrett] McLean Hosp, Lab Psychiat Biostat, Belmont, MA 02178 USA; [Gaziano, Thomas A.] Brigham & Womens Hosp, VA Boston Healthcare Syst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; McLean Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Gaziano, TA (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	tgaziano@partners.org		Atwood, Sidney/0000-0001-8865-6300	FIC NIH HHS [1K01TW007141-01, K01 TW007141-03, K01 TW007141-02, K01 TW007141, K01 TW007141-04, K01 TW007141-01] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [K01TW007141] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Assmann G, 2002, CIRCULATION, V105, P900, DOI 10.1161/hh0702.105723; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Cohen B.B., 1987, PLAN OPERATION NHANE; Collinson P, 1998, HEART, V80, P215, DOI 10.1136/hrt.80.3.215; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cox C.S., 1992, PLAN OPERATION NHANE; COX CS, 1997, PLAN OPERATION NHANE; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Ferrario M, 2005, INT J EPIDEMIOL, V34, P413, DOI 10.1093/ije/dyh405; Finucane F.F., 1990, PLAN OPERATION NHANE; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Gaziano TA, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P645; GOFMAN JW, 1950, SCIENCE, V111, P166, DOI 10.1126/science.111.2877.166; Greenland P, 2005, ARCH INTERN MED, V165, P2454, DOI 10.1001/archinte.165.21.2454; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Jha P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P869; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; LAW MR, 1994, BMJ-BRIT MED J, V308, P363, DOI 10.1136/bmj.308.6925.363; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lindholm LH, 2007, LANCET, V370, P720, DOI 10.1016/S0140-6736(07)61356-7; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MADANS JH, 1995, STAT MED, V14, P643, DOI 10.1002/sim.4780140521; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; *NAT HLTH COMM, 1995, GUID MAN MILD RAIS B; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Rodgers A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P851; *US DHHS, 1971, 1 NAT HLTH NUTR EX S; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; World Bank, 2022, WORLD DEV IND 2022; World Health Organization, 2007, PREV CARD DIS GUID A; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	242	260	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2008	371	9616					923	931		10.1016/S0140-6736(08)60418-3	http://dx.doi.org/10.1016/S0140-6736(08)60418-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342687	Green Accepted			2022-12-28	WOS:000254056800029
J	Bao, HM; Sun, T; Kohl, I; Peng, YB				Bao, Huiming; Sun, Tao; Kohl, Issaku; Peng, Yongbo			Comment on "Early Archaean microorganisms preferred elemental sulfur, not sulfate"	SCIENCE			English	Editorial Material							ATMOSPHERE; CYCLE		[Bao, Huiming; Sun, Tao; Kohl, Issaku; Peng, Yongbo] Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bao, HM (corresponding author), Louisiana State Univ, Dept Geol & Geophys, E235 Howe Russell Geosci Complex, Baton Rouge, LA 70803 USA.	bao@lsu.edu	Peng, Yongbo/I-2228-2013; Bao, Huiming/C-1069-2012	Sun, Tao/0000-0001-6266-3350				Bao HM, 2007, GEOCHIM COSMOCHIM AC, V71, P4868, DOI 10.1016/j.gca.2007.05.032; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861	5	8	8	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868								10.1126/science.1151241	http://dx.doi.org/10.1126/science.1151241			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323434				2022-12-28	WOS:000253712900021
J	Ohsugi, M; Adachi, K; Horai, R; Kakuta, S; Sudo, K; Kotaki, H; Tokai-Nishizumi, N; Sagara, H; Iwakura, Y; Yamamoto, T				Ohsugi, Miho; Adachi, Kenjiro; Horai, Reiko; Kakuta, Shigeru; Sudo, Katsuko; Kotaki, Hayato; Tokai-Nishizumi, Noriko; Sagara, Hiroshi; Iwakura, Yoichiro; Yamamoto, Tadashi			Kid-mediated chromosome compaction ensures proper nuclear envelope formation	CELL			English	Article							CHROMOKINESIN KID; XENOPUS-EMBRYOS; MOUSE EMBRYO; RAN; SPINDLE; TRANSITION; ALIGNMENT; DYNAMICS; ANAPHASE; GTPASE	Toward the end of mitosis, neighboring chromosomes gather closely to form a compact cluster. This is important for reassembling the nuclear envelope around the entire chromosome mass but not individual chromosomes. By analyzing mice and cultured cells lacking the expression of chromokinesin Kid/kinesin-10, we show that Kid localizes to the boundaries of anaphase and telophase chromosomes and contributes to the shortening of the anaphase chromosome mass along the spindle axis. Loss of Kid-mediated anaphase chromosome compaction often causes the formation of multinucleated cells, specifically at oocyte meiosis II and the first couple of mitoses leading to embryonic death. In contrast, neither male meiosis nor somatic mitosis after the morula-stage is affected by Kid deficiency. These data suggest that Kid-mediated anaphase/telophase chromosome compaction prevents formation of multinucleated cells. This protection is especially important during the very early stages of development, when the embryonic cells are rich in ooplasm.	[Ohsugi, Miho; Tokai-Nishizumi, Noriko; Yamamoto, Tadashi] Univ Tokyo, Div Oncol, Dept Canc Biol, Minato Ku, Tokyo 1088639, Japan; [Adachi, Kenjiro; Horai, Reiko; Kakuta, Shigeru; Sudo, Katsuko; Kotaki, Hayato; Iwakura, Yoichiro] Univ Tokyo, Div Cell Biol, Ctr Med Expt, Minato Ku, Tokyo 1088639, Japan; [Sagara, Hiroshi] Univ Tokyo, Lab Proteom, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Yamamoto, T (corresponding author), Univ Tokyo, Div Oncol, Dept Canc Biol, Minato Ku, Tokyo 1088639, Japan.	tyamamot@ims.u-tokyo.ac.jp	Kakuta, Shigeru/L-2241-2018; Iwakura, Yoichiro/E-5457-2011; Ohsugi, Miho/AAY-9339-2020; Sagara, Hiroshi/GRX-7740-2022	Kakuta, Shigeru/0000-0002-5900-1425; Iwakura, Yoichiro/0000-0002-9934-5775; Ohsugi, Miho/0000-0003-0288-3428; Sagara, Hiroshi/0000-0001-8456-8362				Adachi K, 2007, MOL CELL BIOL, V27, P2202, DOI 10.1128/MCB.01908-06; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; BACHVAROVA R, 1980, DEV BIOL, V74, P1, DOI 10.1016/0012-1606(80)90048-2; Bamba C, 2002, CURR BIOL, V12, P503, DOI 10.1016/S0960-9822(02)00741-8; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; Clute P, 1997, DEV BIOL, V185, P1, DOI 10.1006/dbio.1997.8540; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hinkle B, 2002, J CELL SCI, V115, P4685, DOI 10.1242/jcs.00136; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; MONTAG M, 1988, CHROMOSOMA, V96, P187, DOI 10.1007/BF00302357; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Munne S, 1998, HUM REPROD UPDATE, V4, P842, DOI 10.1093/humupd/4.6.842; Nagy A., 2003, MANIPULATING MOUSE E; NEWPORT J, 1989, J CELL SCI, P149; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Ohsugi M, 2003, EMBO J, V22, P2091, DOI 10.1093/emboj/cdg208; Onishi M, 1996, EXP HEMATOL, V24, P324; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Shiroguchi K, 2003, J BIOL CHEM, V278, P22460, DOI 10.1074/jbc.M212274200; SIRACUSA G, 1980, J EMBRYOL EXP MORPH, V60, P71; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Yamagata K, 2005, GENESIS, V43, P71, DOI 10.1002/gene.20158; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 2001, CURR BIOL, V11, P208, DOI 10.1016/S0960-9822(01)00053-7; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	35	69	69	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					771	782		10.1016/j.cell.2008.01.029	http://dx.doi.org/10.1016/j.cell.2008.01.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329364	Bronze			2022-12-28	WOS:000253818000015
J	Shneiderman, B				Shneiderman, Ben			Computer science - Science 2.0	SCIENCE			English	Editorial Material									[Shneiderman, Ben] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Shneiderman, B (corresponding author), Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA.	ben@cs.umd.edu						Bainbridge WS, 2007, SCIENCE, V317, P472, DOI 10.1126/science.1146930; Berners-Lee T, 2006, SCIENCE, V313, P769, DOI 10.1126/science.1126902; BOS N, 2007, J COMPUTER MEDIATED, V12, P2; Fischer G, 2004, SOCIAL CAPTIAL AND INFORMATION TECHNOLOGY, P355; HILTZ R, 1993, NETWORK NATION; HILTZ SR, 2005, LEARNING ONLINE TOGE; Kaptelinin V., 2006, ACTING TECHNOLOGY; Maloney-Krichmar D., 2005, ACM Transactions on Computer-Human Interaction, V12, P201, DOI 10.1145/1067860.1067864; MUMFORD E, 2000, REQUIR ENG, V2, P59; SHNEIDERMAN B, 2002, LEONARDOS LAPTOP HUM; Shneiderman B, 2007, SCIENCE, V315, P944, DOI 10.1126/science.1139088; Suchman L., 1987, PLANS SITUATED ACTIO; Welser HT, 2007, J SOC STRUCT, V8, P2; Yin R.K, 2011, CASE STUDY RES DESIG	14	105	107	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1349	1350		10.1126/science.1153539	http://dx.doi.org/10.1126/science.1153539			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323442				2022-12-28	WOS:000253712900031
J	von Bubnoff, A				von Bubnoff, Andreas			Next-generation sequencing: The race is on	CELL			English	Editorial Material																			0	103	108	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					721	723		10.1016/j.cell.2008.02.028	http://dx.doi.org/10.1016/j.cell.2008.02.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329356	Bronze			2022-12-28	WOS:000253818000006
J	Christner, BC; Morris, CE; Foreman, CM; Cai, RM; Sands, DC				Christner, Brent C.; Morris, Cindy E.; Foreman, Christine M.; Cai, Rongman; Sands, David C.			Ubiquity of biological ice nucleators in snowfall	SCIENCE			English	Article							PROTEINS; BACTERIA		[Christner, Brent C.; Cai, Rongman] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Morris, Cindy E.] INRA, Unite Pathol Vegetale UR407, F-84140 Montfavet, France; [Foreman, Christine M.] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA; [Foreman, Christine M.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Sands, David C.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	Louisiana State University System; Louisiana State University; INRAE; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Christner, BC (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	xner@lsu.edu	Cai, Rongman/C-5998-2015	Cai, Rongman/0000-0003-2404-4852; Foreman, Christine/0000-0003-0230-4692				Jaenicke R, 2005, SCIENCE, V308, P73, DOI 10.1126/science.1106335; Kawahara H, 2002, J BIOSCI BIOENG, V94, P492, DOI 10.1016/S1389-1723(02)80185-2; LINDOW SE, 1989, MOL PLANT MICROBE IN, V2, P262, DOI 10.1094/MPMI-2-262; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Morris CE, 2004, J PHYS IV, V121, P87, DOI 10.1051/jp4:2004121004; Vali G., 1995, BIOL ICE NUCL ITS AP	6	251	263	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1214	1214		10.1126/science.1149757	http://dx.doi.org/10.1126/science.1149757			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309078	Green Submitted			2022-12-28	WOS:000253530600034
J	Olsen, SR; Wilson, RI				Olsen, Shawn R.; Wilson, Rachel I.			Lateral presynaptic inhibition mediates gain control in an olfactory circuit	NATURE			English	Article							DROSOPHILA ANTENNAL LOBE; CENTER-SURROUND INHIBITION; BULB GLOMERULI; ODOR QUALITY; MITRAL CELLS; NEURONS; REPRESENTATIONS; MECHANISMS; RECEPTORS; INPUT	Olfactory signals are transduced by a large family of odorant receptor proteins, each of which corresponds to a unique glomerulus in the first olfactory relay of the brain. Crosstalk between glomeruli has been proposed to be important in olfactory processing, but it is not clear how these interactions shape the odour responses of second- order neurons. In the Drosophila antennal lobe ( a region analogous to the vertebrate olfactory bulb), we selectively removed most interglomerular input to genetically identified second- order olfactory neurons. Here we show that this broadens the odour tuning of these neurons, implying that interglomerular inhibition dominates over interglomerular excitation. The strength of this inhibitory signal scales with total feedforward input to the entire antennal lobe, and has similar tuning in different glomeruli. A substantial portion of this interglomerular inhibition acts at a presynaptic locus, and our results imply that this is mediated by both ionotropic and metabotropic receptors on the same nerve terminal.	[Olsen, Shawn R.; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012	Olsen, Shawn/0000-0002-9568-7057; Wilson, Rachel/0000-0001-8573-9266	NIDCD NIH HHS [R01 DC008174, R01 DC008174-03] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; CHAPUT M, 1980, J PHYSIOL-PARIS, V76, P551; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Distler PG, 1997, J COMP NEUROL, V383, P529, DOI 10.1002/(SICI)1096-9861(19970714)383:4&lt;529::AID-CNE9&gt;3.0.CO;2-4; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Fischer Y, 1996, J NEUROPHYSIOL, V76, P3807, DOI 10.1152/jn.1996.76.6.3807; Fischer Y, 1996, J NEUROPHYSIOL, V75, P1377, DOI 10.1152/jn.1996.75.4.1377; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Laissue PP, 1999, J COMP NEUROL, V405, P543; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MATHEWS DF, 1972, BRAIN RES, V47, P389, DOI 10.1016/0006-8993(72)90647-6; MATTHEWS G, 1994, J NEUROSCI, V14, P1079, DOI 10.1523/JNEUROSCI.14-03-01079.1994; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; MEREDITH M, 1978, J GEN PHYSIOL, V71, P615, DOI 10.1085/jgp.71.6.615; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; NICKELL WT, 1994, BRAIN RES BULL, V35, P119, DOI 10.1016/0361-9230(94)90091-4; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; SHIBUYA T, 1962, P JPN ACAD, V38, P231, DOI 10.2183/pjab1945.38.231; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; STUART GJ, 1992, J PHYSIOL-LONDON, V447, P675, DOI 10.1113/jphysiol.1992.sp019023; TANABE T, 1975, J NEUROPHYSIOL, V38, P1284, DOI 10.1152/jn.1975.38.5.1284; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Vucinic D, 2006, J NEUROPHYSIOL, V95, P1881, DOI 10.1152/jn.00918.2005; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	42	324	328	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					956	U3		10.1038/nature06864	http://dx.doi.org/10.1038/nature06864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18344978	Green Accepted			2022-12-28	WOS:000255208600031
J	Watson-Jones, D; Weiss, HA; Rusizoka, M; Changalucha, J; Baisley, K; Mugeye, K; Tanton, C; Ross, D; Everett, D; Clayton, T; Balira, R; Knight, L; Hambleton, I; Le Goff, J; Belec, L; Hayes, R				Watson-Jones, Deborah; Weiss, Helen A.; Rusizoka, Mary; Changalucha, John; Baisley, Kathy; Mugeye, Kokugonza; Tanton, Clare; Ross, David; Everett, Dean; Clayton, Tim; Balira, Rebecca; Knight, Louise; Hambleton, Ian; Le Goff, Jerome; Belec, Laurent; Hayes, Richard			Effect of herpes simplex suppression on incidence of HIV among women in Tanzania	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	17th Meeting of the International-Society-for-Sexually-Transmitted-Diseases-Research	JUL 29-AUG 01, 2007	Seattle, WA	Int Soc Sexually Transmitted Dis Res			HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED INFECTIONS; NORTHERN TANZANIA; TYPE-2 INFECTION; GENITAL HERPES; RURAL TANZANIA; RISK-FACTORS; SEX WORKERS; ACYCLOVIR; TRIAL	Background: Infection with herpes simplex virus type 2 (HSV-2) is associated with an increased risk of acquiring infection with the human immunodeficiency virus (HIV). This study tested the hypothesis that HSV-2 suppressive therapy reduces the risk of HIV acquisition. Methods: Female workers at recreational facilities in northwestern Tanzania who were 16 to 35 years of age were interviewed and underwent serologic testing for HIV and HSV-2. We enrolled female workers who were HIV-seronegative and HSV-2-seropositive in a randomized, double-blind, placebo-controlled trial of suppressive treatment with acyclovir (400 mg twice daily). Participants attended mobile clinics every 3 months for a follow-up period of 12 to 30 months, depending on enrollment date. The primary outcome was the incidence of infection with HIV. We used a modified intention-to-treat analysis; data for participants who became pregnant were censored. Adherence to treatment was estimated by a tablet count at each visit. Results: A total of 821 participants were randomly assigned to receive acyclovir (400 participants) or placebo (421 participants); 679 (83%) completed follow-up. Mean follow-up for the acyclovir and placebo groups was 1.52 and 1.62 years, respectively. The incidence of HIV infection was 4.27 per 100 person-years (27 participants in the acyclovir group and 28 in the placebo group), and there was no overall effect of acyclovir on the incidence of HIV (rate ratio for the acyclovir group, 1.08; 95% confidence interval, 0.64 to 1.83). The estimated median adherence was 90%. Genital HSV was detected in a similar proportion of participants in the two study groups at 6, 12, and 24 months. No serious adverse events were attributable to treatment with acyclovir. Conclusions: These data show no evidence that acyclovir (400 mg twice daily) as HSV suppressive therapy decreases the incidence of infection with HIV. (Current Controlled Trials number, ISRCTN35385041.).	[Watson-Jones, Deborah; Weiss, Helen A.; Baisley, Kathy; Tanton, Clare; Ross, David; Everett, Dean; Clayton, Tim; Knight, Louise; Hambleton, Ian; Hayes, Richard] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; [Watson-Jones, Deborah; Rusizoka, Mary; Mugeye, Kokugonza] African Med & Res Fdn, Mwanza, Tanzania; [Changalucha, John; Baisley, Kathy; Tanton, Clare; Everett, Dean; Balira, Rebecca; Knight, Louise; Hambleton, Ian] Natl Inst Med Res, Mwanza, Tanzania; [Le Goff, Jerome] Hop St Louis, Microbiol Lab, Paris, France; [Belec, Laurent] INSERM, Unite 743, Paris, France; [Belec, Laurent] Univ Paris 05, Paris, France	University of London; London School of Hygiene & Tropical Medicine; African Medical & Research Foundation (AMREF); National Institute of Medical Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Watson-Jones, D (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	deborah.watson-jones@lshtm.ac.uk	Hambleton, Ian/AAP-3519-2020; le goff, jerome/B-3447-2016; weiss, helen/ABC-7823-2021; LeGoff, jerome/AAP-7880-2021	Hambleton, Ian/0000-0002-5638-9794; le goff, jerome/0000-0001-7111-1865; weiss, helen/0000-0003-3547-7936; Tanton, Clare/0000-0002-4612-1858; Clayton, Tim/0000-0002-1266-3288; Hayes, Richard/0000-0002-1729-9892; Mabey, David/0000-0002-0031-8276; Everett, Dean/0000-0002-8458-6779; Cowan, Frances/0000-0003-3087-4422; Kapiga, Saidi/0000-0003-1753-4060	Medical Research Council [G0400456, G0700837, G0501954] Funding Source: Medline; Wellcome Trust [066688] Funding Source: Medline; MRC [G0400456, G0501954, G0700837] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAETEN JM, 2007, 17 INT SOC SEX TRANS; Benedetti JK, 1999, ANN INTERN MED, V131, P14, DOI 10.7326/0003-4819-131-1-199907060-00004; Chen CY, 2000, SEX TRANSM DIS, V27, P21, DOI 10.1097/00007435-200001000-00005; Conant MA, 2002, INT J STD AIDS, V13, P12, DOI 10.1258/0956462021924550; Cowan FF, 2006, AIDS, V20, P261, DOI 10.1097/01.aids.0000198086.39831.4a; DELANY S, 2007, 14 C RETR OPP INF LO; DUNNE E, 2007, 14 C RETR OPP INF LO; Fonck K, 2000, INT J STD AIDS, V11, P804, DOI 10.1258/0956462001915327; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; Gwanzura L, 1998, J INFECT DIS, V177, P481, DOI 10.1086/517381; HAYES TL, P 27 ANN INT C IEEE; Joint UN Programme on HIV/AIDS, 2006 REP GLOB AIDS E; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Kapiga SH, 2003, SEX TRANSM DIS, V30, P187, DOI 10.1097/00007435-200303000-00001; KOELLE DM, 1992, ANN INTERN MED, V116, P433, DOI 10.7326/0003-4819-116-6-433; Loregian A, 2001, J CHROMATOGR B, V764, P289, DOI 10.1016/S0378-4347(01)00379-6; MARK KE, 2007, 17 INT SOC SEX TRANS; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Obasi A, 1999, J INFECT DIS, V179, P16, DOI 10.1086/314555; Perry CM, 1996, DRUGS, V52, P754, DOI 10.2165/00003495-199652050-00009; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Riedner G, 2003, SEX TRANSM INFECT, V79, P382, DOI 10.1136/sti.79.5.382; RIEDNER G, 2001, 14 INT SOC SEX TRANS; Rodriguez MDM, 2002, AIDS, V16, P451; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; TANTON C, 2007, INT AIDS SOC C SYDN; Vallely A, 2007, SEX TRANSM DIS, V34, P638, DOI 10.1097/OLQ.0b013e3180325120; Vriesendorp R, 2007, EUR J CLIN PHARMACOL, V63, P1115, DOI 10.1007/s00228-007-0369-2; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	33	252	261	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 10	2008	358	15					1560	1571		10.1056/NEJMoa0800260	http://dx.doi.org/10.1056/NEJMoa0800260			12	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	285NK	18337596	Green Accepted			2022-12-28	WOS:000254783300005
J							US Preventive Serv Task Force	Screening for chronic obstructive pulmonary disease using spirometry: US preventive services task force recommendation statement	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINE; NUTRITION-EXAMINATION; GENERAL-PRACTICE; NATIONAL-HEALTH; LUNG-DISEASE; DIAGNOSIS; MANAGEMENT; TRIAL; COPD	Description: New U.S. Preventive Services Task Force (USPSTF) recommendation about screening for chronic obstructive pulmonary disease (COPD) using spirometry. Methods: The USPSTF weighed the benefits (prevention of >= 1 exacerbation and improvement in respiratory-related health status measures) and harms (time and effort required by both patients and the health care system, false-positive screening tests, and adverse effects of subsequent unnecessary therapy) of COPD screening identified in the accompanying review of the evidence. The USPSTF did not consider the financial costs of spirometry testing or COPD therapies. Recommendation: Do not screen adults for COPD using spirometry. (Grade D recommendation).	[US Preventive Serv Task Force] US Prevent Serv Task Force Agcy Healthcare Res &, Rockville, MD USA									Buffels J, 2006, RESP MED, V100, P2012, DOI 10.1016/j.rmed.2006.02.014; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Global Initiative for Chronic Obstructive Lung Disease, 2007, GLOB STRAT DIAGN MAN; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Lin K, 2008, ANN INTERN MED, V148, P535, DOI 10.7326/0003-4819-148-7-200804010-00213; Mannino DM, 2000, ARCH INTERN MED, V160, P1683, DOI 10.1001/archinte.160.11.1683; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; Qaseem A, 2007, ANN INTERN MED, V147, P633, DOI 10.7326/0003-4819-147-9-200711060-00008; SEGNAN N, 1991, CANCER CAUSE CONTROL, V2, P239, DOI 10.1007/BF00052140; *US PREV SERV TASK, 2003, COUS PREV TOB US TOB; VEDAL S, 1983, B EUR PHYSIOPATH RES, V19, P263; Wilt TJ, 2007, ANN INTERN MED, V147, P639, DOI 10.7326/0003-4819-147-9-200711060-00009; Wilt TJ, 2005, AHRQ PUBLICATION	13	97	97	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2008	148	7					529	534		10.7326/0003-4819-148-7-200804010-00212	http://dx.doi.org/10.7326/0003-4819-148-7-200804010-00212			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284IV	18316747				2022-12-28	WOS:000254701000005
J	Dreber, A; Rand, DG; Fudenberg, D; Nowak, MA				Dreber, Anna; Rand, David G.; Fudenberg, Drew; Nowak, Martin A.			Winners don't punish	NATURE			English	Article							ALTRUISTIC PUNISHMENT; REPEATED GAMES; COOPERATION; EVOLUTION; RECIPROCITY	A key aspect of human behaviour is cooperation(1-7). We tend to help others even if costs are involved. We are more likely to help when the costs are small and the benefits for the other person significant. Cooperation leads to a tension between what is best for the individual and what is best for the group. A group does better if everyone cooperates, but each individual is tempted to defect. Recently there has been much interest in exploring the effect of costly punishment on human cooperation(8-23). Costly punishment means paying a cost for another individual to incur a cost. It has been suggested that costly punishment promotes cooperation even in non- repeated games and without any possibility of reputation effects(10). But most of our interactions are repeated and reputation is always at stake. Thus, if costly punishment is important in promoting cooperation, it must do so in a repeated setting. We have performed experiments in which, in each round of a repeated game, people choose between cooperation, defection and costly punishment. In control experiments, people could only cooperate or defect. Here we show that the option of costly punishment increases the amount of cooperation but not the average payoff of the group. Furthermore, there is a strong negative correlation between total payoff and use of costly punishment. Those people who gain the highest total payoff tend not to use costly punishment: winners don't punish. This suggests that costly punishment behaviour is maladaptive in cooperation games and might have evolved for other reasons.	[Dreber, Anna; Rand, David G.; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Rand, David G.] Harvard Univ, Dept Syst Biol, Cambridge, MA 02138 USA; [Fudenberg, Drew] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolut Biol, Cambridge, MA 02138 USA; [Dreber, Anna] Stockholm Sch Econ, Dept Econ, S-11358 Stockholm, Sweden	Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Stockholm School of Economics	Nowak, MA (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Rand, David G./B-3716-2009; Dreber, Anna/D-8709-2010; Nowak, Martin A/A-6977-2008	Rand, David G./0000-0002-2821-468X; Rand, David/0000-0001-8975-2783	NIGMS NIH HHS [R01 GM078986-02, R01 GM078986] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BINMORE KG, 1992, J ECON THEORY, V57, P278, DOI 10.1016/0022-0531(92)90037-I; Bochet O, 2006, J ECON BEHAV ORGAN, V60, P11, DOI 10.1016/j.jebo.2003.06.006; BOTELHO A, 2005, 0523 U CENTR FLOR CO; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Carpenter J., 2006, 0602 MIDDL COLL; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Colman AM, 2013, GAME THEORY ITS APPL; Dal Bo P, 2005, AM ECON REV, V95, P1591; Denant-Boemont L, 2007, ECON THEOR, V33, P145, DOI 10.1007/s00199-007-0212-0; EGAS M, 2005, 1646 IZA I STUD LAB; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; FUDENBERG D, 1990, AM ECON REV, V80, P274; FUDENBERG D, 1993, ADV EC THEOR 6 WORLD, P89; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; HARDIN G, 1968, SCIENCE, V162, P1248; NIKIFORAKIS N, 2005, 0507 ROYAL HOLL U LO; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Page T, 2005, ECON J, V115, P1032, DOI 10.1111/j.1468-0297.2005.01031.x; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Samuelson L, 2005, J ECON LIT, V43, P65, DOI 10.1257/0022051053737816; SEFTON M, 2006, 2006005 CAEPR IND U; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	30	458	466	2	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					348	351		10.1038/nature06723	http://dx.doi.org/10.1038/nature06723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276BX	18354481	Green Accepted, Green Submitted			2022-12-28	WOS:000254117400046
J	Bashor, CJ; Helman, NC; Yan, SD; Lim, WA				Bashor, Caleb J.; Helman, Noah C.; Yan, Shude; Lim, Wendell A.			Using engineered scaffold interactions to reshape MAP kinase pathway signaling dynamics	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; ERK ACTIVATION; STE5 SCAFFOLD; SPECIFICITY; YEAST; CASCADE; TRANSIENT; PROTEINS; SYSTEM; DROSOPHILA	Scaffold proteins link signaling molecules into linear pathways by physically assembling them into complexes. Scaffolds may also have a higher- order role as signal- processing hubs, serving as the target of feedback loops that optimize signaling amplitude and timing. We demonstrate that the Ste5 scaffold protein can be used as a platform to systematically reshape output of the yeast mating MAP kinase pathway. We constructed synthetic positive- and negative- feedback loops by dynamically regulating recruitment of pathway modulators to an artificial binding site on Ste5. These engineered circuits yielded diverse behaviors: ultrasensitive dose response, accelerated or delayed response times, and tunable adaptation. Protein scaffolds provide a flexible platform for reprogramming cellular responses and could be exploited to engineer cells with novel therapeutic and biotechnological functions.	[Bashor, Caleb J.; Helman, Noah C.; Yan, Shude; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Bashor, Caleb J.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu						Acharya A, 2002, BIOCHEMISTRY-US, V41, P14122, DOI 10.1021/bi020486r; ALBERTS B, 2003, ESSENTIAL CELL BIOL; Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Choi BK, 2004, NEUROTOXICOLOGY, V25, P915, DOI 10.1016/j.neuro.2004.06.002; CHOI KY, 1994, CELL, V78, P499; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; FERRELL JE, 2000, SCI STKE, pPE1; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; PRINTEN JA, 1994, GENETICS, V138, P609; Ptashne M, 2001, GENES SIGNALS; Ramezani-Rad M, 2003, CURR GENET, V43, P161, DOI 10.1007/s00294-003-0383-6; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Villedieu M, 2006, GYNECOL ONCOL, V101, P507, DOI 10.1016/j.ygyno.2005.11.017; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690	36	260	271	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1539	1543		10.1126/science.1151153	http://dx.doi.org/10.1126/science.1151153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339942				2022-12-28	WOS:000253943800043
J	Esteller, M				Esteller, Manel			Molecular origins of cancer: Epigenetics in cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TUMOR-SUPPRESSOR GENE; O-6-METHYLGUANINE DNA METHYLTRANSFERASE; HISTONE DEACETYLASE INHIBITOR; H4 LYSINE-20 TRIMETHYLATION; METHYLATION-SPECIFIC PCR; CPG-ISLAND METHYLATION; PROMOTER HYPERMETHYLATION; PROSTATE-CANCER; CHROMOSOMAL INSTABILITY; INACTIVATION		[Esteller, Manel] Spanish Natl Canc Res Ctr, Canc Epigenet Lab, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Esteller, M (corresponding author), Spanish Natl Canc Res Ctr, Canc Epigenet Lab, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	mesteller@cnio.es	Esteller, Manel/L-5956-2014	Esteller, Manel/0000-0003-4490-6093				Agrelo R, 2006, P NATL ACAD SCI USA, V103, P8822, DOI 10.1073/pnas.0600645103; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; Beltran A, 2007, ONCOGENE, V26, P2791, DOI 10.1038/sj.onc.1210072; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bestor TH, 2005, CELL, V122, P322, DOI 10.1016/j.cell.2005.07.024; Bodey B, 2002, EXPERT OPIN BIOL TH, V2, P577, DOI 10.1517/14712598.2.6.577; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Cairns P, 2001, CLIN CANCER RES, V7, P2727; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Cimmino A, 2006, P NATL ACAD SCI USA, V103, P2464, DOI 10.1073/pnas.0510793103; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; Esteller M, 2000, NEW ENGL J MED, V343, P1740; Esteller M, 2006, BRIT J CANCER, V94, P179, DOI 10.1038/sj.bjc.6602918; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; Esteller M, 1999, CANCER RES, V59, P67; Esteller M, 2005, EMBO REP, V6, P624, DOI 10.1038/sj.embor.7400456; Esteller M, 1999, CANCER RES, V59, P793; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2004, ONCOGENE, V23, P1, DOI 10.1038/sj.onc.1207316; Esteller M, 1998, CANCER RES, V58, P4515; Esteller M, 2001, CANCER RES, V61, P3225; Esteller M, 2002, J NATL CANCER I, V94, P26; Esteller M, 1999, CANCER RES, V59, P3853; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fackler MJ, 2006, CLIN CANCER RES, V12, P3306, DOI 10.1158/1078-0432.CCR-05-2733; Feinberg AP, 1999, CANCER RES, V59, p1743S; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feinberg AP, 2002, SEMIN CANCER BIOL, V12, P389, DOI 10.1016/S1044-579X(02)00059-7; Feng QH, 2005, JNCI-J NATL CANCER I, V97, P273, DOI 10.1093/jnci/dji041; Ferreri AJM, 2004, BRIT J HAEMATOL, V126, P657, DOI 10.1111/j.1365-2141.2004.05109.x; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fraga MF, 2004, CANCER RES, V64, P5527, DOI 10.1158/0008-5472.CAN-03-4061; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; Grady WM, 2000, NAT GENET, V26, P16, DOI 10.1038/79120; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hau P, 2007, DIS MARKERS, V23, P97, DOI 10.1155/2007/159242; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; HERMAN JG, 1995, CANCER RES, V55, P4525; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Holm TM, 2006, CANCER CELL, V9, P69, DOI 10.1016/j.ccr.2005.12.028; Holm TM, 2005, CANCER CELL, V8, P433, DOI 10.1016/j.ccr.2005.10.006; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Hoque MO, 2005, J CLIN ONCOL, V23, P6569, DOI 10.1200/JCO.2005.07.009; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jeronimo C, 2001, J NATL CANCER I, V93, P1747, DOI 10.1093/jnci/93.22.1747; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jones PA, 2005, CANCER RES, V65, P11241, DOI 10.1158/0008-5472.CAN-05-3865; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaneda A, 2005, CANCER RES, V65, P11236, DOI 10.1158/0008-5472.CAN-05-2959; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Komine C, 2003, BRAIN PATHOL, V13, P176; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambic A, 2007, CANCER RES, V67, P3492; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Mack GS, 2006, J NATL CANCER I, V98, P1443, DOI 10.1093/jnci/djj447; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Moore Michael, 2003, Briefings in Functional Genomics & Proteomics, V1, P342, DOI 10.1093/bfgp/1.4.342; Muller CI, 2006, CURR PHARM BIOTECHNO, V7, P315, DOI 10.2174/138920106778521523; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Oki Y, 2007, CRIT REV ONCOL HEMAT, V61, P140, DOI 10.1016/j.critrevonc.2006.07.010; Ozdag H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-90; Pogribny IP, 2006, CARCINOGENESIS, V27, P1180, DOI 10.1093/carcin/bgi364; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Ropero S, 2006, NAT GENET, V38, P566, DOI 10.1038/ng1773; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; SAKAI T, 1991, AM J HUM GENET, V48, P880; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Strathdee G, 1999, ONCOGENE, V18, P2335, DOI 10.1038/sj.onc.1202540; Tryndyak VP, 2006, CANCER BIOL THER, V5, P65, DOI 10.4161/cbt.5.1.2288; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Vire E, 2007, NATURE, V446, P824, DOI 10.1038/nature05710; Waddington CH, 1939, P NATL ACAD SCI USA, V25, P299, DOI 10.1073/pnas.25.7.299; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yamada Y, 2005, P NATL ACAD SCI USA, V102, P13580, DOI 10.1073/pnas.0506612102; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P121, DOI [10.1056/NEJMra072067, DOI 10.1056/NEJMRA072067]	108	2625	2758	19	837	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1148	1159		10.1056/NEJMra072067	http://dx.doi.org/10.1056/NEJMra072067			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337604	Green Published			2022-12-28	WOS:000253877200008
J	Gillam, S				Gillam, Stephen			Is the declaration of Alma Ata still relevant to primary health care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COUNTRIES; SYSTEMS; GOALS		[Gillam, Stephen] Inst Publ Hlth, Cambridge CB2 2SR, England	University of Cambridge	Gillam, S (corresponding author), Inst Publ Hlth, Cambridge CB2 2SR, England.	sjg67@medschl.cam.ac.uk						BLANCHET H, 2003, HUMAN RESOURCE CRISI; Brady MA, 2006, TRENDS PARASITOL, V22, P285, DOI 10.1016/j.pt.2006.05.007; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Bryce J, 2005, HLTH POLICY PLAN S1, V20, pi5, DOI [10.1093/heapol/czi055, DOI 10.1093/HEAPOL/CZI055]; De Maeseneer J, 2008, BRIT J GEN PRACT, V58, P3, DOI 10.3399/bjgp08X263721; DeMaeseneer J, 2007, PRIMARY HLTH CARE ST; DERIVERO DAT, 2003, PERSPECTIVES HLTH MA, V8, P1; Doherty J, 2004, COST EFFECTIVENESS P; Freedman LP., 2005, DEVELOPMENT, V48, P19, DOI DOI 10.1057/PALGRAVE.DEVELOPMENT.1100107; Gilson L, 2007, WHO COMM SOC DET HLT; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; Meads G., 2006, PRIMARY CARE 21 CENT; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; *NHS CTR REV DISS, 2000, EV SYST REV RES REL; Pollock A, 2007, BMJ-BRIT MED J, V335, P475, DOI 10.1136/bmj.39303.425359.AD; SKOUFIS E, 2005, 139 IFPRI; Standing H., 2004, UNDERSTANDING DEMAND; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Unger J.-P., 2006, INT J INTEGR CARE, V6, P1; Unger JP, 2002, INT J HEALTH SERV, V32, P799, DOI 10.2190/FN20-AGDQ-GYCP-P8R6; United Nations, 2007, MILL DEV GOALS REP 2; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6; WAGSTAFF M, 2004, MILLENNIUM DEV GOALS, P111; WEINER J, 2002, LESSONS SMALL ISLAND; World Bank, 1994, BETT HLTH AFR EXP LE; World Health Organization, 1978, DECL ALM AT INT C PR	27	54	57	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2008	336	7643					536	538		10.1136/bmj.39469.432118.AD	http://dx.doi.org/10.1136/bmj.39469.432118.AD			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JV	18325964	Green Published			2022-12-28	WOS:000253998500027
J	Muller, RD; Sdrolias, M; Gaina, C; Steinberger, B; Heine, C				Muller, R. Dietmar; Sdrolias, Maria; Gaina, Carmen; Steinberger, Bernhard; Heine, Christian			Long-term sea-level fluctuations driven by ocean basin dynamics	SCIENCE			English	Article							TECTONIC MODEL; MANTLE; AGE; TOPOGRAPHY; BOUNDARIES; CYCLES; DEPTH; FLOW	Earth's long- term sea- level history is characterized by widespread continental flooding in the Cretaceous period (similar to 145 to 65 million years ago), followed by gradual regression of inland seas. However, published estimates of the Late Cretaceous sea- level high differ by half an order of magnitude, from similar to 40 to similar to 250 meters above the present level. The low estimate is based on the stratigraphy of the New Jersey margin. By assimilating marine geophysical data into reconstructions of ancient ocean basins, we model a Late Cretaceous sea level that is 170 ( 85 to 270) meters higher than it is today. We use a mantle convection model to suggest that New Jersey subsided by 105 to 180 meters in the past 70 million years because of North America's westward passage over the subducted Farallon plate. This mechanism reconciles New Jersey margin - based sea- level estimates with ocean basin reconstructions.	[Muller, R. Dietmar; Sdrolias, Maria; Heine, Christian] Univ Sydney, Sch Geosci, EarthByte Grp, Sydney, NSW 2006, Australia; [Gaina, Carmen; Steinberger, Bernhard] Geol Survey Norway, Ctr Geodynam, N-7491 Trondheim, Norway	University of Sydney; Geological Survey of Norway	Muller, RD (corresponding author), Univ Sydney, Sch Geosci, EarthByte Grp, Bldg H11, Sydney, NSW 2006, Australia.	dietmar@geosci.usyd.edu.au	Steinberger, Bernhard/AAG-7148-2019; Seton, Maria/H-8272-2013; Müller, Dietmar/L-1200-2019; Gaina, Carmen/I-5213-2015; Steinberger, Bernhard/ABB-9204-2021	Steinberger, Bernhard/0000-0002-3643-3049; Seton, Maria/0000-0001-8541-1367; Müller, Dietmar/0000-0002-3334-5764; Gaina, Carmen/0000-0001-5533-8103; 				[Anonymous], 1990, E PACIFIC OCEAN HAWA, P15; Becker TW, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000168; BOND GC, 1979, TECTONOPHYSICS, V61, P285, DOI 10.1016/0040-1951(79)90302-0; COFFIN MF, 1992, GEOL SOC SPEC PUBL, P17; Cogne JP, 2006, EARTH PLANET SC LETT, V245, P115, DOI 10.1016/j.epsl.2006.03.020; Conrad CP, 2007, GEOLOGY, V35, P29, DOI 10.1130/G22759A.1; Cox A., 2009, PLATE TECTONICS IT W; Crosby AG, 2006, GEOPHYS J INT, V166, P553, DOI 10.1111/j.1365-246X.2006.03015.x; Doin MP, 2000, GEOPHYS J INT, V143, P582, DOI 10.1046/j.1365-246X.2000.00229.x; Engebretson D., 1985, GEOL SOC AM SPEC PAP, V206, P1, DOI DOI 10.1130/SPE206-P1; Grand SP, 2002, PHILOS T R SOC A, V360, P2475, DOI 10.1098/rsta.2002.1077; HALLAM A, 1963, AM J SCI, V261, P397, DOI 10.2475/ajs.261.5.397; Haq BU, 2005, GEOARABIA, V10, P127; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harrison C. G. A., 1990, SEA LEVEL CHANGE, P141; HAYS JD, 1973, NATURE, V246, P18, DOI 10.1038/246018a0; Heine C, 2004, GEOPHYS MONOGR SER, V149, P37, DOI 10.1029/149GM03; HELLER PL, 1985, EARTH PLANET SC LETT, V75, P417, DOI 10.1016/0012-821X(85)90185-2; Kominz M. A., 1984, AM ASS PET GEOL, V36, P109; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Muller RD, 1998, NATURE, V396, P455, DOI 10.1038/24850; Muller RD, 1997, J GEOPHYS RES-SOL EA, V102, P3211, DOI 10.1029/96JB01781; NAKANISHI M, 1992, GEOPHYS RES LETT, V19, P693, DOI 10.1029/92GL00022; PARSONS B, 1982, J GEOPHYS RES, V87, P289, DOI 10.1029/JB087iB01p00289; PITMAN WC, 1978, GEOL SOC AM BULL, V89, P1389, DOI 10.1130/0016-7606(1978)89<1389:RBEASS>2.0.CO;2; Ritsema J, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002610; ROSS MI, 1988, TECTONOPHYSICS, V155, P139, DOI 10.1016/0040-1951(88)90263-6; Rowley DB, 2002, GEOL SOC AM BULL, V114, P927, DOI 10.1130/0016-7606(2002)114<0927:ROPCAD>2.0.CO;2; SCHUBERT G, 1989, EARTH PLANET SC LETT, V92, P234, DOI 10.1016/0012-821X(89)90049-6; Stampfli GM, 2002, EARTH PLANET SC LETT, V196, P17, DOI 10.1016/S0012-821X(01)00588-X; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; Steinberger B, 2004, NATURE, V430, P167, DOI 10.1038/nature02660; Steinberger B, 2007, PHYS EARTH PLANET IN, V164, P2, DOI 10.1016/j.pepi.2007.04.021; Sykes TJS, 1996, MAR GEOL, V133, P35, DOI 10.1016/0025-3227(96)00016-3; Torsvik TH, 2006, GEOPHYS J INT, V167, P1447, DOI 10.1111/j.1365-246X.2006.03158.x; TURCOTTE DL, 1967, J FLUID MECH, V28, P29, DOI 10.1017/S0022112067001880; Watts A.B., 1984, MAR PETROL GEOL, V1, P319, DOI DOI 10.1016/0264-8172(84)90134-X; WATTS AB, 1979, DEEP DRILLING RESULT, V3, P235; Whittaker JM, 2007, SCIENCE, V318, P83, DOI 10.1126/science.1143769; Xu XQ, 2006, EARTH PLANET SC LETT, V243, P552, DOI 10.1016/j.epsl.2006.01.010	41	518	561	9	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1357	1362		10.1126/science.1151540	http://dx.doi.org/10.1126/science.1151540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323446				2022-12-28	WOS:000253712900035
J	Thompson, JD; Zwickl, BM; Jayich, AM; Marquardt, F; Girvin, SM; Harris, JGE				Thompson, J. D.; Zwickl, B. M.; Jayich, A. M.; Marquardt, Florian; Girvin, S. M.; Harris, J. G. E.			Strong dispersive coupling of a high-finesse cavity to a micromechanical membrane	NATURE			English	Article							RADIATION; PHOTON; NOISE; BAND	Macroscopic mechanical objects and electromagnetic degrees of freedom can couple to each other through radiation pressure. Optomechanical systems in which this coupling is sufficiently strong are predicted to show quantum effects and are a topic of considerable interest. Devices in this regime would offer new types of control over the quantum state of both light and matter(1-4), and would provide a new arena in which to explore the boundary between quantum and classical physics(5-7). Experiments so far have achieved sufficient optomechanical coupling to laser- cool mechanical devices(8-12), but have not yet reached the quantum regime. The outstanding technical challenge in this field is integrating sensitive micromechanical elements ( which must be small, light and flexible) into high- finesse cavities ( which are typically rigid and massive) without compromising the mechanical or optical properties of either. A second, and more fundamental, challenge is to read out the mechanical element's energy eigenstate. Displacement measurements ( no matter how sensitive) cannot determine an oscillator's energy eigenstate(13), and measurements coupling to quantities other than displacement(14-16) have been difficult to realize in practice. Here we present an optomechanical system that has the potential to resolve both of these challenges. We demonstrate a cavity which is detuned by the motion of a 50-nm- thick dielectric membrane placed between two macroscopic, rigid, high- finesse mirrors. This approach segregates optical and mechanical functionality to physically distinct structures and avoids compromising either. It also allows for direct measurement of the square of the membrane's displacement, and thus in principle the membrane's energy eigenstate. We estimate that it should be practical to use this scheme to observe quantum jumps of a mechanical system, an important goal in the field of quantum measurement.	[Thompson, J. D.; Zwickl, B. M.; Jayich, A. M.; Girvin, S. M.; Harris, J. G. E.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Marquardt, Florian] Univ Munich, Dept Phys, Ctr Nanosci, D-80333 Munich, Germany; [Marquardt, Florian] Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, D-80333 Munich, Germany; [Girvin, S. M.; Harris, J. G. E.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	Yale University; University of Munich; University of Munich; Yale University	Harris, JGE (corresponding author), Yale Univ, Dept Phys, 217 Prospect St, New Haven, CT 06520 USA.	jack.harris@yale.edu	Harris, Jack/AAA-3829-2020; Marquardt, Florian/C-2533-2008	Marquardt, Florian/0000-0003-4566-1753; Jayich, Andrew/0000-0003-3137-7356; Thompson, Jeff/0000-0001-8673-052X				Arcizet O, 2006, NATURE, V444, P71, DOI 10.1038/nature05244; Black ED, 2001, AM J PHYS, V69, P79, DOI 10.1119/1.1286663; Bleszynski-Jayich AC, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2821828; Bose S, 1999, PHYS REV A, V59, P3204, DOI 10.1103/PhysRevA.59.3204; BRAGINSKY VB, 1980, SCIENCE, V209, P547, DOI 10.1126/science.209.4456.547; BRUNE M, 1990, PHYS REV LETT, V65, P976, DOI 10.1103/PhysRevLett.65.976; Corbitt T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.150802; FABRE C, 1994, PHYS REV A, V49, P1337, DOI 10.1103/PhysRevA.49.1337; Ferreira A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.060407; Gigan S, 2006, NATURE, V444, P67, DOI 10.1038/nature05273; Giovannetti V, 2001, EUROPHYS LETT, V54, P559, DOI 10.1209/epl/i2001-00284-x; Harry GM, 2002, CLASSICAL QUANT GRAV, V19, P897, DOI 10.1088/0264-9381/19/5/305; HOOD CJ, 1999, PHYS REV A, V64; Jacobs K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.147201; Kilic O, 2004, OPT LETT, V29, P2782, DOI 10.1364/OL.29.002782; Kleckner D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.173901; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Marshall W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130401; Martin I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.120401; Metzger CH, 2004, NATURE, V432, P1002, DOI 10.1038/nature03118; MEYSTRE P, 1985, J OPT SOC AM B, V2, P1830, DOI 10.1364/JOSAB.2.001830; MullerSeydlitz T, 1997, PHYS REV LETT, V78, P1038, DOI 10.1103/PhysRevLett.78.1038; Pinard M, 2005, EUROPHYS LETT, V72, P747, DOI 10.1209/epl/i2005-10317-6; Poenar DP, 1997, APPL OPTICS, V36, P5122, DOI 10.1364/AO.36.005122; Santamore DH, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052105; Schliesser A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.243905; Stipe BC, 1999, REV SCI INSTRUM, V70, P137, DOI 10.1063/1.1149555; Vitali D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.030405; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wilson-Rae I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093901	30	1015	1028	8	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					72	U5		10.1038/nature06715	http://dx.doi.org/10.1038/nature06715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322530	Green Submitted			2022-12-28	WOS:000253671900048
J	Landon, BE; Normand, SLT				Landon, Bruce E.; Normand, Sharon-Lise T.			Performance measurement in the small office practice: Challenges and potential solutions	ANNALS OF INTERNAL MEDICINE			English	Article							REPORT CARDS; QUALITY; BARRIERS; COSTS	Great strides have been made in the creation of programs aimed at improving the safety and quality of health care in the United States, including measurement systems and corresponding standards in the ambulatory setting that are used for public reporting or pay-for-performance. The diversity of physician practices in the United States makes measurement challenging. In many parts of the country, substantial proportions of both primary care and specialist physicians continue to practice in solo or small group practices. This article reviews the practice landscape in the United States; describes performance measurement challenges in small practice settings, including financial and staffing implications; discusses statistical issues that affect assessment of practice quality; and describes potential solutions to the issues raised. Challenges of performance measurement in small practice settings include lack of infrastructure and health information technology, lack of support staff, and increased burden. These issues are compounded by the difficulty of assessing a smaller number of patients spread over multiple payers. To overcome some of these challenges, design and measure selection recommendations for the performance assessment system are presented and practice-level and health plan-level interventions are suggested that might facilitate the inclusion of small practice settings in performance assessment programs. Because a high proportion of U. S. physicians practice in small settings, programs and policies based on physician performance measurement should incorporate features that facilitate the inclusion of these physicians.	[Landon, Bruce E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Landon, BE (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	Landon@hcp.med.harvard.edu		Normand, Sharon-Lise/0000-0001-7027-4769				Brailer D. J, 2003, USE ADOPTION COMPUTE; Burt C. W., 2006, ELECT MED RECORD USE; BURT CW, 2005, USE COMPUTERIZED CLI; Casalino LP, 2003, ARCH INTERN MED, V163, P1958, DOI 10.1001/archinte.163.16.1958; Centers for Medicare & Medicaid Services, 2004, CMS HQI DEM PROJ COM; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; CHERRY DK, 2007, NATL AMBULATORY MED, P1; Fleiss JL., 2003, STAT METHODS RATES P; FLEISS JL, 1986, STAT METHODS RATES P; Greenfield S, 2002, ANN INTERN MED, V136, P111, DOI 10.7326/0003-4819-136-2-200201150-00008; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Normand SLT, 2007, MED DECIS MAKING, V27, P9, DOI 10.1177/0272989X06298028; ROBINSON JC, 1995, NEW ENGL J MED, V333, P1684, DOI 10.1056/NEJM199512213332506; Rosenthal MB, 2001, HEALTH AFFAIR, V20, P187, DOI 10.1377/hlthaff.20.5.187; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Shahian DM, 2001, ANN THORAC SURG, V72, P2155, DOI 10.1016/S0003-4975(01)03222-2; SMART DR, 2004, MED GROUP PRACTICES	18	48	48	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2008	148	5					353	W77		10.7326/0003-4819-148-5-200803040-00006	http://dx.doi.org/10.7326/0003-4819-148-5-200803040-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268SX	18316754				2022-12-28	WOS:000253600800004
J	Chopra, M; Munro, S; Lavis, JN; Vist, G; Bennett, S				Chopra, Mickey; Munro, Salla; Lavis, John N.; Vist, Gunn; Bennett, Sara			Effects of policy options for human resources for health: an analysis of systematic reviews	LANCET			English	Review							QUALITY; CARE; INTERVENTIONS; EFFICIENCY; STRENGTH	Background Policy makers face challenges to ensure an appropriate supply and distribution of trained health workers and to manage their performance in delivery of services, especially in countries with low and middle incomes. We aimed to identify all available policy options to address human resources for health in such countries, and to assess the effectiveness of these policy options. Methods We searched Medline and Embase from 1979 to September, 2006, the Cochrane Library, and the Human Resources for Health Global Resource Center database. We also searched up to 10 years of archives from five relevant journals, and consulted experts. We included systematic reviews in English which assessed the effects of policy options that could affect the training, distribution, regulation, financing, management, Organisation, or performance of health workers. Two reviewers independently assessed each review for eligibility and quality, and systematically extracted data about main effects. We also assessed whether the policy options were equitable in their effects; suitable for scaling up; and applicable to countries with low and middle incomes. Findings 28 of the 759 systematic reviews of effects that we identified were eligible according to our criteria. Of these, only a few included studies from countries with low and middle incomes, and some reviews were of low quality. Most evidence focused on organisational mechanisms for human resources, such as substitution or shifting tasks between different types of health workers, or extension of their roles; performance-enhancing strategies such as quality improvement or continuing education strategies; promotion of teamwork; and changes to workflow. Of all policy options, the use of lay health workers had the greatest proportion of reviews in countries with a range of incomes, from high to low. Interpretation We have identified a need for more systematic reviews on the effects of policy options to improve human resources for health in countries with low and middle incomes, for assessments of any interventions that policy makers introduce to plan and manage human resources for health, and for other research to aid policy makers in these countries.	[Chopra, Mickey; Munro, Salla] Med Res Council S Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Vist, Gunn] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Lavis, John N.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada; [Bennett, Sara] WHO, Alliance Hlth Policy & Syst Res, CH-1211 Geneva, Switzerland	South African Medical Research Council; Norwegian Knowledge Centre for Health Services; McMaster University; World Health Organization	Chopra, M (corresponding author), MRC, Hlth Syst Res Unit, Van Zyl Dr, ZA-7535 Parow, Western Cape, South Africa.	mickey.chopra@mrc.ac.za	Lavis, John N/I-7555-2013	Lavis, John N/0000-0001-7917-3657; Atkins, Salla/0000-0002-4116-893X; bennett, sara/0000-0001-8094-8798				[Anonymous], 2004, HUM RES HLTH OV CRIS; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Atkins D, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-25; Beney J., 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000336; BOWER P, 2000, COCHRANE DB SYST REV, V3, P532; Briggs CJ, 2001, COCHRANE DB SYST REV, V4; Buchan J, 2002, B WORLD HEALTH ORGAN, V80, P575; Chaix-Couturier C, 2000, INT J QUAL HEALTH C, V12, P133, DOI 10.1093/intqhc/12.2.133; Coomarasamy A, 2004, BMJ-BRIT MED J, V329, P1017, DOI 10.1136/bmj.329.7473.1017; Egger M, 2001, CLIN MED, V1, P478, DOI 10.7861/clinmedicine.1-6-478; Engstrom S, 2001, SCAND J PRIM HEALTH, V19, P131; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Gosden T, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002215; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; Jamtvedt G, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858; JEPSON R, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4140; Kane R. L., 2007, NURSE STAFFING QUALI; Lang TA, 2004, J NURS ADMIN, V34, P326, DOI 10.1097/00005110-200407000-00005; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lavis JN, 2004, LANCET, V364, P1615, DOI 10.1016/S0140-6736(04)17317-0; Lewin S., 2006, LAY HLTH WORKERS PRI; McPherson Kathryn, 2006, J Health Serv Res Policy, V11, P240, DOI 10.1258/135581906778476544; Poissant L, 2005, J AM MED INFORM ASSN, V12, P505, DOI 10.1197/jamia.M1700; ROBERTS E, 2006, ACCIDENT EMERGENCY C; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; SANCHEZMCCUTCHE.A, 2005, EVALUATION PATIENT S; Sempowski Ian P, 2004, Can J Rural Med, V9, P82; Stone EG, 2002, ANN INTERN MED, V136, P641, DOI 10.7326/0003-4819-136-9-200205070-00006; Thomas LH, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000349, DOI 10.1002/14651858.CD000349]; Villar J., 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000934; VOLMINK J, 2006, WHICH INTERVENTIONS; Wensing M, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-2; *WHO, 2000, 2000 WORLD HLTH REP; *WHO, 1997, 1997 WORLD HLTH REP; *WHO, 2006, 2006 WORLD HLTH REP; ZWARENSTEIN M, 2000, COCHRANE DB SYST REV, V3, P72	38	136	142	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2008	371	9613					668	674		10.1016/S0140-6736(08)60305-0	http://dx.doi.org/10.1016/S0140-6736(08)60305-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LL	18295024				2022-12-28	WOS:000253436700031
J	Sand, J; Nordback, I				Sand, Juhani; Nordback, Isto			Probiotics in severe acute pancreatitis	LANCET			English	Editorial Material							ENTERAL NUTRITION; DOUBLE-BLIND		[Sand, Juhani; Nordback, Isto] Tampere Univ Hosp, Dept Gastroenterol & Alimentary Tract Surg, FIN-33521 Tampere, Finland	Tampere University; Tampere University Hospital	Sand, J (corresponding author), Tampere Univ Hosp, Dept Gastroenterol & Alimentary Tract Surg, FIN-33521 Tampere, Finland.	juhani.sand@pshp.fi						Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Mazaki T, 2006, BRIT J SURG, V93, P674, DOI 10.1002/bjs.5389; Olah A, 2002, BRIT J SURG, V89, P1103, DOI 10.1046/j.1365-2168.2002.02189.x; Rayes N, 2007, ANN SURG, V246, P36, DOI 10.1097/01.sla.0000259442.78947.19; Ridwan BU, 2008, LETT APPL MICROBIOL, V46, P61, DOI 10.1111/j.1472-765X.2007.02260.x; Timmerman HM, 2007, CLIN NUTR, V26, P450, DOI 10.1016/j.clnu.2007.04.008	7	18	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2008	371	9613					634	635		10.1016/S0140-6736(08)60284-6	http://dx.doi.org/10.1016/S0140-6736(08)60284-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LL	18295012				2022-12-28	WOS:000253436700011
J	Nakao, N; Ono, H; Yamamura, T; Anraku, T; Takagi, T; Higashi, K; Yasuo, S; Katou, Y; Kageyama, S; Uno, Y; Kasukawa, T; Iigo, M; Sharp, PJ; Iwasawa, A; Suzuki, Y; Sugano, S; Niimi, T; Mizutani, M; Namikawa, T; Ebihara, S; Ueda, HR; Yoshimura, T				Nakao, Nobuhiro; Ono, Hiroko; Yamamura, Takashi; Anraku, Tsubasa; Takagi, Tsuyoshi; Higashi, Kumiko; Yasuo, Shinobu; Katou, Yasuhiro; Kageyama, Saburo; Uno, Yumiko; Kasukawa, Takeya; Iigo, Masayuki; Sharp, Peter J.; Iwasawa, Atsushi; Suzuki, Yutaka; Sugano, Sumio; Niimi, Teruyuki; Mizutani, Makoto; Namikawa, Takao; Ebihara, Shizufumi; Ueda, Hiroki R.; Yoshimura, Takashi			Thyrotrophin in the pars tuberalis triggers photoperiodic response	NATURE			English	Article							II IODOTHYRONINE DEIODINASE; COTURNIX-COTURNIX-JAPONICA; JAPANESE-QUAIL; CHICKEN THYROTROPIN; GENE-EXPRESSION; CIRCADIAN CLOCK; BETA-SUBUNIT; HORMONE; RECEPTOR; BRAIN	Molecular mechanisms regulating animal seasonal breeding in response to changing photoperiod are not well understood. Rapid induction of gene expression of thyroid- hormone- activating enzyme ( type 2 deiodinase, DIO2) in the mediobasal hypothalamus ( MBH) of the Japanese quail ( Coturnix japonica) is the earliest event yet recorded in the photoperiodic signal transduction pathway. Here we show cascades of gene expression in the quail MBH associated with the initiation of photoinduced secretion of luteinizing hormone. We identified two waves of gene expression. The first was initiated about 14 h after dawn of the first long day and included increased thyrotrophin ( TSH) beta- subunit expression in the pars tuberalis; the second occurred approximately 4 h later and included increased expression of DIO2. Intracerebroventricular ( ICV) administration of TSH to short- day quail stimulated gonadal growth and expression of DIO2 which was shown to be mediated through a TSH receptor - cyclic AMP ( cAMP) signalling pathway. Increased TSH in the pars tuberalis therefore seems to trigger long- day photoinduced seasonal breeding.	[Nakao, Nobuhiro; Ono, Hiroko; Yamamura, Takashi; Anraku, Tsubasa; Takagi, Tsuyoshi; Higashi, Kumiko; Yasuo, Shinobu; Katou, Yasuhiro; Kageyama, Saburo; Uno, Yumiko; Ebihara, Shizufumi; Yoshimura, Takashi] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Div Biomodelling, Nagoya, Aichi 4648601, Japan; [Kasukawa, Takeya; Ueda, Hiroki R.] RIKEN, Funct Genom Subunit, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Iigo, Masayuki] Utsunomiya Univ, Fac Agr, Dept Appl Biochem, Utsunomiya, Tochigi 3218505, Japan; [Sharp, Peter J.] Univ Edinburgh, Div Genet & Genom, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Sharp, Peter J.] Univ Edinburgh, Div Genet & Genom, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland; [Iwasawa, Atsushi] Gifu Univ, Lab Comparat Biochem, Grad Sch Appl Biol Sci, Gifu 5011193, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Minato Ku, Tokyo 1088639, Japan; [Niimi, Teruyuki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Div Biofunct Dev, Nagoya, Aichi 4648601, Japan; [Mizutani, Makoto; Namikawa, Takao; Ebihara, Shizufumi; Yoshimura, Takashi] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Avian Biosci Res Ctr, Nagoya, Aichi 4648601, Japan; [Ueda, Hiroki R.] RIKEN, Lab Syst Biol, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Yoshimura, Takashi] Nagoya Univ, Chikusa Ku, Inst Adv Res, Nagoya, Aichi 4648601, Japan	Nagoya University; RIKEN; Utsunomiya University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Gifu University; University of Tokyo; Nagoya University; Nagoya University; RIKEN; Nagoya University	Yoshimura, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Div Biomodelling, Furo Cho, Nagoya, Aichi 4648601, Japan.	takashiy@agr.nagoya-u.ac.jp	Kasukawa, Takeya/N-5070-2015; Iigo, Masayuki/I-7110-2013; Yoshimura, Takashi/C-8306-2012; Ueda, Hiroki R/C-5037-2014	Kasukawa, Takeya/0000-0001-5085-0802; Yoshimura, Takashi/0000-0001-7018-9652; Ueda, Hiroki R/0000-0001-8342-9176; Niimi, Teruyuki/0000-0003-3981-0177; Iigo, Masayuki/0000-0001-8251-4141				Bockmann J, 1997, ENDOCRINOLOGY, V138, P1019, DOI 10.1210/en.138.3.1019; Bockmann J, 1997, BIOCHEM BIOPH RES CO, V238, P173, DOI 10.1006/bbrc.1997.7268; Crisanti P, 2001, ENDOCRINOLOGY, V142, P812, DOI 10.1210/en.142.2.812; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Follett B, 1998, BIOL RHYTHMS PHOTOPE; FOLLETT BK, 1988, J COMP PHYSIOL B, V157, P837, DOI 10.1007/BF00691016; Ganong WF, 2000, CLIN EXP PHARMACOL P, V27, P422, DOI 10.1046/j.1440-1681.2000.03259.x; Grommen SVH, 2006, ENDOCRINOLOGY, V147, P3943, DOI 10.1210/en.2005-1223; HOJVAT S, 1982, NEUROENDOCRINOLOGY, V34, P327, DOI 10.1159/000123322; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Iwasawa A, 2002, J REPROD DEVELOP, V48, P197, DOI 10.1262/jrd.48.197; JUSS TS, 1993, P ROY SOC B-BIOL SCI, V254, P21, DOI 10.1098/rspb.1993.0121; JUSS TS, 1993, AVIAN ENDOCRINOLOGY, P47; Klosen P, 2002, J HISTOCHEM CYTOCHEM, V50, P1647, DOI 10.1177/002215540205001209; KRISHNAN KA, 2004, COMP BIOCH PHYSL B, V108, P253; Lincoln GA, 2006, SCIENCE, V314, P1941, DOI 10.1126/science.1132009; MARUYAMA K, 1994, GENE, V138, P171; MATZUK MM, 1988, MOL ENDOCRINOL, V2, P95, DOI 10.1210/mend-2-2-95; Morgan P J, 1996, Rev Reprod, V1, P153, DOI 10.1530/revreprod/1.3.153; Murakami M, 2001, ENDOCRINOLOGY, V142, P2961, DOI 10.1210/en.142.7.2961; Murakami M, 2001, ENDOCRINOLOGY, V142, P1195, DOI 10.1210/en.142.3.1195; NICHOLLS TJ, 1983, J ENDOCRINOL, V97, P121, DOI 10.1677/joe.0.0970121; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Rebay I, 2005, TRENDS GENET, V21, P163, DOI 10.1016/j.tig.2005.01.005; SCHAUB C, 1977, J NEUROL SCI, V31, P123, DOI 10.1016/0022-510X(77)90010-7; SHARP PJ, 1972, Z ZELLFORSCH MIK ANA, V127, P552, DOI 10.1007/BF00306871; SHARP PJ, 1969, NEUROENDOCRINOLOGY, V5, P205, DOI 10.1159/000121861; SILVER R, 1988, CELL TISSUE RES, V253, P189; Takagi T, 2007, ENDOCRINOLOGY, V148, P2788, DOI 10.1210/en.2007-0112; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Turnbull AV, 1998, ENDOCRINOLOGY, V139, P128, DOI 10.1210/en.139.1.128; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; WADA M, 1979, GEN COMP ENDOCR, V39, P141, DOI 10.1016/0016-6480(79)90219-3; WITTKOWSKI W, 1988, CELL TISSUE RES, V251, P183, DOI 10.1007/BF00215463; Wittkowski W, 1999, INT REV CYTOL, V185, P157; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Yasuo S, 2003, ENDOCRINOLOGY, V144, P3742, DOI 10.1210/en.2003-0435; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117	39	358	372	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					317	U1		10.1038/nature06738	http://dx.doi.org/10.1038/nature06738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354476				2022-12-28	WOS:000254117400039
J	Masciari, S; Van den Abbeele, AD; Diller, LR; Rastarhuyeva, I; Yap, J; Schneider, K; Digianni, L; Li, FP; Fraumeni, JF; Syngal, S; Garber, JE				Masciari, Serena; Van den Abbeele, Annick D.; Diller, Lisa R.; Rastarhuyeva, Iryna; Yap, Jeffrey; Schneider, Katherine; Digianni, Lisa; Li, Frederick P.; Fraumeni, Joseph F., Jr.; Syngal, Sapna; Garber, Judy E.			F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SOFT-TISSUE SARCOMA; P53 MUTATIONS; F-18 FLUORODEOXYGLUCOSE; FDG-PET; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; COLORECTAL-CANCER; FAMILIAL SYNDROME; RATIONAL APPROACH; DOSE REDUCTION	Context Individuals with Li-Fraumeni syndrome ( LFS) have an inherited cancer predisposition to a diverse array of malignancies beginning early in life; survivors of one cancer have a markedly elevated risk of additional primary tumors. The underlying genetic defect in the majority of the families is a germline mutation in the TP53 tumor suppressor gene. The diversity of tumors and rarity of families have contributed to the difficulty in devising effective screening recommendations for members of LFS kindreds. Objective To gather preliminary data with which to evaluate F18- fluorodeoxyglucose positron emission tomography/ computed tomography ( FDG- PET/ CT) imaging as a potential surveillance modality to detect early malignancies in asymptomatic members of LFS kindreds. Design, Setting, and Participants Members of LFS families with documented germline TP53 mutations or obligate carrier status, no history of cancer within 5 years of enrollment, and no symptoms of cancer or ill- health were offered FDG-PET/ CT scanning as a screening test in a comprehensive US cancer center from 2006 to 2007. Scans were initially reviewed clinically, then centrally reviewed by an expert radiologist. Main OutcomeMeasure The primary outcome was the detection of new primary cancers using FDG- PET/ CT scanning. Results Of 15 individuals, baseline FDG- PET/ CT scan identified asymptomatic cancers in 3 ( 20%). Two individuals had papillary thyroid cancers ( stage II and stage III) and one individual had stage II esophageal adenocarcinoma. Conclusions These preliminary data provide the first evidence for a potential cancer surveillance strategy that may be worthy of further investigation for patients with LFS. Concerns about radiation exposure and other challenges inherent in screening high-risk patients will require further consideration.	[Masciari, Serena; Schneider, Katherine; Digianni, Lisa; Li, Frederick P.; Syngal, Sapna; Garber, Judy E.] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA; [Van den Abbeele, Annick D.; Rastarhuyeva, Iryna; Yap, Jeffrey] Dana Farber Canc Inst, Dept Radiol, Boston, MA 02115 USA; [Diller, Lisa R.] Dana Farber Canc Inst, Perini Family Survivors Ctr, Boston, MA 02115 USA; [Fraumeni, Joseph F., Jr.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Syngal, Sapna] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital	Garber, JE (corresponding author), Dana Farber Canc Inst, Div Populat Sci, 44 Binney St,SM 209, Boston, MA 02115 USA.	judy_garber@dfci.harvard.edu	Van den Abbeele, Annick/AAK-9792-2020; Pinheiro, Maísa/E-7424-2012	Yap, Jeffrey/0000-0001-5306-2860				Al-Sugair A, 1998, SEMIN NUCL MED, V28, P303, DOI 10.1016/S0001-2998(98)80035-4; American Association of Physicists in Medicine, 96 AAPM; Avril N, 2000, J CLIN ONCOL, V18, P3495, DOI 10.1200/JCO.2000.18.20.3495; BIRCH JM, 1994, CANCER RES, V54, P1298; Boone JM, 2003, RADIOLOGY, V228, P352, DOI 10.1148/radiol.2282020471; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Chao ST, 2001, INT J CANCER, V96, P191, DOI 10.1002/ijc.1016.abs; Chen YK, 2004, ANTICANCER RES, V24, P4103; Chodick G, 2007, ISR MED ASSOC J, V9, P584; Delbeke D, 1999, J NUCL MED, V40, P591; DICHIRO G, 1987, INVEST RADIOL, V22, P360; Eeles RA, 1995, CANCER SURV, V25, P101; Folpe AL, 2000, CLIN CANCER RES, V6, P1279; GARBER JE, 1991, CANCER RES, V51, P6094; Hisada M, 1998, JNCI-J NATL CANCER I, V90, P606, DOI 10.1093/jnci/90.8.606; Hwang SJ, 2003, AM J HUM GENET, V72, P975, DOI 10.1086/374567; Ioannidis JPA, 2003, J NUCL MED, V44, P717; Kalra MK, 2004, RADIOLOGY, V233, P649, DOI 10.1148/radiol.2333031150; Kleihues P, 1997, AM J PATHOL, V150, P1; LI FP, 1988, CANCER RES, V48, P5358; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; LI FP, 1992, J NATL CANCER I, V84, P1156, DOI 10.1093/jnci/84.15.1156; Limacher JM, 2001, INT J CANCER, V96, P238, DOI 10.1002/ijc.1021; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Nichols KE, 2001, CANCER EPIDEM BIOMAR, V10, P83; Oehr P, 1999, J INVEST MED, V47, P452; Shankar LK, 2006, J NUCL MED, V47, P1059; Varley JM, 1997, CANCER RES, V57, P3245; Varley JM, 1997, BRIT J CANCER, V76, P1, DOI 10.1038/bjc.1997.328; Wilting JE, 2001, EUR RADIOL, V11, P2627, DOI 10.1007/s003300101039; Wong P, 2006, GASTROENTEROLOGY, V130, P73, DOI 10.1053/j.gastro.2005.10.014; Yasuda S, 2000, BRIT J CANCER, V83, P1607, DOI 10.1054/bjoc.2000.1496; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4	35	66	69	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1315	1319		10.1001/jama.299.11.1315	http://dx.doi.org/10.1001/jama.299.11.1315			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349092	Bronze			2022-12-28	WOS:000254079100022
J	Schappacher, M; Deffieux, A				Schappacher, Michel; Deffieux, Alain			Synthesis of macrocyclic copolymer brushes and their self-assembly into supramolecular tubes	SCIENCE			English	Article							HIGH MOLECULAR-WEIGHT; FORCE MICROSCOPY; POLYMERS; RING; POLYSTYRENES; STAR; MACROMOLECULES	We report on an efficient route to design large macrocyclic polymers of controlled molar mass and narrow dispersity. The strategy is based on the synthesis of a triblock copolymer ABC, in which the long central block B is extended by two short A and C sequences bearing reactive antagonist functions. When reacted under highly dilute conditions, this precursor produces the corresponding macrocycle by intramolecular coupling of the A and C blocks. Chloroethyl vinyl ether was selected as the monomer for the central block B, because it can be readily derivatized into brushlike polymers by a grafting process. The corresponding macrocyclic brushes were decorated with polystyrene or randomly distributed polystyrene and polyisoprene branches. In a selective solvent for the polyisoprene branches, the macrocyclic brushes self- assemble into cylindrical tubes of up to 700 nanometers.	[Schappacher, Michel; Deffieux, Alain] Univ Bordeaux 1, CNRS, ENSCPB, Lab Chim Polymeres Organ,UMR 5629, F-33607 Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Deffieux, A (corresponding author), Univ Bordeaux 1, CNRS, ENSCPB, Lab Chim Polymeres Organ,UMR 5629, 16 Ave Pey Berland, F-33607 Pessac, France.	deffieux@enscpb.fr						Bielawski CW, 2002, SCIENCE, V297, P2041, DOI 10.1126/science.1075401; BLOOMFIE.V, 1966, J CHEM PHYS, V44, P315, DOI 10.1063/1.1726463; Carlson JCT, 2006, J AM CHEM SOC, V128, P7630, DOI 10.1021/ja060631e; CASSASA EF, 1965, J POLYM SCI A, V3, P605; Deffieux A, 1999, MACROMOLECULES, V32, P1797, DOI 10.1021/ma981612v; DEFFIEUX A, 2007, MACROMOLECULAR ENG P, V2, P875; DULBECCO R, 1963, P NATL ACAD SCI USA, V50, P236, DOI 10.1073/pnas.50.2.236; HADZIIOANNOU G, 1987, MACROMOLECULES, V20, P493, DOI 10.1021/ma00169a006; HILD G, 1983, EUR POLYM J, V19, P721, DOI 10.1016/0014-3057(83)90088-5; Hogen-Esch TE, 2006, J POLYM SCI POL CHEM, V44, P2139, DOI 10.1002/pola.21331; Muchtar Z, 2001, MACROMOLECULES, V34, P7595, DOI 10.1021/ma010429q; ROOVERS J, 1983, MACROMOLECULES, V16, P843, DOI 10.1021/ma00240a002; Schappacher M, 1999, MACROMOL CHEM PHYSIC, V200, P2377, DOI 10.1002/(SICI)1521-3935(19991001)200:10<2377::AID-MACP2377>3.3.CO;2-2; Schappacher M, 2000, MACROMOLECULES, V33, P7371, DOI 10.1021/ma0001436; Schappacher M, 2005, MACROMOLECULES, V38, P4942, DOI 10.1021/ma047518y; SCHAPPACHER M, 1991, MAKROMOL CHEM-RAPID, V12, P447; SEMLYEN JA, 1969, POLYMER, V10, P597, DOI 10.1016/0032-3861(69)90079-2; Sheiko SS, 2000, ADV POLYM SCI, V151, P61; Sheiko SS, 2001, CHEM REV, V101, P4099, DOI 10.1021/cr990129v; Tezuka Y, 2001, J AM CHEM SOC, V123, P11570, DOI 10.1021/ja0114409; Viville P, 2004, POLYMER, V45, P1833, DOI 10.1016/j.polymer.2004.01.030; VOLLMERT B, 1981, MAKROMOL CHEM-RAPID, V2, P467; ZIMM BH, 1949, J CHEM PHYS, V17, P1301, DOI 10.1063/1.1747157	23	234	237	3	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1512	1515		10.1126/science.1153848	http://dx.doi.org/10.1126/science.1153848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339934				2022-12-28	WOS:000253943800034
J	Bawaskar, HS; Bawaskar, PH				Bawaskar, Himmatrao Saluba; Bawaskar, Pramodini Himmatrao			Woke up paralysed - without injury or stroke	LANCET			English	Editorial Material							THYROTOXIC PERIODIC PARALYSIS		[Bawaskar, Himmatrao Saluba; Bawaskar, Pramodini Himmatrao] Bawaskar Hosp & Res Ctr, Maharashtra 402301, India		Bawaskar, HS (corresponding author), Bawaskar Hosp & Res Ctr, Maharashtra 402301, India.	himmatbawaskar@rediffmail.com						Barnabe C, 2005, CAN MED ASSOC J, V172, P471, DOI 10.1503/cmaj.1041042; Boccalandro C, 2003, LANCET, V361, P1432, DOI 10.1016/S0140-6736(03)13137-6; Da Silva MRD, 2002, J CLIN ENDOCR METAB, V87, P4881, DOI 10.1210/jc.2002-020698; Lin SH, 2005, MAYO CLIN PROC, V80, P99, DOI 10.1016/S0025-6196(11)62965-0; Magsino CH, 2000, SOUTHERN MED J, V93, P996	5	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 8	2008	371	9615					870	870		10.1016/S0140-6736(08)60385-2	http://dx.doi.org/10.1016/S0140-6736(08)60385-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272NQ	18328933				2022-12-28	WOS:000253866500034
J	Raices, M; Verdun, RE; Compton, SA; Haggblom, CI; Griffith, JD; Dillin, A; Karlseder, J				Raices, Marcela; Verdun, Ramiro E.; Compton, Sarah A.; Haggblom, Candy I.; Griffith, Jack D.; Dillin, Andrew; Karlseder, Jan			C-elegans telomeres contain G-strand and C-strand overhangs that are bound by distinct proteins	CELL			English	Article							HUMAN-CHROMOSOMES; CAENORHABDITIS-ELEGANS; BINDING PROTEIN; MOUSE CELLS; DNA-DAMAGE; T-LOOPS; CDC13; END; POT1; MAINTENANCE	Single-strand extensions of the G strand of telomeres are known to be critical for chromosome-end protection and length regulation. Here, we report that in C. elegans, chromosome termini possess 30 G-strand overhangs as well as 50 C-strand overhangs. C tails are as abundant as G tails and are generated by a well-regulated process. These two classes of overhangs are bound by two single-stranded DNA binding proteins, CeOB1 and CeOB2, which exhibit specificity for G-rich or C-rich telomeric DNA. Strains of worms deleted for CeOB1 have elongated telomeres as well as extended G tails, whereas CeOB2 deficiency leads to telomere-length heterogeneity. Both CeOB1 and CeOB2 contain OB (oligo-saccharide/oligo-nucleotide binding) folds, which exhibit structural similarity to the second and first OB folds of the mammalian telomere binding protein hPOT1, respectively. Our results suggest that C. elegans telomere homeostasis relies on a novel mechanism that involves 50 and 30 single-stranded termini.	[Raices, Marcela; Verdun, Ramiro E.; Haggblom, Candy I.; Dillin, Andrew; Karlseder, Jan] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Compton, Sarah A.; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA	Salk Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Karlseder, J (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	karlseder@salk.edu			NIA NIH HHS [AG025837] Funding Source: Medline; NIEHS NIH HHS [ES13773] Funding Source: Medline; NIGMS NIH HHS [GM31819, GM06525] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025837] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Anderson EM, 2002, NUCLEIC ACIDS RES, V30, P4305, DOI 10.1093/nar/gkf554; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Booth C, 2001, NUCLEIC ACIDS RES, V29, P4414, DOI 10.1093/nar/29.21.4414; BRENNER S, 1974, GENETICS, V77, P71; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; Cheung I, 2004, NUCLEIC ACIDS RES, V32, P3383, DOI 10.1093/nar/gkh661; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 2001, EMBO J, V20, P6127, DOI 10.1093/emboj/20.21.6127; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; GRAY HB, 1975, NUCLEIC ACIDS RES, V2, P1459, DOI 10.1093/nar/2.9.1459; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; GUBLER U, 1987, METHOD ENZYMOL, V152, P330; Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hope IA., 1999, C ELEGANS PRACTICAL; Jacob NK, 2003, MOL CELL, V11, P1021, DOI 10.1016/S1097-2765(03)00131-X; Jacob NK, 2001, EMBO J, V20, P4299, DOI 10.1093/emboj/20.15.4299; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Lei M, 2002, BIOCHEMISTRY-US, V41, P14560, DOI 10.1021/bi026674z; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Meier B, 2006, PLOS GENET, V2, P187, DOI 10.1371/journal.pgen.0020018; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nakamura M, 2005, MOL CELL BIOL, V25, P11073, DOI 10.1128/MCB.25.24.11073-11088.2005; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Raices M, 2005, PLOS GENET, V1, P295, DOI 10.1371/journal.pgen.0010030; Riha K, 2000, PLANT J, V23, P633, DOI 10.1046/j.1365-313x.2000.00831.x; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; Theobald DL, 2004, STRUCTURE, V12, P1877, DOI 10.1016/j.str.2004.07.015; TRAVERS AA, 2000, DNA PROTEIN INTERACT; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x	53	92	97	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					745	757		10.1016/j.cell.2007.12.039	http://dx.doi.org/10.1016/j.cell.2007.12.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329362	Green Submitted, Bronze			2022-12-28	WOS:000253818000013
J	Schones, DE; Cui, KR; Cuddapah, S; Roh, TY; Barski, A; Wang, ZB; Wei, G; Zhao, KJ				Schones, Dustin E.; Cui, Kairong; Cuddapah, Suresh; Roh, Tae-Young; Barski, Artem; Wang, Zhibin; Wei, Gang; Zhao, Keji			Dynamic regulation of nucleosome positioning in the human genome	CELL			English	Article							EMBRYONIC STEM-CELLS; HISTONE H2A VARIANT; RNA-POLYMERASE; DEVELOPMENTAL REGULATORS; SACCHAROMYCES-CEREVISIAE; STRUCTURAL-ANALYSIS; CHROMATIN-STRUCTURE; SWI/SNF COMPLEX; IN-VIVO; WIDE	The positioning of nucleosomes with respect to DNA plays an important role in regulating transcription. However, nucleosome mapping has been performed for only limited genomic regions in humans. We have generated genome-wide maps of nucleosome positions in both resting and activated human CD4(+) T cells by direct sequencing of nucleosome ends using the Solexa high-throughput sequencing technique. We find that nucleosome phasing relative to the transcription start sites is directly correlated to RNA polymerase II (Pol II) binding. Furthermore, the first nucleosome downstream of a start site exhibits differential positioning in active and silent genes. TCR signaling induces extensive nucleosome reorganization in promoters and enhancers to allow transcriptional activation or repression. Our results suggest that H2A.Z-containing and modified nucleosomes are preferentially lost from the -1 nucleosome position. Our data provide a comprehensive view of the nucleosome landscape and its dynamic regulation in the human genome.	[Schones, Dustin E.; Cui, Kairong; Cuddapah, Suresh; Roh, Tae-Young; Barski, Artem; Wang, Zhibin; Wei, Gang; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	Wei, Gang/A-3291-2011; Cuddapah, Suresh/AAU-4288-2021	Cuddapah, Suresh/0000-0002-4556-2029; Barski, Artem/0000-0002-1861-5316; Roh, Tae-Young/0000-0001-5833-0844	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZICHL006018, Z01HL005801] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AFFYMETRIX I, 2002, STAT ALGORITHMS DESC; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Gutierrez JL, 2007, EMBO J, V26, P730, DOI 10.1038/sj.emboj.7601524; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kornberg RD, 2002, CURR OPIN GENET DEV, V12, P249, DOI 10.1016/S0959-437X(02)00293-9; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Langst G, 1997, NUCLEIC ACIDS RES, V25, P511, DOI 10.1093/nar/25.3.511; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; OwenHughes T, 1996, SCIENCE, V273, P513, DOI 10.1126/science.273.5274.513; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Whitehouse I, 2006, NAT STRUCT MOL BIOL, V13, P633, DOI 10.1038/nsmb1111; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	66	981	1023	2	103	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					887	898		10.1016/j.cell.2008.02.022	http://dx.doi.org/10.1016/j.cell.2008.02.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329373	Bronze			2022-12-28	WOS:000253818000024
J	Farag, N; Burns, R; Come, SE				Farag, Nadine; Burns, Risa; Come, Steven E.			Update: A 62-year-old woman with a new diagnosis of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTMENOPAUSAL WOMEN; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL; ADJUVANT TAMOXIFEN; ANASTROZOLE; LETROZOLE; EXEMESTANE; ATAC											Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Baum M, 2003, Cancer, V98, P1802; Burstein HJ, 2007, BREAST, V16, P223, DOI 10.1016/j.breast.2007.01.011; Buzdar AU, 2006, CLIN CANCER RES, V12, p1037S, DOI 10.1158/1078-0432.CCR-05-2458; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Coleman RE, 2006, J CLIN ONCOL, V24, p5S; Coleman RE, 2007, LANCET ONCOL, V8, P119, DOI 10.1016/S1470-2045(07)70003-7; Come SE, 2006, JAMA-J AM MED ASSOC, V295, P1434, DOI 10.1001/jama.295.12.1434; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Crew KD, 2006, BREAST CANCER RES TR, V100, pS235; Eng-Wong J, 2008, CANCER-AM CANCER SOC, V112, P723, DOI 10.1002/cncr.23188; Forbes JF, 2007, BREAST CANCER RES TR, V106, pS12; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Jonat W, 2006, LANCET ONCOL, V7, P991, DOI 10.1016/S1470-2045(06)70948-2; Lin NU, 2008, J CLIN ONCOL, V26, P798, DOI 10.1200/JCO.2007.15.0946; Partridge AH, 2003, J CLIN ONCOL, V21, P602, DOI 10.1200/JCO.2003.07.071; Ravdin Peter M, 2004, Clin Breast Cancer, V5, P313, DOI 10.3816/CBC.2004.n.047; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747	22	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2008	299	9					1055	1056		10.1001/jama.299.9.1055	http://dx.doi.org/10.1001/jama.299.9.1055			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JH	18319415				2022-12-28	WOS:000253644800023
J	Robertson, M				Robertson, Michad			Lesson of the week - Artificially low HbA(1c) associated with ribavirin	BRITISH MEDICAL JOURNAL			English	Article									Marcham Rd Hlth Ctr, Abingdon OX14 1DB, Oxon, England		Robertson, M (corresponding author), Marcham Rd Hlth Ctr, Abingdon OX14 1DB, Oxon, England.	Michael.robertson@gp-k84041.nhs.uk						*BRIT MED ASS, 2006, BRIT NAT FORM, P335; *NAT I HLTH CLIN E, 2006, REG ALF RIB TREATM M; Reynolds TM, 2006, BMJ-BRIT MED J, V333, P586, DOI 10.1136/bmj.38947.627847.AE; Virtue MA, 2004, AM J HEMATOL, V76, P107, DOI 10.1002/ajh.20069	4	12	12	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2008	336	7642					505	505		10.1136/bmj.39457.828287.47	http://dx.doi.org/10.1136/bmj.39457.828287.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18310007	Green Published			2022-12-28	WOS:000253997500046
J	Leggett, AJ				Leggett, A. J.			Perspective - Quantum liquids	SCIENCE			English	Editorial Material									Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Leggett, AJ (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.							Andrews MR, 1996, SCIENCE, V273, P84, DOI 10.1126/science.273.5271.84; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Bloch I, 2008, SCIENCE, V319, P1202, DOI 10.1126/science.1152501; EINSTEIN A, 1925, ACAD WISS BER, V3, P18; Leggett AJ, 2006, QUANTUM LIQUIDS BOSE; Streater R.F., 1964, PCT SPIN STAT ALL; 1995, SCIENCE, V270	7	12	12	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1203	1205		10.1126/science.1152822	http://dx.doi.org/10.1126/science.1152822			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309073				2022-12-28	WOS:000253530600029
J	Marsh, M; van Meer, G				Marsh, Mark; van Meer, Gerrit			Cell biology - No ESCRTs for exosomes	SCIENCE			English	Editorial Material							TRANSFERRIN RECEPTOR; SHEEP RETICULOCYTES; EXTERNALIZATION; MATURATION; ALIX		[Marsh, Mark] UCL, MRC, Mol Cell Biol Lab, Cell Biol Unit, London WC1E 6BT, England; [Marsh, Mark] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [van Meer, Gerrit] Univ Utrecht, Bijvoet Ctr, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	University of London; University College London; University of London; University College London; Utrecht University	Marsh, M (corresponding author), UCL, MRC, Mol Cell Biol Lab, Cell Biol Unit, Gower St, London WC1E 6BT, England.	m.marsh@ucl.ac.uk; g.vanmeer@uu.nl	van Meer, Gerrit/AAH-1560-2021; Marsh, Mark/B-4105-2009	Marsh, Mark/0000-0002-0213-3259; van Meer, Gerrit/0000-0002-5976-6436	MRC [MC_U122665002, MC_U122663296] Funding Source: UKRI; Medical Research Council [MC_U122665002, U.1226.00.003.00001.01(65002), MC_U122663296] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759	15	49	51	3	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1191	1192		10.1126/science.1155750	http://dx.doi.org/10.1126/science.1155750			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309064				2022-12-28	WOS:000253530600020
J	Maisels, MJ; McDonagh, AF				Maisels, M. Jeffrey; McDonagh, Antony F.			Phototherapy for neonatal jaundice	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLUE-LIGHT PHOTOTHERAPY; BRONZE BABY SYNDROME; BILIRUBIN LEVELS; CONTROLLED-TRIAL; HYPERBILIRUBINEMIA; RISK; INTENSITY; INFANTS; HOME; MORBIDITY	A male infant weighing 3400 g was born at 37 weeks' gestation after an uncomplicated pregnancy. The mother is a 24-year-old primipara who has type A Rh-positive blood. The infant's course in the hospital nursery was uncomplicated. Although his mother needed considerable help in establishing effective breast-feeding, he was exclusively breast-fed. Jaundice was noted at the age of 34 hours. The total serum bilirubin level was 7.5 mg per deciliter (128 mu mol per liter). The infant was discharged at the age of 40 hours and is seen in the pediatrician's office 2 days later, now with marked jaundice. The results of his physical examination are otherwise normal, but his weight, at 3020 g, is 11% below his birth weight. His total serum bilirubin level is 19.5 mg per deciliter (333 mu mol per liter), and his conjugated (direct) bilirubin level 0.6 mg per deciliter (10 mu mol per liter). The complete blood count and peripheral-blood smear are normal. The infant has type A Rh-positive blood. The pediatrician consults a neonatologist regarding the need for phototherapy.	[Maisels, M. Jeffrey] William Beaumont Hosp, Dept Pediat, Royal Oak, MI 48073 USA; [McDonagh, Antony F.] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA USA	Beaumont Health; University of California System; University of California San Francisco	Maisels, MJ (corresponding author), William Beaumont Hosp, Dept Pediat, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.	jmaisels@beaumont.edu	Kemeny, Lajos/ABF-1339-2021	Kemeny, Lajos/0000-0002-2119-9501				*AM AC PED SUBC HY, 2004, PEDIATRICS, V0114, P01138; Aspberg S, 2007, PEDIAT ALLERG IMM-UK, V18, P313, DOI 10.1111/j.1399-3038.2006.00518.x; Avery GB, 2005, NEONATOLOGY PATHOPHY, V6th, P768; Bauer J, 2004, ARCH DERMATOL, V140, P493, DOI 10.1001/archderm.140.4.493; Bhutani VK, 2006, JOGNN-J OBST GYN NEO, V35, P444, DOI 10.1111/J.1552-6909.2006.00044.x; CREMER RJ, 1958, LANCET, V1, P1094; Csoma Z, 2007, PEDIATRICS, V119, P1036, DOI 10.1542/peds.2007-0180; Dahlquist G, 2003, DIABETES CARE, V26, P247, DOI 10.2337/diacare.26.1.247-a; Djokomuljanto S, 2006, ARCH DIS CHILD-FETAL, V91, pF439, DOI 10.1136/adc.2006.095687; DOLLBERG S, 1995, AM J PERINAT, V12, P55, DOI 10.1055/s-2007-994402; Eggert LD, 2006, PEDIATRICS, V117, pE855, DOI 10.1542/peds.2005-1338; EGGERT LD, 1985, PEDIATRICS, V76, P579; EGGERT P, 1984, EUR J PEDIATR, V142, P58, DOI 10.1007/BF00442593; GARG AK, 1995, PEDIATRICS, V95, P914; Gartner L M, 2001, J Perinatol, V21 Suppl 1, pS25, DOI 10.1038/sj.jp.7210629; Hansen TWR, 1996, CLIN PEDIATR, V35, P309, DOI 10.1177/000992289603500604; Hansen TWR, 1997, ACTA PAEDIATR, V86, P843; HOLTROP PC, 1992, PEDIATRICS, V90, P674; JAHRIG K, 1982, ACTA PAEDIATR SCAND, V71, P293, DOI 10.1111/j.1651-2227.1982.tb09417.x; JAHRIG K, 1993, PHOTOTHERAPY TREATIN; JOHN E, 1975, AUST PAEDIATR J, V11, P49; Kaplan M, 2006, ARCH DIS CHILD, V91, P31, DOI 10.1136/adc.2005.081224; Kaplan M, 2003, PEDIATRICS, V111, P886, DOI 10.1542/peds.111.4.886; Kaplan M, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e47; KEENAN WJ, 1985, PEDIATRICS, V75, P417; Keren R, 2005, ARCH DIS CHILD, V90, P415, DOI 10.1136/adc.2004.060079; KOPELMAN AE, 1972, J PEDIATR-US, V81, P466, DOI 10.1016/S0022-3476(72)80172-0; LIGHTNER DA, 1984, ACCOUNTS CHEM RES, V17, P417, DOI 10.1021/ar00108a002; Maayan-Metzger A, 2001, AM J PERINAT, V18, P393, DOI 10.1055/s-2001-18698; Maisels MJ, 2007, J PERINATOL, V27, P565, DOI 10.1038/sj.jp.7211789; Maisels MJ, 2006, J PERINATOL, V26, P498, DOI 10.1038/sj.jp.7211552; Maisels M J, 2001, J Perinatol, V21 Suppl 1, pS93, DOI 10.1038/sj.jp.7210642; Maisels MJ, 2006, PEDIATRICS, V118, P276, DOI 10.1542/peds.2005-3042; Maisels M. Jeffrey, 1992, P507; Maisels MJ, 1996, PEDIATRICS, V98, P283; Maisels MJ, 2004, PEDIATRICS, V114, P297; Maisels MJ, 2003, ARCH DIS CHILD-FETAL, V88, pF459, DOI 10.1136/fn.88.6.F459; Maisels MJ, 2000, MG CLIN PED, P177; Maisels MJ, 2002, ARCH PEDIAT ADOL MED, V156, P669, DOI 10.1001/archpedi.156.7.669; Maisels MJ, 1998, PEDIATRICS, V101, P995, DOI 10.1542/peds.101.6.995; Maisels MJ, 2001, PEDIATRICS, V108, P763; MALLON E, 1995, J AM ACAD DERMATOL, V33, P333, DOI 10.1016/0190-9622(95)91428-5; MCDONAGH AF, 1986, NEW ENGL J MED, V314, P121; MCDONAGH AF, 1990, CLIN PERINATOL, V17, P359, DOI 10.1016/S0095-5108(18)30572-4; McDonagh AF, 2006, PEDIATRICS, V118, P1185, DOI 10.1542/peds.2006-0594; MESSNER KH, 1978, INVEST OPHTH VIS SCI, V17, P178; Myara A, 1997, BIOL NEONATE, V71, P75; Newman TB, 2001, AMBUL PEDIATR, V1, P126, DOI 10.1367/1539-4409(2001)001<0126:LTTE>2.0.CO;2; Newman TB, 2000, ARCH PEDIAT ADOL MED, V154, P1140, DOI 10.1001/archpedi.154.11.1140; Newman TB, 1999, PEDIATRICS, V104, P1198; OSHEA TM, 1992, PEDIATRICS, V90, P888; Paller AS, 1997, PEDIATRICS, V100, P360, DOI 10.1542/peds.100.3.360; Patra K, 2004, J PEDIATR-US, V144, P626, DOI 10.1016/j.jpeds.2004.01.054; ROGERSON AG, 1986, CLIN PEDIATR, V25, P296, DOI 10.1177/000992288602500602; RUBALTELLI FF, 1983, PEDIATR RES, V17, P327, DOI 10.1203/00006450-198305000-00004; Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776; Seidman Daniel S, 2003, J Perinatol, V23, P123, DOI 10.1038/sj.jp.7210862; SLATER L, 1984, PEDIATRICS, V73, P515; Steiner LA, 2007, PEDIATRICS, V120, P27, DOI 10.1542/peds.2006-2910; Suresh GK, 2004, PEDIATRICS, V114, P917, DOI 10.1542/peds.2004-0899; TAN KL, 1982, PEDIATR RES, V16, P670, DOI 10.1203/00006450-198208000-00018; TAN KL, 1992, ACTA PAEDIATR, V81, P870, DOI 10.1111/j.1651-2227.1992.tb12126.x; Tan KL, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e13; TONZ O, 1975, HELV PAEDIATR ACTA, V30, P47; VALAES T, 1994, PEDIATRICS, V93, P1; Vreman HJ, 2004, SEMIN PERINATOL, V28, P326, DOI 10.1053/j.semperi.2004.09.003; Yetman RJ, 1998, J PEDIATR-US, V133, P705, DOI 10.1016/S0022-3476(98)70117-9	67	310	325	11	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					920	928		10.1056/NEJMct0708376	http://dx.doi.org/10.1056/NEJMct0708376			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18305267				2022-12-28	WOS:000253430200007
J	Mills, EJ; Schabas, WA; Volmink, J; Walker, R; Ford, N; Katabira, E; Anema, A; Joffres, M; Cahn, P; Montaner, J				Mills, Edward J.; Schabas, William A.; Volmink, Jimmy; Walker, Roderick; Ford, Nathan; Katabira, Elly; Anema, Aranka; Joffres, Michel; Cahn, Pedro; Montaner, Julio			Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime?	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; HUMAN-RESOURCES; MIGRATION; HIV/AIDS		[Mills, Edward J.; Anema, Aranka; Montaner, Julio] Univ British Columbia, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V5Z 1M9, Canada; [Schabas, William A.] Natl Univ Ireland, Irish Ctr Human Rights, Galway, Ireland; [Volmink, Jimmy] Univ Stellenbosch, Fac Hlth Sci, Cape Town, South Africa; [Walker, Roderick] Rhodes Univ, Fac Pharm, ZA-6140 Grahamstown, South Africa; [Ford, Nathan] Med Sans Frontieres, Johannesburg, South Africa; [Katabira, Elly] Makerere Univ, Dept Med, Kampala, Uganda; [Joffres, Michel] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Ollscoil na Gaillimhe-University of Galway; Stellenbosch University; Rhodes University; Makerere University; Simon Fraser University	Mills, EJ (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	emills@cihhrs.org	Montaner, Julio/K-7621-2012; Walker, Roderick B/B-5212-2009	Walker, Roderick/0000-0003-2781-4154				Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Arah OA, 2008, AM J PUBLIC HEALTH, V98, P148, DOI 10.2105/AJPH.2006.095844; Attaran A, 2008, CAN MED ASSOC J, V178, P265, DOI 10.1503/cmaj.071733; Awases M., 2004, MIGRATION HLTH PROFE; Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; CHIKANDA A, 2004, SKILLED HLTH PROFESS; Department of Health, 2004, COD PRACT INT RECR H; Dovlo D, 2007, HEALTH SERV RES, V42, P1373, DOI 10.1111/j.1475-6773.2007.00712.x; Ihekweazu C, 2005, LANCET, V365, P1847, DOI 10.1016/S0140-6736(05)66612-3; *INT COUNC NURS, 2001, ETH NURS RECR ICN PO; Katerere DR, 2003, AM J HEALTH-SYST PH, V60, P1169, DOI 10.1093/ajhp/60.11.1169; Labonte Ronald, 2006, Hum Resour Health, V4, P22, DOI 10.1186/1478-4491-4-22; Martineau T, 2004, HEALTH POLICY, V70, P1, DOI 10.1016/j.healthpol.2004.01.006; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Murray Mark, 2007, Fam Pract Manag, V14, P44; Pond B, 2006, LANCET, V367, P1448, DOI 10.1016/S0140-6736(06)68346-3; Ross SJ, 2005, INT NURS REV, V52, P253, DOI 10.1111/j.1466-7657.2005.00430.x; TAWFIK L, 2003, IMPACT HIV AIDS HLTH; *UNAIDS, 2007, AIDS EP UPD; United Nations, 1948, UN DECL HUM RIGHTS; *WHO, 2007, INT ACT NEED INCR HE; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; *WHOSIS, WORLD HLTH STAT 2007; World Health Organization, 2007, HUM RES HLTH 2007; World Health Organization, ROL PHARM HLTH CAR S; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	28	73	74	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2008	371	9613					685	688		10.1016/S0140-6736(08)60308-6	http://dx.doi.org/10.1016/S0140-6736(08)60308-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LL	18295027				2022-12-28	WOS:000253436700034
J	Rossant, J				Rossant, Janet			Stem cells and early lineage development	CELL			English	Article							PRIMORDIAL GERM-CELLS; SELF-RENEWAL; PLURIPOTENCY; DIFFERENTIATION; FIBROBLASTS; GENERATION; DERIVATION; EPIBLAST; INDUCTION	The recent derivation of pluripotent stem cell lines from a number of different sources, including reprogrammed adult somatic cells, raises the issue of the developmental equivalence of these different pluripotent states. At least two different states representing the epiblast progenitors in the blastocyst and the pluripotent progenitors of the later gastrulating embryo have been recognized. Understanding the initial developmental status of the different pluripotent lines is critical for defining starting conditions for differentiation toward therapeutically relevant cell types.	Univ Toronto, Dept Mol Genet, Hosp Sick Children, Res Inst,Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Rossant, J (corresponding author), Univ Toronto, Dept Mol Genet, Hosp Sick Children, Res Inst,Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	janet.rossant@sickkids.ca						Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Nichols J, 2001, DEVELOPMENT, V128, P2333; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	28	230	245	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					527	531		10.1016/j.cell.2008.01.039	http://dx.doi.org/10.1016/j.cell.2008.01.039			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295568	Bronze			2022-12-28	WOS:000253817900010
J	Rubin, LL				Rubin, Lee L.			Stem cells and drug discovery: The beginning of a new era?	CELL			English	Article							DIRECTED DIFFERENTIATION; SMALL MOLECULES; SELF-RENEWAL; MIDBRAIN; NEURONS; OSTEOGENESIS; ACTIVATION	Much of the attention focused on stem cells relates to their use in cell replacement therapy; however, stem cells may also transform the way in which therapeutics are discovered and validated.	[Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Rubin, Lee L.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University	Rubin, LL (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	lee_rubin@harvard.edu		Rubin, Lee/0000-0002-8658-841X				Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Chen SB, 2007, P NATL ACAD SCI USA, V104, P10482, DOI 10.1073/pnas.0704360104; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Duckmanton A, 2005, CHEM BIOL, V12, P1117, DOI 10.1016/j.chembiol.2005.07.011; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Rosania GR, 2000, NAT BIOTECHNOL, V18, P304, DOI 10.1038/73753; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SAXE J, 2007, J CHEM BIOL, V14, P1019; Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i; Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908	26	104	120	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					549	552		10.1016/j.cell.2008.02.010	http://dx.doi.org/10.1016/j.cell.2008.02.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295572	Bronze			2022-12-28	WOS:000253817900014
J	Stadler, BM; Ruohola-Baker, H				Stadler, Bradford M.; Ruohola-Baker, Hannele			Small RNAs: Keeping stem cells in line	CELL			English	Review							SELF-RENEWAL; DROSOPHILA; GERMLINE; MICRORNA; MAINTENANCE; PATHWAY; DICER; DCR-1	Stem cells and RNA silencing have emerged as areas of intense interest for both basic and clinical research. Recently these fields have converged with reports implicating small regulatory RNAs in the maintenance and pluripotency of stem cells.	[Stadler, Bradford M.; Ruohola-Baker, Hannele] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Stadler, Bradford M.; Ruohola-Baker, Hannele] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ruohola-Baker, H (corresponding author), Univ Washington, Dept Biochem, 1705 NE Pacific St,Hlth Sci Bldg,Room J-587, Seattle, WA 98195 USA.	hannele@u.washington.edu	Chokri, BEN AMAR/K-5237-2012; Miraoui, Moeiz/I-5637-2019	Chokri, BEN AMAR/0000-0002-0129-7577; Miraoui, Moeiz/0000-0003-2220-8673; Journal, UbiCC/0000-0001-5154-7936	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083867] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM083867-01A2, R01 GM083867] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lakshmipathy U., 2007, STEM CELLS; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Shcherbata HR, 2007, CELL STEM CELL, V1, P698, DOI 10.1016/j.stem.2007.11.007; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yang LL, 2007, DEVELOPMENT, V134, P4265, DOI 10.1242/dev.009159; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	21	82	103	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					563	566		10.1016/j.cell.2008.02.005	http://dx.doi.org/10.1016/j.cell.2008.02.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295575	Green Accepted, Bronze			2022-12-28	WOS:000253817900017
J	Harrington, LE; Janowski, KM; Oliver, JR; Zajac, AJ; Weaver, CT				Harrington, Laurie E.; Janowski, Karen M.; Oliver, James R.; Zajac, Allan J.; Weaver, Casey T.			Memory CD4 T cells emerge from effector T-cell progenitors	NATURE			English	Article							CLASS-II; LINEAGE RELATIONSHIP; VACCINE DEVELOPMENT; ESCHERICHIA-COLI; VIRUS-INFECTION; CUTTING EDGE; IN-VIVO; EXPRESSION; GENERATION; DISTINCT	A hallmark of adaptive immunity is the generation of memory T cells that confer long- lived, antigen- specific protection against repeat challenges by pathogens(1-5). Understanding the mechanisms by which memory T cells arise is important for rational vaccination strategies and improved therapeutic interventions for chronic infections and autoimmune disorders. The large clonal expansion of CD8 T cells in response to some infections has made the development of CD8 T- cell memory more amenable to study, giving rise to a model of memory cell differentiation in which a fraction of fully competent effector T cells transition into long-lived memory T cells(4,6,7). Delineation of CD4 T- cell memory development has proved more difficult as a result of limitations on tracking the smaller populations of CD4 effector T cells generated during a pathogenic challenge(8-10), complicating efforts to determine whether CD4 memory T cells are direct descendants of effector T cells or whether they develop by alternative pathways(3,4). Here, using two complementary cytokine reporter mouse models to identify interferon ( IFN)- gamma-positive effector T cells and track their fate, we show that the lineage relationship between effector and memory CD4 T cells resembles that for CD8 T cells responding to the same pathogen. We find that, in parallel with effector CD8 T cells, IFN-gamma-positive effector CD4 T cells give rise to long- lived memory T cells capable of anamnestic responses to antigenic rechallenge.	[Harrington, Laurie E.; Janowski, Karen M.; Oliver, James R.; Weaver, Casey T.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Zajac, Allan J.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Weaver, CT (corresponding author), Univ Alabama, Dept Pathol, 845 19th St S, Birmingham, AL 35294 USA.	cweaver@uab.edu		Weaver, Casey/0000-0002-2180-1793				Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Bevan MJ, 2002, NATURE, V420, P748, DOI 10.1038/420748a; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Fuller MJ, 2005, J IMMUNOL, V174, P5926, DOI 10.4049/jimmunol.174.10.5926; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Varga SM, 1998, J IMMUNOL, V161, P367; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Whitmire JK, 1998, J VIROL, V72, P8281, DOI 10.1128/JVI.72.10.8281-8288.1998; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	35	183	192	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					356	U8		10.1038/nature06672	http://dx.doi.org/10.1038/nature06672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18322463				2022-12-28	WOS:000254117400048
J	Kathiresan, S; Melander, O; Anevski, D; Guiducci, C; Burtt, NP; Roos, C; Hirschhorn, JN; Berglund, G; Hedblad, B; Groop, L; Altshuler, DM; Newton-Cheh, C; Orho-Melander, M				Kathiresan, Sekar; Melander, Olle; Anevski, Dragi; Guiducci, Candace; Burtt, Noel P.; Roos, Charlotta; Hirschhorn, Joel N.; Berglund, Goran; Hedblad, Bo; Groop, Leif; Altshuler, David M.; Newton-Cheh, Christopher; Orho-Melander, Marju			Polymorphisms associated with cholesterol and risk of cardiovascular events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; HDL-CHOLESTEROL; HEPATIC LIPASE; TRIGLYCERIDES; LOCI; CONTRIBUTES; CURVE; MALMO; PCSK9	Background: Common single-nucleotide polymorphisms (SNPs) that are associated with blood low-density lipoprotein (LDL) or high-density lipoprotein (HDL) cholesterol modestly affect lipid levels. We tested the hypothesis that a combination of such SNPs contributes to the risk of cardiovascular disease. Methods: We studied SNPs at nine loci in 5414 subjects from the cardiovascular cohort of the Malmo Diet and Cancer Study. We first validated the association between SNPs and either LDL or HDL cholesterol and subsequently created a genotype score on the basis of the number of unfavorable alleles. We used Cox proportional-hazards models to determine the time to the first cardiovascular event in relation to the genotype score. Results: All nine SNPs showed replication of an association with levels of either LDL or HDL cholesterol. With increasing genotype scores, the level of LDL cholesterol increased from 152 mg to 171 mg per deciliter (3.9 to 4.4 mmol per liter), whereas HDL cholesterol decreased from 60 mg to 51 mg per deciliter (1.6 to 1.3 mmol per liter). During follow-up (median, 10.6 years), 238 subjects had a first cardiovascular event. The genotype score was associated with incident cardiovascular disease in models adjusted for covariates including baseline lipid levels (P<0.001). The use of the genotype score did not improve the clinical risk prediction, as assessed by the C statistic. However, there was a significant improvement in risk classification with the use of models that included the genotype score, as compared with those that did not include the genotype score. Conclusions: A genotype score of nine validated SNPs that are associated with modulation in levels of LDL or HDL cholesterol was an independent risk factor for incident cardiovascular disease. The score did not improve risk discrimination but did modestly improve clinical risk reclassification for individual subjects beyond standard clinical factors.	[Kathiresan, Sekar; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Dis Prevent Ctr, Div Cardiol, Boston, MA 02114 USA; [Altshuler, David M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Altshuler, David M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Kathiresan, Sekar; Altshuler, David M.; Newton-Cheh, Christopher] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Hirschhorn, Joel N.; Altshuler, David M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol & Genet, Boston, MA 02115 USA; [Kathiresan, Sekar; Guiducci, Candace; Burtt, Noel P.; Hirschhorn, Joel N.; Altshuler, David M.; Newton-Cheh, Christopher] MIT, Broad Inst, Cambridge, MA 02139 USA; [Kathiresan, Sekar; Guiducci, Candace; Burtt, Noel P.; Hirschhorn, Joel N.; Altshuler, David M.; Newton-Cheh, Christopher] Harvard Univ, Cambridge, MA 02138 USA; [Melander, Olle] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Hypertens & Cardiovasc Dis, Malmo, Sweden; [Anevski, Dragi; Roos, Charlotta; Groop, Leif; Orho-Melander, Marju] Lund Univ, Malmo Univ Hosp, Dept Endocrinol & Diabet, Malmo, Sweden; [Berglund, Goran] Lund Univ, Malmo Univ Hosp, Dept Internal Med, Malmo, Sweden; [Hedblad, Bo] Lund Univ, Malmo Univ Hosp, Dept Epidemiol Res, Malmo, Sweden; [Anevski, Dragi] Chalmers Univ Technol, S-41296 Gothenburg, Sweden; [Groop, Leif] Helsinki Univ Hosp, Helsinki, Finland	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Chalmers University of Technology; University of Helsinki; Helsinki University Central Hospital	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Dis Prevent Ctr, Div Cardiol, 25 New Chardon St,Suite 301, Boston, MA 02114 USA.	skathiresan@partners.org	Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; Melander, Olle/0000-0002-2581-484X	NHLBI NIH HHS [K23-HL080025, K23-HL083102] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL083102, K23HL080025] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTSHULER D, 2007, WHOLE GENOME SCANE T; Benn M, 2005, J CLIN ENDOCR METAB, V90, P5797, DOI 10.1210/jc.2005-0974; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Boekholdt SM, 2005, CIRCULATION, V111, P278, DOI 10.1161/01.CIR.0000153341.46271.40; Boright AP, 1998, J HUM GENET, V43, P153, DOI 10.1007/s100380050060; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cooper GR, 1997, JAMA-J AM MED ASSOC, V278, P478; COOPER GR, 1992, JAMA-J AM MED ASSOC, V267, P1652, DOI 10.1001/jama.267.12.1652; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frikke-Schmidt R, 2004, J CLIN INVEST, V114, P1343, DOI 10.1172/JCI200420361; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Guerra R, 1997, P NATL ACAD SCI USA, V94, P4532, DOI 10.1073/pnas.94.9.4532; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Humphries SE, 2007, CLIN CHEM, V53, P8, DOI 10.1373/clinchem.2006.074591; JERNTORP P, 1992, STROKE, V23, P357, DOI 10.1161/01.STR.23.3.357; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; MILLER NE, 1975, LANCET, V1, P1033, DOI 10.1016/S0140-6736(75)91977-7; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; Nettleton JA, 2007, ATHEROSCLEROSIS, V194, pE131, DOI 10.1016/j.atherosclerosis.2006.11.025; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PERO RW, 1993, J INTERN MED, V233, P63, DOI 10.1111/j.1365-2796.1993.tb00650.x; Rip J, 2006, ARTERIOSCL THROM VAS, V26, P1236, DOI 10.1161/01.ATV.0000219283.10832.43; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SING CF, 1985, AM J HUM GENET, V37, P268; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wittrup HH, 2006, J CLIN ENDOCR METAB, V91, P1438, DOI 10.1210/jc.2005-1725	36	543	561	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1240	1249		10.1056/NEJMoa0706728	http://dx.doi.org/10.1056/NEJMoa0706728			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275TL	18354102				2022-12-28	WOS:000254094400005
J	Wilt, TJ				Wilt, Timothy J.			Commentary: controversies in NICE guidance on prostate cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material							GUIDELINES		[Wilt, Timothy J.] Minneapolis VA Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA		Wilt, TJ (corresponding author), Minneapolis VA Ctr Chron Dis Outcomes Res, 1 Vet Dr 111-O, Minneapolis, MN 55417 USA.	Tim.wilt@med.va.gov						Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Heidenreich A, 2008, EUR UROL, V53, P68, DOI 10.1016/j.eururo.2007.09.002; LUYAO G, 2008, GEN CANC S SAN FRANC; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; Wilt TJ, 2008, COMP EFFECTIVENSS RE	7	6	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 15	2008	336	7644					612	614		10.1136/bmj.39501.621690.AD	http://dx.doi.org/10.1136/bmj.39501.621690.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18340077	Green Published			2022-12-28	WOS:000254364500037
J	Wasmer, C; Lange, A; Van Melckebeke, H; Siemer, AB; Riek, R; Meier, BH				Wasmer, Christian; Lange, Adam; Van Melckebeke, Helene; Siemer, Ansgar B.; Riek, Roland; Meier, Beat H.			Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core	SCIENCE			English	Article							HET-S PRION; SOLID-STATE NMR; ANGLE-SPINNING NMR; CRYSTAL-STRUCTURE; PROTEIN; DOMAIN; SPECTROSCOPY; C-13; POLYMORPHISM; CONSTRAINTS	Prion and nonprion forms of proteins are believed to differ solely in their three- dimensional structure, which is therefore of paramount importance for the prion function. However, no atomic-resolution structure of the fibrillar state that is likely infectious has been reported to date. We present a structural model based on solid- state nuclear magnetic resonance restraints for amyloid fibrils from the prion- forming domain ( residues 218 to 289) of the HET- s protein from the filamentous fungus Podospora anserina. On the basis of 134 intra- and intermolecular experimental distance restraints, we find that HET- s( 218 - 289) forms a left- handed beta solenoid, with each molecule forming two helical windings, a compact hydrophobic core, at least 23 hydrogen bonds, three salt bridges, and two asparagine ladders. The structure is likely to have broad implications for understanding the infectious amyloid state.	[Wasmer, Christian; Lange, Adam; Van Melckebeke, Helene; Siemer, Ansgar B.; Riek, Roland; Meier, Beat H.] ETH, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Meier, BH (corresponding author), ETH, CH-8093 Zurich, Switzerland.	beme@ethz.ch	Wasmer, Christian/A-7922-2008; Meier, Beat H/K-4066-2016	Wasmer, Christian/0000-0001-6842-350X; Meier, Beat H/0000-0002-9107-4464; Riek, Roland/0000-0002-6333-066X; Lange, Adam/0000-0002-7534-5973				Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Baxa U, 2006, ADV PROTEIN CHEM, V73, P125, DOI 10.1016/S0065-3233(06)73005-4; Benkemoun L, 2006, FUNGAL GENET BIOL, V43, P789, DOI 10.1016/j.fgb.2006.06.006; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Etzkorn M, 2004, J AM CHEM SOC, V126, P14746, DOI 10.1021/ja0479181; Ferguson N, 2006, P NATL ACAD SCI USA, V103, P16248, DOI 10.1073/pnas.0607815103; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P1, DOI 10.1016/S0065-3233(06)73001-7; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lange A, 2005, ANGEW CHEM INT EDIT, V44, P2089, DOI 10.1002/anie.200462516; Lange A, 2002, J AM CHEM SOC, V124, P9704, DOI 10.1021/ja026691b; Lazo ND, 1998, BIOCHEMISTRY-US, V37, P1731, DOI 10.1021/bi971016d; LeMaster DM, 1996, J AM CHEM SOC, V118, P9255, DOI 10.1021/ja960877r; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Sabate R, 2007, J MOL BIOL, V370, P768, DOI 10.1016/j.jmb.2007.05.014; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sen A, 2007, J BIOL CHEM, V282, P5545, DOI 10.1074/jbc.M611464200; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Siemer AB, 2006, J BIOMOL NMR, V34, P75, DOI 10.1007/s10858-005-5582-7; Siemer AB, 2006, J AM CHEM SOC, V128, P13224, DOI 10.1021/ja063639x; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tycko R, 2006, PROTEIN PEPTIDE LETT, V13, P229, DOI 10.2174/092986606775338470; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	37	789	800	0	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1523	1526		10.1126/science.1151839	http://dx.doi.org/10.1126/science.1151839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339938				2022-12-28	WOS:000253943800038
J	Xiao, H; Jiang, N; Schaffner, E; Stockinger, EJ; van der Knaap, E				Xiao, Han; Jiang, Ning; Schaffner, Erin; Stockinger, Eric J.; van der Knaap, Esther			A retrotransposon-mediated gene duplication underlies morphological variation of tomato fruit	SCIENCE			English	Article							ARABIDOPSIS; DOMESTICATION; BIOSYNTHESIS; TRYPTOPHAN; PROTEIN	Edible fruits, such as that of the tomato plant and other vegetable crops, are markedly diverse in shape and size. SUN, one of the major genes controlling the elongated fruit shape of tomato, was positionally cloned and found to encode a member of the IQ67 domain - containing family. We show that the locus arose as a result of an unusual 24.7- kilobase gene duplication event mediated by the long terminal repeat retrotransposon Rider. This event resulted in a new genomic context that increased SUN expression relative to that of the ancestral copy, culminating in an elongated fruit shape. Our discovery demonstrates that retrotransposons may be a major driving force in genome evolution and gene duplication, resulting in phenotypic change in plants.	[Xiao, Han; Schaffner, Erin; Stockinger, Eric J.; van der Knaap, Esther] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA; [Jiang, Ning] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Schaffner, Erin] Coll Wooster, Wooster, OH 44691 USA	University System of Ohio; Ohio State University; Michigan State University; College of Wooster	van der Knaap, E (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA.	vanderknaap.1@osu.edu	van der Knaap, Esther/D-6307-2012; Jiang, Ning/G-6546-2012; Xiao, Han/C-3295-2012	Xiao, Han/0000-0001-5937-6510; van der Knaap, Esther/0000-0003-4963-7427				Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Ficcadenti N, 1999, MOL BREEDING, V5, P463, DOI 10.1023/A:1009665409959; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Lertpiriyapong K, 2003, PLANT MOL BIOL, V53, P581, DOI 10.1023/B:PLAN.0000019067.05185.d6; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; LEWIN B, 2008, GENES, V9; Majira A, 2002, PLANT MOL BIOL, V50, P551, DOI 10.1023/A:1019851913083; Mikkelsen MD, 2000, J BIOL CHEM, V275, P33712, DOI 10.1074/jbc.M001667200; Pandolfini Tiziana, 2002, BMC Biotechnology, V2, P1, DOI 10.1186/1472-6750-2-1; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Takada S, 2001, DEVELOPMENT, V128, P1127; van der Knaap E, 2004, GENETICS, V168, P2127, DOI 10.1534/genetics.104.031013; van der Knaap E, 2001, THEOR APPL GENET, V103, P353, DOI 10.1007/s001220100623; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	15	369	403	17	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1527	1530		10.1126/science.1153040	http://dx.doi.org/10.1126/science.1153040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339939				2022-12-28	WOS:000253943800039
J	Sharp, D				Sharp, David			Hydrophobia phobia as social history	LANCET			English	Editorial Material							RABIES		Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							BUCHAN W, 1800, DOMESTIC MED TREATIS, P477; Dodet B, 2007, VACCINE, V25, P4123, DOI 10.1016/j.vaccine.2007.03.002; HERMACHUDHA T, 2006, J NEUROVIROL, V12, P407; Hu WT, 2007, NEW ENGL J MED, V357, P945, DOI 10.1056/NEJMc062479; Hunter W. R., 1968, MED HIST, V12, P294; Jackson AC, 2005, NEW ENGL J MED, V352, P2549, DOI 10.1056/NEJMe058092; Jackson AC, 2003, CLIN INFECT DIS, V36, P60, DOI 10.1086/344905; Pemberton N, 2007, SCI TECHNOL MED MOD, P1, DOI 10.1057/9780230589544; QURESHI Y, 2007, MANCHESTER EVEN 1101; Teigen PM, 2007, J HIST MED ALL SCI, V62, P141, DOI 10.1093/jhmas/jrl016; Warrell MJ, 2004, LANCET, V363, P959, DOI 10.1016/S0140-6736(04)15792-9	11	0	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2008	371	9615					797	798		10.1016/S0140-6736(08)60360-8	http://dx.doi.org/10.1016/S0140-6736(08)60360-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272NQ	18328914				2022-12-28	WOS:000253866500010
J	Atkinson, T; Leeder, M				Atkinson, Tim; Leeder, Mike			Geology - Canyon cutting on a grand time scale	SCIENCE			English	Editorial Material							COLORADO PLATEAU; AGE		[Atkinson, Tim] UCL, Dept Earth Sci, London WC1E 6BT, England; [Leeder, Mike] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of London; University College London; University of East Anglia	Atkinson, T (corresponding author), UCL, Dept Earth Sci, Mortimer St, London WC1E 6BT, England.	t.atkinson@ucl.ac.uk; m.leeder@uea.ac.uk						ATKINSON TC, 1992, URANIUM SERIES DISEQ, P669; FARRANT AR, 1995, GEOLOGY, V23, P357, DOI 10.1130/0091-7613(1995)023<0357:LTQURI>2.3.CO;2; FORD DC, 1981, ARCTIC ALPINE RES, V13, P1, DOI 10.2307/1550621; GEIKIE A, 1882, TXB GEOLOGY, P441; Holm RF, 2001, GEOL SOC AM BULL, V113, P1467, DOI 10.1130/0016-7606(2001)113<1467:CPOTCM>2.0.CO;2; Hutton J, 1788, EARTH ENV SCI T R SO, V1, P209, DOI [10.1017/S0080456800029227, DOI 10.1017/S0080456800029227]; Leopold L.B., 1964, FLUVIAL PROCESSES GE, p[76, 180]; Pederson J, 2002, GEOLOGY, V30, P739, DOI 10.1130/0091-7613(2002)030<0739:DIOTGC>2.0.CO;2; Polyak V, 2008, SCIENCE, V319, P1377, DOI 10.1126/science.1151248; Richards DA, 1998, GEOCHIM COSMOCHIM AC, V62, P3683, DOI 10.1016/S0016-7037(98)00256-7; Roy M, 2004, GEOLOGY, V32, P925, DOI 10.1130/G20561.1; SMITH WO, 1961, 295 US GEOL SURV; Walker J, 2006, SCIENCE, V314, P1592, DOI 10.1126/science.1132916	13	0	1	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1343	1344		10.1126/science.1155286	http://dx.doi.org/10.1126/science.1155286			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323437				2022-12-28	WOS:000253712900026
J	Birnbaum, MJ				Birnbaum, Morris J.			Signal transduction - Sweet conundrum	SCIENCE			English	Editorial Material							LIVER		[Birnbaum, Morris J.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania	Birnbaum, MJ (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.	birnbaum@mail.med.upenn.edu		Birnbaum, Morris/0000-0001-9972-8680				Cheng A, 2006, BIOESSAYS, V28, P231, DOI 10.1002/bies.20375; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; EFENDIC S, 1985, P NATL ACAD SCI USA, V82, P2965, DOI 10.1073/pnas.82.9.2965; GARVEY WT, 1985, DIABETES, V34, P222, DOI 10.2337/diabetes.34.3.222; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Kim JK, 2001, J CLIN INVEST, V108, P153, DOI 10.1172/JCI10294; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Massillon D, 1996, J BIOL CHEM, V271, P9871, DOI 10.1074/jbc.271.17.9871; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676	9	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1348	1349		10.1126/science.1155915	http://dx.doi.org/10.1126/science.1155915			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323441				2022-12-28	WOS:000253712900030
J	Tato, CM; Cua, DJ				Tato, Cristina M.; Cua, Daniel J.			SnapShot: Cytokines III	CELL			English	Editorial Material							FAMILY-MEMBERS; LYMPHOTOXIN		[Tato, Cristina M.; Cua, Daniel J.] Schering Plough Biopharma, Palo Alto, CA 94304 USA	Merck & Company	Tato, CM (corresponding author), Schering Plough Biopharma, Palo Alto, CA 94304 USA.			Tato, Cristina M./0000-0002-0614-756X				Abe K, 2000, ANN NY ACAD SCI, V926, P52; Le Pottier L, 2007, ANN NY ACAD SCI, V1110, P426, DOI 10.1196/annals.1423.044; O'Shea JJ, 2008, CLIN IMMUNOLOGY; PAUL NL, 1988, ANNU REV IMMUNOL, V6, P407, DOI 10.1146/annurev.iy.06.040188.002203; Sun M, 2007, J IMMUNOL, V179, P4307, DOI 10.4049/jimmunol.179.7.4307; Tumanov AV, 2007, CURR MOL MED, V7, P567, DOI 10.2174/156652407781695701; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839	7	18	19	1	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					900	U12		10.1016/j.cell.2008.02.023	http://dx.doi.org/10.1016/j.cell.2008.02.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329374	Bronze			2022-12-28	WOS:000253818000025
J	Schwarz, UI; Ritchie, MD; Bradford, Y; Li, C; Dudek, SM; Frye-Anderson, A; Kim, RB; Roden, DM; Stein, CM				Schwarz, Ute I.; Ritchie, Marylyn D.; Bradford, Yuki; Li, Chun; Dudek, Scott M.; Frye-Anderson, Amy; Kim, Richard B.; Roden, Dan M.; Stein, C. Michael			Genetic determinants of response to warfarin during initial anticoagulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REDUCTASE COMPLEX SUBUNIT-1; DOSE REQUIREMENTS; ORAL ANTICOAGULATION; VKORC1 GENE; CYP2C9; THERAPY; POLYMORPHISMS; ASSOCIATION; VARIANTS; COMPLICATIONS	Background: Genetic variants of the enzyme that metabolizes warfarin, cytochrome P-450 2C9 (CYP2C9), and of a key pharmacologic target of warfarin, vitamin K epoxide reductase (VKORC1), contribute to differences in patients' responses to various warfarin doses, but the role of these variants during initial anticoagulation is not clear. Methods: In 297 patients starting warfarin therapy, we assessed CYP2C9 genotypes (CYP2C9 *1, *2, and *3), VKORC1 haplotypes (designated A and non-A), clinical characteristics, response to therapy (as determined by the international normalized ratio [INR]), and bleeding events. The study outcomes were the time to the first INR within the therapeutic range, the time to the first INR of more than 4, the time above the therapeutic INR range, the INR response over time, and the warfarin dose requirement. Results: As compared with patients with the non-A/non-A haplotype, patients with the A/A haplotype of VKORC1 had a decreased time to the first INR within the therapeutic range (P=0.02) and to the first INR of more than 4 (P=0.003). In contrast, the CYP2C9 genotype was not a significant predictor of the time to the first INR within the therapeutic range (P=0.57) but was a significant predictor of the time to the first INR of more than 4 (P=0.03). Both the CYP2C9 genotype and VKORC1 haplotype had a significant influence on the required warfarin dose after the first 2 weeks of therapy. Conclusions: Initial variability in the INR response to warfarin was more strongly associated with genetic variability in the pharmacologic target of warfarin, VKORC1, than with CYP2C9.	[Schwarz, Ute I.; Frye-Anderson, Amy; Kim, Richard B.; Roden, Dan M.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Schwarz, Ute I.; Frye-Anderson, Amy; Kim, Richard B.; Roden, Dan M.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Bradford, Yuki; Dudek, Scott M.] Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Bradford, Yuki; Dudek, Scott M.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37212 USA; [Li, Chun] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Schwarz, UI (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.		Li, Chun/B-8388-2012; Kim, Richard/D-6971-2011; Li, Chun/R-1095-2019; Roden, Dan/ABD-5412-2021; Schwarz, Ute/G-2845-2011; Ritchie, Marylyn/C-1114-2012	Kim, Richard/0000-0001-8148-1632; Li, Chun/0000-0002-8819-2443; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065962, K24HL004012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM031304, U01GM061374] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL065962, U01-HL65962, K24 HL004012, HL04012] Funding Source: Medline; NIGMS NIH HHS [P01 GM031304, U01 GM061374, GM31304, U01-GM61374] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], MICR HEALTHC SER; Ansell J, 2005, CHEST, V127, P415; ANSELL J, 2004, CHEST S, V126, P3; Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beyth RJ, 2000, ANN INTERN MED, V133, P687, DOI 10.7326/0003-4819-133-9-200011070-00010; Cain D, 1997, J BIOL CHEM, V272, P29068, DOI 10.1074/jbc.272.46.29068; Carlquist JF, 2006, J THROMB THROMBOLYS, V22, P191, DOI 10.1007/s11239-006-9030-7; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Dickmann LJ, 2001, MOL PHARMACOL, V60, P382, DOI 10.1124/mol.60.2.382; Gage BF, 2004, THROMB HAEMOSTASIS, V91, P87, DOI 10.1160/TH03-06-0379; Gullov AL, 1999, ARCH INTERN MED, V159, P1322, DOI 10.1001/archinte.159.12.1322; Herman D, 2006, THROMB HAEMOSTASIS, V95, P782, DOI 10.1160/TH05-10-0678; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Lee SC, 2006, CLIN PHARMACOL THER, V79, P197, DOI 10.1016/j.clpt.2005.11.006; Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S; Li T, 2006, J MED GENET, V43, P740, DOI 10.1136/jmg.2005.040410; Lindh JD, 2005, CLIN PHARMACOL THER, V78, P540, DOI 10.1016/j.clpt.2005.08.006; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Margaglione M, 2000, THROMB HAEMOSTASIS, V84, P775; McMahan DA, 1998, J GEN INTERN MED, V13, P311, DOI 10.1046/j.1525-1497.1998.00096.x; Millican EA, 2007, BLOOD, V110, P1511, DOI 10.1182/blood-2007-01-069609; Peyvandi F, 2004, CLIN PHARMACOL THER, V75, P198, DOI 10.1016/j.clpt.2003.09.015; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; SullivanKlose TH, 1996, PHARMACOGENETICS, V6, P341, DOI 10.1097/00008571-199608000-00007; Takahashi H, 2004, CLIN PHARMACOL THER, V75, P376, DOI 10.1016/j.clpt.2004.01.007; Takahashi H, 2006, PHARMACOGENET GENOM, V16, P101, DOI 10.1097/01.fpc.0000184955.08453.a8; Vecsler M, 2006, THROMB HAEMOSTASIS, V95, P205, DOI 10.1160/TH05-06-0446; Veenstra DL, 2005, PHARMACOGENET GENOM, V15, P687, DOI 10.1097/01.fpc.0000174789.77614.68; Veenstra DL, 2005, CLIN PHARMACOL THER, V77, P353, DOI 10.1016/j.clpt.2005.01.019; Voora D, 2005, THROMB HAEMOSTASIS, V93, P700, DOI 10.1160/TH04-08-0542; Wadelius M, 2005, PHARMACOGENOMICS J, V5, P262, DOI 10.1038/sj.tpj.6500313; Xie HG, 2002, ADV DRUG DELIVER REV, V54, P1257, DOI 10.1016/S0169-409X(02)00076-5	37	440	481	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					999	1008		10.1056/NEJMoa0708078	http://dx.doi.org/10.1056/NEJMoa0708078			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18322281	Green Accepted			2022-12-28	WOS:000253644700004
J	Watts, G				Watts, Geoff			Europe seeks to boost research	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						European Federation of Pharmaceutical Industries and Associations, 2007, PHARM IND FIG; *INN MED IN, 2007, ASS EC SOC EFF; *INN MED IN, 2006, STRAT RES AG	3	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 1	2008	336	7642					474	475		10.1136/bmj.39475.547199.AD	http://dx.doi.org/10.1136/bmj.39475.547199.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18309998	Green Published			2022-12-28	WOS:000253997500035
J	Frieden, TR; Mostashari, F				Frieden, Thomas R.; Mostashari, Farzad			Health care as if health mattered	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PAY-FOR-PERFORMANCE; UNITED-STATES; PREVENTIVE SERVICES; MEDICAL-CARE; QUALITY; ADULTS; PHYSICIANS; PREVALENCE; AWARENESS; DELIVERY		[Frieden, Thomas R.] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA; [Mostashari, Farzad] New York City Dept Hlth, Primary Care Informat Project, New York, NY 10013 USA	New York City Department of Health & Mental Hygiene; New York City Department of Health & Mental Hygiene	Frieden, TR (corresponding author), New York City Dept Hlth & Mental Hyg, 125 Worth St,Room 331, New York, NY 10013 USA.	tfrieden@health.nyc.gov		Frieden, Thomas/0000-0002-4759-2256				Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Audet AMJ, 2005, HEALTH AFFAIR, V24, P843, DOI 10.1377/hlthaff.24.3.843; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Ferketich AK, 2006, PREV MED, V43, P472, DOI 10.1016/j.ypmed.2006.07.009; Hyre AD, 2007, ANN EPIDEMIOL, V17, P548, DOI 10.1016/j.annepidem.2007.01.032; Kupersmith J, 2007, HEALTH AFFAIR, V26, pW156, DOI 10.1377/hlthaff.26.2.w156; Landon BE, 2007, NEW ENGL J MED, V356, P921, DOI 10.1056/NEJMsa062860; Linder JA, 2007, ARCH INTERN MED, V167, P1400, DOI 10.1001/archinte.167.13.1400; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Mandel KE, 2007, ARCH PEDIAT ADOL MED, V161, P650, DOI 10.1001/archpedi.161.7.650; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Miller RH, 2005, HEALTH AFFAIR, V24, P1127, DOI 10.1377/hlthaff.24.5.1127; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Pawlson LG, 2007, AM J MANAG CARE, V13, P553; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Poisal JA, 2007, HEALTH AFFAIR, V26, pW242, DOI 10.1377/hlthaff.26.2.w242; *R WOOD JOHNS FDN, 2006, HLTH INF TECHN US IN; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Shekelle Paul G, 2006, Evid Rep Technol Assess (Full Rep), P1; Thomas K, 2007, PALLIATIVE MED, V21, P49, DOI 10.1177/0269216306072501; Wodchis WP, 2007, JAMA-J AM MED ASSOC, V298, P1797, DOI 10.1001/jama.298.15.1797	25	31	31	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2008	299	8					950	952		10.1001/jama.299.8.950	http://dx.doi.org/10.1001/jama.299.8.950			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266DZ	18314438				2022-12-28	WOS:000253413200024
J	Greenland, P; Lloyd-Jones, D				Greenland, Philip; Lloyd-Jones, Donald			Critical lessons from the ENHANCE trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHOLESTEROL; METAANALYSIS		[Greenland, Philip; Lloyd-Jones, Donald] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Greenland, Philip; Lloyd-Jones, Donald] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Greenland, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 750 N Lake Shore Dr,9th Floor, Chicago, IL 60611 USA.		Lloyd-Jones, Donald M/C-5899-2009; Greenland, Philip/ABD-5528-2021	Lloyd-Jones, Donald/0000-0003-0847-6110				Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Carey J, 2008, BUS WEEK, P52; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Kumar Amit, 2007, J Interv Cardiol, V20, P447, DOI 10.1111/j.1540-8183.2007.00298.x; Laine C, 2007, JAMA-J AM MED ASSOC, V298, P93, DOI 10.1001/jama.298.1.jed70037; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Parker-Pope T., 2008, NY TIMES, pD1; PARKERPOPE T, 2008, NY TIMES        0122, pD6; SAUL S, 2008, NY TIMES        0124, pC4; SAUL S, 2008, NY TIMES        0124, pC1; TAUBES G, 2008, NY TIMES        0127; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; WINSLOW R, 2008, WALL STREET J   0115, pA3	14	39	41	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2008	299	8					953	955		10.1001/jama.299.8.953	http://dx.doi.org/10.1001/jama.299.8.953			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266DZ	18314439				2022-12-28	WOS:000253413200025
J	Rothlisberger, D; Khersonsky, O; Wollacott, AM; Jiang, L; DeChancie, J; Betker, J; Gallaher, JL; Althoff, EA; Zanghellini, A; Dym, O; Albeck, S; Houk, KN; Tawfik, DS; Baker, D				Rothlisberger, Daniela; Khersonsky, Olga; Wollacott, Andrew M.; Jiang, Lin; DeChancie, Jason; Betker, Jamie; Gallaher, Jasmine L.; Althoff, Eric A.; Zanghellini, Alexandre; Dym, Orly; Albeck, Shira; Houk, Kendall N.; Tawfik, Dan S.; Baker, David			Kemp elimination catalysts by computational enzyme design	NATURE			English	Article							PHYSICAL ORGANIC-CHEMISTRY; PROTON-TRANSFER; ANTIBODY; PROTEIN; EVOLUTION; BENZISOXAZOLES; SELECTION; DENSITY; DECOMPOSITION	The design of new enzymes for reactions not catalysed by naturally occurring biocatalysts is a challenge for protein engineering and is a critical test of our understanding of enzyme catalysis. Here we describe the computational design of eight enzymes that use two different catalytic motifs to catalyse the Kemp elimination - a model reaction for proton transfer from carbon - with measured rate enhancements of up to 10 5 and multiple turnovers. Mutational analysis confirms that catalysis depends on the computationally designed active sites, and a high- resolution crystal structure suggests that the designs have close to atomic accuracy. Application of in vitro evolution to enhance the computational designs produced a >200-fold increase in k(cat)/K-m (k(cat)/K-m of 2,600 M(-1)s(-1) and k(cat)/k(uncat) of >10(6)). These results demonstrate the power of combining computational protein design with directed evolution for creating new enzymes, and we anticipate the creation of a wide range of useful new catalysts in the future.	[Rothlisberger, Daniela; Wollacott, Andrew M.; Jiang, Lin; Althoff, Eric A.; Zanghellini, Alexandre; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Betker, Jamie; Gallaher, Jasmine L.; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Khersonsky, Olga; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Dym, Orly; Albeck, Shira] Weizmann Inst Sci, Israel Struct Proteom Ctr, IL-76100 Rehovot, Israel; [DeChancie, Jason; Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Weizmann Institute of Science; Weizmann Institute of Science; University of California System; University of California Los Angeles	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dan.tawfik@weizmann.ac.il; dabaker@u.washington.edu	Jiang, Lin/G-1575-2010; Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abecassis V, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e88; Barlow M, 2002, GENETICS, V160, P823; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; CASEY ML, 1973, J ORG CHEM, V38, P2294, DOI 10.1021/jo00953a006; Cesaro-Tadic S, 2003, NAT BIOTECHNOL, V21, P679, DOI 10.1038/nbt828; Chica RA, 2005, CURR OPIN BIOTECH, V16, P378, DOI 10.1016/j.copbio.2005.06.004; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Debler EW, 2005, P NATL ACAD SCI USA, V102, P4984, DOI 10.1073/pnas.0409207102; Frisch M.J., 2016, GAUSSIAN16 REV B01; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Hollfelder F, 2000, J AM CHEM SOC, V122, P1022, DOI 10.1021/ja993471y; Hollfelder F, 1997, J AM CHEM SOC, V119, P9578, DOI 10.1021/ja971970y; Hollfelder F, 1996, NATURE, V383, P60, DOI 10.1038/383060a0; Hu YF, 2004, J AM CHEM SOC, V126, P8197, DOI 10.1021/ja0490727; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; KEMP DS, 1973, J AM CHEM SOC, V95, P6670, DOI 10.1021/ja00801a024; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Misura KMS, 2004, J MOL BIOL, V342, P651, DOI 10.1016/j.jmb.2004.07.038; Na J, 1996, J AM CHEM SOC, V118, P6462, DOI 10.1021/ja953550j; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Press WH., 2002, NUMERICAL RECIPES C, V2; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; THORN SN, 1995, NATURE, V373, P228, DOI 10.1038/373228a0; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; Vartanian JP, 1996, NUCLEIC ACIDS RES, V24, P2627, DOI 10.1093/nar/24.14.2627; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; 1994, ACTA CRYSTALLOGR, V50, P760	34	904	934	10	366	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2008	453	7192					190	U4		10.1038/nature06879	http://dx.doi.org/10.1038/nature06879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18354394	Bronze			2022-12-28	WOS:000255592400032
J	Towers, M; Mahood, R; Yin, YL; Tickle, C				Towers, Matthew; Mahood, Ruth; Yin, Yili; Tickle, Cheryll			Integration of growth and specification in chick wing digit-patterning	NATURE			English	Article							SONIC-HEDGEHOG; CELL-CYCLE; LIMB BUD; POSITIONAL INFORMATION; ANTEROPOSTERIOR AXIS; VALPROIC ACID	In the classical model of chick wing digit- patterning(1), the polarizing region - a group of cells at the posterior margin of the early bud - produces a morphogen gradient, now known to be based on Sonic hedgehog (Shh)(2,3), that progressively specifies anteroposterior positional identities in the posterior digit- forming region(4). Here we add an integral growth component to this model by showing that Shh- dependent proliferation of prospective digit progenitor cells is essential for specifying the complete pattern of digits across the anteroposterior axis. Inhibiting Shh signalling in early wing buds reduced anteroposterior expansion, and posterior digits were lost because all prospective digit precursors formed anterior structures. Inhibiting proliferation also irreversibly reduced anteroposterior expansion, but instead anterior digits were lost because all prospective digit precursors formed posterior structures. When proliferation recovered in such wings, Shh transcription was maintained for longer than normal, suggesting that duration of Shh expression is controlled by a mechanism that measures proliferation. Rescue experiments confirmed that Shh- dependent proliferation controls digit number during a discrete time- window in which Shh- dependent specification normally occurs. Our findings that Shh signalling has dual functions that can be temporally uncoupled have implications for understanding congenital and evolutionary digit reductions.	[Towers, Matthew; Mahood, Ruth; Yin, Yili; Tickle, Cheryll] Univ Dundee, Dept Dev & Cell Biol, Dundee DD1 5EH, Scotland	University of Dundee	Tickle, C (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	cat24@bath.ac.uk		Towers, Matthew/0000-0003-2189-4536	MRC [G9806660] Funding Source: UKRI; Medical Research Council [G9806660] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALBERCH P, 1983, J EMBRYOL EXP MORPH, V76, P177; Alessandri JL, 2000, ARCH PEDIATRIE, V7, P637, DOI 10.1016/S0929-693X(00)80132-3; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; COOKE J, 1980, NATURE, V287, P697, DOI 10.1038/287697a0; Davey MG, 2006, GENE DEV, V20, P1365, DOI 10.1101/gad.369106; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; GABRIEL ML, 1946, J EXP ZOOL, V101, P339, DOI 10.1002/jez.1401010304; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; NIETO A, 1996, METHOD CELL BIOL, P219; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Ohsugi K, 1997, DEV BIOL, V189, P13, DOI 10.1006/dbio.1997.8665; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ros MA, 2003, DEVELOPMENT, V130, P527, DOI 10.1242/dev.00245; Roy S, 2002, J CELL SCI, V115, P4393, DOI 10.1242/jcs.00158; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; SHARONY R, 1993, PRENATAL DIAG, V13, P909, DOI 10.1002/pd.1970131005; SMITH JC, 1979, J EMBRYOL EXP MORPH, V52, P105; SMITH JC, 1981, J EMBRYOL EXP MORPH, V63, P127; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; SUMMERBELL D, 1981, J EMBRYOL EXP MORPH, V63, P161; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; Vargesson N, 1997, DEVELOPMENT, V124, P1909; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yang Y, 1997, DEVELOPMENT, V124, P4393; ZWILLING E, 1956, J EXP ZOOL, V132, P219, DOI 10.1002/jez.1401320203	30	157	159	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2008	452	7189					882	U7		10.1038/nature06718	http://dx.doi.org/10.1038/nature06718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18354396				2022-12-28	WOS:000255026000050
J	Kucharski, R; Maleszka, J; Foret, S; Maleszka, R				Kucharski, R.; Maleszka, J.; Foret, S.; Maleszka, R.			Nutritional control of reproductive status in honeybees via DNA methylation	SCIENCE			English	Article							EPIGENETIC REGULATION; GENE-EXPRESSION; SYSTEM; PLASTICITY; GROWTH; BEE	Fertile queens and sterile workers are alternative forms of the adult female honeybee that develop from genetically identical larvae following differential feeding with royal jelly. We show that silencing the expression of DNA methyltransferase Dnmt3, a key driver of epigenetic global reprogramming, in newly hatched larvae led to a royal jelly- like effect on the larval developmental trajectory; the majority of Dnmt3 small interfering RNA- treated individuals emerged as queens with fully developed ovaries. Our results suggest that DNA methylation in Apis is used for storing epigenetic information, that the use of that information can be differentially altered by nutritional input, and that the flexibility of epigenetic modifications underpins, profound shifts in developmental fates, with massive implications for reproductive and behavioral status.	[Kucharski, R.; Maleszka, J.; Foret, S.; Maleszka, R.] Australian Natl Univ, Arc Ctr Mol Genet & Dev, Res Sch Biol Sci, Canberra, ACT 0200, Australia	Australian National University	Maleszka, R (corresponding author), Australian Natl Univ, Arc Ctr Mol Genet & Dev, Res Sch Biol Sci, Canberra, ACT 0200, Australia.	maleszka@rsbs.anu.edu.au	Blow, joe/C-8616-2009; Foret, Sylvain/C-7661-2011; Maleszka, Ryszard/A-6078-2008	Maleszka, Ryszard/0000-0003-1855-555X; Kucharski, Robert/0000-0002-1708-1877				Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Burdge GC, 2007, BRIT J NUTR, V97, P1036, DOI 10.1017/S0007114507682920; COLHOUN EH, 1960, NATURE, V188, P854, DOI 10.1038/188854a0; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Evans JSO, 2000, INT J INORG MATER, V2, P1; Fry CJ, 2002, SCIENCE, V295, P1847, DOI 10.1126/science.1070260; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Maindonald J, 2007, DATA ANAL GRAPHICS U; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Nelson, 1915, EMBRYOLOGY HONEYBEE; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Schaefer M, 2007, BIOESSAYS, V29, P208, DOI 10.1002/bies.20548; SHUEL R. W., 1960, INSECTES SOCIAUX, V7, P265, DOI 10.1007/BF02224497; ULRICH GM, 1983, CELL TISSUE RES, V230, P49, DOI 10.1007/BF00216026; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WEAVER N, 1957, J ECON ENTOMOL, V50, P759, DOI 10.1093/jee/50.6.759; WEAVER NEVIN, 1957, ANN ENT SOC AMER, V50, P283; West-Eberhard Mary Jane, 2003, pi; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; WILSON EO, 1979, P AM PHILOS SOC, V123, P204	28	752	806	15	342	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2008	319	5871					1827	1830		10.1126/science.1153069	http://dx.doi.org/10.1126/science.1153069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18339900				2022-12-28	WOS:000254394000047
J	Aschwanden, C				Aschwanden, Christie			Managing to excel at science	CELL			English	Editorial Material								Amid growing recognition that a successful scientific career requires skills beyond scientific acumen, institutions are racing to provide management training for newly minted principal investigators.					Barros, César/N-6505-2013	Barros, César/0000-0002-9499-3343					0	3	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 21	2008	132	6					911	913		10.1016/j.cell.2008.03.008	http://dx.doi.org/10.1016/j.cell.2008.03.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	278GR	18358800	Bronze			2022-12-28	WOS:000254273600006
J	Korte, M				Korte, Martin			Neuroscience - A protoplasmic kiss to remember	SCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; PROTEIN-SYNTHESIS; NEUROTROPHINS; PLASTICITY; NEURONS; BDNF; TRKB; LTP		[Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Cellular Neurobiol, D-38106 Braunschweig, Germany	Braunschweig University of Technology	Korte, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Cellular Neurobiol, D-38106 Braunschweig, Germany.	m.korte@tu-bs.de						Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Hebb Donald O., 1949, ORG BEHAV; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Wiese S, 2007, P NATL ACAD SCI USA, V104, P17210, DOI 10.1073/pnas.0705267104; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	14	10	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1627	1628		10.1126/science.1155748	http://dx.doi.org/10.1126/science.1155748			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356512				2022-12-28	WOS:000254172300026
J	Munoz-Price, LS; Weinstein, RA				Munoz-Price, L. Silvia; Weinstein, Robert A.			Current concepts: Acinetobacter infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INTENSIVE-CARE-UNIT; VENTILATOR-ASSOCIATED PNEUMONIA; RESISTANT PSEUDOMONAS-AERUGINOSA; GRAM-NEGATIVE BACTERIA; NOSOCOMIAL INFECTIONS; POLYMYXIN-B; MULTIDRUG-RESISTANCE; INTRAVENOUS COLISTIN; BAUMANNII INFECTIONS; CLINICAL-FEATURES		[Munoz-Price, L. Silvia] Med Specialists, Dyer, IN 46311 USA; [Weinstein, Robert A.] Stroger Cook Cty Hosp, Div Infect Dis, Ruth M Rothstein CORE Ctr, Chicago, IL USA; [Weinstein, Robert A.] Rush Med Coll, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County; Rush University	Munoz-Price, LS (corresponding author), Med Specialists, 919 Main St,Ste 202, Dyer, IN 46311 USA.	simunozprice@gmail.com		Munoz-Price, L. Silvia/0000-0001-8654-5746				Anstey NM, 2002, J CLIN MICROBIOL, V40, P685, DOI 10.1128/JCM.40.2.685-686.2002; BEIJERINCK MW, 1911, CENTRALBL BAKTERIOL, V29, P169; BERG DE, 1995, CLIN INFECT DIS, V21, P588, DOI 10.1093/clinids/21.3.588; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Betrosian AP, 2007, SCAND J INFECT DIS, V39, P38, DOI 10.1080/00365540600951184; Bonomo RA, 2006, CLIN INFECT DIS, V43, pS49, DOI 10.1086/504477; BUXTON AE, 1978, AM J MED, V65, P507, DOI 10.1016/0002-9343(78)90777-5; Carey RB, 2006, 46 INT C ANT AG CHEM; Chan PC, 2007, INFECT CONT HOSP EP, V28, P423, DOI 10.1086/513120; Chen MZ, 2001, CHEST, V120, P1072, DOI 10.1378/chest.120.4.1072; Cisneros JM, 1996, CLIN INFECT DIS, V22, P1026, DOI 10.1093/clinids/22.6.1026; Coelho JM, 2006, J CLIN MICROBIOL, V44, P3623, DOI 10.1128/JCM.00699-06; CORDES LG, 1981, ANN INTERN MED, V95, P688, DOI 10.7326/0003-4819-95-6-688; Dima S, 2007, INFECT CONT HOSP EP, V28, P602, DOI 10.1086/513618; EUZEBY JP, DICT BACTERIOLOGIE V; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; Falagas ME, 2006, ANTIMICROB AGENTS CH, V50, P2274, DOI 10.1128/AAC.00101-06; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Garnacho J, 2003, CRIT CARE MED, V31, P2478, DOI 10.1097/01.CCM.0000089936.09573.F3; Garnacho-Montero J, 2005, INTENS CARE MED, V31, P649, DOI 10.1007/s00134-005-2598-0; Garnacho-Montero J, 2003, CLIN INFECT DIS, V36, P1111, DOI 10.1086/374337; GETCHELLWHITE SI, 1989, INFECT CONT HOSP EP, V10, P402, DOI 10.1086/646061; Griffith ME, 2007, INFECT CONT HOSP EP, V28, P720, DOI 10.1086/518966; Hansen S, 2007, J HOSP INFECT, V65, P348, DOI 10.1016/j.jhin.2006.12.018; HARTSTEIN AI, 1988, AM J MED, V85, P624, DOI 10.1016/S0002-9343(88)80233-X; Hawley JS, 2007, ANTIMICROB AGENTS CH, V51, P376, DOI 10.1128/AAC.00858-06; Holloway KP, 2006, ANN PHARMACOTHER, V40, P1939, DOI 10.1345/aph.1H353; HORTON J, 1982, MED CLIN N AM, V66, P135, DOI 10.1016/S0025-7125(16)31447-X; Houang ETS, 2001, J CLIN MICROBIOL, V39, P228, DOI 10.1128/JCM.39.1.228-234.2001; Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Jimenez-Mejias ME, 2002, EUR J CLIN MICROBIOL, V21, P212, DOI 10.1007/s10096-001-0680-2; Koomanachai P, 2007, INT J INFECT DIS, V11, P402, DOI 10.1016/j.ijid.2006.09.011; Kwa ALH, 2005, CLIN INFECT DIS, V41, P754, DOI 10.1086/432583; Kwon KT, 2007, J ANTIMICROB CHEMOTH, V59, P525, DOI 10.1093/jac/dkl499; Lee NY, 2007, INFECT CONT HOSP EP, V28, P713, DOI 10.1086/517954; Lesho E, 2005, CLIN INFECT DIS, V41, P758, DOI 10.1086/432623; Leung AS, 2006, CHEST, V129, P102, DOI 10.1378/chest.129.1.102; Levin AS, 1999, CLIN INFECT DIS, V28, P1008, DOI 10.1086/514732; Levin AS, 2003, INT J ANTIMICROB AG, V21, P58, DOI 10.1016/S0924-8579(02)00276-5; Li J, 2006, ANTIMICROB AGENTS CH, V50, P2946, DOI 10.1128/AAC.00103-06; LINDBERG RB, 1955, ANN SURG, V141, P369, DOI 10.1097/00000658-195503000-00012; Linden PK, 2006, CLIN INFECT DIS, V43, pS89, DOI 10.1086/504485; Lolans K, 2006, ANTIMICROB AGENTS CH, V50, P2941, DOI 10.1128/AAC.00116-06; Maegele M, 2005, CRIT CARE MED, V33, P1136, DOI 10.1097/01.CCM.0000163269.42524.50; Manikal VM, 2000, CLIN INFECT DIS, V31, P101, DOI 10.1086/313902; Maragakis LL, 2004, JAMA-J AM MED ASSOC, V292, P3006, DOI 10.1001/jama.292.24.3006; Marchaim D, 2007, J CLIN MICROBIOL, V45, P1551, DOI 10.1128/JCM.02424-06; McDonald LC, 1999, CLIN INFECT DIS, V29, P1133, DOI 10.1086/313441; Michalopoulos A, 2005, CRIT CARE, V9, pR53, DOI 10.1186/cc3020; Motaouakkil S, 2006, J INFECTION, V53, P274, DOI 10.1016/j.jinf.2005.11.019; MUNOZPRICE LS, 2006, 46 INT C ANT AG CHEM; Murray CK, 2006, CLIN INFECT DIS, V43, P383, DOI 10.1086/505601; Naas T, 2006, EMERG INFECT DIS, V12, P1214, DOI 10.3201/eid1708.051547; Oncul O, 2002, J HOSP INFECT, V51, P47, DOI 10.1053/jhin.2002.1205; Ouderkirk JP, 2003, ANTIMICROB AGENTS CH, V47, P2659, DOI 10.1128/AAC.47.8.2659-2662.2003; Owen RJ, 2007, J ANTIMICROB CHEMOTH, V59, P473, DOI 10.1093/jac/dkl512; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Peleg AY, 2007, J ANTIMICROB CHEMOTH, V59, P128, DOI 10.1093/jac/dkl441; Peleg AY, 2007, ANTIMICROB AGENTS CH, V51, P2065, DOI 10.1128/AAC.01198-06; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Rice LB, 2006, CLIN INFECT DIS, V43, pS100, DOI 10.1086/504487; Saballs M, 2006, J ANTIMICROB CHEMOTH, V58, P697, DOI 10.1093/jac/dkl274; Schmidt H, 2006, CLIN MICROBIOL REV, V19, P257, DOI 10.1128/CMR.19.1.257.2006; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Schreckenberger PC, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P770; Scott P, 2007, CLIN INFECT DIS, V44, P1577, DOI 10.1086/518170; SEIFERT H, 1995, MEDICINE, V74, P340, DOI 10.1097/00005792-199511000-00004; SMITH PW, 1979, J INFECT DIS, V140, P275, DOI 10.1093/infdis/140.2.275; SNYDMAN DR, 1977, AM J EPIDEMIOL, V106, P154, DOI 10.1093/oxfordjournals.aje.a112445; Sobieszczyk ME, 2004, J ANTIMICROB CHEMOTH, V54, P566, DOI 10.1093/jac/dkh369; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; TONG MJ, 1972, J AMER MED ASSOC, V219, P1044, DOI 10.1001/jama.219.8.1044; Urban C, 2003, CLIN INFECT DIS, V36, P1268, DOI 10.1086/374847; Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205; Wisplinghoff H, 2000, CLIN INFECT DIS, V31, P690, DOI 10.1086/314040; Wood GC, 2003, INTENS CARE MED, V29, P2072, DOI 10.1007/s00134-003-1811-2; Zanetti G, 2007, INFECT CONT HOSP EP, V28, P723, DOI 10.1086/517956; 2004, MMWR MORB MORTAL WKL, V53, P1063	81	533	676	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1271	1281		10.1056/NEJMra070741	http://dx.doi.org/10.1056/NEJMra070741			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275TL	18354105				2022-12-28	WOS:000254094400008
J	Robicsek, A; Beaumont, JL; Paule, SM; Hacek, DM; Thomson, RB; Kaul, KL; King, P; Peterson, LR				Robicsek, Ari; Beaumont, Jennifer L.; Paule, Suzanne M.; Hacek, Donna M.; Thomson, Richard B., Jr.; Kaul, Karen L.; King, Peggy; Peterson, Lance R.			Universal surveillance for methicillin-resistant Staphylocloccus aureus in 3 affiliated hospitals	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL RESISTANCE; ACTIVE SURVEILLANCE; CONTACT ISOLATION; US HOSPITALS; BACTEREMIA; RISK; IMPACT	Background: The effect of large-scale expanded surveillance for methicillin-resistant Staphylococcus aureus (MRSA) on health careassociated MRSA disease is not known. Objective: To examine the effect of 2 expanded surveillance interventions on MRSA disease. Design: Observational study comparing rates of MRSA clinical disease during and after hospital admission in 3 consecutive periods: baseline (12 months), MRSA surveillance for all admissions to the intensive care unit (ICU) (12 months), and universal MRSA surveillance for all hospital admissions (21 months). Setting: A 3-hospital, 850-bed organization with approximately 40 000 annual admissions. Intervention: Polymerase chain reaction-based nasal surveillance for MRSA followed by topical decolonization therapy and contact isolation of patients who tested positive for MRSA. Measurements: Poisson and segmented regression models were used to compare prevalence density of hospital-associated clinical MRSA disease (bloodstream, respiratory, urinary tract, and surgical site) in each period. Rates of bloodstream disease with methicillin-susceptible S. aureus were used as a control. Results: The prevalence density of aggregate hospital-associated MRSA disease (all body sites) per 10 000 patient-days at baseline, during ICU surveillance, and during universal surveillance was 8.9 (95% Cl, 7.6 to 10.4), 7.4 (Cl, 6.1 to 9.0; P = 0.15 compared with baseline), and 3.9 (Cl, 3.2 to 4.7; P < 0.001 compared with baseline and ICU surveillance), respectively. During universal surveillance, the prevalence density of MRSA infection at each body site had a statistically significant decrease compared with baseline. The methicillin-susceptible S. aureus bacteremia rate did not statistically significantly change during the 3 periods. In a segmented regression model, the aggregate hospital-associated MRSA disease prevalence density changed by -36.2% (Cl, -65.4% to 9.8%; P= 0.17) from baseline to ICU surveillance and by -69.6% (Cl, -89.2% to -19.6%]; P = 0.03) from baseline to universal surveillance. During universal surveillance, the MRSA disease rate decreased during hospitalization and in the 30 days after discharge; no further reduction occurred thereafter. Surveillance with clinical cultures would have identified 17.8% of actual MRSA patient-days, and ICU-based surveillance with polymerase chain reaction would have identified 33.3%. Limitation: The findings rely on observational data. Conclusion: The introduction of universal admission surveillance for MRSA was associated with a large reduction in MRSA disease during admission and 30 days after discharge.	Evanston Northwestern Healthcare, Dept Pathol & Lab Med, Evanston, IL 60201 USA; Northwestern Univ, Feinberg Sch Med, Evanston, IL USA	NorthShore University Health System; Northwestern University; Feinberg School of Medicine	Peterson, LR (corresponding author), Evanston Northwestern Healthcare, Dept Pathol & Lab Med, 2650 Ridge Ave, Evanston, IL 60201 USA.	ari.robicsek@gmail.com; lancer@northwestern.edu	Beaumont, Jennifer/AAA-2825-2020	Beaumont, Jennifer/0000-0002-1484-260X				Clancy M, 2006, INFECT CONT HOSP EP, V27, P1009, DOI 10.1086/507915; *CONS UN, HELP STOP DANG SUP B; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Efron B., 1994, MONOGRAPHS STAT APPL; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Farr BM, 2006, INFECT CONT HOSP EP, V27, P999, DOI 10.1086/508672; Fridkin SK, 2002, EMERG INFECT DIS, V8, P697, DOI 10.3201/eid0807.010427; Girou E, 1998, CLIN INFECT DIS, V27, P543, DOI 10.1086/514695; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; Harbarth S, 2006, CRIT CARE, V10, DOI 10.1186/cc3982; *HEALTHC COST UT P, COM SOFTW VERS 3 2; *HLTH PROT AG, MRSA SURV SYST RES; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Jernigan JA, 1996, AM J EPIDEMIOL, V143, P496, DOI 10.1093/oxfordjournals.aje.a008770; JOHNSON S, 1990, LANCET, V336, P97, DOI 10.1016/0140-6736(90)91605-A; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; MCCAUGHEY B, 2006, NY TIMES, P11; Pan A, 2005, INFECT CONT HOSP EP, V26, P127, DOI 10.1086/502515; Paule SM, 2004, J MOL DIAGN, V6, P191, DOI 10.1016/S1525-1578(10)60509-0; Paule SM, 2007, J CLIN MICROBIOL, V45, P2993, DOI 10.1128/JCM.00670-07; Peterson LR, 2007, JT COMM J QUAL PATIE, V33, P732, DOI 10.1016/S1553-7250(07)33088-2; ROBICSEK A, 2006, 46 INT C ANT AG CHEM; Salgado CD, 2006, INFECT CONT HOSP EP, V27, P116, DOI 10.1086/500624; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shardell M, 2007, CLIN INFECT DIS, V45, P901, DOI 10.1086/521255; Shitrit P, 2006, INFECT CONT HOSP EP, V27, P1004, DOI 10.1086/507914; Siegel JD, 2006, MANAGEMENT MULTIDRUG; Warren DK, 2007, CRIT CARE MED, V35, P430, DOI 10.1097/01.CCM.0000253813.98431.28; West TE, 2006, INFECT CONT HOSP EP, V27, P233, DOI 10.1086/500372; 2007, GEN ASS PENNS HOUS B	34	334	335	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2008	148	6					409	418		10.7326/0003-4819-148-6-200803180-00003	http://dx.doi.org/10.7326/0003-4819-148-6-200803180-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279KT	18347349				2022-12-28	WOS:000254354800001
J	Mongillo, G; Barak, O; Tsodyks, M				Mongillo, Gianluigi; Barak, Omri; Tsodyks, Misha			Synaptic theory of working memory	SCIENCE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; NEURAL-NETWORKS; PERSISTENT ACTIVITY; RECURRENT NETWORKS; THETA-OSCILLATIONS; CALCIUM; PLASTICITY; SYNAPSES; DYNAMICS	It is usually assumed that enhanced spiking activity in the form of persistent reverberation for several seconds is the neural correlate of working memory. Here, we propose that working memory is sustained by calcium- mediated synaptic facilitation in the recurrent connections of neocortical networks. In this account, the presynaptic residual calcium is used as a buffer that is loaded, refreshed, and read out by spiking activity. Because of the long time constants of calcium kinetics, the refresh rate can be low, resulting in a mechanism that is metabolically efficient and robust. The duration and stability of working memory can be regulated by modulating the spontaneous activity in the network.	[Barak, Omri; Tsodyks, Misha] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Mongillo, Gianluigi] Ecole Normale Super, Grp Neural Theory, Dept Etud Cognit, F-75231 Paris, France; [Mongillo, Gianluigi] Coll France, F-75231 Paris, France	Weizmann Institute of Science; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; PSL Research University Paris; College de France	Tsodyks, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	misha@weizmann.ac.il	tsodyks, misha/J-4430-2013	Tsodyks, Misha/0000-0002-5661-4349; Barak, Omri/0000-0002-7894-6344; Mongillo, Gianluigi/0000-0002-6885-9394				AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Baddeley A.D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Bertram R, 1996, J NEUROPHYSIOL, V75, P1919, DOI 10.1152/jn.1996.75.5.1919; Brunel N, 2003, CEREB CORTEX, V13, P1151, DOI 10.1093/cercor/bhg096; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hebb Donald O., 1949, ORG BEHAV; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HORN D, 1989, PHYS REV A, V40, P1036, DOI 10.1103/PhysRevA.40.1036; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Loebel A, 2002, J COMPUT NEUROSCI, V13, P111, DOI 10.1023/A:1020110223441; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rainer G, 2002, EUR J NEUROSCI, V15, P1244, DOI 10.1046/j.1460-9568.2002.01958.x; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Tsodyks M, 2000, J NEUROSCI, V20; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Volman V, 2007, PHYS BIOL, V4, P91, DOI 10.1088/1478-3975/4/2/003; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	34	668	673	4	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1543	1546		10.1126/science.1150769	http://dx.doi.org/10.1126/science.1150769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339943				2022-12-28	WOS:000253943800044
J	Saikia, A; Frost, DJ; Rubie, DC				Saikia, Ashima; Frost, Daniel J.; Rubie, David. C.			Splitting of the 520-kilometer seismic discontinuity and chemical heterogeneity in the mantle	SCIENCE			English	Article							TRANSITION ZONE; PHASE-RELATIONS; EARTHS MANTLE; 520-KM DISCONTINUITY; HIGH-PRESSURE; ELASTICITY; SHARPNESS; PRECURSORS; OLIVINE; GPA	Seismic studies indicate that beneath some regions the 520- kilometer seismic discontinuity in Earth's mantle splits into two separate discontinuities ( at similar to 500 kilometers and similar to 560 kilometers). The discontinuity near 500 kilometers is most likely caused by the ( Mg, Fe)(2)SiO4 beta-to-gamma phase transformation. We show that the formation of CaSiO3 perovskite from garnet can cause the deeper discontinuity, and by determining the temperature dependence for this reaction we demonstrate that regional variations in splitting of the discontinuity arise from variability in the calcium concentration of the mantle rather than from temperature changes. This discontinuity therefore is sensitive to large- scale chemical heterogeneity. Its occurrence and variability yield regional information on the fertility of the mantle or the proportion of recycled oceanic crust.	[Saikia, Ashima; Frost, Daniel J.; Rubie, David. C.] Univ Bayreuth, Bayerisches Geoinst, D-95444 Bayreuth, Germany	University of Bayreuth	Saikia, A (corresponding author), Univ Bayreuth, Bayerisches Geoinst, D-95444 Bayreuth, Germany.	ashima.saikia@uni-bayreuth.de	Frost, Daniel J/B-7526-2016	Frost, Daniel J/0000-0002-4443-8149				[Anonymous], 2000, HIST DYNAMICS GLOBAL, DOI DOI 10.1029/GM121P0277; Christensen UR, 1997, J GEOPHYS RES-SOL EA, V102, P22435, DOI 10.1029/97JB01342; Deuss A, 2006, SCIENCE, V311, P198, DOI 10.1126/science.1120020; Deuss A, 2001, SCIENCE, V294, P354, DOI 10.1126/science.1063524; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Flanagan MP, 1998, J GEOPHYS RES-SOL EA, V103, P2673, DOI 10.1029/97JB03212; Frost DJ, 2003, EARTH PLANET SC LETT, V216, P313, DOI 10.1016/S0012-821X(03)00533-8; Gasparik T, 1996, CONTRIB MINERAL PETR, V124, P139, DOI 10.1007/s004100050181; Gilbert H.J., 2003, J GEOPHYS RES, V108; Helffrich GR, 1996, GEOPHYS J INT, V126, pF7, DOI 10.1111/j.1365-246X.1996.tb05292.x; Helffrich GR, 2001, NATURE, V412, P501, DOI 10.1038/35087500; Hirose K, 2002, GEOCHIM COSMOCHIM AC, V66, P2099, DOI 10.1016/S0016-7037(02)00847-5; ITA J, 1992, J GEOPHYS RES-SOL EA, V97, P6849, DOI 10.1029/92JB00068; Li L, 2006, PHYS EARTH PLANET IN, V155, P249, DOI 10.1016/j.pepi.2005.12.006; Litasov KD, 2005, PHYS EARTH PLANET IN, V150, P239, DOI 10.1016/j.pepi.2004.10.010; Matsuzaka K, 2000, PHYS CHEM MINER, V27, P310, DOI 10.1007/s002690050260; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Nishihara Y, 2001, EARTH PLANET SC LETT, V190, P65, DOI 10.1016/S0012-821X(01)00378-8; ONEILL HSC, 1979, CONTRIB MINERAL PETR, V70, P59, DOI 10.1007/BF00371872; SHEARER PM, 1990, NATURE, V344, P121, DOI 10.1038/344121a0; Shearer PM, 1996, J GEOPHYS RES-SOL EA, V101, P3053, DOI 10.1029/95JB02812; Sinogeikin S. V, 2002, GEOPHYS RES LETT, V29; Sinogeikin SV, 2001, GEOPHYS RES LETT, V28, P4335, DOI 10.1029/2001GL013843; Stixrude L, 1997, J GEOPHYS RES-SOL EA, V102, P14835, DOI 10.1029/97JB00550; Suzuki A, 2000, GEOPHYS RES LETT, V27, P803, DOI 10.1029/1999GL008425; van der Meijde M, 2005, PHYS EARTH PLANET IN, V148, P233, DOI 10.1016/j.pepi.2004.09.008; Weidner DJ., 2000, EARTHS DEEP INTERIOR, P215, DOI [10.1029/gm117p0215, DOI 10.1029/GM117P0215]	27	59	66	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1515	1518		10.1126/science.1152818	http://dx.doi.org/10.1126/science.1152818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339935				2022-12-28	WOS:000253943800035
J	Brock, MV; Hooker, CM; Ota-Machida, E; Han, Y; Guo, MZ; Ames, S; Glockner, S; Piantadosi, S; Gabrielson, E; Pridham, G; Pelosky, K; Belinsky, SA; Yang, SC; Baylin, SB; Herman, JG				Brock, Malcolm V.; Hooker, Craig M.; Ota-Machida, Emi; Han, Yu; Guo, Mingzhou; Ames, Stephen; Gloeckner, Sabine; Piantadosi, Steven; Gabrielson, Edward; Pridham, Genevieve; Pelosky, Kristen; Belinsky, Steven A.; Yang, Stephen C.; Baylin, Stephen B.; Herman, James G.			DNA methylation markers and early recurrence in stage I lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE PROMOTER HYPERMETHYLATION; COLORECTAL-CANCER; LYMPH-NODES; ABERRANT METHYLATION; MULTIPLE GENES; TUMORS; ASSOCIATION; P16(INK4A); RESECTION; PROFILE	Background: Despite optimal and early surgical treatment of non-small-cell lung cancer (NSCLC), many patients die of recurrent NSCLC. We investigated the association between gene methylation and recurrence of the tumor. Methods: Fifty-one patients with stage I NSCLC who underwent curative resection but who had a recurrence within 40 months after resection (case patients) were matched on the basis of age, NSCLC stage, sex, and date of surgery to 116 patients with stage I NSCLC who underwent curative resection but who did not have a recurrence within 40 months after resection (controls). We investigated whether the methylation of seven genes in tumor and lymph nodes was associated with tumor recurrence. Results: In a multivariate model, promoter methylation of the cyclin-dependent kinase inhibitor 2A gene p16, the H-cadherin gene CDH13, the Ras association domain family 1 gene RASSF1A, and the adenomatous polyposis coli gene APC in tumors and in histologically tumor-negative lymph nodes was associated with tumor recurrence, independently of NSCLC stage, age, sex, race, smoking history, and histologic characteristics of the tumor. Methylation of the promoter regions of p16 and CDH13 in both tumor and mediastinal lymph nodes was associated with an odds ratio of recurrent cancer of 15.50 in the original cohort and an odds ratio of 25.25 when the original cohort was combined with an independent validation cohort of 20 patients with stage I NSCLC. Conclusions: Methylation of the promoter region of the four genes in patients with stage I NSCLC treated with curative intent by means of surgery is associated with early recurrence.	[Brock, Malcolm V.; Hooker, Craig M.; Ota-Machida, Emi; Han, Yu; Guo, Mingzhou; Ames, Stephen; Gloeckner, Sabine; Piantadosi, Steven; Gabrielson, Edward; Pridham, Genevieve; Pelosky, Kristen; Yang, Stephen C.; Baylin, Stephen B.; Herman, James G.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Belinsky, Steven A.] Lovelace Resp Res Inst, Albuquerque, NM USA	Johns Hopkins University; Johns Hopkins Medicine; Lovelace Respiratory Research Institute	Brock, MV (corresponding author), Johns Hopkins Med Inst, 600 N Wolfe St,Blalock 240, Baltimore, MD 21287 USA.	mabrock@jhmi.edu			NATIONAL CANCER INSTITUTE [P50CA058184] Funding Source: NIH RePORTER; NCI NIH HHS [CA058184-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Belinsky SA, 2006, CANCER RES, V66, P3338, DOI 10.1158/0008-5472.CAN-05-3408; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Brock MV, 2004, ANN THORAC SURG, V77, P271, DOI 10.1016/S0003-4975(03)01470-X; Brock MV, 2003, CLIN CANCER RES, V9, P2912; Esteller M, 2000, NEW ENGL J MED, V343, P1740; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2001, CANCER RES, V61, P3225; Ettinger D S, 1996, Oncology (Williston Park), V10, P81; Ginsberg Robert J., 1995, Annals of Thoracic Surgery, V60, P615, DOI 10.1016/0003-4975(95)00537-U; Gu J, 2006, CLIN CANCER RES, V12, P7329, DOI 10.1158/1078-0432.CCR-06-0894; Guo MZ, 2006, CLIN CANCER RES, V12, P4515, DOI 10.1158/1078-0432.CCR-05-2858; Harden SV, 2003, CLIN CANCER RES, V9, P1370; Hellman S, 1997, NEW ENGL J MED, V337, P996, DOI 10.1056/NEJM199710023371408; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hoffman PC, 2000, LANCET, V355, P1280; House MG, 2003, J GASTROINTEST SURG, V7, P1004, DOI 10.1016/j.gassur.2003.08.002; Johnson ZA, 2001, XENOTRANSPLANTATION, V8, P9; Kollermann J, 2003, EUR UROL, V44, P533, DOI 10.1016/S0302-2838(03)00361-0; Lu C, 2004, J CLIN ONCOL, V22, P4575, DOI 10.1200/JCO.2004.01.091; Machida EO, 2006, CANCER RES, V66, P6210, DOI 10.1158/0008-5472.CAN-05-4447; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; MOUNTAIN CF, 1986, CHEST, V89, pS225, DOI 10.1378/chest.89.4.225S; Pellise M, 2004, CLIN CANCER RES, V10, P4444, DOI 10.1158/1078-0432.CCR-03-0600; RIETHMULLER G, 1992, CURR OPIN IMMUNOL, V4, P647, DOI 10.1016/0952-7915(92)90041-C; Safar AM, 2007, ARCH PATHOL LAB MED, V131, P936; Sanchez-Cespedes M, 1999, CLIN CANCER RES, V5, P2450; Toyooka KO, 2001, CANCER RES, V61, P4556; Toyooka S, 2001, MOL CANCER THER, V1, P61; van Engeland M, 2003, CANCER RES, V63, P3133; van Engeland M, 2002, ONCOGENE, V21, P3792, DOI 10.1038/sj.onc.1205466; Wang J, 2004, CLIN CANCER RES, V10, P6119, DOI 10.1158/1078-0432.CCR-04-0652; Zhu JJG, 1999, NEUROSURGERY, V45, P409, DOI 10.1097/00006123-199908000-00049	35	435	465	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1118	1128		10.1056/NEJMoa0706550	http://dx.doi.org/10.1056/NEJMoa0706550			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337602				2022-12-28	WOS:000253877200005
J	Lerch, V				Lerch, Victor			The only thing that matters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												vlerch@nc.rr.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2008	299	10					1113	1113		10.1001/jama.299.10.1113	http://dx.doi.org/10.1001/jama.299.10.1113			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272CE	18334681				2022-12-28	WOS:000253835000001
J	Shibuya, K				Shibuya, Kenji			Conditional cash transfer: a magic bullet for health?	LANCET			English	Editorial Material							TRANSFER PROGRAMS; CHILD HEALTH; COUNTRIES		WHO, CH-1211 Geneva, Switzerland	World Health Organization	Shibuya, K (corresponding author), WHO, CH-1211 Geneva, Switzerland.	shibuyak@who.int		Shibuya, Kenji/0000-0003-2528-7530				Alkire S., 2002, VALUING FREEDOMS SEN; de Janvry A, 2006, WORLD BANK ECON REV, V20, P1, DOI 10.1093/wber/lhj002; DUGGER CW, 2004, NY TIMES        0103; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Rawlings LB, 2005, WORLD BANK RES OBSER, V20, P29, DOI 10.1093/wbro/lki001; *ROCK FDN, OPP NYC REC DAY DAY; Sen A., 1999, COMMODITIES CAPABILI	11	19	19	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 8	2008	371	9615					789	791		10.1016/S0140-6736(08)60356-6	http://dx.doi.org/10.1016/S0140-6736(08)60356-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	272NQ	18328910				2022-12-28	WOS:000253866500006
J	Frost, A; Perera, R; Roux, A; Spasov, K; Destaing, O; Egelman, EH; De Camilli, P; Unger, VM				Frost, Adam; Perera, Rushika; Roux, Aurelien; Spasov, Krasimir; Destaing, Olivier; Egelman, Edward H.; De Camilli, Pietro; Unger, Vinzenz M.			Structural basis of membrane invagination by F-BAR domains	CELL			English	Article							CLATHRIN-COATED PITS; ACTIN CYTOSKELETON; CRYSTAL-STRUCTURES; DYNAMIN; CURVATURE; PROTEINS; VISUALIZATION; RECONSTRUCTION; CONSTRICTION; AGGREGATION	BAR superfamily domains shape membranes through poorly understood mechanisms. We solved structures of F-BAR modules bound to flat and curved bilayers using electron (cryo) microscopy. We show that membrane tubules form when F-BARs polymerize into helical coats that are held together by lateral and tip-to-tip interactions. On gel-state membranes or after mutation of residues along the lateral interaction surface, F-BARs adsorb onto bilayers via surfaces other than their concave face. We conclude that membrane binding is separable from membrane bending, and that imposition of the module's concave surface forces fluid-phase bilayers to bend locally. Furthermore, exposure of the domain's lateral interaction surface through a change in orientation serves as the crucial trigger for assembly of the helical coat and propagation of bilayer bending. The geometric constraints and sequential assembly of the helical lattice explain how F-BAR and classical BAR domains segregate into distinct microdomains, and provide insight into the spatial regulation of membrane invagination.	[Frost, Adam; Spasov, Krasimir; Unger, Vinzenz M.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Perera, Rushika; Roux, Aurelien; Destaing, Olivier; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Frost, Adam; De Camilli, Pietro; Unger, Vinzenz M.] Yale Univ, Sch Med, Interdept Neurosci Program, New Haven, CT 06510 USA; [Roux, Aurelien; Destaing, Olivier; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Roux, Aurelien; Destaing, Olivier; De Camilli, Pietro] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Roux, Aurelien; Destaing, Olivier; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; [Egelman, Edward H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; University of Virginia	Unger, VM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 208024, New Haven, CT 06520 USA.	vinzenz.unger@yale.edu	Egelman, Edward H/A-2488-2009; destaing, olivier/M-3802-2013; Roux, Aurelien R/G-9541-2013; Roux, Aurelien/AAU-1262-2021	Roux, Aurelien R/0000-0002-6088-0711; Egelman, Edward/0000-0003-4844-5212; destaing, olivier/0000-0001-7622-3700; Frost, Adam/0000-0003-2231-2577	NCI NIH HHS [CA46128, P01 CA046128] Funding Source: Medline; NCRR NIH HHS [P41 RR017573, P41 RR17573] Funding Source: Medline; NIBIB NIH HHS [R01 EB001567, EB001567] Funding Source: Medline; NIDA NIH HHS [P30 DA018343, R21 DA024101, R21 DA024101-01, DA024101] Funding Source: Medline; NIDDK NIH HHS [DK45735, P30 DK045735] Funding Source: Medline; NIGMS NIH HHS [5T32GM07205, GM071590, R01 GM071590-03, R01 GM071590, T32 GM007205, R01 GM071590-02] Funding Source: Medline; PHS HHS [NCRR 19895-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, R01GM071590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343, R21DA024101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Brett TJ, 2006, CURR OPIN CELL BIOL, V18, P395, DOI 10.1016/j.ceb.2006.06.014; Bruinsma R, 1996, CURR OPIN SOLID ST M, V1, P401, DOI 10.1016/S1359-0286(96)80032-5; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Le Goff L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.018101; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Rodriguez Y, 2007, BIOPHYS J, V92, P3071, DOI 10.1529/biophysj.106.089078; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Wang LG, 2006, P NATL ACAD SCI USA, V103, P18528, DOI 10.1073/pnas.0608714103; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	47	405	408	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					807	817		10.1016/j.cell.2007.12.041	http://dx.doi.org/10.1016/j.cell.2007.12.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329367	Green Accepted, Bronze			2022-12-28	WOS:000253818000018
J	Ventura, A; Young, AG; Winslow, MM; Lintault, L; Meissner, A; Erkeland, SJ; Newman, J; Bronson, RT; Crowley, D; Stone, JR; Jaenisch, R; Sharp, PA; Jacks, T				Ventura, Andrea; Young, Amanda G.; Winslow, Monte M.; Lintault, Laura; Meissner, Alex; Erkeland, Stefan J.; Newman, Jamie; Bronson, Roderick T.; Crowley, Denise; Stone, James R.; Jaenisch, Rudolf; Sharp, Phillip A.; Jacks, Tyler			Targeted deletion reveals essential and overlapping functions of the miR-17 similar to 92 family of miRNA clusters	CELL			English	Article							MESSENGER-RNA; LUNG CANCERS; MICE LACKING; BCL-2 FAMILY; MICRORNAS; LET-7; GENE; BIM; EXPRESSION; MIR-17-92	miR-17 similar to 92, miR-106b similar to 25, and miR-106a similar to 363 belong to a family of highly conserved miRNA clusters. Amplification and overexpression of miR-17 similar to 92 is observed in human cancers, and its oncogenic properties have been confirmed in a mouse model of B cell lymphoma. Here we show that mice deficient for miR17 similar to 92 die shortly after birth with lung hypoplasia and a ventricular septal defect. The miR-17 similar to 92 cluster is also essential for B cell development. Absence of miR-17 similar to 92 leads to increased levels of the proapoptotic protein Bim and inhibits B cell development at the pro-Bto pre-B transition. Furthermore, while ablation of miR-106b similar to 25 or miR-106a similar to 363 has no obvious phenotypic consequences, compound mutant embryos lacking both miR-106b similar to 25 and miR-17 similar to 92 die at midgestation. These results provide key insights into the physiologic functions of this family of microRNAs and suggest a link between the oncogenic properties of miR-17 similar to 92 and its functions during B lymphopoiesis and lung development.	[Ventura, Andrea; Young, Amanda G.; Winslow, Monte M.; Lintault, Laura; Newman, Jamie; Crowley, Denise; Sharp, Phillip A.; Jacks, Tyler] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Meissner, Alex; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Erkeland, Stefan J.] Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands; [Bronson, Roderick T.] Tufts Univ, Sch Vet, Dept Biomed Sci, North Grafton, MA USA; [Stone, James R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02114 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Erasmus University Rotterdam; Erasmus MC; Tufts University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.	tjacks@mit.edu	Ventura, Andrea/F-1789-2011	Ventura, Andrea/0000-0003-4320-9907; Erkeland, Stefan/0000-0002-1019-7957; Young, Amanda/0000-0002-2199-1873	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA042063-220012, P30 CA014051-34, P30-CA14051, P01 CA042063, P30 CA014051, P01 CA042063-21A10012, 2-PO1-CA42063-21, P30 CA014051-36, P30 CA014051-35] Funding Source: Medline; NIAID NIH HHS [U19 AI056900] Funding Source: Medline; NIGMS NIH HHS [R01 GM034277, R01-GM34277] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA042063, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chen JN, 2000, TRENDS GENET, V16, P383, DOI 10.1016/S0168-9525(00)02075-8; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LU J, 2005, IN PRESS NATURE; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Martensson IL, 2007, CURR OPIN IMMUNOL, V19, P137, DOI 10.1016/j.coi.2007.02.006; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Novotny GW, 2007, CELL DEATH DIFFER, V14, P879, DOI 10.1038/sj.cdd.4402090; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sakata Y, 2002, P NATL ACAD SCI USA, V99, P16197, DOI 10.1073/pnas.252648999; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Webb S, 1998, CIRC RES, V82, P645, DOI 10.1161/01.RES.82.6.645; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	52	1255	1346	2	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					875	886		10.1016/j.cell.2008.02.019	http://dx.doi.org/10.1016/j.cell.2008.02.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329372	Green Accepted, Bronze			2022-12-28	WOS:000253818000023
J	Choi, KS; Deng, H; Laurat, J; Kimble, HJ				Choi, K. S.; Deng, H.; Laurat, J.; Kimble, H. J.			Mapping photonic entanglement into and out of a quantum memory	NATURE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; SINGLE-PHOTON; ATOMIC ENSEMBLES; LIGHT; STORAGE; COMMUNICATION; TELEPORTATION; RETRIEVAL; PULSES; QUBITS	Developments in quantum information science(1) rely critically on entanglement - a fundamental aspect of quantum mechanics that causes parts of a composite system to show correlations stronger than can be explained classically(2). In particular, scalable quantum networks require the capability to create, store and distribute entanglement among distant matter nodes by means of photonic channels(3). Atomic ensembles can play the role of such nodes(4). Sofar, in the photon- counting regime, heralded entanglement between atomic ensembles has been successfully demonstrated through probabilistic protocols(5,6). But an inherent drawback of this approach is the compromise between the amount of entanglement and its preparation probability, leading to intrinsically low count rates for high entanglement. Here we report a protocol where entanglement between two atomic ensembles is created by coherent mapping of an entangled state of light. By splitting a single photon(7-9) and performing subsequent state transfer, we separate the generation of entanglement and its storage(10). After a programmable delay, the stored entanglement is mapped back into photonic modes with overall efficiency of 17%. Together with improvements in single- photon sources(11), our protocol will allow 'on- demand' entanglement of atomic ensembles, a powerful resource for quantum information science.	[Choi, K. S.; Deng, H.; Laurat, J.; Kimble, H. J.] CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA	California Institute of Technology	Kimble, HJ (corresponding author), CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA.	hjkimble@caltech.edu	Deng, Hui/E-8950-2010; Laurat, Julien/Y-9272-2019; Deng, Hui/A-7115-2009; Choi, Kyung Soo/C-6073-2008; LAURAT, Julien/A-8542-2011; Deng, Hui/AAD-6979-2020	Deng, Hui/0000-0003-0629-3230; Choi, Kyung Soo/0000-0003-0757-1183; LAURAT, Julien/0000-0001-8318-6514; Deng, Hui/0000-0003-0629-3230				Balic V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183601; BRIEGEL HJ, 2000, PHYS QUANTUM INFORMA; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Chen SA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.173004; Chen YA, 2008, NAT PHYS, V4, P103, DOI 10.1038/nphys832; Chou CW, 2007, SCIENCE, V316, P1316, DOI 10.1126/science.1140300; CLAUSER JF, 1978, REP PROG PHYS, V41, P1881, DOI 10.1088/0034-4885/41/12/002; de Riedmatten H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.113603; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Eisaman MD, 2005, NATURE, V438, P837, DOI 10.1038/nature04327; Eisaman MD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.233602; Felinto D, 2006, NAT PHYS, V2, P844, DOI 10.1038/nphys450; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; Gorshkov AV, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.123601; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Hessmo B, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.180401; Jacques V, 2007, SCIENCE, V315, P966, DOI 10.1126/science.1136303; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Laurat J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.180504; Laurat J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/207; Laurat J, 2006, OPT EXPRESS, V14, P6912, DOI 10.1364/OE.14.006912; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Lounis B, 2005, REP PROG PHYS, V68, P1129, DOI 10.1088/0034-4885/68/5/R04; Matsukevich DN, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.013601; Novikova I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.243602; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; Ringot J, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.013403; Sangouard N, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.050301; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; Simon J, 2007, NAT PHYS, V3, P765, DOI 10.1038/nphys726; TAN SM, 1991, PHYS REV LETT, V66, P252, DOI 10.1103/PhysRevLett.66.252; Thompson JK, 2006, SCIENCE, V313, P74, DOI 10.1126/science.1127676; van Enk SJ, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.064306; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Zoller P, 2005, EUR PHYS J D, V36, P203, DOI 10.1140/epjd/e2005-00251-1	37	434	452	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					67	U4		10.1038/nature06670	http://dx.doi.org/10.1038/nature06670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322529	Green Accepted			2022-12-28	WOS:000253671900047
J	Nelson, HD				Nelson, Heidi D.			Menopause	LANCET			English	Review							QUALITY-OF-LIFE; HEALTHY POSTMENOPAUSAL WOMEN; SYMPTOMATIC PERIMENOPAUSAL WOMEN; RANDOMIZED CONTROLLED-TRIAL; ESTROGEN PLUS PROGESTIN; HOT FLASHES; DOUBLE-BLIND; BLACK COHOSH; BREAST-CANCER; VASOMOTOR SYMPTOMS	Menopause is the time of life when menstrual cycles cease, and is caused by reduced secretion of the ovarian hormones oestrogen and progesterone. Although menopause is a normal event for women, individual experiences vary, and some women seek medical advice for the management of symptoms. Many symptoms have been attributed to menopause, but only vasomotor dysfunction and vaginal dryness are consistently associated with this time of life in epidemiological studies. Other common symptoms such as mood changes, sleep disturbances, urinary incontinence, cognitive changes, somatic complaints, sexual dysfunction, and reduced quality of life may be secondary to other symptoms, or related to other causes. Trials of therapies for vasomotor dysfunction have shown improvements with oestrogen, gabapentin, paroxetine, and clonidine, but little or no benefit with other agents; adverse effects of these treatments must also be considered. Many questions about menopausal transition and its effects on health have not been adequately addressed.	Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; Providence Hlth & Serv, Womens & Childrens Hlth Res Ctr, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Dept Med Informat & Clin Epidemiol, Mailcode BICC,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu						Aiello EJ, 2004, MENOPAUSE, V11, P382, DOI 10.1097/01.GME.0000113932.56832.27; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Atkinson C, 2004, BREAST CANCER RES, V6, pR170, DOI 10.1186/bcr773; Avis Nancy E, 2005, Am J Med, V118 Suppl 12B, P37, DOI 10.1016/j.amjmed.2005.09.057; Avis Nancy E., 1994, Annals of Epidemiology, V4, P214; Avis NE, 2003, MED CARE, V41, P1262, DOI 10.1097/01.MLR.0000093479.39115.AF; Avis NE, 2001, SOC SCI MED, V52, P345, DOI 10.1016/S0277-9536(00)00147-7; Baber R J, 1999, Climacteric, V2, P85, DOI 10.3109/13697139909025571; Baksu A, 2005, INT J GYNECOL OBSTET, V91, P58, DOI 10.1016/j.ijgo.2005.04.011; BALK E, 2005, 126 AHRQ; Barnhart KT, 1999, J CLIN ENDOCR METAB, V84, P3896, DOI 10.1210/jc.84.11.3896; Barton DL, 1998, J CLIN ONCOL, V16, P495, DOI 10.1200/JCO.1998.16.2.495; BERGMANS MGM, 1987, MATURITAS, V9, P227, DOI 10.1016/0378-5122(87)90005-3; BOULET MJ, 1994, MATURITAS, V19, P157, DOI 10.1016/0378-5122(94)90068-X; Bromberger JT, 2007, J AFFECT DISORDERS, V103, P267, DOI 10.1016/j.jad.2007.01.034; Brown WJ, 2002, INT J BEHAV MED, V9, P53, DOI 10.1207/S15327558IJBM0901_04; Busch CM, 1994, J AGING HEALTH, V6, P209; Cagnacci A, 2003, MATURITAS, V44, P103, DOI 10.1016/S0378-5122(02)00317-1; Carpenter JS, 2007, ONCOLOGIST, V12, P124, DOI 10.1634/theoncologist.12-1-124; Carpenter Janet S, 2002, Oncol Nurs Forum, V29, pE16, DOI 10.1188/02.ONF.E16-E25; Carranza-Lira S, 2001, INT J FERTIL WOMEN M, V46, P296; CASPER RF, 1985, CLIN ENDOCRINOL, V22, P293, DOI 10.1111/j.1365-2265.1985.tb03243.x; Cassidy A, 2006, P NUTR SOC, V65, P76, DOI 10.1079/PNS2005476; CHENOY R, 1994, BRIT MED J, V308, P501, DOI 10.1136/bmj.308.6927.501; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Cleary C., 1994, COMPLEMENT THER MED, V2, P181, DOI [10.1016/0965-2299(94)90017-5, DOI 10.1016/0965-2299(94)90017-5]; de Wit H, 2001, PSYCHONEUROENDOCRINO, V26, P697, DOI 10.1016/S0306-4530(01)00024-5; Dennerstein L, 1999, J NERV MENT DIS, V187, P685, DOI 10.1097/00005053-199911000-00006; Dennerstein L, 2000, OBSTET GYNECOL, V96, P351, DOI 10.1016/S0029-7844(00)00930-3; Dennerstein L, 2002, FERTIL STERIL, V77, pS42; Dennerstein L, 2001, J NERV MENT DIS, V189, P84, DOI 10.1097/00005053-200102000-00003; Dennerstein L, 2001, FERTIL STERIL, V76, P456, DOI 10.1016/S0015-0282(01)01978-1; Dennerstein Lorraine, 2005, Am J Med, V118 Suppl 12B, P59, DOI 10.1016/j.amjmed.2005.09.034; Dodin S, 2005, J CLIN ENDOCR METAB, V90, P1390, DOI 10.1210/jc.2004-1148; Dudley E C, 1998, Climacteric, V1, P18, DOI 10.3109/13697139809080677; Freedman RR, 1999, AM J OBSTET GYNECOL, V181, P66, DOI 10.1016/S0002-9378(99)70437-0; FREEDMAN RR, 1995, J CLIN ENDOCR METAB, V80, P2354, DOI 10.1210/jc.80.8.2354; Freeman EW, 2006, ARCH GEN PSYCHIAT, V63, P375, DOI 10.1001/archpsyc.63.4.375; Frei-Kleiner S, 2005, MATURITAS, V51, P397, DOI 10.1016/j.maturitas.2004.10.003; Ghali WA, 1997, AM J MED, V103, P3, DOI 10.1016/S0002-9343(97)90049-8; Glazer Greer, 2002, Health Care Women Int, V23, P612, DOI 10.1080/07399330290107377; Gold EB, 2000, AM J EPIDEMIOL, V152, P463, DOI 10.1093/aje/152.5.463; Gold EB, 2001, AM J EPIDEMIOL, V153, P865, DOI 10.1093/aje/153.9.865; Gordon PR, 2006, MENOPAUSE, V13, P568, DOI 10.1097/01.gme.0000196595.82452.ca; Grady D, 2007, OBSTET GYNECOL, V109, P823, DOI 10.1097/01.AOG.0000258278.73505.fa; Grady Deborah, 2005, Am J Med, V118 Suppl 12B, P163, DOI 10.1016/j.amjmed.2005.09.051; GREENE JG, 1976, J PSYCHOSOM RES, V20, P425, DOI 10.1016/0022-3999(76)90005-2; Guttuso T, 2003, OBSTET GYNECOL, V101, P337, DOI 10.1016/S0029-7844(02)02712-6; Haines CJ, 2005, MATURITAS, V52, P264, DOI 10.1016/j.maturitas.2005.03.012; HALLSTROM T, 1985, ACTA OBSTET GYN SCAN, P13; Hardy R, 2002, SOC SCI MED, V55, P1975, DOI 10.1016/S0277-9536(01)00326-4; Harlow SD, 2006, J CLIN ENDOCR METAB, V91, P3432, DOI 10.1210/jc.2005-2810; Heyerick A, 2006, MATURITAS, V54, P164, DOI 10.1016/j.maturitas.2005.10.005; HICKOK LR, 1993, OBSTET GYNECOL, V82, P919; Hidalgo LA, 2005, GYNECOL ENDOCRINOL, V21, P257, DOI 10.1080/09513590500361192; Hilditch JR, 1996, MATURITAS, V24, P161, DOI 10.1016/0378-5122(96)01038-9; Huang MI, 2006, FERTIL STERIL, V86, P700, DOI 10.1016/j.fertnstert.2006.02.100; HUDSON TS, 1998, J NATUROPATHIC MED, V7, P73; Jacobson JS, 2001, J CLIN ONCOL, V19, P2739, DOI 10.1200/JCO.2001.19.10.2739; Jeri AR, 2002, FEMALE PATIENT, V27, P35; Johnston JM, 2006, J WOMENS HEALTH, V15, P1184, DOI 10.1089/jwh.2006.15.1184; KAUFERT PA, 1992, MATURITAS, V14, P143, DOI 10.1016/0378-5122(92)90006-P; Kerr EA, 2005, ANN INTERN MED, V142, P154, DOI 10.7326/0003-4819-142-2-200501180-00021; Kimmick GG, 2006, BREAST J, V12, P114, DOI 10.1111/j.1075-122X.2006.00218.x; Knight D C, 1999, Climacteric, V2, P79, DOI 10.3109/13697139909025570; Komesaroff P A, 2001, Climacteric, V4, P144; Koster A, 2002, Arch Womens Ment Health, V5, P9, DOI 10.1007/s007370200017; Kravitz HM, 2003, MENOPAUSE, V10, P19, DOI 10.1097/01.GME.0000030707.35686.5A; Krebs EE, 2004, OBSTET GYNECOL, V104, P824, DOI 10.1097/01.AOG.0000140688.71638.d3; Landgren MB, 2005, MATURITAS, V50, P222, DOI 10.1016/j.maturitas.2004.06.001; Leonetti HB, 1999, OBSTET GYNECOL, V94, P225, DOI 10.1016/S0029-7844(99)00266-5; Lewis JE, 2006, MENOPAUSE, V13, P631, DOI 10.1097/01.gme.0000191882.59799.67; Loprinzi CL, 2000, LANCET, V356, P2059, DOI 10.1016/S0140-6736(00)03403-6; LOPRINZI CL, 1994, NEW ENGL J MED, V331, P347, DOI 10.1056/NEJM199408113310602; Maartens LWF, 2002, MATURITAS, V42, P195, DOI 10.1016/S0378-5122(02)00038-5; MacLennan A, 2001, Climacteric, V4, P58, DOI 10.1080/713605036; Maclennan A H, 2004, Cochrane Database Syst Rev, pCD002978, DOI 10.1002/14651858.CD002978.pub2; MAKKONEN M, 1993, GYNECOL ENDOCRINOL, V7, P135, DOI 10.3109/09513599309152493; Mansfield PK, 2004, WOMEN HEALTH ISS, V14, P220, DOI 10.1016/j.whi.2004.08.002; MCKINLAY SM, 1989, MENOPAUSE EVALUATION, P137; Meeuwsen IB, 2002, MATURITAS, V41, P35, DOI 10.1016/S0378-5122(01)00251-1; Melby MK, 2005, HUM REPROD UPDATE, V11, P495, DOI 10.1093/humupd/dmi018; Mishra GD, 2003, QUAL LIFE RES, V12, P405, DOI 10.1023/A:1023421128141; Mitchell ES, 1996, MATURITAS, V25, P1, DOI 10.1016/0378-5122(96)01047-X; MORRISON JC, 1980, AM J OBSTET GYNECOL, V138, P99, DOI 10.1016/0002-9378(80)90017-4; Munoz GH, 2003, MATURITAS, V44, pS59, DOI 10.1016/S0378-5122(02)00349-3; *N AM MEN SOC, MEN GUID; *N AM MEN SOC, 2004, MENOPAUSE, V11, P589; Nedrow A, 2006, ARCH INTERN MED, V166, P1453, DOI 10.1001/archinte.166.14.1453; Nelson H.D., 2005, MANAGEMENT MENOPAUSE; Nelson HD, 2004, JAMA-J AM MED ASSOC, V291, P1610, DOI 10.1001/jama.291.13.1610; Nelson HD, 2004, JAMA-J AM MED ASSOC, V291, P1621, DOI 10.1001/jama.291.13.1621; Nelson HD, 2006, JAMA-J AM MED ASSOC, V295, P2057, DOI 10.1001/jama.295.17.2057; NELSON HD, DRUG CLASS REV ESTRO; Newton KM, 2006, ANN INTERN MED, V145, P869, DOI 10.7326/0003-4819-145-12-200612190-00003; *NIH, 2004, ASS IMPR MEAS HOT FL; Osmers R, 2005, OBSTET GYNECOL, V105, P1074, DOI 10.1097/01.AOG.0000158865.98070.89; Pandya KJ, 2005, LANCET, V366, P818, DOI 10.1016/S0140-6736(05)67215-7; Pockaj BA, 2006, J CLIN ONCOL, V24, P2836, DOI 10.1200/JCO.2005.05.4296; Rachev E, 2001, CURR MED RES OPIN, V17, P105; Randolph JF, 2006, J CLIN ENDOCR METAB, V91, P3034, DOI 10.1210/jc.2006-0243; Reddy SY, 2006, OBSTET GYNECOL, V108, P41, DOI 10.1097/01.AOG.0000222383.43913.ed; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Russo Roberto, 2003, Acta Biomed, V74, P137; SCHIFF I, 1980, JAMA-J AM MED ASSOC, V244, P1443, DOI 10.1001/jama.244.13.1443; Sherburn M, 2001, OBSTET GYNECOL, V98, P628, DOI 10.1016/S0029-7844(01)01508-3; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Soules M R, 2001, Menopause, V8, P402, DOI 10.1097/00042192-200111000-00004; Stearns V, 2005, J CLIN ONCOL, V23, P6919, DOI 10.1200/JCO.2005.10.081; Stearns V, 2003, JAMA-J AM MED ASSOC, V289, P2827, DOI 10.1001/jama.289.21.2827; Stephenson J, 2003, JAMA-J AM MED ASSOC, V289, P537, DOI 10.1001/jama.289.5.537; Taffe JR, 2002, MENOPAUSE, V9, P32, DOI 10.1097/00042192-200201000-00006; Tice JA, 2003, JAMA-J AM MED ASSOC, V290, P207, DOI 10.1001/jama.290.2.207; Uebelhack R, 2006, OBSTET GYNECOL, V107, P247, DOI 10.1097/01.AOG.0000196504.49378.83; *US PREV SERV TASK, HORM REPL THER PREV; van de Weijer PHM, 2002, MATURITAS, V42, P187, DOI 10.1016/S0378-5122(02)00080-4; Verhoeven MO, 2005, MENOPAUSE, V12, P412, DOI 10.1097/01.gme.0000170603.63022.62; Vesco KK, 2007, CLIMACTERIC, V10, P448, DOI 10.1080/13697130701611267; Whiting PW, 2002, MED J AUSTRALIA, V177, P440, DOI 10.5694/j.1326-5377.2002.tb04886.x; Williamson J, 2002, BJOG-INT J OBSTET GY, V109, P1050, DOI 10.1111/j.1471-0528.2002.01504.x; Winther K, 2005, CLIMACTERIC, V8, P162, DOI 10.1080/13697130500117987; Woods NF, 1997, RES NURS HEALTH, V20, P119, DOI 10.1002/(SICI)1098-240X(199704)20:2<119::AID-NUR4>3.0.CO;2-N; Wren BG, 2003, MENOPAUSE, V10, P13, DOI 10.1097/01.GME.0000025416.53837.00; Wuttke W, 2003, MATURITAS, V44, pS67, DOI 10.1016/S0378-5122(02)00350-X	125	456	470	10	82	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					760	770		10.1016/S0140-6736(08)60346-3	http://dx.doi.org/10.1016/S0140-6736(08)60346-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313505				2022-12-28	WOS:000253596700030
J	Parker, AJR; Marshall, EJ; Ball, DM				Parker, Andrew J. R.; Marshall, E. Jane; Ball, David M.			Diagnosis and management of alcohol use disorders	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MISUSING PATIENTS; WERNICKES ENCEPHALOPATHY; INTERVENTION		[Parker, Andrew J. R.] Maudsley Hosp & Inst Psychiat, S London & Maudsley NHS Trust, London SE5 8AZ, England; [Marshall, E. Jane] Kings Coll London, Inst Psychiat, Addict Res Unit, London SE5 8AF, England; [Ball, David M.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England	South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London	Parker, AJR (corresponding author), Maudsley Hosp & Inst Psychiat, S London & Maudsley NHS Trust, London SE5 8AZ, England.	andrew.parker@iop.kcl.ac.uk						Allen JP, 1997, J STUD ALCOHOL, V58, P7; Crawford M, 2004, LANCET, V364, P1334, DOI 10.1016/S0140-6736(04)17190-0; Dawson DA, 2005, ADDICTION, V100, P281, DOI 10.1111/j.1360-0443.2004.00964.x; *DEP HLTH, 2006, MOD CAR ALC MIS; Department of Health, 2005, ALC NEEDS ASS RES PR; Edwards G., 2003, TREATMENT DRINKING P; Hodgson R, 2002, ALCOHOL ALCOHOLISM, V37, P61, DOI 10.1093/alcalc/37.1.61; Humphreys K, 2004, CIRCLES RECOVERY SEL; *JOINT FORM COMM, 2007, BRIT NAT FORM; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kaner EFS, 1999, ALCOHOL ALCOHOLISM, V34, P559, DOI 10.1093/alcalc/34.4.559; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; Lingford-Hughes AR, 2004, J PSYCHOPHARMACOL, V18, P293, DOI 10.1177/026988110401800321; Miller WR, 1994, ISSUES ALCOHOL USE M, P55; Orford J, 2005, BMJ-BRIT MED J, V331, P541; *PRIM MIN STRAT UN, 2004, ALC HARM RED STRAT E; Raistrick D, 2006, REV EFFECTIVENESS TR; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Savola O, 2004, ALCOHOL ALCOHOLISM, V39, P340, DOI 10.1093/alcalc/agh064; Smith SGT, 1996, J ACCID EMERG MED, V13, P308; Thomson AD, 2006, ALCOHOL ALCOHOLISM, V41, P159, DOI 10.1093/alcalc/agh250; Thomson AD, 2006, ALCOHOL ALCOHOLISM, V41, P151, DOI 10.1093/alcalc/agh249; Timko C, 2000, J STUD ALCOHOL, V61, P529, DOI 10.15288/jsa.2000.61.529; Timko C, 2006, ADDICTION, V101, P678, DOI 10.1111/j.1360-0443.2006.01391.x; *WHO, 2001, BRIEF INT HAZ HARMF; WHO, 2004, GLOB STAT REP ALC; Williams S, 2005, DRUG ALCOHOL DEPEN, V77, P205, DOI 10.1016/j.drugalcdep.2004.07.011; World Health Organization (WHO), 2001, AUDIT ALC US DIS ID	28	23	23	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2008	336	7642					496	501		10.1136/bmj.39483.457708.80	http://dx.doi.org/10.1136/bmj.39483.457708.80			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	274JL	18310004	Green Published			2022-12-28	WOS:000253997500043
J	Debler, EW; Kaufmann, GF; Meijler, MM; Heine, A; Mee, JM; Pljevaljcic, G; Di Bilio, AJ; Schultz, PG; Millar, DP; Janda, KD; Wilson, IA; Gray, HB; Lerner, RA				Debler, Erik W.; Kaufmann, Gunnar F.; Meijler, Michael M.; Heine, Andreas; Mee, Jenny M.; Pljevaljcic, Goran; Di Bilio, Angel J.; Schultz, Peter G.; Millar, David P.; Janda, Kim D.; Wilson, Ian A.; Gray, Harry B.; Lerner, Richard A.			Deeply inverted electron-hole recombination in a luminescent antibody-stilbene complex	SCIENCE			English	Article							BLUE-FLUORESCENT-ANTIBODIES; PROTEINS; SENSOR	The blue- emissive antibody EP2-19G2 that has been elicited against trans- stilbene has unprecedented ability to produce bright luminescence and has been used as a biosensor in various applications. We show that the prolonged luminescence is not stilbene fluorescence. Instead, the emissive species is a charge- transfer excited complex of an anionic stilbene and a cationic, parallel pi-stacked tryptophan. Upon charge recombination, this complex generates exceptionally bright blue light. Complex formation is enabled by a deeply penetrating ligand-binding pocket, which in turn results from a noncanonical interface between the two variable domains of the antibody.	[Di Bilio, Angel J.; Gray, Harry B.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA; [Debler, Erik W.; Heine, Andreas; Pljevaljcic, Goran; Millar, David P.; Wilson, Ian A.; Lerner, Richard A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Debler, Erik W.; Kaufmann, Gunnar F.; Meijler, Michael M.; Mee, Jenny M.; Schultz, Peter G.; Janda, Kim D.; Wilson, Ian A.; Lerner, Richard A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Kaufmann, Gunnar F.; Meijler, Michael M.; Mee, Jenny M.; Schultz, Peter G.; Janda, Kim D.; Lerner, Richard A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Kaufmann, Gunnar F.; Janda, Kim D.] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Janda, Kim D.] Scripps Res Inst, Worm Inst Res & Med, La Jolla, CA 92037 USA	California Institute of Technology; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Gray, HB (corresponding author), CALTECH, Beckman Inst, Pasadena, CA 91125 USA.	hbgray@caltech.edu; rlerner@scripps.edu	Debler, Erik/D-1794-2013	Debler, Erik/0000-0002-2587-2150; Meijler, Michael/0000-0001-7095-1467	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK019038, R01DK019038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056528, R01GM038273, R29GM038273] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK19038] Funding Source: Medline; NIGMS NIH HHS [GM56528, R01 GM038273, GM38273] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BIRKS JB, 1970, PHOTOPHYSICS AROMATI, P420; Chen DW, 2001, J ORG CHEM, V66, P1725, DOI 10.1021/jo001676f; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; DENZIN LK, 1993, MOL IMMUNOL, V30, P1331, DOI 10.1016/0161-5890(93)90094-R; Di Bilio AJ, 2001, J AM CHEM SOC, V123, P3181, DOI 10.1021/ja0043183; Gotz M, 2002, BIOCHEMISTRY-US, V41, P4156, DOI 10.1021/bi015888y; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Kaufmann GF, 2005, ANGEW CHEM INT EDIT, V44, P2144, DOI 10.1002/anie.200461143; LEWIS FD, 1979, ACCOUNTS CHEM RES, V12, P152, DOI 10.1021/ar50136a007; Matsushita H, 2005, MOL BIOSYST, V1, P303, DOI 10.1039/b511408j; Matsushita M, 2005, ORG LETT, V7, P4943, DOI 10.1021/ol051919w; Matsushita M, 2003, ANGEW CHEM INT EDIT, V42, P5984, DOI 10.1002/anie.200352793; Murza A, 2000, BIOCHEMISTRY-US, V39, P10557, DOI 10.1021/bi000583p; NOVOTNY J, 1985, P NATL ACAD SCI USA, V82, P4592, DOI 10.1073/pnas.82.14.4592; RUOFF RS, 1995, J PHYS CHEM-US, V99, P8843, DOI 10.1021/j100021a060; Saltiel J., 1980, REARRANGEMENTS GROUN, P25, DOI DOI 10.1016/B978-0-12-481303-8.50007-X; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Simeonov A, 2000, SCIENCE, V290, P307, DOI 10.1126/science.290.5490.307; Tian T, 2006, ANGEW CHEM INT EDIT, V45, P7763, DOI 10.1002/anie.200602720; Tommos C, 1999, BIOCHEMISTRY-US, V38, P9495, DOI 10.1021/bi990609g; TURRO NJ, 1991, MODERN MOL PHOTOCHEM, P137; Wang Q, 2003, BIOCONJUGATE CHEM, V14, P38, DOI 10.1021/bc025587g; WHITLOW M, 1995, PROTEIN ENG, V8, P749, DOI 10.1093/protein/8.8.749; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11867, DOI 10.1073/pnas.211440398	27	40	43	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1232	1235		10.1126/science.1153445	http://dx.doi.org/10.1126/science.1153445			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309081				2022-12-28	WOS:000253530600040
J	Kinane, TB; Grabowski, EF; Sharma, A; Nimkin, K; King, ME; Cornell, LD; Fracchia, MS; Harris, NL; Harris, S; Hales, CA				Kinane, T. Bernard; Grabowski, Eric F.; Sharma, Amita; Nimkin, Katherine; King, Mary Etta; Cornell, Lynn D.; Fracchia, Mary Shannon; Harris, Nancy Lee; Harris, Scott; Hales, Charles A.			Case 7-2008: A 17-year-old girl with chest pain and hemoptysis - Membranous glomerulonephritis with the nephrotic syndrome and pulmonary embolus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RIGHT-VENTRICULAR DYSFUNCTION; TISSUE-PLASMINOGEN ACTIVATOR; VENOUS THROMBOEMBOLISM; POSTTHROMBOTIC SYNDROME; FOLLOW-UP; NEPHROPATHY; CHILDREN; THROMBOSIS; THERAPY; THROMBOLYSIS		[Kinane, T. Bernard; Grabowski, Eric F.; Sharma, Amita; King, Mary Etta] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Nimkin, Katherine] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Cornell, Lynn D.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kinane, T. Bernard; Grabowski, Eric F.; Sharma, Amita; King, Mary Etta] Harvard Univ, Sch Med, Dept Pediat, Cambridge, MA 02138 USA; [Nimkin, Katherine] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Cornell, Lynn D.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Kinane, TB (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.							A National Cooperative Study, 1973, CIRCULATION S2, V47, pII1; Brown JH, 1998, NEPHROL DIAL TRANSPL, V13, P443, DOI 10.1093/oxfordjournals.ndt.a027844; Cannizzaro V, 2005, J PEDIAT HEMATOL ONC, V27, P688, DOI 10.1097/01.mph.0000193489.80612.d4; Cattran DC, 2001, KIDNEY INT, V59, P1484, DOI 10.1046/j.1523-1755.2001.0590041484.x; Cattran DC, 1997, KIDNEY INT, V51, P901, DOI 10.1038/ki.1997.127; CATTRAN DC, 1989, NEW ENGL J MED, V320, P210, DOI 10.1056/NEJM198901263200403; Cornell LD, 2005, CURR OPIN NEPHROL HY, V14, P229, DOI 10.1097/01.mnh.0000165888.83125.07; DAGATI VD, 2006, HEPTINSTALLS PATHOLO, P517; Dong B, 2006, COCHRANE DB SYST REV, V2; Fasano R, 2005, J PEDIAT HEMATOL ONC, V27, P692, DOI 10.1097/01.mph.0000194021.40839.05; Goldenberg NA, 2007, BLOOD, V110, P45, DOI 10.1182/blood-2006-12-061234; GRABOWSKI EF, 2006, CURRENT PEDIAT THERA, P933; Grifoni S, 2000, CIRCULATION, V101, P2817, DOI 10.1161/01.CIR.101.24.2817; JENNETTE JC, 1983, KIDNEY INT, V24, P377, DOI 10.1038/ki.1983.170; Kanda H, 2005, LUPUS, V14, P288, DOI 10.1191/0961203305lu2076oa; Konstantinides S, 1998, AM J CARDIOL, V82, P966, DOI 10.1016/S0002-9149(98)00513-X; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Kronenberg F, 2004, KIDNEY INT, V66, P348, DOI 10.1111/j.1523-1755.2004.00737.x; Kucher N, 2005, CIRCULATION, V112, pE28, DOI 10.1161/CIRCULATIONAHA.105.551374; Lee BH, 2006, PEDIATR NEPHROL, V21, P1707, DOI 10.1007/s00467-006-0246-8; McConnell MV, 1996, AM J CARDIOL, V78, P469, DOI 10.1016/S0002-9149(96)00339-6; MEHLS O, 1987, J PEDIATR-US, V110, P862, DOI 10.1016/S0022-3476(87)80397-9; Perna A, 2004, AM J KIDNEY DIS, V44, P385, DOI 10.1053/j.ajkd.2004.05.020; PONTICELLI C, 1995, KIDNEY INT, V48, P1600, DOI 10.1038/ki.1995.453; Ribeiro A, 1997, AM HEART J, V134, P479, DOI 10.1016/S0002-8703(97)70085-1; SCHIEPPATI A, 1993, NEW ENGL J MED, V329, P85, DOI 10.1056/NEJM199307083290203; Schulman S, 2006, J THROMB HAEMOST, V4, P734, DOI 10.1111/j.1538-7836.2006.01795.x; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; STEVENSON GF, 1949, J PEDIATR-US, V34, P62, DOI 10.1016/S0022-3476(49)80200-9; van der Meer RW, 2005, RADIOLOGY, V235, P798, DOI 10.1148/radiol.2353040593; van Ommen CH, 2001, J PEDIATR-US, V139, P676, DOI 10.1067/mpd.2001.118192; Vieillard-Baron A, 2001, INTENS CARE MED, V27, P1481, DOI 10.1007/s001340101032; von Depka M, 2000, BLOOD, V96, P3364; Wang M, 2003, J PEDIAT HEMATOL ONC, V25, P379, DOI 10.1097/00043426-200305000-00006	35	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					941	952		10.1056/NEJMcpc0708507	http://dx.doi.org/10.1056/NEJMcpc0708507			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18305270				2022-12-28	WOS:000253430200011
J	Russell, JA; Walley, KR; Singer, J; Gordon, AC; Hebert, PC; Cooper, DJ; Holmes, CL; Mehta, S; Granton, JT; Storms, MM; Cook, DJ; Presneill, JJ; Ayers, D				Russell, James A.; Walley, Keith R.; Singer, Joel; Gordon, Anthony C.; Hebert, Paul C.; Cooper, D. James; Holmes, Cheryl L.; Mehta, Sangeeta; Granton, John T.; Storms, Michelle M.; Cook, Deborah J.; Presneill, Jeffrey J.; Ayers, Dieter		VASST Investigators	Vasopressin versus norepinephrine infusion in patients with septic shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARGININE-VASOPRESSIN; VASODILATORY SHOCK; DOSE VASOPRESSIN; SEVERE SEPSIS; MANAGEMENT; HYPERSENSITIVITY; HYPOTENSION; DEFICIENCY; DISEASE; TRIAL	Background Vasopressin is commonly used as an adjunct to catecholamines to support blood pressure in refractory septic shock, but its effect on mortality is unknown. We hypothesized that low-dose vasopressin as compared with norepinephrine would decrease mortality among patients with septic shock who were being treated with conventional (catecholamine) vasopressors. Methods In this multicenter, randomized, double-blind trial, we assigned patients who had septic shock and were receiving a minimum of 5 mu g of norepinephrine per minute to receive either low-dose vasopressin (0.01 to 0.03 U per minute) or norepinephrine (5 to 15 mu g per minute) in addition to open-label vasopressors. All vasopressor infusions were titrated and tapered according to protocols to maintain a target blood pressure. The primary end point was the mortality rate 28 days after the start of infusions. Results A total of 778 patients underwent randomization, were infused with the study drug (396 patients received vasopressin, and 382 norepinephrine), and were included in the analysis. There was no significant difference between the vasopressin and norepinephrine groups in the 28-day mortality rate (35.4% and 39.3%, respectively; P=0.26) or in 90-day mortality (43.9% and 49.6%, respectively; P=0.11). There were no significant differences in the overall rates of serious adverse events (10.3% and 10.5%, respectively; P=1.00). In the prospectively defined stratum of less severe septic shock, the mortality rate was lower in the vasopressin group than in the norepinephrine group at 28 days (26.5% vs. 35.7%, P=0.05); in the stratum of more severe septic shock, there was no significant difference in 28-day mortality (44.0% and 42.5%, respectively; P=0.76). A test for heterogeneity between these two study strata was not significant (P=0.10). Conclusions Low-dose vasopressin did not reduce mortality rates as compared with norepinephrine among patients with septic shock who were treated with catecholamine vasopressors. (Current Controlled Trials number, ISRCTN94845869.).	[Russell, James A.; Walley, Keith R.; Singer, Joel; Gordon, Anthony C.; Storms, Michelle M.; Ayers, Dieter] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Russell, James A.; Walley, Keith R.; Gordon, Anthony C.; Storms, Michelle M.] iCAPTURE Ctr, Vancouver, BC, Canada; [Hebert, Paul C.] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada; [Holmes, Cheryl L.] Kelowna Gen Hosp, Kelowna, BC, Canada; [Holmes, Cheryl L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Mehta, Sangeeta] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Granton, John T.] Toronto Gen Hosp, Toronto, ON, Canada; [Granton, John T.] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; [Granton, John T.] Univ Toronto, Toronto, ON, Canada; [Cook, Deborah J.] St Josephs Hosp, Hamilton, ON, Canada; [Cook, Deborah J.] McMaster Univ, Hamilton, ON, Canada; [Cooper, D. James] Alfred Hosp, Melbourne, Vic, Australia; [Cooper, D. James] Monash Univ, Melbourne, Vic 3004, Australia; [Presneill, Jeffrey J.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Presneill, Jeffrey J.] Univ Melbourne, Melbourne, Vic, Australia	St. Paul's Hospital; University of Saskatchewan; University of Ottawa; Ottawa Hospital Research Institute; University of British Columbia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; McGill University; McMaster University; McMaster University; Florey Institute of Neuroscience & Mental Health; Monash University; Royal Melbourne Hospital; University of Melbourne	Russell, JA (corresponding author), St Pauls Hosp, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jrussell@mrl.ubc.ca	Mehta, Sangeeta/C-4623-2015; Cooper, D. James/G-7961-2013; Presneill, Jeffrey J/B-4894-2012; Gordon, Anthony/A-3472-2012	Cooper, D. James/0000-0002-5872-9051; Presneill, Jeffrey J/0000-0001-7177-7667; Gordon, Anthony/0000-0002-0419-547X; NOIRI, Eisei/0000-0002-9515-7582				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Argenziano M, 1997, CIRCULATION, V96, P286; Argenziano M, 1998, J THORAC CARDIOV SUR, V116, P973, DOI 10.1016/S0022-5223(98)70049-2; Argenziano M, 1999, J HEART LUNG TRANSPL, V18, P814, DOI 10.1016/S1053-2498(99)00038-8; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Bernard GR, 1997, CHEST, V112, P164, DOI 10.1378/chest.112.1.164; BOMZON L, 1975, AM J PHYSIOL, V229, P1649, DOI 10.1152/ajplegacy.1975.229.6.1649; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chen JM, 1999, CIRCULATION, V100, P244; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; Dunser MW, 2003, CRIT CARE MED, V31, P1394, DOI 10.1097/01.CCM.0000059722.94182.79; Dunser MW, 2003, CIRCULATION, V107, P2313, DOI 10.1161/01.CIR.0000066692.71008.BB; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Gold J, 2000, AM J CARDIOL, V85, P506, DOI 10.1016/S0002-9149(99)00783-3; HAYES MA, 1992, INTENS CARE MED, V18, P433, DOI 10.1007/BF01694349; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Holmes CL, 2001, INTENS CARE MED, V27, P1416, DOI 10.1007/s001340101014; Holmes CL, 2001, CHEST, V120, P989, DOI 10.1378/chest.120.3.989; Klinzing S, 2003, CRIT CARE MED, V31, P2646, DOI 10.1097/01.CCM.0000094260.05266.F4; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Landry DW, 1997, CIRCULATION, V95, P1122; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Landy DW, 1997, CRIT CARE MED, V25, P1279, DOI 10.1097/00003246-199708000-00012; Luckner G, 2005, CRIT CARE MED, V33, P2659, DOI 10.1097/01.CCM.0000186749.34028.40; Malay MB, 1999, J TRAUMA, V47, P699, DOI 10.1097/00005373-199910000-00014; Morales DLS, 2000, ANN THORAC SURG, V69, P102, DOI 10.1016/S0003-4975(99)01197-2; Patel BM, 2002, ANESTHESIOLOGY, V96, P576, DOI 10.1097/00000542-200203000-00011; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rosenzweig EB, 1999, CIRCULATION, V100, P182; van Haren FMP, 2003, CHEST, V124, P2256, DOI 10.1378/chest.124.6.2256	34	1051	1133	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					877	887		10.1056/NEJMoa067373	http://dx.doi.org/10.1056/NEJMoa067373			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18305265				2022-12-28	WOS:000253430200003
J	Auerbach, PS				Auerbach, Paul S.			Physicians and the environment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stanford Univ, Sch Med, Dept Surg, Div Emergency Med, Palo Alto, CA 94304 USA	Stanford University	Auerbach, PS (corresponding author), Stanford Univ, Sch Med, Dept Surg, Div Emergency Med, 701 Welch Rd,Ste C, Palo Alto, CA 94304 USA.	auerbach@stanford.edu						*BBC WEATH CTR, CLIM CHANG; BOTKIN DB, 2007, WALL STREET J   1017, pA19; Campbell-Lendrum D, 2007, B WORLD HEALTH ORGAN, V85, P235, DOI 10.2471/BLT.06.039503; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Collins W, 2007, SCI AM, V297, P64, DOI 10.1038/scientificamerican0807-64; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; LONGSTRETH J, 1998, ENV EFFECTS OZONE DE; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; National Oceanic and Atmospheric Administration, TRENDS ATM CARB DIOX; Nelson SM, 2002, GEND ARCHAEOL SERIES, V1, P1; NICKLEN P, 2007, NATL GEOGR, V211, P12; Parry M. L., 2007, CLIMATE CHANGE 2007; Patz JA, 2000, ENVIRON HEALTH PERSP, V108, P367, DOI 10.2307/3454357; SACHS JD, CLIMATE CHANGE REFUG; Solomon S., 2007, PHYS SCI BASIS WORKI; Trenberth K, 2007, SCI AM, V297, P44, DOI 10.1038/scientificamerican0707-44; *UN WAT LIF, FACT SHEET WAT SAN; van der Linden P.J, 2007, CLIMATE CHANGE 2007, P391; Wiedinmyer Christine, 2007, Carbon Balance Manag, V2, P10, DOI 10.1186/1750-0680-2-10; *WORLD BANK GROUP, PIL PROGR CONS BRAZ; *WORLD WAT COUNC, WAT CRIS	21	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2008	299	8					956	958		10.1001/jama.299.8.956	http://dx.doi.org/10.1001/jama.299.8.956			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266DZ	18314440				2022-12-28	WOS:000253413200026
J	Emanuel, EJ				Emanuel, Ezekiel J.			The cost-coverage trade-off - "It's health care costs, stupid"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSURANCE; DECLINE		[Emanuel, Ezekiel J.] NIH, Ctr Clin, Dept Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, 10 Ctr Dr,Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@cc.nih.gov						*AG HEALTHC RES QU, 2004, AV TOT FAM PREM DOLL; *AG HLTH RES QUAL, MED EXP PAN SURV TOP; *AG HLTH RES QUAL, 2005, AV TOT FAM PREM DOLL; Blumenthal D, 2006, NEW ENGL J MED, V355, P82, DOI 10.1056/NEJMhpr060703; Centers for Medicare and Medicaid Services, NAT HLTH EXP TYP SER; Chernew M, 2005, HEALTH SERV RES, V40, P1021, DOI 10.1111/j.1475-6773.2005.00409.x; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; Fronstin P, 1996, INQUIRY-J HEALTH CAR, V33, P317; GLIED S, 10029 NAT BUR EC; *GOV ACC OFF, GAOHEHS98203R; *HJ KAIS FAM FDN, 2006, HLTH INS COV TOT POP; *HJ KAIS FAM FDN, EMPL HLTH BEN 2006 A; *HJ KAIS FAM FDN, 2007, KAIS HLTH TRACK POLL; Institute of Medicine, 2002, CAR COV TOO LITTL TO; Kronick R, 1999, HEALTH AFFAIR, V18, P30, DOI 10.1377/hlthaff.18.2.30; Martin AB, 2007, HEALTH AFFAIR, V26, pW651, DOI 10.1377/hlthaff.26.6.w651; Sack K, NY TIMES; U.S. Bureau of Labor Statistics, EMPL STAT CIV NON PO; *US BUR CENS, SEL EC CHAR 2005; *US BUR CENS, HLTH INS COV STAT TY; *US BUR CENS, HOUS INC RIS POV RAT; *US BUR CENS, MOR PEOPL HAV HLTH I	22	14	14	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2008	299	8					947	949		10.1001/jama.299.8.947	http://dx.doi.org/10.1001/jama.299.8.947			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266DZ	18314437				2022-12-28	WOS:000253413200023
J	Glassman, A; Becker, L; Makinen, M; de Ferranti, D				Glassman, Amanda; Becker, Loren; Makinen, Marty; de Ferranti, David			Planning and costing human resources for health	LANCET			English	Article							REQUIREMENTS; CARE		[Glassman, Amanda; Becker, Loren; Makinen, Marty; de Ferranti, David] Brookings Inst, Hlth Financing Task Force, Washington, DC 20036 USA	Brookings Institution	Glassman, A (corresponding author), Brookings Inst, Hlth Financing Task Force, Washington, DC 20036 USA.	aglassman@brookings.edu		Glassman, Amanda/0000-0002-7483-8012				ADANO U, 2006, COLLECTION ANAL HUMA; Bloor K, 2003, PLANNING HUMAN RESOU; Daviauda E, 2008, B WORLD HEALTH ORGAN, V86, P46, DOI 10.2471/BLT.07.042283; Dreesch N, 2005, HEALTH POLICY PLANN, V20, P267, DOI 10.1093/heapol/czi036; Gulliford MC, 2001, J CLIN EPIDEMIOL, V54, P511, DOI 10.1016/S0895-4356(00)00336-X; PREKER AS, 2007, SCALING HLTH ED OPPO; RUWOLDT P, 2007, ZANZIBAR HLTH CARE W; TANGCHAROENSATH.V, DETERMINANTS CLIN PR; VERBOOM P, COST ELIMINATING CRI; VUJICIC M, 2006, MACROECONOMIC FISCAL; Vujicic M, 2006, INT J HEALTH PLAN M, V21, P101, DOI 10.1002/hpm.834; Wennberg John, 2004, HLTH AFF MILLWOOD S, P140, DOI DOI 10.1377/HLTHAFF.VAR.140; Wibulpolprasert Suwit, 2004, Hum Resour Health, V2, P10, DOI 10.1186/1478-4491-2-10; Wibulpolprasert Suwit, 2003, Hum Resour Health, V1, P12, DOI 10.1186/1478-4491-1-12; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	15	8	8	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2008	371	9613					693	695		10.1016/S0140-6736(08)60311-6	http://dx.doi.org/10.1016/S0140-6736(08)60311-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LL	18295030				2022-12-28	WOS:000253436700037
J	Bonetta, L				Bonetta, Laura			European stem cell patents: Taking the moral high road?	CELL			English	Editorial Material								A European law that prevents the patenting of discoveries that contravene morality is causing confusion when it comes to human embryonic stem cells. The ensuing debate is markedly different from the one in the United States, where the scope of stem cell patents and their licensing are under challenge.											0	6	7	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					514	516		10.1016/j.cell.2008.02.012	http://dx.doi.org/10.1016/j.cell.2008.02.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295565	Bronze			2022-12-28	WOS:000253817900007
J	Liu, H; Bravata, DM; Olkin, I; Friedlander, A; Liu, V; Roberts, B; Bendavid, E; Saynina, O; Salpeter, SR; Garber, AM; Hoffman, AR				Liu, Hau; Bravata, Dena M.; Olkin, Ingram; Friedlander, Anne; Liu, Vincent; Roberts, Brian; Bendavid, Eran; Saynina, Olga; Salpeter, Shelley R.; Garber, Alan M.; Hoffman, Andrew R.			Systematic review: The effects of growth hormone on athletic performance	ANNALS OF INTERNAL MEDICINE			English	Review							ANDROGENIC STEROID USERS; RECOMBINANT HUMAN GH; TRAINED ADULT MALES; HEALTHY-ADULTS; BODY-COMPOSITION; YOUNG MEN; SUBSTRATE METABOLISM; THYROID-HORMONES; FUEL OXIDATION; SERUM-LIPIDS	Background: Human growth hormone is reportedly used to enhance athletic performance, although its safety and efficacy for this purpose are poorly understood. Purpose: To evaluate evidence about the effects of growth hormone on athletic performance in physically fit, young individuals. Data Sources: MEDLINE, EMBASE, SPORTDiscus, and Cochrane Collaboration databases were searched for English-language studies published between January 1966 and October 2007. Study Selection: Randomized, controlled trials that compared growth hormone treatment with no growth hormone treatment in community-dwelling healthy participants between 13 and 45 years of age. Data Extraction: 2 authors independently reviewed articles and abstracted data. Data Synthesis: 44 articles describing 27 study samples met inclusion criteria; 303 participants received growth hormone, representing 13.3 person-years of treatment. Participants were young (mean age, 27 years [SD, 3]), lean (mean body mass index, 24 kg/m(2) [SD, 2]), and physically fit (mean maximum oxygen uptake, 51 mL/kg of body weight per minute [SD, 8]). Growth hormone dosage (mean, 36 mu g/kg per day [SD, 21]) and treatment duration (mean, 20 days [SD, 18] for studies giving growth hormone for > 1 day) varied. Lean body mass increased in growth hormone recipients compared with participants who did not receive growth hormone (increase, 2.1 kg [95% CI, 1.3 to 2.9 kg]), but strength and exercise capacity did not seem to improve. Lactate levels during exercise were statistically significantly higher in 2 of 3 studies that evaluated this outcome. Growth hormone-treated participants more frequently experienced soft tissue edema and fatigue than did those not treated with growth hormone. Limitations: Few studies evaluated athletic performance. Growth hormone protocols in the studies may not reflect real-world doses and regimens. Conclusion: Claims that growth hormone enhances physical performance are not supported by the scientific literature. Although the limited available evidence suggests that growth hormone increases lean body mass, it may not improve strength; in addition, it may worsen exercise capacity and increase adverse events. More research is needed to conclusively determine the effects of growth hormone on athletic performance.	[Liu, Hau] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; Stanford Univ, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Santa Clara Valley Medical Center; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Liu, H (corresponding author), Santa Clara Valley Med Ctr, 751 S Bascom Ave,4th Floor Med, San Jose, CA 95128 USA.	hauliu@stanford.edu	Garber, Alan M/F-1476-2010	Hoffman, Andrew/0000-0002-0145-1917	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS000028, T32HS000028] Funding Source: NIH RePORTER; AHRQ HHS [HS000028-19] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Abs R, 1999, CLIN ENDOCRINOL, V50, P703, DOI 10.1046/j.1365-2265.1999.00695.x; [Anonymous], HUMAN GROWTH HORMONE; [Anonymous], 2007, REPORT COMMISSIONER; AUSTEN I, 2007, NY TIMES        0526; Baum HBA, 1996, ANN INTERN MED, V125, P883, DOI 10.7326/0003-4819-125-11-199612010-00003; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; Berggren A, 2005, J CLIN ENDOCR METAB, V90, P3268, DOI 10.1210/jc.2004-1209; Billat VL, 2003, SPORTS MED, V33, P407, DOI 10.2165/00007256-200333060-00003; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; BRIXEN K, 1990, J BONE MINER RES, V5, P609; BRIXEN K, 1992, ACTA ENDOCRINOL-COP, V127, P331, DOI 10.1530/acta.0.1270331; BROOKS G, 2006, EXERCISE PHYSL HUMAN, P283; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Cittadini A, 2002, J CLIN ENDOCR METAB, V87, P1654, DOI 10.1210/jc.87.4.1654; *COCHR COLL, 2004, REVMAN 4 2 US GUID; CRIST DM, 1988, J APPL PHYSIOL, V65, P579, DOI 10.1152/jappl.1988.65.2.579; CRIST DM, 1990, METABOLISM, V39, P1320, DOI 10.1016/0026-0495(90)90191-E; CRIST DM, 1991, MECH AGEING DEV, V58, P191, DOI 10.1016/0047-6374(91)90092-E; CURRY J, 2006, NY TIMES        0607; Dall R, 2000, J CLIN ENDOCR METAB, V85, P4193, DOI 10.1210/jc.85.11.4193; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; DERAY G, 1987, NEW ENGL J MED, V316, P575, DOI 10.1056/NEJM198703053161003; DEYSSIG R, 1993, ACTA ENDOCRINOL-COP, V128, P313, DOI 10.1530/acta.0.1280313; Ehrnborg C, 2005, CLIN ENDOCRINOL, V62, P449, DOI 10.1111/j.1365-2265.2005.02240.x; Ezzat S, 2002, J CLIN ENDOCR METAB, V87, P2725, DOI 10.1210/jc.87.6.2725; FAINARUWADA M, 2004, SAN FRANCISCO C 1202; FAINURAWADA M, 2006, GAME SHADOWS; FITZPATRICK M, 2007, F VINA ADMITS HGH US; Giannoulis MG, 2005, CLIN ENDOCRINOL, V62, P315, DOI 10.1111/j.1365-2265.2005.02216.x; Graham MR, 2007, GROWTH HORM IGF RES, V17, P328, DOI 10.1016/j.ghir.2007.04.003; Graham MR, 2007, GROWTH HORM IGF RES, V17, P201, DOI 10.1016/j.ghir.2007.01.010; Graham MR, 2007, CURR NEUROVASC RES, V4, P9, DOI 10.2174/156720207779940699; Gravholt CH, 1999, AM J PHYSIOL-ENDOC M, V277, pE848, DOI 10.1152/ajpendo.1999.277.5.E848; Hansen M, 2005, AM J PHYSIOL-ENDOC M, V289, pE1030, DOI 10.1152/ajpendo.00124.2005; Hansen M, 2005, J PHYSIOL-LONDON, V567, P1035, DOI 10.1113/jphysiol.2005.089524; HANSEN PS, 1995, METABOLISM, V44, P725, DOI 10.1016/0026-0495(95)90184-1; Hansen TK, 2001, AM J PHYSIOL-ENDOC M, V281, pE1326, DOI 10.1152/ajpendo.2001.281.6.E1326; Hashimoto Y, 2000, J CLIN ENDOCR METAB, V85, P601, DOI 10.1210/jc.85.2.601; Healy ML, 2006, J CLIN ENDOCR METAB, V91, P320, DOI 10.1210/jc.2005-0916; Healy ML, 2003, J CLIN ENDOCR METAB, V88, P5221, DOI 10.1210/jc.2002-021872; Hedges LV, 2014, STAT METHODS META AN; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HORBER FF, 1991, DIABETES, V40, P141, DOI 10.2337/diabetes.40.1.141; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Irving BA, 2004, J CLIN ENDOCR METAB, V89, P4298, DOI 10.1210/jc.2004-0067; JANOFSKY M, 1989, NY TIMES        0314; KAHN SE, 1993, DIABETES, V42, P1082, DOI 10.2337/diabetes.42.7.1082; Kehely A, 2002, J CLIN ENDOCR METAB, V87, P1974, DOI 10.1210/jc.87.5.1974; Kniess A, 2003, ANAL BIOANAL CHEM, V376, P696, DOI 10.1007/s00216-003-1926-x; Lange KHW, 2002, J CLIN ENDOCR METAB, V87, P4966, DOI 10.1210/jc.2001-011797; Liu H, 2007, ANN INTERN MED, V146, P104, DOI 10.7326/0003-4819-146-2-200701160-00005; Longobardi S, 2000, J CLIN ENDOCR METAB, V85, P1505, DOI 10.1210/jc.85.4.1505; *MAJ LEAG BAS, 2005, JOINT DRUG PREV TREA; MOLLER J, 1991, J CLIN ENDOCR METAB, V72, P768, DOI 10.1210/jcem-72-4-768; MOLLER J, 1992, METABOLISM, V41, P728, DOI 10.1016/0026-0495(92)90312-X; Moller J, 1995, SCAND J CLIN LAB INV, V55, P663, DOI 10.3109/00365519509075396; MOLLER N, 1993, CLIN ENDOCRINOL, V39, P577; MOLLER N, 1990, J CLIN ENDOCR METAB, V70, P1179, DOI 10.1210/jcem-70-4-1179; Napoli R, 2003, J CLIN ENDOCR METAB, V88, P2817, DOI 10.1210/jc.2003-030144; *NAT FOOTB LEAG, 2007, POL AN STER REL SUBS; Orwin R.G., 1994, HDB RES SYNTHESIS; Perls TT, 2005, JAMA-J AM MED ASSOC, V294, P2086, DOI 10.1001/jama.294.16.2086; Phillips SM, 1996, J APPL PHYSIOL, V81, P2182, DOI 10.1152/jappl.1996.81.5.2182; Rennie MJ, 2003, BRIT J SPORT MED, V37, P100, DOI 10.1136/bjsm.37.2.100; RUIBAL S, 2006, US TODAY        0702; Saugy M, 2006, BRIT J SPORT MED, V40, P35, DOI 10.1136/bjsm.2006.027573; SCHMIDT MS, 2007, NY TIMES        1216; Skjaerbaek C, 1996, EUR J ENDOCRINOL, V135, P672, DOI 10.1530/eje.0.1350672; SPELLWIN G, CHEM WIZARDRY; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Wallace JD, 1999, J CLIN ENDOCR METAB, V84, P3591, DOI 10.1210/jc.84.10.3591; Wallace JD, 2001, J CLIN ENDOCR METAB, V86, P1731, DOI 10.1210/jc.86.4.1731; West S, 2002, 47 AG HEALTHC RES QU; Wolthers T, 1996, J CLIN ENDOCR METAB, V81, P1416, DOI 10.1210/jc.81.4.1416; Wolthers T, 1996, METABOLISM, V45, P1016, DOI 10.1016/S0026-0495(96)90273-5; Wolthers T, 1998, METABOLISM, V47, P83, DOI 10.1016/S0026-0495(98)90197-4; Wolthers T, 1999, HORM METAB RES, V31, P37, DOI 10.1055/s-2007-978694; *WORLD ANT AG, 2006 PROH LIST; *WORLD ANT AG, Q A HUM GROWTH HORM; *WORLD ANT AG, BRIEF HIST ANT; YARASHESKI KE, 1992, AM J PHYSIOL, V262, pE261, DOI 10.1152/ajpendo.1992.262.3.E261; YARASHESKI KE, 1993, J APPL PHYSIOL, V74, P3073, DOI 10.1152/jappl.1993.74.6.3073; Young J, 2007, BRIT J SPORT MED, V41, P335, DOI 10.1136/bjsm.2006.030585; Yuen K, 2004, J CLIN ENDOCR METAB, V89, P3956, DOI 10.1210/jc.2004-0300; CONTINUOUS CYCLE	85	108	110	2	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2008	148	10					747	U59		10.7326/0003-4819-148-10-200805200-00215	http://dx.doi.org/10.7326/0003-4819-148-10-200805200-00215			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308EX	18347346				2022-12-28	WOS:000256372200004
J	Mi, SJ; Cai, T; Hu, YG; Chen, Y; Hodges, E; Ni, FR; Wu, L; Li, S; Zhou, H; Long, CZ; Chen, S; Hannon, GJ; Qi, YJ				Mi, Shijun; Cai, Tao; Hu, Yugang; Chen, Yemiao; Hodges, Emily; Ni, Fangrui; Wu, Liang; Li, Shan; Zhou, Huanyu; Long, Chengzu; Chen, She; Hannon, Gregory J.; Qi, Yijun			Sorting of small RNAs into Arabidopsis argonaute complexes is directed by the 5 ' terminal nucleotide	CELL			English	Article							TRANS-ACTING SIRNAS; C-ELEGANS; ANTISENSE TRANSCRIPTS; ENDOGENOUS SIRNAS; PROCESSING CENTER; DNA METHYLATION; MESSENGER-RNAS; MICRORNAS; BIOGENESIS; DROSOPHILA	Argonaute (AGO) proteins recruit small RNAs to form the core of RNAi effector complexes. Arabidopsis encodes ten AGO proteins and a large network of small RNAs. How these small RNAs are sorted into specific AGO complexes remains largely unknown. We have cataloged small RNAs resident in four AGO complexes. We found that AGO2 and AGO4 preferentially recruit small RNAs with a 5 ' terminal adenosine, whereas AGO1 harbors microRNAs (miRNAs) that favor a 5 ' terminal uridine. AGO5 predominantly binds small RNAs that initiate with cytosine. Changing the 5 ' terminal nucleotide of an miRNA predictably redirected it into a different AGO complex and alters its biological activity. These results reveal a role for small RNA sequences in assorting among AGO complexes. This suggests that specialization of AGO complexes might involve remodeling the 5 ' end-binding pocket to accept certain small RNA sequences, perhaps explaining the evolutionary drive for miRNAs to initiate with uridine.	[Mi, Shijun; Cai, Tao; Hu, Yugang; Chen, Yemiao; Ni, Fangrui; Wu, Liang; Li, Shan; Zhou, Huanyu; Long, Chengzu; Chen, She; Qi, Yijun] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Hodges, Emily; Hannon, Gregory J.] Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hodges, Emily; Hannon, Gregory J.] Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	National Institute of Biological Sciences, Beijing; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Qi, YJ (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	qiyijun@nibs.ac.cn	Mi, Shijun/C-9777-2012; Qi, Yijun/AAE-8797-2019; Hannon, Gregory/AAB-3568-2019	Li, Shan/0000-0001-8646-3193; Hodges, Emily/0000-0001-6513-610X	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM062534-08, R01 GM062534] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lynn K, 1999, DEVELOPMENT, V126, P469; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Song JJ, 2006, CURR OPIN STRUC BIOL, V16, P5, DOI 10.1016/j.sbi.2006.01.010; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wang H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r92; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	56	931	997	6	154	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 4	2008	133	1					116	127		10.1016/j.cell.2008.02.034	http://dx.doi.org/10.1016/j.cell.2008.02.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18342361	Green Accepted, Bronze			2022-12-28	WOS:000254641300013
J	Self, S; Blake, S; Sharma, K; Widdowson, M; Sephton, S				Self, Stephen; Blake, Stephen; Sharma, Kirti; Widdowson, Mike; Sephton, Sarah			Sulfur and chlorine in Late Cretaceous Deccan magmas and eruptive gas release	SCIENCE			English	Article							CONTINENTAL FLOOD-BASALT; POLLUTION; PAHOEHOE; PROVINCE	Large- volume pahoehoe lava flows erupted 67 to 65 million years ago, forming the Deccan Traps, India. The impact of these flood basalt eruptions on the global atmosphere and the coeval end- Cretaceous mass extinction has been uncertain. To assess the potential gas release from this volcanism, we measured sulfur and chlorine concentrations in rare glass inclusions inside crystals and on glassy selvages preserved within lavas. Concentrations range from similar to 1400 parts per million of S and 900 parts per million of Cl in inclusions down to a few hundred parts per million in the lava. These data indicate that eruptions of Deccan lavas could have released at most 0.103 weight % of S, yielding up to 5.4 teragrams of SO2 per cubic kilometer of lava. A more conservative estimate is 0.07 weight % of S and 0.04 weight % of Cl, yielding 3.5 teragrams of SO2 and 1 teragram of HCl for every cubic kilometer of lava erupted. The flows were very large in volume, and these results imply that huge amounts of S and Cl gases were released. The environmental impact from even individual eruptions during past flood basalt activity was probably severe.	[Self, Stephen; Blake, Stephen; Sharma, Kirti; Widdowson, Mike; Sephton, Sarah] Open Univ, Volcano Dynam Grp, Dept Earth & Environm Sci, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	Self, S (corresponding author), Open Univ, Volcano Dynam Grp, Dept Earth & Environm Sci, Milton Keynes MK7 6AA, Bucks, England.	stephen.self@open.ac.uk	Sharma, Kirti/GQQ-4921-2022	Blake, Stephen/0000-0002-4277-6734	Natural Environment Research Council [NER/B/S/2003/00246] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Chenet AL, 2005, EARTH PLANET SC LETT, V236, P721, DOI 10.1016/j.epsl.2005.04.046; Chenet AL, 2007, EARTH PLANET SC LETT, V263, P1, DOI 10.1016/j.epsl.2007.07.011; COURTILLOT V, 1999, EVOLUTIOANRY CATASTR; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Graf HF, 1998, CHEM GEOL, V147, P131, DOI 10.1016/S0009-2541(97)00177-0; Grattan J, 2005, LITHOS, V79, P343, DOI 10.1016/j.lithos.2004.09.006; Guilbaud MN, 2007, J PETROL, V48, P1265, DOI 10.1093/petrology/egm017; Halmer MM, 2002, J VOLCANOL GEOTH RES, V115, P511, DOI 10.1016/S0377-0273(01)00318-3; Haywood J, 2000, REV GEOPHYS, V38, P513, DOI 10.1029/1999RG000078; Jay AE, 2008, J GEOL SOC LONDON, V165, P177, DOI 10.1144/0016-76492006-062; MATHEZ EA, 1976, J GEOPHYS RES, V81, P4269, DOI 10.1029/JB081i023p04269; Oman L, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006899; Oze C, 2005, J VOLCANOL GEOTH RES, V142, P285, DOI 10.1016/j.jvolgeores.2004.11.008; Sano T, 2001, J PETROL, V42, P2175, DOI 10.1093/petrology/42.12.2175; Scaillet B, 2006, J PETROL, V47, P1413, DOI 10.1093/petrology/egl016; Self S, 2005, ELEMENTS, V1, P283, DOI 10.2113/gselements.1.5.283; SELF S, IN PRESS J VOLCANOL; Self S, 2006, EARTH PLANET SC LETT, V248, P518, DOI 10.1016/j.epsl.2006.05.041; Sharma K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019688; Thordarson T, 2003, GEOL SOC SPEC PUBL, V213, P103, DOI 10.1144/GSL.SP.2003.213.01.07; Thordarson T, 1996, B VOLCANOL, V58, P205, DOI 10.1007/s004450050136; Thordarson T, 1998, J GEOPHYS RES-SOL EA, V103, P27411, DOI 10.1029/98JB01355; Thordarson T, 1996, J VOLCANOL GEOTH RES, V74, P49, DOI 10.1016/S0377-0273(96)00054-6; Thornber CR, 2001, CAN MINERAL, V39, P239, DOI 10.2113/gscanmin.39.2.239; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4	25	119	124	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2008	319	5870					1654	1657		10.1126/science.1152830	http://dx.doi.org/10.1126/science.1152830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356523				2022-12-28	WOS:000254172300037
J	Laiyemo, AO; Murphy, G; Albert, PS; Wang, Z; Cross, AJ; Marcus, PM; Caan, B; Marshall, JR; Lance, P; Paskett, ED; Weissfeld, J; Slattery, ML; Burt, R; Iber, F; Shike, M; Kikendall, JW; Lanza, E; Schatzkin, A				Laiyemo, Adeyinka O.; Murphy, Gwen; Albert, Paul S.; Wang, Zhuoqiao; Cross, Amanda J.; Marcus, Pamela M.; Caan, Bette; Marshall, James R.; Lance, Peter; Paskett, Electra D.; Weissfeld, Joel; Slattery, Martha L.; Burt, Randall; Iber, Frank; Shike, Moshe; Kikendall, J. Walter; Lanza, Elaine; Schatzkin, Arthur			Postpolypectomy colonoscopy surveillance guidelines: Predictive accuracy for advanced adenorna at 4 years	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINES; COLORECTAL-CANCER; NATIONAL-SURVEY; RECURRENCE; PHYSICIANS; UPDATE; POLYPECTOMY; RATIONALE; ADENOMAS; SIZE	Background: Lack of confidence in postpolypectomy surveillance guidelines may be a factor in the observed low adherence rates among providers. Objective: To assess the 2006 postpolypectomy colonoscopy surveillance guidelines, which recommend 3-year follow-up colonoscopy for individuals with high-risk adenomas (defined as >= 3 adenomas or any advanced adenomas) and 5- to 10-year follow-up for patients with 2 or fewer nonadvanced adenomas, who are considered to be at low risk. Design: Analysis of prospective data from the Polyp Prevention Trial. Setting: United States. Participants: 1905 patients who had colorectal adenomas removed at baseline screening or diagnostic colonoscopy and completed the trial. Measurements: Baseline adenoma characteristics, risk-stratified according to definitions used in the guidelines, were examined as predictors for advanced adenoma recurrence. Results: 125 patients (6.6%) had advanced and 629 (33.0%) had nonadvanced adenoma recurrence; 1151 (60.4%) had no recurrence within 4 years of follow-up. The probability of advanced adenoma recurrence was 0.09 (95% Cl, 0.07 to 0.11) among patients with high-risk adenomas at baseline and 0.05 (Cl, 0.04 to 0.06) among those with low-risk adenomas at baseline. The relative risk for advanced adenoma recurrence for patients with high-risk adenomas versus those with low-risk adenomas at baseline was 1.68 (Cl, 1.19 to 2.38) when advanced adenoma recurrence was compared with no advanced adenoma recurrence and 1.76 (Cl, 1.26 to 2.46) when advanced adenoma recurrence was compared with no adenoma recurrence. The c-statistics for these 2 comparisons were 0.68 and 0.72, respectively. Limitation: Participants were self-selected and had restrictions on the degree of obesity. Conclusion: Although the risk for recurrence of advanced adenoma within 4 years is greater for patients with high-risk adenomas at baseline than for those with low-risk adenomas, the discrimination of this risk stratification scheme is relatively low.	NIH, Natl Canc Inst, Bethesda, MD 20892 USA; Informat Management Serv Inc, Rockville, MD USA; Kaiser Fdn Res Inst, Oakland, CA USA; Roswell Pk Canc Inst, Buffalo, NY USA; Arizona Canc Ctr, Tucson, AZ USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Univ Pittsburgh, Pittsburgh, PA USA; Univ Utah, Salt Lake City, UT USA; Edward Hines Jr Hosp Vet Affairs Med Ctr, Hines, IL USA; Walter Reed Army Med Ctr, Washington, DC 20307 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Roswell Park Cancer Institute; Arizona Center Cancer Care; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Laiyemo, AO (corresponding author), NCI, Div Canc Prevent, Biometry Res Grp, Canc Prevent Fellowship Program, 6130 Execut Blvd,Suite 3121, Bethesda, MD 20892 USA.	laiyemoa@mail.nih.gov	Murphy, Gwen/GQB-3897-2022; Murphy, Gwen/AFR-8275-2022; Murphy, Gwen/G-7443-2015	Murphy, Gwen/0000-0003-0118-5337; Caan, Bette/0000-0002-5803-310X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008876] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		*ASGE, 1997, ASGE PUBL, V1030; AUDET AM, 1990, ANN INTERN MED, V113, P709, DOI 10.7326/0003-4819-113-9-709; Avidan B, 2002, AM J GASTROENTEROL, V97, P1524, DOI 10.1016/S0002-9270(02)04157-6; Beck DE, 2000, DIS COLON RECTUM, V43, P1092; Blumberg D, 2000, DIS COLON RECTUM, V43, P1084, DOI 10.1007/BF02236554; Bonithon-Kopp C, 2004, DIS COLON RECTUM, V47, P323, DOI 10.1007/s10350-003-0054-1; Boolchand V, 2006, ANN INTERN MED, V145, P654, DOI 10.7326/0003-4819-145-9-200611070-00007; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Jacobs ET, 2007, CLIN GASTROENTEROL H, V5, P982, DOI 10.1016/j.cgh.2007.03.022; Jonkers D, 2006, EUR J CANCER PREV, V15, P202, DOI 10.1097/01.cej.0000195710.56825.b1; Klabunde CN, 2003, PREV MED, V36, P352, DOI 10.1016/S0091-7435(02)00066-X; Lanza E, 1996, CANCER EPIDEM BIOMAR, V5, P385; Lieberman DA, 2000, GASTROENTEROLOGY, V118, P619, DOI 10.1016/S0016-5085(00)70269-1; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Lloyd-Jones DM, 2006, ANN INTERN MED, V145, P35, DOI 10.7326/0003-4819-145-1-200607040-00129; Martinez ME, 2001, GASTROENTEROLOGY, V120, P1077, DOI 10.1053/gast.2001.23247; Merritt TA, 1999, J EVAL CLIN PRACT, V5, P169, DOI 10.1046/j.1365-2753.1999.00185.x; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; NEUGUT AI, 1995, GASTROENTEROLOGY, V108, P402, DOI 10.1016/0016-5085(95)90066-7; Noshirwani KC, 2000, GASTROINTEST ENDOSC, V51, P433, DOI 10.1016/S0016-5107(00)70444-5; Nusko G, 2002, GUT, V51, P424, DOI 10.1136/gut.51.3.424; Ohman EM, 2000, JAMA-J AM MED ASSOC, V284, P876, DOI 10.1001/jama.284.7.876; Saini S, 2005, GASTROENTEROLOGY, V128, pA97; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Schatzkin A, 1996, CANCER EPIDEM BIOMAR, V5, P375; van Stolk RU, 1998, GASTROENTEROLOGY, V115, P13, DOI 10.1016/S0016-5085(98)70359-2; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; Yang G, 1998, J NATL CANCER I, V90, P1661, DOI 10.1093/jnci/90.21.1661; YU B, 2008, IN PRESS COMPUT METH	35	87	89	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2008	148	6					419	426		10.7326/0003-4819-148-6-200803180-00004	http://dx.doi.org/10.7326/0003-4819-148-6-200803180-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279KT	18347350				2022-12-28	WOS:000254354800002
J	Melzer, D; Hogarth, S; Liddell, K; Ling, T; Sanderson, S; Zimmern, RL				Melzer, David; Hogarth, Stuart; Liddell, Katherine; Ling, Tom; Sanderson, Simon; Zimmern, Ron L.			Genetic tests for common diseases: new insights, old concerns	BRITISH MEDICAL JOURNAL			English	Editorial Material							MACULAR DEGENERATION; METAANALYSIS; ASSOCIATION; AGE; CANCER		[Melzer, David] Univ Exeter, Peninsula Med Sch, Exeter EX1 2LU, Devon, England; [Hogarth, Stuart] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England; [Liddell, Katherine] Univ Cambridge, Cambridge Fac Law, Cambridge CB2 1TN, England; [Ling, Tom] RAND Europe, Cambridge, England; [Sanderson, Simon; Zimmern, Ron L.] PHG Fdn, Cambridge, England	University of Exeter; University of Cambridge; University of Cambridge; RAND Corporation; RAND Europe	Melzer, D (corresponding author), Univ Exeter, Peninsula Med Sch, Exeter EX1 2LU, Devon, England.	david.melzer@pms.ac.uk		Melzer, David/0000-0002-0170-3838; Hogarth, Stuart/0000-0001-6796-8815	NATIONAL INSTITUTE ON AGING [R01AG024233] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG24233-01] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Damani SB, 2007, J AM COLL CARDIOL, V50, P1933, DOI 10.1016/j.jacc.2007.07.062; De Silva NMG, 2007, DIABETIC MED, V24, P1067, DOI 10.1111/j.1464-5491.2007.02253.x; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; HARMON A, 2007, NY TIMES        1117; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hogarth S, 2007, FOOD DRUG LAW J, V62, P831; Lenzer J, 2007, BRIT MED J, V335, P579, DOI 10.1136/bmj.39342.667176.DB; MATHEWS AW, 2008, WALL STREET J   0104; Melzer D, 2007, MECH AGEING DEV, V128, P370, DOI 10.1016/j.mad.2007.03.005; Melzer D, 2007, J GERONTOL A-BIOL, V62, P301, DOI 10.1093/gerona/62.3.301; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Murphy JA, 2004, HUM MUTAT, V24, P296, DOI 10.1002/humu.20083; *OECD, 2006, DRAFT GUID QUAL ASS; Palmer CNA, 2007, J ALLERGY CLIN IMMUN, V120, P64, DOI 10.1016/j.jaci.2007.04.001; Suchard MA, 1999, BRIT J GEN PRACT, V49, P45; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; van der Cammen TJM, 2004, J AM GERIATR SOC, V52, P2110, DOI 10.1111/j.1532-5415.2004.52573.x; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Zeggini E, 2007, DIABETIC MED, V24, P1181, DOI 10.1111/j.1464-5491.2007.02274.x	24	38	39	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 15	2008	336	7644					590	593		10.1136/bmj.39506.601053.BE	http://dx.doi.org/10.1136/bmj.39506.601053.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18340074	Green Published			2022-12-28	WOS:000254364500031
J	Christofk, HR; Vander Heiden, MG; Wu, N; Asara, JM; Cantley, LC				Christofk, Heather R.; Vander Heiden, Matthew G.; Wu, Ning; Asara, John M.; Cantley, Lewis C.			Pyruvate kinase M2 is a phosphotyrosine-binding protein	NATURE			English	Article							ALLOSTERIC REGULATION; RECEPTOR KINASE; CELL-GROWTH; PHOSPHORYLATION; INHIBITION; ENZYMES	Growth factors stimulate cells to take up excess nutrients and to use them for anabolic processes. The biochemical mechanism by which this is accomplished is not fully understood but it is initiated by phosphorylation of signalling proteins on tyrosine residues. Using a novel proteomic screen for phosphotyrosine- binding proteins, we have made the observation that an enzyme involved in glycolysis, the human M2 ( fetal) isoform of pyruvate kinase ( PKM2), binds directly and selectively to tyrosine- phosphorylated peptides. We show that binding of phosphotyrosine peptides to PKM2 results in release of the allosteric activator fructose- 1,6- bisphosphate, leading to inhibition of PKM2 enzymatic activity. We also provide evidence that this regulation of PKM2 by phosphotyrosine signalling diverts glucose metabolites from energy production to anabolic processes when cells are stimulated by certain growth factors. Collectively, our results indicate that expression of this phosphotyrosine- binding form of pyruvate kinase is critical for rapid growth in cancer cells.	[Christofk, Heather R.; Vander Heiden, Matthew G.; Wu, Ning; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center	Cantley, LC (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	lcantley@hms.harvard.edu	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Christofk, Heather/0000-0002-8662-4425	NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009172] Funding Source: Medline; NIGMS NIH HHS [R01 GM056203] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; PRESEK P, 1988, FEBS LETT, V242, P194, DOI 10.1016/0014-5793(88)81014-7; REISS N, 1986, BIOCHEM J, V239, P691, DOI 10.1042/bj2390691; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; SALE EM, 1987, J CELL BIOCHEM, V33, P15, DOI 10.1002/jcb.240330103; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	17	738	790	5	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					181	U27		10.1038/nature06667	http://dx.doi.org/10.1038/nature06667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337815				2022-12-28	WOS:000253925600033
J	Herbst, W; Hamilton, CM; Leduc, K; Winn, JN; Johns-Krull, CM; Mundt, R; Ibrahimov, M				Herbst, William; Hamilton, Catrina M.; LeDuc, Katherine; Winn, Joshua N.; Johns-Krull, Christopher M.; Mundt, Reinhard; Ibrahimov, Mansur			Reflected light from sand grains in the terrestrial zone of a protoplanetary disk	NATURE			English	Article							KH 15D; MYSTERIOUS ECLIPSES; REGION; STAR; HISTORY; ASIAGO	In the standard model of terrestrial planet formation, the first step in the process is for interstellar dust to coagulate within a protoplanetary disk surrounding a young star, forming large grains that settle towards the disk plane(1). Interstellar grains of typical size similar to 0.1 mm are expected to grow to millimetre- ( sand), centimetre( pebble) or even metre- sized ( boulder) objects rather quickly(2). Unfortunately, such evolved disks are hard to observe because the ratio of surface area to volume of their constituents is small. We readily detect dust around young objects known as 'classical' T Tauri stars, but there is little or no evidence of it in the slightly more evolved 'weak- line' systems(3). Here we report observations of a 3-Myr- old star, which show that grains have grown to about millimetre size or larger in the terrestrial zone ( within similar to 3 AU) of this star. The fortuitous geometry of the KH 15D binary star system allows us to infer that, when both stars are occulted by the surrounding disk, it appears as a nearly edge- on ring illuminated by one of the central binary components. This work complements the study of terrestrial zones of younger disks that have been recently resolved by interferometry(4-6).	[Herbst, William; LeDuc, Katherine] Wesleyan Univ, Dept Astron, Middletown, CT 06459 USA; [Hamilton, Catrina M.] Dickinson Coll, Dept Phys & Astron, Carlisle, PA 17013 USA; [Winn, Joshua N.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Johns-Krull, Christopher M.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Mundt, Reinhard] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Ibrahimov, Mansur] Uzbek Acad Sci, Ulugh Beg Astron Inst, Tashkent 700052, Uzbekistan	Wesleyan University; Dickinson College; Massachusetts Institute of Technology (MIT); Rice University; Max Planck Society; Academy of Sciences of Uzbekistan; Ulugh Beg Astronomical Institute (UBAI)	Herbst, W (corresponding author), Wesleyan Univ, Dept Astron, Middletown, CT 06459 USA.	wherbst@wesleyan.edu	Ibrahimov, Mansur/E-6665-2014					Agol E, 2004, ASTROPHYS J, V600, P781, DOI 10.1086/379893; ARTYMOWICZ P, 1994, ASTROPHYS J, V421, P651, DOI 10.1086/173679; Boss A. P., 1996, CHONDRULES PROTOPLAN, V27, P257; BURBINE TH, 1994, P IAU S, V160, P255; Chiang EI, 2004, ASTROPHYS J, V607, P913, DOI 10.1086/383522; DOMINIK C, 2007, PROTOSTARS PLANETS, V5, P783; Eisner JA, 2007, NATURE, V447, P562, DOI 10.1038/nature05867; Golimowski DA, 2006, ASTRON J, V131, P3109, DOI 10.1086/503801; Hamilton CM, 2005, ASTRON J, V130, P1896, DOI 10.1086/432667; Hamilton CM, 2003, ASTROPHYS J, V591, pL45, DOI 10.1086/377039; Hamilton CM, 2001, ASTROPHYS J, V554, pL201, DOI 10.1086/321707; Herbst W, 2002, PUBL ASTRON SOC PAC, V114, P1167, DOI 10.1086/344205; Isella A, 2006, ASTRON ASTROPHYS, V451, P951, DOI 10.1051/0004-6361:20054647; Johnson JA, 2005, ASTRON J, V129, P1978, DOI 10.1086/428597; Johnson JA, 2004, ASTRON J, V128, P1265, DOI 10.1086/422735; Johnson JA, 2004, ASTRON J, V127, P2344, DOI 10.1086/382520; Kearns KE, 1998, ASTRON J, V116, P261, DOI 10.1086/300426; Kusakabe N, 2005, ASTROPHYS J, V632, pL139, DOI 10.1086/497912; Natta A., 2007, PROTOSTARS PLANETS, VV, P767; Tokunaga AT, 2004, ASTROPHYS J, V601, pL91, DOI 10.1086/382701; Winn JN, 2006, ASTROPHYS J, V644, P510, DOI 10.1086/503417; Winn JN, 2004, ASTROPHYS J, V603, pL45, DOI 10.1086/383089; Wolk SJ, 1996, ASTRON J, V111, P2066, DOI 10.1086/117942	24	19	19	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2008	452	7184					194	197		10.1038/nature06671	http://dx.doi.org/10.1038/nature06671			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337817	Green Submitted			2022-12-28	WOS:000253925600035
J	Yeh, JH; Sidhu, SS; Chan, AC				Yeh, Jung-Hua; Sidhu, Sachdev S.; Chan, Andrew C.			Regulation of a late phase of T cell polarity and effector functions by Crtam	CELL			English	Article							IMMUNOLOGICAL SYNAPSE; NK-CELL; RECEPTOR; COMPLEXES; SCRIBBLE; CD4(+); NECTIN; TH1; PROLIFERATION; TRANSCRIPTION	Spatial organization of cellular proteins plays an important role in establishment of cellular polarity to regulate cell division, differentiation, migration, and organogenesis. Activation of T cells by antigen-presenting cells (APCs) results in the formation of an immunological synapse (IS), assembly of a signaling scaffold at the T cell receptor (TCR) contact, cytoskeletal reorganization, and generation of second messengers within the first hours following intercellular contact. We demonstrate here that Crtam (class-I MHC-restricted T-cell associated molecule), an immunoglobulin-superfamily transmembrane protein, coordinates a signaling complex anchored by the Scrib polarity protein to establish a later phase of T cell polarity on a subset of CD4(+) T cells > 6 hours following activation. Maintenance of this late cellular polarity results in the ability of CD4(+) Crtam(+) T cells to selectively produce more IFN gamma and IL22. Crtam engagement thus modulates signals many hours beyond the initial activation event and dynamically influences the adaptive immune response.	[Yeh, Jung-Hua; Chan, Andrew C.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Sidhu, Sachdev S.] Genentech Inc, Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Chan, AC (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	acc@gene.com	YEH, JUNG-HUA/I-6084-2017					Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Du Pasquier L, 2004, CR BIOL, V327, P591, DOI 10.1016/j.crvi.2004.04.004; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Fuchs A, 2006, SEMIN CANCER BIOL, V16, P359, DOI 10.1016/j.semcancer.2006.07.002; GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Holzer U, 2003, J IMMUNOL, V170, P1218, DOI 10.4049/jimmunol.170.3.1218; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Kennedy J, 2000, J LEUKOCYTE BIOL, V67, P725, DOI 10.1002/jlb.67.5.725; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; KUPFER A, 1984, J IMMUNOL, V133, P2762; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; LEZZI G, 1999, EUR J IMMUNOL, V29, P4092; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Nagasaka K, 2006, CANCER SCI, V97, P1217, DOI 10.1111/j.1349-7006.2006.00315.x; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	38	87	92	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					846	859		10.1016/j.cell.2008.01.013	http://dx.doi.org/10.1016/j.cell.2008.01.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329370	Bronze			2022-12-28	WOS:000253818000021
J	Ives, AR; Einarsson, A; Jansen, VAA; Gardarsson, A				Ives, Anthony R.; Einarsson, Arni; Jansen, Vincent A. A.; Gardarsson, Arnthor			High-amplitude fluctuations and alternative dynamical states of midges in Lake Myvatn	NATURE			English	Article							POPULATION-DYNAMICS; DIPTERA; CHAOS; PREDATORS; STABILITY; SYSTEMS; LIMITS	Complex dynamics are often shown by simple ecological models(1,2) and have been clearly demonstrated in laboratory(3,4) and natural systems(5-9). Yet many classes of theoretically possible dynamics are still poorly documented in nature. Here we study long- term time- series data of a midge, Tanytarsus gracilentus ( Diptera: Chironomidae), in Lake Myvatn, Iceland. The midge undergoes density fluctuations of almost six orders of magnitude. Rather than regular cycles, however, these fluctuations have irregular periods of 4 - 7 years, indicating complex dynamics. We fit three consumer - resource models capable of qualitatively distinct dynamics to the data. Of these, the best- fitting model shows alternative dynamical states in the absence of environmental variability; depending on the initial midge densities, the model shows either fluctuations around a fixed point or high- amplitude cycles. This explains the observed complex population dynamics: high-amplitude but irregular fluctuations occur because stochastic variability causes the dynamics to switch between domains of attraction to the alternative states. In the model, the amplitude of fluctuations depends strongly on minute resource subsidies into the midge habitat. These resource subsidies may be sensitive to human- caused changes in the hydrology of the lake, with human impacts such as dredging leading to higher- amplitude fluctuations. Tanytarsus gracilentus is a key component of the Myvatn ecosystem, representing two- thirds of the secondary productivity of the lake(10) and providing vital food resources to fish and to breeding bird populations(11,12). Therefore the high- amplitude, irregular fluctuations in midge densities generated by alternative dynamical states dominate much of the ecology of the lake.	[Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Einarsson, Arni; Gardarsson, Arnthor] Univ Iceland, Myvatn Res Stn, IS-101 Reykjavik, Iceland; [Einarsson, Arni; Gardarsson, Arnthor] Univ Iceland, Inst Biol, IS-101 Reykjavik, Iceland; [Jansen, Vincent A. A.] Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England	University of Wisconsin System; University of Wisconsin Madison; University of Iceland; University of Iceland; University of London; Royal Holloway University London	Ives, AR (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	arives@wisc.edu	Jansen, Vincent A A/C-8353-2009; Ives, Anthony/A-5698-2008	Ives, Anthony/0000-0001-9375-9523; Jansen, Vincent A.A./0000-0002-6518-2090				Becks L, 2005, NATURE, V435, P1226, DOI 10.1038/nature03627; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Carpenter S R, 2003, REGIME SHIFTS LAKE E; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Dwyer G, 2004, NATURE, V430, P341, DOI 10.1038/nature02569; Einarsson A, 2002, J ANIM ECOL, V71, P832, DOI 10.1046/j.1365-2656.2002.00648.x; Gardarsson A, 2004, AQUAT ECOL, V38, P285, DOI 10.1023/B:AECO.0000032058.83651.2c; Gardarsson A, 2004, AQUAT ECOL, V38, P209, DOI 10.1023/B:AECO.0000032051.14118.e1; Gudbergsson G, 2004, AQUAT ECOL, V38, P271, DOI 10.1023/B:AECO.0000032100.28896.81; HANSKI I, 1993, NATURE, V364, P232, DOI 10.1038/364232a0; Harvey A.C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; HASTINGS A, 1993, ANNU REV ECOL SYST, V24, P1, DOI 10.1146/annurev.es.24.110193.000245; Henson SM, 2002, OIKOS, V98, P17, DOI 10.1034/j.1600-0706.2002.980102.x; Ingvason HR, 2004, AQUAT ECOL, V38, P231, DOI 10.1023/B:AECO.0000032053.67992.03; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Ives AR, 2000, ECOLOGY, V81, P3330, DOI 10.1890/0012-9658(2000)081[3330:PMEIPP]2.0.CO;2; JANSEN VAA, 1995, OIKOS, V74, P172, DOI 10.2307/3545688; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; King AA, 1999, J MATH BIOL, V39, P439, DOI 10.1007/s002850050174; Kjaran SP, 2004, AQUAT ECOL, V38, P145, DOI 10.1023/B:AECO.0000032049.94886.5a; KLEBANOFF A, 1994, J MATH BIOL, V32, P427, DOI 10.1007/BF00160167; LINDEGAARD C, 1979, OIKOS, V32, P202, DOI 10.2307/3544228; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; McGovern TH, 2006, ENVIRON ARCHAEOL, V11, P187, DOI 10.1179/174963106x123205; NOYMEIR I, 1975, J ECOL, V63, P459, DOI 10.2307/2258730; Persson L, 2007, SCIENCE, V316, P1743, DOI 10.1126/science.1141412; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Turchin Peter, 2003, Monographs in Population Biology, V35, pi	30	79	82	2	88	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					84	87		10.1038/nature06610	http://dx.doi.org/10.1038/nature06610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322533				2022-12-28	WOS:000253671900051
J	Stepens, A; Logina, I; Liguts, V; Aldins, P; Eksteina, I; Platkajis, A; Martinsone, I; Terauds, E; Rozentale, B; Donaghy, M				Stepens, Ainars; Logina, Inara; Liguts, Viesturs; Aldins, Pauls; Eksteina, Ilze; Platkajis, Ardis; Martinsone, Inese; Terauds, Elmars; Rozentale, Baiba; Donaghy, Michael			A Parkinsonian syndrome in methcathinone users and the role of manganese	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INITIAL MANIFESTATION; MOVEMENT-DISORDERS; T1-WEIGHTED MRI; HIV-INFECTION; LIVER-FAILURE; EXPOSURE; AIDS; ENCEPHALOPATHY; HYPERINTENSITY; INTOXICATION	Background: A distinctive extrapyramidal syndrome has been observed in intravenous methcathinone (ephedrone) users in Eastern Europe and Russia. Methods: We studied 23 adults in Latvia who had extrapyramidal symptoms and who had injected methcathinone for a mean (+/-SD) of 6.7+/-5.1 years. The methcathinone was manufactured under home conditions by potassium permanganate oxidation of ephedrine or pseudoephedrine. All patients were positive for hepatitis C virus, and 20 were also positive for the human immunodeficiency virus (HIV). Results: The patients reported that the onset of their first neurologic symptoms (gait disturbance in 20 and hypophonia in 3) occurred after a mean of 5.8+/-4.5 years of methcathinone use. At the time of neurologic evaluation, all 23 patients had gait disturbance and difficulty walking backward; 11 patients were falling daily, and 1 of these patients used a wheelchair. Twenty-one patients had hypophonic speech in addition to gait disturbance, and one of these patients was mute. No patient reported decline in cognitive function. T-1-weighted magnetic resonance imaging (MRI) showed symmetric hyperintensity in the globus pallidus and in the substantia nigra and innominata in all 10 active methcathinone users. Among the 13 former users (2 to 6 years had passed since the last use), lesser degrees of change in the MRI signal were noted. Whole-blood manganese levels (normal level, <209 nmol per liter) averaged 831 nmol per liter (range, 201 to 2102) in the active methcathinone users and 346 nmol per liter (range, 114 to 727) in former users. The neurologic deficits did not resolve after patients discontinued methcathinone use. Conclusions: Our observation of a distinctive extrapyramidal syndrome, changes in the MRI signal in the basal ganglia, and elevated blood manganese levels in methcathinone users suggests that manganese in the methcathinone solution causes a persistent neurologic disorder.	[Donaghy, Michael] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England; [Stepens, Ainars; Logina, Inara] Riga Stradins Univ, Dept Neurol, Riga, Latvia; [Liguts, Viesturs] Riga Stradins Univ, Dept Anesthesiol & Intens Care, Riga, Latvia; [Aldins, Pauls; Eksteina, Ilze; Rozentale, Baiba] Riga Stradins Univ, Dept Class Infectol TB & AIDS, Riga, Latvia; [Platkajis, Ardis] Riga Stradins Univ, Dept Radiol, Riga, Latvia; [Martinsone, Inese] Riga Stradins Univ, Inst Occupat & Environm Hlth, Riga, Latvia; [Terauds, Elmars] Riga Stradins Univ, Dept Psychiat & Addict, Riga, Latvia	University of Oxford; Riga Stradins University; Riga Stradins University; Riga Stradins University; Riga Stradins University; Riga Stradins University; Riga Stradins University	Donaghy, M (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Level 3,West Wing, Oxford OX3 9DU, England.	joanna.wilkinson@clneuro.ox.ac.uk	Stepens, Ainars/C-7751-2018; Stepens, Ainars/C-7746-2018; Mārtiņsone, Inese/C-5668-2017; Platkajis, Ardis/AFS-1138-2022	Stepens, Ainars/0000-0002-6621-0196; Stepens, Ainars/0000-0002-6621-0196; Mārtiņsone, Inese/0000-0001-6923-5316; 				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; Bader M, 1999, INT ARCH OCC ENV HEA, V72, P521, DOI 10.1007/s004200050410; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P293, DOI 10.1081/CLT-100102427; Bouffard JP, 2003, MOVEMENT DISORD, V18, P1354, DOI 10.1002/mds.10546; Burkhard PR, 2003, ARCH NEUROL-CHICAGO, V60, P521, DOI 10.1001/archneur.60.4.521; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; COOK DG, 1974, ARCH NEUROL-CHICAGO, V30, P59, DOI 10.1001/archneur.1974.00490310061010; Cox G., 2003, ADV PSYCHIAT TREATME, V9, P456, DOI [10.1192/apt.9.6.456, DOI 10.1192/APT.9.6.456]; de Mattos JP, 2002, ARQ NEURO-PSIQUIAT, V60, P525, DOI 10.1590/S0004-282X2002000400002; EJIMA A, 1992, LANCET, V339, P426, DOI 10.1016/0140-6736(92)90109-G; EMERSON TS, 1993, ANN EMERG MED, V22, P1897, DOI 10.1016/S0196-0644(05)80419-6; EMERSON TS, 1994, ANN EMERG MED, V23, P790; Fahn S, 1987, RECENT DEV PARKINSON; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gillingham FJ., 1969, 3 S PARK DIS; Gygi MP, 1997, J PHARMACOL EXP THER, V283, P1350; Hersh BP, 2001, NEUROLOGY, V56, P278, DOI 10.1212/WNL.56.2.278; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUANG CC, 1993, NEUROLOGY, V43, P1479, DOI 10.1212/WNL.43.8.1479; Jankovic J, 2005, NEUROLOGY, V64, P2021, DOI 10.1212/01.WNL.0000166916.40902.63; Josephs KA, 2005, NEUROLOGY, V64, P2033, DOI 10.1212/01.WNL.0000167411.93483.A1; Kim YH, 2004, IND HEALTH, V42, P111, DOI 10.2486/indhealth.42.111; Klos KJ, 2006, NEUROLOGY, V67, P1984, DOI 10.1212/01.wnl.0000247037.37807.76; Koller WC, 2004, NEUROLOGY, V62, P730, DOI 10.1212/01.WNL.0000113726.34734.15; Koutsilieri E, 2002, J NEURAL TRANSM, V109, P767, DOI 10.1007/s007020200063; Levin OS, 2005, Z NEVROL PSIKHIATRII, V105, P12; Maggi P, 2000, NEUROL SCI, V21, P173, DOI 10.1007/s100720070093; McMillan Grant, 2005, Toxicol Rev, V24, P237, DOI 10.2165/00139709-200524040-00004; Mirsattari SM, 1998, MOVEMENT DISORD, V13, P684, DOI 10.1002/mds.870130413; Murakami T, 2000, INTERNAL MED, V39, P1111, DOI 10.2169/internalmedicine.39.1111; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; PUJOL A, 1993, NEUROLOGY, V43, P65, DOI 10.1212/WNL.43.1_Part_1.65; Racette BA, 2001, NEUROLOGY, V56, P8, DOI 10.1212/WNL.56.1.8; Rose C, 1999, GASTROENTEROLOGY, V117, P640, DOI 10.1016/S0016-5085(99)70457-9; Schaumburg, 2006, NEUROLOGY, V67, P1902; Schaumburg HH, 2006, NEUROLOGY, V67, P322, DOI 10.1212/01.wnl.0000225179.21282.58; Shulman LM, 2003, NEUROLOGY, V60, P519, DOI 10.1212/WNL.60.3.519; Tanaka M, 2000, MOVEMENT DISORD, V15, P1032, DOI 10.1002/1531-8257(200009)15:5<1032::AID-MDS1049>3.0.CO;2-X; Tse W, 2004, PARKINSONISM RELAT D, V10, P323, DOI 10.1016/j.parkreldis.2004.03.001; VANLOON JC, 1986, CHEM ANAL, P176; Wu A.H.B., 2006, TIETZ CLIN GUIDE LAB; ZHINGEL KY, 1991, J FORENSIC SCI, V36, P915	42	136	140	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					1009	1017		10.1056/NEJMoa072488	http://dx.doi.org/10.1056/NEJMoa072488			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18322282				2022-12-28	WOS:000253644700005
J	Xu, Y; Feng, L; Jeffrey, PD; Shi, YG; Morel, FMM				Xu, Yan; Feng, Liang; Jeffrey, Philip D.; Shi, Yigong; Morel, Francois M. M.			Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms	NATURE			English	Article							ACTIVE-SITE; CRYSTAL-STRUCTURE; PROTON-TRANSFER; ENZYME; ZINC; BINDING; PHYTOPLANKTON; WATERS; CO2; IDENTIFICATION	Carbonic anhydrase, a zinc enzyme found in organisms from all kingdoms, catalyses the reversible hydration of carbon dioxide and is used for inorganic carbon acquisition by phytoplankton. In the oceans, where zinc is nearly depleted, diatoms use cadmium as a catalytic metal atom in cadmium carbonic anhydrase ( CDCA). Here we report the crystal structures of CDCA in four distinct forms: cadmium- bound, zinc- bound, metal- free and acetate- bound. Despite lack of sequence homology, CDCA is a structural mimic of a functional beta- carbonic anhydrase dimer, with striking similarity in the spatial organization of the active site residues. CDCA readily exchanges cadmium and zinc at its active site - an apparently unique adaptation to oceanic life that is explained by a stable opening of the metal coordinating site in the absence of metal. Given the central role of diatoms in exporting carbon to the deep sea, their use of cadmium in an enzyme critical for carbon acquisition establishes a remarkable link between the global cycles of cadmium and carbon.	[Morel, Francois M. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Xu, Yan] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Feng, Liang; Jeffrey, Philip D.; Shi, Yigong] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Morel, FMM (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	yshi@princeton.edu; morel@princeton.edu		Jeffrey, Philip/0000-0002-4351-5341; Shi, Yigong/0000-0003-2030-168X				AHNER BA, 1994, P NATL ACAD SCI USA, V91, P8433, DOI 10.1073/pnas.91.18.8433; Alber BE, 1999, BIOCHEMISTRY-US, V38, P13119, DOI 10.1021/bi9828876; Badger M, 2003, PHOTOSYNTH RES, V77, P83, DOI 10.1023/A:1025821717773; BOYLE EA, 1976, NATURE, V263, P42, DOI 10.1038/263042a0; BRULAND KW, 1978, LIMNOL OCEANOGR, V23, P618, DOI 10.4319/lo.1978.23.4.0618; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; COLEMAN JE, 1965, BIOCHEMISTRY-US, V4, P2644, DOI 10.1021/bi00888a014; COLEMAN JE, 1967, NATURE, V214, P193, DOI 10.1038/214193a0; Cox EH, 2000, BIOCHEMISTRY-US, V39, P12128, DOI 10.1021/bi001416s; Cronk JD, 2006, BIOCHEMISTRY-US, V45, P4351, DOI 10.1021/bi052272q; Ejnik J, 1999, J BIOL INORG CHEM, V4, P784, DOI 10.1007/s007750050351; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fisher SZ, 2007, BIOCHEMISTRY-US, V46, P3803, DOI 10.1021/bi602620k; FRIDBORG K, 1967, J MOL BIOL, V25, P505, DOI 10.1016/0022-2836(67)90202-1; Gans P, 1996, TALANTA, V43, P1739, DOI 10.1016/0039-9140(96)01958-3; HAKANSSON K, 1992, J MOL BIOL, V227, P1192, DOI 10.1016/0022-2836(92)90531-N; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KANNAN KK, 1971, COLD SPRING HARB SYM, V36, P221, DOI 10.1101/SQB.1972.036.01.030; Kimber MS, 2000, EMBO J, V19, P1407, DOI 10.1093/emboj/19.7.1407; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuss J, 1999, MAR CHEM, V68, P71, DOI 10.1016/S0304-4203(99)00066-3; Lane TW, 2000, P NATL ACAD SCI USA, V97, P4627, DOI 10.1073/pnas.090091397; Lane TW, 2005, NATURE, V435, P42, DOI 10.1038/435042a; LILJAS A, 1972, NATURE-NEW BIOL, V235, P131, DOI 10.1038/newbio235131a0; Liu JB, 2005, BIOCHEMISTRY-US, V44, P5159, DOI 10.1021/bi0476275; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mitsuhashi S, 2000, J BIOL CHEM, V275, P5521, DOI 10.1074/jbc.275.8.5521; MOREL FMM, 1994, NATURE, V369, P740, DOI 10.1038/369740a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Okoniewska M, 2000, BIOCHEM J, V349, P169, DOI 10.1042/0264-6021:3490169; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2007, ENVIRON MICROBIOL, V9, P403, DOI 10.1111/j.1462-2920.2006.01151.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P2045, DOI 10.1021/bi00551a006; PRICE NM, 1990, NATURE, V344, P658, DOI 10.1038/344658a0; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Roberts SB, 1997, J PHYCOL, V33, P845, DOI 10.1111/j.0022-3646.1997.00845.x; Satoh D, 2001, PLANT PHYSIOL, V126, P1459, DOI 10.1104/pp.126.4.1459; Sawaya MR, 2006, J BIOL CHEM, V281, P7546, DOI 10.1074/jbc.M510464200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Sotoj AR, 2006, APPL ENVIRON MICROB, V72, P5500, DOI 10.1128/AEM.00237-06; Strop P, 2001, J BIOL CHEM, V276, P10299, DOI 10.1074/jbc.M009182200; TIBELL L, 1984, BIOCHIM BIOPHYS ACTA, V788, P110, DOI 10.1016/0167-4838(84)90302-9; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200	47	398	406	16	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					56	U3		10.1038/nature06636	http://dx.doi.org/10.1038/nature06636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322527				2022-12-28	WOS:000253671900045
J	Kirschner, M				Kirschner, Marc			Profile - Bruce Alberts, Science's new editor	SCIENCE			English	Biographical-Item									Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School	Kirschner, M (corresponding author), Harvard Univ, Sch Med, Boston, MA 02215 USA.	marc@hms.harvard.edu							0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1199	1199		10.1126/science.1155869	http://dx.doi.org/10.1126/science.1155869			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309070				2022-12-28	WOS:000253530600026
J	Orkin, SH; Zon, LI				Orkin, Stuart H.; Zon, Leonard I.			Hematopoiesis: An evolving paradigm for stem cell biology	CELL			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; MOUSE EMBRYO; TRANSCRIPTION FACTORS; DEFINITIVE HEMATOPOIESIS; LINEAGE COMMITMENT; ZEBRAFISH EMBRYOS; YOLK-SAC; ADULT HEMATOPOIESIS; ENDOTHELIAL-CELLS	Establishment and maintenance of the blood system relies on self-renewing hematopoietic stem cells (HSCs) that normally reside in small numbers in the bone marrow niche of adult mammals. This Review describes the developmental origins of HSCs and the molecular mechanisms that regulate lineage-specific differentiation. Studies of hematopoiesis provide critical insights of general relevance to other areas of stem cell biology including the role of cellular interactions in development and tissue homeostasis, lineage programming and reprogramming by transcription factors, and stage- and age-specific differences in cellular phenotypes.	[Orkin, Stuart H.; Zon, Leonard I.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.; Zon, Leonard I.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Stem Cell Inst, Boston, MA 02115 USA; [Orkin, Stuart H.; Zon, Leonard I.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259, R01HL075735, P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL032259, P01 HL032262, R01 HL032259-27, R01 HL075735, R01 HL075735-06, P01 HL032262-27] Funding Source: Medline; NIDDK NIH HHS [P30 DK049216, P30 DK049216-15] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alden G.S., 2007, NAT REPORTS STEM CEL, DOI [DOI 10.1038/STEMCELLS.2007.42, 10.1038/stemcells.2007.22, DOI 10.1038/STEMCELLS.2007.22]; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Brown RC, 2002, MOL CELL BIOL, V22, P161, DOI 10.1128/MCB.22.1.161-170.2002; Bultman SJ, 2005, GENE DEV, V19, P2849, DOI 10.1101/gad.1364105; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Choi K, 1998, DEVELOPMENT, V125, P725; Ciau-Uitz A, 2000, CELL, V102, P787, DOI 10.1016/S0092-8674(00)00067-2; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Dahl R, 2007, J BIOL CHEM, V282, P6473, DOI 10.1074/jbc.M607613200; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Delassus S, 1996, IMMUNITY, V4, P97, DOI 10.1016/S1074-7613(00)80302-7; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Ema M, 2003, TRENDS CARDIOVAS MED, V13, P254, DOI 10.1016/S1050-1738(03)00105-1; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Galloway JL, 2003, CURR TOP DEV BIOL, V53, P139, DOI 10.1016/S0070-2153(03)53004-6; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Hart DO, 2007, NATURE, V450, P1082, DOI 10.1038/nature06349; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Inman KE, 2007, GENESIS, V45, P237, DOI 10.1002/dvg.20281; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jin H, 2007, BLOOD, V109, P5208, DOI 10.1182/blood-2007-01-069005; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lane MC, 2002, DEV BIOL, V248, P52, DOI 10.1006/dbio.2002.0717; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martinez J, 2007, GENE DEV, V21, P1983, DOI 10.1101/gad.1591407; Maslova M. N., 1993, Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, V29, P211; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Orkin SH, 2003, IMMUNITY, V19, P633, DOI 10.1016/S1074-7613(03)00302-9; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Palis J, 2001, P NATL ACAD SCI USA, V98, P4528, DOI 10.1073/pnas.071002398; Pardanaud L, 1999, DEVELOPMENT, V126, P617; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Perry JM, 2007, CELL, V129, P1045, DOI 10.1016/j.cell.2007.05.053; Porcher C, 1999, DEVELOPMENT, V126, P4603; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Rossant J, 2007, NATURE, V448, P260, DOI 10.1038/448260a; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; SALEQUE S, 2007, COREST MOL CELL, V27, P562; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Turpen JB, 1997, IMMUNITY, V7, P325, DOI 10.1016/S1074-7613(00)80354-4; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Villablanca EJ, 2007, J IMMUNOL, V179, P357, DOI 10.4049/jimmunol.179.1.357; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Weissman I, 1978, DIFFERENTIATION NORM, V5, P33; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yan JZ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000047; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	113	1578	1643	10	291	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					631	644		10.1016/j.cell.2008.01.025	http://dx.doi.org/10.1016/j.cell.2008.01.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295580	Green Accepted, Bronze			2022-12-28	WOS:000253817900022
J	Wu, SM; Chien, KR; Mummery, C				Wu, Sean M.; Chien, Kenneth R.; Mummery, Christine			Origins and fates of cardiovascular progenitor cells	CELL			English	Article							EMBRYONIC STEM-CELLS; BONE-MARROW; SMOOTH-MUSCLE; MYOCARDIAL-INFARCTION; DIFFERENTIATION; CARDIOMYOCYTES; HEART; MULTIPOTENT; EXPRESSION; TRANSPLANTATION	Multipotent cardiac progenitor cells are found in the fetal and adult heart of many mammalian species including humans and form as intermediates during the differentiation of embryonic stem cells. Despite similar biological properties, the molecular identities of these different cardiac progenitor cell populations appear to be distinct. Elucidating the origins and lineage relationships of these cell populations will accelerate clinical applications such as drug screening and cell therapy as well as shedding light on the pathogenic mechanisms underlying cardiac diseases.	[Mummery, Christine] Utrecht & Interuniv Cardiol Inst, Hubrecht Inst, Univ Med Ctr, NL-3584 CT Utrecht, Netherlands; [Wu, Sean M.; Chien, Kenneth R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Chien, Kenneth R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Wu, Sean M.; Chien, Kenneth R.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University	Mummery, C (corresponding author), Utrecht & Interuniv Cardiol Inst, Hubrecht Inst, Univ Med Ctr, NL-3584 CT Utrecht, Netherlands.	c.mummery@niob.knaw.nl		Wu, Sean/0000-0002-0000-3821; Mummery, Christine/0000-0002-4549-6535	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081086] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL081086, K08 HL081086-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Evans SM, 2007, SEMIN CELL DEV BIOL, V18, P153, DOI 10.1016/j.semcdb.2006.12.009; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Hudon-David F, 2007, J MOL CELL CARDIOL, V42, P991, DOI 10.1016/j.yjmcc.2007.02.009; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; KOH GY, 1995, J CLIN INVEST, V96, P2034, DOI 10.1172/JCI118251; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2007, NATURE, V446, P934, DOI 10.1038/nature05790; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Meyer N, 2000, FEBS LETT, V478, P151, DOI 10.1016/S0014-5793(00)01839-1; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Parmacek MS, 2005, CELL, V120, P295, DOI 10.1016/j.cell.2005.01.025; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; POULY J, 2008, THORAC CARDIOVASC SU, DOI DOI 10.1016/J.JTCVS.2007.10.024; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rawles Mary E., 1943, PHYSIOL ZOOL, V16, P22; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Solloway MJ, 2003, CARDIOVASC RES, V58, P264, DOI 10.1016/S0008-6363(03)00286-4; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	63	145	156	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					537	543		10.1016/j.cell.2008.02.002	http://dx.doi.org/10.1016/j.cell.2008.02.002			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295570	Bronze, Green Accepted			2022-12-28	WOS:000253817900012
J	Nadler, JW; Angelaki, DE; DeAngelis, GC				Nadler, Jacob W.; Angelaki, Dora E.; DeAngelis, Gregory C.			A neural representation of depth from motion parallax in macaque visual cortex	NATURE			English	Article							MIDDLE TEMPORAL AREA; BINOCULAR DISPARITY; STEREOSCOPIC DEPTH; CORTICAL AREA; FUNCTIONAL-PROPERTIES; EYE-MOVEMENTS; MT NEURONS; PERCEPTION; MONKEY; DISCRIMINATION	Perception of depth is a fundamental challenge for the visual system, particularly for observers moving through their environment. The brain makes use of multiple visual cues to reconstruct the three- dimensional structure of a scene. One potent cue, motion parallax, frequently arises during translation of the observer because the images of objects at different distances move across the retina with different velocities. Human psychophysical studies have demonstrated that motion parallax can be a powerful depth cue(1-5), and motion parallax seems to be heavily exploited by animal species that lack highly developed binocular vision(6-8). However, little is known about the neural mechanisms that underlie this capacity. Here we show, by using a virtual- reality system to translate macaque monkeys ( Macaca mulatta) while they viewed motion parallax displays that simulated objects at different depths, that many neurons in the middle temporal area ( area MT) signal the sign of depth ( near versus far) from motion parallax in the absence of other depth cues. To achieve this, neurons must combine visual motion with extra- retinal ( non- visual) signals related to the animal's movement. Our findings suggest a new neural substrate for depth perception and demonstrate a robust interaction of visual and non- visual cues in area MT. Combined with previous studies that implicate area MT in depth perception based on binocular disparities(9-12), our results suggest that area MT contains a more general representation of three- dimensional space that makes use of multiple cues.	[Nadler, Jacob W.; Angelaki, Dora E.; DeAngelis, Gregory C.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [DeAngelis, Gregory C.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	Washington University (WUSTL); University of Rochester	DeAngelis, GC (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	gdeangelis@cvs.rochester.edu		DeAngelis, Gregory/0000-0002-1635-1273	NEI NIH HHS [T32 EY013360, R01 EY013644-07, R01 EY013644, R01 EY017866, R01 EY017866-02] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY013360, R01EY013644, R01EY017866] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Bradshaw MF, 1996, VISION RES, V36, P3457, DOI 10.1016/0042-6989(96)00072-7; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Cao A, 2003, VISUAL NEUROSCI, V20, P77, DOI 10.1017/S0952523803201085; DeAngelis GC, 2003, J NEUROPHYSIOL, V89, P1094, DOI 10.1152/jn.00717.2002; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; ELLARD CG, 1984, BEHAV BRAIN RES, V14, P29, DOI 10.1016/0166-4328(84)90017-2; FARBER JM, 1979, J EXP PSYCHOL HUMAN, V5, P494, DOI 10.1037/0096-1523.5.3.494; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Kral K, 2003, BEHAV PROCESS, V64, P1, DOI 10.1016/S0376-6357(03)00054-8; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Nawrot M, 2003, VISION RES, V43, P1553, DOI 10.1016/S0042-6989(03)00144-5; Nawrot M, 2006, VISION RES, V46, P4709, DOI 10.1016/j.visres.2006.07.006; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Nguyenkim JD, 2003, J NEUROSCI, V23, P7117, DOI 10.1523/JNEUROSCI.23-18-07117.2003; Nover H, 2005, J NEUROSCI, V25, P10049, DOI 10.1523/JNEUROSCI.1661-05.2005; ROGERS B, 1982, VISION RES, V22, P261, DOI 10.1016/0042-6989(82)90126-2; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; Rogers B J, 1993, Rev Oculomot Res, V5, P119; ROGERS BJ, 1989, Q J EXP PSYCHOL-A, V41, P697, DOI 10.1080/14640748908402390; ROGERS S, 1992, PERCEPT PSYCHOPHYS, V52, P446, DOI 10.3758/BF03206704; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2003, J NEUROSCI, V23, P3515; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; van der Willigen RF, 2002, J COMP PHYSIOL A, V187, P997, DOI 10.1007/s00359-001-0271-9	30	69	70	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2008	452	7187					642	U10		10.1038/nature06814	http://dx.doi.org/10.1038/nature06814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18344979	Green Accepted			2022-12-28	WOS:000254567200048
J	Amin, R; Widmer, B; Prevost, AT; Schwarze, P; Cooper, J; Edge, J; Marcovecchio, L; Neil, A; Dalton, RN; Dunger, DB				Amin, Rakesh; Widmer, Barry; Prevost, A. Toby; Schwarze, Phillip; Cooper, Jason; Edge, Julie; Marcovecchio, Loredana; Neil, Andrew; Dalton, R. Neil; Dunger, David B.			Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLOMERULAR-FILTRATION-RATE; METABOLIC-CONTROL; GLYCEMIC CONTROL; NATURAL-HISTORY; NEPHROPATHY; YOUNG; MELLITUS; RETINOPATHY; PREDICTOR; CHILDREN	Objectives To describe independent predictors for the development of microalbuminuria and progression to macroalbuminuria in those with childhood onset type 1 diabetes. Design Prospective observational study with follow-up for 9.8 (SD 3.8) years. Setting Oxford regional prospective study. Participants 527 participants with a diagnosis of type 1 diabetes at mean age 8.8 (SD 4.0) years. Main outcome measures Annual measurement of glycated haemoglobin (HbA(1c)) and assessment of urinary albumin: creatinine ratio. Results Cumulative prevalence of microalbuminuria was 25.7% (95% confidence interval 21.3% to 30.1%) after 10 years of diabetes and 50.7% (40.5% to 60.9%) after 19 years of diabetes and 5182 patient years of follow-up. The only modifiable adjusted predictor for microalbuminuria was high HbA(1c) concentrations (hazard ratio per 1% rise in HbA(1c) 1.39, 1.27 to 1.52). Blood pressure and history of smoking were not predictors. Microalbuminuria was persistent in 48% of patients. Cumulative prevalence of progression from microalbuminuria to macroalbuminuria was 13.9% (12.9% to 14.9%); progression occurred at a mean age of 18.5 (5.8) years. Although the sample size was small, modifiable predictors of macroalbuminuria were higher HbA(1c) levels and both persistent and intermittent microalbuminuria hazard ratios 1.42 (1.22 to 1.78), 27.72 (7.99 to 96.12), and 8.76 (2.44 to 31.44), respectively). Conclusion In childhood onset type 1 diabetes, the only modifiable predictors were poor glycaemic control for the development of microalbuminuria and poor control and microalburninuria (both persistent and intermittent) for progression to macroalbuminuria. Risk for macroalbuminuria is similar to that observed in cohorts with adult onset disease but as it occurs in young adult life early intervention in normotensive adolescents might be needed to improve prognosis.	[Amin, Rakesh; Widmer, Barry; Schwarze, Phillip; Marcovecchio, Loredana; Dunger, David B.] Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 0QQ, England; [Prevost, A. Toby] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; [Cooper, Jason] Cambridge Inst Med Res, IDRF Wellcome Trust Diabet Inflammat Lab, Cambridge CB2 0XY, England; [Edge, Julie] John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; [Neil, Andrew] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Dalton, R. Neil] Kings Coll London, Guys Hosp, Wellchild Lab, London WC2R 2LS, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; University of Oxford; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Dunger, DB (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 0QQ, England.	dbd25@cam.ac.uk	Schwarze, Per/I-2080-2016	Dunger, Professor David/0000-0002-2566-9304; Prevost, A. Toby/0000-0003-1723-0796	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amin R, 2005, KIDNEY INT, V68, P1740, DOI 10.1111/j.1523-1755.2005.00590.x; Amin R, 2003, DIABETES CARE, V26, P1456, DOI 10.2337/diacare.26.5.1456; BANGSTAD HJ, 1993, DIABETOLOGIA, V36, P523, DOI 10.1007/BF02743268; Bojestig M, 1996, DIABETES CARE, V19, P313, DOI 10.2337/diacare.19.4.313; BORCHJOHNSEN K, 1987, BMJ-BRIT MED J, V294, P1651, DOI 10.1136/bmj.294.6588.1651; Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536; Diabetes UK, 2004, NAT PAED DIAB AUD RE; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; Gorman D, 1999, J PEDIATR-US, V134, P333, DOI 10.1016/S0022-3476(99)70459-2; Holl RW, 2003, EUR J PEDIATR, V162, P22, DOI 10.1007/s00431-002-1037-2; Hovind P, 2004, BRIT MED J, V328, P1105, DOI 10.1136/bmj.38070.450891.FE; JONER G, 1992, DIABETOLOGIA, V35, P1049, DOI 10.1007/BF02221680; Jones CA, 1998, ARCH DIS CHILD, V78, P518, DOI 10.1136/adc.78.6.518; KROLEWSKI AS, 1985, AM J MED, V78, P785, DOI 10.1016/0002-9343(85)90284-0; Nordwall M, 2004, DIABETOLOGIA, V47, P1266, DOI 10.1007/s00125-004-1431-6; Olsen BS, 2000, J DIABETES COMPLICAT, V14, P295, DOI 10.1016/S1056-8727(00)00078-7; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Reckelhoff JF, 1999, CLIN EXP PHARMACOL P, V26, P127, DOI 10.1046/j.1440-1681.1999.02996.x; RUDBERG S, 1993, DIABETOLOGIA, V36, P1309, DOI 10.1007/BF00400811; RUDBERG S, 1992, KIDNEY INT, V41, P822, DOI 10.1038/ki.1992.126; Schultz CJ, 2000, DIABETES CARE, V23, P1811, DOI 10.2337/diacare.23.12.1811; Schultz CJ, 1999, DIABETES CARE, V22, P495, DOI 10.2337/diacare.22.3.495; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; VIBERTI GC, 1982, LANCET, V2, P611; Warram JH, 2000, DIABETES, V49, P94, DOI 10.2337/diabetes.49.1.94	25	121	126	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2008	336	7646					697	701		10.1136/bmj.39478.378241.BE	http://dx.doi.org/10.1136/bmj.39478.378241.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZS	18349042	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000254675600027
J	Bakker, A; Kirwan, CB; Miller, M; Stark, CEL				Bakker, Arnold; Kirwan, C. Brock; Miller, Michael; Stark, Craig E. L.			Pattern separation in the human hippocampal CA3 and dentate gyrus	SCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; RECOGNITION MEMORY; PLACE CELLS; FMRI; COMPLEMENTARY; REPRESENTATIONS; DISTINCT	Pattern separation, the process of transforming similar representations or memories into highly dissimilar, nonoverlapping representations, is a key component of many functions ascribed to the hippocampus. Computational models have stressed the role of the hippocampus and, in particular, the dentate gyrus and its projections into the CA3 subregion in pattern separation. We used high- resolution ( 1.5- millimeter isotropic voxels) functional magnetic resonance imaging to measure brain activity during incidental memory encoding. Although activity consistent with a bias toward pattern completion was observed in CA1, the subiculum, and the entorhinal and parahippocampal cortices, activity consistent with a strong bias toward pattern separation was observed in, and limited to, the CA3/ dentate gyrus. These results provide compelling evidence of a key role of the human CA3/ dentate gyrus in pattern separation.	[Bakker, Arnold; Stark, Craig E. L.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21204 USA; [Kirwan, C. Brock] Univ Calif San Diego, Inst Neural Computat, San Diego, CA 92103 USA; [Miller, Michael] Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD USA; [Stark, Craig E. L.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA; [Stark, Craig E. L.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA	Johns Hopkins University; University of California System; University of California San Diego; Johns Hopkins University; University of California System; University of California Irvine; University of California System; University of California Irvine	Stark, CEL (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21204 USA.	cestark@uci.edu	Kirwan, Brock/B-1520-2014; Kirwan, Brock/A-8051-2009; Bakker, Arnold B./F-8494-2010	Kirwan, Brock/0000-0003-0768-1446; Bakker, Arnold B./0000-0003-1489-1847	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008171, R01EB000975] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR15241-01A1] Funding Source: Medline; NIBIB NIH HHS [R01 EB000975-04, R01 EB008171-01A1, R01 EB008171, R01 EB000975, R01 EB00975-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Hyde JS, 2001, MAGN RESON MED, V46, P114, DOI 10.1002/mrm.1166; Kirwan CB, 2007, HUM BRAIN MAPP, V28, P959, DOI 10.1002/hbm.20331; Kirwan CB, 2007, LEARN MEMORY, V14, P625, DOI 10.1101/lm.663507; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	22	647	656	3	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1640	1642		10.1126/science.1152882	http://dx.doi.org/10.1126/science.1152882			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356518	Green Accepted			2022-12-28	WOS:000254172300032
J	Uhlmann, WR; Guttmacher, AE				Uhlmann, Wendy R.; Guttmacher, Alan E.			Key Internet genetics resources for the clinician	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Uhlmann, Wendy R.] Univ Michigan, Med Genet Clin, Dept Internal Med, Ann Arbor, MI 48109 USA; [Uhlmann, Wendy R.] Univ Michigan, Med Genet Clin, Dept Human Genet, Ann Arbor, MI 48109 USA; [Guttmacher, Alan E.] NHGRI, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Uhlmann, WR (corresponding author), Univ Michigan, Med Genet Clin, Dept Internal Med, 300 N Ingalls,NI3 A03,SPC 5419, Ann Arbor, MI 48109 USA.	wuhlmann@umich.edu		Uhlmann, Wendy R./0000-0002-4243-438X				*AM COLL MED GEN, POL STAT; *AM COLL MED GEN, STAT DIR TO CONS GEN; *AM COLL MED GEN, PRACT GUID; *AM COLL MED GEN B, ACMG STAT DIR TO CON; *AM SOC AM HUM GEN, GEN TEST AD; *AM SOC HUM GEN, ASHG STAT DIR TO CON; *AM SOC HUM GEN BO, ASHG ACMG REP POINTS; *AM SOC HUM GEN SO, REP GEN AD POINTS CO; *AM SOC HUM GEN SO, ASHG STAT PROF DISCL; Guttmacher AE, 2001, ANNU REV GENOM HUM G, V2, P213, DOI 10.1146/annurev.genom.2.1.213; HIRSCHHORN K, DUTY RECONTACT; *NAT SOC GEN COUNS, POS STAT DIR TO CONS; *NAT SOC GEN COUNS, PRACT GUID; *NAT SOC GEN COUNS, 2002, POS STAT GEN TEST AD; *NAT SOC GEN COUNS, POL STAT; National Society of Genetic Counselors, 1995, POS STAT PREN CHILDH; National Society of Genetic Counselors: Position Statements, POS STAT; PFLEGER L, 2007, J GENET COUNSEL, V16, P665; *SECR ADV COMM GEN, REP COV REIMB GEN TE; Sikorski R, 1997, JAMA, V278, P1212	20	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1356	1358		10.1001/jama.299.11.1356	http://dx.doi.org/10.1001/jama.299.11.1356			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349098				2022-12-28	WOS:000254079100028
J	Bragg, R				Bragg, Rosalind			Maternal deaths and vulnerable migrants	LANCET			English	Editorial Material									Medact, Reaching Out Project, London N1 6HT, England		Bragg, R (corresponding author), Medact, Reaching Out Project, London N1 6HT, England.	rosbragg@medact.org						[Anonymous], SAV MOTH LIV REV MAT; *DEP HLTH, 2004, IMPL OV VIS HOSP CHA; Department of Health, 2004, MAT STAND NAT SERV F; Department of Health, 2007, MAT MATT CHOIC ACC C; Dorkenoo E, 2007, STAT STUDY ESTIMATE; *HOUS LORDS, 2007, TREATM AS SEEK 10 RE, V1; Oxfam and the Refugee Council, 2002, POV AS UK; *SOUTH BLACK SIST, 2006, CAN I SUPP HER	8	18	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2008	371	9616					879	881		10.1016/S0140-6736(08)60393-1	http://dx.doi.org/10.1016/S0140-6736(08)60393-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342669				2022-12-28	WOS:000254056800008
J	Milton, JC; Hill-Smith, I; Jackson, SHD				Milton, James C.; Hill-Smith, Ian; Jackson, Stephen H. D.			Prescribing for older people	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GROWING EVIDENCE BASE; ELDERLY-PATIENTS; DRUG-USE; COMMUNITY PHARMACISTS; HEART-FAILURE; POLYPHARMACY; INDICATORS; BLOCKERS; CRITERIA; QUALITY		[Milton, James C.; Jackson, Stephen H. D.] Kings Coll Hosp Fdn Trust, Clin Age Res Unit, Dept Clin Gerontol, London SE5 9PJ, England; [Hill-Smith, Ian] Churchfield Med Ctr, Stopsley Grp Practice, Luton LU2 9SB, Beds, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Milton, JC (corresponding author), Kings Coll Hosp Fdn Trust, Clin Age Res Unit, Dept Clin Gerontol, London SE5 9PJ, England.	jim_milton@hotmail.com						[Anonymous], 2007, PHARM J; [Anonymous], INT J PHARM PRACT, DOI DOI 10.1111/J.2042-7174.1998.TB00920.X; Batty G. M, 2001, BR J CLIN GOVERN, V6, P252, DOI DOI 10.1108/14664100110408608.BEERS; Batty GM, 2004, J EVAL CLIN PRACT, V10, P273, DOI 10.1111/j.1365-2753.2003.00454.x; Batty GM, 2003, AGE AGEING, V32, P292, DOI 10.1093/ageing/32.3.292; Bond C, 2000, BRIT J GEN PRACT, V50, P271; Campbell SE, 2004, AGE AGEING, V33, P110, DOI 10.1093/ageing/afh036; *DEP HLTH, 2004, PRESCR DISP COMM 199; Department of Health, 2001, MED OLD PEOPL IMPL M; Dhesi JK, 2006, BRIT J CLIN PHARMACO, V61, P521, DOI 10.1111/j.1365-2125.2006.02612.x; Edwards Rebecca F, 2003, Consult Pharm, V18, P37; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; FRANKLIN BD, 2007, INT J PHARM PRACT, V15, P133, DOI DOI 10.1211/ijpp.15.2.0009; Franklin BD, 2007, QUAL SAF HEALTH CARE, V16, P279, DOI 10.1136/qshc.2006.019497; Frazier Susan C, 2005, J Gerontol Nurs, V31, P4; Freemantle N, 2002, BRIT J GEN PRACT, V52, P290; Green Jacqueline L, 2007, Am J Geriatr Pharmacother, V5, P31, DOI 10.1016/j.amjopharm.2007.03.004; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; *INF CTR HLTH CAR, 2007, PRESCR DISP COMM STA; Lapane KL, 2007, J AM GERIATR SOC, V55, P1254, DOI 10.1111/j.1532-5415.2007.01248.x; MA Thomson O'Brien, 2000, COCHRANE DB SYST REV; Mallet L, 2007, LANCET, V370, P185, DOI 10.1016/S0140-6736(07)61092-7; Mangoni AA, 2006, BRIT J CLIN PHARMACO, V61, P513, DOI 10.1111/j.1365-2125.2006.02611.x; Mangoni AA, 2006, BRIT J CLIN PHARMACO, V61, P494, DOI 10.1111/j.1365-2125.2006.02609.x; Mangoni AA, 2006, BRIT J CLIN PHARMACO, V61, P502, DOI 10.1111/j.1365-2125.2006.02610.x; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; *MIDDL PRIM CAR TR, GUID SUPP PROD REP P; *NAT HLTH SERV, 2008, EPRESCRIBING; National Collaborating Centre for Chronic Conditions, 2006, ATR FIBR NAT CLIN GU; Noyce PR, 2007, ANN PHARMACOTHER, V41, P861, DOI 10.1345/aph.1K015; Oborne CA, 1997, BRIT J CLIN PHARMACO, V43, P91, DOI 10.1111/j.1365-2125.1997.tb00038.x; Oborne CA, 2003, AGE AGEING, V32, P102; *OFF NAT STAT, 2005, KEY POP VIT STAT; Rollason V, 2003, DRUG AGING, V20, P817, DOI 10.2165/00002512-200320110-00003; SWIFT CG, 1988, BRIT MED J, V296, P913, DOI 10.1136/bmj.296.6626.913; Wu JYF, 2006, BMJ-BRIT MED J, V333, P522, DOI 10.1136/bmj.38905.447118.2F	37	151	163	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2008	336	7644					606	609		10.1136/bmj.39503.424653.80	http://dx.doi.org/10.1136/bmj.39503.424653.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18340075	Green Published			2022-12-28	WOS:000254364500035
J	Clarke, M				Clarke, Mike			Commentary: Good, but not perfect	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UK Cochrane Ctr, Oxford OX2 7LG, England	Cochrane Centre	Clarke, M (corresponding author), UK Cochrane Ctr, Oxford OX2 7LG, England.	mclarke@cochrane.co.uk						Lemmens T, 2007, GLOBAL FORUM UPDATE, V4, P40; Lim B, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005111.pub3, 10.1002/14651858.CD005111]; Manheimer E, 2008, BMJ-BRIT MED J, V336, P545, DOI 10.1136/bmj.39471.430451.BE; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2008	336	7643					549	549		10.1136/bmj.39490.520046.25	http://dx.doi.org/10.1136/bmj.39490.520046.25			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JV	18325965	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000253998500031
J	Kehlet, H				Kehlet, Henrik			Fast-track colorectal surgery	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; COLONIC SURGERY; RESECTION; RECOVERY; CARE; PROTOCOL		Univ Copenhagen Hosp, Rigshosp, Sect Surg Pathophysiol 4074, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Kehlet, H (corresponding author), Univ Copenhagen Hosp, Rigshosp, Sect Surg Pathophysiol 4074, DK-2100 Copenhagen, Denmark.	henrik.kehlet@rh.dk		Kehlet, Henrik/0000-0002-2209-1711				Andersen H. K., 2006, COCHRANE DB SYST REV, V4, DOI DOI 10.1055/S-0031-128377710.1002/14651858.CD004080.PUB2; Andersen J, 2007, BRIT J SURG, V94, P890, DOI 10.1002/bjs.5669; Bundgaard-Nielsen M, 2007, ACTA ANAESTH SCAND, V51, P331, DOI 10.1111/j.1399-6576.2006.01221.x; Guenaga KF, 2005, COCHRANE DB SYST REV, V1; Jakobsen DH, 2006, COLORECTAL DIS, V8, P683, DOI 10.1111/j.1463-1318.2006.00995.x; JAKOBSEN DH, 2006, J ADV PERIOPERATIVE, V2, P177; Kehlet H, 2006, COLORECTAL DIS, V8, P514, DOI 10.1111/j.1463-1318.2006.00955.x; Kehlet H, 2006, J AM COLL SURGEONS, V202, P45, DOI 10.1016/j.jamcollsurg.2005.08.006; Kehlet H, 2003, LANCET, V362, P1921, DOI 10.1016/S0140-6736(03)14966-5; Khoo CK, 2007, ANN SURG, V245, P867, DOI 10.1097/01.sla.0000259219.08209.36; Lassen K, 2005, BRIT MED J, V330, P1420, DOI 10.1136/bmj.38478.568067.AE; Maessen J, 2007, BRIT J SURG, V94, P224, DOI 10.1002/bjs.5468; Nelson R, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004929.PUB3.NELS0N; Noblett SE, 2006, COLORECTAL DIS, V8, P563, DOI 10.1111/j.1463-1318.2006.00965.x; Noel JK, 2007, J AM COLL SURGEONS, V204, P291, DOI 10.1016/j.jamcollsurg.2006.10.002; Petrowsky H, 2004, ANN SURG, V240, P1074, DOI 10.1097/01.sla.0000146149.17411.c5; Senagore AJ, 2006, AM J SURG, V191, P377, DOI 10.1016/j.amjsurg.2005.10.039; Walter CJ, 2006, ANN ROY COLL SURG, V88, P191, DOI 10.1308/003588406X94940; White PF, 2007, ANESTH ANALG, V104, P1380, DOI 10.1213/01.ane.0000263034.96885.e1; Wind J, 2006, BRIT J SURG, V93, P800, DOI 10.1002/bjs.5384	20	394	426	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2008	371	9615					791	793		10.1016/S0140-6736(08)60357-8	http://dx.doi.org/10.1016/S0140-6736(08)60357-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272NQ	18328911				2022-12-28	WOS:000253866500007
J	Talley, NJ				Talley, Nicholas J.			Commentary: Controversies in NICE guidance on irritable bowel syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									Mayo Clin, Jacksonville, FL 32082 USA	Mayo Clinic	Talley, NJ (corresponding author), Mayo Clin, 4500 San Pablo Rd, Jacksonville, FL 32082 USA.	talley.nicholas@mayo.edu	Talley, Nicholas J/D-5399-2013	Talley, Nicholas J/0000-0003-2537-3092				Brandt LJ, 2002, AM J GASTROENTEROL, V97, pS7; FRANCIS CY, 1994, LANCET, V344, P39, DOI 10.1016/S0140-6736(94)91055-3; Hammer J, 2004, GUT, V53, P666, DOI 10.1136/gut.2003.021857; Sanders DS, 2001, LANCET, V358, P1504, DOI 10.1016/S0140-6736(01)06581-3; Tack J, 2006, GUT, V55, P1095, DOI 10.1136/gut.2005.077503; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1288, DOI 10.1001/jama.289.10.1288; Whitehead WE, 2006, ALIMENT PHARM THER, V24, P137, DOI 10.1111/j.1365-2036.2006.02956.x	7	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 8	2008	336	7643					558	559		10.1136/bmj.39504.409329.AD	http://dx.doi.org/10.1136/bmj.39504.409329.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JV	18325968	Green Published			2022-12-28	WOS:000253998500034
J	Carballo, JA; Johnson, AL; Sedgwick, SG; Cha, RS				Carballo, Jesus A.; Johnson, Anthony L.; Sedgwick, Steven G.; Cha, Rita S.			Phosphorylation of the axial element protein Hop1 by Mec1/Tel1 ensures meiotic interhomolog recombination	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND-BREAK; DNA-DAMAGE; CHROMOSOME SYNAPSIS; SISTER CHROMATIDS; YEAST HOMOLOG; MEIOSIS; KINASE; MEC1; MUTANTS	An essential feature of meiosis is interhomolog recombination whereby a significant fraction of the programmed meiotic double-strand breaks (DSBs) is repaired using an intact homologous non-sister chromatid rather than a sister. Involvement of Mec1 and Tel1, the budding yeast homologs of the mammalian ATR and ATM kinases, in meiotic interhomlog bias has been implicated, but the mechanism remains elusive. Here, we demonstrate that Mec1 and Tel1 promote meiotic interhomolog recombination by targeting the axial element protein Hop1. Without Mec1/Tel1 phosphorylation of Hop1, meiotic DSBs are rapidly repaired via a Dmc1-independent inter-sister repair pathway, resulting in diminished interhomolog crossing-over leading to spore lethality. We find that Mec1/Tel1-mediated phosphorylation of Hop1 is required for activation of Mek1, a meiotic paralogue of the DNA-damage effector kinase, Rad53p/CHK2. Thus, Hop1 is a meiosis-specific adaptor protein of the Mec1/Tel1 signaling pathway that ensures interhomolog recombination by preventing Dmc1-independent repair of meiotic DSBs.	[Carballo, Jesus A.; Johnson, Anthony L.; Sedgwick, Steven G.; Cha, Rita S.] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England	MRC National Institute for Medical Research	Cha, RS (corresponding author), Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England.	rcha@nimr.mrc.ac.uk	Carballo, Jesus/K-9899-2014	Carballo, Jesus/0000-0003-2259-3743; Cha, Rita/0000-0001-8223-1520	MRC [MC_U117531949, MC_U117573806] Funding Source: UKRI; Medical Research Council [MC_U117531949, MC_U117573806] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Anuradha S, 2004, J BIOL CHEM, V279, P28961, DOI 10.1074/jbc.M403727200; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; Bailis JM, 2000, CELL, V101, P211, DOI 10.1016/S0092-8674(00)80831-4; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Burgoyne PS, 2007, BIOESSAYS, V29, P974, DOI 10.1002/bies.20639; Carballo JA, 2007, CHROMOSOME RES, V15, P539, DOI 10.1007/s10577-007-1145-y; Cartagena-Lirola H, 2006, CELL CYCLE, V5, P1549, DOI 10.4161/cc.5.14.2916; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chen Yao-Tseng, 2005, Cancer Immun, V5, P9; de los Santos T, 1999, J BIOL CHEM, V274, P1783, DOI 10.1074/jbc.274.3.1783; DRESSER ME, 1988, J CELL BIOL, V106, P567, DOI 10.1083/jcb.106.3.567; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Grushcow JM, 1999, GENETICS, V153, P607; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; HOLLINGSWORTH NM, 1989, GENETICS, V121, P445; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; KADYK LC, 1992, GENETICS, V132, P387; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; LEEM SH, 1992, NUCLEIC ACIDS RES, V20, P449, DOI 10.1093/nar/20.3.449; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; LOIDL J, 1994, J CELL BIOL, V125, P1191, DOI 10.1083/jcb.125.6.1191; Lorenz A, 2004, J CELL SCI, V117, P3343, DOI 10.1242/jcs.01203; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Mallory JC, 2000, P NATL ACAD SCI USA, V97, P13749, DOI 10.1073/pnas.250475697; MaoDraayer Y, 1996, GENETICS, V144, P71; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; NAG DK, 1995, GENETICS, V141, P75; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; ROCKMILL B, 1991, GENE DEV, V5, P2392, DOI 10.1101/gad.5.12b.2392; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Thompson DA, 1999, GENETICS, V153, P621; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Wan LH, 2004, MOL BIOL CELL, V15, P11, DOI 10.1091/mbc.E03-07-0499; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Woltering D, 2000, MOL CELL BIOL, V20, P6646, DOI 10.1128/MCB.20.18.6646-6658.2000; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	54	194	195	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					758	770		10.1016/j.cell.2008.01.035	http://dx.doi.org/10.1016/j.cell.2008.01.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329363	Bronze			2022-12-28	WOS:000253818000014
J	Jeong, S; Rebeiz, M; Andolfatto, P; Werner, T; True, J; Carroll, SB				Jeong, Sangyun; Rebeiz, Mark; Andolfatto, Peter; Werner, Thomas; True, John; Carroll, Sean B.			The evolution of gene regulation underlies a morphological difference between two Drosophila sister species	CELL			English	Article							PARALLEL EVOLUTION; POSITIVE SELECTION; PIGMENT PATTERNS; MELANOGASTER; STICKLEBACKS; SANTOMEA; HISTORY; YAKUBA; LOCUS; DNA	Understanding the mechanisms underlying the morphological divergence of species is one of the central goals of evolutionary biology. Here, we analyze the genetic and molecular bases of the divergence of body pigmentation patterns between Drosophila yakuba and its sister species Drosophila santomea. We found that loss of pigmentation in D. santomea involved the selective loss of expression of the tan and yellow pigmentation genes. We demonstrate that tan gene expression was eliminated through the mutational inactivation of one specific tan cis-regulatory element (CRE) whereas the Tan protein sequence remained unchanged. Surprisingly, we identify three independent loss-of-function alleles of the tan CRE in the young D. santomea lineage. We submit that there is sufficient empirical evidence to support the general prediction that functional evolutionary changes at pleiotropic loci will most often involve mutations in their discrete, modular cis-regulatory elements.	[Jeong, Sangyun; Rebeiz, Mark; Werner, Thomas; Carroll, Sean B.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Jeong, Sangyun; Rebeiz, Mark; Werner, Thomas; Carroll, Sean B.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Andolfatto, Peter] Univ Calif San Diego, Sect Ecol Behav & Evolut, Div Biol Sci, La Jolla, CA 92093 USA; [True, John] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu		True, John/0000-0001-5124-5495; Rebeiz, Mark/0000-0001-5731-5570; Andolfatto, Peter/0000-0003-3393-4574	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078972] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM-078972] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Bachtrog D, 2006, GENETICS, V174, P2045, DOI 10.1534/genetics.106.062760; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Belting HG, 1998, P NATL ACAD SCI USA, V95, P2355, DOI 10.1073/pnas.95.5.2355; Carbone MA, 2005, GENETICS, V171, P211, DOI 10.1534/genetics.105.044412; Cariou ML, 2001, MOL ECOL, V10, P649, DOI 10.1046/j.1365-294x.2001.01225.x; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Davidson E. H., 2001, DEV EVOLUTION; Drapeau MD, 2006, GENETICS, V172, P1009, DOI 10.1534/genetics.105.045666; DYKHUIZEN D, 1980, GENETICS, V96, P801; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; HUDSON RR, 1985, GENETICS, V111, P147; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; Kim Y, 2003, GENETICS, V164, P389; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Llopart A, 2002, EVOLUTION, V56, P2262; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; NELSON HB, 1993, ROUX ARCH DEV BIOL, V202, P341, DOI 10.1007/BF00188733; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Orr HA, 2001, GENETICS, V157, P875; Pennings PS, 2006, PLOS GENET, V2, P1998, DOI 10.1371/journal.pgen.0020186; Pool JE, 2007, MOL ECOL, V16, P2844, DOI 10.1111/j.1365-294X.2007.03324.x; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Takahashi A, 2007, GENETICS, V177, P1233, DOI 10.1534/genetics.107.075283; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5	52	208	215	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					783	793		10.1016/j.cell.2008.01.014	http://dx.doi.org/10.1016/j.cell.2008.01.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329365	Bronze			2022-12-28	WOS:000253818000016
J	Depine, GV; Andronicos, CL; Phipps-Morgan, J				Depine, Gabriela V.; Andronicos, Christopher L.; Phipps-Morgan, Jason			Near-isothermal conditions in the middle and lower crust induced by melt migration	NATURE			English	Article							THERMAL-PROCESSES; METAMORPHISM; GRANITE; EMPLACEMENT; MOUNTAINS; SOLIDUS; COMPLEX; FLOW	The thermal structure of the crust strongly influences deformation, metamorphism and plutonism(1-3). Models for the geothermal gradient in stable crust predict a steady increase of temperature with depth. This thermal structure, however, is incompatible with observations from high- temperature metamorphic terranes exhumed in orogens(1,4,5,6). Global compilations(7) of peak conditions in high- temperature metamorphic terranes define relatively narrow ranges of peak temperatures over a wide range in pressure, for both isothermal decompression and isobaric cooling paths. Here we develop simple one- dimensional thermal models that include the effects of melt migration. These models show that long- lived plutonism results in a quasi- steady- state geotherm with a rapid temperature increase in the upper crust and nearly isothermal conditions in the middle and lower crust. The models also predict that the upward advection of heat by melt generates granulite facies metamorphism, and widespread andalusite - sillimanite metamorphism in the upper crust. Once the quasi- steady- state thermal profile is reached, the middle and lower crust are greatly weakened due to high temperatures and anatectic conditions, thus setting the stage for gravitational collapse(8), exhumation and isothermal decompression after the onset of plutonism. Near- iso-thermal conditions in the middle and lower crust result from the thermal buffering effect of dehydration melting reactions that, in part, control the shape of the geotherm.	[Depine, Gabriela V.; Andronicos, Christopher L.; Phipps-Morgan, Jason] Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA	Cornell University	Depine, GV (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Snee Hall, Ithaca, NY 14853 USA.	gvd2@cornell.edu	Zhang, Junyuan/P-9292-2018	Morgan, Jason/0000-0002-3100-0877				Andronicos CL, 2003, TECTONICS, V22, DOI 10.1029/2001TC001312; Beaumont C, 2001, NATURE, V414, P738, DOI 10.1038/414738a; Brown M, 1998, GEOL SOC SPEC PUBL, V138, P137, DOI 10.1144/GSL.SP.1996.138.01.09; Brown M, 1998, J STRUCT GEOL, V20, P211, DOI 10.1016/S0191-8141(97)00068-0; Chardon D, 2002, TECTONICS, V21, DOI 10.1029/2001TC901032; DEYOREO JJ, 1991, TECTONOPHYSICS, V188, P209, DOI 10.1016/0040-1951(91)90457-4; Furukawa Y, 1998, GEOPHYS RES LETT, V25, P1087, DOI 10.1029/98GL00545; Gerbi CC, 2006, J METAMORPH GEOL, V24, P107, DOI 10.1111/j.1525-1314.2005.00628.x; Gibson RL, 1998, GEOL SOC SPEC PUBL, V138, P121, DOI 10.1144/GSL.SP.1996.138.01.08; HARLEY SL, 1989, GEOL MAG, V126, P215, DOI 10.1017/S0016756800022330; HODGES KV, 1988, GEOLOGY, V16, P707, DOI 10.1130/0091-7613(1988)016<0707:PTBBCA>2.3.CO;2; Hollister LS, 2006, EARTH PLANET SC LETT, V249, P29, DOI 10.1016/j.epsl.2006.06.042; HOLLISTER LS, 1982, CAN MINERAL, V20, P319; Hollister LS, 2004, EARTH PLANET SC LETT, V221, P397, DOI 10.1016/S0012-821X(04)00067-6; Huerta AD, 1996, SCIENCE, V273, P637, DOI 10.1126/science.273.5275.637; HUTTON DHW, 1988, GEOL SOC AM BULL, V100, P1392, DOI 10.1130/0016-7606(1988)100<1392:IEIASZ>2.3.CO;2; KAY RW, 1993, TECTONOPHYSICS, V219, P177, DOI 10.1016/0040-1951(93)90295-U; KENAH C, 1983, SHIVA GEOLOGY SERIES, P142; Leitch AM, 2002, EARTH PLANET SC LETT, V200, P131, DOI 10.1016/S0012-821X(02)00596-4; Lopez S, 2001, AM MINERAL, V86, P1396; MacCready T, 1997, GEOL SOC AM BULL, V109, P1576, DOI 10.1130/0016-7606(1997)109<1576:MCFDTE>2.3.CO;2; Molnar P., 1988, PROCESSES CONTINENTA, V218, P179, DOI [10.1130/SPE218-p179, DOI 10.1130/SPE218-P179]; MORGAN JP, 1987, GEOPHYS RES LETT, V14, P1238, DOI 10.1029/GL014i012p01238; Patchett PJ, 2002, GEOLOGY, V30, P39, DOI 10.1130/0091-7613(2002)030<0039:ROTCMI>2.0.CO;2; PATINODOUCE AE, 1990, EARTH PLANET SC LETT, V97, P290; PATTISON DRM, 1991, REV MINERAL, V26, P105; Pattison DRM, 2003, J PETROL, V44, P867, DOI 10.1093/petrology/44.5.867; RABINOWICZ M, 2004, J GEOPHYS RES, V109; SANDIFORD M, 1991, EARTH PLANET SC LETT, V107, P164, DOI 10.1016/0012-821X(91)90052-J; Shaw CA, 2005, GEOPHYS MONOGR SER, V154, P163, DOI 10.1029/154GM12; STUWE K, 1995, TECTONOPHYSICS, V248, P39, DOI 10.1016/0040-1951(94)00282-E; Thompson AB, 2001, TECTONOPHYSICS, V332, P115, DOI 10.1016/S0040-1951(00)00252-3; Thomson A, 1999, LAT TRADE, V7, P25; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987	34	64	65	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					80	83		10.1038/nature06689	http://dx.doi.org/10.1038/nature06689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322532				2022-12-28	WOS:000253671900050
J	Goldston, D				Goldston, David			The scientist delusion	NATURE			English	Editorial Material									[Goldston, David] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA	Harvard University	Goldston, D (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	partyofonecolumn@gmail.com							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					17	17		10.1038/452017a	http://dx.doi.org/10.1038/452017a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322497	Bronze			2022-12-28	WOS:000253671900013
J	Murali, R; Attar, BM				Murali, Rangan; Attar, Bashar M.			A medical mystery: Epigastric pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Murali, Rangan; Attar, Bashar M.] Cook Cty John H Stroger Hosp, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County	Murali, R (corresponding author), Cook Cty John H Stroger Hosp, Chicago, IL 60612 USA.	bashar_attar@rush.edu							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					1053	1053		10.1056/NEJMicm067469	http://dx.doi.org/10.1056/NEJMicm067469			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18322286				2022-12-28	WOS:000253644700009
J	Qaseem, A; Snow, V; Cross, JT; Forciea, MA; Hopkins, R; Shekelle, P; Adelman, A; Mehr, D; Schellhase, K; Campos-Outcalt, D; Santaguida, P; Owens, DK				Qaseem, Amir; Snow, Vincenza; Cross, J. Thomas, Jr.; Forciea, Mary Ann; Hopkins, Robert, Jr.; Shekelle, Paul; Adelman, Alan; Mehr, David; Schellhase, Kenneth; Campos-Outcalt, Doug; Santaguida, Pasqualina; Owens, Douglas K.		Joint Amer Coll Phys Amer Acad Fam	Current Pharmacologic treatment of dementia: A clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; MODERATE ALZHEIMERS-DISEASE; RANDOMIZED CONTROLLED-TRIAL; PROBABLE VASCULAR DEMENTIA; MILD COGNITIVE IMPAIRMENT; DOUBLE-BLIND; CEREBROVASCULAR-DISEASE; MEMANTINE TREATMENT; PARKINSONS-DISEASE; PARALLEL-GROUP	Description: The American College of Physicians and American Academy of Family Physicians developed this guideline to present the available evidence on current pharmacologic treatment of dementia. Methods: The targeted literature search included evidence related to the effectiveness of 5 U. S. Food and Drug Administration approved pharmacologic therapies for dementia for outcomes in the domains of cognition, global function, behavior/ mood, and quality of life/ activities of daily living. Recommendation 1: Clinicians should base the decision to initiate a trial of therapy with a cholinesterase inhibitor or memantine on individualized assessment. ( Grade: weak recommendation, moderate-quality evidence.) Recommendation 2: Clinicians should base the choice of pharmacologic agents on tolerability, adverse effect profile, ease of use, and cost of medication. The evidence is insufficient to compare the effectiveness of different pharmacologic agents for the treatment of dementia. ( Grade: weak recommendation, low-quality evidence.) Recommendation 3: There is an urgent need for further research on the clinical effectiveness of pharmacologic management of dementia.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn, Philadelphia, PA 19104 USA; Medstudy, Colorado Springs, CO USA; Univ Arkansas, Little Rock, AR 72204 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Santa Monica, CA USA; RAND Corp, Santa Monica, CA USA; Penn State Univ, Hershey, PA USA; Univ Missouri, Sch Med, Columbia, MO USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Amer Acad Family Phys, Leawood, KS USA; McMaster Univ, Hamilton, ON, Canada; Univ Minnesota, Minneapolis, MN USA; Stanford Univ, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA	American College of Physicians; University of Pennsylvania; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Missouri System; University of Missouri Columbia; Medical College of Wisconsin; McMaster University; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	Casey, Donald/AFM-6658-2022	Casey, Donald/0000-0002-3820-598X; Mehr, David/0000-0002-5194-1383; Peterson, Kevin/0000-0002-6914-8586				Agid Y, 1998, CURR THER RES CLIN E, V59, P837, DOI 10.1016/S0011-393X(98)85048-0; Ancoli-Israel S, 2005, ALZ DIS ASSOC DIS, V19, P240, DOI 10.1097/01.wad.0000189052.48688.36; Ballard C, 2005, BMJ-BRIT MED J, V330, P874, DOI 10.1136/bmj.38369.459988.8F; Bentham P, 2004, LANCET, V363, P2105; Black S, 2003, STROKE, V34, P2323, DOI 10.1161/01.STR.0000091396.95360.E1; Brodaty H, 2005, DEMENT GERIATR COGN, V20, P120, DOI 10.1159/000086613; Bullock R, 2006, CURR MED RES OPIN, V22, P483, DOI 10.1185/030079906X89685; Bullock R, 2005, CURR MED RES OPIN, V21, P1317, DOI 10.1185/030079905X56565; Bullock R, 2004, DEMENT GERIATR COGN, V17, P29, DOI 10.1159/000074140; Burns A, 1999, DEMENT GERIATR COGN, V10, P237, DOI 10.1159/000017126; Emre M, 2004, NEW ENGL J MED, V351, P2509, DOI 10.1056/NEJMoa041470; Erkinjuntti T, 2002, LANCET, V359, P1283, DOI 10.1016/S0140-6736(02)08267-3; Feldman H, 2001, NEUROLOGY, V57, P613, DOI 10.1212/WNL.57.4.613; Forette F, 1999, EUR J NEUROL, V6, P423, DOI 10.1046/j.1468-1331.1999.640423.x; Gutzmann H, 2002, PHARMACOPSYCHIATRY, V35, P12, DOI 10.1055/s-2002-19833; Holmes C, 2004, NEUROLOGY, V63, P214, DOI 10.1212/01.WNL.0000129990.32253.7B; Karaman Y, 2005, DEMENT GERIATR COGN, V19, P51, DOI 10.1159/000080972; Kemp PM, 2003, J NEUROL NEUROSUR PS, V74, P1567, DOI 10.1136/jnnp.74.11.1567; KNAPP MJ, 1994, JAMA-J AM MED ASSOC, V271, P985, DOI 10.1001/jama.271.13.985; Koontz Jennifer, 2005, Am J Alzheimers Dis Other Demen, V20, P295, DOI 10.1177/153331750502000502; Krishnan KRR, 2003, AM J PSYCHIAT, V160, P2003, DOI 10.1176/appi.ajp.160.11.2003; Leroi I, 2004, INT J GERIATR PSYCH, V19, P1, DOI 10.1002/gps.993; MALTBY N, 1994, BMJ-BRIT MED J, V308, P879, DOI 10.1136/bmj.308.6933.879; Mazza M, 2006, EUR J NEUROL, V13, P981, DOI 10.1111/j.1468-1331.2006.01409.x; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; Mohs RC, 2001, NEUROLOGY, V57, P481, DOI 10.1212/WNL.57.3.481; Orgogozo JM, 2002, STROKE, V33, P1834, DOI 10.1161/01.STR.0000020094.08790.49; Peskind ER, 2006, AM J GERIAT PSYCHIAT, V14, P704, DOI 10.1097/01.JGP.0000224350.82719.83; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Potkin SG, 2001, INT J NEUROPSYCHOPH, V4, P223, DOI 10.1017/S1461145701002528; Prasher VP, 2002, INT J GERIATR PSYCH, V17, P270, DOI 10.1002/gps.587; Pratt RD, 2002, ANN NY ACAD SCI, V977, P513, DOI 10.1111/j.1749-6632.2002.tb04859.x; Prentice N, 1996, J PSYCHOPHARMACOL, V10, P175, DOI 10.1177/026988119601000301; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Raskind MA, 2000, NEUROLOGY, V54, P2261, DOI 10.1212/WNL.54.12.2261; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Rockwood K, 2001, J NEUROL NEUROSUR PS, V71, P589, DOI 10.1136/jnnp.71.5.589; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; Rosler M, 1999, BMJ-BRIT MED J, V318, P633, DOI 10.1136/bmj.318.7184.633; Salloway S, 2004, NEUROLOGY, V63, P651, DOI 10.1212/01.WNL.0000134664.80320.92; SANTAGUIDA P, 2004, 04E0182 AHRQ; Seltzer B, 2004, ARCH NEUROL-CHICAGO, V61, P1852, DOI 10.1001/archneur.61.12.1852; Tariot PN, 2000, NEUROLOGY, V54, P2269, DOI 10.1212/WNL.54.12.2269; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Tariot PN, 2001, J AM GERIATR SOC, V49, P1590, DOI 10.1046/j.1532-5415.2001.t01-1-49266.x; Thomas A, 2001, CLIN NEUROPHARMACOL, V24, P31, DOI 10.1097/00002826-200101000-00007; Tune L, 2003, AM J GERIAT PSYCHIAT, V11, P169, DOI 10.1176/appi.ajgp.11.2.169; WDOS SM, 2006, SLEEP, V29, P199; WEINSTEIN HC, 1991, J NEUROL, V238, P34, DOI 10.1007/BF00319708; Wilcock G, 2003, DRUG AGING, V20, P777, DOI 10.2165/00002512-200320100-00006; Wilcock G, 2002, INT CLIN PSYCHOPHARM, V17, P297, DOI 10.1097/00004850-200211000-00005; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445; Wilkinson D, 2003, NEUROLOGY, V61, P479, DOI 10.1212/01.WNL.0000078943.50032.FC; Wilkinson D, 2001, INT J GERIATR PSYCH, V16, P852, DOI 10.1002/gps.409; Wilkinson DG, 2005, INT J GERIATR PSYCH, V20, P489, DOI 10.1002/gps.1301; Winblad B, 2001, NEUROLOGY, V57, P489, DOI 10.1212/WNL.57.3.489; Winblad B, 1999, INT J GERIATR PSYCH, V14, P135, DOI 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0; Winblad B, 2006, LANCET, V367, P1057, DOI 10.1016/S0140-6736(06)68350-5; Wong WJ, 1999, DEMENT GERIATR COGN, V10, P289, DOI 10.1159/000017134; WOOD PC, 1994, INT J GERIATR PSYCH, V9, P649, DOI 10.1002/gps.930090809	62	231	258	2	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2008	148	5					370	W82		10.7326/0003-4819-148-5-200803040-00008	http://dx.doi.org/10.7326/0003-4819-148-5-200803040-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268SX	18316755				2022-12-28	WOS:000253600800006
J	Cayley, WE				Cayley, William E., Jr.			10-minute consultation - Haemochromatosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEREDITARY HEMOCHROMATOSIS		Univ Wisconsin, Dept Family Med, UW Hlth Augusta Family Med Clin, Eau Claire, WI 54701 USA	University of Wisconsin System	Cayley, WE (corresponding author), Univ Wisconsin, Dept Family Med, UW Hlth Augusta Family Med Clin, 617 W Clairemont Ave, Eau Claire, WI 54701 USA.	bcayley@yahoo.com						Brandhagen DJ, 2002, AM FAM PHYSICIAN, V65, P853; Limdi JK, 2004, QJM-INT J MED, V97, P315, DOI 10.1093/qjmed/hch065; Seamark CJ, 2000, BMJ-BRIT MED J, V320, P1314, DOI 10.1136/bmj.320.7245.1314	3	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 1	2008	336	7642					506	506		10.1136/bmj.39357.698889.94	http://dx.doi.org/10.1136/bmj.39357.698889.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18310008	Green Published			2022-12-28	WOS:000253997500047
J	Iyengar, R; Diverse-Pierluissi, MA; Jenkins, SL; Chan, AM; Devi, LA; Sobie, EA; Ting, AT; Weinstein, DC				Iyengar, Ravi; Diverse-Pierluissi, Maria A.; Jenkins, Sherry L.; Chan, Andrew M.; Devi, Lakshmi A.; Sobie, Eric A.; Ting, Adrian T.; Weinstein, Daniel C.			Inquiry learning - Integrating content detail and critical reasoning by peer review	SCIENCE			English	Editorial Material									[Iyengar, Ravi; Diverse-Pierluissi, Maria A.; Jenkins, Sherry L.; Devi, Lakshmi A.; Sobie, Eric A.; Weinstein, Daniel C.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Chan, Andrew M.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Ting, Adrian T.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Iyengar, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ravi.iyengar@mssm.edu	Chan, Andrew Man-Lok/J-9497-2013; Devi P, Lakshmi/GXM-5982-2022; Chan, Andrew/AAC-1145-2020	Chan, Andrew Man-Lok/0000-0001-9923-5464; Devi P, Lakshmi/0000-0001-9274-4776; Chan, Andrew/0000-0001-9923-5464; Jenkins, Sherry/0000-0003-1730-0977; Weinstein, Daniel/0000-0001-7832-9285	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM062754-01, T32GM062754, T32 GM062754] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Branon RF., 2001, TECHTRENDS TECH TREN, V45, P36, DOI DOI 10.1007/BF02763377; Edelson DC, 1999, J LEARN SCI, V8, P391, DOI 10.1207/s15327809jls0803&4_3; Guilford WH, 2001, ADV PHYSIOL EDUC, V25, P167, DOI 10.1152/advances.2001.25.3.167; IYENGAR R, 2005, SCI STKE, pTR3; IYENGAR R, 2008, SCI STKE         FEB; Jenkins SL, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.19tr2; JOHNSON GM, 2007, ANN C AM ED RES ASS; Lightfoot JT, 1998, ADV PHYSIOL EDUC, V19, pS57, DOI 10.1152/advances.1998.274.6.S57; Teikmanis M, 2001, Comput Nurs, V19, P75; WEINSTEIN DC, 2005, SCI STKE, pTR24	10	12	12	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1189	1190		10.1126/science.1149875	http://dx.doi.org/10.1126/science.1149875			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309063	Green Accepted			2022-12-28	WOS:000253530600019
J	Massol, F; Crochet, PA				Massol, Francois; Crochet, Pierre-Andre			Do animal personalities emerge?	NATURE			English	Letter							STRATEGIES; EVOLUTION; DYNAMICS		[Massol, Francois; Crochet, Pierre-Andre] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34293 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Massol, F (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, 1919 Route Mende, F-34293 Montpellier 05, France.	francois.massol@cefe.cnrs.fr	Massol, Francois/D-9872-2013	Massol, Francois/0000-0002-4098-955X				BISHOP DT, 1976, ADV APPL PROBAB, V8, P616, DOI 10.2307/1425917; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Geritz SAH, 1999, THEOR POPUL BIOL, V55, P324, DOI 10.1006/tpbi.1998.1409; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Hofbauer J., 1990, APPL MATH LETT, V3, P75, DOI [10.1016/0893-9659(90)90051-C, DOI 10.1016/0893-9659(90)90051-C, DOI 10.1016/0893-9659(90)90051-C)]; NOWAK M, 1990, ACTA APPL MATH, V20, P247, DOI 10.1007/BF00049570; SLATKIN M, 1980, ECOLOGY, V61, P163, DOI 10.2307/1937166; SMITH JM, 1989, EVOLUTIONARY GENETIC, pCH4; Waxman D, 2005, J EVOLUTION BIOL, V18, P1139, DOI 10.1111/j.1420-9101.2005.00948.x; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835	11	7	7	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					E8	E9		10.1038/nature06743	http://dx.doi.org/10.1038/nature06743			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305490				2022-12-28	WOS:000253453600032
J	Cinalli, RM; Rangan, P; Lehmann, R				Cinalli, Ryan M.; Rangan, Prashanth; Lehmann, Ruth			Germ cells are forever	CELL			English	Review							CAENORHABDITIS-ELEGANS GERMLINE; UNDIFFERENTIATED SPERMATOGONIA; C-ELEGANS; DROSOPHILA; LINEAGE; PIWI; SPECIFICATION; TRANSCRIPTION; METHYLATION; TOTIPOTENCY	Germ cells are the only cell type capable of generating an entirely new organism. In order to execute germline-specific functions and to retain the capacity for totipotency, germ cells repress somatic differentiation, interact with a specialized microenvironment, and use germline-specific networks of RNA regulation.	[Cinalli, Ryan M.; Rangan, Prashanth; Lehmann, Ruth] NYU, Sch Med, Dept Biol, HHMI, New York, NY 10016 USA; [Cinalli, Ryan M.; Rangan, Prashanth; Lehmann, Ruth] NYU, Sch Med, Dept Biol, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University	Lehmann, R (corresponding author), NYU, Sch Med, Dept Biol, HHMI, 540 1st Ave, New York, NY 10016 USA.	lehmann@saturn.med.nyu.edu		Lehmann, Ruth/0000-0002-8454-5651	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041900] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [5R01 HD041900] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bender LB, 2004, CURR BIOL, V14, P1639, DOI 10.1016/j.cub.2004.08.062; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Ghosh D, 2008, GENETICS, V178, P235, DOI 10.1534/genetics.107.083212; HANYUNAKAMURA K, 2008, NATURE; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; WYLIE CC, 1985, COLD SPRING HARB SYM, V50, P37, DOI 10.1101/SQB.1985.050.01.007; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	21	93	98	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					559	562		10.1016/j.cell.2008.02.003	http://dx.doi.org/10.1016/j.cell.2008.02.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295574	Bronze			2022-12-28	WOS:000253817900016
J	Daley, GQ; Scadden, DT				Daley, George Q.; Scadden, David T.			Prospects for stem cell-based therapy	CELL			English	Article							HEMATOPOIETIC STEM; PROGENITOR CELLS; FIBROBLASTS; POPULATION; RECEPTORS; REJECTION; MIGRATION; LINES	Resident pools of somatic stem cells in many organs are responsible for tissue maintenance and repair. The goal of regenerative medicine is to exploit these cells either by transplanting them from an exogenous source or by activating endogenous stem cells pharmacologically. For diseases caused by mutations in a single gene, the therapeutic goal is tissue replacement using stem cells engineered to correct the genetic defect. However, a number of technical hurdles must be overcome before therapies based on pluripotent human stem cells can enter the clinic.	[Daley, George Q.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.; Scadden, David T.] Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; [Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02115 USA; [Scadden, David T.] Harvard Univ, Dept Stem Cell & regenerat Biol, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp, Div Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; scadden.david@mgh.harvard.edu						Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Eckardt S, 2007, GENE DEV, V21, P409, DOI 10.1101/gad.1524207; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; FRENCH AJ, 2008, STEM CELLS; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mandelboim O, 1997, P NATL ACAD SCI USA, V94, P14666, DOI 10.1073/pnas.94.26.14666; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nakajima F, 2007, STEM CELLS, V25, P983, DOI 10.1634/stemcells.2006-0566; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; REVAZOVA ES, 2007, CLONING STEM CELLS; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; SACKSTEIN R, 2008, NAT MED; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; STRAIN L, 1995, NAT GENET, V11, P164, DOI 10.1038/ng1095-164; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu GD, 2003, TRANSPLANTATION, V75, P679, DOI 10.1097/01.TP.0000048488.35010.95; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	42	232	248	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					544	548		10.1016/j.cell.2008.02.009	http://dx.doi.org/10.1016/j.cell.2008.02.009			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295571	Bronze			2022-12-28	WOS:000253817900013
J	Hajkova, P; Ancelin, K; Waldmann, T; Lacoste, N; Lange, UC; Cesari, F; Lee, C; Almouzni, G; Schneider, R; Surani, MA				Hajkova, Petra; Ancelin, Katia; Waldmann, Tanja; Lacoste, Nicolas; Lange, Ulrike C.; Cesari, Francesca; Lee, Caroline; Almouzni, Genevieve; Schneider, Robert; Surani, M. Azim			Chromatin dynamics during epigenetic reprogramming in the mouse germ line	NATURE			English	Article							HISTONE ARGININE METHYLATION; REPAIR; NAP1; SPECIFICATION; DEMETER; BLIMP1	A unique feature of the germ cell lineage is the generation of totipotency. A critical event in this context is DNA demethylation and the erasure of parental imprints in mouse primordial germ cells ( PGCs) on embryonic day 11.5 ( E11.5) after they enter into the developing gonads(1,2). Little is yet known about the mechanism involved, except that it is apparently an active process. We have examined the associated changes in the chromatin to gain further insights into this reprogramming event. Here we show that the chromatin changes occur in two steps. The first changes in nascent PGCs at E8.5 establish a distinctive chromatin signature that is reminiscent of pluripotency. Next, when PGCs are residing in the gonads, major changes occur in nuclear architecture accompanied by an extensive erasure of several histone modifications and exchange of histone variants. Furthermore, the histone chaperones HIRA and NAP- 1 ( NAP111), which are implicated in histone exchange, accumulate in PGC nuclei undergoing reprogramming. We therefore suggest that the mechanism of histone replacement is critical for these chromatin rearrangements to occur. The marked chromatin changes are intimately linked with genome- wide DNA demethylation. On the basis of the timing of the observed events, we propose that if DNA demethylation entails a DNA repair- based mechanism, the evident histone replacement would represent a repair- induced response event rather than being a prerequisite.	[Hajkova, Petra; Ancelin, Katia; Lange, Ulrike C.; Cesari, Francesca; Lee, Caroline; Surani, M. Azim] Univ Cambridge, Welcome Trust Canc Res UK Gordon Inst Canc & Dev, Cambridge CB2 1QN, England; [Schneider, Robert] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Almouzni, Genevieve] Inst Curie, CNRS, F-75248 Paris 05, France	University of Cambridge; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Surani, MA (corresponding author), Univ Cambridge, Welcome Trust Canc Res UK Gordon Inst Canc & Dev, Tennis Court Rd, Cambridge CB2 1QN, England.	as10021@mole.bio.cam.ac.uk	Waldmann, Tanja/A-5145-2010; Almouzni, Genevieve/ABG-1029-2021; Ancelin, Katia/R-1719-2019	Waldmann, Tanja/0000-0001-9276-1592; Almouzni, Genevieve/0000-0001-5570-0723; Hajkova, Petra/0000-0003-4145-1468; Ancelin, Katia/0000-0002-2117-9754; Surani, Azim/0000-0002-8640-4318	Wellcome Trust [083089] Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Durcova-Hills G, 2006, P NATL ACAD SCI USA, V103, P11184, DOI 10.1073/pnas.0602621103; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Kaufman Paul D., 2006, V47, P121; Kepert JF, 2005, J BIOL CHEM, V280, P34063, DOI 10.1074/jbc.M507322200; Lee JD, 2002, DEVELOPMENT, V129, P5697, DOI 10.1242/dev.00159; Levchenko V, 2004, BIOCHEMISTRY-US, V43, P2359, DOI 10.1021/bi035737q; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Saitou M, 2003, PHILOS T R SOC B, V358, P1363, DOI 10.1098/rstb.2003.1324; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Surani MA, 2004, COLD SPRING HARB SYM, V69, P1, DOI 10.1101/sqb.2004.69.40; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Walfridsson J, 2007, EMBO J, V26, P2868, DOI 10.1038/sj.emboj.7601728; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0	30	460	482	1	59	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 17	2008	452	7189					877	U6		10.1038/nature06714	http://dx.doi.org/10.1038/nature06714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18354397	Green Accepted			2022-12-28	WOS:000255026000049
J	Milner, JD; Brenchley, JM; Laurence, A; Freeman, AF; Hill, BJ; Elias, KM; Kanno, Y; Spalding, C; Elloumi, HZ; Paulson, ML; Davis, J; Hsu, A; Asher, AI; O'Shea, J; Holland, SM; Paul, WE; Douek, DC				Milner, Joshua D.; Brenchley, Jason M.; Laurence, Arian; Freeman, Alexandra F.; Hill, Brenna J.; Elias, Kevin M.; Kanno, Yuka; Spalding, Christine; Elloumi, Houda Z.; Paulson, Michelle L.; Davis, Joie; Hsu, Amy; Asher, Ava I.; O'Shea, John; Holland, Steven M.; Paul, William E.; Douek, Daniel C.			Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome	NATURE			English	Article							HELPER T-CELLS; NEUTROPHIL RECRUITMENT; HOST-DEFENSE; IL-21; GENERATION; STAT3; ACTIVATION; EXPRESSION; CYTOKINE; INTERLEUKIN-17	The autosomal dominant hyper-IgE syndrome (HIES, 'Job's syndrome') is characterized by recurrent and often severe pulmonary infections, pneumatoceles, eczema, staphylococcal abscesses, mucocutaneous candidiasis, and abnormalities of bone and connective tissue(1,2). Mutations presumed to underlie HIES have recently been identified in stat3, the gene encoding STAT3 (signal transducer and activator of transcription 3) (refs 3, 4). Although impaired production of interferon-gamma and tumour-necrosis factor by T cells(5), diminished memory T-cell populations, decreased delayed-type-hypersensitivity responses and decreased in vitro lymphoproliferation in response to specific antigens(6) have variably been described, specific immunological abnormalities that can explain the unique susceptibility to particular infections seen in HIES have not yet been defined. Here we show that interleukin (IL)-17 production by T cells is absent in HIES individuals. We observed that ex vivo T cells from subjects with HIES failed to produce IL-17, but not IL-2, tumour-necrosis factor or interferon-gamma, on mitogenic stimulation with staphylococcal enterotoxin B or on antigenic stimulation with Candida albicans or streptokinase. Purified naive T cells were unable to differentiate into IL-17-producing (T(H)17) T helper cells in vitro and had lower expression of retinoid-related orphan receptor (ROR)-gamma t, which is consistent with a crucial role for STAT3 signalling in the generation of T(H)17 cells(7-14). T(H)17 cells have emerged as an important subset of helper T cells(15) that are believed to be critical in the clearance of fungal(16) and extracellular bacterial(17) infections. Thus, our data suggest that the inability to produce T(H)17 cells is a mechanism underlying the susceptibility to the recurrent infections commonly seen in HIES.	[Brenchley, Jason M.; Hill, Brenna J.; Asher, Ava I.; Douek, Daniel C.] NIAMSD, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Milner, Joshua D.; Paul, William E.] NIAMSD, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Laurence, Arian; Elias, Kevin M.; Kanno, Yuka; O'Shea, John] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Freeman, Alexandra F.; Spalding, Christine; Elloumi, Houda Z.; Paulson, Michelle L.; Davis, Joie; Hsu, Amy; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Elias, Kevin M.] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vanderbilt University	Douek, DC (corresponding author), NIAMSD, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	ddouek@nih.gov	Laurence, Arian/H-5534-2019; Laurence, Arian/A-8770-2009; Brenchley, Jason/AAC-5085-2019; Kanno, Yuka/B-5802-2013	Laurence, Arian/0000-0003-0942-8292; Laurence, Arian/0000-0003-0942-8292; Kanno, Yuka/0000-0001-5668-9319; Brenchley, Jason/0000-0001-8357-2984; Elias, Kevin/0000-0003-1502-5553	Intramural NIH HHS [Z99 AI999999] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001029, ZIAAI000493, ZIAAI000646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIAAR041167] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; BUCKLEY RH, 1972, PEDIATRICS, V49, P59; Buckley RH, 2001, CLIN REV ALLERG IMMU, V20, P139, DOI 10.1385/CRIAI:20:1:139; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; DELPRETE G, 1989, J CLIN INVEST, V84, P1830, DOI 10.1172/JCI114368; Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; KING CL, 1991, J IMMUNOL, V146, P1478; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Tanaka T, 2005, CLIN EXP IMMUNOL, V140, P524, DOI 10.1111/j.1365-2249.2005.02805.x; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	30	864	898	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					773	U11		10.1038/nature06764	http://dx.doi.org/10.1038/nature06764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18337720	Green Accepted			2022-12-28	WOS:000254792500050
J	Ditzen, M; Pellegrino, M; Vosshall, LB				Ditzen, Mathias; Pellegrino, Maurizio; Vosshall, Leslie B.			Insect odorant receptors are molecular targets of the insect repellent DEET	SCIENCE			English	Article							AEDES-AEGYPTI; DROSOPHILA-ANTENNA; MEMBRANE TOPOLOGY; IN-VIVO; MOSQUITO; MALARIA; DIPTERA; CULICIDAE; OLFACTION; BEHAVIOR	DEET (N,N-diethyl- meta- toluamide) is the world's most widely used topical insect repellent, with broad effectiveness against most insects. Its mechanism of action and molecular target remain unknown. Here, we show that DEET blocks electrophysiological responses of olfactory sensory neurons to attractive odors in Anopheles gambiae and Drosophila melanogaster. DEET inhibits behavioral attraction to food odors in Drosophila, and this inhibition requires the highly conserved olfactory co- receptor OR83b. DEET inhibits odor- evoked currents mediated by the insect odorant receptor complex, comprising a ligand- binding subunit and OR83b. We conclude that DEET masks host odor by inhibiting subsets of heteromeric insect odorant receptors that require the OR83b co- receptor. The identification of candidate molecular targets for the action of DEET may aid in the design of safer and more effective insect repellents.	[Ditzen, Mathias; Pellegrino, Maurizio; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA	Rockefeller University	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie@mail.rockefeller.edu		Vosshall, Leslie/0000-0002-6060-8099	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008600] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC008600] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Carroll JF, 2005, MED VET ENTOMOL, V19, P101, DOI 10.1111/j.0269-283X.2005.00559.x; DAVIS EE, 1975, J COMP PHYSIOL, V96, P223, DOI 10.1007/BF00612696; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; GILBERT IH, 1955, J ECON ENTOMOL, V48, P741, DOI 10.1093/jee/48.6.741; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Klun JA, 2006, J MED ENTOMOL, V43, P34, DOI 10.1603/0022-2585(2006)043[0034:RADEOS]2.0.CO;2; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; MCCABE ET, 1954, J ORG CHEM, V19, P493, DOI 10.1021/jo01369a003; MCIVER SB, 1981, J MED ENTOMOL, V18, P357, DOI 10.1093/jmedent/18.5.357; Moore S. J., 2004, TRADITIONAL MED PLAN, P343; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; Rowland M, 2004, TROP MED INT HEALTH, V9, P343, DOI 10.1046/j.1365-3156.2003.01183.x; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; SCHRECK CE, 1970, J ECON ENTOMOL, V63, P1576, DOI 10.1093/jee/63.5.1576; TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Xue RD, 2007, EXP PARASITOL, V116, P201, DOI 10.1016/j.exppara.2006.12.011; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	27	240	275	4	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2008	319	5871					1838	1842		10.1126/science.1153121	http://dx.doi.org/10.1126/science.1153121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18339904				2022-12-28	WOS:000254394000050
J	Navrotsky, A; Mazeina, L; Majzlan, J				Navrotsky, Alexandra; Mazeina, Lena; Majzlan, Juraj			Size-driven structural and thermodynamic complexity in iron oxides	SCIENCE			English	Review							GOETHITE ALPHA-FEOOH; SURFACE ENTHALPY; WATER-ADSORPTION; HEMATITE; LEPIDOCROCITE; MAGHEMITE; FERRIHYDRITE; TEMPERATURE; TRANSFORMATION; NANOPARTICLES	Iron oxides occur ubiquitously in environmental, geological, planetary, and technological settings. They exist in a rich variety of structures and hydration states. They are commonly fine- grained ( nanophase) and poorly crystalline. This review summarizes recently measured thermodynamic data on their formation and surface energies. These data are essential for calculating the thermodynamic stability fields of the various iron oxide and oxyhydroxide phases and understanding their occurrence in natural and anthropogenic environments. The competition between surface enthalpy and the energetics of phase transformation leads to the general conclusion that polymorphs metastable as micrometer- sized or larger crystals can often be thermodynamically stabilized at the nanoscale. Such size- driven crossovers in stability help to explain patterns of occurrence of different iron oxides in nature.	[Navrotsky, Alexandra] Univ Calif Davis, Peter A Rock Thermochem Lab, Davis, CA 95616 USA; [Navrotsky, Alexandra] Univ Calif Davis, Nanomat Environm Agr & Technol Organized Res Unit, Davis, CA 95616 USA; [Mazeina, Lena] USN, Res Lab, Washington, DC 20375 USA; [Majzlan, Juraj] Univ Freiburg, Inst Mineral Petrol & Geochem, D-79104 Freiburg, Germany	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Defense; United States Navy; Naval Research Laboratory; University of Freiburg	Navrotsky, A (corresponding author), Univ Calif Davis, Peter A Rock Thermochem Lab, Davis, CA 95616 USA.	anavrotsky@ucdavis.edu						Bomati-Miguel O, 2008, CHEM MATER, V20, P591, DOI 10.1021/cm071178o; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; Dahl JA, 2007, CHEM REV, V107, P2228, DOI 10.1021/cr050943k; DEGRAVE E, 1986, PHYS CHEM MINER, V13, P61, DOI 10.1007/BF00307313; DEORE SW, 2006, THESIS U CALIFORNIA; Hargraves RB, 2000, J GEOPHYS RES-PLANET, V105, P1819, DOI 10.1029/1999JE001032; Janney DE, 2001, AM MINERAL, V86, P327; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; LANG B, 2005, THESIS B YOUNG U; LANGMUIR D, 1971, AM J SCI, V271, P147, DOI 10.2475/ajs.271.2.147; Majzlan J, 2003, AM MINERAL, V88, P846; Majzlan J, 2004, GEOCHIM COSMOCHIM AC, V68, P1049, DOI 10.1016/S0016-7037(03)00371-5; Majzlan J, 2003, EUR J MINERAL, V15, P495, DOI 10.1127/0935-1221/2003/0015-0495; Majzlan J, 2000, CLAY CLAY MINER, V48, P699, DOI 10.1346/CCMN.2000.0480611; MAJZLAN J, 2003, THESIS U CALIFORNIA; Majzlan J, 2007, GEOCHIM COSMOCHIM AC, V71, P615, DOI 10.1016/j.gca.2006.10.010; Mazeina L, 2006, CHEM MATER, V18, P1830, DOI 10.1021/cm052543j; Mazeina L, 2005, CLAY CLAY MINER, V53, P113, DOI 10.1346/CCMN.2005.0530201; Mazeina L, 2007, CHEM MATER, V19, P825, DOI 10.1021/cm0623817; Michel FM, 2007, SCIENCE, V316, P1726, DOI 10.1126/science.1142525; Navrotsky A, 1997, PHYS CHEM MINER, V24, P222, DOI 10.1007/s002690050035; NAVROTSKY A, 1994, AM MINERAL, V79, P1099; Navrotsky A, 2007, J CHEM THERMODYN, V39, P1, DOI 10.1016/j.jct.2006.09.011; Nesterova M, 2003, GEOCHIM COSMOCHIM AC, V67, P1177; Randrianantoandro N, 2001, MATER LETT, V47, P150, DOI 10.1016/S0167-577X(00)00227-5; Robie R. a., 1995, US GEOL SURV B, V2131; SCHWERTMANN U, 1977, SOIL SCI SOC AM J, V41, P1013, DOI 10.2136/sssaj1977.03615995004100050042x; Singer MJ, 1996, QUATERN INT, V34-6, P243, DOI 10.1016/1040-6182(95)00089-5; STANJEK H, 1987, Z PFLANZ BODENKUNDE, V150, P314, DOI 10.1002/jpln.19871500509; Ushakov SV, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2108113; Zhang HZ, 2003, NATURE, V424, P1025, DOI 10.1038/nature01845	31	567	581	12	575	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2008	319	5870					1635	1638		10.1126/science.1148614	http://dx.doi.org/10.1126/science.1148614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356516				2022-12-28	WOS:000254172300030
J	Pearson, TA; Manolio, TA				Pearson, Thomas A.; Manolio, Teri A.			How to interpret a genome-wide association study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FALSE DISCOVERY RATE; POPULATION STRATIFICATION; CROHN-DISEASE; SUSCEPTIBILITY VARIANT; CONFER SUSCEPTIBILITY; COLORECTAL-CANCER; COMMON DISEASES; RISK LOCUS; ERROR RATE; GENE	Genome- wide association ( GWA) studies use high- throughput genotyping technologies to assay hundreds of thousands of single- nucleotide polymorphisms ( SNPs) and relate them to clinical conditions and measurable traits. Since 2005, nearly 100 loci for as many as 40 common diseases and traits have been identified and replicated in GWA studies, many in genes not previously suspected of having a role in the disease under study, and some in genomic regions containing no known genes. GWA studies are an important advance in discovering genetic variants influencing disease but also have important limitations, including their potential for false- positive and false- negative results and for biases related to selection of study participants and genotyping errors. Although these studies are clearly many steps removed from actual clinical use, and specific applications of GWA findings in prevention and treatment are actively being pursued, at present these studies mainly represent a valuable discovery tool for examining genomic function and clarifying pathophysiologic mechanisms. This article describes the design, interpretation, application, and limitations of GWA studies for clinicians and scientists for whom this evolving science may have great relevance.	[Pearson, Thomas A.; Manolio, Teri A.] NHGRI, Off Populat Genom, NIH, Bethesda, MD 20892 USA; [Pearson, Thomas A.] Univ Rochester, Med Ctr, Clin & Translat Sci Inst, Rochester, NY 14642 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Rochester	Manolio, TA (corresponding author), NHGRI, Off Populat Genom, NIH, 31 Ctr Dr,Room 4B-09,MSC 2154, Bethesda, MD 20892 USA.	manolio@nih.gov			NCRR NIH HHS [UL1 RR024160, RR024160] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Christensen K, 2007, NEW ENGL J MED, V356, P1094, DOI 10.1056/NEJMp068126; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Cupples LA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Frayling TM, 2007, DIABETOLOGIA, V50, P2229, DOI 10.1007/s00125-007-0825-7; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; GORDIS L, 2000, EPIDEMIOLOGY, P165; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoover RN, 2007, EPIDEMIOLOGY, V18, P13, DOI 10.1097/01.ede.0000249532.81073.b2; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Khoury MJ, 2007, INT J EPIDEMIOL, V36, P439, DOI 10.1093/ije/dyl253; LAST J, 1983, DICT EPIDEMIOLOGY, P7; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Moskvina V, 2006, HUM HERED, V61, P55, DOI 10.1159/000092553; Mueller PW, 2006, J AM SOC NEPHROL, V17, P1782, DOI 10.1681/ASN.2005080822; *NAT LIB MED NAT C, DAT SINGL NUCL POL; Patterson M, 2005, PLOS BIOL, V3, P1511, DOI 10.1371/journal.pbio.0030327; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sabatti C, 2003, GENETICS, V164, P829; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SLATER EE, 1988, DRUGS, V36, P72, DOI 10.2165/00003495-198800363-00016; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yang Q, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S134; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821; 2007, FED REG, V72, P49290	73	610	652	3	81	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1335	1344		10.1001/jama.299.11.1335	http://dx.doi.org/10.1001/jama.299.11.1335			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349094				2022-12-28	WOS:000254079100024
J	van Meurs, JBJ; Trikalinos, TA; Ralston, SH; Balcells, S; Brandi, ML; Brixen, K; Kiel, DP; Langdahl, BL; Lips, P; Ljunggren, O; Lorenc, R; Obermayer-Pietsch, B; Ohlsson, C; Pettersson, U; Reid, DM; Rousseau, F; Scollen, S; Van Hul, W; Agueda, L; Akesson, K; Benevolenskaya, LI; Ferrari, SL; Hallmans, G; Hofman, A; Husted, LB; Kruk, M; Kaptoge, S; Karasik, D; Karlsson, MK; Lorentzon, M; Masi, L; McGuigan, FEA; Mellstrom, D; Mosekilde, L; Nogues, X; Pols, HAP; Reeve, J; Renner, W; Rivadeneira, F; van Schoor, NM; Weber, K; Ioannidis, JPA; Uitterlinden, AG				van Meurs, Joyce B. J.; Trikalinos, Thomas A.; Ralston, Stuart H.; Balcells, Susana; Brandi, Maria Luisa; Brixen, Kim; Kiel, Douglas P.; Langdahl, Bente L.; Lips, Paul; Ljunggren, Osten; Lorenc, Roman; Obermayer-Pietsch, Barbara; Ohlsson, Claes; Pettersson, Ulrika; Reid, David M.; Rousseau, Francois; Scollen, Serena; Van Hul, Wim; Agueda, Lidia; Akesson, Kristina; Benevolenskaya, Lidia I.; Ferrari, Serge L.; Hallmans, Goran; Hofman, Albert; Husted, Lise Bjerre; Kruk, Marcin; Kaptoge, Stephen; Karasik, David; Karlsson, Magnus K.; Lorentzon, Mattias; Masi, Laura; McGuigan, Fiona E. A.; Mellstrom, Dan; Mosekilde, Leif; Nogues, Xavier; Pols, Huibert A. P.; Reeve, Jonathan; Renner, Wilfried; Rivadeneira, Fernando; van Schoor, Natasja M.; Weber, Kurt; Ioannidis, John P. A.; Uitterlinden, Andre G.		GENOMOS Study	Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECEPTOR-RELATED PROTEIN-5; BONE-MINERAL DENSITY; COMMON GENETIC-VARIATION; FRACTURE RISK; INDEPENDENT PREDICTOR; FREE TESTOSTERONE; ODENSE ANDROGEN; CLINICAL-TRIALS; JAPANESE WOMEN; POLYMORPHISMS	Context Mutations in the low- density lipoprotein receptor - related protein 5 ( LRP5) gene cause rare syndromes characterized by altered bone mineral density ( BMD). More common LRP5 variants may affect osteoporosis risk in the general population. Objective To generate large- scale evidence on whether 2 common variants of LRP5 ( Val667Met,Ala1330Val) and 1 variant of LRP6( Ile1062Val) are associated with BMD and fracture risk. Design and Setting Prospective, multicenter, collaborative study of individual-level data on 37 534 individuals from 18 participating teams in Europe and North America. Data were collected between September 2004 and January 2007; analysis of the collected data was performed between February and May 2007. Bone mineral density was assessed by dual- energy x- ray absorptiometry. Fractures were identified via questionnaire, medical records, or radiographic documentation; incident fracture data were available for some cohorts, ascertained via routine surveillance methods, including radiographic examination for vertebral fractures. Main Outcome Measures Bone mineral density of the lumbar spine and femoral neck; prevalence of all fractures and vertebral fractures. Results The Met667 allele of LRP5 was associated with reduced lumbar spine BMD ( n= 25 052 [ number of participants with available data]; 20- mg/ cm(2) lower BMD per Met667 allele copy; P= 3.3 x 10(-8)), as was the Val1330 allele ( n= 24 812; 14- mg/ cm(2) lower BMD per Val1330 copy; P= 2.6 x 10(-9)). Similar effects were observed for femoral neck BMD, with a decrease of 11 mg/ cm(2) ( P= 3.8 x 10(-5)) and 8 mg/ cm2 ( P= 5.0 x 10(-6)) for the Met667 and Val1330 alleles, respectively ( n= 25 193). Findings were consistent across studies for both LRP5 alleles. Both alleles were associated with vertebral fractures ( odds ratio [ OR], 1.26; 95% confidence interval [ CI], 1.08-1.47 for Met667 [ 2001 fractures among 20 488 individuals] and OR, 1.12; 95% CI, 1.01- 1.24 for Val1330 [ 1988 fractures among 20 096 individuals]). Risk of all fractures was also increased with Met667 ( OR, 1.14; 95% CI, 1.05- 1.24 per allele [ 7876 fractures among 31 435 individuals)]) and Val1330 ( OR, 1.06; 95% CI, 1.01- 1.12 per allele [ 7802 fractures among 31 199 individuals]). Effects were similar when adjustments were made for age, weight, height, menopausal status, and use of hormone therapy. Fracture risks were partly attenuated by adjustment for BMD. Haplotype analysis indicated that Met667 and Val1330 variants both independently affected BMD. The LRP6 Ile1062Val polymorphism was not associated with any osteoporosis phenotype. All aforementioned associations except that between Val1330 and all fractures and vertebral fractures remained significant after multiple-comparison adjustments. Conclusions Common LRP5 variants are consistently associated with BMD and fracture risk across different white populations. The magnitude of the effect is modest. LRP5 may be the first gene to reach a genome- wide significance level ( a conservative level of significance [ herein, unadjusted P < 10(-7)] that accounts for the many possible comparisons in the human genome) for a phenotype related to osteoporosis.	[Trikalinos, Thomas A.; Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [van Meurs, Joyce B. J.; Pols, Huibert A. P.; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Trikalinos, Thomas A.; Ioannidis, John P. A.] Tufts Univ, New England Med Ctr, Ctr Clin Evidence Synth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Trikalinos, Thomas A.] Tufts Univ, New England Med Ctr, Ctr Genet Epidemiol & Modeling, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; [Ralston, Stuart H.] Univ Edinburgh, Rheumat Dis Unit, Edinburgh, Midlothian, Scotland; [Balcells, Susana; Agueda, Lidia] Univ Barcelona, Dept Genet, CIBERER, IBUB, Barcelona, Spain; [Brandi, Maria Luisa; Masi, Laura] Univ Florence, Dept Internal Med, Florence, Italy; [Brixen, Kim] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Ohlsson, Claes; Lorentzon, Mattias; Mellstrom, Dan] Shlgrenska Acad, Dept Internal Med, Ctr Bone Res, Gothenburg, Sweden; [Kiel, Douglas P.; Karasik, David] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA; [Kiel, Douglas P.; Karasik, David] Harvard Univ, Sch Med, Boston, MA USA; [Langdahl, Bente L.; Husted, Lise Bjerre; Mosekilde, Leif] Aarhus Univ Hosp, Dept Endocrinol, DK-8000 Aarhus, Denmark; [Lips, Paul; van Schoor, Natasja M.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Amsterdam, Netherlands; [Ljunggren, Osten] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lorenc, Roman; Kruk, Marcin] Childrens Mem Hlth Inst, Dept Biochem & Expt Med, Warsaw, Poland; [Obermayer-Pietsch, Barbara; Renner, Wilfried] Med Univ Graz, Dept Internal Med, Graz, Austria; [Pettersson, Ulrika] Umea Univ, Dept Pharmacol & Neurosci, Umea, Sweden; [Pettersson, Ulrika] Umea Univ, Dept Sports Med, Umea, Sweden; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Reid, David M.; McGuigan, Fiona E. A.] Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland; [Rousseau, Francois] Ctr Hosp Univ Quebec, Unite Rech Genet Humaine & Mol, Ctr Rech Hop St Francois Assise, Quebec City, PQ, Canada; [Scollen, Serena; Kaptoge, Stephen; Reeve, Jonathan] Univ Cambridge, Strangeways Res Lab, Cambridge, England; [Van Hul, Wim] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; [Akesson, Kristina; Karlsson, Magnus K.] Lund Univ, Dept Orthoped, Malmo Univ Hosp, Lund, Sweden; [Benevolenskaya, Lidia I.] Russian Acad Med Sci, Inst Rheumatol, Moscow 109801, Russia; [Ferrari, Serge L.] Univ Hosp Geneva, Div Bone Dis, Geneva, Switzerland; [Hofman, Albert; Pols, Huibert A. P.; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands; [Nogues, Xavier] UAB, Hosp del Mar, IMIM, Barcelona, Spain; [Weber, Kurt] Univ Hosp, Dept Med, Graz, Austria	University of Ioannina; Erasmus University Rotterdam; Erasmus MC; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Tufts University; University of Edinburgh; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Florence; University of Southern Denmark; Odense University Hospital; Harvard University; Hebrew SeniorLife; Harvard University; Harvard Medical School; Aarhus University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Uppsala University; Children's Memorial Health Institute; Medical University of Graz; Umea University; Umea University; Umea University; University of Aberdeen; Laval University; University of Cambridge; University of Antwerp; Lund University; Skane University Hospital; Russian Academy of Medical Sciences; University of Geneva; Erasmus University Rotterdam; Erasmus MC; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Lewinski, Andrzej/N-3971-2014; Duncan, Emma L/L-1224-2013; Trikalinos, Thomas A/A-1217-2009; Reeve, Jonathan/C-7551-2012; Andersen, Marianne Skovsager/AAE-1751-2019; Ferrari, Serge/ABD-2730-2020; Ohlsson, Claes/HIR-6959-2022; Rivadeneira, Fernando/O-5385-2015; Ohlsson, Claes/AGP-3544-2022; Cannata-Andía, Jorge B L/L-2260-2013; Balcells, Susana/C-5222-2017; Lorentzon, Mattias/W-7878-2019; van Leeuwen, Johannes/D-5015-2014; Ioannidis, John P. A./G-9836-2011; Grinberg, Daniel/F-3641-2010; Da Silva, Jose/K-9769-2018	Duncan, Emma L/0000-0002-8143-4403; Reeve, Jonathan/0000-0002-4364-2682; Andersen, Marianne Skovsager/0000-0002-4603-9504; Ferrari, Serge/0000-0002-1372-4417; Ohlsson, Claes/0000-0002-9633-2805; Rivadeneira, Fernando/0000-0001-9435-9441; Ohlsson, Claes/0000-0002-9633-2805; Cannata-Andía, Jorge B L/0000-0001-6543-9960; Balcells, Susana/0000-0003-1211-1907; Lorentzon, Mattias/0000-0003-0749-1431; van Leeuwen, Johannes/0000-0002-2282-4006; Grinberg, Daniel/0000-0001-9859-2590; van Schoor, Natasja/0000-0002-0870-0795; Pettersson Kymmer, Ulrika/0000-0002-0557-9803; Karasik, David/0000-0002-8826-0530; Bergdahl, Ingvar/0000-0003-1227-6859; Kiel, Douglas/0000-0001-8474-0310; Eiken, Pia/0000-0001-7278-5968; Van Hul, Wim/0000-0002-5065-7858; Jensen, Jens-Erik Beck/0000-0003-4290-0480; Scollen, Serena/0000-0002-9311-1337; Van Duijn, Cornelia/0000-0002-2374-9204; Da Silva, Jose/0000-0002-2782-6780; Nordstrom, Peter/0000-0003-2924-508X; van Meurs, Joyce/0000-0001-6245-2123; Nogues, Xavier/0000-0002-5537-1859; Armas, Jacome/0000-0001-7671-6521; Diez-Perez, Adolfo/0000-0001-8162-0209; Nogues, Xavier/0000-0001-8201-9933	Medical Research Council [MC_UP_A620_1014, G0400491, G0401527] Funding Source: Medline; NHLBI NIH HHS [N01HC25195, N01-HC-25195] Funding Source: Medline; NIAMS NIH HHS [R01 AR041398-17, R01 AR041398, R01 AR050066, R01-AR050066] Funding Source: Medline; NIA NIH HHS [AR/AG41398] Funding Source: Medline; MRC [G0400491] Funding Source: UKRI; Medical Research Council [U1475000001] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050066, R01AR041398] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abrahamsen B, 2006, BONE, V38, P215, DOI 10.1016/j.bone.2005.08.005; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bollerslev J, 2005, BONE, V36, P599, DOI 10.1016/j.bone.2005.01.006; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brixen K, 2007, CALCIFIED TISSUE INT, V81, P421, DOI 10.1007/s00223-007-9088-z; Brown BW, 1997, STAT MED, V16, P2511, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2511::AID-SIM693>3.0.CO;2-4; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bustamante M, 2007, OSTEOPOROSIS INT, V18, P235, DOI 10.1007/s00198-006-0225-8; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; Deeg DJH, 2002, J CLIN EPIDEMIOL, V55, P319, DOI 10.1016/S0895-4356(01)00475-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dobnig H, 2006, J CLIN ENDOCR METAB, V91, P3355, DOI 10.1210/jc.2006-0460; EVANS RA, 1988, ANN INTERN MED, V109, P870, DOI 10.7326/0003-4819-109-11-870; Ezura Y, 2007, BONE, V40, P997, DOI 10.1016/j.bone.2005.06.025; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Ferrari SL, 2004, AM J HUM GENET, V74, P866, DOI 10.1086/420771; Ferrari SL, 2005, CURR OPIN LIPIDOL, V16, P207, DOI 10.1097/01.mol.0000162326.62419.e4; Giroux S, 2007, BONE, V40, P1299, DOI 10.1016/j.bone.2007.01.004; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grundberg E, 2008, OSTEOPOROSIS INT, V19, P829, DOI 10.1007/s00198-007-0512-z; Gugatschka M, 2005, QJM-INT J MED, V98, P857, DOI 10.1093/qjmed/hci140; Hallmans G, 2003, SCAND J PUBLIC HEALT, V31, P18, DOI 10.1080/14034950310001432; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Kiel DP, 2007, BONE, V40, P587, DOI 10.1016/j.bone.2006.09.029; Koay MA, 2007, CALCIFIED TISSUE INT, V81, P1, DOI 10.1007/s00223-007-9024-2; Koay MA, 2004, J BONE MINER RES, V19, P1619, DOI 10.1359/JBMR.040704; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Koller DL, 2005, J BONE MINER RES, V20, P75, DOI 10.1359/JBMR.041019; Kruk M, 2007, CALCIFIED TISSUE INT, V80, pS100; Langdahl BL, 2002, J BONE MINER RES, V17, P1245, DOI 10.1359/jbmr.2002.17.7.1245; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lorentzon M, 2005, J BONE MINER RES, V20, P1334, DOI 10.1359/JBMR.050404; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Masi L, 2001, J CLIN ENDOCR METAB, V86, P2263, DOI 10.1210/jc.86.5.2263; MCCLOSKEY EV, 1993, OSTEOPOROSIS INT, V3, P138, DOI 10.1007/BF01623275; McGuigan FEA, 2007, J BONE MINER RES, V22, P195, DOI [10.1359/jbmr.061016, 10.1359/JBMR.061016]; Mellstrom D, 2006, J BONE MINER RES, V21, P529, DOI 10.1359/JBMR.060110; MELTON LJ, 1993, J BONE MINER RES, V8, P1227; Moonesinghe R, 2008, P NATL ACAD SCI USA, V105, P617, DOI 10.1073/pnas.0705554105; Mosekilde L, 1999, MATURITAS, V31, P207, DOI 10.1016/S0378-5122(99)00006-7; Obermayer-Pietsch BM, 2004, J BONE MINER RES, V19, P42, DOI 10.1359/JBMR.0301207; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Ralston SH, 2005, HUM MOL GENET, V14, P943, DOI 10.1093/hmg/ddi088; Ralston SH, 2006, PLOS MED, V3, P515, DOI 10.1371/journal.pmed.0030090; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROUSSET F, 1995, GENETICS, V140, P1413; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Saarinen A, 2007, BONE, V40, P1006, DOI 10.1016/j.bone.2006.11.010; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Uitterlinden AG, 2006, ANN INTERN MED, V145, P936, DOI 10.7326/0003-4819-145-12-200612190-00021; UITTERLINDEN AG, 2001, OSTEOPOROSIS, P639; Uitterlinden AG, 2006, ANN INTERN MED, V145, P255, DOI 10.7326/0003-4819-145-4-200608150-00005; Urano T, 2004, J BONE MINER METAB, V22, P341, DOI 10.1007/s00774-003-0492-9; Urano T, 2007, SPINE, V32, P25, DOI 10.1097/01.brs.0000251003.62212.5b; van Meurs JBJ, 2006, J BONE MINER RES, V21, P141, DOI 10.1359/JBMR.050904; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Xiong DH, 2007, J BONE MINER RES, V22, P385, DOI 10.1359/JBMR.061116; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang ZL, 2005, ACTA PHARMACOL SIN, V26, P1111, DOI 10.1111/j.1745-7254.2005.00173.x	67	194	202	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1277	1290		10.1001/jama.299.11.1277	http://dx.doi.org/10.1001/jama.299.11.1277			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349089	Green Accepted			2022-12-28	WOS:000254079100019
J	Wood, L; Egger, M; Gluud, LL; Schulz, KF; Juni, P; Altman, DG; Gluud, C; Martin, RM; Wood, AJG; Sterne, JAC				Wood, Lesley; Egger, Matthias; Gluud, Lise Lotte; Schulz, Kenneth F.; Jueni, Peter; Altman, Douglas G.; Gluud, Christian; Martin, Richard M.; Wood, Anthony J. G.; Sterne, Jonathan A. C.			Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED-TRIALS; METHODOLOGICAL QUALITY; ALLOCATION CONCEALMENT; PROTOCOLS	Objective To examine whether the association of inadequate or unclear allocation concealment and lack of blinding with biased estimates of intervention effects varies with the nature of the intervention or outcome. Design Combined analysis of data from three meta-epidemiological studies based on collections of meta-analyses. Data sources 146 meta-analyses including 1346 trials examining a wide range of interventions and outcomes. Main outcome measures Ratios of odds ratios quantifying the degree of bias associated with inadequate or unclear allocation concealment, and lack of blinding, for trials with different types of intervention and outcome. A ratio of odds ratios <1 implies that inadequately concealed or non-blinded trials exaggerate intervention effect estimates. Results In trials with subjective outcomes effect estimates were exaggerated when there was inadequate or unclear allocation concealment (ratio of odds ratios 0.69 (95% Cl 0.59 to 0.82)) or lack of blinding (0.75 (0.61 to 0.93)). In contrast, there was little evidence of bias in trials with objective outcomes: ratios of odds ratios 0.91 (0.80 to 1.03) for inadequate or unclear allocation concealment and 1.01 (0.92 to 1.10) for lack of blinding. There was little evidence for a difference between trials of drug and non-drug interventions. Except for trials with all cause mortality as the outcome, the magnitude of bias varied between meta-analyses. Conclusions The average bias associated with defects in the conduct of randomised trials varies with the type of outcome. Systematic reviewers should routinely assess the risk of bias in the results of trials, and should report meta-analyses restricted to trials at low risk of bias either as the primary analysis or in conjunction with less restrictive analyses.	[Wood, Lesley; Martin, Richard M.; Wood, Anthony J. G.; Sterne, Jonathan A. C.] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Egger, Matthias; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Gluud, Lise Lotte; Gluud, Christian] Copenhagen Univ Hosp, Copenhagen Trial Unit, Ctr Clin Intervent Res, Rigshosp, Copenhagen, Denmark; [Schulz, Kenneth F.] Univ N Carolina, Sch Med, Family Hlth Int, Chapel Hill, NC USA; [Schulz, Kenneth F.] Univ N Carolina, Sch Med, Dept Obstet & Gynaecol, Chapel Hill, NC USA; [Altman, Douglas G.] Ctr Stat Med, Oxford, England	University of Bristol; University of Bern; Rigshospitalet; University of Copenhagen; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Oxford	Sterne, JAC (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	jonathan.sterne@bristol.ac.uk	Gluud, Christian/HGB-3191-2022; Sterne, Jonathan/Z-3106-2019; Juni, Peter/Q-8700-2016; Gluud, Lise L/AAY-2120-2020; Gluud, Christian/AAY-1027-2021	Sterne, Jonathan/0000-0001-8496-6053; Juni, Peter/0000-0002-5985-0670; Gluud, Lise L/0000-0002-9462-4468; Gluud, Christian/0000-0002-8861-0799; Martin, Richard/0000-0002-7992-7719; Egger, Matthias/0000-0001-7462-5132				ALSNIELSEN B, 2004, 12 INT COCHR C OTT C; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Chalmers I, 1995, SYSTEMATIC REV; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Devereaux PJ, 2001, JAMA-J AM MED ASSOC, V285, P2000, DOI 10.1001/jama.285.15.2000; Egger M, 2003, Health Technol Assess, V7, P1; Forder PM, 2005, MED J AUSTRALIA, V182, P87, DOI 10.5694/j.1326-5377.2005.tb06584.x; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Huwiler-Muntener K, 2002, JAMA-J AM MED ASSOC, V287, P2801, DOI 10.1001/jama.287.21.2801; Jackson Rod, 2006, Evid Based Med, V11, P35, DOI 10.1136/ebm.11.2.35; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Naylor CD, 1997, BMJ-BRIT MED J, V315, P617, DOI 10.1136/bmj.315.7109.617; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Siersma V, 2007, STAT MED, V26, P2745, DOI 10.1002/SIM.2752; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; WELTON NJ, IN PRESS J R STAT A	26	1524	1540	0	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2008	336	7644					601	605		10.1136/bmj.39465.451748.AD	http://dx.doi.org/10.1136/bmj.39465.451748.AD			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18316340	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000254364500034
J	D'Ardenne, K; McClure, SM; Nystrom, LE; Cohen, JD				D'Ardenne, Kimberlee; McClure, Samuel M.; Nystrom, Leigh E.; Cohen, Jonathan D.			BOLD responses reflecting dopaminergic signals in the human ventral tegmental area	SCIENCE			English	Article							TEMPORAL DIFFERENCE MODELS; PARKINSONS-DISEASE; REWARD; MIDBRAIN; NEURONS; PREDICTION; NOVELTY; ACTIVATION; MEMORY; HIPPOCAMPUS	Current theories hypothesize that dopamine neuronal firing encodes reward prediction errors. Although studies in nonhuman species provide direct support for this theory, functional magnetic resonance imaging ( fMRI) studies in humans have focused on brain areas targeted by dopamine neurons [ ventral striatum ( VStr)] rather than on brainstem dopaminergic nuclei [ ventral tegmental area ( VTA) and substantia nigra]. We used fMRI tailored to directly image the brainstem. When primary rewards were used in an experiment, the VTA blood oxygen level - dependent ( BOLD) response reflected a positive reward prediction error, whereas the VStr encoded positive and negative reward prediction errors. When monetary gains and losses were used, VTA BOLD responses reflected positive reward prediction errors modulated by the probability of winning. We detected no significant VTA BOLD response to nonrewarding events.	[D'Ardenne, Kimberlee] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [D'Ardenne, Kimberlee; McClure, Samuel M.; Nystrom, Leigh E.; Cohen, Jonathan D.] Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA; [McClure, Samuel M.; Nystrom, Leigh E.; Cohen, Jonathan D.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Cohen, Jonathan D.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Princeton University; Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	D'Ardenne, K (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	dardenne@princeton.edu			NIMH NIH HHS [P50 MH062196, T32 MH065214, F32 MH072141] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065214, P50MH062196, F32MH072141] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Braver TS, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P713; Bunzeck N, 2007, CEREB CORTEX, V17, P2940, DOI 10.1093/cercor/bhm020; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dreher JC, 2006, CEREB CORTEX, V16, P561, DOI 10.1093/cercor/bhj004; Dunckley P, 2005, J NEUROSCI, V25, P7333, DOI 10.1523/JNEUROSCI.1100-05.2005; Duvernoy HM, 1995, HUMAN BRAIN STEM CER; Eckert T, 2004, NEUROIMAGE, V21, P229, DOI 10.1016/j.neuroimage.2003.08.028; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Napadow V, 2006, NEUROIMAGE, V32, P1113, DOI 10.1016/j.neuroimage.2006.05.050; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Oikawa H, 2002, AM J NEURORADIOL, V23, P1747; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; Schneider KA, 2005, J NEUROPHYSIOL, V94, P2491, DOI 10.1152/jn.00288.2005; Schneider KA, 2004, J NEUROSCI, V24, P8975, DOI 10.1523/JNEUROSCI.2413-04.2004; Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Schott BH, 2007, BRAIN, V130, P2412, DOI 10.1093/brain/awm147; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Tobler PN, 2007, NEURON, V54, P167, DOI 10.1016/j.neuron.2007.03.004; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Wittmann BC, 2007, NEUROIMAGE, V38, P194, DOI 10.1016/j.neuroimage.2007.06.038	42	480	481	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1264	1267		10.1126/science.1150605	http://dx.doi.org/10.1126/science.1150605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309087				2022-12-28	WOS:000253530600050
J	Laird, DJ; von Andrian, UH; Wagers, AJ				Laird, Diana J.; von Andrian, Ulrich H.; Wagers, Amy J.			Stem cell trafficking in tissue development, growth, and disease	CELL			English	Review							PRIMORDIAL GERM-CELLS; SKELETAL-MUSCLE DEVELOPMENT; COLONY-STIMULATING FACTOR; C-MET RECEPTOR; HEMATOPOIETIC PROGENITOR CELLS; PROTEIN-KINASE-C; BONE-MARROW; SATELLITE CELLS; IN-VIVO; MOUSE EMBRYO	Regulated movement of stem cells is critical for organogenesis during development and for homeostasis and repair in adulthood. Here we analyze the biological significance and molecular mechanisms underlying stem cell trafficking in the generation of the germline, and the generation and regeneration of blood and muscle. Comparison across organisms and lineages reveals remarkable conservation as well as specialization in homing and migration mechanisms used by mature leukocytes, adult and fetal stem cells, and cancer stem cells. In vivo trafficking underpins the successful therapeutic application of hematopoietic stem cells for bone-marrow transplant, and further elucidation of homing and migration pathways in other systems will enable broader application of stem cells for targeted cell therapy and drug delivery.	[Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Laird, Diana J.] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10058 USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Wagers, Amy J.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Joslin Diabetes Center, Inc.; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Harvard University; Harvard University	Wagers, AJ (corresponding author), Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	amy.wagers@joslin.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Laird, Diana/Y-4387-2019		NHLBI NIH HHS [P01 HL56949] Funding Source: Medline; NIAID NIH HHS [R01 AI069259-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; ALADHAMI MA, 1977, DEV GROWTH DIFFER, V19, P171; Anderson R, 1999, DEVELOPMENT, V126, P1655; Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Bajanca F, 2006, DEVELOPMENT, V133, P1635, DOI 10.1242/dev.02336; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bendel-Stenzel MR, 2000, MECH DEVELOP, V91, P143, DOI 10.1016/S0925-4773(99)00287-7; BERNSTEIN A, 1991, SEMIN HEMATOL, V28, P138; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Blaser H, 2005, J CELL SCI, V118, P4027, DOI 10.1242/jcs.02522; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; Christopherson KW, 2003, BLOOD, V101, P4680, DOI 10.1182/blood-2002-12-3893; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Corbel C, 2007, DEV BIOL, V301, P478, DOI 10.1016/j.ydbio.2006.08.069; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Davy A, 2005, DEV DYNAM, V232, P1, DOI 10.1002/dvdy.20200; De Paepe B, 2004, NEUROMUSCULAR DISORD, V14, P265, DOI 10.1016/j.nmd.2004.01.001; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Disatnik MH, 1999, J BIOL CHEM, V274, P32486, DOI 10.1074/jbc.274.45.32486; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; FLEISCHMAN RA, 1993, TRENDS GENET, V9, P285, DOI 10.1016/0168-9525(93)90015-A; FLEMING WH, 1993, P NATL ACAD SCI USA, V90, P3760, DOI 10.1073/pnas.90.8.3760; Formigli L, 2004, J CELL PHYSIOL, V198, P1, DOI 10.1002/jcp.10366; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Fraser ST, 2002, EXP HEMATOL, V30, P1070, DOI 10.1016/S0301-472X(02)00887-1; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Frey M, 1997, J IMMUNOL, V158, P5424; Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; GODIN I, 1990, DEVELOPMENT, V108, P357; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hollnagel A, 2002, MOL CELL BIOL, V22, P4760, DOI 10.1128/MCB.22.13.4760-4770.2002; HUGHES SM, 1990, NATURE, V345, P350, DOI 10.1038/345350a0; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; JAGLARZ MK, 1994, DEVELOPMENT, V120, P83; Jansen J, 2005, J CELL MOL MED, V9, P37, DOI 10.1111/j.1582-4934.2005.tb00335.x; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Kunwar PS, 2003, PLOS BIOL, V1, P372, DOI 10.1371/journal.pbio.0000080; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; Levesque JP, 2004, BLOOD, V104, P65, DOI 10.1182/blood-2003-05-1589; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mazo IB, 2002, BLOOD, V99, P4182, DOI 10.1182/blood.V99.11.4182; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagata Y, 2006, J CELL BIOL, V174, P245, DOI 10.1083/jcb.200605028; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Papayannopoulou T, 1999, ANN NY ACAD SCI, V872, P187, DOI 10.1111/j.1749-6632.1999.tb08464.x; Papayannopoulou T, 2000, SEMIN HEMATOL, V37, P11, DOI 10.1016/S0037-1963(00)90084-2; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; QIAN F, 1994, CELL, V77, P335, DOI 10.1016/0092-8674(94)90149-X; Qian F, 2001, P NATL ACAD SCI USA, V98, P3976, DOI 10.1073/pnas.061633698; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Renault AD, 2004, SCIENCE, V305, P1963, DOI 10.1126/science.1102421; RHODES KE, 2008, CELL STEM CELL; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Saba JD, 2004, J CELL BIOCHEM, V92, P967, DOI 10.1002/jcb.20128; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103; Shah K, 2005, ANN NEUROL, V57, P34, DOI 10.1002/ana.20306; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; SNOW MHL, 1981, J EMBRYOL EXP MORPH, V65, P269; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; Stebler J, 2004, DEV BIOL, V272, P351, DOI 10.1016/j.ydbio.2004.05.009; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Swartz ME, 2001, DEVELOPMENT, V128, P4669; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Taoudi S, 2005, DEVELOPMENT, V132, P4179, DOI 10.1242/dev.01974; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Taverna D, 1998, J CELL BIOL, V143, P849, DOI 10.1083/jcb.143.3.849; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538; Wagers AJ, 2002, EXP HEMATOL, V30, P176, DOI 10.1016/S0301-472X(01)00777-9; WATT DJ, 1987, ANAT EMBRYOL, V175, P527, DOI 10.1007/BF00309688; Weidinger G, 1999, DEVELOPMENT, V126, P5295; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Yoon C, 1997, DEVELOPMENT, V124, P3157; Yoshimizu T, 2001, DEVELOPMENT, V128, P481; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	143	256	271	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					612	630		10.1016/j.cell.2008.01.041	http://dx.doi.org/10.1016/j.cell.2008.01.041			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295579	Bronze			2022-12-28	WOS:000253817900021
J	Harada, Y; Takagaki, Y; Sunagawa, M; Saito, T; Yamada, L; Taniguchi, H; Shoguchi, E; Sawada, H				Harada, Yoshito; Takagaki, Yuhei; Sunagawa, Masahiko; Saito, Takako; Yamada, Lixy; Taniguchi, Hisaaki; Shoguchi, Eiichi; Sawada, Hitoshi			Mechanism of self-sterility in a hermaphroditic chordate	SCIENCE			English	Article							SEA-URCHIN SPERM; CIONA-INTESTINALIS; PHYSIOLOGICAL PROBLEMS; ACROSOMAL REGION; CATION CHANNEL; FERTILIZATION; PROTEIN; RECOGNITION; INCOMPATIBILITY; DISCRIMINATION	Hermaphroditic organisms avoid inbreeding by a system of self- incompatibility ( SI). A primitive chordate ( ascidian) Ciona intestinalis is an example of such an organism, but the molecular mechanism underlying its SI system is not known. Here, we show that the SI system is governed by two gene loci that act cooperatively. Each locus contains a tightly linked pair of polycystin 1- related receptor ( s- Themis) and fibrinogen- like ligand ( v- Themis) genes, the latter of which is located in the first intron of s- Themis but transcribed in the opposite direction. These genes may encode male- and female- side self- recognition molecules. The SI system of C. intestinalis has a similar framework to that of flowering plants but utilizing different molecules.	[Harada, Yoshito; Takagaki, Yuhei; Sunagawa, Masahiko; Saito, Takako; Sawada, Hitoshi] Nagoya Univ, Sugashima Marine Biol Lab, Grad Sch Sci, Toba 5170004, Japan; [Yamada, Lixy; Taniguchi, Hisaaki] Univ Tokushima, Div Dis Proteom, Inst Enzyme Res, Tokushima 7708503, Japan; [Shoguchi, Eiichi] Kyoto Univ, Dept Zool, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	Nagoya University; Tokushima University; Kyoto University	Harada, Y (corresponding author), Nagoya Univ, Sugashima Marine Biol Lab, Grad Sch Sci, Toba 5170004, Japan.	yharada@bio.nagoya-u.ac.jp; hsawada@bio.nagoya-u.ac.jp	Taniguchi, Hisaaki/I-9171-2012	Saito, Takako/0000-0002-3969-9192				Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; BOOKBINDER LH, 1995, SCIENCE, V269, P86, DOI 10.1126/science.7604284; Casselton LA, 2002, HEREDITY, V88, P142, DOI 10.1038/sj.hdy.6800035; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; Delmas P, 2004, CELL, V118, P145, DOI 10.1016/j.cell.2004.07.007; DESANTIS R, 1991, MOL REPROD DEV, V29, P47, DOI 10.1002/mrd.1080290108; Gao ZQ, 2003, CURR BIOL, V13, P2175, DOI 10.1016/j.cub.2003.11.053; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Inaba K, 2002, MOL REPROD DEV, V62, P431, DOI 10.1002/mrd.10131; Jiang D, 2005, BIOL BULL-US, V209, P107, DOI 10.2307/3593128; KAWAMURA K, 1987, DEV GROWTH DIFFER, V29, P627; Kierszenbaum AL, 2004, MOL REPROD DEV, V67, P385, DOI 10.1002/mrd.20042; Kim JH, 2007, GENOME RES, V17, P1101, DOI 10.1101/gr.5894107; Mengerink KJ, 2002, J BIOL CHEM, V277, P943, DOI 10.1074/jbc.M109673200; Morgan TH, 1942, J EXP ZOOL, V90, P199, DOI 10.1002/jez.1400900205; Morgan TH, 1944, J EXP ZOOL, V95, P37, DOI 10.1002/jez.1400950105; Morgan TH, 1939, J EXP ZOOL, V80, P19, DOI 10.1002/jez.1400800103; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; Murabe N, 2002, ZOOL SCI, V19, P527, DOI 10.2108/zsj.19.527; Neill AT, 2004, MOL REPROD DEV, V67, P472, DOI 10.1002/mrd.20033; Nyholm SV, 2006, IMMUNITY, V25, P163, DOI 10.1016/j.immuni.2006.04.011; ROSATI F, 1978, EXP CELL RES, V112, P111, DOI 10.1016/0014-4827(78)90531-1; Sawada H, 2004, P NATL ACAD SCI USA, V101, P15615, DOI 10.1073/pnas.0401928101; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Uyenoyama MK, 2005, NEW PHYTOL, V165, P63, DOI 10.1111/j.1469-8137.2004.01246.x	27	90	91	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					548	550		10.1126/science.1152488	http://dx.doi.org/10.1126/science.1152488			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18356489	Green Published			2022-12-28	WOS:000255249300055
J	Dunn, CW; Hejnol, A; Matus, DQ; Pang, K; Browne, WE; Smith, SA; Seaver, E; Rouse, GW; Obst, M; Edgecombe, GD; Sorensen, MV; Haddock, SHD; Schmidt-Rhaesa, A; Okusu, A; Kristensen, RM; Wheeler, WC; Martindale, MQ; Giribet, G				Dunn, Casey W.; Hejnol, Andreas; Matus, David Q.; Pang, Kevin; Browne, William E.; Smith, Stephen A.; Seaver, Elaine; Rouse, Greg W.; Obst, Matthias; Edgecombe, Gregory D.; Sorensen, Martin V.; Haddock, Steven H. D.; Schmidt-Rhaesa, Andreas; Okusu, Akiko; Kristensen, Reinhardt Mobjerg; Wheeler, Ward C.; Martindale, Mark Q.; Giribet, Gonzalo			Broad phylogenomic sampling improves resolution of the animal tree of life	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BAYESIAN-INFERENCE; ARTHROPODS; EUKARYOTES; ECDYSOZOA; EVOLUTION; SELECTION; POSITION; DATABASE; CLADE	Long-held ideas regarding the evolutionary relationships among animals have recently been upended by sometimes controversial hypotheses based largely on insights from molecular data(1,2). These new hypotheses include a clade of moulting animals (Ecdysozoa)(3) and the close relationship of the lophophorates to molluscs and annelids (Lophotrochozoa)(4). Many relationships remain disputed, including those that are required to polarize key features of character evolution, and support for deep nodes is often low. Phylogenomic approaches, which use data from many genes, have shown promise for resolving deep animal relationships, but are hindered by a lack of data from many important groups. Here we report a total of 39.9 Mb of expressed sequence tags from 29 animals belonging to 21 phyla, including 11 phyla previously lacking genomic or expressed-sequence-tag data. Analysed in combination with existing sequences, our data reinforce several previously identified clades that split deeply in the animal tree (including Protostomia, Ecdysozoa and Lophotrochozoa), unambiguously resolve multiple long-standing issues for which there was strong conflicting support in earlier studies with less data (such as velvet worms rather than tardigrades as the sister group of arthropods(5)), and provide molecular support for the monophyly of molluscs, a group long recognized by morphologists. In addition, we find strong support for several new hypotheses. These include a clade that unites annelids (including sipunculans and echiurans) with nemerteans, phoronids and brachiopods, molluscs as sister to that assemblage, and the placement of ctenophores as the earliest diverging extant multicellular animals. A single origin of spiral cleavage (with subsequent losses) is inferred from well-supported nodes. Many relationships between a stable subset of taxa find strong support, and a diminishing number of lineages remain recalcitrant to placement on the tree.	[Dunn, Casey W.; Hejnol, Andreas; Matus, David Q.; Pang, Kevin; Browne, William E.; Seaver, Elaine; Martindale, Mark Q.] Univ Hawaii, Kewalo Marine Lab, PBRC, Honolulu, HI 96813 USA; [Smith, Stephen A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Rouse, Greg W.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Obst, Matthias] Kristineberg Marine Res Stn, S-45034 Fiskebackskil, Sweden; [Edgecombe, Gregory D.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Sorensen, Martin V.] Univ Copenhagen, Ancient DNA & Evolut Grp, Inst Biol, DK-2100 Copenhagen, Denmark; [Haddock, Steven H. D.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Schmidt-Rhaesa, Andreas] Univ Hamburg, Museum Zool, D-20146 Hamburg, Germany; [Okusu, Akiko] Simmons Coll, Dept Biol, Boston, MA 02115 USA; [Kristensen, Reinhardt Mobjerg] Univ Copenhagen, Zool Museum, DK-2100 Copenhagen, Denmark; [Wheeler, Ward C.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Giribet, Gonzalo] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Giribet, Gonzalo] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Hawaii System; Yale University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Natural History Museum London; University of Copenhagen; Monterey Bay Aquarium Research Institute; University of Hamburg; Simmons University; University of Copenhagen; American Museum of Natural History (AMNH); Harvard University; Harvard University	Dunn, CW (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, 80 Waterman St, Providence, RI 02912 USA.	casey_dunn@brown.edu	Browne, William E/D-4267-2013; Matus, David/E-9972-2010; Rouse, Greg W/F-2611-2010; Browne, William E./AAV-4035-2021; Hejnol, Andreas/C-5577-2012; Rouse, Gregory/AAW-1494-2021; Smith, Stephen/B-3451-2010; Sørensen, Martin V/A-8852-2013; Kristensen, Reinhardt M/A-8772-2013; Smith, Stephen/AAE-8623-2019; Giribet, Gonzalo/P-1086-2015	Browne, William E/0000-0001-8200-6489; Matus, David/0000-0002-1570-5025; Rouse, Greg W/0000-0001-9036-9263; Browne, William E./0000-0001-8200-6489; Hejnol, Andreas/0000-0003-2196-8507; Rouse, Gregory/0000-0001-9036-9263; Sørensen, Martin V/0000-0002-0377-0276; Kristensen, Reinhardt M/0000-0001-9549-1188; Smith, Stephen/0000-0003-2035-9531; Edgecombe, Gregory/0000-0002-9591-8011; Giribet, Gonzalo/0000-0002-5467-8429; Dunn, Casey/0000-0003-0628-5150				Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Baurain D, 2007, MOL BIOL EVOL, V24, P6, DOI 10.1093/molbev/msl137; Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Freeman G, 2002, DEV BIOL, V252, P301, DOI 10.1006/dbio.2002.0854; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Giribet G, 2002, MOL PHYLOGENET EVOL, V24, P345, DOI 10.1016/S1055-7903(02)00206-3; Giribet G, 2000, SYST BIOL, V49, P539, DOI 10.1080/10635159950127385; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; MORRIS SC, 1995, PHILOS T ROY SOC B, V347, P305, DOI 10.1098/rstb.1995.0029; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Parkinson J, 2004, BIOINFORMATICS, V20, P1398, DOI 10.1093/bioinformatics/bth101; Philip GK, 2005, MOL BIOL EVOL, V22, P1175, DOI 10.1093/molbev/msi102; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Philippe H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000717; Philippe H, 2006, TRENDS ECOL EVOL, V21, P614, DOI 10.1016/j.tree.2006.08.004; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Schmidt-Rhaesa A, 2001, ZOOL ANZ, V240, P549, DOI 10.1078/0044-5231-00066; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Swofford D.L., 2003, PAUP VERSION 40 B10; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Telford MJ, 2005, MOL BIOL EVOL, V22, P1129, DOI 10.1093/molbev/msi099; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorley JL, 1999, J THEOR BIOL, V200, P343, DOI 10.1006/jtbi.1999.0999; Van Dongen S, 2000, THESIS U UTRECHT NET; VANDONGEN S, 2000, INSR0010 STICHT MATH	41	1430	1479	9	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2008	452	7188					745	U5		10.1038/nature06614	http://dx.doi.org/10.1038/nature06614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18322464				2022-12-28	WOS:000254792500044
J	Marx, H; Amin, P; Lazarus, JH				Marx, Helen; Amin, Pina; Lazarus, John H.			Pregnancy plus - Hyperthyroidism and pregnancy	BRITISH MEDICAL JOURNAL			English	Article							THYROTOXICOSIS COMPLICATING PREGNANCY; GRAVES-DISEASE; THYROID-FUNCTION; MANAGEMENT; FETAL; POSTPARTUM; INFANTS	Pregnant women with hyperthyroidism need careful management as some may be at increased risk of fetal loss, pre-eclampsia, heart failure, premature labour, and having a low birthweight baby	[Marx, Helen; Lazarus, John H.] Univ Wales Hosp, Dept Obstet, Cardiff CF14 4XN, Wales; [Amin, Pina] Univ Wales Hosp, Ctr Endocrine & Diabet Sci, Cardiff, Wales	Cardiff University; Cardiff University	Lazarus, JH (corresponding author), Univ Wales Hosp, Dept Obstet, Cardiff CF14 4XN, Wales.	lazarus@cf.ac.uk	Lazarus, John H/H-5108-2017	Lazarus, John H/0000-0001-8852-704X				Abalovich M, 2007, J CLIN ENDOCR METAB, V92, pS1, DOI 10.1210/jc.2007-0141; Anselmo J, 2004, JAMA-J AM MED ASSOC, V292, P691, DOI 10.1001/jama.292.6.691; Azizi F, 2000, J CLIN ENDOCR METAB, V85, P3233, DOI 10.1210/jc.85.9.3233; Casey BM, 2006, OBSTET GYNECOL, V107, P337, DOI 10.1097/01.AOG.0000197991.64246.9a; CLINOER D, 2007, THYROID DIS MANAGER, pCH14; DAVIS LE, 1989, AM J OBSTET GYNECOL, V160, P63, DOI 10.1016/0002-9378(89)90088-4; HAMBURGER JI, 1992, THYROID, V2, P219, DOI 10.1089/thy.1992.2.219; KLASCO RK, 2005, REPROTOX DATABASE; KRIPLANI A, 1994, EUR J OBSTET GYN R B, V54, P159, DOI 10.1016/0028-2243(94)90276-3; Laurberg P, 1998, EUR J ENDOCRINOL, V139, P584, DOI 10.1530/eje.0.1390584; LAZARUS JH, 2007, DIABETES OBES, V14, P389; Lazarus JH, 2005, WOMENS HEALTH, V1, P97, DOI 10.1517/17455057.1.1.097; Lee YS, 2002, J PAEDIATR CHILD H, V38, P206, DOI 10.1046/j.1440-1754.2002.00741.x; Luton D, 2005, J CLIN ENDOCR METAB, V90, P6093, DOI 10.1210/jc.2004-2555; MAJOR C, 1994, HIGH RISK PREGNANCY, P315; MANDEL SJ, 1994, THYROID, V4, P129, DOI 10.1089/thy.1994.4.129; MILLAR LK, 1994, OBSTET GYNECOL, V84, P946; Muller AF, 2001, ENDOCR REV, V22, P605, DOI 10.1210/er.22.5.605; NELSONPIERCY C, 2007, OBSTET MED PROBLEM B; Polak M, 2004, BEST PRACT RES CL EN, V18, P289, DOI 10.1016/j.beem.2004.03.099; Royal College of Physicians, 2007, REP WORK PART; Sheffield JS, 2004, AM J OBSTET GYNECOL, V190, P211, DOI 10.1016/S0002-9378(03)00944-X; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707	23	47	51	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 22	2008	336	7645					663	667		10.1136/bmj.39462.709005.AE	http://dx.doi.org/10.1136/bmj.39462.709005.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RH	18356235	Green Published			2022-12-28	WOS:000254443400028
J	Droser, ML; Gehling, JG				Droser, Mary L.; Gehling, James G.			Synchronous aggregate growth in an abundant new Ediacaran tubular organism	SCIENCE			English	Article							REPRODUCTION; FOSSILS	The most abundant taxon of the Neoproterozoic soft- bodied biota near Ediacara, South Australia, occurs as clusters of similarly sized individuals, which suggests synchronous aggregate growth by spatfall. Tubes of Funisia dorothea gen. et sp. nov. were anchored within the shallow, sandy sea bed and lived in dense, typically monospecific concentrations. Tubes were composed of modular, serially repeating elements. Individuals grew by adding serial elements to the tubular body and by branching of tubes. Their construction and close- packed association imply likely affinity within the Porifera or Cnidaria. These data suggest that several of the most successful marine invertebrate ecological strategies known today were in place in Earth's oldest known metazoan ecosystems before the advent of skeletonization and widespread predation.	[Droser, Mary L.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Gehling, James G.] S Australian Museum, Adelaide, SA 5000, Australia	University of California System; University of California Riverside	Droser, ML (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	Mary.droser@ucr.edu						Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; BENGSTON S, 1992, SCIENCE, V257, P1645; CRISP DJ, 1979, BIOL SYSTEMATICS COL, P319; Droser ML, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P125; Droser ML, 2006, PALAEOGEOGR PALAEOCL, V232, P131, DOI 10.1016/j.palaeo.2005.12.015; Fautin DG, 2002, CAN J ZOOL, V80, P1735, DOI 10.1139/Z02-133; Gehling JG, 2000, PALAEONTOLOGY, V43, P427, DOI 10.1111/j.0031-0239.2000.00134.x; Gehling JG, 1999, PALAIOS, V14, P40, DOI 10.2307/3515360; Gehling JG, 2000, PRECAMBRIAN RES, V100, P65, DOI 10.1016/S0301-9268(99)00069-8; GEHLING JG, 2005, EDIACARA ORGANISMS R; GLAESSNER MF, 1969, LETHAIA, V2, P369, DOI 10.1111/j.1502-3931.1969.tb01258.x; HOLTS LJ, 1993, MAR BIOL, V116, P129, DOI 10.1007/BF00350740; JACKSON JBC, 1983, BIOTIC INTERACTIONS, V3, P39; Jacobs DK, 2005, EVOL DEV, V7, P498, DOI 10.1111/j.1525-142X.2005.05055.x; Peterson KJ, 2003, INTEGR COMP BIOL, V43, P127, DOI 10.1093/icb/43.1.127; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377	16	81	84	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1660	1662		10.1126/science.1152595	http://dx.doi.org/10.1126/science.1152595			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356525				2022-12-28	WOS:000254172300039
J	Feero, WG; Guttmacher, AE; Collins, FS				Feero, W. Gregory; Guttmacher, Alan E.; Collins, Francis S.			The genome gets personal - Almost	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WIDE ASSOCIATION		[Feero, W. Gregory; Guttmacher, Alan E.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Feero, WG (corresponding author), NHGRI, NIH, Bldg 31,Room 4B09,31 Ctr Dr, Bethesda, MD 20892 USA.	feerow@mail.nih.gov						Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; HARRIS L, 2007, J CLIN ONCOL    1022; Hudson KL, 2007, NEW ENGL J MED, V356, P2021, DOI 10.1056/NEJMp078033; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Kaiser J, 2008, SCIENCE, V319, P395, DOI 10.1126/science.319.5862.395; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; 2008, NATURE, V451, P745	15	129	131	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1351	1352		10.1001/jama.299.11.1351	http://dx.doi.org/10.1001/jama.299.11.1351			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349096				2022-12-28	WOS:000254079100026
J	White, HD; Dalby, AJ				White, Harvey D.; Dalby, Anthony J.			Heart disease in Soweto: facing a triple threat	LANCET			English	Editorial Material							CARDIOVASCULAR-DISEASE; AFRICA; BURDEN; CARDIOMYOPATHY; EPIDEMIOLOGY		[White, Harvey D.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1030, New Zealand; [Dalby, Anthony J.] Milpk Hosp, Johannesburg, South Africa	Auckland City Hospital	White, HD (corresponding author), Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1030, New Zealand.	harveyw@adhb.govt.nz						Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Commerford P, 2006, LANCET, V367, P1884, DOI 10.1016/S0140-6736(06)68822-3; Ghaffar A, 2004, BMJ-BRIT MED J, V328, P807, DOI 10.1136/bmj.328.7443.807; Hakim J. G., 1995, Central African Journal of Medicine, V41, P303; MAGOZZINI P, 2007, THER ADV CARDIOVASC, V1, P83; MARAVANYIKA B, 2008, SATURDAY STAR   0119; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Mark DB, 2007, EUR HEART J, V28, P2678, DOI 10.1093/eurheartj/ehm411; Mayosi B, 2006, SAMJ S AFR MED J, V96, P246; Mayosi BM, 2007, HEART, V93, P1176, DOI 10.1136/hrt.2007.127746; Sliwa K, 2005, CIRCULATION, V112, P3577, DOI 10.1161/CIRCULATIONAHA.105.542894; Sliwa K, 2008, LANCET, V371, P915, DOI 10.1016/S0140-6736(08)60417-1; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	13	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 15	2008	371	9616					876	877		10.1016/S0140-6736(08)60391-8	http://dx.doi.org/10.1016/S0140-6736(08)60391-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342667				2022-12-28	WOS:000254056800006
J	Ellegren, H; Sheldon, BC				Ellegren, Hans; Sheldon, Ben C.			Genetic basis of fitness differences in natural populations	NATURE			English	Review							WILD BIRD POPULATION; QUANTITATIVE TRAIT LOCI; CIS-REGULATORY CHANGES; FROG RANA-TEMPORARIA; DARWINS FINCHES; RED DEER; COUNTERGRADIENT VARIATION; EVOLUTIONARY SIGNIFICANCE; MORPHOLOGICAL EVOLUTION; LINKAGE DISEQUILIBRIUM	Genomics profoundly influences current biology. One of many exciting consequences of this revolution is the potential for identifying and studying the genetic basis of those traits affecting fitness that are key to natural selection. Recent studies using a multitude of genomic approaches have established such genotype - phenotype relationships in natural populations, giving new insight into the genetic architecture of quantitative variation. In parallel, an emerging understanding of the quantitative genetics of fitness variation in the wild means that we are poised to see a synthesis of ecological and molecular approaches in evolutionary biology.	[Ellegren, Hans] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; [Sheldon, Ben C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	Uppsala University; University of Oxford	Ellegren, H (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	hans.ellegren@ebc.uu.se; ben.sheldon@zoo.ox.ac.uk	Sheldon, Ben C/A-8056-2010	Sheldon, Ben C/0000-0002-5240-7828				Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Backstrom N, 2006, BIOL LETTERS, V2, P435, DOI 10.1098/rsbl.2006.0507; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beraldi D, 2007, EVOLUTION, V61, P1403, DOI 10.1111/j.1558-5646.2007.00106.x; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Campbell D, 2004, MOL BIOL EVOL, V21, P945, DOI 10.1093/molbev/msh101; CARROLL SB, 2005, ENDLESS FORMS MOST B; Charmantier A, 2006, P NATL ACAD SCI USA, V103, P6587, DOI 10.1073/pnas.0511123103; Charmantier A, 2006, TRENDS ECOL EVOL, V21, P417, DOI 10.1016/j.tree.2006.06.001; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Dahlhoff EP, 2000, P NATL ACAD SCI USA, V97, P10056, DOI 10.1073/pnas.160277697; Derome N, 2006, MOL BIOL EVOL, V23, P2370, DOI 10.1093/molbev/msl110; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; Fisher R.A., 1930, GENETICAL THEORY NAT; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; FRANK SA, 1995, J THEOR BIOL, V175, P373, DOI 10.1006/jtbi.1995.0148; Garant D, 2004, AM NAT, V164, pE115, DOI 10.1086/424764; Garant D, 2005, NATURE, V433, P60, DOI 10.1038/nature03051; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; Gilad Y, 2006, TRENDS GENET, V22, P456, DOI 10.1016/j.tig.2006.06.002; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Knapczyk FN, 2007, AM NAT, V170, P501, DOI 10.1086/521239; Kruuk LEB, 2002, EVOLUTION, V56, P1683, DOI 10.1111/j.0014-3820.2002.tb01480.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kruuk LEB, 2000, P NATL ACAD SCI USA, V97, P698, DOI 10.1073/pnas.97.2.698; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; LANDE R, 1982, ECOLOGY, V63, P607, DOI 10.2307/1936778; Laugen AT, 2003, J EVOLUTION BIOL, V16, P996, DOI 10.1046/j.1420-9101.2003.00560.x; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Lynch M., 1998, GENETICS ANAL QUANTI; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; Metcalf CJE, 2007, TRENDS ECOL EVOL, V22, P205, DOI 10.1016/j.tree.2006.12.001; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; Pennings PS, 2006, PLOS GENET, V2, P1998, DOI 10.1371/journal.pgen.0020186; PRICE GR, 1972, ANN HUM GENET, V36, P129, DOI 10.1111/j.1469-1809.1972.tb00764.x; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rogers SM, 2005, MOL ECOL, V14, P351, DOI 10.1111/j.1365-294X.2004.02396.x; Rosenblum EB, 2004, EVOLUTION, V58, P1794, DOI 10.1111/j.0014-3820.2004.tb00462.x; Schneider RA, 2003, SCIENCE, V299, P565, DOI 10.1126/science.1077827; Slate J, 2007, J EVOLUTION BIOL, V20, P1415, DOI 10.1111/j.1420-9101.2007.01339.x; Slate J, 2002, GENETICS, V162, P1863; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Williams JT, 1999, ANN HUM GENET, V63, P545, DOI 10.1017/S0003480099007848; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wilson AJ, 2006, PLOS BIOL, V4, P1270, DOI 10.1371/journal.pbio.0040216; Wilson AJ, 2007, EVOL ECOL, V21, P337, DOI 10.1007/s10682-006-9106-z; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	74	268	276	1	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2008	452	7184					169	175		10.1038/nature06737	http://dx.doi.org/10.1038/nature06737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337813				2022-12-28	WOS:000253925600031
J	Williams, B; Ruff, TA				Williams, Bill; Ruff, Tilman A.			Getting nuclear-bomb fuel out of radiopharmaceuticals	LANCET			English	Editorial Material									[Williams, Bill; Ruff, Tilman A.] Int Campaign Abolish Nucl Weap, Melbourne, Vic, Australia; [Ruff, Tilman A.] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic 3010, Australia	University of Melbourne	Ruff, TA (corresponding author), Int Campaign Abolish Nucl Weap, Melbourne, Vic, Australia.	tar@unimelb.edu.au						Bunn M, 2006, ANN AM ACAD POLIT SS, V607, P133, DOI 10.1177/0002716206290260; Collier R, 2008, CAN MED ASSOC J, V178, P536, DOI 10.1503/cmaj.080154; GOLDEMBERG J, 2006, MINIMISATION HIGHLY; Helfand I, 2002, BRIT MED J, V324, P356, DOI 10.1136/bmj.324.7333.356; *IAEA, INT VER SER, V3; *IAEA, 2005, ILL NUCL TRAFF FACTS; Kahn Laura H, 2007, J Am Coll Radiol, V4, P248, DOI 10.1016/j.jacr.2006.12.012; Kuperman AJ, 2006, B ATOM SCI, V62, P44, DOI 10.2968/062002012; *NAT AC SCI, MED IS PROD HIGHL EN; National Research Council, 2002, MAK NAT SAF ROL SCI; Williams Bill, 2007, Med Confl Surviv, V23, P267, DOI 10.1080/13623690701596692	11	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2008	371	9615					795	797		10.1016/S0140-6736(08)60359-1	http://dx.doi.org/10.1016/S0140-6736(08)60359-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272NQ	18328913				2022-12-28	WOS:000253866500009
J	Huh, JH; Bauer, MJ; Hsieh, TF; Fischer, RL				Huh, Jin Hoe; Bauer, Matthew J.; Hsieh, Tzung-Fu; Fischer, Robert L.			Cellular programming of plant gene imprinting	CELL			English	Review							MEDEA POLYCOMB GENE; INDEPENDENT SEED DEVELOPMENT; DNA GLYCOSYLASE/LYASE ROS1; ENDOSPERM DEVELOPMENT; ARABIDOPSIS-THALIANA; GROUP PROTEINS; FEMALE GAMETOPHYTE; FERTILIZATION; METHYLATION; EXPRESSION	Gene imprinting, the differential expression of maternal and paternal alleles, independently evolved in mammals and in flowering plants. A unique feature of flowering plants is a double-fertilization event in which the sperm fertilize not only the egg, which forms the embryo, but also the central cell, which develops into the endosperm (an embryo-supporting tissue). The distinctive mechanisms of gene imprinting in the endosperm, which involve DNA demethylation and histone methylation, begin in the central cell and sperm prior to fertilization. Flowering plants might have coevolved double fertilization and imprinting to prevent parthenogenetic development of the endosperm.	[Huh, Jin Hoe; Bauer, Matthew J.; Hsieh, Tzung-Fu; Fischer, Robert L.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Fischer, RL (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	rfischer@berkeley.edu		Bauer, Matthew/0000-0002-1242-0665; Hsieh, Tzung-Fu/0000-0001-7584-3721	NIGMS NIH HHS [R01-GM069415] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069415] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams S, 2000, DEVELOPMENT, V127, P2493; Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Berger E., 2007, V8, P91, DOI 10.1007/7089_2007_111; Bicknell RA, 2004, PLANT CELL, V16, pS228, DOI 10.1105/tpc.017921; BIRCHLER JA, 1993, ANNU REV GENET, V27, P181, DOI 10.1146/annurev.ge.27.120193.001145; Brown R. C., 2007, V8, P1, DOI 10.1007/7089_2007_106; Brown RC, 2003, PROTOPLASMA, V222, P167, DOI 10.1007/s00709-003-0010-x; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; Choi Y, 2004, P NATL ACAD SCI USA, V101, P7481, DOI 10.1073/pnas.0402328101; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Danilevskaya ON, 2003, PLANT CELL, V15, P425, DOI 10.1105/tpc.006759; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Dilkes BP, 2004, PLANT CELL, V16, P3174, DOI 10.1105/tpc.104.161230; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Friedman WE, 2006, NATURE, V441, P337, DOI 10.1038/nature04690; Friedman WE, 2001, CR ACAD SCI III-VIE, V324, P559, DOI 10.1016/S0764-4469(01)01326-9; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guitton AE, 2004, DEVELOPMENT, V131, P2971, DOI 10.1242/dev.01168; Gutierrez-Marcos JF, 2006, NAT GENET, V38, P876, DOI 10.1038/ng1828; Haerizadeh F, 2006, SCIENCE, V313, P496, DOI 10.1126/science.1125526; HAIG D, 1991, PHILOS T ROY SOC B, V333, P1, DOI 10.1098/rstb.1991.0057; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hermon P, 2007, PLANT MOL BIOL, V64, P387, DOI 10.1007/s11103-007-9160-0; Iwakawa H, 2006, PLANT J, V45, P819, DOI 10.1111/j.1365-313X.2005.02643.x; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Jost JP, 2001, NUCLEIC ACIDS RES, V29, P4452, DOI 10.1093/nar/29.21.4452; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Katz A, 2004, PLANT J, V37, P707, DOI 10.1111/j.1365-313X.2003.01996.x; Kawabe A, 2007, CURR BIOL, V17, P1885, DOI 10.1016/j.cub.2007.09.051; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kinoshita T, 2001, P NATL ACAD SCI USA, V98, P14156, DOI 10.1073/pnas.241507798; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Le BH, 2007, PLANT PHYSIOL, V144, P562, DOI 10.1104/pp.107.100362; Leroy O, 2007, DEVELOPMENT, V134, P3639, DOI 10.1242/dev.009027; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; McVean GT, 1997, P ROY SOC B-BIOL SCI, V264, P739, DOI 10.1098/rspb.1997.0105; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Nguyen H, 2000, PROTOPLASMA, V212, P99, DOI 10.1007/BF01279351; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Nowack MK, 2007, NATURE, V447, P312, DOI 10.1038/nature05770; Ohad N, 1999, PLANT CELL, V11, P407, DOI 10.1105/tpc.11.3.407; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Penterman J, 2007, PLANT PHYSIOL, V145, P1549, DOI 10.1104/pp.107.107730; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Scott RJ, 2006, CYTOGENET GENOME RES, V113, P53, DOI 10.1159/000090815; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Singh MB, 2007, BIOESSAYS, V29, P1124, DOI 10.1002/bies.20660; Skinner DJ, 2004, PLANT CELL, V16, pS32, DOI 10.1105/tpc.015933; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Spillane C, 2007, NATURE, V448, P349, DOI 10.1038/nature05984; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; UNG, 2006, NAT GENET, V38, P706; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	80	117	125	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					735	744		10.1016/j.cell.2008.02.018	http://dx.doi.org/10.1016/j.cell.2008.02.018			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329361	Bronze			2022-12-28	WOS:000253818000012
J	Morse, SS				Morse, Stephen S.			Retrospective - Joshua Lederberg (1925-2008)	SCIENCE			English	Biographical-Item									[Morse, Stephen S.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA	Columbia University	Morse, SS (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA.	ssm20@columbia.edu							0	0	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1351	1351		10.1126/science.1156612	http://dx.doi.org/10.1126/science.1156612			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323443				2022-12-28	WOS:000253712900032
J	Staunton, H				Staunton, Hugh			Arousal by stimulation of deep-brain nuclei	NATURE			English	Letter							SYSTEMS		[Staunton, Hugh] Beaumont Hosp, Royal Coll Surg Ireland, Dept Clin Neurol Sci, Dublin 9, Ireland	Royal College of Surgeons - Ireland	Staunton, H (corresponding author), Beaumont Hosp, Royal Coll Surg Ireland, Dept Clin Neurol Sci, Dublin 9, Ireland.	hugh@iol.ie						DIECKMANN G, 1968, J NEUROL SCI, V7, P385, DOI 10.1016/0022-510X(68)90157-3; HASSLER R, 1969, ELECTROEN CLIN NEURO, V27, P689; HASSLER R, 1969, ELECTROEN CLIN NEURO, V27, P306, DOI 10.1016/0013-4694(69)90060-1; JONES EG, 1989, EUR J NEUROSCI, V1, P222, DOI 10.1111/j.1460-9568.1989.tb00791.x; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; KRETSCHMER E, 1940, GESAMTE NEUROL PSYCH, V169, P576; McLardy T, 1968, Trans Am Neurol Assoc, V93, P25; Morison RS, 1942, AM J PHYSIOL, V135, P0281, DOI 10.1152/ajplegacy.1941.135.2.281; SASAKI K, 1970, Experimental Neurology, V26, P369, DOI 10.1016/0014-4886(70)90133-0; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041	10	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					E1	E1		10.1038/nature06574	http://dx.doi.org/10.1038/nature06574			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322474				2022-12-28	WOS:000253671900041
J	Tice, JA; Cummings, SR; Smith-Bindman, R; Ichikawa, L; Barlow, WE; Kerlikowske, K				Tice, Jeffrey A.; Cummings, Steven R.; Smith-Bindman, Rebecca; Ichikawa, Laura; Barlow, William E.; Kerlikowske, Karla			Using clinical factors and mammographic breast density to estimate breast cancer risk: Development and validation of a new predictive model	ANNALS OF INTERNAL MEDICINE			English	Article							PARENCHYMAL PATTERNS; ETHNIC-GROUPS; SCREENING MAMMOGRAPHY; FAMILY-HISTORY; WOMEN; CHEMOPREVENTION; PERFORMANCE; TAMOXIFEN; ACCURACY; MARKER	Background: Current models for assessing breast cancer risk are complex and do not include breast density, a strong risk factor for breast cancer that is routinely reported with mammography. Objective: To develop and validate an easy-to-use breast cancer risk prediction model that includes breast density. Design: Empirical model based on Surveillance, Epidemiology, and End Results incidence, and relative hazards from a prospective cohort. Setting: Screening mammography sites participating in the Breast Cancer Surveillance Consortium. Patients: 1 095 484 women undergoing mammography who had no previous diagnosis of breast cancer. Measurements: Self-reported age, race or ethnicity, family history of breast cancer, and history of breast biopsy. Community radiologists rated breast density by using 4 Breast Imaging Reporting and Data System categories. Results: During 5.3 years of follow-up, invasive breast cancer was diagnosed in 14 766 women. The breast density model was well calibrated overall ( expected-observed ratio, 1.03 [ 95% CI, 0.99 to 1.06]) and in racial and ethnic subgroups. It had modest discriminatory accuracy ( concordance index, 0.66 [ CI, 0.65 to 0.67]). Women with low-density mammograms had 5-year risks less than 1.67% unless they had a family history of breast cancer and were older than age 65 years. Limitation: The model has only modest ability to discriminate between women who will develop breast cancer and those who will not. Conclusion: A breast cancer prediction model that incorporates routinely reported measures of breast density can estimate 5-year risk for invasive breast cancer. Its accuracy needs to be further evaluated in independent populations before it can be recommended for clinical use.	[Tice, Jeffrey A.] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA; Univ Washington, Seattle, WA 98195 USA	University of California System; University of California San Francisco; University of Washington; University of Washington Seattle	Tice, JA (corresponding author), Univ Calif San Francisco, Dept Med, Div Gen Internal Med, 1701 Divisadero St,Suite 554, San Francisco, CA 94143 USA.	jtice@medicine.ucsf.edu		Tice, Jeffrey/0000-0002-9857-2028	NATIONAL CANCER INSTITUTE [U01CA086076, U01CA063731, U01CA069976, U01CA070013, U01CA086082, U01CA063740, U01CA070040, U01CA063736, K07CA086032, K24CA125036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K12AR047659] Funding Source: NIH RePORTER; NCI NIH HHS [U01CA70013, U01CA69976, U01CA63736, U01 CA086082, U01CA70040, K07 CA086032-01, U01 CA063740, U01CA63731, 01CA63740, U01 CA063731, K24 CA125036, U01 CA069976, K07 CA086032, U01CA86082, U01 CA063736, U01 CA070013, U01CA86076, U01 CA086076, U01 CA070040, K07 CA086032-02] Funding Source: Medline; NIAMS NIH HHS [K12 AR47659, K12 AR047659] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AM CANC SOC, 2007, CANC FACTS FIG 2007; Armstrong K, 2006, ARCH INTERN MED, V166, P2260, DOI 10.1001/archinte.166.20.2260; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Boyd NF, 2002, BRIT J CANCER, V87, P876, DOI 10.1038/sj.bjc.6600537; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; CLAUS EB, 1993, BREAST CANCER RES TR, V28, P115, DOI 10.1007/BF00666424; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; D'Orsi C, 2003, BREAST IMAGING REPOR; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Freedman AN, 2005, JNCI-J NATL CANCER I, V97, P715, DOI 10.1093/jnci/dji128; Freedman AN, 2003, JNCI-J NATL CANCER I, V95, P526, DOI 10.1093/jnci/95.7.526; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2007, J NATL CANCER I, V99, P1782, DOI 10.1093/jnci/djm223; Guo YP, 2001, CANCER EPIDEM BIOMAR, V10, P243; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hawes D, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1408; Kaplan CP, 2006, CANCER EPIDEM BIOMAR, V15, P162, DOI 10.1158/1055-9965.EPI-04-0758; Kerlikowske K, 1998, J NATL CANCER I, V90, P1801, DOI 10.1093/jnci/90.23.1801; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Kerlikowske K, 2007, J NATL CANCER I, V99, P386, DOI 10.1093/jnci/djk066; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V53, P1; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; Martin KE, 2006, RADIOLOGY, V240, P656, DOI 10.1148/radiol.2402041947; Nicholson BT, 2006, ACAD RADIOL, V13, P1143, DOI 10.1016/j.acra.2006.06.005; OZA AM, 1993, EPIDEMIOL REV, V15, P196, DOI 10.1093/oxfordjournals.epirev.a036105; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rockhill B, 2003, J CLIN EPIDEMIOL, V56, P856, DOI 10.1016/S0895-4356(03)00124-0; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; SAFTLAS AF, 1989, AM J EPIDEMIOL, V129, P518, DOI 10.1093/oxfordjournals.aje.a115163; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Shepherd JA, 2006, MED PHYS, V33, P1490, DOI 10.1118/1.2193691; Shepherd JA, 2005, TECHNOL CANCER RES T, V4, P173, DOI 10.1177/153303460500400206; Sickles EA, 2005, RADIOLOGY, V235, P775, DOI 10.1148/radiol.2353040738; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Tchou J, 2004, CANCER-AM CANCER SOC, V100, P1800, DOI 10.1002/cncr.20205; Tice JA, 2005, BREAST CANCER RES TR, V94, P115, DOI 10.1007/s10549-005-5152-4; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Vachon CM, 2007, CANCER EPIDEM BIOMAR, V16, P43, DOI 10.1158/1055-9965.EPI-06-0738; van Gils CH, 1998, J EPIDEMIOL COMMUN H, V52, P267, DOI 10.1136/jech.52.4.267; van Gils CH, 1998, EUR J EPIDEMIOL, V14, P315, DOI 10.1023/A:1007423824675; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; WARNER E, 1992, CANCER DETECT PREV, V16, P67; WOLFE JN, 1987, AM J ROENTGENOL, V148, P1087, DOI 10.2214/ajr.148.6.1087	55	368	376	2	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2008	148	5					337	W75		10.7326/0003-4819-148-5-200803040-00004	http://dx.doi.org/10.7326/0003-4819-148-5-200803040-00004			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268SX	18316752	Green Accepted			2022-12-28	WOS:000253600800002
J	Hofmann, DC; Suh, JY; Wiest, A; Duan, G; Lind, ML; Demetriou, MD; Johnson, WL				Hofmann, Douglas C.; Suh, Jin-Yoo; Wiest, Aaron; Duan, Gang; Lind, Mary-Laura; Demetriou, Marios D.; Johnson, William L.			Designing metallic glass matrix composites with high toughness and tensile ductility	NATURE			English	Article							MECHANICAL-PROPERTIES; ENHANCED PLASTICITY; ROOM-TEMPERATURE; MICROSTRUCTURE; ALLOYS; PHASES; PLATES	The selection and design of modern high- performance structural engineering materials is driven by optimizing combinations of mechanical properties such as strength, ductility, toughness, elasticity and requirements for predictable and graceful ( non-catastrophic) failure in service(1). Highly processable bulk metallic glasses ( BMGs) are a new class of engineering materials and have attracted significant technological interest(2-6). Although many BMGs exhibit high strength and show substantial fracture toughness, they lack ductility and fail in an apparently brittle manner in unconstrained loading geometries(7). For instance, some BMGs exhibit significant plastic deformation in compression or bending tests, but all exhibit negligible plasticity (<0.5% strain) in uniaxial tension. To overcome brittle failure in tension, BMG - matrix composites have been introduced(8,9). The inhomogeneous microstructure with isolated dendrites in a BMG matrix stabilizes the glass against the catastrophic failure associated with unlimited extension of a shear band and results in enhanced global plasticity and more graceful failure. Tensile strengths of similar to 1GPa, tensile ductility of similar to 2 - 3 per cent(9), and an enhanced mode I fracture toughness of K-1C approximate to 40 MPa m(1/2) were reported(8,9). Building on this approach, we have developed 'designed composites' by matching fundamental mechanical and microstructural length scales. Here, we report titanium zirconium- based BMG composites with room- temperature tensile ductility exceeding 10 per cent, yield strengths of 1.2 - 1.5 GPa, K-1C up to similar to 170 MPa m(1/)2, and fracture energies for crack propagation as high as G(1C)approximate to 340 kJ m(-2). The K-1C and G(1C) values equal or surpass those achievable in the toughest titanium or steel alloys, placing BMG composites among the toughest known materials.	[Hofmann, Douglas C.; Suh, Jin-Yoo; Wiest, Aaron; Duan, Gang; Lind, Mary-Laura; Demetriou, Marios D.; Johnson, William L.] CALTECH, Keck Lab Engn Mat, Pasadena, CA 91125 USA	California Institute of Technology	Hofmann, DC (corresponding author), CALTECH, Keck Lab Engn Mat, Pasadena, CA 91125 USA.	dch@caltech.edu	Duan, Gang/B-3188-2009; Suh, Jin-Yoo/E-4374-2019	Suh, Jin-Yoo/0000-0003-3786-6652; Lind, Mary Laura/0000-0001-8585-8054				Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051; Ashby Michael F., 1992, MAT SELECTION MECH D; Chen MW, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.245502; Conner RD, 2004, ACTA MATER, V52, P2429, DOI 10.1016/j.actamat.2004.01.034; Conner RD, 2003, J APPL PHYS, V94, P904, DOI 10.1063/1.1582555; Das J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.205501; Eckert J, 2006, INTERMETALLICS, V14, P876, DOI 10.1016/j.intermet.2006.01.003; Eckert J, 2002, INTERMETALLICS, V10, P1183, DOI 10.1016/S0966-9795(02)00133-4; Fan C, 2000, APPL PHYS LETT, V77, P46, DOI 10.1063/1.126872; GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947; Hays CC, 2000, PHYS REV LETT, V84, P2901, DOI 10.1103/PhysRevLett.84.2901; He G, 2003, SCRIPTA MATER, V48, P1531, DOI 10.1016/S1359-6462(03)00128-3; Hofmann DC, 2006, SCRIPTA MATER, V54, P1117, DOI 10.1016/j.scriptamat.2005.11.065; Johnson WL, 1999, MRS BULL, V24, P42, DOI 10.1557/S0883769400053252; Lee MH, 2004, INTERMETALLICS, V12, P1133, DOI 10.1016/j.intermet.2004.04.027; Lee MH, 2004, MATER LETT, V58, P3312, DOI 10.1016/j.matlet.2004.06.026; Lee ML, 2004, ACTA MATER, V52, P4121, DOI 10.1016/j.actamat.2004.05.025; Lee SY, 2007, J MATER RES, V22, P538, DOI 10.1557/JMR.2007.0066; Lewandowski JJ, 2005, PHIL MAG LETT, V85, P77, DOI 10.1080/09500830500080474; Liang JZ, 2000, J APPL POLYM SCI, V77, P409, DOI 10.1002/(SICI)1097-4628(20000711)77:2<409::AID-APP18>3.0.CO;2-N; Liu YH, 2007, SCIENCE, V315, P1385, DOI 10.1126/science.1136726; MYERS MA, 1984, MECH METALLURGY PRIN; PEKER A, 1993, APPL PHYS LETT, V63, P2342, DOI 10.1063/1.110520; Rao X, 2001, MATER LETT, V50, P279, DOI 10.1016/S0167-577X(01)00240-3; Ravichandran G, 2005, ACTA MATER, V53, P4087, DOI 10.1016/j.actamat.2005.05.011; Salimon AI, 2004, MAT SCI ENG A-STRUCT, V375, P385, DOI 10.1016/j.msea.2003.10.167; Schroers J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.255506; Szuecs F, 2001, ACTA MATER, V49, P1507, DOI 10.1016/S1359-6454(01)00068-4; Yao KF, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2187516	29	1183	1248	37	1052	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1085	U3		10.1038/nature06598	http://dx.doi.org/10.1038/nature06598			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305540				2022-12-28	WOS:000253453600037
J	Abrahm, JL; Banffy, MB; Harris, MB				Abrahm, Janet L.; Banffy, Michael B.; Harris, Mitchel B.			Spinal cord compression in patients with advanced metastatic cancer - "All I care about is walking and living my life"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED TRIAL; EPIDURAL METASTASIS; STEREOTACTIC RADIOSURGERY; SURGICAL RESECTION; PROGNOSTIC-FACTORS; RADIATION-THERAPY; NEUROPATHIC PAIN; VERTEBRAL METASTASIS; BREAST-CANCER; RADIOTHERAPY	As 1 of the 12 700 US cancer patients who, each year, develops metastatic spinal cord compression, Ms H wishes to walk and live her life. Sadly, this wish may be difficult to fulfill. Before diagnosis, 83% to95% of patients experience back pain, which often is referred, obscuring the site( s) of the compression( s). Prediction of ambulation depends on a patient's ambulatory status before therapy and time between developing motor defects and starting therapy. Ambulatory patients with no visceral metastases and more than 15 days between developing motor symptoms and receiving therapy have the best rate of survival. To preserve ambulation and optimize survival, magnetic resonance imaging should be performed for cancer patients with new back pain despite normal neurological findings. At diagnosis, counseling, pain management, and corticosteroids are begun. Most patients are offered radiation therapy. Surgery followed by radiation is considered for selected patients with a single high- grade epidural lesion caused by a radioresistant tumor who also have an estimated survival of more than 3 months. Team discussions with the patient and support network help determine therapy options and include patient goals; assessment of risks, benefits, and burdens of each treatment; and discussion of the odds of preserving prognosis of ambulation and of the effect of therapy on the patient's overall prognosis. Rehabilitation improves impaired function and its associated depression. Clinicians can help patients cope with transitions in self- image, independence, family and community roles, and living arrangements and can help patients with limited prognoses identify their end- of- life goals and preferences about resusitation and entering hospice.	[Abrahm, Janet L.] Harvard Univ, Div Psychosocial Oncol & Palliat Care, Dana Farber Canc Inst, Dept Med Oncol,Sch Med, Boston, MA 02115 USA; [Abrahm, Janet L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Banffy, Michael B.] Harvard Univ, Sch Med, Dept Orthoped Surg, Harvard Combined Orthoped Program, Boston, MA 02115 USA; [Harris, Mitchel B.] Harvard Univ, Sch Med, Dept Orthoped Surg, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Abrahm, JL (corresponding author), Harvard Univ, Div Psychosocial Oncol & Palliat Care, Dana Farber Canc Inst, Dept Med Oncol,Sch Med, 44 Binney St SW 420, Boston, MA 02115 USA.	jabrahm@partners.org						ABRAHM J, 2005, PHYS GUIDE PAIN SYMP; BAUER HCF, 1995, ACTA ORTHOP SCAND, V66, P143, DOI 10.3109/17453679508995508; Bayley A, 2001, CANCER, V92, P303, DOI 10.1002/1097-0142(20010715)92:2<303::AID-CNCR1323>3.0.CO;2-F; BONNER JA, 1990, NEW ENGL J MED, V322, P556; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; BURCH PA, 1988, AM J MED, V84, P555, DOI 10.1016/0002-9343(88)90284-7; Cardenas DD, 2002, PAIN, V96, P365, DOI 10.1016/S0304-3959(01)00483-3; Chataigner H, 2000, EUR SPINE J, V9, P523, DOI 10.1007/s005860000163; Chen YJ, 2007, SPINE, V32, pE413, DOI 10.1097/BRS.0b013e318074d6c7; Colletti PM, 1996, COMPUT MED IMAG GRAP, V20, P159, DOI 10.1016/0895-6111(96)00009-2; Connolly PJ, 1998, SPINE, V23, P1426, DOI 10.1097/00007632-199806150-00024; COOPER K, 1990, J NEURO-ONCOL, V8, P275; CRAIG AR, 1994, BRIT J CLIN PSYCHOL, V33, P221, DOI 10.1111/j.2044-8260.1994.tb01116.x; Daw HA, 2000, CLEV CLIN J MED, V67, P497; Degen JW, 2005, J NEUROSURG-SPINE, V2, P540, DOI 10.3171/spi.2005.2.5.0540; DELATTRE JY, 1989, J NEUROSURG, V70, P920, DOI 10.3171/jns.1989.70.6.0920; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; FOLEY KM, 2005, CANC PRINCIPLES PRAC, P2615; Frankel H L, 1969, Paraplegia, V7, P179; Gagnon GJ, 2007, CANCER-AM CANCER SOC, V110, P1796, DOI 10.1002/cncr.22977; Gerszten PC, 2005, J NEUROSURG-SPINE, V3, P288, DOI 10.3171/spi.2005.3.4.0288; Gerszten PC, 2007, SPINE, V32, P193, DOI 10.1097/01.brs.0000251863.76595.a2; Ghogawala Z, 2001, SPINE, V26, P818, DOI 10.1097/00007632-200104010-00025; Gonzalez MV, 1999, FEBS LETT, V459, P272, DOI 10.1016/S0014-5793(99)01257-0; GREENBERG HS, 1980, ANN NEUROL, V8, P361, DOI 10.1002/ana.410080404; HARRINGTON KD, 1988, CLIN ORTHOP RELAT R, P177; Hayashi T, 1999, NEUROPATH APPL NEURO, V25, P63; Helweg-Larsen S, 2000, INT J RADIAT ONCOL, V46, P1163, DOI 10.1016/S0360-3016(99)00333-8; HelwegLarsen S, 1996, ACTA NEUROL SCAND, V94, P269, DOI 10.1111/j.1600-0404.1996.tb07064.x; Husband DJ, 1998, BRIT MED J, V317, P18, DOI 10.1136/bmj.317.7150.18; Katagiri H, 1998, INT J RADIAT ONCOL, V42, P1127, DOI 10.1016/S0360-3016(98)00288-0; Kienstra GEM, 2000, ARCH NEUROL-CHICAGO, V57, P690, DOI 10.1001/archneur.57.5.690; Kim JK, 2000, MAGN RESON IMAGING, V18, P819, DOI 10.1016/S0730-725X(00)00181-8; KIM RY, 1990, RADIOLOGY, V176, P279, DOI 10.1148/radiology.176.1.2353102; Klimo P, 2005, NEURO-ONCOLOGY, V7, P64, DOI 10.1215/S1152851704000262; Knisely J, 2006, NAT CLIN PRACT ONCOL, V3, P14, DOI 10.1038/ncponc0399; Koch M, 2006, LANCET, V367, P109, DOI 10.1016/S0140-6736(06)67954-3; Kunkler I, 2006, LANCET, V367, P109, DOI 10.1016/S0140-6736(06)67955-5; LEVACK P, 2002, CLIN ONCOL-UK, V4, P472; Levendoglu F, 2004, SPINE, V29, P743, DOI 10.1097/01.BRS.0000112068.16108.3A; LI KC, 1988, MAGN RESON IMAGING, V6, P547, DOI 10.1016/0730-725X(88)90129-4; Loblaw DA, 1998, J CLIN ONCOL, V16, P1613, DOI 10.1200/JCO.1998.16.4.1613; Loblaw DA, 2005, J CLIN ONCOL, V23, P2028, DOI 10.1200/JCO.2005.00.067; Loblaw DA, 2003, CLIN ONCOL-UK, V15, P211, DOI 10.1016/S0936-6555(02)00400-4; Loblaw DA, 2003, P AN M AM SOC CLIN, V22, P119; LOBLAW DA, 2004, NEUROONCOLOGY DIS SI; Makris A, 1995, Clin Oncol (R Coll Radiol), V7, P82, DOI 10.1016/S0936-6555(05)80806-4; MARANZANO E, 1995, INT J RADIAT ONCOL, V32, P959, DOI 10.1016/0360-3016(95)00572-G; Maranzano E, 2005, J CLIN ONCOL, V23, P3358, DOI 10.1200/JCO.2005.08.193; Maranzano E, 1996, AM J CLIN ONCOL-CANC, V19, P179, DOI 10.1097/00000421-199604000-00018; Maranzano E, 2001, RADIOTHER ONCOL, V60, P281, DOI 10.1016/S0167-8140(01)00356-5; McKinley WO, 1996, ARCH PHYS MED REHAB, V77, P892, DOI 10.1016/S0003-9993(96)90276-2; Mercadante S, 1997, PAIN, V69, P1, DOI 10.1016/S0304-3959(96)03267-8; MIASKOWSKI C, 2005, APS CLIN PRACTICE GU, V3; MITERA G, 2003, RADIOTHER ONCOL S1, V69, P141; Pannullo S., 1993, PSYCHO-ONCOLOGY, V2, P233, DOI [10.1002/pon.2960020404., DOI 10.1002/PON.2960020404]; Patchell RA, 2006, LANCET, V367, P109, DOI 10.1016/S0140-6736(06)67956-7; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; Posner JB, 1995, NEUROLOGIC COMPLICAT; Prasad D, 2005, LANCET ONCOL, V6, P15, DOI 10.1016/S1470-2045(04)01709-7; Quinn JA, 2000, SEMIN ONCOL, V27, P311; Rades D, 2005, J CLIN ONCOL, V23, P3366, DOI 10.1200/JCO.2005.04.754; Rades D, 2002, INT J RADIAT ONCOL, V53, P975, DOI 10.1016/S0360-3016(02)02819-5; Rades D, 2008, CANCER, V112, P157, DOI 10.1002/cncr.23150; Rades D, 2007, EJC SUPPL, V5, P359, DOI 10.1016/S1359-6349(07)70064-2; Rades D, 2007, NAT CLIN PRACT ONCOL, V4, P400, DOI 10.1038/ncponc0846; Rades D, 2007, J CLIN ONCOL, V25, P50, DOI 10.1200/JCO.2006.08.7155; Rades D, 2007, INT J RADIAT ONCOL, V67, P525, DOI 10.1016/j.ijrobp.2006.09.025; Rades D, 2006, J CLIN ONCOL, V24, P3388, DOI 10.1200/JCO.2005.05.0542; Rock JP, 2006, NEUROSURGERY, V58, P891, DOI 10.1227/01.NEU.0000209913.72761.4F; Rock JP, 2004, J NEURO-ONCOL, V69, P319, DOI 10.1023/B:NEON.0000041890.01837.53; RODICHOK LD, 1986, ANN NEUROL, V20, P696, DOI 10.1002/ana.410200608; Ruckdeschel, 1995, Cancer Control, V2, P320; Ruff RL, 2007, J REHABIL RES DEV, V44, P1, DOI 10.1682/JRRD.2005.10.0168; Ruff RL, 2007, J REHABIL RES DEV, V44, P271, DOI 10.1682/JRRD.2007.01.0006; Ryu S, 2003, CANCER, V97, P2013, DOI 10.1002/cncr.11296; Ryu S, 2007, CANCER, V109, P628, DOI 10.1002/cncr.22442; SCHIFF D, 1995, ANN NEUROL, V37, P583, DOI 10.1002/ana.410370507; Schiff D, 2003, NEUROL CLIN, V21, P67, DOI 10.1016/S0733-8619(02)00033-6; Schiff D, 1997, NEUROLOGY, V49, P452, DOI 10.1212/WNL.49.2.452; Schmidt Meic H, 2005, J Natl Compr Canc Netw, V3, P711; Siddall PJ, 2006, NEUROLOGY, V67, P1792, DOI 10.1212/01.wnl.0000244422.45278.ff; SIEGAL T, 1988, SPINE, V13, P1171; SIOUTOS PJ, 1995, CANCER, V76, P1453, DOI 10.1002/1097-0142(19951015)76:8<1453::AID-CNCR2820760824>3.0.CO;2-T; SLIVKA A, 1993, AM J MED, V94, P216, DOI 10.1016/0002-9343(93)90187-T; SORENSEN PS, 1994, EUR J CANCER, V30A, P22, DOI 10.1016/S0959-8049(05)80011-5; SUNDARESAN N, 1985, J NEUROSURG, V63, P676, DOI 10.3171/jns.1985.63.5.0676; SUNDARESAN N, 1995, J CLIN ONCOL, V13, P2330, DOI 10.1200/JCO.1995.13.9.2330; Thomas KC, 2007, INT J RADIAT ONCOL, V68, P314, DOI 10.1016/j.ijrobp.2006.12.041; Tokuhashi Y, 2005, SPINE, V30, P2186, DOI 10.1097/01.brs.0000180401.06919.a5; TOMITA T, 1983, ACTA RADIOL ONCOL, V22, P135, DOI 10.3109/02841868309134353; TURNER S, 1993, INT J RADIAT ONCOL, V26, P141, DOI 10.1016/0360-3016(93)90185-X; Ulmar B, 2005, SPINE, V30, P2222, DOI 10.1097/01.brs.0000181055.10977.5b; Ulmar B, 2007, ANN SURG ONCOL, V14, P998, DOI 10.1245/s10434-006-9000-5; USHIO Y, 1977, J NEUROSURG, V47, P380, DOI 10.3171/jns.1977.47.3.0380; USHIO Y, 1977, NEUROLOGY, V27, P422, DOI 10.1212/WNL.27.5.422; van den Bent MJ, 2005, LANCET, V366, P609, DOI 10.1016/S0140-6736(05)66955-3; WEISSMAN DE, 1987, J NEURO-ONCOL, V5, P125, DOI 10.1007/BF02571300; Wong ET, 1996, NEUROLOGY, V46, P1543, DOI 10.1212/WNL.46.6.1543; Yamaguchi K, 2002, COORDIN CHEM REV, V226, P235, DOI 10.1016/S0010-8545(01)00440-4	101	96	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2008	299	8					937	946		10.1001/jama.299.8.937	http://dx.doi.org/10.1001/jama.299.8.937			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266DZ	18314436				2022-12-28	WOS:000253413200022
J	Knoblich, JA				Knoblich, Juergen A.			Mechanisms of asymmetric stem cell division	CELL			English	Review							REGULATES SPINDLE ORIENTATION; NEUROBLAST SELF-RENEWAL; DROSOPHILA AURORA-A; TUMOR-SUPPRESSOR; ADHERENS JUNCTIONS; CORTICAL POLARITY; BRAIN-TUMOR; PROTEIN LOCALIZATION; HEMATOPOIETIC STEM; EXTRINSIC CUES	Stem cells self-renew but also give rise to daughter cells that are committed to lineage-specific differentiation. To achieve this remarkable task, they can undergo an intrinsically asymmetric cell division whereby they segregate cell fate determinants into only one of the two daughter cells. Alternatively, they can orient their division plane so that only one of the two daughter cells maintains contact with the niche and stem cell identity. These distinct pathways have been elucidated mostly in Drosophila. Although the molecules involved are highly conserved in vertebrates, the way they act is tissue specific and sometimes very different from invertebrates.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404				Affolter M, 2007, DEV CELL, V13, P321, DOI 10.1016/j.devcel.2007.08.002; Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Cossu G, 2007, CELL, V129, P859, DOI 10.1016/j.cell.2007.05.029; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Frank DJ, 2002, DEVELOPMENT, V129, P399; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Li L, 2000, GENE DEV, V14, P147; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Luo D, 2005, SEMIN CELL DEV BIOL, V16, P612, DOI 10.1016/j.semcdb.2005.07.002; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Mayer B, 2005, CURR BIOL, V15, P1847, DOI 10.1016/j.cub.2005.08.067; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mori T, 2005, CURR TOP DEV BIOL, V69, P67, DOI 10.1016/S0070-2153(05)69004-7; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Park M, 1998, MECH DEVELOP, V75, P117, DOI 10.1016/S0925-4773(98)00098-7; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schroeder T, 2007, CELL STEM CELL, V1, P479, DOI 10.1016/j.stem.2007.10.016; Schulz C, 2002, DEVELOPMENT, V129, P4523; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Stricker SH, 2006, CEREB CORTEX, V16, pI121, DOI 10.1093/cercor/bhj171; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5; Wilson A, 2007, J IMMUNOL, V178, P6746, DOI 10.4049/jimmunol.178.11.6746; Wirtz-Peitz F, 2006, TRENDS CELL BIOL, V16, P234, DOI 10.1016/j.tcb.2006.03.006; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	113	689	714	2	124	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					583	597		10.1016/j.cell.2008.02.007	http://dx.doi.org/10.1016/j.cell.2008.02.007			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295577	Bronze			2022-12-28	WOS:000253817900019
J	Sotin, C; Tobie, G				Sotin, Christophe; Tobie, Gabriel			Planetary science - Titan's hidden ocean	SCIENCE			English	Editorial Material									[Sotin, Christophe] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Tobie, Gabriel] Univ Nantes, Lab Planetol & Geodynam, F-44322 Nantes, France	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Nantes Universite	Sotin, C (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	csotin@jpl.nasa.gov; gabriel.tobie@univ-nantes.fr						Grasset O, 1996, ICARUS, V123, P101, DOI 10.1006/icar.1996.0144; Lorenz RD, 2008, SCIENCE, V319, P1649, DOI 10.1126/science.1151639; Noyelles B, 2008, ASTRON ASTROPHYS, V478, P959, DOI 10.1051/0004-6361:20077991; STILES B, 2007, B AM ASTRON SOC, V39, P543; Tobie G, 2006, NATURE, V440, P61, DOI 10.1038/nature04497; Tokano T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024456; VANHOOLST T, 2008, ICARUS	7	14	15	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1629	1630		10.1126/science.1155964	http://dx.doi.org/10.1126/science.1155964			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356514				2022-12-28	WOS:000254172300028
J	Tucker, SA; Hanuscin, DL; Bearnes, CJ				Tucker, Sheryl A.; Hanuscin, Deborah L.; Bearnes, Constance J.			The pipeline - Igniting girls' interest in science	SCIENCE			English	Editorial Material									[Tucker, Sheryl A.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Tucker, Sheryl A.] Univ Missouri, Grad Sch, Columbia, MO 65211 USA; [Hanuscin, Deborah L.] Univ Missouri, Sci Edu Ctr, Dept Learning Teaching & Curriculum, Columbia, MO 65211 USA; [Hanuscin, Deborah L.] Univ Missouri, Sci Edu Ctr, Dept Phys & Astron, Columbia, MO 65211 USA; [Bearnes, Constance J.] Girl Scouts Heart Missouri Council, Jefferson City, MO 65109 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Tucker, SA (corresponding author), Univ Missouri, Dept Chem, 210 Jesse Hall, Columbia, MO 65211 USA.	tuckers@missouri.edu						*ACS, 1997, BEST WONDERSCIENCE, V1; *ACS, 2001, BEST WONDERSCIENCE, V2; *ACS, 1988, KIDS CHEM HANDS ON A; *ACS, 1995, KIDS CHEM LARG EV GU; CAMPBELL PB, 1995, MATH SCI SPORTS EMPO; Casey D. M., 2005, ORG ACTIVITIES CONTE, P65; FANCSALI C, 2006, SB F, V32, P99; *FANCSALI C, 2003, WHAT WE KNOW GIRLS S; FARENGA S, 1995, THESIS COLUMBIA U; Freeman Catherine E., 2004, 2005016 NCES US DEP; KAHLE JB, 1996, EQUITY EQUATION FOST, P57; KAHLE JB, 1993, ED PSYCHOL, V28, P374; Lauver S. C., 2004, MOVING BARRIERS ATTR; LITTLE PMD, 2003, REV OUT OF SCH TIME; National Research Council, 2000, INQ NAT SCI ED STAND; SHAKESHAFT C, 1995, THEOR PRACT, V34, P74, DOI 10.1080/00405849509543660; Snyder T., 2000, 2000030 NCES US DEP; Tai RH, 2006, SCIENCE, V312, P1143, DOI 10.1126/science.1128690	18	12	13	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1621	1622		10.1126/science.1153261	http://dx.doi.org/10.1126/science.1153261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356508				2022-12-28	WOS:000254172300022
J	Wong, CL; Holroyd-Leduc, J; Thorpe, KE; Straus, SE				Wong, Camilla L.; Holroyd-Leduc, Jayna; Thorpe, Kevin E.; Straus, Sharon E.			Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SERUM-ASCITES ALBUMIN; LARGE-VOLUME PARACENTESIS; INDUCED CIRCULATORY DYSFUNCTION; TRIAL COMPARING ALBUMIN; CIRRHOTIC-PATIENTS; TENSE ASCITES; FLUID PH; INTRAVENOUS ALBUMIN; DIAGNOSTIC-VALUE; DECOMPENSATED CIRRHOSIS	Context Abdominal paracenteses are performed in patients with ascites, most commonly to assess for infection or portal hypertension and to manage refractory ascites. Objectives To systematically review evidence for paracentesis methods that may decrease risk of adverse events or improve diagnostic yield and to determine the accuracy of ascitic fluid analysis for spontaneous bacterial peritonitis or portal hypertension. Data Sources Relevant English- language studies from MEDLINE ( 1966- April 2007) and EMBASE ( 1980- April 2007). Study Selection Paracentesis studies evaluating interventions ( use of preprocedure coagulation parameters, needle type, insertion location, ultrasound guidance, bedside inoculation into blood culture bottles, and use of plasma expanders in therapeutic taps) for reducing adverse events or improving the diagnostic yield, and studies assessing the accuracy of ascitic fluid biochemical analyses for spontaneous bacterial peritonitis or portal hypertension. Data Extraction For technique studies, data on intervention and outcome; and for diagnostic studies, data on parameters for diagnosing spontaneous bacterial peritonitis and portal hypertension ( ie, ascitic fluid white blood cell and polymorphonuclear leukocyte [ PMN] count, ascitic fluid pH, blood - ascitic fluid pH gradient, and serumascites albumin gradient). Data Synthesis Thirty- seven studies met inclusion criteria: 2 showed that obtaining preprocedure coagulation was likely unnecessary prior to paracentesis; 1 showed the 15- gauge, 3.25- inch needle- cannula results in less multiple peritoneal punctures [ P=. 05] and termination due to poor fluid return [ P=. 02] vs a 14- gauge needle in therapeutic paracentesis; 1 showed immediate inoculation of culture bottles improves diagnostic yield vs delayed ( from 77% to 100% [ 95% CI for the difference, 5.3%40.0%]); 9 evaluated therapeutic paracentesis, performed with or without albumin or nonalbumin plasma expanders, and found no consistent effect on morbidity or mortality; 16 showed the accuracy of biochemical analysis of ascitic fluid in patients suspected of having spontaneous bacterial peritonitis to increase the likelihood of spontaneous bacterial peritonitis ( PMN count > 250 cells/mu L [ summary likelihood ratio {LR}, 6.4] 95% CI, 4.6- 8.8; ascitic fluid leukocyte count > 1000 cells/ mu L [ summary LR, 9.1] 95% CI, 5.5- 15.1; pH < 7.35 [ summary LR, 9.0] 95% CI, 2.0- 40.6; or a blood - ascitic fluid pH gradient >= 0.10 [ LR, 11.3] 95% CI, 4.3- 29.9) and other levels lowered the likelihood ( PMN count <= 250 cells/mu L [ summary LR, 0.2] 95% CI, 0.11- 0.37; or a blood-ascitic fluid pH gradient < 0.10 [ summary LR, 0.12] 95% CI, 0.02- 0.77); and 4 showed the diagnostic accuracy of the serum- ascites albumin gradient lowers the likelihood of portal hypertension ( < 1.1 g/ dL [ summary LR, 0.06] 95% CI, 0.02- 0.20). Conclusions Ascitic fluid should be inoculated into blood culture bottles at the bedside. Spontaneous bacterial peritonitis is more likely at predescribed parameters of ascitic PMN count or blood - ascitic fluid pH, and portal hypertension is less likely below a predescribed serum- ascites albumin gradient.	[Wong, Camilla L.] Univ British Columbia, Div Geriatr Med, Vancouver, BC V5Z 1M9, Canada; [Holroyd-Leduc, Jayna; Thorpe, Kevin E.; Straus, Sharon E.] Univ Toronto, Fac Med, Knowledge Translat Program, Toronto, ON, Canada; [Holroyd-Leduc, Jayna; Thorpe, Kevin E.; Straus, Sharon E.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Thorpe, Kevin E.] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; [Holroyd-Leduc, Jayna; Straus, Sharon E.] Univ Calgary, Div Gen Internal Med, Calgary, AB, Canada; [Holroyd-Leduc, Jayna; Straus, Sharon E.] Univ Calgary, Div Geriatr, Calgary, AB, Canada	University of British Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Calgary; University of Calgary	Straus, SE (corresponding author), Foothills Prov Gen Hosp, Dept Med, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	sha-ron.straus@utoronto.ca	Wong, Camilla/J-6419-2019	Wong, Camilla/0000-0002-4430-2321; Thorpe, Kevin/0000-0002-7586-3893				ACHARYA SK, 1992, J CLIN GASTROENTEROL, V14, P31, DOI 10.1097/00004836-199201000-00008; Akriviadis EA, 1996, SCAND J GASTROENTERO, V31, P814, DOI 10.3109/00365529609010358; ALBILLOS A, 1990, GASTROENTEROLOGY, V98, P134, DOI 10.1016/0016-5085(90)91301-L; AlKnawy BA, 1997, ANN SAUDI MED, V17, P26, DOI 10.5144/0256-4947.1997.26; ALMDAL TP, 1987, SCAND J GASTROENTERO, V22, P295, DOI 10.3109/00365528709078594; Altman C, 1998, EUR J GASTROEN HEPAT, V10, P5, DOI 10.1097/00042737-199801000-00002; *AM BOARD INT MED, CERT ABIM; ANTILLON MR, 1991, ARCH INTERN MED, V151, P509, DOI 10.1001/archinte.151.3.509; ANTILLON MR, 1991, GASTROENTEROLOGY, V101, P1455, DOI 10.1016/0016-5085(91)90116-3; Arroyo V, 2003, DIGEST LIVER DIS, V35, P668, DOI 10.1016/S1590-8658(03)00383-9; ASCIONE A, 1990, GASTROENTEROL INT, V3, P120; ATTALI P, 1984, GASTROEN CLIN BIOL, V8, P518; ATTALI P, 1986, GASTROENTEROLOGY, V90, P1255, DOI 10.1016/0016-5085(86)90393-8; Bansal S, 1998, HEPATO-GASTROENTEROL, V45, P1673; BARD C, 1986, CAN MED ASSOC J, V135, P209; BARMEIR S, 1979, DIGEST DIS SCI, V24, P136, DOI 10.1007/BF01324741; BERNARDI M, 1994, J HEPATOL, V20, P289, DOI 10.1016/S0168-8278(05)80071-6; BOCCIA S, 1991, ENDOSCOPY, V23, P83, DOI 10.1055/s-2007-1010619; BORZIO M, 1995, DIGEST DIS SCI, V40, P1054, DOI 10.1007/BF02064198; BOYER TD, 1978, ARCH INTERN MED, V138, P1103, DOI 10.1001/archinte.138.7.1103; BRUNO S, 1992, BRIT MED J, V304, P1655, DOI 10.1136/bmj.304.6843.1655; Burroughs AK, 2003, DIGEST LIVER DIS, V35, P664, DOI 10.1016/S1590-8658(03)00386-4; CABRERA J, 1991, HEPATOLOGY, V14, P1025; CAKALOGLU Y, 1991, GASTROENTEROLOGY, V100, P1484; CHEN SJ, 1994, J GASTROEN HEPATOL, V9, P396, DOI 10.1111/j.1440-1746.1994.tb01262.x; Choi CH, 2005, J GASTROEN HEPATOL, V20, P1215, DOI 10.1111/j.1440-1746.2005.03861.x; COLLI A, 1993, CANCER, V72, P677, DOI 10.1002/1097-0142(19930801)72:3<677::AID-CNCR2820720309>3.0.CO;2-C; CONN HO, 1982, HEPATOLOGY, V2, P507; CORREIA JP, 1975, MED CLIN N AM, V59, P963, DOI 10.1016/S0025-7125(16)31995-2; Dittrich S, 2001, HEPATO-GASTROENTEROL, V48, P166; Duggal P, 2006, CLIN NEPHROL, V66, P171; ELTOUNY M, 1989, J TROP MED HYG, V92, P6; FASSIO E, 1992, J HEPATOL, V14, P310, DOI 10.1016/0168-8278(92)90176-P; Forouzandeh B, 1996, J CLIN GASTROENTEROL, V22, P207, DOI 10.1097/00004836-199604000-00011; GARCIACOMPEAN D, 1993, LIVER, V13, P233; GARCIATSAO G, 1985, HEPATOLOGY, V5, P91, DOI 10.1002/hep.1840050119; Gines A, 1996, GASTROENTEROLOGY, V111, P1002, DOI 10.1016/S0016-5085(96)70068-9; GINES P, 1988, GASTROENTEROLOGY, V94, P1493, DOI 10.1016/0016-5085(88)90691-9; Gines P, 2002, ALIMENT PHARM THER, V16, P24, DOI 10.1046/j.1365-2036.16.s5.4.x; GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124; GITLIN N, 1982, HEPATOLOGY, V2, P408; GOLDBERG BB, 1970, RADIOLOGY, V96, P15, DOI 10.1148/96.1.15; Goyal A K, 1989, Trop Gastroenterol, V10, P51; Grabau CM, 2004, HEPATOLOGY, V40, P484, DOI 10.1002/hep.20317; Graziotto A, 1997, DIGEST DIS SCI, V42, P1708, DOI 10.1023/A:1018865516168; GUPTA R, 1995, J GASTROEN HEPATOL, V10, P295, DOI 10.1111/j.1440-1746.1995.tb01096.x; Hicks CM, 2000, J GEN INTERN MED, V15, P716, DOI 10.1046/j.1525-1497.2000.91104.x; HOEFS JC, 1983, J LAB CLIN MED, V102, P260; JONES SR, 1977, WESTERN J MED, V126, P344; KAJANI MA, 1990, DIGEST DIS SCI, V35, P33, DOI 10.1007/BF01537219; Kao H W, 1983, Hepatology, V3, P275; KELLERMAN PS, 1990, ANN INTERN MED, V112, P889, DOI 10.7326/0003-4819-112-12-889; KEOU FXM, 1992, Q J MED, V83, P401; KLINE MM, 1976, GASTROENTEROLOGY, V70, P408; KOFFEL KK, 1986, J CRIT ILLN, V1, P45; Krencker E, 1907, MUNCHEN MED WSCHR, V54, P2095; Laffi G, 2003, DIGEST LIVER DIS, V35, P660, DOI 10.1016/S1590-8658(03)00384-0; LEE CM, 1992, CANCER, V70, P2057, DOI 10.1002/1097-0142(19921015)70:8<2057::AID-CNCR2820700807>3.0.CO;2-H; LEE HH, 1987, INFECTION, V15, P232, DOI 10.1007/BF01644119; LEE MY, 1994, CHINESE J SURG, V53, P71; Lin CH, 2005, DIGEST LIVER DIS, V37, P946, DOI 10.1016/j.dld.2005.07.009; MALLORY A, 1978, JAMA-J AM MED ASSOC, V239, P628, DOI 10.1001/jama.239.7.628; Maor Y, 2005, ISR MED ASSOC J, V7, P115; MAUER K, 1988, DIGEST DIS SCI, V33, P1208, DOI 10.1007/BF01536667; MCVAY PA, 1991, TRANSFUSION, V31, P164, DOI 10.1046/j.1537-2995.1991.31291142949.x; MEHROTRA MP, 1972, INDIAN J MED RES, V60, P1089; MENETRIER P, 1906, B MEM SOC MED HOP P, V22, P208; MIROS M, 1988, AUST NZ J MED, V18, P143; Moreau R, 2006, LIVER INT, V26, P46, DOI 10.1111/j.1478-3231.2005.01188.x; Nazeer SR, 2005, AM J EMERG MED, V23, P363, DOI 10.1016/j.ajem.2004.11.001; Oxentenko AS, 2003, TEACH LEARN MED, V15, P127, DOI 10.1207/S15328015TLM1502_10; Pache I, 2005, ALIMENT PHARM THER, V21, P525, DOI 10.1111/j.1365-2036.2005.02387.x; PARE P, 1983, GASTROENTEROLOGY, V85, P240; PATEL AS, 1989, ANN INTERN MED, V110, P325, DOI 10.7326/0003-4819-110-4-325_2; Peltekian KM, 1997, AM J GASTROENTEROL, V92, P394; PINTO PC, 1988, HEPATOLOGY, V8, P207, DOI 10.1002/hep.1840080202; PINZELLO G, 1983, HEPATOLOGY, V3, P545; PLANAS R, 1990, GASTROENTEROLOGY, V99, P1736, DOI 10.1016/0016-5085(90)90481-F; POWERS LR, 1992, ACAD MED, V67, P743, DOI 10.1097/00001888-199211000-00006; PRIETO M, 1988, DIGEST DIS SCI, V33, P833, DOI 10.1007/BF01550972; RAI RR, 1988, INDIAN J MED RES, V87, P600; Rana SV, 2005, MED SCI MONITOR, V11, pCR136; REYNOLDS TB, 1986, GASTROENTEROLOGY, V90, P1294, DOI 10.1016/0016-5085(86)90401-4; Rimola A, 2000, J HEPATOL, V32, P142, DOI 10.1016/S0168-8278(00)80201-9; Rubin E, 1997, MAYO CLIN PROC, V72, P487, DOI 10.1016/S0025-6196(11)64872-6; RUNYON BA, 1988, HEPATOLOGY, V8, P1104, DOI 10.1002/hep.1840080521; RUNYON BA, 1990, J CLIN MICROBIOL, V28, P2811, DOI 10.1128/JCM.28.12.2811-2812.1990; RUNYON BA, 1992, ANN INTERN MED, V117, P215, DOI 10.7326/0003-4819-117-3-215; Runyon BA, 2004, HEPATOLOGY, V39, P841, DOI 10.1002/hep.20066; RUNYON BA, 1986, ARCH INTERN MED, V146, P2259, DOI 10.1001/archinte.146.11.2259; RUNYON BA, 1991, HEPATOLOGY, V13, P929, DOI 10.1016/0270-9139(91)90265-W; Sakai H, 2005, LIVER INT, V25, P984, DOI 10.1111/j.1478-3231.2005.01149.x; SALERNO F, 1990, ITAL J GASTROENTEROL, V22, P44; SALERNO F, 1991, HEPATOLOGY, V13, P707, DOI 10.1002/hep.1840130416; SANCHEZLOMBRANA JL, 1995, SCAND J GASTROENTERO, V30, P87, DOI 10.3109/00365529509093241; SCEMAMACLERGUE J, 1985, GUT, V26, P332, DOI 10.1136/gut.26.4.332; Schmidt Lars E, 2002, Ugeskr Laeger, V164, P1196; Shaheen NJ, 1996, AM J GASTROENTEROL, V91, P1731; SIMONETTI RG, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004039; Singh V, 2006, J INTERN MED, V260, P62, DOI 10.1111/j.1365-2796.2006.01654.x; Singh V, 2006, J GASTROEN HEPATOL, V21, P303, DOI 10.1111/j.1440-1746.2006.04182.x; Smith CC, 2004, J GEN INTERN MED, V19, P510, DOI 10.1111/j.1525-1497.2004.30161.x; SOLA R, 1994, J HEPATOL, V20, P282, DOI 10.1016/S0168-8278(05)80070-4; Sola-Vera J, 2003, HEPATOLOGY, V37, P1147, DOI 10.1053/jhep.2003.50169; STASSEN WN, 1986, GASTROENTEROLOGY, V90, P1247, DOI 10.1016/0016-5085(86)90392-6; STORGAARD JS, 1991, LIVER, V11, P248; TERG R, 1992, DIGEST DIS SCI, V37, P79, DOI 10.1007/BF01308346; Thuluvath PJ, 2001, AM J GASTROENTEROL, V96, P1232, DOI 10.1111/j.1572-0241.2001.03708.x; Vila MC, 1999, AM J GASTROENTEROL, V94, P2219; WANG SS, 1994, J HEPATOL, V20, P79, DOI 10.1016/S0168-8278(05)80470-2; WEAVER ME, 1986, MED EDUC, V20, P407, DOI 10.1111/j.1365-2923.1986.tb01185.x; Webster ST, 1996, AM J GASTROENTEROL, V91, P366; Wickstrom GC, 2000, J GEN INTERN MED, V15, P361, DOI 10.1046/j.1525-1497.2000.04118.x; WIGTON RS, 1989, ANN INTERN MED, V111, P932, DOI 10.7326/0003-4819-111-11-932; WILLIAMS JW, 1992, JAMA-J AM MED ASSOC, V267, P2645, DOI 10.1001/jama.267.19.2645; WILSON JAP, 1979, DIGEST DIS SCI, V24, P645, DOI 10.1007/BF01333710; YANG CY, 1985, HEPATOLOGY, V5, P85, DOI 10.1002/hep.1840050118; Zhao J, 2000, CHINESE MED J-PEKING, V113, P27	118	53	57	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2008	299	10					1166	1178		10.1001/jama.299.10.1166	http://dx.doi.org/10.1001/jama.299.10.1166			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272CE	18334692				2022-12-28	WOS:000253835000020
J	Grayling, AC				Grayling, A. C.			Face transplantation and living a flourishing life	LANCET			English	Editorial Material							FACIAL TRANSPLANTATION				Grayling, AC (corresponding author), 14 Gower St, London WC1E 6DP, England.	a.grayling@bbk.ac.uk						BOWEN J, 1999, SALON           0519; Butler PEM, 2006, LANCET, V368, P561, DOI 10.1016/S0140-6736(06)69176-9; Check E, 2004, NATURE, V431, P389, DOI 10.1038/431389a; Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; OREILLY KB, 2005, AM MED NEWS     1017; Powell T, 2006, J LAW MED ETHICS, V34, P111, DOI 10.1111/j.1748-720X.2006.00014.x; SIEMIONOW MZ, 2006, TISSUE SURG; Wiggins OP, 2004, AM J BIOETHICS, V4, P1, DOI 10.1080/15265160490496507	8	8	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 1	2008	371	9614					707	708		10.1016/S0140-6736(08)60322-0	http://dx.doi.org/10.1016/S0140-6736(08)60322-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313489				2022-12-28	WOS:000253596700009
J	Bloch, I				Bloch, Immanuel			Perspective - Quantum gases	SCIENCE			English	Editorial Material							MOTT INSULATOR; ATOMS; SUPERFLUID; PHYSICS; PAIRS		Johannes Gutenberg Univ Mainz, D-55118 Mainz, Germany	Johannes Gutenberg University of Mainz	Bloch, I (corresponding author), Johannes Gutenberg Univ Mainz, D-55118 Mainz, Germany.	bloch@uni-mainz.de	Bloch, Immanuel/G-3174-2010; Bloch, Immanuel/N-9169-2019	Bloch, Immanuel/0000-0002-0679-4759; 				Anderlini M, 2007, NATURE, V448, P452, DOI 10.1038/nature06011; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; [Anonymous], 2003, BOSEEINSTEIN CONDENS; AUERBACH A, 2006, INTERACTING ELECT QU; Bartenstein M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120401; Bourdel T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.050401; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; FULDE P, 1964, PHYS REV, V135, pA550, DOI 10.1103/PhysRev.135.A550; Griessner A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220403; Hofstetter W, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.220407; Jaksch D, 2005, ANN PHYS-NEW YORK, V315, P52, DOI 10.1016/j.aop.2004.09.010; Kuklov AB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.100401; LARKIN AI, 1965, ZH EKSP TEOR FIZ, V20, P762; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; Nelson KD, 2007, NAT PHYS, V3, P556, DOI 10.1038/nphys645; Rapp A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.160405; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Taglieber M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.010401; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Werner F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.056401; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403	27	61	63	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1202	1203		10.1126/science.1152501	http://dx.doi.org/10.1126/science.1152501			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309072				2022-12-28	WOS:000253530600028
J	Cayirlioglu, P; Kadow, IG; Zhan, XL; Okamura, K; Suh, GSB; Gunning, D; Lai, EC; Zipursky, SL				Cayirlioglu, Pelin; Kadow, Ilona Grunwald; Zhan, Xiaoli; Okamura, Katsutomo; Suh, Greg S. B.; Gunning, Dorian; Lai, Eric C.; Zipursky, S. Lawrence			Hybrid neurons in a microRNA mutant are putative evolutionary intermediates in insect CO2 sensory systems	SCIENCE			English	Article							CENTRAL PROJECTIONS; RECEPTOR NEURONS; AEDES-AEGYPTI; DROSOPHILA; MAXILLARY; SENSILLA; MOTHS	Carbon dioxide ( CO2) elicits different olfactory behaviors across species. In Drosophila, neurons that detect CO2 are located in the antenna, form connections in a ventral glomerulus in the antennal lobe, and mediate avoidance. By contrast, in the mosquito these neurons are in the maxillary palps ( MPs), connect to medial sites, and promote attraction. We found in Drosophila that loss of a microRNA, miR- 279, leads to formation of CO2 neurons in the MPs. miR- 279 acts through down- regulation of the transcription factor Nerfin- 1. The ectopic neurons are hybrid cells. They express CO2 receptors and form connections characteristic of CO2 neurons, while exhibiting wiring and receptor characteristics of MP olfactory receptor neurons ( ORNs). We propose that this hybrid ORN reveals a cellular intermediate in the evolution of species- specific behaviors elicited by CO2.	[Cayirlioglu, Pelin; Kadow, Ilona Grunwald; Zhan, Xiaoli; Gunning, Dorian; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Okamura, Katsutomo; Lai, Eric C.] Sloan Kettering Inst, Rockefeller Res Labs 521, New York, NY 10021 USA; [Suh, Greg S. B.] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; California Institute of Technology	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu	Suh, Seong Bae/K-2434-2016; Lai, Eric/AAO-1143-2021; Lai, Eric C/A-3412-2008	Lai, Eric/0000-0002-8432-5851; Grunwald Kadow, Ilona/0000-0002-9085-4274; Zipursky, Stephen/0000-0001-5630-7181	Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [DC006485] Funding Source: Medline; NIGMS NIH HHS [R01 GM083300] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006485] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Anton S, 2003, ARTHROPOD STRUCT DEV, V32, P319, DOI 10.1016/j.asd.2003.09.002; BOGNER F, 1986, J COMP PHYSIOL A, V158, P741, DOI 10.1007/BF01324818; BOGNER F, 1992, PHYSIOL ENTOMOL, V17, P1992; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Distler PG, 1997, J EXP BIOL, V200, P1873; Grant AJ, 1996, CIBA F SYMP, V200, P233; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Ignell R, 2005, J COMP NEUROL, V493, P207, DOI 10.1002/cne.20800; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Kuzin A, 2005, DEV BIOL, V277, P347, DOI 10.1016/j.ydbio.2004.09.027; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2	19	85	89	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1256	1260		10.1126/science.1149483	http://dx.doi.org/10.1126/science.1149483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309086	Green Accepted, Green Submitted			2022-12-28	WOS:000253530600048
J	Chan, MHW				Chan, M. H. W.			Perspective - Supersolidity	SCIENCE			English	Editorial Material							NONCLASSICAL ROTATIONAL INERTIA; BOSE-EINSTEIN CONDENSATION; SOLID HE-4; SOUND-VELOCITY; LIQUID-HELIUM; HCP HE-4; CRYSTALS; DISLOCATIONS; TEMPERATURE		Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Chan, MHW (corresponding author), Penn State Univ, Dept Phys, University Pk, PA 16802 USA.	chan@phys.psu.edu						Allen JF, 1938, NATURE, V141, P75, DOI 10.1038/141075a0; Anderson PW, 2007, NAT PHYS, V3, P160, DOI 10.1038/nphys539; ANDREEV AF, 1969, SOV PHYS JETP-USSR, V29, P1107; Aoki Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.015301; BEAMISH JR, 1983, PHYS REV B, V28, P1419, DOI 10.1103/PhysRevB.28.1419; Boninsegni M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.035301; Boninsegni M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105301; Burovski E, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.165301; CHESTER GV, 1970, PHYS REV A, V2, P256, DOI 10.1103/PhysRevA.2.256; Clark AC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.135302; Clark BK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105302; Day J, 2007, NATURE, V450, P853, DOI 10.1038/nature06383; Goodkind JM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.095301; IWASA I, 1979, J PHYS SOC JPN, V46, P1119, DOI 10.1143/JPSJ.46.1119; Kapitza P, 1938, NATURE, V141, P74, DOI 10.1038/141074a0; Kim E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.065301; Kim E, 2005, J LOW TEMP PHYS, V138, P859, DOI 10.1007/s10909-005-2315-y; Kim E, 2004, SCIENCE, V305, P1941, DOI 10.1126/science.1101501; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; Kondo M, 2007, J LOW TEMP PHYS, V148, P695, DOI 10.1007/s10909-007-9471-1; LEGGETT AJ, 1970, PHYS REV LETT, V25, P1543, DOI 10.1103/PhysRevLett.25.1543; Lin X, 2007, NATURE, V449, P1025, DOI 10.1038/nature06228; MEISEL MW, 1992, PHYSICA B, V178, P121, DOI 10.1016/0921-4526(92)90186-V; Nussinov Z, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014530; PAALANEN MA, 1981, PHYS REV LETT, V46, P664, DOI 10.1103/PhysRevLett.46.664; Penzev A, 2007, J LOW TEMP PHYS, V148, P677, DOI 10.1007/s10909-007-9452-4; Pollet L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.135301; Prokof'ev N, 2007, ADV PHYS, V56, P381, DOI 10.1080/00018730601183025; REATTO L, 1969, PHYS REV, V183, P334, DOI 10.1103/PhysRev.183.334; Rittner ASC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.175302; Rittner ASC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.165301; Sasaki S, 2006, SCIENCE, V313, P1098, DOI 10.1126/science.1130879; Shevchenko S. I., 1987, SOV J LOW TEMP PHYS, V13, P115; WANNER R, 1976, SOLID STATE COMMUN, V18, P853, DOI 10.1016/0038-1098(76)90222-2; Wolfke M., 1939, ANN ACAD SCI TECHN V, V6, P14	35	23	23	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1207	1209		10.1126/science.1155302	http://dx.doi.org/10.1126/science.1155302			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309075				2022-12-28	WOS:000253530600031
J	Muijres, FT; Johansson, LC; Barfield, R; Wolf, M; Spedding, GR; Hedenstrom, A				Muijres, F. T.; Johansson, L. C.; Barfield, R.; Wolf, M.; Spedding, G. R.; Hedenstrom, A.			Leading-edge vortex improves lift in slow-flying bats	SCIENCE			English	Article							PARTICLE IMAGE VELOCIMETRY; LOW REYNOLDS-NUMBERS; ANGLE-OF-ATTACK; INSECT FLIGHT; GENERATING MECHANISMS; DRAGONFLY FLIGHT; AERODYNAMICS; WINGS; FLOW; HAWKMOTH	Staying aloft when hovering and flying slowly is demanding. According to quasi - steady- state aerodynamic theory, slow- flying vertebrates should not be able to generate enough lift to remain aloft. Therefore, unsteady aerodynamic mechanisms to enhance lift production have been proposed. Using digital particle image velocimetry, we showed that a small nectar- feeding bat is able to increase lift by as much as 40% using attached leading- edge vortices ( LEVs) during slow forward flight, resulting in a maximum lift coefficient of 4.8. The airflow passing over the LEV reattaches behind the LEV smoothly to the wing, despite the exceptionally large local angles of attack and wing camber. Our results show that the use of unsteady aerodynamic mechanisms in flapping flight is not limited to insects but is also used by larger and heavier animals.	[Muijres, F. T.; Johansson, L. C.; Barfield, R.; Wolf, M.; Hedenstrom, A.] Lund Univ, Dept Theoret Ecol, SE-22362 Lund, Sweden; [Spedding, G. R.] Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90089 USA	Lund University; University of Southern California	Hedenstrom, A (corresponding author), Lund Univ, Dept Theoret Ecol, SE-22362 Lund, Sweden.	anders.hedenstrom@teorekol.lu.se	Johansson, Christoffer/B-2189-2013; Hedenström, Anders/F-5377-2010; Spedding, Geoffrey R/A-1860-2010; Wolf, Marta/B-4599-2013; Muijres, Florian Titus/N-6483-2015	Johansson, Christoffer/0000-0002-1851-3635; Hedenström, Anders/0000-0002-1757-0945; Spedding, Geoffrey R/0000-0003-3033-7897; Muijres, Florian Titus/0000-0002-5668-0653				Anderson John D, 1991, FUNDAMENTALS AERODYN; Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Birch JM, 2004, J EXP BIOL, V207, P1063, DOI 10.1242/jeb.00848; Bomphrey RJ, 2006, EXP FLUIDS, V40, P546, DOI 10.1007/s00348-005-0094-5; Bomphrey RJ, 2005, J EXP BIOL, V208, P1079, DOI 10.1242/jeb.01471; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; DICKINSON MH, 1993, J EXP BIOL, V174, P45; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P1, DOI 10.1098/rstb.1984.0049; Hedenstrom A, 2007, SCIENCE, V316, P894, DOI 10.1126/science.1142281; Laitone EV, 1997, EXP FLUIDS, V23, P405, DOI 10.1007/s003480050128; Lehmann FO, 2004, NATURWISSENSCHAFTEN, V91, P101, DOI 10.1007/s00114-004-0502-3; Luttges M., 1989, FRONTIERS EXPT FLUID, P429; MAXWORTHY T, 1979, J FLUID MECH, V93, P47, DOI 10.1017/S0022112079001774; Maxworthy T, 2007, J FLUID MECH, V587, P471, DOI 10.1017/S0022112007007616; Norberg U.M., 1975, SWIMMING FLYING NATU, P869, DOI DOI 10.1007/978-1-4757-1326-8_26; Read DA, 2003, J FLUID STRUCT, V17, P163, DOI 10.1016/S0889-9746(02)00115-9; SOMPS C, 1985, SCIENCE, V228, P1326, DOI 10.1126/science.228.4705.1326; Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223; Swartz SM, 1996, J ZOOL, V239, P357, DOI 10.1111/j.1469-7998.1996.tb05455.x; Thomas ALR, 2004, J EXP BIOL, V207, P4299, DOI 10.1242/jeb.01262; VandenBerg C, 1997, PHILOS T ROY SOC B, V352, P329, DOI 10.1098/rstb.1997.0024; Videler JJ, 2004, SCIENCE, V306, P1960, DOI 10.1126/science.1104682; Vogel S, 1994, LIFE MOVING FLUIDS; Warrick DR, 2005, NATURE, V435, P1094, DOI 10.1038/nature03647; WEISFOGH T, 1973, J EXP BIOL, V59, P169; Willmott AP, 1997, J EXP BIOL, V200, P2693	27	224	233	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1250	1253		10.1126/science.1153019	http://dx.doi.org/10.1126/science.1153019			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309085				2022-12-28	WOS:000253530600046
J	Rietjens, J; van Delden, J; Onwuteaka-Philipsen, B; Buiting, H; van der Maas, P; van der Heide, A				Rietjens, Judith; van Delden, Johannes; Onwuteaka-Philipsen, Bregje; Buiting, Hilde; van der Maas, Paul; van der Heide, Agnes			Continuous deep sedation for patients nearing death in the Netherlands: descriptive study	BRITISH MEDICAL JOURNAL			English	Article							PALLIATIVE SEDATION; TERMINAL SEDATION; EUTHANASIA; LIFE; SYMPTOMS	Objectives To study the practice of continuous deep sedation in 2005 in the Netherlands and compare it with findings from 2001. Design Questionnaire study about random samples of deaths reported to a central death registry in 2005 and 2001. Setting Nationwide physician study in the Netherlands. Participants Reporting physicians received a questionnaire about the medical decisions that preceded the patient's death; 78% (n=6860) responded in 2005 and 74% (n=5617) in 2001. Main outcome measures Characteristics of continuous deep sedation (attending physician, types of patients, drugs used, duration, estimated effect on shortening life, palliative consultation). Requests for euthanasia. Results The use of continuous deep sedation increased from 5.6% (95% confidence interval 5.0% to 6.2%) of deaths in 2001 to 7.1% (6.5% to 7.6%) in 2005, mostly in patients treated by general practitioners and in those with cancer (in 2005, 47% of sedated patients had cancer v 33% in 2001). In 83% of cases sedation was induced by benzodiazepines, and in 94% patients were sedated for periods of less than one week until death. Nine per cent of those who received continuous deep sedation had previously requested euthanasia but their requests were not granted. Nine percent of the physicians had consulted a palliative expert. Conclusions The increased use of continuous deep sedation for patients nearing death in the Netherlands and the limited use of palliative consultation suggests that this practice is increasingly considered as part of regular medical practice.	[Rietjens, Judith; Buiting, Hilde; van der Maas, Paul; van der Heide, Agnes] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [van Delden, Johannes] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Onwuteaka-Philipsen, Bregje] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Rietjens, J (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.rietjens@erasmusmc.nl						Chiu TY, 2001, J PAIN SYMPTOM MANAG, V21, P467, DOI 10.1016/S0885-3924(01)00286-X; De Graeff A, 2007, J PALLIAT MED, V10, P67, DOI 10.1089/jpm.2006.0139; Fainsinger RL, 2000, PALLIATIVE MED, V14, P257, DOI 10.1191/026921600666097479; Hasselaar JGJ, 2007, ARCH INTERN MED, V167, P1166, DOI 10.1001/archinte.167.11.1166; Miccinesi G, 2006, J PAIN SYMPTOM MANAG, V31, P122, DOI 10.1016/j.jpainsymman.2005.07.004; Muller-Busch H Christof, 2003, BMC Palliat Care, V2, P2, DOI 10.1186/1472-684X-2-2; Onwuteaka-Philipsen BD, 2003, LANCET, V362, P395, DOI 10.1016/S0140-6736(03)14029-9; Rietjens JAC, 2006, ARCH INTERN MED, V166, P749, DOI 10.1001/archinte.166.7.749; Rietjens JAC, 2004, ANN INTERN MED, V141, P178, DOI 10.7326/0003-4819-141-3-200408030-00006; *STICHT FARM KENG, 2006, PHARM WEEKBLAD, V141, P81; Stone P, 1997, PALLIATIVE MED, V11, P140, DOI 10.1177/026921639701100208; van der Heide A, 2007, NEW ENGL J MED, V356, P1957, DOI 10.1056/NEJMsa071143; Verkerk M, 2007, J PAIN SYMPTOM MANAG, V34, P666, DOI 10.1016/j.jpainsymman.2007.01.005	13	104	105	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR	2008	336	7648					810	813		10.1136/bmj.39504.531505.25	http://dx.doi.org/10.1136/bmj.39504.531505.25			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292ER	18344245	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000255249800043
J	Michishita, E; McCord, RA; Berber, E; Kioi, M; Padilla-Nash, H; Damian, M; Cheung, P; Kusumoto, R; Kawahara, TLA; Barrett, JC; Chang, HY; Bohr, VA; Ried, T; Gozani, O; Chua, KF				Michishita, Eriko; McCord, Ronald A.; Berber, Elisabeth; Kioi, Mitomu; Padilla-Nash, Hesed; Damian, Mara; Cheung, Peggie; Kusumoto, Rika; Kawahara, Tiara L. A.; Barrett, J. Carl; Chang, Howard Y.; Bohr, Vilhelm A.; Ried, Thomas; Gozani, Or; Chua, Katrin F.			SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin	NATURE			English	Article							PROTECTS HUMAN TELOMERES; WERNER-SYNDROME CELLS; S-PHASE; DYSFUNCTIONAL TELOMERES; SYNDROME FIBROBLASTS; GENOMIC INSTABILITY; MAMMALIAN TELOMERES; DNA-DAMAGE; SENESCENCE; TRF2	The Sir2 deacetylase regulates chromatin silencing and lifespan in Saccharomycescerevisiae(1,2). In mice, deficiency for the Sir2 family member SIRT6 leads to a shortened lifespan and a premature ageing- like phenotype(3). However, the molecular mechanisms of SIRT6 function are unclear. SIRT6 is a chromatin- associated protein(3), but no enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown. Here we show that the human SIRT6 protein is an NAD(+)-dependent, histone H3 lysine 9 ( H3K9) deacetylase that modulates telomeric chromatin. SIRT6 associates specifically with telomeres, and SIRT6 depletion leads to telomere dysfunction with end- to- end chromosomal fusions and premature cellular senescence. Moreover, SIRT6- depleted cells exhibit abnormal telomere structures that resemble defects observed in Werner syndrome, a premature ageing disorder(4,5). At telomeric chromatin, SIRT6 deacetylates H3K9 and is required for the stable association of WRN, the factor that is mutated in Werner syndrome(4,5). We propose that SIRT6 contributes to the propagation of a specialized chromatin state at mammalian telomeres, which in turn is required for proper telomere metabolism and function. Our findings constitute the first identification of a physiological enzymatic activity of SIRT6, and link chromatin regulation by SIRT6 to telomere maintenance and a human premature ageing syndrome.	[Michishita, Eriko; McCord, Ronald A.; Berber, Elisabeth; Damian, Mara; Chua, Katrin F.] Stanford Univ, Dept Med, Div Endocrinol Gerontol & Metab, Sch Med, Stanford, CA 94305 USA; [Kioi, Mitomu] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Cheung, Peggie; Gozani, Or] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Kawahara, Tiara L. A.; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA; [Michishita, Eriko; McCord, Ronald A.; Berber, Elisabeth; Damian, Mara; Chua, Katrin F.] VA Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA; [Padilla-Nash, Hesed; Ried, Thomas] NCI, Genet Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Barrett, J. Carl] NCI, Lab Biosyst & Canc, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Kusumoto, Rika; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	Stanford University; Stanford University; Stanford University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chua, KF (corresponding author), Stanford Univ, Dept Med, Div Endocrinol Gerontol & Metab, Sch Med, Stanford, CA 94305 USA.	kfchua@stanford.edu	Bohr, Vilhelm/AAP-5931-2020; Gozani, Or P/I-6157-2013	Kioi, Mitomu/0000-0002-7981-3340; Gozani, Or/0000-0002-1365-4463	NIA NIH HHS [R01 AG028867, K08 AG028961, R01 AG028867-03, K08 AG028961-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM079641-02, R01 GM079641] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028867, K08AG028961, Z01AG000726] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ariyoshi K, 2007, J RADIAT RES, V48, P219, DOI 10.1269/jrr.07017; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Cheng WH, 2007, EXP GERONTOL, V42, P871, DOI 10.1016/j.exger.2007.04.011; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Multani AS, 2007, J CELL SCI, V120, P713, DOI 10.1242/jcs.03397; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Padilla-Nash HM, 2001, GENE CHROMOSOME CANC, V30, P349, DOI 10.1002/gcc.1101; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; TAKEUCHI F, 1982, EXP GERONTOL, V17, P473, DOI 10.1016/S0531-5565(82)80009-0; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630	32	779	830	3	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2008	452	7186					492	U16		10.1038/nature06736	http://dx.doi.org/10.1038/nature06736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18337721	Green Accepted			2022-12-28	WOS:000254341300036
J	Ishiwata, S; Taguchi, Y; Murakawa, H; Onose, Y; Tokura, Y				Ishiwata, Shintaro; Taguchi, Yasujiro; Murakawa, Hiroshi; Onose, Yoshinori; Tokura, Yoshinori			Low-magnetic-field control of electric polarization vector in a helimagnet	SCIENCE			English	Article								The mutual control of the electric and magnetic properties of a solid is currently of great interest because of the possible application for novel electronic devices. We report on the low- magneticfield ( for example, B values of +/- 30 milliteslas) control of the polarization ( P) vector in a hexaferrite, Ba2Mg2Fe12O22, which shows the helimagnetic spin structure with the propagation vector k(0) parallel to [ 001]. The B- induced transverse conical spin structure carries the P vector directing perpendicular to both B and k(0), in accord with the recently proposed spin- current model. Then, the oscillating or multidirectionally rotating B produces the cyclic displacement current via the flexible handling of the magnetic cone axis.	[Ishiwata, Shintaro; Murakawa, Hiroshi; Onose, Yoshinori; Tokura, Yoshinori] Univ Tokyo, Dept Appl Phys, Multiferroics Project, ERATO,Japan Sci & Technol Agcy, Tokyo 1138656, Japan; [Taguchi, Yasujiro; Tokura, Yoshinori] RIKEN, Cross Correlated Mat Res Grp CMRG, FRS, Wako, Saitama 3510198, Japan; [Onose, Yoshinori; Tokura, Yoshinori] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan	Japan Science & Technology Agency (JST); University of Tokyo; RIKEN; University of Tokyo	Ishiwata, S (corresponding author), Univ Tokyo, Dept Appl Phys, Multiferroics Project, ERATO,Japan Sci & Technol Agcy, Tokyo 1138656, Japan.	ishiwata@riken.jp	Tokura, Yoshinori/C-7352-2009; Ishiwata, Shintaro/A-2637-2010; Taguchi, Yasujiro/A-3048-2010; Onose, Yoshinori/F-1977-2010	Tokura, Yoshinori/0000-0002-2732-4983; Ishiwata, Shintaro/0000-0003-1696-2514; Onose, Yoshinori/0000-0002-8398-2956				Arima T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.097202; Arima TH, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.073702; Fiebig M, 2005, J PHYS D APPL PHYS, V38, pR123, DOI 10.1088/0022-3727/38/8/R01; Harris AB, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.184433; Katsura H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.057205; Kenzelmann M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.087206; Kimura T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.220401; Kimura T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.137201; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Lawes G, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.087205; MOMOZAWA N, 1986, J PHYS SOC JPN, V55, P4007, DOI 10.1143/JPSJ.55.4007; MOMOZAWA N, 1993, J PHYS SOC JPN, V62, P1292, DOI 10.1143/JPSJ.62.1292; Momozawa N, 2001, J PHYS SOC JPN, V70, P2724, DOI 10.1143/JPSJ.70.2724; Mostovoy M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067601; Park S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057601; Sergienko IA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094434; Tokura Y, 2006, SCIENCE, V312, P1481, DOI 10.1126/science.1125227; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Yamasaki Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.147204; Yamasaki Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.207204	20	294	300	11	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2008	319	5870					1643	1646		10.1126/science.1154507	http://dx.doi.org/10.1126/science.1154507			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356519				2022-12-28	WOS:000254172300033
J	Bartram, J				Bartram, Jamie			Improving on haves and have-nots	NATURE			English	Editorial Material									WHO, Water Sanitat & Hlth Programme, CH-1211 Geneva, Switzerland	World Health Organization	Bartram, J (corresponding author), WHO, Water Sanitat & Hlth Programme, CH-1211 Geneva, Switzerland.			Bartram, Jamie/0000-0002-6542-6315				Hutton G, 2004, EVALUATION COSTS BEN; Suarez R, 1993, 415 WASH; *WHO GEN UNICEF, 2008, UNR SAN PRACT; *WHO UNICEF JOINT, 2008, SNAPSH SAN AFR	4	47	47	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					283	284		10.1038/452283a	http://dx.doi.org/10.1038/452283a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354459				2022-12-28	WOS:000254117400023
J	Cook, B; Hardy, RW; McConnaughey, WB; Zuker, CS				Cook, Boaz; Hardy, Robert W.; McConnaughey, William B.; Zuker, Charles S.			Preserving cell shape under environmental stress	NATURE			English	Article							MECHANOSENSORY TRANSDUCTION; MECHANICAL-PROPERTIES; DROSOPHILA RETINA; CYTOCHALASIN-D; MECHANORECEPTORS; EYES	Maintaining cell shape and tone is crucial for the function and survival of cells and tissues. Mechanotransduction relies on the transformation of minuscule mechanical forces into high- fidelity electrical responses(1-3). When mechanoreceptors are stimulated, mechanically sensitive cation channels open and produce an inward transduction current that depolarizes the cell. For this process to operate effectively, the transduction machinery has to retain integrity and remain unfailingly independent of environmental changes. This is particularly challenging for poikilothermic organisms, where changes in temperature in the environment may impact the function of mechanoreceptor neurons. Thus, we wondered how insects whose habitat might quickly vary over several tens of degrees of temperature manage to maintain highly effective mechanical senses. We screened for Drosophila mutants with defective mechanical responses at elevated ambient temperatures, and identified a gene, spam, whose role is to protect the mechanosensory organ from massive cellular deformation caused by heat-induced osmotic imbalance. Here we show that Spam protein forms an extracellular shield that guards mechanosensory neurons from environmental insult. Remarkably, heterologously expressed Spam protein also endowed other cells with superb defence against physically and chemically induced deformation. We studied the mechanical impact of Spam coating and show that spam- coated cells are up to ten times stiffer than uncoated controls. Together, these results help explain how poikilothermic organisms preserve the architecture of critical cells during environmental stress, and illustrate an elegant and simple solution to such challenge.	[Cook, Boaz; Hardy, Robert W.; Zuker, Charles S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Cook, Boaz; Hardy, Robert W.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; [Cook, Boaz; Hardy, Robert W.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [McConnaughey, William B.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Washington University (WUSTL)	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	charles@flyeye.ucsd.edu			NATIONAL EYE INSTITUTE [R01EY006979] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY006979-18, R01 EY006979] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barth FG, 2004, CURR OPIN NEUROBIOL, V14, P415, DOI 10.1016/j.conb.2004.07.005; Colclasure J Chris, 2003, Gravit Space Biol Bull, V16, P61; Gibbs AG, 1998, J EXP BIOL, V201, P71; Gopfert MC, 2001, NATURE, V411, P908, DOI 10.1038/35082144; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; KERNAN M, 1995, CURR OPIN NEUROBIOL, V5, P443, DOI 10.1016/0959-4388(95)80003-4; KIGER A, 2003, J BIOL, V2; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Osorio D, 2007, BIOESSAYS, V29, P111, DOI 10.1002/bies.20533; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; ZAHALAK GI, 1990, J BIOMECH ENG-T ASME, V112, P283, DOI 10.1115/1.2891186; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	18	37	37	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					361	U9		10.1038/nature06603	http://dx.doi.org/10.1038/nature06603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18297055	Green Accepted			2022-12-28	WOS:000254117400049
J	Mantzouranis, EC				Mantzouranis, Eva C.			Taking your child's breath away - The extension of asthma's globel reach	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Crete, Iraklion, Greece	University of Crete	Mantzouranis, EC (corresponding author), Univ Crete, Iraklion, Greece.							Khaltaev N, 2007, GLOBAL SURVEILLANCE; Lodha Rakesh, 2003, Indian Pediatr, V40, P874; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mellon Michael, 2004, J Manag Care Pharm, V10, P130	4	8	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1211	1213		10.1056/NEJMp0708621	http://dx.doi.org/10.1056/NEJMp0708621			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275TL	18354100				2022-12-28	WOS:000254094400002
J	Shannon, MA; Bohn, PW; Elimelech, M; Georgiadis, JG; Marinas, BJ; Mayes, AM				Shannon, Mark A.; Bohn, Paul W.; Elimelech, Menachem; Georgiadis, John G.; Marinas, Benito J.; Mayes, Anne M.			Science and technology for water purification in the coming decades	NATURE			English	Review							POLY(VINYLIDENE FLUORIDE) MEMBRANES; ULTRAFILTRATION MEMBRANES; ACTIVATED CARBON; NANOFILTRATION MEMBRANES; POLYMER MEMBRANES; DRINKING-WATER; AMINO-ACIDS; DISINFECTION; DESALINATION; BIOREACTORS	One of the most pervasive problems afflicting people throughout the world is inadequate access to clean water and sanitation. Problems with water are expected to grow worse in the coming decades, with water scarcity occurring globally, even in regions currently considered water- rich. Addressing these problems calls out for a tremendous amount of research to be conducted to identify robust new methods of purifying water at lower cost and with less energy, while at the same time minimizing the use of chemicals and impact on the environment. Here we highlight some of the science and technology being developed to improve the disinfection and decontamination of water, as well as efforts to increase water supplies through the safe re- use of wastewater and efficient desalination of sea and brackish water.	[Shannon, Mark A.; Bohn, Paul W.; Elimelech, Menachem; Georgiadis, John G.; Marinas, Benito J.; Mayes, Anne M.] Univ Illinois, NSF STC WaterCAMPWS, Urbana, IL 61801 USA; [Bohn, Paul W.] Univ Notre Dame, Dept Chem & Biomol Engn, Notre Dame, IN 46556 USA; [Bohn, Paul W.] Univ Notre Dame, Dept Chem, Notre Dame, IN 46556 USA; [Elimelech, Menachem] Yale Univ, Dept Environm & Chem Engn, New Haven, CT 06520 USA; [Shannon, Mark A.; Georgiadis, John G.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Marinas, Benito J.] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [Mayes, Anne M.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Notre Dame; University of Notre Dame; Yale University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Massachusetts Institute of Technology (MIT)	Shannon, MA (corresponding author), Univ Illinois, NSF STC WaterCAMPWS, Urbana, IL 61801 USA.	mshannon@uiuc.edu	Yong, Ng Law/K-4556-2012; Elimelech, Menachem/E-7137-2012	Yong, Ng Law/0000-0002-6868-4977; Elimelech, Menachem/0000-0003-4186-1563; Georgiadis, John/0000-0002-8217-2003				Akthakul A, 2004, MACROMOLECULES, V37, P7663, DOI 10.1021/ma048837s; Asatekin A, 2007, J MEMBRANE SCI, V298, P136, DOI 10.1016/j.memsci.2007.04.011; Asatekin A, 2006, J MEMBRANE SCI, V285, P81, DOI 10.1016/j.memsci.2006.07.042; Avlonitis SA, 2003, DESALINATION, V157, P151, DOI 10.1016/S0011-9164(03)00395-3; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; BEHRMAN JR, 2004, 57489365 OCLC LOND S; Bergt C, 2004, J BIOL CHEM, V279, P7856, DOI 10.1074/jbc.M309046200; Bixio D, 2006, DESALINATION, V187, P89, DOI 10.1016/j.desal.2005.04.070; Blanco-Galvez J, 2007, J SOL ENERG-T ASME, V129, P4, DOI 10.1115/1.2390948; Bourouni K, 2001, DESALINATION, V137, P167, DOI 10.1016/S0011-9164(01)00215-6; Bradley RS, 2006, SCIENCE, V312, P1755, DOI 10.1126/science.1128087; Carroll T, 2002, J MEMBRANE SCI, V203, P3, DOI 10.1016/S0376-7388(01)00701-3; *CDCP, 2000, SAF WAT SYST DEV WOR; Chang IH, 2005, ENVIRON SCI TECHNOL, V39, P3756, DOI 10.1021/es040505f; Changrani RG, 2000, AICHE J, V46, P829, DOI 10.1002/aic.690460416; Chaplin BP, 2006, ENVIRON SCI TECHNOL, V40, P3075, DOI 10.1021/es0525298; Chen ZL, 2006, J SEP SCI, V29, P2671, DOI 10.1002/jssc.200500304; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; Daigger GT, 2005, ENVIRON SCI TECHNOL, V39, p399A, DOI 10.1021/es053358+; Davis AP, 2007, CHEM SOC REV, V36, P348, DOI 10.1039/b512651g; Deratani A, 2007, ANN CHIM-SCI MAT, V32, P107, DOI [10.3166/acsm.32.107-118, 10.3166/acsm.32]; Facciotti MT, 2004, TRENDS BIOCHEM SCI, V29, P445, DOI 10.1016/j.tibs.2004.06.004; FORNASIERO F, IN PRESS P NATL ACAD; Fournier D, 2006, APPL ENVIRON MICROB, V72, P6693, DOI 10.1128/AEM.01535-06; Fu PF, 2004, J MOL CATAL A-CHEM, V221, P81, DOI 10.1016/j.molcata.2004.06.018; Garelick H, 2005, J SOIL SEDIMENT, V5, P182, DOI 10.1065/jss2005.06.140; Gill LW, 2007, J SOL ENERG-T ASME, V129, P111, DOI 10.1115/1.2391316; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hester JF, 2002, J MEMBRANE SCI, V202, P119, DOI 10.1016/S0376-7388(01)00735-9; Hester JF, 1999, MACROMOLECULES, V32, P1643, DOI 10.1021/ma980707u; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; ISHIDA H, 1997, CHEM LETT JPN, V26, P935; Kalra A, 2003, P NATL ACAD SCI USA, V100, P10175, DOI 10.1073/pnas.1633354100; Kang S, 2007, J MEMBRANE SCI, V296, P42, DOI 10.1016/j.memsci.2007.03.012; Khan AH, 2000, J ENVIRON SCI HEAL A, V35, P1021, DOI 10.1080/10934520009377018; Kimura K, 2005, ENVIRON SCI TECHNOL, V39, P6293, DOI 10.1021/es0502425; Kraemer SM, 2002, ENVIRON SCI TECHNOL, V36, P1287, DOI 10.1021/es010182c; Krasner SW, 2006, ENVIRON SCI TECHNOL, V40, P7175, DOI 10.1021/es060353j; Kuo TC, 2003, ANAL CHEM, V75, P1861, DOI 10.1021/ac025958m; Li Q, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2454344; Lima AAM, 2000, J INFECT DIS, V181, P1643, DOI 10.1086/315423; Lin HF, 2005, J APPL ELECTROCHEM, V35, P699, DOI 10.1007/s10800-005-1364-x; Liu JW, 2007, P NATL ACAD SCI USA, V104, P2056, DOI 10.1073/pnas.0607875104; Liu SY, 2003, J GLACIOL, V49, P117, DOI 10.3189/172756503781830926; Lu YY, 2007, CHEM MATER, V19, P3194, DOI 10.1021/cm070200a; Magnuson ML, 2005, ENVIRON SCI TECHNOL, V39, P7706, DOI 10.1021/es0508018; Martz E, 2002, TRENDS BIOCHEM SCI, V27, P107, DOI 10.1016/S0968-0004(01)02008-4; Mathioulakis E, 2007, DESALINATION, V203, P346, DOI 10.1016/j.desal.2006.03.531; McCutcheon JR, 2005, DESALINATION, V174, P1, DOI 10.1016/j.desal.2004.11.002; Medina-Kauwe LK, 2003, ADV DRUG DELIVER REV, V55, P1485, DOI 10.1016/j.addr.2003.07.010; Medina-Valtierra J, 2006, APPL SURF SCI, V252, P3600, DOI 10.1016/j.apsusc.2005.05.045; Molinari R, 2002, J MEMBRANE SCI, V206, P399, DOI 10.1016/S0376-7388(01)00785-2; Montgomery MA, 2007, ENVIRON SCI TECHNOL, V41, P17, DOI 10.1021/es072435t; MORGAN LA, 1998, DESALINATION, V116, P45; Muellner MG, 2007, ENVIRON SCI TECHNOL, V41, P645, DOI 10.1021/es0617441; Nednoor P, 2007, J MATER CHEM, V17, P1755, DOI 10.1039/b703365f; Nightingale ZD, 2000, FREE RADICAL BIO MED, V29, P425, DOI 10.1016/S0891-5849(00)00262-8; Nuanualsuwan S, 2003, APPL ENVIRON MICROB, V69, P350, DOI 10.1128/AEM.69.1.350-357.2003; NUNES SP, 1995, J MEMBRANE SCI, V106, P49, DOI 10.1016/0376-7388(95)00076-O; PARSEGIAN A, 1969, NATURE, V221, P844, DOI 10.1038/221844a0; Pattison DI, 2005, BIOCHEMISTRY-US, V44, P7378, DOI 10.1021/bi0474665; Phillip WA, 2006, J MEMBRANE SCI, V286, P144, DOI 10.1016/j.memsci.2006.09.028; Pitman G.K, 2002, BRIDGING TROUBLED WA; Qiao R, 2006, NANO LETT, V6, P995, DOI 10.1021/nl060253b; Rasul SB, 2002, TALANTA, V58, P33, DOI 10.1016/S0039-9140(02)00254-0; Revanur R, 2007, MACROMOLECULES, V40, P3624, DOI 10.1021/ma0701033; Sarkar S, 2005, WATER RES, V39, P2196, DOI 10.1016/j.watres.2005.04.002; Schideman LC, 2006, ENVIRON SCI TECHNOL, V40, P6805, DOI 10.1021/es060590m; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; SEACORD TF, 2006, INT DESALINATION WAT; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Silliman SE, 2007, J HYDROL, V335, P374, DOI 10.1016/j.jhydrol.2006.12.005; Simonet J, 2006, APPL ENVIRON MICROB, V72, P7671, DOI 10.1128/AEM.01106-06; Singh P, 2005, J HYDROL, V300, P140, DOI 10.1016/j.jhydrol.2004.06.005; Snyder SA, 2005, ENVIRON SCI TECHNOL, V39, P4586, DOI 10.1021/es047935q; Snyder SA, 2007, DESALINATION, V202, P156, DOI 10.1016/j.desal.2005.12.052; Spiegler KS, 2001, DESALINATION, V134, P109, DOI 10.1016/S0011-9164(01)00121-7; Sultan J, 2006, ANAL CHEM, V78, P2905, DOI 10.1021/ac060384x; U. S. Environmental Protection Agency, 2006, FED REGISTER, V71, P387; Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084; Ulbricht M, 1996, J MEMBRANE SCI, V111, P193, DOI 10.1016/0376-7388(95)00207-3; *US EPA, 2006, FED REGISTER, V71, P653; van der Kooij D, 2003, EMERG I WATER INFECT, P199; van Raaij MJ, 1999, VIROLOGY, V262, P333, DOI 10.1006/viro.1999.9849; Veerapaneni S, 2007, J AM WATER WORKS ASS, V99, P95; WALZ T, 1994, J BIOL CHEM, V269, P1583; Wang YQ, 2005, LANGMUIR, V21, P11856, DOI 10.1021/la052052d; World Health Organization, 2003, ETH ADD AB AG 13 15, P1; Yang SY, 2006, ADV MATER, V18, P709, DOI 10.1002/adma.200501500; Yang WB, 2006, J MEMBRANE SCI, V270, P201, DOI 10.1016/j.memsci.2005.07.010; Yates MV, 2006, J AM WATER WORKS ASS, V98, P93; Yavuz CT, 2006, SCIENCE, V314, P964, DOI 10.1126/science.1131475; Yoon K, 2006, POLYMER, V47, P2434, DOI 10.1016/j.polymer.2006.01.042; Zhou MJ, 2005, ADV MATER, V17, P1850, DOI 10.1002/adma.200500444; Zhou Y, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003749; Zhu PX, 2005, BIOSENS BIOELECTRON, V21, P678, DOI 10.1016/j.bios.2005.01.005	98	5911	6142	321	7104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					301	310		10.1038/nature06599	http://dx.doi.org/10.1038/nature06599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354474				2022-12-28	WOS:000254117400037
J	Bhattacharyya, T; Nicholls, SJ; Topol, EJ; Zhang, RL; Yang, X; Schmitt, D; Fu, XM; Shao, MY; Brennan, DM; Ellis, SG; Brennan, ML; Allayee, H; Lusis, AJ; Hazen, SL				Bhattacharyya, Tamali; Nicholls, Stephen J.; Topol, Eric J.; Zhang, Renliang; Yang, Xia; Schmitt, David; Fu, Xiaoming; Shao, Mingyuan; Brennan, Danielle M.; Ellis, Stephen G.; Brennan, Marie-Luise; Allayee, Hooman; Lusis, Aldons J.; Hazen, Stanley L.			Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; SERUM PARAOXONASE; ARTERY-DISEASE; ATHEROSCLEROSIS; MICE; METAANALYSIS; ASSOCIATION; LIPOPROTEIN; PROTEIN; GENOME	Context Paraoxonase 1 ( PON1) is reported to have antioxidant and cardioprotective properties. The relationship between PON1 genotypes and functional activity with systemic measures of oxidative stress and cardiovascular disease ( CVD) risk in humans has not been systematically investigated. Objective To investigate the relationship of genetic and biochemical determinants of PON1 activity with systemic measures of oxidative stress and CVD risk in humans. Design, Setting, and Participants The association between systemic PON1 activity measures and a functional polymorphism ( Q192R) resulting in high PON1 activity with prevalent CVD and future major adverse cardiac events ( myocardial infarction, stroke, or death) was evaluated in 1399 sequential consenting patients undergoing diagnostic coronary angiography between September 2002 and November 2003 at the Cleveland Clinic. Patients were followed up until December 2006. Systemic levels of multiple structurally defined fatty acid oxidation products were also measured by mass spectrometry in 150 age-, sex-, and race- matched patients and compared with regard to PON1 genotype and activity. Main Outcome Measures Relationship between a functional PON1 polymorphism and PON1 activity with global indices of systemic oxidative stress and risk of CVD. Results The PON1 genotype demonstrated significant dose- dependent associations ( QQ192 > QR192 > RR192) with decreased levels of serum PON1 activity and with increased levels of systemic indices of oxidative stress. Compared with participants with either the PON1 RR192 or QR192 genotype, participants with the QQ192 genotype demonstrated an increased risk of all- cause mortality ( 43/ 681 deaths [ 6.75%] in RR192 and QR192 and 62/ 584 deaths [ 11.1%] in QQ192; adjusted hazard ratio, 2.05; 95% confidence interval [ CI], 1.32- 3.18) and of major adverse cardiac events ( 88/ 681 events [ 13.6%] in RR192 and QR192 and 102/ 584 events [ 18.0%] in QQ192; adjusted hazard ratio, 1.48; 95% CI, 1.09- 2.03; P=. 01). The incidence of major adverse cardiac events was significantly lower in participants in the highest PON1 activity quartile ( 23/ 315 [ 7.3%]) and 235/ 324 [ 7.7%] for paraoxonase and arylesterase, respectively) compared with those in the lowest activity quartile ( 78/ 311 [ 25.1%] and 75/ 319 [ 23.5%]; P <. 001 for paraoxonase and arylesterase, respectively). The adjusted hazard ratios for major adverse cardiac events between the highest and lowest PON1 activity quartiles were, for paraoxonase, 3.4 ( 95% CI, 2.1- 5.5; P <. 001) and for arylesterase, 2.9 ( 95% CI, 1.8- 4.7; P <. 001) and remained independent in multivariate analysis. Conclusion This study provides direct evidence for a mechanistic link between genetic determinants and activity of PON1 with systemic oxidative stress and prospective cardiovascular risk, indicating a potential mechanism for the atheroprotective function of PON1.	[Bhattacharyya, Tamali; Nicholls, Stephen J.; Zhang, Renliang; Schmitt, David; Fu, Xiaoming; Brennan, Danielle M.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Bhattacharyya, Tamali; Nicholls, Stephen J.; Zhang, Renliang; Schmitt, David; Fu, Xiaoming; Brennan, Marie-Luise; Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Nicholls, Stephen J.; Shao, Mingyuan; Brennan, Danielle M.; Ellis, Stephen G.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Topol, Eric J.] Scripps Res Inst & Scripps Clin, La Jolla, CA USA; [Yang, Xia; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90024 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Immunol, Los Angeles, CA 90024 USA; [Allayee, Hooman] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Scripps Research Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California	Hazen, SL (corresponding author), Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, 9500 Euclid Ave,NE-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021	Topol, Eric/0000-0002-1478-4729; Nicholls, Stephen/0000-0002-9668-4368	NATIONAL CANCER INSTITUTE [C06CA062528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR010600, C06RR014514, KL2RR024990] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018, P50HL077107, R01HL079353, P01HL076491, P01HL030568] Funding Source: NIH RePORTER; NCI NIH HHS [C06 CA062528, CA62528-01] Funding Source: Medline; NCRR NIH HHS [C06 RR10600-01, C06 RR014514, KL2 RR024990, 1KL2RR024990, RR14514-01] Funding Source: Medline; NHLBI NIH HHS [P01 HL077107, P50 HL077107, P01 HL030568, P01 HL30568, P01 HL087018, R01 HL079353, P01 HL030568-200009, P01 HL076491] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brophy VH, 2001, PHARMACOGENETICS, V11, P77, DOI 10.1097/00008571-200102000-00009; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; Gaidukov L, 2006, J LIPID RES, V47, P2492, DOI 10.1194/jlr.M600297-JLR200; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hegele RA, 1999, ANN MED, V31, P217, DOI 10.3109/07853899909115981; Kattan MW, 2006, CANCER, V107, P2523, DOI 10.1002/cncr.22314; Kattan MW, 2004, CLIN CANCER RES, V10, P822, DOI 10.1158/1078-0432.CCR-03-0061; Lawlor DA, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-17; Li HL, 2003, J MOL MED, V81, P766, DOI 10.1007/s00109-003-0481-4; Lusis AJ, 2004, CIRCULATION, V110, P1868, DOI 10.1161/01.CIR.0000143041.58692.CC; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Mackness M, 2004, FREE RADICAL BIO MED, V37, P1317, DOI 10.1016/j.freeradbiomed.2004.07.034; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542, DOI 10.1161/01.ATV.21.4.542; Robertson KS, 2003, BBA-MOL BASIS DIS, V1639, P203, DOI 10.1016/j.bbadis.2003.09.008; Rosenzweig A, 2007, NEW ENGL J MED, V357, P497, DOI 10.1056/NEJMe078121; Rozenberg O, 2003, FREE RADICAL BIO MED, V34, P774, DOI 10.1016/S0891-5849(02)01429-6; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Shishehbor MH, 2006, FREE RADICAL BIO MED, V41, P1678, DOI 10.1016/j.freeradbiomed.2006.09.001; Shriner D, 2007, SCIENCE, V316, P1840; Thukkani AK, 2003, CIRCULATION, V108, P3128, DOI 10.1161/01.CIR.0000104564.01539.6A; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; Watzinger N, 2002, CARDIOLOGY, V98, P116, DOI 10.1159/000066321; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	31	427	442	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1265	1276		10.1001/jama.299.11.1265	http://dx.doi.org/10.1001/jama.299.11.1265			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349088	Green Accepted, Bronze			2022-12-28	WOS:000254079100018
J	Ciardiello, F; Tortora, G				Ciardiello, Fortunato; Tortora, Giampaolo			Drug therapy: EGFR antagonists in cancer treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GROWTH-FACTOR-RECEPTOR; CELL LUNG-CANCER; TYROSINE KINASE INHIBITOR; PHASE-III TRIAL; K-RAS MUTATION; PREVIOUSLY TREATED PATIENTS; ADVANCED PANCREATIC-CANCER; GENE COPY NUMBER; QUALITY-OF-LIFE; COLORECTAL-CANCER		[Ciardiello, Fortunato] Univ Naples 2, Div Med Oncol, Dept Expt & Clin Med & Surg F Magrassi & A Lanzar, I-80131 Naples, Italy; [Tortora, Giampaolo] Univ Naples Federico II, Div Med Oncol, Dept Mol & Clin Endocrinol & Oncol, Naples, Italy	Universita della Campania Vanvitelli; University of Naples Federico II	Ciardiello, F (corresponding author), Univ Naples 2, Div Med Oncol, Dept Expt & Clin Med & Surg F Magrassi & A Lanzar, Via S Pansini 5, I-80131 Naples, Italy.	fortunato.ciardiello@unina2.it	Tortora, Giampaolo/HGB-6261-2022; Tortora, Giampaolo/AAA-1252-2019	Ciardiello, Fortunato/0000-0002-3369-4841; Tortora, Giampaolo/0000-0002-1378-4962	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; AMADO RG, 2007, EURO J CANC S8, V5; Baselga J, 2000, J CLIN ONCOL, V18, P904, DOI 10.1200/JCO.2000.18.4.904; Baselga J, 2005, J CLIN ONCOL, V23, P5568, DOI 10.1200/JCO.2005.07.119; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; Belani CP, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.12.5435; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bezjak, 2007, J CLIN ONCOL, V25, P167, DOI 10.1200/JCO.2007.11.006; Bezjak A, 2006, J CLIN ONCOL, V24, P3831, DOI 10.1200/JCO.2006.05.8073; Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; Blackhall F, 2007, LANCET ONCOL, V8, P670; Blackhall F, 2006, LANCET ONCOL, V7, P499, DOI 10.1016/S1470-2045(06)70725-2; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bourhis J, 2006, J CLIN ONCOL, V24, P2866, DOI 10.1200/JCO.2005.04.3547; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Camp ER, 2005, CLIN CANCER RES, V11, P397; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chakravarti A, 2002, CANCER RES, V62, P200; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; Ciardiello F, 2004, CLIN CANCER RES, V10, P784, DOI 10.1158/1078-0432.CCR-1100-03; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Dancey JE, 2006, NAT REV DRUG DISCOV, V5, P649, DOI 10.1038/nrd2089; Dancey JE, 2003, LANCET, V362, P62, DOI 10.1016/S0140-6736(03)13810-X; DEROOCK W, IN PRESS ANN ONCOL; Di Maio M, 2005, J CELL PHYSIOL, V205, P355, DOI 10.1002/jcp.20402; DOUILLARD JY, 2007, 12 WORLD C LUNG CANC; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; ENG C, 2007, J CLIN ONCOL S, V25, pS164; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Folprecht G, 2006, ANN ONCOL, V17, P450, DOI 10.1093/annonc/mdj084; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Galizia G, 2007, ONCOGENE, V26, P3654, DOI 10.1038/sj.onc.1210381; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Gridelli C, 2007, ONCOLOGIST, V12, P840, DOI 10.1634/theoncologist.12-7-840; Grunwald V, 2003, JNCI-J NATL CANCER I, V95, P851, DOI 10.1093/jnci/95.12.851; Han SW, 2006, CLIN CANCER RES, V12, P2538, DOI 10.1158/1078-0432.CCR-05-2845; Hecht J, 2006, J CLIN ONCOL, V24, p157S; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Herbst RS, 2002, J CLIN ONCOL, V20, P3815, DOI 10.1200/JCO.2002.03.038; Herbst RS, 2005, J CLIN ONCOL, V23, P5578, DOI 10.1200/JCO.2005.07.120; HERBST RS, 2007, J CLIN ONCOL S, V25, pS395; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267, DOI 10.1200/JCO.2001.19.13.3267; Hirsch FR, 2006, J CLIN ONCOL, V24, P5034, DOI 10.1200/JCO.2006.06.3958; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Isomura M, 2004, J CLIN ONCOL, V22, p200S; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karamouzis MV, 2007, JAMA-J AM MED ASSOC, V298, P70, DOI 10.1001/jama.298.1.70; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kimura H, 2007, CANCER SCI, V98, P1275, DOI 10.1111/j.1349-7006.2007.00510.x; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Lenz HJ, 2006, J CLIN ONCOL, V24, P4914, DOI 10.1200/JCO.2006.06.7595; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; LoRusso PM, 2003, CLIN CANCER RES, V9, P2040; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; MASUI H, 1984, CANCER RES, V44, P1002; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Messersmith WA, 2007, CLIN CANCER RES, V13, P4664, DOI 10.1158/1078-0432.CCR-07-0065; Miller VA, 2004, J CLIN ONCOL, V22, P1103, DOI 10.1200/JCO.2004.08.158; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Morgillo F, 2007, DIFFERENTIATION, V75, P788, DOI 10.1111/j.1432-0436.2007.00200.x; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; Niho S, 2007, J CLIN ONCOL, V25; Nomura M, 2007, PLOS MED, V4, P715, DOI 10.1371/journal.pmed.0040125; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Padron D, 2007, CANCER RES, V67, P7695, DOI 10.1158/0008-5472.CAN-07-0484; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Perez-Torres M, 2006, J BIOL CHEM, V281, P40183, DOI 10.1074/jbc.M607958200; Pham DK, 2006, J CLIN ONCOL, V24, P1700, DOI 10.1200/JCO.2005.04.3224; Philip PA, 2007, J CLIN ONCOL, V25, P1145, DOI 10.1200/JCO.2006.09.6040; Rao G, 2007, J CLIN ONCOL, V25, P2867, DOI 10.1200/JCO.2007.10.8167; RODENHUIS S, 1988, CANCER RES, V48, P5738; ROSELL R, IN PRESS ANN ONCOL; Rossi A, 2006, CRIT REV ONCOL HEMAT, V59, P139, DOI 10.1016/j.critrevonc.2006.02.006; Sakuma Y, 2007, AM J CLIN PATHOL, V128, P100, DOI 10.1309/WVXFGAFLAUX48DU6; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; SALTZ L, 2001, P AN M AM SOC CLIN, V20, pA3; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Sartore-Bianchi A, 2007, J CLIN ONCOL, V25, P3238, DOI 10.1200/JCO.2007.11.5956; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; Sridhar SS, 2003, LANCET ONCOL, V4, P397, DOI 10.1016/S1470-2045(03)01137-9; Steiner P, 2007, CLIN CANCER RES, V13, P1540, DOI 10.1158/1078-0432.CCR-06-1887; Tabernero J, 2007, J CLIN ONCOL, V25, P5225, DOI 10.1200/JCO.2007.13.2183; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Toh CK, 2006, J CLIN ONCOL, V24, P2245, DOI 10.1200/JCO.2005.04.8033; Tsao M, 2006, J CLIN ONCOL, V24, p365S; Tsao MS, 2006, NEW ENGL J MED, V355, P1746; Van Cutsem E, 2007, J CLIN ONCOL S, V25, p164s; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; VERMORKEN JB, 2007, 43 AM SOC CLIN ONC A; Viloria-Petit A, 2001, CANCER RES, V61, P5090; Wacker B, 2007, CLIN CANCER RES, V13, P3913, DOI 10.1158/1078-0432.CCR-06-2610; Xiong HQ, 2004, J CLIN ONCOL, V22, P2610, DOI 10.1200/JCO.2004.12.040; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023	113	1554	1659	6	325	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1160	1174		10.1056/NEJMra0707704	http://dx.doi.org/10.1056/NEJMra0707704			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337605				2022-12-28	WOS:000253877200009
J	Koralov, SB; Muljo, SA; Galler, GR; Krek, A; Chakraborty, T; Kanellopoulou, C; Jensen, K; Cobb, BS; Merkenschlager, M; Rajewsky, N; Rajewsky, K				Koralov, Sergei B.; Muljo, Stefan A.; Galler, Gunther R.; Krek, Azra; Chakraborty, Tirtha; Kanellopoulou, Chryssa; Jensen, Kari; Cobb, Bradley S.; Merkenschlager, Matthias; Rajewsky, Nikolaus; Rajewsky, Klaus			Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage	CELL			English	Article							TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; HEAVY-CHAIN; TRANSGENIC MICE; MESSENGER-RNAS; ENZYME DICER; MICRORNA; BIM; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION	To explore the role of Dicer-dependent control mechanisms in B lymphocyte development, we ablated this enzyme in early B cell progenitors. This resulted in a developmental block at the pro- to pre-B cell transition. Gene-expression profiling revealed a miR-17 similar to 92 signature in the 3'UTRs of genes upregulated in Dicer-deficient pro-B cells; a top miR-17 similar to 92 target, the proapoptotic molecule Bim, was highly upregulated. Accordingly, B cell development could be partially rescued by ablation of Bim or transgenic expression of the prosurvival protein Bcl-2. This allowed us to assess the impact of Dicer deficiency on the V(D)J recombination program in developing B cells. We found intact Ig gene rearrangements in immunoglobulin heavy (IgH) and kappa chain loci, but increased sterile transcription and usage of D-H elements of the DSP family in IgH, and increased N sequence addition in Ig kappa due to deregulated transcription of the terminal deoxynucleotidyl transferase gene.	[Koralov, Sergei B.; Muljo, Stefan A.; Galler, Gunther R.; Chakraborty, Tirtha; Jensen, Kari; Rajewsky, Klaus] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Koralov, Sergei B.; Muljo, Stefan A.; Galler, Gunther R.; Chakraborty, Tirtha; Jensen, Kari; Rajewsky, Klaus] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Krek, Azra; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Krek, Azra] NYU, Dept Phys, New York, NY 10003 USA; [Kanellopoulou, Chryssa] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Cobb, Bradley S.; Merkenschlager, Matthias] Univ London Imperial Coll Sci Technol & Med, Lymphocyte Dev Grp, MRC, Ctr Clin Sci, London W12 0NN, England	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine; New York University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Imperial College London	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 200 Longwood Ave, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu	Muljo, Stefan A/F-5671-2015	Muljo, Stefan A/0000-0003-1013-446X; Koralov, Sergei/0000-0002-4843-3791; Merkenschlager, Matthias/0000-0003-2889-3288; Rajewsky, Klaus/0000-0002-6633-6370; Galler, Gunther/0000-0003-4507-5957; Rajewsky, Nikolaus/0000-0002-4785-4332	MRC [MC_U120027516] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI060302] Funding Source: NIH RePORTER; Medical Research Council [MC_U120027516] Funding Source: Medline; NIAID NIH HHS [AI-060302] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bolland DJ, 2007, MOL CELL BIOL, V27, P5523, DOI 10.1128/MCB.02407-06; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hughes P, 2006, CURR DIRECT AUTOIMMU, V9, P74; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Koralov SB, 2006, IMMUNITY, V25, P43, DOI 10.1016/j.immuni.2006.04.016; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Oliver PM, 2004, J EXP MED, V200, P1179, DOI 10.1084/jem.20041129; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wasserman R, 1997, J IMMUNOL, V158, P1133; XIAO C, 2008, NAT IMMUNOL     0309; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	53	452	477	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					860	874		10.1016/j.cell.2008.02.020	http://dx.doi.org/10.1016/j.cell.2008.02.020			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329371	Bronze			2022-12-28	WOS:000253818000022
J	Regine, WF; Winter, KA; Abrams, RA; Safran, H; Hoffman, JP; Konski, A; Benson, AB; Macdonald, JS; Kudrimoti, MR; Fromm, ML; Haddock, MG; Schaefer, P; Willett, CG; Rich, TA				Regine, William F.; Winter, Kathryn A.; Abrams, Ross A.; Safran, Howard; Hoffman, John P.; Konski, Andre; Benson, Al B.; Macdonald, John S.; Kudrimoti, Mahesh R.; Fromm, Mitchel L.; Haddock, Michael G.; Schaefer, Paul; Willett, Christopher G.; Rich, Tyvin A.			Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COOPERATIVE-ONCOLOGY-GROUP; CURATIVE RESECTION; ADJUVANT THERAPY; RADIATION-THERAPY; PHASE-III; CANCER; CARCINOMA; SURVIVAL; CHEMORADIOTHERAPY; EXPERIENCE	Context Among patients with locally advanced metastatic pancreatic adenocarcinoma, gemcitabine has been shown to improve outcomes compared with fluorouracil. Objective To determine if the addition of gemcitabine to adjuvant fluorouracil chemoradiation ( chemotherapy plus radiation) improves survival for patients with resected pancreatic adenocarcinoma. Design, Setting, and Participants Randomized controlled phase 3 trial of patients with complete gross total resection of pancreatic adenocarcinoma and no prior radiation or chemotherapy enrolled between July 1998 and July 2002 with follow- up through August 18, 2006, at 164 US and Canadian institutions. Intervention Chemotherapy with either fluorouracil ( continuous infusion of 250 mg/m(2) per day; n= 230) or gemcitabine ( 30- minute infusion of 1000 mg/m(2) once per week; n= 221) for 3 weeks prior to chemoradiation therapy and for 12 weeks after chemoradiation therapy. Chemoradiation with a continuous infusion of fluorouracil ( 250 mg/m(2) per day) was the same for all patients ( 50.4 Gy). Main Outcome Measures Survival for all patients and survival for patients with pancreatic head tumors were the primary end points. Secondary end points included toxicity. Results A total of 451 patients were randomized, eligible, and analyzable. Patients with pancreatic head tumors ( n= 388) had a median survival of 20.5 months and a 3- year survival of 31% in the gemcitabine group vs a median survival of 16.9 months and a 3- year survival of 22% in the fluorouracil group ( hazard ratio, 0.82 [ 95% confidence interval, 0.65- 1.03]; P=. 09). The treatment effect was strengthened on multivariate analysis ( hazard ratio, 0.80 [ 95% confidence interval, 0.63- 1.00]; P=. 05). Grade 4 hematologic toxicity was 1% in the fluorouracil group and 14% in the gemcitabine group ( P <. 001) without a difference in febrile neutropenia or infection. There were no differences in the ability to complete chemotherapy or radiation therapy ( > 85%). Conclusions The addition of gemcitabine to adjuvant fluorouracil- based chemoradiation was associated with a survival benefit for patients with resected pancreatic cancer, although this improvement was not statistically significant. Trial Registration clinicaltrials. gov Identifier: NCT00003216.	[Regine, William F.] Univ Maryland, Med Ctr, Dept Radiat Oncol, Baltimore, MD 21030 USA; [Winter, Kathryn A.] Radiat Therapy Oncol Grp, Philadelphia, PA USA; [Abrams, Ross A.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Safran, Howard] Brown Univ, Div Hematol Oncol, Providence, RI 02912 USA; [Hoffman, John P.; Konski, Andre] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Benson, Al B.] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA; [Macdonald, John S.] St Vincents Canc Care Ctr, New York, NY USA; [Kudrimoti, Mahesh R.] Univ Kentucky, Dept Radiat Med, Lexington, KY USA; [Fromm, Mitchel L.] Akron Gen Med Ctr, Akron, OH USA; [Haddock, Michael G.] Mayo Clin, Rochester, MN USA; [Schaefer, Paul] Natalie Warren Canc Ctr, Tulsa, OK USA; [Willett, Christopher G.] Duke Univ, Dept Radiat Oncol, Durham, NC USA; [Rich, Tyvin A.] Univ Virginia, Dept Radiat Oncol, Charlottesville, VA USA	University System of Maryland; University of Maryland Baltimore; Radiation Therapy Oncology Group (RTOG); Rush University; Brown University; Fox Chase Cancer Center; Northwestern University; Saint Vincents Hospital Manhattan; University of Kentucky; Akron General Medical Center; Mayo Clinic; Duke University; University of Virginia	Regine, WF (corresponding author), Univ Maryland, Med Ctr, Dept Radiat Oncol, 22 S Greene St, Baltimore, MD 21030 USA.	wregine@umm.edu			NCI NIH HHS [U10 CA32115, U10 CA21661, U10 CA37422] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA032115, U10CA021661, U10CA037422] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abrams RA, 2001, LANCET, V358, P1565, DOI 10.1016/S0140-6736(01)06666-1; Abrams Ross A, 2004, Surg Oncol Clin N Am, V13, P621, DOI 10.1016/j.soc.2004.06.004; Benson AB, 2007, JAMA-J AM MED ASSOC, V297, P311, DOI 10.1001/jama.297.3.311; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Bydder S, 2004, NEW ENGL J MED, V350, P2714; Choti MA, 2004, NEW ENGL J MED, V350, P1249, DOI 10.1056/NEJMe048002; Cohen SJ, 2005, INT J RADIAT ONCOL, V62, P1345, DOI 10.1016/j.ijrobp.2004.12.074; COX DR, 1972, J R STAT SOC B, V34, P187; Crane CH, 2004, NEW ENGL J MED, V350, P2713; DALTON RR, 1992, SURGERY, V111, P489; FLEMING ID, 1997, AJCC CANC STAGING MA, P121; Garofalo MC, 2006, ANN SURG, V244, P332, DOI 10.1097/01.sla.0000229980.81505.44; GRIFFIN JF, 1990, CANCER, V66, P56, DOI 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6; GUDJONSSON B, 1987, CANCER, V60, P2284, DOI 10.1002/1097-0142(19871101)60:9<2284::AID-CNCR2820600930>3.0.CO;2-V; KALSER MH, 1985, ARCH SURG-CHICAGO, V120, P899; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Koshy MC, 2005, INT J RADIAT ONCOL, V61, P965, DOI 10.1016/j.ijrobp.2004.11.018; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; MANTEL N, 1966, CANCER CHEMOTH REP, V5, P163; Montgomery RC, 1997, ANN SURG ONCOL, V4, P551, DOI 10.1007/BF02305535; Morris SL, 2004, NEW ENGL J MED, V350, P2713; Neoptolemos JP, 2001, LANCET, V358, P1576, DOI 10.1016/S0140-6736(01)06651-X; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; NITECKI SS, 1995, ANN SURG, V221, P59, DOI 10.1097/00000658-199501000-00007; NORDBACK IH, 1992, AM J SURG, V164, P26, DOI 10.1016/S0002-9610(05)80641-5; OCONNELL MJ, 1994, NEW ENGL J MED, V333, P52; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; PIORKOWSKI RJ, 1982, AM J SURG, V143, P189; REGINE WF, 2006, PANCREATIC CANC, P235; Rothenberg ML, 1996, ANN ONCOL, V7, P347; TEPPER J, 1976, CANCER, V37, P1519, DOI 10.1002/1097-0142(197603)37:3<1519::AID-CNCR2820370340>3.0.CO;2-O; WHITTINGTON R, 1995, J CLIN ONCOL, V13, P227, DOI 10.1200/JCO.1995.13.1.227; Yeo CJ, 1997, ANN SURG, V225, P621, DOI 10.1097/00000658-199705000-00018; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	35	571	596	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2008	299	9					1019	1026		10.1001/jama.299.9.1019	http://dx.doi.org/10.1001/jama.299.9.1019			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JH	18319412	Bronze			2022-12-28	WOS:000253644800019
J	Lawrence, EC				Lawrence, E. Clinton			Lung transplantation for COPD: one lung, two lungs, or none?	LANCET			English	Editorial Material							VOLUME REDUCTION; DISEASE; EMPHYSEMA; RECIPIENTS; SINGLE		Emory Univ, Sch Med, McKelvey Ctr Lung Transplantat & Pulm Vasc Dis, Atlanta, GA 30322 USA	Emory University	Lawrence, EC (corresponding author), Emory Univ, Sch Med, McKelvey Ctr Lung Transplantat & Pulm Vasc Dis, Atlanta, GA 30322 USA.	clint.lawrence@emoryhealthcare.org						COOPER JD, 1995, J THORAC CARDIOV SUR, V109, P106, DOI 10.1016/S0022-5223(95)70426-4; COOPER JD, 1989, AM REV RESPIR DIS, V139, P303, DOI 10.1164/ajrccm/139.2.303; GROSS CR, 1995, CHEST, V108, P1587, DOI 10.1378/chest.108.6.1587; HARDY JD, 1963, JAMA-J AM MED ASSOC, V186, P1065; Hosenpud JD, 1998, LANCET, V351, P24, DOI 10.1016/S0140-6736(97)06405-2; LEVINE SM, 1994, AM J RESP CRIT CARE, V150, P398, DOI 10.1164/ajrccm.150.2.8049821; MAL H, 1989, AM REV RESPIR DIS, V140, P797, DOI 10.1164/ajrccm/140.3.797; Reilly J, 2007, CHEST, V131, P1108, DOI 10.1378/chest.06-1754; STEVENS PM, 1970, NEW ENGL J MED, V282, P245, DOI 10.1056/NEJM197001292820504; Strange Charlie, 2007, BMC Pulm Med, V7, P10, DOI 10.1186/1471-2466-7-10; Thabut G, 2008, LANCET, V371, P744, DOI 10.1016/S0140-6736(08)60344-X; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; WILLIAMS TJ, 1992, AM REV RESPIR DIS, V145, P101, DOI 10.1164/ajrccm/145.1.101	13	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 1	2008	371	9614					702	703		10.1016/S0140-6736(08)60319-0	http://dx.doi.org/10.1016/S0140-6736(08)60319-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313486				2022-12-28	WOS:000253596700006
J	Krumholz, MR; McKee, CF				Krumholz, Mark R.; McKee, Christopher F.			A minimum column density of 1 g cm(-2) for massive star formation	NATURE			English	Article							PROTOSTELLAR CORES; MOLECULAR CLOUDS; CLUSTER FORMATION; WATER MASERS; GAS; FRAGMENTATION; TURBULENCE; GALAXIES; DISKS; TIME	Massive stars are very rare, but their extreme luminosities make them both the only type of young star we can observe in distant galaxies and the dominant energy sources in the Universe today. They form rarely because efficient radiative cooling keeps most star- forming gas clouds close to isothermal as they collapse, and this favours fragmentation into stars of one solar mass or lower(1-3). Heating of a cloud by accreting low- mass stars within it can prevent fragmentation and allow formation of massive stars(4,5), but the necessary properties for a cloud to form massive stars - and therefore where massive stars form in a galaxy - have not yet been determined. Here we show that only clouds with column densities of at least 1 g cm(-2) can avoid fragmentation and form massive stars. This threshold, and the environmental variation of the stellar initial mass function that it implies, naturally explain the characteristic column densities associated with massive star clusters(6-9) and the difference between the radial profiles of Ha and ultraviolet emission in galactic disks(10,11). The existence of a threshold also implies that the initial mass function should show detectable variation with environment within the Galaxy, that the characteristic column densities of clusters containing massive stars should vary between galaxies, and that star formation rates in some galactic environments may have been systematically underestimated.	[Krumholz, Mark R.] Princeton Univ, Dept Astrophys, Princeton, NJ 08544 USA; [Krumholz, Mark R.] Univ Calif Santa Cruz, Dept Astrophys, Santa Cruz, CA 95064 USA; [McKee, Christopher F.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [McKee, Christopher F.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	Princeton University; University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Krumholz, MR (corresponding author), Princeton Univ, Dept Astrophys, Princeton, NJ 08544 USA.	krumholz@astro.princeton.edu		Krumholz, Mark/0000-0003-3893-854X				Boissier S, 2007, ASTROPHYS J SUPPL S, V173, P524, DOI 10.1086/516642; Bonnell IA, 2004, MON NOT R ASTRON SOC, V349, P735, DOI 10.1111/j.1365-2966.2004.07543.x; Braine J, 2007, ASTROPHYS J, V669, pL73, DOI 10.1086/524135; Chabrier G, 2005, ASTROPHYS SPACE SC L, V327, P41; Chakrabarti S, 2005, ASTROPHYS J, V631, P792, DOI 10.1086/432659; Feigelson ED, 2008, ASTROPHYS J, V673, P354, DOI 10.1086/524031; Heyer MH, 2004, ASTROPHYS J, V615, pL45, DOI 10.1086/425978; Huff EM, 2006, ASTROPHYS J, V644, P355, DOI 10.1086/503357; Krumholz MR, 2007, ASTROPHYS J, V656, P959, DOI 10.1086/510664; Krumholz MR, 2007, ASTROPHYS J, V654, P304, DOI 10.1086/509101; Krumholz MR, 2005, ASTROPHYS J, V630, P250, DOI 10.1086/431734; Krumholz MR, 2006, ASTROPHYS J, V641, pL45, DOI 10.1086/503771; Martin CL, 2001, ASTROPHYS J, V555, P301, DOI 10.1086/321452; Matzner CD, 2000, ASTROPHYS J, V545, P364, DOI 10.1086/317785; McKee CF, 2003, ASTROPHYS J, V585, P850, DOI 10.1086/346149; McKee CF, 2002, NATURE, V416, P59, DOI 10.1038/416059a; Motte F, 2007, ASTRON ASTROPHYS, V476, P1243, DOI 10.1051/0004-6361:20077843; Mueller KE, 2002, ASTROPHYS J SUPPL S, V143, P469, DOI 10.1086/342881; NEUFELD DA, 1995, ASTROPHYS J SUPPL S, V100, P132, DOI 10.1086/192211; Parravano A, 2003, ASTROPHYS J, V584, P797, DOI 10.1086/345807; Plume R, 1997, ASTROPHYS J, V476, P730, DOI 10.1086/303654; Shirley YL, 2003, ASTROPHYS J SUPPL S, V149, P375, DOI 10.1086/379147; Tan JC, 2006, ASTROPHYS J, V641, pL121, DOI 10.1086/504150; URBAN A, UNPUB ASTROPHYS J; Weingartner JC, 2001, ASTROPHYS J, V548, P296, DOI 10.1086/318651; Wu JW, 2005, ASTROPHYS J, V635, pL173, DOI 10.1086/499623; Young KE, 2004, ASTROPHYS J, V614, P252, DOI 10.1086/423609	30	236	236	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					1082	1084		10.1038/nature06620	http://dx.doi.org/10.1038/nature06620			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305539	Green Submitted			2022-12-28	WOS:000253453600036
J	Bessonov, S; Anokhina, M; Will, CL; Urlaub, H; Luhrmann, R				Bessonov, Sergey; Anokhina, Maria; Will, Cindy L.; Urlaub, Henning; Luehrmann, Reinhard			Isolation of an active step I spliceosome and composition of its RNP core	NATURE			English	Article							BIMOLECULAR EXON LIGATION; PROTEIN-COMPOSITION; COMPLEX; U2; PRP19; SITE	Formation of catalytically active RNA structures within the spliceosome requires the assistance of proteins. However, little is known about the number and nature of proteins needed to establish and maintain the spliceosome's active site. Here we affinity- purified human spliceosomal C complexes and show that they catalyse exon ligation in the absence of added factors. Comparisons of the composition of the precatalytic versus the catalytic spliceosome revealed a marked exchange of proteins during the transition from the B to the C complex, with apparent stabilization of Prp19 - CDC5 complex proteins and destabilization of SF3a/ b proteins. Disruption of purified C complexes led to the isolation of a salt- stable ribonucleoprotein ( RNP) core that contained both splicing intermediates and U2, U5 and U6 small nuclear RNA plus predominantly U5 and human Prp19 - CDC5 proteins and Prp19- related factors. Our data provide insights into the spliceosome's catalytic RNP domain and indicate a central role for the aforementioned proteins in sustaining its catalytically active structure.	[Bessonov, Sergey; Anokhina, Maria; Will, Cindy L.; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Luhrmann, R (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany.	reinhard.luehrmann@mpi-bpc.mpg.de						Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Anderson K, 2000, RNA, V6, P16, DOI 10.1017/S1355838200001862; Anderson K, 1997, SCIENCE, V276, P1712, DOI 10.1126/science.276.5319.1712; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dybkov O, 2006, MOL CELL BIOL, V26, P2803, DOI 10.1128/MCB.26.7.2803-2816.2006; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Konarska MM, 2006, MOL CELL, V21, P543, DOI 10.1016/j.molcel.2006.01.017; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Nilsen TW, 1998, COLD SPRING HARBOR M, P279; Smith DJ, 2007, MOL CELL, V26, P883, DOI 10.1016/j.molcel.2007.05.020; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Umen JG, 1995, RNA, V1, P869; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Will CL, 2006, COLD SPRING HARB MON, V43, P369; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1	27	286	296	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2008	452	7189					846	U3		10.1038/nature06842	http://dx.doi.org/10.1038/nature06842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18322460	Green Published			2022-12-28	WOS:000255026000042
J	Niessen, F; Schaffner, F; Furlan-Freguia, C; Pawlinski, R; Bhattacharjee, G; Chun, J; Derian, CK; Andrade-Gordon, P; Rosen, H; Ruf, W				Niessen, Frank; Schaffner, Florence; Furlan-Freguia, Christian; Pawlinski, Rafal; Bhattacharjee, Gourab; Chun, Jerold; Derian, Claudia K.; Andrade-Gordon, Patricia; Rosen, Hugh; Ruf, Wolfram			Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation	NATURE			English	Article							PROTEASE-ACTIVATED RECEPTORS; TISSUE FACTOR; SPHINGOSINE 1-PHOSPHATE; POLYMICROBIAL SEPSIS; P2X(7) RECEPTOR; MICE DEFICIENT; LYMPH-NODES; MOUSE MODEL; RESPONSES; ENDOTOXEMIA	Defining critical points of modulation across heterogeneous clinical syndromes may provide insight into new therapeutic approaches. Coagulation initiated by the cytokine- receptor family member known as tissue factor is a hallmark of systemic inflammatory response syndromes in bacterial sepsis and viral haemorrhagic fevers(1,2), and anticoagulants can be effective in severe sepsis with disseminated intravascular coagulation(3). The precise mechanism coupling coagulation and inflammation remains unresolved(4-7). Here we show that protease- activated receptor 1 ( PAR1) signalling sustains a lethal inflammatory response that can be interrupted by inhibition of either thrombin or PAR1 signalling. The sphingosine 1- phosphate ( S1P) axis is a downstream component of PAR1 signalling, and by combining chemical and genetic probes for S1P receptor 3 ( S1P3) we show a critical role for dendritic cell PAR1 - S1P3 cross- talk in regulating amplification of inflammation in sepsis syndrome. Conversely, dendritic cells sustain escalated systemic coagulation and are the primary hub at which coagulation and inflammation intersect within the lymphatic compartment. Loss of dendritic cell PAR1 - S1P3 signalling sequesters dendritic cells and inflammation into draining lymph nodes, and attenuates dissemination of interleukin-1 beta to the lungs. Thus, activation of dendritic cells by coagulation in the lymphatics emerges as a previously unknown mechanism that promotes systemic inflammation and lethality in decompensated innate immune responses.	[Niessen, Frank; Schaffner, Florence; Furlan-Freguia, Christian; Pawlinski, Rafal; Bhattacharjee, Gourab; Rosen, Hugh; Ruf, Wolfram] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Chun, Jerold] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Rosen, Hugh] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Derian, Claudia K.; Andrade-Gordon, Patricia] Johnson & Johnson PRD, Spring House, PA 19477 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Johnson & Johnson; Johnson & Johnson USA	Ruf, W (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ruf@scripps.edu	Chun, Jerold/Y-4670-2019; PAwlinski, Rafal/AAD-6090-2022					Ahamed J, 2007, BLOOD, V109, P5251, DOI 10.1182/blood-2006-10-051334; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Baroni M, 2007, FASEB J, V21, P1926, DOI 10.1096/fj.06-7238com; Camerer E, 2006, BLOOD, V107, P3912, DOI 10.1182/blood-2005-08-3130; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Don AS, 2007, J BIOL CHEM, V282, P15833, DOI 10.1074/jbc.M609124200; Efron PA, 2004, J IMMUNOL, V173, P3035, DOI 10.4049/jimmunol.173.5.3035; Esmon CT, 2004, TRENDS IMMUNOL, V25, P536, DOI 10.1016/j.it.2004.08.003; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fujita S, 2006, BLOOD, V107, P3656, DOI 10.1182/blood-2005-10-4190; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maeda Y, 2007, J IMMUNOL, V178, P3437, DOI 10.4049/jimmunol.178.6.3437; Ohteki T, 2006, J EXP MED, V203, P2329, DOI 10.1084/jem.20061297; Opal SM, 2004, J ENDOTOXIN RES, V10, P125, DOI 10.1179/0968051042255004022; Pan SF, 2006, CHEM BIOL, V13, P1227, DOI 10.1016/j.chembiol.2006.09.017; Pawlinski R, 2004, BLOOD, V103, P1342, DOI 10.1182/blood-2003-09-3051; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Ruf W, 2004, TRENDS IMMUNOL, V25, P461, DOI 10.1016/j.it.2004.07.002; Scumpia PO, 2005, J IMMUNOL, V175, P3282, DOI 10.4049/jimmunol.175.5.3282; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Singleton PA, 2007, AM J RESP CELL MOL, V37, P222, DOI 10.1165/rcmb.2006-0327OC; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Taylor FB, 2001, CRIT CARE MED, V29, pS78, DOI 10.1097/00003246-200107001-00026; Xu H, 2006, J PATHOL, V210, P488, DOI 10.1002/path.2073	30	229	250	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2008	452	7187					654	658		10.1038/nature06663	http://dx.doi.org/10.1038/nature06663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18305483	Bronze			2022-12-28	WOS:000254567200051
J	Negi, J; Matsuda, O; Nagasawa, T; Oba, Y; Takahashi, H; Kawai-Yamada, M; Uchimiya, H; Hashimoto, M; Iba, K				Negi, Juntaro; Matsuda, Osamu; Nagasawa, Takashi; Oba, Yasuhiro; Takahashi, Hideyuki; Kawai-Yamada, Maki; Uchimiya, Hirofumi; Hashimoto, Mimi; Iba, Koh			CO2 regulator SLAC1 and its homologues are essential for anion homeostasis in plant cells	NATURE			English	Article							ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; PROTEIN-KINASE; ABSCISIC-ACID; ION CHANNELS; CONDUCTANCE; PROTOPLASTS; ACTIVATION; MALATE; GENE	The continuing rise in atmospheric [ CO2] is predicted to have diverse and dramatic effects on the productivity of agriculture, plant ecosystems and gas exchange(1-3). Stomatal pores in the epidermis provide gates for the exchange of CO2 and water between plants and the atmosphere, processes vital to plant life(4-6). Increased [ CO2] has been shown to enhance anion channel activity(7) proposed to mediate efflux of osmoregulatory anions ( Cl- and malate(2-)) from guard cells during stomatal closure(8,9). However, the genes encoding anion efflux channels in plant plasma membranes remain unknown. Here we report the isolation of an Arabidopsis gene, SLAC1 ( SLOW ANION CHANNEL-ASSOCIATED 1, At1g12480), which mediates CO2 sensitivity in regulation of plant gas exchange. The SLAC1 protein is a distant homologue of bacterial and fungal C4- dicarboxylate transporters, and is localized specifically to the plasma membrane of guard cells. It belongs to a protein family that in Arabidopsis consists of four structurally related members that are common in their plasma membrane localization, but show distinct tissue- specific expression patterns. The loss- of- function mutation in SLAC1 was accompanied by an over- accumulation of the osmoregulatory anions in guard cell protoplasts. Guard- cell- specific expression of SLAC1 or its family members resulted in restoration of the wild- type stomatal responses, including CO2 sensitivity, and also in the dissipation of the over- accumulated anions. These results suggest that SLAC1-family proteins have an evolutionarily conserved function that is required for the maintenance of organic/ inorganic anion homeostasis on the cellular level.	[Negi, Juntaro; Matsuda, Osamu; Nagasawa, Takashi; Oba, Yasuhiro; Hashimoto, Mimi; Iba, Koh] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan; [Takahashi, Hideyuki; Uchimiya, Hirofumi] Iwate Biotechnol Ctr, Kitakami, Iwate 0240003, Japan; [Kawai-Yamada, Maki; Uchimiya, Hirofumi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Kyushu University; University of Tokyo	Iba, K (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan.	koibascb@mbox.nc.kyushu-u.ac.jp	Uchimiya, Hirofumi/B-3813-2012; Takahashi, Hideyuki/V-6943-2018; Kawai-Yamada, Maki/B-2739-2012; Hashimoto-Sugimoto, Mimi/AAJ-6411-2021	Takahashi, Hideyuki/0000-0002-2265-5353; Kawai-Yamada, Maki/0000-0002-8732-052X; Negi, Juntaro/0000-0001-7457-1269				Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; GOTOW K, 1985, PLANT PHYSIOL, V79, P829, DOI 10.1104/pp.79.3.829; Grobler J, 1995, YEAST, V11, P1485, DOI 10.1002/yea.320111503; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Hirata N, 2004, PLANT CELL PHYSIOL, V45, P176, DOI 10.1093/pcp/pch021; Inada H, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P2999; Kohler B, 2000, PLANT PHYSIOL, V122, P243, DOI 10.1104/pp.122.1.243; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Negi J, 2005, PLANT CELL PHYSIOL, V46, pS176; Outlaw WH, 2002, ARCH BIOCHEM BIOPHYS, V407, P63, DOI 10.1016/S0003-9861(02)00460-5; Pandey S, 2002, NEW PHYTOL, V153, P517, DOI 10.1046/j.0028-646X.2001.00329.x; Raschke K, 2003, PLANTA, V217, P639, DOI 10.1007/s00425-003-1033-4; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Uemura T, 2002, GENES CELLS, V7, P743, DOI 10.1046/j.1365-2443.2002.00550.x; Ueno K, 2005, PLANT CELL PHYSIOL, V46, P955, DOI 10.1093/pcp/pci104; Vavasseur A, 2005, NEW PHYTOL, V165, P665, DOI 10.1111/j.1469-8137.2004.01276.x; Willmer C., 1996, STOMATA, DOI DOI 10.1007/978-94-011-0579-8; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; 2007, PFAM DATABASE; 2007, TMHMM SERVER V 2 0	33	424	450	6	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2008	452	7186					483	U13		10.1038/nature06720	http://dx.doi.org/10.1038/nature06720			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18305482				2022-12-28	WOS:000254341300034
J	Teunissen, PW; Dornan, T				Teunissen, P. W.; Dornan, Tim			The competent novice - Lifelong learning at work	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTINUING MEDICAL-EDUCATION; PHYSICIAN; PERFORMANCE	The importance of lifelong learning in medicine is well recognised. This article explores how junior doctors can develop learning strategies for use throughout their working life	[Teunissen, P. W.] Vrije Univ Amsterdam Med Ctr, Inst Med Educ, NL-1081 BT Amsterdam, Netherlands; [Dornan, Tim] Univ Manchester, Sch Med, Manchester M13 9PT, Lancs, England	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Manchester	Teunissen, PW (corresponding author), Vrije Univ Amsterdam Med Ctr, Inst Med Educ, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	pwteunissen@gmail.com		Teunissen, Pim/0000-0002-0930-0048				Bannon M, 2006, ARCH DIS CHILD, V91, P68, DOI 10.1136/adc.2004.070037; Becker JL, 2006, AM J OBSTET GYNECOL, V195, P1444, DOI 10.1016/j.ajog.2006.06.075; Bennett NL, 2006, J CONTIN EDUC HEALTH, V26, P120, DOI 10.1002/chp.60; Brown J, 2007, MED EDUC, V41, P653, DOI 10.1016/j.1365-2923.2007.02785.x; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Davis DA, 2006, JAMA-J AM MED ASSOC, V296, P1094, DOI 10.1001/jama.296.9.1094; Dornan T, 2007, MED EDUC, V41, P84, DOI 10.1111/j.1365-2929.2006.02652.x; ERICSSON KA, 2004, ACAD MED, pS1; Green ML, 2000, AM J MED, V109, P218, DOI 10.1016/S0002-9343(00)00458-7; Hattie J, 2007, REV EDUC RES, V77, P81, DOI 10.3102/003465430298487; Kluger AN, 1996, PSYCHOL BULL, V119, P254, DOI 10.1037/0033-2909.119.2.254; Mazmanian PE, 2002, JAMA-J AM MED ASSOC, V288, P1057, DOI 10.1001/jama.288.9.1057; Prince KJAH, 2005, MED EDUC, V39, P704, DOI 10.1111/j.1365-2929.2005.02207.x; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Slawson DC, 2005, ACAD MED, V80, P685, DOI 10.1097/00001888-200507000-00014; Teunissen PW, 2007, MED EDUC, V41, P1050, DOI 10.1111/j.1365-2923.2007.02858.x; Teunissen PW, 2007, MED EDUC, V41, P763, DOI 10.1111/j.1365-2923.2007.02778.x; Wenger Etienne., 1998, COMMUNITIES PRACTICE, V18th ed; Wilkinson S. S., 1981, DISS ABSTR INT, V41, P3998	19	50	52	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2008	336	7645					667	669		10.1136/bmj.39434.601690.AD	http://dx.doi.org/10.1136/bmj.39434.601690.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	280RH	18356236	Green Published			2022-12-28	WOS:000254443400029
J	Dunn, EW; Aknin, LB; Norton, MI				Dunn, Elizabeth W.; Aknin, Lara B.; Norton, Michael I.			Spending money on others promotes happiness	SCIENCE			English	Article							INCREASE	Although much research has examined the effect of income on happiness, we suggest that how people spend their money may be at least as important as how much money they earn. Specifically, we hypothesized that spending money on other people may have a more positive impact on happiness than spending money on oneself. Providing converging evidence for this hypothesis, we found that spending more of one's income on others predicted greater happiness both cross- sectionally ( in a nationally representative survey study) and longitudinally ( in a field study of windfall spending). Finally, participants who were randomly assigned to spend money on others experienced greater happiness than those assigned to spend money on themselves.	[Dunn, Elizabeth W.; Aknin, Lara B.] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada; [Norton, Michael I.] Harvard Univ, Sch Business, Mkt Unit, Boston, MA 02163 USA	University of British Columbia; Harvard University	Dunn, EW (corresponding author), Univ British Columbia, Dept Psychol, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.	edunn@psych.ubc.ca						Diener E, 2002, SOC INDIC RES, V57, P119, DOI 10.1023/A:1014411319119; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; DIENER E, 1993, SOC INDIC RES, V28, P195, DOI 10.1007/BF01079018; EASTERLIN RA, 1995, J ECON BEHAV ORGAN, V27, P35, DOI 10.1016/0167-2681(95)00003-B; Frank RH, 2004, DAEDALUS-US, V133, P69, DOI 10.1162/001152604323049415; Frey BS, 2000, ECON J, V110, P918, DOI 10.1111/1468-0297.00570; Kahneman D, 2006, SCIENCE, V312, P1908, DOI 10.1126/science.1129688; Kasser T., 2002, J HAPPINESS STUD, V3, P313, DOI [10.1023/A, DOI 10.1023/A]; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Piliavin JA, 2003, FLOURISHING: POSITIVE PSYCHOLOGY AND THE LIFE WELL-LIVED, P227, DOI 10.1037/10594-010; Thoits PA, 2001, J HEALTH SOC BEHAV, V42, P115, DOI 10.2307/3090173; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491	12	777	788	21	339	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1687	1688		10.1126/science.1150952	http://dx.doi.org/10.1126/science.1150952			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276VR	18356530				2022-12-28	WOS:000254172300047
J	Richmond, BG; Jungers, WL				Richmond, Brian G.; Jungers, William L.			Orrorin tugenensis femoral morphology and the evolution of hominin bipedalism	SCIENCE			English	Article							ORIGIN; FEMUR; ENERGETICS; LUKEINO; MIOCENE	Bipedalism is a key human adaptation and a defining feature of the hominin clade. Fossil femora discovered in Kenya and attributed to Orrorin tugenensis, at 6 million years ago, purportedly provide the earliest postcranial evidence of hominin bipedalism, but their functional and phylogenetic affinities are controversial. We show that the O. tugenensis femur differs from those of apes and Homo and most strongly resembles those of Australopithecus and Paranthropus, indicating that O. tugenensis was bipedal but is not more closely related to Homo than to Australopithecus. Femoral morphology indicates that O. tugenensis shared distinctive hip biomechanics with australopiths, suggesting that this complex evolved early in human evolution and persisted for almost 4 million years until modifications of the hip appeared in the late Pliocene in early Homo.	[Richmond, Brian G.] George Washington Univ, Ctr Adv Study Hominid Paleobiol, Dept Anthropol, Washington, DC 20052 USA; [Richmond, Brian G.] Smithsonian Inst, Natl Museum Amer Hist, Human Origins Program, Washington, DC 20560 USA; [Jungers, William L.] SUNY Stony Brook, Dept Anatom Sci, Stony Brook, NY 11794 USA	George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Richmond, BG (corresponding author), George Washington Univ, Ctr Adv Study Hominid Paleobiol, Dept Anthropol, 2110 G St NW, Washington, DC 20052 USA.	brich@gwu.edu						Aiello LC, 2001, NATURE, V410, P526, DOI 10.1038/35069164; Begun DR, 2004, SCIENCE, V303, P1478, DOI 10.1126/science.1095516; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; Cela-Conde CJ, 2003, P NATL ACAD SCI USA, V100, P7684, DOI 10.1073/pnas.0832372100; DAY MH, 1969, NATURE, V221, P230, DOI 10.1038/221230a0; Deino AL, 2002, J HUM EVOL, V42, P117, DOI 10.1006/jhev.2001.0521; Galik K, 2004, SCIENCE, V305, P1450, DOI 10.1126/science.1098807; JENKINS FA, 1972, SCIENCE, V178, P877, DOI 10.1126/science.178.4063.877; JUNGERS WL, 1988, J HUM EVOL, V17, P247, DOI 10.1016/0047-2484(88)90056-5; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; MCHENRY HM, 1978, AM J PHYS ANTHROPOL, V49, P473, DOI 10.1002/ajpa.1330490407; Nakatsukasa M, 2007, PRIMATES, V48, P171, DOI 10.1007/s10329-007-0040-7; Ohman JC, 2005, SCIENCE, V307, P845; Pickford M, 2002, C R PALEVOL, V1, P191, DOI 10.1016/S1631-0683(02)00028-3; Richmond BG, 2002, J HUM EVOL, V43, P529, DOI 10.1006/jhev.2002.0594; Richmond BG, 2001, YEARB PHYS ANTHROPOL, V44, P70, DOI 10.1002/ajpa.10019; Ruff C, 1998, PRIMATE LOCOMOTION, P449; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; STERN JT, 1981, AM J PHYS ANTHROPOL, V55, P153, DOI 10.1002/ajpa.1330550203; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Steudel-Numbers KL, 2006, J HUM EVOL, V51, P445, DOI 10.1016/j.jhevol.2006.05.001; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; WALKER A, 1973, J HUM EVOL, V2, P545, DOI 10.1016/0047-2484(73)90132-2; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; Wood B, 2000, J ANAT, V197, P19, DOI 10.1046/j.1469-7580.2000.19710019.x; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	31	146	153	3	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2008	319	5870					1662	1665		10.1126/science.1154197	http://dx.doi.org/10.1126/science.1154197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356526				2022-12-28	WOS:000254172300040
J	Yuan, ZQ; Becker, EBE; Merlo, P; Yamada, T; DiBacco, S; Konishi, Y; Schaefer, EM; Bonni, A				Yuan, Zengqiang; Becker, Esther B. E.; Merlo, Paola; Yamada, Tomoko; DiBacco, Sara; Konishi, Yoshiyuki; Schaefer, Erik M.; Bonni, Azad			Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons	SCIENCE			English	Article							ALZHEIMERS-DISEASE BRAIN; PHOSPHORYLATION; EXPRESSION; DEATH	Activation of cyclin- dependent kinase 1 ( Cdk1) has been linked to cell death of postmitotic neurons in brain development and disease. We found that Cdk1 phosphorylated the transcription factor FOXO1 at Ser(249) in vitro and in vivo. The phosphorylation of FOXO1 at Ser(249) disrupted FOXO1 binding with 14- 3- 3 proteins and thereby promoted the nuclear accumulation of FOXO1 and stimulated FOXO1-dependent transcription, leading to cell death in neurons. In proliferating cells, Cdk1 induced FOXO1 Ser(249) phosphorylation at the G(2)/M phase of the cell cycle, resulting in FOXO1- dependent expression of the mitotic regulator Polo- like kinase ( Plk). These findings define a conserved signaling link between Cdk1 and FOXO1 that may have a key role in diverse biological processes, including the degeneration of postmitotic neurons.	[Yuan, Zengqiang; Becker, Esther B. E.; Merlo, Paola; Yamada, Tomoko; DiBacco, Sara; Konishi, Yoshiyuki; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Schaefer, Erik M.] Invitrogen Corp, Ctr Signal Transduct, Cellular Anal Business Unit, Biodiscovery Div, Hopkinton, MA 01748 USA	Harvard University; Harvard Medical School; Thermo Fisher Scientific	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	Merlo, Paola/K-5330-2014; Yuan, Zengqiang/G-5245-2017	Merlo, Paola/0000-0003-0105-7044; Becker, Esther B E/0000-0002-5238-4902; Yuan, Zengqiang/0000-0001-5739-2867	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047188] Funding Source: NIH RePORTER; NINDS NIH HHS [NS047188] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Busser J, 1998, J NEUROSCI, V18, P2801; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kurita M, 2006, J NEUROSCI, V26, P12003, DOI 10.1523/JNEUROSCI.3002-06.2006; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vincent I, 1997, J NEUROSCI, V17, P3588	8	137	143	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1665	1668		10.1126/science.1152337	http://dx.doi.org/10.1126/science.1152337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356527	Green Submitted			2022-12-28	WOS:000254172300041
J	Dodson, TB; Raje, NS; Caruso, PA; Rosenberg, AE; Smullin, SE; Harris, NL				Dodson, Thomas B.; Raje, Noopur S.; Caruso, Paul A.; Rosenberg, Andrew E.; Smullin, Steven E.; Harris, Nancy Lee			A woman with a nonhealing ulcer of the jaw - Gingival ulceration, inflammation, and acute osteomyelitis with actinomyces, all associated with necrosis of bone (bisphosphonate-related osteonecrosis of bone)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-MYELOMA; AMERICAN-SOCIETY; ZOLEDRONIC ACID; SKELETAL COMPLICATIONS; BREAST-CARCINOMA; RISK-FACTORS; DOUBLE-BLIND; METASTASES; CANCER; EXPERIENCE		[Dodson, Thomas B.] Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, Boston, MA 02114 USA; [Raje, Noopur S.] Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USA; [Caruso, Paul A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Rosenberg, Andrew E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Caruso, Paul A.] Massachusetts Eye & Ear Infirm, Dept Radiol, Boston, MA 02114 USA; [Dodson, Thomas B.] Harvard Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Cambridge, MA 02138 USA; [Raje, Noopur S.] Harvard Univ, Sch Med, Dept Oncol, Cambridge, MA 02138 USA; [Caruso, Paul A.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Rosenberg, Andrew E.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard University; Harvard University	Dodson, TB (corresponding author), Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, Boston, MA 02114 USA.		Dodson, Thomas Benton/L-6406-2019	Dodson, Thomas Benton/0000-0002-4659-8322				AAOMS, 2007, J ORAL MAXIL SURG, V65, P369, DOI 10.1016/j.joms.2006.11.003; Aspenberg P, 2006, ACTA ORTHOP, V77, P693, DOI 10.1080/17453670610012845; Badros A, 2006, J CLIN ONCOL, V24, P945, DOI 10.1200/JCO.2005.04.2465; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Berenson J, 1996, BRIT J CLIN PRACT, P5; Berenson JR, 2002, J CLIN ONCOL, V20, P3719, DOI 10.1200/JCO.2002.06.037; Berenson JR, 2001, CANCER, V91, P1191, DOI 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-0; Bilezikian JP, 2006, NEW ENGL J MED, V355, P2278, DOI 10.1056/NEJMp068157; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Boyde A., 2006, BONEKEY OSTEOVISION, V3, P19; Coleman RE, 2005, J CLIN ONCOL, V23, P4925, DOI 10.1200/JCO.2005.06.091; Dimopoulos MA, 2006, HAEMATOL-HEMATOL J, V91, P968; Durie BGM, 2005, NEW ENGL J MED, V353, P99; Fleisch H, 1998, ENDOCR REV, V19, P80, DOI 10.1210/er.19.1.80; Hansen T, 2006, J ORAL PATHOL MED, V35, P155, DOI 10.1111/j.1600-0714.2006.00391.x; Hellstein JW, 2005, J ORAL MAXIL SURG, V63, P682, DOI 10.1016/j.joms.2005.01.010; Hillner BE, 2003, J CLIN ONCOL, V21, P4042, DOI 10.1200/JCO.2003.08.017; Hillner BE, 2004, J CLIN ONCOL, V22, P1351; HOFF AO, 2006, J CLIN ONCOL S, V24, P528; Ibrahim A, 2003, CLIN CANCER RES, V9, P2394; Kyle RA, 2007, J CLIN ONCOL, V25, P2464, DOI 10.1200/JCO.2007.12.1269; Lacy MQ, 2006, MAYO CLIN PROC, V81, P1047, DOI 10.4065/81.8.1047; Lipton A, 2000, CANCER, V88, P1082, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; MARX RE, 2007, ORAL INTRAVENOUS BIS, P83; Mavrokokki T, 2007, J ORAL MAXIL SURG, V65, P415, DOI 10.1016/j.joms.2006.10.061; Migliorati CA, 2006, LANCET ONCOL, V7, P533; Migliorati CA, 2006, LANCET ONCOL, V7, P508, DOI 10.1016/S1470-2045(06)70726-4; MILES AEW, 1972, BRIT DENT J, V133, P203, DOI 10.1038/sj.bdj.4802906; Raje N, 2006, EXPERT REV ANTICANC, V6, P1239, DOI 10.1586/14737140.6.9.1239; Reid IR, 2007, BONE, V41, P318, DOI 10.1016/j.bone.2007.04.196; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Roodman GD, 2004, BLOOD CELL MOL DIS, V32, P290, DOI 10.1016/j.bcmd.2004.01.001; Rosen LS, 2003, CANCER-AM CANCER SOC, V98, P1735, DOI 10.1002/cncr.11701; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Russell RGG, 1999, OSTEOPOROSIS INT, V9, P66, DOI 10.1007/PL00004164; SOMERMAN MJ, 2006, BONEKEY OSTEOVISION, V3, P12; Van den Wyngaert T, 2006, ANN ONCOL, V17, P1197, DOI 10.1093/annonc/mdl294; Woo SB, 2006, ANN INTERN MED, V145, P235, DOI 10.7326/0003-4819-145-10-200611210-00023; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; Zervas K, 2006, BRIT J HAEMATOL, V134, P620, DOI 10.1111/j.1365-2141.2006.06230.x	42	31	32	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1283	1291		10.1056/NEJMcpc0800341	http://dx.doi.org/10.1056/NEJMcpc0800341			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275TL	18354107				2022-12-28	WOS:000254094400011
J	Plassman, BL; Langa, KM; Fisher, GG; Heeringa, SG; Weir, DR; Ofstedal, MB; Burke, JR; Hurd, MD; Potter, GG; Rodgers, WL; Steffens, DC; McArdle, JJ; Willis, RJ; Wallace, RB				Plassman, Brenda L.; Langa, Kenneth M.; Fisher, Gwenith G.; Heeringa, Steven G.; Weir, David R.; Ofstedal, Mary Beth; Burke, James R.; Hurd, Michael D.; Potter, Guy G.; Rodgers, Willard L.; Steffens, David C.; McArdle, John J.; Willis, Robert J.; Wallace, Robert B.			Prevalence of cognitive impairment without dementia in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							ALZHEIMERS-DISEASE; HEALTH; POPULATION; CLASSIFICATION; DEMOGRAPHICS; DIAGNOSIS; CONSENSUS; SEVERITY; CRITERIA; MEMORY	Background: Cognitive impairment without dementia is associated with increased risk for disability, increased health care costs, and progression to dementia. There are no population-based prevalence estimates of this condition in the United States. Objective: To estimate the prevalence of cognitive impairment without dementia in the United States and determine longitudinal cognitive and mortality outcomes. Design: Longitudinal study from July 2001 to March 2005. Setting: In-home assessment for cognitive impairment. Participants: Participants in ADAMS (Aging, Demographics, and Memory Study) who were age 71 years or older drawn from the nationally representative HIRS (Health and Retirement Study). Of 1770 selected individuals, 856 completed initial assessment, and of 241 selected individuals, 180 completed 16- to 18-month follow-up assessment. Measurements: Assessments, including neuropsychological testing, neurologic examination, and clinical and medical history, were used to assign a diagnosis of normal cognition, cognitive impairment without dementia, or dementia. National prevalence rates were estimated by using a population-weighted sample. Results: In 2002, an estimated 5.4 million people (22.2%) in the United States age 71 years or older had cognitive impairment without dementia. Prominent subtypes included prodromal Alzheimer disease (8.2%) and cerebrovascular disease (5.7%). Among participants who completed follow-up assessments, 11.7% with cognitive impairment without dementia progressed to dementia annually, whereas those with subtypes of prodromal Alzheimer disease and stroke progressed at annual rates of 17% to 20%. The annual death rate was 8% among those with cognitive impairment without dementia and almost 15% among those with cognitive impairment due to medical conditions. Limitations: Only 56% of the nondeceased target sample completed the initial assessment. Population sampling weights were derived to adjust for at least some of the potential bias due to nonresponse and attrition. Conclusion: Cognitive impairment without dementia is more prevalent in the United States than dementia, and its subtypes vary in prevalence and outcomes.	Duke Univ, Med Ctr, Durham, NC 27701 USA; Univ Michigan, Ann Arbor, MI USA; Vet Affairs Practice Management & Outcomes Res, Ann Arbor, MI USA; RAND Corp, Santa Monica, CA USA; Univ S Carolina, Los Angeles, CA USA; Univ Iowa, Iowa City, IA USA	Duke University; University of Michigan System; University of Michigan; RAND Corporation; University of South Carolina; University of Iowa	Plassman, BL (corresponding author), Duke Univ, Med Ctr, W Main St,Suite 25-D,Box 41, Durham, NC 27701 USA.	brenda.plassman@duke.edu	Burke, James R/E-4245-2016; Plassman, Brenda L/K-2620-2015	Burke, James R/0000-0002-3408-7787; Langa, Kenneth/0000-0002-2798-1836	NATIONAL INSTITUTE ON AGING [U01AG009740, K08AG019180, R01AG027010] Funding Source: NIH RePORTER; NIA NIH HHS [U01 AG09740, K08 AG019180-05, K08 AG019180, U01 AG009740, R01 AG027010-01, R01 AG027010, AG019180] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albert SM, 2002, NEUROLOGY, V59, P573, DOI 10.1212/WNL.59.4.573; *ALZH ASS, 2007, ALZH DIS FACTS FIG; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; BARNHART RL, 1995, J GERIATR PSYCH NEUR, V8, P203, DOI 10.1177/089198879500800401; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Clark CM, 1996, ALZ DIS ASSOC DIS, V10, P31, DOI 10.1097/00002093-199601010-00006; Edland SD, 2002, ARCH NEUROL-CHICAGO, V59, P1589, DOI 10.1001/archneur.59.10.1589; Ernst RL, 1997, ALZ DIS ASSOC DIS, V11, P135; EVANS DA, 1990, MILBANK Q, V68, P267, DOI 10.2307/3350099; Fisk JD, 2003, NEUROLOGY, V61, P1179, DOI 10.1212/01.WNL.0000089238.07771.C7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Hanninen T, 1996, AGE AGEING, V25, P201, DOI 10.1093/ageing/25.3.201; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; HEERINGA SG, 2006, DEMOGRAPHICS MEMORY; HOFMAN A, 1991, INT J EPIDEMIOL, V20, P736, DOI 10.1093/ije/20.3.736; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Larrieu S, 2002, NEUROLOGY, V59, P1594, DOI 10.1212/01.WNL.0000034176.07159.F8; Launer LJ, 2002, AGEING RES REV, V1, P61, DOI 10.1016/S0047-6374(01)00364-5; Little R.J.A., 2002, STAT ANAL MISSING DA; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Matthews FE, 2007, PLOS MED, V4, P1615, DOI 10.1371/journal.pmed.0040304; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moon M, 1995, J HUM RESOUR, V30, pS138, DOI 10.2307/146281; Morris JC, 2006, ARCH NEUROL-CHICAGO, V63, P15, DOI 10.1001/archneur.63.1.15; Ofstedal MB., 2005, HRS DOCUMENTATION RE, DOI DOI 10.1371/journal.pone.0144722; Petersen R. C., 2003, MILD COGNITIVE IMPAI; Petersen RC, 2005, J ALZHEIMERS DIS, V7, P241; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plassman BL, 2006, TWIN RES HUM GENET, V9, P950, DOI 10.1375/183242706779462381; Ritchie K, 2001, NEUROLOGY, V56, P37, DOI 10.1212/WNL.56.1.37; Ritchie Karen, 2004, Dialogues Clin Neurosci, V6, P401; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Soldo BJ, 1997, J GERONTOL B-PSYCHOL, V52, P1, DOI 10.1093/geronb/52B.Special_Issue.1; Tabert MH, 2002, NEUROLOGY, V58, P758, DOI 10.1212/WNL.58.5.758; Unverzagt FW, 2001, NEUROLOGY, V57, P1655, DOI 10.1212/WNL.57.9.1655; *US CENS BUR, 2007, TABL 1 ANN EST POP 5; *US GEN ACC OFF, 1998, ALZH DIS EST PREV US; WILLIS RJ, 1999, LABOUR EC, V0006; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	49	600	620	1	49	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2008	148	6					427	434		10.7326/0003-4819-148-6-200803180-00005	http://dx.doi.org/10.7326/0003-4819-148-6-200803180-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279KT	18347351	Green Accepted			2022-12-28	WOS:000254354800003
J	Ciesla, FJ				Ciesla, Fred J.			Planetary science - Observing our origins	SCIENCE			English	Editorial Material							WATER; REGION		Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Carnegie Institution for Science	Ciesla, FJ (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	fciesla@ciw.edu						Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Carr JS, 2004, ASTROPHYS J, V603, P213, DOI 10.1086/381356; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; Dullemond C. P., 2007, PROTOSTARS PLANETS, P555; Eisner JA, 2007, NATURE, V447, P562, DOI 10.1038/nature05867; Krot A. N., 2000, Protostars and planets 4, P1019; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; van Boekel R, 2007, NATURE, V447, P535, DOI 10.1038/447535a; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989	13	7	7	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1488	1489		10.1126/science.1155858	http://dx.doi.org/10.1126/science.1155858			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339924				2022-12-28	WOS:000253943800023
J	Johnson, KG; Jackson, JBC; Budd, AF				Johnson, Kenneth G.; Jackson, Jeremy B. C.; Budd, Ann F.			Caribbean reef development was independent of coral diversity over 28 million years	SCIENCE			English	Article							EXTINCTION; NEOGENE; PRODUCTIVITY; TEMPERATURE; TURNOVER; CLOSURE	The relationship between natural variations in coral species diversity, reef development, and ecosystem function on coral reefs is poorly understood. Recent coral diversity varies 10- fold among geographic regions, but rates of reef growth are broadly similar, suggesting that diversity is unimportant for reef development. Differences in diversity may reflect regional differences in long- term biotic history in addition to environmental conditions. Using a combination of new and published fossil and stratigraphic data, we compared changes in coral diversity and reef development within the tropical western Atlantic over the past 28 million years. Reef development was unrelated to coral diversity, and the largest reef tracts formed after extinction had reduced diversity by 50%. High diversity is thus not essential for the growth and persistence of coral reefs.	[Johnson, Kenneth G.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Jackson, Jeremy B. C.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Jackson, Jeremy B. C.] Smithsonian Trop Res Inst, Balboa, Panama; [Budd, Ann F.] Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA	Natural History Museum London; University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Iowa	Johnson, KG (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	K.Johnson@nhm.ac.uk						Allmon WD, 2001, PALAEOGEOGR PALAEOCL, V166, P9, DOI 10.1016/S0031-0182(00)00199-1; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bosellini FR, 2008, PALAEOGEOGR PALAEOCL, V258, P71, DOI 10.1016/j.palaeo.2007.10.028; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Budd AF, 1999, PALEOBIOLOGY, V25, P188, DOI 10.1017/S009483730002649X; Budd AF, 2000, CORAL REEFS, V19, P25, DOI 10.1007/s003380050222; BUDD AF, 1994, J PALEONTOL, V68, P951, DOI 10.1017/S0022336000026585; Budd AF, 1998, PALAIOS, V13, P170, DOI 10.2307/3515488; Dullo WC, 2005, FACIES, V51, P33, DOI 10.1007/s10347-005-0060-y; EDINGER EN, 1995, PALEOBIOLOGY, V21, P200, DOI 10.1017/S0094837300013208; EDINGER EN, 1994, PALAIOS, V9, P576, DOI 10.2307/3515129; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Glynn PW, 1996, CORAL REEFS, V15, P71; Hallock P, 2001, T GEOBIOL, V17, P387; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; HATCHER BG, 1990, TRENDS ECOL EVOL, V5, P149, DOI 10.1016/0169-5347(90)90221-X; JACKSON JBC, 1991, BIOSCIENCE, V41, P475, DOI 10.2307/1311805; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JACKSON JBC, 1994, SCIENCE, V264, P1412, DOI 10.1126/science.264.5164.1412; Jain S, 2007, MAR MICROPALEONTOL, V63, P57, DOI 10.1016/j.marmicro.2006.11.003; JOHNSON KG, 2007, FOSSIL CORALS SPONGE, P471; Kiessling W, 2005, NATURE, V433, P410, DOI 10.1038/nature03152; Kleypas JA, 1999, AM ZOOL, V39, P146; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; O'Dea A, 2007, P NATL ACAD SCI USA, V104, P5501, DOI 10.1073/pnas.0610947104; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; Perrin C., 2002, SEPM SPECIAL PUBLICA, V72, P587; Schneider B, 2006, EARTH PLANET SC LETT, V246, P367, DOI 10.1016/j.epsl.2006.04.028; Schuster F., 2002, P199; Vaughan T.W., 1919, US NATL MUSEUM B, V103, P180, DOI DOI 10.5962/BHL.TITLE.46527; Vennin E, 2004, PALAEOGEOGR PALAEOCL, V213, P163, DOI 10.1016/j.palaeo.2004.07.014; Veron J.E.N., 2000, CORALS WORLD, V1-3; von der Heydt A, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001149; WELLS JW, 1957, TREATISE MARINE ECOL, V67	36	88	90	5	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1521	1523		10.1126/science.1152197	http://dx.doi.org/10.1126/science.1152197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339937				2022-12-28	WOS:000253943800037
J	Scalapino, DJ				Scalapino, Douglas J.			Physics - This coincidence cannot be accidental	SCIENCE			English	Editorial Material									[Scalapino, Douglas J.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Scalapino, DJ (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	djs@physics.ucsb.edu						Aynajian P, 2008, SCIENCE, V319, P1509, DOI 10.1126/science.1154115; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; ELIASHBERG GM, 1963, SOV PHYS JETP-USSR, V16, P780; KOHN W, 1959, PHYS REV LETT, V2, P393, DOI 10.1103/PhysRevLett.2.393; MCMILLAN WL, 1965, PHYS REV LETT, V14, P108, DOI 10.1103/PhysRevLett.14.108; SCALAPINO DJ, 1969, SUPERCONDUCTIVITY, V1, pCH10	6	6	6	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1492	1493		10.1126/science.1155859	http://dx.doi.org/10.1126/science.1155859			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339927				2022-12-28	WOS:000253943800026
J	Venail, PA; MacLean, RC; Bouvier, T; Brockhurst, MA; Hochberg, ME; Mouquet, N				Venail, P. A.; MacLean, R. C.; Bouvier, T.; Brockhurst, M. A.; Hochberg, M. E.; Mouquet, N.			Diversity and productivity peak at intermediate dispersal rate in evolving metacommunities	NATURE			English	Article							SPECIES-DIVERSITY; EVOLUTIONARY DIVERSIFICATION; ECOLOGICAL THEORY; CURRENT KNOWLEDGE; ESCHERICHIA-COLI; PLANT DIVERSITY; BIODIVERSITY; POPULATIONS; COEXISTENCE; HETEROGENEITY	Positive relationships between species diversity and productivity have been reported for a number of ecosystems(1,2). Theoretical and experimental studies have attempted to determine the mechanisms that generate this pattern over short timescales(1,2), but little attention has been given to the problem of understanding how diversity and productivity are linked over evolutionary timescales. Here, we investigate the role of dispersal in determining both diversity and productivity over evolutionary timescales, using experimental metacommunities of the bacterium Pseudomonas fluorescens assembled by divergent natural selection. We show that both regional diversity and productivity peak at an intermediate dispersal rate. Moreover, we demonstrate that these two patterns are linked: selection at intermediate rates of dispersal leads to high niche differentiation between genotypes, allowing greater coverage of the heterogeneous environment and a higher regional productivity. We argue that processes that operate over both ecological and evolutionary timescales should be jointly considered when attempting to understand the emergence of ecosystem- level properties such as diversity - function relationships.	[Venail, P. A.; Hochberg, M. E.; Mouquet, N.] Univ Montpellier 2, CNRS, Inst Sci Evolut, UMR 5554, F-34095 Montpellier 05, France; [Bouvier, T.] Univ Montpellier 2, CNRS, IFREMER, Ecosyst Lagunaires UMR 5119, F-34095 Montpellier, France; [MacLean, R. C.] Univ London Imperial Coll Sci Technol & Med, NERC Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Brockhurst, M. A.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Ifremer; Universite de Montpellier; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Liverpool	Venail, PA (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut, UMR 5554, CC065 Pl Eugene Bataillon, F-34095 Montpellier 05, France.	pvenail@univ-montp2.fr; nmouquet@univ-montp2.fr	Mouquet, Nicolas/G-1285-2010; Bouvier, Thierry/A-1895-2013; MOUQUET, Nicolas/AAL-1440-2021; Venail, Patrick/D-2968-2018; Brockhurst, Michael A/A-6247-2009	Venail, Patrick/0000-0003-1126-280X; Mouquet, Nicolas/0000-0003-1840-6984; Brockhurst, Michael/0000-0003-0362-820X; bouvier, thierry/0000-0002-7151-5680; MacLean, Craig/0000-0002-7941-813X	Natural Environment Research Council [cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; Barrett RDH, 2005, AM NAT, V166, P470, DOI 10.1086/444440; BELL G, 1990, PROC R SOC SER B-BIO, V240, P295, DOI 10.1098/rspb.1990.0039; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Cadotte MW, 2005, ECOL LETT, V8, P548, DOI 10.1111/j.1461-0248.2005.00750.x; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Day T, 2000, AM NAT, V155, P790, DOI 10.1086/303356; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Habets MGJL, 2006, ECOL LETT, V9, P1041, DOI 10.1111/j.1461-0248.2006.00955.x; Hall AR, 2007, P ROY SOC B-BIOL SCI, V274, P73, DOI 10.1098/rspb.2006.3703; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; Mouquet N, 2002, ECOL LETT, V5, P56, DOI 10.1046/j.1461-0248.2002.00281.x; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984	29	126	127	0	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					210	U57		10.1038/nature06554	http://dx.doi.org/10.1038/nature06554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337821	Green Published			2022-12-28	WOS:000253925600039
J	Svetkey, LP; Stevens, VJ; Brantley, PJ; Appel, LJ; Hollis, JF; Loria, CM; Vollmer, WM; Gullion, CM; Funk, K; Smith, P; Samuel-Hodge, C; Myers, V; Lien, LF; Laferriere, D; Kennedy, B; Jerome, GJ; Heinith, F; Harsha, DW; Evans, P; Erlinger, TP; Dalcin, AT; Coughlin, J; Charleston, J; Champagne, CM; Bauck, A; Ard, JD; Aicher, K				Svetkey, Laura P.; Stevens, Victor J.; Brantley, Phillip J.; Appel, Lawrence J.; Hollis, Jack F.; Loria, Catherine M.; Vollmer, William M.; Gullion, Christina M.; Funk, Kristine; Smith, Patti; Samuel-Hodge, Carmen; Myers, Valerie; Lien, Lillian F.; Laferriere, Daniel; Kennedy, Betty; Jerome, Gerald J.; Heinith, Fran; Harsha, David W.; Evans, Pamela; Erlinger, Thomas P.; Dalcin, Arline T.; Coughlin, Janelle; Charleston, Jeanne; Champagne, Catherine M.; Bauck, Alan; Ard, Jamy D.; Aicher, Kathleen		Weight Loss Maintenance Collaborat	Comparison of strategies for sustaining weight loss - The weight loss maintenance randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIFE-STYLE INTERVENTION; BLOOD-PRESSURE; DIETARY PATTERNS; CONTROL REGISTRY; MISSING DATA; HYPERTENSION; OVERWEIGHT; REDUCTION; METAANALYSIS; PREVENTION	Context Behavioral weight loss interventions achieve short- term success, but regain is common. Objective To compare 2 weight loss maintenance interventions with a self- directed control group. Design, Setting, and Participants Two- phase trial in which 1032 overweight or obese adults ( 38% African American, 63% women) with hypertension, dyslipidemia, or both who had lost at least 4 kg during a 6- month weight loss program ( phase 1) were randomized to a weight- loss maintenance intervention ( phase 2). Enrollment at 4 academic centers occurred August 2003- July 2004 and randomization, February-December 2004. Data collection was completed in June 2007. Interventions After the phase 1 weight- loss program, participants were randomized to one of the following groups for 30 months: monthly personal contact, unlimited access to an interactive technology - based intervention, or self- directed control. Main Outcome Changes in weight from randomization. Results Mean entry weight was 96.7 kg. During the initial 6- month program, mean weight loss was 8.5 kg. After randomization, weight regain occurred. Participants in the personal- contact group regained less weight ( 4.0 kg) than those in the self- directed group ( 5.5 kg; mean difference at 30 months, - 1.5 kg; 95% confidence interval [ CI], - 2.4 to - 0.6 kg; P=. 001). At 30 months, weight regain did not differ between the interactive technology - based ( 5.2 kg) and self- directed groups ( 5.5 kg; mean difference - 0.3 kg; 95% CI, - 1.2 to 0.6 kg; P=. 51); however, weight regain was lower in the interactive technology - based than in the self- directed group at 18 months ( mean difference, - 1.1 kg; 95% CI, - 1.9 to - 0.4 kg; P=. 003) and at 24 months ( mean difference, - 0.9 kg; 95% CI, - 1.7 to - 0.02 kg; P=. 04). At 30 months, the difference between the personal-contact and interactive technology - based group was - 1.2 kg ( 95% CI - 2.1 to - 0.3; P=. 008). Effects did not differ significantly by sex, race, age, and body mass index subgroups. Overall, 71% of study participants remained below entry weight. Conclusions The majority of individuals who successfully completed an initial behavioral weight loss program maintained a weight below their initial level. Monthly brief personal contact provided modest benefit in sustaining weight loss, whereas an interactive techonology - based intervention provided early but transient benefit. Trial Registration clinicaltrials. gov Identifier: NCT00054925.	[Svetkey, Laura P.; Aicher, Kathleen] Duke Univ, Med Ctr, Duke Hypertens Ctr, Div Nephrol,Dept Med, Durham, NC 27710 USA; [Lien, Lillian F.] Duke Univ, Med Ctr, Duke Hypertens Ctr, Div Endocrinol,Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Stevens, Victor J.; Hollis, Jack F.; Vollmer, William M.; Gullion, Christina M.; Funk, Kristine; Laferriere, Daniel; Heinith, Fran; Evans, Pamela; Bauck, Alan] Kaiser Permanente NW, Hlth Sci Programs, Ctr Hlth Res, Portland, OR USA; [Brantley, Phillip J.; Smith, Patti; Myers, Valerie] Louisiana State Univ, Pennington Biomed Res Ctr, Behav Med Lab, Baton Rouge, LA 70808 USA; [Appel, Lawrence J.; Jerome, Gerald J.; Dalcin, Arline T.; Coughlin, Janelle; Charleston, Jeanne] Johns Hopkins Univ, Prohlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Loria, Catherine M.] NHLBI, Div Prevent & Populat Sci, Bethesda, MD 20892 USA; [Samuel-Hodge, Carmen] Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [Samuel-Hodge, Carmen] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Erlinger, Thomas P.] Univ Texas Austin, Med Branch, Dept Med, Austin, TX 78712 USA; [Ard, Jamy D.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA	Duke University; Duke University; Duke University; Kaiser Permanente; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Texas System; University of Texas Austin; University of Alabama System; University of Alabama Birmingham	Svetkey, LP (corresponding author), Duke Univ, Med Ctr, Duke Hypertens Ctr, Div Nephrol,Dept Med, Box 3075, Durham, NC 27710 USA.	Svetk001@mc.duke.edu	Jerome, Gerald/R-2979-2018; Brantley, Phillip/N-1952-2017; Champagne, Catherine/N-1956-2017; Appel, Larry/GLT-2608-2022	Jerome, Gerald/0000-0003-0612-2626; Brantley, Phillip/0000-0003-4721-7445; Champagne, Catherine/0000-0001-6127-1072; Coughlin, Janelle/0000-0001-7924-5892; Samuel-Hodge, Carmen D/0000-0002-3700-7578; Ard, Jamy/0000-0002-1643-6795	NHLBI NIH HHS [-HL68955, 5-U01 HL68676, 5-U01 HL68790, 5-U01 HL68920, 5-U01 HL68734] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL068734, U01HL068920, U01HL068955, U01HL068676, U01HL068790] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Appel Lawrence J., 1995, Annals of Epidemiology, V5, P149, DOI 10.1016/1047-2797(94)00059-3; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2000, CIRCULATION, V102, P852, DOI 10.1161/01.CIR.102.8.852; Ard JD, 2000, J NATL MED ASSOC, V92, P515; Bassett DR, 2000, MED SCI SPORT EXER, V32, pS471, DOI 10.1097/00005768-200009001-00006; BRANTLEY PJ, IN PRESS J SOC CLIN; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; Dansinger ML, 2007, ANN INTERN MED, V147, P41, DOI 10.7326/0003-4819-147-1-200707030-00007; Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006; ELMER PJ, 1995, PREV MED, V24, P378, DOI 10.1006/pmed.1995.1062; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Harlan L C, 1990, Epidemiology, V1, P224, DOI 10.1097/00001648-199005000-00008; Hill JO, 2005, J NUTR EDUC BEHAV, V37, P206, DOI 10.1016/S1499-4046(06)60248-0; HOLM S, 1979, SCAND J STAT, V6, P65; Ikeda J, 2005, J NUTR EDUC BEHAV, V37, P203, DOI 10.1016/S1499-4046(06)60247-9; Jakicic JM, 2003, JAMA-J AM MED ASSOC, V290, P1323, DOI 10.1001/jama.290.10.1323; Jakicic JM, 1999, JAMA-J AM MED ASSOC, V282, P1554, DOI 10.1001/jama.282.16.1554; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KUMANYAKA SK, 1991, AM J CLIN NUTR, V53, pS1631, DOI 10.1093/ajcn/53.6.1631S; Kumanyika S., 2007, HDB OBESITY PREVENTI; Kumanyika SK, 2003, AM J CLIN NUTR, V77, P1342; Miller ER, 1998, CIRCULATION, V98, P2390, DOI 10.1161/01.CIR.98.22.2390; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; National Heart Lung and Blood Institute., 2004, NIH PUBL, V04-5230; National Heart Lung and Blood Institute, 1998, NIH PUBL, V98-4083; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Obarzanek E, 2001, AM J CLIN NUTR, V74, P80; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Orleans CT, 2000, HEALTH PSYCHOL, V19, P76, DOI 10.1037/0278-6133.19.Suppl1.76; Phelan S, 2005, ARCH INTERN MED, V165, P2430, DOI 10.1001/archinte.165.20.2430-a; Proschan MA, 2000, CONTROL CLIN TRIALS, V21, P527, DOI 10.1016/S0197-2456(00)00106-9; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Stevens Victor J, 2008, J Med Internet Res, V10, pe1, DOI 10.2196/jmir.931; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; Svetkey LP, 1999, ARCH INTERN MED, V159, P285, DOI 10.1001/archinte.159.3.285; Svetkey LP, 2005, J HUM HYPERTENS, V19, P21, DOI 10.1038/sj.jhh.1001770; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wadden TA, 2004, OBES RES, V12, p151S, DOI 10.1038/oby.2004.282; Wadden TA, 2000, MED CLIN N AM, V84, P441, DOI 10.1016/j.psc.2004.09.008; Wadden TA, 2007, GASTROENTEROLOGY, V132, P2226, DOI 10.1053/j.gastro.2007.03.051; Wagner E H, 2001, Jt Comm J Qual Improv, V27, P63; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Wing RR, 2007, J CONSULT CLIN PSYCH, V75, P652, DOI 10.1037/0022-006X.75.4.652; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; WOOD PD, 1988, NEW ENGL J MED, V319, P1173, DOI 10.1056/NEJM198811033191801	53	522	533	0	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2008	299	10					1139	1148		10.1001/jama.299.10.1139	http://dx.doi.org/10.1001/jama.299.10.1139			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272CE	18334689	Bronze			2022-12-28	WOS:000253835000017
J	DeBose, JL; Lema, SC; Nevitt, GA				DeBose, Jennifer L.; Lema, Sean C.; Nevitt, Gabrielle A.			Dimethylsulfoniopropionate as a foraging cue for reef fishes	SCIENCE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; DIMETHYLSULFIDE		[DeBose, Jennifer L.; Nevitt, Gabrielle A.] Univ Calif Davis, Bodega Marine Lab, Davis, CA 95616 USA; [Lema, Sean C.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28403 USA	University of California System; University of California Davis; University of North Carolina; University of North Carolina Wilmington	Nevitt, GA (corresponding author), Univ Calif Davis, Bodega Marine Lab, Davis, CA 95616 USA.	ganevitt@ucdavis.edu		Lema, Sean/0000-0002-2564-8992				Broadbent AD, 2004, MAR FRESHWATER RES, V55, P849, DOI 10.1071/MF04114; DACEY JWH, 1994, MAR ECOL PROG SER, V112, P67, DOI 10.3354/meps112067; Iida H., 1988, B TOKAI TEG FISH RES, V124, P35; Jones GB, 2005, MAR FRESHWATER RES, V56, P85, DOI 10.1071/MF04097; Lieske E., 1994, CORAL REEF FISHES; Steinke M, 2006, LIMNOL OCEANOGR, V51, P1925, DOI 10.4319/lo.2006.51.4.1925	6	70	73	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1356	1356		10.1126/science.1151109	http://dx.doi.org/10.1126/science.1151109			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323445	Green Submitted			2022-12-28	WOS:000253712900034
J	Emanuel, EJ; Fuchs, VR				Emanuel, Ezekiel J.; Fuchs, Victor R.			Who really pays for health care? The myth of "shared responsibility"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Emanuel, Ezekiel J.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Fuchs, Victor R.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Stanford University	Emanuel, EJ (corresponding author), NIH, Dept Bioeth, Ctr Clin, 10 Ctr Dr, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@nih.gov						BAICKER K, 2005, 11160 NBER; Blumenthal D, 2006, NEW ENGL J MED, V355, P82, DOI 10.1056/NEJMhpr060703; BURD S, 2006, M US HLTH CARE CHALL; Catlin A, 2008, HEALTH AFFAIR, V27, P14, DOI 10.1377/hlthaff.27.1.14; *COUNC EC ADV, 2007, EC REP PRES; *CTR MED MED SERV, HLTH EXP SPONS BUS H; EBERTS RW, 1985, SOUTHERN ECON J, V52, P274, DOI 10.2307/1058920; FOSSETT JW, 2004, MEDICAID STATE BUDGE; GALLAGHER C, 2007, GROWING SUPPORT SHAR; Galvin RS, 2006, HEALTH AFFAIR, V25, P1548, DOI 10.1377/hlthaff.25.6.1548; GRUBER J, 1994, AM ECON REV, V84, P622; GRUBER J, 2000, HDB HLTH EC A, V1; KAVILANZ PB, 2007, WAL MART UNION PUSH; MADRIAN BC, 2006, 11980 NBER; Miller Richard D Jr, 2004, Int J Health Care Finance Econ, V4, P27; *NAT GOV ASS NAT A, 2007, FISC SURV STAT; ROYALTY AB, 2003, DISCRETE CHOICE APPR; SHEINER L, 1999, HLTH CARE COSTS WAGE	18	48	48	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2008	299	9					1057	1059		10.1001/jama.299.9.1057	http://dx.doi.org/10.1001/jama.299.9.1057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269JH	18319416				2022-12-28	WOS:000253644800024
J	Conaghan, PG; Dickson, J; Grant, RL				Conaghan, Philip G.; Dickson, John; Grant, Robert L.		Guideline Dev Grp	Guidelines - Care and management of osteoarthritis in adults: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Conaghan, Philip G.] Univ Leeds, Sect Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England; [Dickson, John] Guisborough Primary Care Hosp, Redcar & Cleveland Primary Care Trust, Guisborough TS14 6HZ, England; [Grant, Robert L.] Royal Coll Physicians, London NW1 4LE, England	University of Leeds; Royal College of Physicians	Conaghan, PG (corresponding author), Chapel Allerton Hosp, Sect Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England.	p.conaghan@leeds.ac.uk		Conaghan, Philip/0000-0002-3478-5665				National Institute for Health and Clinical Excellence, 2008, OST NAT CLIN GUID CA	1	235	244	0	27	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 1	2008	336	7642					502	503		10.1136/bmj.39490.608009.AD	http://dx.doi.org/10.1136/bmj.39490.608009.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18310005	Green Published, Green Accepted			2022-12-28	WOS:000253997500044
J	Dalbeth, N; Arroll, B				Dalbeth, Nicola; Arroll, Bruce			Commentary: controversies in NICE guidance on osteoarthritis	BRITISH MEDICAL JOURNAL			English	Editorial Material							KNEE OSTEOARTHRITIS		[Arroll, Bruce] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand; [Dalbeth, Nicola] Univ Auckland, Dept Med, Auckland 1, New Zealand	University of Auckland; University of Auckland	Arroll, B (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand.	b.arroll@auckland.ac.nz						Dehaan MN, 2007, J RHEUMATOL, V34, P2099; Herrero-Beaumont G, 2007, ARTHRITIS RHEUM-US, V56, P555, DOI 10.1002/art.22371; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Scheiman JM, 2006, AM J GASTROENTEROL, V101, P701, DOI 10.1111/j.1572-0241.2006.00499.x; Sullivan T, 1998, ARTHRIT CARE RES, V11, P228, DOI 10.1002/art.1790110403	5	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 1	2008	336	7642					504	504		10.1136/bmj.39496.451898.AD	http://dx.doi.org/10.1136/bmj.39496.451898.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18310006	Green Published			2022-12-28	WOS:000253997500045
J	Stossel, TP; Lee, K				Stossel, Thomas P.; Lee, Kirby			Has the hunt for conflicts of interest gone too far?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Stossel, Thomas P.] Harvard Univ, Sch Med, Dept Med, Translat Med Div,Brigham & Womens Hosp, Boston, MA 02115 USA; [Stossel, Thomas P.] Harvard Univ, Sch Med, Dept Med, Hematol Div,Brigham & Womens Hosp, Boston, MA 02115 USA; [Lee, Kirby] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94118 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Francisco	Stossel, TP (corresponding author), Harvard Univ, Sch Med, Dept Med, Translat Med Div,Brigham & Womens Hosp, 1 Blackfan Circle,Karp 6, Boston, MA 02115 USA.	Tstossel@partners.org; leek@pharmacy.ucsf.edu							0	35	35	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 1	2008	336	7642					476	477		10.1136/bmj.39493.489213.AD	http://dx.doi.org/10.1136/bmj.39493.489213.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18309999	Green Published			2022-12-28	WOS:000253997500036
J	Osborne, I; Coontz, R				Osborne, Ian; Coontz, Robert			Quantum wonderland	SCIENCE			English	Editorial Material																			0	6	6	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1201	1201		10.1126/science.319.5867.1201	http://dx.doi.org/10.1126/science.319.5867.1201			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309071				2022-12-28	WOS:000253530600027
J	Rygg, JR; Seguin, FH; Li, CK; Frenje, JA; Manuel, MJE; Petrasso, RD; Betti, R; Delettrez, JA; Gotchev, OV; Knauer, JP; Meyerhofer, DD; Marshall, FJ; Stoeckl, C; Theobald, W				Rygg, J. R.; Seguin, F. H.; Li, C. K.; Frenje, J. A.; Manuel, M. J. -E.; Petrasso, R. D.; Betti, R.; Delettrez, J. A.; Gotchev, O. V.; Knauer, J. P.; Meyerhofer, D. D.; Marshall, F. J.; Stoeckl, C.; Theobald, W.			Proton radiography of inertial fusion implosions	SCIENCE			English	Article							RAYLEIGH-TAYLOR INSTABILITY; MAGNETIC-FIELD GENERATION; LASER-FUSION; FILAMENTATION; NONUNIFORMITY; TRANSPORT; IGNITION; TARGETS	A distinctive way of quantitatively imaging inertial fusion implosions has resulted in the characterization of two different types of electromagnetic configurations and in the measurement of the temporal evolution of capsule size and areal density. Radiography with a pulsed, monoenergetic, isotropic proton source reveals field structures through deflection of proton trajectories, and areal densities are quantified through the energy lost by protons while traversing the plasma. The two field structures consist of (i) many radial filaments with complex striations and bifurcations, permeating the entire field of view, of magnetic field magnitude 60 tesla and ( ii) a coherent, centrally directed electric field of order 10(9) volts per meter, seen in proximity to the capsule surface. Although the mechanism for generating these fields is unclear, their effect on implosion dynamics is potentially consequential.	[Rygg, J. R.; Seguin, F. H.; Li, C. K.; Frenje, J. A.; Manuel, M. J. -E.; Petrasso, R. D.] MIT, Plasma Sci & Fus Ctr, Cambridge, MA 02139 USA; [Betti, R.; Delettrez, J. A.; Gotchev, O. V.; Knauer, J. P.; Meyerhofer, D. D.; Marshall, F. J.; Stoeckl, C.; Theobald, W.] Univ Rochester, Laser Energet Lab, Rochester, NY 14623 USA	Massachusetts Institute of Technology (MIT); University of Rochester	Petrasso, RD (corresponding author), MIT, Plasma Sci & Fus Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	petrasso@psfc.mit.edu	Manuel, Mario/AAF-8580-2019; Manuel, Mario J E/L-3213-2015; Theobald, Wolfgang/E-8121-2013	Manuel, Mario/0000-0002-5834-1161; Manuel, Mario J E/0000-0002-5834-1161; Rygg, James Ryan/0000-0002-0605-7847				Atzeni S, 2004, PHYS INERTIAL FUSION; DELETTREZ J, 1987, PHYS REV A, V36, P3926, DOI 10.1103/PhysRevA.36.3926; Drake RP, 2006, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/3-540-29315-9; HAINES MG, 1986, CAN J PHYS, V64, P912, DOI 10.1139/p86-160; HAINES MG, 1981, PHYS REV LETT, V47, P917, DOI 10.1103/PhysRevLett.47.917; Kodama R, 2002, NATURE, V418, P933, DOI 10.1038/418933a; Kruer W.L., 2003, PHYS LASER PLASMA IN; Li CK, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.055001; Li CK, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2228252; Li CK, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.135003; LI CK, 1993, PHYS REV LETT, V70, P3059, DOI 10.1103/PhysRevLett.70.3059; Mackinnon AJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.045001; MIMA K, 1978, PHYS REV LETT, V41, P1715, DOI 10.1103/PhysRevLett.41.1715; MOCHIZUKI T, 1980, JPN J APPL PHYS, V19, pL645, DOI 10.1143/JJAP.19.L645; N.R. Council, 2003, FRONT HIGH EN DENS P; Nishiguchi A, 2002, JPN J APPL PHYS 1, V41, P326, DOI 10.1143/JJAP.41.326; NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0; Remington BA, 2006, REV MOD PHYS, V78, P755, DOI 10.1103/RevModPhys.78.755; Stoeckl C, 2005, PLASMA PHYS CONTR F, V47, pB859, DOI 10.1088/0741-3335/47/12B/S68; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; WILLI O, 1981, OPT COMMUN, V37, P45, DOI 10.1016/0030-4018(81)90173-5	21	150	157	4	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1223	1225		10.1126/science.1152640	http://dx.doi.org/10.1126/science.1152640			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309079	Green Submitted			2022-12-28	WOS:000253530600037
J	Wang, YJ; Cheng, H; Edwards, RL; Kong, XG; Shao, XH; Chen, ST; Wu, JY; Jiang, XY; Wang, XF; An, ZS				Wang, Yongjin; Cheng, Hai; Edwards, R. Lawrence; Kong, Xinggong; Shao, Xiaohua; Chen, Shitao; Wu, Jiangyin; Jiang, Xiouyang; Wang, Xianfeng; An, Zhisheng			Millennial- and orbital-scale changes in the East Asian monsoon over the past 224,000 years	NATURE			English	Article							HULU CAVE; CLIMATE; RECORD; HOLOCENE; VARIABILITY; INSOLATION; CYCLE	High- resolution speleothem records from China have provided insights into the factors that control the strength of the East Asian monsoon(1-4). Our understanding of these factors remains incomplete, however, owing to gaps in the record of monsoon history over the past two interglacial - glacial cycles. In particular, missing sections have hampered our ability to test ideas about orbital- scale controls on the monsoon(5-7), the causes of millennial- scale events(8,9) and relationships between changes in the monsoon and climate in other regions. Here we present an absolute- dated oxygen isotope record from Sanbao cave, central China, that completes a Chinese-cave-based record of the strength of the East Asian monsoon that covers the past 224,000 years. The record is dominated by 23,000-year- long cycles that are synchronous within dating errors with summer insolation at 65 degrees N ( ref. 10), supporting the idea that tropical/ subtropical monsoons respond dominantly and directly to changes in Northern Hemisphere summer insolation on orbital timescales(5). The cycles are punctuated by millennial- scale strong-summer-monsoon events ( Chinese interstadials(1)), and the new record allows us to identify the complete series of these events over the past two interglacial - glacial cycles. Their duration decreases and their frequency increases during glacial build- up in both the last and penultimate glacial periods, indicating that ice sheet size affects their character and pacing. The ages of the events are exceptionally well constrained and may thus serve as benchmarks for correlating and calibrating climate records.	[Wang, Yongjin; Cheng, Hai; Kong, Xinggong; Shao, Xiaohua; Chen, Shitao; Wu, Jiangyin; Jiang, Xiouyang] Nanjing Normal Univ, Coll Geog Sci, Jiangsu 210097, Peoples R China; [Cheng, Hai; Edwards, R. Lawrence; Wang, Xianfeng] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA; [An, Zhisheng] Chinese Acad Sci, State Key Lab Loess & Quaternary Geol, Inst Earth Environm, Xian 710054, Peoples R China	Nanjing Normal University; University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; Institute of Earth Environment, CAS	Wang, YJ (corresponding author), Nanjing Normal Univ, Coll Geog Sci, Jiangsu 210097, Peoples R China.	yjwang@njnu.edu.cn; cheng021@umn.edu; edwar001@umn.edu	Wang, Xianfeng/F-1233-2014; CHENG, HAI/H-3413-2017; AN, Zhisheng/F-8834-2012; Edwards, R. Lawrence/I-3124-2014	Wang, Xianfeng/0000-0002-8614-5627; CHENG, HAI/0000-0002-5305-9458; Edwards, R. Lawrence/0000-0002-7027-5881; an, zhi sheng/0000-0002-9538-9826; Jiang, Xiuyang/0000-0001-9617-0431				Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; BENDER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P363, DOI 10.1029/94GB00724; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; Cai YJ, 2006, GEOLOGY, V34, P621, DOI 10.1130/G22567.1; Cheng H, 2006, GEOLOGY, V34, P217, DOI 10.1130/G22289.1; Clemens SC, 2005, QUATERNARY SCI REV, V24, P521, DOI 10.1016/j.quascirev.2004.10.015; Clemens SC, 2003, MAR GEOL, V201, P35, DOI 10.1016/S0025-3227(03)00207-X; Clemens SC, 2007, QUATERNARY SCI REV, V26, P275, DOI 10.1016/j.quascirev.2006.11.010; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; Kelly MJ, 2006, PALAEOGEOGR PALAEOCL, V236, P20, DOI 10.1016/j.palaeo.2005.11.042; KUTZBACH JE, 1981, SCIENCE, V214, P59, DOI 10.1126/science.214.4516.59; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Meese DA, 1997, J GEOPHYS RES-OCEANS, V102, P26411, DOI 10.1029/97JC00269; Morley JJ, 1997, PALEOCEANOGRAPHY, V12, P483, DOI 10.1029/97PA00213; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pisias NG, 1990, PALEOCEANOGRAPHY, V5, P147, DOI 10.1029/PA005i002p00147; Ruddiman WF, 2006, QUATERNARY SCI REV, V25, P657, DOI 10.1016/j.quascirev.2006.02.004; Ruddiman WF, 2003, QUATERNARY SCI REV, V22, P1597, DOI 10.1016/S0277-3791(03)00087-8; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Sima A, 2004, EARTH PLANET SC LETT, V222, P741, DOI 10.1016/j.epsl.2004.03.026; Sinha A, 2005, GEOLOGY, V33, P813, DOI 10.1130/G21498.1; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang ZM, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001238; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220	29	1304	1588	29	481	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1090	1093		10.1038/nature06692	http://dx.doi.org/10.1038/nature06692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305541	Bronze			2022-12-28	WOS:000253453600038
J	Bennett, CL; Silver, SM; Djulbegovic, B; Samaras, AT; Blau, CA; Gleason, KJ; Barnato, SE; Elverman, KM; Courtney, DM; Mckoy, JM; Edwards, BJ; Tigue, CC; Raisch, DW; Yarnold, PR; Dorr, DA; Kuzel, TM; Tallman, MS; Trifilio, SM; West, DP; Lai, SY; Henke, M				Bennett, Charles L.; Silver, Samuel M.; Djulbegovic, Benjamin; Samaras, Athena T.; Blau, C. Anthony; Gleason, Kara J.; Barnato, Sara E.; Elverman, Kathleen M.; Courtney, D. Mark; McKoy, June M.; Edwards, Beatrice J.; Tigue, Cara C.; Raisch, Dennis W.; Yarnold, Paul R.; Dorr, David A.; Kuzel, Timothy M.; Tallman, Martin S.; Trifilio, Steven M.; West, Dennis P.; Lai, Stephen Y.; Henke, Michael			Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLATINUM-BASED CHEMOTHERAPY; PLACEBO-CONTROLLED TRIAL; NON-HODGKINS-LYMPHOMA; CELL LUNG-CANCER; PHASE-III TRIAL; EPOETIN-ALPHA; DOUBLE-BLIND; RANDOMIZED-TRIAL; SOLID TUMORS; NECK-CANCER	Context The erythropoiesis- stimulating agents ( ESAs) erythropoietin and darbepoetin are licensed to treat chemotherapy- associated anemia in patients with nonmyeloid malignancies. Although systematic overviews of trials have identified venous thromboembolism ( VTE) risks, none have identified mortality risks with ESAs. Objective To evaluate VTE and mortality rates associated with ESA administration for the treatment of anemia among patients with cancer. Data Sources A published overview from the Cochrane Collaboration ( search dates: January 1, 1985- April 1, 2005) and MEDLINE and EMBASE databases ( key words: clinical trial, erythropoietin, darbepoetin, and oncology), the public Web site of the US Food and Drug Administration and ESA manufacturers, and safety advisories ( search dates: April 1, 2005- January 17, 2008). Study Selection Phase 3 trials comparing ESAs with placebo or standard of care for the treatment of anemia among patients with cancer. Data Extraction Mortality rates, VTE rates, and 95% confidence intervals (CIs) were extracted by 3 reviewers from 51 clinical trials with 13 611 patients that included survival information and 38 clinical trials with 8172 patients that included information on VTE. Data Synthesis Patients with cancer who received ESAs had increased VTE risks ( 334 VTE events among 4610 patients treated with ESA vs 173 VTE events among 3562 control patients; 7.5% vs 4.9%; relative risk, 1.57; 95% CI, 1.31- 1.87) and increased mortality risks ( hazard ratio, 1.10; 95% CI, 1.01- 1.20). Conclusions Erythropoiesis- stimulating agent administration to patients with cancer is associated with increased risks of VTE and mortality. Our findings, in conjunction with basic science studies on erythropoietin and erythropoietin receptors in solid cancers, raise concern about the safety of ESA administration to patients with cancer.	[Bennett, Charles L.; Samaras, Athena T.; Gleason, Kara J.; Barnato, Sara E.; Elverman, Kathleen M.; Courtney, D. Mark; McKoy, June M.; Edwards, Beatrice J.; Tigue, Cara C.; Yarnold, Paul R.; Kuzel, Timothy M.; Tallman, Martin S.; West, Dennis P.] Northwestern Univ, VA Chicago Healthcare Syst, VA Ctr Management Complex Chron Care, Feinberg Sch Med,Div Hematol Oncol,Dept Med, Chicago, IL 60611 USA; [Bennett, Charles L.; Samaras, Athena T.; Gleason, Kara J.; Barnato, Sara E.; Elverman, Kathleen M.; Courtney, D. Mark; McKoy, June M.; Edwards, Beatrice J.; Tigue, Cara C.; Yarnold, Paul R.; Kuzel, Timothy M.; Tallman, Martin S.; West, Dennis P.] Northwestern Univ, VA Chicago Healthcare Syst, VA Ctr Management Complex Chron Care, Feinberg Sch Med,Div Hematol Oncol,Dept Dermatol, Chicago, IL 60611 USA; [Bennett, Charles L.; Samaras, Athena T.; Gleason, Kara J.; Barnato, Sara E.; Elverman, Kathleen M.; Courtney, D. Mark; McKoy, June M.; Edwards, Beatrice J.; Tigue, Cara C.; Yarnold, Paul R.; Kuzel, Timothy M.; Tallman, Martin S.; West, Dennis P.] Northwestern Univ, VA Chicago Healthcare Syst, VA Ctr Management Complex Chron Care, Feinberg Sch Med,Div Hematol Oncol,Dept Emergency, Chicago, IL 60611 USA; [Bennett, Charles L.; Samaras, Athena T.; Gleason, Kara J.; Barnato, Sara E.; Elverman, Kathleen M.; Courtney, D. Mark; McKoy, June M.; Edwards, Beatrice J.; Tigue, Cara C.; Yarnold, Paul R.; Kuzel, Timothy M.; Tallman, Martin S.; West, Dennis P.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Silver, Samuel M.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Djulbegovic, Benjamin] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Interdisciplinary Oncol Program, Tampa, FL USA; [Blau, C. Anthony] Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; [Blau, C. Anthony] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Raisch, Dennis W.] Univ New Mexico, VA Cooperat Studies Program Clin Res Pharm, Albuquerque, NM 87131 USA; [Dorr, David A.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Trifilio, Steven M.] Northwestern Univ, NW Mem Hosp, Dept Pharm, Chicago, IL 60611 USA; [Lai, Stephen Y.] Univ Pittsburgh, Med Ctr, Dept Otolaryngol, Pittsburgh, PA USA; [Lai, Stephen Y.] Univ Pittsburgh, Med Ctr, Dept Pharmacol, Pittsburgh, PA USA; [Lai, Stephen Y.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Henke, Michael] Univ Hosp Freiberg, Freiberg, Germany	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of Michigan System; University of Michigan; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of New Mexico; Oregon Health & Science University; Northwestern Memorial Hospital; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bennett, CL (corresponding author), Northwestern Univ, VA Chicago Healthcare Syst, VA Ctr Management Complex Chron Care, Feinberg Sch Med,Div Hematol Oncol,Dept Med, 303 E Chicago Ave,Olson Pavil Ste 8250, Chicago, IL 60611 USA.	cbenne@northwestern.edu	Bennett, Charles L/C-2050-2008; MCKOY, JUNE/GRJ-5660-2022; Djulbegovic, Benjamin/I-3661-2012	Djulbegovic, Benjamin/0000-0003-0671-1447; Lai, Stephen/0000-0001-8301-7286; Yarnold, Paul/0000-0002-1648-739X; Edwards, Beatrice/0000-0002-7900-5159; Mould, Kara/0000-0003-2967-2778; West, Dennis Paul/0000-0002-9107-6697	NATIONAL CANCER INSTITUTE [R01CA102713, R01CA125077, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL077404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K08DE018061] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABELS R, 1993, EUR J CANCER, V29A, pS2, DOI 10.1016/S0959-8049(05)80281-3; Acs G, 2004, CANCER LETT, V214, P243, DOI 10.1016/j.canlet.2004.04.027; Acs G, 2001, CANCER RES, V61, P3561; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; *AMG INC, 2007, AR PACK INS; [Anonymous], 2007, EP PACK INS; Bamias A, 2003, ONCOLOGY-BASEL, V64, P102, DOI 10.1159/000067766; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; BLOHMER JU, 2003, EUR CANC C SEPT 21 2; Bohlius J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003407.pub4; Bohlius J, 2005, JNCI-J NATL CANCER I, V97, P489, DOI 10.1093/jnci/dji087; CASCINU S, 1994, J CLIN ONCOL, V12, P1058, DOI 10.1200/JCO.1994.12.5.1058; CASE DC, 1993, J NATL CANCER I, V85, P801, DOI 10.1093/jnci/85.10.801; CAZZOLA M, 1995, BLOOD, V86, P4446, DOI 10.1182/blood.V86.12.4446.bloodjournal86124446; Charu V, 2007, ONCOLOGIST, V12, P727, DOI 10.1634/theoncologist.12-6-727; COIFFIER B, 2001, 6 C EUR HAEM ASS JUN; Dammacco F, 2001, BRIT J HAEMATOL, V113, P172, DOI 10.1046/j.1365-2141.2001.02715.x; DEBUS JHS, GERMAN MED SCI; DelMastro L, 1997, J CLIN ONCOL, V15, P2715, DOI 10.1200/JCO.1997.15.7.2715; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunphy FR, 1999, CANCER, V86, P1362, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1362::AID-CNCR36>3.0.CO;2-T; GLASPY J, 2008, P AM ASS CANC RES AN; GORDON DH, 2006, AM SOC HEM DEC 9 ORL; Grote T, 2005, J CLIN ONCOL, V23, P9377, DOI 10.1200/JCO.2005.01.8507; Hardee ME, 2006, CLIN CANCER RES, V12, P332, DOI 10.1158/1078-0432.CCR-05-1771; Hardee ME, 2006, MOL CANCER THER, V5, P356, DOI 10.1158/1535-7163.MCT-05-0196; Hedenus M, 2003, BRIT J HAEMATOL, V122, P394, DOI 10.1046/j.1365-2141.2003.04448.x; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Henke M, 2006, J CLIN ONCOL, V24, P4708, DOI 10.1200/JCO.2006.06.2737; Henry D H, 1995, Cancer J Sci Am, V1, P252; HENRY DH, 1994, SEMIN ONCOL, V21, P21; Huinink WWT, 1998, MED ONCOL, V15, P174, DOI 10.1007/BF02821936; Kotasek D, 2003, EUR J CANCER, V39, P2026, DOI 10.1016/S0959-8049(03)00456-8; Kumar SM, 2005, AM J PATHOL, V166, P823, DOI 10.1016/S0002-9440(10)62303-6; Kumar SM, 2006, MELANOMA RES, V16, P275, DOI 10.1097/01.cmr.0000222594.60611.c3; Lai SY, 2006, J CLIN ONCOL, V24, P4675, DOI 10.1200/JCO.2006.08.1190; Lai SY, 2005, ONCOGENE, V24, P4442, DOI 10.1038/sj.onc.1208635; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Leyland-Jones B, 2003, LANCET ONCOL, V4, P459, DOI 10.1016/S1470-2045(03)01163-X; Littlewood TJ, 2001, J CLIN ONCOL, V19, P2865, DOI 10.1200/JCO.2001.19.11.2865; Littlewood TJ, 2002, LANCET ONCOL, V3, P459, DOI 10.1016/S1470-2045(02)00827-6; Machtay M, 2007, INT J RADIAT ONCOL, V69, P1008, DOI 10.1016/j.ijrobp.2007.04.063; Moebus V, 2007, J CLIN ONCOL, V25; Mohyeldin A, 2005, NEOPLASIA, V7, P537, DOI 10.1593/neo.04685; Mystakidou K, 2005, ANTICANCER RES, V25, P3495; O'Shaughnessy Joyce A, 2005, Clin Breast Cancer, V5, P439, DOI 10.3816/CBC.2005.n.002; Oberhoff C, 1998, ANN ONCOL, V9, P255, DOI 10.1023/A:1008296622469; Osterborg A, 2005, BRIT J HAEMATOL, V129, P206, DOI 10.1111/j.1365-2141.2005.05440.x; Osterborg A, 1996, BLOOD, V87, P2675, DOI 10.1182/blood.V87.7.2675.bloodjournal8772675; Overgaard J, 2007, EJC SUPPL, V5, P7, DOI 10.1016/S1359-6349(07)70099-X; POLLACK A, 2007, NY TIMES        0126; Razzouk BI, 2004, J CLIN ONCOL, V22, p805S; Rizzo JD, 2008, J CLIN ONCOL, V26, P132, DOI 10.1200/JCO.2007.14.3396; ROSE E, 1994, BLOOD, V84, pA526; Rosenzweig MQ, 2004, J PAIN SYMPTOM MANAG, V27, P185, DOI 10.1016/j.jpainsymman.2003.06.010; SAVONIJE JVG, 2004, J CLIN ONCOL, V22, pS14; Seidenfeld J, 2006, COMP EFFECTIVENESS E; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Smith RE, 2003, BRIT J CANCER, V88, P1851, DOI 10.1038/sj.bjc.6600994; Steinbrook R, 2007, NEW ENGL J MED, V356, P2448, DOI 10.1056/NEJMp078100; STRAUSS HG, INT J GYNECOL CANC; SYTKOWSKI AJ, 2007, SCI STKE, pPE38, DOI DOI 10.1126/STKE.3952007.PE38; TAYLOR KB, 2005, BLOOD ASH ANN ABSTR; Thatcher N, 1999, BRIT J CANCER, V80, P396, DOI 10.1038/sj.bjc.6990369; THOMAS G, GYNECOL ONCOL; THROUVALAS N, 2000, 36 ANN M AM SOC CLIN; *US CTR MED MED SE, 2007, COV DEC MEM US ER ST; *US FDA, SAF ER REC AG ERAS P; *US FDA, FDA AL INF ER STIM A; *US FDA, SAF ER STIM AG ESAS; Vadhan-Raj S, 2004, BLOOD, V104, p797A; Vansteenkiste J, 2002, J NATL CANCER I, V94, P1211; Welch R S, 1995, Cancer J Sci Am, V1, P261; Wilkinson PM, 2006, BRIT J CANCER, V94, P947, DOI 10.1038/sj.bjc.6603004; Wilson J, 2007, HEALTH TECHNOL ASSES, V11, P1; Witzig TE, 2005, J CLIN ONCOL, V23, P2606, DOI 10.1200/JCO.2004.10.020; Wright JR, 2007, J CLIN ONCOL, V25, P1027, DOI 10.1200/JCO.2006.07.1514	77	526	561	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2008	299	8					914	924		10.1001/jama.299.8.914	http://dx.doi.org/10.1001/jama.299.8.914			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266DZ	18314434				2022-12-28	WOS:000253413200020
J	Campbell, BH				Campbell, Bruce H.			Listening to Leviticus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												bcampbel@mcw.edu						*BIBLE, LEVITICUS, V17, P10	1	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2008	299	8					879	880		10.1001/jama.299.8.879	http://dx.doi.org/10.1001/jama.299.8.879			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266DZ	18314424				2022-12-28	WOS:000253413200001
J	Zhai, RG; Zhang, F; Hiesinger, PR; Cao, Y; Haueter, CM; Bellen, HJ				Zhai, R. Grace; Zhang, Fan; Hiesinger, P. Robin; Cao, Yu; Haueter, Claire M.; Bellen, Hugo J.			NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration	NATURE			English	Article							WALLERIAN DEGENERATION; AXON DEGENERATION; NERVOUS-SYSTEM; WLD(S); MICE; MODEL; BIOSYNTHESIS; AGGREGATION; DROSOPHILA; DISEASE	Neurodegeneration can be triggered by genetic or environmental factors. Although the precise cause is often unknown, many neurodegenerative diseases share common features such as protein aggregation and age dependence. Recent studies in Drosophila have uncovered protective effects of NAD synthase nicotinamide mononucleotide adenylyltransferase ( NMNAT) against activity-induced neurodegeneration and injury- induced axonal degeneration(1,2). Here we show that NMNAT overexpression can also protect against spinocerebellar ataxia 1 ( SCA1)- induced neurodegeneration, suggesting a general neuroprotective function of NMNAT. It protects against neurodegeneration partly through a proteasome-mediated pathway in a manner similar to heat- shock protein 70 ( Hsp70). NMNAT displays chaperone function both in biochemical assays and cultured cells, and it shares significant structural similarity with known chaperones. Furthermore, it is upregulated in the brain upon overexpression of poly- glutamine expanded protein and recruited with the chaperone Hsp70 into protein aggregates. Our results implicate NMNAT as a stress- response protein that acts as a chaperone for neuronal maintenance and protection. Our studies provide an entry point for understanding how normal neurons maintain activity, and offer clues for the common mechanisms underlying different neurodegenerative conditions.	[Zhai, R. Grace; Zhang, Fan] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Zhai, R. Grace; Hiesinger, P. Robin; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zhai, R. Grace; Cao, Yu; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	University of Miami; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Zhai, RG (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	gzhai@med.miami.edu; hbellen@bcm.edu	Zhai, R. Grace/AGZ-3936-2022; Zhang, Fan/E-4333-2010	Bellen, Hugo/0000-0001-5992-5989; Zhang, Fan/0000-0002-0744-673X; Zhai, Rong/0000-0002-7599-1430	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [P30 HD024064-20, P30 HD024064] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Chang ZY, 1996, J BIOL CHEM, V271, P7218, DOI 10.1074/jbc.271.12.7218; Conforti L, 2007, CELL DEATH DIFFER, V14, P116, DOI 10.1038/sj.cdd.4401944; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Ferri A, 2003, CURR BIOL, V13, P669, DOI 10.1016/S0960-9822(03)00206-9; Gillingwater TH, 2004, J CEREBR BLOOD F MET, V24, P62, DOI 10.1097/01.WCB.0000095798.98378.34; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; Holm L, 1997, STRUCTURE, V5, P165, DOI 10.1016/S0969-2126(97)00176-7; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Jia HQ, 2007, NEUROSCI LETT, V413, P46, DOI 10.1016/j.neulet.2006.11.067; Kubo Y, 1999, J MOL BIOL, V286, P447, DOI 10.1006/jmbi.1998.2465; Li JZ, 2003, STRUCTURE, V11, P323, DOI 10.1016/S0969-2126(03)00030-3; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; LUDWIN SK, 1992, J NEUROL SCI, V109, P140, DOI 10.1016/0022-510X(92)90160-M; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; RIBCHESTER RR, 1995, EUR J NEUROSCI, V7, P1641, DOI 10.1111/j.1460-9568.1995.tb01159.x; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sajadi A, 2004, CURR BIOL, V14, P326, DOI 10.1016//j.cub.2004.01.053; Samsam M, 2003, J NEUROSCI, V23, P2833; Sousa MC, 2001, STRUCTURE, V9, P1135, DOI 10.1016/S0969-2126(01)00680-3; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	30	159	170	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2008	452	7189					887	U8		10.1038/nature06721	http://dx.doi.org/10.1038/nature06721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18344983	Green Accepted			2022-12-28	WOS:000255026000051
J	Sokol, DK				Sokol, Daniel K.			A crisis of confidence	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, St Georges, London WC1E 7HU, England	University of London	Sokol, DK (corresponding author), Univ London, St Georges, London WC1E 7HU, England.	daniel.sokol@talk21.com						*BMA ETH DEP, 2004, MED ETH TOD BMAS HDB	1	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 22	2008	336	7645					639	639		10.1136/bmj.39521.625486.59	http://dx.doi.org/10.1136/bmj.39521.625486.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RH	18356230	Green Published			2022-12-28	WOS:000254443400021
J	Sanda, MG; Dunn, RL; Michalski, J; Sandler, HM; Northouse, L; Hembroff, L; Lin, XH; Greenfield, TK; Litwin, MS; Saigal, CS; Mahadevan, A; Klein, E; Kibel, A; Pisters, LL; Kuban, D; Kaplan, I; Wood, D; Ciezki, J; Shah, N; Wei, JT				Sanda, Martin G.; Dunn, Rodney L.; Michalski, Jeff; Sandler, Howard M.; Northouse, Laurel; Hembroff, Larry; Lin, Xihong; Greenfield, Thomas K.; Litwin, Mark S.; Saigal, Christopher S.; Mahadevan, Arul; Klein, Eric; Kibel, Adam; Pisters, Louis L.; Kuban, Deborah; Kaplan, Irving; Wood, David; Ciezki, Jay; Shah, Nikhil; Wei, John T.			Quality of life and satisfaction with outcome among prostate-cancer survivors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADICAL PROSTATECTOMY; PATIENT SATISFACTION; SEXUAL FUNCTION; RADIATION-THERAPY; BRACHYTHERAPY; CARE; RADIOTHERAPY; CARCINOMA; URINARY; MEN	Background: We sought to identify determinants of health-related quality of life after primary treatment of prostate cancer and to measure the effects of such determinants on satisfaction with the outcome of treatment in patients and their spouses or partners. Methods: We prospectively measured outcomes reported by 1201 patients and 625 spouses or partners at multiple centers before and after radical prostatectomy, brachytherapy, or external-beam radiotherapy. We evaluated factors that were associated with changes in quality of life within study groups and determined the effects on satisfaction with the treatment outcome. Results: Adjuvant hormone therapy was associated with worse outcomes across multiple quality-of-life domains among patients receiving brachytherapy or radiotherapy. Patients in the brachytherapy group reported having long-lasting urinary irritation, bowel and sexual symptoms, and transient problems with vitality or hormonal function. Adverse effects of prostatectomy on sexual function were mitigated by nerve-sparing procedures. After prostatectomy, urinary incontinence was observed, but urinary irritation and obstruction improved, particularly in patients with large prostates. No treatment-related deaths occurred; serious adverse events were rare. Treatment-related symptoms were exacerbated by obesity, a large prostate size, a high prostate-specific antigen score, and older age. Black patients reported lower satisfaction with the degree of overall treatment outcomes. Changes in quality of life were significantly associated with the degree of outcome satisfaction among patients and their spouses or partners. Conclusions: Each prostate-cancer treatment was associated with a distinct pattern of change in quality-of-life domains related to urinary, sexual, bowel, and hormonal function. These changes influenced satisfaction with treatment outcomes among patients and their spouses or partners.	[Sanda, Martin G.] Beth Israel Deaconess Med Ctr, Div Urol, Dept Surg, Boston, MA 02215 USA; [Kaplan, Irving] Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; [Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Dunn, Rodney L.] Univ Michigan, Biostat Core, Ann Arbor, MI 48109 USA; [Sandler, Howard M.] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Wood, David; Shah, Nikhil; Wei, John T.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Northouse, Laurel] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Northouse, Laurel] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Michalski, Jeff] Washington Univ, Dept Radiat Oncol, St Louis, MO USA; [Kibel, Adam] Washington Univ, Dept Urol, St Louis, MO USA; [Hembroff, Larry] Michigan State Univ, Off Survey Res, Inst Publ Policy & Social Res, E Lansing, MI 48824 USA; [Greenfield, Thomas K.] Inst Publ Hlth, Alcohol Res Grp, Emeryville, CA USA; [Litwin, Mark S.; Saigal, Christopher S.] Univ Calif Los Angeles, Ctr Hlth Sci, Dept Urol, Los Angeles, CA 90024 USA; [Litwin, Mark S.] Univ Calif Los Angeles, Ctr Hlth Sci, Dept Hlth Serv, Los Angeles, CA 90024 USA; [Mahadevan, Arul; Ciezki, Jay] Cleveland Clin Hosp, Dept Radiat Oncol, Cleveland, OH USA; [Klein, Eric] Cleveland Clin Hosp, Dept Urol, Cleveland, OH USA; [Pisters, Louis L.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Kuban, Deborah] Univ Texas Houston, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Washington University (WUSTL); Washington University (WUSTL); Michigan State University; Alcohol Research Group; Public Health Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Sanda, MG (corresponding author), Beth Israel Deaconess Med Ctr, Div Urol, Dept Surg, 330 Brookline Ave,Rabb 440, Boston, MA 02215 USA.	msanda@bidmc.harvard.edu	Wei, John T/E-8967-2012; Sanda, Martin G/B-2023-2015; Sanda, Martin G/A-6202-2013; /C-3160-2011	Ciezki, Jay/0000-0003-1858-6727; Northouse, Laurel/0000-0002-2567-2183; Litwin, Mark/0000-0002-2318-344X; /0000-0002-3108-4812	NATIONAL CANCER INSTITUTE [R01CA095662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA005595] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA95662, R01 CA095662] Funding Source: Medline; NIAAA NIH HHS [P50 AA005595] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Barry MJ, 1999, J UROLOGY, V162, P407, DOI 10.1016/S0022-5347(05)68571-0; Blasko JC, 2002, SEMIN RADIAT ONCOL, V12, P81, DOI 10.1053/srao.2002.28667; Brandeis JM, 2000, J UROLOGY, V163, P851, DOI 10.1016/S0022-5347(05)67818-4; Carvalhal GF, 1999, J UROLOGY, V162, P113, DOI 10.1097/00005392-199907000-00027; Catalona WJ, 1999, J UROLOGY, V162, P433, DOI 10.1016/S0022-5347(05)68578-3; CLEARY PD, 1988, INQUIRY-J HEALTH CAR, V25, P25; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Davis JW, 2001, J UROLOGY, V166, P947, DOI 10.1016/S0022-5347(05)65870-3; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; DONABEDIAN A, 1978, SCIENCE, V200, P856, DOI 10.1126/science.417400; Downs TM, 2003, J UROLOGY, V170, P1822, DOI 10.1097/01.ju.0000091426.55735.f0; Eastham JA, 1996, J UROLOGY, V156, P1707, DOI 10.1016/S0022-5347(01)65488-0; Fitzmaurice GM, 2004, WILEY SERIES PROBABI, P291; GREENFIELD TK, 1989, EVAL PROGRAM PLANN, V12, P271, DOI 10.1016/0149-7189(89)90038-4; Guillonneau B, 2000, J UROLOGY, V163, P1643, DOI 10.1016/S0022-5347(05)67512-X; Harden Janet, 2002, Oncol Nurs Forum, V29, P701, DOI 10.1188/02.ONF.701-709; Hoffman RM, 2003, CANCER, V97, P1653, DOI 10.1002/cncr.11233; *I MED COMM RED HL, 2006, PERF MEAS ACC IMP; Kahn KL, 2002, MED CARE, V40, P73; Kornblith AB, 2001, ANN ONCOL, V12, P633, DOI 10.1023/A:1011102619058; Lee WR, 2003, CANCER, V98, P1987, DOI 10.1002/cncr.11774; Lepor H, 2004, J UROLOGY, V171, P1216, DOI 10.1097/01.ju.0000113964.68020.a7; Litwin MS, 1999, UROLOGY, V54, P503, DOI 10.1016/S0090-4295(99)00172-7; LITWIN MS, 1995, JAMA-J AM MED ASSOC, V273, P129, DOI 10.1001/jama.273.2.129; Lubeck DP, 1996, UROLOGY, V48, P773, DOI 10.1016/S0090-4295(96)00226-9; Lubeck DP, 2000, AM J MANAG CARE, V6, P70; Madalinska JB, 2001, J CLIN ONCOL, V19, P1619, DOI 10.1200/JCO.2001.19.6.1619; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Menon M, 2003, UROLOGY, V61, P15, DOI 10.1016/S0090-4295(03)00116-X; Miller DC, 2005, J CLIN ONCOL, V23, P2772, DOI 10.1200/JCO.2005.07.116; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Potosky AL, 2000, JNCI-J NATL CANCER I, V92, P1582, DOI 10.1093/jnci/92.19.1582; Potosky AL, 2001, J CLIN ONCOL, V19, P3750, DOI 10.1200/JCO.2001.19.17.3750; QUINLAN DM, 1991, J UROLOGY, V145, P998, DOI 10.1016/S0022-5347(17)38512-9; Rabbani F, 2000, J UROLOGY, V164, P1929, DOI 10.1016/S0022-5347(05)66921-2; SHAH NL, 2003, J UROL S11, V169; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Soloway CT, 2005, BJU INT, V95, P780, DOI 10.1111/j.1464-410X.2005.05400.x; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Talcott JA, 2003, J CLIN ONCOL, V21, P3979, DOI 10.1200/JCO.2003.01.199; WALSH PC, 1986, CAMPBELLS UROLOGY, V3, P2754; Ware J E Jr, 1983, Eval Program Plann, V6, P247, DOI 10.1016/0149-7189(83)90005-8; Wei JT, 2002, J CLIN ONCOL, V20, P557, DOI 10.1200/JCO.20.2.557; Wei JT, 2000, UROLOGY, V56, P899, DOI 10.1016/S0090-4295(00)00858-X	46	1682	1717	1	160	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1250	1261		10.1056/NEJMoa074311	http://dx.doi.org/10.1056/NEJMoa074311			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275TL	18354103	Bronze			2022-12-28	WOS:000254094400006
J	Truog, RD				Truog, Robert D.			Consent for organ donation - Balancing cpnflicting ethical obligations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Dept Anesthesia & Social Med, Boston, MA 02115 USA; Childrens Hosp, Div Crit Care Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Truog, RD (corresponding author), Harvard Univ, Sch Med, Dept Anesthesia & Social Med, Boston, MA 02115 USA.							Stein Rob, 2007, Washington Post, pA8; Steinbrook R, 2007, NEW ENGL J MED, V357, P209, DOI 10.1056/NEJMp078066; Zink S, 2006, CRIT CARE NURSE, V26, P129	3	59	59	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1209	1211		10.1056/NEJMp0708194	http://dx.doi.org/10.1056/NEJMp0708194			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275TL	18354099				2022-12-28	WOS:000254094400001
J	Gerber, PA; Homey, B				Gerber, Peter Arne; Homey, Bernhard			Erlotinib-induced hair alterations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gerber, Peter Arne; Homey, Bernhard] Univ Dusseldorf, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Gerber, PA (corresponding author), Univ Dusseldorf, D-40225 Dusseldorf, Germany.	homey@rz.uni-duesseldorf.de	Gerber, Peter Arne/M-2746-2013; Gerber, Peter Arne/C-2000-2009	Gerber, Peter Arne/0000-0003-1657-1863; 					0	11	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1175	1175		10.1056/NEJMicm073144	http://dx.doi.org/10.1056/NEJMicm073144			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337606				2022-12-28	WOS:000253877200010
J	Han, HJ; Russo, J; Kohwi, Y; Kohwi-Shigematsu, T				Han, Hye-Jung; Russo, Jose; Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi			SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis	NATURE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; CANCER METASTASIS; SIGNAL-TRANSDUCTION; BINDING PROTEIN; IN-VIVO; CHROMATIN; CELLS; PROGRESSION; ARCHITECTURE; APOPTOSIS	Mechanisms underlying global changes in gene expression during tumour progression are poorly understood. SATB1 is a genome organizer that tethers multiple genomic loci and recruits chromatin- remodelling enzymes to regulate chromatin structure and gene expression. Here we show that SATB1 is expressed by aggressive breast cancer cells and its expression level has high prognostic significance ( P < 0.0001), independent of lymph- node status. RNA- interference- mediated knockdown of SATB1 in highly aggressive ( MDA- MB- 231) cancer cells altered the expression of >1,000 genes, reversing tumorigenesis by restoring breast- like acinar polarity and inhibiting tumour growth and metastasis in vivo. Conversely, ectopic SATB1 expression in non- aggressive ( SKBR3) cells led to gene expression patterns consistent with aggressive- tumour phenotypes, acquiring metastatic activity in vivo. SATB1 delineates specific epigenetic modifications at target gene loci, directly upregulating metastasis- associated genes while downregulating tumour- suppressor genes. SATB1 reprogrammes chromatin organization and the transcription profiles of breast tumours to promote growth and metastasis; this is a new mechanism of tumour progression.	[Han, Hye-Jung; Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi] Univ Calif Berkeley, Div Life Sci, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Russo, Jose] Fox Chase Canc Ctr, Breast Canc Res Lab, Philadelphia, PA 19111 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Fox Chase Cancer Center	Kohwi-Shigematsu, T (corresponding author), Univ Calif Berkeley, Div Life Sci, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.	YKohwi@lbl.gov; Terumiks@lbl.gov						Alvarez JD, 2000, GENE DEV, V14, P521; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; de Bono JS, 2002, TRENDS MOL MED, V8, pS19, DOI 10.1016/S1471-4914(02)02306-7; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Drobic B, 2006, EXP SUPPL, V96, P25; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Galande S, 2000, J CELL BIOCHEM, P36; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Ince TA, 2002, CANCER CELL, V1, P15, DOI 10.1016/S1535-6108(02)00023-5; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kohwi-Shigematsu T, 1998, METHOD CELL BIOL, V53, P323; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mosesson Y, 2004, SEMIN CANCER BIOL, V14, P262, DOI 10.1016/j.semcancer.2004.04.005; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Parker BS, 2003, CANCER BIOL THER, V2, P14; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Salven P, 1998, AM J PATHOL, V153, P103, DOI 10.1016/S0002-9440(10)65550-2; Severgnini M, 2006, ANAL BIOCHEM, V353, P43, DOI 10.1016/j.ab.2006.03.023; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	50	417	468	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2008	452	7184					187	193		10.1038/nature06781	http://dx.doi.org/10.1038/nature06781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337816				2022-12-28	WOS:000253925600034
J	Pohl, C; Jentsch, S				Pohl, Christian; Jentsch, Stefan			Final stages of cytokinesis and midbody ring formation are controlled by BRUCE	CELL			English	Article							KINESIN-LIKE PROTEIN; NUCLEAR-LOCALIZATION; UBIQUITIN LIGASE; CELL-DIVISION; MITOTIC EXIT; APOPTOSIS; COMPLETION; EXOCYST; ENZYME; PROTEOLYSIS	Cytokinesis involves the formation of a cleavage furrow, followed by abscission, the cutting of the midbody channel, the final bridge between dividing cells. Recently, the midbody ring became known as central for abscission, but its regulation remains enigmatic. Here, we identify BRUCE, a 528 kDa multifunctional protein, which processes ubiquitin-conjugating activity, as a major regulator of abscission. During cytokinesis, BRUCE moves from the vesicular system to the midbody ring and serves as a platform for the membrane delivery machinery and mitotic regulators. Depletion of BRUCE in cell cultures causes defective abscission and cytokinesis-associated apoptosis, accompanied by a block of vesicular targeting and defective formation of the midbody and the midbody ring. Notably, ubiquitin relocalizes from midbody microtubules to the midbody ring during cytokinesis, and depletion of BRUCE disrupts this process. We propose that BRUCE coordinates multiple steps required for abscission and that ubiquitylation may be a crucial trigger.	[Pohl, Christian; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de	Pohl, Christian/D-4700-2011					Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Flemming W., 1891, ARCH MIKROSK ANAT, V37, P685, DOI [DOI 10.1007/BF02954311, 10.1007/BF02954311]; GRENFELL SJ, 1994, BIOCHEM J, V300, P701, DOI 10.1042/bj3000701; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kuriyama R, 2002, J CELL BIOL, V156, P783, DOI 10.1083/jcb.200109090; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu XQ, 2007, BIOCHEM BIOPH RES CO, V353, P960, DOI 10.1016/j.bbrc.2006.12.142; Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004; Matuliene J, 2002, MOL BIOL CELL, V13, P1832, DOI 10.1091/mbc.01-10-0504; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Pines J, 2005, NAT CELL BIOL, V7, P731, DOI 10.1038/ncb0805-731; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Row PE, 2007, J BIOL CHEM, V282, P30929, DOI 10.1074/jbc.M704009200; Samuel T, 2005, CANCER RES, V65, P210; Schmidt K, 2004, CURR BIOL, V14, P1002, DOI 10.1016/j.cub.2004.05.044; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; Verhagen AM, 2001, GENOME BIOL, V2; WOJCIK C, 1995, EUR J CELL BIOL, V68, P191; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yu XZ, 2007, EUR J CELL BIOL, V86, P25, DOI 10.1016/j.ejcb.2006.10.002	36	133	150	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					832	845		10.1016/j.cell.2008.01.012	http://dx.doi.org/10.1016/j.cell.2008.01.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329369	Bronze			2022-12-28	WOS:000253818000020
J	Mermin, J; Were, W; Ekwaru, JP; Moore, D; Downing, R; Behumbiize, P; Lule, JR; Coutinho, A; Tappero, J; Bunnell, R				Mermin, Jonathan; Were, Willy; Ekwaru, John Paul; Moore, David; Downing, Robert; Behumbiize, Prosper; Lule, John R.; Coutinho, Alex; Tappero, Jordan; Bunnell, Rebecca			Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study	LANCET			English	Article							SUB-SAHARAN AFRICA; COTRIMOXAZOLE PROPHYLAXIS; GENDER-DIFFERENCES; THERAPY; AIDS; PROGRESSION; LESSONS	Background Antiretroviral therapy (ART) is increasingly available in Africa, but physicians and clinical services are few. We therefore assessed the effect of a home-based ART programme in Uganda on mortality, hospital admissions, and orphanhood in people with HIV-1 and their household members. Methods In 2001, we enrolled and followed up 466 HIV-infected adults and 1481 HIV-uninfected household members in a prospective cohort study. After 5 months, we provided daily co-trimoxazole (160 mg trimethoprim and 800 mg sulfamethoxazole) prophylaxis to HIV-infected participants. Between May, 2003, and December, 2005, we followed up 138 infected adults who were eligible and 907 new HIV-infected participants and their HIV-negative household members in a study of ART (mainly stavudine, lamivudine, and nevirapine). Households were visited every week by lay providers, and no dinic visits were scheduled after enrolment. We compared rates of death, hospitalisation, and orphanhood during diffierent study periods and calculated the number needed to treat to prevent an outcome. Findings 233 (17%) of 1373 participants with HIV and 40 (1%) of 4601 HIV-uninfected household members died. During the first 16 weeks of ART and co-trimoxazole, mortality in HIV-infected participants was 55% lower than that during co-trimoxazole alone (14 vs 16 deaths per 100 person-years; adjusted hazard ratio 0 . 45, 95% CI 0 . 27-0.74, p=0.0018), and after 16 weeks, was reduced by 92% (3 vs 16 deaths per 100 person-years; 0 . 08, 0.06-0.13, p<0.0001). Compared with no intervention, ART and co-trimoxazole were associated with a 95% reduction in mortality in HIV-indected participants (5 vs 27 deaths per 100 person-years; 0.05, 0.03-0.08, p<0.0001), 81% reduction in mortality in their uninfected children younger than 10 years (0 . 2 vs 1 . 2 deaths per 100 person-years; 0 . 19, 0.06-0.59, p=0.004), and a 93% estimated reduction in orphanhood (0 . 9 vs 12.8 per 100 person-years of adults treated; 0.07, 0.04-0 . 13, p<0 . 0001). Interpretation Expansion of access to ART and co-trimoxazole prophylaxis could substantially reduce mortality and orphanhood among adults with HIV and their families living in resource-poor settings.	[Mermin, Jonathan] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, Coordinating Off Global Hlth, Nairobi, Kenya; [Mermin, Jonathan; Were, Willy; Ekwaru, John Paul; Moore, David; Downing, Robert; Behumbiize, Prosper; Lule, John R.; Tappero, Jordan; Bunnell, Rebecca] Ctr Dis Control & Prevent Uganda, Global AIDS Program, Natl Ctr HIV Viral Hepatitis Sexually Transmitted, Entebbe, Uganda; [Moore, David] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Coutinho, Alex] AIDS Support Org, Kampala, Uganda	Kenya Medical Research Institute; University of British Columbia	Mermin, J (corresponding author), Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, Coordinating Off Global Hlth, Mbagathi Rd, Nairobi, Kenya.	jhm7@cdc.gov	Mermin, Jonathan/J-9847-2012					Akileswaran C, 2005, CLIN INFECT DIS, V41, P376, DOI 10.1086/431482; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Braga P, 2007, AIDS PATIENT CARE ST, V21, P321, DOI 10.1089/apc.2006.0111; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Calmy A, 2004, AIDS, V18, P2353; Colebunders R, 2005, PLOS MED, V2, P941, DOI 10.1371/journal.pmed.0020276; El-Ghannam Ashraf Ragab, 2003, J Health Soc Policy, V16, P1, DOI 10.1300/J045v16n04_01; Hardin JW, 2012, GEN ESTIMATING EQUAT; IWASA S, PLANNING HLTH INFRAS; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Laurent C, 2005, CLIN INFECT DIS, V41, P108, DOI 10.1086/430712; Losina E, 2007, ANTIVIR THER, V12, P543; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Nduati R, 2001, LANCET, V357, P1651, DOI 10.1016/S0140-6736(00)04820-0; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; PAPPAS G, 2006, AIDS PUBLIC POLICY J, V19, P75; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Spacek LA, 2006, CLIN INFECT DIS, V42, P252, DOI 10.1086/499044; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Walker AS, 2007, CLIN INFECT DIS, V44, P1361, DOI 10.1086/515396; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; WHO, WORK TOG HLTH WORLD; *WHO UNAIDS, AIDS EP UPD 2006; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea	33	144	149	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					752	759		10.1016/S0140-6736(08)60345-1	http://dx.doi.org/10.1016/S0140-6736(08)60345-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313504				2022-12-28	WOS:000253596700029
J	Robinson, M; Clark, P				Robinson, Mary; Clark, Peggy			Forging solutions to health worker migration	LANCET			English	Article									[Robinson, Mary; Clark, Peggy] Aspen Inst, Hlth Worker Migrat Global Policy Advisory Council, Washington, DC 20036 USA	Aspen Institute	Clark, P (corresponding author), Aspen Inst, Hlth Worker Migrat Global Policy Advisory Council, Washington, DC 20036 USA.	peggy.clark@aspeninst.org						CONNELL J, 2007, REV PRACTICE MEMORAN; OECD, 2007, INT MIGRATION OUTLOO, P161; *REAL RIGHTS, 2006, GHAN HLTH WORK MIGR; Sullivan P, 1999, CAN MED ASSOC J, V160, P1615; *UK NURS MIDW COUN, 2000, ANN STAT; *WHO, 2006, WORK TOG HLTH WORLD, P192	6	24	26	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2008	371	9613					691	693		10.1016/S0140-6736(08)60310-4	http://dx.doi.org/10.1016/S0140-6736(08)60310-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LL	18295029				2022-12-28	WOS:000253436700036
J	Wang, F; Zhang, YB; Tian, CS; Girit, C; Zettl, A; Crommie, M; Shen, YR				Wang, Feng; Zhang, Yuanbo; Tian, Chuanshan; Girit, Caglar; Zettl, Alex; Crommie, Michael; Shen, Y. Ron			Gate-variable optical transitions in graphene	SCIENCE			English	Article							CARBON NANOTUBES; BILAYER GRAPHENE; DIRAC FERMIONS; BERRYS PHASE	Two-dimensional graphene monolayers and bilayers exhibit fascinating electrical transport behaviors. Using infrared spectroscopy, we find that they also have strong interband transitions and that their optical transitions can be substantially modified through electrical gating, much like electrical transport in field-effect transistors. This gate dependence of interband transitions adds a valuable dimension for optically probing graphene band structure. For a graphene monolayer, it yields directly the linear band dispersion of Dirac fermions, whereas in a bilayer, it reveals a dominating van Hove singularity arising from interlayer coupling. The strong and layer-dependent optical transitions of graphene and the tunability by simple electrical gating hold promise for new applications in infrared optics and optoelectronics.	[Wang, Feng; Zhang, Yuanbo; Tian, Chuanshan; Girit, Caglar; Zettl, Alex; Crommie, Michael; Shen, Y. Ron] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Girit, Caglar; Zettl, Alex; Crommie, Michael; Shen, Y. Ron] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wang, F (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	fengwang76@berkeley.edu	Tian, Chuanshan/GWV-3067-2022; Zettl, Alex K/O-4925-2016; Chuanshan, Tian/AFN-8634-2022; Girit, Çağlar/D-4845-2014; wang, Feng/I-5727-2015; Girit, Çağlar/AFT-1507-2022	Tian, Chuanshan/0000-0003-3341-1378; Zettl, Alex K/0000-0001-6330-136X; Chuanshan, Tian/0000-0003-3341-1378; Girit, Çağlar/0000-0001-8953-9261; wang, Feng/0000-0001-8369-6194; Girit, Çağlar/0000-0001-8953-9261				ABERGEL DSL, 2007, ARXIVORGABSCONDMAT06; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Bostwick A, 2007, NAT PHYS, V3, P36, DOI 10.1038/nphys477; Casiraghi C, 2007, NANO LETT, V7, P2711, DOI 10.1021/nl071168m; CASTRO EV, 2006, ARXIVORGABSCONDMAT06; FALKOVSKY L, 2006, ARXIVORGABSCONDMAT06; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Gusynin VP, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.256802; Huard B, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.236803; Jiang Z, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.197403; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; MCCANN E, 2006, ARXIVORGABSCONDMAT06; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Wang F, 2005, SCIENCE, V308, P838, DOI 10.1126/science.1110265; Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657; Yan J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.166802; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhou SY, 2007, NAT MATER, V6, P770, DOI 10.1038/nmat2003; Zhou SY, 2006, NAT PHYS, V2, P595, DOI 10.1038/nphys393	22	1281	1311	23	663	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2008	320	5873					206	209		10.1126/science.1152793	http://dx.doi.org/10.1126/science.1152793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18339901				2022-12-28	WOS:000254836700036
J	Montgomery, TA; Howell, MD; Cuperus, JT; Li, DW; Hansen, JE; Alexander, AL; Chapman, EJ; Fahlgren, N; Allen, E; Carrington, JC				Montgomery, Taiowa A.; Howell, Miya D.; Cuperus, Josh T.; Li, Dawei; Hansen, Jesse E.; Alexander, Amanda L.; Chapman, Elisabeth J.; Fahlgren, Noah; Allen, Edwards; Carrington, James C.			Specificity of ARGONAUTE7-miR390 interaction and dual functionality in TAS3 trans-acting siRNA formation	CELL			English	Article							DEPENDENT RNA-POLYMERASE; ARABIDOPSIS-THALIANA; MESSENGER-RNAS; BIOGENESIS; MICRORNAS; PATHWAY; PLANTS; MIRNA; SPECIALIZATION; IDENTIFICATION	Trans-acting siRNA form through a refined RNAi mechanism in plants. miRNA-guided cleavage triggers entry of precursor transcripts into an RNA-DEPENDENT RNA POLYMERASE6 pathway, and sets the register for phased tasiRNA formation by DICER-LIKE4. Here, we show that miR390-ARGONAUTE7 complexes function in distinct cleavage or noncleavage modes at two target sites in TAS3a transcripts. The AGO7 cleavage, but not the noncleavage, function could be provided by AGO1, the dominant miRNA-associated AGO, but only when AGO1 was guided to a modified target site through an alternate miRNA. AGO7 was highly selective for interaction with miR390, and miR390 in turn was excluded from association with AGO1 due entirely to an incompatible 50 adenosine. Analysis of AGO1, AGO2, and AGO7 revealed a potent 50 nucleotide discrimination function for some, although not all, ARGONAUTEs. miR390 and AGO7, therefore, evolved as a highly specific miRNA guide/effector protein pair to function at two distinct tasiRNA biogenesis steps.	[Montgomery, Taiowa A.; Howell, Miya D.; Cuperus, Josh T.; Hansen, Jesse E.; Alexander, Amanda L.; Chapman, Elisabeth J.; Fahlgren, Noah; Allen, Edwards; Carrington, James C.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Montgomery, Taiowa A.; Cuperus, Josh T.; Chapman, Elisabeth J.; Fahlgren, Noah] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA; [Howell, Miya D.; Allen, Edwards; Carrington, James C.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Li, Dawei] China Agr Univ, State Key Lab Agro Biotechnol, Beijing 100094, Peoples R China	Oregon State University; Oregon State University; Oregon State University; China Agricultural University	Carrington, JC (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	carrington@cgrb.oregonstate.edu	Li, Dawei/I-8751-2016; Carrington, James C/A-4656-2012; Fahlgren, Noah/D-4404-2011	Li, Dawei/0000-0003-4133-1263; Carrington, James C/0000-0003-3572-129X; Fahlgren, Noah/0000-0002-5597-4537; Cuperus, Josh/0000-0002-8019-7733; Allen, Edwards/0000-0002-8318-6319; Montgomery, Taiowa/0000-0001-7857-3253	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI043288, R01AI043288, R37AI043288] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43288] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Forsyth D, 1907, Q J MED, V1, P287; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hunter C, 2003, CURR BIOL, V13, P1734, DOI 10.1016/j.cub.2003.09.004; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Talmor-Neiman M, 2006, PLANT J, V48, P511, DOI 10.1111/j.1365-313X.2006.02895.x; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	48	556	602	6	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2008	133	1					128	141		10.1016/j.cell.2008.02.033	http://dx.doi.org/10.1016/j.cell.2008.02.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18342362	Bronze			2022-12-28	WOS:000254641300014
J	Strippoli, GFM; Navaneethan, SD; Johnson, DW; Perkovic, V; Pellegrini, F; Nicolucci, A; Craig, JC				Strippoli, Giovanni F. M.; Navaneethan, Sankar D.; Johnson, David W.; Perkovic, Vlado; Pellegrini, Fabio; Nicolucci, Antonio; Craig, Jonathan C.			Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PLACEBO-CONTROLLED TRIAL; COENZYME-A REDUCTASE; RENAL-TRANSPLANT RECIPIENTS; C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; TYPE-2 DIABETES-MELLITUS; ISCHEMIC-HEART-DISEASE; LOW-DOSE SIMVASTATIN; HEMODIALYSIS-PATIENTS; NEPHROTIC SYNDROME	Objective To analyse the benefits and harms of statins in patients with chronic kidney disease (pre-dialysis, dialysis, and transplant populations). Design Meta-analysis. Data sources Cochrane Central Register of Controlled Trials, Medline, Embase, and Renal Health Library (July 2006). Study selection Randomised and quasi-randomised controlled trials of statins compared with placebo or other statins in chronic kidney disease. Data extraction and analysis Two reviewers independently assessed trials for inclusion, extracted data, and assessed trial quality. Differences were resolved by consensus. Treatment effects were summarised as relative risks or weighted mean differences with 95% confidence intervals by using a random effects model. Results Fifty trials (30 144 patients) were included. Compared with placebo, statins significantly reduced total cholesterol (42 studies, 6390 patients; weighted mean difference -42.28 mg/dl (1.10 mmol/1), 95% confidence interval -47.25 to -37.32), low density lipoprotein cholesterol (39 studies, 6216 patients; -43.12 mg/dl (1.12 mmol/1), -47.85 to -38.40), and proteinuria (g/24 hours) (6 trials, 311 patients; -0.73 g/24 hour, -0.95 to -0.52) but did not improve glomerular filtration rate (11 studies, 548 patients; 1.48 ml/min (0.02 ml/s), -2.32 to 5.28). Fatal cardiovascular events (43 studies, 23 266 patients; relative risk 0.81, 0.73 to 0.90) and non-fatal cardiovascular events (8 studies, 22 863 patients; 0.78, 0.73 to 0.84) were reduced with statins, but statins had no significant effect on all cause mortality (44 studies, 23 665 patients; 0.92, 0.82 to 1.03). Meta-regression analysis showed that treatment effects did not vary significantly with stage of chronic kidney disease. The side effect profile of statins was similar to that of placebo. Most of the available studies were small and of suboptimal quality; mortality data were provided by a few large trials only. Conclusion Statins significantly reduce lipid concentrations and cardiovascular end points in patients with chronic kidney disease, irrespective of stage of disease, but no benefit on all cause mortality or the role of statins in primary prevention has been established. Reno-protective effects of statins are uncertain because of relatively sparse data and possible outcomes reporting bias.	[Navaneethan, Sankar D.] Univ Rochester, Div Nephrol, Rochester, NY 14623 USA; [Strippoli, Giovanni F. M.; Craig, Jonathan C.] Univ Sydney, Sch Publ Hlth, NHMRC Ctr Clin Res Excellence Renal Med, Sydney, NSW 2006, Australia; [Strippoli, Giovanni F. M.; Pellegrini, Fabio; Nicolucci, Antonio] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Santa Maria Imbaro, Italy; [Strippoli, Giovanni F. M.; Craig, Jonathan C.] Cochrane Renal Grp, Sydney, NSW, Australia; [Johnson, David W.] Univ Queensland, Brisbane, Qld, Australia; [Perkovic, Vlado] George Inst Int Hlth, Sydney, NSW, Australia	University of Rochester; University of Sydney; Consorzio Mario Negri Sud; University of Queensland; University of Sydney	Navaneethan, SD (corresponding author), Univ Rochester, Div Nephrol, 601 Elmwood Ave,Box 675, Rochester, NY 14623 USA.	sankardass@hotmail.com	Craig, Jonathan/E-2813-2013; Johnson, David/F-2897-2011; Perkovic, Vlado/AAY-1933-2021	Craig, Jonathan/0000-0002-2548-4035; Johnson, David/0000-0001-5491-3460; Perkovic, Vlado/0000-0002-4257-7620; Strippoli, Giovanni/0000-0002-6936-0616				ARNADOTTIR M, 1994, NEPHRON, V68, P57, DOI 10.1159/000188088; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Baigent C, 2005, AM J KIDNEY DIS, V45, P473, DOI 10.1053/j.ajkd.2004.11.015; Baigent C, 2003, KIDNEY INT, V63, pS207, DOI 10.1046/j.1523-1755.63.s84.4.x; Bianchi S, 2003, AM J KIDNEY DIS, V41, P565, DOI 10.1053/ajkd.2003.50140; Buemi M, 2000, CLIN PHARMACOL THER, V67, P427, DOI 10.1067/mcp.2000.105330; Campese VM, 2005, J AM SOC NEPHROL, V16, pS11, DOI 10.1681/ASN.2004110958; CASTELAO AM, 1993, TRANSPLANT P, V25, P1043; Chang JW, 2002, AM J KIDNEY DIS, V39, P1213, DOI 10.1053/ajkd.2002.33393; Cofan F, 2002, TRANSPL P, V34, P389, DOI 10.1016/S0041-1345(01)02814-7; Collins R, 2003, LANCET, V361, P2005; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Costa J, 2006, BMJ-BRIT MED J, V332, P1115, DOI 10.1136/bmj.38793.468449.AE; Dalla Nora E, 2003, J ENDOCRINOL INVEST, V26, P73, DOI 10.1007/BF03345126; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diepeveen SHA, 2005, J INTERN MED, V257, P438, DOI 10.1111/j.1365-2796.2005.01484.x; Dornbrook-Lavender KA, 2005, PHARMACOTHERAPY, V25, P335, DOI 10.1592/phco.25.3.335.61599; Douglas K, 2006, ANN INTERN MED, V145, P117, DOI 10.7326/0003-4819-145-2-200607180-00009; EBPG Expert Group on Renal Transplantation, 2002, Nephrol Dial Transplant, V17 Suppl 4, P26; Fellstrom BC, 2003, KIDNEY INT, V63, pS204, DOI 10.1046/j.1523-1755.63.s84.10.x; Foley RN, 2007, J AM SOC NEPHROL, V18, P2644, DOI 10.1681/ASN.2007020220; Fried LF, 2001, J DIABETES COMPLICAT, V15, P113, DOI 10.1016/S1056-8727(01)00140-4; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Gheith OA, 2002, NEPHRON, V91, P612, DOI 10.1159/000065021; HALSTENSON CE, 1992, J CLIN PHARMACOL, V32, P124, DOI 10.1002/j.1552-4604.1992.tb03816.x; Harris KPG, 2002, KIDNEY INT, V61, P1469, DOI 10.1046/j.1523-1755.2002.00262.x; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; HERNANDEZ BEM, 1993, NEPHROL DIAL TRANSPL, V8, P637; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Holdaas H, 2001, KIDNEY INT, V60, P1990, DOI 10.1046/j.1523-1755.2001.00010.x; Holmberg B, 2005, SCAND J UROL NEPHROL, V39, P503, DOI 10.1080/00365590510031255; HOMMEL E, 1992, DIABETOLOGIA, V35, P447, DOI 10.1007/BF02342442; Ichihara A, 2002, NEPHROL DIAL TRANSPL, V17, P1513, DOI 10.1093/ndt/17.8.1513; Imai Y, 1999, CLIN EXP HYPERTENS, V21, P1345, DOI 10.3109/10641969909070853; Jungers P, 1997, NEPHROL DIAL TRANSPL, V12, P2597, DOI 10.1093/ndt/12.12.2597; *K DOQI, 2003, AM J KIDNEY DIS S, V41, pS39; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Kasiske BL, 2001, TRANSPLANTATION, V72, P223, DOI 10.1097/00007890-200107270-00009; Katznelson S, 1996, TRANSPLANTATION, V61, P1469, DOI 10.1097/00007890-199605270-00010; Keane WF, 2000, KIDNEY INT, V57, pS27, DOI 10.1046/j.1523-1755.2000.07503.x; Kinlay S, 2003, AM J CARDIOL, V91, p9B, DOI 10.1016/S0002-9149(02)03268-X; Kong SXD, 1997, CLIN THER, V19, P778, DOI 10.1016/S0149-2918(97)80102-6; Kosch M, 2003, AM J KIDNEY DIS, V41, P1088, DOI 10.1016/S0272-6386(03)00207-5; LAM KSL, 1995, DIABETOLOGIA, V38, P604, DOI 10.1007/s001250050326; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lee TM, 2005, KIDNEY INT, V68, P779, DOI 10.1111/j.1523-1755.2005.00457.x; Lee TM, 2002, HYPERTENSION, V40, P67, DOI 10.1161/01.HYP.0000022805.11288.7F; Lemos PA, 2005, AM J CARDIOL, V95, P445, DOI 10.1016/j.amjcard.2004.10.008; Lepre F, 1999, CLIN TRANSPLANT, V13, P520, DOI 10.1034/j.1399-0012.1999.130613.x; Lin J, 2006, KIDNEY INT, V69, P336, DOI 10.1038/sj.ki.5000021; Lins RL, 2004, CLIN NEPHROL, V62, P287; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; Mallamaci F, 2002, KIDNEY INT, V61, P609, DOI 10.1046/j.1523-1755.2002.00144.x; MASSY ZA, 1995, KIDNEY INT, V48, P188, DOI 10.1038/ki.1995.284; Nakamura T, 2002, NEPHROL DIAL TRANSPL, V17, P798, DOI 10.1093/ndt/17.5.798; National Kidney Foundation, 2000, K DOQI CLIN PRACT GU; NAVANEETHAN SD, 2004, COCHRANE DB SYST REV; NIELSEN S, 1993, DIABETOLOGIA, V36, P1079, DOI 10.1007/BF02374502; Paczek L, 1997, Pol Arch Med Wewn, V97, P144; PEDERSEN TR, 1994, LANCET, V344, P1383; Rayner BL, 1996, CLIN NEPHROL, V46, P219; *REN ASS, 2007, CLIN PRACT GUID MOD; Renders L, 2001, NEPHROL DIAL TRANSPL, V16, P141, DOI 10.1093/ndt/16.1.141; Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085; ROSSOUW JE, 1990, NEW ENGL J MED, V323, P1112, DOI 10.1056/NEJM199010183231606; Sahu KM, 2001, CLIN TRANSPLANT, V15, P173, DOI 10.1034/j.1399-0012.2001.150305.x; Saltissi D, 2002, AM J KIDNEY DIS, V39, P283, DOI 10.1053/ajkd.2002.30547; Sandhu S, 2006, J AM SOC NEPHROL, V17, P2006, DOI 10.1681/ASN.2006010012; Santos AF, 2001, TRANSPL P, V33, P1194, DOI 10.1016/S0041-1345(00)02382-4; SCANFERLA F, 1991, AM J HYPERTENS, V4, P868, DOI 10.1093/ajh/4.10.868; Seliger SL, 2002, KIDNEY INT, V61, P297, DOI 10.1046/j.1523-1755.2002.00109.x; Sica DA, 2002, CURR OPIN NEPHROL HY, V11, P123, DOI 10.1097/00041552-200203000-00001; Sotiriou CG, 2000, ANN PHARMACOTHER, V34, P1432; Stern RH, 1997, J CLIN PHARMACOL, V37, P816, DOI 10.1002/j.1552-4604.1997.tb05629.x; THOMAS ME, 1993, KIDNEY INT, V44, P1124, DOI 10.1038/ki.1993.358; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; Tonolo G, 1997, DIABETES CARE, V20, P1891, DOI 10.2337/diacare.20.12.1891; Tuncer M, 2000, TRANSPLANT P, V32, P622, DOI 10.1016/S0041-1345(00)00921-0; United States Rena Data System, 2007, MORT CAUS DEATH; van Dijk MA, 2001, NEPHROL DIAL TRANSPL, V16, P2152, DOI 10.1093/ndt/16.11.2152; Verma A, 2005, AM J CARDIOL, V96, P1290, DOI 10.1016/j.amjcard.2005.06.074; WALKER R, 2005, LIPID LOWERING PATIE; Walker RJ, 1997, NEPHROL DIAL TRANSPL, V12, P87, DOI 10.1093/ndt/12.1.87; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; WHEELER DC, 1994, AM J KIDNEY DIS, V23, P331, DOI 10.1016/S0272-6386(12)80994-2; Yasuda G, 2004, RENAL FAILURE, V26, P411, DOI 10.1081/JDI-120039826; ZHANG A, 1995, DIABETES RES CLIN PR, V29, P189, DOI 10.1016/0168-8227(95)01138-2	89	312	323	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2008	336	7645					645	651		10.1136/bmj.39472.580984.AE	http://dx.doi.org/10.1136/bmj.39472.580984.AE			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RH	18299289	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000254443400024
J	Hochella, MF; Lower, SK; Maurice, PA; Penn, RL; Sahai, N; Sparks, DL; Twining, BS				Hochella, Michael F., Jr.; Lower, Steven K.; Maurice, Patricia A.; Penn, R. Lee; Sahai, Nita; Sparks, Donald L.; Twining, Benjamin S.			Nanominerals, mineral nanoparticles, and Earth systems	SCIENCE			English	Review							COLLOIDAL IRON; NORTH-ATLANTIC; SIZE; TRANSPORT; CYCLE; NANODIAMONDS; FERRIHYDRITE; ASSOCIATION; REACTIVITY; PLUTONIUM	Minerals are more complex than previously thought because of the discovery that their chemical properties vary as a function of particle size when smaller, in at least one dimension, than a few nanometers, to perhaps as much as several tens of nanometers. These variations are most likely due, at least in part, to differences in surface and near- surface atomic structure, as well as crystal shape and surface topography as a function of size in this smallest of size regimes. It has now been established that these variations may make a difference in important geochemical and biogeochemical reactions and kinetics. This recognition is broadening and enriching our view of how minerals influence the hydrosphere, pedosphere, biosphere, and atmosphere.	[Hochella, Michael F., Jr.] Virginia Polytech Inst & State Univ, Ctr Nanobioearth, Dept Geosci, Blacksburg, VA 24061 USA; [Lower, Steven K.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Lower, Steven K.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Maurice, Patricia A.] Univ Notre Dame, Dept Civil Engn & Geol Sci, Notre Dame, IN 46556 USA; [Penn, R. Lee] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Sahai, Nita] Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; [Sparks, Donald L.] Univ Delaware, Dept Plant & Soil Sci, Ctr Crit Zone Res, Newark, DE 19717 USA; [Twining, Benjamin S.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	Virginia Polytechnic Institute & State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Notre Dame; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Delaware; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Hochella, MF (corresponding author), Virginia Polytech Inst & State Univ, Ctr Nanobioearth, Dept Geosci, Blacksburg, VA 24061 USA.	hochella@vt.edu	Lower, Steven/A-2440-2008	Lower, Steven/0000-0001-9796-0830; Twining, Benjamin/0000-0002-1365-9192				Anschutz AJ, 2005, GEOCHEM T, V6, P60, DOI 10.1063/1.2037887; Banfield J.F, 2001, NANOPARTICLES ENV; Bell JF, 2000, J GEOPHYS RES-PLANET, V105, P1721, DOI 10.1029/1999JE001060; Bergquist BA, 2007, GEOCHIM COSMOCHIM AC, V71, P2960, DOI 10.1016/j.gca.2007.03.013; Biskos G, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025199; BOSE S, 232 NAT M AM CHEM SO; Dai ZR, 2002, NATURE, V418, P157, DOI 10.1038/nature00897; Dor O, 2006, EARTH PLANET SC LETT, V245, P642, DOI 10.1016/j.epsl.2006.03.034; Gilbert B, 2005, REV MINERAL GEOCHEM, V59, P109, DOI 10.2138/rmg.2005.59.6; Gilbert B, 2004, SCIENCE, V305, P651, DOI 10.1126/science.1098454; GREEN HW, 1989, NATURE, V341, P733, DOI 10.1038/341733a0; Hochella MF, 2005, AM MINERAL, V90, P718, DOI 10.2138/am.2005.1591; Hochella MF, 1999, GEOCHIM COSMOCHIM AC, V63, P3395, DOI 10.1016/S0016-7037(99)00260-4; Junk PC, 2002, J CHEM SOC DALTON, P1024, DOI 10.1039/b105691n; Luther GW, 2005, J NANOPART RES, V7, P389, DOI 10.1007/s11051-005-4272-4; Madden AS, 2006, GEOCHIM COSMOCHIM AC, V70, P4095, DOI 10.1016/j.gca.2006.06.1366; Madden AS, 2005, GEOCHIM COSMOCHIM AC, V69, P389, DOI 10.1016/j.gca.2004.06.035; Michel FM, 2007, SCIENCE, V316, P1726, DOI 10.1126/science.1142525; MOLINA MJ, 1987, SCIENCE, V238, P1253, DOI 10.1126/science.238.4831.1253; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; Murr LE, 2003, ATMOS ENVIRON, V37, P4795, DOI 10.1016/j.atmosenv.2003.08.009; Navrotsky A, 2001, REV MINERAL GEOCHEM, V44, P73, DOI 10.2138/rmg.2001.44.03; Navrotsky A, 2008, SCIENCE, V319, P1635, DOI 10.1126/science.1148614; Navrotsky A, 2007, J CHEM THERMODYN, V39, P1, DOI 10.1016/j.jct.2006.09.011; Nishioka J, 2001, MAR CHEM, V74, P157, DOI 10.1016/S0304-4203(01)00013-5; Nodwell LM, 2001, LIMNOL OCEANOGR, V46, P765, DOI 10.4319/lo.2001.46.4.0765; Novikov AP, 2006, SCIENCE, V314, P638, DOI 10.1126/science.1131307; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; ODowd CD, 1997, ATMOS ENVIRON, V31, P73, DOI 10.1016/S1352-2310(96)00106-9; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; PENROSE WR, 1990, ENVIRON SCI TECHNOL, V24, P228, DOI 10.1021/es00072a012; Poulton SW, 2005, CHEM GEOL, V218, P203, DOI 10.1016/j.chemgeo.2005.01.007; Poulton SW, 2002, AM J SCI, V302, P774, DOI 10.2475/ajs.302.9.774; Prospero JM, 2003, SCIENCE, V302, P1024, DOI 10.1126/science.1089915; Raiswell R, 2006, GEOCHIM COSMOCHIM AC, V70, P2765, DOI 10.1016/j.gca.2005.12.027; RICH HW, 1990, LIMNOL OCEANOGR, V35, P652, DOI 10.4319/lo.1990.35.3.0652; Rosso KM, 2003, J CHEM PHYS, V119, P9207, DOI 10.1063/1.1612912; SAHAI N, 2006, MED MINERALOGY GEOCH; Sahai N, 2007, GEOCHIM COSMOCHIM AC, V71, P3193, DOI 10.1016/j.gca.2007.04.008; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; Smith KL, 2007, SCIENCE, V317, P478, DOI 10.1126/science.1142834; Tang RK, 2004, J MATER CHEM, V14, P2341, DOI 10.1039/b401097c; Tegen I, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019216; Utsunomiya S, 2004, ENVIRON SCI TECHNOL, V38, P2289, DOI 10.1021/es035010p; Verchovsky AB, 2006, ASTROPHYS J, V651, P481, DOI 10.1086/507176; Waychunas GA, 2005, J NANOPART RES, V7, P409, DOI 10.1007/s11051-005-6931-x; WELLS ML, 1994, LIMNOL OCEANOGR, V39, P286, DOI 10.4319/lo.1994.39.2.0286; WELLS ML, 1992, MAR CHEM, V40, P5, DOI 10.1016/0304-4203(92)90045-C; WELLS ML, 1991, NATURE, V353, P342, DOI 10.1038/353342a0; Wigginton NS, 2007, J ENVIRON MONITOR, V9, P1306, DOI 10.1039/b712709j; Wilson B, 2005, NATURE, V434, P749, DOI 10.1038/nature03433; Wu JF, 2001, SCIENCE, V293, P847, DOI 10.1126/science.1059251; Zheng M, 2005, ATMOS ENVIRON, V39, P3967, DOI 10.1016/j.atmosenv.2005.03.036	53	623	641	20	543	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2008	319	5870					1631	1635		10.1126/science.1141134	http://dx.doi.org/10.1126/science.1141134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356515				2022-12-28	WOS:000254172300029
J	Abramson, JS; Almquist, JR; Jenkins, RR; Bocchini, JA; Davis, RM; Langston, EL; Hale, RW; Gall, SA				Abramson, Jon S.; Almquist, Jon R.; Jenkins, Renee R.; Bocchini, Joseph A., Jr.; Davis, Ronald M.; Langston, Edward L.; Hale, Ralph W.; Gall, Stanley A.			Prioritisation of routine vaccines: a mistake for the USA	LANCET			English	Editorial Material							UNITED-STATES; CHILDREN		[Almquist, Jon R.] Amer Acad Pediat, Task Force Immunizat, Elk Grove Village, IL 60007 USA; [Abramson, Jon S.] Wake Forest Univ, Dept Paediat, Winston Salem, NC 27109 USA; [Bocchini, Joseph A., Jr.] Amer Acad Pediat, Comm Infect Dis, Elk Grove Village, IL 60007 USA; [Davis, Ronald M.; Langston, Edward L.] Amer Med Assoc, Board Trustees, Chicago, IL 60610 USA; [Hale, Ralph W.; Gall, Stanley A.] Amer Coll Obstetricians & Gynecologists, Working Grp Immunizat, Washington, DC USA	American Academy of Pediatrics; Wake Forest University; American Academy of Pediatrics; American Medical Association	Almquist, JR (corresponding author), Amer Acad Pediat, Task Force Immunizat, Elk Grove Village, IL 60007 USA.	jonralmquist@msn.com						Davis MM, 2007, JAMA-J AM MED ASSOC, V298, P680, DOI 10.1001/jama.298.6.680; Freed GL, 2005, HEALTH AFFAIR, V24, P755, DOI 10.1377/hlthaff.24.3.755; Lee GM, 2007, JAMA-J AM MED ASSOC, V298, P638, DOI 10.1001/jama.298.6.638; Orenstein WA, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00290-X; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Wooten K. G., 2007, Morbidity and Mortality Weekly Report, V56, P880	6	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 15	2008	371	9616					881	882		10.1016/S0140-6736(08)60394-3	http://dx.doi.org/10.1016/S0140-6736(08)60394-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342670				2022-12-28	WOS:000254056800009
J	Lip, GYH				Lip, Gregory Y. H.			Change page - Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation	BRITISH MEDICAL JOURNAL			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; PLUS ASPIRIN; THERAPY; ANTIPLATELET; WARFARIN; METAANALYSIS; CLOPIDOGREL; PREVENTION; EFFICACY; EVENTS		[Lip, Gregory Y. H.] City Hosp, Univ Dept Med, Birmingham B18 7QH, W Midlands, England	University of Birmingham	Lip, GYH (corresponding author), City Hosp, Univ Dept Med, Birmingham B18 7QH, W Midlands, England.	g.y.h.lip@bham.ac.uk						Andreotti F, 2006, EUR HEART J, V27, P519, DOI 10.1093/eurheartj/ehi485; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Dentali F, 2007, ARCH INTERN MED, V167, P117, DOI 10.1001/archinte.167.2.117; Flaker GC, 2006, AM HEART J, V152, P967, DOI 10.1016/j.ahj.2006.06.024; Karjalainen PP, 2007, EUR HEART J, V28, P726, DOI 10.1093/eurheartj/ehl488; Khurram Zakaria, 2006, J Invasive Cardiol, V18, P162; Lechat P, 2001, CEREBROVASC DIS, V12, P245, DOI 10.1159/000047711; Lip GYH, 2006, THROMB RES, V118, P429, DOI 10.1016/j.thromres.2005.09.012; Lip GYH, 2006, CHEST, V130, P1823, DOI 10.1378/chest.130.6.1823; Lip GYH, 2006, HEART, V92, P155, DOI 10.1136/hrt.2005.066944; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Orford JL, 2004, AM HEART J, V147, P463, DOI 10.1016/j.ahj.2003.06.004; Perez-Gomez F, 2004, J AM COLL CARDIOL, V44, P1557, DOI 10.1016/j.jacc.2004.05.084; Porter A, 2006, CATHETER CARDIO INTE, V68, P56, DOI 10.1002/ccd.20733; Shireman TI, 2004, STROKE, V35, P2362, DOI 10.1161/01.STR.0000141933.75462.c2	15	42	46	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 15	2008	336	7644					614	615		10.1136/bmj.39351.706586.AD	http://dx.doi.org/10.1136/bmj.39351.706586.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18340078	Green Published			2022-12-28	WOS:000254364500038
J	Fusi, S				Fusi, Stefano			Neuroscience - A quiescent working memory	SCIENCE			English	Editorial Material									[Fusi, Stefano] Columbia Univ Coll Phys & Surg, Ctr Theoret Neurosci, New York, NY 10032 USA; [Fusi, Stefano] Univ Zurich, ETH, Inst Neuroinformat, CH-8057 Zurich, Switzerland	Columbia University; ETH Zurich; University of Zurich	Fusi, S (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Theoret Neurosci, 630 W 168th St, New York, NY 10032 USA.	sf2237@columbia.edu	Fusi, Stefano/E-9109-2011	Fusi, Stefano/0000-0002-3035-6652				AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; Baddeley A.D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3	9	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1495	1496		10.1126/science.1155914	http://dx.doi.org/10.1126/science.1155914			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339929				2022-12-28	WOS:000253943800028
J	Dustin, ML				Dustin, Michael L.			Synaptic asymmetry to go	CELL			English	Editorial Material							CELL DIVISIONS; PROTEINS; POLARITY; GROWTH	Cell polarity is critical for T lymphocyte movement during their hunt for antigen-bearing cells and for infected target cells. In this issue of Cell, Yeh et al. (2008) now reveal a direct link between T cell polarity and the production of proinflammatory cytokines in mice lacking the class I MHC-restricted T cell-associated molecule (Crtam).	NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Dustin, ML (corresponding author), NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389				Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9	10	5	6	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					733	734		10.1016/j.cell.2008.02.016	http://dx.doi.org/10.1016/j.cell.2008.02.016			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329360	Bronze			2022-12-28	WOS:000253818000011
J	Sokol, DK				Sokol, Daniel K.			The dilemma of authorship	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Univ London St Georges Hosp, London WC1E 7HU, England	St Georges University London	Sokol, DK (corresponding author), Univ London St Georges Hosp, London WC1E 7HU, England.	daniel.sokol@talk21.com							0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 1	2008	336	7642					478	478		10.1136/bmj.39500.620174.94	http://dx.doi.org/10.1136/bmj.39500.620174.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18310001	Green Published			2022-12-28	WOS:000253997500037
J	Armitage, BA; Berget, PB				Armitage, Bruce A.; Berget, Peter B.			Chemistry - An enlightening structure-function relationship	SCIENCE			English	Editorial Material									[Armitage, Bruce A.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Armitage, Bruce A.; Berget, Peter B.] Carnegie Mellon Univ, MBIC, Pittsburgh, PA 15213 USA; [Berget, Peter B.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Armitage, BA (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.	army@cmu.edu; berget@cmu.edu	Armitage, Bruce/B-6333-2017	Armitage, Bruce/0000-0003-0109-1461; Berget, Peter/0000-0002-4502-2647				Babendure JR, 2003, J AM CHEM SOC, V125, P14716, DOI 10.1021/ja037994o; Debler EW, 2008, SCIENCE, V319, P1232, DOI 10.1126/science.1153445; Kaufmann GF, 2005, ANGEW CHEM INT EDIT, V44, P2144, DOI 10.1002/anie.200461143; Matsushita H, 2005, MOL BIOSYST, V1, P303, DOI 10.1039/b511408j; Matsushita M, 2005, ORG LETT, V7, P4943, DOI 10.1021/ol051919w; Matsushita M, 2003, ANGEW CHEM INT EDIT, V42, P5984, DOI 10.1002/anie.200352793; MATTES SL, 1984, SCIENCE, V226, P917, DOI 10.1126/science.226.4677.917; SALTIEL J, 1990, STUD ORG CHEM, V40, P64; Simeonov A, 2000, SCIENCE, V290, P307, DOI 10.1126/science.290.5490.307; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Tian T, 2006, ANGEW CHEM INT EDIT, V45, P7763, DOI 10.1002/anie.200602720	11	7	7	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1195	1196		10.1126/science.1155093	http://dx.doi.org/10.1126/science.1155093			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309067				2022-12-28	WOS:000253530600023
J	Hu, JJ; Shibata, Y; Voss, C; Shemesh, T; Li, ZL; Coughlin, M; Kozlov, MM; Rapoport, TA; Prinz, WA				Hu, Junjie; Shibata, Yoko; Voss, Christiane; Shemesh, Tom; Li, Zongli; Coughlin, Margaret; Kozlov, Michael M.; Rapoport, Tom A.; Prinz, William A.			Membrane proteins of the endoplasmic reticulum induce high-curvature tubules	SCIENCE			English	Article							MITOCHONDRIAL FUSION; DYNAMIN; DOMAIN; ENDOCYTOSIS; ENDOPHILIN; AMPHIPHYSIN; MECHANISM; FISSION; RINGS	The tubular structure of the endoplasmic reticulum ( ER) appears to be generated by integral membrane proteins, the reticulons and a protein family consisting of DP1 in mammals and Yop1p in yeast. Here, individual members of these families were found to be sufficient to generate membrane tubules. When we purified yeast Yop1p and incorporated it into proteoliposomes, narrow tubules (similar to 15 to 17 nanometers in diameter) were generated. Tubule formation occurred with different lipids; required essentially only the central portion of the protein, including its two long hydrophobic segments; and was prevented by mutations that affected tubule formation in vivo. Tubules were also formed by reconstituted purified yeast Rtn1p. Tubules made in vitro were narrower than normal ER tubules, due to a higher concentration of tubule- inducing proteins. The shape and oligomerization of the "morphogenic" proteins could explain the formation of the tubular ER.	[Hu, Junjie; Shibata, Yoko; Rapoport, Tom A.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Hu, Junjie; Shibata, Yoko; Li, Zongli; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Voss, Christiane; Prinz, William A.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Shemesh, Tom; Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Coughlin, Margaret] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu; wprinz@helix.nih.gov	Shemesh, Tom/J-5060-2013; Hu, Junjie/F-9713-2013; Li, Zongli/AAB-9100-2020		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK060105, ZIADK060105] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gallop JL, 2005, NATURE, V438, P675, DOI 10.1038/nature04136; Griffin EE, 2006, J BIOL CHEM, V281, P16599, DOI 10.1074/jbc.M601847200; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tolley N, 2008, TRAFFIC, V9, P94, DOI 10.1111/j.1600-0854.2007.00670.x; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047	23	310	315	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1247	1250		10.1126/science.1153634	http://dx.doi.org/10.1126/science.1153634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309084				2022-12-28	WOS:000253530600045
J	Calis, JCJ; Phiri, KS; Faragher, EB; Brabin, BJ; Bates, I; Cuevas, LE; de Haan, RJ; Phiri, AI; Malange, P; Khoka, M; Hulshof, PJM; van Lieshout, L; Beld, MGHM; Teo, YY; Rockett, KA; Richardson, A; Kwiatkowski, DP; Molyneux, ME; van Hensbroek, MB				Calis, Job C. J.; Phiri, Kamija S.; Faragher, E. Brian; Brabin, Bernard J.; Bates, Imelda; Cuevas, Luis E.; de Haan, Rob J.; Phiri, Ajib I.; Malange, Pelani; Khoka, Mirriam; Hulshof, Paul J. M.; van Lieshout, Lisette; Beld, Marcel G. H. M.; Teo, Yik Y.; Rockett, Kirk A.; Richardson, Anna; Kwiatkowski, Dominic P.; Molyneux, Malcolm E.; van Hensbroek, Michael Boele			Severe anemia in Malawian children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VITAMIN-A SUPPLEMENTATION; YOUNG-CHILDREN; SALMONELLA BACTEREMIA; PLASMODIUM-FALCIPARUM; ANCYLOSTOMA-DUODENALE; NECATOR-AMERICANUS; BLOOD-TRANSFUSION; SEVERE MALARIA; IRON STATUS; FOLIC-ACID	Background Severe anemia is a major cause of sickness and death in African children, yet the causes of anemia in this population have been inadequately studied. Methods We conducted a case-control study of 381 preschool children with severe anemia (hemoglobin concentration, <5.0 g per deciliter) and 757 preschool children without severe anemia in urban and rural settings in Malawi. Causal factors previously associated with severe anemia were studied. The data were examined by multivariate analysis and structural equation modeling. Results Bacteremia (adjusted odds ratio, 5.3; 95% confidence interval [CI], 2.6 to 10.9), malaria (adjusted odds ratio, 2.3; 95% CI, 1.6 to 3.3), hookworm (adjusted odds ratio, 4.8; 95% CI, 2.0 to 11.8), human immunodeficiency virus infection (adjusted odds ratio, 2.0; 95% CI, 1.0 to 3.8), the G6PD(sup -202/-376) genetic disorder (adjusted odds ratio, 2.4; 95% CI, 1.3 to 4.4), vitamin A deficiency (adjusted odds ratio, 2.8; 95% CI, 1.3 to 5.8), and vitamin B(sub 12) deficiency (adjusted odds ratio, 2.2; 95% CI, 1.4 to 3.6) were associated with severe anemia. Folate deficiency, sickle cell disease, and laboratory signs of an abnormal inflammatory response were uncommon. Iron deficiency was not prevalent in case patients (adjusted odds ratio, 0.37; 95% CI, 0.22 to 0.60) and was negatively associated with bacteremia. Malaria was associated with severe anemia in the urban site (with seasonal transmission) but not in the rural site (where malaria was holoendemic). Seventy-six percent of hookworm infections were found in children under 2 years of age. Conclusions There are multiple causes of severe anemia in Malawian preschool children, but folate and iron deficiencies are not prominent among them. Even in the presence of malaria parasites, additional or alternative causes of severe anemia should be considered.	[Calis, Job C. J.; Brabin, Bernard J.; van Hensbroek, Michael Boele] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Global Child Hlth Grp, NL-1105 AZ Amsterdam, Netherlands; [Calis, Job C. J.; Phiri, Kamija S.; Phiri, Ajib I.; Malange, Pelani; Khoka, Mirriam; Molyneux, Malcolm E.; van Hensbroek, Michael Boele] Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [de Haan, Rob J.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; [Beld, Marcel G. H. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol, NL-1105 AZ Amsterdam, Netherlands; [Faragher, E. Brian; Brabin, Bernard J.; Bates, Imelda; Cuevas, Luis E.; Molyneux, Malcolm E.; van Hensbroek, Michael Boele] Univ Liverpool, Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England; [Hulshof, Paul J. M.] Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands; [van Lieshout, Lisette] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Teo, Yik Y.; Rockett, Kirk A.; Richardson, Anna; Kwiatkowski, Dominic P.] Wellcome Trust Ctr Human Genet, Oxford, England	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Malawi; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Liverpool School of Tropical Medicine; University of Liverpool; Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford; Wellcome Centre for Human Genetics	Calis, JCJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Global Child Hlth Grp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	job.calis@gmail.com	Swinkels, Dorine W./H-8098-2014; van der Ven, A.J.A.M./H-8102-2014; Cuevas, Luis E/I-3697-2015; Brabin, Bernard/AAJ-7389-2020; de Mast, Quirijn/H-3427-2015	Swinkels, Dorine W./0000-0002-1040-9446; van der Ven, A.J.A.M./0000-0003-1833-3391; Cuevas, Luis E/0000-0002-6581-0587; Phiri, Kamija/0000-0003-1753-2727; bates, imelda/0000-0002-0862-8199; Boele van Hensbroek, Michael/0000-0003-1907-5427; Kwiatkowski, Dominic/0000-0002-5023-0176; Hulshof, Paul/0000-0003-3260-2658; Brabin, Bernard/0000-0001-6860-2508	MRC [G19/9, G0600230] Funding Source: UKRI; Medical Research Council [G0600230, G19/9] Funding Source: Medline; Wellcome Trust [064722] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ABDALLA SH, 1990, ANN TROP PAEDIATR, V10, P265, DOI 10.1080/02724936.1990.11747441; Albonico M, 1998, INT J EPIDEMIOL, V27, P530, DOI 10.1093/ije/27.3.530; Arbuckle J. L., 2007, AMOS 6 0 USERS GUIDE; Biemba G, 2000, TROP MED INT HEALTH, V5, P9, DOI 10.1046/j.1365-3156.2000.00506.x; BIERI JG, 1979, AM J CLIN NUTR, V32, P2143, DOI 10.1093/ajcn/32.10.2143; Boom R, 1999, J CLIN MICROBIOL, V37, P1489, DOI 10.1128/JCM.37.5.1489-1497.1999; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; de Gruijter JM, 2005, TROP MED INT HEALTH, V10, P574, DOI 10.1111/j.1365-3156.2005.01440.x; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; Dicko A, 2004, BLOOD, V104, P1198, DOI 10.1182/blood-2003-11-3884; Dierkes J, 1999, METABOLISM, V48, P631, DOI 10.1016/S0026-0495(99)90062-8; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; GALE E, 1963, J CLIN INVEST, V42, P1076, DOI 10.1172/JCI104793; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; KATZ N, 1970, J PARASITOL, V56, P1032, DOI 10.2307/3277532; Koppelman MHGM, 2004, TRANSFUSION, V44, P97, DOI 10.1046/j.0041-1132.2004.00610.x; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; Kurtzhals J, 1999, LANCET, V353, P848; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; Kurtzhals JAL, 1998, LANCET, V352, P242; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; May J, 2000, J INFECT DIS, V182, P1570, DOI 10.1086/315857; Molyneux E, 2004, ARCH DIS CHILD, V89, P395, DOI 10.1136/adc.2003.025890corr1; Molyneux EM, 2003, ARCH DIS CHILD, V88, P1112, DOI 10.1136/adc.88.12.1112; MURRAY MJ, 1978, BRIT MED J, V2, P1113, DOI 10.1136/bmj.2.6145.1113; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Savage DG, 1999, AM J MED SCI, V317, P22, DOI 10.1097/00000441-199901000-00004; Sazawal S, 2006, LANCET, V367, P302; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Shaker Z A, 1994, J Egypt Soc Parasitol, V24, P656; Shankar AH, 1999, LANCET, V354, P203, DOI 10.1016/S0140-6736(98)08293-2; SOMMER A, 1983, LANCET, V2, P585; Sullivan AD, 1996, PARASITOLOGY, V112, P285, DOI 10.1017/S003118200006580X; van den Broek NR, 2000, AM J CLIN NUTR, V72, p247S, DOI 10.1093/ajcn/72.1.247S; van den Broek NR, 1998, BRIT J HAEMATOL, V103, P817, DOI 10.1046/j.1365-2141.1998.01035.x; vandenHombergh J, 1996, J TROP PEDIATRICS, V42, P220, DOI 10.1093/tropej/42.4.220; vanHensbroek MB, 1995, T ROY SOC TROP MED H, V89, P672, DOI 10.1016/0035-9203(95)90438-7; Villamor E, 2000, AM J TROP MED HYG, V62, P590, DOI 10.4269/ajtmh.2000.62.590; WHO, 2001, IRON DEFICIENCY ANAE; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; World Health Organization, 1998, GUID US IR SUPPL PRE	46	249	254	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					888	899		10.1056/NEJMoa072727	http://dx.doi.org/10.1056/NEJMoa072727			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18305266	Green Published			2022-12-28	WOS:000253430200004
J	Cross, M				Cross, Michael			Wallet or web?	BRITISH MEDICAL JOURNAL			English	Editorial Material												michaelcross@fastmail.fm						Cross Michael, 2007, BMJ, V334, P772, DOI 10.1136/bmj.39171.643368.47; HANNAN A, 2008, J COMMUNICATION HEAL, V1, P7	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 22	2008	336	7645					637	638		10.1136/bmj.39518.411146.AD	http://dx.doi.org/10.1136/bmj.39518.411146.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RH	18356229	Green Published			2022-12-28	WOS:000254443400020
J	Kahane, G; Shackel, N				Kahane, Guy; Shackel, Nicholas			Do abnormal responses show utilitarian bias?	NATURE			English	Letter							MORAL JUDGMENT		[Kahane, Guy] Univ Oxford, Oxford Uehiro Ctr Pract Eth, Oxford OX1 1PT, England; [Shackel, Nicholas] Cardiff Univ, Dept Philosophy, ENCAP, Cardiff CF10 3EU, Wales; [Shackel, Nicholas] Univ Oxford, Future Human Inst, Fac Philosophy, Oxford OX1 1PT, England; [Shackel, Nicholas] Univ Oxford, Future Human Inst, James Martin 21 Century Sch, Oxford OX1 1PT, England	University of Oxford; Cardiff University; University of Oxford; University of Oxford	Kahane, G (corresponding author), Univ Oxford, Oxford Uehiro Ctr Pract Eth, Oxford OX1 1PT, England.	shackeln@cardiff.ac.uk		Shackel, Nicholas/0000-0002-1751-1400; Kahane, Guy/0000-0002-6490-3247	NINDS NIH HHS [P01 NS019632-230003, P01 NS019632] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 2005, J ETHICS, DOI DOI 10.1007/S10892-005-3508-Y; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631	6	33	33	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					E5	E5		10.1038/nature06785	http://dx.doi.org/10.1038/nature06785			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354427	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000254117400035
J	Minto, C; Myers, RA; Blanchard, W				Minto, Coilin; Myers, Ransom A.; Blanchard, Wade			Survival variability and population density in fish populations	NATURE			English	Article							MARINE DEMERSAL FISH; DEPENDENCE; RECRUITMENT; MORTALITY; TIME; COD; AGE	To understand the processes that regulate the abundance and persistence of wild populations is a fundamental goal of ecology and a prerequisite for the management of living resources. Variable abundance data, however, make the demonstration of regulation processes challenging(1-3). A previously overlooked aspect in understanding how populations are regulated(4-6) is the possibility that the pattern of variability - its strength as a function of population size - may be more than 'noise', thus revealing much about the characteristics of population regulation. Here we show that patterns in survival variability do provide evidence of regulation through density. Using a large, global compilation of marine, anadromous and freshwater fisheries data, we examine the relationship between the variability of survival and population abundance. The interannual variability in progeny survival increases at low adult abundance in an inversely density- dependent fashion. This pattern is consistent with models in which density dependence enters after the larval stage. The findings are compatible with very simple forms of density dependence: even a linear increase of juvenile mortality with adult density adequately explains the results. The model predictions explain why populations with strong regulation may experience large increases in variability at low densities(7). Furthermore, the inverse relationship between survival variability and the strength of density dependence has important consequences for fisheries management and recovery, and population persistence or extinction(8-10).	[Minto, Coilin] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Blanchard, Wade] Dalhousie Univ, Dept Math & Stat, Halifax, NS B3H 3J5, Canada	Dalhousie University; Dalhousie University	Minto, C (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.	mintoc@mathstat.dal.ca		Minto, Coilin/0000-0003-0630-6775				Berryman AA, 2002, OIKOS, V99, P600, DOI 10.1034/j.1600-0706.2002.12106.x; Boer PJ, 1996, REGULATION STABILIZA; DERISO RB, 1980, CAN J FISH AQUAT SCI, V37, P268, DOI 10.1139/f80-034; Drake JM, 2005, PLOS BIOL, V3, P1300, DOI 10.1371/journal.pbio.0030222; GODFRAY HCJ, 1992, NATURE, V359, P673, DOI 10.1038/359673a0; HASSELL MP, 1989, J ANIM ECOL, V58, P883, DOI 10.2307/5130; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; HUTCHINGS JA, 1993, CAN J FISH AQUAT SCI, V50, P2468, DOI 10.1139/f93-271; Lande R., 2003, OXFORD SERIES ECOLOG; LEIGH EG, 1981, J THEOR BIOL, V90, P213; Manly B., 1990, STAGE STRUCTURED POP; MAY RMC, 1973, STABILITY COMPLEXITY, pCH2; Mertz G., 1994, Fisheries Oceanography, V3, P236, DOI 10.1111/j.1365-2419.1994.tb00101.x; Mertz G, 1996, CAN J FISH AQUAT SCI, V53, P1618, DOI 10.1139/cjfas-53-7-1618; MERTZ G, 1995, FISH B-NOAA, V93, P657; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Murray BG, 1999, OIKOS, V84, P148, DOI 10.2307/3546875; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1591, DOI 10.1139/f93-180; MYERS RA, 1995, SCIENCE, V269, P1106, DOI 10.1126/science.269.5227.1106; Myers RA, 2001, ICES J MAR SCI, V58, P937, DOI 10.1006/jmsc.2001.1109; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; Myers RA, 1995, CAN TECH REP FISH AQ, V2024, P1; Ord K., 1987, KENDALLS ADV THEORY, V1; PETERMAN RM, 1981, CAN J FISH AQUAT SCI, V38, P1113, DOI 10.1139/f81-151; Rosenberg AA, 2005, FRONT ECOL ENVIRON, V3, P84, DOI 10.2307/3868514; Saether BE, 1998, AM NAT, V151, P441, DOI 10.1086/286131; Sale PF, 2000, OECOLOGIA, V124, P166, DOI 10.1007/s004420050003; SCHNUTE J, 1985, CAN J FISH AQUAT SCI, V42, P414, DOI 10.1139/f85-057; Shenk TM, 1998, ECOL MONOGR, V68, P445, DOI 10.1890/0012-9615(1998)068[0445:SVEODD]2.0.CO;2; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; WOLDA H, 1993, OECOLOGIA, V95, P581, DOI 10.1007/BF00317444	33	81	82	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					344	U6		10.1038/nature06605	http://dx.doi.org/10.1038/nature06605			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354480				2022-12-28	WOS:000254117400045
J	Lindbaek, M; Butler, CC				Lindbaek, Morten; Butler, Christopher C.			Antibiotics for sinusitis-like symptoms in primary care	LANCET			English	Editorial Material							INDIVIDUAL PATIENT DATA; ACUTE RHINOSINUSITIS; GENERAL-PRACTICE; METAANALYSES; RESISTANCE; THERAPY		[Lindbaek, Morten] Univ Oslo, Antibiot Ctr Primary Care, N-0317 Oslo, Norway; [Butler, Christopher C.] Cardiff Univ, Dept Publ Hlth & Primary Care, Ctr Hlth Sci Res, Sch Med, Cardiff, Wales	University of Oslo; Cardiff University	Lindbaek, M (corresponding author), Univ Oslo, Antibiot Ctr Primary Care, N-0317 Oslo, Norway.	morten.lindbak@medisin.uio.no	Butler, Christopher C/B-5048-2009	Butler, Christopher/0000-0002-0102-3453				AHSEE K, 2005, CLIN EVID, V13, P646; Bjerrum L, 2004, BRIT J GEN PRACT, V54, P659; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hickner JM, 2001, ANN EMERG MED, V37, P703; Koopman L, 2007, J CLIN EPIDEMIOL, V60, P1002, DOI 10.1016/j.jclinepi.2007.01.018; Lindbaek M, 2004, DRUGS, V64, P805, DOI 10.2165/00003495-200464080-00002; Lindbaek M, 2002, BRIT J GEN PRACT, V52, P491; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS32, DOI 10.1016/j.otohns.2007.06.724; Rovers MM, 2006, LANCET, V368, P1429, DOI 10.1016/S0140-6736(06)69606-2; Simpson SA, 2007, J ANTIMICROB CHEMOTH, V59, P292, DOI [10.1093/jac/dk1467, 10.1093/jac/dkl467]; Wood F, 2007, FAM PRACT, V24, P427, DOI 10.1093/fampra/cmm040; Young J, 2008, LANCET, V371, P908, DOI 10.1016/S0140-6736(08)60416-X	13	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 15	2008	371	9616					874	876		10.1016/S0140-6736(08)60390-6	http://dx.doi.org/10.1016/S0140-6736(08)60390-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342666				2022-12-28	WOS:000254056800005
J	Spiegelman, J; Detsky, AS				Spiegelman, Jamie; Detsky, Allan S.			Instant mobile communication, efficiency, and quality of life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Spiegelman, Jamie; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 427-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Bresnahan TF, 2002, Q J ECON, V117, P339, DOI 10.1162/003355302753399526; *EC INT UN, 2004, COMM MOB WORK WORLD; Hobson CJ, 2001, J EMPLOYMENT COUNS, V38, P38, DOI 10.1002/j.2161-1920.2001.tb00491.x; JARVENPAA SL, 2006, ISM              FAL, P7; KOCK N, 2001, COMMUNICATIONS ASS I, V5, P1; LEVY P, 2006, BLACKBERRY COLD TURK; Mazmanian MA, 2005, INT FED INFO PROC, V185, P337; Middleton CA, 2006, EUR J INFORM SYST, V15, P252, DOI 10.1057/palgrave.ejis.3000614; MOKYR J, 2002, GIFTS ATHENA HIST OR; Rennecker J., 2005, Information and Organization, V15, P247, DOI 10.1016/j.infoandorg.2005.02.004; Rosen Christine, 2004, NEW ATLANTIS, P26; Rosman K., 2006, WALL STREET J   1208, pW1; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386	13	12	12	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2008	299	10					1179	1181		10.1001/jama.299.10.1179	http://dx.doi.org/10.1001/jama.299.10.1179			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272CE	18334693				2022-12-28	WOS:000253835000021
J	Suda, T; Arai, F				Suda, Toshio; Arai, Fumio			Wnt signaling in the niche	CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELL	There is much interest in understanding the signals in the bone marrow niche that keep hematopoietic stem cells (HSCs) in a quiescent state. In the current issue of Cell Stem Cell, Fleming et al. (2008) report that blocking Wnt signaling in the niche increases the number of proliferating HSCs and reduces their ability to reconstitute the hematopoietic system of irradiated recipient mice. These findings show that Wnt/beta-catenin activity is crucial for the maintenance of HSC quiescence in the bone marrow niche.	[Suda, Toshio; Arai, Fumio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Suda, T (corresponding author), Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	sudato@sc.itc.keio.ac.jp	Arai, Fumio/J-5241-2013	Arai, Fumio/0000-0003-1936-4907				Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Nishikawa SI, 2007, PIGM CELL RES, V20, P263, DOI 10.1111/j.1600-0749.2007.00388.x; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	10	38	43	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					729	730		10.1016/j.cell.2008.02.017	http://dx.doi.org/10.1016/j.cell.2008.02.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329358	Bronze			2022-12-28	WOS:000253818000009
J	Fitzpatrick, M				Fitzpatrick, Michael			Medicine and the media - From hero to zero	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												fitz@easynet.co.uk						Boyce T., 2008, HLTH RISK NEWS MMR V	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2008	336	7642					479	479		10.1136/bmj.39492.664225.0F	http://dx.doi.org/10.1136/bmj.39492.664225.0F			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	274JL	18310002	Green Published			2022-12-28	WOS:000253997500038
J	Tobias, DJ; Hemminger, JC				Tobias, Douglas J.; Hemminger, John C.			Chemistry - Getting specific about specific ion effects	SCIENCE			English	Editorial Material							MOLECULAR-DYNAMICS; WATER; INTERFACES; ANIONS		[Tobias, Douglas J.; Hemminger, John C.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Tobias, Douglas J.; Hemminger, John C.] Univ Calif Irvine, AirUCI Environm Mol Sci Inst, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Tobias, DJ (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.	dtobias@uci.edu; jchemmin@uci.edu	Tobias, Douglas J/B-6799-2015					Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Chen X, 2007, J AM CHEM SOC, V129, P12272, DOI 10.1021/ja073869r; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; Ghosal S, 2005, SCIENCE, V307, P563, DOI 10.1126/science.1106525; Gopalakrishnan S, 2006, CHEM REV, V106, P1155, DOI 10.1021/cr040361n; Gopalakrishnan S, 2005, J PHYS CHEM B, V109, P8861, DOI 10.1021/jp0500236; Hofmeister F., 1888, ARCH EXP PATHOL PHAR, V25, P1, DOI DOI 10.1007/BF01838161; Jungwirth P, 2006, CHEM REV, V106, P1259, DOI 10.1021/cr0403741; Krisch MJ, 2007, J PHYS CHEM C, V111, P13497, DOI 10.1021/jp073078b; Kunz W, 2004, CURR OPIN COLLOID IN, V9, P1, DOI 10.1016/j.cocis.2004.05.004; Mancinelli R, 2007, J PHYS CHEM B, V111, P13570, DOI 10.1021/jp075913v; Omta AW, 2003, SCIENCE, V301, P347, DOI 10.1126/science.1084801; Pegram LM, 2007, J PHYS CHEM B, V111, P5411, DOI 10.1021/jp070245z; Petersen PB, 2006, ANNU REV PHYS CHEM, V57, P333, DOI 10.1146/annurev.physchem.57.032905.104609; Smith JD, 2007, J AM CHEM SOC, V129, P13847, DOI 10.1021/ja071933z; Thomas JL, 2007, J PHYS CHEM A, V111, P3091, DOI 10.1021/jp0683972; Vrbka L, 2006, J PHYS CHEM B, V110, P7036, DOI 10.1021/jp0567624; Zangi R, 2007, J AM CHEM SOC, V129, P4678, DOI 10.1021/ja068305m	18	271	278	6	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1197	1198		10.1126/science.1152799	http://dx.doi.org/10.1126/science.1152799			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309069				2022-12-28	WOS:000253530600025
J	Bawaskar, HS; Bawaskar, PH				Bawaskar, Himmatrao Saluba; Bawaskar, Pramodini Himmatrao			Snakebite, cocktails, and a girl with a stomach ache	LANCET			English	Editorial Material									[Bawaskar, Himmatrao Saluba; Bawaskar, Pramodini Himmatrao] Bawaskar Hosp & Res Ctr, Mahad 402301, Maharashtra, India		Bawaskar, HS (corresponding author), Bawaskar Hosp & Res Ctr, Mahad 402301, Maharashtra, India.	himmatbawaskar@rediffmail.com						Bawaskar HS, 2004, WILD ENVIRON MED, V15, P257; Bawaskar HS, 2002, T ROY SOC TROP MED H, V96, P79, DOI 10.1016/S0035-9203(02)90250-6; Seneviratne U, 2002, J Postgrad Med, V48, P275; Warrell DA., 2005, GUIDELINES CLIN MANA	4	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2008	371	9613					696	696		10.1016/S0140-6736(08)60312-8	http://dx.doi.org/10.1016/S0140-6736(08)60312-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LL	18295031				2022-12-28	WOS:000253436700038
J	Parson, AB				Parson, Ann B.			Stem cell biotech: Seeking a piece of the action	CELL			English	Editorial Material								Venture capital groups and big pharma have largely held back from investing in biotech companies focused on regenerative medicine. Will it take a clinical bull's eye to bring venture capitalists and big pharma into the cell therapy arena?											0	22	28	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					511	513		10.1016/j.cell.2008.02.004	http://dx.doi.org/10.1016/j.cell.2008.02.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295564	Bronze			2022-12-28	WOS:000253817900006
J	Lin, K; Watkins, B; Johnson, T; Rodriguez, JA; Barton, MB				Lin, Kenneth; Watkins, Bradley; Johnson, Tamara; Rodriguez, Joy Anne; Barton, Mary B.			Screening for chronic obstructive pulmonary disease using spirometry: Summary of the evidence for the US preventive services task force	ANNALS OF INTERNAL MEDICINE			English	Article							SMOKING-CESSATION; INHALED CORTICOSTEROIDS; CARDIOVASCULAR SAFETY; NUTRITION-EXAMINATION; RANDOMIZED-TRIAL; GENERAL-PRACTICE; NATIONAL-HEALTH; OXYGEN-THERAPY; CLINICAL-TRIAL; BETA-AGONISTS	Background: Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States. Fewer than half of the estimated 24 million Americans with airflow obstruction have received a COPD diagnosis, and diagnosis often occurs in advanced stages of the disease. Purpose: To summarize the evidence on screening for COPD using spirometry for the U.S. Preventive Services Task Force (USPSTF). Data Sources: English-language articles identified in PubMed and the Cochrane Library through January 2007, recent systematic reviews, expert suggestions, and reference lists of retrieved articles. Study Selection: Explicit inclusion and exclusion criteria were used for each of the 8 key questions on benefits and harms of screening. Eligible study types varied by question. Data Extraction: Studies were reviewed, abstracted, and rated for quality by using predefined USPSTF criteria. Data Synthesis: Pharmacologic treatments for COPD reduce acute exacerbations in patients with severe disease. However, severe COPD is uncommon in the general U.S. population. Spirometry has not been shown to independently increase smoking cessation rates. Potential harms from screening include false-positive results and adverse effects from subsequent unnecessary therapy. Data on the prevalence of airflow obstruction in the U.S. population were used to calculate projected outcomes from screening groups defined by age and smoking status. Limitation: No studies provide direct evidence on health outcomes associated with screening for COPD. Conclusion: Screening for COPD using spirometry is likely to identify a predominance of patients with mild to moderate airflow obstruction who would not experience additional health benefits if labeled as having COPD. Hundreds of patients would need to undergo spirometry to defer a single exacerbation.	[Lin, Kenneth] Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnerships, Rockville, MD 20850 USA; Washington DC Vet Affairs Med Ctr, Washington, DC USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Brooks Air Force Base, Brooks AFB, TX USA	Agency for Healthcare Research & Quality; University System of Maryland; University of Maryland Baltimore	Lin, K (corresponding author), Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnerships, 540 Gaither Rd, Rockville, MD 20850 USA.	kenneth.lin@ahrq.hhs.gov						Alfageme I, 2006, THORAX, V61, P189, DOI 10.1136/thx.2005.043323; Alsaeedi A, 2002, AM J MED, V113, P59, DOI 10.1016/S0002-9343(02)01143-9; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P333, DOI 10.1164/rccm.2110093; Barr RG, 2006, THORAX, V61, P854, DOI 10.1136/thx.2006.063271; Barr RG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002876.pub2; Bize R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004705.pub2; Buffels J, 2006, RESP MED, V100, P2012, DOI 10.1016/j.rmed.2006.02.014; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Chaouat A, 1999, EUR RESPIR J, V14, P1002, DOI 10.1183/09031936.99.14510029; Ferguson G T, 2000, Respir Care, V45, P513; Ferguson GT, 2003, CHEST, V123, P1817, DOI 10.1378/chest.123.6.1817; FIELDS CL, 1993, CHEST, V103, P1006, DOI 10.1378/chest.103.4.1006; Gartlehner G, 2006, ANN FAM MED, V4, P253, DOI 10.1370/afm.517; Global Initiative for Chronic Obstructive Lung Disease, 2007, GLOB STRAT DIAGN MAN; Gorecka D, 1997, THORAX, V52, P674, DOI 10.1136/thx.52.8.674; Grange R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001390.pub2; Halpern MT, 2004, ANN ALLERG ASTHMA IM, V92, P201, DOI 10.1016/S1081-1206(10)61548-7; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Kesten S, 2006, CHEST, V130, P1695, DOI 10.1378/chest.130.6.1695; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Lacasse Y, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003793.PUB2; Mannino DM, 2000, ARCH INTERN MED, V160, P1683, DOI 10.1001/archinte.160.11.1683; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; Poole PJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002733.pub2; Salpeter SR, 2006, J GEN INTERN MED, V21, P1011, DOI 10.1111/j.1525-1497.2006.00507.x; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Salpeter SR, 2004, DRUG AGING, V21, P405, DOI 10.2165/00002512-200421060-00005; SEGNAN N, 1991, CANCER CAUSE CONTROL, V2, P239, DOI 10.1007/BF00052140; Sestini P, 2002, COCHRANE DB SYST REV; Sin DD, 2005, THORAX, V60, P992, DOI 10.1136/thx.2005.045385; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; VEDAL S, 1983, B EUR PHYSIOPATH RES, V19, P263; WALKER WB, 1985, BEHAV THER, V16, P263, DOI 10.1016/S0005-7894(85)80014-9; Wilt TJ, 2007, ANN INTERN MED, V147, P639, DOI 10.7326/0003-4819-147-9-200711060-00009; Wilt TJ, 2007, NICOTINE TOB RES, V9, P21, DOI 10.1080/14622200601078509; Wilt TJ, 2005, AHRQ PUBLICATION	36	97	100	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2008	148	7					535	543		10.7326/0003-4819-148-7-200804010-00213	http://dx.doi.org/10.7326/0003-4819-148-7-200804010-00213			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284IV	18316746				2022-12-28	WOS:000254701000006
J	Sorensen, HT; Christensen, S; Mehnert, F; Pedersen, L; Chapurlat, RD; Cummings, SR; Baron, JA				Sorensen, Henrik Toft; Christensen, Steffen; Mehnert, Frank; Pedersen, Lars; Chapurlat, Roland D.; Cummings, Steven R.; Baron, John A.			Use of bisphosphonates among women and risk of atrial-fibrillation and flutter: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OSTEOPOROSIS; EPIDEMIOLOGY; COHORT	Objective To assess the association between atrial fibrillation and flutter and use of bisphosphonates for osteoporosis among women. Design Population based case-control study, using medical databases from Denmark. Setting Northern Denmark. Participants 13 586 patients with atrial fibrillation and flutter and 68 054 population controls, all with complete hospital and prescription history. Main outcome measure Adjusted relative risk of atrial fibrillation and flutter. Results 435 cases (3.2%) and 1958 population controls (2.9%) were current users of bisphosphonates for osteoporosis. Etidronate and alendronate were used with almost the same frequency among cases and controls. The adjusted relative risk of current use of bisphosphonates compared with non-use was 0.95 (95% confidence interval 01.84 to 1.07). New users had a relative risk of 0.75 (0.49 to 1.16), broadly similar to the estimate for continuing users (relative risk 0.96, 95% confidence interval 0.85 to 1.09). The relative risk estimates were independent of number of prescriptions and the position of the atrial fibrillation and flutter diagnosis in the discharge record, and were similar for inpatients and outpatients. Conclusion No evidence was found that use of bisphosphonates increases the risk of atrial fibrillation and flutter.	[Sorensen, Henrik Toft; Christensen, Steffen; Mehnert, Frank; Pedersen, Lars] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark; [Chapurlat, Roland D.] Univ Lyon 1, INSERM Res Unit 831, Dept Orthoped & Rheumatol, Hop Edouard Herriot, Lyon, France; [Cummings, Steven R.] San Francisco Coordinating Ctr, San Francisco, CA USA; [Baron, John A.] Dartmouth Med Sch, Dept Med, Hanover, NH USA; [Baron, John A.] Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH USA	Aarhus University; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; California Pacific Medical Center; California Pacific Medical Center Research Institute; Dartmouth College; Dartmouth College	Sorensen, HT (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Olof Palmes Alle 43-45, DK-8200 Aarhus N, Denmark.	hts@dce.au.dk	CHAPURLAT, ROLAND/AAU-1165-2021; Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Mehnert, Frank/0000-0001-7639-7356				Andersen TF, 1999, DAN MED BULL, V46, P263; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Kannel WB, 2008, MED CLIN N AM, V92, P17, DOI 10.1016/j.mcna.2007.09.002; Karam R, 2007, NEW ENGL J MED, V357, P712; KYLES KW, 2007, NEW ENGL J MED, V357, P1799; Poole KES, 2007, NEW ENGL J MED, V357, P711; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sorensen HT, 2006, ALIMENT PHARM THER, V24, P111, DOI 10.1111/j.1365-2036.2006.02959.x; Sorensen H T, 1997, Int J Risk Saf Med, V10, P1, DOI 10.3233/JRS-1997-10101; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Thomsen RW, 2005, BRIT J CLIN PHARMACO, V60, P534, DOI 10.1111/j.1365-2125.2005.02494.x; Woolf AD, 2003, BMJ-BRIT MED J, V327, P89, DOI 10.1136/bmj.327.7406.89	16	117	124	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR	2008	336	7648					813	816		10.1136/bmj.39507.551644.BE	http://dx.doi.org/10.1136/bmj.39507.551644.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292ER	18334527	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000255249800044
J	Rosenband, T; Hume, DB; Schmidt, PO; Chou, CW; Brusch, A; Lorini, L; Oskay, WH; Drullinger, RE; Fortier, TM; Stalnaker, JE; Diddams, SA; Swann, WC; Newbury, NR; Itano, WM; Wineland, DJ; Bergquist, JC				Rosenband, T.; Hume, D. B.; Schmidt, P. O.; Chou, C. W.; Brusch, A.; Lorini, L.; Oskay, W. H.; Drullinger, R. E.; Fortier, T. M.; Stalnaker, J. E.; Diddams, S. A.; Swann, W. C.; Newbury, N. R.; Itano, W. M.; Wineland, D. J.; Bergquist, J. C.			Frequency ratio of Al+ and Hg+ single-ion optical clocks; Metrology at the 17th decimal place	SCIENCE			English	Article							NOBEL LECTURE; TRAPPED ION; LASER; UNCERTAINTY; SPECTROSCOPY; LINEWIDTHS; STANDARD; LEVEL	Time has always had a special status in physics because of its fundamental role in specifying the regularities of nature and because of the extraordinary precision with which it can be measured. This precision enables tests of fundamental physics and cosmology, as well as practical applications such as satellite navigation. Recently, a regime of operation for atomic clocks based on optical transitions has become possible, promising even higher performance. We report the frequency ratio of two optical atomic clocks with a fractional uncertainty of 5.2 x 10(-17). The ratio of aluminum and mercury single- ion optical clock frequencies nu(Al+)/nu(Hg+) is 1.052871833148990438( 55), where the uncertainty comprises a statistical measurement uncertainty of 4.3 x 10(-17), and systematic uncertainties of 1.9 x 10(-17) and 2.3 x 10(-17) in the mercury and aluminum frequency standards, respectively. Repeated measurements during the past year yield a preliminary constraint on the temporal variation of the fine- structure constant alpha of alpha/alpha = (-1.6 +/- 2. 3) x 10(-17)/year.	[Rosenband, T.; Hume, D. B.; Schmidt, P. O.; Chou, C. W.; Brusch, A.; Lorini, L.; Oskay, W. H.; Drullinger, R. E.; Fortier, T. M.; Stalnaker, J. E.; Diddams, S. A.; Swann, W. C.; Newbury, N. R.; Itano, W. M.; Wineland, D. J.; Bergquist, J. C.] Natl Inst Stand & Technol, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Rosenband, T (corresponding author), Natl Inst Stand & Technol, 325 Broadway, Boulder, CO 80305 USA.	trosen@boulder.nist.gov	Brusch, Anders/B-1027-2011; Itano, Wayne/AAV-8781-2020; Diddams, Scott A/L-2819-2013; Schmidt, Piet/F-6384-2011	Diddams, Scott A/0000-0002-2144-0764; Schmidt, Piet/0000-0003-0773-5889; Newbury, Nathan/0000-0002-4932-2153				Angstmann EJ, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.014102; BERGQUIST JC, 1987, PHYS REV A, V36, P428, DOI 10.1103/PhysRevA.36.428; Berkeland DJ, 1998, J APPL PHYS, V83, P5025, DOI 10.1063/1.367318; Bernard JE, 1998, OPT COMMUN, V150, P170, DOI 10.1016/S0030-4018(98)00121-7; Coddington I, 2007, NAT PHOTONICS, V1, P283, DOI 10.1038/nphoton.2007.71; DEHMELT HG, 1982, IEEE T INSTRUM MEAS, V31, P83, DOI 10.1109/TIM.1982.6312526; Deslauriers L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.103007; DICKE RH, 1953, PHYS REV, V89, P472, DOI 10.1103/PhysRev.89.472; Diddams SA, 2001, SCIENCE, V293, P825, DOI 10.1126/science.1061171; Dzuba VA, 1999, PHYS REV A, V59, P230, DOI 10.1103/PhysRevA.59.230; Fortier TM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.070801; Fortier TM, 2006, OPT LETT, V31, P1011, DOI 10.1364/OL.31.001011; Hansch TW, 2006, REV MOD PHYS, V78, P1297, DOI 10.1103/RevModPhys.78.1297; Hall JL, 2006, REV MOD PHYS, V78, P1279, DOI 10.1103/RevModPhys.78.1279; Hume DB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120502; Itano WM, 2000, J RES NATL INST STAN, V105, P829, DOI 10.6028/jres.105.065; Jefferts SR, 2007, PROC SPIE, V6673, DOI 10.1117/12.734965; Katori H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.173005; Ma LS, 2004, SCIENCE, V303, P1843, DOI 10.1126/science.1095092; Oskay WH, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.020801; Oskay WH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.163001; Pavlis NK, 2003, METROLOGIA, V40, P66, DOI 10.1088/0026-1394/40/2/311; Rosenband T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.220801; SALOMON C, 1988, J OPT SOC AM B, V5, P1576, DOI 10.1364/JOSAB.5.001576; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Stalnaker JE, 2007, APPL PHYS B-LASERS O, V89, P167, DOI 10.1007/s00340-007-2762-z; Swann WC, 2006, OPT LETT, V31, P3046, DOI 10.1364/OL.31.003046; Turchette QA, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063418; WINELAND DJ, 1987, PHYS REV A, V36, P2220, DOI 10.1103/PhysRevA.36.2220; Young BC, 1999, PHYS REV LETT, V82, P3799, DOI 10.1103/PhysRevLett.82.3799	30	1081	1105	4	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2008	319	5871					1808	1812		10.1126/science.1154622	http://dx.doi.org/10.1126/science.1154622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18323415	Green Published			2022-12-28	WOS:000254394000042
J	Scheuner, MT; Sieverding, P; Shekelle, PG				Scheuner, Maren T.; Sieverding, Pauline; Shekelle, Paul G.			Delivery of genomic medicine for common chronic adult diseases - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE PHYSICIANS; FAMILIAL CANCER-RISK; BREAST-CANCER; GENETIC DISCRIMINATION; COLORECTAL-CANCER; PSYCHOLOGICAL OUTCOMES; INFORMATION NEEDS; HEALTH INSURERS; UNITED-STATES	Context The greatest public health benefit of advances in understanding the human genome may be realized for common chronic diseases such as cardiovascular disease, diabetes mellitus, and cancer. Attempts to integrate such knowledge into clinical practice are still in the early stages, and as a result, many questions surround the current state of this translation. Objective To synthesize current information on genetic health services for common adult- onset conditions by examining studies that have addressed the outcomes, consumer information needs, delivery, and challenges in integrating these services. Data Sources MEDLINE articles published between January 2000 and February 2008. Study Selection Original research articles and systematic reviews dealing with common chronic adult- onset conditions were reviewed. A total of 3371 citations were reviewed, 170 articles retrieved, and 68 articles included in the analysis. Data Extraction Data were independently extracted by one reviewer and checked by another with disagreement resolved by consensus. Variables assessed included study design and 4 key areas: outcomes of genomic medicine, consumer information needs, delivery of genomic medicine, and challenges and barriers to integration of genomic medicine. Data Synthesis Sixty- eight articles contributed data to the synthesis: 5 systematic reviews, 8 experimental studies, 35 surveys, 7 pre/ post studies, 3 observational studies, and 10 qualitative reports. Three systematic reviews, 4 experimental studies, and 9 additional studies reported on outcomes of genetic services. Generally there were modest positive effects on psychological outcomes such as worry and anxiety, behavioral outcomes have shown mixed results, and clinical outcomes were less well studied. One systematic review, 1 randomized controlled trial, and 14 other studies assessed consumer information needs and found in general that genetics knowledge was reported to be low but that attitudes were generally positive. Three randomized controlled trials and 13 other studies assessed how genomic medicine is delivered and newer models of delivery. One systematic review and 19 other studies assessed barriers; the most consistent finding was the self- assessed inadequacy of the primary care work-force to deliver genetic services. Additional identified barriers included lack of oversight of genetic testing and concerns about privacy and discrimination. Conclusion Many gaps in knowledge about organization, clinician, and patient needs must be filled to translate basic and clinical science advances in genomics of common chronic diseases into practice.	[Scheuner, Maren T.; Shekelle, Paul G.] RAND Corp, Santa Monica, CA 90401 USA; [Sieverding, Pauline] Dept Vet Affairs, Hlth Serv Res & Dev Serv, Washington, DC USA; [Shekelle, Paul G.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Scheuner, MT (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	scheuner@rand.org						Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Anderson RT, 2005, GENET MED, V7, P557, DOI 10.1097/01.GIM.0000177531.53338.65; Arkadianos I, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-29; Baars MJH, 2005, GENET MED, V7, P295, DOI 10.1097/01.GIM.0000162877.87333.9A; Bernhardt BA, 2000, AM J MED GENET, V94, P189, DOI 10.1002/1096-8628(20000918)94:3<189::AID-AJMG3>3.0.CO;2-E; Butow PN, 2003, MED J AUSTRALIA, V178, P77, DOI 10.5694/j.1326-5377.2003.tb05069.x; Carroll JC, 2003, CAN FAM PHYSICIAN, V49, P45; Chen LS, 2007, GENET MED, V9, P496, DOI 10.1097/GIM.0b013e31812e95b5; Collins V, 2000, CLIN GENET, V58, P460, DOI 10.1034/j.1399-0004.2000.580606.x; Cooksey JA, 2005, GENET MED, V7, P439, DOI 10.1097/01.GIM.0000172416.35285.9F; Cooksey JA, 2006, GENET MED, V8, P603, DOI 10.1097/01.gim.0000242307.83900.77; de Vries H, 2005, PATIENT EDUC COUNS, V56, P154, DOI 10.1016/j.pec.2004.01.002; Doksum T, 2003, GENET MED, V5, P99, DOI 10.1097/01.GIM.0000055198.63593.32; Donnai D, 2001, BRIT MED J, V322, P1048, DOI 10.1136/bmj.322.7293.1048; Drury N, 2007, J Genet Couns, V16, P583, DOI 10.1007/s10897-007-9096-1; Elwyn G, 2002, FAM PRACT, V19, P65, DOI 10.1093/fampra/19.1.65; Emery J, 2007, BRIT J CANCER, V97, P486, DOI 10.1038/sj.bjc.6603897; Esplen MJ, 2007, CLIN GENET, V72, P394, DOI 10.1111/j.1399-0004.2007.00893.x; Freedman AN, 2003, AM J MED GENET A, V120A, P63, DOI 10.1002/ajmg.a.10192; Frezzo TM, 2003, GENET MED, V5, P84, DOI 10.1097/01.GIM.0000055197.23822.5E; Goddard KAB, 2007, GENET MED, V9, P510, DOI 10.1097/GIM.0b013e31812e6ac3; Gramling R, 2004, ANN FAM MED, V2, P130, DOI 10.1370/afm.60; Gramling R, 2003, GENET MED, V5, P172, DOI 10.1097/01.GIM.0000068986.03217.BB; Hall MA, 2000, AM J HUM GENET, V66, P293, DOI 10.1086/302714; Hall MA, 2005, GENET MED, V7, P311, DOI 10.1097/01.GIM.0000162874.58370.C0; Hall MA, 2000, GENET MED, V2, P214, DOI 10.1097/00125817-200007000-00003; Hall MA, 2007, J FAM PRACTICE, V56, P829; Herbild L, 2008, INT J TECHNOL ASSESS, V24, P96, DOI 10.1017/S0266462307080129; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; Holloway S, 2004, BRIT J CANCER, V90, P582, DOI 10.1038/sj.bjc.6601562; Hudson KL, 2006, NAT BIOTECHNOL, V24, P1083, DOI 10.1038/nbt0906-1083; Jenkins J, 2007, GENET MED, V9, P487, DOI 10.1097/GIM.0b013e31812e6220; Lapham EV, 2000, GENET MED, V2, P226, DOI 10.1097/00125817-200007000-00005; Lea DH, 2006, J NURS SCHOLARSHIP, V38, P213, DOI 10.1111/j.1547-5069.2006.00105.x; Lea DH, 2005, GENET MED, V7, P21, DOI 10.1097/01.GIM.0000151150.20570.E7; Levy DE, 2007, GENET MED, V9, P842, DOI 10.1097/GIM.0b013e31815bf953; Lucassen A, 2001, FAM PRACT, V18, P135, DOI 10.1093/fampra/18.2.135; Manne SL, 2007, CANCER EPIDEM BIOMAR, V16, P2110, DOI 10.1158/1055-9965.EPI-07-0412; Maradiegue A, 2006, J AM ACAD NURSE PRAC, V18, P447, DOI 10.1111/j.1745-7599.2006.00156.x; Marteau TM, 2001, BMJ-BRIT MED J, V322, P1056, DOI 10.1136/bmj.322.7293.1056; Metcalfe S, 2002, GENET MED, V4, P71, DOI 10.1097/00125817-200203000-00004; Morren M, 2007, PATIENT EDUC COUNS, V65, P197, DOI 10.1016/j.pec.2006.07.005; Murff HJ, 2004, AM J PREV MED, V27, P239, DOI 10.1016/j.amepre.2004.05.003; O'Neill SC, 2007, J CLIN ONCOL, V25, P4628, DOI 10.1200/JCO.2006.09.6255; O'Neill SM, 2006, AM J MED GENET C, V142C, P221, DOI 10.1002/ajmg.c.30109; Palmer RC, 2007, PREV MED, V45, P336, DOI 10.1016/j.ypmed.2007.07.021; Peters N, 2004, CANCER EPIDEM BIOMAR, V13, P361; Pierce M, 2000, BRIT J GEN PRACT, V50, P867; Pieterse AH, 2005, BRIT J CANCER, V92, P1671, DOI 10.1038/sj.bjc.6602570; Pieterse Arwen H, 2007, J Genet Couns, V16, P85, DOI 10.1007/s10897-006-9048-1; Pletcher BA, 2002, GENET MED, V4, P142, DOI 10.1097/00125817-200205000-00008; Ricker CN, 2007, PREV MED, V44, P241, DOI 10.1016/j.ypmed.2006.08.018; Rief W, 2007, J GEN INTERN MED, V22, P1553, DOI 10.1007/s11606-007-0353-7; Sandhaus LM, 2001, GENET MED, V3, P327, DOI 10.1097/00125817-200109000-00001; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.2002.20.5.1260; Schlich-Bakker KJ, 2007, GENET MED, V9, P766, DOI 10.1097/GIM.0b013e318159a318; Suther S, 2003, GENET MED, V5, P70, DOI 10.1097/01.GIM.0000055201.16487.61; Sweet KM, 2002, J CLIN ONCOL, V20, P528, DOI 10.1200/JCO.20.2.528; Tercyak KP, 2007, GENET TEST, V11, P249, DOI 10.1089/gte.2006.0534; Vadaparampil ST, 2006, CANCER EPIDEM BIOMAR, V15, P618, DOI 10.1158/1055-9965.EPI-05-0378; Vadaparampil ST, 2005, AM J MED GENET A, V135A, P41, DOI 10.1002/ajmg.a.30681; VOS J, PSYCHOONCOLOGY  1221; Walter FM, 2005, ANN FAM MED, V3, P405, DOI 10.1370/afm.368; Walter FM, 2004, ANN FAM MED, V2, P583, DOI 10.1370/afm.242; Westwood G, 2006, J ADV NURS, V53, P591, DOI 10.1111/j.1365-2648.2006.03760.x; Wideroff L, 2003, CANCER EPIDEM BIOMAR, V12, P295; Wilkins-Haug L, 2000, J WOMEN HEALTH GEN-B, V9, P873, DOI 10.1089/152460900750020900	67	228	229	4	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1320	1334		10.1001/jama.299.11.1320	http://dx.doi.org/10.1001/jama.299.11.1320			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349093				2022-12-28	WOS:000254079100023
J	Hviid, A; Rubin, S; Muhlemann, K				Hviid, Anders; Rubin, Steven; Muehlemann, Kathrin			Mumps	LANCET			English	Review							CENTRAL-NERVOUS-SYSTEM; IDIOPATHIC THROMBOCYTOPENIC PURPURA; ENCEPHALOMYELITIS FOLLOWING MUMPS; MATERNAL VIRUS DISEASES; CONTINUOUS CELL-LINES; JERYL-LYNN-MORATEN; REAL-TIME PCR; ASEPTIC-MENINGITIS; ENDOCARDIAL FIBROELASTOSIS; RUBELLA VACCINATION	Mumps is a common childhood infection caused by the mumps virus. The hallmark of infection is swelling of the parotid gland. Aseptic meningitis and encephalitis are common complications of mumps together with orchitis and oophoritis, which can arise in adult men and women, respectively; other complications include deafness and pancreatitis. Clinical diagnosis can be based on the classic parotid swelling; however, this feature is not present in all cases of mumps and can also occur in various other disorders. Laboratory diagnosis is based on isolation of virus, detection of viral nucleic acid, or serological confirmation (generally presence of IgM mumps antibodies). Mumps is vaccine-preventable, and one dose of mumps vaccine is about 80% effective against the disease. Routine vaccination has proven highly effective in reducing the incidence of mumps, and is presently used by most developed countries; however, there have been outbreaks of disease in vaccinated populations. In 2005, a large epidemic peaked in the UK, and in 2006 the American midwest had several outbreaks. In both countries, the largest proportion of cases was in young adults. In the UK, susceptible cohorts too old to have been vaccinated and too young to have been exposed to natural infections were the primary cause of the mumps epidemic. In the USA, effectiveness and uptake in combination appear not to have been sufficient to obtain herd immunity for mumps in populations such as college students.	[Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Rubin, Steven] US FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Bethesda, MD 20982 USA; [Muehlemann, Kathrin] Univ Bern, Bern, Switzerland	Statens Serum Institut; US Food & Drug Administration (FDA); University of Bern	Hviid, A (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	aii@ssi.dk	Hviid, Anders/AAH-4319-2020	Hviid, Anders/0000-0002-7509-9127				Afzal MA, 2005, J VIROL METHODS, V126, P149, DOI 10.1016/j.jviromet.2005.01.032; ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839; ANDERSON RM, 1990, LANCET, V335, P641, DOI 10.1016/0140-6736(90)90420-A; APPELBAUM E, 1952, ARCH INTERN MED, V90, P217, DOI 10.1001/archinte.1952.00240080083007; AZIMI PH, 1969, J AMER MED ASSOC, V207, P509, DOI 10.1001/jama.207.3.509; Backhouse JL, 2006, CLIN VACCINE IMMUNOL, V13, P764, DOI 10.1128/CVI.00199-05; Bajaj NPS, 2001, ACTA NEUROL SCAND, V104, P239, DOI 10.1034/j.1600-0404.2001.00340.x; Bang HO, 1943, ACTA MED SCAND, V113, P487; BARTAK V, 1973, J REPROD FERTIL, V32, P491; Baum GB, 2000, PRINCIPLES PRACTICE, P1776; BEARD CM, 1977, MAYO CLIN PROC, V52, P3; Beardwell A, 1969, Br J Clin Pract, V23, P37; BERTSCHAT FL, 1981, MUNCHEN MED WOCHEN, V123, P606; BJORVATN B, 1973, Scandinavian Journal of Infectious Diseases, V5, P3, DOI 10.3109/inf.1973.5.issue-1.02; BJORVATN B, 1973, SCAND J INFECT DIS, V5, P253, DOI 10.3109/inf.1973.5.issue-4.04; Black S, 1997, PEDIATR INFECT DIS J, V16, P500, DOI 10.1097/00006454-199705000-00009; Bonnet MC, 2006, VACCINE, V24, P7037, DOI 10.1016/j.vaccine.2006.06.049; BOOY R, 2006, CLIN EVID, V15, P448; BRAY PF, 1972, PEDIATRICS, V49, P446; Brent AJ, 2006, CLIN INFECT DIS, V42, P302, DOI 10.1086/499107; Broliden K, 1998, VACCINE, V16, P323, DOI 10.1016/S0264-410X(97)88332-6; BROWN EG, 1991, VACCINE, V9, P840, DOI 10.1016/0264-410X(91)90223-S; BRUYN HENRY B., 1957, CALIFORNIA MED, V86, P153; BUCHENOSMOND C, 2006, ICTVDB UNIVERSAL VIR; Buyukavci M, 2005, J PEDIAT HEMATOL ONC, V27, P56, DOI 10.1097/01.mph.0000151804.79843.c2; CANDEL S, 1951, ANN INTERN MED, V34, P20, DOI 10.7326/0003-4819-34-1-20; CARANASO.GJ, 1967, ARCH INTERN MED, V119, P394, DOI 10.1001/archinte.119.4.394; CHIBA Y, 1973, TOHOKU J EXP MED, V111, P229, DOI 10.1620/tjem.111.229; CHRISTENSON B, 1983, J BIOL STAND, V11, P323, DOI 10.1016/S0092-1157(83)80021-3; CHRISTENSON B, 1990, BIOLOGICALS, V18, P213, DOI 10.1016/1045-1056(90)90009-O; CIZMAN M, 1989, PEDIATR INFECT DIS J, V8, P302; Cohen C, 2007, EMERG INFECT DIS, V13, P12; Cunningham C, 2006, Ir Med J, V99, P171; Cusi MG, 1996, RES VIROLOGY, V147, P227, DOI 10.1016/0923-2516(96)89653-1; da Cunha SS, 2002, VACCINE, V20, P1106, DOI 10.1016/S0264-410X(01)00438-8; DACOUVOU.C, 1974, AM J DIS CHILD, V127, P890, DOI 10.1001/archpedi.1974.02110250116018; DAVIDKIN I, 1995, VACCINE, V13, P1617, DOI 10.1016/0264-410X(95)00064-8; Davidkin I, 2005, J INFECT DIS, V191, P719, DOI 10.1086/427338; Davis L E, 1971, Arch Ophthalmol, V85, P366; de Godoy C V, 1969, Rev Inst Med Trop Sao Paulo, V11, P436; Donohue WL, 1941, J PEDIATR-US, V19, P42, DOI 10.1016/S0022-3476(41)80025-0; DUNCAN S, 1990, J NEUROL NEUROSUR PS, V53, P709, DOI 10.1136/jnnp.53.8.709; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672; ENDERS JF, 1946, J PEDIATR, V29, P129, DOI 10.1016/S0022-3476(46)80101-X; Enders M., 2005, Gynaekologisch-Geburtshilfliche Rundschau, V45, P39, DOI 10.1159/000081715; ENNIS FA, 1968, J PEDIATR-US, V72, P536, DOI 10.1016/S0022-3476(68)80347-6; ERPENBACH KHJ, 1991, J UROLOGY, V146, P54, DOI 10.1016/S0022-5347(17)37713-3; EVERBERG G, 1957, Acta Otolaryngol, V48, P397; FALK WA, 1989, AM J EPIDEMIOL, V130, P736, DOI 10.1093/oxfordjournals.aje.a115395; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; FELDSTEIN JD, 1974, ANN SURG, V180, P85, DOI 10.1097/00000658-197407000-00012; FINE PEM, 1994, AM J EPIDEMIOL, V139, P77, DOI 10.1093/oxfordjournals.aje.a116937; FLEISCHER B, 1982, INFECT IMMUN, V35, P25, DOI 10.1128/IAI.35.1.25-31.1982; FORSBERG P, 1986, ACTA NEUROL SCAND, V73, P372, DOI 10.1111/j.1600-0404.1986.tb03292.x; FOY HM, 1971, AM J EPIDEMIOL, V94, P467, DOI 10.1093/oxfordjournals.aje.a121343; FUJINAGA T, 1991, PEDIATR INFECT DIS J, V10, P204, DOI 10.1097/00006454-199103000-00007; Furesz J, 1990, Can Dis Wkly Rep, V16, P253; Galazka AM, 1999, B WORLD HEALTH ORGAN, V77, P3; GALL EA, 1947, AM J PATHOL, V23, P637; Gans H, 2003, VACCINE, V21, P3398, DOI 10.1016/S0264-410X(03)00341-4; Gans H, 2001, J INFECT DIS, V184, P817, DOI 10.1086/323346; GARCIA AGP, 1980, OBSTET GYNECOL, V56, P756; Gellis S. S., 1944, BULL JOHNS HOPKINS HOSP, V75, P241; GELLIS SS, 1945, AM J MED SCI, V210, P661, DOI 10.1097/00000441-194511000-00017; GERSONY WM, 1966, PEDIATRICS, V37, P430; Goldacre MJ, 2005, DIABETES RES CLIN PR, V69, P256, DOI 10.1016/j.diabres.2005.01.006; GORDON JOHN E., 1940, AMER JOUR MED SCI, V200, P412; GREEN GF, 1964, PRACTITIONER, V192, P550; GROENENDAAL F, 1990, ACTA PAEDIATR SCAND, V79, P1252; Gupta RK, 2005, BMJ-BRIT MED J, V330, P1132, DOI 10.1136/bmj.330.7500.1132; Guy RJ, 2004, EPIDEMIOL INFECT, V132, P391, DOI 10.1017/S0950268804001955; Harling R, 2005, VACCINE, V23, P4070, DOI 10.1016/j.vaccine.2004.10.020; HILLEMAN MR, 1967, NEW ENGL J MED, V276, P252, DOI 10.1056/NEJM196702022760501; HINDEN E, 1962, LANCET, V1, P1381; Hiraiwa K, 2005, EMERG INFECT DIS, V11, P343; HODES D, 1970, PEDIATRICS, V45, P99; HUGHES WT, 1966, AM J DIS CHILD, V111, P297, DOI 10.1001/archpedi.1966.02090060107013; Inou Y, 2004, J MED VIROL, V73, P97, DOI 10.1002/jmv.20065; Ishida M, 2006, LARYNGOSCOPE, V116, P2221, DOI 10.1097/01.mlg.0000246189.38777.2c; Jalal H, 2004, J MED VIROL, V73, P147, DOI 10.1002/jmv.10544; Johansson B, 2002, SCAND J INFECT DIS, V34, P355, DOI 10.1080/00365540110080043; Johnson CD, 1935, AM J HYG, V21, P46, DOI 10.1093/oxfordjournals.aje.a118119; JOHNSON RT, 1968, J NEUROPATH EXP NEUR, V27, P136; JOHNSTONE JA, 1972, ARCH DIS CHILD, V47, P647, DOI 10.1136/adc.47.254.647; JONES JF, 1980, J PEDIATR-US, V96, P912, DOI 10.1016/S0022-3476(80)80577-4; Kalaydjiev S, 2002, FERTIL STERIL, V77, P76, DOI 10.1016/S0015-0282(01)02926-0; Kanra G, 2004, PEDIATR INT, V46, P663, DOI 10.1111/j.1442-200x.2004.01968.x; Kanra G, 2002, PEDIATR INFECT DIS J, V21, P1167, DOI 10.1097/00006454-200212000-00018; KAUFMAN J J, 1963, Br J Urol, V35, P67, DOI 10.1111/j.1464-410X.1963.tb02597.x; KILHAM L, 1949, AM J DIS CHILD, V78, P324; KILHAM L, 1948, P SOC EXP BIOL MED, V69, P99, DOI 10.3181/00379727-69-16629; KIMFARLEY R, 1985, AM J EPIDEMIOL, V121, P593, DOI 10.1093/oxfordjournals.aje.a114037; KOSKINIEMI M, 1983, ACTA PAEDIATR SCAND, V72, P603, DOI 10.1111/j.1651-2227.1983.tb09778.x; KOVAMEES J, 1990, VIRUS RES, V17, P119, DOI 10.1016/0168-1702(90)90073-K; Krause CH, 2007, J CLIN VIROL, V38, P153, DOI 10.1016/j.jcv.2006.10.010; Krause CH, 2006, J CLIN VIROL, V37, P184, DOI 10.1016/j.jcv.2006.07.009; Krause I, 2002, TRANSFUSION MED, V12, P133, DOI 10.1046/j.1365-3148.2002.00360.x; Ku JH, 1999, BJU INT, V84, P839; Kulkarni PS, 2005, VACCINE, V23, P5286, DOI 10.1016/j.vaccine.2005.05.029; KURTZ JB, 1982, BRIT MED J, V284, P471, DOI 10.1136/bmj.284.6314.471; KUSSY JC, 1974, MINN MED, V57, P285; LACOUR M, 1993, EUR J PEDIATR, V152, P739, DOI 10.1007/BF01953989; LAMBERT BENGT, 1951, ACTA GENET STATIST MED, V2, P1; Lane TM, 2006, BJU INT, V97, P1, DOI 10.1111/j.1464-410X.2006.05869.x; LENNETTE EH, 1960, PEDIATRICS, V25, P788; LERMAN SJ, 1981, PEDIATRICS, V68, P18; LEVITT LP, 1970, AM J DIS CHILD, V120, P134, DOI 10.1001/archpedi.1970.02100070078008; LEVITT LP, 1970, NEUROLOGY, V20, P829, DOI 10.1212/WNL.20.8.829; LOVE A, 1985, J VIROL, V53, P67; Mauldin J, 2005, J CLIN MICROBIOL, V43, P4847, DOI 10.1128/JCM.43.9.4847-4851.2005; MCLEAN DM, 1964, CAN MED ASSOC J, V90, P458; Miller E, 2007, AM J EPIDEMIOL, V165, P704, DOI 10.1093/aje/kwk045; MILLER E, 1993, LANCET, V341, P979, DOI 10.1016/0140-6736(93)91069-X; MILLER E, 1995, VACCINE, V13, P799, DOI 10.1016/0264-410X(94)00086-3; MORISHIMA T, 1980, AM J DIS CHILD, V134, P1060, DOI 10.1001/archpedi.1980.02130230040012; MORRISON JC, 1975, FERTIL STERIL, V26, P655; Muhlemann K, 2004, INFECT GENET EVOL, V4, P215, DOI 10.1016/j.meegid.2004.02.003; MURRAY HGS, 1960, BRIT MED J, V1, P1850, DOI 10.1136/bmj.1.5189.1850; Nagai T, 2007, VACCINE, V25, P2742, DOI 10.1016/j.vaccine.2005.11.068; Nardone A, 2003, EPIDEMIOL INFECT, V131, P691, DOI 10.1017/S0950268803008768; Narita M, 1998, CLIN DIAGN LAB IMMUN, V5, P799, DOI 10.1128/CDLI.5.6.799-803.1998; Nickel WR, 1986, CAMPBELLS UROLOGY, V5th, P977; Nojd J, 2001, VACCINE, V19, P1727, DOI 10.1016/S0264-410X(00)00392-3; Onal S, 2005, OCUL IMMUNOL INFLAMM, V13, P395, DOI 10.1080/09273940590950927; Ong G, 2005, J INFECTION, V51, P294, DOI 10.1016/j.jinf.2004.10.001; Orvell C, 1997, J GEN VIROL, V78, P3187, DOI 10.1099/0022-1317-78-12-3187; Orvell C, 2002, J GEN VIROL, V83, P2489, DOI 10.1099/0022-1317-83-10-2489; OVERMAN JR, 1958, ARCH INTERN MED, V102, P354, DOI 10.1001/archinte.1958.00030010354002; Pelosi J, 2001, J Public Health Manag Pract, V7, P69; Peltola H, 2000, JAMA-J AM MED ASSOC, V284, P2643, DOI 10.1001/jama.284.20.2643; PHILIP RN, 1959, AM J HYG, V69, P91; PLOTKIN S A, 2004, VACCINES, P441; PLOTKIN SA, 2004, VACCINES, P452; Poggio GP, 2000, J CLIN MICROBIOL, V38, P274; Polat A, 2005, PEDIATR HEMAT ONCOL, V22, P215, DOI 10.1080/08880010590921487; POPOWKRAUPP T, 1986, J MED VIROL, V18, P69, DOI 10.1002/jmv.1890180109; Reed D, 1967, JAMA, V199, P113, DOI 10.1001/jama.199.13.113; Reef S., 2006, Morbidity and Mortality Weekly Report, V55, P1152; Reina J, 2003, J CLIN MICROBIOL, V41, P5186, DOI 10.1128/JCM.41.11.5186-5187.2003; Reina J, 2001, J CLIN PATHOL, V54, P924, DOI 10.1136/jcp.54.12.924; Richard JL, 2003, EUR J EPIDEMIOL, V18, P569; Richardson M, 2001, PEDIATR INFECT DIS J, V20, P380, DOI 10.1097/00006454-200104000-00004; RITTER BS, 1958, J PEDIATR-US, V52, P424, DOI 10.1016/S0022-3476(58)80063-3; ROBERTS WC, 1965, CIRCULATION, V32, P342, DOI 10.1161/01.CIR.32.3.342; Rotbart HA, 2000, SEMIN NEUROL, V20, P277, DOI 10.1055/s-2000-9427; Rubin S, 2006, VACCINE, V24, P2662, DOI 10.1016/j.vaccine.2005.10.050; Sanz JC, 2006, APMIS, V114, P788, DOI 10.1111/j.1600-0463.2006.apm_463.x; Savage E, 2005, BRIT MED J, V330, P1119, DOI 10.1136/bmj.330.7500.1119; SCHWARZ GA, 1964, ARCH NEUROL-CHICAGO, V11, P453, DOI 10.1001/archneur.1964.00460230003001; Shah AP, 2006, CHRONOBIOL INT, V23, P1065, DOI 10.1080/07420520600920718; SIEGEL M, 1966, NEW ENGL J MED, V274, P768, DOI 10.1056/NEJM196604072741404; SIEGEL M, 1966, J AMER MED ASSOC, V197, P680, DOI 10.1001/jama.197.9.680; SIEGEL M, 1973, JAMA-J AM MED ASSOC, V226, P1521, DOI 10.1001/jama.226.13.1521; Sonmez FM, 2004, PEDIATR NEUROL, V30, P132, DOI 10.1016/j.pediatrneurol.2003.09.004; STGEME JW, 1966, NEW ENGL J MED, V275, P339, DOI 10.1056/NEJM196608182750701; STGEME JW, 1971, PEDIATRICS, V48, P821; SUGG WC, 1968, J PEDIATR-US, V72, P461, DOI 10.1016/S0022-3476(68)80334-8; SUGIURA A, 1991, PEDIATR INFECT DIS J, V10, P209, DOI 10.1097/00006454-199103000-00008; Takahashi Y, 1998, AM J PERINAT, V15, P409, DOI 10.1055/s-2007-993967; TAYLOR FB, 1963, ARCH INTERN MED, V112, P216, DOI 10.1001/archinte.1963.03860020114015; Tecle T, 2000, ARCH VIROL, V145, P1199, DOI 10.1007/s007050070119; TIMMONS GD, 1970, NEW ENGL J MED, V283, P1505, DOI 10.1056/NEJM197012312832707; TRAVIS LW, 1977, OTOLARYNG CLIN N AM, V10, P329; Uchida K, 2005, J MED VIROL, V75, P470, DOI 10.1002/jmv.20291; Unal A, 2005, SPINAL CORD, V43, P441, DOI 10.1038/sj.sc.3101735; Unal M, 1998, INT J PEDIATR OTORHI, V45, P167, DOI 10.1016/S0165-5876(98)00086-X; UTZ JP, 1958, P SOC EXP BIOL MED, V99, P259, DOI 10.3181/00379727-99-24315; UTZ JP, 1964, NEW ENGL J MED, V270, P1283, DOI 10.1056/NEJM196406112702404; Van Loon Frederik P. L., 1995, Morbidity and Mortality Weekly Report, V44, P1; Vandermeulen C, 2004, VACCINE, V22, P2713, DOI 10.1016/j.vaccine.2004.02.001; Vartiainen E, 1998, INT J PEDIATR OTORHI, V43, P253, DOI 10.1016/S0165-5876(98)00010-X; VESIKARI T, 1983, ACTA PAEDIATR SCAND, V72, P41, DOI 10.1111/j.1651-2227.1983.tb09661.x; VESIKARI T, 1984, AM J DIS CHILD, V138, P843, DOI 10.1001/archpedi.1984.02140470043013; VUORI M, 1962, Acta Otolaryngol, V55, P231, DOI 10.3109/00016486209127357; Warrener L, 2006, J CLIN VIROL, V35, P130, DOI 10.1016/j.jcv.2005.10.008; WEIBEL RE, 1988, VACCINES, P231; WELLER TH, 1949, AM J PATHOL, V25, P1105; Wellington K, 2003, DRUGS, V63, P2107, DOI 10.2165/00003495-200363190-00012; WERNER CA, 1950, ANN INTERN MED, V32, P1075, DOI 10.7326/0003-4819-32-6-1075; Wharton IP, 2006, LANCET, V367, P702, DOI 10.1016/S0140-6736(06)68274-3; WOLINSKY JS, 1976, J INFECT DIS, V133, P260, DOI 10.1093/infdis/133.3.260; Zhou FJ, 2004, J INFECT DIS, V189, pS131, DOI 10.1086/378987; 2006, MMWR MORB MORTAL WKL, V55, P173; 2003, MMWR MORB MORTAL WKL, V52, P1023; 2001, WKLY EPIDEMIOL REC, V76, P346	185	314	334	3	61	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2008	371	9616					932	944		10.1016/S0140-6736(08)60419-5	http://dx.doi.org/10.1016/S0140-6736(08)60419-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342688				2022-12-28	WOS:000254056800030
J	Tonks, A				Tonks, Alison			Cabin fever	BRITISH MEDICAL JOURNAL			English	Editorial Material							FLIGHT MEDICAL EMERGENCIES; AIRCRAFT; AIRLINES; EVENTS; AIR					atonks@bmj.com						BRAY A, 2008, INDEPENDENT IE  0129; Cocks R, 2007, EMERG MED AUSTRALAS, V19, P1, DOI 10.1111/j.1742-6723.2006.00928.x; Delaune EF, 2003, AVIAT SPACE ENVIR MD, V74, P62; Dowdall N, 2000, BRIT MED J, V321, P1336, DOI 10.1136/bmj.321.7272.1336; Gendreau MA, 2002, NEW ENGL J MED, V346, P1067, DOI 10.1056/NEJMra012774; General Medical Council, 2006, GOOD MED PRACT; Goodwin T, 2000, BRIT MED J, V321, P1338, DOI 10.1136/bmj.321.7272.1338; HAMER M, 2005, NEW SCI         0520, P8; KIRBY D, 2008, MANCHESTER EVEN 0225; Kuczkowski KM, 2007, CAN J ANAESTH, V54, P401, DOI 10.1007/BF03022669; Qureshi A, 2005, EMERG MED J, V22, P658, DOI 10.1136/emj.2005.024505; Shepherd B, 2006, J ROY SOC MED, V99, P628, DOI 10.1258/jrsm.99.12.628; Sirven JI, 2002, NEUROLOGY, V58, P1739, DOI 10.1212/WNL.58.12.1739; Thibeault C, 2007, AVIAT SPACE ENVIR MD, V78, P1170, DOI 10.3357/ASEM.2188.2007; WALLACE WA, 1995, BRIT MED J, V311, P374, DOI 10.1136/bmj.311.7001.374; *WORLD MED ASS, 2006, INT COD ETH	16	13	13	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 15	2008	336	7644					584	586		10.1136/bmj.39511.444618.AD	http://dx.doi.org/10.1136/bmj.39511.444618.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18340070	Green Published			2022-12-28	WOS:000254364500027
J	Goebel, T; Waters, MR; O'Rourke, DH				Goebel, Ted; Waters, Michael R.; O'Rourke, Dennis H.			The Late Pleistocene dispersal of modern humans in the Americas	SCIENCE			English	Review							MITOCHONDRIAL-DNA; SKELETAL REMAINS; NORTH-AMERICA; SITE; SPECIALIZATION; COLONIZATION; VARIABILITY; PERSPECTIVE; ARCHAEOLOGY; OCCUPATION	When did humans colonize the Americas? From where did they come and what routes did they take? These questions have gripped scientists for decades, but until recently answers have proven difficult to find. Current genetic evidence implies dispersal from a single Siberian population toward the Bering Land Bridge no earlier than about 30,000 years ago ( and possibly after 22,000 years ago), then migration from Beringia to the Americas sometime after 16,500 years ago. The archaeological records of Siberia and Beringia generally support these findings, as do archaeological sites in North and South America dating to as early as 15,000 years ago. If this is the time of colonization, geological data from western Canada suggest that humans dispersed along the recently deglaciated Pacific coastline.	[Goebel, Ted; Waters, Michael R.] Texas A&M Univ, Dept Anthropol, Ctr Study First Amer, College Stn, TX 77843 USA; [Waters, Michael R.] Texas A&M Univ, Dept Geog, Ctr Study First Amer, College Stn, TX 77843 USA; [O'Rourke, Dennis H.] Univ Utah, Dept Anthropol, Salt Lake City, UT 84122 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Utah System of Higher Education; University of Utah	Goebel, T (corresponding author), Texas A&M Univ, Dept Anthropol, Ctr Study First Amer, 4352 TAMU, College Stn, TX 77843 USA.	goebel@tamu.edu	Waters, Michael/ABI-2377-2020; Goebel, Ted/A-7051-2009; Waters, Michael R/A-9430-2009	Waters, Michael/0000-0003-2660-3355; 				Adovasio J., 2004, ENTERING AM NE ASIA, P139; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Bradley B, 2004, WORLD ARCHAEOL, V36, P459, DOI 10.1080/0043824042000303656; Byers DA, 2005, J ARCHAEOL SCI, V32, P1624, DOI 10.1016/j.jas.2005.05.003; Cannon MD, 2004, QUATERNARY SCI REV, V23, P1955, DOI 10.1016/j.quascirev.2004.03.011; Clague J.J., 2004, ENTERING AM NE ASIA, P63; Collins M. B., 2007, FORAGERS TERMINAL PL, P59; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko MV, 2001, AM J HUM GENET, V69, P237, DOI 10.1086/321266; DILLEHAY TD, 1997, MONTE VERDE LOTE PLE, V2; Dixon EJ, 1999, BONES BOATS BISON AR; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; Feathers JK, 2006, QUAT GEOCHRONOL, V1, P167, DOI 10.1016/j.quageo.2006.05.011; Fiedel SJ, 2000, J ARCHAEOL RES, V8, P39, DOI 10.1023/A:1009400309773; Fix AG, 2005, AM J PHYS ANTHROPOL, V128, P430, DOI 10.1002/ajpa.20230; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goebel T, 2003, SCIENCE, V301, P501, DOI 10.1126/science.1086555; Gonzalez-Jose R, 2005, AM J PHYS ANTHROPOL, V128, P772, DOI 10.1002/ajpa.20165; GOODYEAR A. C., 2005, PALEOAMERICAN ORIGIN, P103; GOODYEAR AC, 2005, LEGACY S CAROLINA I; Grayson DK, 2003, J ARCHAEOL SCI, V30, P585, DOI 10.1016/S0305-4403(02)00205-4; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Haynes G., 2002, EARLY SETTLEMENT N A; Haynes Jr C.V., 2005, PALEOAMERICAN ORIGIN, P113; Hill JH, 2004, SETTLEMENT OF THE AMERICAN CONTINENTS, P39; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Hoffecker J. F., 2007, HUMAN ECOLOGY BERING; Holen SR, 2006, QUATERN INT, V142, P30, DOI 10.1016/j.quaint.2005.03.003; HOLMES CE, 2003, 30 ANN M AL ANTHR AS; Jackson D, 2007, CURR ANTHROPOL, V48, P725, DOI 10.1086/520965; Jantz RL, 2001, AM J PHYS ANTHROPOL, V114, P146, DOI 10.1002/1096-8644(200102)114:2<146::AID-AJPA1014>3.0.CO;2-E; Jenkins DL, 2007, PALEOINDIAN PALEOARC, P57; JOHNSON JR, 2007, EOS S, V88; Joyce DJ, 2006, QUATERN INT, V142, P44, DOI 10.1016/j.quaint.2005.03.004; Karafet T.M., 2006, HDB N AM INDIANS, P831; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; McAvoy Joseph M., 1997, RES REPORT SERIES VI, V8; Merriwether D.A., 2006, HDB N AM INDIANS, P817; Metspalu M, 2006, NUCL ACID M, V18, P181; Miotti L, 2003, QUATERN INT, V109, P95, DOI 10.1016/S1040-6182(02)00206-9; Morlan RE, 2003, QUATERNARY RES, V60, P123, DOI 10.1016/S0033-5894(03)00070-X; Morrow JE, 2006, PALEOINDIAN ARCHAEOL; Neves WA, 2007, J HUM EVOL, V52, P16, DOI 10.1016/j.jhevol.2006.07.012; O'Rourke DH, 2000, HUM BIOL, V72, P15; Odess D, 2007, AM ANTIQUITY, V72, P691, DOI 10.2307/25470441; Overstreet David F., 2005, PALEOAMERICAN ORIGIN, P183; Pavlov P, 2001, NATURE, V413, P64, DOI 10.1038/35092552; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Powell J.F., 2005, 1 AM RACE EVOLUTION; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; Sandweiss DH, 1998, SCIENCE, V281, P1830, DOI 10.1126/science.281.5384.1830; Schroeder KB, 2007, BIOL LETTERS, V3, P218, DOI 10.1098/rsbl.2006.0609; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; Seielstad M, 2003, AM J HUM GENET, V73, P700, DOI 10.1086/377589; Shang H, 2007, P NATL ACAD SCI USA, V104, P6573, DOI 10.1073/pnas.0702169104; Smith D., 2005, PALEOAMERICAN ORIGIN, P243; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Surovell T, 2005, P NATL ACAD SCI USA, V102, P6231, DOI 10.1073/pnas.0501947102; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tankersley KB, 2004, SETTLEMENT OF THE AMERICAN CONTINENTS, P49; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; WEBB SD, 2005, 1 FLORIDIANS LAST MA; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	69	488	515	3	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1497	1502		10.1126/science.1153569	http://dx.doi.org/10.1126/science.1153569			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339930	Green Published			2022-12-28	WOS:000253943800029
J	Heath, I				Heath, Iona			"A modest thoughtfulness"	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dsl.pipex.com							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 8	2008	336	7643					535	535		10.1136/bmj.39506.606215.94	http://dx.doi.org/10.1136/bmj.39506.606215.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JV	18325963	Green Published			2022-12-28	WOS:000253998500026
J	Endy, D				Endy, Drew			Genomics - Reconstruction of the Genomes	SCIENCE			English	Editorial Material									MIT, Biol Engn Dept, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Endy, D (corresponding author), MIT, Biol Engn Dept, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	endy@mit.edu		Endy, Drew/0000-0001-6952-8098				Baker D, 2006, SCI AM, V294, P44, DOI 10.1038/scientificamerican0606-44; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bugl H., 2006, PRACTICAL PERSPECTIV; Bugl H, 2007, NAT BIOTECHNOL, V25, P627, DOI 10.1038/nbt0607-627; Carlson Robert, 2003, Biosecur Bioterror, V1, P203, DOI 10.1089/153871303769201851; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Kodumal SJ, 2004, P NATL ACAD SCI USA, V101, P15573, DOI 10.1073/pnas.0406911101; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sanghvi Y. S., 2007, ROADMAP ASSEMBLY SYN; SCHNEIDER TD, 1989, NUCLEIC ACIDS RES, V17, P659, DOI 10.1093/nar/17.2.659; STUDIER FW, 1969, VIROLOGY, V39, P587, DOI 10.1016/0042-6822(69)90106-8	15	9	10	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1196	1197		10.1126/science.1155749	http://dx.doi.org/10.1126/science.1155749			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309068				2022-12-28	WOS:000253530600024
J	Lloyd, S				Lloyd, Seth			Perspective - Quantum information matters	SCIENCE			English	Editorial Material							SYSTEMS		MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lloyd, S (corresponding author), MIT, Dept Mech Engn, MIT 3-160, Cambridge, MA 02139 USA.	slloyd@mit.edu						Bravyi SB, 2002, ANN PHYS-NEW YORK, V298, P210, DOI 10.1006/aphy.2002.6254; Cramer M, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012309; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; HAWKING SW, 1974, NATURE, V248, P30, DOI 10.1038/248030a0; JUDGE P, 2007, D WAVES QUANTUM COMP; KAMINSKY WM, 2003, QUANTUM COMPUTING QU, P229; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lloyd S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.237901; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; MOORE SK, 2007, IEEE SPECTRUM O 0313; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Planck M, 1901, ANN PHYS-BERLIN, V4, P553; Ramanathan C, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.020303; Sachdev S., 1999, QUANTUM PHASE TRANSI; van der Wal CH, 2000, SCIENCE, V290, P773, DOI 10.1126/science.290.5492.773; Wolf MM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.110403	19	15	15	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1209	1211		10.1126/science.1154732	http://dx.doi.org/10.1126/science.1154732			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309076				2022-12-28	WOS:000253530600032
J	Norreys, PA				Norreys, Peter A.			Physics - Complexity in fusion plasmas	SCIENCE			English	Editorial Material							IGNITION; GAIN		Rutherford Appleton Lab, Cent Laser Facil, Chilton OX11 0QX, Oxon, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Norreys, PA (corresponding author), Rutherford Appleton Lab, Cent Laser Facil, Chilton OX11 0QX, Oxon, England.	p.a.norreys@rl.ac.uk						Kodama R, 2002, NATURE, V418, P933, DOI 10.1038/418933a; Kodama R, 2001, NATURE, V412, P798, DOI 10.1038/35090525; LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025; NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0; Rygg JR, 2008, SCIENCE, V319, P1223, DOI 10.1126/science.1152640; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; Zhou CD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.025004	7	10	10	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1193	1194		10.1126/science.1155621	http://dx.doi.org/10.1126/science.1155621			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309066				2022-12-28	WOS:000253530600022
J	Johns, A				Johns, Adrian			When authorship met authenticity	NATURE			English	Editorial Material									[Johns, Adrian] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Johns, A (corresponding author), Univ Chicago, 1126 E 59th St, Chicago, IL 60637 USA.							Green MD, 2006, J POSTGRAD MED, V52, P288	1	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					1058	1059		10.1038/4511058a	http://dx.doi.org/10.1038/4511058a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305531	Bronze			2022-12-28	WOS:000253453600026
J	Sims, DW; Southall, EJ; Humphries, NE; Hays, GC; Bradshaw, CJA; Pitchford, JW; James, A; Ahmed, MZ; Brierley, AS; Hindell, MA; Morritt, D; Musyl, MK; Righton, D; Shepard, ELC; Wearmouth, VJ; Wilson, RP; Witt, MJ; Metcalfe, JD				Sims, David W.; Southall, Emily J.; Humphries, Nicolas E.; Hays, Graeme C.; Bradshaw, Corey J. A.; Pitchford, Jonathan W.; James, Alex; Ahmed, Mohammed Z.; Brierley, Andrew S.; Hindell, Mark A.; Morritt, David; Musyl, Michael K.; Righton, David; Shepard, Emily L. C.; Wearmouth, Victoria J.; Wilson, Rory P.; Witt, Matthew J.; Metcalfe, Julian D.			Scaling laws of marine predator search behaviour	NATURE			English	Article							PATTERNS; ZOOPLANKTON; MOVEMENTS; SUCCESS	Many free- ranging predators have to make foraging decisions with little, if any, knowledge of present resource distribution and availability(1). The optimal search strategy they should use to maximize encounter rates with prey in heterogeneous natural environments remains a largely unresolved issue in ecology(1-3). Levy walks(4) are specialized random walks giving rise to fractal movement trajectories that may represent an optimal solution for searching complex landscapes(5). However, the adaptive significance of this putative strategy in response to natural prey distributions remains untested(6,7). Here we analyse over a million movement displacements recorded from animal- attached electronic tags to show that diverse marine predators - sharks, bony fishes, sea turtles and penguins - exhibit Levy- walk- like behaviour close to a theoretical optimum(2). Prey density distributions also display Levy- like fractal patterns, suggesting response movements by predators to prey distributions. Simulations show that predators have higher encounter rates when adopting Levy- type foraging in natural- like prey fields compared with purely random landscapes. This is consistent with the hypothesis that observed search patterns are adapted to observed statistical patterns of the landscape. This may explain why Levy- like behaviour seems to be widespread among diverse organisms(3), from microbes(8) to humans(9), as a `rule' that evolved in response to patchy resource distributions.	[Sims, David W.; Southall, Emily J.; Humphries, Nicolas E.; Wearmouth, Victoria J.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [Sims, David W.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Sch Biol Sci, Plymouth PL4 8AA, Devon, England; [Ahmed, Mohammed Z.] Univ Plymouth, Sch Comp Commun & Elect, Plymouth PL4 8AA, Devon, England; [Hays, Graeme C.; Shepard, Emily L. C.; Wilson, Rory P.] Univ Coll Swansea, Dept Biol Sci, Inst Environm Sustainabil, Swansea SA2 8PP, W Glam, Wales; [Bradshaw, Corey J. A.] Charles Darwin Univ, Sch Environm Res, Darwin, NT 0909, Australia; [Pitchford, Jonathan W.; James, Alex] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Pitchford, Jonathan W.; James, Alex] Univ York, York Ctr Complex Syst Anal, York YO10 5YW, N Yorkshire, England; [James, Alex] Univ Canterbury, Dept Math & Stat, Christchurch 1, New Zealand; [Brierley, Andrew S.] Univ St Andrews, Gatty Marine Lab, Sch Biol, St Andrews KY16 8LB, Fife, Scotland; [Hindell, Mark A.] Univ Tasmania, Sch Zool, Hobart, Tas 7001, Australia; [Morritt, David] Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Musyl, Michael K.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Pelag Fisheries Res Programme, Kewalo Res Facil,NOAA Fisheries, Honolulu, HI 96814 USA; [Righton, David; Metcalfe, Julian D.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft NR33 0HT, Suffolk, England; [Witt, Matthew J.] Univ Exeter, Ctr Ecol & Conservat, Cornwall TR10 9EZ, England	Marine Biological Association United Kingdom; University of Plymouth; University of Plymouth; Swansea University; Charles Darwin University; University of York - UK; University of York - UK; University of Canterbury; University of St Andrews; University of Tasmania; University of London; Royal Holloway University London; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa; Centre for Environment Fisheries & Aquaculture Science; University of Exeter	Sims, DW (corresponding author), Marine Biol Assoc United Kingdom Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England.	dws@mba.ac.uk	Witt, Matthew/V-3318-2018; Humphries, Nick/AAE-7170-2019; Brierley, Andrew S/G-8019-2011; Hindell, Mark A/K-1131-2013; Witt, Matthew J/C-2279-2008; SOUTHALL, EMILY J/AGP-5395-2022; Ahmed, Mohammed/T-5898-2019; Bradshaw, Corey J.A./A-1311-2008; Righton, David/D-6140-2013; Hindell, Mark A/C-8368-2013	Witt, Matthew/0000-0002-9498-5378; Humphries, Nick/0000-0003-3741-1594; Brierley, Andrew S/0000-0002-6438-6892; SOUTHALL, EMILY J/0000-0001-7246-278X; Bradshaw, Corey J.A./0000-0002-5328-7741; Shepard, Emily/0000-0001-7325-6398; Righton, David/0000-0001-8643-3672; Hindell, Mark/0000-0002-7823-7185; Hays, Graeme/0000-0002-3314-8189; Sims, David/0000-0002-0916-7363; James, Alex/0000-0002-1543-7139	NERC [mba010004] Funding Source: UKRI; Natural Environment Research Council [mba010004, NER/A/S/2003/00302, NER/G/S/2001/00012, NER/A/S/2001/01053, NER/A/S/2001/01251] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bartumeus F, 2007, FRACTALS, V15, P151, DOI 10.1142/S0218348X07003460; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; BRADSHAW CJA, UNPUB J ANIM ECOL; Brierley AS, 2006, LIMNOL OCEANOGR-METH, V4, P18, DOI 10.4319/lom.2006.4.18; CHATFIELD C, 1996, NATL TIME SERIES; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; MACKAS DL, 1979, SCIENCE, V204, P62, DOI 10.1126/science.204.4388.62; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; McMahon CR, 2006, GLOBAL CHANGE BIOL, V12, P1330, DOI 10.1111/j.1365-2486.2006.01174.x; Myers AE, 2006, MAR ECOL PROG SER, V322, P259, DOI 10.3354/meps322259; Perry G, 1997, TRENDS ECOL EVOL, V12, P360, DOI 10.1016/S0169-5347(97)01097-5; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; RUSSELL RW, 1992, LANDSCAPE ECOL, V7, P195, DOI 10.1007/BF00133310; Schuster FL, 1996, J EUKARYOT MICROBIOL, V43, P150, DOI 10.1111/j.1550-7408.1996.tb04496.x; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Steele JH, 1989, LANDSCAPE ECOL, V3, P185, DOI 10.1007/BF00131537; Stephens D.W., 1986, pi; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Viswanathan GM, 2000, PHYSICA A, V282, P1, DOI 10.1016/S0378-4371(00)00071-6	31	681	685	7	376	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1098	U5		10.1038/nature06518	http://dx.doi.org/10.1038/nature06518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305542				2022-12-28	WOS:000253453600040
J	Silva, J; Smith, A				Silva, Jose; Smith, Austin			Capturing pluripotency	CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; LINEAGE-COMMITMENT; MOUSE DEVELOPMENT; X-INACTIVATION; ES CELLS; EPIBLAST; NANOG; DIFFERENTIATION; MAINTENANCE	In this Essay, we argue that pluripotent epiblast founder cells in the embryo and embryonic stem (ES) cells in culture represent the ground state for a mammalian cell, signified by freedom from developmental specification or epigenetic restriction and capacity for autonomous self-replication. We speculate that cell-to-cell variation may be integral to the ES cell condition, safe-guarding self-renewal while continually presenting opportunities for lineage specification.	[Silva, Jose; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Silva, Jose; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	Smith, A (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England.	ags39@cscr.cam.ac.uk	Silva, Jose C R/X-5140-2019; Silva, Jose/G-1920-2014	Silva, Jose C R/0000-0001-5487-1117; Silva, Jose/0000-0001-5487-1117; Smith, Austin/0000-0002-3029-4682	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G19/38] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Smith A, 2005, CELL, V123, P757, DOI 10.1016/j.cell.2005.11.012; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; STEVENS LC, 1983, TERATOCARCINOMA STEM, V10; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Wang ZD, 2004, DEV BIOL, V275, P192, DOI 10.1016/j.ydbio.2004.06.026; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	34	344	363	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					532	536		10.1016/j.cell.2008.02.006	http://dx.doi.org/10.1016/j.cell.2008.02.006			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295569	Green Published, Bronze			2022-12-28	WOS:000253817900011
J	Villa, RA; Capdevila, A				Villa, Roberto A.; Capdevila, Abelardo			Spontaneous otogenic pneumocephalus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Villa, Roberto A.; Capdevila, Abelardo] Hosp Clin Univ Buenos Aires, Buenos Aires, DF, Argentina	University of Buenos Aires	Villa, RA (corresponding author), Hosp Clin Univ Buenos Aires, Buenos Aires, DF, Argentina.	peroxidasa@yahoo.com		Villa, Roberto/0000-0002-4561-9064					0	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					E13	E13		10.1056/NEJMicm063225	http://dx.doi.org/10.1056/NEJMicm063225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275TL	18354098				2022-12-28	WOS:000254094400010
J	Mendis, S; Mohan, V				Mendis, Shanthi; Mohan, V.			Non-laboratory-based prediction of cardiovascular risk	LANCET			English	Editorial Material							BODY-MASS INDEX; METAANALYSIS; OBESITY; FAT		[Mendis, Shanthi] WHO, CH-1211 Geneva, Switzerland; [Mohan, V.] Madreas Diabet Res Fdn, Madras, Tamil Nadu, India	World Health Organization; Madras Diabetes Research Foundation	Mendis, S (corresponding author), WHO, CH-1211 Geneva, Switzerland.	mendiss@who.int	Mendis, Shanthi/GLT-0465-2022	mendis, shanthi/0000-0002-8959-5738				Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Ko GTC, 2007, OBESITY, V15, P2832, DOI 10.1038/oby.2007.336; Mohan V, 2007, DIABETES OBES METAB, V9, P337, DOI 10.1111/j.1463-1326.2006.00612.x; WHO, 2000, OB PREV MAN GLOB EP; *WHO REG OFF W PAC, 2002, INT ASS STUD OB TASK; World Health Organization, 2007, PREV CARD DIS GUID A; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	11	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2008	371	9616					878	879		10.1016/S0140-6736(08)60392-X	http://dx.doi.org/10.1016/S0140-6736(08)60392-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342668				2022-12-28	WOS:000254056800007
J	Kaminsky, R; Ducray, P; Jung, M; Clover, R; Rufener, L; Bouvier, J; Weber, SS; Wenger, A; Wieland-Berghausen, S; Goebel, T; Gauvry, N; Pautrat, F; Skripsky, T; Froelich, O; Komoin-Oka, C; Westlund, B; Sluder, A; Maser, P				Kaminsky, Ronald; Ducray, Pierre; Jung, Martin; Clover, Ralph; Rufener, Lucien; Bouvier, Jacques; Weber, Sandra Schorderet; Wenger, Andre; Wieland-Berghausen, Susanne; Goebel, Thomas; Gauvry, Noelle; Pautrat, Francois; Skripsky, Thomas; Froelich, Olivier; Komoin-Oka, Clarisse; Westlund, Bethany; Sluder, Ann; Maeser, Pascal			A new class of anthelmintics effective against drug-resistant nematodes	NATURE			English	Article							HAEMONCHUS-CONTORTUS; IVERMECTIN; EFFICACY; SUBUNITS	Anthelmintic resistance in human and animal pathogenic helminths has been spreading in prevalence and severity to a point where multidrug resistance against the three major classes of anthelmintics - the benzimidazoles, imidazothiazoles and macrocyclic lactones - has become a global phenomenon in gastrointestinal nematodes of farm animals. Hence, there is an urgent need for an anthelmintic with a new mode of action. Here we report the discovery of the amino- acetonitrile derivatives ( AADs) as a new chemical class of synthetic anthelmintics and describe the development of drug candidates that are efficacious against various species of livestock- pathogenic nematodes. These drug candidates seem to have a novel mode of action involving a unique, nematode- specific clade of acetylcholine receptor subunits. The AADs are well tolerated and of low toxicity to mammals, and overcome existing resistances to the currently available anthelmintics.	[Kaminsky, Ronald; Jung, Martin; Rufener, Lucien; Bouvier, Jacques; Weber, Sandra Schorderet; Wenger, Andre; Froelich, Olivier] Novartis Ctr Rech Sante Animale, CH-1566 St Aubin, Switzerland; [Ducray, Pierre; Wieland-Berghausen, Susanne; Goebel, Thomas; Gauvry, Noelle; Pautrat, Francois; Skripsky, Thomas] Novartis Anim Hlth Inc, CH-4002 Basel, Switzerland; [Clover, Ralph; Westlund, Bethany; Sluder, Ann] Cambria Biosci, Woburn, MA 01801 USA; [Rufener, Lucien; Maeser, Pascal] Lab Cent Vet Bingerville, Lanada, Cote Ivoire	Novartis; Novartis	Kaminsky, R (corresponding author), Novartis Ctr Rech Sante Animale, CH-1566 St Aubin, Switzerland.	ronald.kaminsky@novartis.com	Sluder, Ann/AAS-3102-2020	Maser, Pascal/0000-0003-3122-1941				Anderson P, 1995, METHOD CELL BIOL, V48, P31; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P231, DOI 10.1179/000349804225003253; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Besier B, 2007, TRENDS PARASITOL, V23, P21, DOI 10.1016/j.pt.2006.11.004; BOISVENUE RJ, 1983, VET PARASITOL, V13, P341, DOI 10.1016/0304-4017(83)90050-X; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; DeClercq D, 1997, AM J TROP MED HYG, V57, P25, DOI 10.4269/ajtmh.1997.57.25; Fleming JT, 1997, J NEUROSCI, V17, P5843; Geerts S, 2000, CLIN MICROBIOL REV, V13, P207, DOI 10.1128/CMR.13.2.207-222.2000; Jackson F, 2000, PARASITOLOGY, V120, pS95, DOI 10.1017/S0031182099005740; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P129, DOI 10.1007/s10158-007-0049-z; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Mongan NP, 2002, PROTEIN SCI, V11, P1162, DOI 10.1110/ps.3040102; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Rand James B, 2007, WormBook, P1; Ruaud AF, 2006, DEVELOPMENT, V133, P2211, DOI 10.1242/dev.02392; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treinin M, 1998, P NATL ACAD SCI USA, V95, P15492, DOI 10.1073/pnas.95.26.15492; VANWYK JA, 1988, VET REC, V123, P226, DOI 10.1136/vr.123.9.226; Waller PJ, 1997, VET PARASITOL, V72, P391, DOI 10.1016/S0304-4017(97)00107-6; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; WOOD IB, 1995, VET PARASITOL, V58, P181, DOI 10.1016/0304-4017(95)00806-2	23	362	418	9	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2008	452	7184					176	U19		10.1038/nature06722	http://dx.doi.org/10.1038/nature06722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	273JG	18337814				2022-12-28	WOS:000253925600032
J	Minobe, S; Kuwano-Yoshida, A; Komori, N; Xie, SP; Small, RJ				Minobe, Shoshiro; Kuwano-Yoshida, Akira; Komori, Nobumasa; Xie, Shang-Ping; Small, Richard Justin			Influence of the Gulf Stream on the troposphere	NATURE			English	Article							SEA-SURFACE TEMPERATURE; SATELLITE-OBSERVATIONS; NUMERICAL-SIMULATION; OCEAN; CLIMATE; CONVERGENCE; CIRCULATION; WINDS	The Gulf Stream transports large amounts of heat from the tropics to middle and high latitudes, and thereby affects weather phenomena such as cyclogenesis(1,2) and low cloud formation(3). But its climatic influence, on monthly and longer timescales, remains poorly understood. In particular, it is unclear how the warm current affects the free atmosphere above the marine atmospheric boundary layer. Here we consider the Gulf Stream's influence on the troposphere, using a combination of operational weather analyses, satellite observations and an atmospheric general circulation model(4). Our results reveal that the Gulf Stream affects the entire troposphere. In the marine boundary layer, atmospheric pressure adjustments to sharp sea surface temperature gradients lead to surface wind convergence, which anchors a narrow band of precipitation along the Gulf Stream. In this rain band, upward motion and cloud formation extend into the upper troposphere, as corroborated by the frequent occurrence of very low cloud- top temperatures. These mechanisms provide a pathway by which the Gulf Stream can affect the atmosphere locally, and possibly also in remote regions by forcing planetary waves(5,6). The identification of this pathway may have implications for our understanding of the processes involved in climate change, because the Gulf Stream is the upper limb of the Atlantic meridional overturning circulation, which has varied in strength in the past(7) and is predicted to weaken in response to human- induced global warming in the future(8).	[Minobe, Shoshiro] Hokkaido Univ, Dept Nat Hist Sci, Grad Sch Sci, Sapporo, Hokkaido 0600810, Japan; [Kuwano-Yoshida, Akira; Komori, Nobumasa] Japan Agcy Marine Earth Sci & Technol, Earth Simulator Ctr, Yokohama, Kanagawa 2360001, Japan; [Xie, Shang-Ping; Small, Richard Justin] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Xie, Shang-Ping] Univ Hawaii Manoa, Dept Meteorol, Honolulu, HI 96822 USA	Hokkaido University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Minobe, S (corresponding author), Hokkaido Univ, Dept Nat Hist Sci, Grad Sch Sci, Sapporo, Hokkaido 0600810, Japan.	minobe@sci.hokudai.ac.jp	Kuwano-Yoshida, Akira/Q-5616-2019; Xie, Shang-Ping/C-1254-2009; Kuwano-Yoshida, Akira/AGR-6960-2022; Komori, Nobumasa/D-1989-2013; Kuwano-Yoshida, Akira/I-8652-2014; Minobe, Shoshiro/E-2997-2010	Kuwano-Yoshida, Akira/0000-0003-3151-8550; Xie, Shang-Ping/0000-0002-3676-1325; Kuwano-Yoshida, Akira/0000-0003-3151-8550; Komori, Nobumasa/0000-0001-6067-8356; Kuwano-Yoshida, Akira/0000-0003-3151-8550; Minobe, Shoshiro/0000-0002-9487-9006; Small, Richard/0000-0002-3452-2179				Broecker WS, 2003, SCIENCE, V300, P1519, DOI 10.1126/science.1083797; Chelton DB, 2005, B AM METEOROL SOC, V86, P1097, DOI 10.1175/BAMS-86-8-1097; Chelton DB, 2004, SCIENCE, V303, P978, DOI 10.1126/science.1091901; Christian HJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002347; Ciasto LM, 2004, J CLIMATE, V17, P1617, DOI 10.1175/1520-0442(2004)017<1617:NAAIOI>2.0.CO;2; Czaja A, 2002, J CLIMATE, V15, P606, DOI 10.1175/1520-0442(2002)015<0606:OIOASA>2.0.CO;2; Dai A, 2005, J CLIMATE, V18, P3270, DOI 10.1175/JCLI3481.1; Ducet N, 2001, J GEOPHYS RES-OCEANS, V106, P16603, DOI 10.1029/2000JC000205; Enomoto T, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P77, DOI 10.1007/978-0-387-49791-4_5; Held IM, 2002, J CLIMATE, V15, P2125, DOI 10.1175/1520-0442(2002)015<2125:NWSWTA>2.0.CO;2; HOSKINS BJ, 1990, J ATMOS SCI, V47, P1854, DOI 10.1175/1520-0469(1990)047<1854:OTEOST>2.0.CO;2; KUO YH, 1991, MON WEATHER REV, V119, P368, DOI 10.1175/1520-0493(1991)119<0368:TIBBAD>2.0.CO;2; LINDZEN RS, 1987, J ATMOS SCI, V44, P2418, DOI 10.1175/1520-0469(1987)044<2418:OTROSS>2.0.CO;2; Liu WT, 2002, J OCEANOGR, V58, P121, DOI 10.1023/A:1015832919110; Lund DC, 2006, NATURE, V444, P601, DOI 10.1038/nature05277; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; NEIMAN PJ, 1993, MON WEATHER REV, V121, P2153, DOI 10.1175/1520-0493(1993)121<2153:TLCOAE>2.0.CO;2; O'Neill LW, 2005, J CLIMATE, V18, P2706, DOI 10.1175/JCLI3415.1; Pan JY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015015; Peng SL, 2001, J CLIMATE, V14, P2943, DOI 10.1175/1520-0442(2001)014<2943:RBAIVA>2.0.CO;2; Rio MH, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002226; SANDERS F, 1986, MON WEATHER REV, V114, P1781, DOI 10.1175/1520-0493(1986)114<1781:ECITWC>2.0.CO;2; Skyllingstad ED, 2007, BOUND-LAY METEOROL, V123, P219, DOI 10.1007/s10546-006-9127-8; Small RJ, 2003, J CLIMATE, V16, P3723, DOI 10.1175/1520-0442(2003)016<3723:NSOART>2.0.CO;2; Song QT, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003680; Thiebaux J, 2003, B AM METEOROL SOC, V84, P645, DOI 10.1175/BAMS-84-5-645; Timmermann A, 2007, J CLIMATE, V20, P4899, DOI 10.1175/JCLI4283.1; Tokinaga H, 2005, J CLIMATE, V18, P3470, DOI 10.1175/JCLI3485.1; TRUNK TJ, 1990, MON WEATHER REV, V118, P459, DOI 10.1175/1520-0493(1990)118<0459:MRECDP>2.0.CO;2; Watanabe M, 2006, J ATMOS SCI, V63, P3366, DOI 10.1175/JAS3807.1; Xie SP, 2004, B AM METEOROL SOC, V85, P195, DOI 10.1175/BAMS-85-2-195; Xie SP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015884; Young GS, 2003, MON WEATHER REV, V131, P2177, DOI 10.1175/1520-0493(2003)131<2177:MSBCBG>2.0.CO;2	33	524	550	4	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2008	452	7184					206	U51		10.1038/nature06690	http://dx.doi.org/10.1038/nature06690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337820	Green Submitted			2022-12-28	WOS:000253925600038
J	Paralkar, V				Paralkar, Vikram			Worlds apart - Tuberculosis in India and the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS		[Paralkar, Vikram] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Paralkar, V (corresponding author), Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA.							Bhanu NV, 2004, AM J TROP MED HYG, V70, P527, DOI 10.4269/ajtmh.2004.70.527; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P1072; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Rao KG, 2004, INT J TUBERC LUNG D, V8, P1392; 2007, MMWR MORB MORTAL WKL, V56, P245	5	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1092	1095		10.1056/NEJMp0707933	http://dx.doi.org/10.1056/NEJMp0707933			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	272RK	18337599				2022-12-28	WOS:000253877200002
J	Larroque, B; Ancel, PY; Marret, S; Marchand, L; Andre, M; Arnaud, C; Pierrat, V; Roze, JC; Messer, J; Thiriez, G; Burguet, A; Picaud, JC; Breart, G; Kaminski, M				Larroque, Beatrice; Ancel, Pierre-Yves; Marret, Stephane; Marchand, Laetitia; Andre, Monique; Arnaud, Catherine; Pierrat, Veronique; Roze, Jean-Christophe; Messer, Jean; Thiriez, Gerard; Burguet, Antoine; Picaud, Jean-Charles; Breart, Gerard; Kaminski, Monique		EPIPAGE Study Grp	Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study	LANCET			English	Article							LOW-BIRTH-WEIGHT; SCHOOL-AGED CHILDREN; CEREBRAL-PALSY; PRETERM INFANTS; EARLY INTERVENTION; LESS-THAN-32 WEEKS; OUTCOMES; 1990S; PERFORMANCE; POPULATION	Background The increasing survival rates of children who are born very preterm raise issues about the risks of neurological disabilities and cognitive dysfunction. We aimed to investigate neurodevelopmental outcome and use of special health care at 5 years of age in a population-based cohort of very preterm children. Methods We included all 2901 livebirths between 22 and 32 completed weeks of gestation from nine regions in France in Jan 1-Dec 31, 1997, and a reference group of 667 children from the same regions born at 39-40 weeks of gestation. At 5 years of age, children had a medical examination and a cognitive assessment with the Kaufman assessment battery for children (K-ABC), with scores on the mental processing composite (MPC) scale recorded. Data for health-care use were collected from parents. Severe disability was defined as non-ambulatory cerebral palsy, MPC score less than 55, or severe visual or hearing deficiency; moderate deficiency as cerebral palsy walking with aid or MPC score of 55-69; and minor disability as cerebral palsy walking without aid, MPC score of 70-84, or visual deficit (<3/10 for one eye). Findings In total, 1817 (77%) of the 2357 surviving children born very preterm had a medical assessment at 5 years and 396 (60%) of 664 in the reference group. Cerebral palsy was diagnosed in 159 (9%) of children born very preterm. Scores for MPC were available for 1534 children born very preterm: 503 (32%) had an MPC score less than 85 and 182 (12%) had an MPC score less than 70. Of the 320 children in the reference group, the corresponding values were 37 (12%) and 11 (3%), respectively. In the very preterm group, 83 (5%) had severe disability, 155 (9%) moderate disability, and 398 (25%) minor disability. Disability was highest in children born at 24-28 completed weeks of gestation (195 children [49%]), but the absolute number of children with disabilities was higher for children born at 29-32 weeks (441 children [36%]). Special health-care resources were used by 188 (42%) of children born at 24-28 weeks and 424 (31%) born at 29-32 weeks, compared with only 63 (16%) of those born at 39-40 weeks. Interpretation In children who are born very preterm, cognitive and neuromotor impairments at 5 years of age increase with decreasing gestational age. Many of these children need a high level of specialised care. Prevention of the learning disabilities associated with cognitive deficiencies in this group is an important goal for modern perinatal care for children who are born very preterm and for their families.	[Larroque, Beatrice; Ancel, Pierre-Yves; Marchand, Laetitia; Burguet, Antoine; Breart, Gerard; Kaminski, Monique] INSERM, Res Unit Perinatal Hlth & Womens Hlth, UMR S149, IFR69, Villejuif, France; [Larroque, Beatrice; Ancel, Pierre-Yves; Marchand, Laetitia; Burguet, Antoine; Breart, Gerard; Kaminski, Monique] Univ Paris 06, Paris, France; [Marret, Stephane] Rouen Univ Hosp, Dept Neonatol Med, Rouen, France; [Marret, Stephane] Univ Rouen, Inserm Avenir Res Grp, Inst Biomed Res, Rouen, France; [Andre, Monique] Reg Matern Univ Hosp, Nancy, France; [Arnaud, Catherine] Fac Med Toulouse, INSERM, Res Unit Epidemiol & Publ Hlth, U558, F-31073 Toulouse, France; [Pierrat, Veronique] Jeanne de Flandres Hosp, Dept Neonatol, Lille, France; [Roze, Jean-Christophe] Childrens Hosp, Dept Neonatol, Nantes, France; [Messer, Jean] Hautepierre Hosp, Dept Neonatol, Strasbourg, France; [Thiriez, Gerard] Hop St Jacques, Paediat Intens Care Unit, F-25030 Besancon, France; [Burguet, Antoine] Dept Neonatol, Poitiers, France; [Picaud, Jean-Charles] Hop Arnaud Villeneuve, CHU Montpellier, Dept Neonatol, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Nantes Universite; CHU de Nantes; CHU Strasbourg; Universite de Franche-Comte; CHU Besancon; Universite de Montpellier; CHU de Montpellier	Larroque, B (corresponding author), INSERM, U149, 16 Ave Paul Vaillant, F-94807 Villejuif, France.	Larroque@vjf.inserm.fr	roze, jean christophe/B-5433-2012; Rozé, Jean-Christophe/AAS-1314-2021; ARNAUD, Catherine/AAC-5646-2019	ARNAUD, Catherine/0000-0002-4002-802X; breart, gerard/0000-0003-3142-9128; ANCEL, pierre-yves/0000-0001-9632-7494; Roze, Jean-Christophe/0000-0003-3367-512X; Marret, Stephane/0000-0002-2858-148X; Marchand-Martin, Laetitia/0000-0002-8036-8387				Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Aylward GP, 2002, MENT RETARD DEV D R, V8, P234, DOI 10.1002/mrdd.10043; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Blauw-Hospers CH, 2005, DEV MED CHILD NEUROL, V47, P421, DOI 10.1017/S0012162205000824; Blondel B, 2001, J Gynecol Obstet Biol Reprod (Paris), V30, P552; Bodeau-Livinec F, 2007, ARCH DIS CHILD, V92, P1099, DOI 10.1136/adc.2007.117416; Bowen JR, 2002, J PAEDIATR CHILD H, V38, P438, DOI 10.1046/j.1440-1754.2002.00039.x; Buitendijk S, 2003, EUR J OBSTET GYN R B, V111, pS66, DOI 10.1016/j.ejogrb.2003.09.007; Callanan C, 2001, J PAEDIATR CHILD H, V37, P152, DOI 10.1046/j.1440-1754.2001.00621.x; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Clements KM, 2007, PEDIATRICS, V119, pE866, DOI 10.1542/peds.2006-1729; Cooke RWI, 2003, ARCH DIS CHILD, V88, P482, DOI 10.1136/adc.88.6.482; Grunau RE, 2002, ARCH PEDIAT ADOL MED, V156, P615, DOI 10.1001/archpedi.156.6.615; Hack M, 2005, JAMA-J AM MED ASSOC, V294, P318, DOI 10.1001/jama.294.3.318; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Hack M, 2000, Semin Neonatol, V5, P89, DOI 10.1053/siny.1999.0001; Hille ETM, 2005, PEDIATRICS, V116, pE662, DOI 10.1542/peds.2005-0682; HILLE ETM, 1994, J PEDIATR-US, V125, P426, DOI 10.1016/S0022-3476(05)83290-1; Himmelmann K, 2005, ACTA PAEDIATR, V94, P287, DOI 10.1111/j.1651-2227.2005.tb03071.x; Hintz SR, 2006, ACTA PAEDIATR, V95, P1239, DOI 10.1080/08035250600599727; Johnson S, 2005, ARCH DIS CHILD, V90, P909, DOI 10.1136/adc.2004.057620; Kaufman A, 1983, KAUFMANN ASSESSMENT; KLEBANOV PK, 1994, J DEV BEHAV PEDIATR, V15, P248, DOI 10.1097/00004703-199408000-00005; Larroque B, 2003, J PEDIATR-US, V143, P477, DOI 10.1067/S0022-3476(03)00417-7; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Petrou S, 2006, EARLY HUM DEV, V82, P77, DOI 10.1016/j.earlhumdev.2006.01.002; Platt MJ, 2007, LANCET, V369, P43, DOI 10.1016/S0140-6736(07)60030-0; ROSSANO R, 1970, Bulletin des Societes d'Ophtalmologie de France, V70, P648; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Tin W, 1997, BMJ-BRIT MED J, V314, P107, DOI 10.1136/bmj.314.7074.107; VANZEBENVANDERAA TM, 1989, LANCET, V1, P253; VEEN S, 1991, LANCET, V338, P33, DOI 10.1016/0140-6736(91)90015-H; Vincer MJ, 2006, PEDIATRICS, V118, pE1621, DOI 10.1542/peds.2006-1522; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Whitfield MF, 1997, ARCH DIS CHILD-FETAL, V77, pF85, DOI 10.1136/fn.77.2.F85; Wocadlo C, 2006, EARLY HUM DEV, V82, P29, DOI 10.1016/j.earlhumdev.2005.06.005; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201	37	545	570	0	57	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 8	2008	371	9615					813	820		10.1016/S0140-6736(08)60380-3	http://dx.doi.org/10.1016/S0140-6736(08)60380-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272NQ	18328928				2022-12-28	WOS:000253866500028
J	Lenzer, J; Brownlee, S				Lenzer, Jeanne; Brownlee, Shannon			An untold story?	BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS		[Brownlee, Shannon] New Amer Fdn, Washington, DC USA			jeanne.lenzer@gmail.com						Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Groves T, 2008, BRIT MED J, V336, P170, DOI 10.1136/bmj.39469.465139.80; Juni P, 2005, BMJ-BRIT MED J, V330, P1342, DOI 10.1136/bmj.330.7504.1342; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; LENZER J, 2006, NEW REPUBLIC    1030; LENZER J, 2005, SLATE           0927; Pitkin RM, 1999, JAMA-J AM MED ASSOC, V281, P1110, DOI 10.1001/jama.281.12.1110; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; WAKNINE Y, 2005, MEDSCAPE TODAY  0407	10	11	11	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 8	2008	336	7643					532	534		10.1136/bmj.39504.662685.0F	http://dx.doi.org/10.1136/bmj.39504.662685.0F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JV	18304990	Green Published			2022-12-28	WOS:000253998500025
J	Zarin, DA; Tse, T				Zarin, Deborah A.; Tse, Tony			Medicine - Moving toward transparency of clinical trials	SCIENCE			English	Editorial Material							PUBLICATION BIAS; REGISTRATION; RISK; ROSIGLITAZONE; FDA; LESSONS		[Zarin, Deborah A.; Tse, Tony] NIH, Natl Lib Med, US Dept Hlth & Human Serv, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Zarin, DA (corresponding author), NIH, Natl Lib Med, US Dept Hlth & Human Serv, Bethesda, MD 20894 USA.	dzarin@mail.nih.gov		Tse, Tony/0000-0002-9906-6864	Intramural NIH HHS [Z99 LM999999] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [Z01LM008926] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		[Anonymous], 2007, LANCET, V369, P1834, DOI [10.1016/S0140-6736(07)60787-9, 10.1056/NEJMoao66224]; Avorn J, 2007, NEW ENGL J MED, V357, P2219, DOI 10.1056/NEJMp0706892; Avorn J, 2006, NEW ENGL J MED, V355, P2169, DOI 10.1056/NEJMp068246; BERENSON A, 2008, NY TIMES        0115; BERENSON A, 2007, NY TIMES        1221; BERENSON A, 2006, NY TIMES        0824; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; DIXON K, 2007, REUTERS         0626; Drazen JM, 2007, NEW ENGL J MED, V357, P1756, DOI 10.1056/NEJMe0706501; Dyer C, 2004, BRIT MED J, V329, P591, DOI 10.1136/bmj.329.7466.591-c; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Fisher CB, 2006, SCIENCE, V311, P180, DOI 10.1126/science.1119685; Goodyear M, 2006, BRIT MED J, V332, P677, DOI 10.1136/bmj.38797.635012.47; HARRIS G, 2007, NY TIMES        0912; Hauser RG, 2005, CIRCULATION, V112, P2040, DOI 10.1161/CIRCULATIONAHA.105.580381; Hiatt WR, 2006, NEW ENGL J MED, V355, P2171, DOI 10.1056/NEJMp068252; Holden C, 2004, SCIENCE, V303, P745; Johnson RT, 2007, NAT CLIN PRACT NEURO, V3, P590, DOI 10.1038/ncpneuro0618; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; Laine C, 2002, ANN INTERN MED, V137, P290, DOI 10.7326/0003-4819-137-4-200208200-00015; Laine C, 2007, NEW ENGL J MED, V356, P2734, DOI 10.1056/NEJMe078110; Levin LA, 2007, ARCH INTERN MED, V167, P1576, DOI 10.1001/archinte.167.15.1576; MATHEWS AW, 2008, WALL STREET J   0123, pA14; MEIER B, 2007, NY TIMES        1030; *MERCK CO, 2008, MERCK SCHER PLOUGH P; Miller HI, 2007, NAT REV DRUG DISCOV, V6, P532, DOI 10.1038/nrd2323; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Partridge AH, 2002, JAMA-J AM MED ASSOC, V288, P363, DOI 10.1001/jama.288.3.363; PINCHING AJ, 1995, J ROY SOC MED, V88, P12; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Psaty BM, 2007, NEW ENGL J MED, V357, P67, DOI 10.1056/NEJMe078116; Rennie D, 2004, JAMA-J AM MED ASSOC, V292, P1359, DOI 10.1001/jama.292.11.1359; Rosen CJ, 2007, NEW ENGL J MED, V357, P844, DOI 10.1056/NEJMp078167; Ross DB, 2007, NEW ENGL J MED, V356, P1601, DOI 10.1056/NEJMp078032; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; STEIN R, 2007, WASH POST       0318, pA3; Stephens Joe, 2007, WASHINGTON POST 0530, pA10; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; US National Institutes of Health (NIH), 2003, NIH DAT SHAR POL IMP; Wager E, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010031; Waters R., 2004, SAN FRANCISCO C 0201, pA; WILLIAMS ED, 2007, CLIN TRIALS REPORTIN; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; 2004, NY TIMES        0606	46	130	134	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1340	1342		10.1126/science.1153632	http://dx.doi.org/10.1126/science.1153632			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323436	Green Accepted			2022-12-28	WOS:000253712900025
J	Ringel, SP				Ringel, Steven P.			Lessons from the Santa Fe Trail	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												steven.ringel@uchsc.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2008	299	9					998	999		10.1001/jama.299.9.998	http://dx.doi.org/10.1001/jama.299.9.998			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JH	18319403				2022-12-28	WOS:000253644800001
J	Brett, MJ; Hawkeye, MM				Brett, Michael J.; Hawkeye, Matthew M.			Materials science - New materials at a glance	SCIENCE			English	Editorial Material							ANGLE DEPOSITION; FABRICATION		[Brett, Michael J.; Hawkeye, Matthew M.] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB T6G 2V4, Canada; [Brett, Michael J.] Natl Res Council Canada, Natl Inst Nanotechnol, Edmonton, AB T6G 2E1, Canada	University of Alberta; National Research Council Canada	Brett, MJ (corresponding author), Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB T6G 2V4, Canada.	brett@ece.ualberta.ca						De Silvaa L, 2007, J VAC SCI TECHNOL A, V25, P1118, DOI 10.1116/1.2432347; Dice GD, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2749418; Gaire C, 2008, J MATER RES, V23, P328, DOI 10.1557/JMR.2008.0061; Hawkeye MM, 2007, J VAC SCI TECHNOL A, V25, P1317, DOI 10.1116/1.2764082; Hodgkinson I, 2001, ADV MATER, V13, P889, DOI 10.1002/1521-4095(200107)13:12/13<889::AID-ADMA889>3.0.CO;2-K; HOLLAND L, 1953, J OPT SOC AM, V43, P376, DOI 10.1364/JOSA.43.000376; Jensen MO, 2005, OPT EXPRESS, V13, P3348, DOI 10.1364/OPEX.13.003348; KONIG H, 1950, OPTIK, V6, P111; LAKHTAKIA A, 1995, P R SOC-MATH PHYS SC, V448, P419, DOI 10.1098/rspa.1995.0025; MOTOHIRO T, 1989, APPL OPTICS, V28, P2466, DOI 10.1364/AO.28.002466; Robbie K, 1996, NATURE, V384, P616, DOI 10.1038/384616a0; Singh JP, 2004, APPL PHYS LETT, V84, P3657, DOI 10.1063/1.1738935; Toader O, 2001, SCIENCE, V292, P1133, DOI 10.1126/science.1059479; Ye DX, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.235402; Zhou CM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709929	15	83	88	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1192	1193		10.1126/science.1153910	http://dx.doi.org/10.1126/science.1153910			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309065				2022-12-28	WOS:000253530600021
J	Rahman, A; Isenberg, DA				Rahman, Anisur; Isenberg, David A.			Mechanisms of disease: Systemic lupus erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ANTI-DNA ANTIBODIES; NECROSIS-FACTOR-ALPHA; PLACEBO-CONTROLLED TRIAL; B-LYMPHOCYTE STIMULATOR; CONGENITAL HEART-BLOCK; MONOCLONAL-ANTIBODY; BASEMENT-MEMBRANE; STRANDED-DNA; DOUBLE-BLIND; ANTINUCLEOSOME ANTIBODIES		[Rahman, Anisur; Isenberg, David A.] UCL, Div Med, Ctr Rheumatol Res, London W1T 4JF, England	University of London; University College London	Isenberg, DA (corresponding author), UCL, Div Med, Ctr Rheumatol Res, Rm 331,3rd Fl,46 Cleveland St, London W1T 4JF, England.	d.isenberg@ucl.ac.uk		Isenberg, David/0000-0001-9514-2455				ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1265; Alarcon-Segovia D, 2003, ARTHRITIS RHEUM, V48, P442, DOI 10.1002/art.10763; ALARCONSEGOVIA D, 1989, MEDICINE, V68, P353, DOI 10.1097/00005792-198911000-00003; Amoura Z, 2000, ARTHRITIS RHEUM-US, V43, P76, DOI 10.1002/1529-0131(200001)43:1<76::AID-ANR10>3.0.CO;2-I; Aringer M, 2004, ARTHRITIS RHEUM-US, V50, P3161, DOI 10.1002/art.20576; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baker KP, 2003, ARTHRITIS RHEUM-US, V48, P3253, DOI 10.1002/art.11299; Becker-Merok A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2070; Berden JHM, 1999, CURR OPIN NEPHROL HY, V8, P299, DOI 10.1097/00041552-199905000-00005; BOOTSMA H, 1995, LANCET, V345, P1595, DOI 10.1016/S0140-6736(95)90114-0; BOOTSMA H, 1995, LANCET, V346, P516; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Buyon JP, 2003, SEMIN ARTHRITIS RHEU, V33, P140, DOI 10.1016/j.semarthrit.2003.09.002; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Chambers SA, 2005, LUPUS, V14, P210, DOI 10.1191/0961203305lu2138oa; Chang DM, 2002, ARTHRITIS RHEUM, V46, P2924, DOI 10.1002/art.10615; Charles PJ, 2000, ARTHRITIS RHEUM, V43, P2383, DOI 10.1002/1529-0131(200011)43:11<2383::AID-ANR2>3.3.CO;2-4; Clancy RM, 2004, ARTHRITIS RHEUM, V50, P173, DOI 10.1002/art.11430; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Davidson A, 2005, LUPUS, V14, P197, DOI 10.1191/0961203305lu2136oa; DAVIES KA, 1993, J IMMUNOL, V151, P3866; Deocharan B, 2002, J IMMUNOL, V168, P3072, DOI 10.4049/jimmunol.168.6.3072; Dorner T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1942; Dorner T, 2001, ARTHRITIS RHEUM-US, V44, P2715, DOI 10.1002/1529-0131(200112)44:12<2715::AID-ART458>3.0.CO;2-L; EHRENSTEIN MR, 1995, KIDNEY INT, V48, P705, DOI 10.1038/ki.1995.341; Ehrenstein MR, 2004, OXFORD TXB RHEUMATOL, P819; Gabay C, 1997, J RHEUMATOL, V24, P303; Girardi G, 2004, NAT MED, V10, P1222, DOI 10.1038/nm1121; Gladman D., 2007, DUBOISLUPUS ERYTHEMA, V7, P1333; Grootscholten C, 2003, ARTHRITIS RHEUM, V48, P1355, DOI 10.1002/art.10974; Herrera-Esparza R, 1998, LUPUS, V7, P154, DOI 10.1191/096120398678919949; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOUSSIAU FA, 1995, LUPUS, V4, P393, DOI 10.1177/096120339500400510; Isenberg D, 2006, NAT CLIN PRACT RHEUM, V2, P145, DOI 10.1038/ncprheum0116; Isenberg DA, 2007, RHEUMATOLOGY, V46, P1052, DOI 10.1093/rheumatology/kem112; ISENBERG DA, 1985, ARTHRITIS RHEUM, V28, P999, DOI 10.1002/art.1780280907; JACOB CO, 1988, NATURE, V331, P356, DOI 10.1038/331356a0; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; JOHNSON AE, 1995, ARTHRITIS RHEUM, V38, P551, DOI 10.1002/art.1780380415; Kalaaji M, 2007, KIDNEY INT, V71, P664, DOI 10.1038/sj.ki.5002133; Kalaaji M, 2006, AM J PATHOL, V168, P1779, DOI 10.2353/ajpath.2006.051329; Kang HK, 2005, J IMMUNOL, V174, P3247, DOI 10.4049/jimmunol.174.6.3247; KATZ JB, 1994, J EXP MED, V180, P925, DOI 10.1084/jem.180.3.925; KOFFLER D, 1967, J EXP MED, V126, P607, DOI 10.1084/jem.126.4.607; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; KRAMERS C, 1994, J CLIN INVEST, V94, P568, DOI 10.1172/JCI117371; Lapteva L, 2006, ARTHRITIS RHEUM, V54, P2505, DOI 10.1002/art.22031; Leandro MJ, 2002, ARTHRITIS RHEUM-US, V46, P2673, DOI 10.1002/art.10541; Llorente L, 2000, ARTHRITIS RHEUM, V43, P1790, DOI 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2; Lu LJ, 1999, J CLIN INVEST, V104, P345, DOI 10.1172/JCI6801; MADAIO MP, 1987, J IMMUNOL, V138, P2883; MADDISON PJ, 1979, ARTHRITIS RHEUM, V22, P858; Mannik M, 2003, J RHEUMATOL, V30, P1495; Mason LJ, 2004, ARTHRITIS RHEUM-US, V50, P866, DOI 10.1002/art.20103; MASON LJ, 2005, OXFORD TXB CLIN NEPH, P809; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; MCCARTY GA, 1993, ARTHRITIS RHEUM, V36, P1560, DOI 10.1002/art.1780361110; MERRELL M, 1955, J Chronic Dis, V1, P12, DOI 10.1016/0021-9681(55)90018-7; Merrill JT, 2005, LUPUS, V14, P204, DOI 10.1191/0961203303lu2137oa; Michaud JL, 2003, J AM SOC NEPHROL, V14, P1200, DOI 10.1097/01.ASN.0000059864.88610.5E; Mohan AK, 2002, LANCET, V360, P646, DOI 10.1016/S0140-6736(02)09800-8; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Mostoslavsky G, 2001, EUR J IMMUNOL, V31, P1221, DOI 10.1002/1521-4141(200104)31:4<1221::AID-IMMU1221>3.0.CO;2-P; Mudd PA, 2006, SCAND J IMMUNOL, V64, P211, DOI 10.1111/j.1365-3083.2006.01808.x; Munoz LE, 2005, RHEUMATOLOGY, V44, P1101, DOI 10.1093/rheumatology/keh693; NAMJOU B, 2007, SYSTEMIC LUPUS ERYTH, P74; Ng KP, 2006, ARTHRIT RHEUM-ARTHR, V55, P900, DOI 10.1002/art.22356; OKAMURA M, 1993, ANN RHEUM DIS, V52, P14, DOI 10.1136/ard.52.1.14; Pierangeli SS, 2000, THROMB HAEMOSTASIS, V84, P388; PUJOL M, 1995, BRIT J HAEMATOL, V89, P137, DOI 10.1111/j.1365-2141.1995.tb08919.x; Quisimoro FP, 2007, DUBOIS LUPUS ERYTHEM, P527; Rahman A, 2004, RHEUMATOLOGY, V43, P1326, DOI 10.1093/rheumatology/keh354; Ravirajan CT, 1999, EUR J IMMUNOL, V29, P3052; Ravirajan CT, 1998, EUR J IMMUNOL, V28, P339, DOI 10.1002/(SICI)1521-4141(199801)28:01<339::AID-IMMU339>3.0.CO;2-C; Ronnblom L, 2003, ARTHRITIS RES THER, V5, P68, DOI 10.1186/ar625; Rubin R., 2002, DUBOIS LUPUS ERYTHEM, P885; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; Sidiropoulos PI, 2004, LUPUS, V13, P391, DOI 10.1191/0961203304lu1032oa; SIEGERT CEH, 1993, CLIN IMMUNOL IMMUNOP, V67, P204, DOI 10.1006/clin.1993.1066; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; SONTHEIMER RD, 1982, ANN INTERN MED, V97, P664, DOI 10.7326/0003-4819-97-5-664; Stohl W, 2003, ARTHRITIS RHEUM-US, V48, P3475, DOI 10.1002/art.11354; Sullivan KE, 2000, RHEUM DIS CLIN N AM, V26, P229, DOI 10.1016/S0889-857X(05)70137-X; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TERBORG EJ, 1990, ARTHRITIS RHEUM-US, V33, P634, DOI 10.1002/art.1780330505; Tseng CE, 2006, ARTHRITIS RHEUM-US, V54, P3623, DOI 10.1002/art.22198; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; VANBRUGGEN MC, 1997, EUR J IMMUNOL, V2, P1564; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Walport MJ, 2002, ARTHRITIS RES THER, V4, pS279, DOI 10.1186/ar586; WALPORT MJ, 1982, CLIN RHEUM DIS, V8, P3; Weisman MH, 1997, J RHEUMATOL, V24, P314; Yoshio T, 2006, ARTHRITIS RHEUM, V54, P675, DOI 10.1002/art.21547	97	1341	1432	10	192	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					929	939		10.1056/NEJMra071297	http://dx.doi.org/10.1056/NEJMra071297			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18305268				2022-12-28	WOS:000253430200008
J	Philips, M; Zachariah, R; Venis, S				Philips, Mit; Zachariah, Rony; Venis, Sarah			Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea	LANCET			English	Editorial Material							HEALTH-WORKERS; DISTRICT		[Philips, Mit] Med Sans Frontieres, Brussels Operat Ctr, Anal & Advocacy Unit, B-1090 Brussels, Belgium; [Zachariah, Rony] Med Sans Frontieres, Brussels Operat Ctr, Med Dept Operat Res, B-1090 Brussels, Belgium; [Venis, Sarah] Med Sans Frontieres, London, England	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders	Philips, M (corresponding author), Med Sans Frontieres, Brussels Operat Ctr, Anal & Advocacy Unit, 94 Dupre St, B-1090 Brussels, Belgium.	mit.philips@brussels.msf.org		zachariah, rony/0000-0002-2915-9328				Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; BERMAN PA, 1987, SOC SCI MED, V25, P443, DOI 10.1016/0277-9536(87)90168-7; BLUESTONE J, 2005, TASK SHIFTING STRATE, P72; Buchan J, 2002, B WORLD HEALTH ORGAN, V80, P575; BUCHAN J, 2000, HUM RES HLTH DEV J, V4, P111; Dambisya YM, 2007, REV NONFINANCIAL INC; Dovlo Delanyo, 2004, Hum Resour Health, V2, P7, DOI 10.1186/1478-4491-2-7; Gimbel-Sherr Sarah O, 2007, Hum Resour Health, V5, P7, DOI 10.1186/1478-4491-5-7; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; *HRH WORK GROUP HI, 2005, WORK TOG TACKL CRIS, P72; KOBER K, 2005, EXPERT PATIENTS AIDS, P72; Lewin SA, 2005, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD004015.PUB2; Medecins sans Frontieres, 2007, HELP WANT CONFR HLTH; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Ooms G, 2007, PLOS MED, V4, P605, DOI 10.1371/journal.pmed.0040128; Rowe SY, 2007, T ROY SOC TROP MED H, V101, P188, DOI 10.1016/j.trstmh.2006.02.023; Serneels P, 2007, HEALTH POLICY PLANN, V22, P128, DOI 10.1093/heapol/czm005; Sibbald Bonnie, 2004, J Health Serv Res Policy, V9 Suppl 1, P28, DOI 10.1258/135581904322724112; Van Damme W, 2006, AIDS, V20, P653, DOI 10.1097/01.aids.0000216364.44409.b1; WALT G, 1992, COMMUNITY HLTH WORKE; *WEM FDN, 2005, BUDG CEIL HLTH KEN C, P72; WHO, 2006, WORK TOG HLTH WORLD; World Health Organization, TASK SHIFT RAT RED T; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	25	105	105	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2008	371	9613					682	684		10.1016/S0140-6736(08)60307-4	http://dx.doi.org/10.1016/S0140-6736(08)60307-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LL	18295026				2022-12-28	WOS:000253436700033
J	Datta, SR; Vasconcelos, ML; Ruta, V; Luo, S; Wong, A; Demir, E; Flores, J; Balonze, K; Dickson, BJ; Axel, R				Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Ruta, Vanessa; Luo, Sean; Wong, Allan; Demir, Ebru; Flores, Jorge; Balonze, Karen; Dickson, Barry J.; Axel, Richard			The Drosophila pheromone cVA activates a sexually dimorphic neural circuit	NATURE			English	Article							MALE COURTSHIP BEHAVIOR; OLFACTORY SYSTEM; FRUITLESS GENE; NEURONS; PROTEIN; REPRESENTATION; ORGANIZATION; ORIENTATION; RESPONSES; BRAIN	Courtship is an innate sexually dimorphic behaviour that can be observed in naive animals without previous learning or experience, suggesting that the neural circuits that mediate this behaviour are developmentally programmed(1). In Drosophila, courtship involves a complex yet stereotyped array of dimorphic behaviours that are regulated by Fru(M), a male- specific isoform of the fruitless gene(2-5). Fru(M) is expressed in about 2,000 neurons in the fly brain, including three subpopulations of olfactory sensory neurons and projection neurons ( PNs). One set of Fru(+) olfactory neurons expresses the odorant receptor Or67d and responds to the male-specific pheromone cis- vaccenyl acetate ( cVA)(6-10). These neurons converge on the DA1 glomerulus in the antennal lobe. In males, activation of Or67d 1 neurons by cVA inhibits courtship of other males, whereas in females their activation promotes receptivity to other males(7). These observations pose the question of how a single pheromone acting through the same set of sensory neurons can elicit different behaviours in male and female flies. Anatomical or functional dimorphisms in this neural circuit might be responsible for the dimorphic behaviour. We therefore developed a neural tracing procedure that employs two- photon laser scanning microscopy to activate the photoactivatable green fluorescent protein(11). Here we show, using this technique, that the projections from the DA1 glomerulus to the protocerebrum are sexually dimorphic. We observe a male- specific axonal arbor in the lateral horn whose elaboration requires the expression of the transcription factor Fru(M) in DA1 projection neurons and other Fru(+) cells. The observation that cVA activates a sexually dimorphic circuit in the protocerebrum suggests a mechanism by which a single pheromone can elicit different behaviours in males and in females.	[Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Ruta, Vanessa; Luo, Sean; Wong, Allan; Flores, Jorge; Balonze, Karen; Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Ruta, Vanessa; Luo, Sean; Wong, Allan; Flores, Jorge; Balonze, Karen; Axel, Richard] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Wong, Allan] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; [Wong, Allan] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Demir, Ebru; Dickson, Barry J.] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Columbia University; Columbia University; Howard Hughes Medical Institute; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ra27@columbia.edu	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Datta, Sandeep/0000-0002-8068-3862; Vasconcelos, Maria Luisa/0000-0001-6248-3667; Ruta, Vanessa/0000-0002-4963-2768; Axel, Richard/0000-0002-3141-4076	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; Cajal S., 1889, MANUAL HISTOLOGIA NO; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Heinrichs V, 1998, MOL CELL BIOL, V18, P450, DOI 10.1128/MCB.18.1.450; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Ito K, 1998, LEARN MEMORY, V5, P52; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	27	247	252	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2008	452	7186					473	477		10.1038/nature06808	http://dx.doi.org/10.1038/nature06808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18305480				2022-12-28	WOS:000254341300032
J	Vollbrecht, JE; Rao, DS				Vollbrecht, Jill E.; Rao, D. Sudhaker			Tumor-induced osteomalacia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vollbrecht, Jill E.; Rao, D. Sudhaker] Henry Ford Hlth Syst, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Vollbrecht, JE (corresponding author), Henry Ford Hlth Syst, Detroit, MI 48202 USA.	tjvollbrecht@yahoo.com	Rao, Sudhaker/ABG-8204-2021						0	8	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1282	1282		10.1056/NEJMicm066066	http://dx.doi.org/10.1056/NEJMicm066066			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275TL	18354106				2022-12-28	WOS:000254094400009
J	Ruggenenti, P; Remuzzi, A; Remuzzi, G				Ruggenenti, Piero; Remuzzi, Andrea; Remuzzi, Giuseppe			Decision time for pancreatic islet-cell transplantation	LANCET			English	Editorial Material							MICE		[Ruggenenti, Piero; Remuzzi, Andrea; Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy; [Ruggenenti, Piero; Remuzzi, Giuseppe] Azienda Osped Osped Riuniti, Dept Transplant Med, Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy.	gremuzzi@marionegri.it	Remuzzi, Giuseppe/V-9766-2017; Remuzzi, Andrea/F-2409-2015	Remuzzi, Giuseppe/0000-0002-6194-3446; Remuzzi, Andrea/0000-0002-4301-8927				Amer Diabet Assoc, 2006, DIABETES CARE, V29, P935; Bromberg JS, 2007, AM J TRANSPLANT, V7, P2217, DOI 10.1111/j.1600-6143.2007.01957.x; Campbell PM, 2007, AM J TRANSPLANT, V7, P2311, DOI 10.1111/j.1600-6143.2007.01923.x; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Martina Y, 2006, J VIROL, V80, P3135, DOI 10.1128/JVI.80.7.3135-3146.2006; Matas AJ, 2005, AM J TRANSPLANT, V5, P2473, DOI 10.1111/j.1600-6143.2005.01051.x; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Rajotte RV, 2007, XENOTRANSPLANTATION, V14, P446; Senior PA, 2007, AM J TRANSPLANT, V7, P91, DOI 10.1111/j.1600-6143.2006.01573.x; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; *SYS CON MED, 2007, LIV CELL TECHN ANN 1	11	14	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2008	371	9616					883	884		10.1016/S0140-6736(08)60395-5	http://dx.doi.org/10.1016/S0140-6736(08)60395-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342671				2022-12-28	WOS:000254056800010
J	Poxleitner, MK; Carpenter, ML; Mancuso, JJ; Wang, CJR; Dawson, SC; Cande, WZ				Poxleitner, Marianne K.; Carpenter, Meredith L.; Mancuso, Joel J.; Wang, Chung-Ju R.; Dawson, Scott C.; Cande, W. Zacheus			Evidence for karyogamy and exchange of genetic material in the binucleate intestinal parasite Giardia intestinalis	SCIENCE			English	Article							2 NUCLEI; LAMBLIA; CYTOKINESIS; CHROMOSOMES; MEIOSIS; GENOME	The diplomonad parasite Giardia intestinalis contains two functionally equivalent nuclei that are inherited independently during mitosis. Although presumed to be asexual, Giardia has low levels of allelic heterozygosity, indicating that the two nuclear genomes may exchange genetic material. Fluorescence in situ hybridization performed with probes to an episomal plasmid suggests that plasmids are transferred between nuclei in the cyst, and transmission electron micrographs demonstrate fusion between cyst nuclei. Green fluorescent protein fusions of giardial homologs of meiosis- specific genes localized to the nuclei of cysts, but not the vegetative trophozoite. These data suggest that the fusion of nuclei, or karyogamy, and subsequently somatic homologous recombination facilitated by the meiosis gene homologs, occur in the giardial cyst.	[Poxleitner, Marianne K.; Carpenter, Meredith L.; Mancuso, Joel J.; Wang, Chung-Ju R.; Cande, W. Zacheus] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Dawson, Scott C.] Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA	University of California System; University of California Berkeley; University of California System; University of California Davis	Cande, WZ (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	zcande@berkeley.edu	Carpenter, Meredith/B-4290-2011; Wang, Chung-Ju Rachel/ABH-1022-2020	Wang, Chung-Ju Rachel/0000-0002-1046-3012; Carpenter, Meredith/0000-0002-9798-9374; Dawson, Scott/0000-0002-0843-1759	NIGMS NIH HHS [1F32GM078971] Funding Source: Medline; PHS HHS [A1054693] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078971] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM RD, 1988, NUCLEIC ACIDS RES, V16, P4555, DOI 10.1093/nar/16.10.4555; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Bernander R, 2001, CELL MICROBIOL, V3, P55, DOI 10.1046/j.1462-5822.2001.00094.x; Birky CW, 1996, GENETICS, V144, P427; Cooper MA, 2007, CURR BIOL, V17, P1984, DOI 10.1016/j.cub.2007.10.020; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; KABNICK KS, 1990, J CELL SCI, V95, P353; Kondrashov AS, 1997, ANNU REV ECOL SYST, V28, P391, DOI 10.1146/annurev.ecolsys.28.1.391; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; REINER DS, 1989, INFECT IMMUN, V57, P963, DOI 10.1128/IAI.57.3.963-968.1989; Sagolla MS, 2006, J CELL SCI, V119, P4889, DOI 10.1242/jcs.03276; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Teodorovic S, 2007, EUKARYOT CELL, V6, P1421, DOI 10.1128/EC.00138-07; Villeneuve AM, 2001, CELL, V106, P647, DOI 10.1016/S0092-8674(01)00500-1; Yu LZ, 2002, EUKARYOT CELL, V1, P191, DOI 10.1128/EC.1.2.191-199.2002	16	124	124	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1530	1533		10.1126/science.1153752	http://dx.doi.org/10.1126/science.1153752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339940				2022-12-28	WOS:000253943800040
J	Vaughn, D; Strathmann, RR				Vaughn, Dawn; Strathmann, Richard R.			Predators induce cloning in echinoderm larvae	SCIENCE			English	Article							SIZE; REPRODUCTION		[Vaughn, Dawn; Strathmann, Richard R.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA	University of Washington	Vaughn, D (corresponding author), Univ Washington, Friday Harbor Labs, 620 Univ Rd, Friday Harbor, WA 98250 USA.	dvaughn@u.washington.edu						Allen JD, 2008, BIOL BULL-US, V214, P42, DOI 10.2307/25066658; Eaves AA, 2003, NATURE, V425, P146, DOI 10.1038/425146a; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; JAECKLE WB, 1994, BIOL BULL, V186, P62, DOI 10.2307/1542036; LITVAK MK, 1992, MAR ECOL PROG SER, V81, P13, DOI 10.3354/meps081013; Suchman CL, 2000, J PLANKTON RES, V22, P2289, DOI 10.1093/plankt/22.12.2289; Vickery MS, 2000, BIOL BULL, V199, P298, DOI 10.2307/1543186	7	39	39	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1503	1503		10.1126/science.1151995	http://dx.doi.org/10.1126/science.1151995			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339931				2022-12-28	WOS:000253943800030
J	Yi, R; Poy, MN; Stoffel, M; Fuchs, E				Yi, Rui; Poy, Matthew N.; Stoffel, Markus; Fuchs, Elaine			A skin microRNA promotes differentiation by repressing 'stemness'	NATURE			English	Article							GENE-EXPRESSION; P53 HOMOLOG; IN-VIVO; P63; KERATINOCYTE; CELLS; PROLIFERATION; MORPHOGENESIS; COMMITMENT; ZEBRAFISH	In stratified epithelial tissues, homeostasis relies on the self-renewing capacity of stem cells located within the innermost basal layer(1). As basal cells become suprabasal, they lose proliferative potential and embark on a terminal differentiation programme(2,3). Here, we show that microRNA- 203 is induced in the skin concomitantly with stratification and differentiation. By alteringmiR- 203' s spatiotemporal expression in vivo, we show that miR- 203 promotes epidermal differentiation by restricting proliferative potential and inducing cell- cycle exit. We identify p63 as one of the conserved targets of miR- 203 across vertebrates. Notably, p63 is an essential regulator of stem- cell maintenance in stratified epithelial tissues(4-9). We show that miR- 203 directly represses the expression of p63: it fails to switch off suprabasally when either Dicer1 or miR- 203 is absent and it becomes repressed basally when miR- 203 is prematurely expressed. Our findings suggest that miR- 203 defines a molecular boundary between proliferative basal progenitors and terminally differentiating suprabasal cells, ensuring proper identity of neighbouring layers.	[Yi, Rui; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Yi, Rui; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Poy, Matthew N.; Stoffel, Markus] ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Poy, Matthew/F-6914-2017; Fuchs, Elaine/G-1565-2016	Poy, Matthew/0000-0002-4904-2426; YI, RUI/0000-0002-6934-7091; Stoffel, Markus/0000-0003-1304-5817	Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [R01 AR050452] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Davis S, 2006, NUCLEIC ACIDS RES, V34, P2294, DOI 10.1093/nar/gkl183; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	30	601	642	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					225	U69		10.1038/nature06642	http://dx.doi.org/10.1038/nature06642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18311128	Green Accepted			2022-12-28	WOS:000253925600042
J	Berwick, DM				Berwick, Donald M.			The science of improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL EMERGENCY TEAM; QUALITY IMPROVEMENT; CARE		Inst Healthcare Improvement, Cambridge, MA 02138 USA	Institute for Healthcare Improvement	Berwick, DM (corresponding author), Inst Healthcare Improvement, 20 Univ Rd,7th Floor, Cambridge, MA 02138 USA.	dber-wick@ihi.org	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213				Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Batalden PB, 2007, QUAL SAF HEALTH CARE, V16, P2, DOI 10.1136/qshc.2006.022046; Brennan TA, 2004, QUAL SAF HEALTH CARE, V13, P145, DOI 10.1136/qhc.13.2.145; BROOK RH, 1973, QUALITY CARE ASSESSM; Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; EDDY DM, 1988, HEALTH AFFAIR, V7, P19, DOI 10.1377/hlthaff.7.1.19; Esmonde L, 2006, INTENS CARE MED, V32, P1713, DOI 10.1007/s00134-006-0380-6; Fisher B, 1999, EUR J CANCER, V35, P1963, DOI 10.1016/S0959-8049(99)00217-8; Hillman K, 2005, LANCET, V365, P2091; Hurtado MP, 2001, CROSSING QUALITY CHA; *I MED, 1985, ASS MED TECHN REP CO; KOHN LT, 1999, TO ERR IS HUMAN BUIL; LEMBCKE PA, 1956, JAMA-J AM MED ASSOC, V162, P646, DOI 10.1001/jama.1956.72970240010009; Pawson R., 1997, REALISTIC EVALUATION; Sharek PJ, 2007, JAMA-J AM MED ASSOC, V298, P2267, DOI 10.1001/jama.298.19.2267; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; VERONESI U, 1981, NEW ENGL J MED, V305, P6, DOI 10.1056/NEJM198107023050102; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645; 1979, CAN MED ASS J, V121, P1193	20	540	543	1	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2008	299	10					1182	1184		10.1001/jama.299.10.1182	http://dx.doi.org/10.1001/jama.299.10.1182			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272CE	18334694				2022-12-28	WOS:000253835000022
J	Unger, RH				Unger, Roger H.			Reinventing type 2 diabetes - Pathogenesis, treatment, and prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSULIN-RESISTANCE; METABOLIC SYNDROME; UNITED-STATES; OBESITY; MELLITUS; SENSITIVITY; DISEASE		Univ Texas SW Med Ctr Dallas, Touchstone Ctr Diabet Res, Dallas, TX 75390 USA; Vet Affairs Med Ctr, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Unger, RH (corresponding author), Univ Texas SW Med Ctr Dallas, Touchstone Ctr Diabet Res, 5323 Harry Hines Blvd,L5-202, Dallas, TX 75390 USA.	roger.unger@utsouthwestern.edu						Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P80; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Eaton Danice K., 2006, Morbidity and Mortality Weekly Report, V55, P1; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; MERIMEE TJ, 1971, NEW ENGL J MED, V285, P856, DOI 10.1056/NEJM197110072851511; Nauck MA, 2007, DIABETOLOGIA, V50, P259, DOI 10.1007/s00125-006-0510-2; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; RANDLE PJ, 1963, LANCET, V1, P785; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REAVEN GM, 1984, DIABETES CARE, V7, P17; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; SHERWIN RS, 1974, J CLIN INVEST, V53, P1481, DOI 10.1172/JCI107697; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; YALOW RS, 1960, J CLIN INVEST, V39, P1157, DOI 10.1172/JCI104130	20	77	84	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2008	299	10					1185	1187		10.1001/jama.299.10.1185	http://dx.doi.org/10.1001/jama.299.10.1185			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272CE	18334695				2022-12-28	WOS:000253835000023
J	Capadona, JR; Shanmuganathan, K; Tyler, DJ; Rowan, SJ; Weder, C				Capadona, Jeffrey R.; Shanmuganathan, Kadhiravan; Tyler, Dustin J.; Rowan, Stuart J.; Weder, Christoph			Stimuli-responsive polymer nanocomposites inspired by the sea cucumber dermis	SCIENCE			English	Article							TUNICATE CELLULOSE WHISKERS; MUTABLE COLLAGENOUS TISSUE; COMPOSITE; VISCOSITY; NETWORK; DEVICES	Generation, investigation, and manipulation of nanostructured materials are of fundamental and practical importance for several disciplines, including materials science and medicine. Recently, atmospheric new particle formation in the nanometer- size range has been found to be a global phenomenon. Still, its detailed mechanisms are mostly unknown, largely depending on the incapability to generate and measure nanoparticles in a controlled way. In our experiments, an organic vapor ( n- propanol) condenses on molecular ions, as well as on charged and uncharged inorganic nanoparticles, via initial activation by heterogeneous nucleation. We found a smooth transition in activation behavior as a function of size and activation to occur well before the onset of homogeneous nucleation. Furthermore, nucleation enhancement for charged particles and a substantial negative sign preference were quantitatively detected.	[Capadona, Jeffrey R.; Shanmuganathan, Kadhiravan; Rowan, Stuart J.; Weder, Christoph] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA; [Capadona, Jeffrey R.; Tyler, Dustin J.; Rowan, Stuart J.; Weder, Christoph] Louis Stokes Cleveland DVA Med Ctr, Cleveland, OH 44106 USA; [Capadona, Jeffrey R.; Tyler, Dustin J.; Rowan, Stuart J.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Rowan, Stuart J.; Weder, Christoph] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University	Rowan, SJ (corresponding author), Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA.	stuart.rowan@case.edu; christoph.weder@case.edu	Shanmuganathan, Kadhiravan/AFV-0951-2022; Tyler, Dustin J/C-7995-2015; Weder, Christoph/K-7453-2012; Tyler, Dustin/AAB-4164-2019; Capadona, Jeffrey R/G-4772-2010	Shanmuganathan, Kadhiravan/0000-0001-8062-6684; Tyler, Dustin J/0000-0002-2298-8510; Tyler, Dustin/0000-0002-2298-8510; Weder, Christoph/0000-0001-7183-1790; Rowan, Stuart/0000-0001-8176-0594	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053798] Funding Source: NIH RePORTER; NINDS NIH HHS [R21 NS053798-02, R21 NS053798] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELTON PS, 1989, MACROMOLECULES, V22, P1615, DOI 10.1021/ma00194a019; Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138; Capadona JR, 2007, NAT NANOTECHNOL, V2, P765, DOI 10.1038/nnano.2007.379; Grunlan JC, 2006, NANO LETT, V6, P911, DOI 10.1021/nl052486t; Hajji P, 1996, POLYM COMPOSITE, V17, P612, DOI 10.1002/pc.10651; HALPIN JC, 1972, J APPL PHYS, V43, P2235, DOI 10.1063/1.1661482; Heinzeller T, 2004, ECHINODERMS; Jaber JA, 2006, J AM CHEM SOC, V128, P2940, DOI 10.1021/ja055892n; Kunzelman J, 2007, J MATER CHEM, V17, P2989, DOI 10.1039/b705880b; Lima MMD, 2004, MACROMOL RAPID COMM, V25, P771, DOI 10.1002/marc.200300268; Loveless DM, 2007, J MATER CHEM, V17, P56, DOI 10.1039/b614026b; MOTOKAWA T, 1994, COMP BIOCHEM PHYS B, V109, P613, DOI 10.1016/0305-0491(94)90124-4; NAJAFI K, 1990, IEEE T BIO-MED ENG, V37, P474, DOI 10.1109/10.55638; OUALI N, 1991, J PLAST RUBBER COMP, V16, P55; Rutten WLC, 2002, ANNU REV BIOMED ENG, V4, P407, DOI 10.1146/annurev.bioeng.4.020702.153427; Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Sturcova A, 2005, BIOMACROMOLECULES, V6, P1055, DOI 10.1021/bm049291k; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Szulgit GK, 2000, J EXP BIOL, V203, P1539; Takayanagi M., 1964, J POLYM SCI C, V5, P113, DOI DOI 10.1002/POLC.5070050111; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Thurmond FA, 1996, J EXP BIOL, V199, P1817; Trotter JA, 2000, BIOCHEM SOC T, V28, P357, DOI 10.1042/0300-5127:0280357; Trotter JA, 1999, MATRIX BIOL, V18, P569, DOI 10.1016/S0945-053X(99)00050-5; van den Berg O, 2007, BIOMACROMOLECULES, V8, P1353, DOI 10.1021/bm061104q; Wilkie IC, 2002, J EXP BIOL, V205, P159	27	740	760	31	691	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1370	1374		10.1126/science.1153307	http://dx.doi.org/10.1126/science.1153307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323449				2022-12-28	WOS:000253712900038
J	Hunter, N				Hunter, Neil			Hop1 and the meiotic DNA-damage response	CELL			English	Editorial Material							STRAND BREAK REPAIR; BUDDING YEAST; MEK1 KINASE; CHECKPOINT; MEIOSIS; DOMAIN; RED1; RAD9	During the DNA-damage response, adaptor proteins mediate signaling between the PI3K-like sensor kinases, ATM and ATR, and serine/threonine effector kinases. Carballo et al. (2008) now show that the chromosomal protein Hop1 mediates PI3K-like kinase signaling during the repair of DNA double-strand breaks (DSBs) in meiosis.	[Hunter, Neil] Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hunter, N (corresponding author), Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA.	nhunter@ucdavis.edu						Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Wan LH, 2004, MOL BIOL CELL, V15, P11, DOI 10.1091/mbc.E03-07-0499; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Zhao H, 2004, J BIOL CHEM, V279, P53023, DOI 10.1074/jbc.M410449200	13	7	7	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					731	732		10.1016/j.cell.2008.02.026	http://dx.doi.org/10.1016/j.cell.2008.02.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329359	Bronze			2022-12-28	WOS:000253818000010
J	Keller, M; Ruegg, A; Werner, S; Beer, HD				Keller, Martin; Rueegg, Andreas; Werner, Sabine; Beer, Hans-Dietmar			Active caspase-1 is a regulator of unconventional protein secretion	CELL			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; MASS-SPECTROMETRIC PROTEOMICS; NONCLASSICAL SECRETION; INFLAMMATORY CASPASES; IL-1-BETA SECRETION; MICE DEFICIENT; GROWTH-FACTOR; ACTIVATION; CELLS; EXOCYTOSIS	Mammalian cells export most proteins by the endoplasmic reticulum/Golgi-dependent pathway. However, some proteins are secreted via unconventional, poorly understood mechanisms. The latter include the proinflammatory cytokines interleukin(IL)-1 beta, IL-18, and IL-33, which require activation by caspase-1 for biological activity. Caspase-1 itself is activated by innate immune complexes, the inflammasomes. Here we show that secretion of the leaderless proteins proIL-1 alpha, caspase-1, and fibroblast growth factor (FGF)-2 depends on caspase-1 activity. Although proIL-1 alpha and FGF-2 are not substrates of the protease, we demonstrated their physical interaction. Secretome analysis using iTRAQ proteomics revealed caspase-1-mediated secretion of other leaderless proteins with known or unknown extracellular functions. Strikingly, many of these proteins are involved in inflammation, cytoprotection, or tissue repair. These results provide evidence for an important role of caspase-1 in unconventional protein secretion. By this mechanism, stress-induced activation of caspase-1 directly links inflammation to cytoprotection, cell survival, and regenerative processes.	[Keller, Martin; Rueegg, Andreas; Werner, Sabine; Beer, Hans-Dietmar] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Beer, HD (corresponding author), ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland.	dietmar.beer@cell.biol.ethz.ch		Werner, Sabine/0000-0001-7397-8710; Beer, Hans-Dietmar/0000-0002-8085-713X				Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; BROADLEY KN, 1989, LAB INVEST, V61, P571; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chang JW, 2006, BIOCHEM BIOPH RES CO, V345, P118, DOI 10.1016/j.bbrc.2006.04.073; Cleves AE, 1997, CURR BIOL, V7, pR318, DOI 10.1016/S0960-9822(06)00148-5; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; Danielsen EM, 2003, BIOCHEMISTRY-US, V42, P14670, DOI 10.1021/bi0355239; Di Quinzio MKW, 2007, AUST NZ J OBSTET GYN, V47, P9, DOI 10.1111/j.1479-828X.2006.00671.x; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Donaldson VH, 1998, P ASSOC AM PHYSICIAN, V110, P140; Faure AV, 2002, EXP CELL RES, V276, P79, DOI 10.1006/excr.2002.5512; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Haendeler J, 2006, ANTIOXID REDOX SIGN, V8, P1723, DOI 10.1089/ars.2006.8.1723; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Heidtmann HH, 1997, CLIN EXP METASTAS, V15, P368, DOI 10.1023/A:1018494020001; Huang CM, 2006, PROTEOMICS, V6, P5805, DOI 10.1002/pmic.200600163; Huang CM, 2006, PROTEOMICS, V6, P6107, DOI 10.1002/pmic.200600287; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lanza A, 2006, INT J IMMUNOPATH PH, V19, P399, DOI 10.1177/039463200601900216; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Lolis E, 2003, EXPERT OPIN THER TAR, V7, P153, DOI 10.1517/14728222.7.2.153; Lorusso A, 2006, EMBO J, V25, P5443, DOI 10.1038/sj.emboj.7601419; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Mee JB, 2005, J INVEST DERMATOL, V124, P1267, DOI 10.1111/j.0022-202X.2005.23684.x; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Munding C, 2006, CELL DEATH DIFFER, V13, P1938, DOI 10.1038/sj.cdd.4401896; Nakamura H, 2006, SEMIN CANCER BIOL, V16, P444, DOI 10.1016/j.semcancer.2006.09.001; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; RUBARTELLI A, 1995, CANCER RES, V55, P675; Rubartelli Anna, 2005, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V4, P133, DOI 10.2174/1568014053507104; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Zhao WQ, 2003, J BIOL CHEM, V278, P4205, DOI 10.1074/jbc.M210545200	53	670	699	0	83	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					818	831		10.1016/j.cell.2007.12.040	http://dx.doi.org/10.1016/j.cell.2007.12.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329368	Bronze			2022-12-28	WOS:000253818000019
J	Soetikno, RM; Kaltenbach, T; Rouse, RV; Park, W; Maheshwari, A; Sato, T; Matsui, S; Friedland, S				Soetikno, Roy M.; Kaltenbach, Tonya; Rouse, Robert V.; Park, Walter; Maheshwari, Anamika; Sato, Tohru; Matsui, Suzanne; Friedland, Shai			Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INCREASED RISK; LESIONS; SURVEILLANCE; ADENOMAS; CANCER; COLON; COLONOSCOPY; GUIDELINES; RESECTION; UPDATE	Context Colorectal cancer is the second leading cause of cancer death in the United States. Prevention has focused on the detection and removal of polypoid neoplasms. Data are limited on the significance of nonpolypoid colorectal neoplasms ( NP- CRNs). Objectives To determine the prevalence of NP- CRNs in a veterans hospital population and to characterize their association with colorectal cancer. Design, Setting, and Patients Cross- sectional study at a veterans hospital in California with 1819 patients undergoing elective colonoscopy from July 2003 to June 2004. Main Outcome Measures Endoscopic appearance, location, size, histology, and depth of invasion of neoplasms. Results The overall prevalence of NP- CRNs was 9.35% ( 95% confidence interval [ 95% CI], 8.05%- 10.78%; n= 170). The prevalence of NP- CRNs in the subpopulations for screening, surveillance, and symptoms was 5.84% ( 95% CI, 4.13%- 8.00%; n= 36), 15.44% ( 95% CI, 12.76%- 18.44%; n= 101), and 6.01% ( 95% CI, 4.17%-8.34%; n= 33), respectively. The overall prevalence of NP- CRNs with in situ or submucosal invasive carcinoma was 0.82% ( 95% CI, 0.46%- 1.36%; n= 15); in the screening population, the prevalence was 0.32% ( 95% CI, 0.04%- 1.17%; n= 2). Overall, NP- CRNs were more likely to contain carcinoma ( odds ratio, 9.78; 95% CI, 3.93-24.4) than polypoid lesions, irrespective of the size. The positive size- adjusted association of NP- CRNs with in situ or submucosal invasive carcinoma was also observed in subpopulations for screening ( odds ratio, 2.01; 95% CI, 0.27- 15.3) and surveillance ( odds ratio, 63.7; 95% CI, 9.41- 431). The depressed type had the highest risk ( 33%). Nonpolypoid colorectal neoplasms containing carcinoma were smaller in diameter as compared with the polypoid ones ( mean [ SD] diameter, 15.9 [ 10.2] mm vs 19.2 [ 9.6] mm, respectively). The procedure times did not change appreciably as compared with historical controls. Conclusion In this group of veteran patients, NP- CRNs were relatively common lesions diagnosed during routine colonoscopy and had a greater association with carcinoma compared with polypoid neoplasms, irrespective of size.	[Soetikno, Roy M.; Kaltenbach, Tonya; Rouse, Robert V.; Park, Walter; Maheshwari, Anamika; Sato, Tohru; Matsui, Suzanne; Friedland, Shai] Vet Affairs Palo Alto Hlth Care Syst, Gastroenterol Sect, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Soetikno, RM (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Gastroenterol Sect, 3801 Miranda Ave,GI-111, Palo Alto, CA 94304 USA.	soetikno@earthlink.net		Park, Walter/0000-0001-8187-4188				Fidler JL, 2002, ABDOM IMAGING, V27, P292, DOI 10.1007/s00261-001-0171-z; Fujii T, 2001, ENDOSCOPY, V33, P1036; Fujii T, 1998, ENDOSCOPY, V30, P437, DOI 10.1055/s-2007-1001304; Hamilton SR, 2000, WHO CLASSIFICATION T; Hiraoka S, 2006, GASTROENTEROLOGY, V131, P379, DOI 10.1053/j.gastro.2006.04.027; Hurlstone DP, 2003, AM J GASTROENTEROL, V98, P2543, DOI 10.1016/S0002-9270(03)00664-6; Iishi H, 1996, GASTROINTEST ENDOSC, V44, P594, DOI 10.1016/S0016-5107(96)70015-9; JARAMILLO E, 1995, GASTROINTEST ENDOSC, V42, P114, DOI 10.1016/S0016-5107(95)70066-8; Kaltenbach T, 2007, GASTROINTEST ENDOSC, V65, P857, DOI 10.1016/j.gie.2006.11.035; Kronborg O, 2006, SCAND J GASTROENTERO, V41, P737, DOI 10.1080/00365520500442666; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Kudo S, 2000, WORLD J SURG, V24, P1081, DOI 10.1007/s002680010154; Kudo S., 1996, EARLY COLORECTAL CAN; Lieberman D, 2006, NEW ENGL J MED, V355, P2588, DOI 10.1056/NEJMe068254; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Matsui T, 2000, WORLD J SURG, V24, P1022, DOI 10.1007/s002680010153; MATSUI T, 2005, GASTROENTEROLOGIC EN, V47, P227; Nosho K, 2005, BRIT J CANCER, V92, P1193, DOI 10.1038/sj.bjc.6602442; O'Brien MJ, 2004, CLIN GASTROENTEROL H, V2, P905, DOI 10.1016/S1542-3565(04)00392-1; Park SH, 2007, AM J ROENTGENOL, V188, P953, DOI 10.2214/AJR.06.0436; Pickhardt PJ, 2004, AM J ROENTGENOL, V183, P1343, DOI 10.2214/ajr.183.5.1831343; Rembacken BJ, 2001, ENDOSCOPY, V33, P709, DOI 10.1055/s-2001-16224; Rembacken BJ, 2000, LANCET, V355, P1211, DOI 10.1016/S0140-6736(00)02086-9; Rex DK, 2006, GASTROENTEROLOGY, V130, P1865, DOI 10.1053/j.gastro.2006.03.013; Saitoh Y, 1998, GASTROINTEST ENDOSC, V48, P362, DOI 10.1016/S0016-5107(98)70004-5; Saitoh Y, 2001, GASTROENTEROLOGY, V120, P1657, DOI 10.1053/gast.2001.24886; Soetikno R, 2006, GASTROENTEROLOGY, V130, P566, DOI 10.1053/j.gastro.2005.12.006; SOETIKNO RM, 2004, DIAGNOSIS FLAT DEPRE; Tsuda S, 2002, GUT, V51, P550, DOI 10.1136/gut.51.4.550; Van Gelder RE, 2004, GASTROENTEROLOGY, V127, P41, DOI 10.1053/j.gastro.2004.03.055; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; [No title captured]	35	441	457	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2008	299	9					1027	1035		10.1001/jama.299.9.1027	http://dx.doi.org/10.1001/jama.299.9.1027			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JH	18319413	Bronze			2022-12-28	WOS:000253644800020
J	Walmsley, IA				Walmsley, Ian A.			Perspective - Looking to the future of quantum optics	SCIENCE			English	Editorial Material							LINEAR OPTICS; ONE-ATOM; PHOTON; CAVITY; ENTANGLEMENT; DISTANCE; LIGHT		Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford	Walmsley, IA (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	walmsley@physics.ox.ac.uk		Walmsley, Ian/0000-0002-4714-0575	EPSRC [EP/C013840/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C013840/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Achilles D, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.043602; Acin A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.120405; Bose S, 1999, PHYS REV LETT, V83, P5158, DOI 10.1103/PhysRevLett.83.5158; Browne DE, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.062320; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Fleischhauer M, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.022314; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Gleyzes S, 2007, NATURE, V446, P297, DOI 10.1038/nature05589; Gorshkov AV, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.123601; Higgins BL, 2007, NATURE, V450, P393, DOI 10.1038/nature06257; Hijlkema M, 2007, NAT PHYS, V3, P253, DOI 10.1038/nphys569; Julsgaard B, 2004, NATURE, V432, P482, DOI 10.1038/nature03064; Kleckner D, 2006, NATURE, V444, P75, DOI 10.1038/nature05231; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Nunn J, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.011401; Ourjoumtsev A, 2006, SCIENCE, V312, P83, DOI 10.1126/science.1122858; Prevedel R, 2007, NATURE, V445, P65, DOI 10.1038/nature05346; Stevenson RM, 2006, NATURE, V439, P179, DOI 10.1038/nature04446; Vitali D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.030405; Wasilewski W, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042316	22	26	26	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1211	1213		10.1126/science.1152495	http://dx.doi.org/10.1126/science.1152495			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309077				2022-12-28	WOS:000253530600033
J	Zaanen, J				Zaanen, J.			Perspective - Quantum critical electron systems: The uncharted sign worlds	SCIENCE			English	Editorial Material									Leiden Univ, Inst Lorentz Theoret Phys, NL-2333 CA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Zaanen, J (corresponding author), Leiden Univ, Inst Lorentz Theoret Phys, NL-2333 CA Leiden, Netherlands.	jan@lorentz.leidenuniv.nl						Bloch I, 2008, SCIENCE, V319, P1202, DOI 10.1126/science.1152501; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; Cardy J., 1996, SCALING RENORMALIZAT; Coleman P, 2005, NATURE, V433, P226, DOI 10.1038/nature03279; Georgi H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.221601; Leggett AJ, 2008, SCIENCE, V319, P1203, DOI 10.1126/science.1152822; Levy F, 2007, NAT PHYS, V3, P460, DOI 10.1038/nphys608; Lloyd S, 2008, SCIENCE, V319, P1209, DOI 10.1126/science.1154732; Sachdev S., 1999, QUANTUM PHASE TRANSI; Troyer M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170201; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Zaanen J, 2004, NATURE, V430, P512, DOI 10.1038/430512a	12	19	19	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1205	1207		10.1126/science.1152443	http://dx.doi.org/10.1126/science.1152443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309074	Green Submitted			2022-12-28	WOS:000253530600030
J	Shojania, KG; Burton, EC				Shojania, Kaveh G.; Burton, Elizabeth C.			The vanishing nonforensic autopsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shojania, Kaveh G.] Univ Ottawa, Ottawa, ON, Canada; [Shojania, Kaveh G.] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Burton, Elizabeth C.] Baylor Hlth Care Syst, Dallas, TX USA; [Burton, Elizabeth C.] Baylor Univ, Med Ctr, Dallas, TX USA	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Baylor Health Care System; Baylor University; Baylor University Medical Center	Shojania, KG (corresponding author), Univ Ottawa, Ottawa, ON, Canada.							GOLDMAN L, 1983, NEW ENGL J MED, V308, P1000, DOI 10.1056/NEJM198304283081704; Horowitz RE, 2007, HUM PATHOL, V38, P688, DOI 10.1016/j.humpath.2007.01.001; Nemetz Peter N, 2006, MedGenMed, V8, P80; Shojania KG, 2005, QUAL SAF HEALTH CARE, V14, P408, DOI 10.1136/qshc.2004.011973; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849	5	190	192	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					873	875		10.1056/NEJMp0707996	http://dx.doi.org/10.1056/NEJMp0707996			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18305264				2022-12-28	WOS:000253430200002
J	Brent, D; Emslie, G; Clarke, G; Wagner, KD; Asarnow, JR; Keller, M; Vitiello, B; Ritz, L; Iyengar, S; Abebe, K; Birmaher, B; Ryan, N; Kennard, B; Hughes, C; DeBar, L; McCracken, J; Strober, M; Suddath, R; Spirito, A; Leonard, H; Melhem, N; Porta, G; Onorato, M; Zelazny, J				Brent, David; Emslie, Graham; Clarke, Greg; Wagner, Karen Dineen; Asarnow, Joan Rosenbaum; Keller, Marty; Vitiello, Benedetto; Ritz, Louise; Iyengar, Satish; Abebe, Kaleab; Birmaher, Boris; Ryan, Neal; Kennard, Betsy; Hughes, Carroll; DeBar, Lynn; McCracken, James; Strober, Michael; Suddath, Robert; Spirito, Anthony; Leonard, Henrietta; Melhem, Nadine; Porta, Giovanna; Onorato, Matthew; Zelazny, Jamie			Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression - The TORDIA randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEROTONIN REUPTAKE INHIBITORS; ASTERISK-D REPORT; MAJOR DEPRESSION; DOUBLE-BLIND; ANTIDEPRESSANT TREATMENT; PSYCHOMETRIC PROPERTIES; AFFECTIVE-DISORDERS; SUICIDAL IDEATION; REMISSION RATES; RATING-SCALE	Context Only about 60% of adolescents with depression will show an adequate clinical response to an initial treatment trial with a selective serotonin reuptake inhibitor ( SSRI). There are no data to guide clinicians on subsequent treatment strategy. Objective To evaluate the relative efficacy of 4 treatment strategies in adolescents who continued to have depression despite adequate initial treatment with an SSRI. Design, Setting, and Participants Randomized controlled trial of a clinical sample of 334 patients aged 12 to 18 years with a primary diagnosis of major depressive disorder that had not responded to a 2- month initial treatment with an SSRI, conducted at 6 US academic and community clinics from 2000- 2006. Interventions Twelve weeks of: ( 1) switch to a second, different SSRI ( paroxetine, citalopram, or fluoxetine, 20- 40 mg); ( 2) switch to a different SSRI plus cognitive behavioral therapy; ( 3) switch to venlafaxine ( 150- 225 mg); or ( 4) switch to venlafaxine plus cognitive behavioral therapy. Main OutcomeMeasures Clinical Global Impressions- Improvement score of 2 or less ( much or very much improved) and a decrease of at least 50% in the Children's Depression Rating Scale- Revised ( CDRS- R); and change in CDRS- R over time. Results Cognitive behavioral therapy plus a switch to either medication regimen showed a higher response rate ( 54.8%; 95% confidence interval [ CI], 47%- 62%) than a medication switch alone ( 40.5%; 95% CI, 33%- 48%; P=. 009), but there was no difference in response rate between venlafaxine and a second SSRI ( 48.2%; 95% CI, 41%-56% vs 47.0%; 95% CI, 40%- 55%; P=. 83). There were no differential treatment effects on change in the CDRS- R, self- rated depressive symptoms, suicidal ideation, or on the rate of harm- related or any other adverse events. There was a greater increase in diastolic blood pressure and pulse and more frequent occurrence of skin problems during venlafaxine than SSRI treatment. Conclusions For adolescents with depression not responding to an adequate initial treatment with an SSRI, the combination of cognitive behavioral therapy and a switch to another antidepressant resulted in a higher rate of clinical response than did a medication switch alone. However, a switch to another SSRI was just as efficacious as a switch to venlafaxine and resulted in fewer adverse effects. Trial Registration clinicaltrials. gov Identifier: NCT00018902.	[Brent, David; Iyengar, Satish; Abebe, Kaleab; Birmaher, Boris; Ryan, Neal; Melhem, Nadine; Porta, Giovanna; Onorato, Matthew; Zelazny, Jamie] Univ Pittsburgh, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; [Emslie, Graham; Kennard, Betsy; Hughes, Carroll] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Clarke, Greg; DeBar, Lynn] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Wagner, Karen Dineen] Univ Texas Galveston, Med Branch, Galveston, TX 77550 USA; [Asarnow, Joan Rosenbaum; McCracken, James; Strober, Michael; Suddath, Robert] Univ Calif Los Angeles, Los Angeles, CA USA; [Keller, Marty; Spirito, Anthony; Leonard, Henrietta] Brown Univ, Providence, RI 02912 USA; [Vitiello, Benedetto; Ritz, Louise] NIMH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; University of Texas System; University of Texas Southwestern Medical Center Dallas; Kaiser Permanente; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Los Angeles; Brown University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Brent, D (corresponding author), Univ Pittsburgh, Western Psychiat Inst & Clin, 3811 Ohara St,Room 315 Bellefield Towers, Pittsburgh, PA 15213 USA.	brentda@upmc.edu	Melhem, Nadine M/G-1510-2013; Abebe, Kaleab/K-4400-2019; Zelazny, Jamie/AAL-1692-2021; Vitiello, Benedetto/AAC-1758-2022	Abebe, Kaleab/0000-0002-3644-8419; 	NIMH NIH HHS [U01 MH061864, P30 MH066371, MH61856, MH61869, U01 MH061835-07, P30 MH066371-02, U01 MH061835-04, U01 MH061835-03, U01 MH061835, P30 MH066371-019001, U01 MH061958, U01 MH061835-01, P30 MH066371-03, MH61864, MH66371, U01 MH061869, P30 MH066371-05, U01 MH061835-05, U01 MH061856, MH62014, MH61835, MH61958, P30 MH066371-04, U01 MH061835-02, U01 MH061835-06, U01 MH062014] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH061835, U01MH061958, P30MH066371, U01MH061856, U01MH061869, U01MH061864, U01MH062014] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 2005, STAT STAT SOFTW REL; Axelson D, 2003, J CHILD ADOL PSYCHOP, V13, P463, DOI 10.1089/104454603322724850; Barbe RP, 2004, SUICIDE LIFE-THREAT, V34, P44, DOI 10.1521/suli.34.1.44.27768; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; BECK AT, 1979, COGNITIVE THERAPY DE; BEGG CB, 1980, BIOMETRICS, V36, P81, DOI 10.2307/2530497; Birmaher B, 2007, J AM ACAD CHILD PSY, V46, P1503, DOI 10.1097/chi.0b013e318145ae1c; BONNER CW, 2002, EMOTION REGULATION I; Brent DA, 1998, J AM ACAD CHILD PSY, V37, P906, DOI 10.1097/00004583-199809000-00010; Brent DA, 1997, ARCH GEN PSYCHIAT, V54, P877; BRENT DA, 1993, J AM ACAD CHILD PSY, V32, P770, DOI 10.1097/00004583-199307000-00010; BRENT DA, 1997, COGNITIVE THERAPY MA; BRENT DA, IN PRESS RUTTERS CHI; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Clarke G, 2005, J AM ACAD CHILD PSY, V44, P888, DOI 10.1016/S0890-8567(09)62194-8; CLARKE GN, 1990, INSTRUCTORS MANUAL A; CLERC GE, 1994, INT CLIN PSYCHOPHARM, V9, P139, DOI 10.1097/00004850-199409000-00001; COOPER H, 2006, HDB RES SYNTHESIS; CURRY JF, 2000, TADS ADOLESCENT CBT; Curry J, 2006, J AM ACAD CHILD PSY, V45, P1427, DOI 10.1097/01.chi.0000240838.78984.e2; Dierick M, 1996, PROG NEURO-PSYCHOPH, V20, P57, DOI 10.1016/0278-5846(95)00292-8; DUFF G, SAFETY SEROXAT PAROX; Emslie GJ, 1997, ARCH GEN PSYCHIAT, V54, P1031; Emslie G, 2006, J AM ACAD CHILD PSY, V45, P1440, DOI 10.1097/01.chi.0000240840.63737.1d; Emslie GJ, 2007, J AM ACAD CHILD PSY, V46, P479, DOI 10.1097/chi.0b013e31802f5f03; Fergusson DM, 2002, ARCH GEN PSYCHIAT, V59, P225, DOI 10.1001/archpsyc.59.3.225; Fombonne E, 2001, BRIT J PSYCHIAT, V179, P210, DOI 10.1192/bjp.179.3.210; Friedman ES, 2006, PSYCHIAT ANN, V36, P320; Goodyer I, 2007, BMJ-BRIT MED J, V335, P142, DOI 10.1136/bmj.39224.494340.55; Guy W., 1976, PUBLICATION ADM, V76-338; HILL CE, 1992, J CONSULT CLIN PSYCH, V60, P73, DOI 10.1037/0022-006X.60.1.73; Howell C, 2007, BRIT J CLIN PHARMACO, V64, P192, DOI 10.1111/j.1365-2125.2007.02849.x; Hughes CW, 2007, J AM ACAD CHILD PSY, V46, P667, DOI 10.1097/chi.0b013e31804a859b; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001; Kennard B, 2006, J AM ACAD CHILD PSY, V45, P1404, DOI 10.1097/01.chi.0000242228.75516.21; Kennedy SH, 2006, J PSYCHIATR NEUROSCI, V31, P122; Klein Rachel G., 1994, P501; Lewinsohn PM, 1998, CLIN PSYCHOL REV, V18, P765, DOI 10.1016/S0272-7358(98)00010-5; Libby AM, 2007, AM J PSYCHIAT, V164, P884, DOI 10.1176/appi.ajp.164.6.884; Lin KM, 2001, PSYCHIAT CLIN N AM, V24, P523, DOI 10.1016/S0193-953X(05)70245-8; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Ma J, 2005, J ADOLESCENT HEALTH, V37, P434, DOI 10.1016/j.jadohealth.2005.07.012; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Melvin GA, 2006, J AM ACAD CHILD PSY, V45, P1151, DOI 10.1097/01.chi.0000233157.21925.71; NICE Guidelines, DEPR CHILDR YOUNG PE; Pampallona S, 2004, ARCH GEN PSYCHIAT, V61, P714, DOI 10.1001/archpsyc.61.7.714; Paradis AD, 2006, J NERV MENT DIS, V194, P318, DOI 10.1097/01.nmd.0000217807.56978.5b; Poirier MF, 1999, BRIT J PSYCHIAT, V175, P12, DOI 10.1192/bjp.175.1.12; POLING K, 1997, LIVING DEPRESSION SU, P1; Poznanski EO, 1984, PSYCHOPHARMACOL BULL, V21, P979; Reynolds WM, 1999, SCHOOL PSYCHOL REV, V28, P17; Rohde P, 2006, J CONSULT CLIN PSYCH, V74, P80, DOI 10.1037/0022-006X.74.1.80; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Scott J, 2000, BRIT J PSYCHIAT, V177, P440, DOI 10.1192/bjp.177.5.440; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Silva JCE, 1998, J CLIN PSYCHIAT, V59, P352; Simon GE, 2006, AM J PSYCHIAT, V163, P41, DOI 10.1176/appi.ajp.163.1.41; Smith D, 2002, BRIT J PSYCHIAT, V180, P396, DOI 10.1192/bjp.180.5.396; *SPSS INC, 2005, SPSS WIND RE 14 0 0; Thase ME, 2005, J WOMENS HEALTH, V14, P609, DOI 10.1089/jwh.2005.14.609; Thase ME, 2005, GEN HOSP PSYCHIAT, V27, P100, DOI 10.1016/j.genhosppsych.2004.09.006; Thase ME, 2003, J CLIN PSYCHIAT, V64, P3; Thase ME, 1998, ARCH GEN PSYCHIAT, V55, P138, DOI 10.1001/archpsyc.55.2.138; Thase ME, 1998, J CLIN PSYCHIAT, V59, P502, DOI 10.4088/JCP.v59n1002; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; Thase ME, 2007, AM J PSYCHIAT, V164, P739, DOI 10.1176/appi.ajp.164.5.739; *US FDA, MEDDRA MED DICT REGU; *US FDA, 2003, FDA TALK PAP FDA STA; US Food and Drug Administration, 2004, FDA LAUNCH MULT STRA; VALLIS TM, 1986, J CONSULT CLIN PSYCH, V54, P381, DOI 10.1037/0022-006X.54.3.381; Vitiello B, 2006, J AM ACAD CHILD PSY, V45, P1419, DOI 10.1097/01.chi.0000242229.52646.6e; Weissman MM, 1999, JAMA-J AM MED ASSOC, V281, P1707, DOI 10.1001/jama.281.18.1707; Weisz JR, 2006, PSYCHOL BULL, V132, P132, DOI 10.1037/0033-2909.132.1.132; WELLS K, 2000, TADS FAMILY MANUAL; Wood A, 1996, J CHILD PSYCHOL PSYC, V37, P737, DOI 10.1111/j.1469-7610.1996.tb01466.x	80	412	418	1	62	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2008	299	8					901	913		10.1001/jama.299.8.901	http://dx.doi.org/10.1001/jama.299.8.901			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266DZ	18314433	Green Accepted, Bronze			2022-12-28	WOS:000253413200019
J	Sandborn, WJ				Sandborn, William J.			Initial combination therapy in early Crohn's disease	LANCET			English	Editorial Material							RANDOMIZED-TRIAL; INFLIXIMAB; ASSOCIATION; TERM		Mayo Clin, Div Gastroenterol & Hepatol, Inflammatory Bowel Dis Clin, Rochester, MN 55905 USA	Mayo Clinic	Sandborn, WJ (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Inflammatory Bowel Dis Clin, Rochester, MN 55905 USA.	Sandborn.william@mayo.edu	Sandborn, William/ABE-8342-2020					Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Goekoop-Ruiterman YPM, 2007, ANN INTERN MED, V146, P406, DOI 10.7326/0003-4819-146-6-200703200-00005; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Lichtenstein GR, 2006, CLIN GASTROENTEROL H, V4, P621, DOI 10.1016/j.cgh.2006.03.002; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; TORUNER M, IN PRESS GASTROENTER	9	6	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2008	371	9613					635	636		10.1016/S0140-6736(08)60285-8	http://dx.doi.org/10.1016/S0140-6736(08)60285-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LL	18295013				2022-12-28	WOS:000253436700012
J	Lim, J; Crespo-Barreto, J; Jafar-Nejad, P; Bowman, AB; Richman, R; Hill, DE; Orr, HT; Zoghbi, HY				Lim, Janghoo; Crespo-Barreto, Juan; Jafar-Nejad, Paymaan; Bowman, Aaron B.; Richman, Ronald; Hill, David E.; Orr, Harry T.; Zoghbi, Huda Y.			Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1	NATURE			English	Article							BULBAR MUSCULAR-ATROPHY; MOTOR-NEURON DEGENERATION; TRANSGENIC MOUSE MODEL; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; IN-VIVO; TRINUCLEOTIDE REPEAT; INTERACTION NETWORK; MICE; ATAXIN-1	Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease caused by expansion of a glutamine-encoding repeat in ataxin 1 (ATXN1). In all known polyglutamine diseases, the glutamine expansion confers toxic functions onto the protein; however, the mechanism by which this occurs remains enigmatic, in light of the fact that the mutant protein apparently maintains interactions with its usual partners. Here we show that the expanded polyglutamine tract differentially affects the function of the host protein in the context of different endogenous protein complexes. Polyglutamine expansion in ATXN1 favours the formation of a particular protein complex containing RBM17, contributing to SCA1 neuropathology by means of a gain-of-function mechanism. Concomitantly, polyglutamine expansion attenuates the formation and function of another protein complex containing ATXN1 and capicua, contributing to SCA1 through a partial loss-of-function mechanism. This model provides mechanistic insight into the molecular pathogenesis of SCA1 as well as other polyglutamine diseases.	[Lim, Janghoo; Jafar-Nejad, Paymaan; Bowman, Aaron B.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Crespo-Barreto, Juan; Zoghbi, Huda Y.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Richman, Ronald; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Hill, David E.] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Hill, David E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Hill, David E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Orr, Harry T.] Univ Minnesota, Inst Human Genet, Dept Biochem Biophys & Mol Biol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu	Hill, David E/B-6617-2011	Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349; Bowman, Aaron/0000-0001-8728-3346	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [P30 HD024064, P30 HD024064-19] Funding Source: Medline; NINDS NIH HHS [R01 NS027699-19, R01 NS027699] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chaouki AS, 2006, PLOS GENET, V2, P1974, DOI 10.1371/journal.pgen.0020178; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kiehl TR, 2006, BIOCHEM BIOPH RES CO, V339, P17, DOI 10.1016/j.bbrc.2005.10.186; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li AM, 2007, EMBO J, V26, P2777, DOI 10.1038/sj.emboj.7601726; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; McManamny P, 2002, HUM MOL GENET, V11, P2103, DOI 10.1093/hmg/11.18.2103; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sampath J, 2003, AM J PATHOL, V163, P1781, DOI 10.1016/S0002-9440(10)63538-9; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Thomas PS, 2006, HUM MOL GENET, V15, P2225, DOI 10.1093/hmg/ddl148; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Van Broeck B, 2007, NEURODEGENER DIS, V4, P349, DOI 10.1159/000105156; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	43	234	237	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					713	U1		10.1038/nature06731	http://dx.doi.org/10.1038/nature06731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18337722	Green Accepted			2022-12-28	WOS:000254792500037
J	Dinsdale, EA; Edwards, RA; Hall, D; Angly, F; Breitbart, M; Brulc, JM; Furlan, M; Desnues, C; Haynes, M; Li, LL; McDaniel, L; Moran, MA; Nelson, KE; Nilsson, C; Olson, R; Paul, J; Brito, BR; Ruan, YJ; Swan, BK; Stevens, R; Valentine, DL; Thurber, RV; Wegley, L; White, BA; Rohwer, F				Dinsdale, Elizabeth A.; Edwards, Robert A.; Hall, Dana; Angly, Florent; Breitbart, Mya; Brulc, Jennifer M.; Furlan, Mike; Desnues, Christelle; Haynes, Matthew; Li, Linlin; McDaniel, Lauren; Moran, Mary Ann; Nelson, Karen E.; Nilsson, Christina; Olson, Robert; Paul, John; Brito, Beltran Rodriguez; Ruan, Yijun; Swan, Brandon K.; Stevens, Rick; Valentine, David L.; Thurber, Rebecca Vega; Wegley, Linda; White, Bryan A.; Rohwer, Forest			Functional metagenomic profiling of nine biomes	NATURE			English	Article							MICROBIAL ECOLOGY; GENOME; DIVERSITY; EVOLUTION; COMMUNITY; DATABASE; VIRUSES; BACTERIOPHAGES; BACTERIA; ARCHAEA	Microbial activities shape the biogeochemistry of the planet(1,2) and macroorganism health(3). Determining the metabolic processes performed by microbes is important both for understanding and for manipulating ecosystems ( for example, disruption of key processes that lead to disease, conservation of environmental services, and so on). Describing microbial function is hampered by the inability to culture most microbes and by high levels of genomic plasticity. Metagenomic approaches analyse microbial communities to determine the metabolic processes that are important for growth and survival in any given environment. Here we conduct a metagenomic comparison of almost 15 million sequences from 45 distinct microbiomes and, for the first time, 42 distinct viromes and show that there are strongly discriminatory metabolic profiles across environments. Most of the functional diversity was maintained in all of the communities, but the relative occurrence of metabolisms varied, and the differences between metagenomes predicted the biogeochemical conditions of each environment. The magnitude of the microbial metabolic capabilities encoded by the viromes was extensive, suggesting that they serve as a repository for storing and sharing genes among their microbial hosts and influence global evolutionary and metabolic processes.	[Dinsdale, Elizabeth A.; Edwards, Robert A.; Hall, Dana; Angly, Florent; Furlan, Mike; Desnues, Christelle; Haynes, Matthew; Li, Linlin; Brito, Beltran Rodriguez; Thurber, Rebecca Vega; Wegley, Linda; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Edwards, Robert A.; Rohwer, Forest] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Angly, Florent; Brito, Beltran Rodriguez] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Dinsdale, Elizabeth A.] Flinders Univ S Australia, Sch Biol Sci, Bedford Pk, SA 5042, Australia; [Edwards, Robert A.; Olson, Robert; Stevens, Rick] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Breitbart, Mya; McDaniel, Lauren; Paul, John] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Brulc, Jennifer M.; White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Moran, Mary Ann] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Nelson, Karen E.] J Craig Venter Inst, Rockville, MD 20850 USA; [Nilsson, Christina; Ruan, Yijun] Genome Inst Singapore, Singapore 138672, Singapore; [Swan, Brandon K.; Valentine, David L.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; Flinders University South Australia; United States Department of Energy (DOE); Argonne National Laboratory; State University System of Florida; University of South Florida; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University System of Georgia; University of Georgia; J. Craig Venter Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California Santa Barbara	Dinsdale, EA (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	elizabeth_dinsdale@hotmail.com	Swan, Brandon K/O-9824-2018; Valentine, David/E-5594-2012; Angly, Florent E/A-7717-2011; Desnues, Christelle/ABG-2910-2021; Desnues, Christelle/B-1383-2010; Li, Linlin/E-3335-2010; Moran, Mary Ann/B-6939-2012; Rohwer, Forest/AAC-5315-2019; Breitbart, Mya/B-1366-2009; Edwards, Robert/Q-1691-2019; Martinez, Octavio/B-7375-2009	Swan, Brandon K/0000-0003-0465-1444; Angly, Florent E/0000-0002-8999-0738; Desnues, Christelle/0000-0002-2178-0355; Desnues, Christelle/0000-0002-2178-0355; Breitbart, Mya/0000-0003-3210-2899; Edwards, Robert/0000-0001-8383-8949; dinsdale, elizabeth/0000-0002-2177-203X; Moran, Mary Ann/0000-0002-0702-8167; Rohwer, Forest/0000-0003-1548-5429; Valentine, David/0000-0001-5914-9107				Aksnes A, 2006, AQUACULTURE, V261, P1102, DOI 10.1016/j.aquaculture.2006.07.038; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Davis BM, 2002, MOBILE DNA-UK, P1040, DOI [10.1128/9781555817954.ch45, DOI 10.1128/9781555817954.CH45]; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dunbar J, 2000, APPL ENVIRON MICROB, V66, P2943, DOI 10.1128/AEM.66.7.2943-2950.2000; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Gunn MR, 2007, MOL ECOL NOTES, V7, P393, DOI 10.1111/j.1471-8286.2007.01696.x; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Iwanicka-Nowicka R, 2007, J BACTERIOL, V189, P1675, DOI 10.1128/JB.00592-06; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; MEYER F, UNPUB BMC BIOINF; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Sano E, 2004, APPL ENVIRON MICROB, V70, P5842, DOI 10.1128/AEM.70.10.5842-5846.2004; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065	36	644	661	6	310	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2008	452	7187					629	U8		10.1038/nature06810	http://dx.doi.org/10.1038/nature06810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18337718				2022-12-28	WOS:000254567200045
J	Tushnet, M				Tushnet, Mark			Interpreting the right to bear arms - Gun regulation and constitutional law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University	Tushnet, M (corresponding author), Harvard Univ, Sch Law, Cambridge, MA 02138 USA.								0	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 3	2008	358	14					1424	1426		10.1056/NEJMp0801601	http://dx.doi.org/10.1056/NEJMp0801601			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	282CY	18354095	Green Published, Bronze			2022-12-28	WOS:000254546400002
J	Ball, P				Ball, Philip			Water: Water - an enduring mystery	NATURE			English	Editorial Material																		Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Franks F., 1975, WATER COMPREHENSIVE, V1; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205	5	267	272	0	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					291	292		10.1038/452291a	http://dx.doi.org/10.1038/452291a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354466	Bronze			2022-12-28	WOS:000254117400028
J	Kay, KN; Naselaris, T; Prenger, RJ; Gallant, JL				Kay, Kendrick N.; Naselaris, Thomas; Prenger, Ryan J.; Gallant, Jack L.			Identifying natural images from human brain activity	NATURE			English	Article							HUMAN VISUAL-CORTEX; BOLD FMRI; ORIENTATION; STRIATE; AREAS; RECONSTRUCTION; REPRESENTATION; FREQUENCY; RESPONSES; PATTERNS	A challenging goal in neuroscience is to be able to read out, or decode, mental content from brain activity. Recent functional magnetic resonance imaging ( fMRI) studies have decoded orientation(1,2), position(3) and object category(4,5) from activity in visual cortex. However, these studies typically used relatively simple stimuli ( for example, gratings) or images drawn from fixed categories ( for example, faces, houses), and decoding was based on previous measurements of brain activity evoked by those same stimuli or categories. To overcome these limitations, here we develop a decoding method based on quantitative receptive- field models that characterize the relationship between visual stimuli and fMRI activity in early visual areas. These models describe the tuning of individual voxels for space, orientation and spatial frequency, and are estimated directly from responses evoked by natural images. We show that these receptive- field models make it possible to identify, from a large set of completely novel natural images, which specific image was seen by an observer. Identification is not a mere consequence of the retinotopic organization of visual areas; simpler receptive- field models that describe only spatial tuning yield much poorer identification performance. Our results suggest that it may soon be possible to reconstruct a picture of a person's visual experience from measurements of brain activity alone.	[Kay, Kendrick N.; Gallant, Jack L.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Naselaris, Thomas; Gallant, Jack L.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Prenger, Ryan J.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gallant, JL (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	gallant@berkeley.edu	Gallant, Jack L/C-4426-2011; Kay, Kendrick/A-4344-2009	Kay, Kendrick/0000-0001-6604-9155	NATIONAL EYE INSTITUTE [R01EY019684] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY019684] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Hansen KA, 2004, NEUROIMAGE, V23, P233, DOI 10.1016/j.neuroimage.2004.05.012; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2004, P NATL ACAD SCI USA, V101, P4286, DOI 10.1073/pnas.0307948101; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Lee TS, 1996, IEEE T PATTERN ANAL, V18, P959, DOI 10.1109/34.541406; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Olman CA, 2004, VISION RES, V44, P669, DOI 10.1016/j.visres.2003.10.022; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Sasaki Y, 2006, NEURON, V51, P661, DOI 10.1016/j.neuron.2006.07.021; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	30	747	798	7	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					352	U7		10.1038/nature06713	http://dx.doi.org/10.1038/nature06713			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18322462	Green Accepted			2022-12-28	WOS:000254117400047
J	Rothenberg, ME; Klion, AD; Roufosse, FE; Kahn, JE; Weller, PF; Simon, HU; Schwartz, LB; Rosenwasser, LJ; Ring, J; Griffin, EF; Haig, AE; Frewer, PIH; Parkin, JM; Gleich, GJ				Rothenberg, Marc E.; Klion, Amy D.; Roufosse, Florence E.; Kahn, Jean Emmanuel; Weller, Peter F.; Simon, Hans-Uwe; Schwartz, Lawrence B.; Rosenwasser, Lanny J.; Ring, Johannes; Griffin, Elaine F.; Haig, Ann E.; Frewer, Paul I. H.; Parkin, Jacqueline M.; Gleich, Gerald J.		Mepolizumab HES Study Grp	Treatment of patients with the hypereosinophilic syndrome with mepolizumab	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; ANTI-INTERLEUKIN-5 ANTIBODY; HUMAN INTERLEUKIN-5; ATOPIC-DERMATITIS; EOSINOPHILS; ANTI-IL-5; THERAPY; GLUCOCORTICOIDS; EFFICACY; IMATINIB	Background: The hypereosinophilic syndrome is a group of diseases characterized by persistent blood eosinophilia, defined as more than 1500 cells per microliter with end-organ involvement and no recognized secondary cause. Although most patients have a response to corticosteroids, side effects are common and can lead to considerable morbidity. Methods: We conducted an international, randomized, double-blind, placebo-controlled trial evaluating the safety and efficacy of an anti-interleukin-5 monoclonal antibody, mepolizumab, in patients with the hypereosinophilic syndrome. Patients were negative for the FIP1L1-PDGFRA fusion gene and required prednisone monotherapy, 20 to 60 mg per day, to maintain a stable clinical status and a blood eosinophil count of less than 1000 per microliter. Patients received either intravenous mepolizumab or placebo while the prednisone dose was tapered. The primary end point was the reduction of the prednisone dose to 10 mg or less per day for 8 or more consecutive weeks. Results: The primary end point was reached in 84% of patients in the mepolizumab group, as compared with 43% of patients in the placebo group (hazard ratio, 2.90; 95% confidence interval [CI], 1.59 to 5.26; P<0.001) with no increase in clinical activity of the hypereosinophilic syndrome. A blood eosinophil count of less than 600 per microliter for 8 or more consecutive weeks was achieved in 95% of patients receiving mepolizumab, as compared with 45% of patients receiving placebo (hazard ratio, 3.53; 95% CI, 1.94 to 6.45; P<0.001). Serious adverse events occurred in seven patients receiving mepolizumab (14 events, including one death; mean [+/-SD] duration of exposure, 6.7+/-1.9 months) and in five patients receiving placebo (7 events; mean duration of exposure, 4.3+/-2.6 months). Conclusions: Our study shows that treatment with mepolizumab, an agent designed to target eosinophils, can result in corticosteroid-sparing for patients negative for FIP1L1-PDGFRA who have the hypereosinophilic syndrome. (ClinicalTrials.gov number, NCT00086658.).	[Rothenberg, Marc E.] Univ Cincinnati, Childrens Hosp & Med Ctr, Div Allergy & Immunol, Dept Pediat, Cincinnati, OH 45229 USA; [Klion, Amy D.] NIAID, Bethesda, MD 20892 USA; [Roufosse, Florence E.] Univ Libre Bruxelles, Serv Med Interne, Hop Erasme, Gosselies, Belgium; [Roufosse, Florence E.] Inst Med Immunol, Gosselies, Belgium; [Kahn, Jean Emmanuel] Hop Foch, Serv Med Interne, Suresnes, France; [Weller, Peter F.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Simon, Hans-Uwe] Univ Bern, Bern, Switzerland; [Schwartz, Lawrence B.] Virginia Commonwealth Univ, Richmond, VA USA; [Rosenwasser, Lanny J.] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Ring, Johannes] Tech Univ Munich, Munich, Germany; [Griffin, Elaine F.] Envis Pharma, Horsham, W Sussex, England; [Haig, Ann E.] GlaxoSmithKline, King Of Prussia, PA USA; [Frewer, Paul I. H.; Parkin, Jacqueline M.] GlaxoSmithKline, Middlesex, England; [Gleich, Gerald J.] Univ Utah, Sch Med, Salt Lake City, UT USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universite Libre de Bruxelles; Hospital Foch; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Bern; Virginia Commonwealth University; Children's Mercy Hospital; Technical University of Munich; GlaxoSmithKline; GlaxoSmithKline; Utah System of Higher Education; University of Utah	Rothenberg, ME (corresponding author), Univ Cincinnati, Childrens Hosp & Med Ctr, Div Allergy & Immunol, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	rothenberg@cchmc.org	Ring, Johannes/GLN-4341-2022; Simon, Hans-Uwe/AAU-7410-2020; KAHN, Jean-Emmanuel/S-8509-2018	Ring, Johannes/0000-0001-8236-3152; Simon, Hans-Uwe/0000-0002-9404-7736; KAHN, Jean-Emmanuel/0000-0002-9565-6074; Verstovsek, MD, PhD, Professor of Medicine, Srdan/0000-0002-6912-8569; Klion, Amy/0000-0002-4986-5326	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064, M01RR008084, M01RR001032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061097] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCRR NIH HHS [MO1 RR001032, M01 RR00064, M01 RR 08084] Funding Source: Medline; NIAID NIH HHS [AI61097] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Buttner C, 2003, EUR RESPIR J, V21, P799, DOI 10.1183/09031936.03.00027302; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; CLUTTERBUCK EJ, 1989, BLOOD, V73, P1504; Cook RM, 1998, AM J RESP CRIT CARE, V157, pA604; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Garrett JK, 2004, J ALLERGY CLIN IMMUN, V113, P115, DOI 10.1016/j.jaci.2003.10.049; Gleich GJ, 2005, CURR OPIN IMMUNOL, V17, P679, DOI 10.1016/j.coi.2005.09.008; Hart TK, 2001, J ALLERGY CLIN IMMUN, V108, P250, DOI 10.1067/mai.2001.116576; Kariyawasam HH, 2006, SEMIN RESP CRIT CARE, V27, P117, DOI 10.1055/s-2006-939514; Klion AD, 2004, BLOOD, V103, P2939, DOI 10.1182/blood-2003-10-3620; Klion AD, 2006, J ALLERGY CLIN IMMUN, V117, P1292, DOI 10.1016/j.jaci.2006.02.042; Koury MJ, 2003, AM J MED, V115, P587, DOI 10.1016/S0002-9343(03)00475-3; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; Menzies-Gow A, 2003, J ALLERGY CLIN IMMUN, V111, P714, DOI 10.1067/mai.2003.1382; Oldhoff JM, 2005, ALLERGY, V60, P693, DOI 10.1111/j.1398-9995.2005.00791.x; Pardanani A, 2003, BLOOD, V102, P3093, DOI 10.1182/blood-2003-05-1627; Phipps S, 2004, J INVEST DERMATOL, V122, P1406, DOI 10.1111/j.0022-202X.2004.22619.x; Plotz S, 2003, NEW ENGL J MED, V349, P2334, DOI 10.1056/NEJMoa031261; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Roufosse F, 2006, SEMIN RESP CRIT CARE, V27, P158, DOI 10.1055/s-2006-939519; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; SCHREZENMEIER H, 1993, EXP HEMATOL, V21, P358; Simon D, 2004, ALLERGY, V59, P561, DOI 10.1111/j.1398-9995.2004.00476.x; Stanbury RM, 1998, BRIT J OPHTHALMOL, V82, P704, DOI 10.1136/bjo.82.6.704; Sutton SA, 2005, CLIN IMMUNOL, V115, P51, DOI 10.1016/j.clim.2005.02.006; Ware J.E., 1995, SF 12 SCORE SF 12 PH; Wei L, 2004, ANN INTERN MED, V141, P764, DOI 10.7326/0003-4819-141-10-200411160-00007; Wilkins HJ, 2005, AM J HEMATOL, V80, P148, DOI 10.1002/ajh.20423	30	409	423	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1215	1228		10.1056/NEJMoa070812	http://dx.doi.org/10.1056/NEJMoa070812			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275TL	18344568	Green Published			2022-12-28	WOS:000254094400003
J	Swain, MR; Vasisht, G; Tinetti, G				Swain, Mark R.; Vasisht, Gautam; Tinetti, Giovanna			The presence of methane in the atmosphere of an extrasolar planet	NATURE			English	Article							LIGHT CURVES; SPECTRA; DYNAMICS; TRANSIT	Molecules present in the atmospheres of extrasolar planets are expected to influence strongly the balance of atmospheric radiation, to trace dynamical and chemical processes, and to indicate the presence of disequilibrium effects. As molecules have the potential to reveal atmospheric conditions and chemistry, searching for them is a high priority. The rotational - vibrational transition bands of water, carbon monoxide and methane are anticipated to be the primary sources of non- continuum opacity in hot- Jupiter planets(1-3). As these bands can overlap in wavelength, and the corresponding signatures from them are weak, decisive identification requires precision infrared spectroscopy. Here we report a near- infrared transmission spectrum of the planet HD 189733b that shows the presence of methane. Additionally, a resolved water vapour band at 1.9 mu m confirms the recent claim(4) of water in this object. On thermochemical grounds, carbon monoxide is expected to be abundant in the upper atmosphere of hot- Jupiter planets, but is not identifiable here; therefore the detection of methane rather than carbon monoxide in such a hot planet(5,6) could signal the presence of a horizontal chemical gradient away from the permanent dayside, or it may imply an ill- understood photochemical mechanism that leads to an enhancement of methane.	[Swain, Mark R.; Vasisht, Gautam] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Tinetti, Giovanna] UCL, Dept Phys & Astron, London WC1E 6BT, England	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of London; University College London	Swain, MR (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	Mark.R.Swain@jpl.nasa.gov	Vasisht, Gautam/AAP-3022-2020; Tinetti, Giovanna/G-7956-2017; Tinetti, Giovanna/Q-4697-2019	Vasisht, Gautam/0000-0002-1871-6264; Tinetti, Giovanna/0000-0001-6058-6654; Tinetti, Giovanna/0000-0001-6058-6654				Barber RJ, 2006, MON NOT R ASTRON SOC, V368, P1087, DOI 10.1111/j.1365-2966.2006.10184.x; Borysow A, 2001, J QUANT SPECTROSC RA, V68, P235, DOI 10.1016/S0022-4073(00)00023-6; Brown TM, 2001, ASTROPHYS J, V553, P1006, DOI 10.1086/320950; Burrows A, 2006, ASTROPHYS J, V650, P1140, DOI 10.1086/507269; Burrows A, 2005, NATURE, V433, P261, DOI 10.1038/nature03244; Claret A, 2000, ASTRON ASTROPHYS, V363, P1081; Cooper CS, 2006, ASTROPHYS J, V649, P1048, DOI 10.1086/506312; Fortney JJ, 2006, ASTROPHYS J, V652, P746, DOI 10.1086/508442; Fortney JJ, 2007, ASTROPHYS J, V666, pL45, DOI 10.1086/521603; GILLILAND RL, 2003, 2003001 NICMOS, P1; Grillmair CJ, 2007, ASTROPHYS J, V658, pL115, DOI 10.1086/513741; Hauschildt PH, 1999, ASTROPHYS J, V512, P377, DOI 10.1086/306745; Hubbard WB, 2001, ASTROPHYS J, V560, P413, DOI 10.1086/322490; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Liang MC, 2004, ASTROPHYS J, V605, pL61, DOI 10.1086/392509; Nassar R, 2003, J QUANT SPECTROSC RA, V82, P279, DOI 10.1016/S0022-4073(03)00158-4; Pont F, 2007, ASTRON ASTROPHYS, V476, P1347, DOI 10.1051/0004-6361:20078269; PONT F, IN PRESS MON NOT R A; Richardson LJ, 2007, NATURE, V445, P892, DOI 10.1038/nature05636; Rothman LS, 2005, J QUANT SPECTROSC RA, V96, P139, DOI 10.1016/j.jqsrt.2004.10.008; Seager S, 2000, ASTROPHYS J, V537, P916, DOI 10.1086/309088; Swain MR, 2008, ASTROPHYS J, V674, P482, DOI 10.1086/523832; Tinetti G, 2007, NATURE, V448, P169, DOI 10.1038/nature06002; Tinetti G, 2007, ASTROPHYS J, V654, pL99, DOI 10.1086/510716; Winn JN, 2007, ASTRON J, V133, P1828, DOI 10.1086/512159	25	426	429	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					329	331		10.1038/nature06823	http://dx.doi.org/10.1038/nature06823			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354477				2022-12-28	WOS:000254117400041
J	Reuben, DB				Reuben, David B.			The geriatrician's lab (Yellow)	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Geriatr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Reuben, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Geriatr, Le Conte Ave,Suite 2339, Los Angeles, CA 90095 USA.	dreuben@mednet.ucia.edu							0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2008	148	6					480	481		10.7326/0003-4819-148-6-200803180-00011	http://dx.doi.org/10.7326/0003-4819-148-6-200803180-00011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279KT	18347354				2022-12-28	WOS:000254354800009
J	Burton, B				Burton, Bob			Medicine and the media - The return of the spoof	BRITISH MEDICAL JOURNAL			English	Editorial Material												bobburton@ozemail.com.au						Coombes R, 2007, BRIT MED J, V334, P396, DOI 10.1136/bmj.39133.480880.59; Jackson T, 2001, BRIT MED J, V322, P1312, DOI 10.1136/bmj.322.7297.1312; 2006, BMJ, V332, P1469; 2006, BMJ, V332, P745; 2007, BMJ, V334, P1025	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 15	2008	336	7644					589	589		10.1136/bmj.39503.716412.0F	http://dx.doi.org/10.1136/bmj.39503.716412.0F			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18340073	Green Published			2022-12-28	WOS:000254364500030
J	Graham, J; Baker, M; Macbeth, F; Titshall, V				Graham, John; Baker, Mark; Macbeth, Fergus; Titshall, Victoria		Guideline Dev Grp	Guidelines - Diagnosis and treatment of prostate cancer: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Graham, John] Musgrave Pk Hosp, Taunton & Somerset NHS Fdn Trust, Taunton TA1 5DA, Somerset, England; [Baker, Mark] St James Univ Hosp, Leeds Teaching Hosp NHS Trust, Leeds LS9 7TF, W Yorkshire, England; [Macbeth, Fergus; Titshall, Victoria] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, Wales	Musgrove Park Hospital; Saint James's University Hospital; University of Leeds	Graham, J (corresponding author), Musgrave Pk Hosp, Taunton & Somerset NHS Fdn Trust, Taunton TA1 5DA, Somerset, England.	john.graham@nhs.net		Graham, John/0000-0003-3381-9787				National Institute for Health and Clinical Excellence, 2008, PROST CANC DIAGN TRE	1	66	71	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 15	2008	336	7644					610	612		10.1136/bmj.39498.525706.AD	http://dx.doi.org/10.1136/bmj.39498.525706.AD			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18340076	Green Published			2022-12-28	WOS:000254364500036
J	Bobrow, BJ; Clark, LL; Ewy, GA; Chikani, V; Sanders, AB; Berg, RA; Richman, PB; Kern, KB				Bobrow, Bentley J.; Clark, Lani L.; Ewy, Gordon A.; Chikani, Vatsal; Sanders, Arthur B.; Berg, Robert A.; Richman, Peter B.; Kern, Karl B.			Minimally interrupted cardiac resuscitation by emergency medical services for out-of-hospital cardiac arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE PROFESSIONALS; CARDIOPULMONARY-RESUSCITATION; CARDIOCEREBRAL RESUSCITATION; VENTRICULAR-FIBRILLATION; CHEST COMPRESSIONS; VENTILATION; DEFIBRILLATION; STATEMENT; SURVIVAL; HEART	Context Out- of- hospital cardiac arrest is a major public health problem. Objective To investigate whether the survival of patients with out- of- hospital cardiac arrest would improve with minimally interrupted cardiac resuscitation ( MICR), an alternate emergency medical services ( EMS) protocol. Design, Setting, and Patients A prospective study of survival- to- hospital discharge between January 1, 2005, and November 22, 2007. Patients with out- ofhospital cardiac arrests in 2 metropolitan cities in Arizona before and after MICR training of fire department emergency medical personnel were assessed. In a second analysis of protocol compliance, patients from the 2 metropolitan cities and 60 additional fire departments in Arizona who actually received MICR were compared with patients who did not receive MICR but received standard advanced life support. Intervention Instruction for EMS personnel in MICR, an approach that includes an initial series of 200 uninterrupted chest compressions, rhythm analysis with a single shock, 200 immediate postshock chest compressions before pulse check or rhythm reanalysis, early administration of epinephrine, and delayed endotracheal intubation. Main Outcome Measure Survival- to- hospital discharge. Results Among the 886 patients in the 2 metropolitan cities, survival- to- hospital discharge increased from 1.8% ( 4/ 218) before MICR training to 5.4% ( 36/ 668) after MICR training ( odds ratio [ OR], 3.0; 95% confidence interval [ CI], 1.1- 8.9). In the subgroup of 174 patients with witnessed cardiac arrest and ventricular fibrillation, survival increased from 4.7% ( 2/ 43) before MICR training to 17.6% ( 23/ 131) after MICR training ( OR, 8.6; 95% CI, 1.8- 42.0). In the analysis of MICR protocol compliance involving 2460 patients with cardiac arrest, survival was significantly better among patients who received MICR than those who did not ( 9.1% [ 60/ 661] vs 3.8% [ 69/ 1799]; OR, 2.7; 95% CI, 1.9- 4.1), as well as patients with witnessed ventricular fibrillation ( 28.4% [ 40/ 141] vs 11.9% [ 46/ 387]; OR, 3.4; 95% CI, 2.0- 5.8). Conclusions Survival- to- hospital discharge of patients with out- of- hospital cardiac arrest increased after implementation of MICR as an alternate EMS protocol. These results need to be confirmed in a randomized trial.	[Bobrow, Bentley J.; Richman, Peter B.] Mayo Clin, Dept Emergency Med, Scottsdale, AZ 85259 USA; [Bobrow, Bentley J.; Clark, Lani L.; Chikani, Vatsal] Arizona Dept Hlth Serv, Bur Emergency Med Serv & Trauma Syst, Phoenix, AZ 85007 USA; [Bobrow, Bentley J.; Clark, Lani L.; Ewy, Gordon A.; Sanders, Arthur B.; Berg, Robert A.; Kern, Karl B.] Univ Arizona, Coll Med, Sarver Heart Ctr, Tucson, AZ USA; [Ewy, Gordon A.; Kern, Karl B.] Univ Arizona, Coll Med, Dept Med, Tucson, AZ USA; [Sanders, Arthur B.] Univ Arizona, Coll Med, Dept Emergency Med, Tucson, AZ USA; [Berg, Robert A.] Univ Arizona, Coll Med, Dept Pediat, Tucson, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; Arizona Department of Health Services; University of Arizona; University of Arizona; University of Arizona; University of Arizona	Bobrow, BJ (corresponding author), Mayo Clin, Dept Emergency Med, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	bobrow.bentley@mayo.edu		Chikani, Vatsal/0000-0003-0904-7887				American Heart Association, 2000, CIRCULATION, V102, P122; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Becker LB, 1997, CIRCULATION, V96, P2102, DOI 10.1161/01.CIR.96.6.2102; BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; Berg RA, 1997, CIRCULATION, V95, P1635; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Bobrow B, 2006, CIRCULATION, V114, P354; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; Eckstein M, 2005, ANN EMERG MED, V45, P504, DOI 10.1016/j.annemergmed.2004.11.024; Ewy GA, 2006, AM J MED, V119, P6, DOI 10.1016/j.amjmed.2005.06.067; Ewy GA, 2005, CIRCULATION, V111, P2134, DOI 10.1161/01.CIR.0000162503.57657.FA; Ewy GA, 2003, RESUSCITATION, V58, P271, DOI 10.1016/S0300-9572(03)00268-5; Ewy Gordon A, 2007, Cleve Clin J Med, V74 Suppl 1, pS105; Ewy GA, 2007, LANCET, V369, P882, DOI 10.1016/S0140-6736(07)60422-X; Ewy GA, 2006, CURR OPIN CRIT CARE, V12, P189, DOI 10.1097/01.ccx.0000224859.25217.5b; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kellum MJ, 2006, AM J MED, V119, P335, DOI 10.1016/j.amjmed.2005.11.014; Kern KB, 2005, RESUSCITATION, V64, P261, DOI 10.1016/j.resuscitation.2004.08.009; Kern KB, 2002, CIRCULATION, V105, P645, DOI 10.1161/hc0502.102963; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V27, P678; MILANDER MM, 1995, ACAD EMERG MED, V2, P708, DOI 10.1111/j.1553-2712.1995.tb03622.x; Nichol G, 1996, ANN EMERG MED, V27, P700, DOI 10.1016/S0196-0644(96)70187-7; Ornato JP, 2006, CIRCULATION, V114, P2754, DOI 10.1161/CIRCULATIONAHA.106.668095; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Rea TD, 2006, CIRCULATION, V114, P2760, DOI 10.1161/CIRCULATIONAHA.106.654715; *SAS KANTO STUD GR, 2007, LANCET, V369, P920; *US BUR CENS, AM FACT FIND POP FAC; Vaillancourt C, 2004, CAN J CARDIOL, V20, P1081; Valenzuela TD, 2005, CIRCULATION, V112, P1259, DOI 10.1161/CIRCULATIONAHA.105.537282; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	35	383	402	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2008	299	10					1158	1165		10.1001/jama.299.10.1158	http://dx.doi.org/10.1001/jama.299.10.1158			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272CE	18334691	Bronze			2022-12-28	WOS:000253835000019
J	Tissot, AC; Maurer, P; Nussberger, J; Sabat, R; Pfister, T; Ignatenko, S; Volk, HD; Stocker, H; Muller, P; Jennings, GT; Wagner, F; Bachmann, MF				Tissot, Alain C.; Maurer, Patrik; Nussberger, Juerg; Sabat, Robert; Pfister, Thomas; Ignatenko, Stanislav; Volk, Hans-Dieter; Stocker, Hans; Mueller, Philipp; Jennings, Gary T.; Wagner, Frank; Bachmann, Martin F.			Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study	LANCET			English	Article							VIRUS-LIKE PARTICLES; PRECLINICAL EFFICACY; CIRCADIAN VARIATION; VACCINE; SAFETY; HYPERTENSION; RECEPTOR; THERAPY; RENIN; SURGE	Background Hypertension can be controlled adequately with existing drugs such as angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers. Nevertheless, treatment success is often restricted by patients not adhering to treatment. Immunisation against angiotensin II could solve this problem. We investigated the safety and efficacy of CYT006-AngQb-a vaccine based on a virus-like particle-that targets angiotensin II to reduce ambulatory blood pressure. Methods In this multicentre, double-blind, randomised, placebo-controlled phase IIa trial, 72 patients with mild-to-moderate hypertension were randomly assigned with a computer-generated randomisation list to receive subcutaneous injections of either 100 mu g CYT006-AngQb (n=24), 300 mu g CYT006-AngQb (24), or placebo (24), at weeks 0, 4, and 12. 24-h ambulatory blood pressure was measured before treatment and at week 14. The primary outcomes were safety and tolerability. Analyses were done by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00500786. Findings Two patients in the 100 mu g group, three in the 300 mu g group, and none in the placebo group discontinued study treatment. All patients were included in safety analyses; efficacy analyses did not include the five dropouts, for whom no data were available at week 14. Five serious adverse events were reported (two in the 100 mu g group, two in the 300 mu g group, and one in the placebo group); none were deemed to be treatment related. Most side-effects were mild, transient reactions at the injection site. Mild, transient influenza-like symptoms were seen in three patients in the 100 mu g group, seven in the 300 mu g group, and none in the placebo group. In the 300 mu g group, there was a reduction from baseline in mean ambulatory daytime blood pressure at week 14 by -9.0/-4. 0 mm Hg compared with placebo (p=0 . 015 for systolic and 0.064 for diastolic). The 300 mu g dose reduced the early morning blood-pressure surge compared with placebo (change at 0800 h -25/-13 mm Hg; p<0 . 0001 for systolic, p=0 . 0035 for diastolic). Interpretation Immunisation with CYT006-AngQb was associated with no serious adverse events; most observed adverse events were consistent with local or systemic responses similar to those seen with other vaccines. The 300 mu g dose reduced blood pressure in patients with mild-to-moderate hypertension during the daytime, especially in the early morning.	[Tissot, Alain C.; Maurer, Patrik; Pfister, Thomas; Stocker, Hans; Mueller, Philipp; Jennings, Gary T.; Bachmann, Martin F.] Cytos Biotechnol AG, CH-8952 Schlieren, Switzerland; [Nussberger, Juerg] CHU Vaudois, Div Angiol & Hypertens, CH-1011 Lausanne, Switzerland; [Sabat, Robert] Interdisciplinary Grp Mol Immunopathol Dermatol M, Charite, Berlin, Germany; [Ignatenko, Stanislav] Parexel GmbH, Berlin, Germany; [Volk, Hans-Dieter] Univ Med Berlin, Inst Med Immunol, Charite, Berlin, Germany; [Volk, Hans-Dieter] Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Charite, Berlin, Germany; [Wagner, Frank] Charite Res Org, Berlin, Germany	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bachmann, MF (corresponding author), Cytos Biotechnol AG, Wagistr 25, CH-8952 Schlieren, Switzerland.	Martin.bachmann@cytos.com	volk, hans-dieter/AAV-8053-2021; Stoecker, Horst/F-8382-2012	volk, hans-dieter/0000-0002-7743-6668; Stoecker, Horst/0000-0002-3282-3664				Ambuhl PM, 2007, J HYPERTENS, V25, P63, DOI 10.1097/HJH.0b013e32800ff5d6; Brown MJ, 2004, CLIN SCI, V107, P167, DOI 10.1042/CS20030381; Burnier M, 2000, BLOOD PRESS MONIT, V5, pS31, DOI 10.1097/00126097-200005001-00006; Casetta I, 2002, JAMA-J AM MED ASSOC, V287, P1266, DOI 10.1001/jama.287.10.1266; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Elliott William J, 2003, J Clin Hypertens (Greenwich), V5, P3, DOI 10.1111/j.1524-6175.2003.02463.x; HogenEsch H, 2002, VACCINE, V20, pS34, DOI 10.1016/S0264-410X(02)00169-X; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Kundig TM, 2006, J ALLERGY CLIN IMMUN, V117, P1470, DOI 10.1016/j.jaci.2006.01.040; Maurer P, 2005, EUR J IMMUNOL, V35, P2031, DOI 10.1002/eji.200526285; Metoki H, 2006, HYPERTENSION, V47, P149, DOI 10.1161/01.HYP.0000198541.12640.0f; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; NUSSBERGER J, 1987, CLIN EXP HYPERTENS A, V9, P1353, DOI 10.3109/10641968709158989; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Peixoto AJ, 2007, KIDNEY INT, V71, P855, DOI 10.1038/sj.ki.5002130; Stanton A, 2003, HYPERTENSION, V42, P1137, DOI 10.1161/01.HYP.0000101688.17370.87; White WB, 2004, AM J HYPERTENS, V17, P347, DOI 10.1016/j.amjhyper.2004.02.016; Wise RP, 2004, JAMA-J AM MED ASSOC, V292, P1702, DOI 10.1001/jama.292.14.1702; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2000, BLOOD, V96, P218, DOI 10.1182/blood.V96.1.218.013k04_218_223; Wolk K, 2007, CRIT CARE MED, V35, P458, DOI 10.1097/01.CCM.0000254724.54515.2F	22	208	229	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2008	371	9615					821	827		10.1016/S0140-6736(08)60381-5	http://dx.doi.org/10.1016/S0140-6736(08)60381-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272NQ	18328929				2022-12-28	WOS:000253866500029
J	Halazonetis, TD; Gorgoulis, VG; Bartek, J				Halazonetis, Thanos D.; Gorgoulis, Vassilis G.; Bartek, Jiri			An oncogene-induced DNA damage model for cancer development	SCIENCE			English	Review							GENOMIC INSTABILITY; INDUCED SENESCENCE; CELL-CYCLE; TUMORIGENESIS; CHECKPOINT; P53; REPLICATION; CHROMOSOMES; SUPPRESSION; MUTATION	Of all types of DNA damage, DNA double- strand breaks ( DSBs) pose the greatest challenge to cells. One might have, therefore, anticipated that a sizable number of DNA DSBs would be incompatible with cell proliferation. Yet recent experimental findings suggest that, in both precancerous lesions and cancers, activated oncogenes induce stalling and collapse of DNA replication forks, which in turn leads to formation of DNA DSBs. This continuous formation of DNA DSBs may contribute to the genomic instability that characterizes the vast majority of human cancers. In addition, in precancerous lesions, these DNA DSBs activate p53, which, by inducing apoptosis or senescence, raises a barrier to tumor progression. Breach of this barrier by various mechanisms, most notably by p53 mutations, that impair the DNA damage response pathway allows cancers to develop. Thus, oncogene- induced DNA damage may explain two key features of cancer: genomic instability and the high frequency of p53 mutations.	[Halazonetis, Thanos D.] Univ Geneva, Dept Mol Biol, CH-1205 Geneva, Switzerland; [Halazonetis, Thanos D.] Univ Geneva, Dept Biochem, CH-1205 Geneva, Switzerland; [Gorgoulis, Vassilis G.] Univ Athens, Sch Med, Dept Histol & Embryol, GR-11527 Athens, Greece; [Bartek, Jiri] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; [Bartek, Jiri] Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark	University of Geneva; University of Geneva; Athens Medical School; National & Kapodistrian University of Athens; Danish Cancer Society; Danish Cancer Society	Halazonetis, TD (corresponding author), Univ Geneva, Dept Mol Biol, CH-1205 Geneva, Switzerland.	Thanos.Halazonetis@molbio.unige.ch	Halazonetis, Thanos/D-7923-2011; Gorgoulis, Vassilis/AAD-3630-2019; Bartek, Jiri/G-5870-2014	Gorgoulis, Vassilis/0000-0001-9001-4112; 				Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beckman RA, 2006, P NATL ACAD SCI USA, V103, P14140, DOI 10.1073/pnas.0606271103; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansel DE, 2006, MODERN PATHOL, V19, P772, DOI 10.1038/modpathol.3800591; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Mao L, 1996, NAT MED, V2, P682, DOI 10.1038/nm0696-682; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Moore L, 2003, ONCOGENE, V22, P7831, DOI 10.1038/sj.onc.1206985; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schultz LB, 2000, COLD SPRING HARB SYM, V65, P489, DOI 10.1101/sqb.2000.65.489; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Westphal CH, 1997, NAT GENET, V16, P397, DOI 10.1038/ng0897-397; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	29	1349	1388	2	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1352	1355		10.1126/science.1140735	http://dx.doi.org/10.1126/science.1140735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323444				2022-12-28	WOS:000253712900033
J	Bodenheimer, T				Bodenheimer, Thomas			Coordinating care - A perilous journey through the health care system	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PARTICIPATORY DECISION-MAKING; CONTROLLED-TRIAL; TRANSITIONS INTERVENTION; PHYSICIAN COMMUNICATION; UNITED-STATES; PATIENT-CARE; INFORMATION; TIME; QUALITY; SATISFACTION		[Bodenheimer, Thomas] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Family & Community Med, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Family & Community Med, San Francisco, CA 94143 USA.							*AG HEALTHC RES QU, 2005, AHRQ PARTN IMPL PAT; *AM COLL PHYS, 2006, SYST NEED CHANG REST; American Academy of Family Physicians; American Academy of Pediatrics; American College of Physicians; American Osteopathic Association, 2007, JOINT PRINC PAT CTR; Anderson G, 2001, HEALTH AFFAIR, V20, P146, DOI 10.1377/hlthaff.20.6.146; Anthony D., 2005, ADV PATIENT SAFETY R; Bodenheimer T, 2007, BUILDING TEAMS PRIMA; Bodenheimer T, 2007, ANN FAM MED, V5, P457, DOI 10.1370/afm.731; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Casalino LP, 2003, ARCH INTERN MED, V163, P1958, DOI 10.1001/archinte.163.16.1958; Coleman EA, 2004, J AM GERIATR SOC, V52, P1817, DOI 10.1111/j.1532-5415.2004.52504.x; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Crosson FJ, 2005, HEALTH AFFAIR, V24, P1543, DOI 10.1377/hlthaff.24.6.1543; *CTR STUD HLTH SYS, CTS PHYS SURV; Davis K, 2005, J GEN INTERN MED, V20, P953, DOI 10.1111/j.1525-1497.2005.0178.x; Davis K, 2007, NEW ENGL J MED, V356, P1166, DOI 10.1056/NEJMe078007; Deveugele M, 2004, PATIENT EDUC COUNS, V54, P227, DOI 10.1016/S0738-3991(03)00239-8; Farber J, 2007, ANN INTERN MED, V147, P693, DOI 10.7326/0003-4819-147-10-200711200-00005; Forrest CB, 2000, ARCH PEDIAT ADOL MED, V154, P499, DOI 10.1001/archpedi.154.5.499; Gandhi TK, 2000, J GEN INTERN MED, V15, P626, DOI 10.1046/j.1525-1497.2000.91119.x; Gandhi TK, 2005, ANN INTERN MED, V142, P352, DOI 10.7326/0003-4819-142-5-200503010-00010; Gillies RR, 2006, HEALTH SERV RES, V41, P1181, DOI 10.1111/j.1475-6773.2006.00529.x; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; Gottschalk A, 2005, ANN FAM MED, V3, P488, DOI 10.1370/afm.404; Grumbach K, 2002, JAMA-J AM MED ASSOC, V288, P889, DOI 10.1001/jama.288.7.889; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Halamka J, 2005, HEALTH AFFAIR, V24, P1170, DOI 10.1377/hlthaff.24.5.1170; Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Kaplan SH, 1996, ANN INTERN MED, V124, P497, DOI 10.7326/0003-4819-124-5-199603010-00007; Kilo CM, 2005, HEALTH AFFAIR, V24, P1296, DOI 10.1377/hlthaff.24.5.1296; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Levine C., 1998, ROUGH CROSSINGS FAMI; LIEBHABER A, 2007, 18 CTR STUD HLTH SYS; McDonald CJ, 2005, HEALTH AFFAIR, V24, P1214, DOI 10.1377/hlthaff.24.5.1214; McDonald K, 2007, CLOSING QUALITY GAP, V7; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; *MED PAYM ADV COMM, 2006, INCR VAL MED REP C; Mehrotra A, 2006, ANN INTERN MED, V145, P826, DOI 10.7326/0003-4819-145-11-200612050-00007; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Murray Mark, 2002, Fam Pract Manag, V9, P39; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Naylor MD, 2004, J AM GERIATR SOC, V52, P1228; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Overhage JM, 2002, ANN EMERG MED, V39, P14, DOI 10.1067/mem.2002.120794; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; ROTER DL, 1989, ANNU REV PUBL HEALTH, V10, P163, DOI 10.1146/annurev.pu.10.050189.001115; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; SCHOEN C, 2004, HLTH AFFAIRS W, V4, P487, DOI DOI 10.1377/HLTHAFF.W4.487; Schoen C, 2005, HLTH AFF MILLWOOD S; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	52	642	648	1	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					1064	1071		10.1056/NEJMhpr0706165	http://dx.doi.org/10.1056/NEJMhpr0706165			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269JG	18322289				2022-12-28	WOS:000253644700012
J	Ladet, S; David, L; Domard, A				Ladet, Sebastien; David, Laurent; Domard, Alain			Multi-membrane hydrogels	NATURE			English	Article							PHYSICAL HYDROGELS; HYDROALCOHOLIC MEDIUM; ACETYLATED CHITOSANS; AQUEOUS-SOLUTION; TRANSITION; GELS	Polysaccharide- based hydrogels are useful for numerous applications, from food(1) and cosmetic processing to drug delivery and tissue engineering(2,3). The formation of hydrogels from polyelectrolyte solutions is complex, involving a variety of molecular interactions. The physical gelation of polysaccharides can be achieved by balancing solvophobic and solvophilic interactions(4). Polymer chain reorganization can be obtained by solvent exchange, one of the processing routes forming a simple hydrogel assembly. Nevertheless, many studies on hydrogel formation are empirical with a limited understanding of the mechanisms involved, delaying the processing of more complex structures. Here we use a multi- step interrupted gelation process in controlled physico- chemical conditions to generate complex hydrogels with multi- membrane 'onion-like' architectures. Our approach greatly simplifies the processing of gels with complex shapes and a multi- membrane organization. In contrast with existing assemblies described in the literature, our method allows the formation of free 'inter-membrane' spaces well suited for cell or drug introduction. These architectures, potentially useful in biomedical applications, open interesting perspectives by taking advantage of tailor- made three- dimensional multimembrane tubular or spherical structures.	[Ladet, Sebastien; David, Laurent; Domard, Alain] Univ Lyon 1, CNRS, Polymer Mat Polymeres & Biomat, UMR 5223, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	David, L (corresponding author), Univ Lyon 1, CNRS, Polymer Mat Polymeres & Biomat, UMR 5223, 15 Blvd A Latarjet,Batiment ISTIL, F-69622 Villeurbanne, France.	laurent.david@univ-lyon1.fr; alain.domard@univ-lyon1.fr		DAVID, Laurent/0000-0003-3632-8537				Boucard N, 2005, BIOMACROMOLECULES, V6, P3227, DOI 10.1021/bm050653d; Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021; Domard A., 2001, POLYM BIOMATER, V9, P187, DOI DOI 10.1201/9780203904671.CH9; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; HIRANO S, 1985, J BIOMED MATER RES, V19, P413, DOI 10.1002/jbm.820190406; ILMAIN F, 1991, NATURE, V349, P400, DOI 10.1038/349400a0; Lamarque G, 2005, BIOMACROMOLECULES, V6, P131, DOI 10.1021/bm0496357; MALETTE WG, 1983, ANN THORAC SURG, V36, P55, DOI 10.1016/S0003-4975(10)60649-2; Montembault A, 2006, BIOCHIMIE, V88, P551, DOI 10.1016/j.biochi.2006.03.002; Montembault A, 2005, BIOMATERIALS, V26, P933, DOI 10.1016/j.biomaterials.2004.03.033; Ostroha J, 2004, BIOMATERIALS, V25, P4345, DOI 10.1016/j.biomaterials.2003.11.019; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; PILNIK W, 1985, CARBOHYD RES, V142, P93, DOI 10.1016/S0008-6215(00)90736-5; PORATH J, 1973, NATURE, V245, P465, DOI 10.1038/245465a0; Pu Q, 2004, J PHYS CHEM B, V108, P14124, DOI 10.1021/jp0486200; Schatz C, 2003, BIOMACROMOLECULES, V4, P641, DOI 10.1021/bm025724c; SIEGEL RA, 1988, MACROMOLECULES, V21, P3254, DOI 10.1021/ma00189a021; Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+; Strand SP, 2001, BIOMACROMOLECULES, V2, P126, DOI 10.1021/bm005601x; Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1; VASQUEZ B, 1997, BIOMETERIALS, V18, P521; VONHIPPE.PH, 1969, ACCOUNTS CHEM RES, V2, P257, DOI 10.1021/ar50021a001	22	416	430	14	538	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					76	U6		10.1038/nature06619	http://dx.doi.org/10.1038/nature06619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322531				2022-12-28	WOS:000253671900049
J	Bartelink, H; Arriagada, R				Bartelink, Harry; Arriagada, Rodrigo			Hypofractionation in radiotherapy for breast cancer	LANCET			English	Editorial Material							RECURRENCE; MASTECTOMY; SURVIVAL; FRACTION; TRIAL; BOOST		[Bartelink, Harry] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Arriagada, Rodrigo] Inst Gustave Roussy, Villejuif, France; [Arriagada, Rodrigo] Karolinska Inst, Stockholm, Sweden	Netherlands Cancer Institute; UNICANCER; Gustave Roussy; Karolinska Institutet	Bartelink, H (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	h.bartelink@nki.nl		Arriagada, Rodrigo/0000-0002-3134-1735				Abe O, 2005, LANCET, V366, P2087; ARRIAGADA R, 1995, J CLIN ONCOL, V13, P2869, DOI 10.1200/JCO.1995.13.12.2869; AUQUIER A, 1992, EUR J CANCER, V28A, P433, DOI 10.1016/S0959-8049(05)80070-X; Bartelink H, 2001, NEW ENGL J MED, V345, P1378, DOI 10.1056/NEJMoa010874; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Bentzen SM, 2008, LANCET, V371, P1098, DOI 10.1016/S0140-6736(08)60348-7; Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)70077-9, 10.1016/S1470-2045(08)60348-7]; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Curran D, 1998, EUR J CANCER, V34, P307, DOI 10.1016/S0959-8049(97)00312-2; Hooning MJ, 2007, JNCI-J NATL CANCER I, V99, P365, DOI 10.1093/jnci/djk064; Jung H, 2001, RADIOTHER ONCOL, V61, P233, DOI 10.1016/S0167-8140(01)00457-1; Owen JR, 2006, LANCET ONCOL, V7, P467, DOI 10.1016/S1470-2045(06)70699-4; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Regaud C, 1927, CR SOC BIOL, V97, P431; Romestaing P, 1997, J CLIN ONCOL, V15, P963, DOI 10.1200/JCO.1997.15.3.963; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Yarnold J, 2005, RADIOTHER ONCOL, V75, P9, DOI 10.1016/j.radonc.2005.01.005	17	17	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2008	371	9618					1050	1052		10.1016/S0140-6736(08)60349-9	http://dx.doi.org/10.1016/S0140-6736(08)60349-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RA	18355914				2022-12-28	WOS:000254442700006
J	Gray, JAM; Patnick, J; Blanks, RG				Gray, J. A. Muir; Patnick, J.; Blanks, R. G.			Maximising benefit and minimising harm of screening	BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER; PROGRAM; MAMMOGRAPHY; UK; CONSISTENCY; MORTALITY; SCHEME		[Gray, J. A. Muir] Natl Knowledge Serv, Oxford OX3 7LG, England; [Patnick, J.] NHS Canc Screening Programmes, Sheffield, S Yorkshire, England; [Blanks, R. G.] Inst Canc Res, Surrey, England	University of London; Institute of Cancer Research - UK	Gray, JAM (corresponding author), Natl Knowledge Serv, Oxford OX3 7LG, England.	muir.gray@medknox.net						Ayer A. J., 1936, LANGUAGE TRUTH LOGIC; Blanks R G, 1996, J Med Screen, V3, P79; Blanks RG, 2000, BRIT MED J, V321, P665, DOI 10.1136/bmj.321.7262.665; Blanks RG, 1998, J MED SCREEN, V5, P195, DOI 10.1136/jms.5.4.195; Blanks RG, 2002, J MED SCREEN, V9, P11, DOI 10.1136/jms.9.1.11; Donabedian A, 1980, EXPLORATIONS QUALITY, V1; Ellis IO, 2006, J CLIN PATHOL, V59, P138, DOI 10.1136/jcp.2004.025551; Forrest APM, 1986, REPORT HLTH MINISTER; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; GRAY JAM, 1990, GEN PRINCIPLES QUALI; Prior P, 1996, J Med Screen, V3, P119; PRITCHARD J, 1989, QUALITY ASSURANCE GU; Sauven P, 2003, BRIT J SURG, V90, P82, DOI 10.1002/bjs.4013; Sloane JP, 1999, VIRCHOWS ARCH, V434, P3; SLOANE JP, 1994, EUR J CANCER, V30A, P1414, DOI 10.1016/0959-8049(94)00261-3; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4	16	61	61	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 1	2008	336	7642					480	483		10.1136/bmj.39470.643218.94	http://dx.doi.org/10.1136/bmj.39470.643218.94			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18310003	Green Published			2022-12-28	WOS:000253997500039
J	Rosenbaum, S				Rosenbaum, Sara			The proxy war - SCHIP and the government's role in health care reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, Sara] George Washington Univ, Dept Hlth Policy, Washington, DC 20052 USA; [Rosenbaum, Sara] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA; [Rosenbaum, Sara] George Washington Univ, Sch Med & Law, Washington, DC 20052 USA	George Washington University; George Washington University; George Washington University	Rosenbaum, S (corresponding author), George Washington Univ, Dept Hlth Policy, Washington, DC 20052 USA.							BUSH LC, 2007, WASHINGTON POST 0719, pA3; KU L, 2007, CROWD OUT IS NOT SAM; SMITH DG, 2007, COMMUNICATION   0817	3	12	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					869	872		10.1056/NEJMp0800623	http://dx.doi.org/10.1056/NEJMp0800623			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266JD	18305263				2022-12-28	WOS:000253430200001
J	Li, SP; Matthews, J; Sinha, A				Li, Shuping; Matthews, Jamie; Sinha, Amitabha			Atmospheric hydroxyl radical production from electronically excited NO2 and H2O	SCIENCE			English	Article							LASER-INDUCED FLUORESCENCE; HETEROGENEOUS HYDROLYSIS; CHEMISTRY; MECHANISM; DISSOCIATION; TROPOSPHERE; ABSORPTION; PHOTOLYSIS; THRESHOLD; HOX	Hydroxyl radicals are often called the "detergent" of the atmosphere because they control the atmosphere's capacity to cleanse itself of pollutants. Here, we show that the reaction of electronically excited nitrogen dioxide with water can be an important source of tropospheric hydroxyl radicals. Using measured rate data, along with available solar flux and atmospheric mixing ratios, we demonstrate that the tropospheric hydroxyl contribution from this source can be a substantial fraction ( 50%) of that from the traditional O(D-1) + H2O reaction in the boundary- layer region for high solar zenith angles. Inclusion of this chemistry is expected to affect modeling of urban air quality, where the interactions of sunlight with emitted NOx species, volatile organic compounds, and hydroxyl radicals are central in determining the rate of ozone formation.	[Li, Shuping; Matthews, Jamie; Sinha, Amitabha] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Sinha, A (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	asinha@ucsd.edu						Crowley JN, 1997, J PHYS CHEM A, V101, P4178, DOI 10.1021/jp970319e; CRUTZEN P, 1973, PURE APPL GEOPHYS, V106, P1385, DOI 10.1007/BF00881092; Domine F, 2002, SCIENCE, V297, P1506, DOI 10.1126/science.1074610; Donaldson DJ, 1997, GEOPHYS RES LETT, V24, P2651, DOI 10.1029/97GL02663; DONNELLY VM, 1979, J CHEM PHYS, V71, P659, DOI 10.1063/1.438417; DOUGLAS AE, 1966, J CHEM PHYS, V45, P1007, DOI 10.1063/1.1727650; Dutton G, 1999, J CHEM PHYS, V111, P4976, DOI 10.1063/1.479757; Finlayson-Pitts B.J., 1986, ATMOSPHERIC CHEM; Finlayson-Pitts BJ, 2003, PHYS CHEM CHEM PHYS, V5, P223, DOI 10.1039/b208564j; Hartland GV, 1997, J CHEM PHYS, V107, P2890, DOI 10.1063/1.474648; LEVY H, 1972, PLANET SPACE SCI, V20, P919, DOI 10.1016/0032-0633(72)90177-8; LOGAN JA, 1981, J GEOPHYS RES-OCEANS, V86, P7210, DOI 10.1029/JC086iC08p07210; MADRONICH S, 2006, TROPOSPHERIC ULTRAVI; Matthews J, 2005, P NATL ACAD SCI USA, V102, P7449, DOI 10.1073/pnas.0502687102; Monks PS, 2005, CHEM SOC REV, V34, P376, DOI 10.1039/b307982c; Okabe H., 1978, PHOTOCHEMISTRY SMALL; Ramazan KA, 2006, J PHYS CHEM A, V110, P6886, DOI 10.1021/jp056426n; ROEHL CM, 1994, J PHYS CHEM-US, V98, P7837, DOI 10.1021/j100083a015; Rothman LS, 2003, J QUANT SPECTROSC RA, V82, P5, DOI 10.1016/S0022-4073(03)00146-8; Salawitch RJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015006; SANDER SP, 2003, JPL PUBL, V225; SHIBUYA K, 1986, J CHEM PHYS, V85, P5061, DOI 10.1063/1.451697; Singh HB, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007664; STEVENS CG, 1973, CHEM PHYS LETT, V18, P465, DOI 10.1016/0009-2614(73)80444-0; Thornton JA, 2000, ANAL CHEM, V72, P528, DOI 10.1021/ac9908905; Tyndall G.S., 1999, ATMOSPHERIC CHEM GLO; Wennberg PO, 1999, GEOPHYS RES LETT, V26, P1373, DOI 10.1029/1999GL900255; WINE PH, 1981, CHEM PHYS LETT, V77, P103, DOI 10.1016/0009-2614(81)85609-6	28	194	206	12	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1657	1660		10.1126/science.1151443	http://dx.doi.org/10.1126/science.1151443			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356524				2022-12-28	WOS:000254172300038
J	Lorenz, RD; Stiles, BW; Kirk, RL; Allison, MD; del Marmo, PP; Iess, L; Lunine, JI; Ostro, SJ; Hensley, S				Lorenz, Ralph D.; Stiles, Bryan W.; Kirk, Randolph L.; Allison, Michael D.; del Marmo, Paolo Persi; Iess, Luciano; Lunine, Jonathan I.; Ostro, Steven J.; Hensley, Scott			Titan's rotation reveals an internal ocean and changing zonal winds	SCIENCE			English	Article							GALILEAN SATELLITES; SURFACE	Cassini radar observations of Saturn's moon Titan over several years show that its rotational period is changing and is different from its orbital period. The present- day rotation period difference from synchronous spin leads to a shift of similar to 0.36 per year in apparent longitude and is consistent with seasonal exchange of angular momentum between the surface and Titan's dense superrotating atmosphere, but only if Titan's crust is decoupled from the core by an internal water ocean like that on Europa.	[Lorenz, Ralph D.] Johns Hopkins Univ, Appl Phys Lab, Dept Space, Laurel, MD 20723 USA; [Stiles, Bryan W.; Ostro, Steven J.; Hensley, Scott] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Kirk, Randolph L.] US Geol Survey, Flagstaff, AZ 86001 USA; [Allison, Michael D.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [del Marmo, Paolo Persi; Iess, Luciano] Univ Roma La Sapienza, I-00184 Rome, Italy; [Lunine, Jonathan I.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Sapienza University Rome; University of Arizona	Lorenz, RD (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Dept Space, Johns Hopkins Rd, Laurel, MD 20723 USA.	ralph.lorenz@jhuapl.edu	Lorenz, Ralph D/B-8759-2016; IESS, Luciano/F-4902-2011	Lorenz, Ralph D/0000-0001-8528-4644; IESS, Luciano/0000-0002-6230-5825; Lunine, Jonathan/0000-0003-2279-4131				Bills BG, 2005, ICARUS, V175, P233, DOI 10.1016/j.icarus.2004.10.028; Bird MK, 2005, NATURE, V438, P800, DOI 10.1038/nature04060; DEMALMO PP, 2007, B AM ASTRON SOC, V39, P543; Elachi C, 2006, NATURE, V441, P709, DOI 10.1038/nature04786; Folkner WM, 1997, SCIENCE, V278, P1749, DOI 10.1126/science.278.5344.1749; Fortes AD, 2000, ICARUS, V146, P444, DOI 10.1006/icar.2000.6400; GOLDREICH P, 1961, ASTRON J, V71, P1; Grasset O, 2000, PLANET SPACE SCI, V48, P617, DOI 10.1016/S0032-0633(00)00039-8; GREENBERG R, 1984, ICARUS, V58, P186, DOI 10.1016/0019-1035(84)90038-1; HIDE R, 1980, NATURE, V286, P114, DOI 10.1038/286114a0; Margot JL, 2007, SCIENCE, V316, P710, DOI 10.1126/science.1140514; Peixoto J.P., 1992, PHYS CLIMATE, P520; RADEBAUGH J, 2006, LUNAR PLANET SCI, V37, P1007; Rappaport N, 1997, ICARUS, V126, P313, DOI 10.1006/icar.1996.5661; Richardson J, 2004, ICARUS, V170, P113, DOI 10.1016/j.icarus.2004.03.010; SEARS WD, 1993, ICARUS, V105, P259, DOI 10.1006/icar.1993.1123; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023; Sohl F, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002044; STEVENSON DJ, 1992, ESA SP, V338, P29; STILES B, 2007, B AM ASTRON SOC, V39, P543; Tokano T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024456; WHITE RM, 1949, J METEOROL, V6, P353, DOI 10.1175/1520-0469(1949)006<0353:TROMIT>2.0.CO;2; Zimmer C, 2000, ICARUS, V147, P329, DOI 10.1006/icar.2000.6456	23	140	142	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2008	319	5870					1649	1651		10.1126/science.1151639	http://dx.doi.org/10.1126/science.1151639			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356521				2022-12-28	WOS:000254172300035
J	Wennberg, PO; Dabdub, D				Wennberg, Paul O.; Dabdub, Donald			Atmospheric chemistry - Rethinking ozone production	SCIENCE			English	Editorial Material									[Wennberg, Paul O.] CALTECH, Pasadena, CA 91125 USA; [Dabdub, Donald] Univ Calif Irvine, Dept Mech & Aerosp Engn, Irvine, CA 92697 USA	California Institute of Technology; University of California System; University of California Irvine	Wennberg, PO (corresponding author), CALTECH, Pasadena, CA 91125 USA.	wennberg@caltech.edu; ddabdub@uci.edu	Wennberg, Paul O/A-5460-2012	Wennberg, Paul O/0000-0002-6126-3854				Crowley JN, 1997, J PHYS CHEM A, V101, P4178, DOI 10.1021/jp970319e; Dabdub D, 1996, PARALLEL COMPUT, V22, P111, DOI 10.1016/0167-8191(95)00063-1; HARLEY RA, 1993, ENVIRON SCI TECHNOL, V27, P378, DOI 10.1021/es00039a019; Li SP, 2008, SCIENCE, V319, P1657, DOI 10.1126/science.1151443; *NARSTO SYNTH TEAM, 2000, ASS TROP OZ POLL N A; *NCR COMM TROP OZ, 1991, RETH OZ PROBL URB RE	6	50	52	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1624	1625		10.1126/science.1155747	http://dx.doi.org/10.1126/science.1155747			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356510				2022-12-28	WOS:000254172300024
J	Eremets, MI; Trojan, IA; Medvedev, SA; Tse, JS; Yao, Y				Eremets, M. I.; Trojan, I. A.; Medvedev, S. A.; Tse, J. S.; Yao, Y.			Superconductivity in hydrogen dominant materials: Silane	SCIENCE			English	Article							SOLID HYDROGEN; METALLIZATION; PRESSURE; GPA; EQUATION; METHANE; STATE	The metallization of hydrogen directly would require pressure in excess of 400 gigapascals ( GPa), out of the reach of present experimental techniques. The dense group IVa hydrides attract considerable attention because hydrogen in these compounds is chemically precompressed and a metallic state is expected to be achievable at experimentally accessible pressures. We report the transformation of insulating molecular silane to a metal at 50 GPa, becoming superconducting at a transition temperature of T-c = 17 kelvin at 96 and 120 GPa. The metallic phase has a hexagonal close- packed structure with a high density of atomic hydrogen, creating a three- dimensional conducting network. These experimental findings support the idea of modeling metallic hydrogen with hydrogen- rich alloy.	[Eremets, M. I.; Trojan, I. A.; Medvedev, S. A.] Max Planck Inst Chem, D-55020 Mainz, Germany; [Tse, J. S.; Yao, Y.] Univ Saskatchewan, Dept Phys & Engn Phys, Saskatoon, SK S7N 5E2, Canada	Max Planck Society; University of Saskatchewan	Eremets, MI (corresponding author), Max Planck Inst Chem, Postfach 3060, D-55020 Mainz, Germany.	eremets@mpch-mainz.mpg.de	Medvedev, Sergey A/A-9495-2015; Troyan, Ivan/AAQ-9617-2021; Yao, Yansun/G-3822-2012	Medvedev, Sergey A/0000-0002-2871-0886; Troyan, Ivan/0000-0001-8065-1687; 				ASHCROFT NW, 1968, PHYS REV LETT, V21, P1748, DOI 10.1103/PhysRevLett.21.1748; Ashcroft NW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187002; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; Brovman E. G., 1972, Soviet Physics - JETP, V35, P783; Degtyareva O, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064123; DUCLOS SJ, 1990, PHYS REV B, V41, P12021, DOI 10.1103/PhysRevB.41.12021; Feng J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.017006; FOURNIER RP, 1972, CAN J CHEMISTRY, V50, P35, DOI 10.1139/v72-006; Johnson KA, 2000, NATURE, V403, P632, DOI 10.1038/35001024; Loubeyre P, 1996, NATURE, V383, P702, DOI 10.1038/383702a0; Loubeyre P, 2002, NATURE, V416, P613, DOI 10.1038/416613a; MAO HK, 1994, REV MOD PHYS, V66, P671, DOI 10.1103/RevModPhys.66.671; Martinez-Canales M, 2006, HIGH PRESSURE RES, V26, P369, DOI 10.1080/08957950601104955; Martinez-Canales M, 2006, J PHYS CHEM SOLIDS, V67, P2095, DOI 10.1016/j.jpcs.2006.05.050; Nellis WJ, 2006, REP PROG PHYS, V69, P1479, DOI 10.1088/0034-4885/69/5/R05; Pickard CJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.045504; Stadele M, 2000, PHYS REV LETT, V84, P6070, DOI 10.1103/PhysRevLett.84.6070; Sun LL, 2006, J PHYS CHEM SOLIDS, V67, P2603, DOI 10.1016/j.jpcs.2006.08.003; Tse JS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.117004; Wigner E, 1935, J CHEM PHYS, V3, P764, DOI 10.1063/1.1749590; Yao Y, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/37003	21	312	321	4	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1506	1509		10.1126/science.1153282	http://dx.doi.org/10.1126/science.1153282			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339933				2022-12-28	WOS:000253943800032
J	May, PW				May, Paul W.			Materials science - The new diamond age?	SCIENCE			English	Editorial Material									[May, Paul W.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	May, PW (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	paul.may@bris.ac.uk						GRUEN DM, 2005, SYNTHESIS PROPERTIES; HO SS, 2006, IND DIAMOND REV 0128; Kalish R, 2001, DIAM RELAT MATER, V10, P1749, DOI 10.1016/S0925-9635(01)00426-5; May PW, 2000, PHILOS T ROY SOC A, V358, P473, DOI 10.1098/rsta.2000.0542; Nebel CE, 2007, J R SOC INTERFACE, V4, P439, DOI 10.1098/rsif.2006.0196; Spear K. E., 1994, SYNTHETIC DIAMOND EM, V25	6	83	86	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1490	1491		10.1126/science.1154949	http://dx.doi.org/10.1126/science.1154949			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339926				2022-12-28	WOS:000253943800025
J	Kim, J; Darley, DJ; Buckel, W; Pierik, AJ				Kim, Jihoe; Darley, Daniel J.; Buckel, Wolfgang; Pierik, Antonio J.			An allylic ketyl radical intermediate in clostridial amino-acid fermentation	NATURE			English	Article							IRON-SULFUR CLUSTERS; LYSINE 2,3-AMINOMUTASE; MECHANISTIC PROPOSAL; ANAEROBIC-BACTERIA; DIFFICILE; DEHYDRATASE; LEUCINE; GENOME; ANALOG	The human pathogenic bacterium Clostridium difficile thrives by the fermentation of L- leucine toammonia, CO2, 3-methylbutanoate and 4-methylpentanoate under anaerobic conditions(1). The reductive branch to 4- methylpentanoate proceeds by means of the dehydration of ( R)- 2- hydroxy- 4- methylpentanoyl- CoA to 4- methylpent-2- enoyl- CoA, which is chemically the most demanding step. Ketyl radicals have been proposed(2) to mediate this reaction catalysed by an iron - sulphur- cluster- containing dehydratase, which requires activation by ATP- dependent electron transfer from a second iron - sulphur protein functionally similar to the iron protein of nitrogenase. Here we identify a kinetically competent product-related allylic ketyl radical bound to the enzyme by electron paramagnetic resonance spectroscopy employing isotope- labelled ( R)- 2- hydroxy- 4- methylpentanoyl- CoA species. We also found that the enzyme generated the stabilized pentadienoyl ketyl radical from the substrate analogue 2- hydroxypent- 4- enoyl- CoA, supporting the proposed mechanism. Our results imply that also other 2- hydroxyacyl- CoA dehydratases(3) and the related benzoyl- CoA reductases(4) - present in anaerobically living bacteria - employ ketyl radical intermediates. The absence of radical generators such as coenzyme B-12, S- adenosylmethionine or oxygen makes these enzymes unprecedented in biochemistry.	[Kim, Jihoe; Darley, Daniel J.; Buckel, Wolfgang; Pierik, Antonio J.] Univ Marburg, Fachbereich Biol, Mikrobiol Lab, D-35032 Marburg, Germany	Philipps University Marburg	Pierik, AJ (corresponding author), Univ Marburg, Fachbereich Biol, Mikrobiol Lab, D-35032 Marburg, Germany.	pierik@staff.uni-marburg.de	Pierik, Antonio J/G-1108-2010	Pierik, Antonio J/0000-0002-1509-6370				BALLINGER MD, 1992, BIOCHEMISTRY-US, V31, P949, DOI 10.1021/bi00119a001; BARKER HA, 1981, ANNU REV BIOCHEM, V50, P23, DOI 10.1146/annurev.bi.50.070181.000323; BEINERT H, 1982, BIOCHIM BIOPHYS ACTA, V683, P245, DOI 10.1016/0304-4173(82)90003-9; Boll M, 2005, BIOL CHEM, V386, P989, DOI 10.1515/BC.2005.115; Bruckner R, 2003, REAKTIONSMECHANISMEN; Buckel W, 2004, CURR OPIN CHEM BIOL, V8, P462, DOI 10.1016/j.cbpa.2004.07.001; BUCKEL W, 1995, ANGEW CHEM INT EDIT, V34, P1502, DOI 10.1002/anie.199515021; BUCKEL W, 1980, EUR J BIOCHEM, V106, P439, DOI 10.1111/j.1432-1033.1980.tb04590.x; Buckel W., 1999, BIOL PROKARYOTES, P278; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; ELSDEN SR, 1978, ARCH MICROBIOL, V117, P165, DOI 10.1007/BF00402304; Hans M, 2000, EUR J BIOCHEM, V267, P7082, DOI 10.1046/j.1432-1327.2000.01809.x; Kim J, 2005, FEBS J, V272, P550, DOI 10.1111/j.1742-4658.2004.04498.x; Kim J, 2006, APPL ENVIRON MICROB, V72, P6062, DOI 10.1128/AEM.00772-06; Layer G, 2006, J BIOL CHEM, V281, P15727, DOI 10.1074/jbc.M512628200; Magnusson OT, 2001, BIOCHEMISTRY-US, V40, P7773, DOI 10.1021/bi0104569; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Sebaihia M, 2006, NAT REV MICROBIOL, V4, P882, DOI 10.1038/nrmicro1571; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; SEEBACH D, 1979, ANGEW CHEM INT EDIT, V18, P239, DOI 10.1002/anie.197902393; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; Smith DM, 2003, ANGEW CHEM INT EDIT, V42, P1867, DOI 10.1002/anie.200250502; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Tsai AL, 1998, ANAL BIOCHEM, V264, P165, DOI 10.1006/abio.1998.2774; Weil JA, 2007, ELECT PARAMAGNETIC R, V2nd; Wu WM, 2000, BIOCHEMISTRY-US, V39, P9561, DOI 10.1021/bi000658p	26	53	58	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					239	U85		10.1038/nature06637	http://dx.doi.org/10.1038/nature06637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337824				2022-12-28	WOS:000253925600045
J	Samuelsson, O; Herlitz, H				Samuelsson, Ola; Herlitz, Hans			Vaccination against high blood pressure: a new strategy	LANCET			English	Editorial Material							DOUBLE-BLIND		[Samuelsson, Ola; Herlitz, Hans] Gothenburg Univ, Sahlgrens Hosp, Dept Nephrol, S-41345 Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg	Samuelsson, O (corresponding author), Gothenburg Univ, Sahlgrens Hosp, Dept Nephrol, S-41345 Gothenburg, Sweden.	ola.samuelsson@vgregion.se						Borzecki AM, 2005, AM HEART J, V149, P785, DOI 10.1016/j.ahj.2005.01.047; Brown MJ, 2004, CLIN SCI, V107, P167, DOI 10.1042/CS20030381; Hollenberg N K, 1984, Contrib Nephrol, V43, P102; JOHNSTON CI, 1992, J HYPERTENS, V10, pS13; Menard J, 2007, J HYPERTENS, V25, P41, DOI 10.1097/HJH.0b013e328012981b; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Senior K, 2002, LANCET NEUROL, V1, P3, DOI 10.1016/S1474-4422(02)00023-6; Spinney L, 2004, LANCET NEUROL, V3, P5, DOI [10.1016/S1474-4422(03)00634-3, 10.1016/S1474-4422(03)00635-5]; Taylor JGC, 2003, AM J KIDNEY DIS, V42, DOI 10.1016/S0272-6386(03)00667-X; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5	10	9	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2008	371	9615					788	789		10.1016/S0140-6736(08)60355-4	http://dx.doi.org/10.1016/S0140-6736(08)60355-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272NQ	18328909				2022-12-28	WOS:000253866500005
J	Parisien, M; Major, F				Parisien, Marc; Major, Francois			The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data	NATURE			English	Article							SECONDARY STRUCTURE PREDICTION; ISOSTERICITY MATRICES; ESCHERICHIA-COLI; MESSENGER-RNA; INDUCED FIT; 5-S RNA; RECOGNITION; ELEMENT; PROTEIN; HIV-1	The classical RNA secondary structure model considers A.U and G.U Watson - Crick as well as G.U wobble base pairs. Here we substitute it for a new one, in which sets of nucleotide cyclic motifs define RNA structures. This model allows us to unify all base pairing energetic contributions in an effective scoring function to tackle the problem of RNA folding. We show how pipelining two computer algorithms based on nucleotide cyclic motifs, MC- Fold and MC- Sym, reproduces a series of experimentally determined RNA three- dimensional structures from the sequence. This demonstrates how crucial the consideration of all base- pairing interactions is in filling the gap between sequence and structure. We use the pipeline to define rules of precursor microRNA folding in double helices, despite the presence of a number of presumed mismatches and bulges, and to propose a new model of the human immunodeficiency virus- 1-1 frame- shifting element.	[Parisien, Marc; Major, Francois] Univ Montreal, IRIC, Dept Comp Sci & Operat Res, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Major, F (corresponding author), Univ Montreal, IRIC, Dept Comp Sci & Operat Res, POB 6128,Downtown Stn, Montreal, PQ H3C 3J7, Canada.	francois.major@umontreal.ca		Parisien, Marc/0000-0003-2924-5960				Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRUNEL C, 1991, J MOL BIOL, V221, P293; Clery A, 2007, NUCLEIC ACIDS RES, V35, P1868, DOI 10.1093/nar/gkm066; DAS R, 2007, P NATL ACAD SCI US; Dima RI, 2005, J MOL BIOL, V347, P53, DOI 10.1016/j.jmb.2004.12.012; Do CB, 2006, BIOINFORMATICS, V22, pE90, DOI 10.1093/bioinformatics/btl246; Gaudin C, 2005, J MOL BIOL, V349, P1024, DOI 10.1016/j.jmb.2005.04.045; Gesteland R., 2006, RNA WORLD, V3rd edn. Cold Spring Harbor; Giedroc DP, 2000, J MOL BIOL, V298, P167, DOI 10.1006/jmbi.2000.3668; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JAFFREY SR, 1993, NUCLEIC ACIDS RES, V21, P4627, DOI 10.1093/nar/21.19.4627; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kondo J, 2006, NUCLEIC ACIDS RES, V34, P676, DOI 10.1093/nar/gkj467; Lee BM, 2006, J MOL BIOL, V357, P275, DOI 10.1016/j.jmb.2005.12.010; LEIPUVIENE R, IN PRESS CELL MOL LI; Lemieux S, 2006, NUCLEIC ACIDS RES, V34, P2340, DOI 10.1093/nar/gkl120; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; LEONTIS NB, 1986, BIOCHEMISTRY-US, V25, P3916, DOI 10.1021/bi00361a027; Lescoute A, 2005, NUCLEIC ACIDS RES, V33, P2395, DOI 10.1093/nar/gki535; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; MAJOR F, 1991, SCIENCE, V253, P1255, DOI 10.1126/science.1716375; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; Mathews DH, 2006, J MOL BIOL, V359, P526, DOI 10.1016/j.jmb.2006.01.067; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; PERRET V, 1990, BIOCHIMIE, V72, P735, DOI 10.1016/0300-9084(90)90158-D; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; Shankar N, 2006, BIOCHEMISTRY-US, V45, P11776, DOI 10.1021/bi0605787; Shapiro BA, 2007, CURR OPIN STRUC BIOL, V17, P157, DOI 10.1016/j.sbi.2007.03.001; SIERZPUTOWSKAGRACZ H, 1995, NUCLEIC ACIDS RES, V23, P146, DOI 10.1093/nar/23.1.146; Staple DW, 2005, J MOL BIOL, V349, P1011, DOI 10.1016/j.jmb.2005.03.038; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575	40	563	585	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					51	55		10.1038/nature06684	http://dx.doi.org/10.1038/nature06684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322526				2022-12-28	WOS:000253671900044
J	Bentzen, SM; Agrawal, RK; Aird, EGA; Barrett, JM; Barrett-Lee, PJ; Bliss, JM; Brown, J; Dewar, JA; Dobbs, HJ; Haviland, JS; Hoskin, PJ; Hopwood, P; Lawton, PA; Magee, BJ; Mills, J; Morgan, DAL; Owen, JR; Simmons, S; Sumo, G; Sydenham, MA; Venables, K; Yarnold, JR				Bentzen, S. M.; Agrawal, R. K.; Aird, E. G. A.; Barrett, J. M.; Barrett-Lee, P. J.; Bliss, J. M.; Brown, J.; Dewar, J. A.; Dobbs, H. J.; Haviland, J. S.; Hoskin, P. J.; Hopwood, P.; Lawton, P. A.; Magee, B. J.; Mills, J.; Morgan, D. A. L.; Owen, J. R.; Simmons, S.; Sumo, G.; Sydenham, M. A.; Venables, K.; Yarnold, J. R.		START Trialists Grp	The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial	LANCET			English	Article							QUALITY-OF-LIFE; FRACTIONATION SCHEDULE; EUROPEAN-ORGANIZATION; LOCAL RECURRENCE; CLINICAL-TRIAL; SURGERY; WOMEN; IRRADIATION; LUMPECTOMY; RADIATION	Background The international standard radiotherapy schedule for early breast cancer delivers 50 Gy in 25 fractions of 2. 0 Gy over 5 weeks, but there is a long history of non-standard regimens delivering a lower total dose using fewer, larger fractions (hypofractionation). We aimed to test the benefits of radiotherapy schedules using fraction sizes larger than 2 - 0 Gy in terms of local-regional tumour control, normal tissue responses, quality of life, and economic consequences in women prescribed post-operative radiotherapy. Methods Between 1999 and 2001, 2215 women with early breast cancer (pT1-3a pN0-1 M0) at 23 centres in the UK were randomly assigned after primary surgery to receive 50 Gy in 25 fractions of 2 - 0 Gy over 5 weeks or 40 Gy in 15 fractions of 2.67 Gy over 3 weeks. Women were eligible for the trial if they were aged over 18 years, did not have an immediate reconstruction, and were available for follow-up. Randomisation method was computer generated and was not blinded. The protocol-specified principal endpoints were local-regional tumour relapse, defined as reappearance of cancer at irradiated sites, late normal tissue effects, and quality of life. Analysis was by intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN59368779. Findings 1105 women were assigned to the 50 Gy group and 1110 to the 40 Gy group. After a median follow up of 6.0 years (IQR 5.0-6.2) the rate of local-regional tumour relapse at 5 years was 2.2% (95% Cl 1.3-3.1) in the 40 Gy group and 3.3% (95% Cl 2.2 to 4. 5) in the 50 Gy group, representing an absolute difference of -0 . 7% (95% Cl -1 . 7% to 0.9%)-ie, the absolute difference in local-regional relapse could be up to 1 . 7% better and at most 1% worse after 40 Gy than after 50 Gy. Photographic and patient self-assessments indicated lower rates of late adverse effects after 40 Gy than after 50 Gy. Interpretation A radiation schedule delivering 40 Gy in 15 fractions seems to offer rates of local-regional tumour relapse and late adverse effects at least as favourable as the standard schedule of 50 Gy in 25 fractions.	[Agrawal, R. K.] Shrewsbury & Telford Hosp NHS Trust, Shrewsbury, Salop, England; [Aird, E. G. A.; Hoskin, P. J.; Venables, K.] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England; [Barrett, J. M.] Royal Berkshire NHS Fdn Trust, Reading, Berks, England; [Barrett-Lee, P. J.] Velindre Hosp NHS Trust, Cardiff, Wales; [Bentzen, S. M.] Univ Wisconsin, Sch Med, Madison, WI USA; [Bliss, J. M.; Haviland, J. S.; Mills, J.; Simmons, S.; Sumo, G.; Sydenham, M. A.] ICR CTSU, Sutton, Surrey, England; [Brown, J.] Univ Bristol, MRC Hlth Serv Res Collaborat, Bristol BS8 1TH, Avon, England; [Dewar, J. A.] Ninewells Hosp, Dundee DD1 9SY, Scotland; [Dobbs, H. J.] Guys & St Thomas NHS Trust, London, England; [Hopwood, P.; Magee, B. J.] Christie Hosp, Manchester, Lancs, England; [Lawton, P. A.] City Hosp Nottingham, Nottingham, England; [Morgan, D. A. L.] Univ Nottingham Hosp NHS Trust, Nottingham, England; [Owen, J. R.] Cheltenham Gen Hosp, Cheltenham, Glos, England; [Yarnold, J. R.] Royal Marsden NHS Fdn Trust, Inst Canc Res, Sutton, Surrey, England	Royal Berkshire Hospital; Velindre Hospital; University of Wisconsin System; University of Wisconsin Madison; University of London; Institute of Cancer Research - UK; University of Bristol; University of Dundee; Guy's & St Thomas' NHS Foundation Trust; Christie NHS Foundation Trust; Christie Hospital; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Nottingham University Hospital NHS Trust; Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Yarnold, JR (corresponding author), Royal Marsden Hosp, Dept Clin Radiotherapy, Downs Rd, Sutton SM2 5PT, Surrey, England.		Bentzen, Søren M/E-3997-2012; Bentzen, Soren M/O-7787-2019	Bentzen, Søren M/0000-0002-7444-7564; Bentzen, Soren M/0000-0002-7444-7564; Hoskin, Peter/0000-0001-8323-9567; Haviland, Joanne/0000-0001-5728-3636; Morgan, David/0000-0002-2291-1740; Barrett-Lee, peter/0000-0002-6246-7357; Bliss, Judith/0000-0001-7957-7424	Cancer Research UK [CRUK/96/001] Funding Source: Medline; Medical Research Council [G9600656] Funding Source: Medline; Department of Health [G9600656] Funding Source: Medline; MRC [G9600656] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Abe O, 2005, LANCET, V366, P2087; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; [Anonymous], 1993, 62 ICRU, P357; Ash D V, 1995, Clin Oncol (R Coll Radiol), V7, P93, DOI 10.1016/S0936-6555(05)80808-8; Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)70077-9, 10.1016/S1470-2045(08)60348-7]; Clark RM, 1996, J NATL CANCER I, V88, P1659, DOI 10.1093/jnci/88.22.1659; Dische S, 1998, LANCET, V351, P1967, DOI 10.1016/S0140-6736(05)78663-3; FISHER B, 1993, NEW ENGL J MED, V328, P1581, DOI 10.1056/NEJM199306033282201; FISHER B, 1985, NEW ENGL J MED, V312, P674, DOI 10.1056/NEJM198503143121102; Fyles AW, 2004, NEW ENGL J MED, V351, P963, DOI 10.1056/NEJMoa040595; Hopwood P, 2001, EUR J CANCER, V37, P189, DOI 10.1016/S0959-8049(00)00353-1; Hopwood P, 2007, BREAST, V16, P241, DOI 10.1016/j.breast.2006.11.003; Magee B, 1999, CLIN ONCOL-UK, V11, P40, DOI 10.1053/clon.1999.9007; McBain CA, 2003, CLIN ONCOL-UK, V15, P25, DOI 10.1053/clon.2002.0165; Olivotto IA, 1996, RADIOTHER ONCOL, V41, P7, DOI 10.1016/S0167-8140(96)01824-5; OVERGAARD M, 1987, RADIOTHER ONCOL, V9, P1, DOI 10.1016/S0167-8140(87)80213-X; Owen JR, 2006, LANCET ONCOL, V7, P467, DOI 10.1016/S1470-2045(06)70699-4; PATERSON R, 1948, TREATMENT MALIGNANT; Rodger A, 1998, BMJ-BRIT MED J, V317, P155, DOI 10.1136/bmj.317.7152.155; RUBIN P, 1967, J AMER MED ASSOC, V200, P132; Shelley W, 2000, INT J RADIAT ONCOL, V47, P1219, DOI 10.1016/S0360-3016(00)00567-8; Sprangers MAG, 1996, J CLIN ONCOL, V14, P2756, DOI 10.1200/JCO.1996.14.10.2756; van Dongen J A, 1992, J Natl Cancer Inst Monogr, P15; Venables K, 2006, BRIT J RADIOL, V79, P734, DOI 10.1259/bjr/80814021; Venables K, 2005, CLIN ONCOL-UK, V17, P337, DOI 10.1016/j.clon.2005.03.006; Venables K, 2004, RADIOTHER ONCOL, V71, P303, DOI 10.1016/j.radonc.2004.02.008; Venables K, 2003, INT J RADIAT ONCOL, V55, P271, DOI 10.1016/S0360-3016(02)03808-7; Venables K, 2001, PHYS MED BIOL, V46, P1937, DOI 10.1088/0031-9155/46/7/314; Venables K, 2001, RADIOTHER ONCOL, V60, P311, DOI 10.1016/S0167-8140(01)00376-0; Venables K, 2000, BRIT J RADIOL, V73, P1313, DOI 10.1259/bjr.73.876.11205676; VERONESI U, 1993, NEW ENGL J MED, V328, P1587, DOI 10.1056/NEJM199306033282202; Whelan T, 2002, J NATL CANCER I, V94, P1143; WILLIAMS M, 1985, INT J RADIAT ONCOL, V11, P1570, DOI 10.1016/0360-3016(85)90349-9; Williams SR, 2003, AATCC REV, V3, P14; Yamada Y, 1999, INT J RADIAT ONCOL, V44, P99, DOI 10.1016/S0360-3016(98)00507-0; Yarnold J, 2005, RADIOTHER ONCOL, V75, P9, DOI 10.1016/j.radonc.2005.01.005; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	795	808	0	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2008	371	9618					1098	1107						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RA	18355913	Bronze, Green Published			2022-12-28	WOS:000254442700028
J	Burt, RK; Loh, Y; Pearce, W; Beohar, N; Barr, WG; Craig, R; Wen, YT; Rapp, JA; Kessler, J				Burt, Richard K.; Loh, Yvonne; Pearce, William; Beohar, Nirat; Barr, Walter G.; Craig, Robert; Wen, Yanting; Rapp, Jonathan A.; Kessler, John			Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE MYOCARDIAL-INFARCTION; TERM-FOLLOW-UP; PROGRESSIVE MULTIPLE-SCLEROSIS; DOSE IMMUNOSUPPRESSIVE THERAPY; SEVERE RHEUMATOID-ARTHRITIS; SEVERE SYSTEMIC-SCLEROSIS; LEFT-VENTRICULAR FUNCTION; PERIPHERAL ARTERIAL-DISEASE; GRAFT-VERSUS-AUTOIMMUNITY; BONE-MARROW	Context Stem cell therapy is rapidly developing and has generated excitement and promise as well as confusion and at times contradictory results in the lay and scientific literature. Many types of stem cells show great promise, but clinical application has lagged due to ethical concerns or difficulties in harvesting or safely and efficiently expanding sufficient quantities. In contrast, clinical indications for blood- derived ( from peripheral or umbilical cord blood) and bone marrow - derived stem cells, which can be easily and safely harvested, are rapidly increasing. Objective To summarize new, nonmalignant, nonhematologic clinical indications for use of blood- and bone marrow - derived stem cells. Evidence Acquisition Search of multiple electronic databases ( MEDLINE, EMBASE, Science Citation Index), US Food and Drug Administration [ FDA] Drug Site, and National Institutes of Health Web site to identify studies published from January 1997 to December 2007 on use of hematopoietic stem cells ( HSCs) in autoimmune, cardiac, or vascular diseases. The search was augmented by hand searching of reference lists in clinical trials, review articles, proceedings booklets, FDA reports, and contact with study authors and device and pharmaceutical companies. Evidence Synthesis Of 926 reports identified, 323 were examined for feasibility and toxicity, including those with small numbers of patients, interim or substudy reports, and reports on multiple diseases, treatment of relapse, toxicity, mechanism of action, or stem cell mobilization. Another 69 were evaluated for outcomes. For autoimmune diseases, 26 reports representing 854 patients reported treatment- related mortality of less than 1% ( 2/ 220 patients) for nonmyeloablative, less than 2%( 3/ 197) for dose- reduced myeloablative, and 13% ( 13/ 100) for intense myeloablative regimens, ie, those including total body irradiation or high- dose busulfan. While all trials performed during the inflammatory stage of autoimmune disease suggested that transplantation of HSCs may have a potent disease-remitting effect, remission duration remains unclear, and no randomized trials have been published. For reports involving cardiovascular diseases, including 17 reports involving 1002 patients with acute myocardial infarction, 16 involving 493 patients with chronic coronary artery disease, and 3 meta- analyses, the evidence suggests that stem cell transplantation performed in patients with coronary artery disease may contribute to modest improvement in cardiac function. Conclusions Stem cells harvested from blood or marrow, whether administered as purified HSCs or mesenchymal stem cells or as an unmanipulated or unpurified product can, under appropriate conditions in select patients, provide disease- ameliorating effects in some autoimmune diseases and cardiovascular disorders. Clinical trials are needed to determine the most appropriate cell type, dose, method, timing of delivery, and adverse effects of adult HSCs for these and other nonmalignant disorders.	[Burt, Richard K.; Craig, Robert; Wen, Yanting] Northwestern Univ, Feinberg Sch Med, Div Immunotherapy, Dept Med, Chicago, IL 60611 USA; [Beohar, Nirat; Rapp, Jonathan A.] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Dept Med, Chicago, IL 60611 USA; [Barr, Walter G.] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Dept Med, Chicago, IL 60611 USA; [Craig, Robert] Northwestern Univ, Feinberg Sch Med, Div Gastroenterol, Dept Med, Chicago, IL 60611 USA; [Pearce, William] Northwestern Univ, Feinberg Sch Med, Div Vasc Surg, Dept Surg, Chicago, IL 60611 USA; [Kessler, John] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Loh, Yvonne] Singapore Gen Hosp, Dept Hematol, Singapore 0316, Singapore	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Singapore General Hospital	Burt, RK (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Immunotherapy, Dept Med, 750 N Lake Shore Dr,Room 649, Chicago, IL 60611 USA.	rburt@northwestern.edu		Burt, Richard K/0000-0002-0922-4145				Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Al-Toma A, 2007, BLOOD, V109, P2243, DOI 10.1182/blood-2006-08-042820; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Assmus B, 2007, CIRC RES, V100, P1234, DOI 10.1161/01.RES.0000264508.47717.6b; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Bartsch T, 2007, CLIN RES CARDIOL, V96, P891, DOI 10.1007/s00392-007-0569-x; Bartunek J, 2005, CIRCULATION, V112, pI178, DOI 10.1161/CIRCULATIONAHA.104.522292; Beeres SLMA, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.07.018; BERENSON RJ, 1988, J CLIN INVEST, V81, P951, DOI 10.1172/JCI113409; Binks M, 2001, ANN RHEUM DIS, V60, P577, DOI 10.1136/ard.60.6.577; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Brown JR, 2007, BIOL BLOOD MARROW TR, V13, P1057, DOI 10.1016/j.bbmt.2007.05.012; Burt RK, 2006, ARTHRITIS RHEUM-US, V54, P3750, DOI 10.1002/art.22256; Burt RK, 2006, JAMA-J AM MED ASSOC, V295, P527, DOI 10.1001/jama.295.5.527; Burt RK, 2004, ARTHRITIS RHEUM, V50, P2466, DOI 10.1002/art.20451; Burt RK, 2003, BLOOD, V102, P2373, DOI 10.1182/blood-2003-03-0877; Capello E, 2005, NEUROL SCI, V26, pS200, DOI 10.1007/s10072-005-0514-6; Carreras E, 2003, HAEMATOLOGICA, V88, P306; Chen Shaoliang, 2006, J Invasive Cardiol, V18, P552; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Choi JH, 2007, CIRC J, V71, P486, DOI 10.1253/circj.71.486; Civin CI, 1996, J CLIN ONCOL, V14, P2224, DOI 10.1200/JCO.1996.14.8.2224; Daikeler T, 2007, ANN RHEUM DIS, V66, P202, DOI 10.1136/ard.2006.056630; de Kleer IM, 2004, ANN RHEUM DIS, V63, P1318, DOI 10.1136/ard.2003.017798; Dobert N, 2004, EUR J NUCL MED MOL I, V31, P1146, DOI 10.1007/s00259-004-1490-4; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Durdu S, 2006, J VASC SURG, V44, P732, DOI 10.1016/j.jvs.2006.06.023; Erbs S, 2005, CIRC RES, V97, P756, DOI 10.1161/01.RES.0000185811.71306.8b; Erbs S, 2007, CIRCULATION, V116, P366, DOI 10.1161/CIRCULATIONAHA.106.671545; Esch JSA, 2005, STEM CELLS, V23, P463, DOI 10.1634/stemcells.2004-0283; Fang B, 2006, BONE MARROW TRANSPL, V38, P389, DOI 10.1038/sj.bmt.1705457; Farge D, 2004, ANN RHEUM DIS, V63, P974, DOI 10.1136/ard.2003.011205; Fassas A, 2002, J NEUROL, V249, P1619; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Fuchs S, 2006, AM J CARDIOL, V97, P823, DOI 10.1016/j.amjcard.2005.09.132; Gallacher L, 2000, BLOOD, V95, P2813, DOI 10.1182/blood.V95.9.2813.009k20_2813_2820; Gao LR, 2006, AM J CARDIOL, V98, P597, DOI 10.1016/j.amjcard.2006.03.034; Gratwohl A, 2005, BONE MARROW TRANSPL, V35, P869, DOI 10.1038/sj.bmt.1704892; Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0; Hendrikx M, 2006, CIRCULATION, V114, pI101, DOI 10.1161/CIRCULATIONAHA.105.000505; Hristov M, 2006, J CELL MOL MED, V10, P727, DOI 10.1111/j.1582-4934.2006.tb00432.x; Ishida A, 2005, CIRC J, V69, P1260, DOI 10.1253/circj.69.1260; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Jayne D, 2004, LUPUS, V13, P168, DOI 10.1191/0961203304lu525oa; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kang HJ, 2004, LANCET, V363, P751, DOI 10.1016/S0140-6736(04)15689-4; Kang HJ, 2006, CIRCULATION, V114, pI145, DOI 10.1161/CIRCULATIONAHA.105.001107; Kang HJ, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.11.004; Kawamura A, 2005, THER APHER DIAL, V9, P59, DOI 10.1111/j.1774-9987.2005.00218.x; Kim DI, 2006, STEM CELLS, V24, P1194, DOI 10.1634/stemcells.2005-0349; Kozak T, 2000, BONE MARROW TRANSPL, V25, P525, DOI 10.1038/sj.bmt.1702180; Kozak T, 2002, J NEUROL, V249, P1088, DOI 10.1007/s00415-002-0800-7; Lenk K, 2005, EUR HEART J, V26, P1903, DOI 10.1093/eurheartj/ehi285; Li ZQ, 2007, INT J CARDIOL, V115, P52, DOI 10.1016/j.ijcard.2006.04.005; Lipinski MJ, 2007, J AM COLL CARDIOL, V50, P1761, DOI 10.1016/j.jacc.2007.07.041; Loh Y, 2007, BONE MARROW TRANSPL, V39, P435, DOI 10.1038/sj.bmt.1705611; Loh Y, 2007, BLOOD, V109, P2643, DOI 10.1182/blood-2006-07-035766; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Manginas A, 2007, CATHETER CARDIO INTE, V69, P773, DOI 10.1002/ccd.21023; Mansour S, 2006, J AM COLL CARDIOL, V47, P1727, DOI 10.1016/j.jacc.2006.01.039; Marmont AM, 2006, BONE MARROW TRANSPL, V37, P1061, DOI 10.1038/sj.bmt.1705372; Marmont AM, 2003, BONE MARROW TRANSPL, V31, P399, DOI 10.1038/sj.bmt.1703833; Meluzin J, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.08.004; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Miyamoto K, 2006, CIRCULATION, V114, P2679, DOI 10.1161/CIRCULATIONAHA.106.644203; Mocini D, 2006, AM HEART J, V151, P192, DOI 10.1016/j.ahj.2005.02.001; Mohamadnejad M, 2007, ARCH IRAN MED, V10, P459; Montoto S, 2007, LEUKEMIA, V21, P2324, DOI 10.1038/sj.leu.2404850; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Nash RA, 2003, BLOOD, V102, P2364, DOI 10.1182/blood-2002-12-3908; Nash RA, 2007, BLOOD, V110, P1388, DOI 10.1182/blood-2007-02-072389; Nash RA, 2006, ARTHRITIS RHEUM-US, V54, P1982, DOI 10.1002/art.21908; Ni XS, 2006, CLIN TRANSPLANT, V20, P485, DOI 10.1111/j.1399-0012.2006.00510.x; Openshaw H, 2000, BIOL BLOOD MARROW TR, V6, P563, DOI 10.1016/S1083-8791(00)70066-8; Oryoji K, 2005, CLIN RHEUMATOL, V24, P637, DOI 10.1007/s10067-005-1109-6; Oyama Y, 2007, NEUROLOGY, V69, P1802, DOI 10.1212/01.wnl.0000277266.53449.8b; Oyama Y, 2007, BONE MARROW TRANSPL, V40, P549, DOI 10.1038/sj.bmt.1705782; Oyama Y, 2005, GASTROENTEROLOGY, V128, P552, DOI 10.1053/j.gastro.2004.11.051; Patel AN, 2005, J THORAC CARDIOV SUR, V130, P1631, DOI 10.1016/j.jtcvs.2005.07.056; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; Perin EC, 2004, CIRCULATION, V110, pII213, DOI 10.1161/01.CIR.0000138398.77550.62; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Rocca MA, 2007, AM J NEURORADIOL, V28, P1659, DOI 10.3174/ajnr.A0644; Rosen O, 2000, ARTHRITIS RES, V2, P327, DOI 10.1186/ar107; Saccardi R, 2006, MULT SCLER, V12, P814, DOI 10.1177/1352458506071301; Saigawa T, 2004, CIRC J, V68, P1189, DOI 10.1253/circj.68.1189; Samijn JPA, 2006, J NEUROL NEUROSUR PS, V77, P46, DOI 10.1136/jnnp.2005.063883; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Schaechinger V, 2006, CLIN RES CARDIOL, V95, P13, DOI 10.1007/s00392-006-0314-x; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schaefer A, 2006, EUR HEART J, V27, P929, DOI 10.1093/eurheartj/ehi817; Snowden JA, 2004, J RHEUMATOL, V31, P482; Stamm C, 2007, J THORAC CARDIOV SUR, V133, P717, DOI 10.1016/j.jtcvs.2006.08.077; Statkute L, 2008, ANN RHEUM DIS, V67, P991, DOI 10.1136/ard.2007.070227; Statkute L, 2007, BONE MARROW TRANSPL, V39, P317, DOI 10.1038/sj.bmt.1705579; Strauer BE, 2005, J AM COLL CARDIOL, V46, P1651, DOI 10.1016/j.jacc.2005.01.069; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tatsumi T, 2007, CIRC J, V71, P1199, DOI 10.1253/circj.71.1199; Teng YKO, 2005, ARTHRITIS RHEUM-US, V52, P2272, DOI 10.1002/art.21219; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; van Os R, 2004, STEM CELLS, V22, P1181, DOI 10.1634/stemcells.2004-0095; Verburg RJ, 2005, ANN RHEUM DIS, V64, P1397, DOI 10.1136/ard.2004.033332; VERDA L, 2007, STEM CELLS; Voltarelli JC, 2004, RHEUMATOLOGY, V43, P1308, DOI 10.1093/rheumatology/keh301; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Vonk MC, 2008, ANN RHEUM DIS, V67, P98, DOI 10.1136/ard.2007.071464; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Xu J, 2006, CHINESE MED J-PEKING, V119, P1851, DOI 10.1097/00029330-200611020-00001	112	248	275	2	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2008	299	8					925	936		10.1001/jama.299.8.925	http://dx.doi.org/10.1001/jama.299.8.925			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266DZ	18314435	Bronze			2022-12-28	WOS:000253413200021
J	Birnbaum, KD; Alvarado, AS				Birnbaum, Kenneth D.; Alvarado, Alejandro Sanchez			Slicing across kingdoms: Regeneration in plants and animals	CELL			English	Review							SHOOT APICAL MERISTEM; CUP-SHAPED-COTYLEDON; STEM-CELLS; POLYCOMB-GROUP; HISTONE H3; LIMB REGENERATION; NERVE DEPENDENCE; TOTIPOTENT CELLS; GROUP PROTEINS; ARABIDOPSIS	Multicellular organisms possessing relatively long life spans are subjected to diverse, constant, and often intense intrinsic and extrinsic challenges to their survival. Animal and plant tissues wear out as part of normal physiological functions and can be lost to predators, disease, and injury. Both kingdoms survive this wide variety of insults by strategies that include the maintenance of adult stem cells or the induction of stem cell potential in differentiated cells. Repatterning mechanisms often deploy embryonic genes, but the question remains in both plants and animals whether regeneration invokes embryogenesis, generic patterning mechanisms, or unique circuitry comprised of wellestablished patterning genes.	[Birnbaum, Kenneth D.] NYU, Dept Biol, Ctr Genom Syst Biol, New York, NY 10003 USA; [Alvarado, Alejandro Sanchez] Univ Utah, Sch Med, Dept Neurobiol & Anat, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	New York University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Birnbaum, KD (corresponding author), NYU, Dept Biol, Ctr Genom Syst Biol, New York, NY 10003 USA.	ken.birnbaum@nyu.edu; sanchez@neuro.utah.edu		Sanchez Alvarado, Alejandro/0000-0002-1966-6959	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057260, R01GM078279] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM057260, R0-1 GM078279, R0-1 GM57260, R01 GM078279-03, R01 GM078279] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aida M, 1999, DEVELOPMENT, V126, P1563; Allison SJ, 2004, CARCINOGENESIS, V25, P1551, DOI 10.1093/carcin/bgh212; Allison SJ, 2003, CANCER RES, V63, P6674; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Avel M., 1962, Bulletin de la Societe Zoologique de France, V86, P464; Bardeen CR, 1904, J EXP ZOOL, V1, P191, DOI 10.1002/jez.1400010107; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; BINDING H, 1986, CELL CULTURE SOMATIC, V2, P259; BINDING H, 1975, PLANT PHYSIOL, V35, P325; BINDING H, 1974, PLANT MOL BIOL NEWSL, V1, P77; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bonnet C, 1779, OEUVRES HIST NATUREL; Borgens R B, 1988, Adv Neurol, V47, P547; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; BROCKES JP, 1984, SCIENCE, V225, P1280, DOI 10.1126/science.6474177; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Cailliet GM, 2001, EXP GERONTOL, V36, P739, DOI 10.1016/S0531-5565(00)00239-4; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carlson B. M., 2007, PRINCIPLES REGENERAT; CARNEVALI MDC, 1995, J EXP ZOOL, V272, P464, DOI 10.1002/jez.1402720608; Carnevali MDC, 2001, MICROSC RES TECHNIQ, V55, P403; Caro E, 2007, NATURE, V447, P213, DOI 10.1038/nature05763; Cary AJ, 2002, PLANT J, V32, P867, DOI 10.1046/j.1365-313X.2002.01479.x; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Che P, 2007, PLANTA, V226, P1183, DOI 10.1007/s00425-007-0565-4; CHTING H, 1885, JAHRB WISS BOTANIK, V16; CLARK ME, 1965, REGENERATION ANIMALS, P240; Costa S, 2006, NATURE, V439, P493, DOI 10.1038/nature04269; Costa S, 2007, TRENDS CELL BIOL, V17, P101, DOI 10.1016/j.tcb.2006.12.005; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; Daimon Y, 2003, PLANT CELL PHYSIOL, V44, P113, DOI 10.1093/pcp/pcg038; Dubrovsky JG, 2000, PLANT PHYSIOL, V124, P1648, DOI 10.1104/pp.124.4.1648; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Finch CE, 1990, LONGEVITY SENESCENCE; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Gautheret RJ, 2003, PLANT TISSUE CULTURE: 100 YEARS SINCE GOTTLIEB HABERLANDT, P105; GAUTHERET RJ, 1985, CELL CULTURE SOMATIC; George JC, 1999, CAN J ZOOL, V77, P571, DOI 10.1139/cjz-77-4-571; GIERER A, 1972, NATURE-NEW BIOL, V239, P98, DOI 10.1038/newbio239098a0; GOEBEL K., 1898, ORGANOGRAPHIE PFLANZ; Gordon SP, 2007, DEVELOPMENT, V134, P3539, DOI 10.1242/dev.010298; Grafi G, 2007, DEV BIOL, V306, P838, DOI 10.1016/j.ydbio.2007.03.023; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; GUZZO F, 1994, J EXP BOT, V45, P1427, DOI 10.1093/jxb/45.10.1427; Haberlandt G., 1902, MATH NATURWISS, V111, P69; HALPERIN W, 1986, CELL CULTURE SOMATIC, V3, P3, DOI DOI 10.1016/B978-0-12-715003-1.50007-1; HAY ED, 1959, DEV BIOL, V1, P555, DOI 10.1016/0012-1606(59)90018-1; Henderson JT, 2004, PLANT PHYSIOL, V134, P995, DOI 10.1104/pp.103.030148; Hibara K, 2003, PLANT J, V36, P687, DOI 10.1046/j.1365-313X.2003.01911.x; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; HOLSTEIN TW, 1991, DEV BIOL, V148, P602, DOI 10.1016/0012-1606(91)90277-A; KELLER J, 1894, JEN Z NATURW, P3823; Kiortsis V., 1965, REGENERATION ANIMALS, P250; KRIKORIAN AD, 1969, BOT REV, V35, P59, DOI 10.1007/BF02859888; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lauzon RJ, 2002, DEV BIOL, V249, P333, DOI 10.1006/dbio.2002.0772; LENHOFF HM, 1986, TRANSLATION FRENCH; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Leung AKL, 2006, NUCLEIC ACIDS RES, V34, pD218, DOI 10.1093/nar/gkj004; LOCATELLI P, 1924, ARCH SCI BIOL, V5, P362; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Maki N, 2007, DEV DYNAM, V236, P941, DOI 10.1002/dvdy.21027; Mandoli DF, 1998, ANNU REV PLANT PHYS, V49, P173, DOI 10.1146/annurev.arplant.49.1.173; Martinez DE, 1998, EXP GERONTOL, V33, P217, DOI 10.1016/S0531-5565(97)00113-7; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Meng LJ, 2007, MOL CELL BIOL, V27, P8670, DOI 10.1128/MCB.00635-07; Morgan TH, 1900, ARCH ENTWICKLUNG ORG, V9, P563, DOI 10.1007/BF02156194; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; MUIR WH, 1958, AM J BOT, V45, P589, DOI 10.2307/2439231; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; NOVAK B, 1975, PLANT SCI LETT, V5, P183, DOI 10.1016/0304-4211(75)90031-0; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; Prantl K., 1874, ARB BOT I WURZBURG, V4, P546; RANDOLPH H, 1892, J MORPHOL, V7, P317, DOI DOI 10.1002/JMOR.1050070304; RATHORE KS, 1985, BIO-TECHNOL, V3, P1107, DOI 10.1038/nbt1285-1107; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Rentzsch F, 2007, P NATL ACAD SCI USA, V104, P3249, DOI 10.1073/pnas.0604501104; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; SACHS J, 1893, FLORA, V77, P49; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Shani E, 2006, CURR OPIN PLANT BIOL, V9, P484, DOI 10.1016/j.pbi.2006.07.008; SINGER M, 1947, J EXP ZOOL, V104, P251, DOI 10.1002/jez.1401040205; SINGER M, 1948, J EXP ZOOL, V108, P279, DOI 10.1002/jez.1401080207; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Sinnott EW, 1960, PLANT MORPHOGENESIS; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; SMITH DL, 1989, AM J BOT, V76, P1832, DOI 10.2307/2444481; Sonneborn TM, 1930, J EXP ZOOL, V57, P57, DOI 10.1002/jez.1400570104; SPALLANZANI L, 1769, PRODROMO OPERA IMPRI; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; STEWARD FC, 1958, AM J BOT, V45, P705, DOI 10.2307/2439728; STEWARD FC, 1970, ANN BOT-LONDON, V34, P761, DOI 10.1093/oxfordjournals.aob.a084408; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sugiyama M, 1999, CURR OPIN PLANT BIOL, V2, P61, DOI 10.1016/S1369-5266(99)80012-0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thornton CS, 1938, J MORPHOL, V62, P219, DOI 10.1002/jmor.1050620204; Tillemans V, 2006, PLANT CELL, V18, P3218, DOI 10.1105/tpc.106.044529; TREMBLEY A, MOIRES SERVIR HIST G, P1744; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VASIL V, 1965, SCIENCE, V150, P889, DOI 10.1126/science.150.3698.889; VASIL V, 1974, IN VITRO CELL DEV B, V10, P83; Wang GF, 2004, PLANT PHYSIOL, V135, P1084, DOI 10.1104/pp.104.040436; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; WEISMANN A, 1893, GERM PLASM A THEORY, V1; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Wolff G., 1895, REGEN URODELENLINSE, V1, P380; Wolpert L, 1971, Symp Soc Exp Biol, V25, P391; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	127	262	283	1	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					697	710		10.1016/j.cell.2008.01.040	http://dx.doi.org/10.1016/j.cell.2008.01.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295584	Bronze, Green Accepted			2022-12-28	WOS:000253817900026
J	Colman, A				Colman, Alan			Stem cell research in Singapore	CELL			English	Editorial Material							HUMAN BLASTOCYSTS; LINES	Singapore is investing heavily in stem cell research. This investment is part of an ambitious biomedical science initiative designed to enhance its thriving economy.	Singapore Stem Cell Consortium, ASTAR Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Colman, A (corresponding author), Singapore Stem Cell Consortium, ASTAR Inst Med Biol, Singapore 138648, Singapore.	alan.colman@imb.a-star.edu.sg						BONGSO A, 1994, HUM REPROD, V9, P2110, DOI 10.1093/oxfordjournals.humrep.a138401; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; HOON HT, 2006, BUSINESS TIMES  0614; Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tan DTH, 2004, TRANSPLANTATION, V77, P1729, DOI 10.1097/01.TP.0000127593.65888.A6; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	10	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					519	521		10.1016/j.cell.2008.01.037	http://dx.doi.org/10.1016/j.cell.2008.01.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295566	Bronze			2022-12-28	WOS:000253817900008
J	Sniderman, AD; Furberg, CD				Sniderman, Allan D.; Furberg, Curt D.			Age as a modifiable risk factor for cardiovascular disease	LANCET			English	Editorial Material							C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; LIFETIME RISK; PREDICTION; CHOLESTEROL; LIMITATIONS; RATIO		[Sniderman, Allan D.] McGill Univ, Ctr Hlth, Mike Rosenbloom Lab Cardiovasc Res, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; [Furberg, Curt D.] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA	McGill University; Royal Victoria Hospital; Wake Forest University	Sniderman, AD (corresponding author), McGill Univ, Ctr Hlth, Mike Rosenbloom Lab Cardiovasc Res, Royal Victoria Hosp, Room H7-22,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	allansniderman@hotmail.com						Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Levinson SS, 2007, AM J CLIN PATHOL, V127, P449, DOI 10.1309/22M22RF48PX9UT9T; Lloyd-Jones DM, 2004, AM J CARDIOL, V94, P20, DOI 10.1016/j.amjcard.2004.03.023; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Lloyd-Jones DM, 2006, ANN INTERN MED, V145, P35, DOI 10.7326/0003-4819-145-1-200607040-00129; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Pinto E, 2007, POSTGRAD MED J, V83, P109, DOI 10.1136/pgmj.2006.048371; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Sniderman AD, 2007, AM J CARDIOL, V100, P217, DOI 10.1016/j.amjcard.2007.02.086; STARY HC, 1989, ARTERIOSCLEROSIS, V9, pI19; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	21	97	104	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2008	371	9623					1547	1549		10.1016/s0140-6736(08)60313-x	http://dx.doi.org/10.1016/s0140-6736(08)60313-x			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18321568				2022-12-28	WOS:000255668300032
J	Poudel, B; Hao, Q; Ma, Y; Lan, YC; Minnich, A; Yu, B; Yan, XA; Wang, DZ; Muto, A; Vashaee, D; Chen, XY; Liu, JM; Dresselhaus, MS; Chen, G; Ren, ZF				Poudel, Bed; Hao, Qing; Ma, Yi; Lan, Yucheng; Minnich, Austin; Yu, Bo; Yan, Xiao; Wang, Dezhi; Muto, Andrew; Vashaee, Daryoosh; Chen, Xiaoyuan; Liu, Junming; Dresselhaus, Mildred S.; Chen, Gang; Ren, Zhifeng			High-thermoelectric performance of nanostructured bismuth antimony telluride bulk alloys	SCIENCE			English	Article								The dimensionless thermoelectric figure of merit ( ZT) in bismuth antimony telluride ( BiSbTe) bulk alloys has remained around 1 for more than 50 years. We show that a peak ZT of 1.4 at 100 degrees C can be achieved in a p- type nanocrystalline BiSbTe bulk alloy. These nanocrystalline bulk materials were made by hot pressing nanopowders that were ball- milled from crystalline ingots under inert conditions. Electrical transport measurements, coupled with microstructure studies and modeling, show that the ZT improvement is the result of low thermal conductivity caused by the increased phonon scattering by grain boundaries and defects. More importantly, ZT is about 1.2 at room temperature and 0.8 at 25 degrees C, which makes these materials useful for cooling and power generation. Cooling devices that use these materials have produced high- temperature differences of 86 degrees, 106 degrees, and 119 degrees C with hot- side temperatures set at 50 degrees, 100 degrees, and 150 degrees C, respectively. This discovery sets the stage for use of a new nanocomposite approach in developing high- performance low- cost bulk thermoelectric materials.	[Hao, Qing; Minnich, Austin; Muto, Andrew; Vashaee, Daryoosh; Chen, Xiaoyuan; Chen, Gang] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Poudel, Bed; Ma, Yi; Lan, Yucheng; Yu, Bo; Yan, Xiao; Wang, Dezhi; Ren, Zhifeng] Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA; [Poudel, Bed; Ma, Yi] GMZ Energy Inc, Newton, MA 02458 USA; [Liu, Junming] Nanjing Univ, Solid State Microstruct Lab, Nanjing 210008, Peoples R China; [Liu, Junming] Nanjing Univ, Dept Phys, Nanjing 210008, Peoples R China; [Dresselhaus, Mildred S.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Dresselhaus, Mildred S.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Boston College; Nanjing University; Nanjing University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chen, G (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	gchen2@mit.edu; renzh@bc.edu	Ren, Zhifeng/B-4275-2014; Lan, Yucheng/F-9501-2011; Chen, Gang/J-1325-2014; yan, xiao/A-5458-2011; Hao, Qing/B-8170-2015; Lan, Y/V-8372-2019; Chen, Xiaoyuan/D-1860-2014; Yu, Bo/I-1896-2012	Lan, Yucheng/0000-0002-6737-4168; Chen, Gang/0000-0002-3968-8530; Lan, Y/0000-0002-6737-4168; Chen, Xiaoyuan/0000-0002-9622-0870; Hao, Qing/0000-0002-1503-2203				Chen G, 1998, PHYS REV B, V57, P14958, DOI 10.1103/PhysRevB.57.14958; Dresselhaus MS, 2007, ADV MATER, V19, P1043, DOI 10.1002/adma.200600527; Fluerial J, 1995, P 13 INT C THERM KAN, P40; Goldsmid H.J., 1964, THERMOELECTRIC REFRI; Harman TC, 2002, SCIENCE, V297, P2229, DOI 10.1126/science.1072886; HARMAN TC, 1955, B AM PHYS SOC, V30, P35; Hsu KF, 2004, SCIENCE, V303, P818, DOI 10.1126/science.1092963; Rowe D. M., 1995, CRC HDB THERMOELECTR; Tang XF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2425007; Thonhauser T, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.205207; Tritt TM, 2001, SEMICONDUCT SEMIMET, V69, P25; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Zhao XB, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1863440	13	4295	4400	119	2680	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					634	638		10.1126/science.1156446	http://dx.doi.org/10.1126/science.1156446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18356488				2022-12-28	WOS:000255454300037
J	Hanson, R; Dobrovitski, VV; Feiguin, AE; Gywat, O; Awschalom, DD				Hanson, R.; Dobrovitski, V. V.; Feiguin, A. E.; Gywat, O.; Awschalom, D. D.			Coherent dynamics of a single spin interacting with an adjustable spin bath	SCIENCE			English	Article							SPECTRAL DIFFUSION; QUANTUM DOTS; DIAMOND; RESONANCE; ELECTRON	Phase coherence is a fundamental concept in quantum mechanics. Understanding the loss of coherence is paramount for future quantum information processing. We studied the coherent dynamics of a single central spin ( a nitrogen- vacancy center) coupled to a bath of spins ( nitrogen impurities) in diamond. Our experiments show that both the internal interactions of the bath and the coupling between the central spin and the bath can be tuned in situ, allowing access to regimes with surprisingly different behavior. The observed dynamics are well explained by analytics and numerical simulations, leading to valuable insight into the loss of coherence in spin systems. These measurements demonstrate that spins in diamond provide an excellent test bed for models and protocols in quantum information.	[Hanson, R.; Feiguin, A. E.; Gywat, O.; Awschalom, D. D.] Univ Calif Santa Barbara, Calif Nanosyst Inst, Santa Barbara, CA 93106 USA; [Dobrovitski, V. V.] Ames Lab, Ames, IA 50011 USA; [Dobrovitski, V. V.] Iowa State Univ, Ames, IA 50011 USA	University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University	Hanson, R (corresponding author), Delft Univ Technol, Kavli Inst Nanosci Delft, POB 5046, NL-2600 GA Delft, Netherlands.	r.hanson@tudelft.nl	Hanson, Ronald/B-9555-2008					Chernobrod BM, 2005, J APPL PHYS, V97, DOI 10.1063/1.1829373; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Cucchietti FM, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.052113; de Sousa R, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.115322; Dobrovitski VV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.210401; Epstein RJ, 2005, NAT PHYS, V1, P94, DOI 10.1038/nphys141; Gaebel T, 2006, NAT PHYS, V2, P408, DOI 10.1038/nphys318; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hanson R, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161203; Hanson R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.087601; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kennedy TA, 2003, APPL PHYS LETT, V83, P4190, DOI 10.1063/1.1626791; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; KLAUDER JR, 1962, PHYS REV, V125, P912, DOI 10.1103/PhysRev.125.912; LEGGETT AJ, 1987, REV MOD PHYS, V59, P1, DOI 10.1103/RevModPhys.59.1; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; LOUBSER J, 1978, REP PROG PHYS, V41, P1201, DOI 10.1088/0034-4885/41/8/002; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; Prokof'ev NV, 2000, REP PROG PHYS, V63, P669, DOI 10.1088/0034-4885/63/4/204; Rabeau JR, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2158700; VANOORT E, 1990, PHYS REV B, V42, P8605, DOI 10.1103/PhysRevB.42.8605; ZHIDOMIROV GM, 1969, SOV PHYS JETP-USSR, V29, P1037; Zurek WH, 2003, REV MOD PHYS, V75, P715, DOI 10.1103/RevModPhys.75.715	26	320	348	1	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2008	320	5874					352	355		10.1126/science.1155400	http://dx.doi.org/10.1126/science.1155400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18339902				2022-12-28	WOS:000255026100037
J	Pearce, A; Law, C; Elliman, D; Cole, TJ; Bedford, H				Pearce, Anna; Law, Catherine; Elliman, David; Cole, Tim J.; Bedford, Helen		Millennium Cohort Study Child Hlth	Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; IMMUNIZATION; CHILDREN; EXPENDITURES; INFECTIONS; ATTITUDES; COVERAGE; ENGLAND; RECORDS	Objectives To estimate uptake of the combined measles, mumps, and rubella vaccine (MMR) and single antigen vaccines and explore factors associated with uptake and reasons for not using MMR. Design Nationally representative cohort study. Setting Children born in the UK, 2000-2. Participants 14 578 children for whom data on immunisation were available. Main outcome measures Immunisation status at 3 years defined as "immunised with MMR," "immunised with at least one single antigen vaccine," and "unimmunised." Results 88.6% (13 013) were immunised with MMR and 5.2% (634) had received at least one single antigen vaccine. Children were more likely to be unimmunised if they lived in a household with other children (risk ratio 1.74, 95% confidence interval 1.35 to 2.25, for those living with three or more) or a tone parent (1.31, 1.07 to 1.60) or if their mother was under 20 (1.41, 1.08 to 1.85) or over 34 at cohort child's birth (reaching 2.34, 1.20 to 3.23, for >= 40), more highly educated (1.41, 1.05 to 1.89, for a degree), not employed (1.43, 1.12 to 1.82), or self employed (1.71, 1.18 to 2.47). Use of single vaccines increased with household income (reaching 2.98, 2.05 to 4.32, for incomes of >=52 pound 000 ((euro)69 750, $102 190)), maternal age (reaching 3.04, 2.05 to 4.50, for >= 40), and education (reaching 3.15, 1.78 to 5.58, for a degree). Children were less likely to have received single vaccines if they lived with other children (reaching 0.14, 0.07 to 0.29, for three or more), had mothers who were Indian (0.50, 0.25 to 0.99), Pakistani or Bangladeshi (0.13, 0.04 to 0.39), or black (0.31, 0.14 to 0.64), or aged under 25 (reaching 0.14, 0.05 to 0.36, for 14-19). Nearly three quarters (74.4%, 1110) of parents who did not immunise with MMR made a "conscious decision" not to immunise. Conclusions Although MMR uptake in this cohort is high, a substantial proportion of children remain susceptible to avoidable infection, largely because parents consciously decide not to immunise. Social differentials in uptake could be used to inform targeted interventions to promote uptake.	[Pearce, Anna; Law, Catherine; Cole, Tim J.; Bedford, Helen] UCL, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth, London WC1N 1EH, England; [Elliman, David] Great Ormond St Hosp Sick Children, Childrens Populat Hlth Unit, London WC1N 3JH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Bedford, H (corresponding author), UCL, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth, London WC1N 1EH, England.	h.bedford@ich.ucl.ac.uk	Law, Catherine/A-1353-2009; Pearce, Anna/C-1272-2010; Cole, Tim J/B-7883-2008; Elliman, David/AAK-4595-2020	Pearce, Anna/0000-0003-0085-5263; Cole, Tim J/0000-0001-5711-8200; Law, Catherine/0000-0002-1777-9386; Rahi, Jugnoo/0000-0002-5718-9209	Medical Research Council [G9827821] Funding Source: Medline; Department of Health Funding Source: Medline; MRC [G9827821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AbdelSalam HHM, 2004, CLIN PEDIATR, V43, P83, DOI 10.1177/000992280404300111; BOOY R, 2006, CLIN EVID, V15, P1; Casiday R, 2006, VACCINE, V24, P177, DOI 10.1016/j.vaccine.2005.07.063; Cassell JA, 2006, PUBLIC HEALTH, V120, P783, DOI 10.1016/j.puhe.2006.03.011; *COMM DIS SURV CTR, 1995, CDR WKLY, V5, P301; *CTR LONG STUD, MILL COH STUD SURV D; Demicheli V, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub2; Department of Health, 2004, NHS IMM STAT ENGL 20; DEVLIN NJ, 1993, NEW ZEAL MED J, V106, P126; Evans M, 2001, BRIT J GEN PRACT, V51, P904; Flynn M, 2004, BRIT J GEN PRACT, V54, P526; Friederichs V, 2006, ARCH DIS CHILD, V91, P465, DOI 10.1136/adc.2005.085944; Goldacre B, 2007, BRIT MED J, V335, P126, DOI 10.1136/bmj.39280.447419.59; Hadjikoumi I, 2006, ARCH DIS CHILD, V91, P621, DOI 10.1136/adc.2005.088898; Harrington P M, 2000, Ir Med J, V93, P239; Health Protection Agency, 2003, CDR WKLY, V91, P465; *HLTH PROT AG, MEASL NOT CONF CAS E; *HLTH PROT AG, 2007, HLTH PROT REP, V1; *HLTH PROT AG, 2004, CDR WKLY         JUL, V14; *HLTH PROT AG, 2004, CDR WKLY         JAN, V14; *HLTH PROT AG, 2004, CDR WKLY         OCT, V14; *HLTH PROT AG, 2004, CDR WKLY         APR, V14; HORTON R, 2004, MMR SCI FICTION; JEFFERIES S, 1991, J PUBLIC HEALTH MED, V13, P312; Lamden K, 2004, Commun Dis Public Health, V7, P388; Li J, 1993, Health Trends, V25, P16; LI J, 1993, BRIT MED J, V307, P168, DOI 10.1136/bmj.307.6897.168; Lyratzopoulos G, 2002, Commun Dis Public Health, V5, P305; MCKINNEY PA, 1991, J PUBLIC HEALTH MED, V13, P13, DOI 10.1093/oxfordjournals.pubmed.a042571; Middleton E, 2003, BMJ-BRIT MED J, V326, P854, DOI 10.1136/bmj.326.7394.854; Plewis I, 2004, MILLENNIUM COHORT ST; Plewis I, 2006, MILLENNIUM COHORT ST; Salisbury D, 2006, IMMUNISATION INFECT, V3rd; SHARLAND M, 1997, COMMUN DIS REP CDR R, V7, pR196; Simpson L, 2005, AMBUL PEDIATR, V5, P6, DOI 10.1367/A04-119R.1; Smith A, 2007, VACCINE, V25, P3996, DOI 10.1016/j.vaccine.2007.02.071; Sonnenberg P, 2007, ARCH DIS CHILD, V92, P786, DOI 10.1136/adc.2006.109223; Speers Tammy, 2004, Commun Med, V1, P171; Suarez L, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e3; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wright JA, 2006, EUR J PUBLIC HEALTH, V16, P137, DOI 10.1093/eurpub/cki194	41	110	112	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2008	336	7647					754	757		10.1136/bmj.39489.590671.25	http://dx.doi.org/10.1136/bmj.39489.590671.25			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284JW	18309964	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000254703700031
J	Aarts, H; Custers, R; Marien, H				Aarts, Henk; Custers, Ruud; Marien, Hans			Preparing and motivating behavior outside of awareness	SCIENCE			English	Article									[Aarts, Henk; Custers, Ruud; Marien, Hans] Univ Utrecht, Dept Psychol, NL-3584 CS Utrecht, Netherlands	Utrecht University	Aarts, H (corresponding author), Univ Utrecht, Dept Psychol, Heidelberglaan 1, NL-3584 CS Utrecht, Netherlands.	h.aarts@uu.nl	Custers, Ruud/G-4851-2013	Custers, Ruud/0000-0002-4431-738X				Bargh JA, 2006, EUR J SOC PSYCHOL, V36, P147, DOI 10.1002/ejsp.336; Custers R, 2005, J PERS SOC PSYCHOL, V89, P129, DOI 10.1037/0022-3514.89.2.129; James W, 1890, PRINCIPLES PSYCHOL; Jeannerod M., 1997, COGNITIVE NEUROSCIEN; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Wegner D., 2002, ILLUSION CONSCIOUS W	6	139	145	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2008	319	5870					1639	1639		10.1126/science.1150432	http://dx.doi.org/10.1126/science.1150432			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356517	Green Submitted			2022-12-28	WOS:000254172300031
J	Liu, CZ; Snow, JE; Hellebrand, E; Brugmann, G; von der Handt, A; Buchl, A; Hofmann, AW				Liu, Chuan-Zhou; Snow, Jonathan E.; Hellebrand, Eric; Bruegmann, Gerhard; von der Handt, Anette; Buechl, Anette; Hofmann, Albrecht W.			Ancient, highly heterogeneous mantle beneath Gakkel ridge, Arctic Ocean	NATURE			English	Article							MID-ATLANTIC RIDGE; OSMIUM ISOTOPIC COMPOSITION; ABYSSAL PERIDOTITES; MIDOCEAN RIDGE; OS ISOTOPES; MELT EXTRACTION; INDIAN RIDGE; MORB MANTLE; SYSTEMATICS; BASALTS	The Earth's mantle beneath ocean ridges is widely thought to be depleted by previous melt extraction, but well homogenized by convective stirring. This inference of homogeneity has been complicated by the occurrence of portions enriched in incompatible elements. Here we show that some refractory abyssal peridotites from the ultraslow- spreading Gakkel ridge ( Arctic Ocean) have very depleted Os-187/Os-188 ratios with model ages up to 2 billion years, implying the long- term preservation of refractory domains in the asthenospheric mantle rather than their erasure by mantle convection. The refractory domains would not be sampled by mid- ocean- ridge basalts because they contribute little to the genesis of magmas. We thus suggest that the upwelling mantle beneath mid- ocean ridges is highly heterogeneous, which makes it difficult to constrain its composition by mid- ocean- ridge basalts alone. Furthermore, the existence of ancient domains in oceanic mantle suggests that using osmium model ages to constrain the evolution of continental lithosphere should be approached with caution.	[Liu, Chuan-Zhou] Chinese Acad Sci, State Key Lab Lithospher Evolut, Inst Geol & Geophys, Beijing 100029, Peoples R China; [Liu, Chuan-Zhou; Snow, Jonathan E.; Hellebrand, Eric; Bruegmann, Gerhard; von der Handt, Anette; Buechl, Anette; Hofmann, Albrecht W.] Max Planck Inst Chem, Abt Geochem, D-55020 Mainz, Germany; [Liu, Chuan-Zhou] Grad Univ Chinese Acad Sci, Coll Earth Sci, Beijing 100039, Peoples R China; [Snow, Jonathan E.] Univ Houston, Dept Geosci, Houston, TX 77204 USA; [Hellebrand, Eric; von der Handt, Anette] Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Max Planck Society; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Houston System; University of Houston; University of Hawaii System	Liu, CZ (corresponding author), Chinese Acad Sci, State Key Lab Lithospher Evolut, Inst Geol & Geophys, Beijing 100029, Peoples R China.	chzliu@mail.iggcas.ac.cn	Hellebrand, Eric/L-2898-2013; Snow, Jonathan/E-5591-2011; Liu, Chuanzhou/A-1627-2011	von der Handt, Anette/0000-0003-1975-9909; Liu, Chuan-Zhou/0000-0001-5706-8071; Hellebrand, Eric/0000-0003-1909-6279				Alard O, 2005, NATURE, V436, P1005, DOI 10.1038/nature03902; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Andres M, 2004, EARTH PLANET SC LETT, V225, P89, DOI 10.1016/j.epsl.2004.05.041; Brandon AD, 2000, EARTH PLANET SC LETT, V177, P319, DOI 10.1016/S0012-821X(00)00044-3; Brunelli D, 2006, J PETROL, V47, P745, DOI 10.1093/petrology/egi092; Buchl A, 2002, EARTH PLANET SC LETT, V204, P385, DOI 10.1016/S0012-821X(02)00977-9; Davies GF, 2002, GEOCHIM COSMOCHIM AC, V66, P3125, DOI 10.1016/S0016-7037(02)00915-8; Dick HJB, 2003, NATURE, V426, P405, DOI 10.1038/nature02128; DUPRE B, 1983, NATURE, V303, P142, DOI 10.1038/303142a0; Escrig S, 2005, EARTH PLANET SC LETT, V235, P528, DOI 10.1016/j.epsl.2005.04.035; Frei R, 2006, EARTH PLANET SC LETT, V241, P466, DOI 10.1016/j.epsl.2005.11.043; GOLDSTEIN SL, 2006, OFIOLITI, V31, P234; Graham DW, 2002, REV MINERAL GEOCHEM, V47, P247, DOI 10.2138/rmg.2002.47.8; Graham DW, 2006, NATURE, V440, P199, DOI 10.1038/nature04582; HART SR, 1992, SCIENCE, V256, P517, DOI 10.1126/science.256.5056.517; HART SR, 1984, NATURE, V309, P753, DOI 10.1038/309753a0; Harvey J, 2006, EARTH PLANET SC LETT, V244, P606, DOI 10.1016/j.epsl.2006.02.031; Hassler DR, 1998, SCIENCE, V280, P418, DOI 10.1126/science.280.5362.418; Hauri EH, 2002, PHILOS T R SOC A, V360, P2371, DOI 10.1098/rsta.2002.1073; Hellebrand E, 2005, CONTRIB MINERAL PETR, V150, P486, DOI 10.1007/s00410-005-0036-5; Hellebrand E, 2002, J PETROL, V43, P2305, DOI 10.1093/petrology/43.12.2305; Hellebrand E, 2001, NATURE, V410, P677, DOI 10.1038/35070546; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; JOHNSON KTM, 1990, J GEOPHYS RES-SOLID, V95, P2661, DOI 10.1029/JB095iB03p02661; Jokat W, 2003, NATURE, V423, P962, DOI 10.1038/nature01706; LEROEX AP, 1992, CONTRIB MINERAL PETR, V110, P253, DOI 10.1007/BF00310742; Meibom A, 2002, NATURE, V419, P705, DOI 10.1038/nature01067; Meisel T, 1996, NATURE, V383, P517, DOI 10.1038/383517a0; Meisel T, 2001, GEOCHIM COSMOCHIM AC, V65, P1311, DOI 10.1016/S0016-7037(00)00566-4; Michael PJ, 2003, NATURE, V423, P956, DOI 10.1038/nature01704; Morgan JP, 1999, EARTH PLANET SC LETT, V170, P215, DOI 10.1016/S0012-821X(99)00114-4; Parkinson IJ, 1998, SCIENCE, V281, P2011, DOI 10.1126/science.281.5385.2011; Pearson DG, 2007, NATURE, V449, P202, DOI 10.1038/nature06122; Pearson DG, 2004, CHEM GEOL, V208, P29, DOI 10.1016/j.chemgeo.2004.04.005; Rehkamper M, 1999, EARTH PLANET SC LETT, V172, P65, DOI 10.1016/S0012-821X(99)00193-4; REISBERG L, 1995, NATURE, V376, P159, DOI 10.1038/376159a0; ROYBARMAN M, 1994, GEOCHIM COSMOCHIM AC, V58, P5043, DOI 10.1016/0016-7037(94)90230-5; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; Seyler M, 2004, GEOLOGY, V32, P301, DOI 10.1130/G20191.1; Shirey SB, 1998, ANNU REV EARTH PL SC, V26, P423, DOI 10.1146/annurev.earth.26.1.423; Snow J.E., 2007, REPORTS POLAR MARINE, V544, P153; SNOW JE, 1995, EARTH PLANET SC LETT, V133, P411, DOI 10.1016/0012-821X(95)00099-X; Snow JE, 1999, TERRA NOVA, V11, P45; Snow JE, 2000, EARTH PLANET SC LETT, V175, P119, DOI 10.1016/S0012-821X(99)00280-0; Standish JJ, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000161; Walker RJ, 2005, EARTH PLANET SC LETT, V230, P211, DOI 10.1016/j.epsl.2004.11.009; Walker RJ, 2002, GEOCHIM COSMOCHIM AC, V66, P329, DOI 10.1016/S0016-7037(01)00767-0; WOOD DA, 1979, CONTRIB MINERAL PETR, V70, P319, DOI 10.1007/BF00375360; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	50	246	259	5	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					311	316		10.1038/nature06688	http://dx.doi.org/10.1038/nature06688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354475				2022-12-28	WOS:000254117400038
J	Westbrook, TF; Hu, G; Ang, XLL; Mulligan, P; Pavlova, NN; Liang, A; Leng, YM; Maehr, R; Shi, Y; Harper, JW; Elledge, SJ				Westbrook, Thomas F.; Hu, Guang; Ang, Xiaolu L.; Mulligan, Peter; Pavlova, Natalya N.; Liang, Anthony; Leng, Yumei; Maehr, Rene; Shi, Yang; Harper, J. Wade; Elledge, Stephen J.			SCF beta-TRCP controls oncogenic transformation and neural differentiation through REST degradation	NATURE			English	Article							RESTRICTIVE SILENCER FACTOR; UBIQUITIN-LIGASE COMPLEX; BOX PROTEIN BETA-TRCP1; EMBRYONIC STEM-CELLS; F-BOX; IN-VITRO; EXPRESSION; GENES; TRANSCRIPTION; PRECURSORS	The RE1- silencing transcription factor ( REST, also known as NRSF) is a master repressor of neuronal gene expression and neuronal programmes in non- neuronal lineages(1-3). Recently, REST was identified as a human tumour suppressor in epithelial tissues(4), suggesting that its regulation may have important physiological and pathological consequences. However, the pathways controlling REST have yet to be elucidated. Here we show that REST is regulated by ubiquitin- mediated proteolysis, and use an RNA interference ( RNAi) screen to identify a Skp1- Cul1- F- box protein complex containing the F- box protein beta- TRCP ( SCF beta-TRCP) as an E3 ubiquitin ligase responsible for REST degradation. beta- TRCP binds and ubiquitinates REST and controls its stability through a conserved phospho- degron. During neural differentiation, REST is degraded in a beta-TRCP- dependent manner. beta- TRCP is required for proper neural differentiation only in the presence of REST, indicating that beta- TRCP facilitates this process through degradation of REST. Conversely, failure to degrade REST attenuates differentiation. Furthermore, we find that beta-TRCP overexpression, which is common in human epithelial cancers, causes oncogenic transformation of human mammary epithelial cells and that this pathogenic function requires REST degradation. Thus, REST is a key target in beta- TRCP- driven transformation and the beta- TRCP - REST axis is a new regulatory pathway controlling neurogenesis.	[Westbrook, Thomas F.; Hu, Guang; Pavlova, Natalya N.; Liang, Anthony; Leng, Yumei; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; [Ang, Xiaolu L.; Mulligan, Peter; Shi, Yang; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Maehr, Rene] Harvard Univ, Dept Stem Cell & Regenerat Biol, Howard Hughes Med Inst, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Harvard Partners Ctr Genet & Genom, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu; selledge@genetics.med.harvard.edu	Hu, Guang/E-7474-2016; Cambronne, Xiaolu Ang/GRY-7149-2022	Hu, Guang/0000-0003-0437-4723; Cambronne, Xiaolu Ang/0000-0002-3547-448X; Harper, Jeffrey/0000-0002-6944-7236; Mulligan, Peter/0000-0003-0737-2328	Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [R01 AG011085-16, R01 AG011085] Funding Source: Medline; NIGMS NIH HHS [R01 GM054137, R01 GM054137-13, R01 GM071004] Funding Source: Medline; NINDS NIH HHS [F31 NS054507-01, F31 NS054507] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004, R01GM054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Fuller GN, 2005, MOL CANCER THER, V4, P343; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kudo Y, 2004, MOL CELL BIOL, V24, P8184, DOI 10.1128/MCB.24.18.8184-8194.2004; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Saitoh T, 2001, INT J ONCOL, V18, P959; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Su XH, 2006, MOL CELL BIOL, V26, P1666, DOI 10.1128/MCB.26.5.1666-1678.2006; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	27	246	254	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					370	U11		10.1038/nature06780	http://dx.doi.org/10.1038/nature06780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354483	Green Accepted			2022-12-28	WOS:000254117400051
J	Sliwa, K; Wilkinson, D; Hansen, C; Ntyintyane, L; Tibazarwa, K; Becker, A; Stewart, S				Sliwa, Karen; Wilkinson, David; Hansen, Craig; Ntyintyane, Lucas; Tibazarwa, Kemi; Becker, Anthony; Stewart, Simon			Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study	LANCET			English	Article							CARDIOVASCULAR-DISEASE; MANAGEMENT; BURDEN; HEALTH; PREVENTION; TRANSITION; FAILURE	Background The Heart of Soweto Study aims to increase our understanding of the characteristics and burden imposed by heart disease in an urban African community in probable epidemiological transition. We aimed to investigate the clinical range of disorders related to cardiovascular disease in patients presenting for the first time to a tertiary-care centre. Methods From Jan 1 to Dec 31, 2006, we recorded data for 4162 patients with confirmed cases of cardiovascular disease (1593 newly diagnosed and 2569 previously diagnosed and under treatment) who attended the cardiology unit at the Chris Hani Baragwanath Hospital in Soweto, South Africa. We developed a prospectively designed registry and gathered detailed clinical data relating to the presentation, investigations, and treatment of all 1593 patients with newly diagnosed cardiovascular disease. Findings Most patients were black Africans (n=1359 [85%]), and the study population contained more women (n=939 [59%]) than men. Women were slightly younger than were men (mean 53 [SD 16] years vs 55 [15] years; p=0 . 031), with 399 (25%) patients younger than 40 years. Heart failure was the most common primary diagnosis (704 cases, 44% of total). Moderate to severe systolic dysfunction was evident in 415 (53%) of 844 identified cases of heart failure, 577 (68%) of which were attributable to dilated cardiomyopathy or hypertensive heart disease, or both. Black Africans were more likely to be diagnosed with heart failure than were the rest of the cohort (739 [54%] vs 105 [45%]; odds ratio [OR] 1. 46, 95% Cl 1. 11-1 . 94; p=0.009) but were less likely to be diagnosed with coronary artery disease (77 [6%] vs 88 [38%]; OR 0.10, 0.07-0.14; p<0.0001). Prevalence of cardiovascular risk factors was very high, with 897 (56%) patients diagnosed with hypertension (190 [44%] of whom were also obese). Only 209 (13%) patients had no identifiable risk factors, whereas 933 (59%) had several risk factors. Interpretation We noted many threats to the present and future cardiac health of Soweto, including a high prevalence of modifiable risk factors for atherosclerotic disease and a combination of infectious and non-communicable forms of heart disease, with late clinical presentations. Overall, our findings provide strong evidence that epidemiological transition in Soweto, South Africa has broadened the complexity and spectrum of heart disease in this community. This registry will enable continued monitoring of the range of heart disease.	[Sliwa, Karen; Wilkinson, David; Ntyintyane, Lucas; Tibazarwa, Kemi; Becker, Anthony; Stewart, Simon] Univ Witwatersrand, Soweto Cardiovasc Res Unit, Chris Hani Baragwanath Hosp, ZA-2013 Johannesburg, South Africa; [Wilkinson, David; Hansen, Craig] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Stewart, Simon] Baker Heart Res Inst, Melbourne, Vic, Australia	University of Witwatersrand; University of Queensland; Baker Heart and Diabetes Institute	Stewart, S (corresponding author), Univ Witwatersrand, Soweto Cardiovasc Res Unit, Chris Hani Baragwanath Hosp, POBertsham, ZA-2013 Johannesburg, South Africa.	simon.stewart@baker.edu.au	Stewart, Simon/M-3316-2016; Hansen, Craig/C-7543-2014; Wilkinson, David/A-6207-2008	Stewart, Simon/0000-0001-9032-8998; Hansen, Craig/0000-0002-5227-0155; Wilkinson, David/0000-0002-7265-9846; Sliwa, Karen/0000-0002-8272-0911				AMIRA C, 2006, S AFR HEART J, V3, P7; BARLOW JB, 1990, S AFR MED J, V78, P181; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Commerford P, 2006, LANCET, V367, P1884, DOI 10.1016/S0140-6736(06)68822-3; ESSOP MR, 1993, J AM COLL CARDIOL, V22, P826, DOI 10.1016/0735-1097(93)90197-9; *EUR SOC CARD, ESC GUID; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Gaziano TA, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P645; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Kengne Andre Pascal, 2007, Afr Health Sci, V7, P38; Kruger R, 2006, PUBLIC HEALTH NUTR, V9, P351, DOI 10.1079/PHN2006849; Lawoyin T O, 2002, West Afr J Med, V21, P208; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Mark DB, 2007, EUR HEART J, V28, P2678, DOI 10.1093/eurheartj/ehm411; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; Mayosi BM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-2; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; PEARSON TA, 1993, DIS CONTROL PRIORITI, P577; Prineas R., 1982, MINNESOTA CODE MANUA; Robertson KA, 2006, SAMJ S AFR MED J, V96, P241; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Shisana O, 2006, SAMJ S AFR MED J, V96, P814; Sliwa K, 2005, CIRCULATION, V112, P3577, DOI 10.1161/CIRCULATIONAHA.105.542894; Stewart S, 2006, INT J CARDIOL, V108, P101, DOI 10.1016/j.ijcard.2006.01.001; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; STEYN K, 2006, CHRONIC DIS LIFESTYL, P1; Tibazarwa K, 2009, INT J CARDIOL, V132, P233, DOI 10.1016/j.ijcard.2007.11.067; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; *WHO, 2005, GLOB BURD COR HEART, pCH13; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	33	274	276	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2008	371	9616					915	922		10.1016/S0140-6736(08)60417-1	http://dx.doi.org/10.1016/S0140-6736(08)60417-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342686				2022-12-28	WOS:000254056800028
J	Avidan, MS; Zhang, LN; Burnside, BA; Finkel, KJ; Searleman, AC; Selvidge, JA; Saager, L; Turner, MS; Rao, S; Bottros, M; Hantler, C; Jacobsohn, E; Evers, AS				Avidan, Michael S.; Zhang, Lini; Burnside, Beth A.; Finkel, Kevin J.; Searleman, Adam C.; Selvidge, Jacqueline A.; Saager, Leif; Turner, Michelle S.; Rao, Srikar; Bottros, Michael; Hantler, Charles; Jacobsohn, Eric; Evers, Alex S.			Anesthesia awareness and the bispectral index	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENERAL-ANESTHESIA; RECALL	Background: Awareness during anesthesia is a serious complication with potential long-term psychological consequences. Use of the bispectral index (BIS), developed from a processed electroencephalogram, has been reported to decrease the incidence of anesthesia awareness when the BIS value is maintained below 60. In this trial, we sought to determine whether a BIS-based protocol is better than a protocol based on a measurement of end-tidal anesthetic gas (ETAG) for decreasing anesthesia awareness in patients at high risk for this complication. Methods: We randomly assigned 2000 patients to BIS-guided anesthesia (target BIS range, 40 to 60) or ETAG-guided anesthesia (target ETAG range, 0.7 to 1.3 minimum alveolar concentration [MAC]). Postoperatively, patients were assessed for anesthesia awareness at three intervals (0 to 24 hours, 24 to 72 hours, and 30 days after extubation). Results: We assessed 967 and 974 patients from the BIS and ETAG groups, respectively. Two cases of definite anesthesia awareness occurred in each group (absolute difference, 0%; 95% confidence interval [CI], -0.56 to 0.57%). The BIS value was greater than 60 in one case of definite anesthesia awareness, and the ETAG concentrations were less than 0.7 MAC in three cases. For all patients, the mean (+/-SD) time-averaged ETAG concentration was 0.81+/-0.25 MAC in the BIS group and 0.82+/-0.23 MAC in the ETAG group (P=0.10; 95% CI for the difference between the BIS and ETAG groups, -0.04 to 0.01 MAC). Conclusions: We did not reproduce the results of previous studies that reported a lower incidence of anesthesia awareness with BIS monitoring, and the use of the BIS protocol was not associated with reduced administration of volatile anesthetic gases. Anesthesia awareness occurred even when BIS values and ETAG concentrations were within the target ranges. Our findings do not support routine BIS monitoring as part of standard practice. (ClinicalTrials.gov number, NCT00281489.).	[Avidan, Michael S.; Zhang, Lini; Burnside, Beth A.; Finkel, Kevin J.; Searleman, Adam C.; Selvidge, Jacqueline A.; Saager, Leif; Turner, Michelle S.; Rao, Srikar; Bottros, Michael; Hantler, Charles; Jacobsohn, Eric; Evers, Alex S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Avidan, MS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, 660 S Euclid Ave,Campus Box 8054, St Louis, MO 63110 USA.	avidanm@wustl.edu	Saager, Leif/AHB-6208-2022	Saager, Leif/0000-0003-3416-4727; Avidan, Michael/0000-0001-6248-044X; Evers, Alex/0000-0002-0342-0575; Kaiser, Heiko/0000-0002-6082-9510; Searleman, Adam/0000-0003-1084-2415				[Anonymous], 2006, ANESTHESIOLOGY, V104, P847; *ASP MED SYST, CORP BACKGR; *ASP MED SYST, BIS RANG CLIN STAT; BRICE DD, 1970, BRIT J ANAESTH, V42, P535, DOI 10.1093/bja/42.6.535; Eger EI, 2001, ANESTH ANALG, V93, P947, DOI 10.1097/00000539-200110000-00029; Ekman A, 2004, ACTA ANAESTH SCAND, V48, P20, DOI 10.1111/j.1399-6576.2004.00260.x; Ghoneim MM, 2000, ANESTHESIOLOGY, V92, P597, DOI 10.1097/00000542-200002000-00043; GONSOWSKI CT, 1995, ANESTH ANALG, V80, P568, DOI 10.1097/00000539-199503000-00024; Lennmarken C, 2002, ACTA ANAESTH SCAND, V46, P229, DOI 10.1034/j.1399-6576.2002.t01-1-460301.x; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Morimoto Y, 2004, ANESTH ANALG, V98, P1336, DOI 10.1213/01.ANE.0000105867.17108.B6; Myles PS, 2004, LANCET, V363, P1757, DOI 10.1016/S0140-6736(04)16300-9; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; NUSSMEIER NA, 1988, ANESTH ANALG, V67, P982; PHILLIPS AA, 1993, CAN J ANAESTH, V40, P922, DOI 10.1007/BF03010093; Pollard RJ, 2007, ANESTHESIOLOGY, V106, P269, DOI 10.1097/00000542-200702000-00014; PUNJASAWADWONG Y, 2007, COCHRANE DATABASE SY, V4; Ranta S, 1996, ACTA ANAESTH SCAND, V40, P554, DOI 10.1111/j.1399-6576.1996.tb04487.x; Recart A, 2003, ANESTH ANALG, V97, P1667, DOI 10.1213/01.ANE.0000087041.63034.8C; Sandin RH, 2000, LANCET, V355, P707, DOI 10.1016/S0140-6736(99)11010-9; Sebel PS, 2004, ANESTH ANALG, V99, P833, DOI 10.1213/01.ANE.0000130261.90896.6C; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; The Joint Commission, 2004, SENT EV AL PREV MAN; WALDER B, 1993, J CLIN MONITOR, V9, P364, DOI 10.1007/BF01618679	24	512	550	5	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1097	1108		10.1056/NEJMoa0707361	http://dx.doi.org/10.1056/NEJMoa0707361			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337600				2022-12-28	WOS:000253877200003
J	Frolov, VA; Zimmerberg, J				Frolov, Vadim A.; Zimmerberg, Joshua			Flexible scaffolding made of rigid BARs	CELL			English	Editorial Material							MEMBRANE CURVATURE; DOMAIN; MECHANISMS; PROTEINS	Crescent-shaped BAR domains are generic actors in the creation of membrane curvature. In this issue, Frost et al. (2008) reveal how collective twisting of rigid F-BAR domains on a soft membrane surface may lead to different membrane curvatures.	[Frolov, Vadim A.; Zimmerberg, Joshua] NICHHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Zimmerberg, J (corresponding author), NICHHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA.	joshz@mail.nih.gov	Frolov, Vadim/ABH-3889-2020	Frolov, Vadim/0000-0002-0653-5669	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415, ZIAHD001409] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001415, Z01HD001409] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; HNYROVA AV, 2007, J CELL BIOL, V179, P627; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	10	5	5	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					727	729		10.1016/j.cell.2008.02.025	http://dx.doi.org/10.1016/j.cell.2008.02.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329357	Bronze			2022-12-28	WOS:000253818000008
J	Wickens, M; Kwak, JE				Wickens, Marvin; Kwak, Jae Eun			Molecular biology - A tail tale for U	SCIENCE			English	Editorial Material							MESSENGER-RNA; POLYMERASES		[Wickens, Marvin; Kwak, Jae Eun] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Wickens, M (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	wickens@biochem.wisc.edu						Aphasizhev R, 2005, CELL MOL LIFE SCI, V62, P2194, DOI 10.1007/s00018-005-5198-9; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; LUND E, 1992, SCIENCE, V255, P327, DOI 10.1126/science.1549778; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Song MG, 2007, RNA, V13, P2356, DOI 10.1261/rna.765807; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Trippe R, 2006, RNA, V12, P1494, DOI 10.1261/rna.87706	13	20	21	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1344	1345		10.1126/science.1154946	http://dx.doi.org/10.1126/science.1154946			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323438				2022-12-28	WOS:000253712900027
J	Raina, P; Santaguida, P; Ismaila, A; Patterson, C; Cowan, D; Levine, M; Booker, L; Oremus, M				Raina, Parminder; Santaguida, Pasqualina; Ismaila, Afisi; Patterson, Christopher; Cowan, David; Levine, Mitchell; Booker, Lynda; Oremus, Mark			Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline	ANNALS OF INTERNAL MEDICINE			English	Review							PLACEBO-CONTROLLED TRIAL; MODERATE ALZHEIMERS-DISEASE; QUALITY STANDARDS SUBCOMMITTEE; ESTROGEN REPLACEMENT THERAPY; PROBABLE VASCULAR DEMENTIA; MILD COGNITIVE IMPAIRMENT; CEREBRAL BLOOD-FLOW; LONG-TERM EFFICACY; MINI-MENTAL-STATE; HIGH-DOSE TACRINE	Background: The effectiveness of the 5 U. S. Food and Drug Administration-approved pharmacologic therapies for dementias in achieving clinically relevant improvements is unclear. Purpose: To review the evidence for the effectiveness of cholinesterase inhibitors ( donepezil, galantamine, rivastigmine, and tacrine) and the neuropeptide-modifying agent memantine in achieving clinically relevant improvements, primarily in cognition, global function, behavior, and quality of life, for patients with dementia. Data Sources: Cochrane Central Register of Controlled Trials, MEDLINE, PREMEDLINE, EMBASE, Allied and Complementary Medicine Database, CINAHL, AgeLine, and PsycINFO from January 1986 through November 2006. Study Selection: English-language randomized, controlled trials were included in the review if they evaluated pharmacologic agents for adults with a diagnosis of dementia, did not use a crossover design, and had a quality score of at least 3 on the Jadad scale. Data Extraction: Data were extracted on study characteristics and outcomes, including adverse events. Effect sizes were calculated and data were combined when appropriate. Data Synthesis: 96 publications representing 59 unique studies were eligible for this review. Both cholinesterase inhibitors and memantine had consistent effects in the domains of cognition and global assessment, but summary estimates showed small effect sizes. Outcomes in the domains of behavior and quality of life were evaluated less frequently and showed less consistent effects. Most studies were of short duration ( 6 months), which limited their ability to detect delay in onset or progression of dementia. Three studies directly compared different cholinesterase inhibitors and found no differences in cognition and behavior. Limitations: Limitations of available studies included short duration, inclusion of only patients with mild to moderate Alzheimer disease, poor reporting of adverse events, lack of clear definitions for statistical significance, limited evaluation of behavior and quality-of-life outcomes, and limited direct comparison of different treatments. Conclusions: Treatment of dementia with cholinesterase inhibitors and memantine can result in statistically significant but clinically marginal improvement in measures of cognition and global assessment of dementia.	[Raina, Parminder; Santaguida, Pasqualina; Ismaila, Afisi; Patterson, Christopher; Cowan, David; Levine, Mitchell; Booker, Lynda; Oremus, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, McMaster Univ Evidence Based Pract Ctr, Hamilton, ON L8S 4L8, Canada	McMaster University	Raina, P (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, McMaster Univ Evidence Based Pract Ctr, 1280 Main St W,DTC Room 306, Hamilton, ON L8S 4L8, Canada.	praina@mcmaster.ca			PHS HHS [290-02-0020] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Agid Y, 1998, CURR THER RES CLIN E, V59, P837, DOI 10.1016/S0011-393X(98)85048-0; American Psychiatric Association, 1994, DIAGN CRIT DSM 4; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; Ancoli-Israel S, 2005, ALZ DIS ASSOC DIS, V19, P240, DOI 10.1097/01.wad.0000189052.48688.36; Ballard C, 2005, BMJ-BRIT MED J, V330, P874, DOI 10.1136/bmj.38369.459988.8F; Bentham P, 2004, LANCET, V363, P2105; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Birks JS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001191.pub3; Black S, 2003, STROKE, V34, P2323, DOI 10.1161/01.STR.0000091396.95360.E1; Brodaty H, 2005, DEMENT GERIATR COGN, V20, P120, DOI 10.1159/000086613; Bullock R, 2006, CURR MED RES OPIN, V22, P483, DOI 10.1185/030079906X89685; Bullock R, 2005, CURR MED RES OPIN, V21, P1317, DOI 10.1185/030079905X56565; Bullock R, 2004, DEMENT GERIATR COGN, V17, P29, DOI 10.1159/000074140; Burns A, 1999, DEMENT GERIATR COGN, V10, P237, DOI 10.1159/000017126; Caro JJ, 2003, DIS MANAG HEALTH OUT, V11, P617, DOI 10.2165/00115677-200311100-00002; CIECHANOVER M, 1980, NEPHRON, V26, P20, DOI 10.1159/000181944; COREYBLOOM J, 1998, INT J GERIATR PSYCHO, V1, P55; Cummings JL, 2006, NEUROLOGY, V67, P57, DOI 10.1212/01.wnl.0000223333.42368.f1; Cummings JL, 2004, AM J PSYCHIAT, V161, P532, DOI 10.1176/appi.ajp.161.3.532; DAVIS KL, 1995, DRUG DEVELOP RES, V34, P55, DOI 10.1002/ddr.430340109; DAVIS KL, 1992, NEW ENGL J MED, V327, P1253, DOI 10.1056/NEJM199210293271801; Del Ser T, 2000, INT J GERIATR PSYCH, V15, P1034, DOI 10.1002/1099-1166(200011)15:11<1034::AID-GPS231>3.0.CO;2-5; Doody RS, 2001, ARCH NEUROL-CHICAGO, V58, P427, DOI 10.1001/archneur.58.3.427; Doraiswamy PM, 2002, PROG NEURO-PSYCHOPH, V26, P705, DOI 10.1016/S0278-5846(01)00326-8; Doraiswamy PM, 2001, ALZ DIS ASSOC DIS, V15, P174, DOI 10.1097/00002093-200110000-00003; dos Santos Moraes WA, 2006, SLEEP, V29, P199, DOI 10.1093/sleep/29.2.199; Dujardin K, 2006, J NEUROL, V253, P1154, DOI 10.1007/s00415-006-0175-2; Dunbar F, 2006, CLIN THER, V28, P365, DOI 10.1016/j.clinthera.2006.03.002; Emre M, 2004, NEW ENGL J MED, V351, P2509, DOI 10.1056/NEJMoa041470; Erkinjuntti T, 2002, LANCET, V359, P1283, DOI 10.1016/S0140-6736(02)08267-3; *EUR MED EV AG, NOT GUID MED PROD TR; FARLOW M, 1992, JAMA-J AM MED ASSOC, V268, P2523, DOI 10.1001/jama.268.18.2523; Farlow M, 2000, EUR NEUROL, V44, P236, DOI 10.1159/000008243; Farlow MR, 1998, NEUROLOGY, V50, P669, DOI 10.1212/WNL.50.3.669; Farlow MR, 2001, ARCH NEUROL-CHICAGO, V58, P417, DOI 10.1001/archneur.58.3.417; Farlow MR, 1996, ANN NY ACAD SCI, V802, P101, DOI 10.1111/j.1749-6632.1996.tb32603.x; Feldman H, 2001, NEUROLOGY, V57, P613, DOI 10.1212/WNL.57.4.613; Feldman H, 2003, J AM GERIATR SOC, V51, P737, DOI 10.1046/j.1365-2389.2003.51260.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forette F, 1999, EUR J NEUROL, V6, P423, DOI 10.1046/j.1468-1331.1999.640423.x; FORETTE F, 1995, EUR J NEUROL, V2, P229, DOI 10.1111/j.1468-1331.1995.tb00124.x; Fuschillo C, 2001, ARCH GERONTOL GERIAT, P151; Galasko D, 2004, J AM GERIATR SOC, V52, P1070, DOI 10.1111/j.1532-5415.2004.52303.x; Gauthier S, 2002, CURR MED RES OPIN, V18, P347, DOI 10.1185/030079902125001029; Gauthier S, 2002, INT PSYCHOGERIATR, V14, P389, DOI 10.1017/S104161020200858X; GOAD DL, 1991, J CLIN PSYCHIAT, V52, P342; Gracon SI, 1996, ACTA NEUROL SCAND, V93, P114; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Graham JE, 1996, NEUROEPIDEMIOLOGY, V15, P246, DOI 10.1159/000109914; Gutzmann H, 2002, PHARMACOPSYCHIATRY, V35, P12, DOI 10.1055/s-2002-19833; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Henke CJ, 1997, CLIN THER, V19, P330, DOI 10.1016/S0149-2918(97)80121-X; Holmes C, 2004, NEUROLOGY, V63, P214, DOI 10.1212/01.WNL.0000129990.32253.7B; Homma A, 2000, DEMENT GERIATR COGN, V11, P299, DOI 10.1159/000017259; *INT CLASS DIS, 1989, CLIN MOD; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Karaman Y, 2005, DEMENT GERIATR COGN, V19, P51, DOI 10.1159/000080972; Kemp PM, 2003, J NEUROL NEUROSUR PS, V74, P1567, DOI 10.1136/jnnp.74.11.1567; Kim JM, 2002, INT PSYCHOGERIATR, V14, P187, DOI 10.1017/S1041610202008384; KKONTZ J, 2005, AM J ALZHEIMERS DIS, V20, P295; KNAPP MJ, 1994, JAMA-J AM MED ASSOC, V271, P985, DOI 10.1001/jama.271.13.985; KNAPP MJ, 1994, ALZ DIS ASSOC DIS, V8, pS22; Knopman D, 1996, NEUROLOGY, V47, P166, DOI 10.1212/WNL.47.1.166; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Krishnan KRR, 2003, AM J PSYCHIAT, V160, P2003, DOI 10.1176/appi.ajp.160.11.2003; Kumar V, 2000, EUR J NEUROL, V7, P159, DOI 10.1046/j.1468-1331.2000.00046.x; Lanctot KL, 2003, CAN MED ASSOC J, V169, P557; Leroi I, 2004, INT J GERIATR PSYCH, V19, P1, DOI 10.1002/gps.993; Malouf R, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004395.pub2, DOI 10.1002/14651858.CD004395.PUB2]; MALTBY N, 1994, BMJ-BRIT MED J, V308, P879, DOI 10.1136/bmj.308.6933.879; Markowitz JS, 2003, SLEEP, V26, P602, DOI 10.1093/sleep/26.5.602; Mazza M, 2006, EUR J NEUROL, V13, P981, DOI 10.1111/j.1468-1331.2006.01409.x; Mc Shane R, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003154.pub4; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mobius HJ, 2003, INT PSYCHOGERIATR, V15, P207, DOI 10.1017/S1041610203009219; Mohs RC, 2001, NEUROLOGY, V57, P481, DOI 10.1212/WNL.57.3.481; Moretti Rita, 2002, Am J Alzheimers Dis Other Demen, V17, P338, DOI 10.1177/153331750201700607; Nakano S, 2001, J NUCL MED, V42, P1441; Neumann PJ, 1999, NEUROLOGY, V52, P1138, DOI 10.1212/WNL.52.6.1138; OLIN JT, 1995, INT J GERIATR PSYCH, V10, P753, DOI 10.1002/gps.930100905; Onofrj M, 2002, CLIN NEUROPHARMACOL, V25, P207, DOI 10.1097/00002826-200207000-00004; Orgogozo JM, 2004, CURR MED RES OPIN, V20, P1815, DOI 10.1185/030079904X12555; Orgogozo JM, 2002, STROKE, V33, P1834, DOI 10.1161/01.STR.0000020094.08790.49; Passmore AP, 2005, J NEUROL SCI, V229, P141, DOI 10.1016/j.jns.2004.11.017; PERRAS C, 2005, CHOLINESTERASE INHIB; Peskind ER, 2006, AM J GERIAT PSYCHIAT, V14, P704, DOI 10.1097/01.JGP.0000224350.82719.83; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Potkin SG, 2001, INT J NEUROPSYCHOPH, V4, P223, DOI 10.1017/S1461145701002528; Prasher VP, 2002, INT J GERIATR PSYCH, V17, P270, DOI 10.1002/gps.587; Pratt RD, 2002, ANN NY ACAD SCI, V977, P513, DOI 10.1111/j.1749-6632.2002.tb04859.x; Prentice N, 1996, J PSYCHOPHARMACOL, V10, P175, DOI 10.1177/026988119601000301; Raskind MA, 1997, ARCH NEUROL-CHICAGO, V54, P836, DOI 10.1001/archneur.1997.00550190026010; Raskind MA, 2000, NEUROLOGY, V54, P2261, DOI 10.1212/WNL.54.12.2261; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Rockwood K, 2001, J NEUROL NEUROSUR PS, V71, P589, DOI 10.1136/jnnp.71.5.589; Rogers SL, 2000, EUR NEUROPSYCHOPHARM, V10, P195, DOI 10.1016/S0924-977X(00)00067-5; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; Rogers SL, 1998, EUR NEUROPSYCHOPHARM, V8, P67, DOI 10.1016/S0924-977X(97)00079-5; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Rosler M, 1999, BMJ-BRIT MED J, V318, P633, DOI 10.1136/bmj.318.7184.633; Rosler M, 2001, BRIT MED J, V322, P1456; Rosler M, 1998, BEHAV NEUROL, V11, P211; Rossom Rebecca, 2004, Am J Geriatr Pharmacother, V2, P303, DOI 10.1016/j.amjopharm.2004.12.006; Salloway S, 2004, NEUROLOGY, V63, P651, DOI 10.1212/01.WNL.0000134664.80320.92; SANTAGUIDA PL, 2004, 97 AG HLTH RES QUAL; Saxton J, 2005, AM J GERIAT PSYCHIAT, V13, P999, DOI 10.1176/appi.ajgp.13.11.999; Schneider L, 2004, COCHRANE DB SYST REV; Schneider LS, 1997, ANN NY ACAD SCI, V826, P317, DOI 10.1111/j.1749-6632.1997.tb48482.x; Schneider LS, 1997, ALZ DIS ASSOC DIS, V11, pS22; Schneider LS, 1996, NEUROLOGY, V46, P1580, DOI 10.1212/WNL.46.6.1580; Seltzer B, 2004, ARCH NEUROL-CHICAGO, V61, P1852, DOI 10.1001/archneur.61.12.1852; Smith F, 1996, J Biopharm Stat, V6, P59, DOI 10.1080/10543409608835122; Smith F, 1996, J Biopharm Stat, V6, P395, DOI 10.1080/10543409608835152; Solfrizzi V, 2004, NEUROLOGY, V63, P1882, DOI 10.1212/01.WNL.0000144281.38555.E3; Sparano N, 1998, J FAM PRACTICE, V46, P356; Steele LS, 1999, CAN FAM PHYSICIAN, V45, P917; Tariot PN, 2000, NEUROLOGY, V54, P2269, DOI 10.1212/WNL.54.12.2269; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Tariot PN, 2001, J AM GERIATR SOC, V49, P1590, DOI 10.1046/j.1532-5415.2001.t01-1-49266.x; TEKIN S, 2006, PROGR NEUROTHERAPEUT, V1, P13; Thomas A, 2001, CLIN NEUROPHARMACOL, V24, P31, DOI 10.1097/00002826-200101000-00007; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Trinh NH, 2003, JAMA-J AM MED ASSOC, V289, P210, DOI 10.1001/jama.289.2.210; Tune L, 2003, AM J GERIAT PSYCHIAT, V11, P169, DOI 10.1176/appi.ajgp.11.2.169; van Dyck CH, 2006, AM J GERIAT PSYCHIAT, V14, P428, DOI 10.1097/01.JGP.0000203151.17311.38; WEINSTEIN HC, 1991, J NEUROL, V238, P34, DOI 10.1007/BF00319708; Wesnes KA, 2005, NEUROLOGY, V65, P1654, DOI 10.1212/01.wnl.0000184517.69816.e9; Whitehead A, 2004, INT J GERIATR PSYCH, V19, P624, DOI 10.1002/gps.1133; *WHO, 1992, ICD10 WHO; Wilcock G, 2003, DRUG AGING, V20, P777, DOI 10.2165/00002512-200320100-00006; Wilcock G, 2002, INT CLIN PSYCHOPHARM, V17, P297, DOI 10.1097/00004850-200211000-00005; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445; Wilkinson D, 2003, NEUROLOGY, V61, P479, DOI 10.1212/01.WNL.0000078943.50032.FC; Wilkinson D, 2001, INT J GERIATR PSYCH, V16, P852, DOI 10.1002/gps.409; Wilkinson DG, 2002, INT J CLIN PRACT, V56, P441; Wilkinson DG, 2002, INT J CLIN PRACT, V56, P509; Wilkinson DG, 2005, INT J GERIATR PSYCH, V20, P489, DOI 10.1002/gps.1301; Willan AR, 2006, PHARMACOECONOMICS, V24, P93, DOI 10.2165/00019053-200624010-00008; Wimo A, 2003, DEMENT GERIATR COGN, V15, P44, DOI 10.1159/000066669; Wimo A, 2003, PHARMACOECONOMICS, V21, P327, DOI 10.2165/00019053-200321050-00004; Winblad B, 2001, NEUROLOGY, V57, P489, DOI 10.1212/WNL.57.3.489; Winblad B, 2006, DEMENT GERIATR COGN, V21, P353, DOI 10.1159/000091790; Winblad B, 1999, INT J GERIATR PSYCH, V14, P135, DOI 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0; Winblad B, 2006, LANCET, V367, P1057, DOI 10.1016/S0140-6736(06)68350-5; Wong WJ, 1999, DEMENT GERIATR COGN, V10, P289, DOI 10.1159/000017134; WOOD PC, 1994, INT J GERIATR PSYCH, V9, P649, DOI 10.1002/gps.930090809	152	537	552	0	81	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2008	148	5					379	W85		10.7326/0003-4819-148-5-200803040-00009	http://dx.doi.org/10.7326/0003-4819-148-5-200803040-00009			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268SX	18316756				2022-12-28	WOS:000253600800007
J	Langer, A; Villar, J; Tell, K; Kim, T; Kennedy, S				Langer, Ana; Villar, Jose; Tell, Katie; Kim, Theresa; Kennedy, Stephen			Reducing eclampsia-related deaths - a call to action	LANCET			English	Editorial Material							HYPERTENSIVE DISORDERS; MAGNESIUM-SULFATE; PREECLAMPSIA; PREGNANCY; TRIAL; WOMEN		[Langer, Ana; Tell, Katie; Kim, Theresa] EngenderHlth, New York, NY 10001 USA; [Villar, Jose; Kennedy, Stephen] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	University of Oxford	Langer, A (corresponding author), EngenderHlth, New York, NY 10001 USA.	alanger@engenderhealth.org	Kennedy, Stephen/B-8950-2009					DULEY L, 1995, LANCET, V345, P1455; Duley L, 2003, BRIT MED BULL, V67, P161, DOI 10.1093/bmb/ldg005; DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; MAHLER H, 1987, LANCET, V1, P668; Sevene E, 2005, BMJ-BRIT MED J, V331, P765, DOI 10.1136/bmj.331.7519.765; WHO, 1994, MOTH BAB PACK IMPL S; 2007, LANCET, V370, P1283	9	30	32	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 1	2008	371	9614					705	706		10.1016/S0140-6736(08)60321-9	http://dx.doi.org/10.1016/S0140-6736(08)60321-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313488				2022-12-28	WOS:000253596700008
J	Takeda, S; Gapper, C; Kaya, H; Bell, E; Kuchitsu, K; Dolan, L				Takeda, Seiji; Gapper, Catherine; Kaya, Hidetaka; Bell, Elizabeth; Kuchitsu, Kazuyuki; Dolan, Liam			Local positive feedback regulation determines cell shape in root hair cells	SCIENCE			English	Article							NADPH OXIDASE; TIP GROWTH; INHIBITOR; PROTEIN	The specification and maintenance of growth sites are tightly regulated during cell morphogenesis in all organisms. ROOT HAIR DEFECTIVE 2 reduced nicotinamide adenine dinucleotide phosphate ( RHD2 NADPH) oxidase - derived reactive oxygen species ( ROS) stimulate a Ca2+ influx into the cytoplasm that is required for root hair growth in Arabidopsis thaliana. We found that Ca2+, in turn, activated the RHD2 NADPH oxidase to produce ROS at the growing point in the root hair. Together, these components could establish a means of positive feedback regulation that maintains an active growth site in expanding root hair cells. Because the location and stability of growth sites predict the ultimate form of a plant cell, our findings demonstrate how a positive feedback mechanism involving RHD2, ROS, and Ca2+ can determine cell shape.	[Takeda, Seiji; Gapper, Catherine; Bell, Elizabeth; Dolan, Liam] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Kaya, Hidetaka; Kuchitsu, Kazuyuki] Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba 2788510, Japan; [Kaya, Hidetaka; Kuchitsu, Kazuyuki] Tokyo Univ Sci, Dept Appl Biol Sci, Chiba 2788510, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Tokyo University of Science; Tokyo University of Science	Dolan, L (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk	Kuchitsu, Kazuyuki/G-3024-2013	Kuchitsu, Kazuyuki/0000-0001-8854-0375; Dolan, Liam/0000-0003-1206-7096; Kaya, Hidetaka/0000-0003-4711-8236; Takeda, Seiji/0000-0003-0183-7390	Natural Environment Research Council [NE/C510732/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/B/04498] Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Bibikova TN, 1999, PLANT J, V17, P657, DOI 10.1046/j.1365-313X.1999.00415.x; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Lee SH, 2006, PLANT CELL, V18, P1604, DOI 10.1105/tpc.105.035972; LIU CM, 1978, J BIOL CHEM, V253, P5892; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Ringli C, 2002, PLANT PHYSIOL, V129, P1464, DOI 10.1104/pp.005777; Samaj J, 2006, TRENDS PLANT SCI, V11, P594, DOI 10.1016/j.tplants.2006.10.002; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Webb M, 2002, DEVELOPMENT, V129, P123; Wymer CL, 1997, PLANT J, V12, P427, DOI 10.1046/j.1365-313X.1997.12020427.x; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449	22	374	393	7	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1241	1244		10.1126/science.1152505	http://dx.doi.org/10.1126/science.1152505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309082				2022-12-28	WOS:000253530600043
J	Jiang, W; Baker, ML; Jakana, J; Weigele, PR; King, J; Chiu, W				Jiang, Wen; Baker, Matthew L.; Jakana, Joanita; Weigele, Peter R.; King, Jonathan; Chiu, Wah			Backbone structure of the infectious epsilon 15 virus capsid revealed by electron cryomicroscopy	NATURE			English	Article							DENSITY MAPS; PROTEIN; VIRUSES; BACTERIOPHAGES; MICROSCOPY; PARTICLES; ALGORITHM; EVOLUTION; TOPOLOGY; BINDING	A half- century after the determination of the first three-dimensional crystal structure of a protein(1), more than 40,000 structures ranging from single polypeptides to large assemblies have been reported(2). The challenge for crystallographers, however, remains the growing of a diffracting crystal. Here we report the 4.5- angstrom resolution structure of a 22-MDa macromolecular assembly, the capsid of the infectious epsilon15 ( epsilon 15) particle, by single-particle electron cryomicroscopy. From this density map we constructed a complete backbone trace of its major capsid protein, gene product 7 ( gp7). The structure reveals a similar protein architecture to that of other tailed double- stranded DNA viruses, even in the absence of detectable sequence similarity(3,4). However, the connectivity of the secondary structure elements ( topology) in gp7 is unique. Protruding densities are observed around the two- fold axes that cannot be accounted for by gp7. A subsequent proteomic analysis of the whole virus identifies these densities as gp10, a 12- kDa protein. Its structure, location and high binding affinity to the capsid indicate that the gp10 dimer functions as a molecular staple between neighbouring capsomeres to ensure the particle's stability. Beyond epsilon 15, this method potentially offers a new approach for modelling the backbone conformations of the protein subunits in other macromolecular assemblies at near- native solution states.	[Baker, Matthew L.; Jakana, Joanita; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA; [Jiang, Wen] Purdue Univ, Markey Ctr Struct Biol, Dept Biol Sci, W Lafayette, IN 47907 USA; [Weigele, Peter R.; King, Jonathan] MIT, Dept Biol, Cambridge, MA 02139 USA	Baylor College of Medicine; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Massachusetts Institute of Technology (MIT)	Chiu, W (corresponding author), Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA.	jiang12@purdue.edu; wah@bcm.edu	Weigele, Peter/AIE-8230-2022; jiang, wen/GYI-9662-2022	Weigele, Peter/0000-0003-3696-4541; Jiang, Wen/0000-0002-1292-2411				Agrawal V, 2001, BMC Struct Biol, V1, P5, DOI 10.1186/1472-6807-1-5; Baker ML, 2007, STRUCTURE, V15, P7, DOI 10.1016/j.str.2006.11.008; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Bamford DH, 2005, CURR OPIN STRUC BIOL, V15, P655, DOI 10.1016/j.sbi.2005.10.012; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chen Dong-hua, 2007, Journal of Chinese Electron Microscopy Society, V26, P473; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUJIYOSHI Y, 1991, ULTRAMICROSCOPY, V38, P241, DOI 10.1016/0304-3991(91)90159-4; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; HARAUZ G, 1986, OPTIK, V73, P146; Hendrix RW, 1998, ADV VIRUS RES, V50, P235, DOI 10.1016/S0065-3527(08)60810-6; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Iwasaki K, 2000, VIROLOGY, V271, P321, DOI 10.1006/viro.2000.0321; Jewett AI, 2003, BIOINFORMATICS, V19, P625, DOI 10.1093/bioinformatics/btg035; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; King J, 1996, FASEB J, V10, P57, DOI 10.1096/fasebj.10.1.8566549; Kivioja T, 2000, J STRUCT BIOL, V131, P126, DOI 10.1006/jsbi.2000.4279; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; PREVELIGE PE, 1993, PROG MED VIROL, V40, P206; Saad A, 2001, J STRUCT BIOL, V133, P32, DOI 10.1006/jsbi.2001.4330; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Tang L, 2006, STRUCTURE, V14, P837, DOI 10.1016/j.str.2006.03.010; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yang F, 2000, NAT STRUCT BIOL, V7, P230; Yuan X, 2005, BIOINFORMATICS, V21, P1010, DOI 10.1093/bioinformatics/bti128	35	172	180	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1130	U12		10.1038/nature06665	http://dx.doi.org/10.1038/nature06665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305544				2022-12-28	WOS:000253453600047
J	Service, RF				Service, Robert F.			Structural biology - Protein structure initiative: Phase 3 or phase out	SCIENCE			English	News Item								The production-line approach to finding protein structures is rapidly filling up databases. The determination of structures of various proteins has come a long way, from structuring of the protein GroEL to the various proteins discovered so far. The cost involved in determining the X-ray crystal structures has also increases simultaneously. Protein Structure Initiative (PSI), a big- science project funded by the U. S. National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH) in Bethesda, Maryland. PSI is involved in protein structure determination.											0	13	14	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1610	1613		10.1126/science.319.5870.1610	http://dx.doi.org/10.1126/science.319.5870.1610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356502				2022-12-28	WOS:000254172300011
J	Dalrymple, J; Bullock, I				Dalrymple, J.; Bullock, I.			Guidelines - Diagnosis and management of irritable bowel syndrome in adults in primary care: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dalrymple, J.] Drayton & St Faiths Med Practice, Norwich NR8 6EE, Norfolk, England; [Bullock, I.] Royal Coll Nursing, Oxford, England		Dalrymple, J (corresponding author), Drayton & St Faiths Med Practice, Norwich NR8 6EE, Norfolk, England.	james.dalrymple3@btinternet.com						Agrawal A, 2006, BMJ-BRIT MED J, V332, P280, DOI 10.1136/bmj.332.7536.280; HEATON KW, 1992, GUT, V33, P818, DOI 10.1136/gut.33.6.818; Morgan T, 2002, POSTGRAD MED, V112, P30, DOI 10.3810/pgm.2002.11.1343; National Institute for Health and Clinical Excellence, 2008, IRR BOW SYNDR AD DIA; NHS Scotland, 2021, SCOTT REF GUID SUSP	5	65	66	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 8	2008	336	7643					556	558		10.1136/bmj.39484.712616.AD	http://dx.doi.org/10.1136/bmj.39484.712616.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JV	18325967	Green Published			2022-12-28	WOS:000253998500033
